PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Bennett, RP; Presnyak, V; Wedekind, JE; Smith, HC				Bennett, Ryan P.; Presnyak, Vladimir; Wedekind, Joseph E.; Smith, Harold C.			Nuclear exclusion of the HIV-1 host defense factor APOBEC3G requires a novel cytoplasmic retention signal and is not dependent on RNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B MESSENGER-RNA; INDUCED CYTIDINE DEAMINASE; CLASS SWITCH RECOMBINATION; VIRUS-LIKE PARTICLES; EDITING ENZYME; SOMATIC HYPERMUTATION; LINE-1 RETROTRANSPOSITION; REVERSE TRANSCRIPTION; CATALYTIC SUBUNIT; STRESS GRANULES	Human APOBEC3G ( hA3G) is a host factor that defends against HIV-1 as well as other exogenous retroviruses and endogenous retroelements. To this end, hA3G is restricted to the cytoplasm of T lymphocytes where it interacts with viral RNA and proteins to assemble with viral particles causing a post-entry block during reverse transcription. hA3G also exhibits a mechanism to inhibit the reverse transcription of retroelements by RNA binding and sequestration into mRNA processing centers in the cytoplasm. We have determined that the molecular basis for this specialized property of hA3G is a novel cytoplasmic retention signal ( CRS) that is necessary and sufficient to restrict wild-type hA3G and chimeric constructs to the cytoplasm. The CRS resides within amino acids 113-128 and is embedded within a basic flanking sequence and does not require RNA binding to retain hA3G in the cytoplasm. Paralogs of hA3G that have nuclear or cytoplasmic distributions differ from hA3G within the region encompassing the CRS motif with respect to charge and amino acid composition. We propose that the CRS enables hA3G to interact with cytoplasmic factors, and thereby enables hA3G to serve in host cell defense by restricting an antiviral sentinel to the cytoplasm. The CRS lies in a region involved in both Gag and Vif interactions; therefore, identification of this motif has important implications for the design of therapeutics that target HIV-1 while maintaining antiviral and cellular functions.	[Bennett, Ryan P.; Presnyak, Vladimir; Wedekind, Joseph E.; Smith, Harold C.] Univ Rochester, Sch Med & Dent, Dept Biochem, Rochester, NY 14642 USA	University of Rochester	Smith, HC (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem, Rochester, NY 14642 USA.	harold.smith@rochester.edu		Presnyak, Vladimir/0000-0001-6695-7102; Smith, Harold/0000-0001-6257-6791	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI058789, T32AI049815] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI49815, T32 AI049815, AI058789] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alce TM, 2004, J BIOL CHEM, V279, P34083, DOI 10.1074/jbc.C400235200; Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Bennett RP, 2006, BIOCHEM BIOPH RES CO, V350, P214, DOI 10.1016/j.bbrc.2006.09.032; Bishop KN, 2006, J VIROL, V80, P8450, DOI 10.1128/JVI.00839-06; Bishop KN, 2004, CURR BIOL, V14, P1392, DOI 10.1016/j.cub.2004.06.057; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Burnett A, 2007, J VIROL, V81, P5000, DOI 10.1128/JVI.02237-06; Cen S, 2004, J BIOL CHEM, V279, P33177, DOI 10.1074/jbc.M402062200; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; CHEN SH, 1987, SCIENCE, V238, P363, DOI 10.1126/science.3659919; Chester A, 2003, EMBO J, V22, P3971, DOI 10.1093/emboj/cdg369; Chiu YL, 2006, P NATL ACAD SCI USA, V103, P15588, DOI 10.1073/pnas.0604524103; Chiu YL, 2005, NATURE, V435, P108, DOI 10.1038/nature03493; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Duquette ML, 2005, ONCOGENE, V24, P5791, DOI 10.1038/sj.onc.1208746; Esnault C, 2005, NATURE, V433, P430, DOI 10.1038/nature03238; Gallois-Montbrun S, 2007, J VIROL, V81, P2165, DOI 10.1128/JVI.02287-06; Gasteiger E, 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guo F, 2006, J VIROL, V80, P11710, DOI 10.1128/JVI.01038-06; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Harris RS, 2002, MOL CELL, V10, P1247, DOI 10.1016/S1097-2765(02)00742-6; HIGUCHI K, 1992, J LIPID RES, V33, P1753; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; HUANG J, 2007, J BIOL CHEM; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Khan MA, 2005, J VIROL, V79, P5870, DOI 10.1128/JVI.79.9.5870-5874.2005; Kinomoto M, 2007, NUCLEIC ACIDS RES, V35, P2955, DOI 10.1093/nar/gkm181; Kozak SL, 2006, J BIOL CHEM, V281, P29105, DOI 10.1074/jbc.M601901200; LAU PP, 1991, J BIOL CHEM, V266, P20550; Luo K, 2004, J VIROL, V78, P11841, DOI 10.1128/JVI.78.21.11841-11852.2004; MACELREVEY C, 2008, IN PRESS RNA DNA EDI; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Mangeat B, 2004, J BIOL CHEM, V279, P14481, DOI 10.1074/jbc.C400060200; Mariani R, 2003, CELL, V114, P21, DOI 10.1016/S0092-8674(03)00515-4; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Muramatsu M, 1999, J BIOL CHEM, V274, P18470, DOI 10.1074/jbc.274.26.18470; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Navarro F, 2005, VIROLOGY, V333, P374, DOI 10.1016/j.virol.2005.01.011; Newman ENC, 2005, CURR BIOL, V15, P166, DOI 10.1016/j.cub.2004.12.068; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Oppezzo P, 2003, BLOOD, V101, P4029, DOI 10.1182/blood-2002-10-3175; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; POWELL LM, 1987, CELL, V50, P831, DOI 10.1016/0092-8674(87)90510-1; Prochnow C, 2007, NATURE, V445, P447, DOI 10.1038/nature05492; Rucci F, 2006, GENE, V377, P150, DOI 10.1016/j.gene.2006.03.024; Schafer A, 2004, VIROLOGY, V328, P163, DOI 10.1016/j.virol.2004.08.006; Schrofelbauer B, 2006, J VIROL, V80, P5984, DOI 10.1128/JVI.00388-06; Schrofelbauer R, 2004, P NATL ACAD SCI USA, V101, P3927, DOI 10.1073/pnas.0307132101; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Skuse GR, 1996, NUCLEIC ACIDS RES, V24, P478, DOI 10.1093/nar/24.3.478; Smith HC, 1998, METHODS, V15, P27, DOI 10.1006/meth.1998.0603; Sowden M, 1996, J BIOL CHEM, V271, P3011, DOI 10.1074/jbc.271.6.3011; Sowden MP, 2002, J CELL SCI, V115, P1027; Stopak K, 2003, MOL CELL, V12, P591, DOI 10.1016/S1097-2765(03)00353-8; Svarovskaia ES, 2004, J BIOL CHEM, V279, P35822, DOI 10.1074/jbc.M405761200; Ta VT, 2003, NAT IMMUNOL, V4, P843, DOI 10.1038/ni964; von Wronski MA, 1998, METABOLISM, V47, P869, DOI 10.1016/S0026-0495(98)90128-7; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Wedekind JE, 2006, J BIOL CHEM, V281, P38122, DOI 10.1074/jbc.C600253200; Wichroski MJ, 2005, J BIOL CHEM, V280, P8387, DOI 10.1074/jbc.M408048200; Wichroski MJ, 2006, PLOS PATHOG, V2, pe41, DOI DOI 10.1371/journal.ppat.0020041; Yamanaka S, 1996, J BIOL CHEM, V271, P11506, DOI 10.1074/jbc.271.19.11506; YAMANAKA S, 1995, P NATL ACAD SCI USA, V92, P8483, DOI 10.1073/pnas.92.18.8483; Yamanaka S, 1997, GENE DEV, V11, P321, DOI 10.1101/gad.11.3.321; Yang Y, 1997, J BIOL CHEM, V272, P27700, DOI 10.1074/jbc.272.44.27700; Yang Y, 1997, P NATL ACAD SCI USA, V94, P13075, DOI 10.1073/pnas.94.24.13075; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Yu XH, 2003, SCIENCE, V302, P1056, DOI 10.1126/science.1089591; Zennou W, 2004, J VIROL, V78, P12058, DOI 10.1128/JVI.78.21.12058-12061.2004; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707	79	41	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7320	7327		10.1074/jbc.M708567200	http://dx.doi.org/10.1074/jbc.M708567200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18165230	hybrid			2022-12-25	WOS:000253997900005
J	McCarron, JG; Olson, ML				McCarron, John G.; Olson, Marnie L.			A single luminally continuous sarcoplasmic reticulum with apparently separate Ca2+ stores in smooth muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTALLOID ENDOPLASMIC-RETICULUM; RYANODINE RECEPTOR; INTRACELLULAR CA2+; CALCIUM-RELEASE; NUCLEAR-ENVELOPE; SEA-URCHIN; CELLS; CHANNEL; WAVES; DISTINCT	Whether or not the sarcoplasmic reticulum ( SR) is a continuous, interconnected network surrounding a single lumen or comprises multiple, separate Ca2+ pools was investigated in voltage-clamped single smooth muscle cells using local photolysis of caged compounds and Ca2+ imaging. The entire SR could be depleted or refilled from one small site via either inositol 1,4,5-trisphosphate receptors ( IP3R) or ryanodine receptors ( RyR) suggesting the SR is luminally continuous and that Ca2+ may diffuse freely throughout. Notwithstanding, regulation of the opening of RyR and IP3R, by the [ Ca2+] within the SR, may create several apparent SR elements with various receptor arrangements. IP3R and RyR may appear to exist entirely on a single store, and there may seem to be additional SR elements that express either only RyR or only IP3R. The various SR receptor arrangements and apparently separate Ca2+ storage elements exist in a single luminally continuous SR entity.	[McCarron, John G.; Olson, Marnie L.] Univ Strathclyde, Strathclyde Inst Phar & Biomed Sci, Glasgow G4 0NR, Lanark, Scotland	University of Strathclyde	McCarron, JG (corresponding author), Univ Strathclyde, Strathclyde Inst Phar & Biomed Sci, John Arbuthnott Bldg,27 Taylor St, Glasgow G4 0NR, Lanark, Scotland.	john.mccarron@strath.ac.uk			British Heart Foundation [pg/06/016] Funding Source: Medline; Wellcome Trust [078054/z/05/z] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission)		Bannai H, 2004, J CELL SCI, V117, P163, DOI 10.1242/jcs.00854; BARO I, 1995, J PHYSIOL-LONDON, V482, P247, DOI 10.1113/jphysiol.1995.sp020514; Berridge MJ, 2006, CELL CALCIUM, V40, P405, DOI 10.1016/j.ceca.2006.09.002; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Boittin FX, 1999, AM J PHYSIOL-CELL PH, V277, pC139, DOI 10.1152/ajpcell.1999.277.1.C139; BOLTON TB, 1989, J PHYSIOL-LONDON, V409, P385, DOI 10.1113/jphysiol.1989.sp017504; BOND M, 1984, J PHYSIOL-LONDON, V355, P677, DOI 10.1113/jphysiol.1984.sp015445; Bootman MD, 2006, J CELL SCI, V119, P3915, DOI 10.1242/jcs.03223; BOOTMAN MD, 1992, J PHYSIOL-LONDON, V450, P163, DOI 10.1113/jphysiol.1992.sp019121; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Boulware MJ, 2005, CURR BIOL, V15, P765, DOI 10.1016/j.cub.2005.02.065; BRINI M, 1993, EMBO J, V12, P4813, DOI 10.1002/j.1460-2075.1993.tb06170.x; Chalmers S, 2008, J CELL SCI, V121, P75, DOI 10.1242/jcs.014522; CHEEK TR, 1994, BIOCHEM J, V301, P879, DOI 10.1042/bj3010879; Choi YM, 2006, J NEUROSCI, V26, P12127, DOI 10.1523/JNEUROSCI.3158-06.2006; Dayel MJ, 1999, BIOPHYS J, V76, P2843, DOI 10.1016/S0006-3495(99)77438-2; DEVINE CE, 1972, J CELL BIOL, V52, P690, DOI 10.1083/jcb.52.3.690; Dolman NJ, 2006, CELL CALCIUM, V40, P505, DOI 10.1016/j.ceca.2006.08.012; Flynn ERM, 2001, J BIOL CHEM, V276, P36411, DOI 10.1074/jbc.M104308200; Golovina VA, 1997, SCIENCE, V275, P1643, DOI 10.1126/science.275.5306.1643; Guerrero-Hernandez A, 2002, FRONT BIOSCI-LANDMRK, V7, pD1676, DOI 10.2741/hernande; Gyorke I, 1998, BIOPHYS J, V75, P2801, DOI 10.1016/S0006-3495(98)77723-9; Hanson CJ, 2004, CURR BIOL, V14, pR933, DOI 10.1016/j.cub.2004.10.019; HENSON JH, 1989, J CELL BIOL, V109, P149, DOI 10.1083/jcb.109.1.149; HIROSE K, 1994, NATURE, V372, P791; IINO M, 1987, BIOCHEM BIOPH RES CO, V142, P47, DOI 10.1016/0006-291X(87)90449-9; IINO M, 1988, BIOCHEM BIOPH RES CO, V152, P417, DOI 10.1016/S0006-291X(88)80730-7; Jabr RI, 1997, BRIT J PHARMACOL, V122, P21, DOI 10.1038/sj.bjp.0701326; Janiak R, 2001, AM J PHYSIOL-CELL PH, V280, pC22, DOI 10.1152/ajpcell.2001.280.1.C22; Kamishima T, 1996, J PHYSIOL-LONDON, V492, P61, DOI 10.1113/jphysiol.1996.sp021289; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; KOCH GLE, 1988, J CELL SCI, V91, P511; Laver DR, 2007, BIOPHYS J, V92, P3541, DOI 10.1529/biophysj.106.099028; LEE C, 1988, CELL, V54, P37, DOI 10.1016/0092-8674(88)90177-8; MacMillan D, 2005, J PHYSIOL-LONDON, V569, P533, DOI 10.1113/jphysiol.2005.096529; McCarron JG, 2004, J BIOL CHEM, V279, P8417, DOI 10.1074/jbc.M311797200; McCarron JG, 2002, J CELL SCI, V115, P2207; McCarron JG, 1999, J PHYSIOL-LONDON, V516, P149, DOI 10.1111/j.1469-7793.1999.149aa.x; McCarron JG, 2000, J PHYSIOL-LONDON, V525, P113, DOI 10.1111/j.1469-7793.2000.00113.x; McCarron JG, 2008, J CELL SCI, V121, P86, DOI 10.1242/jcs.017541; Missiaen L, 2007, CELL CALCIUM, V41, P405, DOI 10.1016/j.ceca.2006.11.001; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; Montero M, 1997, J CELL BIOL, V139, P601, DOI 10.1083/jcb.139.3.601; MUALLEM S, 1989, J BIOL CHEM, V264, P205; Ohta T, 2002, NEUROSCI LETT, V326, P167, DOI 10.1016/S0304-3940(02)00333-6; ORCI L, 1984, CELL, V36, P835, DOI 10.1016/0092-8674(84)90033-3; PACAUD P, 1995, J PHYSIOL-LONDON, V484, P549, DOI 10.1113/jphysiol.1995.sp020685; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; PARKER I, 1990, SCIENCE, V250, P977, DOI 10.1126/science.2237441; PATHAK RK, 1986, J CELL BIOL, V102, P2158, DOI 10.1083/jcb.102.6.2158; Petersen OH, 2007, CELL CALCIUM, V42, P373, DOI 10.1016/j.ceca.2007.05.012; Pezzati R, 1997, MOL BIOL CELL, V8, P1501, DOI 10.1091/mbc.8.8.1501; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; POPESCU LM, 1974, CELL TISSUE RES, V154, P357; POPESCU LM, 1975, J CELL BIOL, V67, P911, DOI 10.1083/jcb.67.3.911; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rooney E, 1996, J BIOL CHEM, V271, P29304, DOI 10.1074/jbc.271.46.29304; Rose HJ, 2006, BIOPHYS J, V91, P4024, DOI 10.1529/biophysj.106.088872; SOMLYO AP, 1989, FASEB J, V3, P2266, DOI 10.1096/fasebj.3.11.2506092; SOMLYO AV, 1985, EXPERIENTIA, V41, P841, DOI 10.1007/BF01970000; Subramanian K, 1997, CELL, V89, P963, DOI 10.1016/S0092-8674(00)80281-0; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Tanimura A, 1996, J CELL BIOL, V132, P607, DOI 10.1083/jcb.132.4.607; Terasaki M, 1996, DEV BIOL, V179, P320, DOI 10.1006/dbio.1996.0263; TERASAKI M, 1991, J CELL BIOL, V114, P929, DOI 10.1083/jcb.114.5.929; TERASAKI M, 1994, P NATL ACAD SCI USA, V91, P7510, DOI 10.1073/pnas.91.16.7510; TRIBE RM, 1994, P NATL ACAD SCI USA, V91, P5908, DOI 10.1073/pnas.91.13.5908; Venetucci LA, 2007, CIRC RES, V100, P105, DOI 10.1161/01.RES.0000252828.17939.00; VILLA A, 1993, J CELL BIOL, V121, P1041, DOI 10.1083/jcb.121.5.1041; VOLPE P, 1992, P NATL ACAD SCI USA, V89, P6142, DOI 10.1073/pnas.89.13.6142; Wilson BS, 1998, MOL BIOL CELL, V9, P1465, DOI 10.1091/mbc.9.6.1465; Wu X, 2006, CIRC RES, V99, P283, DOI 10.1161/01.RES.0000233386.02708.72; YAMAZAWA T, 1992, FEBS LETT, V301, P181, DOI 10.1016/0014-5793(92)81243-F	73	32	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7206	7218		10.1074/jbc.M708923200	http://dx.doi.org/10.1074/jbc.M708923200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18096697	hybrid			2022-12-25	WOS:000253779600066
J	Olson, GE; Winfrey, VP; Hill, KE; Burk, RF				Olson, Gary E.; Winfrey, Virginia P.; Hill, Kristina E.; Burk, Raymond F.			Megalin mediates selenoprotein P uptake by kidney proximal tubule epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA GLUTATHIONE-PEROXIDASE; LIPOPROTEIN RECEPTOR FAMILY; ALPHA-2-MACROGLOBULIN RECEPTOR; BRAIN SELENIUM; MICE LACKING; 2 MEMBERS; ENDOCYTOSIS; BINDING; PROTEIN; GP330	Selenoprotein P (Sepp1) contains most of the selenium in blood plasma, and it is utilized by the kidney, brain, and testis as a selenium source for selenoprotein synthesis. We recently demonstrated that apolipoprotein E receptor-2 (ApoER2) is required for Sepp1 uptake by the testis and that deletion of ApoER2 reduces testis and brain, but not kidney, selenium levels. This study examined the kidney Sepp1 uptake pathway. Immunolocalization experiments demonstrated that Sepp1 passed into the glomerular filtrate and was specifically taken up by proximal tubule epithelial cells. Neither the C terminus selenocysteine-rich domain of Sepp1 nor ApoER2 was required for Sepp1 uptake by proximal tubules. Tissue ligand binding assays using cryosections of Sepp1(-/-) kidneys revealed that the proximal tubule epithelium contained Sepp1-binding sites that were blocked by the receptor-associated protein, RAP, an inhibitor of lipoprotein receptor-ligand interactions. Ligand blotting assays of kidney membrane preparations fractionated by SDS-PAGE revealed that Sepp1 binds megalin, a lipoprotein receptor localized to the proximal tubule epithelium. Immunolocalization analyses confirmed the in vivo co-localization of Sepp1 and megalin in wild type kidneys and demonstrated the absence of proximal tubule Sepp1 uptake in megalin null mice. These results demonstrate that kidney selenium homeostasis is mediated by a megalin-dependent Sepp1 uptake pathway in the proximal tubule.	[Olson, Gary E.; Winfrey, Virginia P.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Hill, Kristina E.; Burk, Raymond F.] Vanderbilt Univ, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Olson, GE (corresponding author), Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37232 USA.	gary.olson@vanderbilt.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R37ES002497, R01ES002497] Funding Source: NIH RePORTER; NICHD NIH HHS [HD044863] Funding Source: Medline; NIEHS NIH HHS [ES02497] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AVISSAR N, 1994, AM J PHYSIOL, V266, pC367, DOI 10.1152/ajpcell.1994.266.2.C367; Bajari TM, 2005, METHODS, V36, P109, DOI 10.1016/j.ymeth.2004.11.007; Beffert U, 2004, J LIPID RES, V45, P403, DOI 10.1194/jlr.R300017-JLR200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Burk RF, 2005, ANNU REV NUTR, V25, P215, DOI 10.1146/annurev.nutr.24.012003.132120; Chapon C, 2005, ANAT EMBRYOL, V209, P263, DOI 10.1007/s00429-004-0451-9; Christensen EI, 2001, AM J PHYSIOL-RENAL, V280, pF562, DOI 10.1152/ajprenal.2001.280.4.F562; Christensen EI, 2002, NAT REV MOL CELL BIO, V3, P258, DOI 10.1038/nrm778; CHRISTENSEN EI, 1995, EUR J CELL BIOL, V66, P349; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2007, J BIOL CHEM, V282, P10972, DOI 10.1074/jbc.M700436200; KASIK JW, 1995, PLACENTA, V16, P67, DOI 10.1016/0143-4004(95)90082-9; KERJASCHKI D, 1983, J EXP MED, V157, P667, DOI 10.1084/jem.157.2.667; Kim DH, 1997, J BIOL CHEM, V272, P8498, DOI 10.1074/jbc.272.13.8498; Kim DH, 1996, J BIOL CHEM, V271, P8373, DOI 10.1074/jbc.271.14.8373; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P21162; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Ma SG, 2002, J BIOL CHEM, V277, P12749, DOI 10.1074/jbc.M111462200; MASER RL, 1994, J BIOL CHEM, V269, P27066; May P, 2005, CELL MOL LIFE SCI, V62, P2325, DOI 10.1007/s00018-005-5231-z; May Petra, 2003, Sci STKE, V2003, pPE12, DOI 10.1126/stke.2003.176.pe12; MOESTRUP SK, 1993, J BIOL CHEM, V268, P16564; MOESTRUP SK, 1991, J BIOL CHEM, V266, P14011; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Nielsen R, 2007, P NATL ACAD SCI USA, V104, P5407, DOI 10.1073/pnas.0700330104; Nykjaer A, 1999, CELL, V96, P507, DOI 10.1016/S0092-8674(00)80655-8; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Orlando RA, 1997, P NATL ACAD SCI USA, V94, P2368, DOI 10.1073/pnas.94.6.2368; Renko K, 2008, BIOCHEM J, V409, P741, DOI 10.1042/BJ20071172; SAITO A, 1994, P NATL ACAD SCI USA, V91, P9725, DOI 10.1073/pnas.91.21.9725; Schneider WJ, 2003, CELL MOL LIFE SCI, V60, P892, DOI 10.1007/s00018-003-2183-z; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; TOWBIN H, 1984, J IMMUNOL METHODS, V72, P313, DOI 10.1016/0022-1759(84)90001-2; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Whitin JC, 1998, MOL GENET METAB, V65, P238, DOI 10.1006/mgme.1998.2760; Whitin JC, 2002, AM J PHYSIOL-RENAL, V283, pF20, DOI 10.1152/ajprenal.00014.2001; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; WILSON DS, 1993, J INORG BIOCHEM, V51, P707, DOI 10.1016/0162-0134(93)85003-Q; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321; Zou ZY, 2004, J BIOL CHEM, V279, P34302, DOI 10.1074/jbc.M405608200	44	126	133	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6854	6860		10.1074/jbc.M709945200	http://dx.doi.org/10.1074/jbc.M709945200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18174160	hybrid			2022-12-25	WOS:000253779600028
J	Ashe, M; de Bruin, RAM; Kalashnikova, T; McDonald, WH; Yates, JR; Wittenberg, C				Ashe, Mabelle; de Bruin, Robertus A. M.; Kalashnikova, Tatyana; McDonald, W. Hayes; Yates, John R., III; Wittenberg, Curt			The SBF- and MBF-associated protein Msa1 is required for proper timing of G(1)-specific transcription in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST-CELL-CYCLE; G1-SPECIFIC TRANSCRIPTION; BUDDING YEAST; SIZE CONTROL; G1 CYCLINS; CLN3; MECHANISMS; DIVISION; KINASE; PHOSPHORYLATION	In the budding yeast Saccharomyces cerevisiae, cell cycle initiation is prompted during G(1) phase by Cln3/cyclin-dependent protein kinase-mediated transcriptional activation of G(1)-specific genes. A recent screening performed to reveal novel inter-actors of SCB-binding factor (SBF) and MCB-binding factor (MBF) identified, in addition to the SBF-specific repressor Whi5 and the MBF-specific corepressor Nrm1, a pair of homologous proteins, Msa1 and Msa2 (encoded by YOR066w and YKR077w), as interactors of SBF and MBF, respectively. MSA1 is expressed periodically during the cell cycle with peak mRNA levels occurring at the late M/early G(1) phase and peak protein levels occurring in early G(1). Msa1 associates with SBF- and MBF-regulated target promoters consistent with a role in G(1)-specific transcriptional regulation. Msa1 affects cell cycle initiation by advancing the timing of transcription of G(1)-specific genes. Msa1 binds to SBF- and MBF-regulated promoters and binding is maximal during the G(1) phase. Binding depends upon the cognate transcription factor. Msa1 overexpression advances the timing of SBF- dependent transcription and budding, whereas depletion delays both indicators of cell cycle initiation. Similar effects on MBF-regulated transcription are observed. Based upon these results, we conclude that Msa1 acts to advance the timing of G(1)-specific transcription and cell cycle initiation.	[Ashe, Mabelle; de Bruin, Robertus A. M.; Kalashnikova, Tatyana; Wittenberg, Curt] Scripps Res Inst, Dept Mol Biol, MB 3, La Jolla, CA 92037 USA; [McDonald, W. Hayes; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wittenberg, C (corresponding author), Scripps Res Inst, Dept Mol Biol, MB 3, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	curtw@scripps.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059441, R01GM043487] Funding Source: NIH RePORTER; NCRR NIH HHS [P41 RR 11823] Funding Source: Medline; NIGMS NIH HHS [GM 043487, GM 059441] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AMON A, 1993, CELL, V74, P993, DOI 10.1016/0092-8674(93)90722-3; Boddy MN, 2001, CELL, V107, P537, DOI 10.1016/S0092-8674(01)00536-0; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Costanzo M, 2004, CELL, V117, P899, DOI 10.1016/j.cell.2004.05.024; Costanzo M, 2003, MOL CELL BIOL, V23, P5064, DOI 10.1128/MCB.23.14.5064-5077.2003; CROSS F, 1992, CIBA F SYMP, V170, P20; de Bruin RAM, 2004, CELL, V117, P887, DOI 10.1016/j.cell.2004.05.025; de Bruin RAM, 2006, MOL CELL, V23, P483, DOI 10.1016/j.molcel.2006.06.025; Di Talia S, 2007, NATURE, V448, P947, DOI 10.1038/nature06072; DIRICK L, 1995, EMBO J, V14, P4803, DOI 10.1002/j.1460-2075.1995.tb00162.x; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Flick KM, 2003, MOL BIOL CELL, V14, P3230, DOI 10.1091/mbc.E03-03-0135; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; HADWIGER JA, 1988, MOL CELL BIOL, V8, P2976, DOI 10.1128/MCB.8.7.2976; Hatakeyama M, 1995, Prog Cell Cycle Res, V1, P9; Ho W, 1999, MOL CELL BIOL, V19, P5267; Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026; Iyer VR, 2001, NATURE, V409, P533, DOI 10.1038/35054095; Johnson David G., 1998, Frontiers in Bioscience, V3, pD447; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Jorgensen P, 2002, SCIENCE, V297, P395, DOI 10.1126/science.1070850; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; LEW DJ, 1993, CELL, V72, P488, DOI 10.1016/0092-8674(93)90068-2; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; McDonald WH, 2002, DIS MARKERS, V18, P99, DOI 10.1155/2002/505397; Miller ME, 2001, MOL CELL BIOL, V21, P6292, DOI 10.1128/MCB.21.18.6292-6311.2001; Morris EJ, 2001, ADV CANCER RES, V82, P1, DOI 10.1016/S0065-230X(01)82001-7; Pan HC, 1998, MOL CELL, V2, P283, DOI 10.1016/S1097-2765(00)80273-7; Reed SI, 1997, CANCER SURV, V29, P7; Siegmund RF, 1996, MOL CELL BIOL, V16, P2647; Spellman PT, 1998, MOL BIOL CELL, V9, P3273, DOI 10.1091/mbc.9.12.3273; STUART D, 1995, GENE DEV, V9, P2780, DOI 10.1101/gad.9.22.2780; Titz B, 2006, NUCLEIC ACIDS RES, V34, P955, DOI 10.1093/nar/gkj493; TYERS M, 1993, EMBO J, V12, P1955, DOI 10.1002/j.1460-2075.1993.tb05845.x; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Wijnen H, 1999, GENETICS, V153, P1131; Wittenberg C, 2005, ONCOGENE, V24, P2746, DOI 10.1038/sj.onc.1208606; Wu WS, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-421; Yu YX, 2000, MOL CELL BIOL, V20, P2350, DOI 10.1128/MCB.20.7.2350-2357.2000	40	28	33	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6040	6049		10.1074/jbc.M708248200	http://dx.doi.org/10.1074/jbc.M708248200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18160399	hybrid			2022-12-25	WOS:000253779500009
J	Liu, Y; Vidensky, S; Ruggiero, AM; Maier, S; Sitte, HH; Rothstein, JD				Liu, Yiting; Vidensky, Svetlana; Ruggiero, Alicia M.; Maier, Susanne; Sitte, Harald H.; Rothstein, Jeffrey D.			Reticulon RTN2B regulates trafficking and function of neuronal glutamate transporter EAAC1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM; SYNAPTIC STRENGTH; GABA SYNTHESIS; CELL-SURFACE; NOGO-A; EXPRESSION; PROTEIN; NEUROTRANSMITTER; LOCALIZATION; INTERACTS	Excitatory amino acid transporters (EAATs) are the primary regulators of extracellular glutamate concentrations in the central nervous system. Their dysfunction may contribute to several neurological diseases. To date, five distinct mammalian glutamate transporters have been cloned. In brain, EAAC1 (excitatory amino acid carrier 1) is the primary neuronal glutamate transporter, localized on the perisynaptic membranes that are near release sites. Despite its potential importance in synaptic actions, little is known concerning the regulation of EAAC1 trafficking from the endoplasmic reticulum (ER) to the cell surface. Previously, we identified an EAAC1-associated protein, GTRAP3-18, an ER protein that prevents ER exit of EAAC1 when induced. Here we show that RTN2B, a member of the reticulon protein family that mainly localizes in the ER and ER exit sites interacts with EAAC1 and GTRAP3-18. EAAC1 and GTRAP3-18 bind to different regions of RTN2B. Each protein can separately and independently form complexes with EAAC1. RTN2B enhances ER exit and the cell surface composition of EAAC1 in heterologous cells. Expression of short interfering RNA-mediated knockdown of RTN2B decreases the EAAC1 protein level in neurons. Overall, our results suggest that RTN2B functions as a positive regulator in the delivery of EAAC1 from the ER to the cell surface. These studies indicate that transporter exit from the ER controlled by the interaction with its ER binding partner represents a critical regulatory step in glutamate transporter trafficking to the cell surface.	[Liu, Yiting; Vidensky, Svetlana; Ruggiero, Alicia M.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21287 USA; [Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurosci, Sch Med, Baltimore, MD 21287 USA; [Maier, Susanne; Sitte, Harald H.] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria	Johns Hopkins University; Johns Hopkins University; Medical University of Vienna	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol, Sch Med, Meyer 6-109,600 N Wolfe St, Baltimore, MD 21287 USA.	jrothstein@jhmi.edu	rothstein, jeffrey d/C-9470-2013; Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033958, R01NS052179, U01NS050094, R01NS040151] Funding Source: NIH RePORTER; Austrian Science Fund FWF [P 18706] Funding Source: Medline; NINDS NIH HHS [R01 NS052179-03, U01 NS050094-03, R01 NS040151, R01 NS033958, NS 33958, R01 NS033958-13, U01 NS050094, NS 40151, NS 52179, R01 NS052179] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Austrian Science Fund FWF(Austrian Science Fund (FWF)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aoyama K, 2006, NAT NEUROSCI, V9, P119, DOI 10.1038/nn1609; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Butchbach MER, 2003, J NEUROCHEM, V84, P891, DOI 10.1046/j.1471-4159.2003.01588.x; Coco S, 1997, EUR J NEUROSCI, V9, P1902, DOI 10.1111/j.1460-9568.1997.tb00757.x; Conti F, 1998, CEREB CORTEX, V8, P108, DOI 10.1093/cercor/8.2.108; Crino PB, 2002, EPILEPSIA, V43, P211, DOI 10.1046/j.1528-1157.2002.35001.x; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; De Craene JO, 2006, MOL BIOL CELL, V17, P3009, DOI 10.1091/mbc.e06-01-0080; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dingledine R, 1999, PHARMACOL REV, V51, P7; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Duan SM, 1999, J NEUROSCI, V19, P10193; Eskandari S, 2000, P NATL ACAD SCI USA, V97, P8641, DOI 10.1073/pnas.97.15.8641; Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200; Farhan H, 2006, HANDB EXP PHARM, V175, P233; FONNUM F, 1984, J NEUROCHEM, V42, P1, DOI 10.1111/j.1471-4159.1984.tb09689.x; Furuta A, 2003, AM J PATHOL, V163, P779, DOI 10.1016/S0002-9440(10)63705-4; Geisler JG, 1998, MAMM GENOME, V9, P274, DOI 10.1007/s003359900748; Haugeto O, 1996, J BIOL CHEM, V271, P27715, DOI 10.1074/jbc.271.44.27715; He WX, 2004, NAT MED, V10, P959, DOI 10.1038/nm1088; He Y, 2000, J COMP NEUROL, V418, P255; Horton AC, 2004, NAT CELL BIOL, V6, P585, DOI 10.1038/ncb0704-585; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Iwahashi J, 2003, Cell Mol Biol (Noisy-le-grand), V49 Online Pub, pOL467; Iwahashi J, 2002, BIOCHEM BIOPH RES CO, V293, P698, DOI 10.1016/S0006-291X(02)00282-6; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Levenson J, 2002, NAT NEUROSCI, V5, P155, DOI 10.1038/nn791; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Longhurst DM, 2006, J BIOL CHEM, V281, P12030, DOI 10.1074/jbc.M513756200; Ma D, 2002, CURR OPIN NEUROBIOL, V12, P287, DOI 10.1016/S0959-4388(02)00319-7; Mannan AU, 2006, NEUROGENETICS, V7, P93, DOI 10.1007/s10048-006-0034-4; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; Mathews GC, 2003, J NEUROSCI, V23, P2040; Oertle T, 2003, J NEUROSCI, V23, P5393; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Ozawa S, 1998, PROG NEUROBIOL, V54, P581, DOI 10.1016/S0301-0082(97)00085-3; ROCHE KW, 1995, NEUROSCIENCE, V69, P383, DOI 10.1016/0306-4522(95)00253-F; Roebroek AJM, 1998, GENOMICS, V51, P98, DOI 10.1006/geno.1997.5175; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Rumbaugh G, 2006, P NATL ACAD SCI USA, V103, P4344, DOI 10.1073/pnas.0600084103; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Seal RP, 1999, ANNU REV PHARMACOL, V39, P431, DOI 10.1146/annurev.pharmtox.39.1.431; SENDEN NHM, 1994, EUR J CELL BIOL, V65, P341; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Steiner P, 2004, J NEUROCHEM, V89, P569, DOI 10.1111/j.1471-4159.2004.02345.x; Tagami S, 2000, ONCOGENE, V19, P5736, DOI 10.1038/sj.onc.1203948; Vandenberghe W, 2004, CURR OPIN CELL BIOL, V16, P134, DOI 10.1016/j.ceb.2004.01.003; VANDEVELDE HJK, 1994, J CELL SCI, V107, P2403; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Voutsinos-Porche B, 2006, J CEREBR BLOOD F MET, V26, P1419, DOI 10.1038/sj.jcbfm.9600295; Wakana Y, 2005, BIOCHEM BIOPH RES CO, V334, P1198, DOI 10.1016/j.bbrc.2005.07.012; WIELAND FT, 1987, CELL, V50, P189; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9	55	52	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6561	6571		10.1074/jbc.M708096200	http://dx.doi.org/10.1074/jbc.M708096200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18096700	hybrid, Green Accepted			2022-12-25	WOS:000253779500062
J	Welscher, YMT; Ten Napel, HH; Balague, MM; Souza, CM; Riezman, H; De Kruijff, B; BreukinkO, E				Welscher, Yvonne M. Te; Ten Napel, Hendrik H.; Balague, Miriam Masia; Souza, Cleiton M.; Riezman, Howard; De Kruijff, Ben; BreukinkO, Eefjan			Natamycin blocks fungal growth by binding specifically to ergosterol without permeabilizing the membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBIOTIC-STEROL INTERACTIONS; POLYENE MACROLIDE ANTIBIOTICS; ACHOLEPLASMA-LAIDLAWII CELLS; AMPHOTERICIN-B; INTRACELLULAR PH; SACCHAROMYCES-CEREVISIAE; LECITHIN LIPOSOMES; CANDIDA-ALBICANS; OXIDATIVE DAMAGE; YEAST	Natamycin is a polyene antibiotic that is commonly used as an antifungal agent because of its broad spectrum of activity and the lack of development of resistance. Other polyene antibiotics, like nystatin and filipin are known to interact with sterols, with some specificity for ergosterol thereby causing leakage of essential components and cell death. The mode of action of natamycin is unknown and is investigated in this study using different in vitro and in vivo approaches. Isothermal titration calorimetry and direct binding studies revealed that natamycin binds specifically to ergosterol present in model membranes. Yeast sterol biosynthetic mutants revealed the importance of the double bonds in the B-ring of ergosterol for the natamycin-ergosterol interaction and the consecutive block of fungal growth. Surprisingly, in strong contrast to nystatin and filipin, natamycin did not change the permeability of the yeast plasma membrane under conditions that growth was blocked. Also, in ergosterol containing model membranes, natamycin did not cause a change in bilayer permeability. This demonstrates that natamycin acts via a novel mode of action and blocks fungal growth by binding specifically to ergosterol.	[Welscher, Yvonne M. Te; Ten Napel, Hendrik H.; Balague, Miriam Masia; De Kruijff, Ben; BreukinkO, Eefjan] Univ Utrecht, Biomembrane Inst, Bijvoet Ctr, Dept Membrane Biochem, NL-3584 CH Utrecht, Netherlands; [Souza, Cleiton M.; Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland	Utrecht University; University of Geneva	Welscher, YMT (corresponding author), Padualaan 8, NL-3584 CH Utrecht, Netherlands.	m.tewelscher@uu.nl	Breukink, Eefjan/I-3039-2016	Breukink, Eefjan/0000-0002-7311-0660; Riezman, Howard/0000-0003-4680-9422				Aparicio JF, 1999, J BIOL CHEM, V274, P10133, DOI 10.1074/jbc.274.15.10133; BAGINSKI M, 1989, EUR BIOPHYS J BIOPHY, V17, P159, DOI 10.1007/BF00254770; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X; BOYER MJ, 1994, METHOD CELL BIOL, V41, P135; Bracey D, 1998, J APPL MICROBIOL, V85, P1056, DOI 10.1111/j.1365-2672.1998.tb05271.x; Bracey D, 1998, J MICROBIOL METH, V31, P113, DOI 10.1016/S0167-7012(97)00095-X; BRAJTBURG J, 1985, ANTIMICROB AGENTS CH, V27, P172, DOI 10.1128/AAC.27.2.172; Breukink E, 1997, BIOCHEMISTRY-US, V36, P6968, DOI 10.1021/bi970008u; CLEJAN S, 1985, J BIOL CHEM, V260, P2884; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P30, DOI 10.1016/0005-2736(74)90330-7; DEKRUIJFF B, 1974, BIOCHIM BIOPHYS ACTA, V339, P57, DOI 10.1016/0005-2736(74)90332-0; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; Heese-Peck A, 2002, MOL BIOL CELL, V13, P2664, DOI 10.1091/mbc.E02-04-0186; Kato M, 2001, EMBO J, V20, P4035, DOI 10.1093/emboj/20.15.4035; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; Lascombe MB, 2002, ACTA CRYSTALLOGR D, V58, P1442, DOI 10.1107/S0907444902011745; Lopes SCDN, 2004, J AM CHEM SOC, V126, P5396, DOI 10.1021/ja031782+; MILHAUD J, 1992, BIOCHIM BIOPHYS ACTA, V1105, P307, DOI 10.1016/0005-2736(92)90209-5; MILHAUD J, 1989, EUR BIOPHYS J BIOPHY, V17, P151; MISHRA P, 1992, BIOCHIM BIOPHYS ACTA, V1127, P1, DOI 10.1016/0005-2760(92)90194-Z; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Munn AL, 2001, BBA-MOL BASIS DIS, V1535, P236, DOI 10.1016/S0925-4439(01)00028-X; Rodrigues ML, 2006, BBA-PROTEINS PROTEOM, V1764, P110, DOI 10.1016/j.bbapap.2005.09.008; ROUSER G, 1970, LIPIDS, V5, P496; SOKOLANDERSON ML, 1986, J INFECT DIS, V154, P76, DOI 10.1093/infdis/154.1.76; Takeda T, 2005, CURR BIOL, V15, P1331, DOI 10.1016/j.cub.2005.07.009; van Kan EJM, 2002, BIOCHEMISTRY-US, V41, P7529, DOI 10.1021/bi012162t; Volpon L, 2002, EUR J BIOCHEM, V269, P4533, DOI 10.1046/j.1432-1033.2002.03147.x; Wachtler V, 2006, TRENDS CELL BIOL, V16, P1, DOI 10.1016/j.tcb.2005.11.008	30	171	178	3	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6393	6401		10.1074/jbc.M707821200	http://dx.doi.org/10.1074/jbc.M707821200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165687	hybrid			2022-12-25	WOS:000253779500047
J	Guan, B; Pungaliya, P; Li, X; Uquillas, C; Mutton, LN; Rubin, EH; Bieberich, CJ				Guan, Bin; Pungaliya, Pooja; Li, Xiang; Uquillas, Carlos; Mutton, Laura N.; Rubin, Eric H.; Bieberich, Charles J.			Ubiquitination by TOPORS regulates the prostate tumor suppressor NKX3.1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-I-BINDING; HOMEOBOX GENE; SUMO-1 E3-LIGASE; PROTEIN; CANCER; EXPRESSION; P53; CARCINOGENESIS; DELETION; VIVO	The NKX3.1 gene located at 8p21.2 encodes a homeodomain-containing transcription factor that acts as a haploin sufficient tumor suppressor in prostate cancer. Diminished protein expression of NKX3.1 has been observed in prostate cancer precursors and carcinomas. TOPORS is a ubiquitously expressed E3 ubiquitin ligase that can ubiquitinate tumor suppressor p53. Here we report interaction between NKX3.1 and TOPORS. NKX3.1 can be ubiquitinated by TOPORS in vitro and in vivo, and overexpression of TOPORS leads to NKX3.1 proteasomal degradation in prostate cancer cells. Conversely, small interfering RNA-mediated knockdown of TOPORS leads to an increased steady-state level and prolonged half-life of NKX3.1. These data establish TOPORS as a negative regulator of NKX3.1 and implicate TOPORS in prostate cancer progression.	[Guan, Bin; Li, Xiang; Uquillas, Carlos; Mutton, Laura N.; Bieberich, Charles J.] Univ Maryland, Dept Biol Sci, Baltimore, MD 21250 USA; [Pungaliya, Pooja; Rubin, Eric H.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Med, Inst Canc, New Brunswick, NJ 08901 USA; [Pungaliya, Pooja; Rubin, Eric H.] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Pharmacol, Inst Canc, New Brunswick, NJ 08901 USA; [Bieberich, Charles J.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; University System of Maryland; University of Maryland Baltimore	Bieberich, CJ (corresponding author), Univ Maryland, Dept Biol Sci, Baltimore, MD 21250 USA.	bieberic@umbc.edu		Guan, Bin/0000-0001-5986-5189; Bieberich, Charles/0000-0002-9208-5077	NATIONAL CANCER INSTITUTE [R01CA099951] Funding Source: NIH RePORTER; NCI NIH HHS [CA99951] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Asatiani E, 2005, CANCER RES, V65, P1164, DOI 10.1158/0008-5472.CAN-04-2688; Bethel CR, 2006, CANCER RES, V66, P10683, DOI 10.1158/0008-5472.CAN-06-0963; Bhatia-Gaur R, 1999, GENE DEV, V13, P966, DOI 10.1101/gad.13.8.966; Bieberich CJ, 1996, J BIOL CHEM, V271, P31779, DOI 10.1074/jbc.271.50.31779; Bowen C, 2000, CANCER RES, V60, P6111; Bowen C, 2007, CANCER RES, V67, P455, DOI 10.1158/0008-5472.CAN-06-1591; Bredel M, 2005, CANCER RES, V65, P4088, DOI 10.1158/0008-5472.CAN-04-4229; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Chen H, 2005, DEV DYNAM, V234, P961, DOI 10.1002/dvdy.20596; Chen H, 2005, J CELL BIOCHEM, V94, P168, DOI 10.1002/jcb.20297; Chen H, 2002, CANCER RES, V62, P338; De Marzo AM, 2007, NAT REV CANCER, V7, P256, DOI 10.1038/nrc2090; Gelmann EP, 2002, CANCER RES, V62, P2654; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Haluska P, 1999, NUCLEIC ACIDS RES, V27, P2538, DOI 10.1093/nar/27.12.2538; Hoeller D, 2006, NAT REV CANCER, V6, P776, DOI 10.1038/nrc1994; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Ju JH, 2006, J MOL BIOL, V360, P989, DOI 10.1016/j.jmb.2006.05.064; Kim MJ, 2002, CANCER RES, V62, P2999; Lei QY, 2006, CANCER CELL, V9, P367, DOI 10.1016/j.ccr.2006.03.031; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li X, 2006, MOL CELL BIOL, V26, P3008, DOI 10.1128/MCB.26.8.3008-3017.2006; Magee JA, 2003, CANCER CELL, V3, P273, DOI 10.1016/S1535-6108(03)00047-3; Mani A, 2005, J CLIN ONCOL, V23, P4776, DOI 10.1200/JCO.2005.05.081; Nelson WG, 2003, NEW ENGL J MED, V349, P366, DOI 10.1056/NEJMra021562; Ornstein DK, 2001, J UROLOGY, V165, P1329, DOI 10.1016/S0022-5347(01)69894-X; Oyanagi H, 2004, LUNG CANCER, V46, P21, DOI 10.1016/j.lungcan.2004.03.009; Perinchery G, 1999, INT J CANCER, V83, P610, DOI 10.1002/(SICI)1097-0215(19991126)83:5<610::AID-IJC7>3.0.CO;2-2; Pungaliya P, 2007, J PROTEOME RES, V6, P3918, DOI 10.1021/pr0703674; Rajendra R, 2004, J BIOL CHEM, V279, P36440, DOI 10.1074/jbc.C400300200; Rasheed ZA, 2002, EXP CELL RES, V277, P152, DOI 10.1006/excr.2002.5550; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rockel TD, 2005, J CELL SCI, V118, P5231, DOI 10.1242/jcs.02642; Saleem A, 2004, ONCOGENE, V23, P5293, DOI 10.1038/sj.onc.1207700; Schneider A, 2000, MECH DEVELOP, V95, P163, DOI 10.1016/S0925-4773(00)00355-5; Sciavolino PJ, 1997, DEV DYNAM, V209, P127, DOI 10.1002/(SICI)1097-0177(199705)209:1<127::AID-AJA12>3.0.CO;2-Z; Secombe J, 2004, J BIOL CHEM, V279, P17126, DOI 10.1074/jbc.M310097200; Seeler JS, 2003, NAT REV MOL CELL BIO, V4, P690, DOI 10.1038/nrm1200; Shen MM, 2003, DEV DYNAM, V228, P767, DOI 10.1002/dvdy.10397; Simmons SO, 2006, BIOCHEM J, V393, P397, DOI 10.1042/BJ20051030; Tanaka M, 2000, DEV DYNAM, V219, P248, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1054>3.3.CO;2-5; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; TREIER M, 1994, CELL, V78, P787, DOI 10.1016/S0092-8674(94)90502-9; Voeller HJ, 1997, CANCER RES, V57, P4455; Weger S, 2005, FEBS LETT, V579, P5007, DOI 10.1016/j.febslet.2005.07.088; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Witze ES, 2007, NAT METHODS, V4, P798, DOI 10.1038/nmeth1100; Zhou R, 1999, GENE, V235, P93, DOI 10.1016/S0378-1119(99)00203-6	48	40	42	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4834	4840		10.1074/jbc.M708630200	http://dx.doi.org/10.1074/jbc.M708630200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18077445	hybrid			2022-12-25	WOS:000253426500041
J	Poree, B; Kypriotou, M; Chadjichristos, C; Beauchef, G; Renard, E; Legendre, F; Melin, M; Gueret, S; Hartmann, DJ; Mallein-Gerin, F; Pujol, JP; Boumediene, K; Galera, P				Poree, Benoit; Kypriotou, Magdalini; Chadjichristos, Christos; Beauchef, Gallic; Renard, Emmanuelle; Legendre, Florence; Melin, Martine; Gueret, Sylviane; Hartmann, Daniel-Jean; Mallein-Gerin, Frederic; Pujol, Jean-Pierre; Boumediene, Karim; Galera, Philippe			Interleukin-6 (IL-6) and/or soluble IL-6 receptor down-regulation of human type II collagen gene expression in articular Chondrocytes requires a decrease of Sp1 center dot Sp3 ratio and of the binding activity of both factors to the COL2A1 promoter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-SPECIFIC EXPRESSION; TRANSCRIPTION FACTORS; SYNOVIAL-FLUID; GROWTH-FACTOR; MATRIX-METALLOPROTEINASE; RHEUMATOID-ARTHRITIS; ESTROGEN REGULATION; UP-REGULATION; ONCOSTATIN M; SP PROTEINS	Type II collagen is composed of alpha 1( II) chains encoded by the COL2A1 gene. Alteration of this cartilage marker is a common feature of osteoarthritis. Interleukin-6 (IL-6) is a pro-inflammatory cytokine that needs a soluble form of receptor called sIL-6R to exert its effects in some cellular models. In that case, sIL-6R exerts agonistic action. This mechanism can make up for the partial or total absence of membrane-anchored IL-6 receptors in some cell types, such as chondrocytes. Our study shows that IL-6, sIL-6R, or both inhibit type II collagen production by rabbit articular chondrocytes through a transcriptional control. The cytokine and/or sIL-6R repress COL2A1 transcription by a -63/-35 sequence that binds Sp1 center dot Sp3. Indeed, IL-6 and/ or sIL-6R inhibit Sp1 and Sp3 expression and their binding activity to the 63-bp promoter. In chromatin immunoprecipitation experiments, IL-6 center dot sIL-6R induced an increase in Sp3 recruitment to the detriment of Sp1. Knockdown of Sp1 center dot Sp3 by small interference RNA and decoy strategies were found to prevent the IL-6- and/ or sIL-6R- induced inhibition of COL2A1 transcription, indicating that each of these Sp proteins is required for down-regulation of the target gene and that a heterotypic Sp1 center dot Sp3 complex is involved. Additionally, Sp1 was shown to interact with Sp3 and HDAC1. Indeed, overexpression of a full-length Sp3 cDNA blocked the Sp1 up-regulation of the 63-bp COL2A1 promoter activity, and by itself, inhibits COL2A1 transcription. We can conclude that IL-6, sIL-6R, or both in combination decrease both the Sp1 center dot Sp3 ratio and DNA-binding activities, thus inhibiting COL2A1 transcription.	[Poree, Benoit; Kypriotou, Magdalini; Chadjichristos, Christos; Beauchef, Gallic; Renard, Emmanuelle; Legendre, Florence; Pujol, Jean-Pierre; Boumediene, Karim; Galera, Philippe] Univ Caen Basse Normandie, Lab Biochim Tissu Conjonctif, IFR ICORE 146, Fac Med,CHU Niveau 3, F-14032 Caen, France; [Melin, Martine; Gueret, Sylviane; Hartmann, Daniel-Jean] Univ Lyon 1, Lab Biomat, F-69373 Lyon 08, France; [Melin, Martine; Gueret, Sylviane; Hartmann, Daniel-Jean] Novatec, F-69007 Lyon, France; [Mallein-Gerin, Frederic] Univ Lyon 1 IFR 128 BioSci Lyon Gerland, CNRS,UMR 5086, Inst Biol & Chim Prot, Lab Biol & Ingn Cartilage, F-69367 Lyon 07, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Galera, P (corresponding author), Univ Caen Basse Normandie, Lab Biochim Tissu Conjonctif, IFR ICORE 146, Fac Med,CHU Niveau 3, Ave Cote Nacre, F-14032 Caen, France.	philippe.galera@unicaen.fr	Chadjichristos, Christos E/J-4871-2016	Chadjichristos, Christos E/0000-0001-6657-7900; BOUMEDIENE, Karim/0000-0001-6517-8318; legendre, florence/0000-0002-9951-1585				Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; ANDREWS NC, 1991, NUCLEIC ACIDS RES, V19, P2499, DOI 10.1093/nar/19.9.2499; Beauchef G, 2005, BIOCHEM BIOPH RES CO, V333, P1123, DOI 10.1016/j.bbrc.2005.06.020; Cantwell CA, 1998, MOL CELL BIOL, V18, P2108, DOI 10.1128/MCB.18.4.2108; Carroll G, 1998, INFLAMM RES, V47, P1, DOI 10.1007/s000110050235; Cawston TE, 1998, ARTHRITIS RHEUM-US, V41, P1760, DOI 10.1002/1529-0131(199810)41:10<1760::AID-ART8>3.0.CO;2-M; Chadjichristos C, 2003, J BIOL CHEM, V278, P39762, DOI 10.1074/jbc.M303541200; Chadjichristos C, 2002, J BIOL CHEM, V277, P43903, DOI 10.1074/jbc.M206111200; Choi HS, 2002, BIOCHEM BIOPH RES CO, V296, P1005, DOI 10.1016/S0006-291X(02)02001-6; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P159; de Leon MB, 2005, J BIOL CHEM, V280, P5290, DOI 10.1074/jbc.M411571200; Desgeorges A, 1997, J RHEUMATOL, V24, P1510; EYRE DR, 1992, ARTICULAR CARTILAGE AND OSTEOARTHRITIS, P119; Fan ZY, 2004, CYTOKINE, V28, P17, DOI 10.1016/j.cyto.2004.06.003; Flannery CR, 2000, MATRIX BIOL, V19, P549, DOI 10.1016/S0945-053X(00)00111-6; FRIELING JTM, 1995, J INFECT DIS, V171, P469, DOI 10.1093/infdis/171.2.469; GALERA P, 1992, J CELL PHYSIOL, V153, P596, DOI 10.1002/jcp.1041530322; GALERA P, 1992, EXP CELL RES, V200, P21331; Ghayor C, 2000, J BIOL CHEM, V275, P27421; Ghayor C, 2001, J BIOL CHEM, V276, P36881, DOI 10.1074/jbc.M105083200; Gierens H, 2000, ARTERIOSCL THROM VAS, V20, P1777, DOI 10.1161/01.ATV.20.7.1777; Goldring SR, 2004, CLIN ORTHOP RELAT R, pS27, DOI 10.1097/01.blo.0000144854.66565.8f; Guerne PA, 1999, MATRIX BIOL, V18, P253, DOI 10.1016/S0945-053X(99)00021-9; He SH, 2005, MOL BIOL CELL, V16, P4073, DOI 10.1091/mbc.e05-05-0388; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; HORIUCHI S, 1994, EUR J IMMUNOL, V24, P1945, DOI 10.1002/eji.1830240837; HOUSSIAU FA, 1988, ARTHRITIS RHEUM, V31, P784, DOI 10.1002/art.1780310614; Jikko A, 1998, CELL BIOL INT, V22, P615, DOI 10.1006/cbir.1998.0304; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; KANDEL RA, 1990, J RHEUMATOL, V17, P953; Kaneko S, 2000, CYTOKINES CELL MOL T, V6, P71, DOI 10.1080/13684730050515796; KISHIMOTO T, 1995, BLOOD, V86, P1243, DOI 10.1182/blood.V86.4.1243.bloodjournal8641243; KISHIMOTO T, 1989, BLOOD, V74, P1, DOI 10.1182/blood.V74.1.1.1; Lania L, 1997, INT J BIOCHEM CELL B, V29, P1313, DOI 10.1016/S1357-2725(97)00094-0; Lee LTO, 2004, MOL ENDOCRINOL, V18, P1740, DOI 10.1210/me.2003-0461; Lefebvre V, 1998, EMBO J, V17, P5718, DOI 10.1093/emboj/17.19.5718; Legendre F, 2005, J RHEUMATOL, V32, P1307; Legendre F, 2003, J BIOL CHEM, V278, P2903, DOI 10.1074/jbc.M110773200; Leung KKH, 1998, J CELL BIOL, V141, P1291, DOI 10.1083/jcb.141.6.1291; Li WQ, 2001, J IMMUNOL, V166, P3491, DOI 10.4049/jimmunol.166.5.3491; Liu AG, 2004, J BIOL CHEM, V279, P17449, DOI 10.1074/jbc.M311267200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loeffler S, 2005, INT J CANCER, V115, P202, DOI 10.1002/ijc.20871; Look DC, 1995, J BIOL CHEM, V270, P30264, DOI 10.1074/jbc.270.51.30264; Magee C, 2005, J BIOL CHEM, V280, P25331, DOI 10.1074/jbc.M412549200; Majello B, 1997, J BIOL CHEM, V272, P4021, DOI 10.1074/jbc.272.7.4021; MULLBERG J, 1992, BIOCHEM BIOPH RES CO, V189, P794, DOI 10.1016/0006-291X(92)92272-Y; Osaki M, 2003, BIOCHEM J, V369, P103, DOI 10.1042/BJ20020928; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Rowan AD, 2001, ARTHRITIS RHEUM-US, V44, P1620, DOI 10.1002/1529-0131(200107)44:7<1620::AID-ART285>3.0.CO;2-B; Sandell LJ, 1996, CONNECT TISSUE RES, V35, P1, DOI 10.3109/03008209609029168; Sapetschnig A, 2004, J BIOL CHEM, V279, P42095, DOI 10.1074/jbc.M404989200; SAVAGNER P, 1990, J BIOL CHEM, V265, P6669; Senaldi G, 1999, P NATL ACAD SCI USA, V96, P11458, DOI 10.1073/pnas.96.20.11458; Silacci P, 1998, J BIOL CHEM, V273, P13625, DOI 10.1074/jbc.273.22.13625; Stoner M, 2004, ONCOGENE, V23, P1052, DOI 10.1038/sj.onc.1207201; Sun JM, 2005, EXP CELL RES, V302, P96, DOI 10.1016/j.yexcr.2004.08.015; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; TAGA T, 1989, CELL, V58, P573, DOI 10.1016/0092-8674(89)90438-8; TAGA T, 1995, CURR OPIN IMMUNOL, V7, P17, DOI 10.1016/0952-7915(95)80024-7; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; vandeLoo FAJ, 1997, AM J PATHOL, V151, P177; WEGENKA UM, 1993, MOL CELL BIOL, V13, P276, DOI 10.1128/MCB.13.1.276; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF82, DOI 10.1152/ajprenal.00200.2002; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422; Zhou G, 1998, J BIOL CHEM, V273, P14989, DOI 10.1074/jbc.273.24.14989	67	110	116	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4850	4865		10.1074/jbc.M706387200	http://dx.doi.org/10.1074/jbc.M706387200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18065760	hybrid			2022-12-25	WOS:000253426500043
J	Koutelou, E; Sato, S; Tomomori-Sato, C; Florens, L; Swanson, SK; Washburn, MP; Kokkinaki, M; Conaway, RC; Conaway, JW; Moschonas, NK				Koutelou, Evangelia; Sato, Shigeo; Tomomori-Sato, Chieri; Florens, Laurence; Swanson, Selene K.; Washburn, Michael P.; Kokkinaki, Maria; Conaway, Ronald C.; Conaway, Joan W.; Moschonas, Nicholas K.			Neuralized-like 1 (Neurl1) targeted to the plasma membrane by N-myristoylation regulates the notch ligand Jagged1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; MIND BOMB; CELL FATE; PROTEIN; DELTA; IDENTIFICATION; ENDOCYTOSIS; PROMOTES; HOMOLOG; INTERNALIZATION	Notch signaling constitutes an evolutionarily conserved mechanism that mediates cell-cell interactions in various developmental processes. Numerous regulatory proteins interact with the Notch receptor and its ligands and control signaling at multiple levels. Ubiquitination and endocytosis followed by endosomal sorting of both the receptor and its ligands is essential for Notch-mediated signaling. The E3 ubiquitin ligases, Neuralized (Neur) and Mind Bomb (Mib1), are crucial for regulating the activity and stability of Notch ligands in Drosophila; however, biochemical evidence that the Notch ligands are directly targeted for ubiquitination by Neur and/or Mib1 has been lacking. In this report, we explore the function of Neurl1, a mouse ortholog of Drosophila Neur. We show that Neurl1 can function as an E3 ubiquitin ligase to activate monoubiquitination in vitro of Jagged1, but not other mammalian Notch ligands. Neurl1 expression decreases Jagged1 levels in cells and blocks signaling from Jagged1-expressing cells to neighboring Notch-expressing cells. We demonstrate that Neurl1 is myristoylated at its N terminus, and that myristoylation of Neurl1 targets it to the plasma membrane. Point mutations abolishing either Neurl1 myristoylation and plasma membrane localization or Neurl1 ubiquitin ligase activity impair its ability to down-regulate Jagged1 expression and to block signaling. Taken together, our results argue that Neurl1 at the plasma membrane can affect the signaling activity of Jagged1 by directly enhancing its ubiquitination and subsequent turnover.	[Koutelou, Evangelia; Sato, Shigeo; Tomomori-Sato, Chieri; Florens, Laurence; Swanson, Selene K.; Washburn, Michael P.; Conaway, Ronald C.; Conaway, Joan W.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Kokkinaki, Maria; Moschonas, Nicholas K.] Univ Patras, Sch Med, Biol Lab, GR-26500 Patras, Greece; [Koutelou, Evangelia] Univ Crete, Dept Biol, Joint Grad Program Mol Biol & Biomed, GR-71409 Iraklion, Greece; [Kokkinaki, Maria; Moschonas, Nicholas K.] Univ Crete, Dept Biol, GR-71409 Iraklion, Greece; [Conaway, Ronald C.; Conaway, Joan W.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Patras; University of Crete; University of Crete; University of Kansas; University of Kansas Medical Center	Conaway, JW (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	jlc@stowers-institute.org; n_moschonas@med.upatras.gr	Koutelou, Evangelia/X-7839-2019	Koutelou, Evangelia/0000-0003-0584-8070; Conaway, Joan/0000-0002-2786-0663; Tomomori-Sato, Chieri/0000-0002-2543-293X; Washburn, Michael/0000-0001-7568-2585; Florens, Laurence/0000-0002-9310-6650; Moschonas, Nicholas/0000-0002-2556-537X				Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chen WB, 2004, DEV BIOL, V267, P361, DOI 10.1016/j.ydbio.2003.11.010; Commisso C, 2007, MOL BIOL CELL, V18, P1, DOI 10.1091/mbc.E06-08-0753; Deblandre GA, 2001, DEV CELL, V1, P795, DOI 10.1016/S1534-5807(01)00091-0; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Farazi TA, 2001, J BIOL CHEM, V276, P39501, DOI 10.1074/jbc.R100042200; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; GLITTENBERG M, 2006, EMBO J, P1; Greenwald I, 1998, GENE DEV, V12, P1751, DOI 10.1101/gad.12.12.1751; Hagedorn EJ, 2006, J CELL BIOL, V173, P443, DOI 10.1083/jcb.200602054; HEITZLER P, 1991, CELL, V64, P1083, DOI 10.1016/0092-8674(91)90263-X; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koo BK, 2005, J BIOL CHEM, V280, P22335, DOI 10.1074/jbc.M501631200; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Lai EC, 2005, DEVELOPMENT, V132, P2319, DOI 10.1242/dev.01825; Lai EC, 2001, DEV BIOL, V231, P217, DOI 10.1006/dbio.2000.0124; Le Borgne R, 2005, DEVELOPMENT, V132, P1751, DOI 10.1242/dev.01789; Le Borgne R, 2005, PLOS BIOL, V3, P688, DOI 10.1371/journal.pbio.0030096; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LINDSELL CE, 1995, CELL, V80, P909, DOI 10.1016/0092-8674(95)90294-5; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mukherjee A, 2003, J BIOL CHEM, V278, P40806, DOI 10.1074/jbc.M306440200; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pavlopoulos E, 2001, DEV CELL, V1, P807, DOI 10.1016/S1534-5807(01)00093-4; Pavlopoulos E, 2002, BBA-GENE STRUCT EXPR, V1574, P375, DOI 10.1016/S0167-4781(01)00330-X; Pitsouli C, 2005, DEVELOPMENT, V132, P4041, DOI 10.1242/dev.01979; Resh MD, 2006, NAT CHEM BIOL, V2, P584, DOI 10.1038/nchembio834; Ruan YL, 2001, P NATL ACAD SCI USA, V98, P9907, DOI 10.1073/pnas.171321098; Schweisguth F, 2004, CURR BIOL, V14, pR129, DOI 10.1016/j.cub.2004.01.023; SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253; Song R, 2006, J BIOL CHEM, V281, P36391, DOI 10.1074/jbc.M606601200; Talora C, 2002, GENE DEV, V16, P2252, DOI 10.1101/gad.988902; Timmusk T, 2002, MOL CELL NEUROSCI, V20, P649, DOI 10.1006/mcne.2002.1148; TOWLER DA, 1988, ANNU REV BIOCHEM, V57, P69, DOI 10.1146/annurev.bi.57.070188.000441; Vollrath B, 2001, MOL CELL BIOL, V21, P7481, DOI 10.1128/MCB.21.21.7481-7494.2001; Wang WD, 2005, DEVELOPMENT, V132, P2883, DOI 10.1242/dev.01860; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e	46	59	62	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3846	3853		10.1074/jbc.M706974200	http://dx.doi.org/10.1074/jbc.M706974200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077452	hybrid			2022-12-25	WOS:000253083500019
J	Rush, JS; Gao, N; Lehrman, MA; Waechter, CJ				Rush, Jeffrey S.; Gao, Ningguo; Lehrman, Mark A.; Waechter, Charles J.			Recycling of dolichyl monophosphate to the cytoplasmic leaflet of the endoplasmic reticulum after the cleavage of dolichyl pyrophosphate on the lumenal monolayer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WATER-SOLUBLE ANALOG; GLC-P-DOLICHOL; PHOSPHATE BIOSYNTHESIS; TRANSMEMBRANE MOVEMENT; TRANSBILAYER MOVEMENT; PIG BRAIN; GLYCOSYLATION; MANNOSYLPHOSPHORYLDOLICHOL; DEPHOSPHORYLATION; PHOSPHORYLATION	During protein N-glycosylation, dolichyl pyrophosphate (Dol-P-P) is discharged in the lumenal monolayer of the endoplasmic reticulum (ER). Dol-P-P is then cleaved to Dol-P by Dol-P-P phosphatase (DPPase). Studies with the yeast mutant cwh8 Delta, lacking DPPase activity, indicate that recycling of Dol-P produced by DPPase contributes significantly to the pool of Dol-P utilized for lipid intermediate biosynthesis on the cytoplasmic leaflet. Whether Dol-P formed in the lumen diffuses directly back to the cytoplasmic leaflet or is first dephosphorylated to dolichol has not been determined. Incubation of sealed ER vesicles from calf brain with acetyl-Asn-Tyr-Thr-NH2, an N-glycosylatable peptide, to generate Dol-P-P in the lumenal monolayer produced corresponding increases in the rates of Man-P-Dol, Glc-P-Dol, and GlcNAc-P-P-Dol synthesis in the absence of CTP. No changes in dolichol kinase activity were observed. When streptolysin-O permeabilized CHO cells were incubated with an acceptor peptide, N-glycopeptide synthesis, requiring multiple cycles of the dolichol pathway, occurred in the absence of CTP. The results obtained with sealed microsomes and CHO cells indicate that Dol-P, formed from Dol-P-P, returns to the cytoplasmic leaflet where it can be reutilized for lipid intermediate biosynthesis, and dolichol kinase is not required for recycling. It is possible that the flip-flopping of the carrier lipid is mediated by a flippase, which would provide a mechanism for the recycling of Dol-P derived from Man-P-Dol-mediated reactions in N-, O-, and C-mannosylation of proteins, GPI anchor assembly, and the three Glc-P-Dol-mediated reactions in Glc(3)Man(9)GlcNAc(2)-P-P-Dol (DLO) biosynthesis.	[Rush, Jeffrey S.; Waechter, Charles J.] Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, Lexington, KY 40536 USA; [Gao, Ningguo; Lehrman, Mark A.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Kentucky; University of Texas System; University of Texas Southwestern Medical Center Dallas	Waechter, CJ (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Coll Med, BBSRB 741 S Limestone St, Lexington, KY 40536 USA.	waechte@uky.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102129, R56GM038545, R01GM038545] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM038545-20, R01 GM102129, R01 GM038545, GM38545, GM36035] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BURTON WA, 1979, J BIOL CHEM, V254, P7129; Buton X, 1996, J BIOL CHEM, V271, P6651, DOI 10.1074/jbc.271.12.6651; DANILOV LL, 1981, FEBS LETT, V131, P310, DOI 10.1016/0014-5793(81)80392-4; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gao NG, 2002, J BIOL CHEM, V277, P39425, DOI 10.1074/jbc.M205195200; Gao NG, 2006, METHOD ENZYMOL, V415, P3, DOI 10.1016/S0076-6879(06)15001-6; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; HERSCOVICS A, 1993, FASEB J, V7, P540, DOI 10.1096/fasebj.7.6.8472892; Jaeken J, 2004, CURR OPIN PEDIATR, V16, P434, DOI 10.1097/01.mop.0000133636.56790.4a; Kranz C, 2007, AM J HUM GENET, V80, P433, DOI 10.1086/512130; MCCLOSKEY MA, 1980, BIOCHEMISTRY-US, V19, P2061, DOI 10.1021/bi00551a009; ROSENWALD AG, 1990, J BIOL CHEM, V265, P14544; ROTHMAN JE, 1977, P NATL ACAD SCI USA, V74, P1821, DOI 10.1073/pnas.74.5.1821; RUSH JS, 1993, J BIOL CHEM, V268, P13110; RUSH JS, 1995, J CELL BIOL, V130, P529, DOI 10.1083/jcb.130.3.529; Rush JS, 2005, METHODS, V35, P316, DOI 10.1016/j.ymeth.2004.10.002; Rush JS, 2002, J BIOL CHEM, V277, P45226, DOI 10.1074/jbc.M207076200; Rush JS, 1998, GLYCOBIOLOGY, V8, P1207, DOI 10.1093/glycob/8.12.1207; Rush JS, 1998, GLYCOBIOLOGY, V8, P1195, DOI 10.1093/glycob/8.12.1195; Schenk B, 2001, GLYCOBIOLOGY, V11, p61R, DOI 10.1093/glycob/11.5.61R; SCHER MG, 1980, J NEUROCHEM, V35, P844, DOI 10.1111/j.1471-4159.1980.tb07081.x; SCHER MG, 1984, ARCH BIOCHEM BIOPHYS, V231, P293, DOI 10.1016/0003-9861(84)90391-6; SCHER MG, 1984, J BIOL CHEM, V259, P4580; Shridas P, 2006, J BIOL CHEM, V281, P31696, DOI 10.1074/jbc.M604087200; SIEWERT G, 1967, P NATL ACAD SCI USA, V57, P767, DOI 10.1073/pnas.57.3.767; SPIRO MJ, 1986, J BIOL CHEM, V261, P4725; STONE KJ, 1971, P NATL ACAD SCI USA, V68, P3223, DOI 10.1073/pnas.68.12.3223; van Berkel MAA, 1999, GLYCOBIOLOGY, V9, P243, DOI 10.1093/glycob/9.3.243; WAECHTER CJ, 1976, ARCH BIOCHEM BIOPHYS, V174, P726, DOI 10.1016/0003-9861(76)90403-3; WAECHTER CJ, 1977, ARCH BIOCHEM BIOPHYS, V181, P185, DOI 10.1016/0003-9861(77)90497-0; WELPLY JK, 1983, J BIOL CHEM, V258, P1856	32	25	25	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4087	4093		10.1074/jbc.M707067200	http://dx.doi.org/10.1074/jbc.M707067200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077451	hybrid			2022-12-25	WOS:000253083500044
J	Salameh, MA; Soares, AS; Hockla, A; Radisky, ES				Salameh, Moh'd A.; Soares, Alexei S.; Hockla, Alexandra; Radisky, Evette S.			Structural basis for accelerated cleavage of bovine pancreatic trypsin inhibitor (BPTI) by human mesotrypsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CATIONIC TRYPSINOGEN; SITE PEPTIDE-BOND; REACTIVE-SITE; CRYSTAL-STRUCTURE; HUMAN BRAIN; ALPHA-CHYMOTRYPSIN; PROTEASE-INHIBITOR; ACTIVE-SITE; KINETICS; ZYMOGEN	Human mesotrypsin is an isoform of trypsin that displays unusual resistance to polypeptide trypsin inhibitors and has been observed to cleave several such inhibitors as substrates. Whereas substitution of arginine for the highly conserved glycine 193 in the trypsin active site has been implicated as a critical factor in the inhibitor resistance of mesotrypsin, how this substitution leads to accelerated inhibitor cleavage is not clear. Bovine pancreatic trypsin inhibitor (BPTI) forms an extremely stable and cleavage-resistant complex with trypsin, and thus provides a rigorous challenge of mesotrypsin catalytic activity toward polypeptide inhibitors. Here, we report kinetic constants for mesotrypsin and the highly homologous (but inhibitor sensitive) human cationic trypsin, describing inhibition by, and cleavage of BPTI, as well as crystal structures of the mesotrypsin-BPTI and human cationic trypsin-BPTI complexes. We find that mesotrypsin cleaves BPTI with a rate constant accelerated 350-fold over that of human cationic trypsin and 150,000-fold over that of bovine trypsin. From the crystal structures, we see that small conformational adjustments limited to several side chains enable mesotrypsin-BPTI complex formation, surmounting the predicted steric clash introduced by Arg-193. Our results show that the mesotrypsin-BPTI interface favors catalysis through (a) electrostatic repulsion between the closely spaced mesotrypsin Arg-193 and BPTI Arg-17, and (b) elimination of two hydrogen bonds between the enzyme and the amine leaving group portion of BPTI. Our model predicts that these deleterious interactions accelerate leaving group dissociation and deacylation.	[Salameh, Moh'd A.; Hockla, Alexandra; Radisky, Evette S.] Mayo Clin, Ctr Canc, Dept Canc Biol, Jacksonville, FL 32224 USA; [Soares, Alexei S.] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA	Mayo Clinic; United States Department of Energy (DOE); Brookhaven National Laboratory	Radisky, ES (corresponding author), 310 Griffin Bldg,4500 San Pablo Rd, Jacksonville, FL 32224 USA.	radisky.evette@mayo.edu	Soares, Alexei S/F-4800-2014; Radisky, Evette S/C-8526-2012	Soares, Alexei S/0000-0002-6565-8503; Radisky, Evette S/0000-0003-3121-109X				Afonine P., 2005, CCP4 NEWSLETTER, V42; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BODE W, 1992, EUR J BIOCHEM, V204, P433, DOI 10.1111/j.1432-1033.1992.tb16654.x; Castro MJM, 1996, BIOCHEMISTRY-US, V35, P11435, DOI 10.1021/bi960515w; CHASE T, 1967, BIOCHEM BIOPH RES CO, V29, P508, DOI 10.1016/0006-291X(67)90513-X; Chen JM, 2000, PANCREAS, V21, P57, DOI 10.1097/00006676-200007000-00052; Coligan JE, 1996, CURRENT PROTOCOLS PR; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME, P105; Cottrell GS, 2004, J BIOL CHEM, V279, P13532, DOI 10.1074/jbc.M312090200; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DELMAR EG, 1979, ANAL BIOCHEM, V99, P316, DOI 10.1016/S0003-2697(79)80013-5; Diederichs S, 2004, CANCER RES, V64, P5564, DOI 10.1158/0008-5472.CAN-04-2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ESTELL DA, 1980, BIOCHEMISTRY-US, V19, P131, DOI 10.1021/bi00542a020; Gaboriaud C, 1996, J MOL BIOL, V259, P995, DOI 10.1006/jmbi.1996.0376; Grishina Z, 2005, BRIT J PHARMACOL, V146, P990, DOI 10.1038/sj.bjp.0706410; Hanson WM, 2007, J MOL BIOL, V366, P230, DOI 10.1016/j.jmb.2006.11.003; Holton J, 2004, P NATL ACAD SCI USA, V101, P1537, DOI 10.1073/pnas.0306241101; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Katona G, 2002, J MOL BIOL, V315, P1209, DOI 10.1006/jmbi.2001.5305; Knecht W, 2007, J BIOL CHEM, V282, P26089, DOI 10.1074/jbc.M703840200; Kukor Z, 2002, J BIOL CHEM, V277, P6111, DOI 10.1074/jbc.M110959200; LASKOWSKI M, 1980, ANNU REV BIOCHEM, V49, P593, DOI 10.1146/annurev.bi.49.070180.003113; LASKOWSKI M, 1971, ENZYMES, V3, P375; Lengyel Z, 1998, PROTEIN EXPRES PURIF, V12, P291, DOI 10.1006/prep.1997.0837; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; LONGSTAFF C, 1990, BIOCHEMISTRY-US, V29, P7339, DOI 10.1021/bi00483a025; MARQUART M, 1983, ACTA CRYSTALLOGR B, V39, P480, DOI 10.1107/S010876818300275X; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Medveczky P, 2006, FEBS LETT, V580, P545, DOI 10.1016/j.febslet.2005.12.067; Nemeth AL, 2007, FEBS J, V274, P1610, DOI 10.1111/j.1742-4658.2007.05708.x; Nyaruhucha CNM, 1997, J BIOL CHEM, V272, P10573; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; QUAST U, 1978, EUR J BIOCHEM, V86, P353, DOI 10.1111/j.1432-1033.1978.tb12317.x; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Radisky ES, 2005, BIOCHEMISTRY-US, V44, P6823, DOI 10.1021/bi047301w; Radisky ES, 2004, BIOCHEMISTRY-US, V43, P13648, DOI 10.1021/bi048797k; Radisky ES, 2003, BIOCHEMISTRY-US, V42, P6484, DOI 10.1021/bi034275d; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; RINDERKNECHT H, 1984, GASTROENTEROLOGY, V86, P681; RINDERKNECHT H, 1986, DIGEST DIS SCI, V31, P314, DOI 10.1007/BF01318124; Rowen L, 2005, MOL BIOL EVOL, V22, P1712, DOI 10.1093/molbev/msi166; Sahin-Toth M, 2000, J BIOL CHEM, V275, P22750, DOI 10.1074/jbc.M002943200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Szepessy E, 2006, FEBS J, V273, P2942, DOI 10.1111/j.1742-4658.2006.05305.x; Szmola R, 2003, J BIOL CHEM, V278, P48580, DOI 10.1074/jbc.M310301200; Toth J, 2006, J BIOL CHEM, V281, P12596, DOI 10.1074/jbc.M512301200; Toth J, 2007, NEUROCHEM RES, V32, P1423, DOI 10.1007/s11064-007-9327-8; VINCENT JP, 1972, BIOCHEMISTRY-US, V11, P2967, DOI 10.1021/bi00766a007; WIEGAND U, 1993, GENE, V136, P167, DOI 10.1016/0378-1119(93)90460-K; Word JM, 1999, J MOL BIOL, V285, P1735, DOI 10.1006/jmbi.1998.2401; Zwart PH., 2005, CCP4 NEWSLETTER, V43	54	45	45	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4115	4123		10.1074/jbc.M708268200	http://dx.doi.org/10.1074/jbc.M708268200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077447	hybrid			2022-12-25	WOS:000253083500047
J	Woltering, JM; Durston, AJ				Woltering, Joost M.; Durston, Antony J.			MiR-10 Represses HoxB1a and HoxB3a in Zebrafish	PLOS ONE			English	Article							GENE CLUSTERS; MICRORNA EXPRESSION; RESPONSE ELEMENTS; MESSENGER-RNA; HINDBRAIN; MOUSE; BOUNDARIES; EVOLUTION; PATTERNS; EMBRYOS	Background. The Hox genes are involved in patterning the anterior-posterior axis. In addition to the protein coding Hox genes, the miR-10, miR-196 and miR-615 families of microRNA genes are conserved within the vertebrate Hox clusters. The members of the miR-10 family are located at positions associated with Hox-4 paralogues. No function is yet known for this microRNA family but the genomic positions of its members suggest a role in anterior-posterior patterning. Methodology/Principal Findings. Using sensor constructs, overexpression and morpholino knockdown, we show in Zebrafish that miR-10 targets HoxB1a and HoxB3a and synergizes with HoxB4 in the repression of these target genes. Overexpression of miR-10 also induces specific phenotypes related to the loss of function of these targets. HoxB1a and HoxB3a have a dominant hindbrain expression domain anterior to that of miR-10 but overlap in a weaker expression domain in the spinal cord. In this latter domain, miR-10 knockdown results in upregulation of the target genes. In the case of a HoxB3a splice variant that includes miR-10c within its primary transcript, we show that the microRNA acts in an autoregulatory fashion. Conclusions/Significance. We find that miR-10 acts to repress HoxB1a and HoxB3a within the spinal cord and show that this repression works cooperatively with HoxB4. As with the previously described interactions between miR-196 and HoxA7 and Hox-8 paralogues, the target genes are located in close proximity to the microRNA. We present a model in which we postulate a link between the clustering of Hox genes and post-transcriptional gene regulation. We speculate that the high density of transcription units and enhancers within the Hox clusters places constraints on the precision of the transcriptional control that can be achieved within these clusters and requires the involvement of post-transcriptional gene silencing to define functional domains of genes appropriately.	[Woltering, Joost M.; Durston, Antony J.] Leiden Univ, Inst Biol, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC	Woltering, JM (corresponding author), Leiden Univ, Inst Biol, Leiden, Netherlands.	jmwoltering@hotmail.com		Woltering, Joost/0000-0002-2630-6572	NWO ALW [811.38.006]; EU [LSHM-CT-2003-504468]	NWO ALW(Netherlands Organization for Scientific Research (NWO)); EU(European Commission)	JMW and AJD have been supported by NWO ALW grant 811.38.006 and by the EU network of excellence grant LSHM-CT-2003-504468: Cells Into Organs. Neither organization had influence on the design and conduct of the study, on the collection, analysis, and interpretation of the data, or on the preparation, review, or approval of the manuscript.	Amores A, 1998, SCIENCE, V282, P1711, DOI 10.1126/science.282.5394.1711; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BONCINELLI E, 1994, GENETICA, V94, P127, DOI 10.1007/BF01443427; Corredor-Adamez M, 2005, EVOL DEV, V7, P362, DOI 10.1111/j.1525-142X.2005.05042.x; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Duboule D, 1998, CURR OPIN GENET DEV, V8, P514, DOI 10.1016/S0959-437X(98)80004-X; Ferretti E, 2005, MOL CELL BIOL, V25, P8541, DOI 10.1128/MCB.25.19.8541-8552.2005; Flynt AS, 2007, NAT GENET, V39, P259, DOI 10.1038/ng1953; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Godsave SF, 1998, DEV DYNAM, V213, P39, DOI 10.1002/(SICI)1097-0177(199809)213:1<39::AID-AJA4>3.0.CO;2-Z; Hadrys T, 2004, J EXP ZOOL PART B, V302B, P147, DOI 10.1002/jez.b.20012; Hadrys T, 2006, DEV BIOL, V297, P26, DOI 10.1016/j.ydbio.2006.04.446; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Hoegg S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-317; Hogan BM, 2004, DEV BIOL, V276, P508, DOI 10.1016/j.ydbio.2004.09.018; Hooiveld MHW, 1999, INT J DEV BIOL, V43, P665; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Huang DY, 2002, DEV DYNAM, V223, P353, DOI 10.1002/dvdy.10057; Ikuta T, 2004, P NATL ACAD SCI USA, V101, P15118, DOI 10.1073/pnas.0401389101; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702; Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203; Kloosterman WP, 2006, NUCLEIC ACIDS RES, V34, P2558, DOI 10.1093/nar/gkl278; Kloosterman WP, 2004, NUCLEIC ACIDS RES, V32, P6284, DOI 10.1093/nar/gkh968; Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kwan CT, 2001, DEV BIOL, V232, P176, DOI 10.1006/dbio.2001.0157; Lagos-Quintana M, 2003, RNA, V9, P175, DOI 10.1261/rna.2146903; Langston AW, 1997, J BIOL CHEM, V272, P2167, DOI 10.1074/jbc.272.4.2167; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Mainguy G, 2003, TRENDS GENET, V19, P476, DOI 10.1016/S0168-9525(03)00202-6; Mainguy G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000356; Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421; McClintock JM, 2002, DEVELOPMENT, V129, P2339; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Moens CB, 2002, DEV DYNAM, V224, P1, DOI 10.1002/dvdy.10086; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Plasterk RHA, 2006, CELL, V124, P877, DOI 10.1016/j.cell.2006.02.030; Prochnik SE, 2007, DEV GENES EVOL, V217, P73, DOI 10.1007/s00427-006-0116-1; Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505; Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709; Sirbu IO, 2005, DEVELOPMENT, V132, P2611, DOI 10.1242/dev.01845; Studer M, 1998, DEVELOPMENT, V125, P1025; Tanzer A, 2005, J EXP ZOOL PART B, V304B, P75, DOI 10.1002/jez.b.21021; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wienholds E, 2003, NAT GENET, V35, P217, DOI 10.1038/ng1251; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Woltering JM, 2006, NAT GENET, V38, P601, DOI 10.1038/ng0606-601; Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434	55	133	145	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1396	10.1371/journal.pone.0001396	http://dx.doi.org/10.1371/journal.pone.0001396			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167555	gold, Green Published, Green Submitted			2022-12-25	WOS:000260468900024
J	Gruner, AC; Mauduit, M; Tewari, R; Romero, JF; Depinay, N; Kayibanda, M; Lallemand, E; Chavatte, JM; Crisanti, A; Sinnis, P; Mazier, D; Corradin, G; Snounou, G; Renia, L				Gruener, Anne Charlotte; Mauduit, Marjorie; Tewari, Rita; Romero, Jackeline F.; Depinay, Nadya; Kayibanda, Michele; Lallemand, Eliette; Chavatte, Jean-Marc; Crisanti, Andrea; Sinnis, Photini; Mazier, Dominique; Corradin, Giampietro; Snounou, Georges; Renia, Laurent			Sterile Protection against Malaria Is Independent of Immune Responses to the Circumsporozoite Protein	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; T-CELL-CLONES; IRRADIATED SPOROZOITES; VACCINE CANDIDATE; LIFE-CYCLE; BERGHEI; EFFICACY; ANTIGEN; YOELII; PARASITES	Background. Research aimed at developing vaccines against infectious diseases generally seeks to induce robust immune responses to immunodominant antigens. This approach has led to a number of efficient bacterial and viral vaccines, but it has yet to do so for parasitic pathogens. For malaria, a disease of global importance due to infection by Plasmodium protozoa, immunization with radiation-attenuated sporozoites uniquely leads to long lasting sterile immunity against infection. The circumsporozoite protein (CSP), an important component of the sporozoite's surface, remains the leading candidate antigen for vaccines targeting the parasite's pre-erythrocytic stages. Difficulties in developing CSP-based vaccines that reproduce the levels of protection afforded by radiation-attenuated sporozoites have led us to question the role of CSP in the acquisition of sterile immunity. We have used a parasite transgenic for the CSP because it allowed us to test whether a major immunodominant Plasmodium antigen is indeed needed for the induction of sterile protective immunity against infection. Methodology/Main Findings. We employed a P. berghei parasite line that expresses a heterologous CSP from P. falciparum in order to assess the role of the CSP in the protection conferred by vaccination with radiation-attenuated P. berghei parasites. Our data demonstrated that sterile immunity could be obtained despite the absence of immune responses specific to the CSP expressed by the parasite used for challenge. Conclusions. We conclude that other pre-erythrocytic parasite antigens, possibly hitherto uncharacterised, can be targeted to induce sterile immunity against malaria. From a broader perspective, our results raise the question as to whether immunodominant parasite antigens should be the favoured targets for vaccine development.	[Gruener, Anne Charlotte; Mauduit, Marjorie; Depinay, Nadya; Kayibanda, Michele; Lallemand, Eliette; Renia, Laurent] Univ Paris 05, Inst Cochin, Dept Immunol, CNRS,UMR 8104, Paris, France; [Gruener, Anne Charlotte; Mauduit, Marjorie; Depinay, Nadya; Kayibanda, Michele; Lallemand, Eliette; Renia, Laurent] INSERM, U567, Paris, France; [Tewari, Rita; Crisanti, Andrea] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Fac Nat Sci, London, England; [Romero, Jackeline F.; Corradin, Giampietro] Univ Lausanne, Inst Biochim, Lausanne, Switzerland; [Chavatte, Jean-Marc; Snounou, Georges] Museum Natl Hist Nat, CNRS, Equipe Parasitol Comparee & Modeles Expt, USM0307,IFR101, Paris, France; [Sinnis, Photini] NYU, Sch Med, Dept Med Parasitol, New York, NY USA; [Mazier, Dominique] Univ Paris 06, UMR S511, Paris, France; [Mazier, Dominique] INSERM, U511, Paris, France; [Mazier, Dominique] Grp Hosp Pitie Salpetriere, AP HP, Serv Parasitol Mycol, F-75634 Paris, France; [Renia, Laurent] ASTAR, Singapore Immunol Network, Agcy Sci, Biopolis, Singapore, Singapore	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Imperial College London; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); New York University; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN)	Renia, L (corresponding author), Univ Paris 05, Inst Cochin, Dept Immunol, CNRS,UMR 8104, Paris, France.	renia_laurent@immunol.a-star.edu.sg	Tewari, Rita/M-5698-2014; Renia, Laurent/E-2117-2011; Gruner, Anne Charlotte/C-1841-2012; Snounou, Georges/F-3352-2011	Renia, Laurent/0000-0003-0349-1557; Snounou, Georges/0000-0002-6133-6398; Tewari, Rita/0000-0003-3943-1847; Crisanti, Andrea/0000-0002-2406-4426; Chavatte, Jean-Marc/0000-0002-0003-541X	Institut National de la Sante et de a Recherche Medicale (INSERM); A*STAR; European community [LSH-CT-2005-01299]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056840] Funding Source: NIH RePORTER	Institut National de la Sante et de a Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); A*STAR(Agency for Science Technology & Research (A*STAR)); European community(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a core grant from the Institut National de la Sante et de a Recherche Medicale (INSERM), a core grant from A*STAR to the Singapore Immunology Network (LR) and by the European community (MALINV contract n degrees LSH-CT-2005-01299) (LR). The sponsors had no role in the design, conduct, and analysis of the study.	Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Doolan DL, 2003, P NATL ACAD SCI USA, V100, P9952, DOI 10.1073/pnas.1633254100; DRUILHE P, MALARIA PARASITE BIO, V34, P513; Eberl G, 1999, MOL IMMUNOL, V36, P103, DOI 10.1016/S0161-5890(99)00023-1; Franke-Fayard B, 2004, MOL BIOCHEM PARASIT, V137, P23, DOI 10.1016/j.molbiopara.2004.04.007; GRILLOT D, 1990, EUR J IMMUNOL, V20, P1215, DOI 10.1002/eji.1830200604; Hall N, 2005, SCIENCE, V307, P82, DOI 10.1126/science.1103717; Hill AVS, 2006, NAT REV IMMUNOL, V6, P21, DOI 10.1038/nri1746; Hoffman SL, 2002, J INFECT DIS, V185, P1155, DOI 10.1086/339409; HOFFMAN SL, 1987, SCIENCE, V237, P639, DOI 10.1126/science.3299709; Hoffman SL, 1998, NAT MED, V4, P1351, DOI 10.1038/3934; Hoffman SL, 2006, NATURE, V444, P824, DOI 10.1038/nature05409; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Kumkhaek C, 2005, J IMMUNOL, V175, P3935, DOI 10.4049/jimmunol.175.6.3935; LOCKYER MJ, 1987, MOL BIOCHEM PARASIT, V22, P101, DOI 10.1016/0166-6851(87)90073-9; Lopez JA, 2001, EUR J IMMUNOL, V31, P1989, DOI 10.1002/1521-4141(200107)31:7&lt;1989::AID-IMMU1989&gt;3.0.CO;2-M; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mueller AK, 2005, NATURE, V433, P164, DOI 10.1038/nature03188; Mueller AK, 2005, P NATL ACAD SCI USA, V102, P3022, DOI 10.1073/pnas.0408442102; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Nussenzweig RS, 1997, NEW ENGL J MED, V336, P128, DOI 10.1056/NEJM199701093360210; RENIA L, 1988, J IMMUNOL METHODS, V112, P201, DOI 10.1016/0022-1759(88)90358-4; RENIA L, 1993, J IMMUNOL, V150, P1471; Renia L, 2006, EXPERT REV VACCINES, V5, P473, DOI 10.1586/14760584.5.4.473; RODRIGUES MM, 1991, INT IMMUNOL, V3, P579, DOI 10.1093/intimm/3.6.579; Roggero MA, 1995, MOL IMMUNOL, V32, P1301, DOI 10.1016/0161-5890(95)00136-0; Roggero MA, 2000, EUR J IMMUNOL, V30, P2679, DOI 10.1002/1521-4141(200009)30:9&lt;2679::AID-IMMU2679&gt;3.0.CO;2-#; ROMERO P, 1989, NATURE, V341, P323, DOI 10.1038/341323a0; ROMERO PJ, 1988, EUR J IMMUNOL, V18, P1951, DOI 10.1002/eji.1830181213; Snounou G, 2005, TRENDS PARASITOL, V21, P456, DOI 10.1016/j.pt.2005.08.002; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; van Dijk MR, 2005, P NATL ACAD SCI USA, V102, P12194, DOI 10.1073/pnas.0500925102; Weedall GD, 2007, INT J PARASITOL, V37, P77, DOI 10.1016/j.ijpara.2006.09.001	35	72	75	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1371	10.1371/journal.pone.0001371	http://dx.doi.org/10.1371/journal.pone.0001371			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159254	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459700028
J	Kanakry, CG; Li, Z; Nakai, Y; Sei, Y; Weinberger, DR				Kanakry, Christopher G.; Li, Zhen; Nakai, Yoko; Sei, Yoshitatsu; Weinberger, Daniel R.			Neuregulin-1 Regulates Cell Adhesion via an ErbB2/Phosphoinositide-3 Kinase/Akt-Dependent Pathway: Potential Implications for Schizophrenia and Cancer	PLOS ONE			English	Article								Background. Neuregulin-1 (NRG1) is a putative schizophrenia susceptibility gene involved extensively in central nervous system development as well as cancer invasion and metastasis. Using a B lymphoblast cell model, we previously demonstrated impairment in NRG1 alpha-mediated migration in cells derived from patients with schizophrenia as well as effects of risk alleles in NRG1 and catechol-O-methyltransferase (COMT), a second gene implicated both in schizophrenia susceptibility and in cancer. Methodology/Principal Findings. Here, we examine cell adhesion, an essential component process of cell motility, using an integrin-mediated cell adhesion assay based on an interaction between ICAM-1 and the CD11a/CD18 integrin heterodimer expressed on lymphoblasts. In our assay, NRG1 alpha induces lymphoblasts to assume varying levels of adhesion characterized by time-dependent fluctuations in the firmness of attachment. The maximum range of variation in adhesion over sixty minutes correlates strongly with NRG1a alpha-induced migration (r(2) = 0.61). NRG1 alpha-induced adhesion variation is blocked by erbB2, P13K, and Akt inhibitors, but not by PLC, ROCK, MLCK, or MEK inhibitors, implicating the erbB2/P13K/Akt1 signaling pathway in NRG1-stimulated, integrin-mediated cell adhesion. In cell lines from 20 patients with schizophrenia and 20 normal controls, cells from patients show a significant deficiency in the range of NRG1 alpha-induced adhesion (p = 0.0002). In contrast, the response of patient-derived cells to phorbol myristate acetate is unimpaired. The COMT Val108/158Met genotype demonstrates a strong trend towards predicting the range of the NRG1 alpha-induced adhesion response with risk homozygotes having decreased variation in cell adhesion even in normal subjects (p = 0.063). Conclusion/Significance. Our findings suggest that a mechanism of the NRG1 genetic association with schizophrenia may involve the molecular biology of cell adhesion.	[Kanakry, Christopher G.; Li, Zhen; Nakai, Yoko; Sei, Yoshitatsu; Weinberger, Daniel R.] NIMH, Genes Cognit & Psychosis Program, Intramural Res Program, NIH, Bethesda, MD 20892 USA; [Kanakry, Christopher G.] NIH, Howard Hughes Med Inst, Res Scholars Program, Chevy Chase, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA	Weinberger, DR (corresponding author), NIMH, Genes Cognit & Psychosis Program, Intramural Res Program, NIH, Bethesda, MD 20892 USA.	weinberd@mail.nih.gov			National Institute of Mental Health; NIH; The Howard Hughes Medical Institute; NATIONAL INSTITUTE OF MENTAL HEALTH [Z01MH002907, ZIAMH002904, ZIAMH002907, Z01MH002904] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The Intramural Research Program of the National Institute of Mental Health, NIH, provided the majority of the funding as well as the laboratory space in which these experiments were conducted. The Howard Hughes Medical Institute-NIH Research Scholars Program also provided funding that supported this research project. Neither sponsor was involved in the design or conducting of the research itself, the collection, analysis, or interpretation of data, or in the preparation or review of the resulting manuscript.	Atlas E, 2003, MOL CANCER RES, V1, P165; Bahr BA, 1997, J NEUROSCI, V17, P1320; Chan ASH, 1997, J IMMUNOL, V159, P934; Chan CS, 2003, J NEUROSCI, V23, P7107, DOI 10.1523/JNEUROSCI.23-18-07107.2003; Chavis P, 2001, NATURE, V411, P317, DOI 10.1038/35077101; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cherry LK, 2004, NAT IMMUNOL, V5, P961, DOI 10.1038/ni1103; Colognato H, 2004, J CELL BIOL, V167, P365, DOI 10.1083/jcb.200404076; Corfas G, 2004, NAT NEUROSCI, V7, P575, DOI 10.1038/nn1258; Dedrick RL, 2003, EXPERT OPIN BIOL TH, V3, P85, DOI 10.1517/eobt.3.1.85.20954; Driessens MHE, 1997, EXP CELL RES, V231, P242, DOI 10.1006/excr.1996.3463; Dulabon L, 2000, NEURON, V27, P33, DOI 10.1016/S0896-6273(00)00007-6; Egan MF, 2000, AM J PSYCHIAT, V157, P1309, DOI 10.1176/appi.ajp.157.8.1309; Emamian ES, 2004, NAT GENET, V36, P131, DOI 10.1038/ng1296; Fagerholm S, 2002, J BIOL CHEM, V277, P1728, DOI 10.1074/jbc.M106856200; Falls DL, 2003, EXP CELL RES, V284, P14, DOI 10.1016/S0014-4827(02)00102-7; GALILEO DS, 1992, NEURON, V9, P1117, DOI 10.1016/0896-6273(92)90070-T; Giannone G, 2002, J BIOL CHEM, V277, P26364, DOI 10.1074/jbc.M203952200; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; GOMPERTS BD, 2003, SIGNAL TRANSDUCTION, pR14; Grabham PW, 2000, J CELL SCI, V113, P3003; Grotewiel MS, 1998, NATURE, V391, P455, DOI 10.1038/35079; Harrison PJ, 2006, BIOL PSYCHIAT, V60, P132, DOI 10.1016/j.biopsych.2005.11.002; Harrison PJ, 2005, MOL PSYCHIATR, V10, P40, DOI 10.1038/sj.mp.4001558; HIRATA F, 1980, SCIENCE, V209, P1082, DOI 10.1126/science.6157192; Jacques TS, 1998, DEVELOPMENT, V125, P3167; Juliano RL, 2002, ANNU REV PHARMACOL, V42, P283, DOI 10.1146/annurev.pharmtox.42.090401.151133; KOOPMAN G, 1990, J IMMUNOL, V145, P3589; Kumar R, 2001, SEMIN ONCOL, V28, P27, DOI 10.1016/S0093-7754(01)90279-9; Laudanna C, 1996, SCIENCE, V271, P981, DOI 10.1126/science.271.5251.981; LEUNGHAGESTEIJN CY, 1994, J CELL SCI, V107, P589; Lewis DA, 2002, ANNU REV NEUROSCI, V25, P409, DOI 10.1146/annurev.neuro.25.112701.142754; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Matsui A, 2000, CANCER LETT, V150, P23, DOI 10.1016/S0304-3835(99)00368-7; NESHER G, 1991, ANN RHEUM DIS, V50, P637, DOI 10.1136/ard.50.9.637; Nielsen M, 1996, J IMMUNOL, V157, P5350; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; PATARROYO M, 1985, SCAND J IMMUNOL, V22, P171, DOI 10.1111/j.1365-3083.1985.tb01869.x; Perez-Tenorio G, 2002, BRIT J CANCER, V86, P540, DOI 10.1038/sj.bjc.6600126; Pietri T, 2004, DEVELOPMENT, V131, P3871, DOI 10.1242/dev.01264; PIKE MC, 1981, J IMMUNOL, V127, P1444; PRESSMAN S, 1991, AM J HUM GENET, V49, P467; Richard PT, 2004, INT J BIOCHEM CELL B, V36, P1135, DOI 10.1016/j.biocel.2004.01.010; Rodriguez-Fernandez JL, 2001, J BIOL CHEM, V276, P40518, DOI 10.1074/jbc.M102896200; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; SEI Y, 2007, MOL PSYCHIAT; Shimizu Y, 1995, J CELL BIOL, V131, P1867, DOI 10.1083/jcb.131.6.1867; Shu S, 2006, P NATL ACAD SCI USA, V103, P19788, DOI 10.1073/pnas.0609385103; Smith A, 2003, J CELL SCI, V116, P3123, DOI 10.1242/jcs.00606; SOMANATH PR, 2007, J BIOL CHEM; Staubli U, 1998, J NEUROSCI, V18, P3460; Stefansson H, 2002, AM J HUM GENET, V71, P877, DOI 10.1086/342734; Stewart M, 1996, J CELL BIOCHEM, V61, P554, DOI 10.1002/(SICI)1097-4644(19960616)61:4<554::AID-JCB8>3.0.CO;2-N; Stewart MP, 1998, J CELL BIOL, V140, P699, DOI 10.1083/jcb.140.3.699; Tan M, 1999, CANCER RES, V59, P1620; TAN W, 2007, J BIOL CHEM; Tate MC, 2004, MOL CELL NEUROSCI, V27, P22, DOI 10.1016/j.mcn.2004.05.001; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Tsai MS, 2003, ONCOGENE, V22, P761, DOI 10.1038/sj.onc.1206130; VANKOOYK Y, 1989, NATURE, V342, P811, DOI 10.1038/342811a0; Verploegen S, 2005, BLOOD, V106, P1076, DOI 10.1182/blood-2004-09-3755; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Xu C, 2006, AM J MED GENET B, V141B, P36, DOI 10.1002/ajmg.b.30239; Yanagisawa M, 2004, GENES CELLS, V9, P801, DOI 10.1111/j.1365-2443.2004.00764.x; Zell T, 1996, J IMMUNOL, V156, P883; Zhang ZQ, 1998, J NEUROSCI, V18, P6928; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	69	51	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1369	10.1371/journal.pone.0001369	http://dx.doi.org/10.1371/journal.pone.0001369			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159252	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459700026
J	Takahashi, T; Shirai, Y; Kosaka, T; Hosoya, H				Takahashi, Toshiyuki; Shirai, Yohji; Kosaka, Toshikazu; Hosoya, Hiroshi			Arrest of Cytoplasmic Streaming Induces Algal Proliferation in Green Paramecia	PLOS ONE			English	Article								A green ciliate Paramecium bursaria, bearing several hundreds of endosymbiotic algae, demonstrates rotational microtubule-based cytoplasmic streaming, in which cytoplasmic granules and endosymbiotic algae flow in a constant direction. However, its physiological significance is still unknown. We investigated physiological roles of cytoplasmic streaming in P. bursaria through host cell cycle using video-microscopy. Here, we found that cytoplasmic streaming was arrested in dividing green paramecia and the endosymbiotic algae proliferated only during the arrest of cytoplasmic streaming. Interestingly, arrest of cytoplasmic streaming with pressure or a microtubule drug also induced proliferation of endosymbiotic algae independently of host cell cycle. Thus, cytoplasmic streaming may control the algal proliferation in P. bursaria. Furthermore, confocal microscopic observation revealed that a division septum was formed in the constricted area of a dividing paramecium, producing arrest of cytoplasmic streaming. This is a first report to suggest that cytoplasmic streaming controls proliferation of eukaryotic cells.	[Takahashi, Toshiyuki; Shirai, Yohji; Kosaka, Toshikazu; Hosoya, Hiroshi] Hiroshima Univ, Grad Sch Biol Sci, Hiroshima, Japan	Hiroshima University	Hosoya, H (corresponding author), Hiroshima Univ, Grad Sch Biol Sci, Hiroshima, Japan.	hhosoya@hiroshima-u.ac.jp	Takahashi, Toshiyuki/J-7660-2015	Takahashi, Toshiyuki/0000-0001-8976-7707	Hiroshima University	Hiroshima University	Funding: Grant from Hiroshima University	Badrinath AS, 2003, DEV BIOL, V258, P70, DOI 10.1016/S0012-1606(03)00102-7; Bramhill D, 1997, ANNU REV CELL DEV BI, V13, P395, DOI 10.1146/annurev.cellbio.13.1.395; COHEN J, 1984, CELL MOTIL CYTOSKEL, V4, P443, DOI 10.1002/cm.970040605; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Gonda K, 1999, J CELL SCI, V112, P3619; Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002; Hollenbeck PJ, 2005, J CELL SCI, V118, P5411, DOI 10.1242/jcs.053850; Hosoya H, 1995, ZOOL SCI, V12, P807, DOI 10.2108/zsj.12.807; Jurgens G, 2005, TRENDS CELL BIOL, V15, P277, DOI 10.1016/j.tcb.2005.03.005; Kuroiwa T, 2006, BBA-MOL CELL RES, V1763, P510, DOI 10.1016/j.bbamcr.2006.03.007; Miyagishima S, 2005, J PLANT RES, V118, P295, DOI 10.1007/s10265-005-0226-2; Nishida K, 2005, MOL BIOL CELL, V16, P2493, DOI 10.1091/mbc.e05-01-0068; Nishihara N, 1998, PROTOPLASMA, V203, P91, DOI 10.1007/BF01280591; Nishihara N, 1999, CELL MOTIL CYTOSKEL, V43, P85, DOI 10.1002/(SICI)1097-0169(1999)43:2<85::AID-CM1>3.0.CO;2-5; Numata O, 2001, CELL STRUCT FUNCT, V26, P593, DOI 10.1247/csf.26.593; Okamoto N, 2005, SCIENCE, V310, P287, DOI 10.1126/science.1116125; Osteryoung KW, 2003, SCIENCE, V302, P1698, DOI 10.1126/science.1082192; Shimmen T, 2004, CURR OPIN CELL BIOL, V16, P68, DOI 10.1016/j.ceb.2003.11.009; Takahashi T, 2005, TOXICOL IN VITRO, V19, P99, DOI 10.1016/j.tiv.2004.06.012; TAKAHASHI T, 2005, NEW TECHNOL MED, V6, P50	20	19	19	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1352	10.1371/journal.pone.0001352	http://dx.doi.org/10.1371/journal.pone.0001352			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159235	gold, Green Submitted, Green Published			2022-12-25	WOS:000207459700009
J	Velasco, R; Zharkikh, A; Troggio, M; Cartwright, DA; Cestaro, A; Pruss, D; Pindo, M; FitzGerald, LM; Vezzulli, S; Reid, J; Malacarne, G; Iliev, D; Coppola, G; Wardell, B; Micheletti, D; Macalma, T; Facci, M; Mitchell, JT; Perazzolli, M; Eldredge, G; Gatto, P; Oyzerski, R; Moretto, M; Gutin, N; Stefanini, M; Chen, Y; Segala, C; Davenport, C; Dematte, L; Mraz, A; Battilana, J; Stormo, K; Costa, F; Tao, QZ; Si-Ammour, A; Harkins, T; Lackey, A; Perbost, C; Taillon, B; Stella, A; Solovyev, V; Fawcett, JA; Sterck, L; Vandepoele, K; Grando, SM; Toppo, S; Moser, C; Lanchbury, J; Bogden, R; Skolnick, M; Sgaramella, V; Bhatnagar, SK; Fontana, P; Gutin, A; Van de Peer, Y; Salamini, F; Viola, R				Velasco, Riccardo; Zharkikh, Andrey; Troggio, Michela; Cartwright, Dustin A.; Cestaro, Alessandro; Pruss, Dmitry; Pindo, Massimo; FitzGerald, Lisa M.; Vezzulli, Silvia; Reid, Julia; Malacarne, Giulia; Iliev, Diana; Coppola, Giuseppina; Wardell, Bryan; Micheletti, Diego; Macalma, Teresita; Facci, Marco; Mitchell, Jeff T.; Perazzolli, Michele; Eldredge, Glenn; Gatto, Pamela; Oyzerski, Rozan; Moretto, Marco; Gutin, Natalia; Stefanini, Marco; Chen, Yang; Segala, Cinzia; Davenport, Christine; Dematte, Lorenzo; Mraz, Amy; Battilana, Juri; Stormo, Keith; Costa, Fabrizio; Tao, Quanzhou; Si-Ammour, Azeddine; Harkins, Tim; Lackey, Angie; Perbost, Clotilde; Taillon, Bruce; Stella, Alessandra; Solovyev, Victor; Fawcett, Jeffrey A.; Sterck, Lieven; Vandepoele, Klaas; Grando, Stella M.; Toppo, Stefano; Moser, Claudio; Lanchbury, Jerry; Bogden, Robert; Skolnick, Mark; Sgaramella, Vittorio; Bhatnagar, Satish K.; Fontana, Paolo; Gutin, Alexander; Van de Peer, Yves; Salamini, Francesco; Viola, Roberto			A High Quality Draft Consensus Sequence of the Genome of a Heterozygous Grapevine Variety	PLOS ONE			English	Article							VITIS-VINIFERA L.; GENETIC-LINKAGE MAP; MADS-BOX GENE; QUANTITATIVE TRAIT LOCUS; TRANSCRIPTION FACTOR; PROANTHOCYANIDIN SYNTHESIS; NONHOST RESISTANCE; MOLECULAR ANALYSIS; DEFENSE RESPONSES; DUPLICATION	Background. Worldwide, grapes and their derived products have a large market. The cultivated grape species Vitis vinifera has potential to become a model for fruit trees genetics. Like many plant species, it is highly heterozygous, which is an additional challenge to modern whole genome shotgun sequencing. In this paper a high quality draft genome sequence of a cultivated clone of V. vinifera Pinot Noir is presented. Principal Findings. We estimate the genome size of V. vinifera to be 504.6 Mb. Genomic sequences corresponding to 477.1 Mb were assembled in 2,093 metacontigs and 435.1 Mb were anchored to the 19 linkage groups (LGs). The number of predicted genes is 29,585, of which 96.1% were assigned to LGs. This assembly of the grape genome provides candidate genes implicated in traits relevant to grapevine cultivation, such as those influencing wine quality, via secondary metabolites, and those connected with the extreme susceptibility of grape to pathogens. Single nucleotide polymorphism ( SNP) distribution was consistent with a diffuse haplotype structure across the genome. Of around 2,000,000 SNPs, 1,751,176 were mapped to chromosomes and one or more of them were identified in 86.7% of anchored genes. The relative age of grape duplicated genes was estimated and this made possible to reveal a relatively recent Vitis-specific large scale duplication event concerning at least 10 chromosomes (duplication not reported before). Conclusions. Sanger shotgun sequencing and highly efficient sequencing by synthesis (SBS), together with dedicated assembly programs, resolved a complex heterozygous genome. A consensus sequence of the genome and a set of mapped marker loci were generated. Homologous chromosomes of Pinot Noir differ by 11.2% of their DNA (hemizygous DNA plus chromosomal gaps). SNP markers are offered as a tool with the potential of introducing a new era in the molecular breeding of grape.	[Velasco, Riccardo; Troggio, Michela; Cartwright, Dustin A.; Cestaro, Alessandro; Pindo, Massimo; Vezzulli, Silvia; Malacarne, Giulia; Coppola, Giuseppina; Micheletti, Diego; Facci, Marco; Perazzolli, Michele; Gatto, Pamela; Moretto, Marco; Stefanini, Marco; Segala, Cinzia; Dematte, Lorenzo; Battilana, Juri; Costa, Fabrizio; Si-Ammour, Azeddine; Grando, Stella M.; Moser, Claudio; Fontana, Paolo; Viola, Roberto] IASMA Res Ctr, San Michele All Adige, Trento, Italy; [Zharkikh, Andrey; Cartwright, Dustin A.; Pruss, Dmitry; FitzGerald, Lisa M.; Reid, Julia; Iliev, Diana; Wardell, Bryan; Macalma, Teresita; Mitchell, Jeff T.; Eldredge, Glenn; Oyzerski, Rozan; Gutin, Natalia; Chen, Yang; Davenport, Christine; Lanchbury, Jerry; Skolnick, Mark; Bhatnagar, Satish K.; Gutin, Alexander] Myriad Genet Inc, Salt Lake City, UT USA; [Perbost, Clotilde; Taillon, Bruce] 454 Life Sci Corp, Branford, CT USA; [Harkins, Tim; Lackey, Angie] Roche Diagnost Corp, Roche Appl Sci, Indianapolis, IN USA; [Mraz, Amy; Stormo, Keith; Tao, Quanzhou; Bogden, Robert] Amplicon Express Inc, Pullman, WA USA; [Fawcett, Jeffrey A.; Sterck, Lieven; Vandepoele, Klaas; Van de Peer, Yves] Gent Univ VIB, Dept Plant Syst Biol, Ghent, Belgium; [Toppo, Stefano] Univ Padua, Dept Biol Chem, Padua, Italy; [Solovyev, Victor] Univ London, Dept Comp Sci, Egham, Surrey, England; [Stella, Alessandra; Sgaramella, Vittorio; Salamini, Francesco] Technol Pk Lodi, Lodi, Italy	Fondazione Edmund Mach; Myriad Genetics, Inc; Roche Holding; Flanders Institute for Biotechnology (VIB); Ghent University; University of Padua; University of London; Royal Holloway University London	Velasco, R (corresponding author), IASMA Res Ctr, San Michele All Adige, Trento, Italy.	riccardo.velasco@iasma.it	stella, Alessandra/AAG-6401-2021; Solovyev, Victor/C-4614-2013; Malacarne, Giulia/A-5349-2012; Toppo, Stefano/Z-5479-2019; Stefanini, Marco/AGD-6778-2022; Vandepoele, Klaas/E-7514-2010; Malacarne, Giulia/N-4244-2015; Sterck, Lieven/A-9439-2016; Moser, Claudio/B-4686-2010; Perazzolli, Michele/B-3636-2012; Grando, Maria Stella/D-5448-2011; Viola, Roberto/D-2277-2010; Van de Peer, Yves/AAE-7666-2019; Fawcett, Jeffrey/B-4145-2008; Velasco, Riccardo/G-8710-2011; stella, Alessandra/ABB-1952-2021; Van de Peer, Yves/D-4388-2009; Stella, Alessandra/AAY-7322-2020; Viola, Roberto/F-3657-2014	stella, Alessandra/0000-0003-2850-3964; Solovyev, Victor/0000-0001-8885-493X; Toppo, Stefano/0000-0002-0246-3119; Stefanini, Marco/0000-0001-7829-0528; Vandepoele, Klaas/0000-0003-4790-2725; Malacarne, Giulia/0000-0003-1439-5958; Sterck, Lieven/0000-0001-7116-4000; Moser, Claudio/0000-0002-9141-7850; Perazzolli, Michele/0000-0001-7218-9963; Grando, Maria Stella/0000-0002-6889-1968; Van de Peer, Yves/0000-0003-4327-3730; stella, Alessandra/0000-0003-2850-3964; Van de Peer, Yves/0000-0003-4327-3730; Cestaro, Alessandro/0000-0003-1439-5165; Velasco, Riccardo/0000-0002-8760-5031; Costa, Fabrizio/0000-0003-1416-1078; Fawcett, Jeffrey/0000-0003-3907-2135; Micheletti, Diego/0000-0001-9175-9853; Si Ammour, Azeddine/0000-0002-5504-4444; Viola, Roberto/0000-0002-8202-8503; Moretto, Marco/0000-0003-4555-7243; Vezzulli, Silvia/0000-0002-1447-486X; Pindo, Massimo/0000-0002-8516-9010	Province of Trento, Italy	Province of Trento, Italy(Autonomous Province of Trento)	This work has been funded by the Province of Trento, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam-Blondon AF, 2005, THEOR APPL GENET, V110, P1363, DOI 10.1007/s00122-005-1924-9; Adam-Blondon AF, 2004, THEOR APPL GENET, V109, P1017, DOI 10.1007/s00122-004-1704-y; Aharoni A, 2001, PLANT J, V28, P319, DOI 10.1046/j.1365-313X.2001.01154.x; Akkurt M, 2007, MOL BREEDING, V19, P103, DOI 10.1007/s11032-006-9047-9; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez-Buylla ER, 2000, P NATL ACAD SCI USA, V97, P5328, DOI 10.1073/pnas.97.10.5328; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bai JF, 2002, GENOME RES, V12, P1871, DOI 10.1101/gr.454902; Bakker EG, 2006, PLANT CELL, V18, P1803, DOI 10.1105/tpc.106.042614; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Belhadj A, 2006, J AGR FOOD CHEM, V54, P9119, DOI 10.1021/jf0618022; Bogs J, 2006, PLANT PHYSIOL, V140, P279, DOI 10.1104/pp.105.073262; Bogs J, 2005, PLANT PHYSIOL, V139, P652, DOI 10.1104/pp.105.064238; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Bohlmann J, 1998, P NATL ACAD SCI USA, V95, P4126, DOI 10.1073/pnas.95.8.4126; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Brown JWS, 2001, RNA, V7, P1817; Brunner S, 2005, PLANT CELL, V17, P343, DOI 10.1105/tpc.104.025627; Burns J, 2000, J AGR FOOD CHEM, V48, P220, DOI 10.1021/jf9909757; Buttner M, 1997, P NATL ACAD SCI USA, V94, P5961, DOI 10.1073/pnas.94.11.5961; Byrne KP, 2007, GENETICS, V175, P1341, DOI 10.1534/genetics.106.066951; Cartwright DA, 2007, GENETICS, V176, P2521, DOI 10.1534/genetics.106.063982; Chandler M, 2002, MOBILE DNA, V2, P305; Chen ZY, 2006, PLANT MOL BIOL, V60, P583, DOI 10.1007/s11103-005-5082-x; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Dalbo MA, 2001, J AM SOC HORTIC SCI, V126, P83, DOI 10.21273/JASHS.126.1.83; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; De Bodt S, 2005, TRENDS ECOL EVOL, V20, P591, DOI 10.1016/j.tree.2005.07.008; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Di Gaspero G, 2007, THEOR APPL GENET, V114, P1249, DOI 10.1007/s00122-007-0516-2; Doucleff M, 2004, THEOR APPL GENET, V109, P1178, DOI 10.1007/s00122-004-1728-3; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feschotte C, 2002, NAT REV GENET, V3, P329, DOI 10.1038/nrg793; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Fischer BM, 2004, THEOR APPL GENET, V108, P501, DOI 10.1007/s00122-003-1445-3; Fridman E, 2000, P NATL ACAD SCI USA, V97, P4718, DOI 10.1073/pnas.97.9.4718; Fujita A, 2006, BIOSCI BIOTECH BIOCH, V70, P632, DOI 10.1271/bbb.70.632; Geekiyanage S, 2007, PLANT BIOTECHNOL REP, V1, P11, DOI 10.1007/s11816-006-0001-4; Giovannoni JJ, 2007, CURR OPIN PLANT BIOL, V10, P283, DOI 10.1016/j.pbi.2007.04.008; Goff SA, 2002, SCIENCE, V296, P92, DOI 10.1126/science.1068275; Grando MS, 2003, THEOR APPL GENET, V106, P1213, DOI 10.1007/s00122-002-1170-3; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; GRATTAPAGLIA D, 1994, GENETICS, V137, P1121; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hall D, 2007, PLANT J, V49, P579, DOI 10.1111/j.1365-313X.2006.02987.x; HARBORNE JB, 1991, ECOLOGICAL CHEM BIOC, P399; HENIKOFF S, 1994, J MOL BIOL, V243, P574, DOI 10.1016/0022-2836(94)90032-9; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Jansen RK, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-32; Jeandet P, 2002, J AGR FOOD CHEM, V50, P2731, DOI 10.1021/jf011429s; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Kikkert JR, 2005, IN VITRO CELL DEV-PL, V41, P232, DOI 10.1079/IVP2004609; Korf I, 2001, Bioinformatics, V17 Suppl 1, pS140; Leister D, 2004, TRENDS GENET, V20, P116, DOI 10.1016/j.tig.2004.01.007; LEVADOUX L., 1956, Annales de l'Amelioration des Plantes, V6, P59; LEWIS WH, 1979, POLYPLOIDY BIOL RELE, P241; Li WH, 2001, NATURE, V409, P847, DOI 10.1038/35057039; Lichtenthaler HK, 1997, PHYSIOL PLANTARUM, V101, P643, DOI 10.1111/j.1399-3054.1997.tb01049.x; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lipka V, 2005, SCIENCE, V310, P1180, DOI 10.1126/science.1119409; LODHI MA, 1995, THEOR APPL GENET, V90, P11, DOI 10.1007/BF00220990; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Lowe KM, 2006, THEOR APPL GENET, V112, P1582, DOI 10.1007/s00122-006-0264-8; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luan F, 2002, PHYTOCHEMISTRY, V60, P451, DOI 10.1016/S0031-9422(02)00147-4; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Majoros WH, 2004, BIOINFORMATICS, V20, P2878, DOI 10.1093/bioinformatics/bth315; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin DM, 2004, PHYTOCHEMISTRY, V65, P1223, DOI 10.1016/j.phytochem.2004.03.018; Mattivi F, 2002, ANN NY ACAD SCI, V957, P37, DOI 10.1111/j.1749-6632.2002.tb02904.x; Mauricio R, 2003, GENETICS, V163, P735; McCaskill D, 1998, TRENDS BIOTECHNOL, V16, P349, DOI 10.1016/S0167-7799(98)01231-1; McGovern PE, 2003, ANCIENT WINE SEARCH; Meyers BC, 2005, CURR OPIN PLANT BIOL, V8, P129, DOI 10.1016/j.pbi.2005.01.002; Meyers BC, 1998, PLANT CELL, V10, P1833, DOI 10.1105/tpc.10.11.1833; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841; Ng M, 2001, NAT REV GENET, V2, P186, DOI 10.1038/35056041; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OLMO HP, 1979, EVOLUTION CROP PLANT; Panagiotakos DB, 2004, MED SCI MONITOR, V10, pRA193; Rafalski A, 2002, CURR OPIN PLANT BIOL, V5, P94, DOI 10.1016/S1369-5266(02)00240-6; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Riano-Pachon DM, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-42; Richly E, 2002, MOL BIOL EVOL, V19, P76, DOI 10.1093/oxfordjournals.molbev.a003984; Richter H, 2005, PHYSIOL MOL PLANT P, V67, P248, DOI 10.1016/j.pmpp.2006.03.001; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Rodriguez-Uribe L, 2006, J EXP BOT, V57, P1391, DOI 10.1093/jxb/erj118; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scalbert A, 2005, CRIT REV FOOD SCI, V45, P287, DOI 10.1080/1040869059096; SCHRODER G, 1988, EUR J BIOCHEM, V172, P161, DOI 10.1111/j.1432-1033.1988.tb13868.x; Shen JD, 2006, GENETICS, V172, P1243, DOI 10.1534/genetics.105.047290; Shiu SH, 2005, PLANT PHYSIOL, V139, P18, DOI 10.1104/pp.105.065110; Simillion C, 2004, GENOME RES, V14, P1095, DOI 10.1101/gr.2179004; Simillion C, 2002, P NATL ACAD SCI USA, V99, P13627, DOI 10.1073/pnas.212522399; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; SPARVOLI F, 1994, PLANT MOL BIOL, V24, P743, DOI 10.1007/BF00029856; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Stein M, 2006, PLANT CELL, V18, P731, DOI 10.1105/tpc.105.038372; Sunkar R, 2007, TRENDS PLANT SCI, V12, P301, DOI 10.1016/j.tplants.2007.05.001; Takken FLW, 2006, CURR OPIN PLANT BIOL, V9, P383, DOI 10.1016/j.pbi.2006.05.009; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; This P, 2006, TRENDS GENET, V22, P511, DOI 10.1016/j.tig.2006.07.008; Tholl D, 2006, CURR OPIN PLANT BIOL, V9, P297, DOI 10.1016/j.pbi.2006.03.014; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thornsberry JM, 2001, NAT GENET, V28, P286, DOI 10.1038/90135; Tobler Andreas R, 2005, J Biomol Tech, V16, P398; Troggio M, 2007, GENETICS, V176, P2637, DOI 10.1534/genetics.106.067462; Tsai CJ, 2006, NEW PHYTOL, V172, P47, DOI 10.1111/j.1469-8137.2006.01798.x; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Van de Peer Y, 2001, J MOL EVOL, V53, P436, DOI 10.1007/s002390010233; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; Wang BB, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r102; Wang QC, 2005, PLANT SCI, V168, P565, DOI 10.1016/j.plantsci.2004.09.033; Waterhouse AL, 2002, ANN NY ACAD SCI, V957, P21, DOI 10.1111/j.1749-6632.2002.tb02903.x; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhu QH, 2007, BIOINFORMATICS, V23, P1307, DOI 10.1093/bioinformatics/btm113	129	778	859	8	184	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1326	10.1371/journal.pone.0001326	http://dx.doi.org/10.1371/journal.pone.0001326			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094749	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459600014
J	Kreis, S; Philippidou, D; Margue, C; Rolvering, C; Haan, C; Dumoutier, L; Renauld, JC; Behrmann, I				Kreis, Stephanie; Philippidou, Demetra; Margue, Christiane; Rolvering, Catherine; Haan, Claude; Dumoutier, Laure; Renauld, Jean-Christophe; Behrmann, Iris			Recombinant Interleukin-24 Lacks Apoptosis-Inducing Properties in Melanoma Cells	PLOS ONE			English	Article								IL-24, also known as melanoma differentiation antigen 7 (mda-7), is a member of the IL-10 family of cytokines and is mainly produced by Th-2 cells as well as by activated monocytes. Binding of IL-24 to either of its two possible heterodimeric receptors IL-20R1/IL-20R2 and IL-22R/IL-20R2 activates STAT3 and/or STAT1 in target tissues such as lung, testis, ovary, keratinocytes and skin. To date, the physiological properties of IL-24 are still not well understood but available data suggest that IL-24 affects epidermal functions by increasing proliferation of dermal cells. In stark contrast to its "normal'' and physiological behaviour, IL-24 has been reported to selectively and efficiently kill a vast variety of cancer cells, especially melanoma cells, independent of receptor expression and Jak-STAT signalling. These intriguing properties have led to the development of adenovirally-expressed IL-24, which is currently being evaluated in clinical trials. Using three different methods, we have analysed a large panel of melanoma cell lines with respect to IL-24 and IL-24 receptor expression and found that none of the investigated cell lines expressed sufficient amounts of functional receptor pairs and therefore did not react to IL-24 stimulation with Jak/STAT activation. Results for three cell lines contrasted with previous studies, which reported presence of IL-24 receptors and activation of STAT3 following IL-24 stimulation. Furthermore, evaluating four different sources and modes of IL-24 administration (commercial recombinant IL-24, bacterially expressed GST-IL-24 fusion protein, IL-24 produced from transfected Hek cells, transiently over-expressed IL-24) no induction or increase in cell death was detected when compared to appropriate control treatments. Thus, we conclude that the cytokine IL-24 itself has no cancer-specific apoptosis-inducing properties in melanoma cells.	[Kreis, Stephanie; Philippidou, Demetra; Margue, Christiane; Rolvering, Catherine; Haan, Claude; Behrmann, Iris] Univ Luxembourg, LBPI, Life Sci Res Unit, Luxembourg, Luxembourg; [Dumoutier, Laure; Renauld, Jean-Christophe] Univ Louvain, Ludwig Inst Canc Res, Brussels, Belgium	University of Luxembourg; Ludwig Institute for Cancer Research; Universite Catholique Louvain	Kreis, S (corresponding author), Univ Luxembourg, LBPI, Life Sci Res Unit, Luxembourg, Luxembourg.	stephanie.kreis@uni.lu	; Renauld, Jean-Christophe/B-7268-2012	Kreis, Stephanie/0000-0003-1865-3889; Behrmann, Iris/0000-0003-3688-3645; Dumoutier, Laure/0000-0002-6645-684X; Renauld, Jean-Christophe/0000-0003-1736-2131	University of Luxembourg [R1F107L02]	University of Luxembourg	The study was financed by grant R1F107L02 from the University of Luxembourg.	Allen M, 2005, INT J IMMUNOGENET, V32, P375, DOI 10.1111/j.1744-313X.2005.00540.x; Blumberg H, 2001, CELL, V104, P9, DOI 10.1016/S0092-8674(01)00187-8; Caudell EG, 2002, J IMMUNOL, V168, P6041, DOI 10.4049/jimmunol.168.12.6041; Chada S, 2005, MOL THER, V11, P724, DOI 10.1016/j.ymthe.2004.12.021; Chada S, 2004, MOL THER, V10, P1085, DOI 10.1016/j.ymthe.2004.08.020; Chada S, 2004, INT IMMUNOPHARMACOL, V4, P649, DOI 10.1016/j.intimp.2004.01.017; Dent P, 2005, J CELL BIOCHEM, V95, P712, DOI 10.1002/jcb.20502; Dumoutier L, 2001, J IMMUNOL, V167, P3545, DOI 10.4049/jimmunol.167.7.3545; Dumoutier L, 2002, EUR CYTOKINE NETW, V13, P5; Ekmekcioglu S, 2003, MOL CANCER THER, V2, P9; Ekmekcioglu S, 2001, INT J CANCER, V94, P54, DOI 10.1002/ijc.1437; Ellerhorst JA, 2002, J CLIN ONCOL, V20, P1069, DOI 10.1200/JCO.2002.20.4.1069; Fisher PB, 2005, CANCER RES, V65, P10128, DOI 10.1158/0008-5472.CAN-05-3127; GUPTA P, 2006, PHARM THER; Gupta P, 2006, CANCER RES, V66, P8182, DOI 10.1158/0008-5472.CAN-06-0577; Gupta P, 2006, PHARMACOL THERAPEUT, V111, P596, DOI 10.1016/j.pharmthera.2005.11.005; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Heinrich PC, 2003, BIOCHEM J, V374, P1, DOI 10.1042/BJ20030407; Huang EY, 2001, ONCOGENE, V20, P7051, DOI 10.1038/sj.onc.1204897; Jiang HP, 1995, ONCOGENE, V11, P2477; Jiang HP, 1996, P NATL ACAD SCI USA, V93, P9160, DOI 10.1073/pnas.93.17.9160; Kortylewski M, 2004, J INVEST DERMATOL, V122, P414, DOI 10.1046/j.0022-202X.2004.22237.x; Kortylewski M, 1999, ONCOGENE, V18, P3742, DOI 10.1038/sj.onc.1202708; Kunz S, 2006, EXP DERMATOL, V15, P991, DOI 10.1111/j.1600-0625.2006.00516.x; Lebedeva IV, 2005, MOL THER, V11, P4, DOI 10.1016/j.ymthe.2004.08.012; Lebedeva IV, 2002, ONCOGENE, V21, P708, DOI 10.1038/sj.onc.1205116; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LU C, 1992, P NATL ACAD SCI USA, V89, P9215, DOI 10.1073/pnas.89.19.9215; Namiki S, 2003, BIOCHEM BIOPH RES CO, V305, P592, DOI 10.1016/S0006-291X(03)00807-6; Novak JP, 2002, J BIOL CHEM, V277, P47517, DOI 10.1074/jbc.M205114200; Pataer A, 2005, MOL THER, V11, P717, DOI 10.1016/j.ymthe.2005.01.018; Poindexter NJ, 2005, J LEUKOCYTE BIOL, V78, P745, DOI 10.1189/jlb.0205116; Sarkar D, 2005, P NATL ACAD SCI USA, V102, P14034, DOI 10.1073/pnas.0506837102; Sarkar D, 2002, P NATL ACAD SCI USA, V99, P10054, DOI 10.1073/pnas.152327199; Sauane M, 2004, ONCOGENE, V23, P7679, DOI 10.1038/sj.onc.1207958; Sauane M, 2004, CANCER RES, V64, P2988, DOI 10.1158/0008-5472.CAN-04-0200; Sauane M, 2003, J CELL PHYSIOL, V196, P334, DOI 10.1002/jcp.10309; Sauane M, 2003, CYTOKINE GROWTH F R, V14, P35, DOI 10.1016/S1359-6101(02)00074-6; Sauane M, 2006, CANCER RES, V66, P11869, DOI 10.1158/0008-5472.CAN-06-1887; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Sieger KA, 2004, MOL THER, V9, P355, DOI 10.1016/j.ymthe.2003.11.014; SU Z, 2005, ONCOGENE; Su ZZ, 2003, ONCOGENE, V22, P1164, DOI 10.1038/sj.onc.1206062; Su ZZ, 2005, ONCOGENE, V24, P7552, DOI 10.1038/sj.onc.1208911; Su ZZ, 1998, P NATL ACAD SCI USA, V95, P14400, DOI 10.1073/pnas.95.24.14400; Tong AW, 2005, MOL THER, V11, P160, DOI 10.1016/j.ymthe.2004.09.021; Wang M, 2005, IMMUNOLOGY, V114, P166, DOI 10.1111/j.1365-2567.2005.02094.x; Wang M, 2002, J BIOL CHEM, V277, P7341, DOI 10.1074/jbc.M106043200; Wolk K, 2002, J IMMUNOL, V168, P5397, DOI 10.4049/jimmunol.168.11.5397; Yacoub A, 2004, CANCER BIOL THER, V3, P739, DOI 10.4161/cbt.3.8.968; ZHENG M, 2006, CANC IMMUNOL IMMUNOT	51	29	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1300	10.1371/journal.pone.0001300	http://dx.doi.org/10.1371/journal.pone.0001300			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074024	Green Published, gold			2022-12-25	WOS:000207459500019
J	Torres, M; Fernandez-Fuentes, N; Fiser, A; Casadevall, A				Torres, Marcela; Fernandez-Fuentes, Narcis; Fiser, Andras; Casadevall, Arturo			Exchanging Murine and Human Immunoglobulin Constant Chains Affects the Kinetics and Thermodynamics of Antigen Binding and Chimeric Antibody Autoreactivity	PLOS ONE			English	Article								Mouse-human chimeric antibodies composed of murine variable (V) and human (C) chains are useful therapeutic reagents. Consequently, we investigated whether heterologous C-regions from mice and humans affected specificity and affinity, and determined the contribution of CH glycosylation to antigen binding. The interaction of a 12-mer peptide mimetic with monoclonal antibody (mAb) 18B7 to Cryptococcus neoformans glucuronoxylomannan, and its chimeric (ch) and deglycosylated forms were studied by surface plasmon resonance. The equilibrium and rate association constants for the chAb were higher than for mAb 18B7. V region affinity was not affected by CH region glycosylation whereas heterologous C region of the same isotype altered the Ab binding affinity and the specificity for self-antigens. Structural models displayed local differences that implied changes on the connectivity of residues. These findings suggest that V region conformational changes can be dictated by the CH domains through an allosteric effect involving networks of highly connected amino acids.	[Torres, Marcela; Casadevall, Arturo] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Fernandez-Fuentes, Narcis; Fiser, Andras] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Casadevall, A (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.	casadeva@aecom.yu.edu		Fernandez-Fuentes, Narcis/0000-0002-6421-1080	NIH [GM62519-04, AI033142, AI033774, AI052733, HL059842]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059842] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI033142, R01AI052733, R01AI033142, R01AI033774] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding: This work was funded by NIH grants GM62519-04 (to AF) and AI033142, AI033774, AI052733, and HL059842 (to AC).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Benson DA, 2006, NUCLEIC ACIDS RES, V34, pD16, DOI 10.1093/nar/gkj157; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRADEN BC, 1995, FASEB J, V9, P9, DOI 10.1096/fasebj.9.1.7821765; Butler M, 2003, GLYCOBIOLOGY, V13, P601, DOI 10.1093/glycob/cwg079; CASADEVALL A, 1992, J INFECT DIS, V165, P1086, DOI 10.1093/infdis/165.6.1086; Fernandez C, 1997, SCAND J IMMUNOL, V45, P231, DOI 10.1046/j.1365-3083.1997.d01-397.x; FERNANDEZFUENTE.N, 2007, NUCL ACIDS IN PRESS; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; Gala FA, 2002, J BIOL CHEM, V277, P29005, DOI 10.1074/jbc.M203258200; Greenspan NS, 2001, ADV CANCER RES, V80, P147, DOI 10.1016/S0065-230X(01)80015-4; GREENSPAN NS, 1997, CONCEPTS CHEM CONT C, P383; Hindley Siobhan A., 1993, Biochemical Society Transactions, V21, p337S; HUBER R, 1976, H-S Z PHYSIOL CHEM, V357, P614; Jefferis R, 1998, IMMUNOL REV, V163, P59, DOI 10.1111/j.1600-065X.1998.tb01188.x; Knight DM, 1995, MOL IMMUNOL, V32, P1271, DOI 10.1016/0161-5890(95)00085-2; Larsen RA, 2005, ANTIMICROB AGENTS CH, V49, P952, DOI 10.1128/AAC.49.3.952-958.2005; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lipschultz CA, 2002, J MOL RECOGNIT, V15, P44, DOI 10.1002/jmr.559; McCloskey N, 1996, IMMUNOLOGY, V88, P169, DOI 10.1111/j.1365-2567.1996.tb00001.x; McLean GR, 2002, J IMMUNOL, V169, P1379, DOI 10.4049/jimmunol.169.3.1379; McLean GR, 2000, MOL IMMUNOL, V37, P837, DOI 10.1016/S0161-5890(00)00101-2; MORELOCK MM, 1994, J BIOL CHEM, V269, P13048; NOSE M, 1983, P NATL ACAD SCI-BIOL, V80, P6632, DOI 10.1073/pnas.80.21.6632; POLLACK M, 1995, INFECT IMMUN, V63, P4481, DOI 10.1128/IAI.63.11.4481-4488.1995; Pritsch O, 1996, J CLIN INVEST, V98, P2235, DOI 10.1172/JCI119033; Radaev S, 2001, J BIOL CHEM, V276, P16478, DOI 10.1074/jbc.M100351200; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; ROTHMAN RJ, 1989, BIOCHEMISTRY-US, V28, P1377, DOI 10.1021/bi00429a065; SCHREIBER JR, 1993, J INFECT DIS, V167, P221, DOI 10.1093/infdis/167.1.221; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Stanfield RL, 2006, J MOL BIOL, V357, P1566, DOI 10.1016/j.jmb.2006.01.023; SUTTON BJ, 1983, BIOCHEM SOC T, V11, P130, DOI 10.1042/bst0110130; TAO MH, 1989, J IMMUNOL, V143, P2595; Torres M, 2005, J IMMUNOL, V174, P2132, DOI 10.4049/jimmunol.174.4.2132; Torres M, 2007, J BIOL CHEM, V282, P13917, DOI 10.1074/jbc.M700661200; Valenzuela DM, 2003, NAT BIOTECHNOL, V21, P652, DOI 10.1038/nbt822; WALLICK SC, 1988, J EXP MED, V168, P1099, DOI 10.1084/jem.168.3.1099; Wang F, 2006, MOL IMMUNOL, V43, P987, DOI 10.1016/j.molimm.2005.05.013; WRIGHT A, 1994, J EXP MED, V180, P1087, DOI 10.1084/jem.180.3.1087; WRIGHT A, 1991, EMBO J, V10, P2717, DOI 10.1002/j.1460-2075.1991.tb07819.x; Wright A, 1997, TRENDS BIOTECHNOL, V15, P26, DOI 10.1016/S0167-7799(96)10062-7; WRIGHT JF, 1990, J BIOL CHEM, V265, P10506	46	31	32	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1310	10.1371/journal.pone.0001310	http://dx.doi.org/10.1371/journal.pone.0001310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074033	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459500028
J	Greenberg, Y; King, M; Kiosses, WB; Ewalt, K; Yang, X; Schimmel, P; Reader, JS; Tzima, E				Greenberg, Y.; King, M.; Kiosses, W. B.; Ewalt, K.; Yang, X.; Schimmel, P.; Reader, J. S.; Tzima, E.			The novel fragment of tyrosyl tRNA synthetase, mini-TyrRS, is secreted to induce an angiogenic response in endothelial cells	FASEB JOURNAL			English	Article						angiogenesis; vascular endothelial growth factor receptor 2; noncanonical	NITRIC-OXIDE SYNTHASE; FLUID SHEAR-STRESS; GROWTH-FACTOR; CXC CHEMOKINE; IN-VITRO; RECEPTOR; TRANSACTIVATION; ACTIVATION; PHOSPHORYLATION; KDR/FLK-1	Aminoacyl tRNA synthetases-enzymes that catalyze the first step of protein synthesis-in mammalian cells are now known to have expanded functions, including activities in signal transduction pathways, such as those for angiogenesis and inflammation. The native synthetases themselves are procytokines, having no signal transduction activities. After alternative splicing or natural proteolysis, specific fragments that are potent cytokines and that interact with specific receptors on cell surfaces are released. In this manner, a natural fragment of human tyrosyl tRNA synthetase (TyrRS), mini-TyrRS, has been shown to act as a proangiogenic cytokine. The mechanistic basis for the action of mini-TyrRS in angiogenesis has yet to be established. Here, we show that mini-TyrRS is exported from endothelial cells when they are treated with tumor necrosis factor-alpha. Mini-TyrRS binds to vascular endothelial cells and activates an array of angiogenic signal transduction pathways. Mini-TyrRS-induced angiogenesis requires the activation of vascular endothelial growth factor receptor-2 (VEGFR2/Flk-1/KDR). Mini-TyrRS stimulates VEGFR2 phosphorylation in a VEGF-independent manner, suggesting VEGFR2 transactivation. Transactivation of VEGFR2 and downstream angiogenesis require an intact Glu-Leu-Arg (ELR) motif in mini-TyrRS, which is important for its cytokine activity. These studies therefore suggest a mechanism by which mini-TyrRS induces angiogenesis in endothelial cells and provide further insight into the role of mini-TyrRS as a link between translation and angiogenesis.	[Greenberg, Y.; King, M.; Tzima, E.] Scripps Res Inst, Dept Cell & Mol Physiol, La Jolla, CA 92037 USA; [Kiosses, W. B.; Ewalt, K.; Yang, X.; Schimmel, P.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Reader, J. S.] Univ N Carolina, Dept Med, Chapel Hill, NC USA; [Reader, J. S.; Tzima, E.] Univ N Carolina, Carolina Cardiovasc Biol Ctr, Chapel Hill, NC USA	Scripps Research Institute; Scripps Research Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Tzima, E (corresponding author), Univ N Carolina, Dept Cell & Mol Physiol, 103 Mason Farm Rd, Chapel Hill, NC 27599 USA.	etzima@med.unc.edu	Tzima, Ellie/L-9256-2017; Yang, Xiang-Lei/AAR-7107-2020	Tzima, Ellie/0000-0002-3437-0902; Yang, Xiang-Lei/0000-0003-2554-084X				Bauer PM, 2003, J BIOL CHEM, V278, P14841, DOI 10.1074/jbc.M211926200; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; CLARKLEWIS I, 1991, J BIOL CHEM, V266, P23128; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Conway EM, 2001, CARDIOVASC RES, V49, P507, DOI 10.1016/S0008-6363(00)00281-9; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; Daniel TO, 2000, ANNU REV PHYSIOL, V62, P649, DOI 10.1146/annurev.physiol.62.1.649; Ewalt KL, 2002, BIOCHEMISTRY-US, V41, P13344, DOI 10.1021/bi020537k; Folkman J, 1998, CIRCULATION, V97, P1108, DOI 10.1161/01.CIR.97.12.1108; Fujita Y, 2006, ENDOCRINOLOGY, V147, P1377, DOI 10.1210/en.2005-0644; Halwani R, 2004, J VIROL, V78, P7553, DOI 10.1128/JVI.78.14.7553-7564.2004; Howard OMZ, 2002, J EXP MED, V196, P781, DOI 10.1084/jem.20020186; Jin ZG, 2003, CIRC RES, V93, P354, DOI 10.1161/01.RES.0000089257.94002.96; Jordanova A, 2006, NAT GENET, V38, P197, DOI 10.1038/ng1727; Kraling BM, 1999, J CELL SCI, V112, P1599; Miura S, 2003, HYPERTENSION, V41, P1118, DOI 10.1161/01.HYP.0000064345.33807.57; Murohara T, 1998, J CLIN INVEST, V101, P2567, DOI 10.1172/JCI1560; Nangle LA, 2007, P NATL ACAD SCI USA, V104, P11239, DOI 10.1073/pnas.0705055104; Otani A, 2002, P NATL ACAD SCI USA, V99, P178, DOI 10.1073/pnas.012601899; Papapetropoulos A, 1997, J CLIN INVEST, V100, P3131, DOI 10.1172/JCI119868; Papapetropoulos A, 1997, AM J PATHOL, V150, P1835; Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054; Park SG, 2006, IUBMB LIFE, V58, P556, DOI 10.1080/15216540600735974; Park SG, 2005, TRENDS BIOCHEM SCI, V30, P569, DOI 10.1016/j.tibs.2005.08.004; Presta M, 1999, CANCER RES, V59, P2417; Puyraimond A, 1999, J CELL SCI, V112, P1283; Rottinger E, 2004, DEVELOPMENT, V131, P1075, DOI 10.1242/dev.01000; Seburn KL, 2006, NEURON, V51, P715, DOI 10.1016/j.neuron.2006.08.027; Seye CI, 2004, J BIOL CHEM, V279, P35679, DOI 10.1074/jbc.M401799200; STRIETER RM, 1995, BIOCHEM BIOPH RES CO, V210, P51, DOI 10.1006/bbrc.1995.1626; STRIETER RM, 1995, SHOCK, V4, P155, DOI 10.1097/00024382-199509000-00001; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Tanimoto T, 2002, J BIOL CHEM, V277, P42997, DOI 10.1074/jbc.M204764200; Thuringer D, 2002, J BIOL CHEM, V277, P2028, DOI 10.1074/jbc.M109493200; Tzima E, 2005, J BIOL CHEM, V280, P2405, DOI 10.1074/jbc.C400431200; Tzima E, 2003, P NATL ACAD SCI USA, V100, P14903, DOI 10.1073/pnas.2436330100; Tzima E, 2005, NATURE, V437, P426, DOI 10.1038/nature03952; Tzima E, 2001, EMBO J, V20, P4639, DOI 10.1093/emboj/20.17.4639; Wakasugi K, 2002, J BIOL CHEM, V277, P20124, DOI 10.1074/jbc.C200126200; Wakasugi K, 2002, P NATL ACAD SCI USA, V99, P173, DOI 10.1073/pnas.012602099; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wakasugi K, 1999, SCIENCE, V284, P147, DOI 10.1126/science.284.5411.147; Xie W, 2007, P NATL ACAD SCI USA, V104, P9976, DOI 10.1073/pnas.0703908104; Yang XL, 2004, TRENDS BIOCHEM SCI, V29, P250, DOI 10.1016/j.tibs.2004.03.002; YANG XL, 2007, IN PRESS CHEM BIOL	46	48	83	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1597	1605		10.1096/fj.07-9973com	http://dx.doi.org/10.1096/fj.07-9973com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18165356				2022-12-25	WOS:000255898700031
J	Laulajainen, M; Muranen, T; Carpen, O; Gronholm, M				Laulajainen, M.; Muranen, T.; Carpen, O.; Groenholm, M.			Protein kinase A-mediated phosphorylation of the NF2 tumor suppressor protein merlin at serine 10 affects the actin cytoskeleton	ONCOGENE			Unspecified	Article						NF2; merlin; PKA; phosphorylation; actin	NEUROFIBROMATOSIS TYPE-2; P21-ACTIVATED KINASE; SCHWANN-CELLS; GROWTH; EZRIN; GENE; MEMBRANE; INHIBITION; PRODUCT; BINDING	Mutations in the neuro. bromatosis 2 tumor suppressor gene (NF2) encoding merlin (moesin-ezrin-radixin like-protein) induce tumors of the nervous system. Merlin localizes to the cell membrane where it links the actin cytoskeleton to membrane proteins. Cell proliferation is regulated by merlin in many cell types, but merlin's tumor suppressor function still remains unclear. Phosphorylation has been suggested to regulate merlin's activity. The C-terminal serine 518 is phosphorylated both by p21-activated kinases (PAKs) and protein kinase A (PKA). In this work, we identify a novel PKA phosphorylation site, serine 10, in the N terminus of merlin. We show that a non-phosphorylatable form of serine 10 (S10A) affects cellular morphology. Regulation of this site also influences actin cytoskeleton organization and dynamics in vivo, as merlin S10A reduces the amount of cellular F-actin and merlin S10D stabilizes F-actin. laments. By using a wound-healing assay and live cell imaging, we demonstrate that dephosphorylation of serine 10 leads to defects in migration, possibly through altered ability of the cells to form lamellipodia. This study suggests a role for merlin in mediating PKA-induced changes of the actin cytoskeleton.	[Laulajainen, M.; Muranen, T.; Carpen, O.; Groenholm, M.] Univ Helsinki, Dept Pathol, Helsinki 14, Finland; [Carpen, O.] Univ Turku, Dept Pathol, Turku, Finland; Univ Turku, Cent Hosp, FIN-20520 Turku, Finland	University of Helsinki; University of Turku; University of Turku	Laulajainen, M (corresponding author), Univ Helsinki, Dept Pathol, Haartmaninkatu 8,PL 63, Helsinki 14, Finland.	minja.laulajainen@helsinki.fi	Gronholm, Mikaela/B-4225-2010; Muranen, Taru/AAM-9349-2021	Gronholm, Mikaela/0000-0002-2378-8924; Muranen, Taru/0000-0003-4158-9002				Alfthan K, 2004, J BIOL CHEM, V279, P18559, DOI 10.1074/jbc.M313916200; Bai Y, 2007, ONCOGENE, V26, P836, DOI 10.1038/sj.onc.1209849; Baser ME, 2003, CURR OPIN NEUROL, V16, P27, DOI 10.1097/00019052-200302000-00004; Bohling T, 1996, AM J PATHOL, V148, P367; Brault E, 2001, J CELL SCI, V114, P1901; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; DENBAKKER MA, 1995, AM J PATHOL, V147, P1339; Giovannini M, 2000, GENE DEV, V14, P1617; Golovnina K, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-69; Gonzalez-Agosti C, 1999, J BIOL CHEM, V274, P34438, DOI 10.1074/jbc.274.48.34438; GonzalezAgosti C, 1996, ONCOGENE, V13, P1239; Gronholm M, 2003, J BIOL CHEM, V278, P41167, DOI 10.1074/jbc.M306149200; Gronholm M, 1999, J CELL SCI, V112, P895; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; James MF, 2001, BIOCHEM J, V356, P377, DOI 10.1042/0264-6021:3560377; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Kim HA, 1997, J NEUROSCI RES, V49, P236; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Manent J, 2003, J NEUROSCI METH, V123, P167, DOI 10.1016/S0165-0270(02)00349-7; Morrison H, 2001, GENE DEV, V15, P968, DOI 10.1101/gad.189601; Muranen T, 2007, HUM MOL GENET, V16, P1742, DOI 10.1093/hmg/ddm122; Pelton PD, 1998, ONCOGENE, V17, P2195, DOI 10.1038/sj.onc.1202141; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; ROULEAU GA, 1993, NATURE, V363, P515, DOI 10.1038/363515a0; Sainio M, 1997, J CELL SCI, V110, P2249; Schulze KMM, 2002, HUM MOL GENET, V11, P69, DOI 10.1093/hmg/11.1.69; Shaw RJ, 1998, J BIOL CHEM, V273, P7757, DOI 10.1074/jbc.273.13.7757; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Sherman L, 1997, ONCOGENE, V15, P2505, DOI 10.1038/sj.onc.1201418; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; Surace EI, 2004, ONCOGENE, V23, P580, DOI 10.1038/sj.onc.1207142; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Thaxton C, 2007, MOL CELL NEUROSCI, V34, P231, DOI 10.1016/j.mcn.2006.11.003; Trofatter J A, 1993, Cell, V75, P826; Turunen O, 1998, BBA-PROTEIN STRUCT M, V1387, P1, DOI 10.1016/S0167-4838(98)00103-4; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Xu HM, 1998, J NEUROSCI RES, V51, P403, DOI 10.1002/(SICI)1097-4547(19980201)51:3<403::AID-JNR13>3.0.CO;2-7; Zhou RH, 2003, J BIOL CHEM, V278, P35651, DOI 10.1074/jbc.M303416200	40	35	39	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	23					3233	3243		10.1038/sj.onc.1210988	http://dx.doi.org/10.1038/sj.onc.1210988			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	304LQ	18071304				2022-12-25	WOS:000256111400002
J	Zhou, G; Dada, LA; Chandel, NS; Iwai, K; Lecuona, E; Ciechanover, A; Sznajder, JI				Zhou, Guofei; Dada, Laura A.; Chandel, Navdeep S.; Iwai, Kazuhiro; Lecuona, Emilia; Ciechanover, Aaron; Sznajder, Jacob I.			Hypoxia-mediated Na-K-ATPase degradation requires von Hippel Lindau protein	FASEB JOURNAL			English	Article						hypoxia inducible factor; pVHL	TUMOR-SUPPRESSOR PROTEIN; UBIQUITIN LIGASE; HIF-ALPHA; VHL; IDENTIFICATION; COMPLEX; BINDING; UBIQUITYLATION; HYDROXYLATION; NA,K-ATPASE	Hypoxia inhibits Na-K-ATPase activity and leads to its degradation in mammalian cells. Von Hippel Lindau protein (pVHL) and hypoxia inducible factor (HIF) are key mediators in cellular adaptation to hypoxia; thus, we set out to investigate whether pVHL and HIF participate in the hypoxia-mediated degradation of plasma membrane Na-K-ATPase. We found that in the presence of pVHL hypoxia decreased Na-K-ATPase activity and promoted the degradation of plasma membrane Na-K-ATPase. In pVHL-deficient cells, hypoxia did not decrease the Na-K-ATPase activity and the degradation of plasma membrane Na-K-ATPase was prevented. pVHL-mediated degradation of Na-K-ATPase required the functional pVHL E3 ligase and Ubc5 since pVHL mutants and dominant-negative Ubc5 prevented Na-K-ATPase from degradation. The generation of reactive oxygen species was necessary for pVHL-mediated Na-K-ATPase degradation during hypoxia. Desferrioxamine, which stabilizes HIFI/2 alpha, did not affect the half-fife of plasma membrane Na-K-ATPase. In addition, stabilizing HIF1/2 alpha by infecting mammalian cells with adenoviruses containing the oxygen-dependent degradation domain of HIF1 alpha did not affect the plasma membrane Na-K-ATPase degradation. In cells with suppression of pVHL by short hairpin RNA, the Na-K-ATPase was not degraded during hypoxia, whereas cells with knockdown of HIF1/2 alpha retained the ability to degrade plasma membrane Na-K-ATPase. These findings suggest that pVHL participates in the hypoxia-mediated degradation of plasma membrane Na-K-ATPase in a HIF-independent manner.	[Zhou, Guofei; Dada, Laura A.; Chandel, Navdeep S.; Lecuona, Emilia; Sznajder, Jacob I.] Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care, Chicago, IL 60611 USA; [Iwai, Kazuhiro] Osaka City Univ, Grad Sch Med, Dept Mol Cell Biol, Abeno Ku, Osaka 558, Japan; [Ciechanover, Aaron] Technion Israel Inst Technol, Fac Med, Vasc & Tumor Biol Res Ctr, Haifa, Israel	Northwestern University; Feinberg School of Medicine; Osaka Metropolitan University; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Sznajder, JI (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Pulm & Crit Care, 240 E Huron,McGaw Pavil M-300, Chicago, IL 60611 USA.	i-sznaider@northwestern.edu	Ciechanover, Aaron J/C-9166-2017; IWAI, KAZUHIRO/GSN-7385-2022	Iwai, Kazuhiro/0000-0001-5620-5951	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL071643] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL-071643] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bertorello AM, 1999, AM J PHYSIOL-LUNG C, V276, pL20, DOI 10.1152/ajplung.1999.276.1.L20; Bianchi L, 1999, NUCLEIC ACIDS RES, V27, P4223, DOI 10.1093/nar/27.21.4223; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Block K, 2007, J BIOL CHEM, V282, P8019, DOI 10.1074/jbc.M611569200; Boutilier RG, 2000, COMP BIOCHEM PHYS A, V126, P481, DOI 10.1016/S1095-6433(00)00234-8; Cockman ME, 2000, J BIOL CHEM, V275, P25733, DOI 10.1074/jbc.M002740200; Comellas AP, 2006, CIRC RES, V98, P1314, DOI 10.1161/01.RES.0000222418.99976.1d; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; Fang S, 2004, CELL MOL LIFE SCI, V61, P1546, DOI 10.1007/s00018-004-4129-5; Gonen H, 1999, J BIOL CHEM, V274, P14823, DOI 10.1074/jbc.274.21.14823; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iwai K, 1999, P NATL ACAD SCI USA, V96, P12436, DOI 10.1073/pnas.96.22.12436; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2002, J BIOL CHEM, V277, P30388, DOI 10.1074/jbc.M203344200; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; Kim W, 2003, CURR OPIN GENET DEV, V13, P55, DOI 10.1016/S0959-437X(02)00010-2; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Li ZB, 2002, J BIOL CHEM, V277, P4656, DOI 10.1074/jbc.M108269200; Litvan J, 2006, J BIOL CHEM, V281, P19892, DOI 10.1074/jbc.M602064200; Liu LP, 2006, MOL CELL, V21, P521, DOI 10.1016/j.molcel.2006.01.010; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; Mekhail K, 2006, CELL CYCLE, V5, P2401, DOI 10.4161/cc.5.20.3387; Michiels C, 2004, AM J PATHOL, V164, P1875, DOI 10.1016/S0002-9440(10)63747-9; Na X, 2003, EMBO J, V22, P4249, DOI 10.1093/emboj/cdg410; Okuda H, 2001, J BIOL CHEM, V276, P43611, DOI 10.1074/jbc.M107880200; Planes C, 1996, AM J PHYSIOL-LUNG C, V271, pL70, DOI 10.1152/ajplung.1996.271.1.L70; Semenza GL, 2006, MOL CELL, V22, P437, DOI 10.1016/j.molcel.2006.05.001; Semenza GL, 2004, J APPL PHYSIOL, V96, P1173, DOI 10.1152/japplphysiol.00770.2003; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Vivona ML, 2001, AM J RESP CELL MOL, V25, P554, DOI 10.1165/ajrcmb.25.5.4420; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yan Q, 2004, J BIOL CHEM, V279, P43019, DOI 10.1074/jbc.M408018200; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	41	31	31	3	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1335	1342		10.1096/fj.07-8369com	http://dx.doi.org/10.1096/fj.07-8369com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18073334				2022-12-25	WOS:000255898700007
J	Chen, LC; Nievera, CJ; Lee, AYL; Wu, XH				Chen, Longchuan; Nievera, Christian J.; Lee, Alan Yueh-Luen; Wu, Xiaohua			Cell cycle-dependent complex formation of BRCA1.CtIP.MRN is important for DNA double-strand break repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TELOMERASE CATALYTIC SUBUNIT; HOMOLOGOUS RECOMBINATION; DAMAGE RESPONSE; TUMOR-SUPPRESSOR; MAMMALIAN-CELLS; IONIZING-RADIATION; VERTEBRATE CELLS; SYNDROME PROTEIN; MEIOTIC CELLS; END RESECTION	BRCA1 plays an important role in the homologous recombination (HR)-mediated DNA double-strand break (DSB) repair, but the mechanism is not clear. Here we describe that BRCA1 forms a complex with CtIP and MRN (Mre11/Rad50/Nbs1) in a cell cycle-dependent manner. Significantly, the complex formation, especially the ionizing radiation-enhanced association of BRCA1 with MRN, requires cyclin-dependent kinase activity. CtIP directly interacts with Nbs1. The in vivo association of BRCA1 with MRN is largely dependent on the association of CtIP with the BRCT domains at the C terminus of BRCA1, whereas the N terminus of BRCA1 also contributes to its association with MRN. CtIP, as well as the interaction of BRCA1 with CtIP and MRN, is critical for IR-induced single-stranded DNA formation and cellular resistance to radiation. Consistently, CtIP itself is required for efficient HR-mediated DSB repair, like BRCA1 and MRN. These studies suggest that the complex formation of BRCA1.CtIP.MRN is important for facilitating DSB resection to generate single-stranded DNA that is needed for HR-mediated DSB repair. Because cyclin-dependent kinase is important for establishing IR-enhanced interaction of MRN with BRCA1, we propose that the cell cycle-dependent complex formation of BRCA1, CtIP, and MRN contributes to the activation of HR-mediated DSB repair in the S and G(2) phases of the cell cycle.	[Nievera, Christian J.; Lee, Alan Yueh-Luen; Wu, Xiaohua] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Chen, Longchuan] Vet Affairs Med Ctr, Dept Pathol, Long Beach, CA 90822 USA	Scripps Research Institute; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Long Beach Healthcare System	Wu, XH (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	xiaohwu@scripps.edu	Lee, Alan Yueh-Luen/A-9141-2010; Lee, Alan Yueh-Luen/B-1097-2010	Lee, Alan Yueh-Luen/0000-0003-0252-0571	NATIONAL CANCER INSTITUTE [R01CA102361] Funding Source: NIH RePORTER; NCI NIH HHS [CA102361] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bishop DK, 1998, J BIOL CHEM, V273, P21482, DOI 10.1074/jbc.273.34.21482; Caspari T, 2002, GENE DEV, V16, P1195, DOI 10.1101/gad.221402; Chen JJ, 1998, MOL CELL, V2, P317, DOI 10.1016/S1097-2765(00)80276-2; CHEONG N, 1994, MUTAT RES, V314, P77, DOI 10.1016/0921-8777(94)90063-9; Clerici M, 2005, J BIOL CHEM, V280, P38631, DOI 10.1074/jbc.M508339200; Ferreira MG, 2001, MOL CELL, V7, P55, DOI 10.1016/S1097-2765(01)00154-X; Fusco C, 1998, GENOMICS, V51, P351, DOI 10.1006/geno.1998.5368; Greenberg RA, 2006, GENE DEV, V20, P34, DOI 10.1101/gad.1381306; Ira G, 2004, NATURE, V431, P1011, DOI 10.1038/nature02964; Jazayeri A, 2006, NAT CELL BIOL, V8, P37, DOI 10.1038/ncb1337; Johnson RD, 1999, NATURE, V401, P397, DOI 10.1038/43935; Johnson RD, 2001, BIOCHEM SOC T, V29, P196, DOI 10.1042/BST0290196; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kim JS, 2005, J CELL BIOL, V170, P341, DOI 10.1083/jcb.200411083; Lengsfeld BM, 2007, MOL CELL, V28, P638, DOI 10.1016/j.molcel.2007.11.001; Lewis LK, 2004, GENETICS, V166, P1701, DOI 10.1534/genetics.166.4.1701; Li S, 1999, J BIOL CHEM, V274, P11334, DOI 10.1074/jbc.274.16.11334; Limbo O, 2007, MOL CELL, V28, P134, DOI 10.1016/j.molcel.2007.09.009; Lisby M, 2004, CELL, V118, P699, DOI 10.1016/j.cell.2004.08.015; Masutomi K, 2003, CELL, V114, P241, DOI 10.1016/S0092-8674(03)00550-6; Meloni AR, 1999, P NATL ACAD SCI USA, V96, P9574, DOI 10.1073/pnas.96.17.9574; Meyerson M, 1997, CELL, V90, P785, DOI 10.1016/S0092-8674(00)80538-3; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Moynahan ME, 2001, CANCER RES, V61, P4842; Myers JS, 2006, J BIOL CHEM, V281, P9346, DOI 10.1074/jbc.M513265200; Nathanson KN, 2001, NAT MED, V7, P552, DOI 10.1038/87876; Paull TT, 1998, MOL CELL, V1, P969, DOI 10.1016/S1097-2765(00)80097-0; Penkner A, 2007, EMBO J, V26, P5071, DOI 10.1038/sj.emboj.7601916; Pierce AJ, 1999, GENE DEV, V13, P2633, DOI 10.1101/gad.13.20.2633; Pierce AJ, 2001, TRENDS CELL BIOL, V11, pS52, DOI 10.1016/S0962-8924(01)02149-3; Ranganathan V, 2001, CURR BIOL, V11, P962, DOI 10.1016/S0960-9822(01)00267-6; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Schaeper U, 1998, J BIOL CHEM, V273, P8549, DOI 10.1074/jbc.273.15.8549; Schlegel BP, 2006, CANCER RES, V66, P5181, DOI 10.1158/0008-5472.CAN-05-3209; Scully R, 2000, NATURE, V408, P429, DOI 10.1038/35044000; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Scully R, 1999, MOL CELL, V4, P1093, DOI 10.1016/S1097-2765(00)80238-5; Snouwaert JN, 1999, ONCOGENE, V18, P7900, DOI 10.1038/sj.onc.1203334; Sonoda E, 2006, DNA REPAIR, V5, P1021, DOI 10.1016/j.dnarep.2006.05.022; Starita LM, 2003, CURR OPIN CELL BIOL, V15, P345, DOI 10.1016/S0955-0674(03)00042-5; Takata M, 1998, EMBO J, V17, P5497, DOI 10.1093/emboj/17.18.5497; Tauchi H, 2002, NATURE, V420, P93, DOI 10.1038/nature01125; Uanschou C, 2007, EMBO J, V26, P5061, DOI 10.1038/sj.emboj.7601913; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Wang Y, 2000, GENE DEV, V14, P927; Williams RS, 2003, J BIOL CHEM, V278, P53007, DOI 10.1074/jbc.M310182200; Williams RS, 2001, NAT STRUCT BIOL, V8, P838, DOI 10.1038/nsb1001-838; Wong AKC, 1998, ONCOGENE, V17, P2279, DOI 10.1038/sj.onc.1202150; Wu X, 2000, COLD SPRING HARB SYM, V65, P535, DOI 10.1101/sqb.2000.65.535; Wu X, 2000, Science, V289, P11; Wu XH, 2004, GENE DEV, V18, P1305, DOI 10.1101/gad.1182804; Wu XH, 2000, NATURE, V405, P477, DOI 10.1038/35013089; Yang YG, 2006, EMBO J, V25, P5527, DOI 10.1038/sj.emboj.7601411; Yarden RI, 2002, NAT GENET, V30, P285, DOI 10.1038/ng837; Yu X, 1998, J BIOL CHEM, V273, P25388, DOI 10.1074/jbc.273.39.25388; Yu X, 2000, J BIOL CHEM, V275, P18541, DOI 10.1074/jbc.M909494199; Yu XC, 2004, MOL CELL BIOL, V24, P9478, DOI 10.1128/MCB.24.21.9478-9486.2004; Zhang JR, 2004, MOL CELL BIOL, V24, P708, DOI 10.1128/MCB.24.2.708-718.2004; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	61	303	314	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7713	7720		10.1074/jbc.M710245200	http://dx.doi.org/10.1074/jbc.M710245200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18171670	hybrid			2022-12-25	WOS:000253997900048
J	Cheng, XL; Shen, Z; Yang, JY; Lu, SH; Cui, YP				Cheng, Xiaolong; Shen, Zheng; Yang, Jianyi; Lu, Shih-Hsin; Cui, Yongping			ECRG2 disruption leads to centrosome amplification and spindle checkpoint defects contributing chromosome instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; ASSEMBLY CHECKPOINT; DUPLICATION; CANCER; MPS1; P53; OVEREXPRESSION; ANEUPLOIDY; CENTRIOLE; UBIQUITINATION	Cancer cells contain an abnormal number of chromosomes (aneuploidy), which is a prevalent form of genetic instability in human cancers. Abnormal amplification of centrosomes and defects of spindle assembly checkpoint are the major causes of chromosome instability in cancer cells. Here we present biochemical evidence to suggest a role of ECRG2, a novel tumor suppressor gene, in maintaining chromosome stability. ECRG2 localized to centrosomes during interphase and kinetochores during mitosis. Further analysis revealed that ECRG2 participates in centrosome amplification in a p53-dependent manner. Depletion of ECRG2 not only destabilized p53, down-regulated p21, and increased the cyclin E/CDK2 activity, thus initiating centrosome amplification, but also abolished the ability of p53 localize to centrosomes. Overexpression of ECRG2 restored the p53-dependent suppression of centrosome duplication. Furthermore, ECRG2-depleted cells show severely disrupted spindle phenotype but fail to maintain the mitotic arrest due to minimal BUBR1 protein levels. Taken together, our results indicate that ECRG2 is important for ensuring centrosome duplication, spindle assembly checkpoint, and accurate chromosome segregation, and its depletion may contribute to chromosome instability and aneuploidy in human cancers.	[Cheng, Xiaolong; Yang, Jianyi; Cui, Yongping] Shanxi Med Univ, Dept Cell Biol & Genet, Taiyuan 030001, Peoples R China; [Cheng, Xiaolong; Cui, Yongping] Key Lab Cellular Physiol, Minist Educ, Taiyuan 030001, Peoples R China; [Shen, Zheng] Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing 10008, Peoples R China; [Lu, Shih-Hsin] Chinese Acad Med Sci, Peking Union Med Coll, Inst Canc, Dept Etiol, Beijing 100021, Peoples R China	Shanxi Medical University; Chinese Academy of Sciences; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Cui, YP (corresponding author), Shanxi Med Univ, Dept Cell Biol & Genet, Taiyuan 030001, Peoples R China.	cuiy0922@yahoo.com	yang, jian/HIK-0188-2022					Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Chi YH, 2007, J CELL BIOCHEM, V102, P531, DOI 10.1002/jcb.21484; Cui YP, 2003, BIOCHEM BIOPH RES CO, V302, P904, DOI 10.1016/S0006-291X(03)00122-0; Duensing A, 2006, CELL CYCLE, V5, P2899, DOI 10.4161/cc.5.24.3567; Fisk HA, 2004, CURR BIOL, V14, pR1058, DOI 10.1016/j.cub.2004.11.047; Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100; Fisk HA, 2002, CURR OPIN CELL BIOL, V14, P700, DOI 10.1016/S0955-0674(02)00385-X; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Giono LE, 2006, J CELL PHYSIOL, V209, P13, DOI 10.1002/jcp.20689; HA CH, 2007, CANCER RES, V67, P7155; Hoffmann Ingrid, 2006, V42, P93, DOI 10.1007/b138827; Hontz AE, 2007, CANCER RES, V67, P2957, DOI 10.1158/0008-5472.CAN-06-3296; Huang G, 2005, HYBRIDOMA, V24, P86, DOI 10.1089/hyb.2005.24.86; Huang G, 2007, CARCINOGENESIS, V28, P2274, DOI 10.1093/carcin/bgm140; Jefford CE, 2006, CRIT REV ONCOL HEMAT, V59, P1, DOI 10.1016/j.critrevonc.2006.02.005; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kasbek C, 2007, MOL BIOL CELL, V18, P4457, DOI 10.1091/mbc.E07-03-0283; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Koutsami MK, 2006, J PATHOL, V209, P512, DOI 10.1002/path.2005; Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Mattison Christopher P., 2006, V42, P111, DOI 10.1007/b136685; May KM, 2006, J CELL SCI, V119, P4139, DOI 10.1242/jcs.03165; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Mussman JG, 2000, ONCOGENE, V19, P1635, DOI 10.1038/sj.onc.1203460; Oikawa T, 2005, MOL CELL BIOL, V25, P4046, DOI 10.1128/MCB.25.10.4046-4061.2005; Orr B, 2007, MOL BIOL CELL, V18, P850, DOI 10.1091/mbc.E06-07-0587; Pelletier L, 2007, CURR BIOL, V17, pR770, DOI 10.1016/j.cub.2007.07.025; Peters JM, 2007, NATURE, V446, P868, DOI 10.1038/446868a; Reddy SK, 2007, NATURE, V446, P921, DOI 10.1038/nature05734; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Sankaran S, 2006, J CELL BIOCHEM, V99, P1240, DOI 10.1002/jcb.21003; Schmidt M, 2005, EMBO REP, V6, P866, DOI 10.1038/sj.embor.7400483; Shinmura K, 2007, ONCOGENE, V26, P2939, DOI 10.1038/sj.onc.1210085; Srsen V, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-26; Stegmeier F, 2007, NATURE, V446, P876, DOI 10.1038/nature05694; Tarapore P, 2002, ONCOGENE, V21, P6234, DOI 10.1038/sj.onc.1205707; Tarapore P, 2001, ONCOGENE, V20, P3173, DOI 10.1038/sj.onc.1204424; Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985; Winey M, 1999, CURR BIOL, V9, pR449, DOI 10.1016/S0960-9822(99)80279-6; Yamamoto Y, 2007, CANCER GENET CYTOGEN, V174, P42, DOI 10.1016/j.cancergencyto.2006.11.012; Yamamoto Y, 2006, ONCOLOGY-BASEL, V70, P231, DOI 10.1159/000094416	44	17	21	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5888	5898		10.1074/jbc.M708145200	http://dx.doi.org/10.1074/jbc.M708145200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18162463	hybrid			2022-12-25	WOS:000253426700067
J	Kaji, N; Muramoto, A; Mizuno, K				Kaji, Noriko; Muramoto, Aya; Mizuno, Kensaku			LIM kinase-mediated cofilin phosphorylation during mitosis is required for precise spindle positioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ASYMMETRIC CELL DIVISIONS; SLINGSHOT PHOSPHATASE; ACTIN REORGANIZATION; PROTEIN-KINASE; ACTIVATION; POLARITY; BINDING; GROWTH; DYNEIN; ROLES	The interaction of astral microtubules with cortical actin networks is essential for the correct orientation of the mitotic spindle; however, little is known about how the cortical actin organization is regulated during mitosis. LIM kinase-1 (LIMK1) regulates actin dynamics by phosphorylating and inactivating cofilin, an actin-depolymerizing protein. LIMK1 activity increases during mitosis. Here we show that mitotic LIMK1 activation is critical for accurate spindle orientation in mammalian cells. Knockdown of LIMK1 suppressed a mitosis-specific increase in cofilin phosphorylation and caused unusual cofilin localization in the cell cortex in metaphase, instability of cortical actin organization and astral microtubules, irregular rotation and misorientation of the spindle, and a delay in anaphase onset. Similar results were obtained by treating the cells with a LIMK1 inhibitor peptide or latrunculin A or by overexpressing a non-phosphorylatable cofilin(S3A) mutant. Furthermore, localization of LGN (a protein containing the repetitive Leu-Gly-Asn tripeptide motifs), an important regulator of spindle orientation, in the crescent-shaped cortical regions was perturbed in LIMK1 knockdown cells. Our results suggest that LIMK1-mediated cofilin phosphorylation is required for accurate spindle orientation by stabilizing cortical actin networks during mitosis.	[Kaji, Noriko; Muramoto, Aya; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan	Tohoku University	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Mizuno, Kensaku/G-8631-2015					ABE H, 1989, J BIOCHEM-TOKYO, V106, P696, DOI 10.1093/oxfordjournals.jbchem.a122919; Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; Aizawa H, 2001, NAT NEUROSCI, V4, P367, DOI 10.1038/86011; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017; Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Davila M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-40; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Dujardin DL, 2002, CURR OPIN CELL BIOL, V14, P44, DOI 10.1016/S0955-0674(01)00292-7; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Gundersen GG, 2004, CURR OPIN CELL BIOL, V16, P106, DOI 10.1016/j.ceb.2003.11.010; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Kaji N, 2003, J BIOL CHEM, V278, P33450, DOI 10.1074/jbc.M305802200; Kaushik R, 2003, MOL BIOL CELL, V14, P3144, DOI 10.1091/mbc.E03-04-0212; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Macara IG, 2004, NAT REV MOL CELL BIO, V5, P220, DOI 10.1038/nrm1332; Manneville JB, 2006, BIOL CELL, V98, P557, DOI 10.1042/BC20060017; MOON A, 1995, MOL BIOL CELL, V6, P1423, DOI 10.1091/mbc.6.11.1423; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Tomiyoshi G, 2004, GENES CELLS, V9, P591, DOI 10.1111/j.1356-9597.2004.00745.x; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Wen ZX, 2007, J CELL BIOL, V178, P107, DOI 10.1083/jcb.200703055; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yasumi M, 2005, J BIOL CHEM, V280, P6761, DOI 10.1074/jbc.C400440200; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Yu FW, 2000, CELL, V100, P399, DOI 10.1016/S0092-8674(00)80676-5	44	67	69	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4983	4992		10.1074/jbc.M708644200	http://dx.doi.org/10.1074/jbc.M708644200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18079118	hybrid			2022-12-25	WOS:000253426500056
J	Pauff, JM; Zhang, JJ; Bell, CE; Hille, R				Pauff, James M.; Zhang, Jinjin; Bell, Charles E.; Hille, Russ			Substrate orientation in xanthine oxidase - Crystal structure of enzyme in reaction with 2-hydroxy-6-methylpurine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROMOLECULAR STRUCTURES; MOLYBDENUM; MECHANISM; DEHYDROGENASE; CRYSTALLIZATION; SPECIFICITY; REFINEMENT; CATALYSIS; KINETICS; FAMILY	Xanthine oxidoreductase catalyzes the final two steps of purine catabolism and is involved in a variety of pathological states ranging from hyperuricemia to ischemia-reperfusion injury. The human enzyme is expressed primarily in its dehydrogenase form utilizing NAD(+) as the final electron acceptor from the enzyme's flavin site but can exist as an oxidase that utilizes O-2 for this purpose. Central to an understanding of the enzyme's function is knowledge of purine substrate orientation in the enzyme's molybdenum-containing active site. We report here the crystal structure of xanthine oxidase, trapped at the stage of a critical intermediate in the course of reaction with the slow substrate 2-hydroxy-6-methylpurine at 2.3 (A) over circle. This is the first crystal structure of a reaction intermediate with a purine substrate that is hydroxylated at its C8 position as is xanthine and confirms the structure predicted to occur in the course of the presently favored reaction mechanism. The structure also corroborates recent work suggesting that 2-hydroxy6- methylpurine orients in the active site with its C2 carbonyl group interacting with Arg-880 and extends our hypothesis that xanthine binds opposite this orientation, with its C6 carbonyl positioned to interact with Arg-880 in stabilizing the Mo-V transition state.	[Pauff, James M.; Hille, Russ] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Pauff, James M.; Zhang, Jinjin; Bell, Charles E.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA	University of California System; University of California Riverside; University System of Ohio; Ohio State University	Hille, R (corresponding author), Univ Calif Riverside, Dept Biochem, 2466 Boyce Hall, Riverside, CA 92521 USA.	russ.hille@ucr.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075036] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 075036] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berry CE, 2004, J PHYSIOL-LONDON, V555, P589, DOI 10.1113/jphysiol.2003.055913; BRAY RC, 1985, BIOCHEM SOC T, V13, P560, DOI 10.1042/bst0130560; Canne C, 1999, BIOCHEMISTRY-US, V38, P14077, DOI 10.1021/bi991089s; Choi EY, 2004, J INORG BIOCHEM, V98, P841, DOI 10.1016/j.jinorgbio.2003.11.010; Eger BT, 2000, ACTA CRYSTALLOGR D, V56, P1656, DOI 10.1107/S0907444900012890; ELION GB, 1989, SCIENCE, V244, P41, DOI 10.1126/science.2649979; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enroth C, 2000, P NATL ACAD SCI USA, V97, P10723, DOI 10.1073/pnas.97.20.10723; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; Hille R, 2002, TRENDS BIOCHEM SCI, V27, P360, DOI 10.1016/S0968-0004(02)02107-2; HILLE R, 1995, FASEB J, V9, P995, DOI 10.1096/fasebj.9.11.7649415; Hille R, 2006, EUR J INORG CHEM, P1913, DOI 10.1002/ejic.200600087; Huber R, 1996, P NATL ACAD SCI USA, V93, P8846, DOI 10.1073/pnas.93.17.8846; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kisker C, 1997, ANNU REV BIOCHEM, V66, P233, DOI 10.1146/annurev.biochem.66.1.233; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LORIGAN GA, 1994, BBA-BIOENERGETICS, V1185, P284, DOI 10.1016/0005-2728(94)90243-7; Manikandan P, 2001, J AM CHEM SOC, V123, P2658, DOI 10.1021/ja003894w; MASSEY V, 1969, J BIOL CHEM, V244, P1682; MCWHIRTER RB, 1991, J BIOL CHEM, V266, P23724; MURSHUDOV G, 1996, REFINEMENT PROTEIN S; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nishino T, 2005, J BIOL CHEM, V280, P24888, DOI 10.1074/jbc.M501830200; Pacher P, 2006, PHARMACOL REV, V58, P87, DOI 10.1124/pr.58.1.6; Pannu NS, 1998, ACTA CRYSTALLOGR D, V54, P1285, DOI 10.1107/S0907444998004119; Pauff JM, 2007, J BIOL CHEM, V282, P12785, DOI 10.1074/jbc.M700364200; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Rayment I, 2002, STRUCTURE, V10, P147, DOI 10.1016/S0969-2126(02)00711-6; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Tai LA, 2004, BIOCHEMISTRY-US, V43, P4869, DOI 10.1021/bi035467b; Truglio JJ, 2002, STRUCTURE, V10, P115, DOI 10.1016/S0969-2126(01)00697-9; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yamaguchi Y, 2007, J BIOCHEM, V141, P513, DOI 10.1093/jb/mvm053	35	72	73	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4818	4824		10.1074/jbc.M707918200	http://dx.doi.org/10.1074/jbc.M707918200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18063585	hybrid			2022-12-25	WOS:000253426500039
J	Pawluczyk, IZA; Patel, SR; Harris, KPG				Pawluczyk, Izabella Z. A.; Patel, Samita R.; Harris, Kevin P. G.			Perindoprilat modulates the activity of lipoprotein receptor-related protein in human mesangial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; MATRIX-METALLOPROTEINASE; CATABOLISM; MECHANISM; MMP-9; LRP	Low density lipoprotein receptor-related protein (LRP) is a multifunctional endocytic receptor implicated in the modulation of a number of cellular processes, including the turnover of proteases and the degradation of extracellular matrix proteins. As such, it can play a key role in the control of fibrosis. The aim of this investigation was to as certain whether the anti-fibrotic effects exerted by the angiotensin-converting enzyme inhibitor(ACE-I) perindoprilat on macrophage-conditioned medium (MPCM)-injured human mesangial cells can be modulated by this receptor. Addition of receptor-associated protein to MPCM-injured mesangial cells with and without ACE-I increased the amount of tissue plasminogen activator protein detected in mesangial cell culture supernatants without affecting the protein levels of plasminogen activator inhibitor-1. The ability of ACE-I to reduce fibronectin was diminished in the presence of receptor-associated protein. ACE-I induced an increase in mesangial cell MMP9 mRNA, but reduced the MMP9 enzyme activity detected in mesangial cell supernatants. Mesangial cell lysates from ACE-I-treated cells were able to bind immobilized fibronectin at higher dilutions than cell lysates from untreated cells. Flow cytometry showed that MPCM induced an increase in LRP surface expression in mesangial cells over that in control cells and that this expression was further increased by ACE-I treatment. The increase in LRP expression in response to ACE-I was also observed by Western blotting. Northern blot analysis of RNA extracted from cells following a 24-h exposure to MPCM with and without ACE-I demonstrated that there was no change in LRP mRNA expression upon ACE-I treatment. In conclusion, we show that ACE-I treatment is able to modulate mesangial cell-surface expression of LRP, providing an additional mechanism whereby ACE-Is can mediate anti-fibrotic actions independent of their hemodynamic actions.	[Pawluczyk, Izabella Z. A.] Univ Leicester, John Wall Renal Unit, Leicester Gen Hosp, Leicester LE5 4PW, Leics, England; Univ Leicester, Dept Infect Immunity & Inflammat, Leicester LE5 4PW, Leics, England	University Hospitals of Leicester NHS Trust; Leicester General Hospital; University of Leicester; University of Leicester	Pawluczyk, IZA (corresponding author), Univ Leicester, John Wall Renal Unit, Leicester Gen Hosp, Gwendolen Rd, Leicester LE5 4PW, Leics, England.	izap1@le.ac.uk						FLAVIN MP, 2001, J CEREB BLOOD FLOW M, V21, P631; Guenette SY, 2002, J NEUROCHEM, V82, P755, DOI 10.1046/j.1471-4159.2002.01009.x; Hahn-Dantona E, 2001, J BIOL CHEM, V276, P15498, DOI 10.1074/jbc.M100121200; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Hu KB, 2006, J BIOL CHEM, V281, P2120, DOI 10.1074/jbc.M504988200; Hurst M, 2001, DRUGS, V61, P867, DOI 10.2165/00003495-200161060-00020; Kitching AR, 1997, J EXP MED, V185, P963, DOI 10.1084/jem.185.5.963; MARTIN J, 1994, KIDNEY INT, V46, P877, DOI 10.1038/ki.1994.345; Pawluczyk IZA, 2004, KIDNEY INT, V65, P1240, DOI 10.1111/j.1523-1755.2004.00494.x; Salicioni AM, 2002, J BIOL CHEM, V277, P16160, DOI 10.1074/jbc.M201401200; Wang XY, 2003, NAT MED, V9, P1313, DOI 10.1038/nm926; Weaver AM, 1996, J BIOL CHEM, V271, P24894, DOI 10.1074/jbc.271.40.24894; Welling TH, 1996, J SURG RES, V66, P36, DOI 10.1006/jsre.1996.0369; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Zhuo M, 2000, J NEUROSCI, V20, P542, DOI 10.1523/JNEUROSCI.20-02-00542.2000	16	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4588	4594		10.1074/jbc.M709001200	http://dx.doi.org/10.1074/jbc.M709001200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156630	hybrid			2022-12-25	WOS:000253426500015
J	Tsiavaliaris, G; Fujita-Becker, S; Durrwang, U; Diensthuber, RP; Geeves, MA; Manstein, DJ				Tsiavaliaris, Georgios; Fujita-Becker, Setsuko; Duerrwang, Ulrike; Diensthuber, Ralph P.; Geeves, Michael A.; Manstein, Dietmar J.			Mechanism, regulation, and functional properties of Dictyostelium myosin-1B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS-I MYOSIN; HEAVY-CHAIN PHOSPHORYLATION; KINETIC MECHANISM; DISCOIDEUM MYOSIN; MOTOR DOMAIN; ADENOSINE-TRIPHOSPHATASE; MOLECULAR MOTOR; ADP RELEASE; ACTIN; MOTILITY	Myosin-1B is one of three long tailed class-1 myosins containing an ATP-insensitive actin-binding site in the tail region that are produced in Dictyostelium discoideum. Myosin-1B localizes to actin-rich structures at the leading edge of migrating cells where it has been implicated in the formation and retraction of membrane projections, the recycling of plasma membrane components, and intracellular particle transport. Here, we have used a combination of molecular engineering approaches to describe the kinetic and motile properties of the myosin-1B motor and its regulation by TEDS site phosphorylation. Our results show that myosin-1B is a low duty ratio motor and displays the fastest nucleotide binding kinetics of any of the Dictyostelium class-1 myosins studied so far. Different from Dictyostelium myosin-1D and myosin-1E, dephosphorylated myosin-1B is not inactivated but moves actin filaments efficiently, albeit at an up to 8-fold slower velocity in the in vitro motility assay. A further difference is that myosin-1B lacks the ability to switch between rapid movement and bearing tension upon physiological changes of free Mg2+ ions. In this respect, its motor properties appear to be more closely related to Dictyostelium myosin-2 and rabbit skeletal muscle myosin.	[Tsiavaliaris, Georgios; Diensthuber, Ralph P.; Manstein, Dietmar J.] Hannover Med Sch, Inst Biophys Chem, OE 4350, D-30623 Hannover, Germany; [Fujita-Becker, Setsuko; Duerrwang, Ulrike; Manstein, Dietmar J.] Max Planck Inst Med Res, Dept Biophys, D-69120 Heidelberg, Germany; [Geeves, Michael A.] Univ Kent, Dept Biosci, Canterbury CT2 7NJ, Kent, England	Hannover Medical School; Max Planck Society; University of Kent	Tsiavaliaris, G (corresponding author), Hannover Med Sch, Inst Biophys Chem, OE 4350, Carl Neuberg Str 1, D-30623 Hannover, Germany.	gtsiaval@bpc.mh-hannover.de	Geeves, Michael/F-7583-2011; Manstein, Dietmar J. J/M-1034-2013; Manstein, Dietmar J./AAG-2640-2019	Geeves, Michael/0000-0002-9364-8898; Manstein, Dietmar J. J/0000-0003-0763-0147; Manstein, Dietmar J./0000-0003-0763-0147	Wellcome Trust [070021] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anson M, 1996, EMBO J, V15, P6069, DOI 10.1002/j.1460-2075.1996.tb00995.x; BAGSHAW CR, 1974, BIOCHEM J, V141, P351, DOI 10.1042/bj1410351; BAIN G, 1991, MOL GEN GENET, V226, P59, DOI 10.1007/BF00273587; Batra R, 1999, BIOL CHEM, V380, P1017, DOI 10.1515/BC.1999.126; Batra R, 1999, BIOCHEMISTRY-US, V38, P6126, DOI 10.1021/bi982251e; Brzeska H, 1999, P NATL ACAD SCI USA, V96, P394, DOI 10.1073/pnas.96.2.394; Brzeska H, 1996, J BIOL CHEM, V271, P16983, DOI 10.1074/jbc.271.29.16983; Crawley SW, 2006, J BIOL CHEM, V281, P6307, DOI 10.1074/jbc.M508670200; Cremo CR, 1998, BIOCHEMISTRY-US, V37, P1969, DOI 10.1021/bi9722406; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x; Durrwang U, 2006, J CELL SCI, V119, P550, DOI 10.1242/jcs.02774; El Mezgueldi M, 2002, J BIOL CHEM, V277, P21514, DOI 10.1074/jbc.M200713200; Falk DL, 2003, J CELL SCI, V116, P3985, DOI 10.1242/jcs.00696; FAULSTICH H, 1983, EXP CELL RES, V144, P73, DOI 10.1016/0014-4827(83)90443-3; Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200; Fukui Y, 1997, CELL MOTIL CYTOSKEL, V36, P339; Furch M, 2000, BIOCHEMISTRY-US, V39, P11602, DOI 10.1021/bi000985x; Furch M, 1998, BIOCHEMISTRY-US, V37, P6317, DOI 10.1021/bi972851y; Furch M, 1999, J MOL BIOL, V290, P797, DOI 10.1006/jmbi.1999.2921; Gillespie PG, 2001, J CELL BIOL, V155, P703, DOI 10.1083/jcb.200110032; Gliksman NR, 2001, J BIOL CHEM, V276, P5235, DOI 10.1074/jbc.M008319200; Hachikubo Y, 2007, PLANT CELL PHYSIOL, V48, P886, DOI 10.1093/pcp/pcm054; Ito K, 2003, BIOCHEM BIOPH RES CO, V312, P958, DOI 10.1016/j.bbrc.2003.10.202; JONTES JD, 1995, NATURE, V378, P751, DOI 10.1038/378751a0; Jontes JD, 1997, J CELL BIOL, V139, P683, DOI 10.1083/jcb.139.3.683; Jung G, 2001, J CELL BIOL, V153, P1479, DOI 10.1083/jcb.153.7.1479; JUNG G, 1990, J CELL BIOL, V110, P1955, DOI 10.1083/jcb.110.6.1955; JUNG G, 1993, J BIOL CHEM, V268, P14981; Jung G, 1996, J CELL BIOL, V133, P305, DOI 10.1083/jcb.133.2.305; Kliche W, 2001, EMBO J, V20, P40, DOI 10.1093/emboj/20.1.40; Kollmar M, 2002, EMBO J, V21, P2517, DOI 10.1093/emboj/21.11.2517; KRON SJ, 1986, P NATL ACAD SCI USA, V83, P6272, DOI 10.1073/pnas.83.17.6272; Kurzawa SE, 1997, BIOCHEMISTRY-US, V36, P317, DOI 10.1021/bi962166b; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; MANSTEIN DJ, 1995, GENE, V162, P129, DOI 10.1016/0378-1119(95)00351-6; MILLAR NC, 1983, FEBS LETT, V160, P141, DOI 10.1016/0014-5793(83)80954-5; Neuhaus EM, 2000, J CELL BIOL, V150, P1013, DOI 10.1083/jcb.150.5.1013; Novak KD, 1997, J CELL BIOL, V136, P633, DOI 10.1083/jcb.136.3.633; NOVAK KD, 1995, J CELL BIOL, V131, P1205, DOI 10.1083/jcb.131.5.1205; Novak KD, 1998, MOL BIOL CELL, V9, P75, DOI 10.1091/mbc.9.1.75; Oberholzer U, 2002, EUKARYOT CELL, V1, P213, DOI 10.1128/EC.1.2.213-228.2002; Ostap EM, 2002, BIOCHEMISTRY-US, V41, P12450, DOI 10.1021/bi0262193; PETERSON MD, 1995, J CELL SCI, V108, P1093; Ruff C, 2001, NAT STRUCT BIOL, V8, P226, DOI 10.1038/84962; Schwarz EC, 2000, J CELL SCI, V113, P621; Schwarz Eva C., 1999, Cell Biochemistry and Biophysics, V30, P413, DOI 10.1007/BF02738122; Senda S, 2001, J BIOL CHEM, V276, P2898, DOI 10.1074/jbc.M008059200; SIEMANKOWSKI RF, 1984, J BIOL CHEM, V259, P5045; TITUS MA, 1993, MOL BIOL CELL, V4, P233, DOI 10.1091/mbc.4.2.233; Tsiavaliaris G, 2002, EMBO REP, V3, P1099, DOI 10.1093/embo-reports/kvf214; Veigel C, 1999, NATURE, V398, P530, DOI 10.1038/19104; Wang ZY, 1998, P NATL ACAD SCI USA, V95, P15200, DOI 10.1073/pnas.95.26.15200; Wessels D, 1996, CELL MOTIL CYTOSKEL, V33, P64, DOI 10.1002/(SICI)1097-0169(1996)33:1<64::AID-CM7>3.0.CO;2-I; WESSELS D, 1991, CELL MOTIL CYTOSKEL, V20, P301, DOI 10.1002/cm.970200406; Woodward SKA, 1995, BIOCHEMISTRY-US, V34, P16056, DOI 10.1021/bi00049a020; Yazu M, 1999, BIOCHEM BIOPH RES CO, V255, P711, DOI 10.1006/bbrc.1999.0264	58	17	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4520	4527		10.1074/jbc.M708113200	http://dx.doi.org/10.1074/jbc.M708113200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089562	hybrid			2022-12-25	WOS:000253426500008
J	Flashman, E; Bagg, EAL; Chowdhury, R; Mecinovic, J; Loenarz, C; McDonough, MA; Hewitson, KS; Schofield, CJ				Flashman, Emily; Bagg, Eleanor A. L.; Chowdhury, Rasheduzzaman; Mecinovic, Jasmin; Loenarz, Christoph; McDonough, Michael A.; Hewitson, Kirsty S.; Schofield, Christopher J.			Kinetic rationale for selectivity toward N- and C-terminal oxygen-dependent degradation domain substrates mediated by a loop region of hypoxia-inducible factor prolyl hydroxylases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL FAMILY; CRYSTAL-STRUCTURE; HIF-ALPHA; SYNTHASE; HIF-1-ALPHA; PHD2; PROLYL-HYDROXYLASE-2; 4-HYDROXYLASES; 2-OXOGLUTARATE; DESTRUCTION	Hydroxylation of two conserved prolyl residues in the N- and C-terminal oxygen-dependent degradation domains (NODD and CODD) of the alpha-subunit of hypoxia-inducible factor (HIF) signals for its degradation via the ubiquitin-proteasome pathway. In human cells, three prolyl hydroxylases (PHDs 1-3) belonging to the Fe(II) and 2-oxoglutarate (2OG)-dependent oxygenase family catalyze prolyl hydroxylation with differing selectivity for CODD and NODD. Sequence analysis of the catalytic domains of the PHDs in the light of crystal structures for PHD2, and results for other 2OG oxygenases, suggested that either the C-terminal region or a loop linking two beta-strands (beta 2 and beta 3 in human PHD2) are important in determining substrate selectivity. Mutation analyses on PHD2 revealed that the beta 2 beta 3 loop is a major determinant in conferring selectivity for CODD over NODD peptides. A chimeric PHD in which the beta 2 beta 3 loop of PHD2 was replaced with that of PHD3 displayed an almost complete selectivity for CODD(in competition experiments), as observed for wild-type PHD3. CODD was observed to bind much more tightly to this chimeric protein than the wild type PHD2 catalytic domain.	[Schofield, Christopher J.] Univ Oxford, Dept Chem, Oxford Ctr Integrat Syst Biol, Chem Res Lab, Oxford OX13TA, England	University of Oxford	Schofield, CJ (corresponding author), Univ Oxford, Dept Chem, Oxford Ctr Integrat Syst Biol, Chem Res Lab, Mansfield Rd, Oxford OX13TA, England.	christopher.schofield@chem.ox.ac.uk	Mecinovic, Jasmin/F-9694-2015; McDonough, Michael A/G-2744-2013; McDonough, Michael/N-8913-2019; Chowdhury, Rashed/I-7697-2014	Mecinovic, Jasmin/0000-0002-5559-3822; McDonough, Michael A/0000-0003-4664-6942; McDonough, Michael/0000-0003-4664-6942; Chowdhury, Rashed/0000-0002-8058-6149; Bagg, Eleanor/0000-0001-9209-1891; Loenarz, Christoph/0000-0002-8843-2531; Flashman, Emily/0000-0002-4169-4278	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Appelhoff RJ, 2004, J BIOL CHEM, V279, P38458, DOI 10.1074/jbc.M406026200; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Chan DA, 2005, MOL CELL BIOL, V25, P6415, DOI 10.1128/MCB.25.15.6415-6426.2005; Choi KO, 2005, MOL PHARMACOL, V68, P1803, DOI 10.1124/mol.105.015271; Clifton IJ, 2006, J INORG BIOCHEM, V100, P644, DOI 10.1016/j.jinorgbio.2006.01.024; Ehrismann D, 2007, BIOCHEM J, V401, P227, DOI 10.1042/BJ20061151; Elkins JM, 2003, J BIOL CHEM, V278, P1802, DOI 10.1074/jbc.C200644200; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Hewitson KS, 2007, J BIOL CHEM, V282, P3293, DOI 10.1074/jbc.M608337200; Hewitson KS, 2002, J BIOL CHEM, V277, P26351, DOI 10.1074/jbc.C200273200; Hirsila M, 2003, J BIOL CHEM, V278, P30772, DOI 10.1074/jbc.M304982200; Huang JH, 2002, J BIOL CHEM, V277, P39792, DOI 10.1074/jbc.M206955200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Landazuri MO, 2006, BIOCHEM BIOPH RES CO, V351, P313, DOI 10.1016/j.bbrc.2006.09.170; Lando D, 2002, GENE DEV, V16, P1466, DOI 10.1101/gad.991402; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lange T, 1997, PHYSIOL PLANTARUM, V100, P543, DOI 10.1034/j.1399-3054.1997.1000316.x; Lee HJ, 2001, J MOL BIOL, V308, P937, DOI 10.1006/jmbi.2001.4649; Lloyd MD, 1999, J MOL BIOL, V287, P943, DOI 10.1006/jmbi.1999.2594; Masson N, 2001, EMBO J, V20, P5197, DOI 10.1093/emboj/20.18.5197; McDonough MA, 2006, P NATL ACAD SCI USA, V103, P9814, DOI 10.1073/pnas.0601283103; McNeill LA, 2005, MOL BIOSYST, V1, P321, DOI 10.1039/b511249b; Metzen E, 2003, J CELL SCI, V116, P1319, DOI 10.1242/jcs.00318; ROACH PL, 1995, NATURE, V375, P700, DOI 10.1038/375700a0; Sami M, 1997, FEBS LETT, V405, P191, DOI 10.1016/S0014-5793(97)00176-2; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Strieker M, 2007, ACS CHEM BIOL, V2, P187, DOI 10.1021/cb700012y; Taylor MS, 2001, GENE, V275, P125, DOI 10.1016/S0378-1119(01)00633-3; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuckerman JR, 2004, FEBS LETT, V576, P145, DOI 10.1016/j.febslet.2004.09.005; Villar D, 2007, BIOCHEM J, V408, P231, DOI 10.1042/BJ20071052; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Yu B, 2006, NATURE, V439, P879, DOI 10.1038/nature04561	38	65	66	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3808	3815		10.1074/jbc.M707411200	http://dx.doi.org/10.1074/jbc.M707411200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18063574	hybrid			2022-12-25	WOS:000253083500015
J	Worby, CA; Gentry, MS; Dixon, JE				Worby, Carolyn A.; Gentry, Matthew S.; Dixon, Jack E.			Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRESSIVE MYOCLONUS EPILEPSY; GENOTYPE-PHENOTYPE CORRELATIONS; LAFORA-DISEASE; PHOSPHATASE; METABOLISM; MUTATIONS; GENE; OVEREXPRESSION; SUBUNIT; INSULIN	Lafora disease (LD) is an autosomal recessive neurodegenerative disease that results in progressive myoclonus epilepsy and death. LD is caused by mutations in either the E3 ubiquitin ligase malin or the dual specificity phosphatase laforin. A hallmark of LD is the accumulation of insoluble glycogen in the cytoplasm of cells from most tissues. Glycogen metabolism is regulated by phosphorylation of key metabolic enzymes. One regulator of this phosphorylation is protein targeting to glycogen (PTG/R5), a scaffold protein that binds both glycogen and many of the enzymes involved in glycogen synthesis, including protein phosphatase 1 (PP1), glycogen synthase, phosphorylase, and laforin. Overexpression of PTG markedly increases glycogen accumulation, and decreased PTG expression decreases glycogen stores. To investigate if malin and laforin play a role in glycogen metabolism, we overexpressed PTG, malin, and laforin in tissue culture cells. We found that expression of malin or laforin decreased PTG-stimulated glycogen accumulation by 25%, and co-expression of malin and laforin abolished PTG-stimulated glycogen accumulation. Consistent with this result, we found that malin ubiquitinates PTG in a laforin-dependent manner, both in vivo and in vitro, and targets PTG for proteasome-dependent degradation. These results suggest an additional mechanism, involving laforin and malin, in regulating glycogen metabolism.	[Worby, Carolyn A.; Gentry, Matthew S.; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Worby, Carolyn A.; Gentry, Matthew S.; Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Worby, Carolyn A.; Gentry, Matthew S.; Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Dixon, JE (corresponding author), 9500 Gilman Dr,Leichtag Bldg,RM 284, La Jolla, CA 92093 USA.	jedixon@ucsd.edu			Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [R01 DK018849, DK018849-33] Funding Source: Medline; NINDS NIH HHS [1K99NS061803-01, K99 NS061803, R00 NS061803-03, K99 NS061803-02, R00 NS061803] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK018849] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS061803, R00NS061803] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Armstrong CG, 1997, FEBS LETT, V418, P210, DOI 10.1016/S0014-5793(97)01385-9; BERKOVIC SF, 1986, NEW ENGL J MED, V315, P296, DOI 10.1056/NEJM198607313150506; BERKOVIC SF, 1991, J CLIN NEUROPHYSIOL, V8, P261, DOI 10.1097/00004691-199107010-00003; Blennow A, 2002, TRENDS PLANT SCI, V7, P445, DOI 10.1016/S1360-1385(02)02332-4; BUSARD HLSM, 1987, ANN NEUROL, V21, P599, DOI 10.1002/ana.410210613; Chan EM, 2004, NEUROLOGY, V63, P565, DOI 10.1212/01.WNL.0000133215.65836.03; Chan EM, 2003, NAT GENET, V35, P125, DOI 10.1038/ng1238; Cheng A, 2007, GENE DEV, V21, P2399, DOI 10.1101/gad.1553207; Cid E, 2002, FEBS LETT, V528, P5, DOI 10.1016/S0014-5793(02)03313-6; Crosson SM, 2003, J CLIN INVEST, V111, P1423, DOI 10.1172/JCI200317975; DOHERTY MJ, 1995, FEBS LETT, V375, P294, DOI 10.1016/0014-5793(95)01184-G; Edwards TA, 2003, GENE DEV, V17, P2508, DOI 10.1101/gad.1119403; Fernandez-Sanchez ME, 2003, HUM MOL GENET, V12, P3161, DOI 10.1093/hmg/ddg340; Ferrer JC, 2003, FEBS LETT, V546, P127, DOI 10.1016/S0014-5793(03)00565-9; Fong NM, 2000, J BIOL CHEM, V275, P35034, DOI 10.1074/jbc.M005541200; Fuchs SY, 1998, ONCOGENE, V17, P2543, DOI 10.1038/sj.onc.1202200; Ganesh S, 2002, HUM MOL GENET, V11, P1263, DOI 10.1093/hmg/11.11.1263; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; Gentry MS, 2007, J CELL BIOL, V178, P477, DOI 10.1083/jcb.200704094; Gentry MS, 2005, P NATL ACAD SCI USA, V102, P8501, DOI 10.1073/pnas.0503285102; Gomez-Abad C, 2005, NEUROLOGY, V64, P982, DOI 10.1212/01.WNL.0000154519.10805.F7; Greenberg CC, 2006, MOL CELL BIOL, V26, P334, DOI 10.1128/MCB.26.1.334-342.2006; Greenberg CC, 2003, J BIOL CHEM, V278, P30835, DOI 10.1074/jbc.M303846200; HARRIMAN DGF, 1955, BRAIN, V78, P325, DOI 10.1093/brain/78.3.325; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hodskins MB, 1930, AM J PSYCHIAT, V9, P827; Ianzano Leonarda, 2005, Hum Mutat, V26, P397, DOI 10.1002/humu.9376; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Lafora GR, 1911, Z GESAMTE NEUROL PSY, V6, P1, DOI 10.1007/BF02863929; Lafora GR, 1911, VIRCHOWS ARCH A, V205, P295, DOI 10.1007/BF01989438; Lerin C, 2000, J BIOL CHEM, V275, P39991, DOI 10.1074/jbc.M006251200; Lipford JR, 2003, NAT CELL BIOL, V5, P845, DOI 10.1038/ncb1003-845; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Liu Y, 2006, J BIOL CHEM, V281, P34768, DOI 10.1074/jbc.M607778200; Lohi H, 2007, NEUROLOGY, V68, P996, DOI 10.1212/01.wnl.0000258561.02248.2f; Lohi H, 2005, HUM MOL GENET, V14, P2727, DOI 10.1093/hmg/ddi306; LOMAKO J, 1994, BIOFACTORS, V4, P167; Minassian BA, 1998, NAT GENET, V20, P171, DOI 10.1038/2470; Munro S, 2005, FEBS J, V272, P1478, DOI 10.1111/j.1742-4658.2005.04585.x; Munro S, 2002, DIABETES, V51, P591, DOI 10.2337/diabetes.51.3.591; Niittyla T, 2006, J BIOL CHEM, V281, P11815, DOI 10.1074/jbc.M600519200; O'Doherty RM, 2000, J CLIN INVEST, V105, P479, DOI 10.1172/JCI8673; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Raben N, 2001, NEUROLOGY, V56, P1739, DOI 10.1212/WNL.56.12.1739; Roach Peter J., 2002, Current Molecular Medicine (Hilversum), V2, P101, DOI 10.2174/1566524024605761; ROACH PJ, 2001, ENDOCRINE PANCREAS R, P609; SAKAI M, 1970, NEUROLOGY, V20, P160, DOI 10.1212/WNL.20.2.160; SCHNABEL R, 1968, Pathologia Europaea, V3, P218; SCHWARZ GA, 1965, ARCH NEUROL-CHICAGO, V12, P172, DOI 10.1001/archneur.1965.00460260062008; Serratosa JM, 1999, HUM MOL GENET, V8, P345, DOI 10.1093/hmg/8.2.345; Shen J.-J., 2002, Current Molecular Medicine (Hilversum), V2, P167, DOI 10.2174/1566524024605752; Slack FJ, 1998, TRENDS BIOCHEM SCI, V23, P474, DOI 10.1016/S0968-0004(98)01299-7; SOLAZFUSTER MD, 2007, IN PRESS HUM MOL; Taylor GS, 2000, P NATL ACAD SCI USA, V97, P8910, DOI 10.1073/pnas.160255697; TENHAM MWV, 1975, HDB CLIN NEUROLOGY, P647; Thomas D, 2000, CURR BIOL, V10, pR341, DOI 10.1016/S0960-9822(00)00462-0; Vilchez D, 2007, NAT NEUROSCI, V10, P1407, DOI 10.1038/nn1998; Wang JY, 2002, J BIOL CHEM, V277, P2377, DOI 10.1074/jbc.C100686200; Wang W, 2007, ARCH BIOCHEM BIOPHYS, V457, P264, DOI 10.1016/j.abb.2006.10.017; Wang W, 2006, BIOCHEM BIOPH RES CO, V350, P588, DOI 10.1016/j.bbrc.2006.09.091; Wang Y, 2006, CANCER CELL, V10, P179, DOI 10.1016/j.ccr.2006.08.008; Worby CA, 2006, J BIOL CHEM, V281, P30412, DOI 10.1074/jbc.M606117200; YOKOI S, 1968, ARCH NEUROL-CHICAGO, V19, P15, DOI 10.1001/archneur.1968.00480010033002; YOKOI S, 1967, J NEUROPATH EXP NEUR, V26, P125; Zeeman SC, 2007, BIOCHEM J, V401, P13, DOI 10.1042/BJ20061393	65	117	120	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4069	4076		10.1074/jbc.M708712200	http://dx.doi.org/10.1074/jbc.M708712200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18070875	hybrid, Green Accepted			2022-12-25	WOS:000253083500042
J	Yokouchi, M; Hiramatsu, N; Hayakawa, K; Okamura, M; Du, S; Kasai, A; Takano, Y; Shitamura, A; Shimada, T; Yao, J; Kitamura, M				Yokouchi, Makiko; Hiramatsu, Nobuhiko; Hayakawa, Kunihiro; Okamura, Maro; Du, Shuqi; Kasai, Ayumi; Takano, Yosuke; Shitamura, Akihiro; Shimada, Tsuyoshi; Yao, Jian; Kitamura, Masanori			Involvement of selective reactive oxygen species upstream of proapoptotic branches of unfolded protein response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; GLOMERULAR MESANGIAL CELLS; OXIDATIVE STRESS; SARCOPLASMIC-RETICULUM; INDUCED APOPTOSIS; LLC-PK1 CELLS; UP-REGULATION; KAPPA-B; C-FOS; ACTIVATION	Cadmium triggers apoptosis of LLC-PK1 cells through induction of endoplasmic reticulum (ER) stress. We found that cadmium caused generation of reactive oxygen species (ROS) and that cadmium-induced ER stress was inhibited by antioxidants. In contrast, suppression of ER stress did not attenuate cadmium-triggered oxidative stress, suggesting that ER stress occurs downstream of oxidative stress. Exposure of the cells to either O-2(radical anion), H2O2, or ONOO- caused apoptosis, whereas ER stress was induced only by O-2(radical anion). or ONOO-. Transfection with manganese superoxide dismutase significantly attenuated cadmium-induced ER stress and apoptosis, whereas pharmacological inhibition of ONOO- was ineffective. Interestingly, transfection with catalase attenuated cadmium-induced apoptosis without affecting the level of ER stress. O-2(radical anion). caused activation of the activating transcription factor 6-CCAAT/enhancer-binding protein-homologous protein (CHOP) and the inositol-requiring ER-to-nucleus signal kinase 1-X-box-binding protein 1 (XBP1) proapoptotic cascades, and overexpression of manganese superoxide dismutase attenuated cadmium-triggered induction of both pathways. Furthermore, phosphorylation of proapoptotic c-Jun N-terminal kinase by O-2(radical anion) . or cadmium was suppressed by dominant-negative inhibition of XBP1. These data elucidated 1) cadmium caused ER stress via generation of ROS, 2) O-2(radical anion). was selectively involved in cadmium-triggered, ER stress-mediated apoptosis through activation of the activating transcription factor 6-CHOP and inositol-requiring ER-to-nucleus signal kinase 1-XBP1 pathways, and 3) phosphorylation of JNK was caused by O(radical anion)2-triggered activation of XBP1.	[Yokouchi, Makiko; Hiramatsu, Nobuhiko; Hayakawa, Kunihiro; Okamura, Maro; Kasai, Ayumi; Takano, Yosuke; Shitamura, Akihiro; Shimada, Tsuyoshi; Yao, Jian; Kitamura, Masanori] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Chuo Ku, Yamanashi 4093898, Japan; [Du, Shuqi] China Med Univ, Affiliated Hosp 1, Dept Urol, Shenyang 110001, Peoples R China	University of Yamanashi; China Medical University	Kitamura, M (corresponding author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Mol Signaling, Chuo Ku, Shimokato 1110, Yamanashi 4093898, Japan.	masanori@yamanashi.ac.jp		HAYAKAWA, Kunihiro/0000-0002-8053-746X; Yao, Jian/0000-0003-2622-0215				AMSTAD P, 1990, B CANCER, V77, P501; Brunon J, 2000, NEUROCHIRURGIE, V46, P54; BUTTKE TM, 1994, IMMUNOL TODAY, V15, P7, DOI 10.1016/0167-5699(94)90018-3; Dickhout JG, 2005, ARTERIOSCL THROM VAS, V25, P2623, DOI 10.1161/01.ATV.0000189159.96900.d9; FERRARI R, 1991, CARDIOVASC DRUG THER, V5, P277, DOI 10.1007/BF00054749; Gazit G, 1999, BREAST CANCER RES TR, V54, P135, DOI 10.1023/A:1006102411439; Gennari A, 2003, TOXICOLOGY, V183, P211, DOI 10.1016/S0300-483X(02)00546-2; Hayakawa K, 2006, J IMMUNOL, V176, P2529, DOI 10.4049/jimmunol.176.4.2529; Hayashi T, 2005, J CEREBR BLOOD F MET, V25, P41, DOI 10.1038/sj.jcbfm.9600005; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Iwawaki T, 2006, BIOCHEM BIOPH RES CO, V350, P709, DOI 10.1016/j.bbrc.2006.09.100; Jacobson MD, 1996, TRENDS BIOCHEM SCI, V21, P83, DOI 10.1016/0968-0004(96)20008-8; Kaplan P, 2003, MOL CELL BIOCHEM, V248, P41, DOI 10.1023/A:1024145212616; Katayama T, 2001, J BIOL CHEM, V276, P43446, DOI 10.1074/jbc.M104096200; Kaufman RJ, 2002, J CLIN INVEST, V110, P1389, DOI 10.1172/JC1200216886; Kim R, 2006, APOPTOSIS, V11, P5, DOI 10.1007/s10495-005-3088-0; Kitamura M, 1996, J IMMUNOL, V156, P2964; Lai MT, 2003, CELL SIGNAL, V15, P585, DOI 10.1016/S0898-6568(03)00004-4; Lee AH, 2003, P NATL ACAD SCI USA, V100, P9946, DOI 10.1073/pnas.1334037100; Manna SK, 1998, J BIOL CHEM, V273, P13245, DOI 10.1074/jbc.273.21.13245; MEYER M, 1994, CHEM-BIOL INTERACT, V91, P91, DOI 10.1016/0009-2797(94)90029-9; Moreau VH, 1998, FREE RADICAL BIO MED, V25, P554, DOI 10.1016/S0891-5849(98)00084-7; Oh SH, 2006, TOXICOL APPL PHARM, V212, P212, DOI 10.1016/j.taap.2005.07.018; Ozawa K, 1999, J BIOL CHEM, V274, P6397, DOI 10.1074/jbc.274.10.6397; Park HR, 2004, JNCI-J NATL CANCER I, V96, P1300, DOI 10.1093/jnci/djh243; PROZIALECK WC, 1995, TOXICOL APPL PHARM, V134, P285, DOI 10.1006/taap.1995.1194; RUTHER U, 1985, EMBO J, V4, P1775, DOI 10.1002/j.1460-2075.1985.tb03850.x; Shen JS, 2005, METHODS, V35, P382, DOI 10.1016/j.ymeth.2004.10.011; Szabo C, 1997, NITRIC OXIDE-BIOL CH, V1, P373, DOI 10.1006/niox.1997.0143; Thevenod F, 2000, J BIOL CHEM, V275, P1887, DOI 10.1074/jbc.275.3.1887; Thevenod F, 2003, NEPHRON PHYSIOL, V93, P87, DOI DOI 10.1159/000070241; Ushio-Fukai M, 1998, J BIOL CHEM, V273, P15022, DOI 10.1074/jbc.273.24.15022; Viner RI, 1996, FREE RADICAL RES, V24, P243, DOI 10.3109/10715769609088022; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Watson LM, 2003, J BIOL CHEM, V278, P17438, DOI 10.1074/jbc.M301006200; Yokouchi M, 2007, CELL DEATH DIFFER, V14, P1467, DOI 10.1038/sj.cdd.4402154	36	171	183	4	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4252	4260		10.1074/jbc.M705951200	http://dx.doi.org/10.1074/jbc.M705951200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18086661	hybrid			2022-12-25	WOS:000253083500060
J	Tailleux, L; Waddell, SJ; Pelizzola, M; Mortellaro, A; Withers, M; Tanne, A; Castagnoli, PR; Gicquel, B; Stoker, NG; Butcher, PD; Foti, M; Neyrolles, O				Tailleux, Ludovic; Waddell, Simon J.; Pelizzola, Mattia; Mortellaro, Alessandra; Withers, Michael; Tanne, Antoine; Castagnoli, Paola Ricciardi; Gicquel, Brigitte; Stoker, Neil G.; Butcher, Philip D.; Foti, Maria; Neyrolles, Olivier			Probing Host Pathogen Cross-Talk by Transcriptional Profiling of Both Mycobacterium tuberculosis and Infected Human Dendritic Cells and Macrophages	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; GENE-EXPRESSION; NITRIC-OXIDE; REACTIVE OXYGEN; LISTERIA-MONOCYTOGENES; HYPOXIC RESPONSE; UP-REGULATION; IN-VIVO; SURVIVAL; DORMANCY	Background. Transcriptional profiling using microarrays provides a unique opportunity to decipher host pathogen cross-talk on the global level. Here, for the first time, we have been able to investigate gene expression changes in both Mycobacterium tuberculosis, a major human pathogen, and its human host cells, macrophages and dendritic cells. Methodology/Principal Findings. In addition to common responses, we could identify eukaryotic and microbial transcriptional signatures that are specific to the cell type involved in the infection process. In particular M. tuberculosis shows a marked stress response when inside dendritic cells, which is in accordance with the low permissivity of these specialized phagocytes to the tubercle bacillus and to other pathogens. In contrast, the mycobacterial transcriptome inside macrophages reflects that of replicating bacteria. On the host cell side, differential responses to infection in macrophages and dendritic cells were identified in genes involved in oxidative stress, intracellular vesicle trafficking and phagosome acidification. Conclusions/Significance. This study provides the proof of principle that probing the host and the microbe transcriptomes simultaneously is a valuable means to accessing unique information on host pathogen interactions. Our results also underline the extraordinary plasticity of host cell and pathogen responses to infection, and provide a solid framework to further understand the complex mechanisms involved in immunity to M. tuberculosis and in mycobacterial adaptation to different intracellular environments.			Stoker, NG (corresponding author), Univ London Royal Vet Coll, Dept Pathol & Infect Dis, London, England.	neil.stoker@rvc.ac.uk; butcherp@sgul.ac.uk; maria.foti@unimib.it; olivier.neyrolles@ipbs.fr	Stoker, Neil G/L-8812-2016; Waddell, Simon J/A-9170-2013; Neyrolles, Olivier/AAG-3692-2019; Mortellaro, Alessandra/AAN-4678-2020; Neyrolles, Olivier B/A-3184-2011; Foti, Maria/AAB-9961-2022	Stoker, Neil G/0000-0001-7055-6184; Waddell, Simon J/0000-0002-3684-9116; Neyrolles, Olivier/0000-0003-0047-5885; Mortellaro, Alessandra/0000-0003-1744-2430; Pelizzola, Mattia/0000-0001-6672-9636; FOTI, MARIA/0000-0002-4481-1900; Butcher, Philip/0000-0003-1223-9097; Tailleux, Ludovic/0000-0003-3931-1052	European Community [LSHP-CT-2004-012187]; Wellcome Trust's Functional Genomics Resources Initiative [062511]; EU M.Curie Chair Award	European Community(European Commission); Wellcome Trust's Functional Genomics Resources Initiative(Wellcome Trust); EU M.Curie Chair Award	This work was supported by a 6th Framework Programme Priority [1] grant (Molecular Markers of M. tuberculosis Early Interactions with Host Phagocytes, MM-TB, number LSHP-CT-2004-012187) from the European Community. The whole genome M. tuberculosis microarray was constructed and analysed at St George's University of London as part of the multi-collaborative microbial pathogen microarray facility BuGS, for which funding from The Wellcome Trust's Functional Genomics Resources Initiative is acknowledged (grant number 062511). P.Ricciardi-Castagnoli is a recipient of a EU M.Curie Chair Award.	Bacon J, 2004, TUBERCULOSIS, V84, P205, DOI 10.1016/j.tube.2003.12.011; Barker LP, 1997, INFECT IMMUN, V65, P1497, DOI 10.1128/IAI.65.4.1497-1504.1997; Beste DJV, 2007, J BACTERIOL, V189, P3969, DOI 10.1128/JB.01787-06; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Camacho LR, 1999, MOL MICROBIOL, V34, P257, DOI 10.1046/j.1365-2958.1999.01593.x; Cappelli G, 2006, RES MICROBIOL, V157, P445, DOI 10.1016/j.resmic.2005.10.007; Chaussabel D, 2003, BLOOD, V102, P672, DOI 10.1182/blood-2002-10-3232; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Ehrt S, 2001, J EXP MED, V194, P1123, DOI 10.1084/jem.194.8.1123; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Giacomini E, 2001, J IMMUNOL, V166, P7033, DOI 10.4049/jimmunol.166.12.7033; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Harth G, 2005, MOL MICROBIOL, V58, P1157, DOI 10.1111/j.1365-2958.2005.04899.x; Henderson RA, 1997, J IMMUNOL, V159, P635; Hu YM, 2006, INFECT IMMUN, V74, P861, DOI 10.1128/IAI.74.2.861-868.2006; Hutter B, 1998, FEMS MICROBIOL LETT, V167, P7, DOI 10.1111/j.1574-6968.1998.tb13200.x; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiao XN, 2002, J IMMUNOL, V168, P1294, DOI 10.4049/jimmunol.168.3.1294; Kanehisa M, 1997, TRENDS GENET, V13, P375, DOI 10.1016/S0168-9525(97)01223-7; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kendall SL, 2007, MOL MICROBIOL, V65, P684, DOI 10.1111/j.1365-2958.2007.05827.x; Kendall SL, 2004, TUBERCULOSIS, V84, P247, DOI 10.1016/j.tube.2003.12.007; Kolb-Maurer A, 2000, INFECT IMMUN, V68, P3680, DOI 10.1128/IAI.68.6.3680-3688.2000; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; LOMBARDI D, 1993, EMBO J, V12, P677, DOI 10.1002/j.1460-2075.1993.tb05701.x; Machado FS, 2006, NAT MED, V12, P330, DOI 10.1038/nm1355; Mangan JA, 2002, METHOD MICROBIOL, V33, P137; McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074; Mohagheghpour N, 2000, INFECT IMMUN, V68, P5824, DOI 10.1128/IAI.68.10.5824-5829.2000; Nathan C, 2000, P NATL ACAD SCI USA, V97, P8841, DOI 10.1073/pnas.97.16.8841; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Nicholson S, 1996, J EXP MED, V183, P2293, DOI 10.1084/jem.183.5.2293; Niedergang F, 2000, P NATL ACAD SCI USA, V97, P14650, DOI 10.1073/pnas.97.26.14650; Ohno H, 2003, CELL MICROBIOL, V5, P637, DOI 10.1046/j.1462-5822.2003.00307.x; Parish T, 2000, J BACTERIOL, V182, P5715, DOI 10.1128/JB.182.20.5715-5720.2000; Park HD, 2003, MOL MICROBIOL, V48, P833, DOI 10.1046/j.1365-2958.2003.03474.x; Pelizzola M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-335; Pron B, 2001, CELL MICROBIOL, V3, P331, DOI 10.1046/j.1462-5822.2001.00120.x; Rachman H, 2006, INFECT IMMUN, V74, P1233, DOI 10.1128/IAI.74.2.1233-1242.2006; Ragno S, 2001, IMMUNOLOGY, V104, P99, DOI 10.1046/j.1365-2567.2001.01274.x; Ricciardi-Castagnoli P, 2002, NAT REV IMMUNOL, V2, P881, DOI 10.1038/nri936; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schnappinger D, 2006, MICROBES INFECT, V8, P1132, DOI 10.1016/j.micinf.2005.10.027; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; SMYTH GK, 2004, STAT APPL GENETICS M, V3; Stenger S, 1998, J IMMUNOL, V161, P3582; Stewart GR, 2002, MICROBIOL-SGM, V148, P3129, DOI 10.1099/00221287-148-10-3129; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939; Talaat AM, 2007, J BACTERIOL, V189, P4265, DOI 10.1128/JB.00011-07; Talaat AM, 2004, P NATL ACAD SCI USA, V101, P4602, DOI 10.1073/pnas.0306023101; Tullius MV, 2003, INFECT IMMUN, V71, P3927, DOI 10.1128/IAI.71.7.3927-3936.2003; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Waddell SJ, 2007, CURR OPIN MICROBIOL, V10, P297, DOI 10.1016/j.mib.2007.05.013; Waddell SJ, 2007, CURR MOL MED, V7, P287, DOI 10.2174/156652407780598548; Wang CH, 1998, EUR RESPIR J, V11, P809, DOI 10.1183/09031936.98.11040809; Wang JP, 2003, FEMS IMMUNOL MED MIC, V39, P163, DOI 10.1016/S0928-8244(03)00223-2; Werling D, 2004, IMMUNOLOGY, V111, P41, DOI 10.1111/j.1365-2567.2004.01781.x; Werner E, 2004, J CELL SCI, V117, P143, DOI 10.1242/jcs.00937; Westcott MM, 2007, CELL MICROBIOL, V9, P1397, DOI 10.1111/j.1462-5822.2006.00880.x; Yamauchi A, 2005, J BIOL CHEM, V280, P953, DOI 10.1074/jbc.M408820200; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yuan Y., 1996, J BACTERIOL, V178, P4484, DOI DOI 10.1128/JB.178.15.4484-4492.1996	74	148	156	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1403	10.1371/journal.pone.0001403	http://dx.doi.org/10.1371/journal.pone.0001403			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167562	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000260468900031
J	Abdel-Latief, M				Abdel-Latief, Mohatmed			A Family of Chemoreceptors in Tribolium castaneum (Tenebrionidae: Coleoptera)	PLOS ONE			English	Article							CANDIDATE TASTE RECEPTORS; OLFACTORY RECEPTORS; DROSOPHILA-MELANOGASTER; MOLECULAR-BIOLOGY; MALARIA MOSQUITO; ODORANT; GENE; EXPRESSION; MAP; IDENTIFICATION	Chemoperception in invertebrates is mediated by a family of G-protein-coupled receptors (GPCR). To date nothing is known about the molecular mechanisms of chemoperception in coleopteran species. Recently the genome of Tribolium castaneum was sequenced for use as a model species for the Coleoptera. Using blast searches analyses of the T. castaneum genome with previously predicted amino acid sequences of insect chemoreceptor genes, a putative chemoreceptor family consisting of 62 gustatory receptors (Grs) and 26 olfactory receptors (Ors) was identified. The receptors have seven transmembrane domains (7TMs) and all belong to the GPCR receptor family. The expression of the T. castaneum chemoreceptor genes was investigated using quantification real-time RT-PCR and in situ whole mount RT-PCR analysis in the antennae, mouth parts, and prolegs of the adults and larvae. All of the predicted TcasGrs were expressed in the labium, maxillae, and prolegs of the adults but TcasGr13, 19, 28, 47, 62, 98, and 61 were not expressed in the prolegs. The TcasOrs were localized only in the antennae and not in any of the beetles gustatory organs with one exception; the TcasOr16 (like DmelOr83b), which was localized in the antennae, labium, and prolegs of the beetles. A group of six TcasGrs that presents a lineage with the sugar receptors subfamily in Drosophila melanogaster were localized in the lacinia of the Tribolium larvae. TcasGr1, 3, and 39, presented an ortholog to CO2 receptors in D. melanogaster and Anopheles gambiae was recorded. Low expression of almost all of the predicted chemoreceptor genes was observed in the head tissues that contain the brains and suboesophageal ganglion (SOG). These findings demonstrate the identification of a chemoreceptor family in Tribolium, which is evolutionarily related to other insect species.	Free Univ Berlin, Dept Appl Zool, Inst Biol, D-1000 Berlin, Germany	Free University of Berlin	Abdel-Latief, M (corresponding author), Free Univ Berlin, Dept Appl Zool, Inst Biol, D-1000 Berlin, Germany.	mohatmed@zedat.fu-berlin.de			Free University of Berlin; Department of Applied Zoology/Animal Ecology	Free University of Berlin; Department of Applied Zoology/Animal Ecology	The research was supported by the Free University of Berlin, Department of Applied Zoology/Animal Ecology.	Abdel-Latief M, 2007, INSECT BIOCHEM MOLEC, V37, P999, DOI 10.1016/j.ibmb.2007.05.007; Alekseev M., 2006, ENTOMOL REV, V86, P638; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bargmann CI, 2006, NATURE, V444, P295, DOI 10.1038/nature05402; BEHAN M, 1978, INT J INSECT MORPHOL, V7, P221, DOI 10.1016/0020-7322(78)90005-3; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Chyb S, 2003, P NATL ACAD SCI USA, V100, P14526, DOI 10.1073/pnas.2135339100; Clyne PJ, 1999, NEURON, V22, P327, DOI 10.1016/S0896-6273(00)81093-4; Clyne PJ, 2000, SCIENCE, V287, P1830, DOI 10.1126/science.287.5459.1830; de Bruyne M, 1999, J NEUROSCI, V19, P4520; de Bruyne M, 2001, NEURON, V30, P537, DOI 10.1016/S0896-6273(01)00289-6; Dunipace L, 2001, CURR BIOL, V11, P822, DOI 10.1016/S0960-9822(01)00258-5; Gao Q, 2000, NAT NEUROSCI, V3, P780, DOI 10.1038/77680; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Ghaninia M, 2007, ARTHROPOD STRUCT DEV, V36, P23, DOI 10.1016/j.asd.2006.06.004; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; HARBACH RE, 1977, J INSECT PHYSIOL, V23, P1121, DOI 10.1016/0022-1910(77)90143-3; Heinbockel T, 1996, J INSECT PHYSIOL, V42, P565, DOI 10.1016/0022-1910(95)00133-6; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Jacquin-Joly E, 2004, J CHEM ECOL, V30, P2359, DOI 10.1007/s10886-004-7941-3; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Krieger J, 2003, J COMP PHYSIOL A, V189, P519, DOI 10.1007/s00359-003-0427-x; Krieger J, 2002, EUR J NEUROSCI, V16, P619, DOI 10.1046/j.1460-9568.2002.02109.x; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Libert S, 2007, SCIENCE, V315, P1133, DOI 10.1126/science.1136610; MICNDOO NE, 1915, BIOL BULL, V28, P407; Otaki JM, 2003, J THEOR BIOL, V223, P27, DOI 10.1016/S0022-5193(03)00068-7; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Shanbhag SR, 1999, INT J INSECT MORPHOL, V28, P377, DOI 10.1016/S0020-7322(99)00039-2; STOCKER RF, 1994, CELL TISSUE RES, V275, P3, DOI 10.1007/BF00305372; Trematerra P, 2000, ENTOMOL EXP APPL, V94, P195, DOI 10.1023/A:1003929810978; van Naters WV, 2006, NATURE, V444, P302, DOI 10.1038/nature05403; Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0; Vosshall LB, 1999, CELL, V96, P725, DOI 10.1016/S0092-8674(00)80582-6; Wang ZR, 2004, CELL, V117, P981, DOI 10.1016/j.cell.2004.06.011; Wanner KW, 2007, INSECT MOL BIOL, V16, P107, DOI 10.1111/j.1365-2583.2007.00708.x; Wistrand M, 2006, PROTEIN SCI, V15, P509, DOI 10.1110/ps.051745906; Zhong D, 2004, J HERED, V95, P53, DOI 10.1093/jhered/esh012	48	48	50	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1319	10.1371/journal.pone.0001319	http://dx.doi.org/10.1371/journal.pone.0001319			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091992	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459600007
J	Muller, M; Obeyesekere, M; Mills, GB; Ram, PT				Muller, Melissa; Obeyesekere, Mandri; Mills, Gordon B.; Ram, Prahlad T.			Network topology determines dynamics of the mammalian MAPK1,2 signaling network: bifan motif regulation of C-Raf and B-Raf isoforms by FGFR and MC1R	FASEB JOURNAL			English	Article						computational modeling; proteomics; melanoma	GROWTH-FACTOR; ADJUVANT CHEMOTHERAPY; PHOSPHORYLATION SITES; DEPENDENT ACTIVATION; KINASE ACTIVATION; TYROSINE KINASE; BRAF MUTATIONS; MAP KINASE; CAMP; MELANOMA	Activation of the fibroblast growth factor (FGFR) and melanocyte stimulating hormone (MC1R) receptors stimulates B-Raf and C-Raf isoforms that regulate the dynamics of MAPK1,2 signaling. Network topology motifs in mammalian cells include feed-forward and feedback loops and bifans where signals from two upstream molecules integrate to modulate the activity of two downstream molecules. We computationally modeled and experimentally tested signal processing in the FGFR/MC1R/B-Raf/C-Raf/MAPK1,2 network in human melanoma cells; identifying 7 regulatory loops and a bifan motif. Signaling from FGFR leads to sustained activation of MAPK1,2, whereas signaling from MC1R results in transient activation of MAPK1,2. The dynamics of MAPK activation depends critically on the expression level and connectivity to C-Raf, which is critical for a sustained MAPK1,2 response. A partially incoherent bifan motif with a feedback loop acts as a logic gate to integrate signals and regulate duration of activation of the MAPK signaling cascade. Further reducing a 106-node ordinary differential equations network encompassing the complete network to a 6-node network encompassing rate-limiting processes sustains the feedback loops and the bifan, providing sufficient information to predict biological responses.	[Muller, Melissa; Obeyesekere, Mandri; Mills, Gordon B.; Ram, Prahlad T.] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, Houston, TX 77054 USA	University of Texas System; UTMD Anderson Cancer Center	Ram, PT (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Unit 950, 7435 Fannin St, Houston, TX 77054 USA.	pram@mdanderson.org		Ram, Prahlad/0000-0003-4739-3166	NCI NIH HHS [P50 CA093459, P50 CA098258, P30 CA016672] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, P50CA093459, P50CA098258] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alon U, 2003, SCIENCE, V301, P1866, DOI 10.1126/science.1089072; Balan V, 2006, MOL BIOL CELL, V17, P1141, DOI 10.1091/mbc.E04-12-1123; Bhalla US, 2002, SCIENCE, V297, P1018, DOI 10.1126/science.1068873; Bhalla US, 2002, BIOPHYS J, V83, P740, DOI 10.1016/S0006-3495(02)75205-3; Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Brummer T, 2003, ONCOGENE, V22, P8823, DOI 10.1038/sj.onc.1207185; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Chin L, 2003, NAT REV CANCER, V3, P559, DOI 10.1038/nrc1145; COOK SJ, 1993, SCIENCE, V262, P1069, DOI 10.1126/science.7694367; Cook SJ, 1996, BIOCHEM J, V320, P237, DOI 10.1042/bj3200237; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Dougherty MK, 2005, MOL CELL, V17, P215, DOI 10.1016/j.molcel.2004.11.055; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Dumaz N, 2005, FEBS J, V272, P3491, DOI 10.1111/j.1742-4658.2005.04763.x; Dumaz N, 2003, J BIOL CHEM, V278, P29819, DOI 10.1074/jbc.C300182200; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; Gao L, 2006, CANCER RES, V66, P7880, DOI 10.1158/0008-5472.CAN-06-0254; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Goel VK, 2006, J INVEST DERMATOL, V126, P154, DOI 10.1038/sj.jid.5700026; Goydos JS, 2005, J AM COLL SURGEONS, V200, P362, DOI 10.1016/j.jamcollsurg.2004.10.032; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hornberg JJ, 2004, EUR J BIOCHEM, V271, P3905, DOI 10.1111/j.1432-1033.2004.04327.x; JACOBOWITZ O, 1994, P NATL ACAD SCI USA, V91, P10630, DOI 10.1073/pnas.91.22.10630; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Landi MT, 2006, SCIENCE, V313, P521, DOI 10.1126/science.1127515; LoRusso PM, 2005, J CLIN ONCOL, V23, P5281, DOI 10.1200/JCO.2005.14.415; Ma'ayan A, 2005, SCIENCE, V309, P1078, DOI 10.1126/science.1108876; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Murphy LO, 2002, NAT CELL BIOL, V4, P556, DOI 10.1038/ncb822; Nesbit M, 1999, ONCOGENE, V18, P6469, DOI 10.1038/sj.onc.1203066; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Robubi A, 2005, BIOL CHEM, V386, P1165, DOI 10.1515/BC.2005.133; Romond EH, 2005, NEW ENGL J MED, V353, P1673, DOI 10.1056/NEJMoa052122; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Sasagawa S, 2005, NAT CELL BIOL, V7, P365, DOI 10.1038/ncb1233; Satyamoorthy K, 2003, CANCER RES, V63, P756; Sidovar MF, 2000, J BIOL CHEM, V275, P28688, DOI 10.1074/jbc.M909351199; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Slominski A, 2004, PHYSIOL REV, V84, P1155, DOI 10.1152/physrev.00044.2003; Strumberg D, 2005, DRUGS TODAY, V41, P773, DOI 10.1358/dot.2005.41.12.937959; Sun SY, 2005, CANCER RES, V65, P7052, DOI 10.1158/0008-5472.CAN-05-0917; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Tsao H, 2000, CANCER RES, V60, P1800; Vossler MR, 1997, CELL, V89, P73, DOI 10.1016/S0092-8674(00)80184-1; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; WU J, 1993, SCIENCE, V262, P1065, DOI 10.1126/science.7694366; Yamaguchi T, 2004, J BIOL CHEM, V279, P40419, DOI 10.1074/jbc.M405079200	53	19	19	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1393	1403		10.1096/fj.07-9100com	http://dx.doi.org/10.1096/fj.07-9100com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18171696				2022-12-25	WOS:000255898700012
J	Song, MS; Song, SJ; Kim, SJ; Nakayama, K; Nakayama, KI; Lim, DS				Song, M. S.; Song, S. J.; Kim, S. J.; Nakayama, K.; Nakayama, K. I.; Lim, D-S			Skp2 regulates the antiproliferative function of the tumor suppressor RASSF1A via ubiquitin-mediated degradation at the G(1)-S transition	ONCOGENE			English	Article						Skp2; RASSF1A; cyclin D-Cdk4; ubiquitination; G(1)-S transition	ANAPHASE-PROMOTING COMPLEX; CELL-CYCLE; HUMAN CANCERS; PROTEIN; GENE; PROGRESSION; LIGASE; TRANSCRIPTION; ACCUMULATION; DESTRUCTION	The tumor suppressor RASSF1A is inactivated in many human cancers and is implicated in regulation of microtubule stability, cell cycle progression and apoptosis. However, the precise mechanisms of RASSF1A action and their regulation remain unclear. Here we show that Skp2, an oncogenic subunit of the Skp1-Cul1-F-box ubiquitin ligase complex, interacts with, ubiquitinates, and promotes the degradation of RASSF1A at the G1-S transition of the cell cycle. This Skp2-dependent destruction of RASSF1A requires phosphorylation of the latter on serine-203 by cyclin D-cyclin-dependent kinase 4. Interestingly, mutation of RASSF1A-phosphorylation site Ser(203) to alanine results in a delay in cell cycle progression from G(1) to S phase. Moreover, enforced expression of Skp2 abolishes the inhibitory effect of RASSF1A on cell proliferation. Finally, the delay in G(1)-S progression after Skp2 removal is normalized by depletion of RASSF1A. These findings suggest that the Skp2-mediated degradation of RASSF1A plays an important role in cell proliferation and survival.	[Song, M. S.; Song, S. J.; Kim, S. J.; Lim, D-S] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Nakayama, K.] Tohoku Univ, Grad Sch Med, Ctr Translat & Adv Anim Res Human Dis, Div Dev Genet, Sendai, Miyagi 980, Japan; [Nakayama, K. I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Fukuoka 812, Japan	Korea Advanced Institute of Science & Technology (KAIST); Tohoku University; Kyushu University	Lim, DS (corresponding author), Korea Adv Inst Sci & Technol, Dept Biol Sci, 373-1 Guseong D, Taejon 305701, South Korea.	daesiklim@kaist.ac.kr	Lim, Dae-Sik/C-1599-2011	Lim, Dae-Sik/0000-0003-2356-7555				Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; An HX, 1999, AM J PATHOL, V154, P113, DOI 10.1016/S0002-9440(10)65257-1; Baksh S, 2005, MOL CELL, V18, P637, DOI 10.1016/j.molcel.2005.05.010; BARTKOVA J, 1995, ONCOGENE, V10, P775; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; Bashir T, 2003, ADV CANCER RES, V88, P101, DOI 10.1016/S0065-230X(03)88305-7; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Dammann R, 2000, NAT GENET, V25, P315, DOI 10.1038/77083; Fenton SL, 2004, CANCER RES, V64, P102, DOI 10.1158/0008-5472.CAN-03-2622; Gstaiger M, 2001, P NATL ACAD SCI USA, V98, P5043, DOI 10.1073/pnas.081474898; Harper JW, 2002, TRENDS CELL BIOL, V12, P104, DOI 10.1016/S0962-8924(01)02238-3; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Latres E, 2001, P NATL ACAD SCI USA, V98, P2515, DOI 10.1073/pnas.041475098; Lim DS, 2000, NATURE, V404, P613, DOI 10.1038/35007091; Marti A, 1999, NAT CELL BIOL, V1, P14, DOI 10.1038/8984; Matallanas D, 2007, MOL CELL, V27, P962, DOI 10.1016/j.molcel.2007.08.008; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; Nakayama K, 2000, EMBO J, V19, P2069, DOI 10.1093/emboj/19.9.2069; Nakayama K, 2004, DEV CELL, V6, P661, DOI 10.1016/S1534-5807(04)00131-5; Oh HJ, 2006, CANCER RES, V66, P2562, DOI 10.1158/0008-5472.CAN-05-2951; Pagano M, 2003, CANCER CELL, V4, P251, DOI 10.1016/S1535-6108(03)00243-5; Reed SI, 2003, NAT REV MOL CELL BIO, V4, P855, DOI 10.1038/nrm1246; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; RONG R, 2007, ONCOGENE; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Shivakumar L, 2002, MOL CELL BIOL, V22, P4309, DOI 10.1128/MCB.22.12.4309-4318.2002; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Tommasi S, 2005, CANCER RES, V65, P92; van der Weyden L, 2005, MOL CELL BIOL, V25, P8356, DOI 10.1128/MCB.25.18.8356-8367.2005; Vos MD, 2004, CANCER RES, V64, P4244, DOI 10.1158/0008-5472.CAN-04-0339; Wei W, 2004, NATURE, V428, P194, DOI 10.1038/nature02381; Yokoi S, 2002, AM J PATHOL, V161, P207, DOI 10.1016/S0002-9440(10)64172-7; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039	34	49	50	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2008	27	22					3176	3185		10.1038/sj.onc.1210971	http://dx.doi.org/10.1038/sj.onc.1210971			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	301LL	18071316				2022-12-25	WOS:000255897600010
J	Evans, ZP; Ellett, JD; Schmidt, MG; Schnellmann, RG; Chavin, KD				Evans, Zachary P.; Ellett, Justin D.; Schmidt, Michael G.; Schnellmann, Rick G.; Chavin, Kenneth D.			Mitochondrial uncoupling protein-2 mediates steatotic liver injury following ischemia/reperfusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-CELL DYSFUNCTION; FATTY LIVER; PRIMARY NONFUNCTION; REPERFUSION INJURY; NONALCOHOLIC STEATOHEPATITIS; LIPID-PEROXIDATION; ISCHEMIC-INJURY; DONOR LIVER; PROTON LEAK; UW-SOLUTION	Steatotic livers are not used for transplantation because they have a reduced tolerance for ischemic events with reduced ATP levels and greater levels of cellular necrosis, which ultimately result in total organ failure. Mitochondrial uncoupling protein-2 (UCP2) is highly expressed in steatotic livers and may be responsible for liver sensitivity to ischemia through mitochondrial and ATP regulation. To test this hypothesis, experiments were conducted in lean and steatotic (ob/ob), wild-type, and UCP2 knock-out mice subjected to total warm hepatic ischemia/reperfusion. Although ob/ob UCP2knock-out mice and ob/ob mice have a similar initial phenotype, ob/ob UCP2 knock-out animal survival was 83% when compared with 30% in ob/ob mice 24 h after reperfusion. Serum alanine aminotransferase concentrations and hepatocellular necrosis were decreased in the ob/ob UCP2 knock-out mice when compared with ob/ob mice subjected to ischemia. Liver ATP levels were increased in the ob/ob UCP2 knock-out animals after reperfusion when compared with the ob/ob mice but remained below the concentrations from lean livers. Lipid peroxidation ( thiobarbituric acid-reactive substances) increased after reperfusion most significantly in the steatotic groups, but the increase was not affected by UCP2 deficiency. These results reveal that UCP2 expression is a critical factor, which sensitizes steatotic livers to ischemic injury, regulating liver ATP levels after ischemia and reperfusion.	[Evans, Zachary P.; Ellett, Justin D.; Schmidt, Michael G.; Chavin, Kenneth D.] Med Univ S Carolina, Dept Microbiol & Immunol, Charleston, SC 29425 USA; [Schnellmann, Rick G.] Med Univ S Carolina, Dept Pharmaceut Sci, Charleston, SC 29425 USA; [Chavin, Kenneth D.] Med Univ S Carolina, Dept Transplant Surg, Charleston, SC 29425 USA	Medical University of South Carolina; Medical University of South Carolina; Medical University of South Carolina	Chavin, KD (corresponding author), Med Univ S Carolina, Div Transplant, Dept Surg, 96 Jonathan Lucas St,CB Suite 404, Charleston, SC 29425 USA.	chavinkd@musc.edu		Schmidt, Michael G/0000-0002-7794-7265	NCRR NIH HHS [5 P20 RR 017677-05] Funding Source: Medline; NIDDK NIH HHS [1 R01 DK 069369] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069369] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Baffy G, 2002, HEPATOLOGY, V35, P753, DOI 10.1053/jhep.2002.32028; Birsner JH, 2004, J SURG RES, V120, P97, DOI 10.1016/j.jss.2003.11.022; Bodyak N, 2007, AM J PHYSIOL-HEART C, V293, pH829, DOI 10.1152/ajpheart.01409.2006; Bradbury Michael W, 2004, Clin Liver Dis, V8, P639, DOI 10.1016/j.cld.2004.04.005; CALDWELLKENKEL JC, 1991, HEPATOLOGY, V13, P83, DOI 10.1016/0270-9139(91)90219-L; Chavin KD, 2004, AM J TRANSPLANT, V4, P1440, DOI 10.1111/j.1600-6143.2004.00546.x; Chavin KD, 1999, J BIOL CHEM, V274, P5692, DOI 10.1074/jbc.274.9.5692; Chitturi S, 2001, SEMIN LIVER DIS, V21, P27, DOI 10.1055/s-2001-12927; Collins P, 2005, LIVER INT, V25, P880, DOI 10.1111/j.1478-3231.2005.01104.x; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; DALESSANDRO AM, 1991, TRANSPLANTATION, V51, P157, DOI 10.1097/00007890-199101000-00024; de Bilbao F, 2004, J NEUROCHEM, V89, P1283, DOI 10.1111/j.1471-4159.2004.02432.x; Echtay KS, 2001, P NATL ACAD SCI USA, V98, P1416, DOI 10.1073/pnas.98.4.1416; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; FERGUSON DM, 1991, TRANSPLANT P, V23, P1552; Fernandez-Merino FJ, 2003, TRANSPLANT P, V35, P1793, DOI 10.1016/S0041-1345(03)00722-X; Fiorini RN, 2004, AM J TRANSPLANT, V4, P1567, DOI 10.1111/j.1600-6143.2004.00549.x; Fulop P, 2006, HEPATOLOGY, V44, P592, DOI 10.1002/hep.21310; GAO WS, 1995, TRANSPLANTATION, V59, P674, DOI 10.1097/00007890-199503150-00005; KANNO M, 1993, TRANSPLANT P, V25, P2716; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; Li L, 2005, TOXICOL SCI, V86, P116, DOI 10.1093/toxsci/kfi164; Li L, 2006, TOXICOL SCI, V93, P136, DOI 10.1093/toxsci/kfl039; Marsman WA, 1996, TRANSPLANTATION, V62, P1246, DOI 10.1097/00007890-199611150-00011; Mattiasson G, 2003, NAT MED, V9, P1062, DOI 10.1038/nm903; Mehta K, 2002, NUTR REV, V60, P289, DOI 10.1301/002966402320387224; Mills EM, 2002, J BIOL CHEM, V277, P27385, DOI 10.1074/jbc.M111860200; National Center for Health Statistics, 2006, HLTH US 2006 CHARTB; Neil DAH, 2001, TRANSPLANTATION, V71, P1566, DOI 10.1097/00007890-200106150-00014; OHNO A, 1994, DIGEST DIS SCI, V39, P861, DOI 10.1007/BF02087434; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Rashid A, 1999, HEPATOLOGY, V29, P1131, DOI 10.1002/hep.510290428; Saadeh S, 2007, NUTR CLIN PRACT, V22, P1, DOI 10.1177/011542650702200101; SCHNELLMANN RG, 1988, AM J PHYSIOL, V255, pC28, DOI 10.1152/ajpcell.1988.255.1.C28; Seifalian AM, 1999, TRANSPLANTATION, V68, P780, DOI 10.1097/00007890-199909270-00009; Selzner M, 2000, HEPATOLOGY, V32, P1280, DOI 10.1053/jhep.2000.20528; Stuart JA, 2001, J BIOL CHEM, V276, P18633, DOI 10.1074/jbc.M011566200; Teshima Y, 2003, CIRC RES, V93, P192, DOI 10.1161/01.RES.0000085581.60197.4D; Uchino S, 2004, J SURG RES, V120, P73, DOI 10.1016/j.jss.2003.10.010; Zhang CY, 2006, CELL METAB, V3, P417, DOI 10.1016/j.cmet.2006.04.010; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	44	55	58	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8573	8579		10.1074/jbc.M706784200	http://dx.doi.org/10.1074/jbc.M706784200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18086675	Green Published, hybrid			2022-12-25	WOS:000254288000056
J	El-Mashtoly, SF; Gu, Y; Yoshimura, H; Yoshioka, S; Aono, S; Kitagawa, T				El-Mashtoly, Samir F.; Gu, Yuzong; Yoshimura, Hideaki; Yoshioka, Shiro; Aono, Shigetoshi; Kitagawa, Teizo			Protein conformation changes of HemAT-Bs upon ligand binding probed by ultraviolet resonance Raman spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS; OXYGEN SENSOR; ESCHERICHIA-COLI; SENSING MECHANISM; HYDROGEN-BOND; SIDE-CHAINS; EC DOS; SIGNAL; TRYPTOPHAN; PHOSPHODIESTERASE	HemAT from Bacillus subtilis (HemAT-Bs) is a heme-based O-2 sensor protein that acts as a signal transducer responsible for aerotaxis. HemAT-Bs discriminates its physiological effector (O-2) from other gas molecules (CO and NO), although all of them bind to a heme. To monitor the conformational changes in the protein moiety upon binding of different ligands, we have investigated ultraviolet resonance Raman (UVRR) spectra of the ligand-free and O-2-, CO-, and NO-bound forms of full-length HemAT-Bs and several mutants (Y70F, H86A, T95A, and Y133F) and found that Tyr(70) in the heme distal side and Tyr(133) and Trp(132) from the G-helix in the heme proximal side undergo environmental changes upon ligand binding. In addition, the UVRR results confirmed our previous model, which suggested that Thr(95) forms a hydrogen bond with heme-bound O-2, but Tyr(70) does not. It is deduced from this study that hydrogen bonds between Thr(95) and heme-bound O-2 and between His(86) and heme 6-propionate communicate the heme structural changes to the protein moiety upon O-2 binding but not upon CO and NO binding. Accordingly, the present UVRR results suggest that O-2 binding to heme causes displacement of the G-helix, which would be important for transduction of the conformational changes from the sensor domain to the signaling domain.	[El-Mashtoly, Samir F.; Gu, Yuzong; Yoshimura, Hideaki; Yoshioka, Shiro; Aono, Shigetoshi; Kitagawa, Teizo] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB)	Kitagawa, T (corresponding author), Toyota Phys & Chem Res Inst, Nagakute, Aichi 4801192, Japan.	teizo@ims.ac.jp	El-Mashtoly, Samir/C-8761-2014; Asano, Yasuhisa/K-5898-2016; Yoshimura, Hideaki/T-4488-2017; Aono, Shigetoshi/ABD-7618-2020; Yoshimura, Hideaki/AAV-3735-2020	El-Mashtoly, Samir/0000-0001-6087-8817; Asano, Yasuhisa/0000-0003-3645-3952; Yoshimura, Hideaki/0000-0002-7287-7712; Aono, Shigetoshi/0000-0002-2870-3694; Yoshimura, Hideaki/0000-0002-7287-7712				Aki M, 2000, J PHYS CHEM B, V104, P10765, DOI 10.1021/jp000357p; Aono S, 2002, J BIOL CHEM, V277, P13528, DOI 10.1074/jbc.M112256200; Aono S, 1999, COORDIN CHEM REV, V190, P267, DOI 10.1016/S0010-8545(99)00070-3; Austin J. C., 1993, BIOMOLECULAR SPECT A, P55; BISCHOFF DS, 1992, MOL MICROBIOL, V6, P23, DOI 10.1111/j.1365-2958.1992.tb00833.x; Chan MK, 2001, CURR OPIN CHEM BIOL, V5, P216, DOI 10.1016/S1367-5931(00)00193-9; Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236; Chi ZH, 1998, J PHYS CHEM B, V102, P9595, DOI 10.1021/jp9828336; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; El-Mashtoly SF, 2007, J AM CHEM SOC, V129, P3556, DOI 10.1021/ja0669777; El-Mashtoly SF, 2005, J PHYS CHEM B, V109, P23666, DOI 10.1021/jp054772z; Gao Y, 2006, J BIOL CHEM, V281, P24637, DOI 10.1074/jbc.M603198200; GARRITY LF, 1995, PHARMACOL THERAPEUT, V68, P87, DOI 10.1016/0163-7258(95)00027-5; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; GILLESGONZALEZ MA, 1991, NATURE, V350, P170, DOI 10.1038/350170a0; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Harada I, 1986, SPECTROSCOPY BIOL SY, P113; Hou SB, 2001, P NATL ACAD SCI USA, V98, P9353, DOI 10.1073/pnas.161185598; Hou SB, 2000, NATURE, V403, P540, DOI 10.1038/35000570; Kachalova GS, 1999, SCIENCE, V284, P473, DOI 10.1126/science.284.5413.473; Kubo M, 2006, J BIOL CHEM, V281, P11271, DOI 10.1074/jbc.M513261200; Matsuno M, 1998, B CHEM SOC JPN, V71, P851, DOI 10.1246/bcsj.71.851; MIURA T, 1989, J RAMAN SPECTROSC, V20, P667, DOI 10.1002/jrs.1250201007; MIURA T, 1988, BIOCHEMISTRY-US, V27, P88, DOI 10.1021/bi00401a015; Nakamura H, 2004, P NATL ACAD SCI USA, V101, P2742, DOI 10.1073/pnas.0305795101; Ohta T, 2005, INORG CHEM, V44, P758, DOI 10.1021/ic0486318; Ohta T, 2004, J AM CHEM SOC, V126, P15000, DOI 10.1021/ja046896f; Ottemann KM, 1999, SCIENCE, V285, P1751, DOI 10.1126/science.285.5434.1751; Pinakoulaki E, 2006, P NATL ACAD SCI USA, V103, P14796, DOI 10.1073/pnas.0604248103; Pinakoulaki E, 2006, BIOCHEMISTRY-US, V45, P7763, DOI 10.1021/bi0604072; RODGERS KR, 1992, J AM CHEM SOC, V114, P3697, DOI 10.1021/ja00036a019; Rodgers KR, 1999, CURR OPIN CHEM BIOL, V3, P158, DOI 10.1016/S1367-5931(99)80028-3; Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525; Szurmant H, 2004, J MOL BIOL, V344, P919, DOI 10.1016/j.jmb.2004.09.093; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Takeuchi H, 2003, BIOPOLYMERS, V72, P305, DOI 10.1002/bip.10440; TAKEUCHI H, 1989, J RAMAN SPECTROSC, V20, P233, DOI 10.1002/jrs.1250200407; Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200; TERAOKA J, 1981, J BIOL CHEM, V256, P3969; Uchida T, 2005, ACCOUNTS CHEM RES, V38, P662, DOI 10.1021/ar030267d; Yoshimura H, 2007, BIOCHEM BIOPH RES CO, V357, P1053, DOI 10.1016/j.bbrc.2007.04.041; Yoshimura H, 2006, BIOCHEMISTRY-US, V45, P8301, DOI 10.1021/bi060315c; Zhang W, 2005, BIOPHYS J, V88, P2801, DOI 10.1529/biophysj.104.047936; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	44	23	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6942	6949		10.1074/jbc.M709209200	http://dx.doi.org/10.1074/jbc.M709209200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18162468	hybrid			2022-12-25	WOS:000253779600038
J	Hoe, HS; Minami, SS; Makarova, A; Lee, J; Hyman, BT; Matsuoka, Y; Rebeck, GW				Hoe, Hyang-Sook; Minami, S. Sakura; Makarova, Alexandra; Lee, Jiyeon; Hyman, Bradley T.; Matsuoka, Yasuji; Rebeck, G. William			Fyn modulation of dab1 effects on amyloid precursor protein and ApoE receptor 2 processing	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOLIPOPROTEIN-E RECEPTORS; ALZHEIMERS-DISEASE; TYROSINE KINASE; BRAIN-DEVELOPMENT; BINDING DOMAIN; LIGAND-BINDING; DISABLED 1; PHOSPHORYLATION; DEGRADATION; ADAPTER	Dab1 is an intracellular adaptor protein that interacts with amyloid precursor protein (APP) and apoE receptor 2 (apoEr2), increases their levels on the cell surface, and increases their cleavage by alpha-secretases. To investigate the mechanism underlying these alterations in processing and trafficking of APP and apoEr2, we examined the effect of Fyn, an Src family-tyrosine kinase known to interact with and phosphorylate Dab1. Co-immunoprecipitation, co-immunostaining, and fluorescence lifetime imaging demonstrated an association between Fyn and APP. Fyn induced phosphorylation of APP at Tyr-757 of the (YENPTY762)-Y-757 motif and increased cell surface expression of APP. Overexpression of Fyn alone did not alter levels of sAPP alpha or cytoplasmic C-terminal fragments, although it significantly decreased production of A beta. However, in the presence of Dab1, Fyn significantly increased sAPP alpha and C-terminal fragments. Fyn-induced APP phosphorylation and cell surface levels of APP were potentiated in the presence of Dab1. Fyn also induced phosphorylation of apoEr2 and increased its cell surface levels and, in the presence of Dab1, affected processing of its C-terminal fragment. In vivo studies showed that sAPP alpha was decreased in the Fyn knock-out, supporting a role for Fyn in APP processing. These data demonstrate that Fyn, due in part to its effects on Dab1, regulates the phosphorylation, trafficking, and processing of APP and apoEr2.	[Hoe, Hyang-Sook; Minami, S. Sakura; Rebeck, G. William] Georgetown Univ, Ctr Med, Dept Neurosci, Washington, DC 20057 USA; [Minami, S. Sakura; Matsuoka, Yasuji] Georgetown Univ, Ctr Med, Dept Neurol, Washington, DC 20057 USA; [Makarova, Alexandra; Hyman, Bradley T.] Massachusetts Gen Hosp, MassGen Inst Neurodegenerat Disorders, Dept Neurol, Charlestown, MA 02129 USA; [Lee, Jiyeon] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Lee, Jiyeon] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Georgetown University; Georgetown University; Harvard University; Massachusetts General Hospital; Washington University (WUSTL); Washington University (WUSTL)	Rebeck, GW (corresponding author), Georgetown Univ, Ctr Med, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	gwr2@georgetown.edu	Rebeck, George William/J-2192-2012	Rebeck, George William/0000-0001-6276-248X	NIA NIH HHS [P01 AG030128, AG 14473, AG 022455] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K01AG022455, P01AG030128, R29AG014473, R01AG014473] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arnaud L, 2003, MOL CELL BIOL, V23, P9293, DOI 10.1128/MCB.23.24.9293-9302.2003; Bacskai BJ, 2003, J BIOMED OPT, V8, P368, DOI 10.1117/1.1584442; Bhaskar K, 2005, J BIOL CHEM, V280, P35119, DOI 10.1074/jbc.M505895200; Bock HH, 2004, J BIOL CHEM, V279, P33471, DOI 10.1074/jbc.M401770200; Brandes C, 2001, J BIOL CHEM, V276, P22160, DOI 10.1074/jbc.M102662200; Chin J, 2005, J NEUROSCI, V25, P9694, DOI 10.1523/JNEUROSCI.2980-05.2005; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; Fu ZY, 2007, J NEUROCHEM, V100, P118, DOI 10.1111/j.1471-4159.2006.04195.x; Gotoh H, 2006, BIOCHEM BIOPH RES CO, V346, P600, DOI 10.1016/j.bbrc.2006.05.167; Gotthardt M, 2000, J BIOL CHEM, V275, P25616, DOI 10.1074/jbc.M000955200; Herz J, 2000, NAT REV NEUROSCI, V1, P51, DOI 10.1038/35036221; Hiltunen M, 2006, J BIOL CHEM, V281, P32240, DOI 10.1074/jbc.M603106200; Ho GJ, 2005, NEUROBIOL AGING, V26, P625, DOI 10.1016/j.neurobiolaging.2004.06.016; Hoe HS, 2005, MOL CELL BIOL, V25, P9259, DOI 10.1128/MCB.25.21.9259-9268.2005; Hoe HS, 2005, MOL BRAIN RES, V137, P31, DOI 10.1016/j.molbrainres.2005.02.013; Hoe HS, 2007, J NEUROSCI, V27, P10895, DOI 10.1523/JNEUROSCI.3135-07.2007; Hoe HS, 2006, J BIOL CHEM, V281, P35176, DOI 10.1074/jbc.M602162200; Hoe HS, 2006, J BIOL CHEM, V281, P24521, DOI 10.1074/jbc.M600728200; Horikoshi Y, 2004, BIOCHEM BIOPH RES CO, V319, P733, DOI 10.1016/j.bbrc.2004.05.051; Howell BW, 1999, GENE DEV, V13, P643, DOI 10.1101/gad.13.6.643; Howell BW, 1997, EMBO J, V16, P121, DOI 10.1093/emboj/16.1.121; Howell BW, 1999, MOL CELL BIOL, V19, P5179; Hung CC, 2006, BIOCHEM SOC T, V34, P743, DOI 10.1042/BST0340743; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kojima N, 1997, P NATL ACAD SCI USA, V94, P4761, DOI 10.1073/pnas.94.9.4761; MARENGERE LEM, 1994, J CELL SCI, P97; Nishitomi K, 2006, J NEUROCHEM, V99, P1555, DOI 10.1111/j.1471-4159.2006.04178.x; Pak DTS, 2001, NEURON, V31, P289, DOI 10.1016/S0896-6273(01)00355-5; Parisiadou L, 2007, NEUROBIOL AGING, V28, P377, DOI 10.1016/j.neurobiolaging.2005.12.015; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Qiu Z, 2003, NEUROSCIENCE, V122, P291, DOI 10.1016/j.neuroscience.2003.08.017; SHIRAZI SK, 1993, NEUROREPORT, V4, P435, DOI 10.1097/00001756-199304000-00024; Sperber BR, 2001, J NEUROSCI, V21, P2039, DOI 10.1523/JNEUROSCI.21-06-02039.2001; Tezuka T, 1999, P NATL ACAD SCI USA, V96, P435, DOI 10.1073/pnas.96.2.435; Wallace TA, 2005, VASC PHARMACOL, V43, P336, DOI 10.1016/j.vph.2005.08.022; Yamada K, 2004, DRUG NEWS PERSPECT, V17, P435, DOI 10.1358/dnp.2004.17.7.863702	36	37	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6288	6299		10.1074/jbc.M704140200	http://dx.doi.org/10.1074/jbc.M704140200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18089558	hybrid			2022-12-25	WOS:000253779500036
J	Mitobe, J; Morita-Ishihara, T; Ishihama, A; Watanabe, H				Mitobe, Jiro; Morita-Ishihara, Tomoko; Ishihama, Akira; Watanabe, Haruo			Involvement of RNA-binding protein Hfq in the post-transcriptional regulation of invE gene expression in Shigella sonnei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORM-I PLASMID; ESCHERICHIA-COLI; H-NS; VIRULENCE GENE; HOST FACTOR; MESSENGER-RNA; CHROMOSOMAL GENES; STATIONARY-PHASE; Q-BETA; FLEXNERI	The temperature-dependent regulation of Shigella virulence genes is believed to be accomplished at the transcriptional stage by the regulators VirF and InvE. Several lines of evidence herein described indicate that post-transcriptional regulation of InvE expression plays a key role in the temperature-dependent regulation of virulence gene expression: (i) a considerable amount of invE mRNA continues to be transcribed under low temperature conditions, where the production of InvE protein is tightly repressed; (ii) the stability of invE mRNA markedly decreases, because its decay rate is significantly increased under the repressing conditions. Strikingly, in the hfq mutant of Shigella sonnei, a considerable amount of InvE protein was produced even at low temperature. This increase in the InvE level was found to be associated with the improved stability of invE mRNA, in agreement with the finding that the RNA chaperon Hfq influences post-transcriptional regulations of various genes. Consistently, overexpression of the Hfq protein decreased the production of InvE protein even under the expressing condition at 37 degrees C. The binding in vitro of purified Hfq protein to invE RNA was shown to be stronger at 30 degrees C than at 37 degrees C in two experiments, gel shift analysis and surface plasmon resonance (Biacore) analysis. These results altogether suggest that Hfq plays an important role in the temperature-dependent regulation of invE expression at the post-transcriptional step.	[Mitobe, Jiro; Morita-Ishihara, Tomoko; Watanabe, Haruo] NIAID, Dept Bacteriol, Shinjuku Ku, Tokyo 1628640, Japan; [Ishihama, Akira] Hosei Univ, Dept Frontier Biosci, Tokyo 1848584, Japan	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Hosei University	Watanabe, H (corresponding author), NIAID, Dept Bacteriol, Shinjuku Ku, Tokyo 1628640, Japan.	haruwata@nih.go.jp		Mitobe, Jiro/0000-0003-1424-4594				ADLER B, 1989, MOL MICROBIOL, V3, P627, DOI 10.1111/j.1365-2958.1989.tb00210.x; Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; Akabayov B, 2003, IEEE T NANOBIOSCI, V2, P70, DOI 10.1109/TNB.2003.813937; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Azam TA, 1999, J BIOL CHEM, V274, P33105, DOI 10.1074/jbc.274.46.33105; Beloin C, 2003, MOL MICROBIOL, V47, P825, DOI 10.1046/j.1365-2958.2003.03347.x; Bhagwat AA, 2003, J MICROBIOL METH, V55, P399, DOI 10.1016/S0167-7012(03)00175-1; Chowdhury S, 2003, J BIOL CHEM, V278, P47915, DOI 10.1074/jbc.M306874200; Chowdhury S, 2006, EMBO J, V25, P2487, DOI 10.1038/sj.emboj.7601128; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Derbise A, 2003, FEMS IMMUNOL MED MIC, V38, P113, DOI 10.1016/S0928-8244(03)00181-0; Ding YP, 2004, MOL MICROBIOL, V53, P345, DOI 10.1111/j.1365-2958.2004.04142.x; Dorman CJ, 1998, MOL MICROBIOL, V29, P677, DOI 10.1046/j.1365-2958.1998.00902.x; DORMAN CJ, 1990, NATURE, V344, P789, DOI 10.1038/344789a0; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Geissmann TA, 2004, EMBO J, V23, P396, DOI 10.1038/sj.emboj.7600058; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hashimoto-Gotoh T, 2000, GENE, V241, P185, DOI 10.1016/S0378-1119(99)00434-5; Higashi K, 2006, J BIOL CHEM, V281, P9527, DOI 10.1074/jbc.M513752200; ITO K, 1991, MICROBIOL IMMUNOL, V35, P335, DOI 10.1111/j.1348-0421.1991.tb01563.x; Jishage M, 1998, P NATL ACAD SCI USA, V95, P4953, DOI 10.1073/pnas.95.9.4953; KAJITANI M, 1994, J BACTERIOL, V176, P531, DOI 10.1128/JB.176.2.531-534.1994; KAJITANI M, 1991, NUCLEIC ACIDS RES, V19, P1063, DOI 10.1093/nar/19.5.1063; KATO JI, 1989, INFECT IMMUN, V57, P1391, DOI 10.1128/IAI.57.5.1391-1398.1989; LETT MC, 1989, J BACTERIOL, V171, P353, DOI 10.1128/jb.171.1.353-359.1989; Majdalani N, 1998, P NATL ACAD SCI USA, V95, P12462, DOI 10.1073/pnas.95.21.12462; Masse E, 2002, P NATL ACAD SCI USA, V99, P4620, DOI 10.1073/pnas.032066599; MAURELLI AT, 1984, INFECT IMMUN, V43, P195, DOI 10.1128/IAI.43.1.195-201.1984; MAURELLI AT, 1988, P NATL ACAD SCI USA, V85, P2820, DOI 10.1073/pnas.85.8.2820; McNealy TL, 2005, J BACTERIOL, V187, P1527, DOI 10.1128/JB.187.4.1527-1532.2005; MILLER PS, 1992, BIOCONJUGATE CHEM, V3, P74, DOI 10.1021/bc00013a012; Mitobe J, 2005, J BACTERIOL, V187, P107, DOI 10.1128/JB.187.1.107-113.2005; NAKAYAMA S, 1995, J BACTERIOL, V177, P5062, DOI 10.1128/jb.177.17.5062-5069.1995; Narberhaus F, 2006, FEMS MICROBIOL REV, V30, P3, DOI 10.1111/j.1574-6976.2005.004.x; Ono S, 2005, BIOCHEM J, V391, P203, DOI 10.1042/BJ20050453; Porter ME, 1997, J BACTERIOL, V179, P6537, DOI 10.1128/jb.179.21.6537-6550.1997; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Roux A, 2005, J BACTERIOL, V187, P1001, DOI 10.1128/JB.187.3.1001-1013.2005; Sambrook J., 2002, MOL CLONING LAB MANU; Sharma AK, 2006, MOL MICROBIOL, V62, P1498, DOI 10.1111/j.1365-2958.2006.05449.x; Sittka A, 2007, MOL MICROBIOL, V63, P193, DOI 10.1111/j.1365-2958.2006.05489.x; Sonnleitner E, 2003, MICROB PATHOGENESIS, V35, P217, DOI 10.1016/S0882-4010(03)00149-9; Storz G, 2004, CURR OPIN MICROBIOL, V7, P140, DOI 10.1016/j.mib.2004.02.015; Taniya T, 2003, J BACTERIOL, V185, P5158, DOI 10.1128/JB.185.17.5158-5165.2003; Terui Y, 2007, J BACTERIOL, V189, P2359, DOI 10.1128/JB.01562-06; TOBE T, 1993, J BACTERIOL, V175, P6142, DOI 10.1128/JB.175.19.6142-6149.1993; TOBE T, 1994, MOL MICROBIOL, V12, P267, DOI 10.1111/j.1365-2958.1994.tb01015.x; TSUI HCT, 1994, MOL MICROBIOL, V13, P35, DOI 10.1111/j.1365-2958.1994.tb00400.x; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vassilieva IM, 2002, BIOCHEMISTRY-MOSCOW+, V67, P1293, DOI 10.1023/A:1021365808520; WATANABE H, 1990, J BACTERIOL, V172, P619, DOI 10.1128/jb.172.2.619-629.1990; Wei J, 2003, INFECT IMMUN, V71, P2775, DOI 10.1128/IAI.71.5.2775-2786.2003; Yamamoto S, 2006, J BACTERIOL, V188, P958, DOI 10.1128/JB.188.3.958-967.2006	53	25	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5738	5747		10.1074/jbc.M710108200	http://dx.doi.org/10.1074/jbc.M710108200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18156173	hybrid			2022-12-25	WOS:000253426700055
J	Hebbar, PB; Archer, TK				Hebbar, Pratibha B.; Archer, Trevor K.			Altered histone H1 stoichiometry and an absence of nucleosome positioning on transfected DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR VIRUS PROMOTER; IN-VIVO; LINKER HISTONE; TRANSCRIPTIONAL ACTIVATION; CHROMATIN-STRUCTURE; MMTV PROMOTER; REPLICATION; TEMPLATES; COMPLEXES; MECHANISM	The packaging of DNA with histones to form chromatin represents an important and powerful mechanism to regulate gene expression. Critical aspects of chromatin-specific contributions to gene regulation have been revealed by the comparison of the activities from DNA regulatory elements examined both as transiently transfected reporters and stably integrated reporters organized as chromatin. Using the mouse mammary tumor virus ( MMTV) promoter as a model, we probed the structural differences between transiently transfected and stably integrated DNA templates. We demonstrated that all four core histones and the linker histone (H1) are associated with the transient template. However, whereas the core histones were present at a similar stoichiometry between the transient and the stable templates, we found that linker histone H1 molecules are fewer on the transient template. By using supercoiling assay, we show that the transient template shows intermediate levels of nucleosomal assembly. Overexpression of H1 resulted in repression of MMTV transcriptional activity and reduced accessibility to restriction endonucleases on the transient MMTV promoter. However, the addition of exogenous H1 failed to impose a normal chromatin structure on the transient template as measured by micrococcal nuclease digestion pattern. Thus, our results suggest that while transiently transfected DNA acquires a full complement of core histones, the underrepresentation of H1 on the transient template is indicative of structural differences between the two templates that may underlie the differences in the mechanisms of activation of the two templates.	[Hebbar, Pratibha B.; Archer, Trevor K.] NIEHS, Natl Inst Hlth, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Archer, TK (corresponding author), NIEHS, Natl Inst Hlth, Mol Carcinogenesis Lab, 111 Alexander Dr,MD D4-01,POB 12233, Res Triangle Pk, NC 27709 USA.	archer1@niehs.nih.gov	Archer, Trevor K/E-5191-2019	Archer, Trevor K/0000-0001-7651-3644	Intramural NIH HHS [Z01 ES071006-09] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071006] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Archer TK, 1997, METHODS, V11, P235, DOI 10.1006/meth.1996.0410; ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; ARCHER TK, 1992, SCIENCE, V255, P1573, DOI 10.1126/science.1347958; BAVYKIN S, 1993, P NATL ACAD SCI USA, V90, P3918, DOI 10.1073/pnas.90.9.3918; Bednar J, 1998, P NATL ACAD SCI USA, V95, P14173, DOI 10.1073/pnas.95.24.14173; BRESNICK EH, 1990, P NATL ACAD SCI USA, V87, P3977, DOI 10.1073/pnas.87.10.3977; CEREGHINI S, 1984, EMBO J, V3, P1243, DOI 10.1002/j.1460-2075.1984.tb01959.x; Deroo BJ, 2001, MOL BIOL CELL, V12, P3365, DOI 10.1091/mbc.12.11.3365; Fan YH, 2005, CELL, V123, P1199, DOI 10.1016/j.cell.2005.10.028; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; GARNER MM, 1987, P NATL ACAD SCI USA, V84, P2620, DOI 10.1073/pnas.84.9.2620; Gerber AN, 1997, GENE DEV, V11, P436, DOI 10.1101/gad.11.4.436; Hebbar PB, 2003, MOL CELL BIOL, V23, P887, DOI 10.1128/MCB.23.3.887-898.2003; Hebbar PB, 2007, J BIOL CHEM, V282, P8284, DOI 10.1074/jbc.M610554200; JEONG SW, 1994, NUCLEIC ACIDS RES, V22, P370, DOI 10.1093/nar/22.3.370; Lee HL, 1998, EMBO J, V17, P1454, DOI 10.1093/emboj/17.5.1454; Lin QC, 2004, J BIOL CHEM, V279, P23525, DOI 10.1074/jbc.M400925200; Misteli T, 2000, NATURE, V408, P877, DOI 10.1038/35048610; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Ramachandran A, 2003, J BIOL CHEM, V278, P48590, DOI 10.1074/jbc.M309033200; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; Trotter KW, 2004, MOL CELL BIOL, V24, P3347, DOI 10.1128/MCB.24.8.3347-3358.2004; Wilson MA, 2002, J BIOL CHEM, V277, P15171, DOI 10.1074/jbc.M200349200; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3	27	52	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4595	4601		10.1074/jbc.M709121200	http://dx.doi.org/10.1074/jbc.M709121200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156629	Green Accepted, hybrid			2022-12-25	WOS:000253426500016
J	Ohnuma, T; Onaga, S; Murata, K; Taira, T; Katoh, E				Ohnuma, Takayuki; Onaga, Shoko; Murata, Katsuyoshi; Taira, Toki; Katoh, Etsuko			LysM domains from Pteris ryukyuensis Chitinase-A - A stability study and characterization of the chitin-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIFFERENTIAL SCANNING CALORIMETRY; ENTEROPATHOGENIC ESCHERICHIA-COLI; ISOTHERMAL TITRATION CALORIMETRY; PROTEIN; RECEPTOR; NMR; RECOGNITION; TOOLS; PERCEPTION; BACTERIA	The LysM domain probably binds peptidoglycans, but how it does so has yet to be described. For this report, we measured the thermal stabilities of recombinant LysM domains derived from Pteris ryukyuensis chitinase-A (PrChi-A) and monitored their binding to N-acetylglucosamine oligomers ((GlcNAc)(n)) using differential scanning calorimetry, isothermal titration calorimetry, and NMR spectroscopy. We thereby characterized certain of the domains' functional and structural features. We observed that the domains are very resistant to thermal denaturation and that this resistance depends on the presence of disulfide bonds. We also show that the stoichiometry of (GlcNAc)(n)/LysM domain binding is 1:1. (GlcNAc)(5) titration experiments, monitored by NMR spectroscopy, allowed us to identify the domain residues that are critical for (GlcNAc)(5) binding. The binding site is a shallow groove formed by the N-terminal part of helix 1, the loop between strand 1 and helix 1, the C-terminal part of helix 2, and the loop between helix 2 and strand 2. Furthermore, mutagenesis experiments reiterate the critical involvement of Tyr(72) in (GlcNAc)(n)/LysM domain binding. Ours is the first report describing the physical structure of a LysM oligosaccharide-binding site based on experimental data.	[Ohnuma, Takayuki; Murata, Katsuyoshi; Katoh, Etsuko] Natl Inst Agrobiol Sci, Div Plant Sci, Tsukuba, Ibaraki 3058602, Japan; [Onaga, Shoko; Taira, Toki] Univ Ryukyus, Fac Agr, Dept Biosci & Biotechnol, Nishihara, Okinawa 9030213, Japan	National Institute of Agrobiological Sciences - Japan; University of the Ryukyus	Katoh, E (corresponding author), Natl Inst Agrobiol Sci, Div Plant Sci, Tsukuba, Ibaraki 3058602, Japan.	ekatoh@nias.affrc.go.jp	OHNUMA, Takayuki/T-8839-2019	Taira, Toki/0000-0002-8100-8113				Bateman A, 2000, J MOL BIOL, V299, P1113, DOI 10.1006/jmbi.2000.3778; BAX A, 1993, ACCOUNTS CHEM RES, V26, P131, DOI 10.1021/ar00028a001; Bielnicki J, 2006, PROTEINS, V62, P144, DOI 10.1002/prot.20702; BIRKELAND NK, 1994, CAN J MICROBIOL, V40, P658, DOI 10.1139/m94-104; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; CLARK M, 1989, J COMPUT CHEM, V10, P982, DOI 10.1002/jcc.540100804; Clore GM, 1998, TRENDS BIOTECHNOL, V16, P22, DOI 10.1016/S0167-7799(97)01135-9; CLORE GM, 1991, SCIENCE, V252, P1390, DOI 10.1126/science.2047852; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Frankel G, 1996, J BIOL CHEM, V271, P20359, DOI 10.1074/jbc.271.34.20359; Gabius HJ, 2004, CHEMBIOCHEM, V5, P740, DOI 10.1002/cbic.200300753; GODDARD TD, SPARKY, V3; Jain AN, 2007, J COMPUT AID MOL DES, V21, P281, DOI 10.1007/s10822-007-9114-2; Jelesarov I, 1999, J MOL RECOGNIT, V12, P3, DOI 10.1002/(SICI)1099-1352(199901/02)12:1<3::AID-JMR441>3.0.CO;2-6; JERSE AE, 1990, P NATL ACAD SCI USA, V87, P7839, DOI 10.1073/pnas.87.20.7839; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Limpens E, 2003, SCIENCE, V302, P630, DOI 10.1126/science.1090074; LIVE DH, 1984, J AM CHEM SOC, V106, P1934; Madsen EB, 2003, NATURE, V425, P637, DOI 10.1038/nature02045; Mulder L, 2006, GLYCOBIOLOGY, V16, P801, DOI 10.1093/glycob/cwl006; Pellegrini M, 1999, P NATL ACAD SCI USA, V96, P4285, DOI 10.1073/pnas.96.8.4285; Pierce MM, 1999, METHODS, V19, P213, DOI 10.1006/meth.1999.0852; Ponting CP, 1999, J MOL BIOL, V289, P729, DOI 10.1006/jmbi.1999.2827; Radutoiu S, 2003, NATURE, V425, P585, DOI 10.1038/nature02039; Remmele RL, 2000, BIOPHARM-APPL T BIO, V13, P36; Rudiger H, 2001, GLYCOCONJUGATE J, V18, P589, DOI 10.1023/A:1020687518999; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Topham C M, 1990, Biochem Soc Symp, V57, P1; Waldherr-Teschner M., 1992, Advances in Scientific Visualization, P58; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2; Yamagami T, 1996, BIOSCI BIOTECH BIOCH, V60, P1081, DOI 10.1271/bbb.60.1081	37	90	94	2	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5178	5187		10.1074/jbc.M707156200	http://dx.doi.org/10.1074/jbc.M707156200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18083709	hybrid			2022-12-25	WOS:000253426500075
J	Saleem, M; Meyer, MC; Breitenstein, D; Galla, HJ				Saleem, Mohammed; Meyer, Michaela C.; Breitenstein, Daniel; Galla, Hans-Joachim			The surfactant peptide KL4 in lipid monolayers - Phase behavior, topography, and chemical distribution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SP-B; BOVINE PULMONARY SURFACTANT; LUNG SURFACTANT; HYDROPHOBIC PEPTIDE; PHYSICAL-PROPERTIES; SCANNING FORCE; SP-C; PERCOLATION; FILMS; PHOSPHATIDYLCHOLINE	Studies of different fragments and mutants of SP-B suggest that the function related structural and compositional characteristics in SP-B are its positive charges with intermittent hydrophobic domains. KL4 ([lysine-(leucine)(4)](4)-lysine) is a synthetic peptide based on SP-B structure and is the major constituent of Surfaxin(R), a potential therapeutic agent for respiratory distress syndrome in premature infants. There is, however, no clear understanding about the possible lipid-KL4 interactions behind its function, which is an inevitable knowledge to design improved therapeutic agents. To examine the phase behavior, topography, and lipid specificity of KL4/lipid systems, we aimed to study different surfactant model systems containing KL4, neutral dipalmitoylphosphatidylcholine (DPPC) and/or negatively charged dipalmitoylphosphatidylglycerol (DPPG) in the presence of Ca2+ ions. Surface pressure-area isotherms, fluorescence microscopic images, scanning force microscopy as well as time-of-flight secondary ion mass spectrometry suggest (i) that KL4 is not miscible with DPPC and therefore forms peptide aggregates in DPPC/KL4 mixtures; (ii) that KL4 specifically interacts with DPPG via electrostatic interactions and induces percolation of DPPG-rich phases; (iii) that existing DPPG-Ca2+ interactions are too strong to be overcome by KL4, the reason why the peptide remains excluded from condensed DPPG domains and passively colocalizes with DPPC in a demixed fluid phase; and (iv) that the presence of negatively charged lipid is necessary for the formation of bilayer protrusions. These results indicate that the capability of the peptide to induce the formation of a defined surface-confined reservoir depends on the lipid environment, especially on the presence of anionic lipids.	[Saleem, Mohammed; Meyer, Michaela C.; Galla, Hans-Joachim] Univ Munster, Inst Biochem, D-48149 Munster, Germany; [Breitenstein, Daniel] Tascon GmbH, D-48149 Munster, Germany	University of Munster	Galla, HJ (corresponding author), Univ Munster, Inst Biochem, Wilhelm-Klemm-Str 2, D-48149 Munster, Germany.	gallah@unimuenster.de	Saleem, Mohammed/I-6067-2018; Saleem, Mohammed/AAI-4466-2020	Saleem, Mohammed/0000-0002-1798-1269; 				Alonso C, 2005, BIOPHYS J, V89, P266, DOI 10.1529/biophysj.104.052092; Amrein M, 1997, EUR BIOPHYS J BIOPHY, V26, P349, DOI 10.1007/s002490050089; BAATZ JE, 1990, BIOCHEMISTRY-US, V29, P6714, DOI 10.1021/bi00480a022; BAATZ JE, 1991, CHEM PHYS LIPIDS, V60, P163, DOI 10.1016/0009-3084(91)90039-E; Biesinger MC, 2002, ANAL CHEM, V74, P5711, DOI 10.1021/ac020311n; Bourdos N, 2000, LANGMUIR, V16, P1481, DOI 10.1021/la9912693; Bourdos N, 2000, BIOPHYS J, V79, P357, DOI 10.1016/S0006-3495(00)76297-7; Breitenstein D, 2006, BIOPHYS J, V91, P1347, DOI 10.1529/biophysj.105.073247; Cai P, 2003, BIOCHEMISTRY-US, V42, P9446, DOI 10.1021/bi030052b; Cochrane CG, 1996, AM J RESP CRIT CARE, V153, P404, DOI 10.1164/ajrccm.153.1.8542150; COCHRANE CG, 1991, SCIENCE, V254, P566, DOI 10.1126/science.1948032; COCKSHUTT AM, 1991, BIOCHIM BIOPHYS ACTA, V1085, P248, DOI 10.1016/0005-2760(91)90101-M; Coelho FP, 1997, BIOPHYS J, V72, P1501, DOI 10.1016/S0006-3495(97)78798-8; Creuwels LAJM, 1997, LUNG, V175, P1, DOI 10.1007/PL00007554; Curstedt T, 2006, BIOL NEONATE, V89, P336, DOI 10.1159/000092871; Curstedt T, 2006, BIOL NEONATE, V89, P258, DOI 10.1159/000090115; Diemel RV, 2002, J BIOL CHEM, V277, P21179, DOI 10.1074/jbc.M111758200; Ding JQ, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.168102; FLEMING BD, 1988, CHEM PHYS LIPIDS, V49, P81, DOI 10.1016/0009-3084(88)90067-9; Garidel P, 2000, BBA-BIOMEMBRANES, V1466, P245, DOI 10.1016/S0005-2736(00)00166-8; GOERKE J, 1974, BIOCHIM BIOPHYS ACTA, V344, P241, DOI 10.1016/0304-4157(74)90009-4; Gustafsson M, 1996, FEBS LETT, V384, P185, DOI 10.1016/0014-5793(96)00290-6; HAWGOOD S, 1985, BIOCHEMISTRY-US, V24, P184, DOI 10.1021/bi00322a026; HAWGOOD S, 1991, ANNU REV PHYSIOL, V53, P375, DOI 10.1146/annurev.ph.53.030191.002111; Holm BA, 1996, PEDIATR RES, V39, P805, DOI 10.1203/00006450-199605000-00010; Johansson J, 1997, EUR J BIOCHEM, V244, P675, DOI 10.1111/j.1432-1033.1997.00675.x; JOHANSSON J, 1994, BIOCHEMISTRY-US, V33, P6015, DOI 10.1021/bi00185a042; King DM, 2002, AM J PHYSIOL-LUNG C, V282, pL277, DOI 10.1152/ajplung.00199.2001; Krol S, 2000, BIOPHYS J, V79, P904, DOI 10.1016/S0006-3495(00)76346-6; Lahiri T, 1999, J COLLOID INTERF SCI, V211, P89, DOI 10.1006/jcis.1998.5934; LONGO ML, 1993, SCIENCE, V261, P453, DOI 10.1126/science.8332910; Ma JW, 1998, BIOPHYS J, V74, P1899, DOI 10.1016/S0006-3495(98)77899-3; MOHWALD H, 1990, ANNU REV PHYS CHEM, V41, P441, DOI 10.1146/annurev.pc.41.100190.002301; NAG K, 1994, THIN SOLID FILMS, V244, P841; Nakorn PN, 2007, EUR BIOPHYS J BIOPHY, V36, P477, DOI 10.1007/s00249-006-0102-6; NIELSON DW, 1986, J APPL PHYSIOL, V60, P972, DOI 10.1152/jappl.1986.60.3.972; OOSTERLAKENDIJKSTERHUIS MA, 1992, BIOCHIM BIOPHYS ACTA, V1110, P45, DOI 10.1016/0005-2736(92)90292-T; PASTRANARIOS B, 1994, BIOCHEMISTRY-US, V33, P5121, DOI 10.1021/bi00183a016; Piknova B, 1996, BIOPHYS J, V71, P892, DOI 10.1016/S0006-3495(96)79291-3; REVAK SD, 1988, J CLIN INVEST, V81, P826, DOI 10.1172/JCI113391; Robertson B, 1998, BBA-MOL BASIS DIS, V1408, P346, DOI 10.1016/S0925-4439(98)00080-5; Robertson B, 2000, MOL MED TODAY, V6, P119, DOI 10.1016/S1357-4310(99)01656-1; Ross M, 2001, LANGMUIR, V17, P2437, DOI 10.1021/la001617x; Saenz A, 2006, FEBS J, V273, P2515, DOI 10.1111/j.1742-4658.2006.05258.x; Schurch S, 1998, BBA-MOL BASIS DIS, V1408, P180, DOI 10.1016/S0925-4439(98)00067-2; SCHURCH S, 1995, BIOL NEONATE, V67, P61; Seifert M, 2007, BIOPHYS J, V93, P1192, DOI 10.1529/biophysj.107.106765; TAKAHASHI A, 1990, BIOCHIM BIOPHYS ACTA, V1044, P43, DOI 10.1016/0005-2760(90)90216-K; Takamoto DY, 2001, BIOPHYS J, V81, P153, DOI 10.1016/S0006-3495(01)75688-3; TANAKA Y, 1983, CHEM PHARM BULL, V31, P4100; TANEVA S, 1994, BIOPHYS J, V66, P1137, DOI 10.1016/S0006-3495(94)80895-1; Veldhuizen EJA, 2000, BIOPHYS J, V79, P3164, DOI 10.1016/S0006-3495(00)76550-7; Veldhuizen R, 1998, BBA-MOL BASIS DIS, V1408, P90, DOI 10.1016/S0925-4439(98)00061-1; VINCENT JS, 1993, BIOCHEMISTRY-US, V32, P8228, DOI 10.1021/bi00083a025; vonNahmen A, 1997, EUR BIOPHYS J BIOPHY, V26, P359, DOI 10.1007/s002490050090; vonNahmen A, 1997, BIOPHYS J, V72, P463, DOI 10.1016/S0006-3495(97)78687-9; WANG ZD, 1995, J LIPID RES, V36, P1283; WARING A, 1989, Peptide Research, V2, P308; Wimley WC, 1998, J MOL BIOL, V277, P1091, DOI 10.1006/jmbi.1998.1640; YU S, 1983, LIPIDS, V18, P522, DOI 10.1007/BF02535391	60	17	18	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5195	5207		10.1074/jbc.M705944200	http://dx.doi.org/10.1074/jbc.M705944200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093983	hybrid			2022-12-25	WOS:000253426500077
J	Martin, MC; Allan, LA; Mancini, EJ; Clarke, PR				Martin, Morag C.; Allan, Lindsey A.; Mancini, Erika J.; Clarke, Paul R.			The docking interaction of caspase-9 with ERK2 provides a mechanism for the selective inhibitory phosphorylation of caspase-9 at threonine 125	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASES; MAP KINASES; TRANSCRIPTION FACTORS; STRUCTURAL BASIS; IN-VIVO; CYTOCHROME-C; CELL-DEATH; IDENTIFICATION; SPECIFICITY; SUBSTRATE	Caspase-9 plays a critical role in the initiation of apoptosis by the mitochondrial pathway. Activation of caspase-9 is inhibited by phosphorylation at Thr125 by ERK1/2 MAPKs in response to growth factors. Here, we show that phosphorylation of this site is specific for these classical MAPKs and is not strongly induced when JNK and p38 alpha/beta MAPKs are activated by anisomycin. By deletion and mutagenic analysis, we identify domains in caspase-9 and ERK2 that mediate their interaction. Binding of ERK2 to caspase-9 and subsequent phosphorylation of caspase-9 requires a basic docking domain (D domain) in the N-terminal prodomain of the caspase. Mutational analysis of ERK2 reveals a (TTCD160)-T-157 motif required for recognition of caspase-9 that acts independently of the putative common docking domain. Molecular modeling supports the conclusion that Arg(10) in the D domain of caspase-9 interacts with Asp(160) in the TTCD motif of ERK2. Differences in the TTCD motif in other MAPK family members could account for the selective recognition of caspase-9 by ERK1/2. This selectivity may be important for the antiapoptotic role of classical MAPKs in contrast to the proapoptotic roles of stress-activated MAPKs.	[Martin, Morag C.; Allan, Lindsey A.; Clarke, Paul R.] Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Dundee DD1 9SY, Scotland; [Mancini, Erika J.] Div Struct Biol, Oxford OX37BN, England	University of Dundee	Clarke, PR (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Biomed Res Ctr, Level 5, Dundee DD1 9SY, Scotland.	p.r.clarke@dundee.ac.uk	Mancini, Erika J/J-9880-2013; Clarke, Paul R./AAA-6803-2020; Clarke, Paul/B-1684-2009	Mancini, Erika J/0000-0001-9591-7898; Clarke, Paul/0000-0003-3525-2622; Martin, Morag/0000-0002-8667-6057	Cancer Research UK Funding Source: Medline; Medical Research Council Funding Source: Medline	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acehan D, 2002, MOL CELL, V9, P423, DOI 10.1016/S1097-2765(02)00442-2; Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Bardwell AJ, 2001, J BIOL CHEM, V276, P10374, DOI 10.1074/jbc.M010271200; Barsyte-Lovejoy D, 2002, J BIOL CHEM, V277, P9896, DOI 10.1074/jbc.M108145200; Brady SC, 2005, MOL CELL BIOL, V25, P10543, DOI 10.1128/MCB.25.23.10543-10555.2005; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chang CI, 2002, MOL CELL, V9, P1241, DOI 10.1016/S1097-2765(02)00525-7; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Dimitri CA, 2005, CURR BIOL, V15, P1319, DOI 10.1016/j.cub.2005.06.037; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Fuentes-Prior P, 2004, BIOCHEM J, V384, P201, DOI 10.1042/BJ20041142; Galanis A, 2001, J BIOL CHEM, V276, P965, DOI 10.1074/jbc.M007697200; GONZALEZ FA, 1991, J BIOL CHEM, V266, P22159; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; Jacobson MD, 1997, CELL, V88, P347, DOI 10.1016/S0092-8674(00)81873-5; Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360; Kuma Y, 2004, BIOCHEM J, V379, P133, DOI 10.1042/BJ20031559; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lim YM, 1999, GENETICS, V153, P763; Liu SJ, 2006, P NATL ACAD SCI USA, V103, P5326, DOI 10.1073/pnas.0510506103; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Martin MC, 2005, J BIOL CHEM, V280, P15449, DOI 10.1074/jbc.M414325200; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Pop C, 2006, MOL CELL, V22, P269, DOI 10.1016/j.molcel.2006.03.009; Pramanik R, 2003, J BIOL CHEM, V278, P4831, DOI 10.1074/jbc.M207732200; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schafer ZT, 2006, DEV CELL, V10, P549, DOI 10.1016/j.devcel.2006.04.008; Seidel JJ, 2002, GENE DEV, V16, P127, DOI 10.1101/gad.950902; Sharrocks AD, 2000, TRENDS BIOCHEM SCI, V25, P448, DOI 10.1016/S0968-0004(00)01627-3; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tarrega C, 2002, J BIOL CHEM, V277, P2629, DOI 10.1074/jbc.M108874200; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yang SH, 1999, MOL CELL BIOL, V19, P4028; Yin Q, 2006, MOL CELL, V22, P259, DOI 10.1016/j.molcel.2006.03.030; Zhang JL, 2003, J BIOL CHEM, V278, P29901, DOI 10.1074/jbc.M303909200; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	43	30	32	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3854	3865		10.1074/jbc.M705647200	http://dx.doi.org/10.1074/jbc.M705647200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18083711	hybrid			2022-12-25	WOS:000253083500020
J	Miller, WL; Matewish, MJ; McNally, DJ; Ishiyama, N; Anderson, EM; Brewer, D; Brisson, JR; Berghuis, AM; Lam, JS				Miller, Wayne L.; Matewish, Mauricia J.; McNally, David J.; Ishiyama, Noboru; Anderson, Erin M.; Brewer, Dyanne; Brisson, Jean-Robert; Berghuis, Albert M.; Lam, Joseph S.			Flagellin glycosylation in Pseudomonas aeruginosa PAK requires the O-antigen biosynthesis enzyme WbpO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-SPECIFICITY; FUNCTIONAL-CHARACTERIZATION; GENETIC-CHARACTERIZATION; SEROTYPE O6; BIOCHEMICAL-CHARACTERIZATION; NEISSERIA-MENINGITIDIS; PILIN GLYCOSYLATION; CYSTIC-FIBROSIS; C4 EPIMERASE; LIPOPOLYSACCHARIDE	Pseudomonas aeruginosa PAK (serotype O6) produces a single polar, glycosylated flagellum composed of a-type flagellin. To determine whether or not flagellin glycosylation in this serotype requires O-antigen genes, flagellin was isolated from the wild type, three O-antigen-deficient mutants wbpL, wbpO, and wbpP, and a wbpO mutant complemented with a plasmid containing a wild-type copy of wbpO. Flagellin from the wbpO mutant was smaller (42 kDa) than that of the wild type (45 kDa), or other mutants strains, and exhibited an altered isoelectric point (pI 4.8) when compared with PAK flagellin (pI 4.6). These differences were because of the truncation of the glycan moiety in the wbpO-flagellin. Thus, flagellin glycosylation in P. aeruginosa PAK apparently requires a functional WbpO but not WbpP. Because WbpP was previously proposed to catalyze a metabolic step in the biosynthesis of B-band O-antigen that precedes the action of WbpO, these results prompted us to reevaluate the two-step pathway catalyzed by WbpO and WbpP. Results from WbpO-WbpP-coupled enzymatic assays showed that either WbpO or WbpP is capable of initiating the two-step pathway; however, the kinetic parameters favored the WbpO reaction to occur first, converting UDP-N-acetyl-D-glucosamine to UDP-N-acetyl-D-glucuronic acid prior to the conversion to UDP-N-acetyl-D-galacturonic acid by WbpP. This is the first report to show that a C4 epimerase could utilize UDP-N-acetyl-hexuronic acid as a substrate.	[Miller, Wayne L.; Matewish, Mauricia J.; Anderson, Erin M.; Brewer, Dyanne; Lam, Joseph S.] Univ Guelph, Dept Mol & Cell Biol, Guelph, ON N1G 2W1, Canada; [Ishiyama, Noboru; Berghuis, Albert M.] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A4, Canada; [Ishiyama, Noboru; Berghuis, Albert M.] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ H3A 1A4, Canada; [McNally, David J.; Brisson, Jean-Robert] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada	University of Guelph; McGill University; McGill University; National Research Council Canada	Lam, JS (corresponding author), Univ Guelph, Dept Mol & Cell Biol, Guelph, ON N1G 2W1, Canada.	jlam@uoguelph.ca	Berghuis, Albert M/A-6495-2008	Berghuis, Albert/0000-0002-2663-025X	CIHR [48370] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		ALLISON JS, 1985, INFECT IMMUN, V49, P770, DOI 10.1128/IAI.49.3.770-774.1985; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ANSORG R, 1978, ZBL BAKT-INT J MED M, V242, P228; Arora SK, 2001, P NATL ACAD SCI USA, V98, P9342, DOI 10.1073/pnas.161249198; Belanger M, 1999, MICROBIOL-UK, V145, P3505, DOI 10.1099/00221287-145-12-3505; Bengoechea JA, 2002, J BACTERIOL, V184, P4277, DOI 10.1128/JB.184.15.4277-4287.2002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brimer CD, 1998, J BACTERIOL, V180, P3209, DOI 10.1128/JB.180.12.3209-3217.1998; BRISSON JR, 2002, NMR SPECTROSCOPY GLY, P59; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; COLLINS KD, 1985, Q REV BIOPHYS, V18, P323, DOI 10.1017/S0033583500005369; Creuzenet C, 2000, J BIOL CHEM, V275, P19060, DOI 10.1074/jbc.M001171200; Demendi M, 2005, BIOCHEM J, V389, P173, DOI 10.1042/BJ20050263; DiGiandomenico A, 2002, MOL MICROBIOL, V46, P519, DOI 10.1046/j.1365-2958.2002.03171.x; Feldman M, 1998, INFECT IMMUN, V66, P43, DOI 10.1128/IAI.66.1.43-51.1998; Frirdich E, 2005, J BACTERIOL, V187, P4104, DOI 10.1128/JB.187.12.4104-4115.2005; Frisk A, 2002, J BACTERIOL, V184, P1514, DOI 10.1128/JB.184.6.1514-1521.2002; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; HANCOCK REW, 1983, INFECT IMMUN, V42, P170, DOI 10.1128/IAI.42.1.170-177.1983; Ishiyama N, 2004, J BIOL CHEM, V279, P22635, DOI 10.1074/jbc.M401642200; Knirel' Iu A, 1994, Biokhimiia, V59, P1784; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAM MYC, 1989, J CLIN MICROBIOL, V27, P962, DOI 10.1128/JCM.27.5.962-967.1989; LANYI B, 1970, ACTA MICROBIOL HUNG, V17, P35; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Miller WL, 2004, J BIOL CHEM, V279, P37551, DOI 10.1074/jbc.M404749200; OSHANNESSY DJ, 1987, ANAL BIOCHEM, V163, P204, DOI 10.1016/0003-2697(87)90114-X; Power PM, 2003, MOL MICROBIOL, V49, P833, DOI 10.1046/j.1365-2958.2003.03602.x; Power PM, 2000, MICROBIOL-UK, V146, P967, DOI 10.1099/00221287-146-4-967; Rahim R, 2000, MICROBIOL-UK, V146, P2803, DOI 10.1099/00221287-146-11-2803; Rahim R, 2001, MOL MICROBIOL, V40, P708, DOI 10.1046/j.1365-2958.2001.02420.x; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Schirm M, 2004, J BACTERIOL, V186, P2523, DOI 10.1128/JB.186.9.2523-2531.2004; Spangenberg C, 1996, FEBS LETT, V396, P213, DOI 10.1016/0014-5793(96)01099-X; STIMSON E, 1995, MOL MICROBIOL, V17, P1201, DOI 10.1111/j.1365-2958.1995.mmi_17061201.x; Tang HB, 1996, INFECT IMMUN, V64, P37, DOI 10.1128/IAI.64.1.37-43.1996; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TOTTEN PA, 1990, J BACTERIOL, V172, P7188, DOI 10.1128/jb.172.12.7188-7199.1990; Uhrin D, 2000, NMR IN MICROBIOLOGY: THEORY AND APPLICATIONS, P165; Wenzel CQ, 2005, MOL MICROBIOL, V57, P1288, DOI 10.1111/j.1365-2958.2004.04767.x; Zhao X, 2000, J BIOL CHEM, V275, P33252, DOI 10.1074/jbc.M004191200	41	33	33	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3507	3518		10.1074/jbc.M708894200	http://dx.doi.org/10.1074/jbc.M708894200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065759	hybrid, Green Accepted			2022-12-25	WOS:000253083000056
J	Buck, M; Chojkier, M				Buck, Martina; Chojkier, Mario			A Ribosomal S-6 Kinase-Mediated Signal to C/EBP-beta Is Critical for the Development of Liver Fibrosis	PLOS ONE			English	Article							TRANSCRIPTIONAL ACTIVATOR; OXIDATIVE STRESS; HEPATIC-FIBROSIS; PHOSPHORYLATION; INHIBITION; INDUCTION; PATHWAY; PROTEIN; LAP; PROLIFERATION	Background. In response to liver injury, hepatic stellate cell (HSC) activation causes excessive liver fibrosis. Here we show that activation of RSK and phosphorylation of C/EBP beta on Thr217 in activated HSC is critical for the progression of liver fibrosis. Methodology/Principal Findings. Chronic treatment with the hepatotoxin CCl4 induced severe liver fibrosis in C/EBP beta(+/+) mice but not in mice expressing C/EBP beta-Ala217, a non-phosphorylatable RSK-inhibitory transgene. C/EBP beta-Ala217 was present within the death receptor complex II, with active caspase 8, and induced apoptosis of activated HSC. The C/EBPb-Ala217 peptides directly stimulated caspase 8 activation in a cell-free system. C/EBP beta (+/+) mice with CCl4-induced severe liver fibrosis, while continuing on CCl4, were treated with a cell permeant RSK-inhibitory peptide for 4 or 8 weeks. The peptide inhibited RSK activation, stimulating apoptosis of HSC, preventing progression and inducing regression of liver fibrosis. We found a similar activation of RSK and phosphorylation of human C/EBP beta on Thr266 (human phosphoacceptor) in activated HSC in patients with severe liver fibrosis but not in normal livers, suggesting that this pathway may also be relevant in human liver fibrosis. Conclusions/Significance. These data indicate that the RSK-C/EBP beta phosphorylation pathway is critical for the development of liver fibrosis and suggest a potential therapeutic target.	[Buck, Martina; Chojkier, Mario] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Buck, Martina; Chojkier, Mario] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Buck, Martina; Chojkier, Mario] Vet Affairs Healthcare Ctr, Dept Med, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Buck, M (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	mbuck@ucsd.edu	Ramos, Joe W./L-6189-2013	Ramos, Joe W./0000-0002-9708-2115	NIDDK; NCI; Department of Veterans Affairs	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Veterans Affairs(US Department of Veterans Affairs)	Grants from the NIDDK, NCI, and the Department of Veterans Affairs	ANKOMASEY V, 1998, LIVER GROWTH REPAIR, P512; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; BRAVO R, 1987, NATURE, V326, P515, DOI 10.1038/326515a0; Buck M, 1996, EMBO J, V15, P1753, DOI 10.1002/j.1460-2075.1996.tb00524.x; BUCK M, 1994, EMBO J, V13, P851, DOI 10.1002/j.1460-2075.1994.tb06328.x; Buck M, 1999, MOL CELL, V4, P1087, DOI 10.1016/S1097-2765(00)80237-3; Buck M, 2001, MOL CELL, V8, P807, DOI 10.1016/S1097-2765(01)00374-4; Buck M, 2001, EMBO J, V20, P6712, DOI 10.1093/emboj/20.23.6712; CHOJKIER M, 1985, GASTROENTEROLOGY, V88, P115, DOI 10.1016/S0016-5085(85)80142-6; Chojkier M, 2005, HEPATOLOGY, V41, P237, DOI 10.1002/hep.20567; Chojkier M, 2003, J HEPATOL, V39, P437, DOI 10.1016/S0168-8278(03)00231-9; Chojkier M, 1998, LIVER GROWTH REPAIR, P430; CHUNG R, 2005, HARRISONS PRINCIPLES, P1754; Constandinou C, 2005, METH MOLEC MED, V117, P237; DESCOMBES P, 1990, GENE DEV, V4, P1541, DOI 10.1101/gad.4.9.1541; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Friedman SL, 2006, HEPATOLOGY, V43, pS82, DOI 10.1002/hep.20974; FRIEDMAN SL, 1989, J CLIN INVEST, V84, P1780, DOI 10.1172/JCI114362; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Gross SD, 1999, SCIENCE, V286, P1365, DOI 10.1126/science.286.5443.1365; Iredale JP, 2001, SEMIN LIVER DIS, V21, P427, DOI 10.1055/s-2001-17557; JIMENEZ W, 1985, HEPATOLOGY, V5, P815, DOI 10.1002/hep.1840050517; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; LEE KS, 1995, J CLIN INVEST, V96, P2461, DOI 10.1172/JCI118304; Leite F, 2002, INFECT IMMUN, V70, P4336, DOI 10.1128/IAI.70.8.4336-4343.2002; Marks BD, 2002, ASSAY DRUG DEV TECHN, V1, P73, DOI 10.1089/154065802761001329; MATSUOKA M, 1990, HEPATOLOGY, V11, P599, DOI 10.1002/hep.1840110412; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Nakajima T, 1996, CELL, V86, P465, DOI 10.1016/S0092-8674(00)80119-1; *NIH, 2004, ACT PLAN LIV DIS RES, P1; *NIII, 2004, ACT PLAN LIV DIS RES, P137; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; Ranjan P, 2006, APOPTOSIS, V11, P1837, DOI 10.1007/s10495-006-9530-0; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; SCREPANTI I, 1995, EMBO J, V14, P1932, DOI 10.1002/j.1460-2075.1995.tb07185.x; Spierings D, 2005, SCIENCE, V310, P66, DOI 10.1126/science.1117105; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Stennicke HR, 2000, METHOD ENZYMOL, V322, P91; TANAKA T, 1995, CELL, V80, P353, DOI 10.1016/0092-8674(95)90418-2; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; TRAUTWEIN C, 1993, NATURE, V364, P544, DOI 10.1038/364544a0; *WHO, RED RISKS PROM HLTH, P1; Yoon K, 2007, ONCOGENE, V26, P360, DOI 10.1038/sj.onc.1209797; Zhang HZ, 2003, BIOCONJUGATE CHEM, V14, P458, DOI 10.1021/bc0256188	50	33	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1372	10.1371/journal.pone.0001372	http://dx.doi.org/10.1371/journal.pone.0001372			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159255	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459700029
J	Ukena, SN; Singh, A; Dringenberg, U; Engelhardt, R; Seidler, U; Hansen, W; Bleich, A; Bruder, D; Franzke, A; Rogler, G; Suerbaum, S; Buer, J; Gunzer, F; Westendorf, AM				Ukena, Sya N.; Singh, Anurag; Dringenberg, Ulrike; Engelhardt, Regina; Seidler, Ursula; Hansen, Wiebke; Bleich, Andre; Bruder, Dunja; Franzke, Anke; Rogler, Gerhard; Suerbaum, Sebastian; Buer, Jan; Gunzer, Florian; Westendorf, Astrid M.			Probiotic Escherichia coli Nissle 1917 Inhibits Leaky Gut by Enhancing Mucosal Integrity	PLOS ONE			English	Article								Background. Probiotics are proposed to positively modulate the intestinal epithelial barrier formed by intestinal epithelial cells (IECs) and intercellular junctions. Disruption of this border alters paracellular permeability and is a key mechanism for the development of enteric infections and inflammatory bowel diseases (IBDs). Methodology and Principal Findings. To study the in vivo effect of probiotic Escherichia coli Nissle 1917 (EcN) on the stabilization of the intestinal barrier under healthy conditions, germfree mice were colonized with EcN or K12 E. coli strain MG1655. IECs were isolated and analyzed for gene and protein expression of the tight junction molecules ZO-1 and ZO-2. Then, in order to analyze beneficial effects of EcN under inflammatory conditions, the probiotic was orally administered to BALB/c mice with acute dextran sodium sulfate (DSS) induced colitis. Colonization of gnotobiotic mice with EcN resulted in an up-regulation of ZO-1 in IECs at both mRNA and protein levels. EcN administration to DSS-treated mice reduced the loss of body weight and colon shortening. In addition, infiltration of the colon with leukocytes was ameliorated in EcN inoculated mice. Acute DSS colitis did not result in an anion secretory defect, but abrogated the sodium absorptive function of the mucosa. Additionally, intestinal barrier function was severely affected as evidenced by a strong increase in the mucosal uptake of Evans blue in vivo. Concomitant administration of EcN to DSS treated animals resulted in a significant protection against intestinal barrier dysfunction and IECs isolated from these mice exhibited a more pronounced expression of ZO-1. Conclusion and Significance. This study convincingly demonstrates that probiotic EcN is able to mediate up-regulation of ZO-1 expression in murine IECs and confer protection from the DSS colitis-associated increase in mucosal permeability to luminal substances.	[Ukena, Sya N.; Hansen, Wiebke; Westendorf, Astrid M.] Helmholtz Ctr Infect Res, Dept Mucosal Immun, Braunschweig, Germany; [Ukena, Sya N.; Franzke, Anke; Suerbaum, Sebastian] Hannover Med Sch, Dept Haematol Haemostaseol & Oncol, D-3000 Hannover, Germany; [Singh, Anurag; Dringenberg, Ulrike; Engelhardt, Regina; Seidler, Ursula] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-3000 Hannover, Germany; [Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, D-3000 Hannover, Germany; [Bleich, Andre] Hannover Med Sch, Ctr Anim Facil, D-3000 Hannover, Germany; [Bruder, Dunja] Helmholtz Ctr Infect Res, Immune Regulat Grp, Braunschweig, Germany; [Rogler, Gerhard] Univ Zurich Hosp, Dept Internal Med, Gastroenterol & Hepatol Unit, Zurich, Switzerland; [Buer, Jan] Univ Hosp Essen, Inst Med Microbiol, Essen, Germany; [Gunzer, Florian] Tech Univ Dresden, Inst Med Microbiol & Hyg, Fac Med Carl Gustav Carus, D-8027 Dresden, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Helmholtz Association; Helmholtz-Center for Infection Research; University of Zurich; University Zurich Hospital; University of Duisburg Essen; Technische Universitat Dresden	Ukena, SN (corresponding author), Helmholtz Ctr Infect Res, Dept Mucosal Immun, Braunschweig, Germany.	Florian.Gunzer@tu-dresden.de	Rogler, Gerhard/O-5308-2015; Westendorf, Astrid M./AAX-1937-2020; Seidler, Ursula/HII-8049-2022; Franzke, Anke/AAE-7883-2021	Rogler, Gerhard/0000-0002-1733-9188; Seidler, Ursula/0000-0002-9600-2769; Hansen, Wiebke/0000-0002-6020-0886; Buer, Jan/0000-0002-7602-1698; Singh, Anurag Kumar/0000-0003-0818-0993	Deutsche Forschungsgemeinschaft [SFB 621]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Funding: Supported by grants from the Deutsche Forschungsgemeinschaft (SFB 621).	Alberda C, 2007, AM J CLIN NUTR, V85, P816, DOI 10.1093/ajcn/85.3.816; Barmeyer C, 2004, AM J PHYSIOL-GASTR L, V286, pG244, DOI 10.1152/ajpgi.00141.2003; BLEICH A, 2007, INT J EXP PATHO 1113; Clayburgh DR, 2005, J CLIN INVEST, V115, P2702, DOI 10.1172/JCI24970; Dotan I, 2005, CURR OPIN GASTROEN, V21, P426; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Fasano A, 1997, J CLIN INVEST, V99, P1158, DOI 10.1172/JCI119271; FASANO A, 1991, P NATL ACAD SCI USA, V88, P5242, DOI 10.1073/pnas.88.12.5242; Grabig A, 2006, INFECT IMMUN, V74, P4075, DOI 10.1128/IAI.01449-05; GUMBINER B, 1991, P NATL ACAD SCI USA, V88, P3460, DOI 10.1073/pnas.88.8.3460; Gunzer Florian, 2003, Methods Mol Med, V73, P307; HAVENAAR R, 1992, LACTIC ACID BACTERIA, P209; Henker J, 2007, EUR J PEDIATR, V166, P311, DOI 10.1007/s00431-007-0419-x; Hollander D, 1999, Curr Gastroenterol Rep, V1, P410, DOI 10.1007/s11894-999-0023-5; Ivanov Andrei I, 2004, Novartis Found Symp, V263, P115; JEPSON MA, 1995, INFECT IMMUN, V63, P356, DOI 10.1128/IAI.63.1.356-359.1995; Jepson MA, 2000, INFECT IMMUN, V68, P7202, DOI 10.1128/IAI.68.12.7202-7208.2000; KAPEMBWA MS, 1991, CLIN SCI, V81, P327, DOI 10.1042/cs0810327; Kawachiya T, 2005, INT J MOL MED, V15, P417; Kruis W, 1997, ALIMENT PHARM THER, V11, P853, DOI 10.1046/j.1365-2036.1997.00225.x; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Kunzelmann K, 2002, PHYSIOL REV, V82, P245, DOI 10.1152/physrev.00026.2001; LEVINE MM, 1988, INFECT IMMUN, V56, P161, DOI 10.1128/IAI.56.1.161-167.1988; Ma TY, 2005, AM J PHYSIOL-GASTR L, V288, pG422, DOI 10.1152/ajpgi.00412.2004; McCarthy J, 2003, GUT, V52, P975, DOI 10.1136/gut.52.7.975; Nejdfors P, 1998, SCAND J GASTROENTERO, V33, P749; Parassol N, 2005, RES MICROBIOL, V156, P256, DOI 10.1016/j.resmic.2004.09.013; Philpott DJ, 1998, INFECT IMMUN, V66, P1680, DOI 10.1128/IAI.66.4.1680-1687.1998; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Rachmilewitz D, 2004, GASTROENTEROLOGY, V126, P520, DOI 10.1053/j.gastro.2003.11.019; Rembacken BJ, 1999, LANCET, V354, P635, DOI 10.1016/S0140-6736(98)06343-0; RENE E, 1989, DIGEST DIS SCI, V34, P773, DOI 10.1007/BF01540353; Resta-Lenert S, 2005, AM J PHYSIOL-GASTR L, V289, pG153, DOI 10.1152/ajpgi.00395.2004; Resta-Lenert S, 2003, GUT, V52, P988, DOI 10.1136/gut.52.7.988; Rogler G, 1998, LAB INVEST, V78, P889; Sartor RB, 2004, GASTROENTEROLOGY, V126, P1620, DOI 10.1053/j.gastro.2004.03.024; Sartor RB, 1997, ALIMENT PHARM THERAP, V11, P53; Schmitz H, 2002, AIDS, V16, P983, DOI 10.1097/00002030-200205030-00004; Schmitz H, 1999, GASTROENTEROLOGY, V116, P301, DOI 10.1016/S0016-5085(99)70126-5; Schultz M, 2004, CLIN DIAGN LAB IMMUN, V11, P372, DOI 10.1128/CDLI.11.2.372-378.2004; Schultz M, 2002, INFLAMM BOWEL DIS, V8, P71, DOI 10.1097/00054725-200203000-00001; Schurmann G, 1999, INT J COLORECTAL DIS, V14, P41, DOI 10.1007/s003840050181; Seidler U, 2006, ANN NY ACAD SCI, V1072, P262, DOI 10.1196/annals.1326.024; SMITH PD, 1988, ANN INTERN MED, V108, P328, DOI 10.7326/0003-4819-108-3-328; Spyridonidis A, 2004, AM J PATHOL, V164, P1147, DOI 10.1016/S0002-9440(10)63203-8; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; Stockmann M, 1998, AIDS, V12, P43, DOI 10.1097/00002030-199801000-00006; Walsh-Reitz MM, 2005, AM J PHYSIOL-GASTR L, V289, pG163, DOI 10.1152/ajpgi.00013.2005; Wang FJ, 2005, AM J PATHOL, V166, P409, DOI 10.1016/S0002-9440(10)62264-X; Westendorf AM, 2005, FEMS IMMUNOL MED MIC, V43, P373, DOI 10.1016/j.femsim.2004.10.023; Whiting CV, 2005, INFLAMM BOWEL DIS, V11, P340, DOI 10.1097/01.MIB.0000164016.98913.7c; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Wu ZY, 1996, MICROB PATHOGENESIS, V21, P111, DOI 10.1006/mpat.1996.0047; Wu ZY, 2000, CELL MICROBIOL, V2, P11, DOI 10.1046/j.1462-5822.2000.00025.x; WYATT J, 1993, LANCET, V341, P1437, DOI 10.1016/0140-6736(93)90882-H; Zyrek AA, 2007, CELL MICROBIOL, V9, P804, DOI 10.1111/j.1462-5822.2006.00836.x	56	316	375	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1308	10.1371/journal.pone.0001308	http://dx.doi.org/10.1371/journal.pone.0001308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074031	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459500026
J	Zhou, L; Wang, J; Zhang, LH				Zhou, Lian; Wang, Jing; Zhang, Lian-Hui			Modulation of Bacterial Type III Secretion System by a Spermidine Transporter Dependent Signaling Pathway	PLOS ONE			English	Article								Background. Many gram-negative bacterial pathogens employ Type III secretion systems (T3SS) to inject effector proteins into host cells in infectious processes. Methodology/Principal Findings. By screening a transposon mutant library of P. aeruginosa, we found that mutation of spuDEFGH, which encode a major spermidine uptake system, abolished the expression of the exsCEBA operon that codes for key T3SS regulators under inducing conditions (low calcium). Whole genome microarray analysis revealed that inactivation of the spermidine uptake system significantly decreased the transcriptional expression of most, if not all, T3SS genes. Consistently, the spermidine uptake mutants showed decreased expression of the T3SS genes in responding to host cell extract and attenuated cytotoxicity. Furthermore, exogenous addition of spermidine to the wild type strain PAO1 enhanced the expression of exsCEBA and also the effector protein genes. Conclusion/Significance. Cumulatively, these data have depicted a novel spermidine transporter-dependent signaling pathway, which appears to play an essential role in modulation of T3SS expression in P. aeruginosa.	[Zhou, Lian; Wang, Jing; Zhang, Lian-Hui] Natl Univ Singapore, Inst Mol & Cell Biol, Singapore 117548, Singapore; [Zhang, Lian-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117548, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); National University of Singapore; National University of Singapore	Zhang, LH (corresponding author), Natl Univ Singapore, Inst Mol & Cell Biol, 10 Kent Ridge Crescent, Singapore 117548, Singapore.	lianhui@imcb.a-star.edu.sg			Agency of Science, Technology and Research (A*Star), Singapore	Agency of Science, Technology and Research (A*Star), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency of Science, Technology and Research (A*Star), Singapore.	Becher A, 2000, BIOTECHNIQUES, V29, P948, DOI 10.2144/00295bm04; BODEY GP, 1983, REV INFECT DIS, V5, P279; CAETANOANNOLES G, 1993, PCR METH APPL, V28, P85; Feltman H, 2001, MICROBIOL-SGM, V147, P2659, DOI 10.1099/00221287-147-10-2659; Frank DW, 1997, MOL MICROBIOL, V26, P621, DOI 10.1046/j.1365-2958.1997.6251991.x; FrithzLindsten E, 1997, MOL MICROBIOL, V25, P1125, DOI 10.1046/j.1365-2958.1997.5411905.x; Galan JE, 1996, ANNU REV CELL DEV BI, V12, P221, DOI 10.1146/annurev.cellbio.12.1.221; Ganesan AK, 1998, J BIOL CHEM, V273, P7332, DOI 10.1074/jbc.273.13.7332; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Goehring UM, 1999, J BIOL CHEM, V274, P36369, DOI 10.1074/jbc.274.51.36369; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926; Hoang TT, 2000, PLASMID, V43, P59, DOI 10.1006/plas.1999.1441; HOVEY AK, 1995, J BACTERIOL, V177, P4427, DOI 10.1128/jb.177.15.4427-4436.1995; Hueck CJ, 1998, MICROBIOL MOL BIOL R, V62, P379, DOI 10.1128/MMBR.62.2.379-433.1998; Igarashi K, 2001, RES MICROBIOL, V152, P271, DOI 10.1016/S0923-2508(01)01198-6; Igarashi K, 1999, BIOCHEM J, V344, P633, DOI 10.1042/0264-6021:3440633; Igarashi K, 2000, BIOCHEM BIOPH RES CO, V271, P559, DOI 10.1006/bbrc.2000.2601; Krall R, 2000, INFECT IMMUN, V68, P6066, DOI 10.1128/IAI.68.10.6066-6068.2000; Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x; Larque E, 2007, NUTRITION, V23, P87, DOI 10.1016/j.nut.2006.09.006; Laskowski MA, 2004, MOL MICROBIOL, V54, P1090, DOI 10.1111/j.1365-2958.2004.04331.x; Lee J, 2001, P NATL ACAD SCI USA, V98, P289, DOI 10.1073/pnas.011265298; Lu CD, 2002, J BACTERIOL, V184, P3765, DOI 10.1128/JB.184.14.3765-3773.2002; Mills SD, 1997, P NATL ACAD SCI USA, V94, P12638, DOI 10.1073/pnas.94.23.12638; Moss J, 2001, INFECT IMMUN, V69, P1185, DOI 10.1128/IAI.69.2.1185-1188.2001; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Sambrook J, 1987, MOL CLONING LAB MANU; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Slater H, 2000, MOL MICROBIOL, V38, P986, DOI 10.1046/j.1365-2958.2000.02196.x; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Sun JJ, 2003, J BIOL CHEM, V278, P32794, DOI 10.1074/jbc.M304290200; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Vallis AJ, 1999, INFECT IMMUN, V67, P914, DOI 10.1128/IAI.67.2.914-920.1999; Vallis AJ, 1999, INFECT IMMUN, V67, P2040; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; Wu WH, 2004, J BACTERIOL, V186, P7575, DOI 10.1128/JB.186.22.7575-7585.2004; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; Yahr TL, 1996, MOL MICROBIOL, V22, P991, DOI 10.1046/j.1365-2958.1996.01554.x; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; ZHANG LH, 1991, J BACTERIOL, V173, P1867, DOI 10.1128/jb.173.6.1867-1872.1991; Zhou DG, 1999, P NATL ACAD SCI USA, V96, P10176, DOI 10.1073/pnas.96.18.10176	43	51	56	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1291	10.1371/journal.pone.0001291	http://dx.doi.org/10.1371/journal.pone.0001291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074016	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459500010
J	Murtaza, I; Wang, HX; Feng, X; Alenina, N; Bader, M; Prabhakar, BS; Li, PF				Murtaza, Iram; Wang, Hong-Xia; Feng, Xue; Alenina, Natalia; Bader, Michael; Prabhakar, Bellur S.; Li, Pei-Feng			Down-regulation of catalase and oxidative modification of protein kinase CK2 lead to the failure of apoptosis repressor with caspase recruitment domain to inhibit cardiomyocyte hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; RAT CARDIAC MYOCYTE; TRANSGENIC MICE; ANGIOTENSIN-II; CYTOCHROME-C; VENTRICULAR MYOCYTES; CELL-DEATH; HEART; ARC; RECEPTOR	Cardiac hypertrophy is regulated by a complex interplay of pro- and anti-hypertrophic factors. Here, we report a novel anti-hypertrophic pathway composed of catalase, protein kinase CK2 ( CK2), and apoptosis repressor with caspase recruitment domain ( ARC). Our results showed that ARC phosphorylation levels, CK2 activity, and catalase expression levels were decreased in the hearts of the angiotensinogen transgenic mice and in cardiomyocytes treated with the hypertrophic stimuli, including phenylephrine, tumor necrosis factor-alpha, and angiotensin II. To understand the role of ARC in hypertrophy, we observed that enforced expression of ARC could inhibit hypertrophy. Knockdown of endogenous ARC or inhibition of its phosphorylation could sensitize cardiomyocytes to undergoing hypertrophy. The phosphorylatable, but not the nonphosphorylatable, ARC could inhibit hypertrophy. Thus, ARC is able to inhibit hypertrophy in a phosphorylation-dependent manner. In exploring the molecular mechanism by which CK2 activity is reduced, we found that CK2 was carbonylated in angiotensinogen transgenic mice and in cardiomyocytes treated with the hypertrophic stimuli. The decrease in catalase expression led to an elevated level of reactive oxygen species. The latter oxidatively modified CK2, resulting in its carbonylation. CK2 lost its catalytic activity upon carbonylation. ARC is phosphorylated by CK2, and ARC phosphorylation levels were reduced as a consequence of the decrease of CK2 activity. To understand the molecular mechanism by which ARC inhibits hypertrophy, we observed that ARC could inhibit the activation of mitochondrial permeability transition. These results suggest that catalase, CK2, and ARC constitute an anti-hypertrophic pathway in the heart.	[Murtaza, Iram; Wang, Hong-Xia; Feng, Xue; Li, Pei-Feng] Chinese Acad Sci, Inst Zool, Natl Key Lab Biomembrane & Membrane Biotechnol, Div Cardiovasc Res, Beijing 100101, Peoples R China; [Prabhakar, Bellur S.] Univ Illinois, Coll Med, Chicago, IL 60612 USA; [Alenina, Natalia; Bader, Michael] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany	Chinese Academy of Sciences; Institute of Zoology, CAS; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Li, PF (corresponding author), Chinese Acad Sci, Inst Zool, Natl Key Lab Biomembrane & Membrane Biotechnol, Div Cardiovasc Res, Beijing 100101, Peoples R China.	peifli@ioz.ac.cn	Murtaza, Iram/I-6804-2013; Bader, Michael/K-2124-2013; Li, Peifeng/AHE-6906-2022; Li, Peifeng/ABD-5663-2021	Murtaza, Iram/0000-0001-8092-5211; Li, Peifeng/0000-0002-0969-9407; Bader, Michael/0000-0003-4780-4164				Barlucchi L, 2001, CIRC RES, V88, P298, DOI 10.1161/01.RES.88.3.298; Capetanaki Y, 1998, Subcell Biochem, V31, P463; Condorelli G, 2002, P NATL ACAD SCI USA, V99, P12333, DOI 10.1073/pnas.172376399; Conrad Craig C, 2000, Biol Proced Online, V2, P39, DOI 10.1251/bpo17; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Ekhterae D, 1999, CIRC RES, V85, pE70; Geertman R, 1996, BBA-GENE STRUCT EXPR, V1306, P147, DOI 10.1016/0167-4781(96)00036-X; Grune T, 2005, FREE RADICAL BIO MED, V39, P1208, DOI 10.1016/j.freeradbiomed.2005.06.009; Guo JF, 2006, CIRC RES, V99, P1367, DOI 10.1161/01.RES.0000252830.01581.fd; Gustafsson AB, 2002, CIRCULATION, V106, P735, DOI 10.1161/01.CIR.0000023943.50821.F7; Gustafsson AB, 2004, J BIOL CHEM, V279, P21233, DOI 10.1074/jbc.M400695200; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hirotani S, 2002, CIRCULATION, V105, P509, DOI 10.1161/hc0402.102863; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Javadov S, 2005, J MOL CELL CARDIOL, V38, P135, DOI 10.1016/j.yjmcc.2004.10.007; Kang NL, 2002, J MOL MED, V80, P359, DOI 10.1007/s00109-002-0326-6; KIMURA S, 1992, EMBO J, V11, P821, DOI 10.1002/j.1460-2075.1992.tb05119.x; Koseki T, 1998, P NATL ACAD SCI USA, V95, P5156, DOI 10.1073/pnas.95.9.5156; Kuster GM, 2005, CIRCULATION, V111, P1192, DOI 10.1161/01.CIR.0000157148.59308.F5; Li J, 2002, APOPTOSIS, V7, P511, DOI 10.1023/A:1020639025669; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Li PF, 2002, MOL CELL, V10, P247, DOI 10.1016/S1097-2765(02)00600-7; Li PF, 1997, CIRCULATION, V96, P3602; Loizou JI, 2004, CELL, V117, P17, DOI 10.1016/S0092-8674(04)00206-5; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Morissette MR, 2006, CIRC RES, V99, P15, DOI 10.1161/01.RES.0000231290.45676.d4; Nakamura K, 1998, CIRCULATION, V98, P794, DOI 10.1161/01.CIR.98.8.794; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Nebigil CG, 2003, CIRCULATION, V107, P3223, DOI 10.1161/01.CIR.0000074224.57016.01; Neuss M, 2001, J BIOL CHEM, V276, P33915, DOI 10.1074/jbc.M104080200; Nishida M, 2000, NATURE, V408, P492, DOI 10.1038/35044120; O'Rourke B, 2004, CIRC RES, V94, P420, DOI 10.1161/01.RES.0000117583.66950.43; Rota M, 2005, CIRC RES, V97, P1332, DOI 10.1161/01.RES.0000196568.11624.ae; Shioi T, 2002, MOL CELL BIOL, V22, P2799, DOI 10.1128/MCB.22.8.2799-2809.2002; Srivastava S, 2007, CARDIOVASC RES, V74, P445, DOI 10.1016/j.cardiores.2007.02.016; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; Tanaki K, 2001, J AM COLL CARDIOL, V37, P676, DOI 10.1016/S0735-1097(00)01123-2; Weisleder N, 2004, P NATL ACAD SCI USA, V101, P769, DOI 10.1073/pnas.0303202101; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Xia Y, 2004, J MOL CELL CARDIOL, V37, P1063, DOI 10.1016/j.yjmcc.2004.07.002; Zhang YQ, 2006, J CELL BIOCHEM, V99, P575, DOI 10.1002/jcb.20946; Zhou CM, 2006, CIRC RES, V98, P1040, DOI 10.1161/01.RES.0000218989.52072.e7	43	76	83	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					5996	6004		10.1074/jbc.M706466200	http://dx.doi.org/10.1074/jbc.M706466200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171680	hybrid			2022-12-25	WOS:000253779500004
J	Hato, T; Yamanouchi, J; Tamura, T; Yakushijin, Y; Sakai, I; Yasukawa, M				Hato, Takaaki; Yamanouchi, Jun; Tamura, Tatsushiro; Yakushijin, Yoshihiro; Sakai, Ikuya; Yasukawa, Masaki			Cooperative role of the membrane-proximal and -distal residues of the integrin beta 3 cytoplasmic domain in regulation of talin-mediated alpha IIb beta 3 activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING AFFINITY; INSIDE-OUT; STRUCTURAL BASIS; GLANZMANN THROMBASTHENIA; FILAMIN BINDING; OUTSIDE-IN; ACTIVATION; ALPHA(IIB)BETA(3); SUBUNIT; TAIL	Integrin cytoplasmic tails regulate integrin activation that is required for high affinity binding with ligands. The interaction of the integrin beta subunit tail with a cytoplasmic protein, talin, largely contributes to integrin activation. Here we report the cooperative interaction of the beta 3 membrane-proximal and -distal residues in regulation of talin-mediated alpha IIb beta 3 activation. Because a chimeric integrin, alpha IIb beta 3/beta 1, in which the beta 3 tail was replaced with the beta 1 tail was constitutively active, we searched for the residues responsible for integrin activation among the residues that differed between the beta 3 and beta 1 tails. Single amino acid substitutions of Ile-719 and Glu-749 in the beta 3 membraneproximal and -distal regions, respectively, with the corresponding beta 1 residues or alanine rendered alpha IIb beta 3 constitutively active. The I719M/E749S double mutant had the same ligand binding activity as alpha IIb beta 3/beta 1. These beta 3 mutations also induced alpha V beta 3 activation. Conversely, substitution of Met-719 or Ser-749 in the beta 1 tail with the corresponding beta 3 tail residue (M7191 or S749E) inhibited alpha IIb beta 3/beta 1 activation, and the M719I/S749E double mutant inhibited ligand binding to a level comparable with that of the wild-type alpha IIb beta 3. Knock down of talin by short hairpin RNA inhibited the I719M- and E749S-induced alpha IIb beta 3 activation. These results suggest that the beta 3 membraneproximal and -distal residues cooperatively regulate talin-mediated alpha IIb beta 3 activation.	[Hato, Takaaki] Ehime Univ, Grad Sch Med, Div Blood Transfus, Shigenobu, Ehime 7910295, Japan; [Yamanouchi, Jun; Tamura, Tatsushiro; Yakushijin, Yoshihiro; Sakai, Ikuya; Yasukawa, Masaki] Ehime Univ, Grad Sch Med, Dept Bioregulat Med, Shigenobu, Ehime 7910295, Japan	Ehime University; Ehime University	Hato, T (corresponding author), 454 Shitsukawa, Shigenobu, Ehime 7910295, Japan.	takahato@m.ehime-u.ac.jp	Hato, Takaaki/AAH-8356-2021					Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Bennett JS, 2005, J CLIN INVEST, V115, P3363, DOI 10.1172/JCI26989; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; CHEN YP, 1992, P NATL ACAD SCI USA, V89, P10169, DOI 10.1073/pnas.89.21.10169; de Virgilio M, 2004, J CELL BIOL, V165, P305, DOI 10.1083/jcb.200402064; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Ginsberg MH, 2001, J BIOL CHEM, V276, P22514, DOI 10.1074/jbc.M101915200; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Huang CL, 2004, J BIOL CHEM, V279, P42279, DOI 10.1074/jbc.M402540200; HUGHES PE, 1995, J BIOL CHEM, V270, P12411, DOI 10.1074/jbc.270.21.12411; Hughes PE, 1996, J BIOL CHEM, V271, P6571, DOI 10.1074/jbc.271.12.6571; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Leisner TM, 1999, J BIOL CHEM, V274, P12945, DOI 10.1074/jbc.274.18.12945; Luo BH, 2005, P NATL ACAD SCI USA, V102, P3679, DOI 10.1073/pnas.0409440102; Luo BH, 2004, PLOS BIOL, V2, P776, DOI 10.1371/journal.pbio.0020153; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Vinogradova O, 2000, P NATL ACAD SCI USA, V97, P1450, DOI 10.1073/pnas.040548197; Vinogradova O, 2004, P NATL ACAD SCI USA, V101, P4094, DOI 10.1073/pnas.0400742101; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wang RG, 1997, J CLIN INVEST, V100, P2393, DOI 10.1172/JCI119780; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Weljie AM, 2002, P NATL ACAD SCI USA, V99, P5878, DOI 10.1073/pnas.092515799; Xi XD, 2003, J CELL BIOL, V162, P329, DOI 10.1083/jcb.200303120; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Yamanouchi J, 2004, BIOCHEM J, V379, P317, DOI 10.1042/BJ20031753; Yamanouchi J, 2002, THROMB HAEMOSTASIS, V87, P756, DOI 10.1055/s-0037-1613076	33	8	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5662	5668		10.1074/jbc.M707246200	http://dx.doi.org/10.1074/jbc.M707246200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18174155	hybrid			2022-12-25	WOS:000253426700046
J	Li, XL; Su, V; Kurata, WE; Jin, C; Lau, AF				Li, Xinli; Su, Vivian; Kurata, Wendy E.; Jin, Chengshi; Lau, Alan F.			A novel connexin43-interacting protein, CIP75, which belongs to the UbL-UBA protein family, regulates the turnover of connexin43	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAP-JUNCTION PROTEIN; UBIQUITIN-LIKE PROTEIN; PROTEASOME-DEPENDENT DEGRADATION; DAMAGE-INDUCIBLE PROTEINS; EPITHELIAL NA+ CHANNEL; CARDIAC MYOCYTES; INTERCELLULAR COMMUNICATION; LIDDLES-SYNDROME; 26S PROTEASOME; LIGASE NEDD4	The degradation of connexin43 (Cx43) has been reported to involve both lysosomal and proteasomal degradation pathways; however, very little is known about the mechanisms regulating these Cx43 degradation pathways. Using yeast two-hybrid, glutathione S-transferase pull-down, and co-immunoprecipitation approaches, we have identified a novel Cx43-interacting protein of similar to 75 kDa, CIP75. Laser confocal microscopy showed that CIP75 is located primarily at the endoplasmic reticulum, as indicated by the calnexin marker, with Cx43 co-localization in this perinuclear region. CIP75 belongs to the UbL (ubiquitin-like)-UBA (ubiquitin-associated) domain-containing protein family with a N-terminal UbL domain and a C-terminal UBA domain. The UBA domain of CIP75 is the main element mediating the interaction with Cx43, whereas the CIP75-interacting region in Cx43 resides in the PY motif and multiphosphorylation sites located between Lys(264) and Asn(302). Interestingly, the UbL domain interacts with the S2/RPN1 and S5a/RPN10 protein subunits of the regulatory 19 S proteasome cap subunit of the 26 S proteasome complex. Overexpression experiments suggested that CIP75 is involved in the turnover of Cx43 as measured by a significant stimulation of Cx43 degradation and reduction in its half-life with the opposite effects on Cx43 degradation observed in small interference RNA knockdown experiments.	[Li, Xinli; Su, Vivian; Kurata, Wendy E.; Lau, Alan F.] Canc Res Ctr Hawaii, Natl Prod & Canc Biol Program, Honolulu, HI 96813 USA; [Jin, Chengshi] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lau, Alan F.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	Cancer Research Center of Hawaii; University of California System; University of California San Francisco; University of Hawaii System; University of Hawaii Manoa	Lau, AF (corresponding author), Canc Res Ctr Hawaii, Natl Prod & Canc Biol Program, 651 Ilalo St,BSB 222L, Honolulu, HI 96813 USA.	aflau@crch.hawaii.edu	LI, XINLI/Q-6808-2019		NATIONAL CANCER INSTITUTE [R01CA052098] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA052098-18, R01 CA052098, CA052098] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abriel H, 2000, FEBS LETT, V466, P377, DOI 10.1016/S0014-5793(00)01098-X; Abriel H, 1999, J CLIN INVEST, V103, P667, DOI 10.1172/JCI5713; Barker RJ, 2002, CIRC RES, V90, P317, DOI 10.1161/hh0302.104471; Beardslee MA, 2000, CIRC RES, V87, P656, DOI 10.1161/01.RES.87.8.656; Beardslee MA, 1998, CIRC RES, V83, P629, DOI 10.1161/01.RES.83.6.629; Bedford FK, 2001, NAT NEUROSCI, V4, P908, DOI 10.1038/nn0901-908; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; BEYER EC, 1990, J MEMBRANE BIOL, V116, P187, DOI 10.1007/BF01868459; Biggins S, 1996, J CELL BIOL, V133, P1331, DOI 10.1083/jcb.133.6.1331; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Chen L, 2002, MOL CELL BIOL, V22, P4902, DOI 10.1128/MCB.22.13.4902-4913.2002; DARROW BJ, 1995, CIRC RES, V76, P381, DOI 10.1161/01.RES.76.3.381; Davidson JD, 2000, HUM MOL GENET, V9, P2305, DOI 10.1093/oxfordjournals.hmg.a018922; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; FALLON RF, 1981, J CELL BIOL, V90, P521, DOI 10.1083/jcb.90.2.521; Fuertes G, 2003, BIOCHEM J, V375, P75, DOI 10.1042/BJ20030282; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Giepmans BNG, 2001, CURR BIOL, V11, P1364, DOI 10.1016/S0960-9822(01)00424-9; Girao H, 2003, MOL VIS, V9, P24; Goodenough DA, 1996, ANNU REV BIOCHEM, V65, P475, DOI 10.1146/annurev.bi.65.070196.002355; Hiyama H, 1999, J BIOL CHEM, V274, P28019, DOI 10.1074/jbc.274.39.28019; HOLLENBERG SM, 1995, MOL CELL BIOL, V15, P3813; JIN C, 1998, CHARACTERIZATION NOV, P230; Jin CS, 2000, METHODS, V20, P219, DOI 10.1006/meth.1999.0939; Kim I, 2004, MOL BIOL CELL, V15, P3357, DOI 10.1091/mbc.E03-11-0835; Kleijnen MF, 2003, MOL BIOL CELL, V14, P3868, DOI 10.1091/mbc.E02-11-0766; Kumar NM, 1996, CELL, V84, P381, DOI 10.1016/S0092-8674(00)81282-9; LAING JG, 1995, J BIOL CHEM, V270, P26399, DOI 10.1074/jbc.270.44.26399; Laing JG, 1997, EXP CELL RES, V236, P482, DOI 10.1006/excr.1997.3747; Laing JG, 1998, CARDIOVASC RES, V38, P711, DOI 10.1016/S0008-6363(98)00060-1; LAIRD DW, 1991, BIOCHEM J, V273, P67, DOI 10.1042/bj2730067; Lambertson D, 2003, CURR GENET, V42, P199, DOI 10.1007/s00294-002-0350-7; Lan Z, 2005, BIOCHEMISTRY-US, V44, P2385, DOI 10.1021/bi048306w; Leithe E, 2004, J BIOL CHEM, V279, P50089, DOI 10.1074/jbc.M402006200; Leithe E, 2004, J CELL SCI, V117, P1211, DOI 10.1242/jcs.00951; Leykauf K, 2006, J CELL SCI, V119, P3634, DOI 10.1242/jcs.03149; Matsuda M, 2001, BIOCHEM BIOPH RES CO, V280, P535, DOI 10.1006/bbrc.2000.4149; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller TD, 2003, EMBO J, V22, P4634, DOI 10.1093/emboj/cdg467; Musil LS, 2000, J BIOL CHEM, V275, P25207, DOI 10.1074/jbc.275.33.25207; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Ortolan TG, 2000, NAT CELL BIOL, V2, P601, DOI 10.1038/35023547; Qin H, 2003, J BIOL CHEM, V278, P30005, DOI 10.1074/jbc.M300614200; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Romisch K, 2005, ANNU REV CELL DEV BI, V21, P435, DOI 10.1146/annurev.cellbio.21.012704.133250; Roth AF, 1998, J CELL BIOL, V142, P949, DOI 10.1083/jcb.142.4.949; Rutz ML, 2001, EUR J CELL BIOL, V80, P20, DOI 10.1078/0171-9335-00140; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Sohl G, 2005, NAT REV NEUROSCI, V6, P191, DOI 10.1038/nrn1627; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Thomas MA, 2003, J CELL SCI, V116, P2213, DOI 10.1242/jcs.00440; Toyofuku T, 1998, J BIOL CHEM, V273, P12725, DOI 10.1074/jbc.273.21.12725; Toyofuku T, 2001, J BIOL CHEM, V276, P1780, DOI 10.1074/jbc.M005826200; TRAUB O, 1989, J CELL BIOL, V108, P1039, DOI 10.1083/jcb.108.3.1039; VanSlyke JK, 2002, J CELL BIOL, V157, P381, DOI 10.1083/jcb.200111045; Verma R, 2004, CELL, V118, P99, DOI 10.1016/j.cell.2004.06.014; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wei CJ, 2004, ANNU REV CELL DEV BI, V20, P811, DOI 10.1146/annurev.cellbio.19.111301.144309; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Willecke K, 2002, BIOL CHEM, V383, P725, DOI 10.1515/BC.2002.076	66	54	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5748	5759		10.1074/jbc.M709288200	http://dx.doi.org/10.1074/jbc.M709288200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18079109	hybrid, Green Accepted			2022-12-25	WOS:000253426700056
J	Kraut-Cohen, J; Muller, WJ; Elson, A				Kraut-Cohen, Judith; Muller, William J.; Elson, Ari			Protein-tyrosine phosphatase epsilon regulates Shc signaling in a kinase-specific manner - Increasing coherence in tyrosine phosphatase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMARY-TUMOR CELLS; PTP-EPSILON; PHOSPHORYLATION SITES; C-SRC; INSULIN SENSITIVITY; CYTOPLASMIC FORMS; ADAPTER PROTEIN; MICE LACKING; HUMAN GENOME; IN-VIVO	Individual protein tyrosine kinases and phosphatases target multiple substrates; this may generate conflicting signals, possibly within a single pathway. Protein-tyrosine phosphatase epsilon (PTP epsilon) performs two potentially opposing roles: in Neu-induced mammary tumors, PTP epsilon activates Src downstream of Neu, whereas in other systems PTP epsilon can indirectly down-regulate MAP kinase signaling. We now show that the latter effect is mediated at least in part via the adaptor protein Shc. PTP epsilon binds and dephosphorylates Shc in vivo, reducing the association of Shc with Grb2 and inhibiting downstream ERK activation. PTP epsilon binds Shc in a phosphotyrosine-independent manner mediated by the Shc PTB domain and aided by a sequence of 10 N-terminal residues in PTP epsilon. Surprisingly, PTP epsilon dephosphorylates Shc in a kinase-dependent manner; PTP epsilon targets Shc in the presence of Src but not in the presence of Neu. Using a series of point mutants of Shc and Neu, we show that Neu protects Shc from dephosphorylation by binding the PTB domain of Shc, most likely competing against PTP epsilon for binding the same domain. In agreement, PTP epsilon dephosphorylates Shc in mouse embryo fibroblasts but not in Neu-induced mammary tumor cells. We conclude that in the context of Neu-induced mammary tumor cells, Neu prevents PTP epsilon from targeting Shc and from reducing its promitogenic signal while phosphorylating PTP epsilon and directing it to activate Src in support of mitogenesis. In so doing, Neu contributes to the coherence of the promitogenic role of PTP epsilon in this system.	[Kraut-Cohen, Judith; Elson, Ari] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Muller, William J.] McGill Univ, Mol Oncol Grp, Montreal, PQ H3A 1A1, Canada; [Muller, William J.] McGill Univ, Dept Biochem & Med, Montreal, PQ H3A 1A1, Canada	Weizmann Institute of Science; McGill University; McGill University	Elson, A (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	ari.elson@weizmann.ac.il		Elson, Ari/0000-0001-9808-9135				AGAMIZRACHI S, 2007, IN PRESS ENDOCRINOLO; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2001, BIOCHEM J, V354, P581, DOI 10.1042/0264-6021:3540581; Berman-Golan D, 2007, ONCOGENE, V26, P7028, DOI 10.1038/sj.onc.1210505; Bonfini L, 1996, TRENDS BIOCHEM SCI, V21, P257, DOI 10.1016/S0968-0004(96)10033-5; Chagnon MJ, 2004, BIOCHEM CELL BIOL, V82, P664, DOI 10.1139/O04-120; Charest A, 1996, J BIOL CHEM, V271, P8424, DOI 10.1074/jbc.271.14.8424; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Dankort D, 2001, J BIOL CHEM, V276, P38921, DOI 10.1074/jbc.M106239200; Dankort D, 2001, MOL CELL BIOL, V21, P1540, DOI 10.1128/MCB.21.5.1540-1551.2001; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; den Hertog J, 2005, ARCH BIOCHEM BIOPHYS, V434, P11, DOI 10.1016/j.abb.2004.05.024; Dube N, 2004, P NATL ACAD SCI USA, V101, P1834, DOI 10.1073/pnas.0304242101; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; ELSON A, 1995, J BIOL CHEM, V270, P26116, DOI 10.1074/jbc.270.44.26116; Elson A, 1995, P NATL ACAD SCI USA, V92, P12235, DOI 10.1073/pnas.92.26.12235; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; FRANGIONI JV, 1993, EMBO J, V12, P4843, DOI 10.1002/j.1460-2075.1993.tb06174.x; Gil-Henn H, 2000, ONCOGENE, V19, P4375, DOI 10.1038/sj.onc.1203790; Gil-Henn H, 2001, J BIOL CHEM, V276, P31772, DOI 10.1074/jbc.M103395200; Gil-Henn H, 2003, J BIOL CHEM, V278, P15579, DOI 10.1074/jbc.M210273200; Gotoh N, 1997, MOL CELL BIOL, V17, P1824, DOI 10.1128/MCB.17.4.1824; Jiang GL, 1999, NATURE, V401, P606, DOI 10.1038/44170; Jiang GQ, 2000, MOL CELL BIOL, V20, P5917, DOI 10.1128/MCB.20.16.5917-5929.2000; Klaman LD, 2000, MOL CELL BIOL, V20, P5479, DOI 10.1128/MCB.20.15.5479-5489.2000; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Kraut J, 2002, EXP CELL RES, V281, P182, DOI 10.1006/excr.2002.5661; Lai KMV, 2000, GENE DEV, V14, P1132; Lee MS, 2004, ONCOGENE, V23, P3048, DOI 10.1038/sj.onc.1207451; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; Nakagawa Y, 2005, ZOOL SCI, V22, P169, DOI 10.2108/zsj.22.169; Nakamura K, 1996, BIOCHEM BIOPH RES CO, V218, P726, DOI 10.1006/bbrc.1996.0129; Peretz A, 2000, EMBO J, V19, P4036, DOI 10.1093/emboj/19.15.4036; Purdom S, 2003, TRENDS MOL MED, V9, P206, DOI 10.1016/S1471-4914(03)00048-0; Rauh MJ, 1999, MOL CELL BIOL, V19, P8169; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; RICCI A, 1995, ONCOGENE, V11, P1519; Sato K, 2005, J BIOCHEM, V137, P61, DOI 10.1093/jb/mvi011; Sato K, 1997, BIOCHEM BIOPH RES CO, V240, P399, DOI 10.1006/bbrc.1997.7667; Sato K, 2002, J BIOL CHEM, V277, P29568, DOI 10.1074/jbc.M203179200; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Stoker AW, 2005, J ENDOCRINOL, V185, P19, DOI 10.1677/joe.1.06069; Tanuma N, 2003, ONCOGENE, V22, P1758, DOI 10.1038/sj.onc.1206267; Thompson LJ, 2001, AM J PHYSIOL-HEART C, V281, pH396, DOI 10.1152/ajpheart.2001.281.1.H396; Toledano-Katchalski H, 1999, ONCOGENE, V18, P5024, DOI 10.1038/sj.onc.1202883; Toledano-Katchalski H, 2003, MOL CELL BIOL, V23, P5460, DOI 10.1128/MCB.23.15.5460-5471.2003; Toledano-Katchalski H, 2003, MOL CANCER RES, V1, P541; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; Ugi S, 2002, MOL CELL BIOL, V22, P2375, DOI 10.1128/MCB.22.7.2375-2387.2002; van der Wijk T, 2005, METHODS, V35, P73, DOI 10.1016/j.ymeth.2004.07.010; Wabakken T, 2002, SCAND J IMMUNOL, V56, P195, DOI 10.1046/j.1365-3083.2002.01126.x; Webster MA, 1998, MOL CELL BIOL, V18, P2344, DOI 10.1128/MCB.18.4.2344; Zheng XM, 2000, EMBO J, V19, P964, DOI 10.1093/emboj/19.5.964; Zheng XM, 2002, J BIOL CHEM, V277, P21922, DOI 10.1074/jbc.M201394200	55	22	22	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4612	4621		10.1074/jbc.M708822200	http://dx.doi.org/10.1074/jbc.M708822200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093973	hybrid			2022-12-25	WOS:000253426500018
J	Ouellet, H; Podust, LM; de Montellano, PRO				Ouellet, Hugues; Podust, Larissa M.; de Montellano, Paul R. Ortiz			Mycobacterium tuberculosis CYP130 - Crystal structure, biophysical characterization, and interactions with antifungal azole drugs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME P450 REDUCTASE; ANTIMYCOBACTERIAL ACTIVITY; CATALYTIC-ACTIVITY; LIVER-MICROSOMES; EFFLUX PUMP; SYSTEMS; COMPLEX; BINDING; PURIFICATION; CHOLESTEROL	CYP130 is one of the 20 Mycobacterium tuberculosis cytochrome P450 enzymes, only two of which, CYP51 and CYP121, have so far been studied as individually expressed proteins. Here we characterize a third heterologously expressed M. tuberculosis cytochrome P450, CYP130, by UV-visible spectroscopy, isothermal titration calorimetry, and x-ray crystallography, including determination of the crystal structures of ligand-free and econazole-bound CYP130 at a resolution of 1.46 and 3.0 angstrom, respectively. Ligand-free CYP130 crystallizes in an '' open '' conformation as a monomer, whereas the econazole-bound form crystallizes in a '' closed '' conformation as a dimer. Conformational changes enabling the '' open-closed '' transition involve repositioning of the BC-loop and the F and G helices that envelop the inhibitor in the binding site and reshape the protein surface. Crystal structure analysis shows that the portion of the BC-loop relocates as much as 18 angstrom between the open and closed conformations. Binding of econazole to CYP130 involves a conformational change and is mediated by both a set of hydrophobic interactions with amino acid residues in the active site and coordination of the heme iron. CYP130 also binds miconazole with virtually the same binding affinity as econazole and clotrimazole and ketoconazole with somewhat lower affinities, which makes it a plausible target for this class of therapeutic drugs. Overall, binding of the azole inhibitors is a sequential two-step, entropy-driven endothermic process. Binding of econazole and clotrimazole exhibits positive cooperativity that may reflect a propensity of CYP130 to associate into a dimeric structure.	[Ouellet, Hugues; Podust, Larissa M.; de Montellano, Paul R. Ortiz] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	de Montellano, PRO (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, 600 16th St, San Francisco, CA 94158 USA.	ortiz@cgl.ucsf.edu	Podust, Larissa/ABB-7940-2020	Podust, Larissa/0000-0002-8537-8760	NIAID NIH HHS [R01 AI74824, R01 AI074824, R01 AI074824-01] Funding Source: Medline; NIGMS NIH HHS [R01 GM025515, R01 GM25515, R01 GM078553, R37 GM025515, R01 GM078553-01, R01 GM025515-26] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI074824] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078553, R01GM025515, R37GM025515] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad Z, 2005, FEMS MICROBIOL LETT, V251, P19, DOI 10.1016/j.femsle.2005.07.022; Ahmad Z, 2006, FEMS MICROBIOL LETT, V258, P200, DOI 10.1111/j.1574-6968.2006.00224.x; Ahmad Z, 2006, INT J ANTIMICROB AG, V28, P543, DOI 10.1016/j.ijantimicag.2006.07.028; Ahmad Z, 2006, FEMS MICROBIOL LETT, V261, P181, DOI 10.1111/j.1574-6968.2006.00350.x; Ainsa JA, 1998, J BACTERIOL, V180, P5836; Backes WL, 1998, BIOCHEMISTRY-US, V37, P12852, DOI 10.1021/bi980674a; BACKES WL, 1989, J BIOL CHEM, V264, P6252; Banfi E, 2006, J ANTIMICROB CHEMOTH, V58, P76, DOI 10.1093/jac/dkl182; BARNES HJ, 1991, P NATL ACAD SCI USA, V88, P5597, DOI 10.1073/pnas.88.13.5597; Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cawley GF, 2001, DRUG METAB DISPOS, V29, P1529; CAWLEY GF, 1995, BIOCHEMISTRY-US, V34, P1244, DOI 10.1021/bi00004a018; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cupp-Vickery J, 2000, P NATL ACAD SCI USA, V97, P3050, DOI 10.1073/pnas.050406897; De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EVANS SV, 1993, J MOL GRAPHICS, V11, P134, DOI 10.1016/0263-7855(93)87009-T; Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647; Guardiola-Diaz HM, 2001, BIOCHEM PHARMACOL, V61, P1463, DOI 10.1016/S0006-2952(01)00571-8; Hazai E, 2005, J COMPUT AID MOL DES, V19, P271, DOI 10.1007/s10822-005-4995-4; Hazai E, 2005, DRUG METAB DISPOS, V33, P157, DOI 10.1124/dmd.104.001578; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jamakhandi AP, 2007, BIOCHEMISTRY-US, V46, P10192, DOI 10.1021/bi7003476; Job P, 1928, ANN CHIM FRANCE, V9, P113; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KAMINSKY LS, 1985, EUR J BIOCHEM, V149, P479, DOI 10.1111/j.1432-1033.1985.tb08950.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; McLean KJ, 2007, ARCH BIOCHEM BIOPHYS, V464, P228, DOI 10.1016/j.abb.2007.03.026; McLean KJ, 2002, MICROBIOL-SGM, V148, P2937, DOI 10.1099/00221287-148-10-2937; McLean KJ, 2002, J INORG BIOCHEM, V91, P527, DOI 10.1016/S0162-0134(02)00479-8; Migneault I, 2004, BIOTECHNIQUES, V37, P790, DOI 10.2144/04375RV01; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; OMURA T, 1964, J BIOL CHEM, V239, P2379; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patchkovskii S, 2000, INORG CHEM, V39, P5354, DOI 10.1021/ic0005691; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Podust LM, 2001, P NATL ACAD SCI USA, V98, P3068, DOI 10.1073/pnas.061562898; Podust LM, 2003, J BIOL CHEM, V278, P12214, DOI 10.1074/jbc.M212210200; Recchi C, 2003, J BIOL CHEM, V278, P33763, DOI 10.1074/jbc.M305963200; Seward HE, 2006, J BIOL CHEM, V281, P39437, DOI 10.1074/jbc.M607665200; Sheehan DJ, 1999, CLIN MICROBIOL REV, V12, P40, DOI 10.1128/CMR.12.1.40; Sherman DH, 2006, J BIOL CHEM, V281, P26289, DOI 10.1074/jbc.M605478200; Siddiqi N, 2004, INFECTION, V32, P109, DOI 10.1007/s15010-004-3097-x; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Xiang H, 2000, J BIOL CHEM, V275, P35999, DOI 10.1074/jbc.M005811200; Ying Z, 2005, ANNU REV PHARMACOL, V45, P529, DOI 10.1146/annurev.pharmtox.45.120403.100120; Yoon MY, 2004, DRUG METAB REV, V36, P219, DOI 10.1081/DMR-120033998; Zhao B, 2005, J BIOL CHEM, V280, P11599, DOI 10.1074/jbc.M410933200	53	72	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5069	5080		10.1074/jbc.M708734200	http://dx.doi.org/10.1074/jbc.M708734200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089574	Green Accepted, hybrid			2022-12-25	WOS:000253426500064
J	Jullien, N; Goddard, I; Selmi-Ruby, S; Fina, JL; Cremer, H; Herman, JP				Jullien, Nicolas; Goddard, Isabelle; Selmi-Ruby, Samia; Fina, Jean-Luc; Cremer, Harold; Herman, Jean-Paul			Conditional Transgenesis Using Dimerizable Cre (DiCre)	PLOS ONE			English	Article							SITE-SPECIFIC RECOMBINATION; EMBRYONIC STEM-CELLS; GENE-EXPRESSION; NEONATAL TREATMENT; DNA RECOMBINATION; MOUSE LINE; MICE; PROTEIN; TAMOXIFEN; BRAIN	Cre recombinase is extensively used to engineer the genome of experimental animals. However, its usefulness is still limited by the lack of an efficient temporal control over its activity. We have recently developed a conceptually new approach to regulate Cre recombinase, that we have called Dimerizable Cre or DiCre. It is based on splitting Cre into two inactive moieties and fusing them to FKBP12 (FK506-binding protein) and FRB (binding domain of the FKBP12-rapamycin associated protein), respectively. These latter can be efficiently hetero-dimerized by rapamycin, leading to the reinstatement of Cre activity. We have been able to show, using in vitro approaches, that this ligand-induced dimerization is an efficient way to regulate Cre activity, and presents a low background activity together with a high efficiency of recombination following dimerization. To test the in vivo performance of this system, we have, in the present work, knocked-in DiCre into the Rosa26 locus of mice. To evaluate the performance of the DiCre system, mice have been mated with indicator mice (Z/EG or R26R) and Cre-induced recombination was examined following activation of DiCre by rapamycin during embryonic development or after birth of progenies. No recombination could be observed in the absence of treatment of the animals, indicating a lack of background activity of DiCre in the absence of rapamycin. Postnatal rapamycin treatment (one to five daily injection, 10 mg/kg i.p) induced recombination in a number of different tissues of progenies such as liver, heart, kidney, muscle, etc. On the other hand, recombination was at a very low level following in utero treatment of DiCrexR26R mice. In conclusion, DiCre has indeed the potentiality to be used to establish conditional Cre-deleter mice. An added advantage of this system is that, contrary to other modulatable Cre systems, it offers the possibility of obtaining regulated recombination in a combinatorial manner, i.e. induce recombination at any desired time-point specifically in cells characterized by the simultaneous expression of two different promoters.	[Jullien, Nicolas; Herman, Jean-Paul] Univ Aix Marseille 2, CNRS, UMR 6544, ICNE, Marseille, France; [Goddard, Isabelle; Fina, Jean-Luc] Inst Federatif Rech Jean Roche, Fac Med Nord, Ctr Transgenese, Marseille, France; [Selmi-Ruby, Samia] Univ Lyon 1, Fac Med RTH Laennec, INSERM, UMR 664, F-69365 Lyon, France; [Cremer, Harold] Univ Aix Marseille 2, CNRS, UMR 6216, IBDML, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Herman, JP (corresponding author), Univ Aix Marseille 2, CNRS, UMR 6544, ICNE, Marseille, France.	jean-paul.herman@univmed.fr	selmi-ruby, Samia/L-3509-2016; RUBY, Samia/T-1131-2019; Jullien, Nicolas/O-1947-2015	RUBY, Samia/0000-0001-9491-9285; Jullien, Nicolas/0000-0001-8273-2106; Cremer, Harold/0000-0002-8673-5176	CNRS; Universite de la Mediterranee; European community through the network of excellence NeuroNE; Association Francaise contre les Myopathies (AFM)	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de la Mediterranee; European community through the network of excellence NeuroNE; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies)	Funding: This work was supported by institutional funding from the CNRS and Universite de la Mediterranee. HC has been supported by the European community through the network of excellence NeuroNE and the Association Francaise contre les Myopathies (AFM).	AUSABEL FM, 2007, CURRENT PROTOCOLS MO; Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025; Bayle JH, 2006, CHEM BIOL, V13, P99, DOI 10.1016/j.chembiol.2005.10.017; Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Casanova E, 2003, GENESIS, V37, P25, DOI 10.1002/gene.10227; CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574; Clackson T, 1998, P NATL ACAD SCI USA, V95, P10437, DOI 10.1073/pnas.95.18.10437; Csaba G, 2001, PHARMACOL RES, V43, P531, DOI 10.1006/phrs.2001.0818; Dymecki SM, 2007, NEURON, V54, P17, DOI 10.1016/j.neuron.2007.03.009; Easton JB, 2004, EXPERT OPIN THER TAR, V8, P551, DOI 10.1517/14728222.8.6.551; Feil R, 1996, P NATL ACAD SCI USA, V93, P10887, DOI 10.1073/pnas.93.20.10887; Forni PE, 2006, J NEUROSCI, V26, P9593, DOI 10.1523/JNEUROSCI.2815-06.2006; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Gallant-Haidner HL, 2000, THER DRUG MONIT, V22, P31, DOI 10.1097/00007691-200002000-00006; Gossen M, 2002, ANNU REV GENET, V36, P153, DOI 10.1146/annurev.genet.36.041002.120114; HAMEYER D, 2007, PHYSL GENOMICS; Hentges KE, 2001, P NATL ACAD SCI USA, V98, P13796, DOI 10.1073/pnas.241184198; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Iuliucci JD, 2001, J CLIN PHARMACOL, V41, P870, DOI 10.1177/00912700122010771; Jullien N, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng131; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kellendonk C, 1996, NUCLEIC ACIDS RES, V24, P1404, DOI 10.1093/nar/24.8.1404; Kellendonk C, 1999, J MOL BIOL, V285, P175, DOI 10.1006/jmbi.1998.2307; Kisseberth WC, 1999, DEV BIOL, V214, P128, DOI 10.1006/dbio.1999.9417; Kwan KM, 2002, GENESIS, V32, P49, DOI 10.1002/gene.10068; Liu KJ, 2007, NATURE, V446, P79, DOI 10.1038/nature05557; Miyoshi G, 2006, CURR OPIN NEUROBIOL, V16, P577, DOI 10.1016/j.conb.2006.08.013; Nagy A, 2000, GENESIS, V26, P99, DOI 10.1002/(SICI)1526-968X(200002)26:2<99::AID-GENE1>3.0.CO;2-B; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Nagy A., 2003, MANIPULATING MOUSE E; Naik K, 2006, J MOL ENDOCRINOL, V37, P63, DOI 10.1677/jme.1.02053; Napoli KL, 1997, CLIN BIOCHEM, V30, P135, DOI 10.1016/S0009-9120(96)00157-9; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Pollock R, 2002, CURR OPIN BIOTECH, V13, P459, DOI 10.1016/S0958-1669(02)00373-7; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973; SAUER B, 1993, METHOD ENZYMOL, V225, P890; Schonig K, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf134; Sclafani AM, 2006, GENESIS, V44, P336, DOI 10.1002/dvg.20220; Seibler J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng012; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; StOnge L, 1996, NUCLEIC ACIDS RES, V24, P3875, DOI 10.1093/nar/24.19.3875; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7; Utomo ARH, 1999, NAT BIOTECHNOL, V17, P1091, DOI 10.1038/15073; Vancutsem PM, 1997, TERATOLOGY, V56, P220, DOI 10.1002/(SICI)1096-9926(199709)56:3<220::AID-TERA5>3.3.CO;2-D; Vooijs M, 2001, EMBO REP, V2, P292, DOI 10.1093/embo-reports/kve064; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xu YW, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm559; Yazawa S, 2003, COMP BIOCHEM PHYS A, V136, P391, DOI 10.1016/S1095-6433(03)00197-1; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010; Zinyk DL, 1998, CURR BIOL, V8, P665, DOI 10.1016/S0960-9822(98)70255-6	54	41	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1355	10.1371/journal.pone.0001355	http://dx.doi.org/10.1371/journal.pone.0001355			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159238	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459700012
J	Arvand, M; Feil, EJ; Giladi, M; Boulouis, HJ; Viezens, J				Arvand, Mardjan; Feil, Edward J.; Giladi, Michael; Boulouis, Henri-Jean; Viezens, Juliane			Multi-Locus Sequence Typing of Bartonella henselae Isolates from Three Continents Reveals Hypervirulent and Feline-Associated Clones	PLOS ONE			English	Article							CAT-SCRATCH DISEASE; DOMESTIC CATS; NATURAL-POPULATION; RISK-FACTORS; PREVALENCE; DNA; BACTEREMIA; IDENTIFICATION; RELATEDNESS; DIVERSITY	Bartonella henselae is a zoonotic pathogen and the causative agent of cat scratch disease and a variety of other disease manifestations in humans. Previous investigations have suggested that a limited subset of B. henselae isolates may be associated with human disease. In the present study, 182 human and feline B. henselae isolates from Europe, North America and Australia were analysed by multi-locus sequence typing (MLST) to detect any associations between sequence type (ST), host species and geographical distribution of the isolates. A total of 14 sequence types were detected, but over 66% (16/24) of the isolates recovered from human disease corresponded to a single genotype, ST1, and this type was detected in all three continents. In contrast, 27.2% (43/158) of the feline isolates corresponded to ST7, but this ST was not recovered from humans and was restricted to Europe. The difference in host association of STs 1 (human) and 7 (feline) was statistically significant (P <= 0.001). eBURST analysis assigned the 14 STs to three clonal lineages, which contained two or more STs, and a singleton comprising ST7. These groups were broadly consistent with a neighbour-joining tree, although splits decomposition analysis was indicative of a history of recombination. These data indicate that B. henselae lineages differ in their virulence properties for humans and contribute to a better understanding of the population structure of B. henselae.	[Arvand, Mardjan; Viezens, Juliane] Univ Rostock, Inst Med Mikrobiol Virol & Hyg, Rostock, Germany; [Feil, Edward J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Giladi, Michael] Tel Aviv Med Ctr & Sch Med, Bernard Pridan Lab Mol Biol Infect Dis, Tel Aviv, Israel; [Boulouis, Henri-Jean] Ecole Natl Vet Alfort, Unite Mixte Rech, Maisons Alfort, France	University of Rostock; University of Bath; Tel Aviv University; Sackler Faculty of Medicine; Ecole Nationale Veterinaire d'Alfort (ENVA)	Arvand, M (corresponding author), Univ Rostock, Inst Med Mikrobiol Virol & Hyg, Rostock, Germany.	mardjan.arvand@med.uni-rostock.de	Giladi, Michael/GVU-6295-2022; Giladi, Michael/AAQ-6176-2020		Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This project was supported by a grant from the Deutsche Forschungsgemeinschaft to MA.	Arvand M, 2006, J CLIN MICROBIOL, V44, P2288, DOI 10.1128/JCM.00239-06; Arvand M, 1998, CLIN INFECT DIS, V26, P1296, DOI 10.1086/516348; Arvand M, 2001, J CLIN MICROBIOL, V39, P743, DOI 10.1128/JCM.39.2.743-746.2001; Arvand M, 2007, INT J MED MICROBIOL, V297, P255, DOI 10.1016/j.ijmm.2007.02.001; Avidor B, 2001, AM J CLIN PATHOL, V115, P900, DOI 10.1309/Y468-82G5-ACHW-YRMV; Bergmans AMC, 1996, J CLIN MICROBIOL, V34, P254, DOI 10.1128/JCM.34.2.254-260.1996; Bergmans AMC, 1997, J CLIN MICROBIOL, V35, P2256, DOI 10.1128/JCM.35.9.2256-2261.1997; Birtles RJ, 2002, VET REC, V151, P225, DOI 10.1136/vr.151.8.225; Branley J, 1996, PATHOLOGY, V28, P262, DOI 10.1080/00313029600169124; CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995; Dillon B, 2002, J CLIN MICROBIOL, V40, P4691, DOI 10.1128/JCM.40.12.4691-4699.2002; DOLAN MJ, 1993, ANN INTERN MED, V118, P331, DOI 10.7326/0003-4819-118-5-199303010-00002; Drancourt M, 1996, LANCET, V347, P441, DOI 10.1016/S0140-6736(96)90012-4; Ehrenborg C, 2000, J CLIN MICROBIOL, V38, P682, DOI 10.1128/JCM.38.2.682-687.2000; Fabbi M, 2004, J CLIN MICROBIOL, V42, P264, DOI 10.1128/JCM.42.1.264-268.2004; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Feil EJ, 2004, CURR OPIN MICROBIOL, V7, P308, DOI 10.1016/j.mib.2004.04.002; Guptill L, 2004, J CLIN MICROBIOL, V42, P652, DOI 10.1128/JCM.42.2.652-659.2004; Guptill L, 1997, J INFECT DIS, V176, P206, DOI 10.1086/514026; Gurfield AN, 2001, VET MICROBIOL, V80, P185, DOI 10.1016/S0378-1135(01)00304-2; Heller R, 1997, J CLIN MICROBIOL, V35, P1327, DOI 10.1128/JCM.35.6.1327-1331.1997; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Iredell J, 2003, J CLIN MICROBIOL, V41, P5071, DOI 10.1128/JCM.41.11.5071-5079.2003; KOEHLER JE, 1992, NEW ENGL J MED, V327, P1625, DOI 10.1056/NEJM199212033272303; La Scola B, 2002, J CLIN MICROBIOL, V40, P2002, DOI 10.1128/JCM.40.6.2002-2008.2002; Lindroos H, 2006, J BACTERIOL, V188, P7426, DOI 10.1128/JB.00472-06; Margileth A M, 1993, Adv Pediatr Infect Dis, V8, P1; Melter O, 2003, VET MICROBIOL, V93, P261, DOI 10.1016/S0378-1135(03)00032-4; Renesto P, 2001, J CLIN MICROBIOL, V39, P430, DOI 10.1128/JCM.39.2.430-437.2001; RODRIGUEZBARRADAS MC, 1995, J CLIN MICROBIOL, V33, P1089, DOI 10.1128/JCM.33.5.1089-1093.1995; Sander A, 1997, J CLIN MICROBIOL, V35, P584, DOI 10.1128/JCM.35.3.584-587.1997; Sander A, 1999, J CLIN MICROBIOL, V37, P993, DOI 10.1128/JCM.37.4.993-997.1999; Sander A, 1998, J CLIN MICROBIOL, V36, P2973, DOI 10.1128/JCM.36.10.2973-2981.1998; SLATER LN, 1990, NEW ENGL J MED, V323, P1587, DOI 10.1056/NEJM199012063232303; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Turner KME, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-30; Zeaiter Z, 2002, J CLIN MICROBIOL, V40, P1023, DOI 10.1128/JCM.40.3.1023-1030.2002	37	44	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1346	10.1371/journal.pone.0001346	http://dx.doi.org/10.1371/journal.pone.0001346			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094753	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459600028
J	Baird, SK; Aerts, JL; Eddaoudi, A; Lockley, M; Lemoine, NR; McNeish, IA				Baird, S. K.; Aerts, J. L.; Eddaoudi, A.; Lockley, M.; Lemoine, N. R.; McNeish, I. A.			Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer	ONCOGENE			English	Article						adenovirus; ovarian cancer; apoptosis; autophagy; necrosis	INDUCED APOPTOSIS; AUTOPHAGY; PROTEIN; INHIBITION; RB; 3-METHYLADENINE; BIOLUMINESCENCE; PATHWAYS; GENES; ADP	Oncolytic adenoviral mutants have considerable activity in ovarian cancer. However, the mechanisms by which they induce cell death remain uncertain. dl922-947, which contains a 24 bp deletion in E1A CR2, is more potent than both E1A wild-type adenoviruses and the E1B-55K deletion mutant dl1520 (Onyx-015). We investigated the mode of death induced by three E1A CR2-deleted replicating adenoviruses in models of ovarian cancer and also the importance of E3 11.6 (adenovirus death protein) in determining this mode of death. Ovarian cancer cells were infected with dl922-947 (E3 11.6(+)) and dlCR2 (E3 11.6(-)). We also generated dlCR2 tSmac, which also encodes the gene for processed Smac/DIABLO. Classical apoptosis does not occur in adenoviral cell death and there is no role for mitochondria. Expression of Smac/DIABLO does not enhance cytotoxicity nor increase apoptotic features. A role for cathepsins and lysosomal membrane permeability was excluded. Autophagy is induced, but is not the mode of death and may act as a cell survival mechanism. There is no evidence of pure necrosis, while the presence of E3 11.6 does not modulate the mode or extent of cell death. Thus, E1A CR2-deleted oncolytic adenoviral cytotoxicity in ovarian cancer may de. ne a novel mode of programmed cell death.	[Baird, S. K.; Aerts, J. L.; Lockley, M.; Lemoine, N. R.; McNeish, I. A.] John Vane Sci Ctr, Barts & London Queen Marys Sch Med, Inst Canc, Canc Res UK Clin Ctr,Ctr Mol Oncol, London EC1M 6BQ, England; [Eddaoudi, A.] Canc Res UK London Res Inst, FACS Lab, London, England	Cancer Research UK; University of London; Queen Mary University London; Cancer Research UK	McNeish, IA (corresponding author), John Vane Sci Ctr, Barts & London Queen Marys Sch Med, Inst Canc, Canc Res UK Clin Ctr,Ctr Mol Oncol, Charterhouse Sq, London EC1M 6BQ, England.	iain.mcneish@cancer.org.uk	Aerts, Joeri/J-6957-2014	Aerts, Joeri/0000-0002-9902-3696; McNeish, Iain/0000-0002-9387-7586; lockley, michelle/0000-0002-9281-5789; Eddaoudi, Ayad/0000-0001-5272-6426	MRC [G0601891, G84/6553] Funding Source: UKRI; Cancer Research UK [A4119, C9423/A4119] Funding Source: Medline; Medical Research Council [G84/6553, G0601891, G0601891(82080)] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abou El Hassan MAI, 2004, J VIROL, V78, P12243, DOI 10.1128/JVI.78.22.12243-12251.2004; Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bauvy C, 2001, EXP CELL RES, V268, P139, DOI 10.1006/excr.2001.5285; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; Castino R, 2002, INT J CANCER, V97, P775, DOI 10.1002/ijc.10139; Cereghetti GM, 2006, ONCOGENE, V25, P4717, DOI 10.1038/sj.onc.1209605; CHIOU SK, 1994, J VIROL, V68, P6553, DOI 10.1128/JVI.68.10.6553-6566.1994; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Fueyo J, 2003, J NATL CANCER I, V95, P652, DOI 10.1093/jnci/95.9.652; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Hall AR, 1998, NAT MED, V4, P1068, DOI 10.1038/2057; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; Ito H, 2006, JNCI-J NATL CANCER I, V98, P625, DOI 10.1093/jnci/djj161; Jiang H, 2007, J NATL CANCER I, V99, P1410, DOI 10.1093/jnci/djm102; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Lelli JL, 1998, FREE RADICAL BIO MED, V25, P694, DOI 10.1016/S0891-5849(98)00107-5; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Leyton J, 2006, CANCER RES, V66, P9178, DOI 10.1158/0008-5472.CAN-06-1539; Lockley M, 2006, CANCER RES, V66, P989, DOI 10.1158/0008-5472.CAN-05-2691; McNeish IA, 2003, EXP CELL RES, V286, P186, DOI 10.1016/S0014-4827(03)00073-9; McNeish IA, 2001, CANCER GENE THER, V8, P308, DOI 10.1038/sj.cgt.7700305; Opipari AW, 2004, CANCER RES, V64, P696, DOI 10.1158/0008-5472.CAN-03-2404; RAO L, 1992, P NATL ACAD SCI USA, V89, P7742, DOI 10.1073/pnas.89.16.7742; Robert A, 2002, J CELL BIOL, V158, P519, DOI 10.1083/jcb.200201106; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Steegenga WT, 1998, ONCOGENE, V16, P349, DOI 10.1038/sj.onc.1201540; Stroikin Y, 2004, EUR J CELL BIOL, V83, P583, DOI 10.1078/0171-9335-00433; Subramanian T, 2006, J VIROL, V80, P2000, DOI 10.1128/JVI.80.4.2000-2012.2006; Talloczy Z, 2002, P NATL ACAD SCI USA, V99, P190, DOI 10.1073/pnas.012485299; Terman A, 2003, EXP GERONTOL, V38, P863, DOI 10.1016/S0531-5565(03)00114-1; Tollefson AE, 1996, VIROLOGY, V220, P152, DOI 10.1006/viro.1996.0295; Yaginuma Y, 1997, EXP CELL RES, V233, P233, DOI 10.1006/excr.1997.3560; Ying BL, 2003, VIROLOGY, V313, P224, DOI 10.1016/S0042-6822(03)00287-3; Zong WX, 2004, GENE DEV, V18, P1272, DOI 10.1101/gad.1199904	37	61	62	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	22					3081	3090		10.1038/sj.onc.1210977	http://dx.doi.org/10.1038/sj.onc.1210977			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	301LL	18071311	Green Accepted			2022-12-25	WOS:000255897600001
J	Gaillard, D; Laugerette, F; Darcel, N; El-Yassimi, A; Passilly-Degrace, P; Hichami, A; Khan, NA; Montmayeur, JP; Besnard, P				Gaillard, Dany; Laugerette, Fabienne; Darcel, Nicolas; El-Yassimi, Abdelghani; Passilly-Degrace, Patricia; Hichami, Aziz; Khan, Naim Akhtar; Montmayeur, Jean-Pierre; Besnard, Philippe			The gustatory pathway is involved in CD36-mediated orosensory perception of long-chain fatty acids in the mouse	FASEB JOURNAL			English	Article						dietary lipid perception; gustation; feeding behavior; obesity risk	CONDITIONED TASTE-AVERSION; FOS-LIKE IMMUNOREACTIVITY; CIRCUMVALLATE PAPILLAE; ALPHA-GUSTDUCIN; CORN-OIL; EXPRESSION; CD36; PREFERENCE; MICE; RAT	The sense of taste informs the body about the quality of ingested foods. Tastant-mediated signals are generated by a rise in free intracellular calcium levels ([Ca2+]i) in the taste bud cells and then are transferred to the gustatory area of brain via connections between the gustatory nerves (chorda tympani and glossopharyngeal nerves) and the nucleus of solitary tract in the brain stem. We have recently shown that lingual CD36 contributes to fat preference and early digestive secretions in the mouse. We show here that 1) the induction of an increase in [Ca2+]i by linoleic acid is CD36-dependent in taste receptor cells, 2) the spontaneous preference for or conversely conditioned aversion to linoleic acid requires intact gustatory nerves, and 3) the activation of gustatory neurons in the nucleus of the solitary tract elicited by a linoleic acid deposition on the tongue in wild-type mice cannot be reproduced in CD36-null animals. We conclude that the CD36-mediated perception of long-chain fatty acids involves the gustatory pathway, suggesting that the mouse may have a "taste" for fatty foods. This system would constitute a potential physiological advantage under conditions of food scarcity by leading the mouse to select and absorb fatty foods. However, it might also lead to a risk of obesity and associated diseases in a context of constantly abundant food.	[Gaillard, Dany; Laugerette, Fabienne; Passilly-Degrace, Patricia; Besnard, Philippe] Univ Bourgogne 1, Ecole Natl Super Biol Appl Nutr & Alimentat, INSERM, UMR,U 866, F-21000 Dijon, France; [Laugerette, Fabienne; Montmayeur, Jean-Pierre] Univ Bourgogne, INRA 1214, Ctr Europeen Sci Gout, Ctr Natl Rech Sci,UMR 5170, Dijon, France; [Darcel, Nicolas] Inst Natl Agron Paris Grignon, UMR 914, INRA, Paris, France; [El-Yassimi, Abdelghani; Hichami, Aziz; Khan, Naim Akhtar] Univ Bourgogne, UPRES, Dijon, France	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; INRAE; Institut Agro; AgroSup Dijon; Centre National de la Recherche Scientifique (CNRS); Universite de Bourgogne; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Universite de Bourgogne	Besnard, P (corresponding author), Univ Bourgogne 1, Ecole Natl Super Biol Appl Nutr & Alimentat, INSERM, UMR,U 866, Esplanade Erasme, F-21000 Dijon, France.	pbesnard@u-bourgogne.fr	Montmayeur, Jean-Pierre R/A-5723-2009; Darcel, Nicolas P/B-5071-2013; Passilly-Degrace, Patricia/AAF-5903-2021	Montmayeur, Jean-Pierre/0000-0002-0942-1114; hichami, aziz/0000-0003-4331-5152; Gaillard, Dany/0000-0002-6875-025X				Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Berthoud HR, 2002, NEUROSCI BIOBEHAV R, V26, P393, DOI 10.1016/S0149-7634(02)00014-3; Boughter JD, 1997, J NEUROSCI, V17, P2852; Chale-Rush A, 2007, CHEM SENSES, V32, P423, DOI 10.1093/chemse/bjm007; DREWNOWSKI A, 1985, PHYSIOL BEHAV, V35, P617, DOI 10.1016/0031-9384(85)90150-7; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; Fukuwatari T, 2003, PHYSIOL BEHAV, V78, P579, DOI 10.1016/S0031-9384(03)00037-4; Gilbertson TA, 2003, NEUROREPORT, V14, P905, DOI 10.1097/01.wnr.0000074346.81633.76; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guagliardo NA, 2007, J COMP NEUROL, V504, P206, DOI 10.1002/cne.21436; HAMOSH M, 1990, NUTRITION, V6, P421; HARMON CM, 1991, J MEMBRANE BIOL, V121, P261, DOI 10.1007/BF01951559; Harrer MI, 1996, BRAIN RES, V711, P125, DOI 10.1016/0006-8993(95)01410-1; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Huang YJ, 2001, ANAT EMBRYOL, V204, P493, DOI 10.1007/s429-001-8006-1; INGRAM DK, 1982, J GEN PSYCHOL, V106, P233; Kawai T, 2003, AM J PHYSIOL-REG I, V285, pR447, DOI 10.1152/ajpregu.00729.2002; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mattes RD, 2005, PHYSIOL BEHAV, V86, P691, DOI 10.1016/j.physbeh.2005.08.058; Mattes RD, 2001, PHYSIOL BEHAV, V74, P343, DOI 10.1016/S0031-9384(01)00578-9; McCormack DN, 2006, PHYSIOL BEHAV, V87, P582, DOI 10.1016/j.physbeh.2005.12.004; MELA DJ, 1991, AM J CLIN NUTR, V53, P908, DOI 10.1093/ajcn/53.4.908; MELA DJ, 1988, APPETITE, V10, P37, DOI 10.1016/S0195-6663(88)80031-X; MOREAU H, 1988, GASTROENTEROLOGY, V95, P1221, DOI 10.1016/0016-5085(88)90354-X; Morris-Wiman J, 1999, DEV BRAIN RES, V116, P141, DOI 10.1016/S0165-3806(99)00086-3; Paxinos G, 2000, MOUSE BRAIN STEREOTA; Pittman D, 2007, BRAIN RES, V1151, P74, DOI 10.1016/j.brainres.2007.03.027; Rolls ET, 2005, PHYSIOL BEHAV, V85, P45, DOI 10.1016/j.physbeh.2005.04.012; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1504, DOI 10.1152/ajpregu.00364.2007; Sollars SI, 1996, PHYSIOL BEHAV, V60, P65, DOI 10.1016/0031-9384(95)02235-X; Spencer CM, 2001, MOL BRAIN RES, V93, P113, DOI 10.1016/S0169-328X(01)00173-5; STJOHN SJ, 1995, AM J PHYSIOL-REG I, V269, pR141, DOI 10.1152/ajpregu.1995.269.1.R141; Takeda M, 2000, LIFE SCI, V67, P197, DOI 10.1016/S0024-3205(00)00614-7; Takeda M, 1996, CELL TISSUE RES, V286, P55, DOI 10.1007/s004410050674; Takeda M, 2001, LIFE SCI, V69, P847, DOI 10.1016/S0024-3205(01)01180-8; Takeda M, 2001, NUTRITION, V17, P117, DOI 10.1016/S0899-9007(00)00513-X; Tedder TF, 2002, BIOCHEM SOC T, V30, P807, DOI 10.1042/bst0300807; Travers SP, 2002, AM J PHYSIOL-REG I, V282, pR1798, DOI 10.1152/ajpregu.00590.2001; Tsuruta M, 1999, PHYSIOL BEHAV, V66, P285, DOI 10.1016/S0031-9384(98)00299-6; Zhang XQ, 2003, LAB INVEST, V83, P317, DOI 10.1097/01.LAB.0000059923.67198.BA	42	167	173	0	20	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1458	1468		10.1096/fj.07-8415com	http://dx.doi.org/10.1096/fj.07-8415com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18162488				2022-12-25	WOS:000255898700018
J	Nowacki, S; Skowron, M; Oberthuer, A; Fagin, A; Voth, H; Brors, B; Westermann, F; Eggert, A; Hero, B; Berthold, F; Fischer, M				Nowacki, S.; Skowron, M.; Oberthuer, A.; Fagin, A.; Voth, H.; Brors, B.; Westermann, F.; Eggert, A.; Hero, B.; Berthold, F.; Fischer, M.			Expression of the tumour suppressor gene CADM1 is associated with favourable outcome and inhibits cell survival in neuroblastoma	ONCOGENE			English	Article						CADM1; neuroblastoma; tumor suppressor; outcome assessment (health care); cell proliferation; disease progression	LACTATE-DEHYDROGENASE RELEASE; PROMOTER METHYLATION; ADHESION MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; STAGE NEUROBLASTOMA; CERVICAL-CANCER; LUNG-CANCER; TSLC1 GENE; IN-SILICO; CARCINOMA	Cell adhesion molecule 1 (CADM1) is a putative tumour suppressor gene, which is downregulated in many solid tumours. In neuroblastoma, loss of CADM1 expression has recently been found in disseminated tumours with adverse outcome, prompting us to investigate its role in neuroblastoma tumour progression. Oligonucleotide-microarray analysis of 251 neuroblastoma specimens demonstrated that CADM1 downregulation is associated with unfavourable prognostic markers like disseminated stage 4, age > 18 months, MYCN amplification and chromosome 11q alterations (P < 0.001 each). Furthermore, low CADM1 expression was signficantly correlated with unfavourable gene expression-based classification (P < 0.001) and adverse patient outcome (P < 0.001). Bisulphite sequencing and genetic analysis of 18 primary neuroblastomas suggested that neither haploinsufficiency nor hypermethylation is regularly involved in CADM1 gene silencing in neuroblastoma, which is in contrast to results obtained in other malignancies. In addition, no mutations disrupting the CADM1 reading frame were found in 25 primary neuroblastomas. Over-expression of CADM1 in neuroblastoma cells resulted in significant reduction of proliferation, viability and colony formation in soft agar. Collectively, our results suggest that downregulation of CADM1 tumour suppressor gene expression is a critical event in neuroblastoma pathogenesis resulting in tumour progression and unfavourable patient outcome.	[Nowacki, S.; Skowron, M.; Oberthuer, A.; Voth, H.; Hero, B.; Berthold, F.; Fischer, M.] Univ Cologne, Childrens Hosp, Dept Pediat Oncol & Hematol, D-50924 Cologne, Germany; [Brors, B.] German Canc Res Ctr, Dept Theoret Bioinformat B080, D-6900 Heidelberg, Germany; [Fagin, A.; Eggert, A.] Univ Hosp Essen, Dept Pediat Oncol & Hematol, Essen, Germany; [Westermann, F.] German Canc Res Ctr, Dept Tumor Genet B030, D-6900 Heidelberg, Germany	University of Cologne; Helmholtz Association; German Cancer Research Center (DKFZ); University of Duisburg Essen; Helmholtz Association; German Cancer Research Center (DKFZ)	Fischer, M (corresponding author), Univ Cologne, Childrens Hosp, Dept Pediat Oncol & Hematol, Kerpener St 62, D-50924 Cologne, Germany.	matthias.fischer@uk-koeln.de	Westermann, Frank/F-7509-2013; Brors, Benedikt/E-5620-2013; Eggert, Angelika/AAE-6907-2022	Brors, Benedikt/0000-0001-5940-3101; Eggert, Angelika/0000-0003-3476-8184				Berwanger B, 2002, CANCER CELL, V2, P377, DOI 10.1016/S1535-6108(02)00179-4; Bock C, 2005, BIOINFORMATICS, V21, P4067, DOI 10.1093/bioinformatics/bti652; BRODEUR GM, 1993, J CLIN ONCOL, V11, P1466, DOI 10.1200/JCO.1993.11.8.1466; CICCARONE V, 1989, CANCER RES, V49, P219; De Preter K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r84; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; Ehrlich M, 2006, ONCOGENE, V25, P2636, DOI 10.1038/sj.onc.1209145; Fischer M, 2006, CLIN CANCER RES, V12, P5118, DOI 10.1158/1078-0432.CCR-06-0985; Fukami T, 2003, INT J CANCER, V107, P53, DOI 10.1002/ijc.11348; Fukuhara H, 2002, JPN J CANCER RES, V93, P605, DOI 10.1111/j.1349-7006.2002.tb01297.x; Gomyo H, 1999, GENOMICS, V62, P139, DOI 10.1006/geno.1999.6001; Heller G, 2007, BREAST CANCER RES TR, V103, P283, DOI 10.1007/s10549-006-9377-7; Houshmandi SS, 2006, NEUROLOGY, V67, P1863, DOI 10.1212/01.wnl.0000244472.56198.84; Ito A, 2003, BLOOD, V101, P2601, DOI 10.1182/blood-2002-07-2265; Ito T, 2003, CANCER RES, V63, P6320; Jansen M, 2002, CANCER BIOL THER, V1, P293, DOI 10.4161/cbt.84; Katoh M, 2004, ONCOL REP, V12, P429; Katoh M, 2003, INT J ONCOL, V23, P1213; Kikuchi S, 2006, CANCER-AM CANCER SOC, V106, P1751, DOI 10.1002/cncr.21800; Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934; Li JD, 2005, GYNECOL ONCOL, V96, P150, DOI 10.1016/j.ygyno.2004.08.050; Lombet A, 2001, EUR J BIOCHEM, V268, P1352, DOI 10.1046/j.1432-1327.2001.02002.x; Mao XL, 2004, ONCOGENE, V23, P5632, DOI 10.1038/sj.onc.1207756; Mertens F, 1997, CANCER RES, V57, P2765; Murakami Y, 2005, CANCER SCI, V96, P543, DOI 10.1111/j.1349-7006.2005.00089.x; Naishiro Y, 2005, ONCOGENE, V24, P3141, DOI 10.1038/sj.onc.1208517; NAKAGAWARA A, 1993, NEW ENGL J MED, V328, P847, DOI 10.1056/NEJM199303253281205; Oberthuer A, 2004, CLIN CANCER RES, V10, P4307, DOI 10.1158/1078-0432.CCR-03-0813; Oberthuer A, 2006, J CLIN ONCOL, V24, P5070, DOI 10.1200/JCO.2006.06.1879; Ohira M, 2005, CANCER CELL, V7, P337, DOI 10.1016/j.ccr.2005.03.019; Ojeda SR, 2006, ENDOCRINOLOGY, V147, P1166, DOI 10.1210/en.2005-1136; RACHER AJ, 1990, CYTOTECHNOLOGY, V3, P301, DOI 10.1007/BF00365494; SCHWAB M, 1983, NATURE, V305, P245, DOI 10.1038/305245a0; Steenbergen RDM, 2004, JNCI-J NATL CANCER I, V96, P294, DOI 10.1093/jnci/djh031; Surace EI, 2004, J NEUROPATH EXP NEUR, V63, P1015, DOI 10.1093/jnen/63.10.1015; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; Waha A, 2003, J NEUROPATH EXP NEUR, V62, P1192, DOI 10.1093/jnen/62.11.1192; Wakayama T, 2003, BIOL REPROD, V68, P1755, DOI 10.1095/biolreprod.102.012344; Worsham MJ, 2006, ARCH OTOLARYNGOL, V132, P668, DOI 10.1001/archotol.132.6.668	40	39	44	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2008	27	23					3329	3338		10.1038/sj.onc.1210996	http://dx.doi.org/10.1038/sj.onc.1210996			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	304LQ	18084322				2022-12-25	WOS:000256111400011
J	Sharples, RA; Vella, LJ; Nisbet, RM; Naylor, R; Perez, K; Barnham, KJ; Masters, CL; Hill, AF				Sharples, Robyn A.; Vella, Laura J.; Nisbet, Rebecca M.; Naylor, Ryan; Perez, Keyla; Barnham, Kevin J.; Masters, Colin L.; Hill, Andrew F.			Inhibition of gamma-secretase causes increased secretion of amyloid precursor protein C-terminal fragments in association with exosomes	FASEB JOURNAL			English	Article						Alzheimer's disease; protein processing; APP; secretases	CELL-DERIVED EXOSOMES; ALZHEIMERS-DISEASE; BETA-PROTEIN; ALPHA-SECRETASE; MULTIVESICULAR BODIES; TRANSGENIC MICE; PEPTIDE LEVELS; HUMAN BRAIN; CLEAVAGE; APP	Alzheimer's disease (AD) is the most common form of dementia and is associated with the deposition of the 39- to 43-amino acid beta-amyloid peptide (A beta) in the brain. C-terminal fragments (CTFs) of amyloid precursor protein (APP) can accumulate in endosomally derived multivesicular bodies (MVBs). These intracellular structures contain intraluminal vesicles that are released from the cell as exosomes when the MVB fuses with the plasma membrane. Here we have investigated the role of exosomes in the processing of APP and show that these vesicles contain APP-CTFs, as well as A beta. In addition, inhibition of gamma-secretase results in a significant increase in the amount of alpha-and beta-secretase cleavage, further increasing the amount of APP-CTFs contained within these exosomes. We identify several key members of the secretase family of proteases (BACE, PS1, PS2, and ADAM10) to be localized in exosomes, suggesting they may be a previously unidentified site of APP cleavage. These results provide further evidence for a novel pathway in which APP fragments are released from cells and have implications for the analysis of APP processing and diagnostics for Alzheimer's disease.	[Sharples, Robyn A.; Vella, Laura J.; Nisbet, Rebecca M.; Naylor, Ryan; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia; [Vella, Laura J.; Nisbet, Rebecca M.; Naylor, Ryan; Perez, Keyla; Barnham, Kevin J.; Masters, Colin L.; Hill, Andrew F.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Vella, Laura J.; Nisbet, Rebecca M.; Naylor, Ryan; Perez, Keyla; Barnham, Kevin J.; Masters, Colin L.; Hill, Andrew F.] Mental Hlth Res Inst, Parkville, Vic, Australia	University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health	Hill, AF (corresponding author), Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia.	a.hill@unimelb.edu.au	Hill, Andrew F./AAH-2854-2020; Nisbet, Rebecca/P-6492-2017; Hill, Andrew F./GZL-4124-2022; Hill, Andrew F/B-4527-2009; Vella, laura/N-2733-2017	Nisbet, Rebecca/0000-0002-3751-9119; Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; Vella, laura/0000-0002-1869-6291; Naylor, Ryan/0000-0001-6880-6463				Abusamra AJ, 2005, BLOOD CELL MOL DIS, V35, P169, DOI 10.1016/j.bcmd.2005.07.001; Andre F, 2002, LANCET, V360, P295, DOI 10.1016/S0140-6736(02)09552-1; Asai M, 2003, BIOCHEM BIOPH RES CO, V301, P231, DOI 10.1016/S0006-291X(02)02999-6; BUSCIGLIO J, 1993, P NATL ACAD SCI USA, V90, P2092, DOI 10.1073/pnas.90.5.2092; Buxbaum JD, 1998, J BIOL CHEM, V273, P27765, DOI 10.1074/jbc.273.43.27765; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; CAI XD, 1993, SCIENCE, V259, P514, DOI 10.1126/science.8424174; Culvenor JG, 2004, EUR J BIOCHEM, V271, P375, DOI 10.1046/j.1432-1033.2003.03936.x; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Eckman CB, 1997, HUM MOL GENET, V6, P2087, DOI 10.1093/hmg/6.12.2087; ESTUS S, 1992, SCIENCE, V255, P726, DOI 10.1126/science.1738846; Evin G, 2002, PEPTIDES, V23, P1285, DOI 10.1016/S0196-9781(02)00063-3; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Findeis MA, 2000, BBA-MOL BASIS DIS, V1502, P76, DOI 10.1016/S0925-4439(00)00034-X; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Gastpar R, 2005, CANCER RES, V65, P5238, DOI 10.1158/0008-5472.CAN-04-3804; GOLDE TE, 1992, SCIENCE, V255, P728, DOI 10.1126/science.1738847; GOODMAN Y, 1994, EXP NEUROL, V128, P1, DOI 10.1006/exnr.1994.1107; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; HAASS C, 1992, NATURE, V359, P322, DOI 10.1038/359322a0; HAASS C, 1993, J BIOL CHEM, V268, P3021; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Keller S, 2006, IMMUNOL LETT, V107, P102, DOI 10.1016/j.imlet.2006.09.005; Kienlen-Campard P, 2002, J BIOL CHEM, V277, P15666, DOI 10.1074/jbc.M200887200; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; Kimberly WT, 2003, BIOCHEMISTRY-US, V42, P137, DOI 10.1021/bi026888g; Kowalska A, 2003, FOLIA NEUROPATHOL, V41, P35; Kwok JBJ, 2000, ANN NEUROL, V47, P249, DOI 10.1002/1531-8249(200002)47:2<249::AID-ANA18>3.3.CO;2-#; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Langui D, 2004, AM J PATHOL, V165, P1465, DOI 10.1016/S0002-9440(10)63405-0; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Masciopinto F, 2004, EUR J IMMUNOL, V34, P2834, DOI 10.1002/eji.200424887; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; McLean CA, 1999, ANN NEUROL, V46, P860, DOI 10.1002/1531-8249(199912)46:6<860::AID-ANA8>3.0.CO;2-M; Murakami K, 2002, BIOCHEM BIOPH RES CO, V294, P5, DOI 10.1016/S0006-291X(02)00430-8; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Potolicchio A, 2005, J IMMUNOL, V175, P2237, DOI 10.4049/jimmunol.175.4.2237; Rajendran L, 2006, P NATL ACAD SCI USA, V103, P11172, DOI 10.1073/pnas.0603838103; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Saura CA, 2005, J NEUROSCI, V25, P6755, DOI 10.1523/JNEUROSCI.1247-05.2005; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; SELKOE DJ, 1994, ANNU REV CELL BIOL, V10, P373, DOI 10.1146/annurev.cb.10.110194.002105; Selkoe DJ, 1996, COLD SPRING HARB SYM, V61, P587; Serpell LC, 2000, J MOL BIOL, V299, P225, DOI 10.1006/jmbi.2000.3650; SEUBERT P, 1992, NATURE, V359, P325, DOI 10.1038/359325a0; SEUBERT P, 1993, NATURE, V361, P260, DOI 10.1038/361260a0; Shi XP, 2003, J BIOL CHEM, V278, P21286, DOI 10.1074/jbc.M209859200; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Stoeck A, 2006, BIOCHEM J, V393, P609, DOI 10.1042/BJ20051013; Stoorvogel W, 2002, TRAFFIC, V3, P321, DOI 10.1034/j.1600-0854.2002.30502.x; SUZUKI N, 1994, SCIENCE, V264, P1336, DOI 10.1126/science.8191290; Takahashi RH, 2002, AM J PATHOL, V161, P1869, DOI 10.1016/S0002-9440(10)64463-X; Thery C, 2002, NAT IMMUNOL, V3, P1156, DOI 10.1038/ni854; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 1999, J CELL BIOL, V147, P599, DOI 10.1083/jcb.147.3.599; van Niel G, 2002, AM J PHYSIOL-GASTR L, V283, pG251, DOI 10.1152/ajpgi.00102.2002; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vella LJ, 2007, J PATHOL, V211, P582, DOI 10.1002/path.2145; Vingtdeux V, 2007, J BIOL CHEM, V282, P18197, DOI 10.1074/jbc.M609475200; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Wolfe MS, 2002, INT IMMUNOPHARMACOL, V2, P1919, DOI 10.1016/S1567-5769(02)00179-0; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Yamazaki T, 1996, J CELL SCI, V109, P999; Yu CJ, 2001, J BIOL CHEM, V276, P43756, DOI 10.1074/jbc.C100410200; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu HK, 2001, NEURON, V31, P713, DOI 10.1016/S0896-6273(01)00417-2; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje	79	203	206	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1469	1478		10.1096/fj.07-9357com	http://dx.doi.org/10.1096/fj.07-9357com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18171695				2022-12-25	WOS:000255898700019
J	Zwerner, JP; Joo, J; Warner, KL; Christensen, L; Hu-Lieskovan, S; Triche, TJ; May, WA				Zwerner, J. P.; Joo, J.; Warner, K. L.; Christensen, L.; Hu-Lieskovan, S.; Triche, T. J.; May, W. A.			The EWS/FLI1 oncogenic transcription factor deregulates GLI1	ONCOGENE			English	Article						Ewing's sarcoma; EWS/FLI1; GLI1; Hedgehog; Ewing family tumors	HEDGEHOG SIGNALING PATHWAY; DNA-BINDING; SONIC HEDGEHOG; EWINGS-SARCOMA; FUSION PROTEIN; TARGET GENES; GROWTH-FACTOR; SELF-RENEWAL; STEM-CELLS; PDGF-C	Ewing family tumors ( EFT), classically Ewing's sarcoma and peripheral primitive neuroectodermal tumor, share a common class of tumor-specific fusion genes thought to be key mediators of tumor biology. Here we demonstrate that the most common Ewing's fusion, EWS/FLI1, produces transcriptional upregulation of GLI1 and its direct transcriptional target PATCHED1 in a model transformation system. This deregulation of GLI1 is common to other EWS/ets chimera and depends on the functional transcriptional regulatory domains. Inhibition of GLI1 via RNAi or via overexpression of endogenous inhibitors results in a reduction of EWS/FLI1 transformation activity. Activation of GLI1 appears to occur in a Hedgehog- independent fashion as blockade of Hedgehog signaling has only a modest effect on EFT cells. We present evidence that EWS/FLI1 upregulation of cMYC may play a role in the upregulation of GLI1 in EWS/ FLI1-transformed NIH3T3 cells. Finally, we demonstrate that observations made in a model transformation system translate to an Ewing cellular background. EFT cell lines express GLI1 and PATCHED and this expression is EWS/ FLI1 dependent. Inhibition of GLI1 expression via RNAi results in reduced anchorage-independent growth in an EFT cell line. GLI1 appears to be a transcriptionally deregulated target of EWS/FLI1 that mediates a portion of its tumorigenic phenotype.	[Joo, J.; Warner, K. L.; Christensen, L.; May, W. A.] Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Dept Pediat,Div Hematol Oncol, Los Angeles, CA 90027 USA; [Zwerner, J. P.] Stanford Univ, Sch Med, Dept Dermatol, Palo Alto, CA 94304 USA; [Hu-Lieskovan, S.; Triche, T. J.] Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Dept Pathol, Los Angeles, CA 90027 USA	Children's Hospital Los Angeles; University of Southern California; Stanford University; Children's Hospital Los Angeles; University of Southern California	May, WA (corresponding author), Univ So Calif, Childrens Hosp Los Angeles, Saban Res Inst, Dept Pediat,Div Hematol Oncol, 4650 Sunset Blvd Mail Stop 54, Los Angeles, CA 90027 USA.	wmay@chla.usc.edu			NCI NIH HHS [R01 CA090666, CA90666] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090666] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Aparicio LMA, 2007, CLIN TRANSL ONCOL, V9, P66, DOI 10.1007/s12094-007-0015-6; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; BACCI G, 1982, CANCER-AM CANCER SOC, V48, P1561, DOI 10.1002/1097-0142(19820415)49:8<1561::AID-CNCR2820490808>3.0.CO;2-K; Bailey EC, 2002, J BIOL CHEM, V277, P33632, DOI 10.1074/jbc.M202203200; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; BOYER CW, 1967, CANCER, V20, P1602, DOI 10.1002/1097-0142(196710)20:10<1602::AID-CNCR2820201006>3.0.CO;2-H; BRAUN BS, 1995, MOL CELL BIOL, V15, P4623; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Dauphinot L, 2001, ONCOGENE, V20, P3258, DOI 10.1038/sj.onc.1204437; DELATTRE O, 1992, NATURE, V359, P162, DOI 10.1038/359162a0; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Guney I, 2006, P NATL ACAD SCI USA, V103, P3645, DOI 10.1073/pnas.0600069103; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Hepker J, 1997, DEVELOPMENT, V124, P549; Hu-Lieskovan S, 2005, CANCER RES, V65, P8984, DOI 10.1158/0008-5472.CAN-05-0565; Hu-Lieskovan S, 2005, CANCER RES, V65, P4633, DOI 10.1158/0008-5472.CAN-04-2857; Huntzicker EG, 2006, GENE DEV, V20, P276, DOI 10.1101/gad.1380906; Jaishankar S, 1999, ONCOGENE, V18, P5592, DOI 10.1038/sj.onc.1202940; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; Kenney AM, 2003, DEVELOPMENT, V130, P15, DOI 10.1242/dev.00182; Koch A, 2004, NEUROPATH APPL NEURO, V30, P532, DOI 10.1111/j.1365-2990.2004.00560.x; Kogerman P, 1999, NAT CELL BIOL, V1, P312, DOI 10.1038/13031; Lauth M, 2007, ONCOGENE, V26, P5163, DOI 10.1038/sj.onc.1210321; Lazar A, 2006, ARCH PATHOL LAB MED, V130, P1199; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lokker NA, 2002, CANCER RES, V62, P3729; Marigo V, 1996, DEVELOPMENT, V122, P1225; May WA, 1997, NAT GENET, V17, P495, DOI 10.1038/ng1297-495; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Pizzo PA, 2005, PRINCIPLES PRACTICE; Rao G, 2003, NEOPLASIA, V5, P198, DOI 10.1016/S1476-5586(03)80052-0; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Stein U, 1999, CANCER RES, V59, P1890; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taylor MD, 2002, NAT GENET, V31, P306, DOI 10.1038/ng916; Teitell MA, 1999, LAB INVEST, V79, P1535; Welford SM, 2001, J BIOL CHEM, V276, P41977, DOI 10.1074/jbc.M106757200; Xie JW, 2001, P NATL ACAD SCI USA, V98, P9255, DOI 10.1073/pnas.151173398; Zhou JX, 2006, HUM REPROD, V21, P1698, DOI 10.1093/humrep/del086; Zwerner JP, 2001, ONCOGENE, V20, P626, DOI 10.1038/sj.onc.1204133	47	92	96	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	23					3282	3291		10.1038/sj.onc.1210991	http://dx.doi.org/10.1038/sj.onc.1210991			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	304LQ	18084326				2022-12-25	WOS:000256111400007
J	Baumer, AT; ten Freyhaus, H; Sauer, H; Wartenberg, M; Kappert, K; Schnabel, P; Konkol, C; Hescheler, J; Vantler, M; Rosenkranz, S				Baeumer, Anselm T.; ten Freyhaus, Henrik; Sauer, Heinrich; Wartenberg, Maria; Kappert, Kai; Schnabel, Petra; Konkol, Christian; Hescheler, Juergen; Vantler, Marius; Rosenkranz, Stephan			Phosphatidylinositol 3-kinase-dependent membrane recruitment of Rac-1 and p47(phox) is critical for alpha-platelet-derived growth factor receptor-induced production of reactive oxygen species	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; NADPH OXIDASE ACTIVATION; C PDGF-C; ANGIOTENSIN-II; PHOSPHOINOSITIDE 3-KINASE; SIGNAL-TRANSDUCTION; HYDROGEN-PEROXIDE; SUPEROXIDE ANION; NAD(P)H OXIDASE; INHIBITION	Platelet-derived growth factor (PDGF) plays a critical role in the pathogenesis of proliferative diseases. NAD(P) H oxidase (Nox)-derived reactive oxygen species (ROS) are essential for signal transduction by growth factor receptors. Here we investigated the dependence of PDGF-AA-induced ROS production on the cytosolic Nox subunits Rac-1 and p47phox, and we systematically evaluated the signal relay mechanisms by which the alpha PDGF receptor (alpha PDGFR) induces ROS liberation. Stimulation of the alpha PDGFR led to a time-dependent increase of intracellular ROS levels in fibroblasts. Pharmacological inhibitor experiments and enzyme activity assays disclosed Nox as the source of ROS. alpha PDGFR activation is rapidly followed by the translocation of p47phox and Rac-1 from the cytosol to the cell membrane. Experiments performed in p47(phox)(-/-) cells and inhibition of Rac-1 or overexpression of dominant-negative Rac revealed that these Nox subunits are required for PDGF-dependent Nox activation and ROS liberation. To evaluate the signaling pathway mediating PDGF-AA-dependent ROS production, we investigated Ph cells expressing mutant alpha PDGFRs that lack specific binding sites for alpha PDGFR-associated signaling molecules (Src, phosphatidylinositol 3-kinase (PI3K), phospholipase C gamma, and SHP-2). Lack of PI3K signaling (but not Src, phospholipase C gamma, or SHP-2) completely abolished PDGF-dependent p47phox and Rac-1 translocation, increase of Nox activity, and ROS production. Conversely, a mutant alpha PDGFR able to activate only PI3K was sufficient to mediate these subcellular events. Furthermore, the catalytic PI3K subunit p110 alpha(but not p110 beta) was identified as the crucial isoform that elicits alpha PDGFR-mediated production of ROS. Finally, bromodeoxyuridine incorporation and chemotaxis assays revealed that the lack of ROS liberation blunted PDGF-AA-dependent chemotaxis but not cycle progression. We conclude that PI3K/p110 alpha mediates growth factor-dependent ROS production by recruiting p47phox and Rac-1 to the cell membrane, thereby assembling the active Nox complex. ROS are required for PDGF-AA-dependent chemotaxis but not proliferation.	[Baeumer, Anselm T.; ten Freyhaus, Henrik; Kappert, Kai; Schnabel, Petra; Konkol, Christian; Vantler, Marius; Rosenkranz, Stephan] Univ Cologne, Innere Med Klin 3, Inst Physiol, D-50937 Cologne, Germany; [Sauer, Heinrich] Univ Giessen, D-35392 Giessen, Germany; [Wartenberg, Maria] GKSS Res Inst, Dept Cell Biol, D-14513 Teltow, Germany; [Hescheler, Juergen] Univ Cologne, Inst Neurophysiol, D-50937 Cologne, Germany; [Vantler, Marius; Rosenkranz, Stephan] Univ Cologne, Ctr Mol Med Cologne, D-50937 Cologne, Germany	University of Cologne; Justus Liebig University Giessen; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Cologne; University of Cologne	Rosenkranz, S (corresponding author), Univ Cologne, Innere Med Klin 3, Inst Physiol, Kerpener Str 62, D-50937 Cologne, Germany.	stephan.rosenkranz@uk-koeln.de	Kappert, Kai/H-4116-2017	Kappert, Kai/0000-0001-6976-0428				ARAKI E, 1994, NATURE, V372, P186, DOI 10.1038/372186a0; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; Bae YS, 2000, J BIOL CHEM, V275, P10527, DOI 10.1074/jbc.275.14.10527; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Bazenet CE, 1996, MOL CELL BIOL, V16, P6926; Bokoch GM, 1996, BIOCHEM J, V315, P775, DOI 10.1042/bj3150775; Bruning JC, 1997, MOL CELL BIOL, V17, P1513; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; Diatchuk V, 1997, J BIOL CHEM, V272, P13292, DOI 10.1074/jbc.272.20.13292; Dijkmans J, 2002, INT J BIOCHEM CELL B, V34, P414, DOI 10.1016/S1357-2725(01)00124-8; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; Dupuy C, 1999, J BIOL CHEM, V274, P37265, DOI 10.1074/jbc.274.52.37265; Fleming IN, 2000, BIOCHEM J, V351, P173, DOI 10.1042/0264-6021:3510173; Flesch M, 1999, CIRCULATION, V100, P346, DOI 10.1161/01.CIR.100.4.346; FRENKEL K, 1991, FREE RADICAL RES COM, V12-3, P783, DOI 10.3109/10715769109145860; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; Gelderloos JA, 1998, J BIOL CHEM, V273, P5908, DOI 10.1074/jbc.273.10.5908; Gilbertson DG, 2001, J BIOL CHEM, V276, P27406, DOI 10.1074/jbc.M101056200; Godwin SL, 1997, J BIOL CHEM, V272, P11307; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Harrison DG, 1997, CLIN CARDIOL, V20, P11; Hart B A, 1992, Biotechnol Ther, V3, P119; HAWKINS PT, 1995, CURR BIOL, V5, P393, DOI 10.1016/S0960-9822(95)00080-7; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Kim KS, 1998, J CLIN INVEST, V101, P1821, DOI 10.1172/JCI1830; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Kreuzer J, 2002, FASEB J, V16, P38, DOI 10.1096/fj.01-1036fje; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lavigne MC, 2001, CIRCULATION, V104, P79, DOI 10.1161/01.CIR.104.1.79; Li XR, 2000, NAT CELL BIOL, V2, P302, DOI 10.1038/35010579; Meyer JW, 1999, ENDOTHELIUM-NEW YORK, V7, P11, DOI 10.3109/10623329909165308; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; NISHINAKA Y, 1993, BIOCHEM BIOPH RES CO, V193, P554, DOI 10.1006/bbrc.1993.1659; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pani G, 2000, J BIOL CHEM, V275, P38891, DOI 10.1074/jbc.M007319200; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Rathaus M, 2002, NEPHROL DIAL TRANSPL, V17, P216, DOI 10.1093/ndt/17.2.216; Reif K, 1996, CURR BIOL, V6, P1445, DOI 10.1016/S0960-9822(96)00749-X; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Rosenkranz S, 1999, GROWTH FACTORS, V16, P201, DOI 10.3109/08977199909002130; Rosenkranz S, 1999, J BIOL CHEM, V274, P28335, DOI 10.1074/jbc.274.40.28335; SEIFERT RA, 1993, J BIOL CHEM, V268, P4473; Seshiah PN, 2002, CIRC RES, V91, P406, DOI 10.1161/01.RES.0000033523.08033.16; STOLK J, 1994, AM J RESP CELL MOL, V11, P95, DOI 10.1165/ajrcmb.11.1.8018341; Sugihara K, 1998, ONCOGENE, V17, P3427, DOI 10.1038/sj.onc.1202595; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Sundaresan M, 1996, BIOCHEM J, V318, P379, DOI 10.1042/bj3180379; ten Freyhaus H, 2006, CARDIOVASC RES, V71, P331, DOI 10.1016/j.cardiores.2006.01.022; Thannickal VJ, 1995, J BIOL CHEM, V270, P30334, DOI 10.1074/jbc.270.51.30334; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Viedt C, 2004, J MOL MED, V82, P31, DOI 10.1007/s00109-003-0500-5; Wassmann S, 2002, ARTERIOSCL THROM VAS, V22, P300, DOI 10.1161/hq0202.104081; Wassmann S, 2001, MOL PHARMACOL, V59, P646, DOI 10.1124/mol.59.3.646; Welch HCE, 2003, FEBS LETT, V546, P93, DOI 10.1016/S0014-5793(03)00454-X; Worthylake DK, 2000, NATURE, V408, P682, DOI 10.1038/35047014; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200	63	74	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7864	7876		10.1074/jbc.M704997200	http://dx.doi.org/10.1074/jbc.M704997200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18070887	hybrid			2022-12-25	WOS:000253997900062
J	Wang, PY; Weng, J; Lee, S; Anderson, RGW				Wang, Ping-Yuan; Weng, Jian; Lee, Sungsoo; Anderson, Richard G. W.			The N terminus controls sterol binding while the C terminus regulates the scaffolding function of OSBP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; PLECKSTRIN HOMOLOGY DOMAIN; HAMSTER OVARY CELLS; GOLGI LOCALIZATION; LIGAND-BINDING; CHOLESTEROL; MEMBRANE; 25-HYDROXYCHOLESTEROL; PHOSPHORYLATION; SPECIFICITY	Previously we reported that when cell cholesterol is acutely lowered with beta-methyl-cyclodextrin the amount of activated ERK1/2 in caveolae dramatically increases. We traced the origin of this novel method of pERK1/2 accumulation to a macromolecular complex with dual specific phosphatase activity that contains the serine/threonine phosphatase PP2A, the tyrosine phosphatase HePTP, the oxysterol-binding protein OSBP and cholesterol. When cell cholesterol is lowered, or oxysterols is introduced, the complex disassembles and pERK1/2 increases. In an effort to better understand how OSBP functions as a cholesterol-regulated scaffolding protein, we have mapped the functional parts of the molecule. The command center of the molecule is a centrally located, 51 amino acids (408-459) long sterol-binding domain that can bind both cholesterol and 25-hydroxycholesterol. This domain is functional whether attached to the N- or the C-terminal half of OSBP. Introduction of a Y458S mutation impairs binding. Even though 25-hydroxycholesterol will compete for cholesterol binding to OSBP408-809, it will not compete for cholesterol binding in full-length OSBP. Upon further analysis we found that a glycine-alanine-rich region at the N- terminal end of OSBP works with the PH domain to control cholesterol binding without affecting 25-hydroxycholesterol binding. Finally, we found that HePTP and PP2A bind the C-terminal half of OSBP, HePTP binds a coiled-coil domain ( amino acids 732-761), and PP2A binds neither the coiled-coil nor HePTP. On the basis of this information we propose a new model for how OSBP is able to sense both membrane cholesterol and oxidized sterols and link this information to the ERK1/2 signaling pathway.	[Wang, Ping-Yuan; Weng, Jian; Lee, Sungsoo; Anderson, Richard G. W.] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Anderson, RGW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA.	richard.anderson@utsouthwestern.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL020948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052016] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL20948] Funding Source: Medline; NIGMS NIH HHS [R01 GM052016-14, GM52016, R01 GM052016] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Augustine KA, 2000, ANAT REC, V258, P221, DOI 10.1002/(SICI)1097-0185(20000301)258:3<221::AID-AR1>3.0.CO;2-W; BERGER B, 1995, P NATL ACAD SCI USA, V92, P8259, DOI 10.1073/pnas.92.18.8259; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Clark R, 2005, J BIOL CHEM, V280, P30935, DOI 10.1074/jbc.M504698200; DAWSON PA, 1989, J BIOL CHEM, V264, P16798; DAWSON PA, 1989, J BIOL CHEM, V264, P9046; Friedland N, 2003, P NATL ACAD SCI USA, V100, P2512, DOI 10.1073/pnas.0437840100; Furuchi T, 1998, J BIOL CHEM, V273, P21099, DOI 10.1074/jbc.273.33.21099; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Jamin N, 2005, MOL ENDOCRINOL, V19, P588, DOI 10.1210/me.2004-0308; Lagace TA, 1997, BIOCHEM J, V326, P205, DOI 10.1042/bj3260205; Levine T, 2005, MOL CELL, V19, P722, DOI 10.1016/j.molcel.2005.08.006; Levine TP, 2002, CURR BIOL, V12, P695, DOI 10.1016/S0960-9822(02)00779-0; Levine TP, 1998, CURR BIOL, V8, P729, DOI 10.1016/S0960-9822(98)70296-9; Mohammadi A, 2001, J LIPID RES, V42, P1062; Mumby M, 2007, ACS CHEM BIOL, V2, P99, DOI 10.1021/cb700021z; Perry RJ, 2006, MOL BIOL CELL, V17, P2604, DOI 10.1091/mbc.E06-01-0060; RIDGWAY ND, 1992, J CELL BIOL, V116, P307, DOI 10.1083/jcb.116.2.307; Storey MK, 1998, BIOCHEM J, V336, P247, DOI 10.1042/bj3360247; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Sullivan DP, 2006, BIOCHEM SOC T, V34, P356, DOI 10.1042/BST0340356; TAYLOR FR, 1985, CHEM PHYS LIPIDS, V38, P187, DOI 10.1016/0009-3084(85)90066-0; Wang PH, 2005, EMBO J, V24, P2989, DOI 10.1038/sj.emboj.7600764; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Wang PY, 2005, SCIENCE, V307, P1472, DOI 10.1126/science.1107710; Xiao H, 2005, J AM SOC MASS SPECTR, V16, P869, DOI 10.1016/j.jasms.2005.02.020; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yan DG, 2007, ARTERIOSCL THROM VAS, V27, P1108, DOI 10.1161/ATVBAHA.106.138545; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200	30	40	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					8034	8045		10.1074/jbc.M707631200	http://dx.doi.org/10.1074/jbc.M707631200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18165705	hybrid			2022-12-25	WOS:000253997900078
J	Diao, A; Frost, L; Morohashi, Y; Lowe, M				Diao, Aipo; Frost, Laura; Morohashi, Yuichi; Lowe, Martin			Coordination of golgin tethering and SNARE assembly - GM130 binds syntaxin 5 in a p115-regulated manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX PROTEIN GM130; GIANTIN INTERACTS; MEMBRANE-FUSION; IN-VIVO; P115; VESICLE; COMPLEX; TRANSPORT; DOCKING; GRASP65	During membrane traffic, transport carriers are first tethered to the target membrane prior to undergoing fusion. Mechanisms exist to connect tethering with fusion, but in most cases, the details remain poorly understood. GM130 is a member of the golgin family of coiled-coil proteins that is involved in membrane tethering at the endoplasmic reticulum ( ER) to Golgi intermediate compartment and cis-Golgi. Here, we demonstrate that GM130 interacts with syntaxin 5, a t-SNARE also localized to the early secretory pathway. Binding to syntaxin 5 is specific, direct, and mediated by the membrane-proximal region of GM130. Interestingly, interaction with syntaxin 5 is inhibited by the binding of the vesicle docking protein p115 to a distal binding site in GM130. The interaction between GM130 and the small GTPase Rab1 is also inhibited by p115 binding. Our findings suggest a mechanism for coupling membrane tethering and fusion at the ER to Golgi intermediate compartment and cis-Golgi, with GM130 playing a central role in linking these processes. Consistent with this hypothesis, we find that depletion of GM130 by RNA interference slows the rate of ER to Golgi trafficking in vivo. The interactions of GM130 with syntaxin 5 and Rab1 are also regulated by mitotic phosphorylation, which is likely to contribute to the inhibition of ER to Golgi trafficking that occurs when mammalian cells enter mitosis.	[Diao, Aipo; Frost, Laura; Morohashi, Yuichi; Lowe, Martin] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Manchester	Lowe, M (corresponding author), Univ Manchester, Fac Life Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	martin.lowe@manchester.ac.uk			MRC [G117/494] Funding Source: UKRI; Medical Research Council [G117/494, g117/494] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Alvarez C, 2001, J BIOL CHEM, V276, P2693, DOI 10.1074/jbc.M007957200; BAILLY E, 1991, NATURE, V350, P715, DOI 10.1038/350715a0; Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258; Beard M, 2005, J BIOL CHEM, V280, P25840, DOI 10.1074/jbc.M503925200; Behnia R, 2007, J CELL BIOL, V176, P255, DOI 10.1083/jcb.200607151; Bentley M, 2006, J BIOL CHEM, V281, P38825, DOI 10.1074/jbc.M606044200; Brandon E, 2006, MOL BIOL CELL, V17, P2996, DOI 10.1091/mbc.e05-09-0862; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014; Hui N, 1997, MOL BIOL CELL, V8, P1777, DOI 10.1091/mbc.8.9.1777; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Lesa GM, 2000, J BIOL CHEM, V275, P2831, DOI 10.1074/jbc.275.4.2831; Levine TP, 1996, J BIOL CHEM, V271, P17304, DOI 10.1074/jbc.271.29.17304; Linstedt AD, 2000, J BIOL CHEM, V275, P10196, DOI 10.1074/jbc.275.14.10196; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Lupashin V, 2005, BBA-MOL CELL RES, V1744, P325, DOI 10.1016/j.bbamcr.2005.03.013; Marra P, 2001, NAT CELL BIOL, V3, P1101, DOI 10.1038/ncb1201-1101; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; Moyer BD, 2001, TRAFFIC, V2, P268, DOI 10.1034/j.1600-0854.2001.1o007.x; Muller JMM, 2002, J CELL BIOL, V157, P1161, DOI 10.1083/jcb.200202082; Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319; Preisinger C, 2005, EMBO J, V24, P753, DOI 10.1038/sj.emboj.7600569; Preisinger C, 2004, J CELL BIOL, V164, P1009, DOI 10.1083/jcb.200310061; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101; Puthenveedu MA, 2001, J CELL BIOL, V155, P227, DOI 10.1083/jcb.200105005; Rosing M, 2007, EXP CELL RES, V313, P2318, DOI 10.1016/j.yexcr.2007.03.031; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; Seemann J, 2000, MOL BIOL CELL, V11, P635, DOI 10.1091/mbc.11.2.635; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 2002, J CELL BIOL, V157, P45, DOI 10.1083/jcb.200112127; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Sonnichsen B, 1998, J CELL BIOL, V140, P1013, DOI 10.1083/jcb.140.5.1013; Suga K, 2005, FEBS LETT, V579, P4226, DOI 10.1016/j.febslet.2005.06.053; Vasile E, 2003, TRAFFIC, V4, P254, DOI 10.1034/j.1600-0854.2003.00080.x; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; Weide T, 2001, EMBO REP, V2, P336, DOI 10.1093/embo-reports/kve065; Yoshimura S, 2004, J BIOCHEM, V135, P201, DOI 10.1093/jb/mvh024	45	61	72	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6957	6967		10.1074/jbc.M708401200	http://dx.doi.org/10.1074/jbc.M708401200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18167358	hybrid			2022-12-25	WOS:000253779600040
J	Fokine, A; Miroshnikov, KA; Shneider, MM; Mesyanzhinov, VV; Rossmann, MG				Fokine, Andrei; Miroshnikov, Konstantin A.; Shneider, Mikhail M.; Mesyanzhinov, Vadim V.; Rossmann, Michael G.			Structure of the bacteriophage phi KZ lytic transglycosylase gp144	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DIMENSIONAL STRUCTURE; LYSOZYME; ENDOLYSINS; SOFTWARE; PROGRAM; GENOME; HEN	Lytic transglycosylases are enzymes that act on the peptidoglycan of bacterial cell walls. They cleave the glycosidic linkage between N-acetylmuramoyl and N-acetylglucosaminyl residues with the concomitant formation of a 1,6-anhydromuramoyl product. The x-ray structure of the lytic transglycosylase gp144 from the Pseudomonas bacteriophage phi KZ has been determined to 2.5-angstrom resolution. This protein is probably employed by the bacteriophage in the late stage of the virus reproduction cycle to destroy the bacterial cell wall to release the phage progeny. phi KZgp144 is a 260-residue alpha-helical protein composed of a 70-residue N-terminal cell wall-binding domain and a C-terminal catalytic domain. The fold of the N-terminal domain is similar to the peptidoglycan-binding domain from Streptomyces albus G D-Ala-D-Ala carboxypeptidase and to the N-terminal prodomain of human metalloproteinases that act on extracellular matrices. The C-terminal catalytic domain of gp144 has a structural similarity to the catalytic domain of the transglycosylase Slt70 from Escherichia coli and to lysozymes. The gp144 catalytic domain has an elongated groove that can bind at least five sugar residues at sites A-E. As in other lysozymes, the peptidoglycan cleavage ( catalyzed by Glu(115) in gp144) occurs between sugar-binding subsites D and E. The x-ray structure of the phi KZ transglycosylase complexed with the chitotetraose ( N-acetylglucosamine) 4 has been determined to 2.6-angstrom resolution. The N-acetylglucosamine residues of the chitotetraose bind in sites A-D.	[Fokine, Andrei; Rossmann, Michael G.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA; [Miroshnikov, Konstantin A.; Shneider, Mikhail M.; Mesyanzhinov, Vadim V.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow 117997, Russia	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences	Rossmann, MG (corresponding author), Purdue Univ, Dept Biol Sci, 915 W State St, W Lafayette, IN 47907 USA.	mr@purdue.edu	Miroshnikov, Konstantin A/Q-5515-2016; Miroshnikov, Konstantin/D-5950-2018; Fokine, Andrei/A-1330-2013; Shneider, Mikhail/AAL-6817-2020	Miroshnikov, Konstantin A/0000-0002-4468-4091; Miroshnikov, Konstantin/0000-0002-4468-4091; Shneider, Mikhail/0000-0002-3768-3541				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P., 2005, CCP4 NEWSLETTER; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Blackburn NT, 2001, J MOL EVOL, V52, P78, DOI 10.1007/s002390010136; BLAKE CCF, 1965, NATURE, V206, P757, DOI 10.1038/206757a0; BLAKE CCF, 2006, INT TABLES CRYSTALLO, VF, P745; Briers Y, 2007, MOL MICROBIOL, V65, P1334, DOI 10.1111/j.1365-2958.2007.05870.x; Briers Y, 2007, J BIOCHEM BIOPH METH, V70, P531, DOI 10.1016/j.jbbm.2006.10.009; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charlier P, 2004, HDB METALLOPROTEINS, V3, P164; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DIDEBERG O, 1982, NATURE, V299, P469, DOI 10.1038/299469a0; Elkins PA, 2002, ACTA CRYSTALLOGR D, V58, P1182, DOI 10.1107/S0907444902007849; Fokine A, 2005, J MOL BIOL, V352, P117, DOI 10.1016/j.jmb.2005.07.018; Fokine A, 2007, STRUCTURE, V15, P1099, DOI 10.1016/j.str.2007.07.008; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; GHUYSEN JM, 1994, FEBS LETT, V342, P23, DOI 10.1016/0014-5793(94)80577-6; Giamarellou H, 2000, INT J ANTIMICROB AG, V16, P103, DOI 10.1016/S0924-8579(00)00212-0; GRUTTER MG, 1983, NATURE, V303, P828, DOI 10.1038/303828a0; HOLTJE JV, 1975, J BACTERIOL, V124, P1067; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; Kanamaru S, 2002, NATURE, V415, P553, DOI 10.1038/415553a; KOHN EC, 1995, CANCER RES, V55, P1856; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KRYLOV VN, 1978, VOP VIRUSOL+, P568; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leiman PG, 2003, CELL MOL LIFE SCI, V60, P2356, DOI 10.1007/s00018-003-3072-1; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; LUZZATI V, 1952, ACTA CRYSTALLOGR, V5, P802, DOI 10.1107/S0365110X52002161; MATTHEWS BW, 1974, P NATL ACAD SCI USA, V71, P4178, DOI 10.1073/pnas.71.10.4178; McRee DE, 2004, ACTA CRYSTALLOGR D, V60, P2276, DOI 10.1107/S0907444904025491; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mesyanzhinov VV, 2002, J MOL BIOL, V317, P1, DOI 10.1006/jmbi.2001.5396; Miroshnikov KA, 2006, BIOCHEMISTRY-MOSCOW+, V71, P300, DOI 10.1134/S0006297906030102; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paradis-Bleau C, 2007, FEMS MICROBIOL LETT, V266, P201, DOI 10.1111/j.1574-6968.2006.00523.x; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; SALI A, 1995, PROTEINS, V23, P318, DOI 10.1002/prot.340230306; Scheurwater E, 2008, INT J BIOCHEM CELL B, V40, P586, DOI 10.1016/j.biocel.2007.03.018; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tang L, 2005, EMBO J, V24, P2087, DOI 10.1038/sj.emboj.7600695; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; THUNNISSEN AMWH, 1995, PROTEINS, V22, P245, DOI 10.1002/prot.340220305; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; van Asselt EJ, 1999, J MOL BIOL, V291, P877, DOI 10.1006/jmbi.1999.3013	48	46	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7242	7250		10.1074/jbc.M709398200	http://dx.doi.org/10.1074/jbc.M709398200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18160394	hybrid			2022-12-25	WOS:000253779600069
J	Surmann-Schmitt, C; Dietz, U; Kireva, T; Adam, N; Park, J; Tagariello, A; Oennerfjord, P; Heinegard, D; Schlotzer-Schrehardt, U; Deutzmann, R; von der Mark, K; Stock, M				Surmann-Schmitt, Cordula; Dietz, Uwe; Kireva, Trayana; Adam, Nadia; Park, Jung; Tagariello, Andreas; Oennerfjord, Patrik; Heinegard, Dick; Schloetzer-Schrehardt, Ursula; Deutzmann, Rainer; von der Mark, Klaus; Stock, Michael			Ucma, a novel secreted cartilage-specific protein with implications in osteogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE O-SULFATION; INDIAN HEDGEHOG; CHONDROCYTE DIFFERENTIATION; PROHORMONE CONVERTASES; MASS-SPECTROMETRY; EXPRESSION; IDENTIFICATION; PROPROTEIN; GASTRULATION; MATURATION	Here we report on the structure, expression, and function of a novel cartilage-specific gene coding for a 17-kDa small, highly charged, and secreted protein that we termed Ucma ( unique cartilage matrix-associated protein). The protein is processed by a furin-like protease into an N-terminal peptide of 37 amino acids and a C-terminal fragment ( Ucma-C) of 74 amino acids. Ucma is highly conserved between mouse, rat, human, dog, clawed frog, and zebrafish, but has no homology to other known proteins. Remarkable are 1-2 tyrosine sulfate residues/ molecule and dense clusters of acidic and basic residues in the C-terminal part. In the developing mouse skeleton Ucma mRNA is expressed in resting chondrocytes in the distal and peripheral zones of epiphyseal and vertebral cartilage. Ucma is secreted into the extracellular matrix as an uncleaved precursor and shows the same restricted distribution pattern in cartilage as Ucma mRNA. In contrast, antibodies prepared against the processed C-terminal fragment located Ucma-C in the entire cartilage matrix, indicating that it either diffuses or is retained until chondrocytes reach hypertrophy. During differentiation of an MC615 chondrocyte subclone in vitro, Ucma expression parallels largely the expression of collagen II and decreases with maturation toward hypertrophic cells. Recombinant Ucma-C does not affect expression of chondrocyte-specific genes or proliferation of chondrocytes, but interferes with osteogenic differentiation of primary osteoblasts, mesenchymal stem cells, and MC3T3-E1pre-osteoblasts. These findings suggest that Ucma may be involved in the negative control of osteogenic differentiation of osteochondrogenic precursor cells in peripheral zones of fetal cartilage and at the cartilage-bone interface.	[Surmann-Schmitt, Cordula; Dietz, Uwe; Kireva, Trayana; Adam, Nadia; Park, Jung; von der Mark, Klaus; Stock, Michael] Univ Erlangen Nurnberg, Dept Expt Med 1, Nikolaus Fiebiger Ctr Mol Med, D-91054 Erlangen, Germany; [Tagariello, Andreas] Univ Hosp, Inst Human Genet, D-91054 Erlangen, Germany; [Oennerfjord, Patrik; Heinegard, Dick] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden; [Schloetzer-Schrehardt, Ursula] Univ Hosp, Hosp Eye, D-91054 Erlangen, Germany; [Deutzmann, Rainer] Univ Regensburg, Inst Biochem, D-93053 Regensburg, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; Lund University; University of Erlangen Nuremberg; University of Regensburg	Stock, M (corresponding author), Univ Erlangen Nurnberg, Dept Expt Med 1, Nikolaus Fiebiger Ctr Mol Med, Glueckstr 6, D-91054 Erlangen, Germany.	mstock@molmed.uni-erlangen.de	Stock, Michael/B-9829-2009; Surmann-Schmitt, Cordula/B-9792-2009; von+der+Mark, Klaus/AAJ-1443-2020; Onnerfjord, Patrik/R-3131-2019	Onnerfjord, Patrik/0000-0002-2345-2937; Stock, Michael/0000-0002-3322-0961				Azizan A, 2001, J BIOL CHEM, V276, P23632, DOI 10.1074/jbc.M009967200; Beck S, 2002, NAT CELL BIOL, V4, P981, DOI 10.1038/ncb890; Bianco P, 1998, MATRIX BIOL, V17, P185, DOI 10.1016/S0945-053X(98)90057-9; Bundgaard JR, 1997, J BIOL CHEM, V272, P21700, DOI 10.1074/jbc.272.35.21700; CANCEDDA R, 1995, INT REV CYTOL, V159, P265, DOI 10.1016/S0074-7696(08)62109-9; Constam DB, 1996, J CELL BIOL, V134, P181, DOI 10.1083/jcb.134.1.181; Cui YZ, 1998, EMBO J, V17, P4735, DOI 10.1093/emboj/17.16.4735; de Crombrugghe B, 2001, CURR OPIN CELL BIOL, V13, P721, DOI 10.1016/S0955-0674(00)00276-3; DeLise AM, 2000, OSTEOARTHR CARTILAGE, V8, P309, DOI 10.1053/joca.1999.0306; Duckert P, 2004, PROTEIN ENG DES SEL, V17, P107, DOI 10.1093/protein/gzh013; Farach-Carson MC, 2005, CRIT REV EUKAR GENE, V15, P29, DOI 10.1615/CritRevEukaryotGeneExpr.v15.i1.30; Goldring MB, 2006, J CELL BIOCHEM, V97, P33, DOI 10.1002/jcb.20652; Grimsrud CD, 2001, J ORTHOPAED RES, V19, P18, DOI 10.1016/S0736-0266(00)00017-6; HUANG SC, 1989, PEPTIDES, V10, P785, DOI 10.1016/0196-9781(89)90114-9; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Koziel L, 2005, DEVELOPMENT, V132, P5249, DOI 10.1242/dev.02097; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEYTE A, 1991, J BIOL CHEM, V266, P740; MALLEINGERIN F, 1993, P NATL ACAD SCI USA, V90, P3289, DOI 10.1073/pnas.90.8.3289; Moore KL, 2003, J BIOL CHEM, V278, P24243, DOI 10.1074/jbc.R300008200; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Schmidl M, 2006, J BIOL CHEM, V281, P31790, DOI 10.1074/jbc.M603419200; Seibert C, 2002, P NATL ACAD SCI USA, V99, P11031, DOI 10.1073/pnas.172380899; SEIDAH N, 1994, BIOCHIMIE, V76, P197, DOI 10.1016/0300-9084(94)90147-3; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Stock M, 2004, J BONE MINER RES, V19, P959, DOI 10.1359/jbmr.2004.19.6.959; Stock M, 2003, J BIOL CHEM, V278, P17360, DOI 10.1074/jbc.M207631200; Tagariello A, 2008, MATRIX BIOL, V27, P3, DOI 10.1016/j.matbio.2007.07.004; Thomas JT, 2006, J BIOL CHEM, V281, P26725, DOI 10.1074/jbc.M603851200; Tsuji A, 2003, BBA-PROTEINS PROTEOM, V1645, P95, DOI 10.1016/S1570-9639(02)00532-0; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wagner EF, 2001, CURR OPIN GENET DEV, V11, P527, DOI 10.1016/S0959-437X(00)00228-8; Weisser A, 2002, EXP CELL RES, V279, P1, DOI 10.1006/excr.2002.5580; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; ZHENG M, 1994, J NEUROSCI, V14, P4656	37	59	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7082	7093		10.1074/jbc.M702792200	http://dx.doi.org/10.1074/jbc.M702792200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18156182	hybrid			2022-12-25	WOS:000253779600053
J	Gao, F; Koenitzer, JR; Tobolewski, JM; Jiang, DH; Liang, JR; Noble, PW; Oury, TD				Gao, Fei; Koenitzer, Jeffrey R.; Tobolewski, Jacob M.; Jiang, Dianhua; Liang, Jiurong; Noble, Paul W.; Oury, Tim D.			Extracellular superoxide dismutase inhibits inflammation by preventing oxidative fragmentation of hyaluronan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BRONCHOALVEOLAR LAVAGE FLUID; METAL-CATALYZED OXIDATION; HEPARIN-BINDING DOMAIN; PULMONARY EC-SOD; LUNG INJURY; RECEPTOR RHAMM; NITRIC-OXIDE; I COLLAGEN; CD44; ACCUMULATION	Extracellular superoxide dismutase (EC-SOD) is expressed at high levels in lungs. EC-SOD has a polycationic matrix-binding domain that binds to polyanionic constituents in the matrix. Previous studies indicate that EC-SOD protects the lung in both bleomycin- and asbestos-induced models of pulmonary fibrosis. Although the mechanism of EC-SOD protection is not fully understood, these studies indicate that EC-SOD plays an important role in regulating inflammatory responses to pulmonary injury. Hyaluronan is a polyanionic high molecular mass polysaccharide found in the extracellular matrix that is sensitive to oxidant-mediated fragmentation. Recent studies found that elevated levels of low molecular mass hyaluronan are associated with inflammatory conditions. We hypothesize that EC-SOD may inhibit pulmonary inflammation in part by preventing superoxide-mediated fragmentation of hyaluronan to low molecular mass fragments. We found that EC-SOD directly binds to hyaluronan and significantly inhibits oxidant-induced degradation of this glycosaminoglycan. In vitro human polymorphic neutrophil chemotaxis studies indicate that oxidative fragmentation of hyaluronan results in polymorphic neutrophil chemotaxis and that EC-SOD can completely prevent this response. Intratracheal injection of crocidolite asbestos in mice leads to pulmonary inflammation and injury that is enhanced in EC-SOD knock-out mice. Notably, hyaluronan levels are increased in the bronchoalveolar lavage fluid after asbestos-induced pulmonary injury, and this response is markedly enhanced in EC-SOD knock-out mice. These data indicate that inhibition of oxidative hyaluronan fragmentation probably represents one mechanism by which EC-SOD inhibits inflammation in response to lung injury.	[Gao, Fei; Koenitzer, Jeffrey R.; Tobolewski, Jacob M.; Oury, Tim D.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15261 USA; [Jiang, Dianhua; Liang, Jiurong; Noble, Paul W.] Duke Univ, Dept Med, Durham, NC 27708 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Duke University	Gao, F (corresponding author), Univ Pittsburgh, Dept Pathol, W905 BST,200 Lothrop St, Pittsburgh, PA 15261 USA.	Feg2@pitt.edu	Jiang, Dianhua/B-1421-2009; Liang, Carol Jiurong/AAI-4963-2021	Jiang, Dianhua/0000-0002-4508-3829; Liang, Jiurong/0000-0001-5179-5016	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES015383] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL063700, R01 HL063700-07, R01 HL 63700] Funding Source: Medline; NIEHS NIH HHS [F32 ES 015383-01, F32 ES015383] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ADACHI T, 1992, ARCH BIOCHEM BIOPHYS, V297, P155, DOI 10.1016/0003-9861(92)90654-F; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bai KJ, 2005, AM J RESP CRIT CARE, V172, P92, DOI 10.1164/rccm.200405-652OC; BARRY FP, 1995, J BIOL CHEM, V270, P20516, DOI 10.1074/jbc.270.35.20516; BJERMER L, 1989, THORAX, V44, P126, DOI 10.1136/thx.44.2.126; Bowler RP, 2002, AM J PHYSIOL-LUNG C, V282, pL719, DOI 10.1152/ajplung.00058.2001; Casalino-Matsuda SM, 2006, AM J RESP CELL MOL, V34, P581, DOI 10.1165/rcmb.2005-0386OC; Clark RA, 1996, J CELL BIOL, V134, P1075, DOI 10.1083/jcb.134.4.1075; DeGrendele HC, 1996, J EXP MED, V183, P1119, DOI 10.1084/jem.183.3.1119; Deguine V, 1998, INT J BIOL MACROMOL, V22, P17, DOI 10.1016/S0141-8130(97)00084-6; Dorger M, 2002, TOXICOL APPL PHARM, V181, P93, DOI 10.1006/taap.2002.9388; Fattman CL, 2000, BIOCHEM BIOPH RES CO, V275, P542, DOI 10.1006/bbrc.2000.3327; Fattman CL, 2006, FREE RADICAL BIO MED, V40, P601, DOI 10.1016/j.freeradbiomed.2005.09.030; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P763, DOI 10.1016/S0891-5849(03)00402-7; Fattman CL, 2003, FREE RADICAL BIO MED, V35, P236, DOI 10.1016/S0891-5849(03)00275-2; Fattman CL, 2001, FREE RADICAL BIO MED, V31, P1198, DOI 10.1016/S0891-5849(01)00699-2; Forteza R, 2001, FASEB J, V15, P2179, DOI 10.1096/fj.01-0036com; Ghio AJ, 1998, FREE RADICAL BIO MED, V24, P11, DOI 10.1016/S0891-5849(97)00063-4; GUNTENHONER MW, 1992, MATRIX, V12, P388, DOI 10.1016/S0934-8832(11)80035-1; HALLGREN R, 1989, AM REV RESPIR DIS, V139, P682; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; HARDWICK C, 1992, J CELL BIOL, V117, P1343, DOI 10.1083/jcb.117.6.1343; HERNNAS J, 1992, EUR RESPIR J, V5, P404; Ikegami-Kawai M, 2004, GLYCOBIOLOGY, V14, P65, DOI 10.1093/glycob/cwh011; Jiang DH, 2005, NAT MED, V11, P1173, DOI 10.1038/nm1315; KARLSSON K, 1988, BIOCHEM J, V256, P29, DOI 10.1042/bj2560029; Kato Y, 2001, FREE RADICAL BIO MED, V31, P624, DOI 10.1016/S0891-5849(01)00623-2; Kinnula VL, 2005, AM J RESP CRIT CARE, V172, P417, DOI 10.1164/rccm.200501-017PP; Kinnula VL, 1999, EUR RESPIR J, V14, P706, DOI 10.1034/j.1399-3003.1999.14c35.x; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; LEBARON RG, 1992, J BIOL CHEM, V267, P10003; Lookene A, 2000, BIOCHEMISTRY-US, V39, P230, DOI 10.1021/bi991512x; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; MARKLUND SL, 1982, CLIN CHIM ACTA, V126, P41, DOI 10.1016/0009-8981(82)90360-6; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; MIURA RO, 1995, ANAL BIOCHEM, V225, P333, DOI 10.1006/abio.1995.1163; MIYAKE K, 1990, J EXP MED, V172, P69, DOI 10.1084/jem.172.1.69; MONBOISSE JC, 1990, BIOCHEM J, V270, P459, DOI 10.1042/bj2700459; MOSSMAN BT, 1989, NEW ENGL J MED, V320, P1721, DOI 10.1056/NEJM198906293202604; Mossman BT, 1997, AM J PUBLIC HEALTH, V87, P689, DOI 10.2105/AJPH.87.4.689; Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; NETTELBLADT O, 1989, AM REV RESPIR DIS, V140, P1028, DOI 10.1164/ajrccm/140.4.1028; NETTELBLADT O, 1989, AM REV RESPIR DIS, V139, P759, DOI 10.1164/ajrccm/139.3.759; Noble Paul W, 2006, Proc Am Thorac Soc, V3, P401, DOI 10.1513/pats.200604-097AW; Noble PW, 2004, CLIN CHEST MED, V25, P749, DOI 10.1016/j.ccm.2004.04.003; Noble PW, 1996, J EXP MED, V183, P2373, DOI 10.1084/jem.183.5.2373; NOBLE PW, 1993, J CLIN INVEST, V91, P2368, DOI 10.1172/JCI116469; OURY TD, 1994, LAB INVEST, V70, P889; Oury TD, 1996, BIOCHEM J, V317, P51, DOI 10.1042/bj3170051; Oury TD, 2002, AM J PHYSIOL-LUNG C, V283, pL777, DOI 10.1152/ajplung.00011.2002; Oury TD, 1996, FREE RADICAL BIO MED, V20, P957, DOI 10.1016/0891-5849(95)02222-8; Pascal M, 2000, T ROY SOC TROP MED H, V94, P66, DOI 10.1016/S0035-9203(00)90443-7; Petersen SV, 2004, J BIOL CHEM, V279, P13705, DOI 10.1074/jbc.M310217200; Porter DW, 2006, TOXICOL SCI, V90, P188, DOI 10.1093/toxsci/kfj075; RAUCH U, 1992, J BIOL CHEM, V267, P19536; SAARI H, 1991, ANN RHEUM DIS, V50, P389, DOI 10.1136/ard.50.6.389; SANDSTROM J, 1992, J BIOL CHEM, V267, P18205; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; Shukla A, 2003, FREE RADICAL BIO MED, V34, P1117, DOI 10.1016/S0891-5849(03)00060-1; SODERBERG M, 1989, INT ARCH ALLER A IMM, V88, P373, DOI 10.1159/000234719; Tan RJ, 2006, AM J RESP CELL MOL, V34, P226, DOI 10.1165/rcmb.2005-0212OC; Tan RJ, 2004, J APPL PHYSIOL, V97, P2006, DOI 10.1152/japplphysiol.00480.2004; Teder P, 2002, SCIENCE, V296, P155, DOI 10.1126/science.1069659; TENGBLAD A, 1979, BIOCHIM BIOPHYS ACTA, V578, P281, DOI 10.1016/0005-2795(79)90158-2; Tibell LAE, 1997, BBA-PROTEIN STRUCT M, V1340, P21, DOI 10.1016/S0167-4838(97)00024-1; UCHIYAMA H, 1990, J BIOL CHEM, V265, P7753; Watanabe H, 1997, J BIOL CHEM, V272, P28057, DOI 10.1074/jbc.272.44.28057; Zaman A, 2005, AM J RESP CELL MOL, V33, P447, DOI 10.1165/rcmb.2004-0333OC; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X; Zen K, 2006, J IMMUNOL METHODS, V309, P86, DOI 10.1016/j.jim.2005.11.014; Zhang SW, 1998, J BIOL CHEM, V273, P11342, DOI 10.1074/jbc.273.18.11342; Zhao F, 1997, J BIOL CHEM, V272, P9019	73	142	148	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6058	6066		10.1074/jbc.M709273200	http://dx.doi.org/10.1074/jbc.M709273200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165226	Green Accepted, hybrid			2022-12-25	WOS:000253779500011
J	Pabla, N; Huang, S; Mi, QS; Daniel, R; Dong, Z				Pabla, Navjotsingh; Huang, Shuang; Mi, Qing-Sheng; Daniel, Rene; Dong, Zheng			ATR-Chk2 signaling in p53 activation and DNA damage response during cisplatin-induced apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBULAR CELL APOPTOSIS; TUMOR-SUPPRESSOR; ATM; CHK2; DEATH; PATHWAY; REPAIR; ALPHA; INVOLVEMENT; MECHANISMS	Cisplatin is one of the most effective anti-cancer drugs; however, the use of cisplatin is limited by its toxicity in normal tissues, particularly injury of the kidneys. The mechanisms underlying the therapeutic effects of cisplatin in cancers and side effects in normal tissues are largely unclear. Recent work has suggested a role for p53 in cisplatin-induced renal cell apoptosis and kidney injury; however, the signaling pathway leading to p53 activation and renal apoptosis is unknown. Here we demonstrate an early DNA damage response during cisplatin treatment of renal cells and tissues. Importantly, in the DNA damage response, we demonstrate a critical role for ATR, but not ATM (ataxia telangiectasia mutated) or DNA-PK (DNA-dependent protein kinase), in cisplatin-induced p53 activation and apoptosis. We show that ATR is specifically activated during cisplatin treatment and co-localizes with H2AX, forming nuclear foci at the site of DNA damage. Blockade of ATR with a dominant-negative mutant inhibits cisplatin-induced p53 activation and renal cell apoptosis. Consistently, cisplatin-induced p53 activation and apoptosis are suppressed in ATR-deficient fibroblasts. Downstream of ATR, both Chk1 and Chk2 are phosphorylated during cisplatin treatment in an ATR-dependent manner. Interestingly, following phosphorylation, Chk1 is degraded via the proteosomal pathway, whereas Chk2 is activated. Inhibition of Chk2 by a dominant-negative mutant or gene deficiency attenuates cisplatin-induced p53 activation and apoptosis. In vivo in C57BL/6 mice, ATR and Chk2 are activated in renal tissues following cisplatin treatment. Together, the results suggest an important role for the DNA damage response mediated by ATR-Chk2 in p53 activation and renal cell apoptosis during cisplatin nephrotoxicity.	[Pabla, Navjotsingh; Dong, Zheng] Med Coll Georgia, Dept Cell Biol & Anat, Augusta, GA 30912 USA; [Huang, Shuang] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Mi, Qing-Sheng] Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA 30912 USA; [Mi, Qing-Sheng] Charlie Norwood Vet Affairs Med Ctr, Augusta, GA 30912 USA; [Daniel, Rene] Thomas Jefferson Univ, Dept Med, Philadelphia, PA 19107 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jefferson University	Dong, Z (corresponding author), Med Coll Georgia, Dept Cell Biol & Anat, 1459 Laney Walker Blvd, Augusta, GA 30912 USA.	zdong@mail.mcg.edu	Pabla, Navjotsingh/H-3568-2011	Pabla, Navjot/0000-0001-9408-0539; Daniel, Rene/0000-0002-3876-6242	NATIONAL CANCER INSTITUTE [R01CA125272] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA125272] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; AGARWAL A, 1995, KIDNEY INT, V48, P1298, DOI 10.1038/ki.1995.414; Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Arany I, 2003, SEMIN NEPHROL, V23, P460, DOI 10.1016/S0270-9295(03)00089-5; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Baliga R, 1999, DRUG METAB REV, V31, P971, DOI 10.1081/DMR-100101947; Berns JS, 1997, SEMIN NEPHROL, V17, P54; Busby EC, 2000, CANCER RES, V60, P2108; Colton SL, 2006, J BIOL CHEM, V281, P27117, DOI 10.1074/jbc.M602826200; Cummings BS, 2002, J PHARMACOL EXP THER, V302, P8, DOI 10.1124/jpet.302.1.8; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Hirao A, 2002, MOL CELL BIOL, V22, P6521, DOI 10.1128/MCB.22.18.6521-6532.2002; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Jiang M, 2006, ONCOGENE, V25, P4056, DOI 10.1038/sj.onc.1209440; Jiang M, 2004, AM J PHYSIOL-RENAL, V287, pF1140, DOI 10.1152/ajprenal.00262.2004; Jiang M, 2007, BIOCHEM PHARMACOL, V73, P1499, DOI 10.1016/j.bcp.2007.01.010; Jiang M, 2007, J BIOL CHEM, V282, P2636, DOI 10.1074/jbc.M606928200; Joe YS, 2006, J BIOL CHEM, V281, P28764, DOI 10.1074/jbc.M604392200; Jung YW, 2003, J BIOL CHEM, V278, P52084, DOI 10.1074/jbc.M310120200; Li SY, 2004, AM J PHYSIOL-RENAL, V287, pF990, DOI 10.1152/ajprenal.00206.2004; MIYASHITA T, 1995, CELL, V80, P293; Norbury CJ, 2004, ONCOGENE, V23, P2797, DOI 10.1038/sj.onc.1207532; Nowak G, 2002, J BIOL CHEM, V277, P43377, DOI 10.1074/jbc.M206373200; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Paulsen RD, 2007, DNA REPAIR, V6, P953, DOI 10.1016/j.dnarep.2007.02.015; Price PM, 2003, SEMIN NEPHROL, V23, P449, DOI 10.1016/S0270-9295(03)00087-1; Ramesh G, 2004, KIDNEY INT, V66, pS56, DOI 10.1111/j.1523-1755.2004.09109.x; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Roos WP, 2006, TRENDS MOL MED, V12, P440, DOI 10.1016/j.molmed.2006.07.007; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Seth R, 2005, J BIOL CHEM, V280, P31230, DOI 10.1074/jbc.M503305200; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; TAKAHARA PM, 1995, NATURE, V377, P649, DOI 10.1038/377649a0; Turchi JJ, 2000, NUCLEIC ACIDS RES, V28, P4634, DOI 10.1093/nar/28.23.4634; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Wang J, 2004, J BIOL CHEM, V279, P39584, DOI 10.1074/jbc.M400015200; Wang JZ, 2006, AM J PHYSIOL-RENAL, V291, pF1300, DOI 10.1152/ajprenal.00509.2005; Wang JZ, 2004, J BIOL CHEM, V279, P19948, DOI 10.1074/jbc.M313629200; Wei Q, 2007, KIDNEY INT, V72, P53, DOI 10.1038/sj.ki.5002256; Wei QQ, 2007, AM J PHYSIOL-RENAL, V293, pF1282, DOI 10.1152/ajprenal.00230.2007; Wei QQ, 2005, AM J NEPHROL, V25, P491, DOI 10.1159/000088171; Wilsker D, 2007, MOL CANCER THER, V6, P1406, DOI 10.1158/1535-7163.MCT-06-0679; Woost PG, 1996, KIDNEY INT, V50, P125, DOI 10.1038/ki.1996.295; Wright JA, 1998, P NATL ACAD SCI USA, V95, P7445, DOI 10.1073/pnas.95.13.7445; Yang J, 2003, CARCINOGENESIS, V24, P1571, DOI 10.1093/carcin/bgg137; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367	50	217	222	3	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6572	6583		10.1074/jbc.M707568200	http://dx.doi.org/10.1074/jbc.M707568200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18162465	hybrid			2022-12-25	WOS:000253779500063
J	Sun, X; Belouzard, S; Whittaker, GR				Sun, Xiangjie; Belouzard, Sandrine; Whittaker, Gary R.			Molecular architecture of the bipartite fusion loops of vesicular stomatitis virus glycoprotein G, a class III viral fusion protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLATHRIN-MEDIATED ENDOCYTOSIS; MEMBRANE-FUSION; TRYPTOPHAN RESIDUES; SEMLIKI-FOREST; INFLUENZA HEMAGGLUTININ; ENVELOPE GLYCOPROTEIN; CONFORMATIONAL CHANGE; CHOLESTEROL-BINDING; MUTATIONAL EVIDENCE; CRYSTAL-STRUCTURE	The glycoprotein of vesicular stomatitis virus (VSV G) mediates fusion of the viral envelope with the host cell, with the conformational changes that mediate VSV G fusion activation occurring in a reversible, low pH-dependent manner. Based on its novel structure, VSV G has been classified as class III viral fusion protein, having a predicted bipartite fusion domain comprising residues Trp-72, Tyr-73, Tyr-116, and Ala-117 that interacts with the host cell membrane to initiate the fusion reaction. Here, we carried out a systematic mutagenesis study of the predicted VSV G fusion loops, to investigate the functional role of the fusion domain. Using assays of low pH-induced cell-cell fusion and infection studies of mutant VSV G incorporated into viral particles, we show a fundamental role for the bipartite fusion domain. We show that Trp-72 is a critical residue for VSV G-mediated membrane fusion. Trp-72 could only tolerate mutation to a phenylalanine residue, which allowed only limited fusion. Tyr-73 and Tyr-116 could be mutated to other aromatic residues without major effect but could not tolerate any other substitution. Ala-117 was a less critical residue, with only charged residues unable to allow fusion activation. These data represent a functional analysis of predicted bipartite fusion loops of VSV G, a founder member of the class III family of viral fusion proteins.	[Sun, Xiangjie; Belouzard, Sandrine; Whittaker, Gary R.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14853 USA; [Sun, Xiangjie] Cornell Univ, Grad Program Microbiol, Ithaca, NY 14853 USA	Cornell University; Cornell University	Whittaker, GR (corresponding author), Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, C4127 VMC, Ithaca, NY 14853 USA.	grw7@cornell.edu	Belouzard, Sandrine/AAX-1584-2021; Sun, Xiangjie/AAP-5409-2020; Belouzard, Sandrine/O-8527-2016	Belouzard, Sandrine/0000-0002-9972-4054; Belouzard, Sandrine/0000-0002-9972-4054				Ahn A, 2002, J VIROL, V76, P3267, DOI 10.1128/JVI.76.7.3267-3275.2002; Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001; BACKOVIC M, 2007, VIROLOGY; Backovic M, 2007, J VIROL, V81, P9596, DOI 10.1128/JVI.00758-07; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Beyer WR, 2002, J VIROL, V76, P1488, DOI 10.1128/JVI.76.3.1488-1495.2002; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Carneiro FA, 2006, EUR BIOPHYS J BIOPHY, V35, P145, DOI 10.1007/s00249-005-0012-z; Carneiro FA, 2003, J BIOL CHEM, V278, P13789, DOI 10.1074/jbc.M210615200; CARR CM, 1993, CELL, V73, P823, DOI 10.1016/0092-8674(93)90260-W; Colman PM, 2003, NAT REV MOL CELL BIO, V4, P309, DOI 10.1038/nrm1076; Cronin J, 2005, CURR GENE THER, V5, P387, DOI 10.2174/1566523054546224; Da Poian AT, 2005, BRAZ J MED BIOL RES, V38, P813, DOI 10.1590/S0100-879X2005000600002; Duntsch CD, 2004, J NEUROSURG, V100, P1049, DOI 10.3171/jns.2004.100.6.1049; Durell SR, 1997, MOL MEMBR BIOL, V14, P97, DOI 10.3109/09687689709048170; DURRER P, 1995, J BIOL CHEM, V270, P17575, DOI 10.1074/jbc.270.29.17575; Earp LJ, 2005, CURR TOP MICROBIOL, V285, P25; FREDERICKSEN BL, 1995, J VIROL, V69, P1435, DOI 10.1128/JVI.69.3.1435-1443.1995; Gaudin Y, 2000, Subcell Biochem, V34, P379; HAMMOND C, 1995, CURR OPIN CELL BIOL, V7, P523, DOI 10.1016/0955-0674(95)80009-3; Han X, 2001, NAT STRUCT BIOL, V8, P715, DOI 10.1038/90434; Hannah BP, 2007, J VIROL, V81, P4858, DOI 10.1128/JVI.02755-06; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Jayakar HR, 2004, VIRUS RES, V106, P117, DOI 10.1016/j.virusres.2004.08.009; Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036; KLENK HD, 1994, COLD SPRING HARBOR M, P241; Lai AL, 2005, PROTEIN-LIPID INTERACTIONS: FROM MEMBRANE DOMAINS TO CELLULAR NETWORKS, P279; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; LEFRANCOIS L, 1983, J IMMUNOL, V130, P394; LEVYMINTZ P, 1991, J VIROL, V65, P4292, DOI 10.1128/JVI.65.8.4292-4300.1991; LI Y, 1993, J VIROL, V67, P4070, DOI 10.1128/JVI.67.7.4070-4077.1993; Lyles D, 2007, FIELDS VIROLOGY, P1364; MARSH M, 1989, ADV VIRUS RES, V36, P107, DOI 10.1016/S0065-3527(08)60583-7; Nakamura M, 1998, J BIOCHEM, V123, P1145; Norman KE, 2006, BIOPHYS J, V91, P2046, DOI 10.1529/biophysj.105.080275; Pak CC, 1997, BIOCHEMISTRY-US, V36, P8890, DOI 10.1021/bi9702851; Plassmeyer ML, 2007, VIROLOGY, V358, P273, DOI 10.1016/j.virol.2006.08.050; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; REGAN AD, 2008, VIRAL ENTRY HOST CEL; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Russell D., 2001, ENDOCYTOSIS PATHOG E, P247; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; SekinoSuzuki N, 1996, EUR J BIOCHEM, V241, P941, DOI 10.1111/j.1432-1033.1996.00941.x; Shokralla S, 1998, VIROLOGY, V242, P39, DOI 10.1006/viro.1997.8986; Steven AC, 2006, SCIENCE, V313, P177, DOI 10.1126/science.1129761; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Teissier E, 2007, EUR BIOPHYS J BIOPHY, V36, P887, DOI 10.1007/s00249-007-0201-z; Walker PJ, 1999, J GEN VIROL, V80, P1211, DOI 10.1099/0022-1317-80-5-1211; Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; White SH, 1999, ANNU REV BIOPH BIOM, V28, P319, DOI 10.1146/annurev.biophys.28.1.319; WIMLEY WC, 1992, BIOCHEMISTRY-US, V31, P12813, DOI 10.1021/bi00166a015; YAMADA S, 1986, BIOCHEMISTRY-US, V25, P3703, DOI 10.1021/bi00360a034; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; ZHANG L, 1994, J VIROL, V68, P2186, DOI 10.1128/JVI.68.4.2186-2193.1994	58	48	50	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6418	6427		10.1074/jbc.M708955200	http://dx.doi.org/10.1074/jbc.M708955200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165228	hybrid			2022-12-25	WOS:000253779500049
J	Cerpa, W; Godoy, JA; Alfaro, I; Farlas, GG; Metcalfe, MJ; Fuentealba, R; Bonansco, C; Inestrosa, NC				Cerpa, Waldo; Godoy, Juan A.; Alfaro, Ivan; Farlas, Ginny G.; Metcalfe, Maria J.; Fuentealba, Rodrigo; Bonansco, Christian; Inestrosa, Nibaldo C.			Wnt-7a modulates the synaptic vesicle cycle and synaptic transmission in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PEPTIDE NEUROTOXICITY; LONG-TERM POTENTIATION; EXCITATORY POSTSYNAPTIC CURRENTS; PAIRED-PULSE FACILITATION; SIGNALING PATHWAY; DROSOPHILA WNT; SYNAPSIN-I; PROTEIN; CATENIN; RELEASE	Wnt signaling is essential for neuronal development and the maintenance of the developing nervous system. Recent studies indicated that Wnt signaling modulates long term potentiation in adult hippocampal slices. We report here that different Wnt ligands are present in hippocampal neurons of rat embryo and adult rat, including Wnt-4, -5a, -7a, and -11. Wnt-7a acts as a canonical Wnt ligand in rat hippocampal neurons, stimulates clustering of presynaptic proteins, and induces recycling and exocytosis of synaptic vesicles as studied by FM dyes. Wnt-3a has a moderate effect on recycling of synaptic vesicles, and no effect of Wnt-1 and Wnt-5a was detected. Electrophysiological analysis on adult rat hippocampal slices indicates that Wnt-7a, but not Wnt-5a, increases neurotransmitter release in CA3-CA1 synapses by decreasing paired pulse facilitation and increasing the miniature excitatory post-synaptic currents frequency. These results indicate that the presynaptic function of rat hippocampal neurons is modulated by the canonical Wnt signaling.	[Cerpa, Waldo; Godoy, Juan A.; Alfaro, Ivan; Farlas, Ginny G.; Metcalfe, Maria J.; Fuentealba, Rodrigo; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Ctr Regul Celular & Patol Joaquin V Luco, Dept Biol Celular & Mol, Santiago 8331010, Chile; [Bonansco, Christian] Univ Valparaiso, Fac Ciencias, Dept Fisiol, Valparaiso, Chile	Pontificia Universidad Catolica de Chile; Universidad de Valparaiso	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Biomed Ctr, CRCP, Almeda 340, Santiago 8331010, Chile.	ninestrosa@bio.puc.cl	Godoy, Juan A/F-5398-2018; Cerpa, Waldo/GSI-5204-2022	Godoy, Juan A/0000-0001-9920-6698; Cerpa, Waldo/0000-0001-7344-0144; Metcalfe, Mariajose/0000-0002-5016-8739; Fuentealba, Rodrigo/0000-0001-8724-091X				Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Alvarez AR, 2004, EXP CELL RES, V297, P186, DOI 10.1016/j.yexcr.2004.02.028; ANDERSEN P, 1978, BRAIN RES, V144, P11, DOI 10.1016/0006-8993(78)90431-6; Bamji SX, 2003, NEURON, V40, P719, DOI 10.1016/S0896-6273(03)00718-9; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Bonansco C, 2003, HIPPOCAMPUS, V13, P150, DOI 10.1002/hipo.10067; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; CLARK KA, 1994, EXP BRAIN RES, V101, P272, DOI 10.1007/BF00228747; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Conroy WG, 1998, MOL PHARMACOL, V53, P392, DOI 10.1124/mol.53.3.392; Dabdoub A, 2003, DEVELOPMENT, V130, P2375, DOI 10.1242/dev.00448; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; FLETCHER TL, 1991, J NEUROSCI, V11, P1617; Fradkin LG, 2005, J NEUROSCI, V25, P10376, DOI 10.1523/JNEUROSCI.3429-05.2005; FRADKIN LG, 1995, DEV BIOL, V168, P202, DOI 10.1006/dbio.1995.1072; Fuentealba RA, 2004, BRAIN RES REV, V47, P275, DOI 10.1016/j.brainresrev.2004.07.018; Garrido JL, 2002, FASEB J, V16, P1982, DOI 10.1096/fj.02-0327fje; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Hu H, 2001, J NEUROSCI, V21, P9585, DOI 10.1523/JNEUROSCI.21-24-09585.2001; Inestrosa NC, 2002, NEUROCHEM INT, V41, P341, DOI 10.1016/S0197-0186(02)00056-6; Jope RS, 2003, TRENDS PHARMACOL SCI, V24, P441, DOI 10.1016/S0165-6147(03)00206-2; Kay AR, 1999, NEURON, V24, P809, DOI 10.1016/S0896-6273(00)81029-6; Kishida S, 2007, GENES CELLS, V12, P49, DOI 10.1111/j.1365-2443.2006.01030.x; Krylova O, 2002, NEURON, V35, P1043, DOI 10.1016/S0896-6273(02)00860-7; KUHNT U, 1994, NEUROSCIENCE, V62, P391, DOI 10.1016/0306-4522(94)90374-3; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lucas FR, 1997, DEV BIOL, V192, P31, DOI 10.1006/dbio.1997.8734; MANABE T, 1992, NATURE, V355, P50, DOI 10.1038/355050a0; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Okuda T, 2007, P NATL ACAD SCI USA, V104, P13479, DOI 10.1073/pnas.0702334104; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Scheiffele P, 2003, ANNU REV NEUROSCI, V26, P485, DOI 10.1146/annurev.neuro.26.043002.094940; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tai CY, 2007, NEURON, V54, P771, DOI 10.1016/j.neuron.2007.05.013; Tissir F, 2006, EUR J NEUROSCI, V23, P597, DOI 10.1111/j.1460-9568.2006.04596.x; WYLLIE DJA, 1994, NEURON, V12, P127, DOI 10.1016/0896-6273(94)90158-9	47	166	172	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5918	5927		10.1074/jbc.M705943200	http://dx.doi.org/10.1074/jbc.M705943200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18096705	hybrid			2022-12-25	WOS:000253426700070
J	Drake, MT; Violin, JD; Whalen, EJ; Wisler, JW; Shenoy, SK; Lefkowitz, RJ				Drake, Matthew T.; Violin, Jonathan D.; Whalen, Erin J.; Wisler, James W.; Shenoy, Sudha K.; Lefkowitz, Robert J.			beta-Arrestin-biased Agonism at the beta 2-Adrenergic Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; RESONANCE ENERGY-TRANSFER; 7-TRANSMEMBRANE RECEPTORS; ERK1/2 ACTIVATION; INVERSE AGONISTS; TRANSGENIC MICE; KINASE; BETA(2)-ADRENOCEPTOR; PHOSPHORYLATION; EFFICACY	Classically, the beta(2)-adrenergic receptor (beta(2)AR)and other members of the seven-transmembrane receptor (7TMR) superfamily activate G protein-dependent signaling pathways in response to ligand stimulus. It has recently been discovered, however, that a number of 7TMRs, including beta 2AR, can signal via beta-arrestin- dependent pathways independent of G protein activation. It is currently unclear if among beta(2)AR agonists there exist ligands that disproportionately signal via G proteins or beta-arrestins and are hence "biased." Using a variety of approaches that include highly sensitive fluorescence resonance energy transfer-based methodologies, including a novel assay for receptor internalization, we show that the majority of known beta(2)AR agonists exhibit relative efficacies for beta-arrestin- associated activities (beta-arrestin membrane translocation and beta(2)AR internalization) identical to their relative efficacies for G protein dependent signaling ( cyclic AMP generation). However, for three beta AR ligands there is a marked bias toward beta-arrestin signaling; these ligands stimulate beta-arrestin-dependent receptor activities to a much greater extent than would be expected given their efficacy for G protein-dependent activity. Structural comparison of these biased ligands reveals that all three are catecholamines containing an ethyl substitution on the alpha-carbon, a motif absent on all of the other, unbiased ligands tested. Thus, these studies demonstrate the potential for developing a novel class of 7TMR ligands with a distinct bias for beta-arrestin-mediated signaling.	[Lefkowitz, Robert J.] Duke Univ, Med Ctr, Howard Hughes Med Inst, Durham, NC 27710 USA; [Drake, Matthew T.; Violin, Jonathan D.; Whalen, Erin J.; Wisler, James W.; Shenoy, Sudha K.; Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Lefkowitz, Robert J.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University; Howard Hughes Medical Institute; Duke University; Duke University	Lefkowitz, RJ (corresponding author), Duke Univ, Med Ctr, Howard Hughes Med Inst, Box 3821, Durham, NC 27710 USA.	lefko001@receptor-biol.duke.edu	Shenoy, Sudha/AAN-4075-2021; soler, martha maricel m gomez/L-6025-2014; Lefkowitz, Robert/AAW-2649-2021	Shenoy, Sudha/0000-0002-2565-4663; soler, martha maricel m gomez/0000-0002-4412-8108; 	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL016037, R01HL070631] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NHLBI NIH HHS [R01 HL16037, R01 HL70631] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; ATTRAMADAL H, 1992, J BIOL CHEM, V267, P17882; Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; BENOVIC JL, 1988, J BIOL CHEM, V263, P3893; Berg KA, 1998, MOL PHARMACOL, V54, P94, DOI 10.1124/mol.54.1.94; BOND RA, 1995, NATURE, V374, P272, DOI 10.1038/374272a0; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; Galandrin S, 2006, MOL PHARMACOL, V70, P1575, DOI 10.1124/mol.106.026716; Gesty-Palmer D, 2006, J BIOL CHEM, V281, P10856, DOI 10.1074/jbc.M513380200; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; Granier S, 2007, J BIOL CHEM, V282, P13895, DOI 10.1074/jbc.M611904200; Holloway AC, 2002, MOL PHARMACOL, V61, P768, DOI 10.1124/mol.61.4.768; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; KENAKIN T, 1995, TRENDS PHARMACOL SCI, V16, P256, DOI 10.1016/S0165-6147(00)89037-9; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Kim J, 2005, P NATL ACAD SCI USA, V102, P1442, DOI 10.1073/pnas.0409532102; Lefkowitz RJ, 2004, CURR OPIN CELL BIOL, V16, P162, DOI 10.1016/j.ceb.2004.01.001; Lefkowitz RJ, 2006, MOL CELL, V24, P643, DOI 10.1016/j.molcel.2006.11.007; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Neubig RR, 2007, MOL PHARMACOL, V71, P1200, DOI 10.1124/mol.107.034926; Rajagopal K, 2006, P NATL ACAD SCI USA, V103, P16284, DOI 10.1073/pnas.0607583103; Ren XR, 2005, P NATL ACAD SCI USA, V102, P1448, DOI 10.1073/pnas.0409534102; Shenoy SK, 2006, J BIOL CHEM, V281, P1261, DOI 10.1074/jbc.M506576200; Tran TM, 2004, MOL PHARMACOL, V65, P196, DOI 10.1124/mol.65.1.196; Vassilatis DK, 2003, P NATL ACAD SCI USA, V100, P4903, DOI 10.1073/pnas.0230374100; Violin JD, 2008, J BIOL CHEM, V283, P2949, DOI 10.1074/jbc.M707009200; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; Violin JD, 2006, J BIOL CHEM, V281, P20577, DOI 10.1074/jbc.M513605200; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6; Wisler JW, 2007, P NATL ACAD SCI USA, V104, P16657, DOI 10.1073/pnas.0707936104; YU SS, 1993, J BIOL CHEM, V268, P337; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhai PY, 2005, J CLIN INVEST, V115, P3045, DOI 10.1172/JCI25330	38	201	208	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5669	5676		10.1074/jbc.M708118200	http://dx.doi.org/10.1074/jbc.M708118200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086673	hybrid			2022-12-25	WOS:000253426700047
J	Long, J; Gallagher, TRA; Cavey, JR; Sheppard, PW; Ralston, SH; Layfield, R; Searle, MS				Long, Jed; Gallagher, Thomas R. A.; Cavey, James R.; Sheppard, Paul W.; Ralston, Stuart H.; Layfield, Robert; Searle, Mark S.			Ubiquitin recognition by the ubiquitin-associated domain of p62 involves a novel conformational switch	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; REPAIR PROTEIN HHR23A; LYS48-LINKED POLYUBIQUITIN CHAIN; FAMILIAL EXPANSILE OSTEOLYSIS; CAUSE PAGETS-DISEASE; UBA DOMAIN; 3-DIMENSIONAL STRUCTURES; BIOMOLECULAR STRUCTURE; MULTIUBIQUITIN CHAINS; NMR-SPECTROSCOPY	The p62 protein functions as a scaffold in signaling pathways that lead to activation of NF-kappa B and is an important regulator of osteoclastogenesis. Mutations affecting the receptor activator of NF-kappa B signaling axis can result in human skeletal disorders, including those identified in the C-terminal ubiquitin-associated (UBA) domain of p62 in patients with Paget disease of bone. These observations suggest that the disease may involve a common mechanism related to alterations in the ubiquitin-binding properties of p62. The structural basis for ubiquitin recognition by the UBA domain of p62 has been investigated using NMR and reveals a novel binding mechanism involving a slow exchange structural reorganization of the UBA domain to a "bound" non-canonical UBA conformation that is not significantly populated in the absence of ubiquitin. The repacking of the three-helix bundle generates a binding surface localized around the conserved Xaa-Gly-Phe-Xaa loop that appears to optimize both hydrophobic and electrostatic surface complementarity with ubiquitin. NMR titration analysis shows that the p62-UBA binds to Lys(48)-linked di-ubiquitin with similar to 4-fold lower affinity than to mono-ubiquitin, suggesting preferential binding of the p62-UBA to single ubiquitin units, consistent with the apparent in vivo preference of the p62 protein for Lys(63)-linked polyubiquitin chains (which adopt a more open and extended structure). The conformational switch observed on binding may represent a novel mechanism that underlies specificity in regulating signal-induced protein recognition events.	[Long, Jed; Gallagher, Thomas R. A.; Searle, Mark S.] Univ Nottingham, Ctr Biomol Sci, Sch Chem, Nottingham NG7 2RD, England; [Cavey, James R.; Layfield, Robert] Univ Nottingham, Queens Med Ctr, Sch Biomed Sci, Nottingham NG7 2UH, England; [Sheppard, Paul W.] Palatine House, BIOMOL Int, Exeter EX2 8NL, Devon, England; [Ralston, Stuart H.] Univ Edinburgh, Western Gen Hosp, Rheumat Dis Unit, Edinburgh EH2 2XU, Midlothian, Scotland	University of Nottingham; University of Nottingham; University of Edinburgh	Layfield, R (corresponding author), Univ Nottingham, Ctr Biomol Sci, Sch Chem, Nottingham NG7 2RD, England.	robert.layfield@nottingham.ac.uk; mark.searle@nottingham.uk		Layfield, Robert/0000-0003-0702-3259; Searle, Mark/0000-0001-8387-9978; Cavey, James/0000-0003-4515-0515	Arthritis Research UK Funding Source: Medline; Biotechnology and Biological Sciences Research Council Funding Source: Medline; Medical Research Council Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002; Cavanagh J., 1996, PROTEIN NMR SPECTROS; Cavey JR, 2006, CALCIFIED TISSUE INT, V78, P271, DOI 10.1007/s00223-005-1299-6; Cavey JR, 2005, J BONE MINER RES, V20, P619, DOI 10.1359/JBMR.041205; Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594; Ciani B, 2003, J BIOL CHEM, V278, P37409, DOI 10.1074/jbc.M307416200; COOK WJ, 1994, J MOL BIOL, V236, P601, DOI 10.1006/jmbi.1994.1169; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dieckmann T, 1998, NAT STRUCT BIOL, V5, P1042, DOI 10.1038/4220; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; Duran A, 2004, DEV CELL, V6, P303, DOI 10.1016/S1534-5807(03)00403-9; EVANS CL, 2008, IN PRESS PROTEINS ST; Falchetti A, 2004, J BONE MINER RES, V19, P1013, DOI 10.1359/JBMR.040203; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Hocking LJ, 2004, J BONE MINER RES, V19, P1122, DOI 10.1359/JBMR.0403015; Hocking LJ, 2002, HUM MOL GENET, V11, P2735, DOI 10.1093/hmg/11.22.2735; Hofmann K, 1996, TRENDS BIOCHEM SCI, V21, P172, DOI 10.1016/0968-0004(96)30015-7; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Hughes AE, 2000, NAT GENET, V24, P45, DOI 10.1038/71667; Ishii Y, 2001, J BIOMOL NMR, V21, P141, DOI 10.1023/A:1012417721455; Johnson-Pais TL, 2003, J BONE MINER RES, V18, P1748, DOI 10.1359/jbmr.2003.18.10.1748; Kang RS, 2003, CELL, V113, P621, DOI 10.1016/S0092-8674(03)00362-3; Kanis J., 1998, PATHOPHYSIOLOGY TREA, VSecond; Kim S, 2002, NAT CELL BIOL, V4, P826, DOI 10.1038/ncb863; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Laurin N, 2002, AM J HUM GENET, V70, P1582, DOI 10.1086/340731; Mesleh MF, 2003, J AM CHEM SOC, V125, P8928, DOI 10.1021/ja034211q; Mittag T, 2006, J AM CHEM SOC, V128, P9844, DOI 10.1021/ja0616128; Mueller TD, 2004, J BIOL CHEM, V279, P11926, DOI 10.1074/jbc.M312865200; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Murphy JM, 2007, P NATL ACAD SCI USA, V104, P14336, DOI 10.1073/pnas.0703012104; NILGES M, 1988, PROTEIN ENG, V2, P27, DOI 10.1093/protein/2.1.27; NILGES M, 1988, FEBS LETT, V239, P129, DOI 10.1016/0014-5793(88)80559-3; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Piotrowski J, 1997, J BIOL CHEM, V272, P23712, DOI 10.1074/jbc.272.38.23712; Prag G, 2003, CELL, V113, P609, DOI 10.1016/S0092-8674(03)00364-7; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Raasi S, 2004, J MOL BIOL, V341, P1367, DOI 10.1016/j.jmb.2004.06.057; Raasi S, 2005, NAT STRUCT MOL BIOL, V12, P708, DOI 10.1038/nsmb962; Ryu KS, 2003, J BIOL CHEM, V278, P36621, DOI 10.1074/jbc.M304628200; Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shin J, 1998, ARCH PHARM RES, V21, P629, DOI 10.1007/BF02976748; Sloper-Mould KE, 2001, J BIOL CHEM, V276, P30483, DOI 10.1074/jbc.M103248200; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Swanson KA, 2006, J MOL BIOL, V358, P713, DOI 10.1016/j.jmb.2006.02.059; Tang C, 2005, J BIOL CHEM, V280, P11770, DOI 10.1074/jbc.M414300200; Trempe JF, 2005, EMBO J, V24, P3178, DOI 10.1038/sj.emboj.7600797; Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q; Vadlamudi RK, 1996, J BIOL CHEM, V271, P20235, DOI 10.1074/jbc.271.34.20235; Varadan R, 2005, MOL CELL, V18, P687, DOI 10.1016/j.molcel.2005.05.013; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Vaynberg J, 2006, TRENDS BIOTECHNOL, V24, P22, DOI 10.1016/j.tibtech.2005.09.006; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Walsh JD, 2005, J MAGN RESON, V174, P152, DOI 10.1016/j.jmr.2005.01.018; Walsh JP, 2004, MED J AUSTRALIA, V181, P262, DOI 10.5694/j.1326-5377.2004.tb06265.x; Walters KJ, 2003, P NATL ACAD SCI USA, V100, P12694, DOI 10.1073/pnas.1634989100; Wang QH, 2003, BIOCHEMISTRY-US, V42, P13529, DOI 10.1021/bi035391j; Whyte MP, 2002, J BONE MINER RES, V17, P26, DOI 10.1359/jbmr.2002.17.1.26; Withers-Ward ES, 2000, BIOCHEMISTRY-US, V39, P14103, DOI 10.1021/bi0017071; Yuan XM, 2004, EMBO J, V23, P1463, DOI 10.1038/sj.emboj.7600152	67	115	117	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5427	5440		10.1074/jbc.M704973200	http://dx.doi.org/10.1074/jbc.M704973200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18083707	hybrid			2022-12-25	WOS:000253426700023
J	Oliva, JL; Caino, MC; Senderowicz, AM; Kazanietz, MG				Oliva, Jose L.; Caino, M. Cecilia; Senderowicz, Adrian M.; Kazanietz, Marcelo G.			S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; VASCULAR ENDOTHELIAL-CELLS; CYCLIN-DEPENDENT KINASES; H-RAS ONCOGENE; PHORBOL ESTER; P21(WAF1/CIP1) EXPRESSION; TUMOR SUPPRESSION; MELANOMA-CELLS; MESSENGER-RNA; DNA-SYNTHESIS	Protein kinase C (PKC) has been widely implicated in positive and negative control of cell proliferation. We have recently shown that treatment of non-small cell lung cancer (NSCLC) cells with phorbol 12-myristate 13-acetate (PMA) during G(1) phase inhibits the progression into S phase, an effect mediated by PKC delta-induced up-regulation of the cell cycle inhibitor p21(Cip1). However, PMA treatment in asynchronously growing NSCLC cells leads to accumulation of cells in G(2)/M. Studies in post-G(1) phases revealed that PMA induced an irreversible G(2)/M cell cycle arrest in NSCLC cells and conferred morphological and biochemical features of senescence, including elevated SA-beta-Gal activity and reduced telomerase activity. Remarkably, this effect was phase-specific, as it occurred only when PKC was activated in S, but not in G(1) phase. Mechanistic analysis revealed a crucial role for the classical PKC alpha isozyme as mediator of the G(2)/M arrest and senescence, as well as for inducing p21(Cip1) an obligatory event for conferring the senescence phenotype. In addition to the unappreciated role of PKC isozymes, and specifically PKC alpha, in senescence, our data introduce the paradigm that discrete PKCs trigger distinctive responses when activated in different phases of the cell cycle via a common mechanism that involves p21(Cip1) up-regulation.	[Kazanietz, Marcelo G.] Univ Penn, Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Oliva, Jose L.; Caino, M. Cecilia; Kazanietz, Marcelo G.] Univ Penn, Sch Med, Inst Translat Med & Therapeut, Dept Pharmacol, Philadelphia, PA 19104 USA; [Oliva, Jose L.; Senderowicz, Adrian M.] CDER, Food & Drug Adm, Silver Spring, MD 20993 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; US Food & Drug Administration (FDA)	Oliva, JL (corresponding author), Ctr Nacl Microbiol Virol & Inmunol Sanitarias Maja, Inst Salud Carlos III, Unidad Biol Celular, Carretera Majadahonda Pozuelo,Km 2 Majahonda, Madrid 28220, Spain.	jloliva@isciii.es; marcelo@spirit.gcrc.upenn.edu			NATIONAL CANCER INSTITUTE [R01CA089202, P01CA092537] Funding Source: NIH RePORTER; NCI NIH HHS [CA-92537, CA-89202] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akashi M, 1999, BIOCHEM J, V337, P607, DOI 10.1042/0264-6021:3370607; Arita Y, 1998, EXP CELL RES, V242, P381, DOI 10.1006/excr.1997.3911; Barboule N, 1999, FEBS LETT, V444, P32, DOI 10.1016/S0014-5793(99)00022-8; Barry OP, 2001, CURR PHARM DESIGN, V7, P1725, DOI 10.2174/1381612013397041; Caloca MJ, 1997, J BIOL CHEM, V272, P26488, DOI 10.1074/jbc.272.42.26488; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Cozzi SJ, 2006, CANCER RES, V66, P10083, DOI 10.1158/0008-5472.CAN-06-0348; Dangi S, 2006, CELL PROLIFERAT, V39, P261, DOI 10.1111/j.1365-2184.2006.00388.x; Deng WG, 2007, CANCER RES, V67, P709, DOI 10.1158/0008-5472.CAN-06-3463; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Doller A, 2007, MOL BIOL CELL, V18, P2137, DOI 10.1091/mbc.E06-09-0850; Esposito F, 1997, EUR J BIOCHEM, V245, P730, DOI 10.1111/j.1432-1033.1997.00730.x; Facchinetti MM, 2004, CANCER RES, V64, P3629, DOI 10.1158/0008-5472.CAN-03-3741; Fishman DD, 1998, INT J ONCOL, V12, P181; Fong KM, 2003, THORAX, V58, P892, DOI 10.1136/thorax.58.10.892; Frey MR, 1997, J BIOL CHEM, V272, P9424; Fujii T, 2000, J BIOL CHEM, V275, P7574, DOI 10.1074/jbc.275.11.7574; Garcia-Bermejo ML, 2002, J BIOL CHEM, V277, P645, DOI 10.1074/jbc.M107639200; Gavrielides MV, 2004, CURR DRUG TARGETS, V5, P431, DOI 10.2174/1389450043345380; Giles KM, 2003, J BIOL CHEM, V278, P2937, DOI 10.1074/jbc.M208439200; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Guadagno TM, 1996, CELL, V84, P73, DOI 10.1016/S0092-8674(00)80994-0; Han ZT, 1998, P NATL ACAD SCI USA, V95, P5362, DOI 10.1073/pnas.95.9.5362; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HSIAO WLW, 1989, MOL CELL BIOL, V9, P2641, DOI 10.1128/MCB.9.6.2641; Kashiwagi M, 2000, ONCOGENE, V19, P6334, DOI 10.1038/sj.onc.1204028; Khan QA, 2001, TOXICOL APPL PHARM, V173, P105, DOI 10.1006/taap.2001.9172; Kosaka C, 1996, AM J PHYSIOL-CELL PH, V270, pC170, DOI 10.1152/ajpcell.1996.270.1.C170; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; LACAL JC, 1987, MOL CELL BIOL, V7, P4146, DOI 10.1128/MCB.7.11.4146; Liu Y, 1996, CANCER RES, V56, P31; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Marquez VE, 2003, ACCOUNTS CHEM RES, V36, P434, DOI 10.1021/ar020124b; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Nakagawa M, 2005, J BIOL CHEM, V280, P33926, DOI 10.1074/jbc.M505748200; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Ohba M, 1998, MOL CELL BIOL, V18, P5199, DOI 10.1128/MCB.18.9.5199; Ostrovsky O, 2003, J BIOL CHEM, V278, P21221, DOI 10.1074/jbc.M211357200; Paz-Ares L, 2006, J CLIN ONCOL, V24, P1428, DOI 10.1200/JCO.2005.04.3299; Roninson IB, 2003, CANCER RES, V63, P2705; Russo M, 2003, ONCOGENE, V22, P3330, DOI 10.1038/sj.onc.1206493; Schiller JH, 2001, ONCOLOGY-BASEL, V61, P1, DOI 10.1159/000055385; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Soh JW, 2003, J BIOL CHEM, V278, P34709, DOI 10.1074/jbc.M302016200; Strair RK, 2002, CLIN CANCER RES, V8, P2512; te Poele RH, 2002, CANCER RES, V62, P1876; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Wu WS, 2006, CANCER LETT, V239, P27, DOI 10.1016/j.canlet.2005.07.034; Zeng YX, 1996, ONCOGENE, V12, P1557; Zhou BBS, 2000, NATURE, V408, P433, DOI 10.1038/35044005; Zhou BHP, 2001, NAT CELL BIOL, V3, P245, DOI 10.1038/35060032; ZHOU W, 1993, J BIOL CHEM, V268, P23041; Zou YY, 1998, J NATL CANCER I, V90, P1130, DOI 10.1093/jnci/90.15.1130	55	44	46	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5466	5476		10.1074/jbc.M707576200	http://dx.doi.org/10.1074/jbc.M707576200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18162471	hybrid			2022-12-25	WOS:000253426700027
J	Wiener, R; Haitin, Y; Shamgar, L; Fernandez-Alonso, MC; Martos, A; Chomsky-Hecht, O; Rivas, G; Attali, B; Hirsch, JA				Wiener, Reuven; Haitin, Yoni; Shamgar, Liora; Fernandez-Alonso, M. Carmen; Martos, Ariadna; Chomsky-Hecht, Orna; Rivas, German; Attali, Bernard; Hirsch, Joel A.			The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit assembly and protein interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELICAL COILED-COILS; POTASSIUM CHANNELS; K+ CHANNEL; MACROMOLECULAR STRUCTURES; CRYSTAL-STRUCTURE; CALMODULIN; DOMAIN; ULTRACENTRIFUGATION; MODULATION; TETRAMERIZATION	The Kv7 subfamily of voltage-dependent potassium channels, distinct from other subfamilies by dint of its large intracellular COOH terminus, acts to regulate excitability in cardiac and neuronal tissues. KCNQ1 (Kv7.1), the founding subfamily member, encodes a channel subunit directly implicated in genetic disorders, such as the long QT syndrome, a cardiac pathology responsible for arrhythmias. We have used a recombinant protein preparation of the COOH terminus to probe the structure and function of this domain and its individual modules. The COOH-terminal proximal half associates with one calmodulin constitutively bound to each subunit where calmodulin is critical for proper folding of the whole intracellular domain. The distal half directs tetramerization, employing tandem coiled-coils. The first coiled-coil complex is dimeric and undergoes concentration dependent self-association to form a dimer of dimers. The outer coiled-coil is parallel tetrameric, the details of which have been elucidated based on 2.0 angstrom crystallographic data. Both coiled-coils act in a coordinate fashion to mediate the formation and stabilization of the tetrameric distal half. Functional studies, including characterization of structure-based and long QT mutants, prove the requirement for both modules and point to complex roles for these modules, including folding, assembly, trafficking, and regulation.	[Wiener, Reuven; Martos, Ariadna; Chomsky-Hecht, Orna; Hirsch, Joel A.] Fac Life Sci, Daniella Rich Inst Struct Biol, Dept Biochem, Tel Aviv, Israel; [Haitin, Yoni; Shamgar, Liora; Attali, Bernard] Tel Aviv Univ, Fac Med, Dept Physiol & Pharmacol, IL-69978 Ramat Aviv, Israel; [Fernandez-Alonso, M. Carmen; Rivas, German] CSIC, CIB, E-28040 Madrid, Spain	Tel Aviv University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Hirsch, JA (corresponding author), Tel Aviv Univ, Fac Life Sci, Dept Biochem, IL-69978 Ramat Aviv, Israel.	jhirsch@post.tau.ac.il	Rivas, German/AFL-7528-2022; Haitin, Yoni/AAQ-4571-2021; Hirsch, Joel/AAC-8000-2021; Rivas, German/AAG-7458-2022	Rivas, German/0000-0003-3450-7478; Haitin, Yoni/0000-0002-1648-6792; Hirsch, Joel/0000-0001-7544-8668; Rivas, German/0000-0003-3450-7478				Abbott G W, 2001, Mol Interv, V1, P95; Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Bixby KA, 1999, NAT STRUCT BIOL, V6, P38; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cole JL, 2004, METHOD ENZYMOL, V384, P212; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; Ducros V, 1998, NAT STRUCT BIOL, V5, P310, DOI 10.1038/nsb0498-310; Fleming PJ, 2000, J MOL BIOL, V299, P487, DOI 10.1006/jmbi.2000.3750; Gamper N, 2005, MOL BIOL CELL, V16, P3538, DOI 10.1091/mbc.E04-09-0849; Gamper N, 2003, J NEUROSCI, V23, P84; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; Jenke M, 2003, EMBO J, V22, P395, DOI 10.1093/emboj/cdg035; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Jentsch TJ, 2004, NAT CELL BIOL, V6, P1039, DOI 10.1038/ncb1104-1039; Kammerer RA, 1998, P NATL ACAD SCI USA, V95, P13419, DOI 10.1073/pnas.95.23.13419; Kanki H, 2004, J BIOL CHEM, V279, P33976, DOI 10.1074/jbc.M404539200; Kass RS, 2003, TRENDS CARDIOVAS MED, V13, P52, DOI 10.1016/S1050-1738(02)00211-6; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Lee DL, 2001, J MOL BIOL, V306, P539, DOI 10.1006/jmbi.2000.4351; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; Mason JM, 2006, P NATL ACAD SCI USA, V103, P8989, DOI 10.1073/pnas.0509880103; Minton A.P., 1994, MODERN ANAL ULTRACEN, P81; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rivas G, 1999, METHODS, V19, P194, DOI 10.1006/meth.1999.0851; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Robinson JM, 2005, NEURON, V45, P223, DOI 10.1016/j.neuron.2004.12.043; Schmitt N, 2000, EMBO J, V19, P332, DOI 10.1093/emboj/19.3.332; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; van Holde K. E., 1986, PHYSICAL BIOCH, P110; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; WAXMAN E, 1993, BIOCHEMISTRY-US, V32, P3005, DOI 10.1021/bi00063a011; Wen H, 2002, J NEUROSCI, V22, P7991, DOI 10.1523/jneurosci.22-18-07991.2002; Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zerangue N, 2000, P NATL ACAD SCI USA, V97, P3591, DOI 10.1073/pnas.060016797	47	102	105	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5815	5830		10.1074/jbc.M707541200	http://dx.doi.org/10.1074/jbc.M707541200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165683	Green Published, hybrid			2022-12-25	WOS:000253426700062
J	Gamsjaeger, R; Swanton, MK; Kobus, FJ; Lehtomaki, E; Lowry, JA; Kwan, AH; Matthews, JM; Mackay, JP				Gamsjaeger, Roland; Swanton, Michael K.; Kobus, Felix J.; Lehtomaki, Eija; Lowry, Jason A.; Kwan, Ann H.; Matthews, Jacqueline M.; Mackay, Joel P.			Structural and biophysical analysis of the DNA binding properties of myelin transcription factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR STRUCTURE CALCULATION; ZINC-FINGER; OLIGODENDROCYTE LINEAGE; PROTEIN STRUCTURES; ESCHERICHIA-COLI; HISTONE H3K4ME3; NERVOUS-SYSTEM; RECOGNITION; FAMILY; DOCKING	Zinc binding domains, or zinc fingers (ZnFs), form one of the most numerous and most diverse superclasses of protein structural motifs in eukaryotes. Although our understanding of the functions of several classes of these domains is relatively well developed, we know much less about the molecular mechanisms of action of many others. Myelin transcription factor 1 (MyT1) type ZnFs are found in organisms as diverse as nematodes and mammals and are found in a range of sequence contexts. MyT1, one of the early transcription factors expressed in the developing central nervous system, contains seven MyT1 ZnFs that are very highly conserved both within the protein and between species. We have used a range of biophysical techniques, including NMR spectroscopy and data-driven macromolecular docking, to investigate the structural basis for the interaction between MyT1 ZnFs and DNA. Our data indicate that MyT1 ZnFs recognize the major groove of DNA in a way that appears to differ from other known zinc binding domains.	[Gamsjaeger, Roland; Swanton, Michael K.; Kobus, Felix J.; Lehtomaki, Eija; Lowry, Jason A.; Kwan, Ann H.; Matthews, Jacqueline M.; Mackay, Joel P.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia	University of Sydney	Mackay, JP (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Bldg G08, Sydney, NSW 2006, Australia.	j.mackay@mmb.usyd.edu.au	Matthews, Jacqueline/A-7322-2013; Mackay, Joel/D-6834-2011	Kwan, Ann/0000-0002-1506-2226; Gamsjaeger, Roland/0000-0003-1095-2569; Matthews, Jacqueline/0000-0001-8518-3472; Mackay, Joel/0000-0001-7508-8033				Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Bellefroid EJ, 1996, CELL, V87, P1191, DOI 10.1016/S0092-8674(00)81815-2; Berkovits-Cymet HJ, 2004, BIOCHEMISTRY-US, V43, P898, DOI 10.1021/bi035159d; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; EDISON AS, 1994, J BIOMOL NMR, V4, P543, DOI 10.1007/BF00156619; Flanagan JF, 2005, NATURE, V438, P1181, DOI 10.1038/nature04290; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Iwahara J, 2001, J BIOMOL NMR, V19, P231, DOI 10.1023/A:1011296112710; Jandrig B, 2004, ONCOGENE, V23, P9295, DOI 10.1038/sj.onc.1208131; Jiang YH, 1996, J BIOL CHEM, V271, P10723, DOI 10.1074/jbc.271.18.10723; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kalodimos CG, 2002, EMBO J, V21, P2866, DOI 10.1093/emboj/cdf318; Kamphuis MB, 2006, J MOL BIOL, V357, P115, DOI 10.1016/j.jmb.2005.12.033; Kim JG, 1997, J NEUROSCI RES, V50, P272, DOI 10.1002/(SICI)1097-4547(19971015)50:2<272::AID-JNR16>3.0.CO;2-A; KIM JG, 1992, MOL CELL BIOL, V12, P5632, DOI 10.1128/MCB.12.12.5632; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Kowalski K, 2002, J BIOL CHEM, V277, P35720, DOI 10.1074/jbc.M204663200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Linge JP, 2003, BIOINFORMATICS, V19, P315, DOI 10.1093/bioinformatics/19.2.315; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; Lu XJ, 2003, NUCLEIC ACIDS RES, V31, P5108, DOI 10.1093/nar/gkg680; Macke T., 1998, MODELING UNUSUAL NUC; Matsushita F, 2002, MECH DEVELOP, V118, P209, DOI 10.1016/S0925-4773(02)00250-2; NEUHAUS D, 1992, J MOL BIOL, V228, P637, DOI 10.1016/0022-2836(92)90846-C; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; PELTON JG, 1993, PROTEIN SCI, V2, P543; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Romm E, 2005, J NEUROCHEM, V93, P1444, DOI 10.1111/j.1471-4159.2005.03131.x; Rubin GM, 2000, SCIENCE, V287, P2204, DOI 10.1126/science.287.5461.2204; SEAVEY B R, 1991, Journal of Biomolecular NMR, V1, P217, DOI 10.1007/BF01875516; Simpson RJY, 2003, J BIOL CHEM, V278, P28011, DOI 10.1074/jbc.M211146200; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; van Dijk ADJ, 2006, BIOINFORMATICS, V22, P2340, DOI 10.1093/bioinformatics/btl395; van Dijk M, 2006, NUCLEIC ACIDS RES, V34, P3317, DOI 10.1093/nar/gkl412; WOLF P, 1983, ANAL BIOCHEM, V129, P145, DOI 10.1016/0003-2697(83)90062-3; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yee KSY, 1998, J BIOL CHEM, V273, P5366, DOI 10.1074/jbc.273.9.5366; Zhang XX, 2006, J BIOL CHEM, V281, P8296, DOI 10.1074/jbc.M512015200	50	27	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5158	5167		10.1074/jbc.M703772200	http://dx.doi.org/10.1074/jbc.M703772200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18073212	hybrid			2022-12-25	WOS:000253426500073
J	Nishihara, T; Nagawa, F; Imai, T; Sakano, H				Nishihara, Tadashi; Nagawa, Fumikiyo; Imai, Takeshi; Sakano, Hitoshi			RAG-heptamer interaction in the synaptic complex is a crucial biochemical checkpoint for the 12/23 recombination rule	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAIRPIN FORMATION STEP; SINGLE ACTIVE-SITE; C-TERMINAL REGION; V(D)J RECOMBINATION; SIGNAL SEQUENCES; IN-VITRO; STRUCTURE REQUIREMENTS; SOMATIC RECOMBINATION; FOOTPRINT ANALYSIS; IMMUNE-SYSTEM	In V(D) J recombination, the RAG1 and RAG2 protein complex cleaves the recombination signal sequences (RSSs), generating a hairpin structure at the coding end. The cleavage occurs only between two RSSs with different spacer lengths of 12 and 23 bp. Here we report that in the synaptic complex, recombination-activating gene (RAG) proteins interact with the 7-mer and unstack the adjacent base in the coding region. We generated a RAG1 mutant that exhibits reduced RAG-7-mer interaction, unstacking of the coding base, and hairpin formation. Mutation of the 23-RSS at the first position of the 7-mer, which has been reported to impair the cleavage of the partner 12-RSS, demonstrated phenotypes similar to those of the RAG1 mutant; the RAG interaction and base unstacking in the partner 12-RSS are reduced. We propose that the RAG-7-mer interaction is a critical step for coding DNA distortion and hairpin formation in the context of the 12/23 rule.	[Nishihara, Tadashi; Nagawa, Fumikiyo; Imai, Takeshi; Sakano, Hitoshi] Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, Tokyo 1130032, Japan	University of Tokyo	Sakano, H (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biochem & Biophys, Bunkyo Ku, 2-11-16 Yayoi, Tokyo 1130032, Japan.	sakano@mail.ecc.u-tokyo.ac.jp	Imai, Takeshi/L-2201-2013	Imai, Takeshi/0000-0002-8449-0080				Agrawal A, 1998, NATURE, V394, P744, DOI 10.1038/29457; Akamatsu Y, 1998, MOL CELL BIOL, V18, P4670, DOI 10.1128/MCB.18.8.4670; AKIRA S, 1987, SCIENCE, V238, P1134, DOI 10.1126/science.3120312; Cannon JP, 2004, IMMUNOL REV, V200, P12, DOI 10.1111/j.0105-2896.2004.00166.x; Chatterji M, 2006, MOL CELL BIOL, V26, P1558, DOI 10.1128/MCB.26.4.1558-1568.2006; Ciubotaru M, 2004, MOL CELL BIOL, V24, P8727, DOI 10.1128/MCB.24.19.8727-8744.2004; Ciubotaru M, 2007, MOL CELL BIOL, V27, P4745, DOI 10.1128/MCB.00177-07; Clatworthy AE, 2003, MOL CELL, V12, P489, DOI 10.1016/S1097-2765(03)00305-8; Cuomo CA, 1996, MOL CELL BIOL, V16, P5683; Curry JD, 2005, NAT IMMUNOL, V6, P1272, DOI 10.1038/ni1270; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; De P, 2004, IMMUNOL REV, V200, P70, DOI 10.1111/j.0105-2896.2004.00154.x; Difilippantonio MJ, 1996, CELL, V87, P253, DOI 10.1016/S0092-8674(00)81343-4; Eason DD, 2004, SEMIN IMMUNOL, V16, P215, DOI 10.1016/j.smim.2004.08.001; Eastman QM, 1997, NUCLEIC ACIDS RES, V25, P4370, DOI 10.1093/nar/25.21.4370; Eastman QM, 1996, NATURE, V380, P85, DOI 10.1038/380085a0; Eastman QM, 1999, MOL CELL BIOL, V19, P3788; Fugmann SD, 2006, P NATL ACAD SCI USA, V103, P3728, DOI 10.1073/pnas.0509720103; Fugmann SD, 2000, MOL CELL, V5, P97, DOI 10.1016/S1097-2765(00)80406-2; Grundy GJ, 2007, P NATL ACAD SCI USA, V104, P3078, DOI 10.1073/pnas.0611293104; Hiom K, 1998, CELL, V94, P463, DOI 10.1016/S0092-8674(00)81587-1; Hiom K, 1997, CELL, V88, P65, DOI 10.1016/S0092-8674(00)81859-0; Hiom K, 1998, MOL CELL, V1, P1011, DOI 10.1016/S1097-2765(00)80101-X; Jones JM, 2004, IMMUNOL REV, V200, P233, DOI 10.1111/j.0105-2896.2004.00168.x; Jones JM, 2002, EMBO J, V21, P4162, DOI 10.1093/emboj/cdf394; Kale SB, 2001, MOL CELL BIOL, V21, P459, DOI 10.1128/MCB.21.2.459-466.2001; Kapitonov VV, 2005, PLOS BIOL, V3, P998, DOI 10.1371/journal.pbio.0030181; Kim DR, 1998, MOL CELL BIOL, V18, P4679, DOI 10.1128/MCB.18.8.4679; Kim DR, 1999, GENE DEV, V13, P3070, DOI 10.1101/gad.13.23.3070; Kriatchko AN, 2006, MOL CELL BIOL, V26, P4712, DOI 10.1128/MCB.02487-05; Landree MA, 2001, MOL CELL BIOL, V21, P4256, DOI 10.1128/MCB.21.13.4256-4264.2001; Lu CP, 2006, NAT STRUCT MOL BIOL, V13, P1010, DOI 10.1038/nsmb1154; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; Messier TL, 2003, EMBO J, V22, P1381, DOI 10.1093/emboj/cdg137; Mo XM, 1999, J BIOL CHEM, V274, P7025, DOI 10.1074/jbc.274.11.7025; Mo XM, 2001, MOL CELL BIOL, V21, P2038, DOI 10.1128/MCB.21.6.2038-2047.2001; Mundy CL, 2002, MOL CELL BIOL, V22, P69, DOI 10.1128/MCB.22.1.69-77.2002; Nagawa F, 2004, J BIOL CHEM, V279, P38360, DOI 10.1074/jbc.M405485200; Nagawa F, 2002, MOL CELL BIOL, V22, P7217, DOI 10.1128/MCB.22.20.7217-7225.2002; Nagawa F, 1998, MOL CELL BIOL, V18, P655, DOI 10.1128/MCB.18.1.655; Neiditch MB, 2002, MOL CELL, V9, P871, DOI 10.1016/S1097-2765(02)00494-X; Nishihara T, 2004, MOL CELL BIOL, V24, P3692, DOI 10.1128/MCB.24.9.3692-3702.2004; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Peak MM, 2003, J BIOL CHEM, V278, P18235, DOI 10.1074/jbc.M302041200; Ramsden DA, 1996, EMBO J, V15, P3197, DOI 10.1002/j.1460-2075.1996.tb00682.x; Reddy YVR, 2006, GENE DEV, V20, P1575, DOI 10.1101/gad.1432706; SAKANO H, 1979, NATURE, V280, P288, DOI 10.1038/280288a0; SAKANO H, 1980, NATURE, V286, P676, DOI 10.1038/286676a0; Santagata S, 1999, MOL CELL, V4, P935, DOI 10.1016/S1097-2765(00)80223-3; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Spanopoulou E, 1996, CELL, V87, P263, DOI 10.1016/S0092-8674(00)81344-6; Swanson PC, 2002, MOL CELL BIOL, V22, P7790, DOI 10.1128/MCB.22.22.7790-7801.2002; Swanson PC, 1998, IMMUNITY, V9, P115, DOI 10.1016/S1074-7613(00)80593-2; Swanson PC, 2001, MOL CELL BIOL, V21, P449, DOI 10.1128/MCB.21.2.449-458.2001; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Tsai CL, 2003, EMBO J, V22, P1922, DOI 10.1093/emboj/cdg185; vanGent DC, 1996, CELL, V85, P107, DOI 10.1016/S0092-8674(00)81086-7; VANGENT DC, 1995, CELL, V81, P925, DOI 10.1016/0092-8674(95)90012-8; vanGent DC, 1996, SCIENCE, V271, P1592, DOI 10.1126/science.271.5255.1592; West RB, 1998, MOL CELL BIOL, V18, P6408, DOI 10.1128/MCB.18.11.6408; Yu KF, 2000, MOL CELL BIOL, V20, P7914, DOI 10.1128/MCB.20.21.7914-7921.2000	62	8	8	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4877	4885		10.1074/jbc.M709890200	http://dx.doi.org/10.1074/jbc.M709890200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089566	hybrid			2022-12-25	WOS:000253426500045
J	Perez, TD; Tamada, M; Sheetz, MP; Nelson, WJ				Perez, Tomas D.; Tamada, Masako; Sheetz, Michael P.; Nelson, W. James			Immediate-early signaling induced by E-cadherin engagement and adhesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL ADHESION; SINGLE-PARTICLE TRACKING; RHO-FAMILY GTPASES; PHOSPHATIDYLINOSITOL 3-KINASE; CONTACT FORMATION; BETA-CATENIN; FLUORESCENT PROTEIN; MEMBRANE ADHESION; EPITHELIAL-CELLS; RAC	Epithelial cell-cell interactions require localized adhesive interactions between E-cadherin on opposing membranes and the activation of downstream signaling pathways that affect membrane and actin dynamics. However, it is not known whether E-cadherin engagement and activation of these signaling pathways are locally coordinated or whether signaling is sustained or locally down-regulated like other receptor-mediated pathways. To obtain high spatiotemporal resolution of immediate early signaling events upon E-cadherin engagement, we used laser tweezers to place beads coated with functional E-cadherin extracellular domain on cells. We show that cellular E-cadherin accumulated rapidly around beads, reaching a sustained plateau level in 1-3 min. Phosphoinositides and Rac1 co-accumulated with E-cadherin, reached peak levels with E-cadherin, but then rapidly dispersed. Both E-cadherin and Rac1 accumulated independently of Rac1 GTP binding/hydrolysis, but these activities were required for Rac1 dispersal. E-cadherin accumulation was dependent on membrane dynamics and actin polymerization, but actin did not stably co-accumulate with E-cadherin; mathematical modeling showed that diffusion-mediated trapping could account for the initial E-cadherin accumulation. We propose that initial E-cadherin accumulation requires active membrane dynamics and involves diffusion-mediated trapping at contact sites; to propagate further contacts, phosphatidylinositol 3-kinase and Rac1 are transiently activated by E-cadherin engagement and initiate a new round of membrane dynamics, but they are subsequently suppressed at that site to allow maintenance of weak E-cadherin mediated adhesion.	[Perez, Tomas D.; Nelson, W. James] Stanford Univ, James H Clark Ctr, Bio X Program, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA; [Nelson, W. James] Stanford Univ, Dept Biol Sci, Stanford, CA 94305 USA; [Tamada, Masako; Sheetz, Michael P.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA	Stanford University; Stanford University; Columbia University	Nelson, WJ (corresponding author), Stanford Univ, James H Clark Ctr, Bio X Program, Dept Mol & Cellular Physiol, 318 Campus Dr,E200-B, Stanford, CA 94305 USA.	wjnelson@stanford.edu			Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R37 GM035527, GM35527, R01 GM035527] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035527, R37GM035527] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1996, J CELL BIOCHEM, V61, P514, DOI 10.1002/(SICI)1097-4644(19960616)61:4<514::AID-JCB4>3.0.CO;2-R; Adams CL, 1998, J CELL BIOL, V142, P1105, DOI 10.1083/jcb.142.4.1105; Adams CL, 1996, J CELL BIOL, V135, P1899, DOI 10.1083/jcb.135.6.1899; Betson M, 2002, J BIOL CHEM, V277, P36962, DOI 10.1074/jbc.M207358200; Braga VMM, 1997, J CELL BIOL, V137, P1421, DOI 10.1083/jcb.137.6.1421; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Drees Frauke, 2004, V294, P303; Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7; Ehrlich JS, 2002, DEV CELL, V3, P259, DOI 10.1016/S1534-5807(02)00216-2; Fukata M, 1999, J BIOL CHEM, V274, P26044, DOI 10.1074/jbc.274.37.26044; Goodwin M, 2003, J BIOL CHEM, V278, P20533, DOI 10.1074/jbc.M213171200; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Kovacs EM, 2002, CURR BIOL, V12, P379, DOI 10.1016/S0960-9822(02)00661-9; Kovacs EM, 2002, J BIOL CHEM, V277, P6708, DOI 10.1074/jbc.M109640200; Kraemer A, 2007, AM J PHYSIOL-CELL PH, V292, pC1061, DOI 10.1152/ajpcell.00073.2006; KUSUMI A, 1993, BIOPHYS J, V65, P2021, DOI 10.1016/S0006-3495(93)81253-0; Lambert M, 2002, J CELL BIOL, V157, P469, DOI 10.1083/jcb.200107104; Lambert M, 2000, J CELL SCI, V113, P2207; Malliri A, 2004, J BIOL CHEM, V279, P30092, DOI 10.1074/jbc.M401192200; Michiels F, 1997, J CELL BIOL, V137, P387, DOI 10.1083/jcb.137.2.387; Nakagawa M, 2001, J CELL SCI, V114, P1829; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Noren NK, 2001, J BIOL CHEM, V276, P33305, DOI 10.1074/jbc.C100306200; Pece S, 1999, J BIOL CHEM, V274, P19347, DOI 10.1074/jbc.274.27.19347; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; RIMM DL, 1995, P NATL ACAD SCI USA, V92, P8813, DOI 10.1073/pnas.92.19.8813; Sako Y, 1998, J CELL BIOL, V140, P1227, DOI 10.1083/jcb.140.5.1227; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Singh S., 1976, Sugarcane Pathologists' Newsletter, P1; Takaishi K, 1997, J CELL BIOL, V139, P1047, DOI 10.1083/jcb.139.4.1047; TAKEICHI M, 1991, SCIENCE, V251, P1451, DOI 10.1126/science.2006419; Thoumine O, 2005, BIOPHYS J, V89, pL40, DOI 10.1529/biophysj.105.071688; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Vasioukhin V, 2000, CELL, V100, P209, DOI 10.1016/S0092-8674(00)81559-7; Woodfield RJ, 2001, BIOCHEM J, V360, P335, DOI 10.1042/0264-6021:3600335; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yamada S, 2007, J CELL BIOL, V178, P517, DOI 10.1083/jcb.200701058; Yap AS, 1997, CURR BIOL, V7, P308, DOI 10.1016/S0960-9822(06)00154-0; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049	41	78	80	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5014	5022		10.1074/jbc.M705209200	http://dx.doi.org/10.1074/jbc.M705209200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089563	hybrid, Green Accepted			2022-12-25	WOS:000253426500059
J	Tanimoto, A; Murata, Y; Wang, KY; Tsutsui, M; Kohno, K; Sasaguri, Y				Tanimoto, Akihide; Murata, Yoshitaka; Wang, Ke-Yong; Tsutsui, Masato; Kohno, Kimitoshi; Sasaguri, Yasuyuki			Monocyte chemoattractant protein-1 expression is enhanced by granulocyte-macrophage colony-stimulating factor via jak2-stat5 signaling and inhibited by atorvastatin in human monocytic U937 cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CHEMOKINE RECEPTOR EXPRESSION; MESSENGER-RNA STABILITY; GM-CSF; GENE-EXPRESSION; GROWTH-FACTOR; BINDING PROTEIN; FLOW CONDITIONS; RHO GTPASE; IN-VITRO	The proinflammatory cytokine granulocyte-macrophage colonystimulating factor (GM-CSF) is expressed in inflammatory and atherosclerotic lesions. GM-CSF is known to enhance monocytic expression of monocyte chemoattractant protein-1 (MCP-1). However, the molecular mechanism(s) by which GMCSF up-regulates the MCP-1 expression remains to be clarified. Thus, in this study, we examined our hypothesis that GM-CSF up-regulates the MCP-1 expression via Jak2-Stat5 signaling pathway. In human monocytic cell line U937, GM-CSF increased MCP-1 expression in protein and mRNA levels. Furthermore, analysis of the GM-CSF promoter element revealed that the STAT5 (signal transducer and activator of transcription5) transcription factor binding site, located between-152 and -144 upstream of the transcription start site, as well as Janus kinase-2-mediated Stat5 activation were necessary for the GM-CSF-induced transcriptional up-regulation of the MCP-1 gene. This GM-CSF-induced MCP-1 expression, measured as both protein and mRNA levels, was down-regulated by atorvastatin, a 3-hydroxy-3-methylglutaryl-CoA reductase inhibitor. However, this decrease in MCP-1 expression was not at the transcriptional level of MCP-1 gene but rather at the level of the stability of MCP-1 mRNA. These results indicate that GM-CSF regulates MCP-1 expression via Janus kinase-2-Stat5 pathway and by a novel regulatory mechanism of statins to reduce inflammatory reactions by down-regulating the expression of monocytic MCP-1, which promotes atherogenesis.	[Tanimoto, Akihide; Wang, Ke-Yong; Sasaguri, Yasuyuki] Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Tsutsui, Masato] Univ Occupat & Environm Hlth, Sch Med, Dept Pharmacol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Kohno, Kimitoshi] Univ Occupat & Environm Hlth, Sch Med, Dept Mol Biol, Yahatanishi Ku, Kitakyushu, Fukuoka 8078555, Japan; [Murata, Yoshitaka] Kyurin Corp, Kyurin Omtest Lab Dept, Yahatanishi Ku, Kitakyushu, Fukuoka 8060046, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Tanimoto, A (corresponding author), Univ Occupat & Environm Hlth, Sch Med, Dept Pathol & Cell Biol, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	aki@med.uoeh-u.ac.jp		wang, ke-yong/0000-0001-8295-1229				Ascer E, 2004, ATHEROSCLEROSIS, V177, P161, DOI 10.1016/j.atherosclerosis.2004.07.003; Biswas P, 1998, BLOOD, V91, P258, DOI 10.1182/blood.V91.1.258.258_258_265; Bogdanov VY, 1998, J BIOL CHEM, V273, P24932, DOI 10.1074/jbc.273.38.24932; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Calabro P, 2005, CURR OPIN CARDIOL, V20, P541, DOI 10.1097/01.hco.0000181482.99067.bf; Chen YM, 2004, J PHARMACOL EXP THER, V309, P978, DOI 10.1124/jpet.103.062620; Choi EK, 2004, FEBS LETT, V559, P141, DOI 10.1016/S0014-5793(04)00058-4; EIERMAN DF, 1989, J IMMUNOL, V142, P1970; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; GASSON JC, 1991, BLOOD, V77, P1131, DOI 10.1182/blood.V77.6.1131.1131; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Gu L, 1998, MOL CELL, V2, P275, DOI 10.1016/S1097-2765(00)80139-2; Hansson GK, 1997, CURR OPIN LIPIDOL, V8, P301, DOI 10.1097/00041433-199710000-00009; Ilaria RL, 1999, BLOOD, V93, P4154, DOI 10.1182/blood.V93.12.4154.412k15_4154_4166; Jarmin DI, 1999, EXP HEMATOL, V27, P1735, DOI 10.1016/S0301-472X(99)00115-0; Jost MM, 2003, FASEB J, V17, P2281, DOI 10.1096/fj.03-0071fje; Kao CY, 1999, J BIOL CHEM, V274, P23043, DOI 10.1074/jbc.274.33.23043; Kawakami A, 2002, CIRC RES, V91, P263, DOI 10.1161/01.RES.0000028454.42385.8B; Kinlay S, 2003, CIRCULATION, V108, P1560, DOI 10.1161/01.CIR.0000091404.09558.AF; Kohno Y, 2004, PATHOL INT, V54, P693, DOI 10.1111/j.1440-1827.2004.01682.x; Kwon EM, 2000, BLOOD, V95, P2552, DOI 10.1182/blood.V95.8.2552.008k30_2552_2558; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Lehtonen A, 2002, J LEUKOCYTE BIOL, V71, P511; Mason RP, 2005, AM J CARDIOL, V96, p11F, DOI 10.1016/j.amjcard.2005.06.008; Murata Y, 2005, ARTERIOSCL THROM VAS, V25, P430, DOI 10.1161/01.ATV.0000148705.13411.65; Ni WH, 2001, CIRCULATION, V103, P2096; Plenz G, 1997, ARTERIOSCL THROM VAS, V17, P2489, DOI 10.1161/01.ATV.17.11.2489; Poon M, 1999, MOL CELL BIOL, V19, P6471; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Senokuchi T, 2005, J BIOL CHEM, V280, P6627, DOI 10.1074/jbc.M412531200; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; Takahashi M, 1996, CIRCULATION, V93, P1185, DOI 10.1161/01.CIR.93.6.1185; TAKAHASHI M, 1995, CIRC RES, V76, P750, DOI 10.1161/01.RES.76.5.750; Tanimoto A, 2006, TRENDS CARDIOVAS MED, V16, P280, DOI 10.1016/j.tcm.2006.06.001; TAUBMAN MB, 1992, CIRC RES, V70, P314, DOI 10.1161/01.RES.70.2.314; Tebo J, 2003, J BIOL CHEM, V278, P12085, DOI 10.1074/jbc.M212992200; Ueda A, 1997, J BIOL CHEM, V272, P31092, DOI 10.1074/jbc.272.49.31092; Veillard NR, 2006, ATHEROSCLEROSIS, V188, P51, DOI 10.1016/j.atherosclerosis.2005.10.015; Warby TJ, 2003, J VIROL, V77, P12630, DOI 10.1128/JVI.77.23.12630-12638.2003; Wassmann S, 2001, MOL PHARMACOL, V59, P646, DOI 10.1124/mol.59.3.646; Wu LH, 2001, BIOCHEM BIOPH RES CO, V285, P300, DOI 10.1006/bbrc.2001.5161; YAMADA M, 2001, ARTERIOSCLER THROMB, V23, P1996; Yoshida M, 2001, ARTERIOSCL THROM VAS, V21, P1165, DOI 10.1161/hq0701.092143	45	41	48	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4643	4651		10.1074/jbc.M708853200	http://dx.doi.org/10.1074/jbc.M708853200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089573	hybrid			2022-12-25	WOS:000253426500021
J	Wood, RJ; Hulett, MD				Wood, Robert J.; Hulett, Mark D.			Cell surface-expressed cation-independent mannose 6-phosphate receptor (CD222) binds enzymatically active heparanase independently of mannose 6-phosphate to promote extracellular matrix degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-II RECEPTOR; GROWTH-FACTOR; GENE-EXPRESSION; SULFATE PROTEOGLYCANS; MAMMALIAN HEPARANASE; MOLECULAR-PROPERTIES; CANCER METASTASIS; LYSOSOMAL-ENZYMES; PANCREATIC ADENOCARCINOMA; REGULATES DEGRADATION	Heparanase is a beta-D-endoglucuronidase that cleaves heparan sulfate, an important structural component of the extracellular matrix (ECM) and vascular basement membrane (BM). The cleavage of heparan sulfate by heparanase-expressing cells, such as activated leukocytes, metastatic tumor cells, and proliferating endothelial cells, facilitates degradation of the ECM/BM to promote cell invasion associated with inflammation, tumor metastasis, and angiogenesis. In addition to its enzymatic function, heparanase has also recently been shown to act as a cell adhesion and/or signaling molecule upon interaction with cell surfaces. Despite the obvious importance of the mechanisms for the binding of heparanase to cell surfaces, the receptor(s) for heparanase remain poorly defined. In this study, we identify the 300-kDa cation-independent mannose 6-phosphate receptor (CIMPR) as a cell surface receptor for heparanase. Purified platelet heparanase was shown to bind the human CIMPR expressed on the surface of a transfected mouse L cell line. Optimal binding was determined to be at a slightly acidic pH (6.5-7.0) with heparanase remaining on the cell surface for up to 10 min at 37 degrees C. In contrast, mouse L cells or Chinese hamster ovary cells expressing the cation-dependent mannose 6-phosphate receptor (CDMPR) showed no binding of heparanase. Interestingly, the binding of heparanase to CIMPR was independent of Man-6-P moieties. Significantly, primary human T cells upon activation were shown to dramatically up-regulate levels of cell surface-expressed CIMPR, which showed a concomitant increase in their capacity to bind heparanase. Furthermore, the tethering of heparanase to the surface of cells via CIMPR was found to increase their capacity to degrade an ECM or a reconstituted BM. These data suggest an important role for CIMPR in the cell surface presentation of enzymatically active heparanase for the efficient passage of T cells into an inflammatory site and have implications for the use of this mechanism by other cell types to enhance cell invasion.	[Wood, Robert J.; Hulett, Mark D.] Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canc & Mol Immunol Grp, Acton, ACT 2601, Australia	Australian National University; John Curtin School of Medical Research	Hulett, MD (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Mol Biosci, Canc & Mol Immunol Grp, Acton, ACT 2601, Australia.	mark.hulett@anu.edu.au	Hulett, Mark D/C-4160-2012	Hulett, Mark/0000-0003-2072-5968				Abboud-Jarrous G, 2005, J BIOL CHEM, V280, P13568, DOI 10.1074/jbc.M413370200; BARTLETT MR, 1995, J LEUKOCYTE BIOL, V57, P207, DOI 10.1002/jlb.57.2.207; Basbaum CB, 1996, CURR OPIN CELL BIOL, V8, P731, DOI 10.1016/S0955-0674(96)80116-5; Benhamron S, 2006, J IMMUNOL, V176, P6417, DOI 10.4049/jimmunol.176.11.6417; BRAUKER JH, 1986, EXP CELL RES, V164, P115, DOI 10.1016/0014-4827(86)90459-3; CHAO HHJ, 1990, EMBO J, V9, P3507, DOI 10.1002/j.1460-2075.1990.tb07559.x; Chapman HA, 1997, CURR OPIN CELL BIOL, V9, P714, DOI 10.1016/S0955-0674(97)80126-3; Chen Wen-Tien, 1992, Current Opinion in Cell Biology, V4, P802; CHUNG AE, 1977, CANCER RES, V37, P2072; CLEMENTS PR, 1985, EUR J BIOCHEM, V152, P21, DOI 10.1111/j.1432-1033.1985.tb09158.x; Cohen E, 2005, FEBS LETT, V579, P2334, DOI 10.1016/j.febslet.2005.03.030; Collen D, 1999, THROMB HAEMOSTASIS, V82, P259; DAHMS NM, 1994, J BIOL CHEM, V269, P3802; Dahms NM, 2002, BBA-GEN SUBJECTS, V1572, P317, DOI 10.1016/S0304-4165(02)00317-3; de Mestre AM, 2005, J BIOL CHEM, V280, P35136, DOI 10.1074/jbc.M503414200; de Mestre AM, 2003, J BIOL CHEM, V278, P50377, DOI 10.1074/jbc.M310154200; de Mestre AM, 2007, IMMUNOL CELL BIOL, V85, P205, DOI 10.1038/sj.icb.7100022; Dempsey LA, 2000, GLYCOBIOLOGY, V10, P467, DOI 10.1093/glycob/10.5.467; Edovitsky E, 2006, BLOOD, V107, P3609, DOI 10.1182/blood-2005-08-3301; Edovitsky E, 2004, JNCI-J NATL CANCER I, V96, P1219, DOI 10.1093/jnci/djh230; Elkin M, 2001, FASEB J, V15, P1661, DOI 10.1096/fj.00-0895fje; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Fairbanks MB, 1999, J BIOL CHEM, V274, P29587, DOI 10.1074/jbc.274.42.29587; Freeman C, 1998, BIOCHEM J, V330, P1341, DOI 10.1042/bj3301341; FRIDMAN R, 1987, J CELL PHYSIOL, V130, P85, DOI 10.1002/jcp.1041300113; Friedmann Y, 2000, AM J PATHOL, V157, P1167, DOI 10.1016/S0002-9440(10)64632-9; GARMROUDI F, 1994, J BIOL CHEM, V269, P26944; GILAT D, 1995, J EXP MED, V181, P1929, DOI 10.1084/jem.181.5.1929; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P23536, DOI 10.1074/jbc.M400554200; Godar S, 1999, EUR J IMMUNOL, V29, P1004, DOI 10.1002/(SICI)1521-4141(199903)29:03<1004::AID-IMMU1004>3.0.CO;2-Q; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; Goldschmidt O, 2003, FASEB J, V17, P1015, DOI 10.1096/fj.02-0773com; Haimov-Kochman R, 2002, MOL HUM REPROD, V8, P566, DOI 10.1093/molehr/8.6.566; Hancock MK, 2002, J BIOL CHEM, V277, P47205, DOI 10.1074/jbc.M208534200; Hawkes C, 2006, J NEUROSCI, V26, P585, DOI 10.1523/JNEUROSCI.2730-05.2006; HILLEREHFELD A, 1995, BBA-REV BIOMEMBRANES, V1241, P177, DOI 10.1016/0304-4157(95)00004-B; Hindmarsh EJ, 2001, IMMUNOL CELL BIOL, V79, P436, DOI 10.1046/j.1440-1711.2001.01026.x; Hiraoka N, 1998, CELL, V95, P365, DOI 10.1016/S0092-8674(00)81768-7; Hotary K, 2000, J CELL BIOL, V149, P1309, DOI 10.1083/jcb.149.6.1309; Hulett MD, 1999, NAT MED, V5, P803, DOI 10.1038/10525; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; Iozzo RV, 2001, J CLIN INVEST, V108, P349, DOI 10.1172/JCI13738; ISHAIMICHAELI R, 1990, CELL REGUL, V1, P833, DOI 10.1091/mbc.1.11.833; Kang JX, 1997, P NATL ACAD SCI USA, V94, P13671, DOI 10.1073/pnas.94.25.13671; Katz A, 2002, ISRAEL MED ASSOC J, V4, P996; Kim AW, 2002, J GASTROINTEST SURG, V6, P167, DOI 10.1016/S1091-255X(01)00087-7; KJELLEN L, 1991, ANNU REV BIOCHEM, V60, P443, DOI 10.1146/annurev.bi.60.070191.002303; Koliopanos A, 2001, CANCER RES, V61, P4655; KORNFELD S, 1992, ANNU REV BIOCHEM, V61, P307, DOI 10.1146/annurev.bi.61.070192.001515; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Kussie PH, 1999, BIOCHEM BIOPH RES CO, V261, P183, DOI 10.1006/bbrc.1999.0962; KYLE JW, 1988, J BIOL CHEM, V263, P16230; Leksa V, 2005, J CELL SCI, V118, P4577, DOI 10.1242/jcs.02587; Leksa V, 2002, J BIOL CHEM, V277, P40575, DOI 10.1074/jbc.M207979200; Levidiotis V, 2004, J AM SOC NEPHROL, V15, P68, DOI 10.1097/01.ASN.0000103229.25389.40; Levy-Adam F, 2005, J BIOL CHEM, V280, P20457, DOI 10.1074/jbc.M414546200; LIDER O, 1990, EUR J IMMUNOL, V20, P493, DOI 10.1002/eji.1830200306; LOBEL P, 1988, J BIOL CHEM, V263, P2563; Maxhimer JB, 2005, DIABETES, V54, P2172, DOI 10.2337/diabetes.54.7.2172; Maxhimer JB, 2002, SURGERY, V132, P326, DOI 10.1067/msy.2002.125719; Murphy G, 1999, CURR OPIN CELL BIOL, V11, P614, DOI 10.1016/S0955-0674(99)00022-8; Nadav L, 2002, J CELL SCI, V115, P2179; NAPARSTEK Y, 1984, NATURE, V310, P241, DOI 10.1038/310241a0; NOVOKHATNY V, 1992, J BIOL CHEM, V267, P3878; Nykjaer A, 1998, J CELL BIOL, V141, P815, DOI 10.1083/jcb.141.3.815; PARISH CR, 1987, INT J CANCER, V40, P511, DOI 10.1002/ijc.2910400414; Parish CR, 2001, BIOCHIM BIOPHYS ACTA, V1471, P99, DOI DOI 10.1016/S0304-419X(01)00017-8; Reddy ST, 2004, J BIOL CHEM, V279, P38658, DOI 10.1074/jbc.M407474200; ROCHEFORT H, 1990, CANCER METAST REV, V9, P321, DOI 10.1007/BF00049522; ROFF CF, 1983, EXP CELL RES, V144, P333, DOI 10.1016/0014-4827(83)90412-3; ROGERS SA, 1990, J BIOL CHEM, V265, P9722; Rohloff J, 2002, BRIT J CANCER, V86, P1270, DOI 10.1038/sj.bjc.6600232; Sasaki N, 2004, J IMMUNOL, V172, P3830, DOI 10.4049/jimmunol.172.6.3830; SCHMIDT B, 1995, J BIOL CHEM, V270, P14975, DOI 10.1074/jbc.270.25.14975; Sotnikov I, 2004, J IMMUNOL, V172, P5185, DOI 10.4049/jimmunol.172.9.5185; Takaoka M, 2003, LAB INVEST, V83, P613, DOI 10.1097/01.LAB.0000067482.84946.BD; Toyoshima M, 1999, J BIOL CHEM, V274, P24153, DOI 10.1074/jbc.274.34.24153; Uno F, 2001, CANCER RES, V61, P7855; Vlodavsky I, 2001, J CLIN INVEST, V108, P341, DOI 10.1172/JCI200113662; VLODAVSKY I, 1992, INVAS METAST, V12, P112; Vlodavsky I, 1999, NAT MED, V5, P793, DOI 10.1038/10518; Vlodavsky I, 2001, BIOCHIMIE, V83, P831, DOI 10.1016/S0300-9084(01)01318-9; VLODAVSKY I, 1999, CURRENT PROTOCOLS CE, V1; Vreys V, 2005, J BIOL CHEM, V280, P33141, DOI 10.1074/jbc.M503007200; Warren HS, 2003, J IMMUNOL METHODS, V280, P135, DOI 10.1016/S0022-1759(03)00106-6; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; YURCHENCO PD, 1990, FASEB J, V4, P1577, DOI 10.1096/fasebj.4.6.2180767; Zcharia E, 2001, J MAMMARY GLAND BIOL, V6, P311, DOI 10.1023/A:1011375624902; Zetser A, 2006, CANCER RES, V66, P1455, DOI 10.1158/0008-5472.CAN-05-1811; Zetser A, 2004, J CELL SCI, V117, P2249, DOI 10.1242/jcs.01068	92	41	44	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4165	4176		10.1074/jbc.M708723200	http://dx.doi.org/10.1074/jbc.M708723200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073203	hybrid			2022-12-25	WOS:000253083500052
J	Jamieson, KV; Wu, J; Hubbard, SR; Meruelo, D				Jamieson, Kelly V.; Wu, Jinhua; Hubbard, Stevan R.; Meruelo, Daniel			Crystal structure of the human laminin receptor precursor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN; VIRUS; ANGIOGENESIS; DOMAINS; CELLS; GENE; TEA	The human laminin receptor (LamR) interacts with many ligands, including laminin, prions, Sindbis virus, and the polyphenol (-)-epigallocatechin-3-gallate (EGCG), and has been implicated in a number of diseases. LamR is overexpressed on tumor cells, and targeting LamR elicits anti-cancer effects. Here, we report the crystal structure of human LamR, which provides insights into its function and should facilitate the design of novel therapeutics targeting LamR.	[Jamieson, Kelly V.; Meruelo, Daniel] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Jamieson, Kelly V.; Meruelo, Daniel] NYU, Sch Med, Gene Therapy Ctr, New York, NY 10016 USA; [Wu, Jinhua; Hubbard, Stevan R.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Wu, Jinhua; Hubbard, Stevan R.] NYU, Sch Med, Struct Biol Program, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA	New York University; New York University; New York University; New York University	Meruelo, D (corresponding author), NYU, Sch Med, Dept Pathol, 550 1St Ave, New York, NY 10016 USA.	daniel.meruelo@med.nyu.edu		Hubbard, Stevan/0000-0002-2707-9383	NCI NIH HHS [CA100687, CA68498] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA068498, R01CA100687] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Akache B, 2006, J VIROL, V80, P9831, DOI 10.1128/JVI.00878-06; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; AUTH D, 1992, P NATL ACAD SCI USA, V89, P4368, DOI 10.1073/pnas.89.10.4368; Badger J, 2005, PROTEINS, V60, P787, DOI 10.1002/prot.20541; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cao YH, 1999, NATURE, V398, P381, DOI 10.1038/18793; CASTRONOVO V, 1991, J BIOL CHEM, V266, P20440; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ford CL, 1999, CANCER RES, V59, P704; Gauczynski S, 2001, EMBO J, V20, P5863, DOI 10.1093/emboj/20.21.5863; Jackers P, 1996, ONCOGENE, V13, P495; LANDOWSKI TH, 1995, BIOCHEMISTRY-US, V34, P11276, DOI 10.1021/bi00035a037; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Ludwig GV, 1996, J VIROL, V70, P5592, DOI 10.1128/JVI.70.8.5592-5599.1996; McNichol BA, 2007, INFECT IMMUN, V75, P5095, DOI 10.1128/IAI.00075-07; Menard S, 1998, BREAST CANCER RES TR, V52, P137, DOI 10.1023/A:1006171403765; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; RAO NC, 1983, BIOCHEM BIOPH RES CO, V111, P804, DOI 10.1016/0006-291X(83)91370-0; Sato M, 1996, BIOCHEM BIOPH RES CO, V229, P896, DOI 10.1006/bbrc.1996.1899; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Tanaka M, 2000, CANCER LETT, V153, P161, DOI 10.1016/S0304-3835(00)00365-7; Tseng JC, 2004, NAT BIOTECHNOL, V22, P70, DOI 10.1038/nbt917; WANG KS, 1992, J VIROL, V66, P4992, DOI 10.1128/JVI.66.8.4992-5001.1992; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006	26	44	47	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3002	3005		10.1074/jbc.C700206200	http://dx.doi.org/10.1074/jbc.C700206200			4	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18063583	hybrid			2022-12-25	WOS:000253083000002
J	Raven, JF; Baltzis, D; Wang, S; Mounir, Z; Papadakis, AI; Gao, HQ; Koromilas, AE				Raven, Jennifer F.; Baltzis, Dionissios; Wang, Shuo; Mounir, Zineb; Papadakis, Andreas I.; Gao, Hong Qing; Koromilas, Antonis E.			PKR and PKR-like endoplasmic reticulum kinase induce the proteasome-dependent degradation of cyclin D1 via a mechanism requiring eukaryotic initiation factor 2 alpha phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; CELL-CYCLE PROGRESSION; INITIATION-FACTOR 4E; ELONGATION-FACTOR 1A; TRANSLATIONAL CONTROL; ORNITHINE-DECARBOXYLASE; D1 EXPRESSION; FUNCTIONALLY SUBSTITUTE; MEDIATED DEGRADATION; SELECTIVE INHIBITOR	Cyclin D1 plays a critical role in controlling the G(1)/S transition via the regulation of cyclin-dependent kinase activity. Several studies have indicated that cyclin D1 translation is decreased upon activation of the eukaryotic initiation factor 2 alpha (eIF2 alpha) kinases. We examined the effect of activation of the eIF2 alpha kinases PKR and PKR-like endoplasmic reticulum kinase ( PERK) on cyclin D1 protein levels and translation and determined that cyclin D1 protein levels decrease upon the induction of PKR and PERK catalytic activity but that this decrease is not due to translation. Inhibition of the 26 S proteasome with MG132 rescued cyclin D1 protein levels, indicating that rather than inhibiting translation, PKR and PERK act to increase cyclin D1 degradation. Interestingly, this effect still requires eIF2 alpha phosphorylation at serine 51, as cyclin D1 remains unaffected in cells containing a non-phosphorylatable form of the protein. This proteasome-dependent degradation of cyclin D1 requires an intact ubiquitination pathway, although the ubiquitination of cyclin D1 is not itself affected. Furthermore, this degradation is independent of phosphorylation of cyclin D1 at threonine 286, which is mediated by the glycogen synthase kinase 3 beta and mitogen-activated protein kinase pathways as described in previous studies. Our study reveals a novel functional cross-talk between eIF2 alpha phosphorylation and the proteasomal degradation of cyclin D1 and that this degradation is dependent upon eIF2 alpha phosphorylation during short, but not prolonged, periods of stress.	[Raven, Jennifer F.; Baltzis, Dionissios; Wang, Shuo; Mounir, Zineb; Papadakis, Andreas I.; Gao, Hong Qing; Koromilas, Antonis E.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Raven, Jennifer F.; Baltzis, Dionissios; Mounir, Zineb; Papadakis, Andreas I.; Koromilas, Antonis E.] McGill Univ, Fac Med, Dept Oncol, Montreal, PQ H2W 1S6, Canada	Lady Davis Institute; McGill University; McGill University	Koromilas, AE (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Rm 508,3999 Ch De La Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	antonis.koromilas@mcgill.ca						Albanese C, 1999, J BIOL CHEM, V274, P34186, DOI 10.1074/jbc.274.48.34186; ALBANESE C, 1995, J BIOL CHEM, V270, P23589, DOI 10.1074/jbc.270.40.23589; Asher G, 2002, P NATL ACAD SCI USA, V99, P3099, DOI 10.1073/pnas.052706799; Asher G, 2005, MOL CELL, V17, P645, DOI 10.1016/j.molcel.2005.01.020; Asher G, 2002, P NATL ACAD SCI USA, V99, P13125, DOI 10.1073/pnas.202480499; Balasubramanyam M, 2005, MOL CELL BIOCHEM, V275, P117, DOI 10.1007/s11010-005-1083-y; Baltzis D, 2004, J VIROL, V78, P12747, DOI 10.1128/JVI.78.23.12747-12761.2004; Baltzis D, 2007, J BIOL CHEM, V282, P31675, DOI 10.1074/jbc.M704491200; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Boyce M, 2005, SCIENCE, V307, P935, DOI 10.1126/science.1101902; Brewer JW, 2000, P NATL ACAD SCI USA, V97, P12625, DOI 10.1073/pnas.220247197; Brewer JW, 1999, P NATL ACAD SCI USA, V96, P8505, DOI 10.1073/pnas.96.15.8505; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Chen JJ, 2007, BLOOD, V109, P2693, DOI 10.1182/blood-2006-08-041830; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Coffino P, 2001, BIOCHIMIE, V83, P319, DOI 10.1016/S0300-9084(01)01252-4; DEVER TE, 1993, P NATL ACAD SCI USA, V90, P4616, DOI 10.1073/pnas.90.10.4616; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fu MF, 2003, MOL CELL BIOL, V23, P8563, DOI 10.1128/MCB.23.23.8563-8575.2003; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Holnthoner W, 2002, J BIOL CHEM, V277, P45847, DOI 10.1074/jbc.M209354200; Horstmann S, 2000, ONCOGENE, V19, P298, DOI 10.1038/sj.onc.1203302; Hotokezaka Y, 2002, J BIOL CHEM, V277, P18545, DOI 10.1074/jbc.M201022200; Kazemi S, 2004, MOL CELL BIOL, V24, P3415, DOI 10.1128/MCB.24.8.3415-3429.2004; Kazemi S, 2007, MOL BIOL CELL, V18, P3635, DOI 10.1091/mbc.E07-01-0053; Koziczak M, 2004, J BIOL CHEM, V279, P50004, DOI 10.1074/jbc.M404252200; Kronfeld-Kinar Y, 1999, CELL GROWTH DIFFER, V10, P201; KULKA RG, 1988, J BIOL CHEM, V263, P15726; Kunick C, 2004, BIOORG MED CHEM LETT, V14, P413, DOI 10.1016/j.bmcl.2003.10.062; Lamb J, 2003, CELL, V114, P323, DOI 10.1016/S0092-8674(03)00570-1; Lee RJ, 2000, MOL CELL BIOL, V20, P672, DOI 10.1128/MCB.20.2.672-683.2000; Lee RJ, 1999, J BIOL CHEM, V274, P7341, DOI 10.1074/jbc.274.11.7341; Li SY, 2001, J BIOL CHEM, V276, P13881, DOI 10.1074/jbc.M008140200; Lin DI, 2006, MOL CELL, V24, P355, DOI 10.1016/j.molcel.2006.09.007; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Malki A, 2002, BIOCHEM BIOPH RES CO, V296, P749, DOI 10.1016/S0006-291X(02)00935-X; Matsumura I, 1999, EMBO J, V18, P1367, DOI 10.1093/emboj/18.5.1367; MOTOKURA T, 1991, NATURE, V350, P512, DOI 10.1038/350512a0; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Nelsen CJ, 2003, J BIOL CHEM, V278, P25853, DOI 10.1074/jbc.M302360200; Newman RM, 2004, J BIOL CHEM, V279, P41504, DOI 10.1074/jbc.M407349200; Okabe H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000128; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; Ron D, 2002, J CLIN INVEST, V110, P1383, DOI 10.1172/JCI200216784; ROSENWALD IB, 1995, J BIOL CHEM, V270, P21176, DOI 10.1074/jbc.270.36.21176; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Salzberg S, 2000, EXP CELL RES, V254, P45, DOI 10.1006/excr.1999.4721; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Shao JY, 2000, J BIOL CHEM, V275, P22916, DOI 10.1074/jbc.M002235200; Shi YG, 2003, ENDOCR REV, V24, P91, DOI 10.1210/er.2002-0018; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Sonenberg N, 2001, SCIENCE, V293, P818, DOI 10.1126/science.1062937; Stewart D, 2004, J GEN VIROL, V85, P1419, DOI 10.1099/vir.0.19679-0; Suzui M, 2002, CANCER RES, V62, P3997; Terada Y, 1999, KIDNEY INT, V56, P1258, DOI 10.1046/j.1523-1755.1999.00704.x; Ung TL, 2001, EMBO J, V20, P3728, DOI 10.1093/emboj/20.14.3728; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang XM, 2001, EMBO J, V20, P4349, DOI 10.1093/emboj/20.16.4349; Yang K, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-33	67	79	81	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3097	3108		10.1074/jbc.M709677200	http://dx.doi.org/10.1074/jbc.M709677200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18063576	hybrid			2022-12-25	WOS:000253083000013
J	Rott, R; Szargel, R; Haskin, J; Shani, V; Shainskaya, A; Manov, I; Liani, E; Avraham, E; Engelender, S				Rott, Ruth; Szargel, Raymonde; Haskin, Joseph; Shani, Vered; Shainskaya, Alla; Manov, Irena; Liani, Esti; Avraham, Eyal; Engelender, Simone			Monoubiquitylation of alpha-synuclein by seven in absentia homolog (SIAH) promotes its aggregation in dopaminergic cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL PARKINSONS-DISEASE; LEWY-BODY FORMATION; UBIQUITIN-BINDING PROTEINS; INCLUSION FORMATION; PROTEASOME IMPAIRMENT; DROSOPHILA MODEL; FIBRIL FORMATION; TRANSGENIC MICE; SYNPHILIN-1; MUTATION	alpha-Synuclein plays a major role in Parkinson disease. Unraveling the mechanisms of alpha-synuclein aggregation is essential to understand the formation of Lewy bodies and their involvement in dopaminergic cell death. alpha-Synuclein is ubiquitylated in Lewy bodies, but the role of alpha-synuclein ubiquitylation has been mysterious. We now report that the ubiquitin-protein isopeptide ligase seven in absentia homolog (SIAH) directly interacts with and monoubiquitylates alpha-synuclein and promotes its aggregation in vitro and in vivo, which is toxic to cells. Mass spectrometry analysis demonstrates that SIAH monoubiquitylates alpha-synuclein at lysines 12, 21, and 23, which were previously shown to be ubiquitylated in Lewy bodies. SIAH ubiquitylates lysines 10, 34, 43, and 96 as well. Suppression of SIAH expression by short hairpin RNA to SIAH-1 and SIAH-2 abolished alpha-synuclein monoubiquitylation in dopaminergic cells, indicating that endogenous SIAH ubiquitylates alpha-synuclein. Moreover, SIAH co-immunoprecipitated with alpha-synuclein from brain extracts. Inhibition of proteasomal, lysosomal, and autophagic pathways, as well as overexpression of a ubiquitin mutant less prone to deubiquitylation, G76A, increased monoubiquitylation of alpha-synuclein by SIAH. Monoubiquitylation increased the aggregation of alpha-synuclein in vitro. At the electron microscopy level, monoubiquitylated alpha-synuclein promoted the formation of massive amounts of amorphous aggregates. Monoubiquitylation also increased alpha-synuclein aggregation in vivo as observed by increased formation of alpha-synuclein inclusion bodies within dopaminergic cells. These inclusions are toxic to cells, and their formation was prevented when endogenous SIAH expression was suppressed. Our data suggest that monoubiquitylation represents a possible trigger event for alpha-synuclein aggregation and Lewy body formation.	[Rott, Ruth; Szargel, Raymonde; Haskin, Joseph; Shani, Vered; Liani, Esti; Avraham, Eyal; Engelender, Simone] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Pharmacol, IL-31096 Haifa, Israel; [Rott, Ruth; Szargel, Raymonde; Haskin, Joseph; Shani, Vered; Liani, Esti; Avraham, Eyal; Engelender, Simone] Technion Israel Inst Technol, Inst Med Res, IL-31096 Haifa, Israel; [Shainskaya, Alla] Weizmann Inst Sci, Dept Biol Serv, Biol Mass Spectrometry Facil, IL-76100 Rehovot, Israel; [Manov, Irena] Technion Israel Inst Technol, Bruce Rappaport Fac Med, Pediat Res & Electron Microscopy Unit, IL-31096 Haifa, Israel	Technion Israel Institute of Technology; Rappaport Faculty of Medicine; Technion Israel Institute of Technology; Weizmann Institute of Science; Technion Israel Institute of Technology; Rappaport Faculty of Medicine	Engelender, S (corresponding author), Technion Israel Inst Technol, Bruce Rappaport Fac Med, Dept Pharmacol, IL-31096 Haifa, Israel.	simone@tx.technion.ac.il		Engelender, Simone/0000-0001-7401-6855; Manov, Irena/0000-0001-8523-0849				Anderson JP, 2006, J BIOL CHEM, V281, P29739, DOI 10.1074/jbc.M600933200; Antony T, 2003, J BIOL CHEM, V278, P3235, DOI 10.1074/jbc.M208249200; Ardley HC, 2004, J NEUROCHEM, V90, P379, DOI 10.1111/j.1471-4159.2004.02485.x; Auluck PK, 2002, SCIENCE, V295, P865, DOI 10.1126/science.1067389; Avraham E, 2005, J BIOL CHEM, V280, P42877, DOI 10.1074/jbc.M505608200; Avraham E, 2007, J BIOL CHEM, V282, P12842, DOI 10.1074/jbc.M608243200; Baba M, 1998, AM J PATHOL, V152, P879; Bennett MC, 1999, J BIOL CHEM, V274, P33855, DOI 10.1074/jbc.274.48.33855; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chung KKK, 2001, NAT MED, V7, P1144, DOI 10.1038/nm1001-1144; Conway KA, 2000, BIOCHEMISTRY-US, V39, P2552, DOI 10.1021/bi991447r; Conway KA, 2000, P NATL ACAD SCI USA, V97, P571, DOI 10.1073/pnas.97.2.571; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Cuervo AM, 2004, SCIENCE, V305, P1292, DOI 10.1126/science.1101738; Engelender S, 1999, NAT GENET, V22, P110, DOI 10.1038/8820; Eyal A, 2006, P NATL ACAD SCI USA, V103, P5917, DOI 10.1073/pnas.0509707103; Eyal A, 2006, CELL CYCLE, V5, P2082, DOI 10.4161/cc.5.18.3209; Feany MB, 2000, NATURE, V404, P394, DOI 10.1038/35006074; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200; Greenbaum EA, 2005, J BIOL CHEM, V280, P7800, DOI 10.1074/jbc.M411638200; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 2005, NAT REV MOL CELL BIO, V6, P610, DOI 10.1038/nrm1701; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hoeller D, 2006, NAT CELL BIOL, V8, P163, DOI 10.1038/ncb1354; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Junn E, 2002, J BIOL CHEM, V277, P47870, DOI 10.1074/jbc.M203159200; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kussmann M, 1997, J MASS SPECTROM, V32, P483; KUZUHARA S, 1988, ACTA NEUROPATHOL, V75, P345, DOI 10.1007/BF00687787; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lee VMY, 2006, NEURON, V52, P33, DOI 10.1016/j.neuron.2006.09.026; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Liani E, 2004, P NATL ACAD SCI USA, V101, P5500, DOI 10.1073/pnas.0401081101; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Marx FP, 2003, HUM MOL GENET, V12, P1223, DOI 10.1093/hmg/ddg134; McNaught KSP, 2001, NEUROSCI LETT, V297, P191, DOI 10.1016/S0304-3940(00)01701-8; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Moore DJ, 2005, ANNU REV NEUROSCI, V28, P57, DOI 10.1146/annurev.neuro.28.061604.135718; Mueller TD, 2002, J MOL BIOL, V319, P1243, DOI 10.1016/S0022-2836(02)00302-9; Muqit MMK, 2006, J NEUROCHEM, V98, P156, DOI 10.1111/j.1471-4159.2006.03845.x; Neumann M, 2002, J CLIN INVEST, V110, P1429, DOI 10.1172/JC1200215777; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nonaka T, 2005, BIOCHEMISTRY-US, V44, P361, DOI 10.1021/bi0485528; Outeiro TF, 2007, SCIENCE, V317, P516, DOI 10.1126/science.1143780; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Periquet M, 2007, J NEUROSCI, V27, P3338, DOI 10.1523/JNEUROSCI.0285-07.2007; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Ribeiro CS, 2002, J BIOL CHEM, V277, P23927, DOI 10.1074/jbc.M201115200; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shimura H, 2001, SCIENCE, V293, P263, DOI 10.1126/science.1060627; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Smith WW, 2005, J NEUROSCI, V25, P5544, DOI 10.1523/JNEUROSCI.0482-05.2005; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Tanaka M, 2004, J BIOL CHEM, V279, P4625, DOI 10.1074/jbc.M310994200; Tofaris GK, 2003, J BIOL CHEM, V278, P44405, DOI 10.1074/jbc.M308041200; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; VORM O, 1994, ANAL CHEM, V66, P3281, DOI 10.1021/ac00091a044; Webb JL, 2003, J BIOL CHEM, V278, P25009, DOI 10.1074/jbc.M300227200; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wilm M, 1996, ANAL CHEM, V68, P527, DOI 10.1021/ac950875+; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	74	126	134	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3316	3328		10.1074/jbc.M704809200	http://dx.doi.org/10.1074/jbc.M704809200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070888	hybrid			2022-12-25	WOS:000253083000036
J	Back, M; Hlawaty, H; Labat, C; Michel, JB; Brink, C				Baeck, Magnus; Hlawaty, Hanna; Labat, Carlos; Michel, Jean-Baptiste; Brink, Charles			The Oral Cavity and Age: A Site of Chronic Inflammation?	PLOS ONE			English	Article								Background. Aging may be accompanied by a low grade chronic up-regulation of inflammatory mediators. A variety of endogenous locally released mediators as well as inflammatory cells have been reported in the human oral cavity. The aim of this investigation was to determine the presence of different classes of inflammatory mediators in human saliva and correlate the levels with age. Methodology and Principal Findings. Unstimulated whole buccal salivary samples were obtained in the morning from 94 healthy volunteers within 30 minutes after waking. None of the participants had taken aspirin in the week prior to the saliva collection. Lysozyme activity, eicosanoid levels (prostaglandin E-2 and leukotriene B-4) and MMP-9 activity were measured. The antimicrobial activity (lysozyme activity) was not correlated with age whereas PGE(2) levels were markedly correlated with age (r = 0.29; P<0.05; n = 56). Saliva from healthy subjects (<40 years) compared with data derived from older volunteers (>40 years) demonstrated a significant increase in the mean values for PGE(2) and MMP-9 activity with age. In addition, significant correlations were observed between LTB4 and PGE(2) (r = 0.28; P<0.05; n = 56) and between LTB4 levels and MMP-9 activity in smokers (r = 0.78; P<0.001; n = 15). Conclusions/Significance. The presence of significant levels and activity of inflammatory mediators in saliva suggests that the oral cavity of healthy subjects may be in a constant low state of inflammation associated with age.	[Baeck, Magnus; Hlawaty, Hanna; Michel, Jean-Baptiste; Brink, Charles] Univ Paris 07, Bichat Hosp, INSERM, U698, Paris, France; [Hlawaty, Hanna] Univ Paris 13, Inst Galilee UP13, F-93430 Villetaneuse, France; [Labat, Carlos] INSERM, U684, Nancy, France; [Labat, Carlos] Henri Poincare Univ, Nancy, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Universite de Lorraine	Brink, C (corresponding author), Univ Paris 07, Bichat Hosp, INSERM, U698, Paris, France.	charlesbrink@hotmail.com	Labat, Carlos/F-7492-2010; Michel, Jean-Baptiste/AAH-9336-2020; Back, Magnus/E-4879-2011	Labat, Carlos/0000-0002-5275-3405; Back, Magnus/0000-0003-0853-5141; Hlawaty, Hanna/0000-0003-3877-4266; Hlawaty, Hanna/0000-0002-4758-0941	University of Paris 13 (Institut Galilee UP13, Villetauneuse, France); Leducq Transatlantic Network of Excellence on Atherothrombosis Research; French National Academy of Medicine; French-Swedish Foundation; INSERM	University of Paris 13 (Institut Galilee UP13, Villetauneuse, France); Leducq Transatlantic Network of Excellence on Atherothrombosis Research; French National Academy of Medicine; French-Swedish Foundation; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	Funding: HH was supported by a PhD scholarship from University of Paris 13 (Institut Galilee UP13, Villetauneuse, France). This study was supported by the Leducq Transatlantic Network of Excellence on Atherothrombosis Research, the French National Academy of Medicine, the French-Swedish Foundation and INSERM.	Back M, 2007, ATHEROSCLEROSIS, V193, P389, DOI 10.1016/j.atherosclerosis.2006.07.003; Badier-Commander C, 2000, J PATHOL, V192, P105, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH670>3.0.CO;2-1; Berry KAZ, 2003, J BIOL CHEM, V278, P24449, DOI 10.1074/jbc.M300856200; Bjorne H, 2005, CRIT CARE MED, V33, P1722, DOI 10.1097/01.CCM.0000171304.59502.AA; Castaneda FE, 2005, GASTROENTEROLOGY, V129, P1991, DOI 10.1053/j.gastro.2005.09.017; Cesari M, 2003, AM J CARDIOL, V92, P522, DOI 10.1016/S0002-9149(03)00718-5; Fennerty MB, 2002, CRIT CARE MED, V30, pS351, DOI 10.1097/00003246-200206001-00002; FRANKEN C, 1989, J HISTOCHEM CYTOCHEM, V37, P493, DOI 10.1177/37.4.2926127; Gaber F, 2006, EUR RESPIR J, V28, P1229, DOI 10.1183/09031936.00151905; GIBBONS RJ, 1966, J DENT RES, V45, P877, DOI 10.1177/00220345660450036201; GREEN FA, 1987, ARCH BIOCHEM BIOPHYS, V257, P321, DOI 10.1016/0003-9861(87)90572-8; HARRIES AD, 1982, BRIT MED J, V284, P706, DOI 10.1136/bmj.284.6317.706; KLOCKARS M, 1975, J HISTOCHEM CYTOCHEM, V23, P932, DOI 10.1177/23.12.1104708; LOE H, 1971, J DENT RES, V50, P256, DOI 10.1177/00220345710500021701; MAKELA M, 1994, J DENT RES, V73, P1397, DOI 10.1177/00220345940730080201; METZGER K, 1995, FREE RADICAL BIO MED, V18, P185, DOI 10.1016/0891-5849(94)00108-V; OFFENBACHER S, 1986, J PERIODONTAL RES, V21, P101, DOI 10.1111/j.1600-0765.1986.tb01443.x; OLSON BL, 1985, J DENT RES, V64, P826, DOI 10.1177/00220345850640050901; Peppard PE, 2000, NEW ENGL J MED, V342, P1378, DOI 10.1056/NEJM200005113421901; Rao RK, 1997, DIGEST DIS SCI, V42, P2175, DOI 10.1023/A:1018855525989; RIGAS B, 1983, ARCH ORAL BIOL, V28, P1031, DOI 10.1016/0003-9969(83)90058-4; RIGAS B, 1983, ARCH ORAL BIOL, V28, P1135, DOI 10.1016/0003-9969(83)90171-1; RIGAS B, 1983, BIOCHEM BIOPH RES CO, V115, P201, DOI 10.1016/0006-291X(83)90989-0; Roger P, 1999, MEDIAT INFLAMM, V8, P319, DOI 10.1080/09629359990333; Rosin M, 1999, Clin Oral Investig, V3, P133, DOI 10.1007/s007840050091; Sarosiek J, 1996, GASTROENTEROLOGY, V110, P675, DOI 10.1053/gast.1996.v110.pm8608875; SCHIOTT C R, 1970, Journal of Periodontal Research, V5, P36; STUCHELL RN, 1983, J DENT RES, V62, P552, DOI 10.1177/00220345830620050701; TENOVUO J, 1987, J DENT RES, V66, P475, DOI 10.1177/00220345870660021501; Tjaderhane L, 1998, J DENT RES, V77, P1622, DOI 10.1177/00220345980770081001; Tsai CC, 1998, J DENT, V26, P97, DOI 10.1016/S0300-5712(96)00084-X; Westerlund U, 1996, J DENT RES, V75, P1553, DOI 10.1177/00220345960750080601; WOOLWEAVER DA, 1972, J DENT RES, V51, P929, DOI 10.1177/00220345720510043401; WUWANG CY, 1992, PROSTAG LEUKOTR ESS, V47, P101, DOI 10.1016/0952-3278(92)90144-8; Yeh CK, 1997, ARCH ORAL BIOL, V42, P25, DOI 10.1016/S0003-9969(96)00104-5; ZIJLSTRA FJ, 1992, AGENTS ACTIONS, pC53	36	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1351	10.1371/journal.pone.0001351	http://dx.doi.org/10.1371/journal.pone.0001351			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159234	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459700008
J	Giles, SS; Zaas, AK; Reidy, MF; Perfect, JR; Wright, JR				Giles, Steven S.; Zaas, Aimee K.; Reidy, Mike F.; Perfect, John R.; Wright, Jo Rae			Cryptococcus neoformans Is Resistant to Surfactant Protein A Mediated Host Defense Mechanisms	PLOS ONE			English	Article								Initiation of a protective immune response to infection by the pathogenic fungus Cryptococcus neoformans is mediated in part by host factors that promote interactions between immune cells and C. neoformans yeast. Surfactant protein A (SP-A) contributes positively to pulmonary host defenses against a variety of bacteria, viruses, and fungi in part by promoting the recognition and phagocytosis of these pathogens by alveolar macrophages. In the present study we investigated the role of SP-A as a mediator of host defense against the pulmonary pathogen, C. neoformans. Previous studies have shown that SP-A binds to acapsular and minimally encapsulated strains of C. neoformans. Using in vitro binding assays we confirmed that SP-A does not directly bind to a fully encapsulated strain of C. neoformans (H99). However, we observed that when C. neoformans was incubated in bronchoalveolar fluid, SP-A binding was detected, suggesting that another alveolar host factor may enable SP-A binding. Indeed, we discovered that SP-A binds encapsulated C. neoformans via a previously unknown IgG dependent mechanism. The consequence of this interaction was the inhibition of IgG-mediated phagocytosis of C. neoformans by alveolar macrophages. Therefore, to assess the contribution of SP-A to the pulmonary host defenses we compared in vivo infections using SP-A null mice (SP-A-/-) and wild-type mice in an intranasal infection model. We found that the immune response assessed by cellular counts, TNF alpha cytokine production, and fungal burden in lungs and bronchoalveolar lavage fluids during early stages of infection were equivalent. Furthermore, the survival outcome of C. neoformans infection was equivalent in SP-A-/- and wild-type mice. Our results suggest that unlike a variety of bacteria, viruses, and other fungi, progression of disease with an inhalational challenge of C. neoformans does not appear to be negatively or positively affected by SP-A mediated mechanisms of pulmonary host defense.	[Giles, Steven S.; Wright, Jo Rae] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Zaas, Aimee K.; Reidy, Mike F.; Perfect, John R.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Duke University	Wright, JR (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	j.wright@cellbio.duke.edu			National Institutes of Health RSUM [HL-51134, HL-30923, AI-051445]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL051134, R01HL030923, R23HL030923] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI051445] Funding Source: NIH RePORTER	National Institutes of Health RSUM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (HL-51134 and HL-30923). SSG was supported by a National Institutes of Health RSUM (HL-51134). The Duke Human Vaccine Institute Flow Cytometry Core Facility is supported by a National Institutes of Health grant (AI-051445). These funders had no role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Alcorn JF, 2004, AM J PHYSIOL-LUNG C, V286, pL129, DOI 10.1152/ajplung.00427.2002; Allen MJ, 2001, INFECT IMMUN, V69, P2037, DOI 10.1128/IAI.69.4.2037-2044.2001; Atochina EN, 2004, INFECT IMMUN, V72, P6002, DOI 10.1128/IAI.72.10.6002-6011.2004; Awasthi S, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-28; Crouch E, 2001, ANNU REV PHYSIOL, V63, P521, DOI 10.1146/annurev.physiol.63.1.521; Crowther JE, 2004, J IMMUNOL, V172, P6866, DOI 10.4049/jimmunol.172.11.6866; CRUICKSHANK JG, 1973, APPL MICROBIOL, V25, P309, DOI 10.1128/AEM.25.2.309-312.1973; Ghildyal R, 1999, J INFECT DIS, V180, P2009, DOI 10.1086/315134; Giles SS, 2005, EUKARYOT CELL, V4, P46, DOI 10.1128/EC.4.1.46-54.2005; Giles SS, 2005, FUNGAL GENET BIOL, V42, P20, DOI 10.1016/j.fgb.2004.09.003; Giles SS, 2006, EUKARYOT CELL, V5, P1447, DOI 10.1128/EC.00098-06; GRANGER DL, 1985, J CLIN INVEST, V76, P508, DOI 10.1172/JCI112000; Hartshorn KL, 1997, AM J PHYSIOL-LUNG C, V273, pL1156, DOI 10.1152/ajplung.1997.273.6.L1156; HAURUM JS, 1993, BIOCHEM J, V293, P873, DOI 10.1042/bj2930873; Kishore U, 2002, IMMUNOBIOLOGY, V205, P610, DOI 10.1078/0171-2985-00158; Lin PM, 2006, AM J PHYSIOL-LUNG C, V291, pL1199, DOI 10.1152/ajplung.00188.2006; Madan T, 1997, INFECT IMMUN, V65, P3171, DOI 10.1128/IAI.65.8.3171-3179.1997; McCormack FX, 2003, J BIOL CHEM, V278, P36250, DOI 10.1074/jbc.M303086200; McCormack FX, 1997, BIOCHEMISTRY-US, V36, P8092, DOI 10.1021/bi970313f; MITCHELL TG, 1995, CLIN MICROBIOL REV, V8, P515, DOI 10.1128/CMR.8.4.515; Nosanchuk JD, 1997, INFECT IMMUN, V65, P1836, DOI 10.1128/IAI.65.5.1836-1841.1997; SCHELENZ S, 1995, INFECT IMMUN, V63, P3360, DOI 10.1128/IAI.63.9.3360-3366.1995; Tino MJ, 1996, AM J PHYSIOL-LUNG C, V270, pL677, DOI 10.1152/ajplung.1996.270.4.L677; Walenkamp AME, 1999, EUR J CLIN INVEST, V29, P83, DOI 10.1046/j.1365-2362.1999.00429.x; Wright JR, 2005, NAT REV IMMUNOL, V5, P58, DOI 10.1038/nri1528; Wright JR, 1997, PHYSIOL REV, V77, P931, DOI 10.1152/physrev.1997.77.4.931; Zaragoza O, 2006, CELL MICROBIOL, V8, P1862, DOI 10.1111/j.1462-5822.2006.00753.x; ZIMMERMAN PE, 1992, J CLIN INVEST, V89, P143, DOI 10.1172/JCI115554	28	24	26	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1370	10.1371/journal.pone.0001370	http://dx.doi.org/10.1371/journal.pone.0001370			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159253	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459700027
J	Franklin, DW; So, U; Burdet, E; Kawato, M				Franklin, David W.; So, Udell; Burdet, Etienne; Kawato, Mitsuo			Visual Feedback Is Not Necessary for the Learning of Novel Dynamics	PLOS ONE			English	Article								Background. When learning to perform a novel sensorimotor task, humans integrate multi-modal sensory feedback such as vision and proprioception in order to make the appropriate adjustments to successfully complete the task. Sensory feedback is used both during movement to control and correct the current movement, and to update the feed-forward motor command for subsequent movements. Previous work has shown that adaptation to stable dynamics is possible without visual feedback. However, it is not clear to what degree visual information during movement contributes to this learning or whether it is essential to the development of an internal model or impedance controller. Methodology/Principle Findings. We examined the effects of the removal of visual feedback during movement on the learning of both stable and unstable dynamics in comparison with the case when both vision and proprioception are available. Subjects were able to learn to make smooth movements in both types of novel dynamics after learning with or without visual feedback. By examining the endpoint stiffness and force after learning it could be shown that subjects adapted to both types of dynamics in the same way whether they were provided with visual feedback of their trajectory or not. The main effects of visual feedback were to increase the success rate of movements, slightly straighten the path, and significantly reduce variability near the end of the movement. Conclusions/Significance. These findings suggest that visual feedback of the hand during movement is not necessary for the adaptation to either stable or unstable novel dynamics. Instead vision appears to be used to fine-tune corrections of hand trajectory at the end of reaching movements.	[Franklin, David W.] Natl Inst Informat & Commun Technol, Keihanna Sci City, Kyoto, Japan; [Franklin, David W.; So, Udell; Kawato, Mitsuo] ATR Computat Neurosci Labs, Keihanna Sci City, Kyoto, Japan; [Franklin, David W.] Univ Cambridge, Dept Engn, Cambridge CB2 1PZ, England; [Burdet, Etienne] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London, England	National Institute of Information & Communications Technology (NICT) - Japan; University of Cambridge; Imperial College London	Franklin, DW (corresponding author), Natl Inst Informat & Commun Technol, Keihanna Sci City, Kyoto, Japan.	dwf25@cam.ac.uk	Franklin, David/A-2371-2009	Franklin, David/0000-0001-9530-0820; Burdet, Etienne/0000-0002-2123-0185	NICT, Japan; DWF; NSERC, Canada	NICT, Japan; DWF; NSERC, Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by funding from NICT, Japan. DWF was supported in part by a fellowship from NSERC, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKESON CG, 1985, J NEUROSCI, V5, P2318; Bedard P, 2004, EXP BRAIN RES, V158, P75, DOI 10.1007/s00221-004-1874-5; Bernier PM, 2006, NEUROREPORT, V17, P1421, DOI 10.1097/01.wnr.0000233096.13032.34; Bernier PM, 2006, J MOTOR BEHAV, V38, P331, DOI 10.3200/JMBR.38.5.331-338; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Brenner E, 2003, SPATIAL VISION, V16, P365, DOI 10.1163/156856803322467581; Burdet E, 2006, BIOL CYBERN, V94, P20, DOI 10.1007/s00422-005-0025-9; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Burdet E, 1998, BIOL CYBERN, V78, P307, DOI 10.1007/s004220050435; Burdet E, 2000, J BIOMECH, V33, P1705, DOI 10.1016/S0021-9290(00)00142-1; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; CORDO P, 1994, J NEUROPHYSIOL, V71, P1848, DOI 10.1152/jn.1994.71.5.1848; DiZio P, 2000, J NEUROPHYSIOL, V84, P2175, DOI 10.1152/jn.2000.84.4.2175; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2004, J NEUROPHYSIOL, V92, P3097, DOI 10.1152/jn.00364.2004; Franklin DW, 2003, J NEUROPHYSIOL, V90, P3270, DOI 10.1152/jn.01112.2002; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Ghahramani Z, 1997, NATURE, V386, P392, DOI 10.1038/386392a0; GHEZ C, 1995, J NEUROPHYSIOL, V73, P361, DOI 10.1152/jn.1995.73.1.361; GHEZ C, 1995, CAN J PHYSIOL PHARM, V73, P273, DOI 10.1139/y95-038; GIELEN CCAM, 1988, J PHYSIOL-LONDON, V407, P275, DOI 10.1113/jphysiol.1988.sp017415; Gomi H, 1998, J NEUROSCI, V18, P8965; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; GOODALE MA, 1986, NATURE, V320, P748, DOI 10.1038/320748a0; GORDON J, 1995, J NEUROPHYSIOL, V73, P347, DOI 10.1152/jn.1995.73.1.347; Graziano MSA, 1999, P NATL ACAD SCI USA, V96, P10418, DOI 10.1073/pnas.96.18.10418; HOGAN N, 1985, BIOL CYBERN, V52, P315, DOI 10.1007/BF00355754; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; IVALDI FAM, 1985, J NEUROSCI, V5, P2732; JORDAN MI, 1992, COGNITIVE SCI, V16, P307, DOI 10.1207/s15516709cog1603_1; Koshland GF, 2000, EXP BRAIN RES, V132, P485; LACKNER JR, 1994, J NEUROPHYSIOL, V72, P299, DOI 10.1152/jn.1994.72.1.299; Lateiner JE, 2003, EXP BRAIN RES, V151, P446, DOI 10.1007/s00221-003-1503-8; Mattar AAG, 2007, J NEUROPHYSIOL, V97, P220, DOI 10.1152/jn.00736.2006; MEYER DE, 1988, PSYCHOL REV, V95, P340, DOI 10.1037/0033-295X.95.3.340; MIALL RC, 1995, EXP BRAIN RES, V103, P421; MILNER TE, 1990, NEUROSCIENCE, V35, P365, DOI 10.1016/0306-4522(90)90090-Q; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Osu R, 2004, NAT NEUROSCI, V7, P111, DOI 10.1038/nn1184; Osu R, 2003, J NEUROPHYSIOL, V90, P3255, DOI 10.1152/jn.00073.2003; PELISSON D, 1986, EXP BRAIN RES, V62, P303; PRABLANC C, 1986, EXP BRAIN RES, V62, P293; Safstrom D, 2004, LEARN MEMORY, V11, P356, DOI 10.1101/lm.71804; SAINBURG RL, 1995, J NEUROPHYSIOL, V73, P820, DOI 10.1152/jn.1995.73.2.820; Sainburg RL, 2003, J NEUROPHYSIOL, V89, P401, DOI 10.1152/jn.00243.2002; Sarlegna F, 2004, EXP BRAIN RES, V157, P468, DOI 10.1007/s00221-004-1860-y; Saunders JA, 2004, J NEUROSCI, V24, P3223, DOI 10.1523/JNEUROSCI.4319-03.2004; Saunders JA, 2003, EXP BRAIN RES, V152, P341, DOI 10.1007/s00221-003-1525-2; Scheidt RA, 2005, J NEUROPHYSIOL, V93, P3200, DOI 10.1152/jn.00947.2004; Selen LPJ, 2005, BIOL CYBERN, V93, P373, DOI 10.1007/s00422-005-0015-y; Selen LPJ, 2006, EXP BRAIN RES, V172, P129, DOI 10.1007/s00221-005-0320-7; Sergio LE, 1998, EXP BRAIN RES, V122, P157, DOI 10.1007/s002210050503; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Sober SJ, 2005, NAT NEUROSCI, V8, P490, DOI 10.1038/nn1427; SOECHTING JF, 1988, J NEUROPHYSIOL, V59, P1296, DOI 10.1152/jn.1988.59.4.1296; Takahashi CD, 2001, J NEUROPHYSIOL, V86, P1047, DOI 10.1152/jn.2001.86.2.1047; Tong C, 2002, J NEUROSCI, V22, P1108, DOI 10.1523/JNEUROSCI.22-03-01108.2002; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; van Beers RJ, 1999, J NEUROPHYSIOL, V81, P1355, DOI 10.1152/jn.1999.81.3.1355; Vetter P, 2000, J NEUROPHYSIOL, V84, P1026, DOI 10.1152/jn.2000.84.2.1026; WOLPERT DM, 1995, SCIENCE, V269, P1880, DOI 10.1126/science.7569931	63	64	64	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1336	10.1371/journal.pone.0001336	http://dx.doi.org/10.1371/journal.pone.0001336			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092002	gold, Green Published			2022-12-25	WOS:000207459600020
J	Huang, AM; Rudelius, M; Sharan, S; McAllister, JM; Raffeld, M; Christenson, LK; Sterneck, E				Huang, A-Mei; Rudelius, Martina; Sharan, Shikha; McAllister, Jan M.; Raffeld, Mark; Christenson, Lane K.; Sterneck, Esta			The Cebpd (C/EBP delta) Gene Is Induced by Luteinizing Hormones in Ovarian Theca and Interstitial Cells But Is Not Essential for Mouse Ovary Function	PLOS ONE			English	Article								The CCAAT/enhancer binding protein (CEBP) family of transcription factors includes five genes. In the ovary, both Cebpa and Cebpb are essential for granulosa cell function. In this study we have explored the role of the Cebpd gene in ovarian physiology by expression and functional studies. Here we report that Cebpd (C/EBPd) is expressed in the mouse ovary in a highly restricted temporal and spatial pattern. In response to luteinizing hormone (LH/hCG), CEBPD expression is transiently induced in interstitial cells and in theca cells of follicles from the primary to pre-ovulatory stage, and overlaps in part with expression of the alpha-smooth muscle actin protein. Efficient down-regulation of CEBPD was dependent on a functional Cebpb gene. Proliferating human theca cells in culture also express Cebpd. Cells from patients with polycystic ovarian syndrome (PCOS) exhibited higher Cebpd expression levels. However, deletion of Cebpd in mice had no overt effect on ovarian physiology and reproductive function. Very little is known at present about the molecular mechanisms underlying theca/interstitial cell functions. The expression pattern of CEBPD reported here identifies a novel functional unit of mouse theca cells of primary through tertiary follicles responding to LH/hCG together with a subset of interstitial cells. This acute stimulation of CEBPD expression may be exploited to further characterize the hormonal regulation and function of theca and interstitial cells.	[Huang, A-Mei; Sharan, Shikha; Sterneck, Esta] NCI, Ctr Canc Res, Frederick, MD 21701 USA; [Rudelius, Martina; Raffeld, Mark] NCI, Pathol Lab, Bethesda, MD 20892 USA; [McAllister, Jan M.] Penn State Univ, Dept Cellular & Mol Physiol, Coll Med, Hershey, PA USA; [Christenson, Lane K.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Kansas; University of Kansas Medical Center	Sterneck, E (corresponding author), NCI, Ctr Canc Res, Frederick, MD 21701 USA.	sterneck@ncifcrf.gov	Christenson, Lane K/G-6435-2013	Sterneck, Esta/0000-0001-7716-8766; Huang, A-Mei/0000-0003-3723-0443	Intramural Research Program of the NIH; National Cancer Institute; National Institutes of Child Health and Human Development [HD045519]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD045519] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, and the National Institutes of Child Health and Human Development (HD045519; L.K.C).	Ascoli M, 2002, ENDOCR REV, V23, P141, DOI 10.1210/er.23.2.141; Billiard J, 2001, J BIOL CHEM, V276, P31238, DOI 10.1074/jbc.M103634200; Breed DR, 1997, ENDOCRINOLOGY, V138, P5527, DOI 10.1210/en.138.12.5527; Carvalho CRO, 2003, ENDOCRINOLOGY, V144, P638, DOI 10.1210/en.2002-220706; Cassel TN, 2000, AM J RESP CELL MOL, V22, P469, DOI 10.1165/ajrcmb.22.4.3916; Chiang MC, 1997, COMP BIOCHEM PHYS A, V116, P361, DOI 10.1016/S0300-9629(96)00375-1; Christenson LK, 2001, J BIOL CHEM, V276, P27392, DOI 10.1074/jbc.M101650200; Fukuoka T, 1999, J BIOL CHEM, V274, P25576, DOI 10.1074/jbc.274.36.25576; Gigliotti AP, 2003, EXP BIOL MED, V228, P278, DOI 10.1177/153537020322800306; GUDERMANN T, 1992, MOL ENDOCRINOL, V6, P272, DOI 10.1210/me.6.2.272; Huang AM, 2004, ONCOGENE, V23, P1549, DOI 10.1038/sj.onc.1207285; Jansen E, 2004, MOL ENDOCRINOL, V18, P3050, DOI 10.1210/me.2004-0074; Mizutani T, 2001, MOL ENDOCRINOL, V15, P1693, DOI 10.1210/me.15.10.1693; Nelson VL, 1999, MOL ENDOCRINOL, V13, P946, DOI 10.1210/me.13.6.946; Nelson VL, 2001, J CLIN ENDOCR METAB, V86, P5925, DOI 10.1210/jc.86.12.5925; O'Rourke JP, 1999, J BIOL CHEM, V274, P16582, DOI 10.1074/jbc.274.23.16582; Park JY, 2004, SCIENCE, V303, P682, DOI 10.1126/science.1092463; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/BJ20020508; Richards JS, 2001, ENDOCRINOLOGY, V142, P2184, DOI 10.1210/en.142.6.2184; RICKLES RJ, 1988, J BIOL CHEM, V263, P1563; Robinson GW, 1998, GENE DEV, V12, P1907, DOI 10.1101/gad.12.12.1907; Russell DL, 2003, MOL ENDOCRINOL, V17, P520, DOI 10.1210/me.2002-0066; Sekar N, 2001, ENDOCRINOLOGY, V142, P2921, DOI 10.1210/en.142.7.2921; SIROIS J, 1992, J BIOL CHEM, V267, P11586; Sterneck E, 1996, J NEUROCHEM, V67, P1365; Sterneck E, 1998, P NATL ACAD SCI USA, V95, P10908, DOI 10.1073/pnas.95.18.10908; Sterneck E, 1997, GENE DEV, V11, P2153, DOI 10.1101/gad.11.17.2153; Sterneck E, 2000, SERONO SYMP, P277; Sugahara K, 1999, CELL TISSUE RES, V297, P261, DOI 10.1007/s004410051354; Takiguchi M, 1998, INT J EXP PATHOL, V79, P369, DOI 10.1046/j.1365-2613.1998.00082.x; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; TESSAROLLO L, 1995, METHOD ENZYMOL, V254, P419; TEUBNER A, 1994, CELL TISSUE RES, V276, P535, DOI 10.1007/BF00343950; Thangaraju M, 2005, DEVELOPMENT, V132, P4675, DOI 10.1242/dev.02050; Tremblay JJ, 2003, J STEROID BIOCHEM, V85, P291, DOI 10.1016/S0960-0760(03)00211-5; Umayahara Y, 1997, J BIOL CHEM, V272, P31793, DOI 10.1074/jbc.272.50.31793; Wood JR, 2003, J BIOL CHEM, V278, P26380, DOI 10.1074/jbc.M300688200	37	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1334	10.1371/journal.pone.0001334	http://dx.doi.org/10.1371/journal.pone.0001334			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092000	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459600018
J	So, PW; Yu, WS; Kuo, YT; Wasserfall, C; Goldstone, AP; Bell, JD; Frost, G				So, Po-Wah; Yu, Wei-Sheng; Kuo, Yu-Ting; Wasserfall, Clive; Goldstone, Anthony P.; Bell, Jimmy D.; Frost, Gary			Impact of Resistant Starch on Body Fat Patterning and Central Appetite Regulation	PLOS ONE			English	Article								Background. Adipose tissue patterning has a major influence on the risk of developing chronic disease. Environmental influences on both body fat patterning and appetite regulation are not fully understood. This study was performed to investigate the impact of resistant starch (RS) on adipose tissue deposition and central regulation of appetite in mice. Methodology and Principle Findings. Forty mice were randomised to a diet supplemented with either the high resistant starch (HRS), or the readily digestible starch (LRS). Using 1 H magnetic resonance (MR) methods, whole body adiposity, intrahepatocellular lipids (IHCL) and intramyocellular lipids (IMCL) were measured. Manganese-enhanced MRI (MEMRI) was used to investigate neuronal activity in hypothalamic regions involved in appetite control when fed ad libitum. At the end of the interventional period, adipocytes were isolated from epididymal adipose tissue and fasting plasma collected for hormonal and adipokine measurement. Mice on the HRS and LRS diet had similar body weights although total body adiposity, subcutaneous and visceral fat, IHCL, plasma leptin, plasma adiponectin plasma insulin/glucose ratios was significantly greater in the latter group. Adipocytes isolated from the LRS group were significantly larger and had lower insulin-stimulated glucose uptake. MEMRI data obtained from the ventromedial and paraventricular hypothalamic nuclei suggests a satiating effect of the HRS diet despite a lower energy intake. Conclusion and Significance. Dietary RS significantly impacts on adipose tissue patterning, adipocyte morphology and metabolism, glucose and insulin metabolism, as well as affecting appetite regulation, supported by changes in neuronal activity in hypothalamic appetite regulation centres which are suggestive of satiation.	[Frost, Gary] Univ Surrey, Sch Biomed & Mol Sci, Dept Nutr Dietet & Food Sci, Guildford GU2 5XH, Surrey, England; [So, Po-Wah] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Imaging Sci Dept, Biol Imaging Ctr, London, England; [Yu, Wei-Sheng; Kuo, Yu-Ting; Goldstone, Anthony P.; Bell, Jimmy D.] Univ London Imperial Coll Sci Technol & Med, MRC Clin Sci Ctr, Imaging Sci Dept, Mol Imaging Grp, London, England; [Kuo, Yu-Ting] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung Med Univ Hosp,Dept Med Imaging, Kaohsiung, Taiwan; [Kuo, Yu-Ting] Kaohsiung Med Univ, Coll Med, Fac Med, Kaohsiung Med Univ Hosp,Dept Radiol, Kaohsiung, Taiwan; [Wasserfall, Clive] Univ Florida, Coll Med, Dept Pathol, Gainesville, FL USA	University of Surrey; Imperial College London; Imperial College London; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; State University System of Florida; University of Florida	Frost, G (corresponding author), Univ Surrey, Sch Biomed & Mol Sci, Dept Nutr Dietet & Food Sci, Guildford GU2 5XH, Surrey, England.	g.frost@surrey.ac.uk	wasserfall, clive/J-9078-2012; Wasserfall, Clive/ABF-9385-2020; So, Po-Wah/B-5892-2012; So, Po-Wah/AAJ-5501-2020	wasserfall, clive/0000-0002-3522-8932; Wasserfall, Clive/0000-0002-3522-8932; So, Po-Wah/0000-0003-3449-8532; Bell, Jimmy/0000-0003-3804-1281; Goldstone, Anthony/0000-0001-8179-7071	MRC; BBSRC; Wellcome Trust; Medical Research Council [MC_U120061305] Funding Source: researchfish; MRC [MC_U120061305] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: The MRC and BBSRC are acknowledged for financial support. The Wellcome Trust is acknowledged for funding the Biological Imaging Centre facility and Ivan Nelson Olivares Coronel por inspiratio. None of the funders had any influence on the conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Anderson GH, 2003, NUTR REV, V61, pS17, DOI 10.1301/nr.2003.may.S17-S26; BJORNTORP P, 1985, ANN INTERN MED, V103, P994, DOI 10.7326/0003-4819-103-6-994; Bouche C, 2002, DIABETES CARE, V25, P822, DOI 10.2337/diacare.25.5.822; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Chaudhri OB, 2006, BIOCHEM BIOPH RES CO, V350, P298, DOI 10.1016/j.bbrc.2006.09.033; *DEFRA, 2006, FAM FOOD REP EXP FOO; Degawa-Yamauchi M, 2005, OBES RES, V13, P662, DOI 10.1038/oby.2005.74; Delzenne NM, 2005, BRIT J NUTR, V93, pS157, DOI 10.1079/BJN20041342; Fei H, 1997, P NATL ACAD SCI USA, V94, P7001, DOI 10.1073/pnas.94.13.7001; Frost G, 1996, METABOLISM, V45, P669, DOI 10.1016/S0026-0495(96)90129-8; Frost G, 1998, METABOLISM, V47, P1245, DOI 10.1016/S0026-0495(98)90331-6; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Huypens P, 2006, HORM METAB RES, V38, P486, DOI 10.1055/s-2006-949520; Kabir M, 1998, J NUTR, V128, P35, DOI 10.1093/jn/128.1.35; Kasim-Karakas SE, 2006, AM J CLIN NUTR, V83, P774, DOI 10.1093/ajcn/83.4.774; Keenan MJ, 2006, OBESITY, V14, P1523, DOI 10.1038/oby.2006.176; KUO Y, 2007, J NEUROSCIE IN PRESS; Kuo YT, 2006, NMR BIOMED, V19, P1028, DOI 10.1002/nbm.1070; Lee K, 2005, ENDOCRINOLOGY, V146, P3, DOI 10.1210/en.2004-0968; Ludwig DS, 2003, LIPIDS, V38, P117, DOI 10.1007/s11745-003-1040-x; Ludwig DS, 1999, JAMA-J AM MED ASSOC, V282, P1539, DOI 10.1001/jama.282.16.1539; MacLean PS, 2006, AM J PHYSIOL-REG I, V290, pR1577, DOI 10.1152/ajpregu.00810.2005; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR288, DOI 10.1152/ajpregu.00010.2004; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Mystkowski P, 2000, INT J OBESITY, V24, P719, DOI 10.1038/sj.ijo.0801231; Nowak L, 2005, AM J HYPERTENS, V18, P1470, DOI 10.1016/j.amjhyper.2005.05.026; Pagano G, 2002, HEPATOLOGY, V35, P367, DOI 10.1053/jhep.2002.30690; Pawlak DB, 2004, LANCET, V364, P778, DOI 10.1016/S0140-6736(04)16937-7; Paxinos G., 2001, MOUSE BRAIN STEREOTA, P1; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; Perez C, 2004, DIABETES, V53, P347, DOI 10.2337/diabetes.53.2.347; Robertson MD, 2007, P NUTR SOC, V66, P351, DOI 10.1017/S0029665107005617; Robertson MD, 2005, AM J CLIN NUTR, V82, P559, DOI 10.1093/ajcn/82.3.559; Skurk T, 2007, J CLIN ENDOCR METAB, V92, P1023, DOI 10.1210/jc.2006-1055; So PW, 2005, INT J OBESITY, V29, P603, DOI 10.1038/sj.ijo.0802917; Thomas EL, 2005, GUT, V54, P122, DOI 10.1136/gut.2003.036566; Ueno N, 2004, ENDOCRINOLOGY, V145, P4176, DOI 10.1210/en.2004-0262; Unger RH, 2003, TRENDS ENDOCRIN MET, V14, P398, DOI 10.1016/j.tem.2003.09.008; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; *WHO, 2007, OB HLTH; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Yao MJ, 2001, NUTR REV, V59, P247; Zhang Y, 2002, BBA-MOL CELL BIOL L, V1584, P115, DOI 10.1016/S1388-1981(02)00298-6	44	91	96	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1309	10.1371/journal.pone.0001309	http://dx.doi.org/10.1371/journal.pone.0001309			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074032	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459500027
J	Tao, WJ; Lin, H; Sun, T; Samanta, AK; Arlinghaus, R				Tao, W. J.; Lin, H.; Sun, T.; Samanta, A. K.; Arlinghaus, R.			BCR-ABL oncogenic transformation of NIH 3T3 fibroblasts requires the IL-3 receptor	ONCOGENE			English	Article						BCR-ABL; interleukin-3 receptor; leukemia; oncogenic transformation	TYROSINE PHOSPHORYLATION; MYELOID-LEUKEMIA; CELLS; JAK2; P210; ACTIVATION; INHIBITOR; BCR/ABL; GROWTH; MYC	Oncogenic transformation of hematopoietic cells by the Bcr-Abl oncoprotein directly involves the activation Jak2 tyrosine kinase and the Stat5 transcription factor. Both proteins are normally linked to the interleukin (IL)-3/granulocyte- macrophage colony-stimulating factor receptors for growth and survival. Since fibroblastic cells are not targets of BCR-ABL-induced oncogenesis, we determined whether forced expression of the IL-3 receptor would allow oncogenic transformation of NIH 3T3 fibroblasts known to be resistant to transformation by BCR-ABL. NIH 3T3 cells transduced with the human IL-3 receptor alpha and beta chains were highly susceptible to oncogenic transformation by expression of BCR-ABL. Forced expression of both receptor chains but not either one alone allowed efficient foci formation of NIH 3T3 cells expressing BCR-ABL (triple positive cells), and these cells formed colonies in soft agar, whereas BCR-ABL+ NIH 3T3 cells lacking IL-3 receptor expression did not. Signaling studies indicate that the BCR-ABL/IL-3 receptor+ NIH 3T3 cells utilize the Gab2/PI-3 kinase pathway activated by Jak2, and the Stat5 pathway activated separately by Bcr-Abl, whereas BCR-ABL+ NIH 3T3 cells lacking the IL-3 receptor do not utilize the Jak2 pathway, but still maintain activation of Stat5. The Bcr-Abl kinase inhibitor imatinib mesylate (1 mu M) and two Jak2 kinase inhibitors strongly inhibited agar colony formation and the activation of Gab2 caused by Jak2. All of these findings indicate that Bcr-Abl oncoprotein requires the IL-3 receptor/Jak2/Stat5 pathways for oncogenic transformation of NIH 3T3 fibroblasts.	[Tao, W. J.; Lin, H.; Sun, T.; Samanta, A. K.; Arlinghaus, R.] Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, Houston, TX 77054 USA	University of Texas System; UTMD Anderson Cancer Center	Arlinghaus, R (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Pathol, 7435 Fannin St,Unit 951, Houston, TX 77054 USA.	rarlingh@mdanderson.org			NATIONAL CANCER INSTITUTE [P01CA049639] Funding Source: NIH RePORTER; NCI NIH HHS [CA49639, P01 CA049639-09A10019, P01 CA049639] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		DALEY GQ, 1987, SCIENCE, V237, P532, DOI 10.1126/science.2440107; Deininger MWN, 2000, BLOOD, V96, P3343, DOI 10.1182/blood.V96.10.3343; GROFFEN J, 1993, LEUKEMIA LYMPHOMA, V11, P19, DOI 10.3109/10428199309047857; Ilaria RL, 1996, J BIOL CHEM, V271, P31704, DOI 10.1074/jbc.271.49.31704; Klejman A, 2002, EMBO J, V21, P5766, DOI 10.1093/emboj/cdf562; LUGO TG, 1989, MOL CELL BIOL, V9, P1263, DOI 10.1128/MCB.9.3.1263; Miyamoto N, 2001, LEUKEMIA, V15, P1758, DOI 10.1038/sj.leu.2402260; QUELLE FW, 1994, MOL CELL BIOL, V14, P4335, DOI 10.1128/MCB.14.7.4335; Samanta AK, 2006, CANCER RES, V66, P6468, DOI 10.1158/0008-5472.CAN-06-0025; Sandberg EM, 2005, J MED CHEM, V48, P2526, DOI 10.1021/jm049470k; SIRARD C, 1994, BLOOD, V83, P1575; Watanabe Sumiko, 1997, Leukemia (Basingstoke), V11, P76; WilsonRawls J, 1996, CANCER RES, V56, P3426; Xie SH, 2002, ONCOGENE, V21, P7137, DOI 10.1038/sj.onc.1205942; Xie SH, 2001, ONCOGENE, V20, P6188, DOI 10.1038/sj.onc.1204834; YOKOTA T, 1993, LEUKEMIA, V7, pS102	16	20	21	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	22					3194	3200		10.1038/sj.onc.1210979	http://dx.doi.org/10.1038/sj.onc.1210979			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	301LL	18071309	Green Accepted			2022-12-25	WOS:000255897600012
J	Tao, Y; Zhang, P; Girdler, F; Frascogna, V; Castedo, M; Bourhis, J; Kroemer, G; Deutsch, E				Tao, Y.; Zhang, P.; Girdler, F.; Frascogna, V.; Castedo, M.; Bourhis, J.; Kroemer, G.; Deutsch, E.			Enhancement of radiation response in p53-deficient cancer cells by the Aurora-B kinase inhibitor AZD1152	ONCOGENE			English	Article						cell cycle; checkpoints; AZD1152 Aurora-B; ionizing radiation; p53	SPINDLE ASSEMBLY CHECKPOINT; MITOTIC CATASTROPHE; DNA-DAMAGE; P53; APOPTOSIS; PHOSPHORYLATION; DIVISION; VX-680; GROWTH; DEATH	Overexpression of the Aurora-B kinase correlates with oncogenic transformation and poor prognosis. We evaluated the effects of the bona. de Aurora-B kinase inhibitor AZD1152 on tumor responses to ionizing radiation (IR). When p53(wt) HCT116 and A549 cells were pretreated with AZD1152-HQPA prior to IR, additive effects were observed. Interestingly, more pronounced tumoricidal effects were observed in p53-deficient HCT116 and HT29 cells, as well as A549 cells treated with the p53 inhibitor cyclic pifithrin-a. In vivo studies on xenografted mice confirmed enhanced tumor growth delay after the combination of IR plus AZD1152-IR as compared to IR alone. Again, this effect was more pronounced with p53(-/-) HCT116 and p53-mutant xenografts. The AZD1152-mediated radiosensitization was mimicked by knockdown of Aurora-B with a short interference RNA or by inhibition of Aurora-B by transfection with an inducible kinase-dead Aurora-B. The radiosensitizing effect of AZD1152 was lost in CHK2(-/-) and 14-3-3(-/-) HCT116 cells. Altogether, these data indicate that AZD1152 can radiosensitize tumor cell lines in vitro and in vivo, the fact that these effects are exacerbated in p53-deficient cancer cells is of potential interest for further clinical development.	[Tao, Y.; Zhang, P.; Frascogna, V.; Bourhis, J.; Deutsch, E.] Inst Gustave Roussy, PRI, Lab UPRES Radiosensit Tumors & Normal Tissues EA2, F-94805 Villejuif, France; [Tao, Y.; Bourhis, J.; Kroemer, G.] Univ Paris 11, Le Kremlin Bicetre, France; [Tao, Y.] Fu Dan Hosp, Canc Hosp, Shanghai, Peoples R China; [Girdler, F.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Castedo, M.; Kroemer, G.] INSERM, U848, Villejuif, France; [Tao, Y.; Zhang, P.; Frascogna, V.; Castedo, M.; Bourhis, J.; Kroemer, G.; Deutsch, E.] Inst Gustave Roussy, Villejuif, France	UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Fudan University; University of Manchester; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy	Deutsch, E (corresponding author), Inst Gustave Roussy, PRI, Lab UPRES Radiosensit Tumors & Normal Tissues EA2, 39 Rue Camille Desmoulins, F-94805 Villejuif, France.	deutsch@igr.fr	Kroemer, Guido/AAY-9859-2020; KROEMER, Guido/B-4263-2013	KROEMER, Guido/0000-0002-9334-4405; deutsch, eric/0000-0002-8223-3697; Bourhis, Jean/0000-0001-5162-1171; Zhang, Ping/0000-0002-3043-8738; tao, yungan/0000-0002-6916-5263				Adams RR, 2001, TRENDS CELL BIOL, V11, P49, DOI 10.1016/S0962-8924(00)01880-8; Anand S, 2003, CANCER CELL, V3, P51, DOI 10.1016/S1535-6108(02)00235-0; Andrews PD, 2005, ONCOGENE, V24, P5005, DOI 10.1038/sj.onc.1208752; Bischoff JR, 1998, EMBO J, V17, P3052, DOI 10.1093/emboj/17.11.3052; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Carmena M, 2003, NAT REV MOL CELL BIO, V4, P842, DOI 10.1038/nrm1245; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Chan TA, 1999, NATURE, V401, P616, DOI 10.1038/44188; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Gadea BB, 2005, MOL BIOL CELL, V16, P1305, DOI 10.1091/mbc.E04-10-0891; Giet R, 2005, TRENDS CELL BIOL, V15, P241, DOI 10.1016/j.tcb.2005.03.004; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Gizatullin F, 2006, CANCER RES, V66, P7668, DOI 10.1158/0008-5472.CAN-05-3353; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092; Hirota T, 2003, CELL, V114, P585, DOI 10.1016/S0092-8674(03)00642-1; Jallepalli PV, 2003, J BIOL CHEM, V278, P20475, DOI 10.1074/jbc.M213159200; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Keen N, 2004, NAT REV CANCER, V4, P927, DOI 10.1038/nrc1502; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006; Milas L, 1999, SEMIN RADIAT ONCOL, V9, P12; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; Ouchi M, 2004, J BIOL CHEM, V279, P19643, DOI 10.1074/jbc.M311780200; Pawlik TM, 2004, INT J RADIAT ONCOL, V59, P928, DOI 10.1016/j.ijrobp.2004.03.005; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Zhang P, 2006, ONCOGENE, V25, P7758, DOI 10.1038/sj.onc.1209744; Zhou BBS, 2004, NAT REV CANCER, V4, P216, DOI 10.1038/nrc1296	31	77	79	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2008	27	23					3244	3255		10.1038/sj.onc.1210990	http://dx.doi.org/10.1038/sj.onc.1210990			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	304LQ	18084327				2022-12-25	WOS:000256111400003
J	Vinge, LE; Von Lueder, TG; Aasum, E; Qvigstad, E; Gravning, JA; How, OJ; Edvardsen, T; Bjornerheim, R; Ahmed, MS; Mikkelsen, BW; Oie, E; Attramadal, T; Skomedal, T; Smiseth, OA; Koch, WJ; Larsen, TS				Vinge, Leif Erik; Von Lueder, Thomas G.; Aasum, Ellen; Qvigstad, Eirik; Gravning, Jorgen A.; How, Ole-Jakob; Edvardsen, Thor; Bjornerheim, Reidar; Ahmed, M. Shakil; Mikkelsen, Birthe W.; Oie, Erik; Attramadal, Toril; Skomedal, Tor; Smiseth, Otto A.; Koch, Walter J.; Larsen, Terje S.		Havard Attramadal	Cardiac-restricted expression of the carboxyl-terminal fragment of GRK3 uncovers distinct functions of GRK3 in regulation of cardiac contractility and growth - GRK3 controls cardiac alpha(1)-adrenergic receptor responsiveness	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ALPHA(1B)-ADRENERGIC RECEPTOR; TRANSGENIC MICE; BLOOD-PRESSURE; HEART-FAILURE; G-PROTEINS; HYPERTROPHY; KINASE; OVEREXPRESSION; PHOSPHORYLATION	G protein-coupled receptor kinase-2 and -3 (GRK2 and GRK3) in cardiac myocytes catalyze phosphorylation and desensitization of different G protein-coupled receptors through specificity controlled by their carboxyl-terminal pleckstrin homology domain. Although GRK2 has been extensively investigated, the function of cardiac GRK3 remains unknown. Thus, in this study cardiac function of GRK3 was investigated in transgenic (Tg) mice with cardiac-restricted expression of a competitive inhibitor of GRK3, i.e. the carboxyl-terminal plasma membrane targeting domain of GRK3 (GRK3ct). Cardiac myocytes from Tg-GRK3ct mice displayed significantly enhanced agonist-stimulated alpha(1)-adrenergic receptor-mediated activation of ERK1/2 versus cardiac myocytes from nontransgenic littermate control (NLC) mice consistent with inhibition of GRK3. Tg-GRK3ct mice did not display alterations of cardiac mass or left ventricular dimensions compared with NLC mice. Tail-cuff plethysmography of 3- and 9-month-old mice revealed elevated systolic blood pressure in Tg-GRK3ct mice versus control mice (3- month-old mice, 136.8 +/- 3.6 versus 118.3 +/- 4.7 mm Hg, p < 0.001), an observation confirmed by radiotelemetric recording of blood pressure of conscious, unrestrained mice. Simultaneous recording of left ventricular pressure and volume in vivo by miniaturized conductance micromanometry revealed increased systolic performance with significantly higher stroke volume and stroke work in Tg-GRK3ct mice than in NLC mice. This phenotype was corroborated in electrically paced ex vivo perfused working hearts. However, analysis of left ventricular function ex vivo as a function of increasing filling pressure disclosed significantly reduced (dP/dt)(min) and prolonged time constant of relaxation (tau) in Tg-GRK3ct hearts at elevated supraphysiological filling pressure compared with control hearts. Thus, inhibition of GRK3 apparently reduces tolerance to elevation of preload. In conclusion, inhibition of cardiac GRK3 causes hypertension because of hyperkinetic myocardium and increased cardiac output relying at least partially on cardiac myocyte alpha(1)-adrenergic receptor hyper-responsiveness. The reduced tolerance to elevation of preload may cause impaired ability to withstand pathophysiological mechanisms of heart failure.	Rikshosp Radiumhosp Med Ctr, Inst Surg Res, N-0027 Oslo, Norway; Univ Oslo, N-0027 Oslo, Norway; [Von Lueder, Thomas G.; Edvardsen, Thor; Oie, Erik; Smiseth, Otto A.] Rikshosp Radiumhosp Med Ctr, Dept Cardiol, N-0027 Oslo, Norway; [Aasum, Ellen] Univ Tromso, Dept Med Physiol, N-9037 Tromso, Norway; [Qvigstad, Eirik; Skomedal, Tor] Univ Oslo, Dept Pharmacol, N-0316 Oslo, Norway; [Bjornerheim, Reidar] Ullevaal Univ Hosp, Dept Cardiol, N-0407 Oslo, Norway; [Koch, Walter J.] Jefferson Med Coll, Ctr Translat Med, Philadelphia, PA 19107 USA	University of Oslo; University of Oslo; University of Oslo; UiT The Arctic University of Tromso; University of Oslo; University of Oslo; Jefferson University	Vinge, LE (corresponding author), Rikshosp Radiumhosp Med Ctr, Inst Surg Res, N-0027 Oslo, Norway.		Edvardsen, Thor/A-1876-2008; Edvardsen, Thor/F-4079-2012	Edvardsen, Thor/0000-0002-3800-765X; Attramadal, Havard/0000-0001-9506-0687				Adams JW, 1998, P NATL ACAD SCI USA, V95, P10140, DOI 10.1073/pnas.95.17.10140; Andersen GO, 2002, AM J PHYSIOL-HEART C, V283, pH1471, DOI 10.1152/ajpheart.00232.2002; Arnett DK, 2001, HYPERTENSION, V38, P767, DOI 10.1161/hy1001.092650; Eckhart AD, 2000, CIRC RES, V86, P43, DOI 10.1161/01.RES.86.1.43; Gan XQ, 2000, J BIOL CHEM, V275, P8469, DOI 10.1074/jbc.275.12.8469; Georgakopoulos D, 1998, AM J PHYSIOL-HEART C, V274, pH1416, DOI 10.1152/ajpheart.1998.274.4.H1416; Grupp IL, 1998, AM J PHYSIOL-HEART C, V275, pH1338, DOI 10.1152/ajpheart.1998.275.4.H1338; How OJ, 2005, AM J PHYSIOL-HEART C, V288, pH2979, DOI 10.1152/ajpheart.00084.2005; Iaccarino G, 1998, AM J PHYSIOL-HEART C, V275, pH1298, DOI 10.1152/ajpheart.1998.275.4.H1298; IKEDA U, 1991, AM J PHYSIOL, V260, pH953, DOI 10.1152/ajpheart.1991.260.3.H953; JULIUS S, 1988, AM HEART J, V116, P600, DOI 10.1016/0002-8703(88)90557-1; Keys JR, 2002, HYPERTENSION, V40, P660, DOI 10.1161/01.HYP.0000035397.73223.CE; KOCH WJ, 1995, SCIENCE, V268, P1350, DOI 10.1126/science.7761854; KOCH WJ, 1993, J BIOL CHEM, V268, P8256; KREGE JH, 1995, HYPERTENSION, V25, P1111, DOI 10.1161/01.HYP.25.5.1111; Lemire I, 2001, AM J PHYSIOL-HEART C, V281, pH931, DOI 10.1152/ajpheart.2001.281.2.H931; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; MILANO CA, 1994, P NATL ACAD SCI USA, V91, P10109, DOI 10.1073/pnas.91.21.10109; Mills PA, 2000, J APPL PHYSIOL, V88, P1537, DOI 10.1152/jappl.2000.88.5.1537; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; PITCHER JA, 1992, SCIENCE, V257, P1264, DOI 10.1126/science.1325672; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Rockman HA, 1998, J BIOL CHEM, V273, P18180, DOI 10.1074/jbc.273.29.18180; Vinge LE, 2001, AM J PHYSIOL-HEART C, V281, pH2490, DOI 10.1152/ajpheart.2001.281.6.H2490; Vinge LE, 2007, MOL PHARMACOL, V72, P582, DOI 10.1124/mol.107.035766; Walker JKL, 1999, AM J PHYSIOL-REG I, V276, pR1214, DOI 10.1152/ajpregu.1999.276.4.R1214	26	29	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10601	10610		10.1074/jbc.M708912200	http://dx.doi.org/10.1074/jbc.M708912200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18165681	hybrid			2022-12-25	WOS:000254894700042
J	Davey, AM; Krise, KM; Sheets, ED; Heikal, AA				Davey, Angel M.; Krise, Keith M.; Sheets, Erin D.; Heikal, Ahmed A.			Molecular perspective of antigen-mediated mast cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-EPSILON-RI; GPI-ANCHORED PROTEINS; FLUID/FLUID PHASE-SEPARATION; TIME-RESOLVED FLUORESCENCE; RESONANCE ENERGY-TRANSFER; PLASMA-MEMBRANE VESICLES; LIPID RAFTS; IMMUNOGLOBULIN-E; MODEL MEMBRANES; LIVING CELLS	Antigen-mediated cross-linking of the high affinity receptor for IgE (Fc epsilon RI), in the plasma membrane of mast cells, is the first step in the allergic immune response. This event triggers the phosphorylation of specific tyrosines in the cytoplasmic segments of the beta and gamma subunits of Fc epsilon RI by the Src tyrosine kinase Lyn, which is anchored to the inner leaflet of the plasma membrane. Lyn-induced phosphorylation of Fc epsilon RI occurs in a cholesterol-dependent manner, leading to the hypothesis that cholesterol-rich domains, or "lipid rafts," may act as functional platforms for IgE receptor signaling. Testing this hypothesis under physiological conditions remains challenging because of the notion that these functional domains are likely transient and much smaller than the diffraction limit of optical microscopy. Here we use ultrafast fluorescence dynamics to investigate the correlation between nanostructural changes in the plasma membrane ( labeled with 1,1'-dioctadecyl-3,3,3',3'-tetramethyl-indocarbocyanine (diI-C-18)) and IgE-Fc epsilon RI cross-linking in adherent RBL mast cells stimulated with multivalent antigen. Time-dependent two-photon fluorescence lifetime imaging microscopy of diI-C18 shows changes in lifetime that agree with the kinetics of stimulated tyrosine phosphorylation of Fc epsilon RI, the first identifiable biochemical step of the allergic response, under the same conditions. In addition, two-photon fluorescence lifetime imaging microscopy of Alexa Fluor 488-labeled IgE indicates that Forster resonance energy transfer occurs with diI-C-18 in the plasma membrane. Our live cell studies provide direct evidence for the association of IgE-Fc epsilon RI with specialized cholesterol-rich domains within similar to 4-nm proximity and with an energy transfer efficiency of 0.22 +/- 0.01 at maximal association during IgE receptor signaling.	[Davey, Angel M.; Krise, Keith M.; Sheets, Erin D.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Heikal, Ahmed A.] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA; [Sheets, Erin D.; Heikal, Ahmed A.] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Sheets, ED (corresponding author), Penn State Univ, Dept Chem, 104 Chem Bldg, University Pk, PA 16802 USA.	eds11@psu.edu; aah12@psu.edu		Sheets, Erin/0000-0002-5980-3225	NIA NIH HHS [AG030949] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R21AG030949] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abramson J, 2007, IMMUNOL REV, V217, P231, DOI 10.1111/j.1600-065X.2007.00518.x; Ariola FS, 2006, PHYS CHEM CHEM PHYS, V8, P4517, DOI 10.1039/b608629b; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bacia K, 2004, BIOPHYS J, V87, P1034, DOI 10.1529/biophysj.104.040519; BAIRD B, 1985, BIOCHEMISTRY-US, V24, P6252, DOI 10.1021/bi00343a032; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Davey AM, 2007, BIOPHYS J, V92, P343, DOI 10.1529/biophysj.106.088815; Dietrich C, 2002, BIOPHYS J, V82, P274, DOI 10.1016/S0006-3495(02)75393-9; Dietrich C, 2001, P NATL ACAD SCI USA, V98, P10642, DOI 10.1073/pnas.191168698; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Draber P, 2002, MOL IMMUNOL, V38, P1247, DOI 10.1016/S0161-5890(02)00071-8; Feigenson GW, 2001, BIOPHYS J, V80, P2775, DOI 10.1016/S0006-3495(01)76245-5; FIELD KA, 1995, P NATL ACAD SCI USA, V92, P9201, DOI 10.1073/pnas.92.20.9201; Frigeri L, 1999, J IMMUNOL, V162, P2243; FURUICHI K, 1984, J IMMUNOL, V133, P1513; Ge MT, 2003, BIOPHYS J, V85, P1278, DOI 10.1016/S0006-3495(03)74563-9; Ge MT, 1999, BIOPHYS J, V76, P264, DOI 10.1016/S0006-3495(99)77195-X; Gidwani A, 2001, BIOCHEMISTRY-US, V40, P12422, DOI 10.1021/bi010496c; Hess ST, 2003, BIOPHYS J, V85, P2566, DOI 10.1016/S0006-3495(03)74679-7; Holowka D, 2000, J CELL SCI, V113, P1009; HOLOWKA D, 2005, BIOCHIM BIOPHYS ACTA, V1743, P252; Holowka D, 2007, IMMUNOL REV, V217, P269, DOI 10.1111/j.1600-065X.2007.00517.x; Hullin-Matsuda F, 2007, CELL MOL LIFE SCI, V64, P2492, DOI 10.1007/s00018-007-7281-x; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; KINOSITA K, 1977, BIOPHYS J, V20, P289, DOI 10.1016/S0006-3495(77)85550-1; KINOSITA K, 1982, BIOPHYS J, V37, P461, DOI 10.1016/S0006-3495(82)84692-4; Lagerholm BC, 2005, ANNU REV PHYS CHEM, V56, P309, DOI 10.1146/annurev.physchem.56.092503.141211; Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, V2nd, DOI 10.1007/978-0-387-46312-4; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; Mayor S, 2004, TRAFFIC, V5, P231, DOI 10.1111/j.1600-0854.2004.00172.x; Mukherjee S, 2004, ANNU REV CELL DEV BI, V20, P839, DOI 10.1146/annurev.cellbio.20.010403.095451; Navratil M, 2006, ANAL CHEM, V78, P4005, DOI 10.1021/ac0606756; Ortega E, 1999, J IMMUNOL, V162, P176; Owen DM, 2007, SEMIN CELL DEV BIOL, V18, P591, DOI 10.1016/j.semcdb.2007.07.011; Panchuk-Voloshina N, 1999, J HISTOCHEM CYTOCHEM, V47, P1179, DOI 10.1177/002215549904700910; Pyenta PS, 2003, J PHYS CHEM A, V107, P8310, DOI 10.1021/jp030005t; Rivera J, 2007, IMMUNOL REV, V217, P255, DOI 10.1111/j.1600-065X.2007.00505.x; Sengupta P, 2007, SEMIN CELL DEV BIOL, V18, P583, DOI 10.1016/j.semcdb.2007.07.010; Sengupta P, 2007, BIOPHYS J, V92, P3564, DOI 10.1529/biophysj.106.094730; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Shaw AS, 2006, NAT IMMUNOL, V7, P1139, DOI 10.1038/ni1405; Sheets ED, 1999, J CELL BIOL, V145, P877, DOI 10.1083/jcb.145.4.877; Sheets ED, 1997, BIOCHEMISTRY-US, V36, P12449, DOI 10.1021/bi9710939; Sheets ED, 1999, CURR OPIN CHEM BIOL, V3, P95, DOI 10.1016/S1367-5931(99)80017-9; Silvius JR, 2006, MOL MEMBR BIOL, V23, P5, DOI 10.1080/09687860500473002; Sinha M, 2003, EUR BIOPHYS J BIOPHY, V32, P381, DOI 10.1007/s00249-003-0281-3; Stottrup BL, 2004, BIOPHYS J, V86, P2942, DOI 10.1016/S0006-3495(04)74345-3; Suhling K, 2005, PHOTOCH PHOTOBIO SCI, V4, P13, DOI 10.1039/b412924p; Swamy MJ, 2006, BIOPHYS J, V90, P4452, DOI 10.1529/biophysj.105.070839; THOMAS JL, 1994, J CELL BIOL, V125, P795, DOI 10.1083/jcb.125.4.795; Varma R, 1998, NATURE, V394, P798, DOI 10.1038/29563; Veatch SL, 2004, BIOPHYS J, V86, P2910, DOI 10.1016/S0006-3495(04)74342-8; Xu K, 1998, J CELL SCI, V111, P2385; Xu KL, 1998, J IMMUNOL, V160, P3225; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zewail AH, 2001, ANGEW CHEM INT EDIT, V40, P4371, DOI 10.1002/1521-3773(20011203)40:23<4371::AID-ANIE4371>3.0.CO;2-I	57	31	32	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7117	7127		10.1074/jbc.M708879200	http://dx.doi.org/10.1074/jbc.M708879200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18093971	hybrid			2022-12-25	WOS:000253779600057
J	Bouaouina, M; Lad, Y; Calderwood, DA				Bouaouina, Mohamed; Lad, Yatish; Calderwood, David A.			The N-terminal domains of talin cooperate with the phosphotyrosine binding-like domain to activate beta 1 and beta 3 integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA CYTOPLASMIC DOMAIN; INTEGRIN ACTIVATION; FERM DOMAIN; INSIDE-OUT; TRANSDOMINANT INHIBITION; CYTOSKELETAL PROTEINS; MAP KINASE; TAILS; ALPHA(IIB)BETA(3); ALPHA-IIB-BETA-3	The activation of integrin adhesion receptors from low to high affinity in response to intracellular cues controls cell adhesion and signaling. Binding of the cytoskeletal protein talin to the beta 3 integrin cytoplasmic tail is required for beta 3 activation, and the integrin-binding PTB-like F3 domain of talin is sufficient to activate beta 3 integrins. Here we report that, whereas the conserved talin-integrin interaction is also required for beta 1 activation, and talin F3 binds beta 1 and beta 3 integrins with comparable affinity, expression of the talin F3 domain is not sufficient to activate beta 1 integrins. beta 1 integrin activation could, however, be detected following expression of larger talin fragments that included the N-terminal and F1 domains, and mutagenesis indicates that these domains cooperate with talin F3 to mediate beta 1 activation. This effect is not due to increased affinity for the integrin beta tail and we hypothesize that the N-terminal domains function by targeting or orienting talin in such a way as to optimize the interaction with the integrin tail. Analysis of beta 3 integrin activation indicates that inclusion of the N-terminal and F1 domains also enhances F3-mediated beta 3 activation. Our results therefore reveal a role for the N-terminal and F1 domains of talin during integrin activation and highlight differences in talin-mediated activation of beta 1 and beta 3 integrins.	Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; Yale Univ, Interdept Program Vasc Biol & Transplantat, New Haven, CT 06520 USA	Yale University; Yale University	Calderwood, DA (corresponding author), 333 Ceder St,POB 208066, New Haven, CT 06520 USA.	david.calderwood@yale.edu	Calderwood, David A/AAC-6954-2019	Calderwood, David A/0000-0002-0791-4142	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL089433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068600] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL 089433] Funding Source: Medline; NIGMS NIH HHS [GM 068600] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arias-Salgado EG, 2005, J BIOL CHEM, V280, P29699, DOI 10.1074/jbc.M503508200; BROWN PJ, 1985, SCIENCE, V228, P1448, DOI 10.1126/science.4012302; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2003, P NATL ACAD SCI USA, V100, P2272, DOI 10.1073/pnas.262791999; Calderwood DA, 2004, J BIOL CHEM, V279, P28889, DOI 10.1074/jbc.M402161200; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Chen H, 2006, GENE DEV, V20, P927, DOI 10.1101/gad.1408306; Critchley DR, 2004, BIOCHEM SOC T, V32, P831, DOI 10.1042/BST0320831; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; DiazGonzalez F, 1996, MOL BIOL CELL, V7, P1939, DOI 10.1091/mbc.7.12.1939; Evans RD, 2003, J CELL BIOL, V160, P589, DOI 10.1083/jcb.200209016; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; GETTNER SN, 1995, J CELL BIOL, V129, P1127, DOI 10.1083/jcb.129.4.1127; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Heckmann D, 2007, ANGEW CHEM INT EDIT, V46, P3571, DOI 10.1002/anie.200700008; Hughes PE, 2002, MOL BIOL CELL, V13, P2256, DOI 10.1091/mbc.01-10-0480; Hughes PE, 1997, CELL, V88, P521, DOI 10.1016/S0092-8674(00)81892-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Keller RS, 2001, AM J PATHOL, V158, P1079, DOI 10.1016/S0002-9440(10)64055-2; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kuo JC, 2006, J CELL BIOL, V172, P619, DOI 10.1083/jcb.200505138; Lad Y, 2007, METHOD ENZYMOL, V426, P69, DOI 10.1016/S0076-6879(07)26004-5; LEPTIN M, 1989, CELL, V56, P401, DOI 10.1016/0092-8674(89)90243-2; Liddington RC, 2002, J CELL BIOL, V158, P833, DOI 10.1083/jcb.200206011; Ma YQ, 2006, BIOCHEMISTRY-US, V45, P6656, DOI 10.1021/bi060279h; Martin-Bermudo MD, 1998, J CELL BIOL, V141, P1073, DOI 10.1083/jcb.141.4.1073; McDowall A, 2003, J CLIN INVEST, V111, P51, DOI 10.1172/JCI200314076; OTOOLE TE, 1995, J BIOL CHEM, V270, P8553, DOI 10.1074/jbc.270.15.8553; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Palecek SP, 1997, NATURE, V385, P537, DOI 10.1038/385537a0; Pearson MA, 2000, CELL, V101, P259, DOI 10.1016/S0092-8674(00)80836-3; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104; REES DJG, 1990, NATURE, V347, P685, DOI 10.1038/347685a0; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Tohyama Y, 2003, MOL BIOL CELL, V14, P2570, DOI 10.1091/mbc.E02-09-0615; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; Ulmer TS, 2003, BIOCHEMISTRY-US, V42, P8307, DOI 10.1021/bi034384s; Ulmer TS, 2001, BIOCHEMISTRY-US, V40, P7498, DOI 10.1021/bi010338l; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WU CY, 1995, CELL, V83, P715, DOI 10.1016/0092-8674(95)90184-1; Yan B, 2001, J BIOL CHEM, V276, P28164, DOI 10.1074/jbc.M104161200; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; Zou ZY, 2007, BLOOD, V109, P3284, DOI 10.1182/blood-2006-10-051664	52	110	114	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6118	6125		10.1074/jbc.M709527200	http://dx.doi.org/10.1074/jbc.M709527200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165225	hybrid			2022-12-25	WOS:000253779500018
J	Davis, B; Koster, G; Douet, LJ; Scigelova, M; Woffendin, G; Ward, JM; Smith, A; Humphries, J; Burnand, KG; Macphee, CH; Postle, AD				Davis, Bill; Koster, Grielof; Douet, Lisa J.; Scigelova, Michaela; Woffendin, Gary; Ward, Joanna M.; Smith, Alberto; Humphries, Julia; Burnand, Kevin G.; Macphee, Colin H.; Postle, Anthony D.			Electrospray ionization mass spectrometry identifies substrates and products of lipoprotein-associated phospholipase A(2) in oxidized human low density lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLATELET-ACTIVATING-FACTOR; SCAVENGER RECEPTOR CD36; CORONARY-HEART-DISEASE; FACTOR ACETYLHYDROLASE; OXIDATION-PRODUCTS; ENDOTHELIAL-CELLS; STRUCTURAL IDENTIFICATION; ATHEROSCLEROTIC LESIONS; THERAPEUTIC TARGET; PROTEIN	There is increasing evidence that modified phospholipid products of low density lipoprotein (LDL) oxidation mediate inflammatory processes within vulnerable atherosclerotic lesions. Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is present in vulnerable plaque regions where it acts on phospholipid oxidation products to generate the pro-inflammatory lysophsopholipids and oxidized non-esterified fatty acids. This association together with identification of circulating Lp-PLA(2) levels as an independent predictor of cardiovascular disease provides a rationale for development of Lp-PLA(2) inhibitors as therapy for atherosclerosis. Here we report a systematic analysis of the effects of in vitro oxidation in the absence and presence of an Lp-PLA(2) inhibitor on the phosphatidylcholine (PC) composition of human LDL. Mass spectrometry identifies three classes of PC whose concentration is significantly enhanced during LDL oxidation. Of these, a series of molecules, represented by peaks in the m/z range 594-666 and identified as truncated PC oxidation products by accurate mass measurements using an LTQ Orbitrap mass spectrometer, are the predominant substrates for Lp-PLA(2). A second series of oxidation products, represented by peaks in the m/z range 746-830 and identified by LTQ Orbitrap analysis as non-truncated oxidized PCs, are quantitatively more abundant but are less efficient Lp-PLA(2) substrates. The major PC products of Lp-PLA(2), saturated and mono-unsaturated lyso-PC, constitute the third class. Mass spectrometric analysis confirms the presence of many of these PCs within human atherosclerotic lesions, suggesting that they could potentially be used as in vivo markers of atherosclerotic disease progression and response to Lp-PLA(2) inhibitor therapy.	[Davis, Bill; Ward, Joanna M.] GlaxoSmithKline Inc, Clin Unit, Cambridge, England; [Davis, Bill; Ward, Joanna M.] Addenbrookes Ctr Clin Invest, Cambridge CB2 2GG, England; [Koster, Grielof; Douet, Lisa J.; Postle, Anthony D.] Univ Southampton, Sch Med, Div Infect Inflammat & Repair, Southampton SO16 6YD, Hants, England; [Scigelova, Michaela; Woffendin, Gary] Thermo Elect Corp, Hempstead HP2 7GE, England; [Smith, Alberto; Humphries, Julia; Burnand, Kevin G.] St Thomas Hosp, Univ London Kings Coll, Div Cardiovasc, Acad Dept Surg, London SE1 7EH, England; [Macphee, Colin H.] GlaxoSmithKline Inc, Cardiovasc Ctr Excellence Drug Discovery, King Of Prussia, PA 19406 USA	GlaxoSmithKline; University of Southampton; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; GlaxoSmithKline	Davis, B (corresponding author), GlaxoSmithKline Inc, Clin Unit, Cambridge, England.	Bill.G.Davis@GSK.com	koster, grielof/F-3129-2012	, Julia/0000-0003-2672-6654; Postle, Anthony/0000-0001-7361-0756				Berliner J, 2002, VASC PHARMACOL, V38, P187, DOI 10.1016/S1537-1891(02)00168-4; Berliner JA, 2001, TRENDS CARDIOVAS MED, V11, P142, DOI 10.1016/S1050-1738(01)00098-6; Birukov KG, 2004, CIRC RES, V95, P892, DOI 10.1161/01.RES.0000147310.18962.06; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bochkov VN, 2002, NATURE, V419, P77, DOI 10.1038/nature01023; Carpenter KLH, 2001, FEBS LETT, V505, P357, DOI 10.1016/S0014-5793(01)02840-X; Caslake MJ, 2000, ATHEROSCLEROSIS, V150, P413, DOI 10.1016/S0021-9150(99)00406-2; Davies SS, 2001, J BIOL CHEM, V276, P16015, DOI 10.1074/jbc.M100878200; Furnkranz A, 2004, CURR PHARM DESIGN, V10, P915, DOI 10.2174/1381612043452929; Harrison KA, 2000, J MASS SPECTROM, V35, P224, DOI 10.1002/(SICI)1096-9888(200002)35:2<224::AID-JMS933>3.0.CO;2-G; Hoff HF, 2003, ARTERIOSCL THROM VAS, V23, P275, DOI 10.1161/01.ATV.0000051407.42536.73; Hunt AN, 2001, J BIOL CHEM, V276, P8492, DOI 10.1074/jbc.M009878200; Ishida M, 2004, RAPID COMMUN MASS SP, V18, P2486, DOI 10.1002/rcm.1650; Koenig W, 2004, CIRCULATION, V110, P1903, DOI 10.1161/01.CIR.0000143377.53389.C8; Kohno M, 1998, CIRCULATION, V98, P353, DOI 10.1161/01.CIR.98.4.353; Koivusalo M, 2001, J LIPID RES, V42, P663; Kolodgie FD, 2006, ARTERIOSCL THROM VAS, V26, P2523, DOI 10.1161/01.ATV.0000244681.72738.bc; Leach CA, 2001, FARMACO, V56, P45, DOI 10.1016/S0014-827X(01)01011-4; Leitinger N, 2003, CURR OPIN LIPIDOL, V14, P421, DOI 10.1097/00041433-200310000-00002; Macphee CH, 2006, CURR OPIN PHARMACOL, V6, P154, DOI 10.1016/j.coph.2005.11.008; Macphee CH, 1999, BIOCHEM J, V338, P479, DOI 10.1042/0264-6021:3380479; Min JH, 1999, BIOCHEMISTRY-US, V38, P12935, DOI 10.1021/bi991149u; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Oei HHS, 2005, CIRCULATION, V111, P570, DOI 10.1161/01.CIR.0000154553.12214.CD; Ohkura N, 2004, ANTIOXID REDOX SIGN, V6, P705, DOI 10.1089/1523086041361686; Ozaki H, 1999, ATHEROSCLEROSIS, V143, P261, DOI 10.1016/S0021-9150(98)00297-4; Packard CJ, 2000, NEW ENGL J MED, V343, P1148, DOI 10.1056/NEJM200010193431603; Papaspyridonos M, 2006, ARTERIOSCL THROM VAS, V26, P1837, DOI 10.1161/01.ATV.0000229695.68416.76; Podrez EA, 2002, J BIOL CHEM, V277, P38517, DOI 10.1074/jbc.M205924200; Podrez EA, 2002, J BIOL CHEM, V277, P38503, DOI 10.1074/jbc.M203318200; Rikitake Y, 2000, ATHEROSCLEROSIS, V152, P79, DOI 10.1016/S0021-9150(99)00453-0; SCHUMAKER VN, 1986, METHOD ENZYMOL, V128, P155; Stafforini DM, 2006, J BIOL CHEM, V281, P4616, DOI 10.1074/jbc.M507340200; Stafforini DM, 1999, J BIOL CHEM, V274, P7018, DOI 10.1074/jbc.274.11.7018; STAFFORINI DM, 1987, J BIOL CHEM, V262, P4215; STREMLER KE, 1991, J BIOL CHEM, V266, P11095; Subbanagounder G, 2000, ARTERIOSCL THROM VAS, V20, P2248, DOI 10.1161/01.ATV.20.10.2248; Subbanagounder G, 2002, VASC PHARMACOL, V38, P201, DOI 10.1016/S1537-1891(02)00170-2; Subbanagounder G, 2002, J BIOL CHEM, V277, P7271, DOI 10.1074/jbc.M107602200; Suckling Keith E, 2002, Expert Opin Ther Targets, V6, P309; Trostchansky A, 2001, ARCH BIOCHEM BIOPHYS, V395, P225, DOI 10.1006/abbi.2001.2583; Ueno Y, 1999, FEBS LETT, V457, P241, DOI 10.1016/S0014-5793(99)01049-2; Walton KA, 2003, ARTERIOSCL THROM VAS, V23, P1197, DOI 10.1161/01.ATV.0000079340.80744.B8; Watson AD, 1999, J BIOL CHEM, V274, P24787, DOI 10.1074/jbc.274.35.24787; Watson AD, 1997, J BIOL CHEM, V272, P13597, DOI 10.1074/jbc.272.21.13597; Witztum JL, 1998, CURR OPIN LIPIDOL, V9, P441, DOI 10.1097/00041433-199810000-00008; Zalewski A, 2005, ARTERIOSCL THROM VAS, V25, P923, DOI 10.1161/01.ATV.0000160551.21962.a7	47	96	98	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6428	6437		10.1074/jbc.M709970200	http://dx.doi.org/10.1074/jbc.M709970200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165686	hybrid			2022-12-25	WOS:000253779500050
J	Bernstein, J; Patterson, DN; Wilson, GM; Toth, EA				Bernstein, Jade; Patterson, Dimeka N.; Wilson, Gerald M.; Toth, Eric A.			Characterization of the essential activities of Saccharomyces cerevisiae Mtr4p, a 3 '-> 5 ' helicase partner of the nuclear exosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INITIATION-FACTOR 4A; BOX RNA HELICASES; TRANSLATION-INITIATION; CRYSTAL-STRUCTURE; POLY(A) POLYMERASE; KINETIC-ANALYSIS; STRUCTURAL BASIS; RIBOSOMAL-RNA; IN-VIVO; PROTEIN	Mtr4p belongs to the Ski2p family of DEVH-box containing proteins and is required for processing and degradation of a variety of RNA substrates in the nucleus. In particular, Mtr4p is required for creating the 5.8 S ribosomal RNA from its 7 S precursor, proper 3'-end processing of the U4 small nuclear RNA and some small nucleolar RNAs, and degradation of aberrant mRNAs and tRNAs. In these studies we have shown that Mtr4p has RNA-dependent ATPase (or dATPase) activity that is stimulated effectively by likely substrates (e. g. tRNA) but surprisingly weakly by poly(A). Using an RNA strand-displacement assay, we have demonstrated that Mtr4p can, in the presence of ATP or dATP, unwind the duplex region of a partial duplex RNA substrate in the 3' -> 5' direction. We have examined the ability of Mtr4p to bind model RNA substrates in the presence of nucleotides that mimic the stages (i.e. ATP-bound, ADP-bound, and nucleotide-free) of the unwinding reaction. Our results demonstrate that the presence of a non-hydrolyzable ATP analog allows Mtr4p to discriminate between partial duplex RNA substrates, binding a 3'-tailed substrate with 5-fold higher affinity than a 5'-tailed substrate. In addition, Mtr4p displays a marked preference for binding to poly(A) RNA relative to an oligoribo nucleotide of the same length and a random sequence. This binding exhibits apparent cooperativity and different dynamic behavior from binding to the random single-stranded RNA. This unique binding mode might be employed primarily for degradation.	[Bernstein, Jade; Patterson, Dimeka N.; Wilson, Gerald M.; Toth, Eric A.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Wilson, Gerald M.; Toth, Eric A.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Canc Ctr, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Toth, EA (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, 108 N Greene St, Baltimore, MD 21201 USA.	etoth001@umaryland.edu	Wilson, Gerald/AAF-3874-2019	Wilson, Gerald/0000-0002-1273-7507	NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA102428] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005; Benz J, 1999, STRUCTURE, V7, P671, DOI 10.1016/S0969-2126(99)80088-4; Bernstein KA, 2006, MOL CELL BIOL, V26, P1195, DOI 10.1128/MCB.26.4.1195-1208.2006; Blum E, 1999, J BIOL CHEM, V274, P4009, DOI 10.1074/jbc.274.7.4009; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Burkard KTD, 2000, MOL CELL BIOL, V20, P604, DOI 10.1128/MCB.20.2.604-616.2000; Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5; Dandliker W B, 1981, Methods Enzymol, V74 Pt C, P3; de la Cruz J, 1999, TRENDS BIOCHEM SCI, V24, P192, DOI 10.1016/S0968-0004(99)01376-6; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Du MX, 2002, BIOCHEM J, V363, P147, DOI 10.1042/0264-6021:3630147; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Haracska L, 2005, MOL CELL BIOL, V25, P10183, DOI 10.1128/MCB.25.22.10183-10189.2005; Heilman-Miller SL, 2001, J MOL BIOL, V306, P1157, DOI 10.1006/jmbi.2001.4437; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612; Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677; Jancarik J, 2004, ACTA CRYSTALLOGR D, V60, P1670, DOI 10.1107/S0907444904010972; Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239; Johnson ER, 1999, RNA, V5, P1526, DOI 10.1017/S1355838299991410; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; LANZETTA PA, 1979, ANAL BIOCHEM, V100, P95, DOI 10.1016/0003-2697(79)90115-5; Levin MK, 2003, J BIOL CHEM, V278, P23311, DOI 10.1074/jbc.M301283200; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Lundblad JR, 1996, MOL ENDOCRINOL, V10, P607, DOI 10.1210/me.10.6.607; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Pang PS, 2002, EMBO J, V21, P1168, DOI 10.1093/emboj/21.5.1168; Preugschat F, 1996, J BIOL CHEM, V271, P24449, DOI 10.1074/jbc.271.40.24449; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; SEAL SN, 1983, P NATL ACAD SCI-BIOL, V80, P6562, DOI 10.1073/pnas.80.21.6562; SEIFRIED SE, 1988, J BIOL CHEM, V263, P13511; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101; SHUMAN S, 1993, J BIOL CHEM, V268, P11798; Smith CA, 1996, BIOPHYS J, V70, P1590, DOI 10.1016/S0006-3495(96)79745-X; Tai CL, 1996, J VIROL, V70, P8477, DOI 10.1128/JVI.70.12.8477-8484.1996; Tanaka N, 2005, BIOCHEMISTRY-US, V44, P9795, DOI 10.1021/bi050407m; Torchet C, 2002, MOL CELL, V9, P1285, DOI 10.1016/S1097-2765(02)00544-0; Tsu CA, 1998, BIOCHEMISTRY-US, V37, P16989, DOI 10.1021/bi981837y; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Vasiljeva L, 2006, MOL CELL, V21, P239, DOI 10.1016/j.molcel.2005.11.028; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 2005, REV FLUORESCENCE, V2, P223; Wilson GM, 2001, J BIOL CHEM, V276, P44450, DOI 10.1074/jbc.M108521200; Wilson GM, 2001, J BIOL CHEM, V276, P8695, DOI 10.1074/jbc.M009848200; XU FF, 1995, NATURE, V374, P180, DOI 10.1038/374180a0; XU FF, 1993, P NATL ACAD SCI USA, V90, P6756, DOI 10.1073/pnas.90.14.6756; Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006	55	55	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4930	4942		10.1074/jbc.M706677200	http://dx.doi.org/10.1074/jbc.M706677200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18096702	hybrid			2022-12-25	WOS:000253426500051
J	Kang, DW; Park, MH; Lee, YJ; Kim, HS; Kwon, TK; Park, WS; Min, DS				Kang, Dong Woo; Park, Mi Hee; Lee, Young Jun; Kim, Hyung Sik; Kwon, Taeg Kyu; Park, Won-Sang; Min, Do Sik			Phorbol ester up-regulates phospholipase D1 but not phospholipase D2 expression through a PKC/Ras/ERK/NF kappa B-dependent pathway and enhances matrix metalloproteinase-9 secretion in colon cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; HUMAN FIBROSARCOMA CELLS; MEDIATED APOPTOSIS; RAS; TUMOR; TRANSFORMATION; INDUCTION; DOMAIN; METALLOPROTEINASE; PROLIFERATION	Despite its importance in cell proliferation and tumorigenesis, very little is known about the molecular mechanism underlying the regulation of phospholipase D (PLD) expression. PLD isozymes are significantly co-overexpressed with cancer marker genes in colorectal carcinoma. Phorbol 12-myristate 13-acetate (PMA) treatment, as a mitogenic signal in colon cancer cells, selectively increases PLD1 expression in transcription and post-transcription. Moreover, experiments using intraperitoneal injection of PMA into mice showed selective PLD1 induction in the intestine and lung tissues, which suggests its physiological relevance in vivo. Therefore, we have undertaken a detailed analysis of the effects of PMA on the promoter activity of PLD genes. Protein kinase C inhibitors, but not a protein kinase A inhibitor, were found to suppress the up-regulation of PLD1 but not PLD2. Dominant-negative mutants of Ras, Raf, and MEK suppressed the induction and activity of PLD1. Moreover, depletion of the supposedly involved proteins reduced the endogenous PLD1 protein level. An important role for NF kappa B as a downstream target of ERK in PMA-induced PLD1 induction was also demonstrated using the inhibitor, small interfering RNA, chromatin immunoprecipitation assay, and site-specific mutagenesis. Furthermore, inhibitors of these signaling proteins and depletion of PLD1 suppressed PMA-induced matrix metalloproteinase-9 secretion and PLD1 induction. In conclusion, we demonstrate for the first time that induction of PLD1 through a protein kinase C/Ras/ERK/NF kappa B-dependent pathway is involved in the secretion of matrix metalloproteinase-9 in colorectal cancer cells.	[Kang, Dong Woo; Park, Mi Hee; Min, Do Sik] Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, Pusan 609735, South Korea; [Lee, Young Jun; Kim, Hyung Sik] Pusan Natl Univ, Coll Pharm, Pusan 609735, South Korea; [Kwon, Taeg Kyu] Keimyung Univ, Sch Med, Dept Immunol, Taegu 700712, South Korea; [Park, Won-Sang] Catholic Univ, Coll Med, Dept Pathol, Seoul 137701, South Korea	Pusan National University; Pusan National University; Keimyung University; Catholic University of Korea	Min, DS (corresponding author), Pusan Natl Univ, Dept Mol Biol, Coll Nat Sci, 30 Jangjeon Dong, Pusan 609735, South Korea.	minds@pusan.ac.kr						Abbas T, 2004, J BIOL CHEM, V279, P9970, DOI 10.1074/jbc.M306979200; Ahn BH, 2003, MOL CELL BIOL, V23, P3103, DOI 10.1128/MCB.23.9.3103-3115.2003; ASTLER VB, 1954, ANN SURG, V139, P846, DOI 10.1097/00000658-195406000-00015; BALLIN M, 1988, BIOCHEM BIOPH RES CO, V154, P832, DOI 10.1016/0006-291X(88)90215-X; BLOBE GC, 1994, CANCER METAST REV, V13, P411, DOI 10.1007/BF00666107; BOS JL, 1989, CANCER RES, V49, P4682; Buchanan FG, 2005, P NATL ACAD SCI USA, V102, P1638, DOI 10.1073/pnas.0406698102; Caretti G, 2003, J BIOL CHEM, V278, P30435, DOI 10.1074/jbc.M304606200; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Exton JH, 1999, BBA-MOL CELL BIOL L, V1439, P121, DOI 10.1016/S1388-1981(99)00089-X; Foster DA, 2003, MOL CANCER RES, V1, P789; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Gustin DM, 2002, CANCER METAST REV, V21, P323, DOI 10.1023/A:1021271229476; Herrant M, 2002, ONCOGENE, V21, P4957, DOI 10.1038/sj.onc.1205689; Kato Y, 2005, J BIOL CHEM, V280, P10938, DOI 10.1074/jbc.M411313200; Kikuchi R, 2007, ONCOGENE, V26, P1802, DOI 10.1038/sj.onc.1209973; Kim J, 2006, CANCER RES, V66, P784, DOI 10.1158/0008-5472.CAN-05-1316; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kurland JF, 2003, J BIOL CHEM, V278, P32465, DOI 10.1074/jbc.M212919200; LIOTTA LA, 1979, P NATL ACAD SCI USA, V76, P2268, DOI 10.1073/pnas.76.5.2268; LIOTTA LA, 1981, BIOCHEMISTRY-US, V20, P100, DOI 10.1021/bi00504a017; MACKAY AR, 1992, INVAS METAST, V12, P168; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Min DS, 2001, CARCINOGENESIS, V22, P1641, DOI 10.1093/carcin/22.10.1641; MOERKERK P, 1994, CANCER RES, V54, P3376; OKADA Y, 1992, J BIOL CHEM, V267, P21712; Park WS, 2000, GASTROENTEROLOGY, V119, P691, DOI 10.1053/gast.2000.16483; Pospisilova S, 2004, BIOCHEM J, V378, P939, DOI 10.1042/BJ20030662; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; Thomas RP, 2002, SURGERY, V132, P127, DOI 10.1067/msy.2002.124930; Vojtek AB, 1998, J BIOL CHEM, V273, P19925, DOI 10.1074/jbc.273.32.19925; Wakelam MJO, 1997, ADV ENZYME REGUL, V37, P29, DOI 10.1016/S0065-2571(96)00023-4; Wang QD, 2006, INT J CANCER, V118, P326, DOI 10.1002/ijc.21373; Wang QD, 2003, J BIOL CHEM, V278, P51091, DOI 10.1074/jbc.M306541200; Wang XF, 2004, ONCOGENE, V23, P1885, DOI 10.1038/sj.onc.1207312; Williger BT, 1999, J BIOL CHEM, V274, P735, DOI 10.1074/jbc.274.2.735	37	60	65	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4094	4104		10.1074/jbc.M707416200	http://dx.doi.org/10.1074/jbc.M707416200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18084005	hybrid, Green Published			2022-12-25	WOS:000253083500045
J	Chan, CHF; Camacho-Leal, P; Stanners, CP				Chan, Carlos H. F.; Camacho-Leal, Pilar; Stanners, Clifford P.			Colorectal Hyperplasia and Dysplasia Due to Human Carcinoembryonic Antigen (CEA) Family Member Expression in Transgenic Mice	PLOS ONE			English	Article							HUMAN TUMOR-MARKER; CELL-ADHESION; CANCER CELLS; INTEGRIN; COLON; CEACAM6; DIFFERENTIATION; MODEL; APOPTOSIS; POLYPS	CEA and CEACAM6 are immunoglobulin family intercellular adhesion molecules that are up-regulated without structural mutations in approximately 70% of human cancers. Results in in vitro systems showing tumorigenic effects for these molecules suggest that this correlation could indicate an instrumental role in tumorigenesis. To test whether this applies in vivo, transgenic mice harboring 187 kb of the human genome containing four CEA family member genes including the CEA and CEACAM6 genes were created and their copy numbers increased by mating until colonocyte expression levels reached levels seen in human colorectal carcinomas. The colonocyte surface level of integrin alpha 5 and the activation of AKT increased progressively with the expression levels of CEA/CEACAM6. Colonic crypts showed a progressive increase in colonocyte proliferation, an increase in crypt fission, and a strong inhibition of both differentiation and anoikis/apoptosis. All transgenic mice showed massively enlarged colons comprising a continuous mosaic of severe hyperplasia, dysplasia and serrated adenomatous morphology. These results suggest that up-regulated non-mutated adhesion molecules could have a significant instrumental role in human cancer.	[Chan, Carlos H. F.; Camacho-Leal, Pilar; Stanners, Clifford P.] McGill Univ, Dept Biochem, McGill Canc Ctr, Montreal, PQ, Canada	McGill University	Chan, CHF (corresponding author), McGill Univ, Dept Biochem, McGill Canc Ctr, Montreal, PQ, Canada.	carlos.chan@mcgill.ca; cliff.stanners@mcgill.ca		Chan, Carlos HF/0000-0003-3656-2470	National Cancer Institute of Canada; Canadian Cancer Society; Canadian Institutes of Health Research; National Science Council (CONACYT) of Mexico	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science Council (CONACYT) of Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)Ministry of Science and Technology, Taiwan)	Funding: This work was supported by grants from the National Cancer Institute of Canada with funds from the Canadian Cancer Society, and by the Canadian Institutes of Health Research. CHFC was supported by a MD/PhD studentship from the Canadian Institutes of Health Research. PC was supported by a studentship from the National Science Council (CONACYT) of Mexico.	ALLARD WJ, 1994, CANCER RES, V54, P1227; Baker K, 2004, J CLIN PATHOL, V57, P1089, DOI 10.1136/jcp.2004.016600; BALLESTA AM, 1995, TUMOR BIOL, V16, P32, DOI 10.1159/000217926; BRETSCHER MS, 1992, EMBO J, V11, P405, DOI 10.1002/j.1460-2075.1992.tb05068.x; Camacho-Leal P, 2007, J CELL PHYSIOL, V211, P791, DOI 10.1002/jcp.20989; Caswell PT, 2006, TRAFFIC, V7, P14, DOI 10.1111/j.1600-0854.2005.00362.x; Chan CHF, 2006, CARCINOGENESIS, V27, P1909, DOI 10.1093/carcin/bgl040; Chan CHF, 2004, MOL THER, V9, P775, DOI 10.1016/j.ymthe.2004.03.009; CHEVINSKY AH, 1991, SEMIN SURG ONCOL, V7, P162, DOI 10.1002/ssu.2980070309; Clarke P, 1998, CANCER RES, V58, P1469; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Duxbury MS, 2004, ANN SURG, V240, P667, DOI 10.1097/01.sla.0000140755.97224.9a; Duxbury MS, 2004, CANCER RES, V64, P3987, DOI 10.1158/0008-5472.CAN-04-0424; Duxbury MS, 2004, BIOCHEM BIOPH RES CO, V317, P133, DOI 10.1016/j.bbrc.2004.03.018; Duxbury MS, 2004, ONCOGENE, V23, P465, DOI 10.1038/sj.onc.1207036; EADESPERNER AM, 1994, CANCER RES, V54, P4169; EIDELMAN FJ, 1993, J CELL BIOL, V123, P467, DOI 10.1083/jcb.123.2.467; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Goldstein NS, 2006, AM J CLIN PATHOL, V125, P146, DOI 10.1309/87BD0C6UCGUG126J; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hammarstrom S, 1998, CELL ADHES COMMUN S, V5, P1; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ilantzis C, 1997, LAB INVEST, V76, P703; Ilantzis C, 2002, NEOPLASIA, V4, P151, DOI 10.1038/sj.neo.7900201; Jantscheff P, 2003, J CLIN ONCOL, V21, P3638, DOI 10.1200/JCO.2003.55.135; Jass JR, 2002, GASTROENTEROLOGY, V123, P862, DOI 10.1053/gast.2002.35392; JASS JR, 1984, CANCER-AM CANCER SOC, V53, P510, DOI 10.1002/1097-0142(19840201)53:3<510::AID-CNCR2820530324>3.0.CO;2-O; Jones SM, 2006, NAT REV CANCER, V6, P175, DOI 10.1038/nrc1817; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Leconte A, 1999, BRIT J CANCER, V80, P1373, DOI 10.1038/sj.bjc.6690531; LYNCH MJ, 1969, MED LAB TECHNOLOGY C; Mandir N, 2005, INT J EXP PATHOL, V86, P125, DOI 10.1111/j.0959-9673.2005.00422.x; Maxwell P, 1999, BRIT J BIOMED SCI, V56, P209; Nicholson TB, 2006, J CELL BIOL, V175, P647, DOI 10.1083/jcb.200605001; Ordonez C, 2000, CANCER RES, V60, P3419; Ordonez C, 2007, J CELL PHYSIOL, V210, P757, DOI 10.1002/jcp.20887; Park CC, 2006, CANCER RES, V66, P1526, DOI 10.1158/0008-5472.CAN-05-3071; PRETLOW TP, 1994, GASTROENTEROLOGY, V107, P1719, DOI 10.1016/0016-5085(94)90812-5; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; RIJKERS T, 1994, TRANSGENIC RES, V3, P203, DOI 10.1007/BF02336773; Rojas M, 1996, CELL GROWTH DIFFER, V7, P655; Schoenthaler SJ, 2000, J ALTERN COMPLEM MED, V6, P7, DOI 10.1089/acm.2000.6.7; Screaton RA, 1997, J CELL BIOL, V137, P939, DOI 10.1083/jcb.137.4.939; Screaton RA, 2000, J CELL BIOL, V150, P613, DOI 10.1083/jcb.150.3.613; Soeth E, 2001, CLIN CANCER RES, V7, P2022; SPECTOR DL, 1998, CELL LAB MANUAL; Stanners CP, 1998, CELL ADHES COMMUN S, V5, P141; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Taheri M, 2003, J BIOL CHEM, V278, P14632, DOI 10.1074/jbc.M212500200; Thompson JA, 1997, INT J CANCER, V72, P197, DOI 10.1002/(SICI)1097-0215(19970703)72:1<197::AID-IJC28>3.0.CO;2-F; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wirth T, 2002, CLIN EXP METASTAS, V19, P155, DOI 10.1023/A:1014566127493; ZHOU H, 1993, CANCER RES, V53, P3817; Zimmermann W, 1998, CELL ADHES COMMUN S, V5, P31	57	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1353	10.1371/journal.pone.0001353	http://dx.doi.org/10.1371/journal.pone.0001353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159236	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459700010
J	Bauer, JA; Lupica, JA; Schmidt, H; Morrison, BH; Haney, RM; Masci, RK; Lee, RM; DiDonato, JA; Lindner, DJ				Bauer, Joseph A.; Lupica, Joseph A.; Schmidt, Heidi; Morrison, Bei H.; Haney, Rebecca M.; Masci, Rhonda K.; Lee, Rebecca M.; DiDonato, Joseph A.; Lindner, Daniel J.			Nitrosylcobalamin Potentiates the Anti-Neoplastic Effects of Chemotherapeutic Agents via Suppression of Survival Signaling	PLOS ONE			English	Article							NF-KAPPA-B; AKT/PROTEIN KINASE-B; NITRIC-OXIDE; TRANSCRIPTION FACTOR; INDUCED APOPTOSIS; CONSTITUTIVE ACTIVATION; ANTITUMOR-ACTIVITY; RELA/P65 SUBUNIT; S-NITROSYLATION; DNA-BINDING	Background. Nitrosylcobalamin (NO-Cbl) is a chemotherapeutic pro-drug derived from vitamin B12 that preferentially delivers nitric oxide (NO) to tumor cells, based upon increased receptor expression. NO-Cbl induces Apo2L/TRAIL-mediated apoptosis and inhibits survival signaling in a variety of malignant cell lines. Chemotherapeutic agents often simultaneously induce an apoptotic signal and activation of NF-kappa B, which has the undesired effect of promoting cell survival. The specific aims of this study were to 1) measure the anti-tumor effects of NO-Cbl alone and in combination with conventional chemotherapeutic agents, and to 2) examine the mechanism of action of NO-Cbl as a single agent and in combination therapy. Methodology. Using anti-proliferative assays, electrophoretic mobility shift assay (EMSA), immunoblot analysis and kinase assays, we demonstrate an increase in the effectiveness of chemotherapeutic agents in combination with NO-Cbl as a result of suppressed NF-kappa B activation. Results. Eighteen chemotherapeutic agents were tested in combination with NOCbl, in thirteen malignant cell lines, resulting in a synergistic anti-proliferative effect in 78% of the combinations tested. NO-Cbl pre-treatment resulted in decreased NF-kappa B DNA binding activity, inhibition of I kappa B kinase (IKK) enzymatic activity, decreased AKT activation, increased caspase-8 and PARP cleavage, and decreased cellular XIAP protein levels. Conclusion. The use of NO-Cbl to inhibit survival signaling may enhance drug efficacy by preventing concomitant activation of NF-kappa B or AKT.	[Bauer, Joseph A.; Schmidt, Heidi; Morrison, Bei H.; Haney, Rebecca M.; Masci, Rhonda K.; Lee, Rebecca M.; Lindner, Daniel J.] Cleveland Clin Fdn, Ctr Hematol & Oncol Mol Therapeut, Taussig Canc Ctr, Cleveland, OH 44195 USA; [Lupica, Joseph A.; DiDonato, Joseph A.] Cleveland Clin Fdn, Lerner Res Inst, Dept Cell Biol, Cleveland, OH 44195 USA; [Lupica, Joseph A.] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Lindner, Daniel J.] Cleveland Clin Fdn, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Cleveland Clinic Foundation	Bauer, JA (corresponding author), Cleveland Clin Fdn, Ctr Hematol & Oncol Mol Therapeut, Taussig Canc Ctr, 9500 Euclid Ave, Cleveland, OH 44195 USA.	bauerj@ccf.org; lindned@ccf.org	Hazen, Stanley L/ABD-5845-2021; Lindner, Daniel/ABB-5440-2020	Lupica, Joseph/0000-0003-1476-037X; Bauer, Joseph/0000-0003-4972-6008	Public Health Service [CA095020]; National Cancer Institute [CA84406]; NATIONAL CANCER INSTITUTE [R01CA084406, R01CA095020] Funding Source: NIH RePORTER	Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding: This work was supported by Public Health Service grant CA095020 to D.J.L. and CA84406 to J.A.D. from the National Cancer Institute and gifts from the Mareb Foundation, the Reuter Foundation, and the Charles R. Jelm Foundation to J.A.B.	Arlt A, 2001, ONCOGENE, V20, P859, DOI 10.1038/sj.onc.1204168; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Baldwin AS, 2001, J CLIN INVEST, V107, P241, DOI 10.1172/JCI11991; Bauer JA, 1998, ANTI-CANCER DRUG, V9, P239, DOI 10.1097/00001813-199803000-00006; Bauer JA, 2002, J NATL CANCER I, V94, P1010; Bava SV, 2005, J BIOL CHEM, V280, P6301, DOI 10.1074/jbc.M410647200; Bender K, 1998, EMBO J, V17, P5170, DOI 10.1093/emboj/17.17.5170; Buchholz TA, 2005, CLIN CANCER RES, V11, P8398, DOI 10.1158/1078-0432.CCR-05-0885; Chawla-Sarkar M, 2003, J BIOL CHEM, V278, P39461, DOI 10.1074/jbc.M306111200; CHENG JQ, 1992, P NATL ACAD SCI USA, V89, P9267, DOI 10.1073/pnas.89.19.9267; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Collins DA, 1997, J NUCL MED, V38, P717; Collins DA, 2000, MAYO CLIN PROC, V75, P568, DOI 10.4065/75.6.568; COOPERMAN JM, 1960, J BIOL CHEM, V235, P191; Dan HC, 2004, J BIOL CHEM, V279, P5405, DOI 10.1074/jbc.M312044200; Das KC, 1997, J BIOL CHEM, V272, P14914, DOI 10.1074/jbc.272.23.14914; DelaTorre A, 1997, BIOCHEM BIOPH RES CO, V238, P703, DOI 10.1006/bbrc.1997.7279; Dhawan P, 2002, CANCER RES, V62, P7335; Dhawan P, 2002, J BIOL CHEM, V277, P7920, DOI 10.1074/jbc.M112210200; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; DIDONATO JA, 1995, MOL CELL BIOL, V15, P1302; DiDonato JA, 2000, METHOD ENZYMOL, V322, P393; Dong QG, 2002, ONCOGENE, V21, P6510, DOI 10.1038/sj.onc.1205848; Fahy BN, 2004, J AM COLL SURGEONS, V198, P591, DOI 10.1016/j.jamcollsurg.2003.12.005; FLODH H, 1968, INT J CANCER, V3, P694, DOI 10.1002/ijc.2910030518; Gasparian AV, 2002, J CELL SCI, V115, P141; Hochwald SN, 2003, AM SURGEON, V69, P15; Huang Y, 2002, MOL PHARMACOL, V61, P105, DOI 10.1124/mol.61.1.105; Israel A, 2000, TRENDS CELL BIOL, V10, P129, DOI 10.1016/S0962-8924(00)01729-3; Karin M, 1999, ONCOGENE, V18, P6867, DOI 10.1038/sj.onc.1203219; Karin M, 1999, J BIOL CHEM, V274, P27339, DOI 10.1074/jbc.274.39.27339; Khwaja A, 1999, NATURE, V401, P33, DOI 10.1038/43354; Kim D, 2002, J BIOCHEM MOL BIOL, V35, P106; Kim SH, 2007, ANN NY ACAD SCI, V1095, P82, DOI 10.1196/annals.1397.012; Kroncke KD, 2000, FASEB J, V14, P166; Lind DS, 2001, SURGERY, V130, P363, DOI 10.1067/msy.2001.116672; Mabuchi S, 2004, CLIN CANCER RES, V10, P7645, DOI 10.1158/1078-0432.CCR-04-0958; Mabuchi S, 2004, J BIOL CHEM, V279, P23477, DOI 10.1074/jbc.M313709200; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Madrid LV, 2001, J BIOL CHEM, V276, P18934, DOI 10.1074/jbc.M101103200; Manderscheid M, 2001, J AM SOC NEPHROL, V12, P1151, DOI 10.1681/ASN.V1261151; Mannick JB, 2004, FREE RADICAL RES, V38, P1, DOI 10.1080/10715760310001629065; Marshall HE, 2001, BIOCHEMISTRY-US, V40, P1688, DOI 10.1021/bi002239y; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Mocellin S, 2007, MED RES REV, V27, P317, DOI 10.1002/med.20092; Murphy MP, 1999, BBA-BIOENERGETICS, V1411, P401, DOI 10.1016/S0005-2728(99)00029-8; Nakanishi C, 2005, NAT REV CANCER, V5, P297, DOI 10.1038/nrc1588; Ozes ON, 1999, NATURE, V401, P82; Park SW, 2005, MOL CELL PROTEOMICS, V4, P300, DOI 10.1074/mcp.M400195-MCP200; Ray A, 2007, CELL MOL BIOL, V53, P3, DOI 10.1170/T771; Reynaert NL, 2004, P NATL ACAD SCI USA, V101, P8945, DOI 10.1073/pnas.0400588101; Rossi A, 2000, NATURE, V403, P103, DOI 10.1038/47520; RUBINSTEIN LV, 1990, J NATL CANCER I, V82, P1113, DOI 10.1093/jnci/82.13.1113; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Seetharam B, 2000, Vitam Horm, V59, P337, DOI 10.1016/S0083-6729(00)59012-8; Seetharam B, 1999, J NUTR, V129, P1761, DOI 10.1093/jn/129.10.1761; Sharma V, 2007, CURR MED CHEM, V14, P1061, DOI 10.2174/092986707780362844; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Stamler JS, 2001, CELL, V106, P675, DOI 10.1016/S0092-8674(01)00495-0; Storling J, 2005, DIABETOLOGIA, V48, P2039, DOI 10.1007/s00125-005-1912-2; Sun M, 2001, AM J PATHOL, V159, P431, DOI 10.1016/S0002-9440(10)61714-2; Tang Z, 2006, MOL CELL BIOL, V26, P5588, DOI 10.1128/MCB.00199-06; Tergaonkar V, 2003, MOL CELL BIOL, V23, P8070, DOI 10.1128/MCB.23.22.8070-8083.2003; Uetsuka H, 2003, EXP CELL RES, V289, P27, DOI 10.1016/S0014-4827(03)00223-4; VOLK T, 1995, BIOCHEM BIOPH RES CO, V213, P196, DOI 10.1006/bbrc.1995.2116; Waldow T, 2006, NITRIC OXIDE-BIOL CH, V15, P103, DOI 10.1016/j.niox.2005.12.005; Wang CY, 1999, NAT MED, V5, P412, DOI 10.1038/7410; Weldon CB, 2001, SURGERY, V130, P143, DOI 10.1067/msy.2001.115512; Wink DA, 1996, ARCH BIOCHEM BIOPHYS, V331, P241, DOI 10.1006/abbi.1996.0304; Yasukawa T, 2005, J BIOL CHEM, V280, P7511, DOI 10.1074/jbc.M411871200; Yeh PY, 2003, BIOCHEM PHARMACOL, V66, P25, DOI 10.1016/S0006-2952(03)00250-8; Yuan ZQ, 2003, J BIOL CHEM, V278, P23432, DOI 10.1074/jbc.M302674200; Yuan ZQ, 2000, ONCOGENE, V19, P2324, DOI 10.1038/sj.onc.1203598; Zandi E, 1998, SCIENCE, V281, P1360, DOI 10.1126/science.281.5381.1360	76	23	24	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1313	10.1371/journal.pone.0001313	http://dx.doi.org/10.1371/journal.pone.0001313			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074035	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459500030
J	Kramer, OH; Muller, S; Reichardt, S; Heinzel, T				Kraemer, Oliver H.; Mueller, Sylvia; Reichardt, Sigrid; Heinzel, Thorsten			Mechanism for ubiquitylation of the leukemia fusion proteins AML1-ETO and PML-RAR alpha	FASEB JOURNAL			English	Article						proteasomal degradation; RLIM; siah-1; UbcH8; HDAC-inhibitor VPA	ACUTE MYELOID-LEUKEMIA; HISTONE DEACETYLASE INHIBITORS; ACUTE PROMYELOCYTIC LEUKEMIA; TRANS-RETINOIC ACID; VALPROIC ACID; TRANSCRIPTIONAL REPRESSION; MAMMALIAN HOMOLOGS; N-COR; DEGRADATION; ACETYLATION	The chromosomal translocation products AML1-ETO and PML-RAR alpha contribute to the pathogenesis of leukemias. Here, we demonstrate that both AML1-ETO and PML-RAR alpha are degraded by the ubiquitin-proteasome system and that their turnover critically depends on the E2-conjugase UbcH8 and the E3-ligase SIAH-1. Contrary to its role in HDAC2 degradation, the E3-ligase RLIM does not target AML1-ETO and PML-RAR alpha for ubiquitin-dependent elimination. RLIM rather is a substrate of SLAH-1, which indicates that these E3-ligases operate in a hierarchical order. Remarkably, proteasomal degradation of leukemia fusion proteins, in addition to the block of histone deacetylase (HDAC) enzymatic activity is a consequence of HDAC-inhibitor treatment. The former requires the induction of UbcH8 expression and each of these processes might be beneficial for leukemia treatment. Our observations shed light on the mechanism determining the interplay between E2-conjugases, E3-ligases, and their substrates and suggest a strategy for utilizing the ubiquitylation machinery in a therapeutic setting.	[Kraemer, Oliver H.; Mueller, Sylvia; Reichardt, Sigrid; Heinzel, Thorsten] Univ Jena, Inst Biochem & Biophys, D-07743 Jena, Germany	Friedrich Schiller University of Jena	Kramer, OH (corresponding author), Univ Jena, Inst Biochem & Biophys, Philosophenweg 12, D-07743 Jena, Germany.	o.kraemer@uni-jena.de	Krämer, Oliver H/L-9266-2015; Heinzel, Thorsten/B-1013-2015	Krämer, Oliver H/0000-0003-3973-045X; 				Bali P, 2005, J BIOL CHEM, V280, P26729, DOI 10.1074/jbc.C500186200; Bug G, 2005, CANCER, V104, P2717, DOI 10.1002/cncr.21589; Bursen A, 2004, ONCOGENE, V23, P6237, DOI 10.1038/sj.onc.1207837; Caron C, 2005, BIOESSAYS, V27, P408, DOI 10.1002/bies.20210; Driever PH, 1999, KLIN PADIATR, V211, P323, DOI 10.1055/s-2008-1043809; Fanelli M, 2004, J BIOL CHEM, V279, P5374, DOI 10.1074/jbc.M306407200; Garcia-Manero G, 2006, BLOOD, V108, P3271, DOI 10.1182/blood-2006-03-009142; GAUB MP, 1992, EXP CELL RES, V201, P335, DOI 10.1016/0014-4827(92)90282-D; George P, 2005, BLOOD, V105, P1768, DOI 10.1182/blood-2004-09-3413; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Gozzini A, 2003, CANCER RES, V63, P8955; Gurvich N, 2004, CANCER RES, V64, P1079, DOI 10.1158/0008-5472.CAN-03-0799; Heinzel T, 1997, NATURE, V387, P43, DOI 10.1038/387043a0; Hicke L, 2001, NAT REV MOL CELL BIO, V2, P195, DOI 10.1038/35056583; Hildebrand D, 2001, J BIOL CHEM, V276, P9889, DOI 10.1074/jbc.M010582200; House CM, 2003, P NATL ACAD SCI USA, V100, P3101, DOI 10.1073/pnas.0534783100; Hu G, 1999, MOL CELL BIOL, V19, P724; Kovacs JJ, 2005, MOL CELL, V18, P601, DOI 10.1016/j.molcel.2005.04.021; Kramer OH, 2006, GENE DEV, V20, P473, DOI 10.1101/gad.364306; Kramer OH, 2001, TRENDS ENDOCRIN MET, V12, P294, DOI 10.1016/S1043-2760(01)00438-6; Kramer OH, 2003, EMBO J, V22, P3411, DOI 10.1093/emboj/cdg315; Kuendgen A, 2006, CANCER-AM CANCER SOC, V106, P112, DOI 10.1002/cncr.21552; Lane AA, 2003, CELL, V115, P305, DOI 10.1016/S0092-8674(03)00852-3; Lutterbach B, 1998, MOL CELL BIOL, V18, P7176, DOI 10.1128/MCB.18.12.7176; Matsuzawa S, 1998, EMBO J, V17, P2736, DOI 10.1093/emboj/17.10.2736; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Nuber U, 1996, J BIOL CHEM, V271, P2795, DOI 10.1074/jbc.271.5.2795; Ostendorff HP, 2002, NATURE, V416, P99, DOI 10.1038/416099a; Peterson LF, 2004, ONCOGENE, V23, P4255, DOI 10.1038/sj.onc.1207727; Phiel CJ, 2001, J BIOL CHEM, V276, P36734, DOI 10.1074/jbc.M101287200; Slack JL, 2000, ANN HEMATOL, V79, P227, DOI 10.1007/s002770050585; Sugimoto T, 2000, AM J HEMATOL, V64, P101, DOI 10.1002/(SICI)1096-8652(200006)64:2<101::AID-AJH5>3.0.CO;2-X; Tou LQ, 2004, MOL CELL BIOL, V24, P3132, DOI 10.1128/MCB.24.8.3132-3139.2004; Wheeler TC, 2002, J BIOL CHEM, V277, P10273, DOI 10.1074/jbc.M107857200; Xie Q, 2002, NATURE, V419, P167, DOI 10.1038/nature00998; Yan M, 2006, NAT MED, V12, P945, DOI 10.1038/nm1443; Yang G, 2007, ONCOGENE, V26, P91, DOI 10.1038/sj.onc.1209760; Yeung MC, 2002, BIOTECHNIQUES, V33, P734, DOI 10.2144/02334bm03; Yoo CB, 2006, NAT REV DRUG DISCOV, V5, P37, DOI 10.1038/nrd1930; Zhang JS, 2001, MOL CELL BIOL, V21, P156, DOI 10.1128/MCB.21.1.156-163.2001; Zhang JS, 1998, GENE DEV, V12, P1775, DOI 10.1101/gad.12.12.1775; Zhao C, 2004, P NATL ACAD SCI USA, V101, P7578, DOI 10.1073/pnas.0402528101; Zhu P, 2004, CANCER CELL, V5, P455, DOI 10.1016/S1535-6108(04)00114-X; [No title captured]	44	63	66	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2008	22	5					1369	1379		10.1096/fj.06-8050com	http://dx.doi.org/10.1096/fj.06-8050com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18073335				2022-12-25	WOS:000255898700010
J	Hu, P; Kinyamu, HK; Wang, LL; Martin, J; Archer, TK; Teng, C				Hu, Peng; Kinyamu, H. Karimi; Wang, Liangli; Martin, Jessica; Archer, Trevor K.; Teng, Christina			Estrogen induces estrogen-related receptor alpha gene expression and chromatin structural changes in estrogen receptor (ER)-positive and ER-negative breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; PROTEIN-COUPLED RECEPTOR; INDEPENDENT TRANSCRIPTIONAL ACTIVATION; HORMONE RESPONSE ELEMENT; HUMAN LACTOFERRIN GENE; GROWTH-FACTOR RECEPTOR; LIGAND-BINDING DOMAIN; NUCLEAR RECEPTORS; ORPHAN RECEPTOR; COACTIVATOR-1-ALPHA PGC-1-ALPHA	Estrogen-related receptor alpha(ERR alpha), a member of the nuclear receptor superfamily, is closely related to the estrogen receptors (ER alpha and ER beta). The ERR alpha gene is estrogen-responsive in several mouse tissues and cell lines, and a multiple hormone-response element (MHRE) in the promoter is an important regulatory region for estrogen- induced ERR alpha gene expression. ERR alpha was recently shown to be a negative prognostic factor for breast cancer survival, with its expression being highest in cancer cells lacking functional ER alpha. The contribution of ERR alpha in breast cancer progression remains unknown but may have important clinical implications. In this study, we investigated ERR alpha gene expression and chromatin structural changes under the influence of 17 beta- estradiol in both ER-positive MCF-7 and ER-negative SKBR3 breast cancer cells. We mapped the nucleosome positions of the ERR alpha promoter around the MHRE region and found that the MHRE resides within a single nucleosome. Local chromatin structure of the MHRE exhibited increased restriction enzyme hypersensitivity and enhanced histone H3 and H4 acetylation upon estrogen treatment. Interestingly, estrogen- induced chromatin structural changes could be repressed by estrogen antagonist ICI 182 780 in MCF-7 cells yet were enhanced in SKBR3 cells. We demonstrated, using chromatin immunoprecipitation assays, that 17 beta- estradiol induces ERR alpha gene expression in MCF-7 cells through active recruitment of co-activators and release of co-repressors when ERR alpha and AP1 bind and ER alpha is tethered to the MHRE. We also found that this estrogen effect requires the MAPK signaling pathway in both cell lines.	[Hu, Peng; Wang, Liangli; Martin, Jessica; Teng, Christina] NIEHS, NIH, Reprod & Dev Toxicol Lab, Gene Regulat Sect, Res Triangle Pk, NC 27709 USA; [Hu, Peng; Wang, Liangli; Martin, Jessica; Teng, Christina] NIEHS, NIH, Chromatin & Gene Express Sect, Res Triangle Pk, NC 27709 USA; [Kinyamu, H. Karimi; Archer, Trevor K.] NIEHS, NIH, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Teng, C (corresponding author), NIEHS, NIH, Reprod & Dev Toxicol Lab, Gene Regulat Sect, 111 Alexander Dr,POB 12233,MD E2-01, Res Triangle Pk, NC 27709 USA.	teng1@niehs.nih.gov	kinyamu, Harriet/AAG-9069-2019; Archer, Trevor K/E-5191-2019	kinyamu, Harriet/0000-0002-2377-7408; Archer, Trevor K/0000-0001-7651-3644	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES071006, ZIAES071006, Z01ES070067] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		ARCHER TK, 1991, MOL CELL BIOL, V11, P688, DOI 10.1128/MCB.11.2.688; Ariazi EA, 2006, CURR TOP MED CHEM, V6, P203, DOI 10.2174/1568026610606030203; Ariazi EA, 2002, CANCER RES, V62, P6510; Ariazi EA, 2007, MOL CANCER RES, V5, P71, DOI 10.1158/1541-7786.MCR-06-0227; Auwerx J, 1999, CELL, V97, P161; Barry JB, 2006, MOL ENDOCRINOL, V20, P302, DOI 10.1210/me.2005-0313; Barry JB, 2005, CANCER RES, V65, P6120, DOI 10.1158/0008-5472.CAN-05-0922; Beato M, 1997, NUCLEIC ACIDS RES, V25, P3559, DOI 10.1093/nar/25.18.3559; Bonnelye E, 1997, MECH DEVELOP, V65, P71, DOI 10.1016/S0925-4773(97)00059-2; Cavallini A, 2005, EUR J CANCER, V41, P1487, DOI 10.1016/j.ejca.2005.04.008; Chen JG, 2006, MOL ENDOCRINOL, V20, P1, DOI 10.1210/me.2005-0192; Chen S, 1999, ENDOCR-RELAT CANCER, V6, P149, DOI 10.1677/erc.0.0060149; CLARK GM, 1983, BREAST CANCER RES TR, V3, pS69, DOI 10.1007/BF01855130; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; DYNAN WS, 1983, CELL, V35, P79, DOI 10.1016/0092-8674(83)90210-6; Filardo EJ, 2005, TRENDS ENDOCRIN MET, V16, P362, DOI 10.1016/j.tem.2005.08.005; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; Fujimura T, 2007, INT J CANCER, V120, P2325, DOI 10.1002/ijc.22363; Gao M, 2006, INT J GYNECOL CANCER, V16, P827, DOI 10.1111/j.1525-1438.2006.00527.x; GAUB MP, 1990, CELL, V63, P1267, DOI 10.1016/0092-8674(90)90422-B; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Greschik H, 2002, MOL CELL, V9, P303, DOI 10.1016/S1097-2765(02)00444-6; Gustafsson JA, 2000, SEMIN PERINATOL, V24, P66, DOI 10.1016/S0146-0005(00)80059-2; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; HYNES NE, 1994, BBA-REV CANCER, V1198, P165, DOI 10.1016/0304-419X(94)90012-4; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Johnston SD, 1997, MOL ENDOCRINOL, V11, P342, DOI 10.1210/me.11.3.342; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; Kallen J, 2004, J BIOL CHEM, V279, P49330, DOI 10.1074/jbc.M407999200; Katzenellenbogen BS, 2000, BREAST CANCER RES, V2, P335, DOI 10.1186/bcr78; Klinge CM, 2004, J MOL ENDOCRINOL, V33, P387, DOI 10.1677/jme.1.01541; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kraus RJ, 2002, J BIOL CHEM, V277, P24826, DOI 10.1074/jbc.M202952200; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Laganiere J, 2004, J BIOL CHEM, V279, P18504, DOI 10.1074/jbc.M313543200; Levin ER, 2005, MOL ENDOCRINOL, V19, P1951, DOI 10.1210/me.2004-0390; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Liu D, 2005, J MOL ENDOCRINOL, V34, P473, DOI 10.1677/jme.1.01586; Liu DX, 2003, ENDOCRINOLOGY, V144, P4894, DOI 10.1210/en.2003-0432; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maggiolini M, 2004, J BIOL CHEM, V279, P27008, DOI 10.1074/jbc.M403588200; Matthews Jason, 2003, Mol Interv, V3, P281, DOI 10.1124/mi.3.5.281; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Moggs JG, 2001, EMBO REP, V2, P775, DOI 10.1093/embo-reports/kve185; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Paech K, 1997, SCIENCE, V277, P1508, DOI 10.1126/science.277.5331.1508; Porter W, 1997, MOL ENDOCRINOL, V11, P1569, DOI 10.1210/me.11.11.1569; Prossnitz ER, 2007, MOL CELL ENDOCRINOL, V265, P138, DOI 10.1016/j.mce.2006.12.010; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; RICHARDFOY H, 1987, EMBO J, V6, P2321, DOI 10.1002/j.1460-2075.1987.tb02507.x; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; Seely J, 2005, ENDOCRINOLOGY, V146, P3605, DOI 10.1210/en.2004-1619; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Shi HP, 1997, GENOMICS, V44, P52, DOI 10.1006/geno.1997.4850; Shigeta H, 1997, J MOL ENDOCRINOL, V19, P299, DOI 10.1677/jme.0.0190299; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Sonoda J, 2007, P NATL ACAD SCI USA, V104, P5223, DOI 10.1073/pnas.0611623104; Stein RA, 2006, ENDOCR-RELAT CANCER, V13, pS25, DOI 10.1677/erc.1.01292; Sun PM, 2005, J MOL MED, V83, P457, DOI 10.1007/s00109-005-0639-3; Suzuki T, 2004, CANCER RES, V64, P4670, DOI 10.1158/0008-5472.CAN-04-0250; TENG CT, 1986, BIOCHEM J, V240, P413, DOI 10.1042/bj2400413; Teng CT, 2002, MOL HUM REPROD, V8, P58, DOI 10.1093/molehr/8.1.58; Tremblay GB, 2002, CRIT REV EUKAR GENE, V12, P1, DOI 10.1615/CritRevEukaryotGeneExpr.v12.i1.10; UMAYAHARA Y, 1994, J BIOL CHEM, V269, P16433; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Vasudevan N, 2007, ENDOCR REV, V28, P1, DOI 10.1210/er.2005-0021; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang L, 2006, J BIOL CHEM, V281, P37773, DOI 10.1074/jbc.M608410200; Wehling M, 2006, J STEROID BIOCHEM, V102, P180, DOI 10.1016/j.jsbmb.2006.09.016; Weigel NL, 2007, MOL ENDOCRINOL, V21, P2311, DOI 10.1210/me.2007-0101; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Yager JD, 2006, NEW ENGL J MED, V354, P270, DOI 10.1056/NEJMra050776; Yang C, 1998, CANCER RES, V58, P5695; Yang NY, 1996, J BIOL CHEM, V271, P5795, DOI 10.1074/jbc.271.10.5795; Zhang Y, 2006, J BIOL CHEM, V281, P39897, DOI 10.1074/jbc.M608657200; Zhang ZP, 2007, MOL CELL ENDOCRINOL, V264, P128, DOI 10.1016/j.mce.2006.11.002; Zhang ZP, 2006, MOL ENDOCRINOL, V20, P1547, DOI 10.1210/me.2005-0252; Zhang ZP, 2000, J BIOL CHEM, V275, P20837, DOI 10.1074/jbc.M001880200	83	19	21	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6752	6763		10.1074/jbc.M705937200	http://dx.doi.org/10.1074/jbc.M705937200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18174157	hybrid			2022-12-25	WOS:000253779600017
J	Meran, S; Thomas, DW; Stephens, P; Enoch, S; Martin, J; Steadman, R; Phillips, AO				Meran, Soma; Thomas, David W.; Stephens, Phillip; Enoch, Stuart; Martin, John; Steadman, Robert; Phillips, Aled O.			Hyaluronan facilitates transforming growth factor-beta(1)-mediated fibroblast proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX REORGANIZATION; RICH PERICELLULAR MATRIX; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; SIGNAL-TRANSDUCTION; ORAL FIBROBLASTS; CD44 INTERACTION; RECEPTOR; VERSICAN	This study aims to understand the role of the matrix polysaccharide hyaluronan (HA) in influencing fibroblast proliferation and thereby affecting wound healing outcomes. To determine mechanisms that underlie scarred versus scar-free healing, patient-matched dermal and oral mucosal fibroblasts were used as models of scarring and non-scarring fibroblast phenotypes. Specifically, differences in HA generation between these distinct fibroblast populations have been examined and related to differences in transforming growth factor-beta(1) (TGF-beta(1))-dependent proliferative responses and Smad signaling. There was a differential growth response to TGF-beta(1), with it inducing proliferation in dermal fibroblasts but an anti-proliferative response in oral fibroblasts. Both responses were Smad3-dependent. Furthermore, the two fibroblast populations also demonstrated differences in their HA regulation, with dermal fibroblasts generating increased levels of HA, compared with oral fibroblasts. Inhibition of HA synthesis in dermal fibroblasts was shown to abrogate the TGF-beta(1)-mediated induction of proliferation. Inhibition of HA synthesis also led to an attenuation of Smad3 signaling in dermal fibroblasts. Microarray analysis demonstrated no difference in the genes involved in TGF-beta(1) signaling between dermal and oral fibroblasts, whereas there was a distinct difference in the pattern of genes involved in HA regulation. In conclusion, these two distinct fibroblast populations demonstrate a differential proliferative response to TGF-beta(1), which is associated with differences in HA generation. TGF-beta(1) regulates proliferation through Smad3 signaling in both fibroblast populations; however, it is the levels of HA generated by the cells that influence the outcome of this response.	[Meran, Soma; Martin, John; Steadman, Robert; Phillips, Aled O.] Cardiff Univ Heath Pk, Inst Nephrol, Sch Med, Cardiff CF14 4XN, S Glam, Wales; [Thomas, David W.; Stephens, Phillip; Enoch, Stuart] Cardiff Univ Heath Pk, Dept Oral Surg, Sch Dent, Cardiff Inst Tissue Engn & Repair, Cardiff CF14 4XN, S Glam, Wales	Cardiff University; Cardiff University	Phillips, AO (corresponding author), Cardiff Univ Heath Pk, Inst Nephrol, Sch Med, Cardiff CF14 4XN, S Glam, Wales.	phillipsao@cf.ac.uk	Steadman, Robert/O-1614-2016	Steadman, Robert/0000-0002-1303-2496; Thomas, David/0000-0001-7319-5820				Anttila MA, 2000, CANCER RES, V60, P150; ANVERSA P, 1993, CARDIOVASC RES, V27, P145, DOI 10.1093/cvr/27.2.145; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Auvinen P, 2000, AM J PATHOL, V156, P529, DOI 10.1016/S0002-9440(10)64757-8; Auvinen PK, 1997, INT J CANCER, V74, P477, DOI 10.1002/(SICI)1097-0215(19971021)74:5<477::AID-IJC1>3.3.CO;2-X; Bedossa P, 2003, J PATHOL, V200, P504, DOI 10.1002/path.1397; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; BORDER WA, 1992, J CLIN INVEST, V90, P1, DOI 10.1172/JCI115821; BORDER WA, 1995, J CLIN INVEST, V96, P655, DOI 10.1172/JCI118107; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bourguignon Lilly Y. W., 1998, Frontiers in Bioscience, V3, pD637; Bourguignon LYW, 2001, J BIOL CHEM, V276, P7327, DOI 10.1074/jbc.M006498200; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; BOURGUIGNON LYW, 1992, MOL CELL BIOL, V12, P4464, DOI 10.1128/MCB.12.10.4464; Brown J A, 2004, J Wound Care, V13, P48; Cantor Jerome O., 2006, Inflammation & Allergy Drug Targets, V5, P257, DOI 10.2174/187152806779010936; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Diegelmann RF, 2004, FRONT BIOSCI-LANDMRK, V9, P283, DOI 10.2741/1184; Eckes B, 2000, MATRIX BIOL, V19, P325, DOI 10.1016/S0945-053X(00)00077-9; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Evanko SP, 1999, ARTERIOSCL THROM VAS, V19, P1004, DOI 10.1161/01.ATV.19.4.1004; FRANCIS GS, 1995, AM J CARDIOL, V75, pA11, DOI 10.1016/S0002-9149(99)80378-6; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Geary RL, 1998, J VASC SURG, V27, P96, DOI 10.1016/S0741-5214(98)70296-4; Green FHY, 2002, CHEST, V122, p334S, DOI 10.1378/chest.122.6_suppl.334S; GRINNELL F, 1994, J CELL BIOL, V124, P401, DOI 10.1083/jcb.124.4.401; HALLGREN R, 1985, BRIT MED J, V290, P1778, DOI 10.1136/bmj.290.6484.1778; HELDIN P, 1993, EXP CELL RES, V208, P422, DOI 10.1006/excr.1993.1264; Ito T, 2004, J BIOL CHEM, V279, P25326, DOI 10.1074/jbc.M403135200; Jenkins RH, 2004, J BIOL CHEM, V279, P41453, DOI 10.1074/jbc.M401678200; Johnsson C, 1996, KIDNEY INT, V50, P1224, DOI 10.1038/ki.1996.431; Kakizaki I, 2004, J BIOL CHEM, V279, P33281, DOI 10.1074/jbc.M405918200; KNUDSON CB, 1993, FASEB J, V7, P1233, DOI 10.1096/fasebj.7.13.7691670; Knudson CB, 1999, BIOCHEM SOC T, V27, P142, DOI 10.1042/bst0270142; KNUDSON CB, 1993, J CELL BIOL, V120, P825, DOI 10.1083/jcb.120.3.825; KNUDSON CB, 1995, DEV DYNAM, V204, P186, DOI 10.1002/aja.1002040209; KNUDSON CB, 1990, CANCER LETT, V52, P113, DOI 10.1016/0304-3835(90)90253-T; KNUDSON CB, 1985, DEV BIOL, V112, P308, DOI 10.1016/0012-1606(85)90401-4; Knudson Warren, 1998, Frontiers in Bioscience, V3, pD604; Krieg T, 1989, Recenti Prog Med, V80, P594; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Kurtis MS, 2001, J ORTHOP RES, V19, P1122, DOI 10.1016/S0736-0266(01)00051-1; Labropoulou VT, 2006, HISTOPATHOLOGY, V49, P582, DOI 10.1111/j.1365-2559.2006.02558.x; Laurent TC, 1996, ANN MED, V28, P241, DOI 10.3109/07853899609033126; Lemire JM, 2007, J CELL BIOCHEM, V101, P753, DOI 10.1002/jcb.21235; Letterio JJ, 1998, ANNU REV IMMUNOL, V16, P137, DOI 10.1146/annurev.immunol.16.1.137; Lewington AJP, 2000, AM J PHYSIOL-REG I, V278, pR247, DOI 10.1152/ajpregu.2000.278.1.R247; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; MERAN S, 2006, J AM SOC NEPHROL, V17, P126; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Moustakas A, 2002, IMMUNOL LETT, V82, P85, DOI 10.1016/S0165-2478(02)00023-8; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Nakamura T, 1997, BIOCHEM MOL BIOL INT, V43, P263; NAKAMURA T, 1995, BIOCHEM BIOPH RES CO, V208, P470, DOI 10.1006/bbrc.1995.1362; Nara Y, 1997, HISTOCHEM J, V29, P21, DOI 10.1023/A:1026460700592; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Nicolas FJ, 2003, J BIOL CHEM, V278, P3251, DOI 10.1074/jbc.M209019200; Okamoto I, 1999, J BIOL CHEM, V274, P25525, DOI 10.1074/jbc.274.36.25525; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Roberts AB, 2001, CHEST, V120, p43S, DOI 10.1378/chest.120.1_suppl.S43-a; Sakaguchi M, 2004, J CELL BIOL, V164, P979, DOI 10.1083/jcb.200312041; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; Selbi W, 2006, KIDNEY INT, V70, P1287, DOI 10.1038/sj.ki.5001760; Selbi W, 2006, J AM SOC NEPHROL, V17, P1553, DOI 10.1681/ASN.2005080879; SHIHAB FS, 1995, J AM SOC NEPHROL, V6, P286; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Sleeman J, 1996, J CELL BIOL, V135, P1139, DOI 10.1083/jcb.135.4.1139; Stephens P, 1996, J DENT RES, V75, P1358, DOI 10.1177/00220345960750060601; Stephens P, 2001, BRIT J DERMATOL, V144, P229, DOI 10.1046/j.1365-2133.2001.04006.x; Szpaderska AM, 2003, J DENT RES, V82, P621, DOI 10.1177/154405910308200810; Ten Dijke PT, 2002, J CELL PHYSIOL, V191, P1, DOI 10.1002/jcp.10066; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Wang LW, 1998, J BIOL CHEM, V273, P8522, DOI 10.1074/jbc.273.14.8522; WELLS A, 1993, TRANSPLANTATION, V55, P1346, DOI 10.1097/00007890-199306000-00025; Wenner CE, 2003, J CELL PHYSIOL, V196, P42, DOI 10.1002/jcp.10243; WOLF YG, 1994, J CLIN INVEST, V93, P1172, DOI 10.1172/JCI117070; Yi JY, 2005, J BIOL CHEM, V280, P10870, DOI 10.1074/jbc.M413223200; Zoltan-Jones A, 2003, J BIOL CHEM, V278, P45801, DOI 10.1074/jbc.M308168200	80	97	103	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6530	6545		10.1074/jbc.M704819200	http://dx.doi.org/10.1074/jbc.M704819200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18174158	hybrid			2022-12-25	WOS:000253779500060
J	Ding, B; Lengyel, P				Ding, Bo; Lengyel, Peter			p204 protein is a novel modulator of Ras activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNALS; NF-KAPPA-B; H-RAS; TUMOR-SUPPRESSOR; K-RAS; MYOBLAST DIFFERENTIATION; CELL-PROLIFERATION; TRANSFORMING GENE; MULTIPLE PATHWAYS; GROWTH-FACTOR	The murine p200 family protein, p204, modulates cell proliferation and tissue differentiation. Many of its activities are exerted in the nucleus. However, in cardiac myocytes, p204 accumulated in the cytoplasm. A yeast two-hybrid assay revealed a p204-cytoplasmic Ras protein interaction. This was confirmed (i) by coimmunoprecipitation of p204 with Ras in mouse heart extract and with endogenous or ectopic H-Ras and K-Ras in cell lysates as well as (ii) by binding of purified H-RasGTP to purified p204 in vitro. p204 inhibited (i) the cleavage of RasGTP to RasGDP by RasGAP; (ii) the binding to RasGTP of Raf-1, phosphatidylinositol 3-kinase, and Ral-GDS, effectors of Ras signaling; and (iii) activation by the Ras pathway of the phosphorylation and thus activation of downstream targets (e. g. MEK, Akt, and p38(MAPK)). Oncogenic Ras expression triggered the phosphorylation and translocation of p204 from the nucleus to the cytoplasm. This is expected to increase the interaction between the two proteins. Translocation triggered by Ras oncoprotein was blocked by the LY294002 inhibitor of phosphatidylinositol 3-kinase. Ras did not promote phosphorylation or translocation to the cytoplasm of mutated p204 in which serine 179 was replaced by alanine. p204 overexpression inhibited the anchorage-independent proliferation of cells expressing Ras(Q61L) oncoprotein. Ras oncoprotein triggered in MEF3T3 cells the rearrangement of the actin cytoskeleton and the enhancement of cell migration through a membrane. Overexpression of p204 inhibited both. Ras oncoprotein or activated, wild-type Ras was described to increase Egr-1 transcription factor expression. We report that a sequence in the gene encoding p204 bound Egr-1, and Egr-1 activated p204 expression. Ras oncoprotein or activated wild-type Ras increased the expression in 3T3 cells of p204 together with that of Egr-1. Furthermore, the activation of expression of a single copy of K-ras oncogene in cultured murine embryonic cells induced the expression of a high level of p204 as well as its distribution between the nuclei and the cytoplasm. Thus, p204 may serve as a negative feedback inhibitor of Ras activity.	[Ding, Bo; Lengyel, Peter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Lengyel, P (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.	peter.lengyel@yale.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI012320, R21AI012320, R01AI012320] Funding Source: NIH RePORTER; NIAID NIH HHS [AI12320] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agathanggelou A, 2005, CANCER RES, V65, P3497, DOI 10.1158/0008-5472.CAN-04-4088; Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Asefa B, 2006, FEBS LETT, V580, P1205, DOI 10.1016/j.febslet.2006.01.032; Bardeesy N, 2006, P NATL ACAD SCI USA, V103, P5947, DOI 10.1073/pnas.0601273103; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; BARSAGI D, 1986, SCIENCE, V233, P1061, DOI 10.1126/science.3090687; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; Bouck N, 1979, Methods Enzymol, V58, P296; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Charest PG, 2007, BIOCHEM J, V401, P377, DOI 10.1042/BJ20061432; CHOUBEY D, 1992, J CELL BIOL, V116, P1333, DOI 10.1083/jcb.116.6.1333; CHOUBEY D, 1989, J BIOL CHEM, V264, P17182; Classon M, 2000, P NATL ACAD SCI USA, V97, P10826, DOI 10.1073/pnas.190343597; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Cuenda A, 2000, METH MOL B, V99, P161; Dalal K, 2006, FEBS LETT, V580, P3083, DOI 10.1016/j.febslet.2006.04.056; Dauffy J, 2006, J LEUKOCYTE BIOL, V79, P173, DOI 10.1189/jlb.0205083; Deschamps S, 2003, GENOMICS, V82, P34, DOI 10.1016/S0888-7543(03)00092-2; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Ding B, 2006, J BIOL CHEM, V281, P14882, DOI 10.1074/jbc.M511747200; Ding Y, 2006, MOL CELL BIOL, V26, P1979, DOI 10.1128/MCB.26.5.1979-1996.2006; DOWNWARD J, 1990, NATURE, V346, P719, DOI 10.1038/346719a0; FEIG LA, 1988, MOL CELL BIOL, V8, P3235, DOI 10.1128/MCB.8.8.3235; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GIBBS JB, 1984, P NATL ACAD SCI-BIOL, V81, P5704, DOI 10.1073/pnas.81.18.5704; Goldberg L, 2006, CANCER RES, V66, P11709, DOI 10.1158/0008-5472.CAN-06-1878; GOLDFARB M, 1982, NATURE, V296, P404, DOI 10.1038/296404a0; GOODY RS, 1992, PHILOS T ROY SOC B, V336, P3, DOI 10.1098/rstb.1992.0037; GUPTA MP, 1991, J BIOL CHEM, V266, P12813; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Hertel L, 2000, ONCOGENE, V19, P3598, DOI 10.1038/sj.onc.1203697; Hjoberg J, 2004, AM J PHYSIOL-LUNG C, V286, pL817, DOI 10.1152/ajplung.00190.2003; HOFER F, 1994, P NATL ACAD SCI USA, V91, P11089, DOI 10.1073/pnas.91.23.11089; Khachigian LM, 2006, CIRC RES, V98, P186, DOI 10.1161/01.RES.0000200177.53882.c3; Kumbrink J, 2005, J BIOL CHEM, V280, P42785, DOI 10.1074/jbc.M511079200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee S, 2004, J BIOL CHEM, V279, P1885, DOI 10.1074/jbc.M306968200; Liu CJ, 2000, MOL CELL BIOL, V20, P7024, DOI 10.1128/MCB.20.18.7024-7036.2000; Liu CJ, 1999, EMBO J, V18, P2845, DOI 10.1093/emboj/18.10.2845; Liu CJ, 2005, J BIOL CHEM, V280, P2788, DOI 10.1074/jbc.M412604200; Liu CJ, 2002, MOL CELL BIOL, V22, P2893, DOI 10.1128/MCB.22.9.2893-2905.2002; Ludlow LEA, 2005, EXP CELL RES, V308, P1, DOI 10.1016/j.yexcr.2005.03.032; Ma XY, 2003, J BIOL CHEM, V278, P23008, DOI 10.1074/jbc.M302105200; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; MARUTA H, 1994, BIOESSAYS, V16, P489, DOI 10.1002/bies.950160708; MCGRATH JP, 1984, NATURE, V310, P644, DOI 10.1038/310644a0; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; MCMAHON SB, 1995, J EXP MED, V181, P417, DOI 10.1084/jem.181.1.417; Min W, 1996, MOL CELL BIOL, V16, P359; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Mitin N, 2005, CURR BIOL, V15, pR563, DOI 10.1016/j.cub.2005.07.010; MOODIE SA, 1993, SCIENCE, V260, P1658, DOI 10.1126/science.8503013; Ohba Y, 2000, J BIOL CHEM, V275, P20020, DOI 10.1074/jbc.M000981200; Oxford G, 2003, CANCER LETT, V189, P117, DOI 10.1016/S0304-3835(02)00510-4; Pan F, 2007, NATURE, V445, P433, DOI 10.1038/nature05476; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; PULCIANI S, 1982, P NATL ACAD SCI-BIOL, V79, P2845, DOI 10.1073/pnas.79.9.2845; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RodriguezViciana P, 1997, CELL, V89, P457, DOI 10.1016/S0092-8674(00)80226-3; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Rolle S, 2001, VIROLOGY, V286, P249, DOI 10.1006/viro.2001.1021; Samuel CE, 2007, J BIOL CHEM, V282, P20045, DOI 10.1074/jbc.R700025200; Sarkar SN, 2004, PHARMACOL THERAPEUT, V103, P245, DOI 10.1016/j.pharmthera.2004.07.007; Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shao HP, 2000, J BIOL CHEM, V275, P26914; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; SHIH C, 1982, CELL, V29, P161, DOI 10.1016/0092-8674(82)90100-3; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; SHIROUZU M, 1994, ONCOGENE, V9, P2153; SPAARGAREN M, 1994, P NATL ACAD SCI USA, V91, P12609, DOI 10.1073/pnas.91.26.12609; SWEET RW, 1984, NATURE, V311, P273, DOI 10.1038/311273a0; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Tuveson DA, 2004, CANCER CELL, V5, P375, DOI 10.1016/S1535-6108(04)00085-6; Vos MD, 2003, J BIOL CHEM, V278, P28045, DOI 10.1074/jbc.M300554200; WARNE PH, 1993, NATURE, V364, P352, DOI 10.1038/364352a0; WEBER H, 1987, EMBO J, V6, P591, DOI 10.1002/j.1460-2075.1987.tb04795.x; WILLUMSEN BM, 1984, NATURE, V310, P583, DOI 10.1038/310583a0; Xin H, 2003, J CELL BIOCHEM, V88, P191, DOI 10.1002/jcb.10372; YAMADA H, 1990, MOL CELL BIOL, V10, P1822, DOI 10.1128/MCB.10.4.1822; Yang JJ, 1998, MOL CELL BIOL, V18, P2586, DOI 10.1128/MCB.18.5.2586; Zhang R, 2007, J BIOL CHEM, V282, P14788, DOI 10.1074/jbc.M701148200	85	17	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5831	5848		10.1074/jbc.M709680200	http://dx.doi.org/10.1074/jbc.M709680200			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165224	hybrid			2022-12-25	WOS:000253426700063
J	Hoeberichts, FA; Vaeck, E; Kiddle, G; Coppens, E; van de Cotte, B; Adamantidis, A; Ormenese, S; Foyer, CH; Zabeau, M; Inze, D; Perilleux, C; Van Breusegem, F; Vuylsteke, M				Hoeberichts, Frank A.; Vaeck, Elke; Kiddle, Guy; Coppens, Emmy; van de Cotte, Brigitte; Adamantidis, Antoine; Ormenese, Sandra; Foyer, Christine H.; Zabeau, Marc; Inze, Dirk; Perilleux, Claire; Van Breusegem, Frank; Vuylsteke, Marnik			A temperature-sensitive mutation in the Arabidopsis thaliana phosphomannomutase gene disrupts protein glycosylation and triggers cell death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							L-ASCORBIC-ACID; CELLULOSE BIOSYNTHESIS; DISULFIDE-ISOMERASE; GLUCOSIDASE-I; HIGHER-PLANTS; GDP-MANNOSE; VITAMIN-C; DEFICIENT; MUTANTS; OLIGOSACCHARYLTRANSFERASE	Eukaryotic phosphomannomutases (PMMs) catalyze the interconversion of mannose 6-phosphate to mannose 1-phosphate and are essential to the biosynthesis of GDP-mannose. As such, plant PMMs are involved in ascorbic acid (AsA) biosynthesis and N-glycosylation. We report on the conditional phenotype of the temperature-sensitive Arabidopsis thaliana pmm- 12 mutant. Mutant seedlings were phenotypically similar to wild type seedlings when grown at 16 - 18 degrees C but died within several days after transfer to 28 degrees C. This phenotype was observed throughout both vegetative and reproductive development. Protein extracts derived from pmm-12 plants had lower PMM protein and enzyme activity levels. In vitro biochemical analysis of recombinant proteins showed that the mutant PMM protein was compromised in its catalytic efficiency (K-cat/K-m). Despite significantly decreased AsA levels in pmm-12 plants, AsA deficiency could not account for the observed phenotype. Since, at restrictive temperature, total glycoprotein patterns were altered and glycosylation of protein-disulfide isomerase was perturbed, we propose that a deficiency in protein glycosylation is responsible for the observed cell death phenotype.	[Hoeberichts, Frank A.; Vaeck, Elke; Coppens, Emmy; van de Cotte, Brigitte; Inze, Dirk; Van Breusegem, Frank; Vuylsteke, Marnik] Univ Ghent VIB, Dept Plant Syst Biol, Vrije Univ Brussel VIB, B-9052 Ghent, Belgium; [Kiddle, Guy; Foyer, Christine H.] Crop Performance & Improvement Div, Rothamsted Res, Harpenden AL5 2JQ, Herts, England; [Adamantidis, Antoine; Ormenese, Sandra; Perilleux, Claire] Univ Liege, Dept Plant Physiol, B-4000 Liege, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University; Vrije Universiteit Brussel; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Liege	Van Breusegem, F (corresponding author), Univ Ghent VIB, Dept Plant Syst Biol, Technologiepark 927, B-9052 Ghent, Belgium.	frank.vanbreusegem@psb.ugent.be	Inzé, Dirk/AAW-6381-2021; Foyer, Christine/K-2143-2012; Van Breusegem, Frank/AAJ-2647-2020; Van Breusegem, Frank/Y-2999-2019	Inzé, Dirk/0000-0002-3217-8407; Van Breusegem, Frank/0000-0002-3147-0860; Adamantidis, Antoine/0000-0003-2531-5175; Foyer, Christine/0000-0001-5989-6989; Perilleux, Claire/0000-0001-7653-2431				BELL CJ, 1994, GENOMICS, V19, P137, DOI 10.1006/geno.1994.1023; BERNSTEIN M, 1985, J CELL BIOL, V101, P2374, DOI 10.1083/jcb.101.6.2374; Boisson M, 2001, EMBO J, V20, P1010, DOI 10.1093/emboj/20.5.1010; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Collet JF, 1998, J BIOL CHEM, V273, P14107, DOI 10.1074/jbc.273.23.14107; Conklin PL, 1996, P NATL ACAD SCI USA, V93, P9970, DOI 10.1073/pnas.93.18.9970; Conklin PL, 1997, PLANT PHYSIOL, V115, P1277, DOI 10.1104/pp.115.3.1277; Conklin PL, 1999, P NATL ACAD SCI USA, V96, P4198, DOI 10.1073/pnas.96.7.4198; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; FAYE L, 1985, ANAL BIOCHEM, V149, P218, DOI 10.1016/0003-2697(85)90498-1; FOYER C, 1983, PLANTA, V157, P239, DOI 10.1007/BF00405188; Garami A, 2001, MOL CELL BIOL, V21, P8168, DOI 10.1128/MCB.21.23.8168-8183.2001; Gillmor CS, 2005, PLANT CELL, V17, P1128, DOI 10.1105/tpc.105.031815; Gillmor CS, 2002, J CELL BIOL, V156, P1003, DOI 10.1083/jcb.200111093; Hancock Robert D., 2003, BMC Plant Biology, V3, P7, DOI 10.1186/1471-2229-3-7; Hashimoto H, 1997, J BIOL CHEM, V272, P16308, DOI 10.1074/jbc.272.26.16308; Jander G, 2002, PLANT PHYSIOL, V129, P440, DOI 10.1104/pp.003533; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Karimi M, 2002, TRENDS PLANT SCI, V7, P193, DOI 10.1016/S1360-1385(02)02251-3; KEPES F, 1988, J BIOL CHEM, V263, P9155; Kinoshita T, 2000, CURR OPIN CHEM BIOL, V4, P632, DOI 10.1016/S1367-5931(00)00151-4; Koiwa H, 2003, PLANT CELL, V15, P2273, DOI 10.1105/tpc.013862; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; Kukuruzinska MA, 1999, BBA-GEN SUBJECTS, V1426, P359, DOI 10.1016/S0304-4165(98)00136-6; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; Lerouxel O, 2005, PLANT J, V42, P455, DOI 10.1111/j.1365-313X.2005.02392.x; Lukowitz W, 2001, P NATL ACAD SCI USA, V98, P2262, DOI 10.1073/pnas.051625798; McGuffin LJ, 2003, BIOINFORMATICS, V19, P874, DOI 10.1093/bioinformatics/btg097; Morais MC, 2000, BIOCHEMISTRY-US, V39, P10385, DOI 10.1021/bi001171j; NAKASHIMA T, 1993, MOL CELL BIOL, V13, P6367, DOI 10.1128/MCB.13.10.6367; Peters JL, 2004, THEOR APPL GENET, V108, P321, DOI 10.1007/s00122-003-1427-5; Peters JL, 2001, PLANT PHYSIOL, V127, P1579, DOI 10.1104/pp.010504; Qian WQ, 2007, PLANT J, V49, P399, DOI 10.1111/j.1365-313X.2006.02967.x; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Rozen S, 2000, Methods Mol Biol, V132, P365; Seifert GJ, 2004, CURR OPIN PLANT BIOL, V7, P277, DOI 10.1016/j.pbi.2004.03.004; SHIMONI Y, 1995, PLANT PHYSIOL, V108, P327, DOI 10.1104/pp.108.1.327; SHORROSH BS, 1993, PLANT PHYSIOL, V103, P719, DOI 10.1104/pp.103.3.719; SILBERSTEIN S, 1995, J CELL BIOL, V131, P371, DOI 10.1083/jcb.131.2.371; Silvaggi NR, 2006, J BIOL CHEM, V281, P14918, DOI 10.1074/jbc.M601505200; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Thiel C, 2006, MOL CELL BIOL, V26, P5615, DOI 10.1128/MCB.02391-05; VAECK E, 2006, THESIS GHENT U GENT; VanSchaftingen E, 1995, FEBS LETT, V377, P318, DOI 10.1016/0014-5793(95)01357-1; VERNON LP, 1960, ANAL CHEM, V32, P1144, DOI 10.1021/ac60165a029; Vuylsteke M, 2007, NAT PROTOC, V2, P1387, DOI 10.1038/nprot.2007.175; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2007, PHYTOCHEMISTRY, V68, P2602, DOI 10.1016/j.phytochem.2007.08.034	49	51	58	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5708	5718		10.1074/jbc.M704991200	http://dx.doi.org/10.1074/jbc.M704991200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086684	Green Published, hybrid			2022-12-25	WOS:000253426700052
J	Kotzsch, A; Nickel, J; Seher, A; Heinecke, K; van Geersdaele, L; Herrmann, T; Sebald, W; Mueller, TD				Kotzsch, Alexander; Nickel, Joachim; Seher, Axel; Heinecke, Kai; van Geersdaele, Laura; Herrmann, Thomas; Sebald, Walter; Mueller, Thomas D.			Structure analysis of bone morphogenetic protein-2 type I receptor complexes reveals a mechanism of receptor inactivation in juvenile polyposis syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TGF-BETA SUPERFAMILY; GROWTH-FACTOR-BETA; CELL-LINE; MUTATIONS; BINDING; DIFFERENTIATION; BMP-2; OSTEOBLAST; LIGAND; GENE	Bone morphogenetic proteins regulate many developmental processes during embryogenesis as well as tissue homeostasis in the adult. Signaling of bone morphogenetic proteins (BMPs) is accomplished by binding to two types of serine/threonine kinase transmembrane receptors termed type I and type II. Because a large number of ligands signal through a limited number of receptors, ligand-receptor interaction in the BMP superfamily is highly promiscuous, with a ligand binding to various receptors and a receptor binding many different BMP ligands. In this study we investigate the interaction of BMP-2 with its two high affinity type I receptors, BMP receptors IA (BMPR-IA) and BMPR-IB. Interestingly, 50% of the residues in the BMP-2 binding epitope of the BMPR-IA receptor are exchanged in BMPR-IB without a decrease in binding affinity or specificity for BMP-2. Our structural and functional analyses show that promiscuous binding of BMP-2 to both type I receptors is achieved by inherent backbone and side-chain flexibility as well as by variable hydration of the ligand-receptor interface enabling the BMP-2 surface to adapt to different receptor geometries. Despite the high degree of amino acid variability found in BMPR-IA and BMPR-IB binding equally to BMP-2, three single point missense mutations in the ectodomain of BMPR-IA cannot be tolerated. In juvenile polyposis syndrome these mutations have been shown to inactivate BMPR-IA. On the basis of our biochemical and biophysical analyses, we can show that the mutations, which are located outside the ligand binding epitope, alter the local or global fold of the receptor, thereby inactivating BMPR-IA and causing a loss of the BMP-2 tumor suppressor function in colon epithelial cells.	[Kotzsch, Alexander; Mueller, Thomas D.] Univ Wurzburg, Lehrstuhl Bot 1, Julius Von Sachs Inst, D-97082 Wurzburg, Germany; [Nickel, Joachim; Seher, Axel; Heinecke, Kai; van Geersdaele, Laura; Sebald, Walter] Univ Wurzburg, Lehrstuhl Physiol Chem 2, Theodor Boveri Inst, Biowissenschaften Biozentrum, D-97074 Wurzburg, Germany; [Herrmann, Thomas] Univ Wurzburg, Inst Virol & Immunobiol, D-97070 Wurzburg, Germany; [Sebald, Walter; Mueller, Thomas D.] Univ Wurzburg, Rudolf Virchow Zentrum, Deutsch Forschungsgemeinschaft Forschungzentrum, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Mueller, TD (corresponding author), Univ Wurzburg, Dept Mol Plant Physiol & Biophys, Julius Von Sachs Platz 2, D-97082 Wurzburg, Germany.	mueller@biozentrum.uni-wuerzburg.de	Herrmann, Thomas/J-4943-2012	Herrmann, Thomas/0000-0002-1093-0194; Mueller, Thomas/0000-0003-1862-7357				Akiyama S, 1997, EXP CELL RES, V235, P362, DOI 10.1006/excr.1997.3680; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; Auclair BA, 2007, GASTROENTEROLOGY, V133, P887, DOI 10.1053/j.gastro.2007.06.066; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; de Caestecker MP, 2000, JNCI-J NATL CANCER I, V92, P1388, DOI 10.1093/jnci/92.17.1388; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Ebisawa T, 1999, J CELL SCI, V112, P3519; Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006; Ely KR, 2002, J MOL RECOGNIT, V15, P286, DOI 10.1002/jmr.589; Everman DB, 2002, AM J MED GENET, V112, P291, DOI 10.1002/ajmg.10777; Greenwald J, 2003, MOL CELL, V11, P605, DOI 10.1016/S1097-2765(03)00094-7; Hardwick JCH, 2004, GASTROENTEROLOGY, V126, P111, DOI 10.1053/j.gastro.2003.10.067; HEMMATIBRIVANLOU A, 1995, DEV GENET, V17, P78, DOI 10.1002/dvg.1020170109; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Howe JR, 2004, J MED GENET, V41, P484, DOI 10.1136/jmg.2004.018598; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Howe JR, 2001, NAT GENET, V28, P184, DOI 10.1038/88919; Kaplan FS, 2007, EXPERT OPIN BIOL TH, V7, P705, DOI 10.1517/14712598.7.5.705; Keller S, 2004, NAT STRUCT MOL BIOL, V11, P481, DOI 10.1038/nsmb756; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; KINGSLEY DM, 1994, GENE DEV, V8, P133, DOI 10.1101/gad.8.2.133; Kirsch T, 2000, EMBO J, V19, P3314, DOI 10.1093/emboj/19.13.3314; Kwan KM, 2004, GENESIS, V39, P10, DOI 10.1002/gene.20021; Lehmann K, 2003, P NATL ACAD SCI USA, V100, P12277, DOI 10.1073/pnas.2133476100; Li CL, 2003, J BIOL CHEM, V278, P50523, DOI 10.1074/jbc.M309381200; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Ma BY, 2002, PROTEIN SCI, V11, P184, DOI 10.1110/ps.21302; Mace PD, 2006, BIOCHEM BIOPH RES CO, V351, P831, DOI 10.1016/j.bbrc.2006.10.109; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Massague J, 1998, ANNU REV BIOCHEM, V67, P753, DOI 10.1146/annurev.biochem.67.1.753; Mehler MF, 1997, TRENDS NEUROSCI, V20, P309, DOI 10.1016/S0166-2236(96)01046-6; Mishina Y, 1995, GENE DEV, V9, P3027, DOI 10.1101/gad.9.24.3027; Miyazono K, 2001, J CELL PHYSIOL, V187, P265, DOI 10.1002/jcp.1080; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Nishitoh H, 1996, J BIOL CHEM, V271, P21345, DOI 10.1074/jbc.271.35.21345; Phillips DJ, 1999, J ENDOCRINOL, V162, P111, DOI 10.1677/joe.0.1620111; Ro TB, 2004, ONCOGENE, V23, P3024, DOI 10.1038/sj.onc.1207386; Samad TA, 2005, J BIOL CHEM, V280, P14122, DOI 10.1074/jbc.M410034200; Seemann P, 2005, J CLIN INVEST, V115, P2373, DOI 10.1172/JCI25118; Shukunami C, 1998, EXP CELL RES, V241, P1, DOI 10.1006/excr.1998.4045; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; URIST MR, 1983, P SOC EXP BIOL MED, V173, P194; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Zhang S, 2003, AM J PHYSIOL-LUNG C, V285, pL740, DOI 10.1152/ajplung.00284.2002	47	47	49	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5876	5887		10.1074/jbc.M706029200	http://dx.doi.org/10.1074/jbc.M706029200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18160401	hybrid			2022-12-25	WOS:000253426700066
J	Yu, SB; Jiang, Y; Galson, DL; Luo, M; Lai, YM; Lu, Y; Ouyang, HJ; Zhang, J; Xiao, GZ				Yu, Shibing; Jiang, Yu; Galson, Deborah L.; Luo, Min; Lai, Yumei; Lu, Yi; Ouyang, Hong-Jiao; Zhang, Jian; Xiao, Guozhi			General transcription factor IIA-gamma increases osteoblast-specific Osteocalcin gene expression via activating transcription factor 4 and runt-related transcription factor 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; IN-VITRO; BONE-FORMATION; FACTOR TFIIA; COOPERATIVE INTERACTIONS; CLEIDOCRANIAL DYSPLASIA; SELECTIVE INHIBITORS; SIGNALING PATHWAYS; BINDING PROTEINS; RESPONSE ELEMENT	ATF4 (activating transcription factor 4) is an osteoblast-enriched transcription factor that regulates terminal osteoblast differentiation and bone formation. ATF4 knock-out mice have reduced bone mass ( severe osteoporosis) throughout life. Runx2 (runt-related transcription factor 2) is a runt domain-containing transcription factor that is essential for bone formation during embryogenesis and postnatal life. In this study, we identified general transcription factor IIA gamma(TFIIA gamma) as a Runx2- interacting factor in a yeast two-hybrid screen. Immunoprecipitation assays confirmed that TFIIA gamma interacts with Runx2 in osteoblasts and when coexpressed in COS-7 cells or using purified glutathione S-transferase fusion proteins. Chromatin immuno-precipitation assay of MC3T3-E1 ( clone MC-4) preosteoblast cells showed that in intact cells TFIIA gamma is recruited to the region of the osteocalcin promoter previously shown to bind Runx2 and ATF4. A small region of Runx2 ( amino acids 258 - 286) was found to be required for TFIIA gamma binding. Although TFIIA gamma interacts with Runx2, it does not activate Runx2. Instead, TFIIA gamma binds to and activates ATF4. Furthermore, TFIIA gamma together with ATF4 and Runx2 stimulates osteocalcin promoter activity and endogenous mRNA expression. Small interfering RNA silencing of TFIIA gamma markedly reduces levels of endogenous ATF4 protein and Ocn mRNA in osteoblastic cells. Overexpression of TFIIA gamma increases levels of ATF4 protein. Finally, TFIIA gamma significantly prevents ATF4 degradation. This study shows that a general transcription factor, TFIIA gamma, facilitates osteoblast-specific gene expression through interactions with two important bone transcription factors ATF4 and Runx2.	[Yu, Shibing; Galson, Deborah L.; Luo, Min; Lai, Yumei; Lu, Yi; Ouyang, Hong-Jiao; Zhang, Jian; Xiao, Guozhi] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15240 USA; [Jiang, Yu] Univ Pittsburgh, Dept Pharmacol, Pittsburgh, PA 15240 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Xiao, GZ (corresponding author), Univ Pittsburgh, Vet Affairs Pittsburg Healthcare Syst Res & Dev, Dept Med, Div Hematol & Oncol, 151-U Rm 2W-111,Univ Dr, Pittsburgh, PA 15240 USA.	xiaog@upmc.edu	YU, SHIBING/B-7648-2012; Galson, Deborah L./E-9370-2010; ZHANG, JIAN/Q-6334-2018; Lu, Yi/J-6746-2018	Galson, Deborah L./0000-0002-2045-8807; Lu, Yi/0000-0002-1060-6925	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR059647] Funding Source: Medline; NIDDK NIH HHS [R01 DK072230-01A2, R01 DK072230-03, R01 DK072230, DK072230, R01 DK072230-02S1, R01 DK072230-02] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Brindle PK, 1992, CURR OPIN GENET DEV, V2, P199, DOI 10.1016/S0959-437X(05)80274-6; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; Clemens KE, 1996, MOL CELL BIOL, V16, P4656; CONAWAY RC, 1989, P NATL ACAD SCI USA, V86, P7356, DOI 10.1073/pnas.86.19.7356; De Cesare D, 2003, MOL ENDOCRINOL, V17, P2554, DOI 10.1210/me.2003-0280; DEJONG J, 1995, P NATL ACAD SCI USA, V92, P3313, DOI 10.1073/pnas.92.8.3313; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; DUVALL JF, 1995, J VIROL, V69, P5077, DOI 10.1128/JVI.69.8.5077-5086.1995; Frendo JL, 1998, J BIOL CHEM, V273, P30509, DOI 10.1074/jbc.273.46.30509; Garrett IR, 2003, J CLIN INVEST, V111, P1771, DOI 10.1172/JCI200316198; Geoffroy V, 1995, J BIOL CHEM, V270, P30973, DOI 10.1074/jbc.270.52.30973; Gilbert L, 2002, J BIOL CHEM, V277, P2695, DOI 10.1074/jbc.M106339200; Guo B, 1997, P NATL ACAD SCI USA, V94, P121, DOI 10.1073/pnas.94.1.121; Hai T, 1999, GENE EXPRESSION, V7, P321; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hatta M, 2006, INT J MOL MED, V17, P425; Hoiby T, 2004, EMBO J, V23, P3083, DOI 10.1038/sj.emboj.7600304; HOIBY T, 2007, BIOCHIM BIOPHYS ACTA, V1769, P529; Hurley MM, 1999, J BONE MINER RES, V14, P776, DOI 10.1359/jbmr.1999.14.5.776; Jiang D, 2004, J BIOL CHEM, V279, P5329, DOI 10.1074/jbc.M311547200; Jurutka PW, 1997, J BIOL CHEM, V272, P14592, DOI 10.1074/jbc.272.23.14592; KARPINSKI BA, 1992, P NATL ACAD SCI USA, V89, P4820, DOI 10.1073/pnas.89.11.4820; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002-0225; Kurihara N, 2004, J BONE MINER RES, V19, P1154, DOI 10.1359/JBMR.040312; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Lassot I, 2005, J BIOL CHEM, V280, P41537, DOI 10.1074/jbc.M505294200; Lavery DN, 2006, BIOCHEM SOC T, V34, P1054, DOI 10.1042/BST0341054; Lee DH, 1996, J BIOL CHEM, V271, P27280, DOI 10.1074/jbc.271.44.27280; Lian J. B., 2003, Current Pharmaceutical Design, V9, P2677, DOI 10.2174/1381612033453659; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; MERRIMAN HL, 1995, BIOCHEMISTRY-US, V34, P13125, DOI 10.1021/bi00040a025; Meyer T, 1997, J BIOL CHEM, V272, P30709, DOI 10.1074/jbc.272.49.30709; MEYER TE, 1993, ENDOCR REV, V14, P269, DOI 10.1210/er.14.3.269; Montero A, 2000, J CLIN INVEST, V105, P1085, DOI 10.1172/JCI8641; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; Newberry EP, 1997, BIOCHEMISTRY-US, V36, P10451, DOI 10.1021/bi971008x; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; SASSONECORSI P, 1994, EMBO J, V13, P4717, DOI 10.1002/j.1460-2075.1994.tb06797.x; Stein GS, 1997, MOL BIOL REP, V24, P185, DOI 10.1023/A:1006803615430; TSUJIMOTO A, 1991, J VIROL, V65, P1420, DOI 10.1128/JVI.65.3.1420-1426.1991; Wang D, 1999, J BONE MINER RES, V14, P893, DOI 10.1359/jbmr.1999.14.6.893; Wang J, 2004, CANCER RES, V64, P1861, DOI 10.1158/0008-5472.CAN-03-2968; Willis DM, 2002, J BIOL CHEM, V277, P37280, DOI 10.1074/jbc.M206482200; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Xiao GZ, 2002, J BIOL CHEM, V277, P36181, DOI 10.1074/JBC.m206057200; Xiao GZ, 2002, J BONE MINER RES, V17, P101, DOI 10.1359/jbmr.2002.17.1.101; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Xiao ZS, 2001, J CELL BIOCHEM, V82, P647, DOI 10.1002/jcb.1192; Yakar S, 2002, J CLIN INVEST, V110, P771, DOI 10.1172/JCI200215463; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Zhang X, 2002, BIOCHEM BIOPH RES CO, V290, P526, DOI 10.1006/bbrc.2001.6217; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zhou HQ, 2006, MOL CELL BIOL, V26, P2728, DOI 10.1128/MCB.26.7.2728-2735.2006; ZIFF EB, 1990, TRENDS GENET, V6, P69, DOI 10.1016/0168-9525(90)90081-G	66	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5542	5553		10.1074/jbc.M705653200	http://dx.doi.org/10.1074/jbc.M705653200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18171674	Green Accepted, hybrid			2022-12-25	WOS:000253426700035
J	Zhao, Y; Fang, QH; Straub, SG; Sharp, GWG				Zhao, Ying; Fang, Qinghua; Straub, Susanne G.; Sharp, Geoffrey W. G.			Both G(i) and G(o) Heterotrimeric G proteins are required to exert the full effect of norepinephrine on the beta-cell K-ATP channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SENSITIVE POTASSIUM CHANNELS; GTP-BINDING PROTEINS; ADENYLYL-CYCLASE; INDUCED HYPERPOLARIZATION; INSULIN-SECRETION; GAMMA-SUBUNIT; ACTIVATION; INHIBITION; SOMATOSTATIN; GLUCOSE	The effects of norepinephrine (NE), an inhibitor of insulin secretion, were examined on membrane potential and the ATP-sensitive K+ channel (K-ATP) in INS 832/13 cells. Membrane potential was monitored under the whole cell current clamp mode. NE hyperpolarized the cell membrane, an effect that was abolished by tolbutamide. The effect of NE on K-ATP channels was investigated in parallel using outside-out single channel recording. This revealed that NE enhanced the open activities of the K-ATP channels similar to 2-fold without changing the single channel conductance, demonstrating that NE-induced hyperpolarization was mediated by activation of the K-ATP channels. The NE effect was abolished in cells preincubated with pertussis toxin, indicating coupling to heterotrimeric G(i)/G(o) proteins. To identify the G proteins involved, antisera raised against alpha and beta subunits (anti-G alpha(common), anti-G beta, anti-G alpha(i1/2/3), and anti-G alpha(o)) were used. Anti-G alpha(common) totally blocked the effects of NE on membrane potential and KATP channels. Individually, anti-G alpha(i1/2/3) and anti-G alpha(o) only partially inhibited the action of NE on K-ATP channels. However, the combination of both completely eliminated the action. Antibodies against G(beta) had no effects. To confirm these results and to further identify the G protein subunits involved, the blocking effects of peptides containing the sequence of 11 amino acids at the C termini of the alpha subunits were used. The data obtained were similar to those derived from the antibody work with the additional information that G alpha(i3) and G alpha(o1) were not involved. In conclusion, both G(i) and G(o) proteins are required for the full effect of norepinephrine to activate the K-ATP channel.	[Zhao, Ying; Straub, Susanne G.; Sharp, Geoffrey W. G.] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA; [Fang, Qinghua] Cornell Univ, Dept Appl Engn & Phys, Ithaca, NY 14853 USA	Cornell University; Cornell University	Sharp, GWG (corresponding author), Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA.	gws2@cornell.edu			NIDDK NIH HHS [DK54243, DK56737] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054243, R01DK056737] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Abel KB, 1996, PFLUG ARCH EUR J PHY, V432, P89, DOI 10.1007/s004240050109; Bloc A, 2000, J PHYSIOL-LONDON, V529, P723, DOI 10.1111/j.1469-7793.2000.00723.x; Bryan J, 2005, CURR PHARM DESIGN, V11, P2699, DOI 10.2174/1381612054546879; Bryan J, 2004, DIABETES, V53, pS104, DOI 10.2337/diabetes.53.suppl_3.S104; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8; DEWEILLE JR, 1989, P NATL ACAD SCI USA, V86, P2971; DIVERSEPIERLUISSI M, 1995, NEURON, V14, P191, DOI 10.1016/0896-6273(95)90254-6; Drain P, 1998, P NATL ACAD SCI USA, V95, P13953, DOI 10.1073/pnas.95.23.13953; DUNNE MJ, 1989, EMBO J, V8, P413, DOI 10.1002/j.1460-2075.1989.tb03392.x; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; FINDLAY I, 1987, J PHYSIOL-LONDON, V391, P611, DOI 10.1113/jphysiol.1987.sp016759; Gilchrist A, 1998, J BIOL CHEM, V273, P14912, DOI 10.1074/jbc.273.24.14912; Gilchrist A, 2001, J BIOL CHEM, V276, P25672, DOI 10.1074/jbc.M100914200; Gribble FM, 1997, J PHYSIOL-LONDON, V504, P35, DOI 10.1111/j.1469-7793.1997.00035.x; Gribble FM, 1998, DIABETES, V47, P1412, DOI 10.2337/diabetes.47.9.1412; HILLE B, 1992, NEURON, V9, P187, DOI 10.1016/0896-6273(92)90158-A; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; INAGAKI N, 1995, SCIENCE, V270, P1166, DOI 10.1126/science.270.5239.1166; INAGAKI N, 1995, J BIOL CHEM, V270, P5691, DOI 10.1074/jbc.270.11.5691; ITO H, 1992, J GEN PHYSIOL, V99, P961, DOI 10.1085/jgp.99.6.961; Kanzaki M, 1997, J BIOL CHEM, V272, P14733, DOI 10.1074/jbc.272.23.14733; Kuzhikandathil EV, 2002, MOL PHARMACOL, V62, P119, DOI 10.1124/mol.62.1.119; Leech CA, 1999, BIOCHEM BIOPH RES CO, V254, P703, DOI 10.1006/bbrc.1998.9906; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; MCDERMOTT AM, 1995, DIABETES, V44, P453, DOI 10.2337/diabetes.44.4.453; MOGAMI H, 1995, ENDOCRINOLOGY, V136, P2960, DOI 10.1210/en.136.7.2960; PETERSEN OH, 1987, PHYSIOL REV, V67, P1054, DOI 10.1152/physrev.1987.67.3.1054; PHILIPSON LH, 1995, J BIOL CHEM, V270, P14604, DOI 10.1074/jbc.270.24.14604; Reimann F, 1999, J PHYSIOL-LONDON, V520, P661, DOI 10.1111/j.1469-7793.1999.00661.x; REUVENY E, 1994, NATURE, V370, P143, DOI 10.1038/370143a0; RIBALET B, 1995, J PHYSIOL-LONDON, V485, P73, DOI 10.1113/jphysiol.1995.sp020713; RORSMAN P, 1991, NATURE, V349, P77, DOI 10.1038/349077a0; SACKMANN B, 1995, SINGLE CHANNEL RECOR, P45; Schermerhorn T, 2000, CELL CALCIUM, V27, P163, DOI 10.1054/ceca.2000.0107; Seino S, 1999, ANNU REV PHYSIOL, V61, P337, DOI 10.1146/annurev.physiol.61.1.337; Sharp GWG, 1996, AM J PHYSIOL-CELL PH, V271, pC1781, DOI 10.1152/ajpcell.1996.271.6.C1781; Shyng SL, 1997, J GEN PHYSIOL, V110, P643, DOI 10.1085/jgp.110.6.643; Sieg A, 2004, AM J PHYSIOL-ENDOC M, V286, pE463, DOI 10.1152/ajpendo.00365.2003; Smith PA, 2001, J PHYSIOL-LONDON, V532, P127, DOI 10.1111/j.1469-7793.2001.0127g.x; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Tucker SJ, 1998, EMBO J, V17, P3290, DOI 10.1093/emboj/17.12.3290; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; ULLRICH S, 1984, J BIOL CHEM, V259, P4111; WICKMAN K, 1995, PHYSIOL REV, V75, P865, DOI 10.1152/physrev.1995.75.4.865; Yamada M, 1998, PHARMACOL REV, V50, P723; Yan LM, 2003, J BIOL CHEM, V278, P18177, DOI 10.1074/jbc.M301116200; Yang SM, 2004, MOL ENDOCRINOL, V18, P2312, DOI 10.1210/me.2004-0148	49	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5306	5316		10.1074/jbc.M707695200	http://dx.doi.org/10.1074/jbc.M707695200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18162464	hybrid			2022-12-25	WOS:000253426700010
J	Balannik, V; Lamb, RA; Pinto, LH				Balannik, Victoria; Lamb, Robert A.; Pinto, Lawrence H.			The oligomeric state of the active BM2 ion channel protein of influenza B virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRAL MEMBRANE-PROTEIN; RESONANCE ENERGY-TRANSFER; TRANSFER FRET MEASUREMENT; M-2 PROTON CHANNEL; A VIRUS; POTASSIUM CHANNEL; M2 PROTEIN; CONFOCAL MICROSCOPY; CELL-SURFACE; SELECTIVITY	Influenza A virus and influenza B virus particles both contain small integral membrane proteins (A/M2 and BM2, respectively) that function as a pH-sensitive proton channel and are essential for virus replication. The mechanism of action of the M2 channels is a subject of scientific interest particularly as A/M2 channel was shown to be a target for the action of the antiviral drug amantadine. Unfortunately, an inhibitor of the BM2 channel activity is not known. Thus, knowledge of the structural and functional properties of the BM2 channel is essential for the development of potent antiviral drugs. The characterization of the oligomeric state of the BM2 channel is an essential first step in the understanding of channel function. Here we describe determination of the stoichiometry of the BM2 proton channel by utilizing three different approaches. 1) We demonstrated that BM2 monomers can be chemically cross-linked to yield species consistent with dimers, trimers, and tetramers. 2) We studied electrophysiological and biochemical properties of mixed oligomers consisting of wild-type and mutated BM2 subunits and related these data to predicted binomial distribution models. 3) We used fluorescence resonance energy transfer (FRET) in combination with biochemical measurements to estimate the relationships between BM2 channel subunits expressed in the plasma membrane. Our experimental data are consistent with a tetrameric structure of the BM2 channel. Finally, we demonstrated that BM2 transmembrane domain is responsible for the channel oligomerization.	[Balannik, Victoria; Pinto, Lawrence H.] Northwestern Univ, Dept Neurobiol & Physiol, Evanston, IL 60208 USA; [Lamb, Robert A.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Lamb, Robert A.] Northwestern Univ, Howard Hughes Med Inst, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Howard Hughes Medical Institute; Northwestern University	Pinto, LH (corresponding author), Northwestern Univ, Dept Neurobiol & Physiol, Hogan Hall,2205 Tech Dr, Evanston, IL 60208 USA.	larry-pinto@northwestern.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057363] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [AI-57363] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Clegg R.M., 1996, FLUORESCENCE IMAGING, V137, P179; DUFF KC, 1992, VIROLOGY, V190, P485, DOI 10.1016/0042-6822(92)91239-Q; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; Gu Y, 2004, J MICROSC-OXFORD, V215, P162, DOI 10.1111/j.0022-2720.2004.01365.x; HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R; HORVATH CM, 1990, EMBO J, V9, P2639, DOI 10.1002/j.1460-2075.1990.tb07446.x; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Jares-Erijman EA, 2003, NAT BIOTECHNOL, V21, P1387, DOI 10.1038/nbt896; Karpova TS, 2003, J MICROSC-OXFORD, V209, P56, DOI 10.1046/j.1365-2818.2003.01100.x; Kerschensteiner D, 2005, P NATL ACAD SCI USA, V102, P6160, DOI 10.1073/pnas.0500468102; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Lakowicz J. R., 1999, PRINCIPLES FLUORESCE, P369, DOI DOI 10.1007/978-1-4757-3061-6; Lamb R. A., 1994, RECEPTOR MEDIATED VI, P303; LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9; MACKINNON R, 1991, NATURE, V350, P232, DOI 10.1038/350232a0; Mould JA, 2000, J BIOL CHEM, V275, P8592, DOI 10.1074/jbc.275.12.8592; Mould JA, 2003, DEV CELL, V5, P175, DOI 10.1016/S1534-5807(03)00190-4; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Odagiri T, 1999, J GEN VIROL, V80, P2573, DOI 10.1099/0022-1317-80-10-2573; PANAYOTOV PP, 1992, VIROLOGY, V186, P352, DOI 10.1016/0042-6822(92)90096-8; Paterson RG, 2003, VIROLOGY, V306, P7, DOI 10.1016/S0042-6822(02)00083-1; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Pinto LH, 1997, P NATL ACAD SCI USA, V94, P11301, DOI 10.1073/pnas.94.21.11301; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Riven I, 2003, NEURON, V38, P225, DOI 10.1016/S0896-6273(03)00193-4; Sakaguchi T, 1997, P NATL ACAD SCI USA, V94, P5000, DOI 10.1073/pnas.94.10.5000; Shimbo K, 1996, BIOPHYS J, V70, P1335, DOI 10.1016/S0006-3495(96)79690-X; Shuck K, 2000, J VIROL, V74, P7755, DOI 10.1128/JVI.74.17.7755-7761.2000; STOUFFER AL, 2007, IN PRESS NATURE; SUGRUE RJ, 1991, VIROLOGY, V180, P617, DOI 10.1016/0042-6822(91)90075-M; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; Tobler K, 1999, J VIROL, V73, P9695, DOI 10.1128/JVI.73.12.9695-9701.1999; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; VONHEIJNE G, 1988, EUR J BIOCHEM, V174, P671; Wallrabe H, 2006, MICROSC RES TECHNIQ, V69, P196, DOI 10.1002/jemt.20281; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988	41	33	33	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4895	4904		10.1074/jbc.M709433200	http://dx.doi.org/10.1074/jbc.M709433200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18073201	hybrid			2022-12-25	WOS:000253426500047
J	Hebbachi, AM; Knight, BL; Wiggins, D; Patel, DD; Gibbons, GF				Hebbachi, Abdel M.; Knight, Brian L.; Wiggins, David; Patel, Dilip D.; Gibbons, Geoffrey F.			Peroxisome proliferator-activated receptor alpha deficiency abolishes the response of lipogenic gene expression to re-feeding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN-1C; FATTY-ACID SYNTHESIS; LIVER-X-RECEPTOR; PPAR-ALPHA; INSULIN-RESISTANCE; LIPID-METABOLISM; MICE; GLUCOSE; CHOLESTEROL; SREBP-1C	The mRNA expression of lipogenic genes Scd-1 and Fas is regulated partly by the insulin-sensitive transcription factor SREBP-1c and liver X receptor alpha (LXR alpha). Compared with normal mice, the increase in the mRNA expression of hepatic Scd-1, Fas, and Srebp-1c was severely attenuated in peroxisome proliferator-activated receptor alpha(PPAR alpha)-deficient mice during the transition from the starved to the re-fed states. The concentration of the membrane-bound form of SREBP-1c was also lower in the livers of the PPAR alpha-deficient mice during re-feeding but there was little difference in the concentration of the active, nuclear form, or in the abundance of Insig-2a mRNA. The response of plasma insulin to starvation and re-feeding was normal in the PPAR alpha-deficient mice. Rat hepatocytes transfected with an adenovirus encoding a dominant negative form of PPAR alpha were resistant to the stimulatory effects of insulin on Fas and Scd-1 mRNA expression in vitro. When LXR alpha was activated in vivo by inclusion of a non-steroidal ligand in the diet, the expression of the mRNA for hepatic Srebp-1c, Fas, and Scd-1 was increased severalfold in mice of both genotypes and resistance associated with PPAR alpha deficiency was abolished during re-feeding. However, although re-feeding the LXR alpha ligand induced the immature form of SREBP-1c equally in the livers of both genotypes, the concentration of the nuclear form remained relatively low in the livers of the PPAR alpha-deficient mice. We conclude that intact PPAR alpha is required to mediate the response of Scd-1 and Fas gene expression to insulin and that this is normally achieved directly by activation of LXR alpha.	[Hebbachi, Abdel M.; Wiggins, David; Gibbons, Geoffrey F.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Met Res Lab, Oxford OX3 7LJ, England; [Knight, Brian L.; Patel, Dilip D.] Univ London Imperial Coll Sci Technol & Med, Sch Med, Med Res Council Ctr Clin Sci, London W12 0NN, England	University of Oxford; Imperial College London	Gibbons, GF (corresponding author), Churchill Hosp, OCDEM, Old Rd, Oxford OX3 7LJ, England.	geoff.gibbons@mrl.ox.ac.uk			Medical Research Council Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Azzout-Marniche D, 2000, BIOCHEM J, V350, P389, DOI 10.1042/0264-6021:3500389; BARTLETT SM, 1988, BIOCHEM J, V249, P37, DOI 10.1042/bj2490037; BOURGEOIS CS, 1995, AM J PHYSIOL-ENDOC M, V269, pE208, DOI 10.1152/ajpendo.1995.269.2.E208; Bulow J, 1999, J LIPID RES, V40, P2034; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Chakravarthy MV, 2005, CELL METAB, V1, P309, DOI 10.1016/j.cmet.2005.04.002; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Chou CJ, 2002, J BIOL CHEM, V277, P24484, DOI 10.1074/jbc.M202449200; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Gibbons G, 2005, NAT MED, V11, P722, DOI 10.1038/nm0705-722; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; GORSKI K, 1986, CELL, V47, P767, DOI 10.1016/0092-8674(86)90519-2; Guerre-Millo M, 2001, DIABETES, V50, P2809, DOI 10.2337/diabetes.50.12.2809; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kim HJ, 2002, J LIPID RES, V43, P1750, DOI 10.1194/jlr.M100433-JLR200; Knight BL, 2005, BIOCHEM J, V389, P413, DOI 10.1042/BJ20041896; Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044; Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899; Li Y, 2005, J LIPID RES, V46, P2432, DOI 10.1194/jlr.M500237-JLR200; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McGarry JD, 1998, AM J CLIN NUTR, V67, p500S, DOI 10.1093/ajcn/67.3.500S; Miller CW, 1996, P NATL ACAD SCI USA, V93, P9443, DOI 10.1073/pnas.93.18.9443; Mitro N, 2007, NATURE, V445, P219, DOI 10.1038/nature05449; Mziaut H, 2000, P NATL ACAD SCI USA, V97, P8883, DOI 10.1073/pnas.97.16.8883; Patel DD, 2001, J LIPID RES, V42, P328; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200; Postic C, 2007, ANNU REV NUTR, V27, P179, DOI 10.1146/annurev.nutr.27.061406.093618; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Schwarz JM, 2003, AM J CLIN NUTR, V77, P43, DOI 10.1093/ajcn/77.1.43; Semple RK, 2005, ENDOCRINOLOGY, V146, P1871, DOI 10.1210/en.2004-1405; Shimomura I, 2000, MOL CELL, V6, P77, DOI 10.1016/S1097-2765(00)00009-5; Shimomura L, 1999, P NATL ACAD SCI USA, V96, P13656, DOI 10.1073/pnas.96.24.13656; Sugden MC, 2002, BIOCHEM J, V364, P361, DOI 10.1042/BJ20011699; Tobin KAR, 2002, J BIOL CHEM, V277, P10691, DOI 10.1074/jbc.M109771200; Trickett JI, 2001, J BIOL CHEM, V276, P39522, DOI 10.1074/jbc.M101764200; Yabe D, 2003, P NATL ACAD SCI USA, V100, P3155, DOI 10.1073/pnas.0130116100	45	46	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4866	4876		10.1074/jbc.M709471200	http://dx.doi.org/10.1074/jbc.M709471200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18079124	hybrid			2022-12-25	WOS:000253426500044
J	Niles, BJ; Clegg, MS; Hanna, LA; Chou, SS; Momma, TY; Hong, H; Keen, CL				Niles, Brad J.; Clegg, Michael S.; Hanna, Lynn A.; Chou, Susan S.; Momma, Tony Y.; Hong, Heeok; Keen, Carl L.			Zinc deficiency-induced iron accumulation, a consequence of alterations in iron regulatory protein-binding activity, iron transporters, and iron storage proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-DEATH; NITRIC-OXIDE; OXIDATIVE STRESS; TRANSLATIONAL REGULATION; RESPONSIVE ELEMENTS; RNA-BINDING; FERRITIN; IRP2; DEGRADATION; MODULATION	One consequence of zinc deficiency is an elevation in cell and tissue iron concentrations. To examine the mechanism(s) underlying this phenomenon, Swiss 3T3 cells were cultured in zinc-deficient (D, 0.5 mu M zinc), zinc-supplemented (S, 50 mu M zinc), or control (C, 4 mu M zinc) media. After 24 h of culture, cells in the D group were characterized by a 50% decrease in intracellular zinc and a 35% increase in intracellular iron relative to cells in the S and C groups. The increase in cellular iron was associated with increased transferrin receptor 1 protein and mRNA levels and increased ferritin light chain expression. The divalent metal transporter 1(+) iron-responsive element isoform mRNA was decreased during zinc deficiency-induced iron accumulation. Examination of zinc-deficient cells revealed increased binding of iron regulatory protein 2 (IRP2) and decreased binding of IRP1 to a consensus iron-responsive element. The increased IRP2-binding activity in zinc-deficient cells coincided with an increased level of IRP2 protein. The accumulation of IRP2 protein was independent of zinc deficiency-induced intracellular nitric oxide production but was attenuated by the addition of the antioxidant N-acetylcysteine or ascorbate to the D medium. These data support the concept that zinc deficiency can result in alterations in iron transporter, storage, and regulatory proteins, which facilitate iron accumulation.	[Niles, Brad J.; Clegg, Michael S.; Hanna, Lynn A.; Chou, Susan S.; Momma, Tony Y.; Keen, Carl L.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Keen, Carl L.] Univ Calif Davis, Dept Internal Med, Davis, CA 95616 USA; [Hong, Heeok] Sangmyung Univ, Dept Food Serv Management & Nutr, Seoul 110743, South Korea	University of California System; University of California Davis; University of California System; University of California Davis; Sang Myung University	Keen, CL (corresponding author), Univ Calif Davis, Dept Nutr, 1 Shields Ave, Davis, CA 95616 USA.	clkeen@ucdavis.edu		Hong, Heeok/0000-0001-6533-6064	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD001743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007355] Funding Source: NIH RePORTER; NICHD NIH HHS [HD01743] Funding Source: Medline; NIDDK NIH HHS [DK07355] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bouton C, 1997, J BIOL CHEM, V272, P19969, DOI 10.1074/jbc.272.32.19969; Bouton C, 1998, J BIOL CHEM, V273, P9403, DOI 10.1074/jbc.273.16.9403; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cairo G, 2002, BIOCHEMISTRY-US, V41, P7435, DOI 10.1021/bi025756k; Caltagirone A, 2001, J BIOL CHEM, V276, P19738, DOI 10.1074/jbc.M100245200; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Chou SS, 2004, BIOCHEM J, V383, P63, DOI 10.1042/BJ20040074; Clegg MS, 2005, IUBMB LIFE, V57, P661, DOI 10.1080/15216540500264554; Cui L, 1997, J NUTR, V127, P1729, DOI 10.1093/jn/127.9.1729; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Gariboldi MB, 2000, FREE RADICAL BIO MED, V29, P633, DOI 10.1016/S0891-5849(00)00347-6; Gerald D, 2004, CELL, V118, P781, DOI 10.1016/j.cell.2004.08.025; Gunshin H, 2001, FEBS LETT, V509, P309, DOI 10.1016/S0014-5793(01)03189-1; GUO B, 1994, J BIOL CHEM, V269, P24252; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; HENDERSON BR, 1995, J BIOL CHEM, V270, P20509, DOI 10.1074/jbc.270.35.20509; Henderson ER, 1996, J BIOL CHEM, V271, P4900; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Hubert N, 2002, P NATL ACAD SCI USA, V99, P12345, DOI 10.1073/pnas.192423399; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Iwai K, 1998, P NATL ACAD SCI USA, V95, P4924, DOI 10.1073/pnas.95.9.4924; KEEN CL, 1988, AM J CLIN NUTR, V47, P1041, DOI 10.1093/ajcn/47.6.1041; KEEN CL, 1985, BIOL TRACE ELEM RES, V8, P123, DOI 10.1007/BF02917466; Kohl R, 2006, FREE RADICAL BIO MED, V40, P1430, DOI 10.1016/j.freeradbiomed.2005.12.012; Kruszewski M, 2003, MUTAT RES-FUND MOL M, V531, P81, DOI 10.1016/j.mrfmmm.2003.08.004; Liuzzi JP, 2006, P NATL ACAD SCI USA, V103, P13612, DOI 10.1073/pnas.0606424103; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Oliveira L, 1999, J BIOL CHEM, V274, P516, DOI 10.1074/jbc.274.1.516; Oteiza PI, 2000, FREE RADICAL BIO MED, V28, P1091, DOI 10.1016/S0891-5849(00)00200-8; OTEIZA PI, 1995, J NUTR, V125, P823; Pantopoulos K, 1996, MOL CELL BIOL, V16, P3781; Phillips JD, 1996, BLOOD, V87, P2983, DOI 10.1182/blood.V87.7.2983.bloodjournal8772983; Picard V, 1998, J BIOL CHEM, V273, P15382, DOI 10.1074/jbc.273.25.15382; Recalcati S, 1998, BLOOD, V91, P1059, DOI 10.1182/blood.V91.3.1059.1059_1059_1066; ROGERS JM, 1985, TERATOLOGY, V31, P89, DOI 10.1002/tera.1420310111; ROGERS JM, 1987, J NUTR, V117, P1875, DOI 10.1093/jn/117.11.1875; Schalinske KL, 1997, P NATL ACAD SCI USA, V94, P10681, DOI 10.1073/pnas.94.20.10681; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Schneider BD, 2003, BLOOD, V102, P3404, DOI 10.1182/blood-2003-02-0433; Shindo M, 2006, HEPATOL RES, V35, P152, DOI 10.1016/j.hepres.2006.03.011; Tsuji Y, 2000, MOL CELL BIOL, V20, P5818, DOI 10.1128/MCB.20.16.5818-5827.2000; VanOrden HE, 2006, ANN PHARMACOTHER, V40, P1110, DOI 10.1345/aph.1G566; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wang J, 2005, MOL CELL BIOL, V25, P1347, DOI 10.1128/MCB.25.4.1347-1353.2005; Wang J, 2004, MOL CELL BIOL, V24, P954, DOI 10.1128/MCB.24.3.954-965.2004; Wang J, 2006, MOL CELL BIOL, V26, P1948, DOI 10.1128/MCB.26.5.1948-1954.2006; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x; Whitington PF, 2006, HEPATOLOGY, V43, P654, DOI 10.1002/hep.21129; Xu XY, 2004, ANN NY ACAD SCI, V1012, P299, DOI 10.1196/annals.1306.024	50	31	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5168	5177		10.1074/jbc.M709043200	http://dx.doi.org/10.1074/jbc.M709043200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18073202	hybrid			2022-12-25	WOS:000253426500074
J	Kramer, DL; Diegelman, P; Jell, J; Vujcic, S; Merali, S; Porter, CW				Kramer, Debora L.; Diegelman, Paula; Jell, Jason; Vujcic, Slavoljub; Merali, Salim; Porter, Carl W.			Polyamine acetylation modulates polyamine metabolic flux, a prelude to broader metabolic consequences	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPERMIDINE SPERMINE N1-ACETYLTRANSFERASE; S-ADENOSYLMETHIONINE DECARBOXYLASE; ORNITHINE-DECARBOXYLASE; RELATIVE ABILITIES; FAT-METABOLISM; ADIPOSE-TISSUE; CANCER-THERAPY; GROWTH; CATABOLISM; MICE	Recent studies suggest that overexpression of the polyamine-acetylating enzyme spermidine/spermine N-1-acetyltransferase (SSAT) significantly increases metabolic flux through the polyamine pathway. The concept derives from the observation that SSAT-induced acetylation of polyamines gives rise to a compensatory increase in biosynthesis and presumably to increased flow through the pathway. Despite the strength of this deduction, the existence of heightened polyamine flux has not yet been experimentally demonstrated. Here, we use the artificial polyamine precursor 4-fluoro-ornithine to measure polyamine flux by tracking fluorine unit permeation of polyamine pools in human prostate carcinoma LNCaP cells. Conditional overexpression of SSAT was accompanied by a massive increase in intracellular and extracellular acetylated spermidine and by a 6-20-fold increase in biosynthetic enzyme activities. In the presence of 300 mu M 4-fluoro-ornithine, SSAT overexpression led to the sequential appearance of fluorinated putrescine, spermidine, acetylated spermidine, and spermine. As fluorinated polyamines increased, endogenous polyamines decreased, so that the total polyamine pool size remained relatively constant. At 24 h, 56% of the spermine pool in the induced SSAT cells was fluorine-labeled compared with only 12% in uninduced cells. Thus, SSAT induction increased metabolic flux by similar to 5-fold. Flux could be interrupted by inhibition of polyamine biosynthesis but not by inhibition of polyamine oxidation. Overall, the findings are consistent with a paradigm whereby flux is initiated by SSAT acetylation of spermine and particularly spermidine followed by a marked increase in key biosynthetic enzymes. The latter sustains the flux cycle by providing a constant supply of polyamines for subsequent acetylation by SSAT. The broader metabolic implications of this futile metabolic cycling are discussed in detail.	[Kramer, Debora L.; Diegelman, Paula; Jell, Jason; Vujcic, Slavoljub; Porter, Carl W.] Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA; [Merali, Salim] Temple Univ, Sch Med, Fels Inst, Philadelphia, PA 19140 USA; [Merali, Salim] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA	Roswell Park Cancer Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Porter, CW (corresponding author), Roswell Pk Canc Inst, Dept Pharmacol & Therapeut, Buffalo, NY 14263 USA.	carl.porter@roswellpark.org			NCI NIH HHS [CA-76428, CA 109619, CA-09072, CA-22153] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA022153, R01CA076428, R01CA109619] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Alhonen L, 1998, J BIOL CHEM, V273, P1964, DOI 10.1074/jbc.273.4.1964; ASK A, 1992, CANCER LETT, V66, P29, DOI 10.1016/0304-3835(92)90276-2; Beckers A, 2007, CANCER RES, V67, P8180, DOI 10.1158/0008-5472.CAN-07-0389; BYERS TL, 1990, J CELL PHYSIOL, V143, P460, DOI 10.1002/jcp.1041430309; CASERO RA, 1989, CANCER RES, V49, P3829; CASERO RA, 1993, FASEB J, V7, P653, DOI 10.1096/fasebj.7.8.8500690; Casero RA, 2007, NAT REV DRUG DISCOV, V6, P373, DOI 10.1038/nrd2243; Chen Y, 2003, MOL PHARMACOL, V64, P1153, DOI 10.1124/mol.64.5.1153; Chen Y, 2001, CANCER RES, V61, P6437; CLARK JL, 1975, BIOCHEMISTRY-US, V14, P4403, DOI 10.1021/bi00691a010; DEZEURE F, 1988, INT J BIOCHEM, V20, P1299, DOI 10.1016/0020-711X(88)90235-2; FogelPetrovic M, 1996, FEBS LETT, V391, P89, DOI 10.1016/0014-5793(96)00710-7; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; Gschwend JE, 1997, PROSTATE, V33, P166; Hector S, 2004, MOL CANCER THER, V3, P813; Janne J, 2006, J BIOCHEM, V139, P155, DOI 10.1093/jb/mvj035; JANNE J, 1978, BIOCHIM BIOPHYS ACTA, V473, P241, DOI 10.1016/0304-419X(78)90015-X; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; KABRA PM, 1986, J CHROMATOGR, V380, P19, DOI 10.1016/S0378-4347(00)83621-X; KAKINUMA Y, 1988, EUR J BIOCHEM, V176, P409, DOI 10.1111/j.1432-1033.1988.tb14297.x; KAMEJI T, 1987, J BIOL CHEM, V262, P2427; Kee K, 2004, J BIOL CHEM, V279, P40076, DOI 10.1074/jbc.M406002200; Kee K, 2004, J BIOL CHEM, V279, P27050, DOI 10.1074/jbc.M403323200; KRAMER D, 1995, BIOCHEM PHARMACOL, V50, P1433, DOI 10.1016/0006-2952(95)02037-3; KRAMER D, 1995, J BIOL CHEM, V270, P2124, DOI 10.1074/jbc.270.5.2124; KRAMER DL, 1993, J CELL PHYSIOL, V155, P399, DOI 10.1002/jcp.1041550222; KRAMER DL, 1989, BIOCHEM J, V259, P325, DOI 10.1042/bj2590325; KRAMER DL, 2004, CANC DRUG DISC DEV, P339; LIBBY PR, 1991, ARCH BIOCHEM BIOPHYS, V284, P238, DOI 10.1016/0003-9861(91)90291-P; MADHUBALA R, 1988, BIOCHEM J, V254, P45, DOI 10.1042/bj2540045; McCloskey DE, 1999, J BIOL CHEM, V274, P6175, DOI 10.1074/jbc.274.10.6175; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; MOULINOUX JP, 1991, J UROLOGY, V146, P1408, DOI 10.1016/S0022-5347(17)38125-9; Oh WK, 2005, P NATL ACAD SCI USA, V102, P1384, DOI 10.1073/pnas.0409451102; PEGG AE, 1988, CANCER RES, V48, P759; PERSSON L, 1988, CANCER RES, V48, P4807; Pietila M, 1997, J BIOL CHEM, V272, P18746, DOI 10.1074/jbc.272.30.18746; Pirinen E, 2007, MOL CELL BIOL, V27, P4953, DOI 10.1128/MCB.02034-06; Porter C W, 1988, Adv Exp Med Biol, V250, P677; PORTER CW, 1987, BIOCHEM J, V242, P433, DOI 10.1042/bj2420433; PORTER CW, 1985, CANCER RES, V45, P2050; PORTER CW, 1991, CANCER RES, V51, P3715; PORTER CW, 1988, ADV ENZYME REGUL, V27, P57; PORTER CW, 1987, CANCER RES, V47, P2821; PORTER CW, 1990, BIOCHEM J, V268, P207, DOI 10.1042/bj2680207; SARHAN S, 1989, ANTICANCER RES, V9, P215; SEILER N, 1980, J CHROMATOGR, V221, P227, DOI 10.1016/S0378-4347(00)84307-8; Seiler N, 2004, AMINO ACIDS, V26, P217, DOI 10.1007/s00726-004-0070-z; Seiler N, 2003, CURR DRUG TARGETS, V4, P537, DOI 10.2174/1389450033490885; Seiler N, 2003, CURR DRUG TARGETS, V4, P565, DOI 10.2174/1389450033490876; SEILER N, 1987, CAN J PHYSIOL PHARM, V65, P2024, DOI 10.1139/y87-317; Seiler Nikolaus, 2002, Prog Drug Res, V59, P1; SHAPPELL NW, 1993, FEBS LETT, V321, P179, DOI 10.1016/0014-5793(93)80103-2; Tucker JM, 2005, CANCER RES, V65, P5390, DOI 10.1158/0008-5472.CAN-05-0229; Vujcic S, 2000, J BIOL CHEM, V275, P38319, DOI 10.1074/jbc.M003270200; Wallace H M, 1988, Adv Exp Med Biol, V250, P331; WALLACE HM, 1985, BIOCHEM SOC T, V13, P329, DOI 10.1042/bst0130329; Wang XJ, 2007, CARCINOGENESIS, V28, P2404, DOI 10.1093/carcin/bgm162	59	60	64	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4241	4251		10.1074/jbc.M706806200	http://dx.doi.org/10.1074/jbc.M706806200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18089555	hybrid			2022-12-25	WOS:000253083500059
J	Thakran, S; Li, HF; Lavine, CL; Miller, MA; Bina, JE; Bina, XWR; Re, F				Thakran, Shalini; Li, Hanfen; Lavine, Christy L.; Miller, Mark A.; Bina, James E.; Bina, Xiaowen R.; Re, Fabio			Identification of Francisella tularensis lipoproteins that stimulate the toll-like receptor (TLR)2/TLR1 heterodimer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVE-VACCINE STRAIN; NF-KAPPA-B; MEMBRANE-PROTEINS; INFLAMMATORY RESPONSES; MEDIATED-IMMUNITY; CELL ACTIVATION; TLR2; LVS; INNATE; LIPOPOLYSACCHARIDE	The innate immune response to Francisella tularensis is primarily mediated by TLR2, though the bacterial products that stimulate this receptor remain unknown. Here we report the identification of two Francisella lipoproteins, TUL4 and FTT1103, which activate TLR2. We demonstrate that TUL4 and FTT1103 stimulate chemokine production in human and mouse cells in a TLR2-dependent way. Using an assay that relies on chimeric TLR proteins, we show that TUL4 and FTT1103 stimulate exclusively the TLR2/TLR1 heterodimer. Our results also show that yet unidentified Francisella proteins, possibly unlipidated, have the ability to stimulate the TLR2/TLR6 heterodimer. Through domain-exchange analysis, we determined that an extended region that comprises LRR9-17 in the extracellular portion of TLR1 mediates response to Francisella lipoproteins and triacylated lipopeptide. Substitution of the corresponding LRR of TLR6 with the LRR derived from TLR1 enables TLR6 to recognize TUL4, FTT1103, and triacylated lipopeptide. This study identifies for the first time specific Francisella products capable of stimulating a proinflammatory response and the cellular receptors they trigger.	[Thakran, Shalini; Li, Hanfen; Lavine, Christy L.; Miller, Mark A.; Bina, James E.; Bina, Xiaowen R.; Re, Fabio] Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, Memphis, TN 38163 USA	University of Tennessee System; University of Tennessee Health Science Center	Re, F (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Mol Sci, 858 Madison Ave, Memphis, TN 38163 USA.	fre@utmem.edu	Bina, Xiaowen/AAE-9100-2022		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI061260, R21AI074582] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI074582, AI061260, AI-05466501, AI074582] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alexopoulou L, 2002, NAT MED, V8, P878, DOI 10.1038/nm732; Ancuta P, 1996, INFECT IMMUN, V64, P2041, DOI 10.1128/IAI.64.6.2041-2046.1996; Argueta JGM, 2006, ORAL MICROBIOL IMMUN, V21, P245, DOI 10.1111/j.1399-302X.2006.00286.x; Asai Y, 2005, INFECT IMMUN, V73, P2157, DOI 10.1128/IAI.73.4.2157-2163.2005; Baron SD, 2007, INFECT IMMUN, V75, P2152, DOI 10.1128/IAI.01606-06; Bina XWR, 2006, ARCH MICROBIOL, V186, P219, DOI 10.1007/s00203-006-0140-6; BORDIER C, 1981, J BIOL CHEM, V256, P1604; BRAUN V, 1993, BACTERIAL CELL WALL, V27, P319; Buwitt-Beckmann U, 2005, EUR J IMMUNOL, V35, P282, DOI 10.1002/eji.200424955; Cognet I, 2003, J IMMUNOL METHODS, V272, P199, DOI 10.1016/S0022-1759(02)00506-9; Cole LE, 2007, INFECT IMMUN, V75, P4127, DOI 10.1128/IAI.01868-06; da Costa CP, 2002, EUR J IMMUNOL, V32, P2460, DOI 10.1002/1521-4141(200209)32:9<2460::AID-IMMU2460>3.0.CO;2-M; Dreisbach VC, 2000, INFECT IMMUN, V68, P1988, DOI 10.1128/IAI.68.4.1988-1996.2000; Elkins KL, 2003, MICROBES INFECT, V5, P135, DOI 10.1016/S1286-4579(02)00084-9; Hashimoto M, 2006, INT IMMUNOL, V18, P355, DOI 10.1093/intimm/dxh374; Huntley JF, 2007, J BACTERIOL, V189, P561, DOI 10.1128/JB.01505-06; Janovska S, 2007, IMMUNOL LETT, V108, P151, DOI 10.1016/j.imlet.2006.12.004; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Katz J, 2006, INFECT IMMUN, V74, P2809, DOI 10.1128/IAI.74.5.2809-2816.2006; Lavine CL, 2007, EUR J IMMUNOL, V37, P3007, DOI 10.1002/eji.200737620; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Li HF, 2006, J LEUKOCYTE BIOL, V80, P766, DOI 10.1189/jlb.0406294; Malik M, 2006, INFECT IMMUN, V74, P3657, DOI 10.1128/IAI.02030-05; Massari P, 2006, J IMMUNOL, V176, P2373, DOI 10.4049/jimmunol.176.4.2373; Meng GX, 2003, J BIOL CHEM, V278, P39822, DOI 10.1074/jbc.M304766200; Omueti KO, 2005, J BIOL CHEM, V280, P36616, DOI 10.1074/jbc.M504320200; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Ray A, 2004, MOL IMMUNOL, V41, P1167, DOI 10.1016/j.molimm.2004.06.007; Re F, 2001, J BIOL CHEM, V276, P37692, DOI 10.1074/jbc.M105927200; Sandor F, 2003, J CELL BIOL, V162, P1099, DOI 10.1083/jcb.200304093; Shimizu T, 2005, J IMMUNOL, V175, P4641, DOI 10.4049/jimmunol.175.7.4641; SJOSTEDT A, 1991, INFECT IMMUN, V59, P3163; SJOSTEDT A, 1989, MICROB PATHOGENESIS, V6, P403, DOI 10.1016/0882-4010(89)90082-X; SJOSTEDT A, 1992, INFECT IMMUN, V60, P2855; Takeda K, 2005, INT IMMUNOL, V17, P1, DOI 10.1093/intimm/dxh186; Takenaka R, 2004, MICROBIOL-SGM, V150, P3913, DOI 10.1099/mic.0.27527-0; Takeuchi O, 2002, J IMMUNOL, V169, P10, DOI 10.4049/jimmunol.169.1.10; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Travassos LH, 2004, EMBO REP, V5, P1000, DOI 10.1038/sj.embor.7400248; Twine SM, 2006, BIOCHEM BIOPH RES CO, V346, P999, DOI 10.1016/j.bbrc.2006.06.008	40	84	87	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3751	3760		10.1074/jbc.M706854200	http://dx.doi.org/10.1074/jbc.M706854200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079113	hybrid			2022-12-25	WOS:000253083500008
J	Tiruppathi, C; Shimizu, J; Miyawaki-Shimizu, K; Vogel, SM; Bair, AM; Minshall, RD; Predescu, D; Malik, AB				Tiruppathi, Chinnaswamy; Shimizu, Jun; Miyawaki-Shimizu, Kayo; Vogel, Stephen M.; Bair, Angela M.; Minshall, Richard D.; Predescu, Dan; Malik, Asrar B.			Role of NF-kappa B-dependent caveolin-1 expression in the mechanism of increased endothelial permeability induced by lipopolysaccharide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL LIPOPOLYSACCHARIDE; MICROVASCULAR PERMEABILITY; DIFFERENTIAL EXPRESSION; PROTEIN EXPRESSION; UP-REGULATION; ACTIVATION; CELLS; RECEPTOR; TRANSCYTOSIS; TRANSPORT	We investigated the role of NF-kappa B activation by the bacterial product lipopolysaccharide (LPS) in inducing caveolin-1 (Cav-1) expression and its consequence in contributing to the leakiness of the endothelial barrier. We observed that LPS challenge of human lung microvascular endothelial cells induced concentration-and time-dependent increases in expression of Cav-1 mRNA and protein. The NEMO (NF-kappa B essential modifier binding domain)-binding domain peptide (IkB kinase (IKK)-NEMO-binding domain (NBD) peptide), which prevents NF-kappa B activation by inhibiting the interaction of IKK gamma with the IKK complex, blocked LPS-induced Cav-1 mRNA and protein expression. Knockdown of NF-kappa B subunit p65/RelA expression with small interfering RNA also prevented LPS-induced Cav-1 expression. Caveolae open to the apical and basal plasmalemma of endothelial cells increased 2-4-fold within 4 h of LPS exposure. IKK-NBD peptide markedly reduced the LPS-induced increase in the number of caveolae as well as transendothelial albumin permeability. These observations were recapitulated in mouse studies in which IKK-NBD peptide prevented Cav-1 expression and interfered with the increase in lung microvessel permeability induced by LPS. Thus, LPS mediates NF-kappa B-dependent Cav-1 expression that results in increased caveolae number and thereby contributes to the mechanism of increased transendothelial albumin permeability.	[Tiruppathi, Chinnaswamy; Shimizu, Jun; Miyawaki-Shimizu, Kayo; Vogel, Stephen M.; Bair, Angela M.; Minshall, Richard D.; Predescu, Dan; Malik, Asrar B.] Univ Illinois, Dept Pharmacol, Coll Med, Chicago, IL 60612 USA; [Tiruppathi, Chinnaswamy; Shimizu, Jun; Miyawaki-Shimizu, Kayo; Vogel, Stephen M.; Bair, Angela M.; Minshall, Richard D.; Predescu, Dan; Malik, Asrar B.] Univ Illinois, Ctr Lung & Vasc Biol, Coll Med, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Malik, AB (corresponding author), Univ Illinois, Dept Pharmacol, Coll Med, M-C 868,835 S Wolcott Ave, Chicago, IL 60612 USA.	abmalik@uic.edu		Malik, Asrar/0000-0002-8205-7128	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL077806, P01HL060678, R01HL045638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058531] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01HL045638, P01HL060678, P01 HL077806, P01 HL060678-09, P01 HL077806-03, R01 HL045638-19, P01 HL060678, P01HL077806, R01 HL045638] Funding Source: Medline; NIGMS NIH HHS [R01 GM058531-10, R01 GM58531, R01 GM058531] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andonegui G, 2003, J CLIN INVEST, V111, P1011, DOI 10.1172/JCI200316510; Bannerman DD, 1999, LAB INVEST, V79, P1181; Bauer PM, 2005, P NATL ACAD SCI USA, V102, P204, DOI 10.1073/pnas.0406092102; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Engelman JA, 1997, J BIOL CHEM, V272, P16374, DOI 10.1074/jbc.272.26.16374; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655; Garrean S, 2006, J IMMUNOL, V177, P4853, DOI 10.4049/jimmunol.177.7.4853; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; John TA, 2003, AM J PHYSIOL-LUNG C, V284, pL187, DOI 10.1152/ajplung.00152.2002; LANTZ RC, 1991, AM REV RESPIR DIS, V144, P167, DOI 10.1164/ajrccm/144.1.167; Lei MG, 2000, INFECT IMMUN, V68, P5084, DOI 10.1128/IAI.68.9.5084-5089.2000; Lei MG, 2005, INFECT IMMUN, V73, P8136, DOI 10.1128/IAI.73.12.8136-8143.2005; Li XW, 2003, INFECT IMMUN, V71, P4414, DOI 10.1128/IAI.71.8.4414-4420.2003; Lin FY, 2006, ARTERIOSCL THROM VAS, V26, P2622, DOI 10.1161/01.ATV.0000246779.78003.cf; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Minshall RD, 2000, J CELL BIOL, V150, P1057, DOI 10.1083/jcb.150.5.1057; Misquitta CM, 2006, CELL CALCIUM, V40, P329, DOI 10.1016/j.ceca.2006.04.004; Miyawaki-Shimizu K, 2006, AM J PHYSIOL-LUNG C, V290, pL405, DOI 10.1152/ajplung.00292.2005; Molinero LL, 2004, J IMMUNOL, V173, P5583, DOI 10.4049/jimmunol.173.9.5583; Pascariu M, 2004, J HISTOCHEM CYTOCHEM, V52, P65, DOI 10.1177/002215540405200107; Rahman A, 1998, AM J PHYSIOL-LUNG C, V275, pL533, DOI 10.1152/ajplung.1998.275.3.L533; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Schjerven H, 2004, J IMMUNOL, V173, P1849, DOI 10.4049/jimmunol.173.3.1849; Schubert W, 2001, J BIOL CHEM, V276, P48619, DOI 10.1074/jbc.C100613200; Shajahan AN, 2004, J BIOL CHEM, V279, P48055, DOI 10.1074/jbc.M405837200; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; STEPHENS KE, 1988, AM REV RESPIR DIS, V137, P1364, DOI 10.1164/ajrccm/137.6.1364; Tiruppathi C, 1997, J BIOL CHEM, V272, P25968, DOI 10.1074/jbc.272.41.25968; TIRUPPATHI C, 1992, P NATL ACAD SCI USA, V89, P7919, DOI 10.1073/pnas.89.17.7919; Vogel SM, 2000, PHYSIOL GENOMICS, V4, P137, DOI 10.1152/physiolgenomics.2000.4.2.137; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zhang GL, 2000, J ENDOTOXIN RES, V6, P453, DOI 10.1179/096805100101532414; Zhao BT, 2001, AM J PHYSIOL-CELL PH, V281, pC1587, DOI 10.1152/ajpcell.2001.281.5.C1587	37	88	99	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4210	4218		10.1074/jbc.M703153200	http://dx.doi.org/10.1074/jbc.M703153200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077459	Green Accepted, hybrid			2022-12-25	WOS:000253083500056
J	Bogenhagen, DF; Rousseau, D; Burke, S				Bogenhagen, Daniel F.; Rousseau, Denis; Burke, Stephanie			The layered structure of human mitochondrial DNA nucleoids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMALDEHYDE CROSS-LINKING; INNER MEMBRANE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; LON PROTEASE; IN-VIVO; POLYMERASE-DELTA; TOPOISOMERASE-I; MESSENGER-RNA; LIGASE-III	Mitochondrial DNA (mtDNA) occurs in cells in nucleoids containing several copies of the genome. Previous studies have identified proteins associated with these large DNA structures when they are biochemically purified by sedimentation and immunoaffinity chromatography. In this study, formaldehyde cross-linking was performed to determine which nucleoid proteins are in close contact with the mtDNA. A set of core nucleoid proteins is found in both native and cross-linked nucleoids, including 13 proteins with known roles in mtDNA transactions. Several other metabolic proteins and chaperones identified in native nucleoids, including ATAD3, were not observed to cross-link to mtDNA. Additional immunofluorescence and protease susceptibility studies showed that an N-terminal domain of ATAD3 previously proposed to bind to the mtDNA D-loop is directed away from the mitochondrial matrix, so it is unlikely to interact with mtDNA in vivo. These results are discussed in relation to a model for a layered structure of mtDNA nucleoids in which replication and transcription occur in the central core, whereas translation and complex assembly may occur in the peripheral region.	[Bogenhagen, Daniel F.; Burke, Stephanie] SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Rousseau, Denis] UJF, CNRS,CEA, Lab Biochim & Biophys Syst Integres P438B, Inst Rec Technol & Sci, F-38054 Grenoble 09, France	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Bogenhagen, DF (corresponding author), SUNY Stony Brook, Dept Pharmacol Sci, Stony Brook, NY 11794 USA.	dan@pharm.sunysb.edu			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012039] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01-ES12039] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Adams DJ, 2003, J BIOL CHEM, V278, P44894, DOI 10.1074/jbc.M307782200; Alam TI, 2003, NUCLEIC ACIDS RES, V31, P1640, DOI 10.1093/nar/gkg251; ALBRING M, 1977, P NATL ACAD SCI USA, V74, P1348, DOI 10.1073/pnas.74.4.1348; Arakaki N, 2006, BBA-GEN SUBJECTS, V1760, P1364, DOI 10.1016/j.bbagen.2006.05.012; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Bateman JM, 2002, J BIOL CHEM, V277, P47946, DOI 10.1074/jbc.M209071200; BOGENHAGEN D, 1977, CELL, V11, P719, DOI 10.1016/0092-8674(77)90286-0; Bogenhagen DF, 2003, MOL CELL PROTEOMICS, V2, P1205, DOI 10.1074/mcp.M300035-MCP200; Bryan AC, 2002, GENETICS, V160, P75; CANTATORE P, 1987, FEBS LETT, V213, P144, DOI 10.1016/0014-5793(87)81480-1; Cao LQ, 2007, NAT GENET, V39, P386, DOI 10.1038/ng1970; Capaldi RA, 2002, BBA-BIOENERGETICS, V1555, P192, DOI 10.1016/S0005-2728(02)00277-3; Cerritelli SM, 2003, MOL CELL, V11, P807, DOI 10.1016/S1097-2765(03)00088-1; Chen HC, 2005, J BIOL CHEM, V280, P26185, DOI 10.1074/jbc.M503062200; Chen HC, 2007, CELL, V130, P548, DOI 10.1016/j.cell.2007.06.026; Chen XJ, 2007, P NATL ACAD SCI USA, V104, P13738, DOI 10.1073/pnas.0703078104; Chen XJ, 2005, SCIENCE, V307, P714, DOI 10.1126/science.1106391; Chen XJ, 2005, NAT REV GENET, V6, P815, DOI 10.1038/nrg1708; Cheng XL, 2005, J BIOCHEM, V138, P673, DOI 10.1093/jb/mvi169; Cotney J, 2007, NUCLEIC ACIDS RES, V35, P4042, DOI 10.1093/nar/gkm424; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Davis AF, 1996, J CELL BIOL, V135, P883, DOI 10.1083/jcb.135.4.883; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; FernandezSilva P, 1997, EMBO J, V16, P1066, DOI 10.1093/emboj/16.5.1066; Fu GK, 1998, BIOCHEMISTRY-US, V37, P1905, DOI 10.1021/bi970928c; Garrido N, 2003, MOL BIOL CELL, V14, P1583, DOI 10.1091/mbc.E02-07-0399; GELFAND R, 1981, MOL CELL BIOL, V1, P497, DOI 10.1128/MCB.1.6.497; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.bi.54.070185.005055; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Kaufman BA, 2000, P NATL ACAD SCI USA, V97, P7772, DOI 10.1073/pnas.140063197; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Kucej M, 2007, TRENDS CELL BIOL, V17, P586, DOI 10.1016/j.tcb.2007.08.007; Kurdistani SK, 2003, METHODS, V31, P90, DOI 10.1016/S1046-2023(03)00092-6; LAIPIS PJ, 1988, P NATL ACAD SCI USA, V85, P8107, DOI 10.1073/pnas.85.21.8107; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Lee DG, 2000, CURR OPIN CELL BIOL, V12, P280, DOI 10.1016/S0955-0674(00)00089-2; Liu L, 2003, J BIOL CHEM, V278, P10041, DOI 10.1074/jbc.M208694200; Liu MQ, 2000, J BIOL CHEM, V275, P29400, DOI 10.1074/jbc.M002173200; Liu T, 2004, J BIOL CHEM, V279, P13902, DOI 10.1074/jbc.M309642200; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; LYNCH AS, 1993, J BACTERIOL, V175, P1645, DOI 10.1128/JB.175.6.1645-1655.1993; Malka F, 2006, BBA-MOL CELL RES, V1763, P463, DOI 10.1016/j.bbamcr.2006.04.001; Marchington DR, 1998, AM J HUM GENET, V63, P769, DOI 10.1086/302009; McCulloch V, 2002, MOL CELL BIOL, V22, P1116, DOI 10.1128/MCB.22.4.1116-1125.2002; Mili S, 2003, MOL CELL BIOL, V23, P4972, DOI 10.1128/MCB.23.14.4972-4982.2003; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORRISSEY JH, 1981, ANAL BIOCHEM, V117, P307, DOI 10.1016/0003-2697(81)90783-1; NASS MMK, 1969, SCIENCE, V165, P25, DOI 10.1126/science.165.3888.25; Neuwald AF, 2005, NUCLEIC ACIDS RES, V33, P3614, DOI 10.1093/nar/gki674; Orlando V, 2000, TRENDS BIOCHEM SCI, V25, P99, DOI 10.1016/S0968-0004(99)01535-2; Park CB, 2007, CELL, V130, P273, DOI 10.1016/j.cell.2007.05.046; Partikian A, 1998, J CELL BIOL, V140, P821, DOI 10.1083/jcb.140.4.821; Perez-Jannotti RM, 2001, J BIOL CHEM, V276, P48978, DOI 10.1074/jbc.M107177200; Schaffrik M, 2006, CELL MOL LIFE SCI, V63, P2162, DOI 10.1007/s00018-006-6200-x; SCHWERZMANN K, 1986, J CELL BIOL, V102, P97, DOI 10.1083/jcb.102.1.97; Shen EL, 2001, NUCLEIC ACIDS RES, V29, P2822, DOI 10.1093/nar/29.13.2822; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; TZAGOLOFF A, 1982, MITOCHONDRIA, P211; Valgardsdottir R, 2001, J BIOL CHEM, V276, P32056, DOI 10.1074/jbc.M011629200; Wang YS, 2006, J BIOL CHEM, V281, P25791, DOI 10.1074/jbc.M604501200; Wang ZB, 2007, J BIOL CHEM, V282, P12610, DOI 10.1074/jbc.M700461200; Wells J, 2002, METHODS, V26, P48, DOI 10.1016/S1046-2023(02)00007-5; WHITFORD TA, 1993, THESIS STATE U NEW Y; Wiesner RJ, 2006, FREE RADICAL RES, V40, P1284, DOI 10.1080/10715760600913168; Woldringh CL, 2002, MOL MICROBIOL, V45, P17, DOI 10.1046/j.1365-2958.2002.02993.x; Xie B, 2005, J BIOL CHEM, V280, P22375, DOI 10.1074/jbc.M414597200; Xu FH, 2004, BIOCHEM J, V382, P331, DOI 10.1042/BJ20040469; ZELENAYATROITSKAYA O, 1995, EMBO J, V14, P3268, DOI 10.1002/j.1460-2075.1995.tb07330.x; Zhang HL, 2001, P NATL ACAD SCI USA, V98, P10608, DOI 10.1073/pnas.191321998	72	318	335	2	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3665	3675		10.1074/jbc.M708444200	http://dx.doi.org/10.1074/jbc.M708444200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18063578	hybrid			2022-12-25	WOS:000253083000071
J	Kweon, SM; Cho, YJ; Minoo, P; Groffen, J; Heisterkamp, N				Kweon, Soo-Mi; Cho, Young Jin; Minoo, Parviz; Groffen, John; Heisterkamp, Nora			Activity of the Bcr GTPase-activating domain is regulated through direct protein protein interaction with the rho guanine nucleotide dissociation inhibitor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE ENCODES; LACKING ABR; BINDING; PHOSPHORYLATION; COMPLEX; FAMILY; GDI; SUPEROXIDE; MOLECULES	The cycling of Rac GTPases, alternating between an active GTP-and an inactive GDP-bound state, is controlled by guanine nucleotide exchange factors, GTPase-activating proteins (GAPs), and guanine nucleotide dissociation inhibitors (GDIs). Little is known about how these controlling activities are coordinated. Studies using null mutant mice have demonstrated that Bcr and Abr are two physiologically important GAPs for Rac. Here, we report that in the presence of RhoGDI alpha, Bcr is unable to convert Rac-GTP to Rac-GDP because RhoGDI forms a direct protein complex with Bcr. Interestingly, RhoGDI alpha binds to the GAP domain in Bcr and Abr, a domain that also binds to Rac-GTP and catalyzes conversion of the bound GTP to GDP on Rac. The presence of activated Rac diminished the Bcr/RhoGDI alpha interaction. Moreover, a Bcr mutant that lacks the ability to promote hydrolysis of Rac-GTP bound to its GAP domain did not bind to RhoGDI alpha in cell lysates, indicating that binding of RhoGDI alpha and Rac-GTP to the Bcr GAP domain is mutually exclusive. Our results provide the first identification of a protein that regulates BcrGAP activity.	[Kweon, Soo-Mi; Cho, Young Jin; Groffen, John; Heisterkamp, Nora] Childrens Hosp, Div Hematol Oncol, Sect Mol Carcinogenesis, Saban Res Inst, Los Angeles, CA 90027 USA; [Minoo, Parviz] Univ Calif Los Angeles, Keck Sch Med, Dept Pediat, Los Angeles, CA 90033 USA; [Groffen, John; Heisterkamp, Nora] Univ Calif Los Angeles, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	Children's Hospital Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Heisterkamp, N (corresponding author), Childrens Hosp, Div Hematol Oncol, Sect Mol Carcinogenesis, Saban Res Inst, Ms 54,4650 Sunset Blvd, Los Angeles, CA 90027 USA.	heisterk@hsc.usc.edu	Heisterkamp, Nora/C-1698-2012	Heisterkamp, Nora/0000-0003-2769-2273	NHLBI NIH HHS [HL71945, HL060231] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071945, P01HL060231] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; CHUANG TH, 1993, J BIOL CHEM, V268, P775; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; DerMardirossian C, 2006, MOL BIOL CELL, V17, P4760, DOI 10.1091/mbc.E06-06-0533; Dovas A, 2005, BIOCHEM J, V390, P1, DOI 10.1042/BJ20050104; Dransart E, 2005, TRAFFIC, V6, P957, DOI 10.1111/j.1600-0854.2005.00335.x; Guillemot JC, 1996, BLOOD, V88, P2722, DOI 10.1182/blood.V88.7.2722.bloodjournal8872722; Haataja L, 2002, J BIOL CHEM, V277, P8321, DOI 10.1074/jbc.M105363200; HANCOCK JF, 1993, EMBO J, V12, P1915, DOI 10.1002/j.1460-2075.1993.tb05840.x; HART MJ, 1992, SCIENCE, V258, P812, DOI 10.1126/science.1439791; Heisterkamp N, 2002, ONCOGENE, V21, P8536, DOI 10.1038/sj.onc.1206080; Kaartinen V, 2002, DEV DYNAM, V223, P517, DOI 10.1002/dvdy.10071; Kaartinen V, 2001, DEVELOPMENT, V128, P4217; Kuribayashi K, 2007, J CELL BIOL, V176, P1049, DOI 10.1083/jcb.200607019; LEONARD D, 1992, J BIOL CHEM, V267, P22860; Lian LY, 2000, STRUCT FOLD DES, V8, P47, DOI 10.1016/S0969-2126(00)00080-0; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; Moissoglu K, 2006, MOL BIOL CELL, V17, P2770, DOI 10.1091/mbc.E06-01-0005; Molnar G, 2001, BIOCHEMISTRY-US, V40, P10542, DOI 10.1021/bi011158e; Newcombe AR, 1999, BIOCHEMISTRY-US, V38, P6879, DOI 10.1021/bi9829837; Nomanbhoy TK, 1996, J BIOL CHEM, V271, P10004, DOI 10.1074/jbc.271.17.10004; Olabisi OO, 2006, CANCER RES, V66, P6250, DOI 10.1158/0008-5472.CAN-06-0536; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Radziwill G, 2003, MOL CELL BIOL, V23, P4663, DOI 10.1128/MCB.23.13.4663-4672.2003; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; SASAKI T, 1993, J BIOL CHEM, V268, P23959; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; STAM K, 1987, MOL CELL BIOL, V7, P1955, DOI 10.1128/MCB.7.5.1955; Takahashi K, 1997, J BIOL CHEM, V272, P23371, DOI 10.1074/jbc.272.37.23371; TAN EC, 1993, J BIOL CHEM, V268, P27291; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045	35	13	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3023	3030		10.1074/jbc.M705513200	http://dx.doi.org/10.1074/jbc.M705513200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070886	hybrid			2022-12-25	WOS:000253083000005
J	Leclerc, D; Rozen, R				Leclerc, Daniel; Rozen, Rima			Endoplasmic reticulum stress increases the expression of methylenetetrahydrofolate reductase through the IRE1 transducer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VASCULAR ENDOTHELIAL-CELLS; GLYCOGEN-SYNTHASE KINASE-3; UNFOLDED PROTEIN RESPONSE; N-TERMINAL KINASE; GENE-EXPRESSION; MICE DEFICIENT; MESSENGER-RNA; TRANSMEMBRANE PROTEIN; METHIONINE SYNTHASE; KAPPA-B	Methylenetetrahydrofolate reductase ( MTHFR), an enzyme in folate and homocysteine metabolism, influences many cellular processes including methionine and nucleotide synthesis, methylation reactions, and maintenance of homocysteine at nontoxic levels. Mild deficiency of MTHFR is common in many populations and modifies risk for several complex traits including vascular disease, birth defects, and cancer. We recently demonstrated that MTHFR can be up-regulated by NF-kappa B, an important mediator of cell survival that is activated by endoplasmic reticulum ( ER) stress. This observation, coupled with the reports that homocysteine can induce ER stress, prompted us to examine the possible regulation of MTHFR by ER stress. We found that several well characterized stress inducers ( tunicamycin, thapsigargin, and A23187) as well as homocysteine could increase Mthfr mRNA and protein in Neuro-2a cells. The induction of MTHFR was also observed after overexpression of inositol-requiring enzyme-1 (IRE1) and was inhibited by a dominant-negative mutant of IRE1. Because IRE1 triggers c-Jun signaling, we examined the possible involvement of c-Jun in up-regulation of MTHFR. Transfection of c-Jun and two activators of c-Jun (LiCl and sodium valproate) increased MTHFR expression, whereas a reported inhibitor of c-Jun (SP600125) and a dominant-negative derivative of c-Jun N-terminal kinase-1 reduced MTHFR activation. We conclude that ER stress increases MTHFR expression and that IRE1 and c-Jun mediate this activation. These findings provide a novel mechanism by which the ER can regulate homeostasis and allude to an important role for MTHFR in cell survival.	[Leclerc, Daniel; Rozen, Rima] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Human Genet, Montreal, PQ H3Z 2Z3, Canada; [Leclerc, Daniel; Rozen, Rima] McGill Univ, Montreal Childrens Hosp, Ctr Hlth, Dept Pediat, Montreal, PQ H3Z 2Z3, Canada	McGill University; McGill University	Rozen, R (corresponding author), 4060 Ste Catherine W,Rm 200, Montreal, PQ H3Z 2Z3, Canada.	rima.rozen@mcgill.ca	Leclerc, Daniel/B-6375-2012; Longo, Kenneth A/A-5631-2010; Leclerc, Daniel/AAB-4524-2021; Rozen, Rima/AAE-9294-2020	Leclerc, Daniel/0000-0002-9766-8941; 				Agarwala KL, 2000, BIOCHEM BIOPH RES CO, V272, P641, DOI 10.1006/bbrc.2000.2833; Althausen S, 2000, MOL BRAIN RES, V84, P32, DOI 10.1016/S0169-328X(00)00208-4; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Cai Y, 2000, BLOOD, V96, P2140, DOI 10.1182/blood.V96.6.2140.h8002140_2140_2148; Chen G, 1999, MOL BRAIN RES, V64, P52, DOI 10.1016/S0169-328X(98)00303-9; Chen Zhoutao, 2002, Brain Res Gene Expr Patterns, V1, P89; Chen ZT, 2005, INT J DEV NEUROSCI, V23, P465, DOI 10.1016/j.ijdevneu.2005.05.007; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Ghandour H, 2004, J NUTR, V134, P2975, DOI 10.1093/jn/134.11.2975; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Jacobsen DW, 2005, CLIN CHEM LAB MED, V43, P1076, DOI 10.1515/CCLM.2005.188; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; Kaneko M, 2004, BIOL PHARM BULL, V27, P1202, DOI 10.1248/bpb.27.1202; Kokame K, 1996, J BIOL CHEM, V271, P29659, DOI 10.1074/jbc.271.47.29659; LECLERC D, 2005, MTHFR POLYMORPHISMS, P1; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; LENTZ SR, 1991, J CLIN INVEST, V88, P1906, DOI 10.1172/JCI115514; Lenz B, 2006, EXP CELL RES, V312, P4049, DOI 10.1016/j.yexcr.2006.09.004; Leonardi A, 2002, ENDOCRINOLOGY, V143, P2169, DOI 10.1210/en.143.6.2169; Liberman Z, 2005, J BIOL CHEM, V280, P4422, DOI 10.1074/jbc.M410610200; Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361; MACEJAK DG, 1991, NATURE, V353, P90, DOI 10.1038/353090a0; Oltean S, 2005, J BIOL CHEM, V280, P32662, DOI 10.1074/jbc.M501964200; Ortiou S, 2004, CELL PHYSIOL BIOCHEM, V14, P407, DOI 10.1159/000080350; Outinen PA, 1998, BIOCHEM J, V332, P213, DOI 10.1042/bj3320213; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Pickell L, 2005, BBA-GENE STRUCT EXPR, V1731, P104, DOI 10.1016/j.bbaexp.2005.09.002; Ramaswami G, 2004, J VASC SURG, V40, P1216, DOI 10.1016/j.jvs.2004.09.021; Robert K, 2004, J NEUROCHEM, V89, P33, DOI 10.1046/j.1471-4159.2003.02297.x; Song L, 2002, J BIOL CHEM, V277, P44701, DOI 10.1074/jbc.M206047200; Tran P, 2002, MAMM GENOME, V13, P483, DOI 10.1007/s00335-002-2167-6; UELAND PM, 2005, MTHFR POLYMORPHISM D; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; WANG WW, 1995, BIOCHEM BIOPH RES CO, V210, P1009, DOI 10.1006/bbrc.1995.1757; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Xu X, 1997, P NATL ACAD SCI USA, V94, P12655, DOI 10.1073/pnas.94.23.12655; Yamada K, 2005, P NATL ACAD SCI USA, V102, P10454, DOI 10.1073/pnas.0504786102; Yuan PX, 1999, J NEUROCHEM, V73, P2299, DOI 10.1046/j.1471-4159.1999.0732299.x; Zhang C, 2001, J BIOL CHEM, V276, P35867, DOI 10.1074/jbc.M100747200	51	17	19	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3151	3160		10.1074/jbc.M708598200	http://dx.doi.org/10.1074/jbc.M708598200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065414	hybrid			2022-12-25	WOS:000253083000018
J	Marshall, HM; Ronen, K; Berry, C; Llano, M; Sutherland, H; Saenz, D; Bickmore, W; Poeschla, E; Bushman, FD				Marshall, Heather M.; Ronen, Keshet; Berry, Charles; Llano, Manuel; Sutherland, Heidi; Saenz, Dyana; Bickmore, Wendy; Poeschla, Eric; Bushman, Frederic D.			Role of PSIP1/LEDGF/p75 in Lentiviral Infectivity and Integration Targeting	PLOS ONE			English	Article								Background. To replicate, lentiviruses such as HIV must integrate DNA copies of their RNA genomes into host cell chromosomes. Lentiviral integration is favored in active transcription units, which allows efficient viral gene expression after integration, but the mechanisms directing integration targeting are incompletely understood. A cellular protein, PSIP1/LEDGF/p75, binds tightly to the lentiviral-encoded integrase protein (IN), and has been reported to be important for HIV infectivity and integration targeting. Methodology. Here we report studies of lentiviral integration targeting in 1) human cells with intensified RNAi knockdowns of PSIP1/LEDGF/p75, and 2) murine cells with homozygous gene trap mutations in the PSIP1/LEDGF/p75 locus. Infections with vectors derived from equine infections anemia virus (EIAV) and HIV were compared. Integration acceptor sites were analyzed by DNA bar coding and pyrosequencing. Conclusions/Significance. In both PSIP1/LEDGF/p75-depleted cell lines, reductions were seen in lentiviral infectivity compared to controls. For the human cells, integration was reduced in transcription units in the knockdowns, and this reduction was greater than in our previous studies of human cells less completely depleted for PSIP1/LEDGF/p75. For the homozygous mutant mouse cells, similar reductions in integration in transcription units were seen, paralleling a previous study of a different mutant mouse line. Integration did not become random, however-integration in transcription units in both cell types was still favored, though to a reduced degree. New trends also appeared, including favored integration near CpG islands. In addition, we carried out a bioinformatic study of 15 HIV integration site data sets in different cell types, which showed that the frequency of integration in transcription units was correlated with the cell-type specific levels of PSIP1/LEDGF/p75 expression.	[Marshall, Heather M.; Ronen, Keshet; Bushman, Frederic D.] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Berry, Charles; Saenz, Dyana] Univ Calif San Diego, Dept Family, San Diego, CA 92103 USA; [Sutherland, Heidi; Bickmore, Wendy] MRC, Human Genet Unit, Edinburgh, Midlothian, Scotland; [Llano, Manuel; Poeschla, Eric] Mayo Clin, Coll Med, Program Mol Med, Rochester, MN USA	University of Pennsylvania; University of California System; University of California San Diego; University of Edinburgh; Mayo Clinic	Bushman, FD (corresponding author), Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA.	bushman@mail.med.upenn.edu	Bickmore, Wendy A/C-7314-2013	Bickmore, Wendy A/0000-0001-6660-7735; Bushman, Frederic/0000-0003-4740-4056; Sutherland, Heidi/0000-0002-8512-1498	NIH [AI52845, AI66290, AI47536]; Tietze Foundation; James B. Pendleton Charitable Trust; The Penn Genomics Institute; Robin and Frederic Withington;  [T32 07229-33];  [AI007632]; Medical Research Council [MC_U127527202] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI047536, T32AI007632, U19AI066290, R01AI047536, R01AI052845, R01AI077344] Funding Source: NIH RePORTER; MRC [MC_U127527202] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Tietze Foundation; James B. Pendleton Charitable Trust; The Penn Genomics Institute; Robin and Frederic Withington; ; ; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by NIH grants AI52845, AI66290, AI47536, the Tietze Foundation, the James B. Pendleton Charitable Trust, The Penn Genomics Institute, and Robin and Frederic Withington. Keshet Ronen was supported by T32 07229-33. Heather Marshall was supported by AI007632.	Barr SD, 2005, J VIROL, V79, P12035, DOI 10.1128/JVI.79.18.12035-12044.2005; Barr SD, 2006, MOL THER, V14, P218, DOI 10.1016/j.ymthe.2006.03.012; Berry C, 2006, PLOS COMPUT BIOL, V2, P1450, DOI 10.1371/journal.pcbi.0020157; Binladen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000197; Bisgrove Dwayne, 2005, Expert Rev Anti Infect Ther, V3, P805, DOI 10.1586/14787210.3.5.805; Bushman F, 2005, NAT REV MICROBIOL, V3, P848, DOI 10.1038/nrmicro1263; Bushman FD, 2001, LATERAL DNA TRANSFER; Busschots K, 2005, J BIOL CHEM, V280, P17841, DOI 10.1074/jbc.M411681200; Butler SL, 2002, J VIROL, V76, P3739, DOI 10.1128/JVI.76.8.3739-3747.2002; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Carteau S, 1998, J VIROL, V72, P4005, DOI 10.1128/JVI.72.5.4005-4014.1998; Cherepanov P, 2005, P NATL ACAD SCI USA, V102, P17308, DOI 10.1073/pnas.0506924102; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2004, J BIOL CHEM, V279, P48883, DOI 10.1074/jbc.M406307200; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Ciuffi A, 2006, MOL THER, V13, P366, DOI 10.1016/j.ymthe.2005.10.009; Ciuffi A, 2005, NAT MED, V11, P1287, DOI 10.1038/nm1329; Ciuffi A, 2006, HUM GENE THER, V17, P960, DOI 10.1089/hum.2006.17.960; Coffin J, 1997, RETROVIRUSES; Crise B, 2005, J VIROL, V79, P12199, DOI 10.1128/JVI.79.19.12199-12204.2005; De Rijck J, 2006, J VIROL, V80, P11498, DOI 10.1128/JVI.00801-06; Emiliani S, 2005, J BIOL CHEM, V280, P25517, DOI 10.1074/jbc.M501378200; Follenzi A, 2000, NAT GENET, V25, P217, DOI 10.1038/76095; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hacker CV, 2006, MOL THER, V14, P536, DOI 10.1016/j.ymthe.2006.06.006; Hematti P, 2004, PLOS BIOL, V2, P2183, DOI 10.1371/journal.pbio.0020423; Hoffmann C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm435; Holman AG, 2005, P NATL ACAD SCI USA, V102, P6103, DOI 10.1073/pnas.0501646102; Jordan A, 2003, EMBO J, V22, P1868, DOI 10.1093/emboj/cdg188; Jordan A, 2001, EMBO J, V20, P1726, DOI 10.1093/emboj/20.7.1726; Kang YB, 2006, J VIROL, V80, P8820, DOI 10.1128/JVI.00719-06; Levine BL, 2006, P NATL ACAD SCI USA, V103, P17372, DOI 10.1073/pnas.0608138103; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Lewinski MK, 2005, J VIROL, V79, P6610, DOI 10.1128/JVI.79.11.6610-6619.2005; Llano M, 2004, J BIOL CHEM, V279, P55570, DOI 10.1074/jbc.M408508200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; Llano M, 2006, J MOL BIOL, V360, P760, DOI 10.1016/j.jmb.2006.04.073; MacNeil A, 2006, J VIROL, V80, P7316, DOI 10.1128/JVI.00604-06; Maertens G, 2003, J BIOL CHEM, V278, P33528, DOI 10.1074/jbc.M303594200; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miller DG, 2005, J VIROL, V79, P11434, DOI 10.1128/JVI.79.17.11434-11442.2005; Mitchell RS, 2004, PLOS BIOL, V2, P1127, DOI 10.1371/journal.pbio.0020234; Molteni V, 2001, ACTA CRYSTALLOGR D, V57, P536, DOI 10.1107/S0907444901001652; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Olsen JC, 1998, GENE THER, V5, P1481, DOI 10.1038/sj.gt.3300768; PRYCIAK PM, 1992, EMBO J, V11, P291, DOI 10.1002/j.1460-2075.1992.tb05052.x; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Shoemaker DD, 1996, NAT GENET, V14, P450, DOI 10.1038/ng1296-450; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Stevens SW, 1996, J VIROL, V70, P6459, DOI 10.1128/JVI.70.9.6459-6462.1996; STONE M, 1974, J R STAT SOC B, V36, P111, DOI 10.1111/j.2517-6161.1974.tb00994.x; Sutherland HG, 2006, MOL CELL BIOL, V26, P7201, DOI 10.1128/MCB.00459-06; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Turlure F, 2006, NUCLEIC ACIDS RES, V34, P1653, DOI 10.1093/nar/gkl052; Turlure F, 2004, FRONT BIOSCI-LANDMRK, V9, P3187, DOI 10.2741/1472; Vandegraaff N, 2006, VIROLOGY, V346, P415, DOI 10.1016/j.virol.2005.11.022; Vandekerckhove L, 2006, J VIROL, V80, P1886, DOI 10.1128/JVI.80.4.1886-1896.2006; Vanegas M, 2005, J CELL SCI, V118, P1733, DOI 10.1242/jcs.02299; Wang GP, 2007, GENOME RES, V17, P1186, DOI 10.1101/gr.6286907; Wu XL, 2005, J VIROL, V79, P5211, DOI 10.1128/JVI.79.8.5211-5214.2005; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Yamashita M, 2004, J VIROL, V78, P5670, DOI 10.1128/JVI.78.11.5670-5678.2004; Zielske SP, 2006, J VIROL, V80, P7275, DOI 10.1128/JVI.02470-05	66	182	185	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1340	10.1371/journal.pone.0001340	http://dx.doi.org/10.1371/journal.pone.0001340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092005	Green Published, gold			2022-12-25	WOS:000207459600023
J	Higgs, BW; Mohtashemi, M; Grinsdale, J; Kawamura, LM				Higgs, Brandon W.; Mohtashemi, Mojdeh; Grinsdale, Jennifer; Kawamura, L. Masae			Early Detection of Tuberculosis Outbreaks among the San Francisco Homeless: Trade-Offs Between Spatial Resolution and Temporal Scale	PLOS ONE			English	Article								Background. San Francisco has the highest rate of tuberculosis (TB) in the U. S. with recurrent outbreaks among the homeless and marginally housed. It has been shown for syndromic data that when exact geographic coordinates of individual patients are used as the spatial base for outbreak detection, higher detection rates and accuracy are achieved compared to when data are aggregated into administrative regions such as zip codes and census tracts. We examine the effect of varying the spatial resolution in the TB data within the San Francisco homeless population on detection sensitivity, timeliness, and the amount of historical data needed to achieve better performance measures. Methods and Findings. We apply a variation of space-time permutation scan statistic to the TB data in which a patient's location is either represented by its exact coordinates or by the centroid of its census tract. We show that the detection sensitivity and timeliness of the method generally improve when exact locations are used to identify real TB outbreaks. When outbreaks are simulated, while the detection timeliness is consistently improved when exact coordinates are used, the detection sensitivity varies depending on the size of the spatial scanning window and the number of tracts in which cases are simulated. Finally, we show that when exact locations are used, smaller amount of historical data is required for training the model. Conclusion. Systematic characterization of the spatio-temporal distribution of TB cases can widely benefit real time surveillance and guide public health investigations of TB outbreaks as to what level of spatial resolution results in improved detection sensitivity and timeliness. Trading higher spatial resolution for better performance is ultimately a tradeoff between maintaining patient confidentiality and improving public health when sharing data. Understanding such tradeoffs is critical to managing the complex interplay between public policy and public health. This study is a step forward in this direction.	[Higgs, Brandon W.; Mohtashemi, Mojdeh] Mitre Corp, Mclean, VA USA; [Mohtashemi, Mojdeh] MIT, Dept Comp Sci, Cambridge, MA 02139 USA; [Grinsdale, Jennifer; Kawamura, L. Masae] San Francisco Dept Publ Hlth, TB Control Sect, San Francisco, CA USA	MITRE Corporation; Massachusetts Institute of Technology (MIT); San Francisco Department of Public Health	Higgs, BW (corresponding author), Mitre Corp, Mclean, VA USA.	bhiggs100@yahoo.com		Higgs, Brandon/0000-0002-2951-0245	MITRE internal research program	MITRE internal research program	This work was funded exclusively by the MITRE internal research program.	[Anonymous], 1995, CONTROL COMMUNICABLE; DWASS M, 1957, ANN MATH STAT, V29; Ginsberg AM, 2000, CLIN INFECT DIS, V30, pS233, DOI 10.1086/313867; Gregorio David I, 2005, Int J Health Geogr, V4, P6, DOI 10.1186/1476-072X-4-6; Gregorio DI, 2002, INT J CANCER, V100, P194, DOI 10.1002/ijc.10431; Kleinman KP, 2005, EPIDEMIOL INFECT, V133, P409, DOI 10.1017/S0950268804003528; Klovdahl AS, 2001, SOC SCI MED, V52, P681, DOI 10.1016/S0277-9536(00)00170-2; Krieger N, 2002, AM J EPIDEMIOL, V156, P471, DOI 10.1093/aje/kwf068; Kulldorff M, 2005, PLOS MED, V2, P216, DOI 10.1371/journal.pmed.0020059; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lewis MD, 2002, AM J PREV MED, V23, P180, DOI 10.1016/S0749-3797(02)00490-7; Mandl KD, 2004, J AM MED INFORM ASSN, V11, P141, DOI 10.1197/jamia.M1356; MCELROY PD, 2003, INT J TUBERC LUNG, pS486; Mohtashemi M, 2007, STAT MED, V26, P5203, DOI 10.1002/sim.2872; Mohtashemi M, 2006, J THEOR BIOL, V241, P954, DOI 10.1016/j.jtbi.2006.01.031; NAUS JI, 1965, J AM STAT ASSOC, V60, P532, DOI 10.2307/2282688; NEILL DB, 2003, ADV IN NEURAL INFORM, V16; Olson KL, 2006, AM J PUBLIC HEALTH, V96, P2002, DOI 10.2105/AJPH.2005.069526; Reis BY, 2003, P NATL ACAD SCI USA, V100, P1961, DOI 10.1073/pnas.0335026100; Sheehan T J, 2000, J Public Health Manag Pract, V6, P48; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; vanDeutekom H, 1997, CLIN INFECT DIS, V25, P1071, DOI 10.1086/516072; WALLENSTEIN S, 1980, AM J EPIDEMIOL, V111, P367, DOI 10.1093/oxfordjournals.aje.a112908; WEINSTOCK MA, 1981, INT J EPIDEMIOL, V10, P289, DOI 10.1093/ije/10.3.289; World Health Organization, 2004, WORLD HLTH REP 2004	25	23	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1284	10.1371/journal.pone.0001284	http://dx.doi.org/10.1371/journal.pone.0001284			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074010	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459500003
J	Stolarczyk, E; Le Gall, M; Even, P; Houllier, A; Serradas, P; Brot-Laroche, E; Leturque, A				Stolarczyk, Emilie; Le Gall, Maude; Even, Patrick; Houllier, Anne; Serradas, Patricia; Brot-Laroche, Edith; Leturque, Armelle			Loss of Sugar Detection by GLUT2 Affects Glucose Homeostasis in Mice	PLOS ONE			English	Article								Background. Mammals must sense the amount of sugar available to them and respond appropriately. For many years attention has focused on intracellular glucose sensing derived from glucose metabolism. Here, we studied the detection of extracellular glucose concentrations in vivo by invalidating the transduction pathway downstream from the transporter-detector GLUT2 and measured the physiological impact of this pathway. Methodology/Principal Findings. We produced mice that ubiquitously express the largest cytoplasmic loop of GLUT2, blocking glucose-mediated gene expression in vitro without affecting glucose metabolism. Impairment of GLUT2-mediated sugar detection transiently protected transgenic mice against starvation and streptozotocin-induced diabetes, suggesting that both low- and high-glucose concentrations were not detected. Transgenic mice favored lipid oxidation, and oral glucose was slowly cleared from blood due to low insulin production, despite massive urinary glucose excretion. Kidney adaptation was characterized by a lower rate of glucose reabsorption, whereas pancreatic adaptation was associated with a larger number of small islets. Conclusions/Significance. Molecular invalidation of sugar sensing in GLUT2-loop transgenic mice changed multiple aspects of glucose homeostasis, highlighting by a top-down approach, the role of membrane glucose receptors as potential therapeutic targets.	[Stolarczyk, Emilie; Le Gall, Maude; Houllier, Anne; Serradas, Patricia; Brot-Laroche, Edith; Leturque, Armelle] Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, Paris, France; [Stolarczyk, Emilie; Le Gall, Maude; Houllier, Anne; Serradas, Patricia; Brot-Laroche, Edith; Leturque, Armelle] Univ Paris 05, UMR S 872, Paris, France; [Stolarczyk, Emilie; Le Gall, Maude; Houllier, Anne; Serradas, Patricia; Brot-Laroche, Edith; Leturque, Armelle] INSERM, U872, Paris, France; [Even, Patrick] AgroParisTech, French Natl Inst Agr Res, UMR Nutr Physiol & Ingest Behav 914, CRNH IdF, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Leturque, A (corresponding author), Univ Paris 06, Ctr Rech Cordeliers, UMR S 872, Paris, France.	armelle.leturque@crc.jussieu.fr	Le Gall, Maude/C-3917-2017; Serradas, Patricia/R-2185-2017; Le Gall, Maude/W-2593-2019; Leturque, Armelle/Q-9437-2017	Le Gall, Maude/0000-0002-5372-4585; Serradas, Patricia/0000-0002-6652-9746; Le Gall, Maude/0000-0002-5372-4585; Leturque, Armelle/0000-0001-6570-6387; Even, Patrick/0000-0001-5733-3023; HOULLIER, ANNE/0000-0002-4153-2535	CNRS; INSERM; UPMC; ALFEDIAM Merck Lipha; Benjamin Delessert; PNRD; French MRT; Fondation pour la Recherche Medicale fellowships	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); UPMC; ALFEDIAM Merck Lipha; Benjamin Delessert; PNRD; French MRT; Fondation pour la Recherche Medicale fellowships(Fondation pour la Recherche Medicale)	EBL and AL are grateful to CNRS, INSERM and UPMC for support. AL is recipient of ALFEDIAM Merck Lipha grant. MLG is an INSERM fellow and recipient of Benjamin Delessert and PNRD grants. ES is recipient of the French MRT and the Fondation pour la Recherche Medicale fellowships.	Bady I, 2006, DIABETES, V55, P988, DOI 10.2337/diabetes.55.04.06.db05-1386; Bandyopadhyay G, 2000, J BIOL CHEM, V275, P40817, DOI 10.1074/jbc.M007920200; Bernard C, 1998, DIABETES, V47, P1058, DOI 10.2337/diabetes.47.7.1058; Bernard C, 1999, FASEB J, V13, P1195, DOI 10.1096/fasebj.13.10.1195; Berry GT, 2005, MOL GENET METAB, V86, P473, DOI 10.1016/j.ymgme.2005.09.010; BONNERWEIR S, 1989, DIABETES, V38, P49, DOI 10.2337/diabetes.38.1.49; CHICK WL, 1973, DIABETES, V22, P687, DOI 10.2337/diab.22.9.687; Dai CS, 2005, AM J PATHOL, V167, P429, DOI 10.1016/S0002-9440(10)62987-2; Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200; Diez-Sampedro A, 2003, P NATL ACAD SCI USA, V100, P11753, DOI 10.1073/pnas.1733027100; Even PC, 2003, AM J PHYSIOL-REG I, V284, pR751, DOI 10.1152/ajpregu.00268.2002; EVEN PC, 1994, NEUROSCI BIOBEHAV R, V18, P435, DOI 10.1016/0149-7634(94)90056-6; EVEN PC, 1991, PHYSIOL BEHAV, V49, P177, DOI 10.1016/0031-9384(91)90252-J; GIDDINGS SJ, 1981, J CLIN INVEST, V67, P952, DOI 10.1172/JCI110145; Girard J, 1997, ANNU REV NUTR, V17, P325, DOI 10.1146/annurev.nutr.17.1.325; Gouyon F, 2003, J PHYSIOL-LONDON, V552, P823, DOI 10.1113/jphysiol.2003.049247; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Guillam MT, 2000, DIABETES, V49, P1485, DOI 10.2337/diabetes.49.9.1485; Guillemain G, 2000, J CELL SCI, V113, P841; Guillemain G, 2002, BIOCHEM J, V364, P201, DOI 10.1042/bj3640201; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Holsbeeks I, 2004, TRENDS BIOCHEM SCI, V29, P556, DOI 10.1016/j.tibs.2004.08.010; Hoorens A, 1996, J CLIN INVEST, V98, P1568, DOI 10.1172/JCI118950; Hull R, 2005, DIABETOLOGIA, V48, P1350, DOI 10.1007/s00125-005-1772-9; ITOH N, 1980, NATURE, V283, P100, DOI 10.1038/283100a0; Izzedine H, 2003, AM J KIDNEY DIS, V41, P292, DOI 10.1053/ajkd.2003.50037; Jouannot E, 2006, ULTRASOUND MED BIOL, V32, P183, DOI 10.1016/j.ultrasmedbio.2005.10.008; Kaiser N, 2003, J PEDIATR ENDOCR MET, V16, P5, DOI 10.1515/JPEM.2003.16.1.5; Martinet W, 2006, AUTOPHAGY, V2, P55, DOI 10.4161/auto.2217; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Matschinsky FM, 1998, DIABETES, V47, P307, DOI 10.2337/diabetes.47.3.307; Menzel R, 1998, DIABETIC MED, V15, P816, DOI 10.1002/(SICI)1096-9136(199810)15:10<816::AID-DIA714>3.0.CO;2-P; MEUGNIER E, 2007, DIABETES; NIELSEN DA, 1985, J BIOL CHEM, V260, P3585; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Otani K, 2004, AM J PHYSIOL-ENDOC M, V286, pE41, DOI 10.1152/ajpendo.00533.2001; Ozcan S, 1996, P NATL ACAD SCI USA, V93, P12428, DOI 10.1073/pnas.93.22.12428; Path G, 2006, AM J PHYSIOL-ENDOC M, V291, pE1168, DOI 10.1152/ajpendo.00436.2005; Poitout V, 2004, ANN ENDOCRINOL-PARIS, V65, P37, DOI 10.1016/S0003-4266(04)95628-4; Pontoglio M, 2000, EMBO REP, V1, P359, DOI 10.1093/embo-reports/kvd071; Quinet EM, 2004, J LIPID RES, V45, P1929, DOI 10.1194/jlr.M400257-JLR200; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Santer R, 1998, EUR J PEDIATR, V157, P783, DOI 10.1007/s004310050937; Schuit F, 2002, DIABETES, V51, pS326, DOI 10.2337/diabetes.51.2007.S326; SCHUIT FC, 1988, P NATL ACAD SCI USA, V85, P3865, DOI 10.1073/pnas.85.11.3865; Skelly RH, 1996, DIABETES, V45, P37, DOI 10.2337/diabetes.45.1.37; Szkudelski T, 2001, PHYSIOL RES, V50, P537; Teegarden D, 2005, J NUTR, V135, P2749, DOI 10.1093/jn/135.12.2749; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; Vaulont S, 2000, J BIOL CHEM, V275, P31555, DOI 10.1074/jbc.R000016200; VOURETCRAVIARI V, 1993, BIOCHEM J, V289, P209, DOI 10.1042/bj2890209; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; WELSH M, 1985, J BIOL CHEM, V260, P3590; Wicksteed B, 2003, J BIOL CHEM, V278, P42080, DOI 10.1074/jbc.M303509200; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Yvan-Charvet L, 2005, DIABETES, V54, P991, DOI 10.2337/diabetes.54.4.991	56	31	34	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1288	10.1371/journal.pone.0001288	http://dx.doi.org/10.1371/journal.pone.0001288			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074013	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459500007
J	Wang, JH; Valo, Z; Smith, D; Singer-Sam, J				Wang, Jinhui; Valo, Zuzana; Smith, David; Singer-Sam, Judith			Monoallelic Expression of Multiple Genes in the CNS	PLOS ONE			English	Article							ALLELE-SPECIFIC EXPRESSION; ASYNCHRONOUS REPLICATION; METHYLATION STATUS; PRADER-WILLI; CPG ISLANDS; MOUSE; PATTERNS; INTERLEUKIN-2; HIPPOCAMPAL; EVOLUTION	The inheritance pattern of a number of major genetic disorders suggests the possible involvement of genes that are expressed from one allele and silent on the other, but such genes are difficult to detect. Since DNA methylation in regulatory regions is often a mark of gene silencing, we modified existing microarray-based assays to detect both methylated and unmethylated DNA sequences in the same sample, a variation we term the MAUD assay. We probed a 65 Mb region of mouse Chr 7 for gene-associated sequences that show two distinct DNA methylation patterns in the mouse CNS. Selected genes were then tested for allele-specific expression in clonal neural stem cell lines derived from reciprocal F1 (C57BL/6xJF1) hybrid mice. In addition, using a separate approach, we directly analyzed allele-specific expression of a group of genes interspersed within clusters of OlfR genes, since the latter are subject to allelic exclusion. Altogether, of the 500 known genes in the chromosomal region surveyed, five show monoallelic expression, four identified by the MAUD assay (Agc1, p (pink-eyed dilution), P4ha3 and Thrsp), and one by its proximity to OlfR genes (Trim12). Thrsp (thyroid hormone responsive SPOT14 homolog) is expressed in hippocampus, but the human protein homolog, S14, has also been implicated in aggressive breast cancer. Monoallelic expression of the five genes is not coordinated at a chromosome-wide level, but rather regulated at individual loci. Taken together, our results suggest that at least 1% of previously untested genes are subject to allelic exclusion, and demonstrate a dual approach to expedite their identification.	[Wang, Jinhui; Valo, Zuzana; Singer-Sam, Judith] City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA; [Smith, David] City Hope Natl Med Ctr, Beckman Res Inst, Div Informat Sci, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope	Singer-Sam, J (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Biol, Duarte, CA 91010 USA.	jsam@coh.org	Smith, David/A-4115-2017	Smith, David/0000-0001-9644-2353	NIH NIMH [R21 MH073754]; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH073754] Funding Source: NIH RePORTER	NIH NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by NIH NIMH grant R21 MH073754 to JS.	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Allen E, 2003, P NATL ACAD SCI USA, V100, P9940, DOI 10.1073/pnas.1737401100; Bix M, 1998, SCIENCE, V281, P1352, DOI 10.1126/science.281.5381.1352; Chai JH, 2001, MAMM GENOME, V12, P813, DOI 10.1007/s00335-001-2083-1; CHESS A, 1994, CELL, V78, P823, DOI 10.1016/S0092-8674(94)90562-2; Gabriel JM, 1998, MAMM GENOME, V9, P788, DOI 10.1007/s003359900868; Gimelbrant AA, 2005, J BIOL CHEM, V280, P1354, DOI 10.1074/jbc.M411283200; Gimelbrant AA, 2006, GENOME RES, V16, P723, DOI 10.1101/gr.5023706; Glusman G, 2000, GENOMICS, V63, P227, DOI 10.1006/geno.1999.6030; Godfrey PA, 2004, P NATL ACAD SCI USA, V101, P2156, DOI 10.1073/pnas.0308051100; Goldmit M, 2004, IMMUNOL REV, V200, P197, DOI 10.1111/j.0105-2896.2004.00158.x; Grillasca JP, 1997, FEBS LETT, V401, P38, DOI 10.1016/S0014-5793(96)01433-0; Hanel ML, 2001, MOL CELL BIOL, V21, P2384, DOI 10.1128/MCB.21.7.2384-2392.2001; Held W, 1997, EUR J IMMUNOL, V27, P2876, DOI 10.1002/eji.1830271120; Hollander GA, 1998, SCIENCE, V279, P2118, DOI 10.1126/science.279.5359.2118; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kelly BL, 2000, J IMMUNOL, V165, P2982, DOI 10.4049/jimmunol.165.6.2982; Khulan B, 2006, GENOME RES, V16, P1046, DOI 10.1101/gr.5273806; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; MALISSEN M, 1992, IMMUNOL TODAY, V13, P315, DOI 10.1016/0167-5699(92)90044-8; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Mann JR, 2000, CRIT REV EUKAR GENE, V10, P241; Moncur JT, 1998, P NATL ACAD SCI USA, V95, P6989, DOI 10.1073/pnas.95.12.6989; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nutt SL, 1999, NAT GENET, V21, P390, DOI 10.1038/7720; Pfister S, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm094; Pham NV, 1998, BRAIN RES, V810, P1, DOI 10.1016/S0006-8993(98)00783-5; Rhoades KL, 2000, CURR BIOL, V10, P789, DOI 10.1016/S0960-9822(00)00565-0; RIMM IJ, 1989, MOL BIOL MED, V6, P355; RINCHIK EM, 1993, NATURE, V361, P72, DOI 10.1038/361072a0; RITTENHOUSE E, 1978, J EMBRYOL EXP MORPH, V43, P71; Riviere I, 1998, IMMUNITY, V9, P217, DOI 10.1016/S1074-7613(00)80604-4; Rodin SN, 2003, J MOL EVOL, V56, P718, DOI 10.1007/s00239-002-2446-6; Rodriguez I, 1999, CELL, V97, P199, DOI 10.1016/S0092-8674(00)80730-8; Sano Y, 2001, GENOME RES, V11, P1833, DOI 10.1101/gr.194301; Schumacher A, 2006, NUCLEIC ACIDS RES, V34, P528, DOI 10.1093/nar/gkj461; Shen SI, 1998, MOL GENET METAB, V63, P96, DOI 10.1006/mgme.1997.2668; Singh N, 2003, NAT GENET, V33, P339, DOI 10.1038/ng1102; Strichman-Almashanu LZ, 2002, GENOME RES, V12, P543, DOI 10.1101/gr.224102; Torrey EF, 1994, SCHIZOPHRENIA MANIC, P274; Van den Diepstraten C, 2003, CIRCULATION, V108, P508, DOI 10.1161/01.CIR.0000080883.53863.5C; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Yamada Y, 2004, GENOME RES, V14, P247, DOI 10.1101/gr.1351604	43	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1293	10.1371/journal.pone.0001293	http://dx.doi.org/10.1371/journal.pone.0001293			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074017	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459500012
J	Bourguet, D; Delmotte, F; Franck, P; Guillemaud, T; Reboud, X; Vacher, C; Walker, AS				Bourguet, Denis; Delmotte, Francois; Franck, Pierre; Guillemaud, Thomas; Reboud, Xavier; Vacher, Corinne; Walker, Anne-Sophie		REX Consortium	Structure of the Scientific Community Modelling the Evolution of Resistance	PLOS ONE			English	Article							INSECTICIDE RESISTANCE; ANTIBIOTIC-RESISTANCE; POPULATION-GENETICS; DYNAMICS; LESSONS	Faced with the recurrent evolution of resistance to pesticides and drugs, the scientific community has developed theoretical models aimed at identifying the main factors of this evolution and predicting the efficiency of resistance management strategies. The evolutionary forces considered by these models are generally similar for viruses, bacteria, fungi, plants or arthropods facing drugs or pesticides, so interaction between scientists working on different biological organisms would be expected. We tested this by analysing co-authorship and co-citation networks using a database of 187 articles published from 1977 to 2006 concerning models of resistance evolution to all major classes of pesticides and drugs. These analyses identified two main groups. One group, led by ecologists or agronomists, is interested in agricultural crop or stock pests and diseases. It mainly uses a population genetics approach to model the evolution of resistance to insecticidal proteins, insecticides, herbicides, antihelminthic drugs and miticides. By contrast, the other group, led by medical scientists, is interested in human parasites and mostly uses epidemiological models to study the evolution of resistance to antibiotic and antiviral drugs. Our analyses suggested that there is also a small scientific group focusing on resistance to antimalaria drugs, and which is only poorly connected with the two larger groups. The analysis of cited references indicates that each of the two large communities publishes its research in a different set of literature and has its own keystone references: citations with a large impact in one group are almost never cited by the other. We fear the lack of exchange between the two communities might slow progress concerning resistance evolution which is currently a major issue for society.	[Vacher, Corinne] INRA, UMR Biodiversite Genes & Communautes BioGeCo 1210, F-33140 Villenave Dornon, France; [Walker, Anne-Sophie] INRA, UMR BIOGER CPP 1290, F-78026 Versailles, France; [Bourguet, Denis] INRA, UMR Ctr Biol & Gest Populat CBGP, F-34988 Montferrier Sur Lez, France; [Delmotte, Francois] INRA, UMR Sante Vegetale, F-33140 Villenave Dornon, France; [Franck, Pierre] INRA, UR Plantes & Syst Culture Horticoles 1115, F-84000 Avignon, France; [Guillemaud, Thomas] INRA, UMR ROSE 1112, F-06903 Sophia Antipolis, France; [Reboud, Xavier] INRA, UMR Biol & Gest Adventices 1210, F-21065 Dijon, France	INRAE; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE; Institut de Recherche pour le Developpement (IRD); INRAE; INRAE; INRAE; INRAE	Vacher, C (corresponding author), INRA, UMR Biodiversite Genes & Communautes BioGeCo 1210, F-33140 Villenave Dornon, France.	cvacher@bordeaux.inra.fr	Delmotte, Francois/B-4728-2013; Vacher, Corinne/Q-3182-2019; Vacher, Corinne/J-1777-2012; guillemaud, thomas/B-4899-2012; Vacher, Corinne/ABG-8163-2020	Delmotte, Francois/0000-0002-7138-8239; Vacher, Corinne/0000-0003-3023-6113; guillemaud, thomas/0000-0003-0451-1644; Vacher, Corinne/0000-0003-3023-6113; Bourguet, Denis/0000-0002-2109-5323	Departement Sante des Plantes et Environnement (SPE) of the Institut National de la Recherche Agronomique (INRA)	Departement Sante des Plantes et Environnement (SPE) of the Institut National de la Recherche Agronomique (INRA)	Financial support for this study was provided by the Departement Sante des Plantes et Environnement (SPE) of the Institut National de la Recherche Agronomique (INRA).	ANDERSON R M, 1991; [Anonymous], 1986, PESTICIDE RESISTANCE; [Anonymous], [No title captured]; AUBER D, 2002, GRAPH DRAWING, P488; Austin DJ, 1999, PHILOS T R SOC B, V354, P721, DOI 10.1098/rstb.1999.0425; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P6971, DOI 10.1073/pnas.94.13.6971; Bonhoeffer S, 1997, P NATL ACAD SCI USA, V94, P12106, DOI 10.1073/pnas.94.22.12106; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; Clarke T, 2003, NATURE, V425, P225, DOI 10.1038/425225a; COMINS HN, 1977, J THEOR BIOL, V64, P177, DOI 10.1016/0022-5193(77)90119-9; CSARDI G, 2006, IGRAPH IGRAPH CLASS; D'Alessandro U, 2001, TROP MED INT HEALTH, V6, P845, DOI 10.1046/j.1365-3156.2001.00819.x; Finch R, 2006, CLIN MICROBIOL INFEC, V12, P3, DOI 10.1111/j.1469-0691.2006.01624.x; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gubbins S, 1999, P ROY SOC B-BIOL SCI, V266, P2539, DOI 10.1098/rspb.1999.0957; Guillemot D, 1999, CURR OPIN MICROBIOL, V2, P494, DOI 10.1016/S1369-5274(99)00006-5; Hastings IM, 2004, TRENDS PARASITOL, V20, P512, DOI 10.1016/j.pt.2004.08.006; Hastings IM, 2001, TROP MED INT HEALTH, V6, P883, DOI 10.1046/j.1365-3156.2001.00800.x; Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371; Koella JC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-3; Levin BR, 1997, CLIN INFECT DIS, V24, pS9, DOI 10.1093/clinids/24.Supplement_1.S9; Levin BR, 2002, NETH J MED, V60, P58; Levin BR, 2001, CLIN INFECT DIS, V33, pS161, DOI 10.1086/321843; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Marrone PG, 1999, OUTLOOK AGR, V28, P149, DOI 10.5367/000000099101292917; MAY RM, 1988, PHILOS T R SOC B, V318, P129, DOI 10.1098/rstb.1988.0002; Maynard-Smith J., 1998, EVOLUTIONARY GENETIC; MAYNARDSMITH J, 1993, P NATIONAL ACADEMY S, V90, P4384; Mielke P. W., 2001, PERMUTATION METHODS; Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1; Nowak MA, 1997, J THEOR BIOL, V184, P205, DOI 10.1006/jtbi.1996.0307; Oksanen J., 2006, VEGAN COMMUNITY ECOL; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Peck SL, 2001, TRENDS MICROBIOL, V9, P286, DOI 10.1016/S0966-842X(01)02042-X; Prado PI, 2004, J ANIM ECOL, V73, P1168, DOI 10.1111/j.0021-8790.2004.00891.x; R Development Core Team, 2006, R LANG ENV STAT COMP; Simon JC, 2003, BIOL J LINN SOC, V79, P151, DOI 10.1046/j.1095-8312.2003.00175.x; Stewart FM, 1998, THEOR POPUL BIOL, V53, P152, DOI 10.1006/tpbi.1997.1352	41	11	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1275	10.1371/journal.pone.0001275	http://dx.doi.org/10.1371/journal.pone.0001275			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060069	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459400022
J	Howarth, KD; Blood, KA; Ng, BL; Beavis, JC; Chua, Y; Cooke, SL; Raby, S; Ichimura, K; Collins, VP; Carter, NP; Edwards, PAW				Howarth, K. D.; Blood, K. A.; Ng, B. L.; Beavis, J. C.; Chua, Y.; Cooke, S. L.; Raby, S.; Ichimura, K.; Collins, V. P.; Carter, N. P.; Edwards, P. A. W.			Array painting reveals a high frequency of balanced translocations in breast cancer cell lines that break in cancer-relevant genes	ONCOGENE			English	Article						breast cancer; chromosome rearrangements; microarrays	COMPARATIVE GENOMIC HYBRIDIZATION; POLYCYSTIC KIDNEY-DISEASE; CHROMOSOME REARRANGEMENT; CYTOGENETIC ANALYSIS; COLORECTAL CANCERS; MYELOID-LEUKEMIA; DNA MICROARRAYS; PROSTATE-CANCER; GAMMA-HEREGULIN; FUSION GENES	Chromosome translocations in the common epithelial cancers are abundant, yet little is known about them. They have been thought to be almost all unbalanced and therefore dismissed as mostly mediating tumour suppressor loss. We present a comprehensive analysis by array painting of the chromosome translocations of breast cancer cell lines HCC1806, HCC1187 and ZR-75-30. In array painting, chromosomes are isolated by flow cytometry, amplified and hybridized to DNA microarrays. A total of 200 breakpoints were identified and all were mapped to 1Mb resolution on bacterial artificial chromosome (BAC) arrays, then 40 selected breakpoints, including all balanced breakpoints, were further mapped on tiling-path BAC arrays or to around 2 kb resolution using oligonucleotide arrays. Many more of the translocations were balanced at 1Mb resolution than expected, either reciprocal (eight in total) or balanced for at least one participating chromosome (19 paired breakpoints). Second, many of the breakpoints were at genes that are plausible targets of oncogenic translocation, including balanced breaks at CTCF, EP300/p300 and FOXP4. Two gene fusions were demonstrated, TAX1BP1-AHCY and RIF1-PKD1L1. Our results support the idea that chromosome rearrangements may play an important role in common epithelial cancers such as breast cancer.	[Howarth, K. D.; Blood, K. A.; Beavis, J. C.; Chua, Y.; Cooke, S. L.; Raby, S.; Edwards, P. A. W.] Univ Cambridge, Hutchison MRC Res Ctr, Dept Pathol, Cambridge CB2 0XZ, England; [Ng, B. L.; Carter, N. P.] Wellcome Trust Sanger, Cambridge, England; [Ichimura, K.; Collins, V. P.] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Mol Histopathol, Cambridge CB2 0XZ, England	University of Cambridge; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Edwards, PAW (corresponding author), Univ Cambridge, Hutchison MRC Res Ctr, Dept Pathol, Hills Rd, Cambridge CB2 0XZ, England.	pawe1@cam.ac.uk	Edwards, Paul A/M-8291-2014	Edwards, Paul A/0000-0002-4789-3374	Cancer Research UK [A4392] Funding Source: Medline; Wellcome Trust [077008] Funding Source: Medline; Breast Cancer Now [2005NOV68] Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Breast Cancer Now		Abdel-Rahman WM, 2001, P NATL ACAD SCI USA, V98, P2538, DOI 10.1073/pnas.041603298; Adeyinka A, 2000, INT J MOL MED, V5, P235; Alsop AE, 2006, CANCER GENET CYTOGEN, V164, P97, DOI 10.1016/j.cancergencyto.2005.09.011; Barlund M, 2002, GENE CHROMOSOME CANC, V35, P311, DOI 10.1002/gcc.10121; BRIAND P, 1987, IN VITRO CELL DEV B, V23, P181, DOI 10.1007/BF02623578; Carlsson P, 2002, DEV BIOL, V250, P1, DOI 10.1006/dbio.2002.0780; Chaffanet M, 2000, GENE CHROMOSOME CANC, V28, P138, DOI 10.1002/(SICI)1098-2264(200006)28:2<138::AID-GCC2>3.0.CO;2-2; Chin KT, 2007, CANCER RES, V67, P1072, DOI 10.1158/0008-5472.CAN-06-3053; Davidson JM, 2000, BRIT J CANCER, V83, P1309, DOI 10.1054/bjoc.2000.1458; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delmas P, 2005, PFLUG ARCH EUR J PHY, V451, P264, DOI 10.1007/s00424-005-1431-5; Dorssers LCJ, 1997, INT J CANCER, V72, P700, DOI 10.1002/(SICI)1097-0215(19970807)72:4<700::AID-IJC24>3.0.CO;2-D; Dutrillaux B, 1995, ADV CANCER RES, V67, P59, DOI 10.1016/S0065-230X(08)60710-1; ENGEL LW, 1978, CANCER RES, V38, P3352; Fiegler H, 2003, GENE CHROMOSOME CANC, V36, P361, DOI 10.1002/gcc.10155; Fiegler H, 2003, J MED GENET, V40, P664, DOI 10.1136/jmg.40.9.664; Gayther SA, 2000, NAT GENET, V24, P300, DOI 10.1038/73536; Gazdar AF, 1998, INT J CANCER, V78, P766, DOI 10.1002/(SICI)1097-0215(19981209)78:6<766::AID-IJC15>3.0.CO;2-L; Gribble SM, 2007, J MED GENET, V44, P51, DOI 10.1136/jmg.2006.044909; Gribble SM, 2005, J MED GENET, V42, P8, DOI 10.1136/jmg.2004.024141; Grigorova M, 2005, CANCER GENET CYTOGEN, V162, P1, DOI 10.1016/j.cancergencyto.2005.03.007; Hahn Y, 2004, P NATL ACAD SCI USA, V101, P13257, DOI 10.1073/pnas.0405490101; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Huang HE, 2004, CANCER RES, V64, P6840, DOI 10.1158/0008-5472.CAN-04-1762; Ichimura K, 2006, ONCOGENE, V25, P1261, DOI 10.1038/sj.onc.1209156; Ida K, 1997, BLOOD, V90, P4699, DOI 10.1182/blood.V90.12.4699.4699_4699_4704; Krzywinski M, 2004, NUCLEIC ACIDS RES, V32, P3651, DOI 10.1093/nar/gkh700; Liu XF, 1999, ONCOGENE, V18, P7110, DOI 10.1038/sj.onc.1203136; McMullan TFW, 2002, HUM GENET, V110, P244, DOI 10.1007/s00439-002-0679-5; Mehra R, 2007, MODERN PATHOL, V20, P538, DOI 10.1038/modpathol.3800769; Mitelman F, 2005, GENE CHROMOSOME CANC, V43, P350, DOI 10.1002/gcc.20212; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Mitelman F, 2000, MUTAT RES-REV MUTAT, V462, P247, DOI 10.1016/S1383-5742(00)00006-5; Morris JS, 1997, GENE CHROMOSOME CANC, V20, P120, DOI 10.1002/(SICI)1098-2264(199710)20:2<120::AID-GCC3>3.0.CO;2-5; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Ng BL, 2006, CYTOM PART A, V69A, P1028, DOI 10.1002/cyto.a.20330; Ogryzko VV, 1996, CELL, V87, P953, DOI 10.1016/S0092-8674(00)82001-2; Persson K, 1999, GENE CHROMOSOME CANC, V25, P115, DOI 10.1002/(SICI)1098-2264(199906)25:2<115::AID-GCC7>3.0.CO;2-2; Pole JCM, 2006, ONCOGENE, V25, P5693, DOI 10.1038/sj.onc.1209570; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Roschke AV, 2003, CANCER RES, V63, P8634; Rowley JD, 1998, ANNU REV GENET, V32, P495, DOI 10.1146/annurev.genet.32.1.495; Seng TJ, 2005, GENE CHROMOSOME CANC, V43, P181, DOI 10.1002/gcc.20181; Shillingford JM, 2006, P NATL ACAD SCI USA, V103, P5466, DOI 10.1073/pnas.0509694103; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sinclair PB, 2000, BLOOD, V95, P738, DOI 10.1182/blood.V95.3.738.003k21_738_743; Sirivatanauksorn V, 2001, INT J CANCER, V91, P350, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1049>3.3.CO;2-3; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Theodorou V, 2007, NAT GENET, V39, P759, DOI 10.1038/ng2034; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Wang XZ, 1999, ONCOGENE, V18, P5718, DOI 10.1038/sj.onc.1202950; Yuasa T, 2002, GENOMICS, V79, P376, DOI 10.1006/geno.2002.6719	55	49	50	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	23					3345	3359		10.1038/sj.onc.1210993	http://dx.doi.org/10.1038/sj.onc.1210993			15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	304LQ	18084325	Green Accepted			2022-12-25	WOS:000256111400013
J	Jeon, JH; Kim, KY; Kim, JH; Baek, A; Cho, H; Lee, YH; Kim, JW; Kim, D; Han, SH; Lim, JS; Kim, KI; Yoon, DY; Kim, SH; Oh, GT; Kim, E; Yang, Y				Jeon, Jun Ho; Kim, Kun-Yong; Kim, Jae Hyeong; Baek, Ahmi; Cho, Hyungin; Lee, Young Ho; Kim, Jong Wan; Kim, Dohee; Han, Seung Hyun; Lim, Jong-Seok; Kim, Keun Il; Yoon, Do Young; Kim, Soo-Hyun; Oh, Goo Taeg; Kim, Eunjoon; Yang, Young			A novel adipokine CTRP1 stimulates aldosterone production	FASEB JOURNAL			English	Article						hypertension; adipocytes; obesity; CYP11B2	HUMAN ADRENOCORTICAL-CELLS; RAT ADRENAL-CORTEX; ANGIOTENSIN-II; ADIPOSE-TISSUE; MACULAR DEGENERATION; HYPERTENSION; OBESITY; PROTEIN; MECHANISMS; RECEPTORS	Complement-C1q TNF-related protein 1 (CTRP1), a member of the CTRP superfamily, is expressed at high levels in adipose tissues of obese Zucker diabetic fatty (fa/fa) rats, and CTRP1 expression is induced by proinflammatory cytokines, including TNF-alpha and IL-1 beta. In the present study, we investigated stimulation of aldosterone production by CTRP1, since it was observed that CTRP1 was specifically expressed in the zona glomerulosa of the adrenal cortex, where aldosterone is produced. Increased aldosterone production by CTRP1 in cells of the human adrenal cortical cell line H295R was dose-dependent. Expression levels of aldosterone synthase CYP11B2 were examined to investigate the molecular mechanisms by which CTRP1 enhances the production of aldosterone. The expression of CYP11B2 was greatly increased by treatment with CTRP1, as was the expression of the transcription factors NGFIB and NURR1, which play critical roles in stimulation of CYP11B2 gene expression. It was also revealed that angiotensin H-induced aldosterone production is, at least in part, mediated by the stimulation of CTRP1 secretion, not by the increase of CTRP1 mRNA transcription. In addition, the levels of CTRP1 were significantly up-regulated in hypertensive patients' serum. As CTRP1 was highly expressed in obese subjects as wen as up-regulated in hypertensive patients, CTRP1 may be a newly identified molecular link between obesity and hypertension.	[Jeon, Jun Ho; Kim, Kun-Yong; Kim, Jae Hyeong; Baek, Ahmi; Cho, Hyungin; Lim, Jong-Seok; Kim, Keun Il; Kim, Eunjoon; Yang, Young] Sookmyung Womens Univ, Dept Life Sci, Res Ctr Womens Dis, Seoul 140742, South Korea; [Lee, Young Ho] Chungnam Natl Univ, Coll Med, Dept Anat & Pathol, Taejon, South Korea; [Kim, Jong Wan; Kim, Dohee] Dankook Univ, Coll Med, Dept Internal Med, Cheonan, South Korea; [Han, Seung Hyun] Seoul Natl Univ, Sch Dent, Dept Oral Microbiol & Immunol, Seoul, South Korea; [Han, Seung Hyun] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul, South Korea; [Yoon, Do Young; Kim, Soo-Hyun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul, South Korea; [Oh, Goo Taeg] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul, South Korea; [Kim, Kun-Yong; Kim, Eunjoon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea	Sookmyung Women's University; Chungnam National University; Dankook University; Seoul National University (SNU); Seoul National University (SNU); Konkuk University; Ewha Womans University; Korea Advanced Institute of Science & Technology (KAIST)	Yang, Y (corresponding author), Sookmyung Womens Univ, Dept Life Sci, Res Ctr Womens Dis, Seoul 140742, South Korea.	yyang@sookmyung.ac.kr	KIM, KEUN IL/D-2959-2011; Oh, Goo Taeg/AAQ-9995-2021; Kim, Eunjoon/C-1566-2011	Yang, Young/0000-0003-4239-0804; Kim, Jae Hyeong/0000-0003-4675-5305; Lim, Jong-Seok/0000-0003-4024-6868				ABAYASEKARA DRE, 1989, J ENDOCRINOL, V122, P625, DOI 10.1677/joe.0.1220625; Aguilera G, 1996, ENDOCR RES, V22, P433, DOI 10.1080/07435809609043729; Bassett MH, 2004, MOL ENDOCRINOL, V18, P279, DOI 10.1210/me.2003-0005; Blume A, 2001, CURR OPIN NEPHROL HY, V10, P239, DOI 10.1097/00041552-200103000-00013; Booth RE, 2002, ADV PHYSIOL EDUC, V26, P8, DOI 10.1152/advan.00051.2001; Cherradi N, 1998, EUR J ENDOCRINOL, V139, P249, DOI 10.1530/eje.0.1390249; Cooper R, 1997, J HUM HYPERTENS, V11, P107, DOI 10.1038/sj.jhh.1000391; Ehrhart-Bornstein M, 2003, P NATL ACAD SCI USA, V100, P14211, DOI 10.1073/pnas.2336140100; Foster RH, 1997, GEN PHARMACOL, V28, P647, DOI 10.1016/S0306-3623(96)00290-X; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Ganguly A, 1998, NEW ENGL J MED, V339, P1828, DOI 10.1056/NEJM199812173392507; Goodfriend TL, 1998, ENDOCR RES, V24, P789, DOI 10.3109/07435809809032689; Goodfriend TL, 1999, OBES RES, V7, P355, DOI 10.1002/j.1550-8528.1999.tb00418.x; Hayward C, 2003, HUM MOL GENET, V12, P2657, DOI 10.1093/hmg/ddg289; Jones BH, 1997, AM J PHYSIOL-REG I, V273, pR236, DOI 10.1152/ajpregu.1997.273.1.R236; Jonsson J R, 1994, Blood Press, V3, P72; Karlsson C, 1998, J CLIN ENDOCR METAB, V83, P3925, DOI 10.1210/jc.83.11.3925; Kaschina E, 2003, BLOOD PRESSURE, V12, P70, DOI 10.1080/08037050310001057; Kim KY, 2006, FEBS LETT, V580, P3953, DOI 10.1016/j.febslet.2006.06.034; Lamounier-Zepter V, 2004, HORM METAB RES, V36, P376, DOI 10.1055/s-2004-814583; Lasser G, 2006, BLOOD, V107, P423, DOI 10.1182/blood-2005-04-1425; Li JH, 2003, J BIOL CHEM, V278, P52355, DOI 10.1074/jbc.M305232200; Maeda T, 2006, J CELL PHYSIOL, V206, P537, DOI 10.1002/jcp.20493; Mitani F, 1996, ENDOCR RES, V22, P421, DOI 10.1080/07435809609043728; Ngarmukos C, 2001, AM J PHYSIOL-ENDOC M, V281, pE1122, DOI 10.1152/ajpendo.2001.281.6.E1122; Okubo S, 1997, J CLIN INVEST, V99, P855, DOI 10.1172/JCI119249; PASCOE L, 1992, P NATL ACAD SCI USA, V89, P4996, DOI 10.1073/pnas.89.11.4996; Pausova Z, 2006, CURR OPIN NEPHROL HY, V15, P173, DOI 10.1097/01.mnh.0000214775.42103.a5; Romero DG, 2004, PHYSIOL GENOMICS, V19, P106, DOI 10.1152/physiolgenomics.00097.2004; Schinner S, 2007, INT J OBESITY, V31, P864, DOI 10.1038/sj.ijo.0803508; Shu XH, 2006, HUM MOL GENET, V15, P1680, DOI 10.1093/hmg/ddl091; Stewart PM, 1999, LANCET, V353, P1341, DOI 10.1016/S0140-6736(98)06102-9; Takeda Y, 2000, HYPERTENSION, V36, P495, DOI 10.1161/01.HYP.36.4.495; TREMBLAY A, 1992, ENDOCRINOLOGY, V130, P3152, DOI 10.1210/en.130.6.3152; Unger T, 1999, J HYPERTENS, V17, P1775, DOI 10.1097/00004872-199917121-00001; Vasan RS, 2004, NEW ENGL J MED, V351, P33, DOI 10.1056/NEJMoa033263; Weigert J, 2005, FEBS LETT, V579, P5565, DOI 10.1016/j.febslet.2005.09.022	37	128	138	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1502	1511		10.1096/fj.07-9412com	http://dx.doi.org/10.1096/fj.07-9412com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18171693				2022-12-25	WOS:000255898700022
J	Shirokova, E; Raguse, JD; Meyerhof, W; Krautwurst, D				Shirokova, Elena; Raguse, Jan Dirk; Meyerhof, Wolfgang; Krautwurst, Dietmar			The human vomeronasal type-1 receptor family - detection of volatiles and cAMP signaling in HeLa/Olf cells	FASEB JOURNAL			English	Article						pheromones; key aroma volatiles; G protein	PUTATIVE PHEROMONE RECEPTORS; MULTIGENE FAMILY; OLFACTORY RECEPTORS; ADENYLYL-CYCLASE; SOCIAL SIGNALS; GENES; IDENTIFICATION; ACTIVATION; EXPRESSION; ODORANT	The human genome harbors 5 remnant genes coding for vomeronasal type-1 receptors, compared with 187 of such receptors in mice. In rodents, vomeronasal type-1 receptors are typically expressed in the vomeronasal organ. They are believed to be highly selective and sensitive pheromone detectors, as may be inferred from one receptor, V1rb2, responding to picomolar concentrations of the mouse pheromone 2-heptanone. Expression patterns, ligands, and signal transduction of human vomeronasal type-1 receptors have, however, remained largely obscure. Our aim was to deorphan and functionally characterize these 5 putative human pheromone receptors. Here, we report functional expression for all 5 receptors in HeLa/Olf cells. The recombinant, N-terminally tagged receptors expressed at the plasma membrane of HeLa/Olf cells and responded differentially to 19 of 140 odorants in a combinatorial way. C9-C10 aliphatic alcohols or aldehydes emerged as the best agonists at submicromolar concentrations above human odorant thresholds. Surprisingly, and in contrast to mouse V1rb2, all human vomeronasal type-1 receptors activated cAMP signaling via G protein alpha olf, when expressed in HeLa/Olf cells. While a biological function of human vomeronasal type-1 receptors is still elusive, our data show that their major functional characteristics are similar to those of odorant receptors.	[Shirokova, Elena; Meyerhof, Wolfgang; Krautwurst, Dietmar] German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, D-14558 Nuthetal, Germany; [Raguse, Jan Dirk] Charite, Clin Oral & Maxillofacial Surg & Plast Surg, D-13353 Berlin, Germany	Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Krautwurst, D (corresponding author), German Inst Human Nutr Potsdam Rehbrucke, Dept Mol Genet, Arthur Scheunert Allee 114-116, D-14558 Nuthetal, Germany.	dietmark@dife.de	Krautwurst, Dietmar/AAD-5579-2019	Krautwurst, Dietmar/0000-0002-3350-8682				Belluscio L, 1999, CELL, V97, P209, DOI 10.1016/S0092-8674(00)80731-X; Berghard A, 1996, P NATL ACAD SCI USA, V93, P2365, DOI 10.1073/pnas.93.6.2365; Bergstrom L, 1996, ASTROPART PHYS, V5, P263, DOI 10.1016/0927-6505(96)00027-8; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Boschat C, 2002, NAT NEUROSCI, V5, P1261, DOI 10.1038/nn978; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Buettner A, 2001, J AGR FOOD CHEM, V49, P2387, DOI 10.1021/jf001363l; DULAC C, 1995, CELL, V83, P195, DOI 10.1016/0092-8674(95)90161-2; Gaillard I, 2002, EUR J NEUROSCI, V15, P409, DOI 10.1046/j.0953-816x.2001.01871.x; Halpern M, 2003, PROG NEUROBIOL, V70, P245, DOI 10.1016/S0301-0082(03)00103-5; Herrada G, 1997, CELL, V90, P763, DOI 10.1016/S0092-8674(00)80536-X; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Karunadasa DK, 2006, EUR J NEUROSCI, V23, P2563, DOI 10.1111/j.1460-9568.2006.04795.x; Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X; Krieger J, 1999, J BIOL CHEM, V274, P4655, DOI 10.1074/jbc.274.8.4655; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Leinders-Zufall T, 2000, NATURE, V405, P792, DOI 10.1038/35015572; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Lin DY, 2005, NATURE, V434, P470, DOI 10.1038/nature03414; Lucas P, 2003, NEURON, V40, P551, DOI 10.1016/S0896-6273(03)00675-5; Luo MM, 2003, SCIENCE, V299, P1196, DOI 10.1126/science.1082133; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Matsunami H, 1997, CELL, V90, P775, DOI 10.1016/S0092-8674(00)80537-1; Milligan G, 2003, TRENDS PHARMACOL SCI, V24, P87, DOI 10.1016/S0165-6147(02)00027-5; Rodriguez I, 2000, NAT GENET, V26, P18, DOI 10.1038/79124; Rodriguez I, 2002, CURR BIOL, V12, pR409, DOI 10.1016/S0960-9822(02)00909-0; Runnenburger K, 2002, EUR J CELL BIOL, V81, P539, DOI 10.1078/0171-9335-00277; Ryba NJP, 1997, NEURON, V19, P371, DOI 10.1016/S0896-6273(00)80946-0; Sam M, 2001, NATURE, V412, P142, DOI 10.1038/35084137; Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013; Shi P, 2005, J MOL EVOL, V60, P566, DOI 10.1007/s00239-004-0172-y; Shirokova E, 2005, J BIOL CHEM, V280, P11807, DOI 10.1074/jbc.M411508200; Spehr M, 2006, J NEUROSCI, V26, P1961, DOI 10.1523/JNEUROSCI.4939-05.2006; THASTRUP O, 1994, AGENTS ACTIONS, V43, P187, DOI 10.1007/BF01986687; Vosshall LB, 2005, CURR BIOL, V15, pR255, DOI 10.1016/j.cub.2005.03.027; Wang ZS, 2006, J NEUROSCI, V26, P7375, DOI 10.1523/JNEUROSCI.1967-06.2006; Witt M, 2002, HISTOCHEM CELL BIOL, V117, P493, DOI 10.1007/s00418-002-0407-1; Wysocki CJ, 2004, ANAT REC PART A, V281A, P1201, DOI 10.1002/ar.a.20125; Zhang JZ, 2003, P NATL ACAD SCI USA, V100, P8337, DOI 10.1073/pnas.1331721100; Zhang XM, 2004, GENOMICS, V83, P802, DOI 10.1016/j.ygeno.2003.10.009; Zufall F, 2005, Naunyn Schmiedebergs Arch Pharmacol, V371, P245, DOI 10.1007/s00210-005-1028-8	41	31	31	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1416	1425		10.1096/fj.07-9233com	http://dx.doi.org/10.1096/fj.07-9233com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18096815				2022-12-25	WOS:000255898700014
J	Dror, V; Kalynyak, TB; Bychkivska, Y; Frey, MHZ; Tee, M; Jeffrey, KD; Nguyen, V; Luciani, DS; Johnson, JD				Dror, Vardit; Kalynyak, Tatyana B.; Bychkivska, Yaryna; Frey, Matthew H. Z.; Tee, May; Jeffrey, Kristin D.; Nguyen, Vy; Luciani, Dan S.; Johnson, James D.			Glucose and endoplasmic reticulum calcium channels regulate HIF-1 beta via presenilin in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; GENE-EXPRESSION; RYANODINE RECEPTORS; IN-VIVO; MEDIATED APOPTOSIS; INTRACELLULAR CA2+; HYPOXIA; ISLETS; RELEASE; LOCALIZATION	Pancreatic beta-cell death is a critical event in type 1 diabetes, type 2 diabetes, and clinical islet transplantation. We have previously shown that prolonged block of ryanodine receptor (RyR)-gated release from intracellular Ca2+ stores activates calpain-10-dependent apoptosis in beta-cells. In the present study, we further characterized intracellular Ca2+ channel expression and function in human islets and the MIN6 beta-cell line. All three RyR isoforms were identified in human islets and MIN6 cells, and these endoplasmic reticulum channels were observed in close proximity to mitochondria. Blocking RyR channels, but not sarco/endoplasmic reticulum ATPase (SERCA) pumps, reduced the ATP/ADP ratio. Blocking Ca2+ flux through RyR or inositol trisphosphate receptor channels, but not SERCA pumps, increased the expression of hypoxia-inducible factor (HIF-1 beta). Moreover, inhibition of RyR or inositol trisphosphate receptor channels, but not SERCA pumps, increased the expression of presenilin-1. Both HIF-1 beta and presenilin-1 expression were also induced by low glucose. Overexpression of presenilin-1 increased HIF-1 beta, suggesting that HIF is downstream of presenilin. Our results provide the first evidence of a presenilin-HIF signaling network in beta-cells. We demonstrate that this pathway is controlled by Ca2+ flux through intracellular channels, likely via changes in mitochondrial metabolism and ATP. These findings provide a mechanistic understanding of the signaling pathways activated when intracellular Ca2+ homeostasis and metabolic activity are suppressed in diabetes and islet transplantation.	[Dror, Vardit; Kalynyak, Tatyana B.; Bychkivska, Yaryna; Frey, Matthew H. Z.; Tee, May; Jeffrey, Kristin D.; Nguyen, Vy; Luciani, Dan S.; Johnson, James D.] Univ British Columbia, Diabet Res Grp, Dept Cellular & Physiol Sci, Lab Mol Signaling Diabet, Vancouver, BC V6T 1Z3, Canada; [Dror, Vardit; Kalynyak, Tatyana B.; Bychkivska, Yaryna; Frey, Matthew H. Z.; Tee, May; Jeffrey, Kristin D.; Nguyen, Vy; Luciani, Dan S.; Johnson, James D.] Univ British Columbia, Dept Surg, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Johnson, JD (corresponding author), Univ British Columbia, Diabet Res Grp, Dept Cellular & Physiol Sci, Lab Mol Signaling Diabet, 5358 Life Sci Bldg 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	jimjohn@interchange.ubc.ca		Luciani, Dan/0000-0002-4318-4159; Johnson, James/0000-0002-7523-9433				Anantharaman M, 2006, AM J PATHOL, V168, P1608, DOI 10.2353/ajpath.2006.051223; Ankarcrona M, 2002, BIOCHEM BIOPH RES CO, V295, P766, DOI 10.1016/S0006-291X(02)00735-0; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Bazan NG, 2002, J BIOL CHEM, V277, P30359, DOI 10.1074/jbc.M203201200; Beauvois MC, 2004, J PHYSIOL-LONDON, V559, P141, DOI 10.1113/jphysiol.2004.067454; Bergsten P, 2000, DIABETES-METAB RES, V16, P179, DOI 10.1002/1520-7560(200005/06)16:3<179::AID-DMRR115>3.3.CO;2-3; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cai CX, 2006, J BIOL CHEM, V281, P16649, DOI 10.1074/jbc.M512026200; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chan SL, 2000, J BIOL CHEM, V275, P18195, DOI 10.1074/jbc.M000040200; Cui JG, 2004, NEUROREPORT, V15, P2025, DOI 10.1097/00001756-200409150-00006; Davalli AM, 1996, DIABETES, V45, P1161, DOI 10.2337/diabetes.45.9.1161; Demaurex N, 2003, SCIENCE, V300, P65, DOI 10.1126/science.1083628; Doglio LE, 2006, NEURON, V50, P359, DOI 10.1016/j.neuron.2006.03.038; Dotsch J, 2006, EUR J ENDOCRINOL, V154, P781, DOI 10.1530/eje.1.02150; Dror V, 2007, DIABETOLOGIA, V50, P2504, DOI 10.1007/s00125-007-0835-5; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; Ferraro-Peyret C, 2002, J IMMUNOL, V169, P4805, DOI 10.4049/jimmunol.169.9.4805; Figueroa DJ, 2001, J ALZHEIMERS DIS, V3, P393, DOI 10.3233/JAD-2001-3405; Gasparini L, 1999, ANN NY ACAD SCI, V893, P294, DOI 10.1111/j.1749-6632.1999.tb07840.x; George CH, 2007, CIRC RES, V100, P874, DOI 10.1161/01.RES.0000260804.77807.cf; Ghidoni R, 2003, J NEURAL TRANSM, V110, P1029, DOI 10.1007/s00702-003-0015-9; Giacomello M, 2005, NEUROBIOL DIS, V18, P638, DOI 10.1016/j.nbd.2004.10.016; Giuliani M, 2005, CELL TRANSPLANT, V14, P67, DOI 10.3727/000000005783983287; Gunton JE, 2005, CELL, V122, P337, DOI 10.1016/j.cell.2005.05.027; Hajnoczky G, 2000, CELL CALCIUM, V28, P349, DOI 10.1054/ceca.2000.0169; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Higashide S, 2004, J NEUROCHEM, V91, P1191, DOI 10.1111/j.1471-4159.2004.02798.x; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Hung MS, 2006, HUM MOL GENET, V15, P2732, DOI 10.1093/hmg/ddl209; Jaikaran ETAS, 1999, J CELL SCI, V112, P2137; Janson J, 2004, DIABETES, V53, P474, DOI 10.2337/diabetes.53.2.474; Jansson L, 2002, DIABETOLOGIA, V45, P749, DOI 10.1007/s00125-002-0827-4; Johnson JD, 2006, P NATL ACAD SCI USA, V103, P19575, DOI 10.1073/pnas.0604208103; Johnson JD, 2004, FASEB J, V18, P878, DOI 10.1096/fj.03-1280fje; Johnson JD, 2004, J BIOL CHEM, V279, P24794, DOI 10.1074/jbc.M401216200; Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Lah JJ, 1997, J NEUROSCI, V17, P1971; Lee SM, 2005, J NEUROSCI RES, V82, P542, DOI 10.1002/jnr.20655; Lee SY, 2006, FASEB J, V20, pA173; Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900; Li JH, 1997, CELL, V90, P917, DOI 10.1016/S0092-8674(00)80356-6; Liauw J, 2002, MOL BRAIN RES, V109, P56, DOI 10.1016/S0169-328X(02)00491-6; Lukiw WJ, 2001, NEUROREPORT, V12, P53, DOI 10.1097/00001756-200101220-00019; Marks AR, 1997, AM J PHYSIOL-HEART C, V272, pH597, DOI 10.1152/ajpheart.1997.272.2.H597; Martins IJ, 2006, MOL PSYCHIATR, V11, P721, DOI 10.1038/sj.mp.4001854; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Matikainen T, 2001, NAT GENET, V28, P355, DOI 10.1038/ng575; Matschinsky FM, 1996, DIABETES, V45, P223, DOI 10.2337/diabetes.45.2.223; Mattson MP, 2000, J NEUROSCI, V20, P1358; Mattson MP, 2003, CELL CALCIUM, V34, P385, DOI 10.1016/S0143-4160(03)00128-3; Mohuczy D, 2002, REGUL PEPTIDES, V110, P1, DOI 10.1016/S0167-0115(02)00225-2; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Park KT, 2005, MOL PHARMACOL, V67, P612, DOI 10.1124/mol.104.005223; Popescu BO, 2002, J CELL MOL MED, V6, P555, DOI 10.1111/j.1582-4934.2002.tb00454.x; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Takeda T, 2005, FASEB J, V19, P2069, DOI 10.1096/fj.05-3744fje; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Vanderklish PW, 2000, INT J EXP PATHOL, V81, P323, DOI 10.1046/j.1365-2613.2000.00169.x; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4	65	43	43	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9909	9916		10.1074/jbc.M710601200	http://dx.doi.org/10.1074/jbc.M710601200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18174159	hybrid			2022-12-25	WOS:000254671600047
J	Granata, A; Watson, R; Collinson, LM; Schiavo, G; Warner, TT				Granata, Alessandra; Watson, Rose; Collinson, Lucy M.; Schiavo, Giampietro; Warner, Thomas T.			The dystonia-associated protein torsinA modulates synaptic vesicle recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT TORSINA; MOUSE MODEL; NUCLEAR-ENVELOPE; SNAPIN; BINDING; EXOCYTOSIS; INTERACTS; MEMBRANE; PHOSPHORYLATION; IDENTIFICATION	The loss of a glutamic acid residue in the AAA-ATPase (ATPases associated with diverse cellular activities) torsinA is responsible for most cases of early onset autosomal dominant primary dystonia. In this study, we found that snapin, which binds SNAP-25 (synaptosome-associated protein of 25,000 Da) and enhances the association of the SNARE complex with synaptotagmin, is an interacting partner for both wild type and mutant torsinA. Snapin co-localized with endogenous torsinA on dense core granules in PC12 cells and was recruited to perinuclear inclusions containing mutant Delta E-torsinA in neuroblastoma SH-SY5Y cells. In view of these observations, synaptic vesicle recycling was analyzed using the lipophilic dye FM1 - 43 and an antibody directed against an intravesicular epitope of synaptotagmin I. We found that overexpression of wild type torsinA negatively affects synaptic vesicle endocytosis. Conversely, overexpression of Delta E-torsinA in neuroblastoma cells increases FM1 - 43 uptake. Knockdown of snapin and/or torsinA using small interfering RNAs had a similar inhibitory effect on the exo-endocytic process. In addition, down-regulation of torsinA causes the persistence of synaptotagmin I on the plasma membrane, which closely resembles the effect observed by the overexpression of the Delta E-torsinA mutant. Altogether, these findings suggest that torsinA plays a role together with snapin in regulated exocytosis and that Delta E-torsinA exerts its pathological effects through a loss of function mechanism. This may affect neuronal uptake of neurotransmitters, such as dopamine, playing a role in the development of dystonic movements.	[Granata, Alessandra; Watson, Rose; Collinson, Lucy M.; Schiavo, Giampietro] Canc Res UK London Res Inst, Lincolns Inn Fields Labs, London WC2A 3PX, England; [Granata, Alessandra; Warner, Thomas T.] Royal Free & Univ Coll Med Sch, UCL Inst Neurol, Dept Clin Neurosci, London NW3 2PF, England	Cancer Research UK; University of London; University College London	Schiavo, G (corresponding author), Canc Res UK London Res Inst, Lincolns Inn Fields Labs, 44 Licolns Inn Fields, London WC2A 3PX, England.	giampietro.schiavo@cancer.org.uk; t.warner@medsch.ucl.ac.uk		Collinson, Lucy/0000-0003-0260-613X; Schiavo, Giampietro/0000-0002-4319-8745; Warner, Thomas/0000-0001-6195-6995	Cancer Research UK Funding Source: Medline; Wellcome Trust Funding Source: Medline	Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission)		Augood SJ, 1999, ANN NEUROL, V46, P761, DOI 10.1002/1531-8249(199911)46:5<761::AID-ANA12>3.3.CO;2-Q; Balcioglu A, 2007, J NEUROCHEM, V102, P783, DOI 10.1111/j.1471-4159.2007.04590.x; Bandmann O, 1998, ANN NEUROL, V44, P649, DOI 10.1002/ana.410440411; BRESSMAN SB, 1994, ANN NEUROL, V36, P771, DOI 10.1002/ana.410360514; Brumback AC, 2004, METHODS, V33, P287, DOI 10.1016/j.ymeth.2004.01.002; Buxton P, 2003, BIOCHEM J, V375, P433, DOI 10.1042/BJ20030427; Caldwell GA, 2003, HUM MOL GENET, V12, P307, DOI 10.1093/hmg/ddg027; Callan AC, 2007, BIOCHEM J, V401, P607, DOI 10.1042/BJ20061313; Chheda MG, 2001, NAT CELL BIOL, V3, P331, DOI 10.1038/35070000; Cochilla AJ, 1999, ANNU REV NEUROSCI, V22, P1, DOI 10.1146/annurev.neuro.22.1.1; Cookson MR, 2005, NEURON, V48, P875, DOI 10.1016/j.neuron.2005.12.006; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Fahn S, 1998, Adv Neurol, V78, P1; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; Herreros J, 2001, MOL BIOL CELL, V12, P2947, DOI 10.1091/mbc.12.10.2947; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett J, 2003, J NEUROSCI RES, V72, P158, DOI 10.1002/jnr.10567; Ilardi JM, 1999, NAT NEUROSCI, V2, P119, DOI 10.1038/5673; ISHIKAWA A, 1995, MOV DISCORD, V40, P482; Kamm C, 2004, J BIOL CHEM, V279, P19882, DOI 10.1074/jbc.M401332200; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Lalli G, 1999, J CELL SCI, V112, P2715; Liu ZH, 2003, BIOCHEM J, V374, P117, DOI 10.1042/BJ20030258; MATTEOLI M, 1992, J CELL BIOL, V117, P849, DOI 10.1083/jcb.117.4.849; Matteoli M, 2004, TRENDS CELL BIOL, V14, P133, DOI 10.1016/j.tcb.2004.01.007; McNaught KS, 2004, ANN NEUROL, V56, P540, DOI 10.1002/ana.20225; Misbahuddin A, 2005, MOVEMENT DISORD, V20, P432, DOI 10.1002/mds.20351; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Muraro NI, 2006, J NEUROBIOL, V66, P1338, DOI 10.1002/neu.20313; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Neuwald AF, 1999, GENOME RES, V9, P27; Oorschot V, 2002, J HISTOCHEM CYTOCHEM, V50, P1067, DOI 10.1177/002215540205000809; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Pisani A, 2006, NEUROBIOL DIS, V24, P318, DOI 10.1016/j.nbd.2006.07.006; Rizo J, 2006, TRENDS CELL BIOL, V16, P339, DOI 10.1016/j.tcb.2006.04.006; ROPOSO G, 1997, IMMUNOGLOD LABELING, P78; Rostasy K, 2003, NEUROBIOL DIS, V12, P11, DOI 10.1016/S0969-9961(02)00010-4; Ruder C, 2005, MOL BIOL CELL, V16, P1245, DOI 10.1091/mbc.E04-09-0817; Sharma N, 2005, J NEUROSCI, V25, P5351, DOI 10.1523/JNEUROSCI.0855-05.2005; Shashidharan P, 2000, BRAIN RES, V853, P197, DOI 10.1016/S0006-8993(99)02232-5; Shashidharan P, 2005, HUM MOL GENET, V14, P125, DOI 10.1093/hmg/ddi012; Starcevic M, 2004, J BIOL CHEM, V279, P28393, DOI 10.1074/jbc.M402513200; Thakur P, 2004, J NEUROSCI, V24, P6476, DOI 10.1523/JNEUROSCI.0590-04.2004; Tian JH, 2005, J NEUROSCI, V25, P10546, DOI 10.1523/JNEUROSCI.3275-05.2005; Torres GE, 2004, P NATL ACAD SCI USA, V101, P15650, DOI 10.1073/pnas.0308088101; Vites O, 2004, J BIOL CHEM, V279, P26251, DOI 10.1074/jbc.M404079200	50	84	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7568	7579		10.1074/jbc.M704097200	http://dx.doi.org/10.1074/jbc.M704097200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18167355	hybrid			2022-12-25	WOS:000253997900032
J	Berthold, CL; Toyota, CG; Richards, NGJ; Lindqvist, Y				Berthold, Catrine L.; Toyota, Cory G.; Richards, Nigel G. J.; Lindqvist, Ylva			Reinvestigation of the catalytic mechanism of formyl-CoA transferase, a class IIICoA-transferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COENZYME-A TRANSFERASE; CRYSTAL-STRUCTURE; ENZYME; FAMILY; IDENTIFICATION; DECARBOXYLASE; INTERMEDIATE; PURIFICATION; OXALATE; LYASE	Formyl-coenzyme A transferase from Oxalobacter formigenes belongs to the Class III coenzyme A transferase family and catalyzes the reversible transfer of a CoA carrier between formyl-CoA and oxalate, forming oxalyl-CoA and formate. Formyl-CoA transferase has a unique three-dimensional fold composed of two interlaced subunits locked together like rings of a chain. We here present an intermediate in the reaction, formyl-CoA transferase containing the covalent beta-aspartyl-CoA thioester, adopting different conformations in the two active sites of the dimer, which was identified through crystallographic freeze-trapping experiments with formyl-CoA and oxalyl-CoA in the absence of acceptor carboxylic acid. The formation of the enzyme-CoA thioester was also confirmed by mass spectrometric data. Further structural data include a trapped aspartyl-formyl anhydride protected by a glycine loop closing down over the active site. In a crystal structure of the beta-aspartyl-CoA thioester of an inactive mutant variant, oxalate was found bound to the open conformation of the glycine loop. Together with hydroxylamine trapping experiments and kinetic as well as mutagenesis data, the structures of these formyl-CoA transferase complexes provide new information on the Class III CoA-transferase family and prompt redefinition of the catalytic steps and the modified reaction mechanism of formyl-CoA transferase proposed here.	[Berthold, Catrine L.; Lindqvist, Ylva] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden; [Toyota, Cory G.; Richards, Nigel G. J.] Univ Florida, Dept Chem, Gainesville, FL 32611 USA	Karolinska Institutet; State University System of Florida; University of Florida	Lindqvist, Y (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	Ylva.Lindqvist@ki.se	Lindqvist, Ylva/F-9009-2010	Lindqvist, Ylva/0000-0003-3162-8661	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061666] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK 61666] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALLISON MJ, 1985, ARCH MICROBIOL, V141, P1, DOI 10.1007/BF00446731; BAETZ AL, 1990, J BACTERIOL, V172, P3537, DOI 10.1128/jb.172.7.3537-3540.1990; BAETZ AL, 1989, J BACTERIOL, V171, P2605, DOI 10.1128/jb.171.5.2605-2608.1989; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berthold CL, 2005, J BIOL CHEM, V280, P41645, DOI 10.1074/jbc.M509921200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUCKEL W, 1976, EUR J BIOCHEM, V64, P255, DOI 10.1111/j.1432-1033.1976.tb10295.x; Cornick NA, 1996, APPL ENVIRON MICROB, V62, P3011, DOI 10.1128/AEM.62.8.3011-3013.1996; DeLano W, 2002, PYMOL 0 99; Dickert S, 2000, EUR J BIOCHEM, V267, P3874, DOI 10.1046/j.1432-1327.2000.01427.x; DIMROTH P, 1975, P NATL ACAD SCI USA, V72, P3458, DOI 10.1073/pnas.72.9.3458; Gruez A, 2003, J BIOL CHEM, V278, P34582, DOI 10.1074/jbc.C300282200; Heider J, 2001, FEBS LETT, V509, P345, DOI 10.1016/S0014-5793(01)03178-7; Jonsson S, 2004, J BIOL CHEM, V279, P36003, DOI 10.1074/jbc.M404873200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 1992, JOINT CCP4 ESF EAMCB, V26; Leutwein C, 2001, J BACTERIOL, V183, P4288, DOI 10.1128/JB.183.14.4288-4295.2001; Lloyd AJ, 2001, BIOCHEMISTRY-US, V40, P2455, DOI 10.1021/bi002169v; Lohkamp B., 2005, CCP4 NEWSLETTER, V42; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; QUAYLE JR, 1963, BIOCHEM J, V87, P368, DOI 10.1042/bj0870368; Rangarajan ES, 2005, J BIOL CHEM, V280, P42919, DOI 10.1074/jbc.M510522200; Rangarajan ES, 2005, BIOCHEMISTRY-US, V44, P5728, DOI 10.1021/bi047656f; Ricagno S, 2003, EMBO J, V22, P3210, DOI 10.1093/emboj/cdg333; Selmer T, 1999, J BIOL CHEM, V274, P20772, DOI 10.1074/jbc.274.30.20772; Sidhu H, 1997, J CLIN MICROBIOL, V35, P350, DOI 10.1128/JCM.35.2.350-353.1997; SOLOMON F, 1969, J BIOL CHEM, V244, P1079; Stenmark P, 2004, BIOCHEMISTRY-US, V43, P13996, DOI 10.1021/bi048481c; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766	30	29	30	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6519	6529		10.1074/jbc.M709353200	http://dx.doi.org/10.1074/jbc.M709353200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18162462	hybrid			2022-12-25	WOS:000253779500059
J	Heikkinen, LS; Kazlauskas, A; Melen, K; Wagner, R; Ziegler, T; Julkunen, I; Saksela, K				Heikkinen, Leena S.; Kazlauskas, Arunas; Melen, Krister; Wagner, Ralf; Ziegler, Thedi; Julkunen, Ilkka; Saksela, Kalle			Avian and 1918 Spanish influenza a virus NS1 proteins bind to Crk/CrkL src homology 3 domains to activate host cell signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-MESSENGER-RNAS; ADAPTER PROTEIN; SH3 DOMAINS; 3-KINASE/AKT PATHWAY; ANTIVIRAL RESPONSES; PANDEMIC INFLUENZA; PHAGE-DISPLAY; SPECIFICITY; INTERFERON; SEQUENCE	NS1 (nonstructural protein 1) is an important virulence factor of the influenza A virus. We observed that NS1 proteins of the 1918 pandemic virus (A/ Brevig Mission/ 1/ 18) and many avian influenza A viruses contain a consensus Src homology 3 (SH3) domain-binding motif. Screening of a comprehensive human SH3 phage library revealed the N-terminal SH3 of Crk and CrkL as the preferred binding partners. Studies with recombinant proteins confirmed avid binding of NS1 proteins of the 1918 virus and a representative avian H7N3 strain to Crk/ CrkL SH3 but not to other SH3 domains tested, including p85 alpha and p85 beta. Endogenous CrkL readily co-precipitated NS1 from cells infected with the H7N3 virus. In transfected cells association with CrkL was observed for NS1 of the 1918 and H7N3 viruses but not A/ Udorn/ 72 or A/WSN/ 33 NS1 lacking this sequence motif. SH3 binding was dispensable for suppression of interferoninduced gene expression by NS1 but was associated with enhanced phosphatidylinositol 3-kinase signaling, as evidenced by increased Akt phosphorylation. Thus, the Spanish Flu virus resembles avian influenza A viruses in its ability to recruit Crk/CrkL to modulate host cell signaling.	[Heikkinen, Leena S.; Kazlauskas, Arunas; Saksela, Kalle] Univ Helsinki, Cent Hosp, Hoartman Inst, Dept Virol, FIN-00014 Helsinki, Finland; [Melen, Krister; Ziegler, Thedi; Julkunen, Ilkka] Natl Inst Publ Hlth, Dept Viral Dis & Immunol, FIN-00300 Helsinki, Finland; [Wagner, Ralf] Univ Regensburg, Inst Med Microbiol & Hyg, D-93053 Regensburg, Germany	University of Helsinki; Helsinki University Central Hospital; University of Regensburg	Saksela, K (corresponding author), Univ Helsinki, Cent Hosp, Hoartman Inst, Dept Virol, Haartmaninkatu 3 POB 21, FIN-00014 Helsinki, Finland.	kalle.saksela@helsinki.fi		Saksela, Kalle/0000-0003-0827-122X				Akagi T, 2000, P NATL ACAD SCI USA, V97, P7290, DOI 10.1073/pnas.140210297; Basler CF, 2001, P NATL ACAD SCI USA, V98, P2746, DOI 10.1073/pnas.031575198; Bliska J, 1996, CHEM BIOL, V3, P7, DOI 10.1016/S1074-5521(96)90076-9; Cooray S, 2004, J GEN VIROL, V85, P1065, DOI 10.1099/vir.0.19771-0; CRONAN JE, 1990, J BIOL CHEM, V265, P10327; Dupraz P, 1997, J VIROL, V71, P2615, DOI 10.1128/JVI.71.4.2615-2620.1997; Ehrhardt C, 2007, J VIROL, V81, P3058, DOI 10.1128/JVI.02082-06; Ehrhardt C, 2006, CELL MICROBIOL, V8, P1336, DOI 10.1111/j.1462-5822.2006.00713.x; Feller SM, 2001, ONCOGENE, V20, P6348, DOI 10.1038/sj.onc.1204779; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Garcia-Sastre A, 2004, CURR TOP MICROBIOL, V283, P249; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Geiss GK, 2002, P NATL ACAD SCI USA, V99, P10736, DOI 10.1073/pnas.112338099; Gelkop S, 2001, J BIOL CHEM, V276, P36174, DOI 10.1074/jbc.M100731200; Hale BG, 2007, BIOCHEM SOC T, V35, P186, DOI 10.1042/BST0350186; Hale BG, 2008, J BIOL CHEM, V283, P1372, DOI 10.1074/jbc.M708862200; Hale BG, 2006, P NATL ACAD SCI USA, V103, P14194, DOI 10.1073/pnas.0606109103; Hayman A, 2007, J VIROL, V81, P2318, DOI 10.1128/JVI.01856-06; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Karkkainen S, 2006, EMBO REP, V7, P186, DOI 10.1038/sj.embor.7400596; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kay-Jackson PC, 2004, J GEN VIROL, V85, P119, DOI 10.1099/vir.0.19435-0; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; KNUDSEN BS, 1995, EMBO J, V14, P2191, DOI 10.1002/j.1460-2075.1995.tb07213.x; Kochs G, 2007, J VIROL, V81, P7011, DOI 10.1128/JVI.02581-06; Korkaya H, 2001, J BIOL CHEM, V276, P42389, DOI 10.1074/jbc.M101546200; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lamb RA, 2001, FIELDS VIROL, V1, P1487; Li EG, 2000, J BIOL CHEM, V275, P14729, DOI 10.1074/jbc.275.19.14729; Li SSC, 2005, BIOCHEM J, V390, P641, DOI 10.1042/BJ20050411; Li ZJ, 2006, J VIROL, V80, P11115, DOI 10.1128/JVI.00993-06; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Longnecker R, 2000, EXP CELL RES, V257, P332, DOI 10.1006/excr.2000.4900; LU Y, 1995, VIROLOGY, V214, P222, DOI 10.1006/viro.1995.9937; Mayer B.J., 2004, STRUCTURE FUNCTION M, P37; MAYER BJ, 1988, NATURE, V332, P272, DOI 10.1038/332272a0; McMullen JR, 2007, CELL CYCLE, V6, P910, DOI 10.4161/cc.6.8.4124; Melen K, 2007, J VIROL, V81, P5995, DOI 10.1128/JVI.01714-06; Min JY, 2006, P NATL ACAD SCI USA, V103, P7100, DOI 10.1073/pnas.0602184103; Mongiovi AM, 1999, EMBO J, V18, P5300, DOI 10.1093/emboj/18.19.5300; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Neumann G, 2006, EMERG INFECT DIS, V12, P881, DOI 10.3201/eid1206.051336; Noah DL, 2003, VIROLOGY, V307, P386, DOI 10.1016/S0042-6822(02)00127-7; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; RICKLES RJ, 1995, P NATL ACAD SCI USA, V92, P10909, DOI 10.1073/pnas.92.24.10909; RONNI T, 1995, J IMMUNOL, V154, P2764; SAKSELA K, 1995, EMBO J, V14, P484, DOI 10.1002/j.1460-2075.1995.tb07024.x; Shaw M, 2002, J MED VIROL, V66, P107, DOI 10.1002/jmv.2118; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Shin YK, 2007, J GEN VIROL, V88, P942, DOI 10.1099/vir.0.82483-0; Shin YK, 2007, J GEN VIROL, V88, P13, DOI 10.1099/vir.0.82419-0; Subbarao K, 2006, INFLUENZA VIROLOGY: CURRENT TOPICS, P229; Tan SL, 1999, P NATL ACAD SCI USA, V96, P5533, DOI 10.1073/pnas.96.10.5533; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; Tumpey TM, 2005, SCIENCE, V310, P77, DOI 10.1126/science.1119392; ZHAO JJ, 2006, SCI STKE; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	59	79	87	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5719	5727		10.1074/jbc.M707195200	http://dx.doi.org/10.1074/jbc.M707195200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165234	hybrid			2022-12-25	WOS:000253426700053
J	Jia, SH; Parodo, J; Kapus, A; Rotstein, OD; Marshall, JC				Jia, Song Hui; Parodo, Jean; Kapus, Andras; Rotstein, Ori D.; Marshall, John C.			Dynamic regulation of neutrophil survival through tyrosine phosphorylation or dephosphorylation of caspase-8	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS FOLLOWING INGESTION; COLONY-STIMULATING FACTOR; NF-KAPPA-B; CELL-DEATH; KINASE; INFLAMMATION; INHIBITION; SEPSIS; RESOLUTION; FAMILY	Efficient expression of innate immunity is critically dependent upon the capacity of the neutrophil to be activated rapidly in the face of an acute threat and to involute once that threat has been eliminated. Here we report a novel mechanism regulating neutrophil survival dynamically through the tyrosine phosphorylation or dephosphorylation of caspase-8. Caspase-8 is tyrosine-phosphorylated in freshly isolated neutrophils but spontaneously dephosphorylates in culture, in association with the progression of constitutive apoptosis. Phosphorylation of caspase-8 on Tyr-310 facilitates its interaction with the Src-homology domain 2 containing tyrosine phosphatase-1 (SHP-1) and enables SHP-1 to dephosphorylate caspase-8, permitting apoptosis to proceed. The non-receptor tyrosine kinase, Lyn, can phosphorylate caspase-8 on Tyr- 397 and Tyr-465, rendering it resistant to activational cleavage and inhibiting apoptosis. Exposure to lipopolysaccharide reduces SHP-1 activity and binding to caspase-8, caspase-8 activity, and rates of spontaneous apoptosis. SHP-1 activity is reduced and Lyn increased in neutrophils from patients with sepsis, in association with profoundly delayed apoptosis; inhibition of Lyn can partially reverse this delay. Thus the phosphorylation and dephosphorylation of caspase-8, mediated by Lyn and SHP-1, respectively, represents a novel, dynamic post-translational mechanism for the regulation of neutrophil apoptosis whose dysregulation contributes to persistent neutrophil survival in sepsis.	[Jia, Song Hui; Parodo, Jean; Kapus, Andras; Rotstein, Ori D.; Marshall, John C.] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Marshall, John C.] Univ Toronto, Interdept Div Crit Care Med, Toronto, ON, Canada; [Jia, Song Hui; Parodo, Jean; Kapus, Andras; Rotstein, Ori D.; Marshall, John C.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Sepsis Res Lab, Toronto, ON M5B 1W8, Canada	University of Toronto; University of Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Marshall, JC (corresponding author), St Michaels Hosp, 4th Floor Bond Wing,Rm 4-007,30 Bond St, Toronto, ON M5B 1W8, Canada.	marshallj@smh.toronto.on.ca						Allan LA, 2003, NAT CELL BIOL, V5, P647, DOI 10.1038/ncb1005; Alvarado-Kristensson M, 2004, J EXP MED, V199, P449, DOI 10.1084/jem.20031771; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Arabaci G, 1999, J AM CHEM SOC, V121, P5085, DOI 10.1021/ja9906756; ATHENS JW, 1961, J CLIN INVEST, V40, P989, DOI 10.1172/JCI104338; Blanchard H, 1999, STRUCTURE, V7, P1125, DOI 10.1016/S0969-2126(99)80179-8; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Brannigan AE, 2000, SHOCK, V13, P361, DOI 10.1097/00024382-200005000-00003; Burshtyn DN, 1999, J IMMUNOL, V162, P897; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carrington PE, 2006, MOL CELL, V22, P599, DOI 10.1016/j.molcel.2006.04.018; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Cursi S, 2006, EMBO J, V25, P1895, DOI 10.1038/sj.emboj.7601085; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; DeLeo FR, 2004, APOPTOSIS, V9, P399, DOI 10.1023/B:APPT.0000031448.64969.fa; El Kebir D, 2006, CELL SIGNAL, V18, P2302, DOI 10.1016/j.cellsig.2006.05.013; Eyles JL, 2006, NAT CLIN PRACT RHEUM, V2, P500, DOI 10.1038/ncprheum0291; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; Garcia-Calvo M, 1998, J BIOL CHEM, V273, P32608, DOI 10.1074/jbc.273.49.32608; Guo RF, 2006, J LEUKOCYTE BIOL, V80, P1575, DOI 10.1189/jlb.0106065; Hasegawa M, 2005, J BIOL CHEM, V280, P15122, DOI 10.1074/jbc.M412284200; Himeji D, 2002, BLOOD, V99, P4070, DOI 10.1182/blood.V99.11.4070; Hotchkiss RS, 1999, P NATL ACAD SCI USA, V96, P14541, DOI 10.1073/pnas.96.25.14541; Hu ZH, 2005, AM J PHYSIOL-CELL PH, V288, pC1171, DOI 10.1152/ajpcell.00312.2004; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Jimenez MF, 1997, ARCH SURG-CHICAGO, V132, P1263; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kruger J, 2000, J IMMUNOL, V165, P5847, DOI 10.4049/jimmunol.165.10.5847; Kupfner JG, 2001, J IMMUNOL, V167, P7044, DOI 10.4049/jimmunol.167.12.7044; Liles WC, 1996, J EXP MED, V184, P429, DOI 10.1084/jem.184.2.429; MARSHALL J, 1990, ARCH SURG-CHICAGO, V125, P17; Marshall John C, 2007, Novartis Found Symp, V280, P53; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Meyn MA, 2006, J BIOL CHEM, V281, P30907, DOI 10.1074/jbc.M605902200; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Necula M, 2005, FEBS LETT, V579, P1453, DOI 10.1016/j.febslet.2005.01.047; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Rossi AG, 2006, NAT MED, V12, P1056, DOI 10.1038/nm1468; Rotstein D, 2000, SHOCK, V14, P278, DOI 10.1097/00024382-200014030-00006; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Scaffidi C, 1997, J BIOL CHEM, V272, P26953, DOI 10.1074/jbc.272.43.26953; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Vlahos R, 2006, PHARMACOL THERAPEUT, V112, P106, DOI 10.1016/j.pharmthera.2006.03.007; Watson RWG, 1997, FEBS LETT, V412, P603, DOI 10.1016/S0014-5793(97)00779-5; Watson RWG, 1996, J IMMUNOL, V156, P3986; Watt W, 1999, STRUCTURE, V7, P1135, DOI 10.1016/S0969-2126(99)80180-4; Wei S, 1996, J IMMUNOL, V157, P5155; WEISS SJ, 1989, NEW ENGL J MED, V320, P365; William R, 1998, J IMMUNOL, V161, P957; Yamamoto A, 2002, CLIN EXP IMMUNOL, V129, P479, DOI 10.1046/j.1365-2249.2002.01930.x; Zhu XT, 1999, STRUCTURE, V7, P651, DOI 10.1016/S0969-2126(99)80086-0	57	65	69	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5402	5413		10.1074/jbc.M706462200	http://dx.doi.org/10.1074/jbc.M706462200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086677	hybrid			2022-12-25	WOS:000253426700020
J	Laviad, EL; Albee, L; Pankova-Kholmyansky, I; Epstein, S; Park, H; Merrill, AH; Futerman, AH				Laviad, Elad L.; Albee, Lee; Pankova-Kholmyansky, Irene; Epstein, Sharon; Park, Hyejung; Merrill, Alfred H., Jr.; Futerman, Anthony H.			Characterization of ceramide synthase 2 - Tissue distribution, substrate specificity, and inhibition by sphingosine 1-phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONGEVITY ASSURANCE GENE-1; HOUSEKEEPING GENES; FAMILY-MEMBERS; SPHINGOLIPIDS; SPHINGOSINE-1-PHOSPHATE; IDENTIFICATION; TRAFFICKING; APOPTOSIS; GROWTH; LAG1	Ceramide is an important lipid signaling molecule and a key intermediate in sphingolipid biosynthesis. Recent studies have implied a previously unappreciated role for the ceramide N-acyl chain length, inasmuch as ceramides containing specific fatty acids appear to play defined roles in cell physiology. The discovery of a family of mammalian ceramide synthases (CerS), each of which utilizes a restricted subset of acyl-CoAs for ceramide synthesis, strengthens this notion. We now report the characterization of mammalian CerS2. qPCR analysis reveals that CerS2 mRNA is found at the highest level of all CerS and has the broadest tissue distribution. CerS2 has a remarkable acyl-CoA specificity, showing no activity using C16:0-CoA and very low activity using C18:0, rather utilizing longer acyl-chain CoAs (C20 - C26) for ceramide synthesis. There is a good correlation between CerS2 mRNA levels and levels of ceramide and sphingomyelin containing long acyl chains, at least in tissues where CerS2 mRNA is expressed at high levels. Interestingly, the activity of CerS2 can be regulated by another bioactive sphingolipid, sphingosine 1-phosphate (S1P), via interaction of S1P with two residues that are part of an S1P receptor-like motif found only in CerS2. These findings provide insight into the biochemical basis for the ceramide N-acyl chain composition of cells, and also reveal a novel and potentially important interplay between two bioactive sphingolipids that could be relevant to the regulation of sphingolipid metabolism and the opposing functions that these lipids play in signaling pathways.	[Laviad, Elad L.; Albee, Lee; Pankova-Kholmyansky, Irene; Epstein, Sharon; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Park, Hyejung; Merrill, Alfred H., Jr.] Georgia Inst Technol, Sch Biol, Petit Ins Bioengn & Biosci, Atlanta, GA 30332 USA	Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il		Futerman, Anthony/0000-0003-0013-0115; Merrill, Alfred/0000-0002-6673-968X	NIGMS NIH HHS [GM076217] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BECKER I, 2007, IN PRESS HISTOCHEM C; Eisenberg E, 2003, TRENDS GENET, V19, P362, DOI 10.1016/S0168-9525(03)00140-9; Eller CD, 2007, GENE, V390, P153, DOI 10.1016/j.gene.2006.09.018; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Futerman AH, 2006, BBA-BIOMEMBRANES, V1758, P1885, DOI 10.1016/j.bbamem.2006.08.004; Ganapathi M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-126; Hait NC, 2006, BBA-BIOMEMBRANES, V1758, P2016, DOI 10.1016/j.bbamem.2006.08.007; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Kouadjo KE, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-127; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Kumagai K, 2005, J BIOL CHEM, V280, P6488, DOI 10.1074/jbc.M409290200; Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Lee S, 2007, J BIOCHEM MOL BIOL, V40, P226; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Mandala SM, 2000, P NATL ACAD SCI USA, V97, P7859, DOI 10.1073/pnas.120146897; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Merrill AH, 2007, TRENDS BIOCHEM SCI, V32, P457, DOI 10.1016/j.tibs.2007.09.004; Mizutani Y, 2005, BIOCHEM J, V390, P263, DOI 10.1042/BJ20050291; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Pewzner-Jung Y, 2006, J BIOL CHEM, V281, P25001, DOI 10.1074/jbc.R600010200; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Schenck M, 2007, ARCH BIOCHEM BIOPHYS, V462, P171, DOI 10.1016/j.abb.2007.03.031; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; SULLARDS MC, 2001, SCI STKE, V67, P1; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Xu RJ, 2006, FASEB J, V20, P1813, DOI 10.1096/fj.05-5689com; Yu J, 2007, J BIOL CHEM, V282, P25940, DOI 10.1074/jbc.M701812200; Zondag GCM, 1998, BIOCHEM J, V330, P605, DOI 10.1042/bj3300605	36	343	351	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5677	5684		10.1074/jbc.M707386200	http://dx.doi.org/10.1074/jbc.M707386200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165233	hybrid			2022-12-25	WOS:000253426700048
J	Li, F; Sonbuchner, L; Kyes, SA; Epp, C; Deitsch, KW				Li, Felomena; Sonbuchner, Lakshmi; Kyes, Sue A.; Epp, Christian; Deitsch, Kirk W.			Nuclear non-coding RNAs are transcribed from the centromeres of plasmodium falciparum and are associated with centromeric chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITES; GENE-EXPRESSION; ERYTHROCYTIC STAGES; FISSION YEAST; ANTISENSE TRANSCRIPTS; HETEROCHROMATIN; DNA; TRANSFORMATION; LOCALIZATION; PROTEINS	Non-coding RNAs (ncRNAs) play an important role in a variety of nuclear processes, including genetic imprinting, RNA interference-mediated transcriptional repression, and dosage compensation. These transcripts are thought to influence chromosome organization and, in some cases, gene expression by directing the assembly of specific chromatin modifications to targeted regions of the genome. In the malaria parasite Plasmodium falciparum, little is known about the regulation of nuclear organization or gene expression, although a notable scarcity of identifiable transcription factors encoded in its genome has led to speculation that this organism may be unusually reliant on chromatin modifications as a mechanism for regulating gene expression. To study the mechanisms that regulate chromatin structure in malaria parasites, we examined the role of ncRNAs in the assembly of chromatin at the centromeres of P. falciparum. We show that centromeric regions within the Plasmodium genome contain bidirectional promoter activity driving the expression of short ncRNAs that are localized within the nucleus and appear to associate with the centromeres themselves, strongly suggesting that they are central characters in the maintenance and function of centromeric chromatin. These observations support the hypothesis that ncRNAs play an important role in the proper organizational assembly of chromatin in P. falciparum, perhaps compensating for a lack of both regulatory transcription factors and RNA interference machinery.	[Li, Felomena; Sonbuchner, Lakshmi; Epp, Christian; Deitsch, Kirk W.] Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA; [Kyes, Sue A.] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9D5, England	Cornell University; University of Oxford	Deitsch, KW (corresponding author), Cornell Univ, Weill Med Coll, Dept Microbiol & Immunol, 1300 York Ave,Box 62, New York, NY 10021 USA.	kwd2001@med.cornell.edu			NIAID NIH HHS [R01 AI052390, AI52390] Funding Source: Medline; NIGMS NIH HHS [T32 GM007739, GM07739] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI052390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Carroll CW, 2006, TRENDS CELL BIOL, V16, P70, DOI 10.1016/j.tcb.2005.12.008; Chang SC, 2006, FRONT BIOSCI-LANDMRK, V11, P852, DOI 10.2741/1842; Chen ES, 2003, MOL CELL, V11, P175, DOI 10.1016/S1097-2765(03)00011-X; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; Cooke HJ, 2004, TRENDS BIOTECHNOL, V22, P319, DOI 10.1016/j.tibtech.2004.04.015; Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604; de la Espina SMD, 2005, EUR J CELL BIOL, V84, P137, DOI 10.1016/j.ejcb.2005.01.002; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Ekwall K, 2004, CHROMOSOME RES, V12, P535, DOI 10.1023/B:CHRO.0000036584.40567.e5; FIDOCK DA, 1994, MOL BIOCHEM PARASIT, V64, P219, DOI 10.1016/0166-6851(94)00012-3; Fidock DA, 1997, P NATL ACAD SCI USA, V94, P10931, DOI 10.1073/pnas.94.20.10931; Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531; Gerbi SA, 2002, MOL BIOL CELL, V13, P3123, DOI 10.1091/mbc.01-12-0596; Guenatri M, 2004, J CELL BIOL, V166, P493, DOI 10.1083/jcb.200403109; Gunasekera AM, 2004, MOL BIOCHEM PARASIT, V136, P35, DOI 10.1016/j.molbiopara.2004.02.007; Karpen GH, 1997, TRENDS GENET, V13, P489, DOI 10.1016/S0168-9525(97)01298-5; Kelly JM, 2006, P NATL ACAD SCI USA, V103, P6706, DOI 10.1073/pnas.0510363103; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; Kyes SA, 2003, MOL MICROBIOL, V48, P1339, DOI 10.1046/j.1365-2958.2003.03505.x; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Lewis A, 2006, CYTOGENET GENOME RES, V113, P81, DOI 10.1159/000090818; Maison C, 2002, NAT GENET, V30, P329, DOI 10.1038/ng843; Malhotra P, 2002, MOL MICROBIOL, V45, P1245, DOI 10.1046/j.1365-2958.2002.03105.x; Marty AJ, 2006, MOL MICROBIOL, V62, P72, DOI 10.1111/j.1365-2958.2006.05364.x; Mizuta R, 2005, J ELECTRON MICROSC, V54, P403, DOI 10.1093/jmicro/dfi058; Morey C, 2004, FEBS LETT, V567, P27, DOI 10.1016/j.febslet.2004.03.117; Nakano M, 2003, J CELL SCI, V116, P4021, DOI 10.1242/jcs.00697; Patankar S, 2001, MOL BIOL CELL, V12, P3114, DOI 10.1091/mbc.12.10.3114; Pidoux AL, 2005, PHILOS T R SOC B, V360, P569, DOI 10.1098/rstb.2004.1611; Rea S, 2006, CURR TOP MICROBIOL, V310, P117; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; Thompson Joanne, 2002, Methods Mol Med, V72, P225, DOI 10.1385/1-59259-271-6:225; Topp CN, 2004, P NATL ACAD SCI USA, V101, P15986, DOI 10.1073/pnas.0407154101; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TRAGER W, 1977, B WORLD HEALTH ORGAN, V55, P363; Valgardsdottir R, 2005, MOL BIOL CELL, V16, P2597, DOI 10.1091/mbc.E04-12-1078; Verdel A, 2005, FEBS LETT, V579, P5872, DOI 10.1016/j.febslet.2005.08.083; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wickstead B, 2003, MICROBIOL MOL BIOL R, V67, P360, DOI 10.1128/MMBR.67.3.360-375.2003; WU YM, 1995, P NATL ACAD SCI USA, V92, P973, DOI 10.1073/pnas.92.4.973; ZOTALL M, 2006, MOL CELL, V22, P681	45	56	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5692	5698		10.1074/jbc.M707344200	http://dx.doi.org/10.1074/jbc.M707344200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165241	hybrid			2022-12-25	WOS:000253426700050
J	Lim, D; Fedrizzi, L; Tartari, M; Zuccato, C; Cattaneo, E; Brini, M; Carafoli, E				Lim, Dmitry; Fedrizzi, Laura; Tartari, Marzia; Zuccato, Chiara; Cattaneo, Elena; Brini, Marisa; Carafoli, Ernesto			Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIUM SPINY NEURONS; WILD-TYPE HUNTINGTIN; MUTANT HUNTINGTIN; 3-NITROPROPIONIC ACID; CELL-DEATH; OXIDATIVE STRESS; MOUSE MODEL; DNA DAMAGE; TRANSCRIPTIONAL REPRESSION; SELECTIVE VULNERABILITY	Dysfunctions of Ca2+ homeostasis and of mitochondria have been studied in immortalized striatal cells from a commonly used Huntington disease mouse model. Transcriptional changes in the components of the phosphatidylinositol cycle and in the receptors for myo-inositol trisphosphate-linked agonists have been found in the cells and in the striatum of the parent Huntington disease mouse. The overall result of the changes is to delay myo-inositol trisphosphate production and to decrease basal Ca2+ in mutant cells. When tested directly, mitochondria in mutant cells behave nearly normally, but are unable to handle large Ca2+ loads. This appears to be due to the increased Ca2+ sensitivity of the permeability transition pore, which dissipates the membrane potential, prompting the release of accumulated Ca2+. Harmful reactive oxygen species, which are produced by defective mitochondria and may in turn stress them, increase in mutant cells, particularly if the damage to mitochondria is artificially exacerbated, for instance with complex II inhibitors. Mitochondria in mutant cells are thus peculiarly vulnerable to stresses induced by Ca2+ and reactive oxygen species. The observed decrease of cell Ca2+ could be a compensatory attempt to prevent the Ca2+ stress that would irreversibly damage mitochondria and eventually lead to cell death.	Venetian Inst Mol Med, I-35129 Padua, Italy; [Lim, Dmitry; Fedrizzi, Laura; Carafoli, Ernesto] Univ Padua, Dept Biochem, I-35131 Padua, Italy; [Fedrizzi, Laura; Brini, Marisa] Univ Padua, Dept Expt Vet Sci, I-35131 Padua, Italy; [Tartari, Marzia; Zuccato, Chiara; Cattaneo, Elena; Carafoli, Ernesto] Univ Milan, Dept Pharmacol Sci, Milan, Italy	Veneto Institute Molecular Medicine; University of Padua; University of Padua; University of Milan	Carafoli, E (corresponding author), Venetian Inst Mol Med, Via Orus 2, I-35129 Padua, Italy.	ernesto.carafoli@unipd.it	Brini, Marisa/K-5189-2016; Carafoli, Ernesto/K-5192-2016; Lim, Dmitry/H-9101-2012	Carafoli, Ernesto/0000-0002-7826-0094; Brini, Marisa/0000-0001-5141-0243; CATTANEO, ELENA/0000-0002-0755-4917; ZUCCATO, CHIARA/0000-0003-1771-3392	Telethon [GGP04169] Funding Source: Medline	Telethon(Fondazione Telethon)		Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; BEAL MF, 1993, J NEUROSCI, V13, P4181; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; Bezprozvanny I, 2004, BIOCHEM BIOPH RES CO, V322, P1310, DOI 10.1016/j.bbrc.2004.08.035; Bowyer JF, 1996, BRAIN RES, V712, P221, DOI 10.1016/0006-8993(95)01417-9; BRINI M, 1995, J BIOL CHEM, V270, P9896, DOI 10.1074/jbc.270.17.9896; Brini M, 2003, CELL CALCIUM, V34, P399, DOI 10.1016/S0143-4160(03)00145-3; Brouillet E, 2005, J NEUROCHEM, V95, P1521, DOI 10.1111/j.1471-4159.2005.03515.x; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Browne SE, 2004, NEUROCHEM RES, V29, P531, DOI 10.1023/B:NERE.0000014824.04728.dd; Burnstock G, 2006, TRENDS PHARMACOL SCI, V27, P166, DOI 10.1016/j.tips.2006.01.005; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cepeda C, 2001, J NEUROSCI RES, V66, P525, DOI 10.1002/jnr.1244; Choo YS, 2004, HUM MOL GENET, V13, P1407, DOI 10.1093/hmg/ddh162; Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015; Duchen MR, 2003, METHOD ENZYMOL, V361, P353; Follenzi Antonia, 2002, Methods Mol Med, V69, P259; Goffredo D, 2002, J BIOL CHEM, V277, P39594, DOI 10.1074/jbc.C200353200; GREENE JG, 1995, J NEUROCHEM, V64, P430; Jiang HB, 2003, HUM MOL GENET, V12, P1, DOI 10.1093/hmg/ddg002; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lorenc-Koci E, 2005, BRAIN RES, V1051, P145, DOI 10.1016/j.brainres.2005.06.007; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mandavilli BS, 2005, MOL BRAIN RES, V133, P215, DOI 10.1016/j.molbrainres.2004.10.033; Maragos WF, 2004, NEUROCHEM RES, V29, P741, DOI 10.1023/B:NERE.0000018845.82808.45; Milakovic T, 2005, J BIOL CHEM, V280, P30773, DOI 10.1074/jbc.M504749200; Milakovic T, 2006, J BIOL CHEM, V281, P34785, DOI 10.1074/jbc.M603845200; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Panov AV, 2002, NAT NEUROSCI, V5, P731, DOI 10.1038/nn884; Perez-Severiano F, 2004, NEUROCHEM RES, V29, P729, DOI 10.1023/B:NERE.0000018843.83770.4b; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ruan QM, 2004, HUM MOL GENET, V13, P669, DOI 10.1093/hmg/ddh082; Salazar JJ, 1997, MUTAT RES-DNA REPAIR, V385, P139, DOI 10.1016/S0921-8777(97)00047-5; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Scemes E, 2003, J NEUROSCI, V23, P11444; Schwab BL, 2002, CELL DEATH DIFFER, V9, P818, DOI 10.1038/sj.cdd.4401042; Seong IS, 2005, HUM MOL GENET, V14, P2871, DOI 10.1093/hmg/ddi319; Shehadeh J, 2006, NEUROBIOL DIS, V21, P392, DOI 10.1016/j.nbd.2005.08.001; Sieradzan KA, 2001, NEUROPATH APPL NEURO, V27, P1, DOI 10.1046/j.0305-1846.2001.00299.x; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Tang TS, 2004, EUR J NEUROSCI, V20, P1779, DOI 10.1111/j.1460-9568.2004.03633.x; Tang TS, 2005, P NATL ACAD SCI USA, V102, P2602, DOI 10.1073/pnas.0409402102; Tang TS, 2003, NEURON, V39, P227, DOI 10.1016/S0896-6273(03)00366-0; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; von Kugelgen I, 2000, N-S ARCH PHARMACOL, V362, P310, DOI 10.1007/s002100000310; Wang J, 2001, J NEUROCHEM, V77, P804, DOI 10.1046/j.1471-4159.2001.00271.x; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004; Yakes FM, 1997, P NATL ACAD SCI USA, V94, P514, DOI 10.1073/pnas.94.2.514; Zeron MM, 2002, NEURON, V33, P849, DOI 10.1016/S0896-6273(02)00615-3; Zhai WG, 2005, CELL, V123, P1241, DOI 10.1016/j.cell.2005.10.030; Zuccato C, 2007, PROG NEUROBIOL, V81, P294, DOI 10.1016/j.pneurobio.2007.01.003	57	148	150	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5780	5789		10.1074/jbc.M704704200	http://dx.doi.org/10.1074/jbc.M704704200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18156184	hybrid			2022-12-25	WOS:000253426700059
J	Lu, XH; Huang, LJS; Lodish, HF				Lu, Xiaohui; Huang, Lily Jun-Shen; Lodish, Harvey F.			Dimerization by a cytokine receptor is necessary for constitutive activation of JAK2V617F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JAK2 V617F MUTATION; CHRONIC-MYELOMONOCYTIC-LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE JAK2; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; ERYTHROPOIETIN RECEPTOR; MEGAKARYOBLASTIC LEUKEMIA; JANUS KINASES; FERM DOMAIN	The majority of the BCR-ABL-negative myeloproliferative disorders express the mutant JAK2, JAK2V617F. Previously we showed that constitutive activation of this oncogenic JAK2 mutant in Ba/F3 or 32D cells requires coexpression of a cognate homodimeric cytokine receptor, such as the EpoR. However, overexpression of JAK2V617F in Ba/F3 cells renders them cytokine-independent for growth in the absence of an exogenous cytokine receptor. Here, we demonstrated that JAK2V617F domains required for receptor association are essential for cytokine-independent growth by overexpressed JAK2V617F, suggesting JAK2V617F is binding to an unknown endogenous cytokine receptor(s) for its activation. We further showed that disruption of EpoR dimerization by coexpressing a truncated EpoR disrupted JAK2V617F-mediated transformation, indicating that EpoR dimerization plays an essential role in the activation of JAK2V617F. Interestingly, coexpression of JAK2V617F with EpoR mutants that retain JAK2 binding but are defective in mediating Epo-dependent JAK2 activation due to mutations in a conserved juxtamembrane motif does lead to cytokine-independent activation of JAK2V617F. Overall, these findings confirm that JAK2V617F requires binding to a dimerized cytokine receptor for its activation, and that the key EpoR juxtamembrane regulatory motif essential for Epo-dependent JAK2 activation is not essential for the activation of JAK2V617F. The structure of the activated JAK2V617F is thus likely to be different from that of the activated wild-type JAK2, raising the possibility of developing a specifically targeted therapy for myeloproliferative disorders.	[Lu, Xiaohui; Lodish, Harvey F.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Huang, Lily Jun-Shen] Univ Texas SW Med Ctr Dallas, Dept Cell Biol, Dallas, TX 75390 USA; [Lodish, Harvey F.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT)	Lodish, HF (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	lodish@wi.mit.edu			NATIONAL CANCER INSTITUTE [K01CA095150] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL032262] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA95150] Funding Source: Medline; NHLBI NIH HHS [P01 HL 32262] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARBER DL, 1994, MOL CELL BIOL, V14, P2257, DOI 10.1128/MCB.14.4.2257; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Bumm TGP, 2006, CANCER RES, V66, P11156, DOI 10.1158/0008-5472.CAN-06-2210; Constantinescu SN, 2001, MOL CELL, V7, P377, DOI 10.1016/S1097-2765(01)00185-X; Constantinescu SN, 2001, P NATL ACAD SCI USA, V98, P4379, DOI 10.1073/pnas.081069198; Funakoshi-Tago M, 2006, EMBO J, V25, P4763, DOI 10.1038/sj.emboj.7601365; Huang LJS, 2001, MOL CELL, V8, P1327, DOI 10.1016/S1097-2765(01)00401-4; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Johan MF, 2005, BRIT J HAEMATOL, V130, P968, DOI 10.1111/j.1365-2141.2005.05719.x; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Lee JW, 2006, ONCOGENE, V25, P1434, DOI 10.1038/sj.onc.1209163; Levine RL, 2005, BLOOD, V106, P3377, DOI 10.1182/blood-2005-05-1898; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Liu XD, 2000, ANAL BIOCHEM, V280, P20, DOI 10.1006/abio.2000.4478; Lu XH, 2005, P NATL ACAD SCI USA, V102, P18962, DOI 10.1073/pnas.0509714102; Mercher T, 2006, BLOOD, V108, P2770, DOI 10.1182/blood-2006-04-014712; Naoe T, 2004, CELL MOL LIFE SCI, V61, P2932, DOI 10.1007/s00018-004-4274-x; Ohyashiki K, 2005, LEUKEMIA, V19, P2359, DOI 10.1038/sj.leu.2403989; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Saharinen P, 2000, MOL CELL BIOL, V20, P3387, DOI 10.1128/MCB.20.10.3387-3395.2000; Schwaller J, 1998, EMBO J, V17, P5321, DOI 10.1093/emboj/17.18.5321; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Scott LM, 2005, BLOOD, V106, P2920, DOI 10.1182/blood-2005-05-2087; Staerk J, 2005, J BIOL CHEM, V280, P41893, DOI 10.1074/jbc.C500358200; Syed RS, 1998, NATURE, V395, P511, DOI 10.1038/26773; Tefferi A, 2007, CELL CYCLE, V6, P550, DOI 10.4161/cc.6.5.3919; Walters DK, 2006, CANCER CELL, V10, P65, DOI 10.1016/j.ccr.2006.06.002; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829; Zhou YJ, 2001, MOL CELL, V8, P959, DOI 10.1016/S1097-2765(01)00398-7	34	100	107	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5258	5266		10.1074/jbc.M707125200	http://dx.doi.org/10.1074/jbc.M707125200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18158285	hybrid			2022-12-25	WOS:000253426700005
J	Chen, HJ; Levine, YC; Golan, DE; Michel, T; Lin, AJ				Chen, Hongjie; Levine, Yehoshua C.; Golan, David E.; Michel, Thomas; Lin, Alison J.			Atrial natriuretic peptide-initiated cGMP pathways regulate vasodilator-stimulated phosphoprotein phosphorylation and angiogenesis in vascular endothelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; DEPENDENT PROTEIN-KINASE; SOLUBLE GUANYLYL CYCLASE; SMOOTH-MUSCLE FUNCTION; ENA/VASP PROTEINS; EXTRACELLULAR-MATRIX; MEDIATED ANGIOGENESIS; ACTIN CYTOSKELETON; BASEMENT-MEMBRANE; MAMMALIAN-CELLS	Nitric oxide (NO)- and atrial natriuretic peptide (ANP)-initiated cGMP signaling cascades are important in the maintenance of cardiovascular homeostasis. The molecular signaling mechanisms downstream of cGMP are not well understood, however. We have used small interfering RNA (siRNA) approaches to specifically knock down a series of signaling proteins in bovine aortic endothelial cells, and we have combined biochemical analyses with physiological assays to investigate cGMP-mediated signal transduction pathways. Activation of particulate guanylate cyclase (GC-A) by ANP leads to a substantial, dose-dependent, rapid, and sustained increase in intracellular cGMP. In contrast, stimulation of soluble guanylate cyclase by NO yields only a weak and transient increase in cGMP. ANP-induced cGMP production is selectively suppressed by siRNA-mediated knockdown of GC-A. ANP greatly enhances the phosphorylation at Ser-239 of the vasodilator-stimulated phosphoprotein (VASP), a major substrate of cGMP-dependent protein kinase (PKG) that significantly influences actin dynamics. Moreover, the ANP-induced phosphorylation of VASP at Ser-239 is accompanied by increased actin stress fiber formation and enhanced endothelial tube formation. siRNA-mediated knockdown of GC-A, VASP, or PKG abolishes ANP-induced VASP Ser-239 phosphorylation, stress fiber formation, and endothelial tube formation. We have demonstrated similar findings in human umbilical vein endothelial cells, where ANP substantially enhances intracellular cGMP content, phosphorylation of VASP at Ser-239, and endothelial tube formation. Taken together, our findings suggest that ANP-mediated cGMP signal transduction pathways regulate PKG phosphorylation of VASP Ser-239 in endothelial cells, resulting in reorganization of the actin cytoskeleton and enhancement of angiogenesis.	[Chen, Hongjie; Levine, Yehoshua C.; Michel, Thomas; Lin, Alison J.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Cardiovasc,Med Sch, Boston, MA 02115 USA; [Golan, David E.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Hematol,Med Sch, Boston, MA 02115 USA; [Golan, David E.; Michel, Thomas; Lin, Alison J.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Golan, DE (corresponding author), 250 Longwood Ave,SGMB 304, Boston, MA 02115 USA.	dgolan@hms.harvard.edu; tmichel@rics.bwh.harvard.edu; alison_lin@hms.harvard.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL032854, R01HL032854, U54HL070819, P01HL048743, R29HL046457, R01HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL32854, HL70819, HL48743, HL46457] Funding Source: Medline; NIGMS NIH HHS [GM36259] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ahmad S, 2006, CIRC RES, V99, P715, DOI 10.1161/01.RES.0000243989.46006.b9; Al-Ani B, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000025; Arguinzonis MIG, 2002, J BIOL CHEM, V277, P45604, DOI 10.1074/jbc.M202873200; Aszodi A, 1999, EMBO J, V18, P37, DOI 10.1093/emboj/18.1.37; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Barzik M, 2005, J BIOL CHEM, V280, P28653, DOI 10.1074/jbc.M503957200; Bear JE, 2002, CELL, V109, P509, DOI 10.1016/S0092-8674(02)00731-6; Browner NC, 2004, J BIOL CHEM, V279, P46631, DOI 10.1074/jbc.M408518200; Bubikat A, 2005, J BIOL CHEM, V280, P21594, DOI 10.1074/jbc.m501103200; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cea Luis Bolanos, 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P87, DOI 10.2174/1568016053544309; Chen LH, 2004, ARTERIOSCL THROM VAS, V24, P1403, DOI 10.1161/01.ATV.0000134705.39654.53; Davis GE, 2005, CIRC RES, V97, P1093, DOI 10.1161/01.RES.0000191547.64391.e3; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Denninger JW, 1999, BBA-BIOENERGETICS, V1411, P334, DOI 10.1016/S0005-2728(99)00024-9; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Galler AB, 2006, HISTOCHEM CELL BIOL, V125, P457, DOI 10.1007/s00418-005-0091-z; Gonzalez E, 2004, J BIOL CHEM, V279, P40659, DOI 10.1074/jbc.M407051200; GRANT DS, 1994, PATHOL RES PRACT, V190, P854; Hamad AM, 2003, AM J PHYSIOL-LUNG C, V285, pL973, DOI 10.1152/ajplung.00033.2003; Han B, 2003, CARDIOVASC DRUG THER, V17, P41, DOI 10.1023/A:1024255808831; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Hofmann F, 2005, J BIOL CHEM, V280, P1, DOI 10.1074/jbc.R400035200; Hohenstein B, 2005, J AM SOC NEPHROL, V16, P986, DOI 10.1681/ASN.2004070591; Huppi K, 2005, MOL CELL, V17, P1, DOI 10.1016/j.molcel.2004.12.017; Ibarra-Alvarado C, 2002, MOL PHARMACOL, V61, P312, DOI 10.1124/mol.61.2.312; Igarashi J, 2001, J BIOL CHEM, V276, P12420, DOI 10.1074/jbc.M008375200; ISHII K, 1989, AM J PHYSIOL, V256, pC495, DOI 10.1152/ajpcell.1989.256.3.C495; ITOH H, 1992, HYPERTENSION, V19, P758, DOI 10.1161/01.HYP.19.6.758; Kawasaki K, 2003, MOL CELL BIOL, V23, P5726, DOI 10.1128/MCB.23.16.5726-5737.2003; Kiemer Alexandra K., 2005, Current Medicinal Chemistry - Cardiovascular & Hematological Agents, V3, P11; KISHI Y, 1994, J CARDIOVASC PHARM, V24, P351, DOI 10.1097/00005344-199409000-00001; KLEINMAN HK, 1982, BIOCHEMISTRY-US, V21, P6188, DOI 10.1021/bi00267a025; Kook H, 2003, AM J PHYSIOL-HEART C, V284, pH1388, DOI 10.1152/ajpheart.00414.2002; Krause M, 2002, J CELL SCI, V115, P4721, DOI 10.1242/jcs.00218; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Kuhn M, 2003, CIRC RES, V93, P700, DOI 10.1161/01.RES.0000094745.28948.4D; KUZUYA M, 1994, J CELL PHYSIOL, V161, P267, DOI 10.1002/jcp.1041610211; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; LEITMAN DC, 1988, J BIOL CHEM, V263, P3720; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; MADRI JA, 1988, J CELL BIOL, V106, P1375, DOI 10.1083/jcb.106.4.1375; MADRI JA, 1986, J HISTOCHEM CYTOCHEM, V34, P85, DOI 10.1177/34.1.2416801; Massberg S, 2004, BLOOD, V103, P136, DOI 10.1182/blood-2002-11-3417; Melichar VO, 2004, P NATL ACAD SCI USA, V101, P16671, DOI 10.1073/pnas.0405509101; Merajver SD, 2005, J MAMMARY GLAND BIOL, V10, P291, DOI 10.1007/s10911-006-9002-8; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Moncada S., 2006, V176, P213; Morbidelli L, 2003, CURR PHARM DESIGN, V9, P521, DOI 10.2174/1381612033391405; Moro MA, 1996, P NATL ACAD SCI USA, V93, P1480, DOI 10.1073/pnas.93.4.1480; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Oelze M, 2000, CIRC RES, V87, P999, DOI 10.1161/01.RES.87.11.999; Pedram A, 2001, ENDOCRINOLOGY, V142, P1578, DOI 10.1210/en.142.4.1578; Price CJ, 2000, ARTERIOSCL THROM VAS, V20, P2051, DOI 10.1161/01.ATV.20.9.2051; Rikitake Y, 2002, ARTERIOSCL THROM VAS, V22, P108, DOI 10.1161/hq0102.101843; Rivero-Vilches FJ, 2003, AM J PHYSIOL-CELL PH, V285, pC891, DOI 10.1152/ajpcell.00590.2002; RUSKOAHO H, 1992, PHARMACOL REV, V44, P479; Salazar R, 1999, EXP CELL RES, V249, P22, DOI 10.1006/excr.1999.4460; Shen WG, 2007, CELL BIOL INT, V31, P126, DOI 10.1016/j.cellbi.2006.09.017; Smolenski A, 2000, J BIOL CHEM, V275, P25723, DOI 10.1074/jbc.M909632199; Sporbert A, 1999, MOL BRAIN RES, V67, P258, DOI 10.1016/S0169-328X(99)00067-4; Su YC, 2006, FASEB J, V20, P1443, DOI 10.1096/fj.05-5354com; Vaandrager AB, 1996, MOL CELL BIOCHEM, V157, P23, DOI 10.1007/BF00227877; Yamahara K, 2003, P NATL ACAD SCI USA, V100, P3404, DOI 10.1073/pnas.0538059100; Zhu B, 2005, AM J PHYSIOL-LUNG C, V289, pL196, DOI 10.1152/ajplung.00433.2004	70	65	69	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4439	4447		10.1074/jbc.M709439200	http://dx.doi.org/10.1074/jbc.M709439200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079117	hybrid			2022-12-25	WOS:000253083500078
J	Gomes, DA; Rodrigues, MA; Leite, MF; Gomez, MV; Varnai, P; Balla, T; Bennett, AM; Nathanson, MH				Gomes, Dawidson A.; Rodrigues, Michele A.; Leite, M. Fatima; Gomez, Marcus V.; Varnai, Peter; Balla, Tamas; Bennett, Anton M.; Nathanson, Michael H.			C-met must translocate to the nucleus to initiate calcium signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; PERFUSED-RAT-LIVER; TYROSINE PHOSPHORYLATION; CELL-PROLIFERATION; DOWN-REGULATION; FACTOR RECEPTOR; BILE SECRETION; CA2+; LOCALIZATION; RELEASE	Hepatocyte growth factor (HGF) is important for cell proliferation, differentiation, and related activities. HGF acts through its receptor c-Met, which activates downstream signaling pathways. HGF binds to c-Met at the plasma membrane, where it is generally believed that c-Met signaling is initiated. Here we report that c-Met rapidly translocates to the nucleus upon stimulation with HGF. Ca2+ signals that are induced by HGF result from phosphatidylinositol 4,5-bisphosphate hydrolysis and inositol 1,4,5-trisphosphate formation within the nucleus rather than within the cytoplasm. Translocation of c-Met to the nucleus depends upon the adaptor protein Gab1 and importin beta 1, and formation of Ca2+ signals in turn depends upon this translocation. HGF may exert its particular effects on cells because it bypasses signaling pathways in the cytoplasm to directly activate signaling pathways in the nucleus.	[Gomes, Dawidson A.; Rodrigues, Michele A.; Nathanson, Michael H.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Bennett, Anton M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06520 USA; [Gomez, Marcus V.] Univ Fed Minas Gerais, Dept Pharmacol, BR-31270901 Belo Horizonte, MG, Brazil; [Gomes, Dawidson A.; Rodrigues, Michele A.; Leite, M. Fatima] Univ Fed Minas Gerais, Dept Physiol & Biophys, BR-31270901 Belo Horizonte, MG, Brazil; [Varnai, Peter; Balla, Tamas] NICHD, Sect Mol Signal Transduct, NIH, Bethesda, MD 20892 USA	Yale University; Yale University; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Nathanson, MH (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Rm TAC S241D, New Haven, CT 06520 USA.	michael.nathanson@yale.edu	de Fatima Leite, Maria/AAK-2555-2021; Gomes, Dawidson Assis/O-1372-2013; Gomez, Marcus Vinicius/I-4081-2012	Gomes, Dawidson Assis/0000-0001-7714-991X; Gomez, Marcus Vinicius/0000-0002-6082-930X; Bennett, Anton/0000-0001-5187-7599; Balla, Tamas/0000-0002-9077-3335	Howard Hughes Medical Institute Funding Source: Medline; NIDDK NIH HHS [DK37989, P01 DK057751, R01 DK045710-06A2, DK57751, P01 DK057751-01A1, P30 DK034989, P30 DK034989-169004, R01 DK045710, DK45710] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989, R01DK045710, R01DK037989, P01DK057751, R29DK045710] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSON D, 1990, SCIENCE, V250, P979, DOI 10.1126/science.2173144; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Birnbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406, DOI 10.1016/S1043-2760(00)00304-0; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Deisseroth K, 1998, NATURE, V392, P198, DOI 10.1038/32448; Di Fiore PP, 2001, CELL, V106, P1, DOI 10.1016/S0092-8674(01)00428-7; Echevarria W, 2003, NAT CELL BIOL, V5, P440, DOI 10.1038/ncb980; Fukatsu K, 2004, J BIOL CHEM, V279, P48976, DOI 10.1074/jbc.M408364200; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; GERASIMENKO OV, 1995, CELL, V80, P439, DOI 10.1016/0092-8674(95)90494-8; Gray A, 2003, ANAL BIOCHEM, V313, P234, DOI 10.1016/S0003-2697(02)00607-3; Gu HH, 2003, TRENDS CELL BIOL, V13, P122, DOI 10.1016/S0962-8924(03)00002-3; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hernandez E, 2007, J BIOL CHEM, V282, P10057, DOI 10.1074/jbc.M700746200; Irvine RF, 2003, NAT REV MOL CELL BIO, V4, P349, DOI 10.1038/nrm1100; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; KIM SJ, 1993, J CELL PHYSIOL, V157, P217, DOI 10.1002/jcp.1041570203; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Leite MF, 2003, P NATL ACAD SCI USA, V100, P2975, DOI 10.1073/pnas.0536590100; Leite MF, 2002, J BIOL CHEM, V277, P16313, DOI 10.1074/jbc.M109207200; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lohmann C, 2002, NATURE, V418, P177, DOI 10.1038/nature00850; MAHER JJ, 1993, J CLIN INVEST, V91, P2244, DOI 10.1172/JCI116451; MALVIYA AN, 1990, P NATL ACAD SCI USA, V87, P9270, DOI 10.1073/pnas.87.23.9270; Martelli AM, 2000, FEBS LETT, V486, P230, DOI 10.1016/S0014-5793(00)02313-9; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Mendes CCP, 2005, J BIOL CHEM, V280, P40892, DOI 10.1074/jbc.M506623200; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Nagata J, 2007, GASTROENTEROLOGY, V133, P256, DOI 10.1053/j.gastro.2007.03.115; NATHANSON MH, 1992, AM J PHYSIOL, V262, pG1079, DOI 10.1152/ajpgi.1992.262.6.G1079; Nathanson MH, 1999, GASTROENTEROLOGY, V116, P1176, DOI 10.1016/S0016-5085(99)70021-1; NATHANSON MH, 1992, HEPATOLOGY, V15, P107, DOI 10.1002/hep.1840150119; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; OKANO Y, 1993, BIOCHEM BIOPH RES CO, V190, P842, DOI 10.1006/bbrc.1993.1125; Osawa M, 2004, J BIOL CHEM, V279, P29691, DOI 10.1074/jbc.M309371200; Petrelli A, 2002, NATURE, V416, P187, DOI 10.1038/416187a; Pusl T, 2002, J BIOL CHEM, V277, P27517, DOI 10.1074/jbc.M203002200; Reilly JF, 2001, J CELL BIOL, V152, P1307, DOI 10.1083/jcb.152.6.1307; Rodrigues MA, 2007, J BIOL CHEM, V282, P17061, DOI 10.1074/jbc.M700490200; SCHMIDT C, 1995, NATURE, V373, P699, DOI 10.1038/373699a0; SHANKAR G, 1993, J CELL SCI, V105, P61; SHIOTA G, 1992, P NATL ACAD SCI USA, V89, P373, DOI 10.1073/pnas.89.1.373; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; STEHNOBITTEL L, 1995, NEURON, V14, P163, DOI 10.1016/0896-6273(95)90250-3; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; WAHL MI, 1989, MOL CELL BIOL, V9, P2934, DOI 10.1128/MCB.9.7.2934; Wells A, 2002, NAT REV MOL CELL BIO, V3, P697, DOI 10.1038/nrm905; Xiao B, 2000, CURR OPIN NEUROBIOL, V10, P370, DOI 10.1016/S0959-4388(00)00087-8	49	116	125	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4344	4351		10.1074/jbc.M706550200	http://dx.doi.org/10.1074/jbc.M706550200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073207	hybrid, Green Accepted			2022-12-25	WOS:000253083500069
J	Heras, B; Kurz, M; Jarrott, R; Shouldice, SR; Frei, P; Robin, G; Cemazar, M; Thony-Meyer, L; Glockshuber, R; Martin, JL				Heras, Begona; Kurz, Mareike; Jarrott, Russell; Shouldice, Stephen R.; Frei, Patrick; Robin, Gautier; Cemazar, Masa; Thoeny-Meyer, Linda; Glockshuber, Rudi; Martin, Jennifer L.			Staphylococcus aureus DsbA does not have a destabilizing disulfide - A new paradigm for bacterial oxidative folding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-POSITIVE BACTERIA; BOND FORMATION INVIVO; III SECRETION SYSTEM; FORMATION IN-VIVO; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; ACTIVE-SITE; ANOMALOUS DIFFRACTION; VIRULENCE FACTORS; CRYSTAL-STRUCTURE	In Gram-negative bacteria, the introduction of disulfide bonds into folding proteins occurs in the periplasm and is catalyzed by donation of an energetically unstable disulfide from DsbA, which is subsequently re-oxidized through interaction with DsbB. Gram-positive bacteria lack a classic periplasm but nonetheless encode Dsb-like proteins. Staphylococcus aureus encodes just one Dsb protein, a DsbA, and no DsbB. Here we report the crystal structure of S. aureus DsbA (SaDsbA), which incorporates a thioredoxin fold with an inserted helical domain, like its Escherichia coli counterpart EcDsbA, but it lacks the characteristic hydrophobic patch and has a truncated binding groove near the active site. These findings suggest that SaDsbA has a different substrate specificity than EcDsbA. Thermodynamic studies indicate that the oxidized and reduced forms of SaDsbA are energetically equivalent, in contrast to the energetically unstable disulfide form of EcDsbA. Further, the partial complementation of EcDsbA by SaDsbA is independent of EcDsbB and biochemical assays show that SaDsbA does not interact with EcDsbB. The identical stabilities of oxidized and reduced SaDsbA may facilitate direct re-oxidation of the protein by extracellular oxidants, without the need for DsbB.	[Heras, Begona; Kurz, Mareike; Jarrott, Russell; Shouldice, Stephen R.; Robin, Gautier; Cemazar, Masa; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Frei, Patrick; Glockshuber, Rudi] ETH, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Thoeny-Meyer, Linda] EMPA, Lab Biomat, CH-9014 St Gallen, Switzerland	University of Queensland; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Heras, B (corresponding author), Univ Queensland, Inst Mol Biosci, Queensland Biosci Precinct,Bldg 80 Carmody Rd, Brisbane, Qld 4072, Australia.	bheras@imb.uq.edu.au	Heras, Begona/H-8686-2014; Martin, Jennifer L./A-6039-2010	Heras, Begona/0000-0003-3469-7988; Martin, Jennifer L./0000-0002-9225-8863; Jarrott, Russell/0000-0003-4326-1203				Bader MW, 2000, J BIOL CHEM, V275, P26082, DOI 10.1074/jbc.M003850200; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Charbonnier JB, 1999, PROTEIN SCI, V8, P96; Delano W.L., 2002, DELANO SCI; Dorenbos R, 2002, J BIOL CHEM, V277, P16682, DOI 10.1074/jbc.M201158200; Dumoulin A, 2005, ARCH MICROBIOL, V184, P117, DOI 10.1007/s00203-005-0024-1; Dziewanowska K, 1996, ARCH BIOCHEM BIOPHYS, V335, P102, DOI 10.1006/abbi.1996.0486; Ellermeier CD, 2004, J BACTERIOL, V186, P68, DOI 10.1128/JB.186.1.68-79.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erlendsson LS, 2002, J BACTERIOL, V184, P1423, DOI 10.1128/JB.184.5.1423-1429.2002; Goulding CW, 2004, J BIOL CHEM, V279, P3516, DOI 10.1074/jbc.M311833200; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Guddat LW, 1997, PROTEIN SCI, V6, P1893, DOI 10.1002/pro.5560060910; Guddat LW, 1997, PROTEIN SCI, V6, P1148, DOI 10.1002/pro.5560060603; Ha UH, 2003, INFECT IMMUN, V71, P1590, DOI 10.1128/IAI.71.3.1590-1595.2003; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Heras B, 2007, ACTA CRYSTALLOGR F, V63, P953, DOI 10.1107/S174430910704821X; Heras B, 2003, STRUCTURE, V11, P139, DOI 10.1016/S0969-2126(03)00005-4; HILLSON DA, 1984, METHOD ENZYMOL, V107, P281; Hiniker A, 2007, P NATL ACAD SCI USA, V104, P11670, DOI 10.1073/pnas.0704692104; HOLMGREN A, 1979, J BIOL CHEM, V254, P3664; HOVDE CJ, 1994, MOL MICROBIOL, V13, P897, DOI 10.1111/j.1365-2958.1994.tb00481.x; Huber-Wunderlich M, 1998, FOLD DES, V3, P161, DOI 10.1016/S1359-0278(98)00024-8; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; ISHIHARA T, 1995, J BACTERIOL, V177, P745, DOI 10.1128/jb.177.3.745-749.1995; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kadokura H, 2003, ANNU REV BIOCHEM, V72, P111, DOI 10.1146/annurev.biochem.72.121801.161459; Kouwen TRHM, 2007, MOL MICROBIOL, V64, P984, DOI 10.1111/j.1365-2958.2007.05707.x; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krupka HI, 2002, PROTEIN SCI, V11, P642, DOI 10.1110/ps.39702; Lewin A, 2006, J BIOL CHEM, V281, P35467, DOI 10.1074/jbc.M607047200; MARTIN JL, 1993, NATURE, V365, P464, DOI 10.1038/365464a0; Masip L, 2004, SCIENCE, V303, P1185, DOI 10.1126/science.1092612; Matias VRF, 2006, J BACTERIOL, V188, P1011, DOI 10.1128/JB.188.3.1011-1021.2006; Meima R, 2002, J BIOL CHEM, V277, P6994, DOI 10.1074/jbc.M111380200; Messens J, 2006, INT J BIOCHEM CELL B, V38, P1050, DOI 10.1016/j.biocel.2005.12.011; Miki T, 2004, J BIOL CHEM, V279, P34631, DOI 10.1074/jbc.M402760200; Mossner E, 1999, J BIOL CHEM, V274, P25254, DOI 10.1074/jbc.274.36.25254; Nakamoto H, 2004, BBA-MOL CELL RES, V1694, P111, DOI 10.1016/j.bbamcr.2004.02.012; NELSON JW, 1994, BIOCHEMISTRY-US, V33, P5974, DOI 10.1021/bi00185a039; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; OKAMOTO K, 1995, J BACTERIOL, V177, P4579, DOI 10.1128/jb.177.16.4579-4586.1995; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pace C N, 1986, Methods Enzymol, V131, P266; PEEK JA, 1992, P NATL ACAD SCI USA, V89, P6210, DOI 10.1073/pnas.89.13.6210; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pooley HM, 1996, MICROB DRUG RESIST, V2, P9, DOI 10.1089/mdr.1996.2.9; Qin J, 1996, STRUCTURE, V4, P613, DOI 10.1016/S0969-2126(96)00065-2; SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014; Sarvas M, 2004, BBA-MOL CELL RES, V1694, P311, DOI 10.1016/j.bbamcr.2004.04.009; Stein T, 2005, MOL MICROBIOL, V56, P845, DOI 10.1111/j.1365-2958.2005.04587.x; Stenson TH, 2002, INFECT IMMUN, V70, P2297, DOI 10.1128/IAI.70.5.2297-2303.2002; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; WUNDERLICH M, 1993, PROTEIN SCI, V2, P717, DOI 10.1002/pro.5560020503; Yu J, 1999, MICROBES INFECT, V1, P1221, DOI 10.1016/S1286-4579(99)00239-7; ZAPUN A, 1993, BIOCHEMISTRY-US, V32, P5083, DOI 10.1021/bi00070a016	60	56	58	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4261	4271		10.1074/jbc.M707838200	http://dx.doi.org/10.1074/jbc.M707838200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077463	Green Published, hybrid			2022-12-25	WOS:000253083500061
J	Hampl, V; Silberman, JD; Stechmann, A; Diaz-Trivino, S; Johnson, PJ; Roger, AJ				Hampl, Vladimir; Silberman, Jeffrey D.; Stechmann, Alexandra; Diaz-Trivino, Sara; Johnson, Patricia J.; Roger, Andrew J.			Genetic Evidence for a Mitochondriate Ancestry in the 'Amitochondriate' Flagellate Trimastix pyriformis	PLOS ONE			English	Article							PARASITE ENTAMOEBA-HISTOLYTICA; TRICHOMONAS-VAGINALIS; PROCESSING PEPTIDASE; HYDROGENOSOMES CONTAIN; CRYPTOSPORIDIUM-PARVUM; PRIMITIVE EUKARYOTES; PROTEIN IMPORT; CARRIER FAMILY; FE-HYDROGENASE; SECONDARY LOSS	Most modern eukaryotes diverged from a common ancestor that contained the alpha-proteobacterial endosymbiont that gave rise to mitochondria. The 'amitochondriate' anaerobic protist parasites that have been studied to date, such as Giardia and Trichomonas harbor mitochondrion-related organelles, such as mitosomes or hydrogenosomes. Yet there is one remaining group of mitochondrion-lacking flagellates known as the Preaxostyla that could represent a primitive 'pre-mitochondrial' lineage of eukaryotes. To test this hypothesis, we conducted an expressed sequence tag (EST) survey on the preaxostylid flagellate Trimastix pyriformis, a poorly-studied free-living anaerobe. Among the ESTs we detected 19 proteins that, in other eukaryotes, typically function in mitochondria, hydrogenosomes or mitosomes, 12 of which are found exclusively within these organelles. Interestingly, one of the proteins, aconitase, functions in the tricarboxylic acid cycle typical of aerobic mitochondria, whereas others, such as pyruvate: ferredoxin oxidoreductase and [FeFe] hydrogenase, are characteristic of anaerobic hydrogenosomes. Since Trimastix retains genetic evidence of a mitochondriate ancestry, we can now say definitively that all known living eukaryote lineages descend from a common ancestor that had mitochondria.	[Hampl, Vladimir; Silberman, Jeffrey D.; Stechmann, Alexandra; Diaz-Trivino, Sara; Roger, Andrew J.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada; [Silberman, Jeffrey D.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR USA; [Johnson, Patricia J.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA	Dalhousie University; University of Arkansas System; University of Arkansas Fayetteville; University of California System; University of California Los Angeles	Roger, AJ (corresponding author), Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS, Canada.	Andrew.Roger@Dal.Ca	Silberman, Jeffrey D/AAK-8220-2020; Hampl, Vladimir/A-4339-2008	Silberman, Jeffrey D/0000-0002-2965-9197; Hampl, Vladimir/0000-0002-5430-7564	Canadian Institutes for Health Research (CIHR) [MOP-62809, postdoctoral fellowship]; Canadian Institute for Advanced Research (CIFAR) [fellowship, Steacie Memorial Fellowship]; Natural Sciences and Engineering Research Council of Canada [Steacie Memorial Fellowship]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Institute for Advanced Research (CIFAR)(Canadian Institute for Advanced Research (CIFAR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Trimastix pyriformis EST data were generated as part of AJRs involvement in the Genome Atlantic/Genome Canada sponsored Protist EST Program Project. This work and partial salary support for VH, JDS and SDT came from an operating grant MOP-62809 from the Canadian Institutes for Health Research (CIHR) awarded to AJR. VH was also supported by a fellowship from the Canadian Institute for Advanced Research (CIFAR). AS was supported by a postdoctoral fellowship from the Canadian Institutes of Health Research (CIHR). AJR is supported by the E.W.R. Steacie Memorial Fellowship from the Natural Sciences and Engineering Research Council of Canada and the CIFAR Program in Integrated Microbial Diversity.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andreoli C, 2004, NUCLEIC ACIDS RES, V32, pD459, DOI 10.1093/nar/gkh137; Bedhomme M, 2005, J BIOL CHEM, V280, P34823, DOI 10.1074/jbc.M506045200; BLOODGOO.RA, 1974, J MORPHOL, V143, P77, DOI 10.1002/jmor.1051430104; Bozner P, 1997, J PARASITOL, V83, P224, DOI 10.2307/3284444; Braun HP, 1997, INT J BIOCHEM CELL B, V29, P1043, DOI 10.1016/S1357-2725(97)00032-0; Brown MT, 2007, MOL MICROBIOL, V64, P1154, DOI 10.1111/j.1365-2958.2007.05719.x; Brugerolle G, 1997, EUR J PROTISTOL, V33, P121, DOI 10.1016/S0932-4739(97)80029-6; Bui ETN, 1996, P NATL ACAD SCI USA, V93, P9651, DOI 10.1073/pnas.93.18.9651; CAROTHERS DJ, 1989, ARCH BIOCHEM BIOPHYS, V268, P409, DOI 10.1016/0003-9861(89)90309-3; CARPENTER KJ, 2007, PROTIST IN PRESS, DOI DOI 10.1016/J.PROTIS.2007.09.002; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; CAVALIERSMITH T, 1983, ENDOCYTOBIOLOGY, V2, P265; Chan KW, 2005, CURR BIOL, V15, P737, DOI 10.1016/j.cub.2005.02.068; CLARK CG, 1995, P NATL ACAD SCI USA, V92, P6518, DOI 10.1073/pnas.92.14.6518; Dacks JB, 2001, MOL BIOL EVOL, V18, P1034, DOI 10.1093/oxfordjournals.molbev.a003875; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Dolezal P, 2005, P NATL ACAD SCI USA, V102, P10924, DOI 10.1073/pnas.0500349102; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Dyall SD, 2000, MOL CELL BIOL, V20, P2488, DOI 10.1128/MCB.20.7.2488-2497.2000; Dyall SD, 2004, NATURE, V431, P1103, DOI 10.1038/nature02990; Embley TM, 2006, PHILOS T R SOC B, V361, P1055, DOI 10.1098/rstb.2006.1844; Germot A, 1996, P NATL ACAD SCI USA, V93, P14614, DOI 10.1073/pnas.93.25.14614; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hampl V, 2005, MOL BIOL EVOL, V22, P2508, DOI 10.1093/molbev/msi245; Hirt RP, 1997, CURR BIOL, V7, P995, DOI 10.1016/S0960-9822(06)00420-9; Horner DS, 1996, P ROY SOC B-BIOL SCI, V263, P1053, DOI 10.1098/rspb.1996.0155; Horner DS, 2001, MOL BIOL EVOL, V18, P1970, DOI 10.1093/oxfordjournals.molbev.a003737; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Jordan SW, 1997, J BIOL CHEM, V272, P17903, DOI 10.1074/jbc.272.29.17903; Karlin S, 1999, P NATL ACAD SCI USA, V96, P9190, DOI 10.1073/pnas.96.16.9190; KRUGER N, 1994, J BACTERIOL, V176, P3614; Kulda J., 1978, P1; Kunji ERS, 2006, BBA-BIOENERGETICS, V1757, P1237, DOI 10.1016/j.bbabio.2006.03.021; LaGier MJ, 2003, MICROBIOL-SGM, V149, P3519, DOI 10.1099/mic.0.26365-0; Leander BS, 2004, J EUKARYOT MICROBIOL, V51, P291, DOI 10.1111/j.1550-7408.2004.tb00569.x; Luciano P, 1997, J MOL BIOL, V272, P213, DOI 10.1006/jmbi.1997.1231; Macasev D, 2004, MOL BIOL EVOL, V21, P1557, DOI 10.1093/molbev/msh166; Margulis L, 2000, P NATL ACAD SCI USA, V97, P6954, DOI 10.1073/pnas.97.13.6954; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; Moreira D, 1998, J MOL EVOL, V47, P517, DOI 10.1007/PL00006408; Mukherjee M, 2006, EUKARYOT CELL, V5, P2062, DOI 10.1128/EC.00205-06; MULLER M, 1993, J GEN MICROBIOL, V139, P2879, DOI 10.1099/00221287-139-12-2879; Nagao Y, 2000, J BIOL CHEM, V275, P34552, DOI 10.1074/jbc.M003110200; O'Kelly CJ, 1999, PROTIST, V150, P149, DOI 10.1016/S1434-4610(99)70018-0; OLAUSSON T, 1995, BBA-BIOENERGETICS, V1231, P1, DOI 10.1016/0005-2728(95)00058-Q; Palmieri L, 2001, EMBO J, V20, P5049, DOI 10.1093/emboj/20.18.5049; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Putz S, 2006, EUKARYOT CELL, V5, P579, DOI 10.1128/EC.5.3.579-586.2006; REEVES RE, 1977, J BIOL CHEM, V252, P726; Regoes A, 2005, J BIOL CHEM, V280, P30557, DOI 10.1074/jbc.M500787200; Riordan CE, 2003, CURR GENET, V44, P138, DOI 10.1007/s00294-003-0432-1; Roger AJ, 1998, P NATL ACAD SCI USA, V95, P229, DOI 10.1073/pnas.95.1.229; Roger AJ, 1996, P NATL ACAD SCI USA, V93, P14618, DOI 10.1073/pnas.93.25.14618; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Satre M, 2007, BIOCHIMIE, V89, P1058, DOI 10.1016/j.biochi.2007.03.004; Simpson AGB, 2002, J EUKARYOT MICROBIOL, V49, P239, DOI 10.1111/j.1550-7408.2002.tb00529.x; Simpson AGB, 2000, EUR J PROTISTOL, V36, P229, DOI 10.1016/S0932-4739(00)80001-2; Simpson AGB, 2003, INT J SYST EVOL MICR, V53, P1759, DOI 10.1099/ijs.0.02578-0; Simpson AGB, 2006, MOL BIOL EVOL, V23, P615, DOI 10.1093/molbev/msj068; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Tachezy J, 2001, MOL BIOL EVOL, V18, P1919, DOI 10.1093/oxfordjournals.molbev.a003732; Taylor SW, 2003, NAT BIOTECHNOL, V21, P281, DOI 10.1038/nbt793; Tovar J, 1999, MOL MICROBIOL, V32, P1013, DOI 10.1046/j.1365-2958.1999.01414.x; Tovar J, 2003, NATURE, V426, P172, DOI 10.1038/nature01945; Townson SM, 1996, MOL BIOCHEM PARASIT, V79, P183, DOI 10.1016/0166-6851(96)02661-8; van der Giezen M, 2003, MOL BIOL EVOL, V20, P1051, DOI 10.1093/molbev/msg103; van der Giezen M, 2002, EMBO J, V21, P572, DOI 10.1093/emboj/21.4.572; Vignais PM, 2001, FEMS MICROBIOL REV, V25, P455, DOI 10.1111/j.1574-6976.2001.tb00587.x; Williams BAP, 2002, NATURE, V418, P865, DOI 10.1038/nature00949	72	46	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1383	10.1371/journal.pone.0001383	http://dx.doi.org/10.1371/journal.pone.0001383			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167542	gold, Green Published, Green Submitted			2022-12-25	WOS:000260468900011
J	Apidianakis, Y; Mindrinos, MN; Xiao, WZ; Tegos, GP; Papisov, MI; Hamblin, MR; Davis, RW; Tompkins, RG; Rahme, LG				Apidianakis, Yiorgos; Mindrinos, Michael N.; Xiao, Wenzhong; Tegos, George P.; Papisov, Michail I.; Hamblin, Michael R.; Davis, Ronald W.; Tompkins, Ronald G.; Rahme, Laurence G.			Involvement of Skeletal Muscle Gene Regulatory Network in Susceptibility to Wound Infection Following Trauma	PLOS ONE			English	Article								Despite recent advances in our understanding the pathophysiology of trauma, the basis of the predisposition of trauma patients to infection remains unclear. A Drosophila melanogaster/Pseudomonas aeruginosa injury and infection model was used to identify host genetic components that contribute to the hyper-susceptibility to infection that follows severe trauma. We show that P. aeruginosa compromises skeletal muscle gene (SMG) expression at the injury site to promote infection. We demonstrate that activation of SMG structural components is under the control of cJun-N-terminal Kinase (JNK) Kinase, Hemipterous (Hep), and activation of this pathway promotes local resistance to P. aeruginosa in flies and mice. Our study links SMG expression and function to increased susceptibility to infection, and suggests that P. aeruginosa affects SMG homeostasis locally by restricting SMG expression in injured skeletal muscle tissue. Local potentiation of these host responses, and/or inhibition of their suppression by virulent P. aeruginosa cells, could lead to novel therapies that prevent or treat deleterious and potentially fatal infections in severely injured individuals.	[Apidianakis, Yiorgos; Tompkins, Ronald G.; Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Tegos, George P.; Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Apidianakis, Yiorgos; Tompkins, Ronald G.; Rahme, Laurence G.] Shriners Burn Inst, Boston, MA 02114 USA; [Mindrinos, Michael N.; Xiao, Wenzhong; Davis, Ronald W.] Stanford Univ, Dept Biochem, Sch Med, Stanford, CA 94305 USA; [Tegos, George P.; Hamblin, Michael R.] Harvard Univ, Sch Med, Dept Dermatol, Boston, MA 02115 USA; [Papisov, Michail I.] Massachusetts Gen Hosp, Dept Radiol, Div Nucl Med, Lab Mol Bioengn, Boston, MA 02114 USA; [Rahme, Laurence G.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Stanford University; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Rahme, LG (corresponding author), Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA.	rahme@amber.mgh.harvard.edu	Hamblin, Mike/AAB-2511-2022; Apidianakis, Yiorgos/ABF-7464-2020; Tegos, George/C-8830-2011; Hamblin, Michael R/H-2758-2019	Apidianakis, Yiorgos/0000-0002-7465-3560; Hamblin, Michael R/0000-0001-6431-4605; Papisov, Mikhail/0000-0003-4716-2122; xiao, wenzhong/0000-0003-4944-6380	Shriners Research [8892]; Shriners Post-doctoral Fellowship; NIH [AI050875];  [DK43351];  [DK57521]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK057521, P30DK043351] Funding Source: NIH RePORTER	Shriners Research; Shriners Post-doctoral Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by the Shriners Research grant #8892 to LGR. YA was supported by a Shriners Post-doctoral Fellowship, MRH by NIH Grant AI050875 and electron microscopy core by grants DK43351 and DK57521.	Apidianakis Y, 2005, P NATL ACAD SCI USA, V102, P2573, DOI 10.1073/pnas.0409588102; Baldini RL, 2002, METHOD ENZYMOL, V358, P3; Baue AE, 1998, SHOCK, V10, P79, DOI 10.1097/00024382-199808000-00001; BEALL C, 1992, BIOCHEM GENET, V30, P515, DOI 10.1007/BF01037590; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Chang LF, 2003, DEV CELL, V4, P521, DOI 10.1016/S1534-5807(03)00094-7; Clayton JD, 1998, J MUSCLE RES CELL M, V19, P117, DOI 10.1023/A:1005304527563; COX DR, 1972, J R STAT SOC B, V187, P220; D'Argenio DA, 2001, J BACTERIOL, V183, P1466, DOI 10.1128/JB.183.4.1466-1471.2001; Delaney JR, 2006, EMBO J, V25, P3068, DOI 10.1038/sj.emboj.7601182; FERNANDES J, 1991, DEVELOPMENT, V113, P67; FRANCIOSA H, 1995, INSECT BIOCHEM MOLEC, V25, P311, DOI 10.1016/0965-1748(94)00053-K; Galko MJ, 2004, PLOS BIOL, V2, P1114, DOI 10.1371/journal.pbio.0020239; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; HALDANE JBS, 1956, EXPERIENTIA, V12, P205, DOI 10.1007/BF02170512; Hamblin MR, 2003, J INFECT DIS, V187, P1717, DOI 10.1086/375244; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Harden N, 2005, SCIENCE, V308, P364, DOI 10.1126/science.1112050; Herranz R, 2004, GENE EXPR PATTERNS, V4, P183, DOI 10.1016/j.modgep.2003.09.008; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Jais PH, 2005, GENET MED, V7, P83, DOI 10.1097/01.GIM.0000153665.55420.C3; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kaplan EL, 1958, J AM STAT ASSOC, V53, P562; Lau GW, 2003, INFECT IMMUN, V71, P4059, DOI 10.1128/IAI.71.7.4059-4066.2003; Lyczak JB, 2000, MICROBES INFECT, V2, P1051, DOI 10.1016/S1286-4579(00)01259-4; Padfield KE, 2005, P NATL ACAD SCI USA, V102, P5368, DOI 10.1073/pnas.0501211102; Papa S, 2004, J CELL SCI, V117, P5197, DOI 10.1242/jcs.01483; Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Rahme LG, 2000, P NATL ACAD SCI USA, V97, P8815, DOI 10.1073/pnas.97.16.8815; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Singh SP, 2001, EUR J BIOCHEM, V268, P2912, DOI 10.1046/j.1432-1327.2001.02179.x; Stronach BE, 1999, ONCOGENE, V18, P6172, DOI 10.1038/sj.onc.1203125; Tsuda M, 2005, EMBO REP, V6, P1082, DOI 10.1038/sj.embor.7400537; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Wolfgang MC, 2003, P NATL ACAD SCI USA, V100, P8484, DOI 10.1073/pnas.0832438100; Zhang JY, 2004, GENE DEV, V18, P17, DOI 10.1101/gad.1160904	41	28	30	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1356	10.1371/journal.pone.0001356	http://dx.doi.org/10.1371/journal.pone.0001356			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159239	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459700013
J	Quignon, P; Herbin, L; Cadieu, E; Kirkness, EF; Hedan, B; Mosher, DS; Galibert, F; Andre, C; Ostrander, EA; Hitte, C				Quignon, Pascale; Herbin, Laetitia; Cadieu, Edouard; Kirkness, Ewen F.; Hedan, Benoit; Mosher, Dana S.; Galibert, Francis; Andre, Catherine; Ostrander, Elaine A.; Hitte, Christophe			Canine Population Structure: Assessment and Impact of Intra-Breed Stratification on SNP-Based Association Studies	PLOS ONE			English	Article								Background. In canine genetics, the impact of population structure on whole genome association studies is typically addressed by sampling approximately equal numbers of cases and controls from dogs of a single breed, usually from the same country or geographic area. However one way to increase the power of genetic studies is to sample individuals of the same breed but from different geographic areas, with the expectation that independent meiotic events will have shortened the presumed ancestral haplotype around the mutation differently. Little is known, however, about genetic variation among dogs of the same breed collected from different geographic regions. Methodology/Principal Findings. In this report, we address the magnitude and impact of genetic diversity among common breeds sampled in the U.S. and Europe. The breeds selected, including the Rottweiler, Bernese mountain dog, flat-coated retriever, and golden retriever, share susceptibility to a class of soft tissue cancers typified by malignant histiocytosis in the Bernese mountain dog. We genotyped 722 SNPs at four unlinked loci (between 95 and 271 per locus) on canine chromosome 1 (CFA1). We showed that each population is characterized by distinct genetic diversity that can be correlated with breed history. When the breed studied has a reduced intra-breed diversity, the combination of dogs from international locations does not increase the rate of false positives and potentially increases the power of association studies. However, over-sampling cases from one geographic location is more likely to lead to false positive results in breeds with significant genetic diversity. Conclusions. These data provide new guidelines for association studies using purebred dogs that take into account population structure.	[Quignon, Pascale; Cadieu, Edouard; Mosher, Dana S.; Ostrander, Elaine A.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Herbin, Laetitia; Hedan, Benoit; Galibert, Francis; Andre, Catherine; Hitte, Christophe] Univ Rennes 1, CNRS, UMR Genet & Dev 6061, IFR140, CS-34317 Rennes, France; [Kirkness, Ewen F.] J Craig Venter Inst, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Centre National de la Recherche Scientifique (CNRS); Universite de Rennes; J. Craig Venter Institute	Ostrander, EA (corresponding author), NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA.	eostrand@mail.nih.gov; hitte@univ-rennes1.fr	Fiumefreddo, Andrea/T-2977-2019	Hitte, Christophe/0000-0003-1714-437X; Ostrander, Elaine/0000-0001-6075-9738	American Kennel Club Canine Health Foundation; French Centre National de la Recherche Scientifique (CNRS); National Human Genome Research Institute; National Institutes of Health; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200325, Z01HG200325] Funding Source: NIH RePORTER	American Kennel Club Canine Health Foundation; French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank the American Kennel Club Canine Health Foundation, the French Centre National de la Recherche Scientifique (CNRS) and the intramural program of the National Human Genome Research Institute of the National Institutes of Health for supporting this work.	Acland GM, 1998, P NATL ACAD SCI USA, V95, P3048, DOI 10.1073/pnas.95.6.3048; Acland GM, 1999, GENOMICS, V59, P134, DOI 10.1006/geno.1999.5842; Affolter VK, 2002, VET PATHOL, V39, P74, DOI 10.1354/vp.39-1-74; AMERICAN KC, 1998, COMPLETE DOG BOOK KR; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Chase K, 2006, INT J IMMUNOGENET, V33, P179, DOI 10.1111/j.1744-313X.2006.00593.x; Chase K, 2002, P NATL ACAD SCI USA, V99, P9930, DOI 10.1073/pnas.152333099; GALIBERT F, 2007, COMP BIOC D IN PRESS; Galibert F, 2006, M S-MED SCI, V22, P806, DOI 10.1051/medsci/20062210806; GOLDSTEIN O, 2006, GENOMICS, V18, P18; Guldbrandtsen B, 2000, J HERED, V91, P178, DOI 10.1093/jhered/91.2.178; HEDAN B, 2006, BMC VET RES, V27, P9; Hitte C, 2005, NAT REV GENET, V6, P643, DOI 10.1038/nrg1658; Kent WJ, 2002, GENOME RES, V12, P656, DOI 10.1101/gr.229202; Kirkness EF, 2003, SCIENCE, V301, P1898, DOI 10.1126/science.1086432; Leegwater PA, 2007, J HERED, V98, P549, DOI 10.1093/jhered/esm022; Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Lowe JK, 2003, GENOMICS, V82, P86, DOI 10.1016/S0888-7543(03)00078-8; MOORE PF, 1986, VET PATHOL, V23, P1; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Ostrander EA, 2005, GENOME RES, V15, P1706, DOI 10.1101/gr.3736605; Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Parker HG, 2005, PLOS GENET, V1, P507, DOI 10.1371/journal.pgen.0010058; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, AM J HUM GENET, V67, P170, DOI 10.1086/302959; Pritchard JK, 2000, GENETICS, V155, P945; Ramsey IK, 1996, VET REC, V138, P440, DOI 10.1136/vr.138.18.440; ROSIN A, 1986, J AM VET MED ASSOC, V188, P1041; Sambrook J., 2002, MOL CLONING LAB MANU; Scheet P, 2006, AM J HUM GENET, V78, P629, DOI 10.1086/502802; SCHMIDT ML, 1993, VET QUART, V15, P117, DOI 10.1080/01652176.1993.9694387; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Sutter NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604; WAYNE RK, 2007, LESSONS LEARNED DOG; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142	38	54	56	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1324	10.1371/journal.pone.0001324	http://dx.doi.org/10.1371/journal.pone.0001324			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091995	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459600012
J	Tsantoulis, PK; Kotsinas, A; Sfikakis, PP; Evangelou, K; Sideridou, M; Levy, B; Mo, L; Kittas, C; Wu, XR; Papavassiliou, AG; Gorgoulis, VG				Tsantoulis, P. K.; Kotsinas, A.; Sfikakis, P. P.; Evangelou, K.; Sideridou, M.; Levy, B.; Mo, L.; Kittas, C.; Wu, X-R; Papavassiliou, A. G.; Gorgoulis, V. G.			Oncogene-induced replication stress preferentially targets common fragile sites in preneoplastic lesions. A genome-wide study	ONCOGENE			English	Article						fragile sites; DNA damage; cancer; nucleic acid repetitive sequences; preneoplastic lesions; replication stress	DNA-DAMAGE RESPONSE; INDUCED SENESCENCE; CANCER; TUMORIGENESIS; FLEXIBILITY; BREAKPOINTS; INSTABILITY; ACTIVATION; CHECKPOINT; BREAKAGE	Common fragile sites (CFSs) are regions of the genome prone to breakage by replication inhibitors ( extrinsic replication stress). Recently, we and others observed that oncogene-induced replication stress (RS) induces DNA damage from the earliest stages of cancer. Our aim was to perform a genome-wide analysis in precancerous and cancerous experimental models to examine whether allelic imbalance occurs within CFSs. Subsequently, CFSs sequence characteristics were assessed. We used a growth-factor-induced human skin hyperplasia and a H-ras-induced mouse hyperplastic urothelium as preneoplastic models, along with an inducible U2OS-CDT1(Tet-ON) cancer cell line model, all bearing established oncogene-induced RS stimuli. Human DNA was analysed with Affymetrix SNP microarrays, while mouse DNA was analysed with Nimblegen array CGH. We studied 56 aphidicolin-type CFSs and 1914 regions of control, nonfragile DNA. Our theoretical in silico analysis spanned 2.16 billion nonoverlapping bases on human chromosomes 1-22. Our results provide direct experimental evidence indicating that genomic alterations were more common within CFSs in epidermal and urothelial preneoplastic lesions as well as in cancer. CFSs were on average less flexible than nonfragile regions, contained more guanine-cytosine (GC) and Alu sequences. Importantly, regions with loss-of-heterozygosity were also less flexible and had a higher Alu percentage.	[Tsantoulis, P. K.; Kotsinas, A.; Evangelou, K.; Sideridou, M.; Kittas, C.; Gorgoulis, V. G.] Univ Athens, Sch Med, Dept Histol & Embryol, Mol Carcinogenesis Grp, GR-11527 Athens, Greece; [Sfikakis, P. P.] Univ Athens, Sch Med, Dept Propedeut & Internal Med 1, GR-11527 Athens, Greece; [Levy, B.] Columbia Univ, Coll Phys & Surg, Clin Cytogenet Lab, New York, NY USA; [Mo, L.; Wu, X-R] NYU, Sch Med, Dept Urol, New York, NY 10003 USA; [Papavassiliou, A. G.] Univ Athens, Sch Med, Dept Biochem, GR-11527 Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; National & Kapodistrian University of Athens; Columbia University; New York University; Athens Medical School; National & Kapodistrian University of Athens	Gorgoulis, VG (corresponding author), Antaiou 53 St, GR-11146 Athens, Greece.	papavas@med.uoa.gr; histoclub@ath.forthnet.gr	Evangelou, Konstantinos/AAG-5092-2020; Sfikakis, Petros/AAD-7289-2019; Gorgoulis, Vassilis/AAD-3630-2019; Tsantoulis, Petros/AAM-1653-2020; Karamouzis, Michalis/AAD-2860-2020; Tsantoulis, Petros/AAO-5211-2021	Evangelou, Konstantinos/0000-0002-2462-5748; Gorgoulis, Vassilis/0000-0001-9001-4112; Tsantoulis, Petros/0000-0003-3613-6682; Wu, Xue-Ru/0000-0001-6058-6291				Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Arlt MF, 2006, DNA REPAIR, V5, P1126, DOI 10.1016/j.dnarep.2006.05.010; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Berking C, 2004, CANCER RES, V64, P807, DOI 10.1158/0008-5472.CAN-03-3438; Ciullo M, 2002, HUM MOL GENET, V11, P2887, DOI 10.1093/hmg/11.23.2887; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Glover TW, 2006, CANCER LETT, V232, P4, DOI 10.1016/j.canlet.2005.08.032; GLOVER TW, 1988, AM J HUM GENET, V43, P265; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Helmrich A, 2007, INT J CANCER, V120, P48, DOI 10.1002/ijc.22049; Helmrich A, 2006, GENOME RES, V16, P1222, DOI 10.1101/gr.5335506; HIRSCH B, 1991, HUM GENET, V87, P302; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Mimori K, 1999, P NATL ACAD SCI USA, V96, P7456, DOI 10.1073/pnas.96.13.7456; Mishmar D, 1999, AM J HUM GENET, V64, P908, DOI 10.1086/302299; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Mo L, 2007, J CLIN INVEST, V117, P314, DOI 10.1172/JCI30062; Morelli C, 2002, ONCOGENE, V21, P7266, DOI 10.1038/sj.onc.1205573; Murnane JP, 2006, DNA REPAIR, V5, P1082, DOI 10.1016/j.dnarep.2006.05.030; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Olson WK, 1998, P NATL ACAD SCI USA, V95, P11163, DOI 10.1073/pnas.95.19.11163; Packer MJ, 2000, J MOL BIOL, V295, P71, DOI 10.1006/jmbi.1999.3236; SARAI A, 1989, BIOCHEMISTRY-US, V28, P7842, DOI 10.1021/bi00445a046; Smith DI, 2007, SEMIN CANCER BIOL, V17, P31, DOI 10.1016/j.semcancer.2006.10.003; Toledo F, 2000, NUCLEIC ACIDS RES, V28, P4805, DOI 10.1093/nar/28.23.4805; Vaziri C, 2003, MOL CELL, V11, P997, DOI 10.1016/S1097-2765(03)00099-6; Wistuba II, 2000, CANCER RES, V60, P1949; Wu XR, 2005, NAT REV CANCER, V5, P713, DOI 10.1038/nrc1697; Zanesi N, 2001, P NATL ACAD SCI USA, V98, P10250, DOI 10.1073/pnas.191345898; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	35	127	129	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	23					3256	3264		10.1038/sj.onc.1210989	http://dx.doi.org/10.1038/sj.onc.1210989			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	304LQ	18084328				2022-12-25	WOS:000256111400004
J	Ikushiro, H; Fujii, S; Shiraiwa, Y; Hayashi, H				Ikushiro, Hiroko; Fujii, Shigeru; Shiraiwa, Yuka; Hayashi, Hideyuki			Acceleration of the substrate C alpha deprotonation by an analogue of the second substrate palmitoyl-CoA in serine palmitoyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOLIPID SYNTHESIS; 8-AMINO-7-OXONONANOATE SYNTHASE; 5-AMINOLEVULINATE SYNTHASE; SACCHAROMYCES-CEREVISIAE; REACTION-MECHANISM; KEY ENZYME; BIOSYNTHESIS; CLONING; LCB1; COMPONENT	Serine palmitoyltransferase (SPT) is a key enzyme of sphingolipid biosynthesis and catalyzes the pyridoxal 5'-phosphate (PLP)-dependent decarboxylative condensation reaction of L-serine with palmitoyl-CoA to generate 3-ketodihydrosphingosine. The binding of L-serine alone to SPT leads to the formation of the external aldimine but does not produce a detectable amount of the quinonoid intermediate. However, the further addition of S-(2-oxoheptadecyl)-CoA, a nonreactive analogue of palmitoyl-CoA, caused the apparent accumulation of the quinonoid. NMR studies showed that the hydrogen-deuterium exchange at C alpha of L-serine is very slow in the SPT-L-serine external aldimine complex, but the rate is 100-fold increased by the addition of S-(2-oxoheptadecyl)CoA, showing a remarkable substrate synergism in SPT. In addition, the observation that the nonreactive palmitoyl-CoA facilitated alpha-deprotonation indicates that the alpha-deprotonation takes place before the Claisen-type C -C bond formation, which is consistent with the accepted mechanism of the alpha-oxamine synthase subfamily enzymes. Structural modeling of both the SPT-L-serine external aldimine complex and SPT-L-serine -palmitoyl-CoA ternary complex suggests a mechanism in which the binding of palmitoyl-CoA to SPT induced a conformation change in the PLP-L-serine external aldimine so that the C alpha-H bond of L-serine becomes perpendicular to the plane of the PLP-pyridine ring and is favorable for the alpha-deprotonation. The model also proposed that the two alternative hydrogen bonding interactions of His(159) with L-serine and palmitoyl-CoA play an important role in the conformational change of the external aldimine. This is the unique mechanism of SPT that prevents the formation of the reactive intermediate before the binding of the second substrate.	[Ikushiro, Hiroko; Shiraiwa, Yuka; Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Osaka 5698686, Japan; [Fujii, Shigeru] Kansai Med Univ, Chem Lab, Osaka 5731136, Japan	Osaka Medical College; Kansai Medical University	Ikushiro, H (corresponding author), Osaka Med Coll, Dept Biochem, 2-7 Daigakumachi, Osaka 5698686, Japan.	ikushiro@art.osaka-med.ac.jp; hayashi@art.osaka-med.ac.jp						Alexeev D, 2006, ORG BIOMOL CHEM, V4, P1209, DOI 10.1039/b517922j; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Bashir Q, 2006, CHEM COMMUN, P5065, DOI 10.1039/b609925d; BRAUN PE, 1968, J BIOL CHEM, V243, P3775; BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; Ikushiro H, 2003, BBA-PROTEINS PROTEOM, V1647, P116, DOI 10.1016/S1570-9639(03)00074-8; Ikushiro H, 2000, BIOCHEMISTRY AND MOLECULAR BIOLOGY OF VITAMIN B6 AND PQQ-DEPENDENT PROTEINS, P251; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; Ikushiro H, 2007, J BACTERIOL, V189, P5749, DOI 10.1128/JB.00194-07; KARLSSON KA, 1970, CHEM PHYS LIPIDS, V5, P6, DOI 10.1016/0009-3084(70)90008-3; KRISNANGKURA K, 1976, J BIOL CHEM, V251, P1597; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Nagiec MM, 1996, GENE, V177, P237, DOI 10.1016/0378-1119(96)00309-5; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; ONUFFER JJ, 1994, PROTEIN ENG, V7, P413, DOI 10.1093/protein/7.3.413; PINTO WJ, 1992, J BACTERIOL, V174, P2565, DOI 10.1128/jb.174.8.2565-2574.1992; Ploux O, 1996, EUR J BIOCHEM, V236, P301, DOI 10.1111/j.1432-1033.1996.00301.x; RUDNICK DA, 1991, J BIOL CHEM, V266, P9732; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Weiss B, 1997, EUR J BIOCHEM, V249, P239, DOI 10.1111/j.1432-1033.1997.00239.x; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200	34	28	28	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7542	7553		10.1074/jbc.M706874200	http://dx.doi.org/10.1074/jbc.M706874200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18167344	hybrid			2022-12-25	WOS:000253997900029
J	Roepstorff, K; Rasmussen, I; Sawada, M; Cudre-Maroux, C; Salmon, P; Bokoch, G; van Deurs, B; Vilhardt, F				Roepstorff, Kirstine; Rasmussen, Izabela; Sawada, Makoto; Cudre-Maroux, Cristophe; Salmon, Patrick; Bokoch, Gary; van Deurs, Bo; Vilhardt, Frederik			Stimulus-dependent regulation of the phagocyte NADPH oxidase by a VAV1, Rac1, and PAK1 signaling axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; RESPIRATORY BURST OXIDASE; PHOSPHORYLATION-INDUCED ACTIVATION; RECEPTOR-MEDIATED PHAGOCYTOSIS; NUCLEOTIDE EXCHANGE FACTOR; HUMAN NEUTROPHILS; P21-ACTIVATED-KINASE-1 PAK1; ARACHIDONIC-ACID; EPITHELIAL-CELLS; PLASMA-MEMBRANE	The p21-activated kinase-1 (PAK1) is best known for its role in the regulation of cytoskeletal and transcriptional signaling pathways. We show here in the microglia cell line Ra2 that PAK1 regulates NADPH oxidase (NOX-2) activity in a stimulus-specific manner. Thus, conditional expression of PAK1 dominant-positive mutants enhanced, whereas dominant-negative mutants inhibited, NADPH oxidase-mediated superoxide generation following formyl-methionyl-leucylphenylalanine or phorbol 12-myristate 13-acetate stimulation. Both Rac1 and the GTP exchange factor VAV1 were required as upstream signaling proteins in the formyl-methionylleucyl- phenylalanine-induced activation of endogenous PAK1. In contrast, PAK1 mutants had no effect on superoxide generation downstream of Fc gamma R signaling during phagocytosis of IgG-immune complexes. We further present evidence that the effect of PAK1 on the respiratory burst is mediated through phosphorylation of p47(Phox), and we show that expression of a p47(Phox) (S303D/ S304D/ S320D) mutant, which mimics phosphorylation by PAK1, induced basal superoxide generation in vivo. In contrast PAK1 substrates LIMK-1 or RhoGDI are not likely to contribute to the PAK1 effect on NADPH oxidase activation. Collectively, our findings define a VAV1-Rac1-PAK1 signaling axis in mononuclear phagocytes regulating superoxide production in a stimulusdependent manner.	[Roepstorff, Kirstine; Rasmussen, Izabela; van Deurs, Bo; Vilhardt, Frederik] Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Fac Hlth Sci, DK-2200 Copenhagen N, Denmark; [Cudre-Maroux, Cristophe; Salmon, Patrick] Univ Geneva, Dept Microbiol, CH-1211 Geneva, Switzerland; [Bokoch, Gary] Scripps Res Inst, Dept Immunol & Cell Biol, La Jolla, CA 92037 USA; [Sawada, Makoto] Nagoya Univ, Environm Med Res Inst, Dept Brain Funct, Nagoya, Aichi 4648601, Japan	University of Copenhagen; University of Geneva; Scripps Research Institute; Nagoya University	Vilhardt, F (corresponding author), Univ Copenhagen, Panum Inst, Dept Cellular & Mol Med, Fac Hlth Sci, Bldg 18-4,Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	f.vilhardt@mai.ku.dk	Vilhardt, Frederik/AAX-4766-2021	Vilhardt, Frederik/0000-0001-8604-7165	NHLBI NIH HHS [HL48008] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL048008] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adak S, 2001, J BIOL CHEM, V276, P1244, DOI 10.1074/jbc.M006857200; Ago T, 1999, J BIOL CHEM, V274, P33644, DOI 10.1074/jbc.274.47.33644; Ago T, 2003, P NATL ACAD SCI USA, V100, P4474, DOI 10.1073/pnas.0735712100; Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730; Bokoch GM, 2005, TRENDS CELL BIOL, V15, P163, DOI 10.1016/j.tcb.2005.01.002; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Chen QD, 2003, J IMMUNOL, V170, P5302, DOI 10.4049/jimmunol.170.10.5302; CLARK RA, 1990, J CLIN INVEST, V85, P714, DOI 10.1172/JCI114496; Dang PMC, 2006, J CLIN INVEST, V116, P2033, DOI 10.1172/JCI27544; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Dharmawardhane S, 1999, J LEUKOCYTE BIOL, V66, P521, DOI 10.1002/jlb.66.3.521; Dharmawardhane S, 2000, MOL BIOL CELL, V11, P3341, DOI 10.1091/mbc.11.10.3341; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; DORSEUIL O, 1995, J LEUKOCYTE BIOL, V58, P108, DOI 10.1002/jlb.58.1.108; ElBenna J, 1996, J BIOL CHEM, V271, P6374; FAUST LP, 1995, J CLIN INVEST, V96, P1499, DOI 10.1172/JCI118187; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; GABIG TG, 1995, BLOOD, V85, P804, DOI 10.1182/blood.V85.3.804.bloodjournal853804; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Groemping Y, 2003, CELL, V113, P343, DOI 10.1016/S0092-8674(03)00314-3; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Heyworth PG, 1997, HISTOCHEM CELL BIOL, V108, P221, DOI 10.1007/s004180050162; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Inoue H, 1999, GLIA, V28, P265, DOI 10.1002/(SICI)1098-1136(199912)28:3<265::AID-GLIA10>3.0.CO;2-F; Kawahara T, 2005, J BIOL CHEM, V280, P31859, DOI 10.1074/jbc.M501882200; Kim C, 2006, J LEUKOCYTE BIOL, V79, P223, DOI 10.1189/jlb.0705371; Kim C, 2003, J IMMUNOL, V171, P4425, DOI 10.4049/jimmunol.171.8.4425; KNAUS UG, 1995, SCIENCE, V269, P221, DOI 10.1126/science.7618083; Korchak HM, 1998, J BIOL CHEM, V273, P27292, DOI 10.1074/jbc.273.42.27292; Lin MI, 2003, J BIOL CHEM, V278, P44719, DOI 10.1074/jbc.M302836200; MALY FE, 1994, J BIOL CHEM, V269, P18743; Martyn KD, 2005, BLOOD, V106, P3962, DOI 10.1182/blood-2005-03-0859; Matsui S, 2002, J BIOL CHEM, V277, P544, DOI 10.1074/jbc.M110153200; Morgan D, 2007, J PHYSIOL-LONDON, V579, P327, DOI 10.1113/jphysiol.2006.124248; MUKHERJEE G, 1994, J LEUKOCYTE BIOL, V55, P685, DOI 10.1002/jlb.55.6.685; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; QUINN MT, 1993, J BIOL CHEM, V268, P20983; Sawada M., 2007, U.S. Patent, Patent No. [6.673,6,5, 667365]; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shiose A, 2000, J BIOL CHEM, V275, P13793, DOI 10.1074/jbc.275.18.13793; Sumimoto H, 1996, J BIOL CHEM, V271, P22152, DOI 10.1074/jbc.271.36.22152; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Vilhardt F, 2004, EMBO J, V23, P739, DOI 10.1038/sj.emboj.7600066; Vilhardt F, 1999, MOL BIOL CELL, V10, P179, DOI 10.1091/mbc.10.1.179; Vutskits GV, 2006, BREAST CANCER RES TR, V99, P143, DOI 10.1007/s10549-006-9195-y; Waki K, 2006, FREE RADICAL RES, V40, P359, DOI 10.1080/10715760500539121; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3; Wu RF, 2004, J VIROL, V78, P779, DOI 10.1128/JVI.78.2.779-789.2004; Zenke FT, 1999, J BIOL CHEM, V274, P32565, DOI 10.1074/jbc.274.46.32565; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhang JM, 2005, MOL BIOL CELL, V16, P824, DOI 10.1091/mbc.e04-06-0463	56	48	50	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7983	7993		10.1074/jbc.M708281200	http://dx.doi.org/10.1074/jbc.M708281200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18160398	hybrid			2022-12-25	WOS:000253997900073
J	Fitzgerald, JB; Jin, M; Chai, DH; Siparsky, P; Fanning, P; Grodzinsky, AJ				Fitzgerald, Jonathan B.; Jin, Moonsoo; Chai, Diana H.; Siparsky, Patrick; Fanning, Paul; Grodzinsky, Alan J.			Shear- and compression-induced chondrocyte transcription requires MAPK activation in cartilage explants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ARTICULAR CHONDROCYTES; FACTOR-KAPPA-B; GENE-EXPRESSION; PROTEIN-KINASE; MECHANICAL STIMULATION; GROWTH-FACTOR; BIOSYNTHETIC RESPONSE; SIGNALING PATHWAYS; TERMINAL KINASE; P38	Chondrocytes regulate the composition of cartilage extracellular matrix in response to mechanical signals, but the intracellular pathways involved in mechanotransduction are still being defined. Mitogen-activated protein kinase ( MAPK) pathways are activated by static and dynamic compression of cartilage, which simultaneously induce intratissue fluid flow, pressure gradients, cell, and matrix deformation. First, to determine whether cell and matrix deformation alone could induce MAPK activation, we applied dynamic shear to bovine cartilage explants. Using Western blotting, we measured ERK1/2 and p38 activation at multiple time points over 24 h. Distinct activation time courses were observed for different MAPKs: a sustained 50% increase for ERK1/2 and a delayed increase in p38 of 180%. We then investigated the role of MAPK activation in mechano-induced chondrocyte gene expression. Cartilage explants were preincubated with inhibitors of ERK1/2 and p38 activation before application of 1-24 h of three distinct mechanical stimuli relevant to in vivo loading ( 50% static compression, 3% dynamic compression at 0.1 Hz, or 3% dynamic shear at 0.1 Hz). mRNA levels of selected genes involved in matrix homeostasis were measured using real-time PCR and analyzed by k-means clustering to characterize the time- and load-dependent effects of the inhibitors. Most genes examined required ERK1/2 and p38 activation to be regulated by these loading regimens, including matrix proteins aggrecan and type II collagen, matrix metalloproteinases MMP13, and ADAMTS5, and transcription factors downstream of the MAPK pathway, c-Fos, and c-Jun. Thus, we demonstrated that the MAPK pathway is a central conduit for transducing mechanical forces into biological responses in cartilage.	[Jin, Moonsoo; Grodzinsky, Alan J.] MIT, Ctr Biomed Engn, Cambridge, MA 02139 USA; [Fitzgerald, Jonathan B.; Chai, Diana H.; Siparsky, Patrick; Grodzinsky, Alan J.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Grodzinsky, Alan J.] MIT, Dept Elect Engn & Comp Sci, Cambridge, MA 02139 USA; [Fanning, Paul] Univ Massachusetts, Sch Med, Dept Orthoped, Boston, MA 02215 USA; [Fanning, Paul] Univ Massachusetts, Sch Med, Dept Cell Biol, Boston, MA 02215 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University of Massachusetts System; University of Massachusetts Boston; University of Massachusetts System; University of Massachusetts Boston	Grodzinsky, AJ (corresponding author), MIT, Ctr Biomed Engn, NE 47-377,77 Massachusetts Ave, Cambridge, MA 02139 USA.	alg@mit.edu	Jin, Moonsoo/D-6128-2011		NIAMS NIH HHS [AR33236] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR033236, R01AR033236] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101; AUTDERHEIDE AC, 2006, ANN BIOMED ENG, V34, P1463; Badger AM, 1998, J IMMUNOL, V161, P467; Borden P, 1996, J BIOL CHEM, V271, P33706, DOI 10.1074/jbc.271.52.33706; De Croos JNA, 2006, MATRIX BIOL, V25, P323, DOI 10.1016/j.matbio.2006.03.005; Durrant LA, 1999, J ANAT, V194, P343, DOI 10.1046/j.1469-7580.1999.19430343.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan ZY, 2004, CYTOKINE, V28, P17, DOI 10.1016/j.cyto.2004.06.003; Fanning PJ, 2003, J BIOL CHEM, V278, P50940, DOI 10.1074/jbc.M305107200; Fitzgerald JB, 2004, J BIOL CHEM, V279, P19502, DOI 10.1074/jbc.M400437200; Fitzgerald JB, 2006, J BIOL CHEM, V281, P24095, DOI 10.1074/jbc.M510858200; Geng Y, 1996, J CLIN INVEST, V98, P2425, DOI 10.1172/JCI119056; GRAY ML, 1989, BIOCHIM BIOPHYS ACTA, V991, P415, DOI 10.1016/0304-4165(89)90067-6; Grodzinsky AJ, 2000, ANNU REV BIOMED ENG, V2, P691, DOI 10.1146/annurev.bioeng.2.1.691; Guilak F, 1994, Osteoarthritis Cartilage, V2, P91, DOI 10.1016/S1063-4584(05)80059-7; Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097; Hui A, 1998, ARTHRITIS RHEUM, V41, P869, DOI 10.1002/1529-0131(199805)41:5<869::AID-ART15>3.0.CO;2-3; Hung CT, 2000, J BIOMECH, V33, P73, DOI 10.1016/S0021-9290(99)00176-1; Jin M, 2001, ARCH BIOCHEM BIOPHYS, V395, P41, DOI 10.1006/abbi.2001.2543; Kim YJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P331, DOI 10.1006/abbi.1996.0181; KIM YJ, 1994, ARCH BIOCHEM BIOPHYS, V311, P1, DOI 10.1006/abbi.1994.1201; Klooster AR, 2005, ARTHRITIS RES THER, V7, pR127, DOI 10.1186/ar1464; Lee JH, 2005, ARTHRITIS RHEUM-US, V52, P2386, DOI 10.1002/art.21215; Li KW, 2003, ARTHRITIS RHEUM-US, V48, P689, DOI 10.1002/art.10849; Liacini A, 2003, EXP CELL RES, V288, P208, DOI 10.1016/S0014-4827(03)00180-0; Liacini A, 2002, MATRIX BIOL, V21, P251, DOI 10.1016/S0945-053X(02)00007-0; Mengshol JA, 2000, ARTHRITIS RHEUM, V43, P801, DOI 10.1002/1529-0131(200004)43:4<801::AID-ANR10>3.0.CO;2-4; Millward-Sadler SJ, 2000, ARTHRITIS RHEUM, V43, P2091, DOI 10.1002/1529-0131(200009)43:9<2091::AID-ANR21>3.0.CO;2-C; Millward-Sadler SJ, 2000, OSTEOARTHR CARTILAGE, V8, P272, DOI 10.1053/joca.1999.0301; Mobasheri A, 2002, CELL BIOL INT, V26, P1, DOI 10.1006/cbir.2001.0826; Murakami S, 2000, P NATL ACAD SCI USA, V97, P1113, DOI 10.1073/pnas.97.3.1113; Ragan PM, 1999, J ORTHOPAED RES, V17, P836, DOI 10.1002/jor.1100170608; Ridley SH, 1997, J IMMUNOL, V158, P3165; SAH RLY, 1989, J ORTHOPAED RES, V7, P619, DOI 10.1002/jor.1100070502; Salter DM, 2002, BIORHEOLOGY, V39, P97; Scherle PA, 1997, BIOCHEM BIOPH RES CO, V230, P573, DOI 10.1006/bbrc.1996.5985; Starkman BG, 2005, BIOCHEM J, V389, P723, DOI 10.1042/BJ20041636; Steinmeyer J, 1997, OSTEOARTHR CARTILAGE, V5, P331, DOI 10.1016/S1063-4584(97)80037-4; Studer RK, 2005, J ORTHOP RES, V23, P454, DOI 10.1016/j.orthres.2004.08.012; Studer RK, 2004, ARTHRITIS RES THER, V6, pR56, DOI 10.1186/ar1022; Szafranski JD, 2004, OSTEOARTHR CARTILAGE, V12, P937, DOI 10.1016/j.joca.2004.08.004; Tan LJ, 2003, J BIOL CHEM, V278, P17688, DOI 10.1074/jbc.M301676200; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; Valhmu WB, 1998, ARCH BIOCHEM BIOPHYS, V353, P29, DOI 10.1006/abbi.1998.0633; Vincent T, 2006, BIOCHEM SOC T, V34, P456, DOI 10.1042/BST0340456; VINCENTI MP, 1994, NUCLEIC ACIDS RES, V22, P4818, DOI 10.1093/nar/22.22.4818; Vincenti MP, 2002, ARTHRITIS RES, V4, P157, DOI 10.1186/ar401; vonKempis J, 1997, OSTEOARTHR CARTILAGE, V5, P394, DOI 10.1016/S1063-4584(97)80044-1; Watanabe H, 2001, J BIOL CHEM, V276, P14466, DOI 10.1074/jbc.M005724200; Wong M, 1999, MATRIX BIOL, V18, P391, DOI 10.1016/S0945-053X(99)00029-3; Yang SH, 2003, GENE, V320, P3, DOI 10.1016/S0378-1119(03)00816-3; Young PR, 1997, J BIOL CHEM, V272, P12116, DOI 10.1074/jbc.272.18.12116	52	74	75	2	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6735	6743		10.1074/jbc.M708670200	http://dx.doi.org/10.1074/jbc.M708670200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18086670	hybrid			2022-12-25	WOS:000253779600015
J	Hirano, S; Asamizu, S; Onaka, H; Shiro, Y; Nagano, S				Hirano, Satoshi; Asamizu, Shumpei; Onaka, Hiroyasu; Shiro, Yoshitsugu; Nagano, Shingo			Crystal structure of VioE, a key player in the construction of the molecular skeleton of violacein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOSYNTHETIC-PATHWAY; CHROMOPYRROLIC ACID; STAUROSPORINE; TRYPTOPHAN; SOFTWARE; MODEL; MAD	Violacein and the indolocarbazoles are naturally occurring bisindole products with various biological activities, including antitumor activity. Although these compounds have markedly different molecular skeletons, their biosynthetic pathways share the same intermediate "compound X," which is produced from L-tryptophan via indole-3-pyruvic acid imine. Compound X is a short-lived intermediate that is spontaneously converted to chromopyrrolic acid for indolocarbazole biosynthesis, whereas VioE transforms compound X into protodeoxyviolaceinic acid, which is further modified by other enzymes to produce violacein. Thus, VioE plays a key role in the construction of the molecular skeleton of violacein. Here, we present the crystal structure of VioE, which consists of two subunits, each of which forms a structure resembling a baseball glove. Each subunit has a positively charged pocket at the center of the concave surface of the structure. Mutagenesis analysis of the surface pocket and other surface residues showed that the surface pocket serves as an active site. We have also solved the crystal structure of a complex of VioE and phenylpyruvic acid as an analogue of a VioE-substrate complex. A docking simulation with VioE and the IPA imine dimer, which is proposed to be compound X, agreed with the results from the mutational analysis and the VioE-phenylpyruvic acid complex structure. Based on these results, we propose that VioE traps the highly reactive substrate within the surface pocket to suppress CPA formation and promote protodeoxyviolaceinic acid formation caused by proximity and orientation effects.	[Asamizu, Shumpei; Onaka, Hiroyasu] Toyama Prefectural Univ, Dept Biotechnol, Fac Engn, Toyama 9390398, Japan; [Hirano, Satoshi; Shiro, Yoshitsugu; Nagano, Shingo] RIKEN, SPring Ctr 8, Biomet Sci Lab, Mikazuki, Hyogo 6795148, Japan; [Onaka, Hiroyasu] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan	Toyama Prefectural University; RIKEN; Toyama Prefectural University	Onaka, H (corresponding author), Toyama Prefectural Univ, Dept Biotechnol, Fac Engn, Toyama 9390398, Japan.	onaka@putoyama.ac.jp	Shiro, Yoshitsugu Y/J-3757-2014; Asamizu, Shumpei/GOJ-8839-2022	Shiro, Yoshitsugu Y/0000-0003-0695-8327; Asamizu, Shumpei/0000-0002-7178-5410; Onaka, Hiroyasu/0000-0003-4536-1881				Asamizu S, 2006, TETRAHEDRON LETT, V47, P473, DOI 10.1016/j.tetlet.2005.11.061; Asamizu S, 2007, TETRAHEDRON LETT, V48, P2923, DOI 10.1016/j.tetlet.2007.02.062; August PR, 2000, J MOL MICROB BIOTECH, V2, P513; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Duran N, 2001, CRIT REV MICROBIOL, V27, P201, DOI 10.1080/20014091096747; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; HENDRICKSON WA, 1990, EMBO J, V9, P1665, DOI 10.1002/j.1460-2075.1990.tb08287.x; HOSHINO T, 1993, BIOSCI BIOTECH BIOCH, V57, P775, DOI 10.1271/bbb.57.775; Kim DY, 2007, P NATL ACAD SCI USA, V104, P8779, DOI 10.1073/pnas.0703117104; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LEMASTER DM, 1985, BIOCHEMISTRY-US, V24, P7263, DOI 10.1021/bi00346a036; Makino M, 2007, P NATL ACAD SCI USA, V104, P11591, DOI 10.1073/pnas.0702946104; Matz C, 2004, APPL ENVIRON MICROB, V70, P1593, DOI 10.1128/AEM.70.3.1593-1599.2004; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; OMURA S, 1995, J ANTIBIOT, V48, P535, DOI 10.7164/antibiotics.48.535; Onaka H, 2002, J ANTIBIOT, V55, P1063, DOI 10.7164/antibiotics.55.1063; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sanchez C, 2006, CHEMBIOCHEM, V7, P1231, DOI 10.1002/cbic.200600029; Shinoda K, 2007, CHEM COMMUN, P4140, DOI 10.1039/b705358d; Sulzenbacher G, 2006, EMBO J, V25, P1436, DOI 10.1038/sj.emboj.7601048; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Yao M, 2006, ACTA CRYSTALLOGR D, V62, P189, DOI 10.1107/S0907444905038965	27	32	32	1	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6459	6466		10.1074/jbc.M708109200	http://dx.doi.org/10.1074/jbc.M708109200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171677	hybrid			2022-12-25	WOS:000253779500053
J	Sun, S; Yu, JP; Chen, F; Zhao, TJ; Fang, XH; Li, YQ; Sui, SF				Sun, Shan; Yu, Jun-Ping; Chen, Feng; Zhao, Tong-Jin; Fang, Xiao-Hong; Li, Yi-Qin; Sui, Sen-Fang			TINY, a dehydration-responsive element (DRE)-binding protein-like transcription factor connecting the DRE- and ethylene-responsive element-mediated signaling pathways in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; GENE-EXPRESSION; LOW-TEMPERATURE; GCC-BOX; FREEZING TOLERANCE; OSMOTIC-STRESS; ERF/AP2 DOMAIN; HIGH-SALT; IN-VITRO; DROUGHT	Dehydration-responsive element-binding proteins (DREBs) and ethylene-responsive element (ERE) binding factors are two major subfamilies of the AP2/ethylene-responsive element-binding protein family and play crucial roles in the regulation of abiotic-and biotic-stress responses, respectively. In the present work, we have reported a previously identified DREB-like factor, TINY, that was involved in both abiotic- and biotic-stress signaling pathways. TINY was capable of binding to both DRE and ERE with similar affinity and could activate the expression of reporter genes driven by either of these two elements in tobacco cells. The 15th amino acid in the APETALA2 (AP2)/ethylene-responsive element-binding factor domain was demonstrated to be essential for its specific binding to ERE, whereas the 14th and 19th amino acids were responsible for the binding to DRE. The expression of TINY was greatly activated by drought, cold, ethylene, and slightly by methyl jasmonate. Additionally, overexpression of TINY in Arabidopsis resulted in elevated expressions of both the DRE- and the ERE-containing genes. Moreover, the expression of DRE- regulated genes, such as COR6.6 and ERD10, was up-regulated upon ethylene treatment, and the expression of ERE-regulated genes, such as HLS1, was also increased by cold stress, when the expression of TINY was being induced. These results strongly suggested that TINY might play a role in the cross-talk between abiotic- and biotic-stress-responsive gene expressions by connecting the DRE- and ERE-mediated signaling pathways. The results herein might promote the understanding of the mechanisms of specific DNA recognition and gene expression regulation by DREBs.	[Sun, Shan; Chen, Feng; Zhao, Tong-Jin; Li, Yi-Qin; Sui, Sen-Fang] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Sun, Shan; Chen, Feng; Zhao, Tong-Jin; Sui, Sen-Fang] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China; [Yu, Jun-Ping; Fang, Xiao-Hong] Chinese Acad Sci, Inst Chem, Beijing 100080, Peoples R China	Tsinghua University; Tsinghua University; Chinese Academy of Sciences; Institute of Chemistry, CAS	Sui, SF (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	suisf@mail.tsinghua.edu.cn	Zhao, Tong-Jin/AFH-2915-2022; Yu, Junping/O-9887-2018	Yu, Junping/0000-0001-9024-0793				ABELES FB, 1992, ETHYLENE PLANT BIOL, P196; Allen MD, 1998, EMBO J, V17, P5484, DOI 10.1093/emboj/17.18.5484; An YQ, 1996, PLANT J, V10, P107, DOI 10.1046/j.1365-313X.1996.10010107.x; Baumgartner W, 2000, ULTRAMICROSCOPY, V82, P85, DOI 10.1016/S0304-3991(99)00154-0; Broekaert WF, 2006, ANNU REV PHYTOPATHOL, V44, P393, DOI 10.1146/annurev.phyto.44.070505.143440; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Cao ZF, 2001, BIOCHEMISTRY-MOSCOW+, V66, P623, DOI 10.1023/A:1010251129429; Dong XN, 1998, CURR OPIN PLANT BIOL, V1, P316, DOI 10.1016/1369-5266(88)80053-0; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; GALLIE DR, 1987, NUCLEIC ACIDS RES, V15, P8693, DOI 10.1093/nar/15.21.8693; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Hao DY, 2002, BIOCHEMISTRY-US, V41, P4202, DOI 10.1021/bi015979v; Huang ZJ, 2004, FEBS LETT, V573, P110, DOI 10.1016/j.febslet.2004.07.064; Jaglo-Ottosen KR, 1998, SCIENCE, V280, P104, DOI 10.1126/science.280.5360.104; Kasuga M, 1999, NAT BIOTECHNOL, V17, P287, DOI 10.1038/7036; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Lee JH, 2004, PLANT MOL BIOL, V55, P61, DOI 10.1007/s11103-004-0417-6; Lehman A, 1996, CELL, V85, P183, DOI 10.1016/S0092-8674(00)81095-8; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu Y, 2006, FEBS LETT, V580, P1303, DOI 10.1016/j.febslet.2006.01.048; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Manners JM, 1998, PLANT MOL BIOL, V38, P1071, DOI 10.1023/A:1006070413843; Medina J, 1999, PLANT PHYSIOL, V119, P463, DOI 10.1104/pp.119.2.463; Mitsuhara I, 1996, PLANT CELL PHYSIOL, V37, P49, DOI 10.1093/oxfordjournals.pcp.a028913; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Onate-Sanchez L, 2002, PLANT PHYSIOL, V128, P1313, DOI 10.1104/pp.010862; Park JM, 2001, PLANT CELL, V13, P1035, DOI 10.1105/tpc.13.5.1035; Qin F, 2004, PLANT CELL PHYSIOL, V45, P1042, DOI 10.1093/pcp/pch118; Riechmann JL, 1998, BIOL CHEM, V379, P633; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Sasaki K, 2007, PLANT J, V50, P1079, DOI 10.1111/j.1365-313X.2007.03111.x; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Souter MA, 2004, PLANTA, V219, P773, DOI 10.1007/s00425-004-1280-z; Stockinger EJ, 1997, P NATL ACAD SCI USA, V94, P1035, DOI 10.1073/pnas.94.3.1035; Wang H, 2004, PLANT MOL BIOL, V55, P183, DOI 10.1007/s11103-004-0113-6; Wei G, 2005, J BIOCHEM MOL BIOL, V38, P440; Wilson K, 1996, PLANT CELL, V8, P659, DOI 10.1105/tpc.8.4.659; YAMAGUCHISHINOZAKI K, 1994, PLANT CELL, V6, P251, DOI 10.1105/tpc.6.2.251; Yi SY, 2004, PLANT PHYSIOL, V136, P2862, DOI 10.1104/pp.104.042903; Yu JP, 2006, POLYMER, V47, P2533, DOI 10.1016/j.polymer.2005.12.087; Zhao TJ, 2006, J BIOL CHEM, V281, P10752, DOI 10.1074/jbc.M510535200; ZHIFANG C, 2001, TSINGHUA SCI TECHNOL, V6, P432	47	112	125	3	36	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6261	6271		10.1074/jbc.M706800200	http://dx.doi.org/10.1074/jbc.M706800200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18089556	hybrid			2022-12-25	WOS:000253779500033
J	Allagnat, F; Alonso, F; Martin, D; Abderrahmani, A; Waeber, G; Haefliger, JA				Allagnat, Florent; Alonso, Florian; Martin, David; Abderrahmani, Amar; Waeber, Gerard; Haefliger, Jacques-Antoine			ICER-1 gamma overexpression drives palmitate-mediated connexin36 down-regulation in insulin-secreting cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELL; LONG-TERM EXPOSURE; FREE FATTY-ACIDS; CARBOXYLASE GENE-EXPRESSION; BASAL INSULIN; GLUCOSE-CONCENTRATIONS; CA2+ OSCILLATIONS; RAT ISLETS; RELEASE; STIMULATION	Channels formed by the gap junction protein connexin36 (Cx36) contribute to the proper control of insulin secretion. We investigated the impact of chronic hyperlipidemia on Cx36 expression in pancreatic beta-cells. Prolonged exposure to the saturated free fatty acid palmitate reduced the expression of Cx36 in several insulin-secreting cell lines and isolated mouse islets. The effect of palmitate was fully blocked upon protein kinase A (PKA) inhibition by H89 and (Rp)-cAMP, indicating that the cAMP/PKA pathway is involved in the control of Cx36 expression. Palmitate treatment led to overexpression of the inducible cAMP early repressor (ICER-1 gamma), which bound to a functional cAMP-response element located in the promoter of the CX36 gene. Inhibition of ICER-1 gamma overexpression prevented the Cx36 decrease, as well as the palmitate-induced beta-cell secretory dysfunction. Finally, freshly isolated islets from mice undergoing a long term high fat diet expressed reduced Cx36 levels and increased ICER-1 gamma levels. Taken together, these data demonstrate that chronic exposure to palmitate inhibits the Cx36 expression through PKA-mediated ICER-1 gamma overexpression. This Cx36 down-regulation may contribute to the reduced glucose sensitivity and altered insulin secretion observed during the pre-diabetic stage and in the metabolic syndrome.	[Allagnat, Florent; Alonso, Florian; Martin, David; Waeber, Gerard; Haefliger, Jacques-Antoine] CHU Vaudois, Univ Hosp, Dept Med, CH-1011 Lausanne, Switzerland; [Abderrahmani, Amar] Univ Lausanne, Dept Cellular Biol & Morphol, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	Haefliger, JA (corresponding author), CHU Vaudois, Univ Hosp, Dept Med, Mol Med Lab, 19-135S, CH-1011 Lausanne, Switzerland.	Jacques-Antoine.Haefliger@chuv.ch	Abderrahmani, Amar/O-3124-2017; Allagnat, Florent/X-3772-2019; Allagnat, Florent/A-4471-2017; Allagnat, Florent/AAY-7188-2021; Alonso, Florian/AAA-2776-2020	Abderrahmani, Amar/0000-0003-0752-0343; Allagnat, Florent/0000-0001-6528-679X; Allagnat, Florent/0000-0001-6528-679X; Alonso, Florian/0000-0002-6794-1513; Haefliger, Jacques-Antoine/0000-0003-2732-1667; Waeber, Gerard/0000-0003-4193-788X				Abderrahmani A, 2006, EMBO J, V25, P977, DOI 10.1038/sj.emboj.7601008; Allagnat F, 2005, J CELL SCI, V118, P5335, DOI 10.1242/jcs.02600; Andreolas C, 2002, DIABETES, V51, P2536, DOI 10.2337/diabetes.51.8.2536; ASFARI M, 1992, ENDOCRINOLOGY, V130, P167, DOI 10.1210/en.130.1.167; AssimacopoulosJeannet F, 1997, J BIOL CHEM, V272, P1659, DOI 10.1074/jbc.272.3.1659; Beeharry N, 2003, MUTAT RES-FUND MOL M, V530, P27, DOI 10.1016/S0027-5107(03)00134-9; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; Boden Guenther, 2005, Curr Diab Rep, V5, P167, DOI 10.1007/s11892-005-0004-5; Bollheimer LC, 1998, J CLIN INVEST, V101, P1094, DOI 10.1172/JCI420; Briaud I, 1999, METABOLISM, V48, P319, DOI 10.1016/S0026-0495(99)90079-3; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Brun T, 1997, DIABETES, V46, P393, DOI 10.2337/diabetes.46.3.393; Burcelin R, 1999, METABOLISM, V48, P252, DOI 10.1016/S0026-0495(99)90043-4; Calabrese A, 2003, DIABETES, V52, P417, DOI 10.2337/diabetes.52.2.417; Caton D, 2003, J CELL SCI, V116, P2285, DOI 10.1242/jcs.00442; Cook S, 2004, DIABETES, V53, P2067, DOI 10.2337/diabetes.53.8.2067; Diakogiannaki E, 2007, J ENDOCRINOL, V194, P283, DOI 10.1677/JOE-07-0082; Diraison F, 2004, BIOCHEM J, V378, P769, DOI 10.1042/BJ20031277; Dobbins RL, 1998, J CLIN INVEST, V101, P2370, DOI 10.1172/JCI1813; Gumbiner B, 1996, J CLIN ENDOCR METAB, V81, P2061, DOI 10.1210/jc.81.6.2061; Haber EP, 2006, INT REV CYTOL, V248, P1, DOI 10.1016/S0074-7696(06)48001-3; Haber EP, 2003, J CELL PHYSIOL, V194, P1, DOI 10.1002/jcp.10187; Inada A, 1998, BIOCHEM BIOPH RES CO, V253, P712, DOI 10.1006/bbrc.1998.9833; LANG DA, 1982, DIABETES, V31, P22, DOI 10.2337/diabetes.31.1.22; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; LANG DA, 1981, DIABETES, V30, P435, DOI 10.2337/diabetes.30.5.435; Le Gurun S, 2003, J BIOL CHEM, V278, P37690, DOI 10.1074/jbc.M212382200; Lilla V, 2003, ENDOCRINOLOGY, V144, P1368, DOI 10.1210/en.2002-220916; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; Martin D, 2003, J BIOL CHEM, V278, P53082, DOI 10.1074/jbc.M306861200; McGarry JD, 1999, DIABETOLOGIA, V42, P128, DOI 10.1007/s001250051130; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Michon L, 2005, BBA-BIOMEMBRANES, V1719, P82, DOI 10.1016/j.bbamem.2005.11.003; MOLINA CA, 1993, CELL, V75, P875, DOI 10.1016/0092-8674(93)90532-U; Moreno AP, 2005, AM J PHYSIOL-ENDOC M, V288, pE948, DOI 10.1152/ajpendo.00216.2004; Okajima F, 2005, BBA-MOL CELL BIOL L, V1687, P173, DOI 10.1016/j.bbalip.2004.11.018; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; Parker SM, 2003, METABOLISM, V52, P1367, DOI 10.1016/S0026-0495(03)00279-8; Poitout V, 2006, J NUTR, V136, P873, DOI 10.1093/jn/136.4.873; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Ravier MA, 2002, DIABETOLOGIA, V45, P1154, DOI 10.1007/s00125-002-0883-9; Raz I, 2005, DIABETES-METAB RES, V21, P3, DOI 10.1002/dmrr.493; Robertson RP, 2004, DIABETES, V53, pS119, DOI 10.2337/diabetes.53.2007.S119; Roehrich ME, 2003, J BIOL CHEM, V278, P18368, DOI 10.1074/jbc.M300102200; Serre-Beinier V, 2000, DIABETES, V49, P727, DOI 10.2337/diabetes.49.5.727; Speier S, 2007, DIABETES, V56, P1078, DOI 10.2337/db06-0232; Thams P, 2001, DIABETOLOGIA, V44, P738, DOI 10.1007/s001250051683; Theis M, 2004, EXP CELL RES, V294, P18, DOI 10.1016/j.yexcr.2003.09.031; Wang HY, 2003, J BIOL CHEM, V278, P16622, DOI 10.1074/jbc.M212488200; WARNOTTE C, 1994, DIABETES, V43, P703, DOI 10.2337/diabetes.43.5.703; WELSH M, 1986, J BIOL CHEM, V261, P2915; Wyne KL, 2003, AM J MED, V115, P29, DOI 10.1016/j.amjmed.2003.09.004; Yuan L., 2004, J HUAZHONG U SCI TEC, V24, P364; Yuan Li, 2004, J Huazhong Univ Sci Technolog Med Sci, V24, P358; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; ZHOU YP, 1995, J CLIN ENDOCR METAB, V80, P1584, DOI 10.1210/jc.80.5.1584; Zhou YP, 2003, J BIOL CHEM, V278, P51316, DOI 10.1074/jbc.M307972200; ZHOU YP, 1995, DIABETES, V44, P394, DOI 10.2337/diabetes.44.4.394	60	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5226	5234		10.1074/jbc.M708181200	http://dx.doi.org/10.1074/jbc.M708181200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18073214	hybrid			2022-12-25	WOS:000253426700002
J	Ho, KK; Anderson, AA; Rosivatz, E; Lam, EWF; Woscholski, R; Mann, DJ				Ho, Ka-Kei; Anderson, Alexandra A.; Rosivatz, Erika; Lam, Eric W. -F.; Woscholski, Rudiger; Mann, David J.			Identification of cyclin A(2) as the downstream effector of the nuclear phosphatidylinositol 4,5-bisphosphate signaling network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SWISS 3T3 CELLS; GROWTH-FACTOR-I; PHOSPHOLIPASE-C; INDUCED MITOGENESIS; PHORBOL ESTERS; D1; PHOSPHORYLATION; TRANSLOCATION; LOCALIZATION	In addition to the well characterized phosphoinositide second messengers derived from the plasma membrane, increasing evidence supports the existence of a nuclear phosphoinositide signaling network. The aim of this investigation was to dissect the role played by nuclear phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5) P-2) in cell cycle progression and to determine the cell cycle regulatory component(s) that are involved. A number of cytosolic/nuclear PtdIns(4,5) P-2-deficient Swiss 3T3 cell lines were established, and their G(0)/G(1)/S cell cycle phase transitions induced by defined mitogens were examined. Our results demonstrate that nuclear PtdIns(4,5) P-2 down-regulation caused a delay in phorbol ester-induced S phase entry and that this was at least in part channeled through cyclin A(2) at the transcriptional level. In summary, these data identify cyclin A(2) as a downstream effector of the nuclear PtdIns(4,5) P-2 signaling network and highlight the importance of nuclear PtdIns(4,5) P-2 in the regulation of mammalian mitogenesis.	[Ho, Ka-Kei; Anderson, Alexandra A.; Rosivatz, Erika; Woscholski, Rudiger; Mann, David J.] Univ London Imperial Coll Sci & Technol, Div Cell & Mol Biol, London SW7 2AZ, England; [Ho, Ka-Kei; Lam, Eric W. -F.] Univ London Imperial Coll Sci & Technol, Dept Oncol, Canc Res UK, London W12 0NN, England	Imperial College London; Cancer Research UK; Imperial College London	Mann, DJ (corresponding author), Univ London Imperial Coll Sci & Technol, Div Cell & Mol Biol, Exhibit Rd, London SW7 2AZ, England.	d.mann@imperial.ac.uk	Lam, Eric W-F/AAW-8566-2020; Rosivatz, Erika/K-4341-2012	Lam, Eric W-F/0000-0003-1274-3576; Rosivatz, Erika/0000-0002-7111-1416	MRC [G0000138] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/C508134/1] Funding Source: Medline; Medical Research Council [G0000138] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ALBERT DA, 1992, P NATL ACAD SCI USA, V89, P1597, DOI 10.1073/pnas.89.5.1597; Backers K, 2003, ADV ENZYME REGUL, V43, P15, DOI 10.1016/S0065-2571(02)00043-2; Bunce MW, 2006, BBA-MOL CELL BIOL L, V1761, P560, DOI 10.1016/j.bbalip.2006.03.002; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339; Chu EC, 2004, MED SCI MONITOR, V10, pRA235; COCCO L, 1995, ADV ENZYME REGUL, V35, P23, DOI 10.1016/0065-2571(94)00004-M; Crowder RJ, 1998, J NEUROSCI, V18, P2933; Deleris P, 2006, J CELL BIOCHEM, V98, P469, DOI 10.1002/jcb.20695; Diehl JA, 1998, GENE DEV, V12, P3499, DOI 10.1101/gad.12.22.3499; DIVECHA N, 1991, EMBO J, V10, P3207, DOI 10.1002/j.1460-2075.1991.tb04883.x; FILMUS J, 1994, ONCOGENE, V9, P3627; Gille H, 1999, J BIOL CHEM, V274, P22033, DOI 10.1074/jbc.274.31.22033; Gurung R, 2003, J BIOL CHEM, V278, P11376, DOI 10.1074/jbc.M209991200; Haller H, 1998, CIRC RES, V82, P157; Ijuin T, 2000, J BIOL CHEM, V275, P10870, DOI 10.1074/jbc.275.15.10870; Ijuin T, 2003, MOL CELL BIOL, V23, P1209, DOI 10.1128/MCB.23.4.1209-1220.2003; Irvine RF, 2006, BBA-MOL CELL BIOL L, V1761, P505, DOI 10.1016/j.bbalip.2006.02.008; Jarviluoma A, 2006, MOL CELL BIOL, V26, P2430, DOI 10.1128/MCB.26.6.2430-2440.2006; Jones DR, 2004, CURR OPIN GENET DEV, V14, P196, DOI 10.1016/j.gde.2004.02.003; Kerkhoff E, 1997, MOL CELL BIOL, V17, P2576, DOI 10.1128/MCB.17.5.2576; Lavoie JN, 1996, J BIOL CHEM, V271, P20608, DOI 10.1074/jbc.271.34.20608; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li C, 2002, ACTA PHYSIOL SCAND, V174, P237, DOI 10.1046/j.1365-201x.2002.00945.x; LOVEC H, 1994, ONCOGENE, V9, P323; Mann DJ, 1997, ONCOGENE, V14, P1759, DOI 10.1038/sj.onc.1201134; Mann DJ, 2006, SIGNAL TRANSDUCTION, V6, P92; Manzoli L, 1997, CANCER RES, V57, P2137; Martelli AM, 1999, J CELL BIOCHEM, V72, P339, DOI 10.1002/(SICI)1097-4644(19990301)72:3<339::AID-JCB3>3.0.CO;2-L; MARTELLI AM, 1992, NATURE, V358, P242, DOI 10.1038/358242a0; Muise-Helmericks RC, 1998, J BIOL CHEM, V273, P29864, DOI 10.1074/jbc.273.45.29864; Neri LM, 1997, CELL SIGNAL, V9, P353, DOI 10.1016/S0898-6568(96)00178-7; Nishio M, 2007, NAT CELL BIOL, V9, P36, DOI 10.1038/ncb1515; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Okada M, 2005, FEBS LETT, V579, P4949, DOI 10.1016/j.febslet.2005.07.082; Ramakrishnan M, 1998, AM J RESP CELL MOL, V18, P736, DOI 10.1165/ajrcmb.18.6.3152; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P2936, DOI 10.1073/pnas.80.10.2936; Schmid AC, 2004, FEBS LETT, V576, P9, DOI 10.1016/j.febslet.2004.08.052; Shears SB, 2000, BIOESSAYS, V22, P786, DOI 10.1002/1521-1878(200009)22:9<786::AID-BIES3>3.3.CO;2-S; Singh AT, 2003, J BONE MINER RES, V18, P1453, DOI 10.1359/jbmr.2003.18.8.1453; Sun B, 1997, J BIOL CHEM, V272, P26313, DOI 10.1074/jbc.272.42.26313; Wang QMJ, 1999, J BIOL CHEM, V274, P37233, DOI 10.1074/jbc.274.52.37233; Xu AM, 2001, MOL CELL BIOL, V21, P2981, DOI 10.1128/MCB.21.9.2981-2990.2001; York JD, 1999, SCIENCE, V285, P96, DOI 10.1126/science.285.5424.96; YORK JD, 1994, J BIOL CHEM, V269, P7847; ZACHARY I, 1987, BIOCHEM BIOPH RES CO, V146, P456, DOI 10.1016/0006-291X(87)90551-1	46	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5477	5485		10.1074/jbc.M706623200	http://dx.doi.org/10.1074/jbc.M706623200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18077453	hybrid			2022-12-25	WOS:000253426700028
J	Chopra, S; Dooling, RM; Horner, CG; Howell, EE				Chopra, Shaileja; Dooling, Russell M.; Horner, Caroline Glyn; Howell, Elizabeth E.			A balancing act between net uptake of water during dihydrofolate binding and net release of water upon NADPH binding in R67 dihydrofolate reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DNA INTERACTIONS; ESCHERICHIA-COLI; OSMOTIC-STRESS; LIGAND-BINDING; PREFERENTIAL HYDRATION; TERNARY COMPLEX; BOUND WATER; PYRIDINE-NUCLEOTIDES; PEPTIDE BINDING; EXCLUDED-VOLUME	R67 dihydrofolate reductase (DHFR) catalyzes the reduction of dihydrofolate (DHF) to tetrahydrofolate using NADPH as a cofactor. This enzyme is a homotetramer possessing 222 symmetry, and a single active site pore traverses the length of the protein. A promiscuous binding surface can accommodate either DHF or NADPH, thus two nonproductive complexes can form (2NADPH or 2DHF) as well as a productive complex (NADPH center dot DHF). The role of water in binding was monitored using a number of different osmolytes. From isothermal titration calorimetry (ITC) studies, binding of NADPH is accompanied by the net release of 38 water molecules. In contrast, from both steady state kinetics and ITC studies, binding of DHF is accompanied by the net uptake of water. Although different osmolytes have similar effects on NADPH binding, variable results are observed when DHF binding is probed. Sensitivity to water activity can also be probed by an in vivo selection using the antibacterial drug, trimethoprim, where the water content of the media is decreased by increasing concentrations of sorbitol. The ability of wild type and mutant clones of R67 DHFR to allow host Escherichia coli to grow in the presence of trimethoprim plus added sorbitol parallels the catalytic efficiency of the DHFR clones, indicating water content strongly correlates with the in vivo function of R67 DHFR.	[Chopra, Shaileja; Dooling, Russell M.; Horner, Caroline Glyn; Howell, Elizabeth E.] Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA	University of Tennessee System; University of Tennessee Knoxville	Howell, EE (corresponding author), Univ Tennessee, Dept Biochem Cellular & Mol Biol, Knoxville, TN 37996 USA.	lzh@utk.edu		Howell, Elizabeth/0000-0001-6157-433X				AMYES SGB, 1976, EUR J BIOCHEM, V61, P597, DOI 10.1111/j.1432-1033.1976.tb10055.x; ARAKAWA T, 1985, BIOPHYS J, V47, P411, DOI 10.1016/S0006-3495(85)83932-1; Auton M, 2005, P NATL ACAD SCI USA, V102, P15065, DOI 10.1073/pnas.0507053102; BALDWIN WW, 1995, J BACTERIOL, V177, P235, DOI 10.1128/jb.177.1.235-237.1995; Beck DAC, 2007, METHOD ENZYMOL, V428, P373, DOI 10.1016/S0076-6879(07)28022-X; BENNAIM A, 1975, BIOPOLYMERS, V14, P1337, DOI 10.1002/bip.1975.360140704; Bennion BJ, 2004, P NATL ACAD SCI USA, V101, P6433, DOI 10.1073/pnas.0308633101; BHAT R, 1992, PROTEIN SCI, V1, P1133, DOI 10.1002/pro.5560010907; Bradrick TD, 1996, BIOCHEMISTRY-US, V35, P11414, DOI 10.1021/bi960205d; BRITO RMM, 1991, BIOCHEMISTRY-US, V30, P1461, DOI 10.1021/bi00220a003; Cayley S, 2004, J MOL RECOGNIT, V17, P488, DOI 10.1002/jmr.695; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Cayley S, 2003, BIOCHEMISTRY-US, V42, P12596, DOI 10.1021/bi0347297; CHERVENAK MC, 1994, J AM CHEM SOC, V116, P10533, DOI 10.1021/ja00102a021; Chik J, 2005, J PHYS CHEM B, V109, P9111, DOI 10.1021/jp046999k; Chopra S, 2006, BIOCHEMISTRY-US, V45, P6596, DOI 10.1021/bi052504l; Cooper A, 2005, BIOPHYS CHEM, V115, P89, DOI 10.1016/j.bpc.2004.12.011; Courtenay ES, 2000, BIOCHEMISTRY-US, V39, P4455, DOI 10.1021/bi992887l; Csonka L N, 1981, Basic Life Sci, V18, P533; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Dashnau JL, 2005, J PHYS CHEM B, V109, P24152, DOI 10.1021/jp0543072; Davis-Searles PR, 1998, BIOCHEMISTRY-US, V37, P17048, DOI 10.1021/bi981364v; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; DZINGELESKI GD, 1993, BIOCHEMISTRY-US, V32, P9143, DOI 10.1021/bi00086a020; Edsall J., 1943, PROTEINS AMINO ACIDS, P140; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; FIERKE CA, 1987, COLD SPRING HARB SYM, V52, P631, DOI 10.1101/SQB.1987.052.01.072; Fried MG, 2002, J BIOL CHEM, V277, P50676, DOI 10.1074/jbc.M208540200; Frisch C, 1997, J MOL BIOL, V267, P696, DOI 10.1006/jmbi.1997.0892; Furukawa Y, 2001, J BIOL CHEM, V276, P12983, DOI 10.1074/jbc.M010217200; GARNER MM, 1995, EMBO J, V14, P1257, DOI 10.1002/j.1460-2075.1995.tb07109.x; GARNER MM, 1994, AM J PHYSIOL, V266, pC877, DOI 10.1152/ajpcell.1994.266.4.C877; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Gulotta M, 2007, BIOCHEMISTRY-US, V46, P10055, DOI 10.1021/bi700990d; HAMMALVAREZ SF, 1990, J BIOL CHEM, V265, P9850; Harries D, 2005, J AM CHEM SOC, V127, P2184, DOI 10.1021/ja045541t; Hicks SN, 2004, J BIOL CHEM, V279, P46995, DOI 10.1074/jbc.M404484200; Hicks SN, 2003, BIOCHEMISTRY-US, V42, P10569, DOI 10.1021/bi034643d; Holdgate GA, 1997, BIOCHEMISTRY-US, V36, P9663, DOI 10.1021/bi970294+; Howell EE, 2005, CHEMBIOCHEM, V6, P591, DOI 10.1002/cbic.200400237; Howell EE, 2001, J COMPUT AID MOL DES, V15, P1035, DOI 10.1023/A:1014824725891; HOWELL EE, 1987, BIOCHEMISTRY-US, V26, P8591, DOI 10.1021/bi00400a015; Hultgren A, 2004, BIOCHEMISTRY-US, V43, P8272, DOI 10.1021/bi049559s; Isbister BD, 1995, J AM CHEM SOC, V117, P12877, DOI 10.1021/ja00156a033; Jackson M, 2005, BIOCHEMISTRY-US, V44, P12420, DOI 10.1021/bi050881s; Janin J, 1999, STRUCT FOLD DES, V7, pR277, DOI 10.1016/S0969-2126(00)88333-1; JELESAROV I, 1994, BIOCHEMISTRY-US, V33, P13321, DOI 10.1021/bi00249a019; Kiser JR, 2005, BIOCHEMISTRY-US, V44, P16988, DOI 10.1021/bi051769x; KORNBLATT JA, 1993, BIOPHYS J, V65, P1059, DOI 10.1016/S0006-3495(93)81168-8; Kornblatt JA, 2002, BBA-PROTEIN STRUCT M, V1595, P30, DOI 10.1016/S0167-4838(01)00333-8; Krahn JM, 2007, BIOCHEMISTRY-US, V46, P14878, DOI 10.1021/bi701532r; Ladbury JE, 1996, CHEM BIOL, V3, P973, DOI 10.1016/S1074-5521(96)90164-7; Larsen J, 1996, TOXICOL APPL PHARM, V140, P296, DOI 10.1006/taap.1996.0225; Levy Y, 2006, ANNU REV BIOPH BIOM, V35, P389, DOI 10.1146/annurev.biophys.35.040405.102134; Li DW, 2001, BIOCHEMISTRY-US, V40, P4242, DOI 10.1021/bi0026425; LiCata VJ, 1997, BIOCHEMISTRY-US, V36, P10161, DOI 10.1021/bi970669r; LiCata VJ, 1998, METHOD ENZYMOL, V295, P42; MCLAGGAN D, 1990, J BACTERIOL, V172, P3631, DOI 10.1128/jb.172.7.3631-3636.1990; MINTON AP, 1981, BIOPOLYMERS, V20, P2093, DOI 10.1002/bip.1981.360201006; Modig K, 2003, J MOL BIOL, V332, P965, DOI 10.1016/S0022-2836(03)00968-9; NARAYANA N, 1995, NAT STRUCT BIOL, V2, P1018, DOI 10.1038/nsb1195-1018; Park H, 1997, PROTEIN ENG, V10, P1415, DOI 10.1093/protein/10.12.1415; Parsegian VA, 2000, P NATL ACAD SCI USA, V97, P3987, DOI 10.1073/pnas.97.8.3987; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; Petrone PM, 2004, J MOL BIOL, V338, P419, DOI 10.1016/j.jmb.2004.02.039; Pitcher WH, 2003, BIOCHEMISTRY-US, V42, P11150, DOI 10.1021/bi0349874; QUIOCHO FA, 1989, NATURE, V340, P404, DOI 10.1038/340404a0; REECE LJ, 1991, BIOCHEMISTRY-US, V30, P10895, DOI 10.1021/bi00109a013; Reid C, 1997, BIOPHYS J, V72, P1022, DOI 10.1016/S0006-3495(97)78754-X; Robinson CR, 1995, METHOD ENZYMOL, V259, P395; Sambrook J., 1989, MOL CLONING LAB MANU; Saunders AJ, 2000, BIOPOLYMERS, V53, P293, DOI 10.1002/(SICI)1097-0282(20000405)53:4<293::AID-BIP2>3.3.CO;2-K; Schellman JA, 2003, BIOPHYS J, V85, P108, DOI 10.1016/S0006-3495(03)74459-2; Schurr JM, 2005, BIOPHYS J, V89, P2258, DOI 10.1529/biophysj.104.057331; Sidorova N, 2004, NUCL ACID M, V14, P319; Sidorova NY, 2006, J BIOL CHEM, V281, P35656, DOI 10.1074/jbc.M608018200; Sleigh SH, 1999, J MOL BIOL, V291, P393, DOI 10.1006/jmbi.1999.2929; Smiley RD, 2004, ANAL BIOCHEM, V334, P204, DOI 10.1016/j.ab.2004.06.040; Smiley RD, 2002, BIOCHEMISTRY-US, V41, P15664, DOI 10.1021/bi026676j; SMITH SL, 1983, P NATL ACAD SCI-BIOL, V80, P4619, DOI 10.1073/pnas.80.15.4619; Stanley C, 2006, BIOPHYS J, V91, P912, DOI 10.1529/biophysj.106.086579; Stinnett LG, 2004, J BIOL CHEM, V279, P47003, DOI 10.1074/jbc.M404485200; STONE SR, 1986, BIOCHIM BIOPHYS ACTA, V869, P275, DOI 10.1016/0167-4838(86)90067-1; Strader MB, 2001, BIOCHEMISTRY-US, V40, P11344, DOI 10.1021/bi0110544; Street TO, 2006, P NATL ACAD SCI USA, V103, P13997, DOI 10.1073/pnas.0606236103; SWEENEY TE, 1993, AM J PHYSIOL, V264, pR469, DOI 10.1152/ajpregu.1993.264.3.R469; TAYLOR IW, 1982, CANCER RES, V42, P5159; Timasheff SN, 2002, P NATL ACAD SCI USA, V99, P9721, DOI 10.1073/pnas.122225399; TIMASHEFF SN, 1993, ANNU REV BIOPH BIOM, V22, P67, DOI 10.1146/annurev.bb.22.060193.000435; Vippagunta SR, 2007, J PHARM SCI-US, V96, P294, DOI 10.1002/jps.20754; Vossen KM, 1997, BIOCHEMISTRY-US, V36, P11640, DOI 10.1021/bi971193e; Weber A, 2006, J BACTERIOL, V188, P7165, DOI 10.1128/JB.00508-06; WILLENBROCK F, 1995, BIOCHEMISTRY-US, V34, P12012, DOI 10.1021/bi00037a044; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; WYMAN J, 1964, ADV PROTEIN CHEM, V19, P223, DOI 10.1016/S0065-3233(08)60190-4; Xavier KA, 1997, BIOPHYS J, V73, P2116, DOI 10.1016/S0006-3495(97)78242-0; YU HA, 1988, J CHEM PHYS, V89, P2366, DOI 10.1063/1.455080	99	19	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4690	4698		10.1074/jbc.M709443200	http://dx.doi.org/10.1074/jbc.M709443200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086667	hybrid			2022-12-25	WOS:000253426500027
J	Querin, L; Sanvito, R; Magni, F; Busti, S; Van Dorsselaer, A; Alberghina, L; Vanoni, M				Querin, Lorenzo; Sanvito, Rossella; Magni, Fulvio; Busti, Stefano; Van Dorsselaer, Alain; Alberghina, Lilia; Vanoni, Marco			Proteomic analysis of a nutritional shift-up in Saccharomyces cerevisiae identifies Gvp36 as a BAR-containing protein involved in vesicular traffic and nutritional adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST ACTIN CYTOSKELETON; CELL-CYCLE PROGRESSION; BUDDING YEAST; GENE-EXPRESSION; MESSENGER-RNAS; BUD EMERGENCE; REVEALS ROLES; GROWTH; LOCALIZATION; TRANSITION	Yeast cells undergoing a nutritional shift-up from a poor to a rich carbon source take several hours to adapt to the novel, richer carbon source. The budding index is a physiologically relevant "global" parameter that reflects the complex links between cell growth and division that are both coordinately and deeply affected by nutritional conditions. We used changes in budding index as a guide to choose appropriate, relevant time points during an ethanol to glucose nutritional shift-up for preparation of samples for the analysis of proteome by two-dimensional electro-phoresis/mass spectrometry. About 600 spots were detected. 90 spots, mostly comprising proteins involved in intermediary metabolism, protein synthesis, and response to stress, showed differential expression after glucose addition. Among modulated proteins we identified a protein of previously unknown function, Gvp36, showing a transitory increase corresponding to the drop of the fraction of budded cells. A gvp36 Delta strain shares several phenotypes( including general growth defects, heat shock, and high salt sensitivity, defects in polarization of the actin cytoskeleton, in endocytosis and in vacuolar biogenesis, defects in entering stationary phase upon nutrient starvation) with secretory pathway mutants and with mutants in genes encoding the two previously known yeast BAR proteins (RSV161 and RSV167). We thus propose that Gvp36 represents a novel yeast BAR protein involved in vesicular traffic and in nutritional adaptation.	[Querin, Lorenzo; Busti, Stefano; Alberghina, Lilia] Univ Milan, Dept Biosci & Biotechnol, I-20126 Milan, Italy; [Sanvito, Rossella; Magni, Fulvio] Univ Milan, DIMESAB, I-20052 Monza, Italy; [Van Dorsselaer, Alain] Univ Strasbourg, CNRS, LSMBO, F-67070 Strasbourg, France	University of Milan; University of Milan; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Vanoni, M (corresponding author), Piazza Sci 2, I-20126 Milan, Italy.	marco.vanoni@unimib.it	Vanoni, Marco/AAA-3699-2021; Magni, Fulvio/A-7340-2014	Vanoni, Marco/0000-0002-8690-2587; Alberghina, Lilia/0000-0003-1694-931X; Magni, Fulvio/0000-0002-8663-0374				Alberghina L, 2004, J CELL BIOL, V167, P433, DOI 10.1083/jcb.200405102; Alberghina L, 1998, J BACTERIOL, V180, P3864, DOI 10.1128/JB.180.15.3864-3872.1998; Alberghina L, 2005, TOP CURR GENET, V13, P325, DOI 10.1007/b138746; Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399; Basmaji F, 2006, MOL GENET GENOMICS, V275, P217, DOI 10.1007/s00438-005-0082-8; BATAILLE N, 1988, ELECTROPHORESIS, V9, P774, DOI 10.1002/elps.1150091113; BATAILLE N, 1991, YEAST, V7, P367, DOI 10.1002/yea.320070407; BAUER F, 1993, MOL CELL BIOL, V13, P5070, DOI 10.1128/MCB.13.8.5070; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Blader IJ, 1999, MOL BIOL CELL, V10, P581, DOI 10.1091/mbc.10.3.581; BOLES E, 1993, ARCH MICROBIOL, V160, P324, DOI 10.1007/BF00292085; BOUCHERIE H, 1985, J BACTERIOL, V161, P385, DOI 10.1128/JB.161.1.385-392.1985; Bowers K, 2005, BBA-MOL CELL RES, V1744, P438, DOI 10.1016/j.bbamcr.2005.04.004; Brizzio V, 1998, J CELL BIOL, V141, P567, DOI 10.1083/jcb.141.3.567; Brown AJP, 2001, EMBO J, V20, P3177, DOI 10.1093/emboj/20.12.3177; Care A, 2004, GENETICS, V166, P707, DOI 10.1534/genetics.166.2.707; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Cereghino GP, 1996, EMBO J, V15, P363, DOI 10.1002/j.1460-2075.1996.tb00366.x; CHOWDHURY S, 1992, J CELL BIOL, V118, P561, DOI 10.1083/jcb.118.3.561; Crespo JL, 2002, MICROBIOL MOL BIOL R, V66, P579, DOI 10.1128/MMBR.66.4.579-591.2002; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Deutschbauer AM, 2002, P NATL ACAD SCI USA, V99, P15530, DOI 10.1073/pnas.202604399; ENTIAN KD, 1997, YEAST SUGAR METABOLI, P409; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; Friesen H, 2006, MOL BIOL CELL, V17, P1306, DOI 10.1091/mbc.e05-06-0476; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GOLLEAU A, 1996, SCIENCE, V274, P563; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Haurie V, 2004, PROTEOMICS, V4, P364, DOI 10.1002/pmic.200300564; Horak CE, 2002, GENE DEV, V16, P3017, DOI 10.1101/gad.1039602; Hughes TR, 2004, CURR OPIN MICROBIOL, V7, P546, DOI 10.1016/j.mib.2004.08.015; IIDA H, 1984, J CELL BIOL, V98, P1185, DOI 10.1083/jcb.98.4.1185; Inadome H, 2005, MOL CELL BIOL, V25, P7696, DOI 10.1128/MCB.25.17.7696-7710.2005; Johnston M, 1999, TRENDS GENET, V15, P29, DOI 10.1016/S0168-9525(98)01637-0; JOHNSTON M, 1992, MOL BIOL YEAST SACCH; KIEF DR, 1981, MOL CELL BIOL, V1, P1007, DOI 10.1128/MCB.1.11.1007; Kubota S, 2004, BIOSCI BIOTECH BIOCH, V68, P968, DOI 10.1271/bbb.68.968; Kumar A, 2002, GENE DEV, V16, P707, DOI 10.1101/gad.970902; LOMBARDO A, 1992, MOL CELL BIOL, V12, P2941, DOI 10.1128/MCB.12.7.2941; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; Martin-Yken H, 2002, CURR GENET, V41, P323, DOI 10.1007/s00294-002-0299-6; MERCADO JJ, 1994, EUR J BIOCHEM, V224, P473, DOI 10.1111/j.1432-1033.1994.00473.x; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Mulholland J, 1997, MOL BIOL CELL, V8, P1481, DOI 10.1091/mbc.8.8.1481; MUNN AL, 1995, MOL BIOL CELL, V6, P1721, DOI 10.1091/mbc.6.12.1721; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Ren G, 2006, MICROBIOL MOL BIOL R, V70, P37, DOI 10.1128/MMBR.70.1.37-120.2006; Roberts GG, 2006, MOL GENET GENOMICS, V276, P170, DOI 10.1007/s00438-006-0133-9; Rolland F, 2002, FEMS YEAST RES, V2, P183, DOI 10.1111/j.1567-1364.2002.tb00084.x; STURANI E, 1976, EXP CELL RES, V99, P245, DOI 10.1016/0014-4827(76)90580-2; SUROSKY RT, 1994, MOL CELL BIOL, V14, P3446, DOI 10.1128/MCB.14.5.3446; Thevelein JM, 1999, MOL MICROBIOL, V33, P904, DOI 10.1046/j.1365-2958.1999.01538.x; VANONI M, 1991, EUR J CELL BIOL, V55, P179; VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779; Wang Y, 2004, PLOS BIOL, V2, P610, DOI 10.1371/journal.pbio.0020128; WARNER JR, 1989, MICROBIOL REV, V53, P256, DOI 10.1128/MMBR.53.2.256-271.1989; WINDERICKX J, 2003, YEAST STRESS RESPONS, P307; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; Yin ZK, 2003, MOL MICROBIOL, V48, P713, DOI 10.1046/j.1365-2958.2003.03478.x; Zheng B, 1998, P NATL ACAD SCI USA, V95, P11721, DOI 10.1073/pnas.95.20.11721	68	14	14	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4730	4743		10.1074/jbc.M707787200	http://dx.doi.org/10.1074/jbc.M707787200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156177	hybrid			2022-12-25	WOS:000253426500031
J	Chen, SJ; Lin, G; Chang, KJ; Yeh, LS; Wang, CC				Chen, Shun-Jia; Lin, Grace; Chang, Kuang-Jung; Yeh, Lu-Shu; Wang, Chien-Chia			Translational efficiency of a non-AUG initiation codon is significantly affected by its sequence context in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSFER-RNA SYNTHETASE; SACCHAROMYCES-CEREVISIAE; STRUCTURAL FEATURES; RIBOSOMAL-SUBUNIT; GENE ENCODES; MITOCHONDRIAL; SELECTION; PROTEIN; NUCLEOTIDES; MECHANISM	Previous studies have shown that translation of mRNA for yeast glycyl-tRNA synthetase is alternatively initiated from UUG and a downstream AUG initiation codon. Evidence presented here shows that unlike an AUG initiation codon, efficiency of this non-AUG initiation codon is significantly affected by its sequence context, in particular the nucleotides at positions -3 to -1 relative to the initiation codon. A/A/R (R represents A or G) and C/G/C appear to be the most and least favorable sequences at these positions, respectively. Mutation of the native context sequence -3 to -1 from AAA to CGC reduced translation initiation from the UUG codon up to 32-fold and resulted in loss of mitochondrial respiration. Although an AUG initiation codon is, in general, unresponsive to context changes in yeast, an AAA (-3 to -1) to CGC mutation still reduced its initiating activity up to 8-fold under similar conditions. These results suggest that sequence context is more important for translation initiation in yeast than previously appreciated.	[Chen, Shun-Jia; Lin, Grace; Chang, Kuang-Jung; Wang, Chien-Chia] Natl Cent Univ, Dept Life Sci, Jungli 32001, Taiwan; [Yeh, Lu-Shu] Tzu Chi Univ, Dept Life Sci, Hualin 97041, Taiwan	National Central University; Tzu Chi University	Wang, CC (corresponding author), Natl Cent Univ, Dept Life Sci, Jungli 32001, Taiwan.	dukewang@cc.ncu.edu.tw	Chang, Kuang-Jung/J-2193-2012	Chen, Shun-Jia/0000-0002-5489-4930				Abramczyk D, 2003, YEAST, V20, P1045, DOI 10.1002/yea.1020; ACLAND P, 1990, NATURE, V343, P662, DOI 10.1038/343662a0; BAIM SB, 1988, MOL CELL BIOL, V8, P1591, DOI 10.1128/MCB.8.4.1591; BENNETZEN JL, 1982, J BIOL CHEM, V257, P3018; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chang KJ, 2006, J BIOL CHEM, V281, P7775, DOI 10.1074/jbc.M511265200; Chang KJ, 2004, J BIOL CHEM, V279, P13778, DOI 10.1074/jbc.M311269200; CHATTON B, 1988, J BIOL CHEM, V263, P52; Cheung YN, 2007, GENE DEV, V21, P1217, DOI 10.1101/gad.1528307; CIGAN AM, 1987, GENE, V59, P1; CIGAN AM, 1988, MOL CELL BIOL, V8, P2964, DOI 10.1128/MCB.8.7.2964; CLEMENTS JM, 1988, MOL CELL BIOL, V8, P4533, DOI 10.1128/MCB.8.10.4533; DIETRICH A, 1992, ANNU REV CELL BIOL, V8, P115, DOI 10.1146/annurev.cb.08.110192.000555; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; HANN SR, 1992, GENE DEV, V6, P1229, DOI 10.1101/gad.6.7.1229; Huang CL, 2006, MATER LETT, V60, P198, DOI 10.1016/j.matlet.2005.08.016; Huang HY, 2006, J BIOL CHEM, V281, P31430, DOI 10.1074/jbc.M601869200; HUANG S, 1987, BIOCHEMISTRY-US, V26, P8242, DOI 10.1021/bi00399a033; KOZAK M, 1990, P NATL ACAD SCI USA, V87, P8301, DOI 10.1073/pnas.87.21.8301; KOZAK M, 1989, MOL CELL BIOL, V9, P5073, DOI 10.1128/MCB.9.11.5073; Kozak M, 1999, GENE, V234, P187, DOI 10.1016/S0378-1119(99)00210-3; KOZAK M, 1991, J BIOL CHEM, V266, P19867; MARTINIS SA, 1996, ESCHERICHIA COLI SAL, P887; NATSOULIS G, 1986, CELL, V46, P235, DOI 10.1016/0092-8674(86)90740-3; Packham G, 1997, BIOCHEM J, V328, P807, DOI 10.1042/bj3280807; Pelchat M, 1999, BIOCHEM CELL BIOL, V77, P343, DOI 10.1139/bcb-77-4-343; Pisarev AV, 2006, GENE DEV, V20, P624, DOI 10.1101/gad.1397906; Polevoda B, 1999, EMBO J, V18, P6155, DOI 10.1093/emboj/18.21.6155; Riechmann JL, 1999, MOL CELL BIOL, V19, P8505; Sadler R, 1999, J VIROL, V73, P5722, DOI 10.1128/JVI.73.7.5722-5730.1999; SARIS CJM, 1991, EMBO J, V10, P655, DOI 10.1002/j.1460-2075.1991.tb07994.x; SHERMAN F, 1980, CELL, V20, P215, DOI 10.1016/0092-8674(80)90249-4; SIKORSKI RS, 1989, GENETICS, V122, P19; SLUSHER LB, 1991, P NATL ACAD SCI USA, V88, P9789, DOI 10.1073/pnas.88.21.9789; Souciet G, 1999, EUR J BIOCHEM, V266, P848, DOI 10.1046/j.1432-1327.1999.00922.x; Tang HL, 2004, J BIOL CHEM, V279, P49656, DOI 10.1074/jbc.M408081200; Turner RJ, 2000, J BIOL CHEM, V275, P27681; Unbehaun A, 2004, GENE DEV, V18, P3078, DOI 10.1101/gad.1255704; Wang CC, 2003, BIOCHEMISTRY-US, V42, P1646, DOI 10.1021/bi025964c; WOLFE CL, 1994, J BIOL CHEM, V269, P13361; YOON H, 1992, MOL MICROBIOL, V6, P1413, DOI 10.1111/j.1365-2958.1992.tb00861.x; ZITOMER RS, 1984, MOL CELL BIOL, V4, P1191, DOI 10.1128/MCB.4.7.1191	42	44	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3173	3180		10.1074/jbc.M706968200	http://dx.doi.org/10.1074/jbc.M706968200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065417	hybrid			2022-12-25	WOS:000253083000020
J	Piao, W; Song, C; Chen, H; Wahl, LM; Fitzgerald, KA; O'Neill, LA; Medvedev, AE				Piao, Wenji; Song, Chang; Chen, Haiyan; Wahl, Larry M.; Fitzgerald, Katherine A.; O'Neill, Luke A.; Medvedev, Andrei E.			Tyrosine phosphorylation of MyD88 adapter-like (Mal) is critical for signal transduction and blocked in endotoxin tolerance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOLL-LIKE RECEPTORS; NF-KAPPA-B; DOMAIN-CONTAINING ADAPTER; DOUBLE-STRANDED-RNA; CUTTING EDGE; TIR-DOMAIN; DOWN-REGULATION; KINASE; INNATE; ACTIVATION	Toll-like receptor 4 (TLR4) recognition of lipopolysaccharide triggers signalosome assembly among TLR4, sorting ( e. g. MyD88 adapter-like (Mal)) and signaling (e.g. MyD88) adapters, initiating recruitment and activation of kinases, activation of transcription factors, and production of inflammatory mediators. In this study we examined whether tyrosine phosphorylation of Mal regulates its interactions with TLR4, MyD88, interleukin-1 (IL-1) receptor-associated kinase (IRAK)-2, and tumor necrosis factor receptor-associated factor (TRAF)-6 and is important for signaling. Overexpression of wild-type Mal in human embryonic kidney 293T cells induced its constitutive tyrosine phosphorylation and led to activation of p38, NF-kappa B, and IL-8 gene expression. Mutagenesis of Tyr-86, Tyr-106, and Tyr-159 residues within the Toll-IL-1 receptor domain impaired Mal tyrosine phosphorylation, interactions with Bruton tyrosine kinase, phosphorylation of p38, and NF-kappa B activation. Lipopolysaccharide triggered tyrosine phosphorylation of endogenous Mal and initiated Mal-Bruton-tyrosine kinase interactions in 293/TLR4/MD-2 cells and human monocytes that were suppressed in endotoxin-tolerant cells. Compared with wild-type Mal, Y86A-,Y06A-, and Y159A-Mal variants exhibited higher interactions with TLR4 and MyD88, whereas associations with IRAK-2 and TRAF-6 were not affected. Overexpression of Y86A- and Y106A-Mal in 293/TLR4/MD-2 cells exerted dominant-negative effects on TLR4-inducible p38 phosphorylation and NF-kappa B reporter activation to the extent comparable with P125H-Mal-mediated suppression. In contrast, tyrosine-deficient Mal species did not affect NF-kappa B activation when signaling was initiated at the post-receptor level by overexpression of MyD88, IRAK-2, or TRAF-6. Thus, tyrosine phosphorylation of Mal is required for adapter signaling, regulates Mal interactions with TLR4 and receptor signaling, and is inhibited in endotoxin tolerance.	[Piao, Wenji; Song, Chang; Chen, Haiyan; Medvedev, Andrei E.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Wahl, Larry M.] NIDCR, NIH, Bethesda, MD 20892 USA; [Fitzgerald, Katherine A.] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [O'Neill, Luke A.] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin 2, Ireland	University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Massachusetts System; University of Massachusetts Worcester; Trinity College Dublin	Medvedev, AE (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, 660 W Red Wood St,Howard Hall Bldg,Rm HH 324, Baltimore, MD 21201 USA.	amedvedev@som.umaryland.edu	Chen, Haiyan/HGB-6216-2022; Fitzgerald, Katherine/ABE-6317-2020	Fitzgerald, Kate/0000-0003-3175-609X; O'Neill, Luke/0000-0002-4333-2748	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059524] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000456] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI059524-04, R01 AI-059524, R01 AI059524-05, R01 AI059524] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abe T, 2005, J VIROL, V79, P2847, DOI 10.1128/JVI.79.5.2847-2858.2005; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arbibe L, 2000, NAT IMMUNOL, V1, P533, DOI 10.1038/82797; Bin LH, 2003, J BIOL CHEM, V278, P24526, DOI 10.1074/jbc.M303451200; Cao ZD, 1996, SCIENCE, V271, P1128, DOI 10.1126/science.271.5252.1128; Carty M, 2006, NAT IMMUNOL, V7, P1074, DOI 10.1038/ni1382; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; ERTEL W, 1995, BLOOD, V85, P1341, DOI 10.1182/blood.V85.5.1341.bloodjournal8551341; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gay NJ, 2007, ANNU REV BIOCHEM, V76, P141, DOI 10.1146/annurev.biochem.76.060305.151318; Gay NJ, 2006, NAT REV IMMUNOL, V6, P693, DOI 10.1038/nri1916; Gray P, 2006, J BIOL CHEM, V281, P10489, DOI 10.1074/jbc.M508892200; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hochrein H, 2004, P NATL ACAD SCI USA, V101, P11416, DOI 10.1073/pnas.0403555101; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Horng T, 2001, P NATL ACAD SCI USA, V98, P12654, DOI 10.1073/pnas.231471798; Horng T, 2001, NAT IMMUNOL, V2, P835, DOI 10.1038/ni0901-835; Ivison SM, 2007, BIOCHEM BIOPH RES CO, V352, P936, DOI 10.1016/j.bbrc.2006.11.132; Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112; Jiang ZF, 2002, MOL CELL BIOL, V22, P7158, DOI 10.1128/MCB.22.20.7158-7167.2002; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaisho T, 2006, J ALLERGY CLIN IMMUN, V117, P979, DOI 10.1016/j.jaci.2006.02.023; Kawai T, 2004, NAT IMMUNOL, V5, P1061, DOI 10.1038/ni1118; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Kim TW, 2007, J EXP MED, V204, P1025, DOI 10.1084/jem.20061825; Kubo-Murai M, 2007, MOL IMMUNOL, V44, P2257, DOI 10.1016/j.molimm.2006.11.005; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Li LW, 2000, J BIOL CHEM, V275, P23340, DOI 10.1074/jbc.M001950200; Li SY, 2002, P NATL ACAD SCI USA, V99, P5567, DOI 10.1073/pnas.082100399; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mansell A, 2006, NAT IMMUNOL, V7, P148, DOI 10.1038/ni1299; McGettrick AF, 2006, P NATL ACAD SCI USA, V103, P9196, DOI 10.1073/pnas.0600462103; Medvedev AE, 2000, J IMMUNOL, V164, P5564, DOI 10.4049/jimmunol.164.11.5564; Medvedev AE, 2002, J IMMUNOL, V169, P5209, DOI 10.4049/jimmunol.169.9.5209; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Medvedev AE, 2006, J ENDOTOXIN RES, V12, P133, DOI 10.1179/096805106X102255; Medzhitov R, 2000, NEW ENGL J MED, V343, P338, DOI 10.1056/NEJM200008033430506; Miggin SM, 2007, P NATL ACAD SCI USA, V104, P3372, DOI 10.1073/pnas.0608100104; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Nomura F, 2000, J IMMUNOL, V164, P3476, DOI 10.4049/jimmunol.164.7.3476; O'Neill LAJ, 2006, CURR OPIN IMMUNOL, V18, P3, DOI 10.1016/j.coi.2005.11.012; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oshiumi H, 2003, J BIOL CHEM, V278, P49751, DOI 10.1074/jbc.M305820200; Pasare C, 2005, ADV EXP MED BIOL, V560, P11; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Qureshi ST, 1999, J EXP MED, V189, P615, DOI 10.1084/jem.189.4.615; Rowe DC, 2006, P NATL ACAD SCI USA, V103, P6299, DOI 10.1073/pnas.0510041103; Sarkar SN, 2003, J BIOL CHEM, V278, P4393, DOI 10.1074/jbc.C200655200; Sheedy FJ, 2007, J LEUKOCYTE BIOL, V82, P196, DOI 10.1189/jlb.1206750; Takaoka A, 2005, NATURE, V434, P243, DOI 10.1038/nature03308; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Yamamoto M, 2002, J IMMUNOL, V169, P6668, DOI 10.4049/jimmunol.169.12.6668; Yamamoto M, 2003, NAT IMMUNOL, V4, P1144, DOI 10.1038/ni986; Yarovinsky F, 2005, SCIENCE, V308, P1626, DOI 10.1126/science.1109893; Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554	62	62	62	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3109	3119		10.1074/jbc.M707400200	http://dx.doi.org/10.1074/jbc.M707400200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070880	Green Accepted, Green Submitted, hybrid			2022-12-25	WOS:000253083000014
J	Bernacer, J; Prensa, L; Gimenez-Amaya, JM				Bernacer, Javier; Prensa, Lucia; Manuel Gimenez-Amaya, Jose			Cholinergic Interneurons Are Differentially Distributed in the Human Striatum	PLOS ONE			English	Article								Background. The striatum (caudate nucleus, CN, and putamen, Put) is a group of subcortical nuclei involved in planning and executing voluntary movements as well as in cognitive processes. Its neuronal composition includes projection neurons, which connect the striatum with other structures, and interneurons, whose main roles are maintaining the striatal organization and the regulation of the projection neurons. The unique electrophysiological and functional properties of the cholinergic interneurons give them a crucial modulating function on the overall striatal response. Methodology/Principle Findings. This study was carried out using stereological methods to examine the volume and density (cells/mm(3)) of these interneurons, as visualized by choline acetyltransferase (ChAT) immunoreactivity, in the following territories of the CN and Put of nine normal human brains: 1) precommissural head; 2) postcommissural head; 3) body; 4) gyrus and 5) tail of the CN; 6) precommissural and 7) postcommissural Put. The distribution of ChAT interneurons was analyzed with respect to the topographical, functional and chemical territories of the dorsal striatum. The CN was more densely populated by cholinergic neurons than the Put, and their density increased along the anteroposterior axis of the striatum with the CN body having the highest neuronal density. The associative territory of the dorsal striatum was by far the most densely populated. The striosomes of the CN precommissural head and the postcommissural Put contained the greatest number of ChAT-ir interneurons. The intrastriosomal ChAT-ir neurons were abundant on the periphery of the striosomes throughout the striatum. Conclusions/Significance. All these data reveal that cholinergic interneurons are differentially distributed in the distinct topographical and functional territories of the human dorsal striatum, as well as in its chemical compartments. This heterogeneity may indicate that the posterior aspects of the CN require a special integration of information by interneurons. Interestingly, these striatal regions have been very much left out in functional studies.	[Bernacer, Javier; Prensa, Lucia; Manuel Gimenez-Amaya, Jose] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain	Autonomous University of Madrid	Gimenez-Amaya, JM (corresponding author), Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain.	josemanuel.gimenezamaya@uam.es	Bernacer, Javier/P-5810-2014; Waldvogel, Henry/D-6691-2012	Bernacer, Javier/0000-0002-4341-9763; Waldvogel, Henry/0000-0003-2165-8568; Prensa Sepulveda, Lucia/0000-0003-2217-3271	Ministerio de Educacion y Ciencia [BFI2003-02909]; Comunidad de Madrid; Ministerio de Educacion y Ciencia	Ministerio de Educacion y Ciencia(Spanish Government); Comunidad de Madrid(Comunidad de Madrid); Ministerio de Educacion y Ciencia(Spanish Government)	Ministerio de Educacion y Ciencia (BFI2003-02909). JB was supported by the Comunidad de Madrid (FPI-CAM) and LP is supported by the Ramon y Cajal program of the Ministerio de Educacion y Ciencia.	AOSAKI T, 1995, J NEUROPHYSIOL, V73, P1234, DOI 10.1152/jn.1995.73.3.1234; AOSAKI T, 1994, J NEUROSCI, V14, P3969; Apicella P, 2002, EUR J NEUROSCI, V16, P2017, DOI 10.1046/j.1460-9568.2002.02262.x; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Benke T, 2003, NEUROCASE, V9, P70, DOI 10.1076/neur.9.1.70.14374; Bernacer J, 2005, J COMP NEUROL, V489, P311, DOI 10.1002/cne.20616; BERNACER J, 2007, J NEURAL TRANSM, DOI DOI 10.1007/S00702-00007-00803-00708; BERNACER J, 2005, 1808 SOC NEUR; BERTORELLI R, 1990, J NEUROCHEM, V54, P2145, DOI 10.1111/j.1471-4159.1990.tb04922.x; BJUGN R, 1993, J COMP NEUROL, V328, P406, DOI 10.1002/cne.903280307; Brauer K, 2000, BRAIN RES, V858, P151, DOI 10.1016/S0006-8993(00)01938-7; Calabresi P, 2000, TRENDS NEUROSCI, V23, P120, DOI 10.1016/S0166-2236(99)01501-5; CAVADA C, 1991, NEUROSCIENCE, V42, P683, DOI 10.1016/0306-4522(91)90037-O; Centonze D, 1999, BRAIN RES REV, V31, P1, DOI 10.1016/S0165-0173(99)00018-1; Cerasa A, 2005, NEUROSCI LETT, V373, P32, DOI 10.1016/j.neulet.2004.09.076; CHANG HT, 1988, BRAIN RES BULL, V21, P295, DOI 10.1016/0361-9230(88)90244-4; Cragg SJ, 2006, TRENDS NEUROSCI, V29, P125, DOI 10.1016/j.tins.2006.01.003; DEBOER P, 1992, N-S ARCH PHARMACOL, V345, P144, DOI 10.1007/BF00165729; DeBoer P, 1996, J PHARMACOL EXP THER, V277, P775; DIFIGLIA M, 1976, BRAIN RES, V114, P245, DOI 10.1016/0006-8993(76)90669-7; FLAHERTY AW, 1994, J NEUROSCI, V14, P599; Flaherty AW, 1995, J NEUROPHYSIOL, V74, P2638, DOI 10.1152/jn.1995.74.6.2638; Fudge JL, 2002, J NEUROSCI, V22, P10078; Fudge JL, 2002, NEUROSCIENCE, V110, P257, DOI 10.1016/S0306-4522(01)00546-2; Galarraga E, 1999, J NEUROSCI, V19, P3629, DOI 10.1523/jneurosci.19-09-03629.1999; Gimenez-Amaya JM, 2000, HISTOL HISTOPATHOL, V15, P1285, DOI 10.14670/HH-15.1285; GIMENEZAMAYA JM, 1995, J COMP NEUROL, V354, P127, DOI 10.1002/cne.903540109; GRAVELAND GA, 1985, J COMP NEUROL, V234, P317, DOI 10.1002/cne.902340304; GRAYBIEL AM, 1978, P NATL ACAD SCI USA, V75, P5723, DOI 10.1073/pnas.75.11.5723; Haber SN, 2003, J CHEM NEUROANAT, V26, P317, DOI 10.1016/j.jchemneu.2003.10.003; Haber SN, 2006, J NEUROSCI, V26, P8368, DOI 10.1523/JNEUROSCI.0271-06.2006; Holt DJ, 1999, NEUROSCIENCE, V94, P21, DOI 10.1016/S0306-4522(99)00279-1; Holt DJ, 1997, J COMP NEUROL, V384, P1, DOI 10.1002/(SICI)1096-9861(19970721)384:1<1::AID-CNE1>3.0.CO;2-5; Holt DJ, 2005, BIOL PSYCHIAT, V58, P408, DOI 10.1016/j.biopsych.2005.04.007; Holt DJ, 1996, NEUROSCIENCE, V74, P67, DOI 10.1016/0306-4522(96)00094-2; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P580; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Koikkalainen J, 2007, NEUROIMAGE, V34, P85, DOI 10.1016/j.neuroimage.2006.08.039; Koos T, 2002, J NEUROSCI, V22, P529, DOI 10.1523/JNEUROSCI.22-02-00529.2002; KUBOTA Y, 1987, BRAIN RES, V413, P179, DOI 10.1016/0006-8993(87)90167-3; KUNZLE H, 1975, BRAIN RES, V88, P195, DOI 10.1016/0006-8993(75)90384-4; LAPPER SR, 1992, NEUROSCIENCE, V51, P533, DOI 10.1016/0306-4522(92)90293-B; LEHERICY S, 1989, P NATL ACAD SCI USA, V86, P8580, DOI 10.1073/pnas.86.21.8580; Lehericy S, 2006, CEREB CORTEX, V16, P149, DOI 10.1093/cercor/bhi089; Mai J.K., 1997, ATLAS HUMAN BRAIN; Martin R, 2000, J HISTOCHEM CYTOCHEM, V48, P1121, DOI 10.1177/002215540004800809; Mayhew TM, 1996, J ANAT, V188, P1; McFarland NR, 2001, J COMP NEUROL, V429, P321, DOI 10.1002/1096-9861(20000108)429:2<321::AID-CNE11>3.0.CO;2-A; McFarland NR, 2000, J NEUROSCI, V20, P3798, DOI 10.1523/JNEUROSCI.20-10-03798.2000; Mengual E, 1999, J CHEM NEUROANAT, V16, P187; MESULAM MM, 1984, NEUROSCIENCE, V12, P669, DOI 10.1016/0306-4522(84)90163-5; Miyachi S, 2002, EXP BRAIN RES, V146, P122, DOI 10.1007/s00221-002-1213-7; Monchi O, 2001, J NEUROSCI, V21, P7733, DOI 10.1523/JNEUROSCI.21-19-07733.2001; Morris G, 2004, NEURON, V43, P133, DOI 10.1016/j.neuron.2004.06.012; Pakhotin P, 2007, J NEUROSCI, V27, P391, DOI 10.1523/JNEUROSCI.3709-06.2007; PARENT A, 1990, TRENDS NEUROSCI, V13, P254, DOI 10.1016/0166-2236(90)90105-J; Perez-Rosello T, 2005, J NEUROPHYSIOL, V93, P2507, DOI 10.1152/jn.00853.2004; Picconi B, 2006, NEUROBIOL DIS, V22, P143, DOI 10.1016/j.nbd.2005.10.009; PINEDA JC, 1995, EUR J PHARMACOL, V281, P271, DOI 10.1016/0014-2999(95)00263-K; Prensa L, 1999, J COMP NEUROL, V413, P603; Prensa L, 2003, J COMP NEUROL, V460, P345, DOI 10.1002/cne.10627; Raghavan R., 1997, ELECT CLIN BRAIN ATL; Rakovska A, 2002, NEUROCHEM INT, V40, P269, DOI 10.1016/S0197-0186(01)00037-7; Rakovska A, 2003, BRAIN RES BULL, V61, P529, DOI 10.1016/S0361-9230(03)00192-8; Raz N, 2003, AM J NEURORADIOL, V24, P1849; Roberts RC, 1996, J COMP NEUROL, V374, P523; ROBERTSON GS, 1994, NEUROSCIENCE, V59, P375, DOI 10.1016/0306-4522(94)90603-3; SADIKOT AF, 1992, J COMP NEUROL, V320, P228, DOI 10.1002/cne.903200207; Schaltenbrand G., 1977, ATLAS STEREOTAXY HUM; SELDEN N, 1994, NEUROSCIENCE, V60, P621, DOI 10.1016/0306-4522(94)90491-X; SELEMON LD, 1985, J NEUROSCI, V5, P776; SMITH Y, 1986, NEUROSCIENCE, V18, P347, DOI 10.1016/0306-4522(86)90159-4; STERIO DC, 1984, J MICROSC-OXFORD, V134, P127, DOI 10.1111/j.1365-2818.1984.tb02501.x; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; VIZI ES, 1977, POL J PHARMACOL PHAR, V29, P201; Waldvogel HJ, 2004, J COMP NEUROL, V470, P339, DOI 10.1002/cne.20005; Wang ZF, 2006, NEURON, V50, P443, DOI 10.1016/j.neuron.2006.04.010; Warren NM, 2005, BRAIN, V128, P239, DOI 10.1093/brain/awh391; WILSON CJ, 1990, J NEUROSCI, V10, P508; WOOLF NJ, 1981, BRAIN RES BULL, V7, P487, DOI 10.1016/0361-9230(81)90004-6; WREFORD NG, 1995, MICROSC RES TECHNIQ, V32, P423, DOI 10.1002/jemt.1070320505; Wu Y, 2000, BRAIN RES, V863, P182, DOI 10.1016/S0006-8993(00)02135-1; Yamada H, 2004, J NEUROSCI, V24, P3500, DOI 10.1523/JNEUROSCI.0068-04.2004; YELNIK J, 1991, J COMP NEUROL, V313, P273, DOI 10.1002/cne.903130207	85	50	51	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 14	2007	2	11							e1174	10.1371/journal.pone.0001174	http://dx.doi.org/10.1371/journal.pone.0001174			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JA	18080007	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459100016
J	Williamson, R; Usardi, A; Hanger, DP; Anderton, BH				Williamson, Ritchie; Usardi, Alessia; Hanger, Diane P.; Anderton, Brian H.			Membrane-bound beta-amyloid oligomers are recruited into lipid rafts by a fyn-dependent mechanism	FASEB JOURNAL			English	Article						Alzheimer's disease; ADDLs; protein aggregation; tau	ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; COMMON MECHANISM; TAU; PEPTIDE; TOXICITY; KINASE; BRAIN; NEURONS; NEURODEGENERATION	Recently published research indicates that soluble oligomers of beta-amyloid (AD) may be the key neurotoxic species associated with the progression of Alzheimer's disease (AD) and that the process of AD aggregation may drive this event. Furthermore, soluble oligomers of AD and tau accumulate in the lipid rafts of brains from AD patients through an as yet unknown mechanism. Using cell culture models we report a novel action of AD on neuronal plasma membranes where exogenously applied AD in the form of ADDLs can be trafficked on the neuronal membrane and accumulate in lipid rafts. ADDI-induced dynamic alterations in lipid raft protein composition were found to facilitate this movement. We show clear associations between AD accumulation and redistribution on the neuronal membrane and alterations in the protein composition of lipid rafts. In addition, our data from fyn(-/-) transgenic mice show that accumulation of AD on the neuronal surface was not sufficient to cause cell death but that fyn is required for both the redistribution of AD and subsequent cell death. These results identify fyn-dependent AD redistribution and accumulation in lipid rafts as being key to ADDL-induced cell death and defines a mechanism by which oligomers of AD and tau accumulate in lipid rafts.	[Williamson, Ritchie; Usardi, Alessia; Hanger, Diane P.; Anderton, Brian H.] Kings Coll London, Inst Psychiat, Dept Neurosci Box 037, MRC Ctr Neurodegenerat Res, London SE5 8AF, England	University of London; King's College London	Williamson, R (corresponding author), Kings Coll London, Inst Psychiat, Dept Neurosci Box 037, MRC Ctr Neurodegenerat Res, Crespigny Pk, London SE5 8AF, England.	ritchie.williamson@iop.kcl.ac.uk	Williamson, Ritchie/E-1522-2012; Hanger, Diane/C-5697-2009	Williamson, Ritchie/0000-0003-4278-0909; Hanger, Diane/0000-0002-3044-9816	MRC [G0400050] Funding Source: UKRI; Medical Research Council [G0400050] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Arispe N, 2002, FASEB J, V16, P1526, DOI 10.1096/fj.02-0829com; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cecchi C, 2005, J CELL SCI, V118, P3459, DOI 10.1242/jcs.02473; Chin J, 2004, J NEUROSCI, V24, P4692, DOI 10.1523/JNEUROSCI.0277-04.2004; ChooSmith LP, 1997, J BIOL CHEM, V272, P22987, DOI 10.1074/jbc.272.37.22987; Cordy JM, 2003, P NATL ACAD SCI USA, V100, P11735, DOI 10.1073/pnas.1635130100; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fulga TA, 2007, NAT CELL BIOL, V9, P139, DOI 10.1038/ncb1528; Gellermann GP, 2005, P NATL ACAD SCI USA, V102, P6297, DOI 10.1073/pnas.0407035102; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Hayashi H, 2004, J NEUROSCI, V24, P4894, DOI 10.1523/JNEUROSCI.0861-04.2004; Heredia L, 2006, J NEUROSCI, V26, P6533, DOI 10.1523/JNEUROSCI.5567-05.2006; Hering H, 2003, J NEUROSCI, V23, P3262; Kakio A, 2003, BIOCHEM BIOPH RES CO, V303, P514, DOI 10.1016/S0006-291X(03)00386-3; Kawarabayashi T, 2004, J NEUROSCI, V24, P3801, DOI 10.1523/JNEUROSCI.5543-03.2004; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kelly BL, 2006, J BIOL CHEM, V281, P28079, DOI 10.1074/jbc.M605081200; Kim SI, 2006, J CELL BIOCHEM, V99, P878, DOI 10.1002/jcb.20978; Klein C, 2002, J NEUROSCI, V22, P698, DOI 10.1523/JNEUROSCI.22-03-00698.2002; Klein WL, 2002, NEUROCHEM INT, V41, P345, DOI 10.1016/S0197-0186(02)00050-5; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Lambert MP, 1998, P NATL ACAD SCI USA, V95, P6448, DOI 10.1073/pnas.95.11.6448; Liu TB, 2004, J NEUROCHEM, V88, P554, DOI 10.1046/j.1471-4159.2003.02196.x; Lue LF, 1999, AM J PATHOL, V155, P853, DOI 10.1016/S0002-9440(10)65184-X; Maloney MT, 2005, J NEUROSCI, V25, P11313, DOI 10.1523/JNEUROSCI.3711-05.2005; Morishima-Kawashima M, 1998, BIOCHEMISTRY-US, V37, P15247, DOI 10.1021/bi981843u; Morrow IC, 2005, TRAFFIC, V6, P725, DOI 10.1111/j.1600-0854.2005.00318.x; Naslund J, 2000, JAMA-J AM MED ASSOC, V283, P1571, DOI 10.1001/jama.283.12.1571; Oshima N, 2001, AM J PATHOL, V158, P2209, DOI 10.1016/S0002-9440(10)64693-7; Rapoport M, 2002, P NATL ACAD SCI USA, V99, P6364, DOI 10.1073/pnas.092136199; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Sharma VM, 2007, J CELL SCI, V120, P748, DOI 10.1242/jcs.03378; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wogulis M, 2005, J NEUROSCI, V25, P1071, DOI 10.1523/JNEUROSCI.2381-04.2005; Yamamoto N, 2007, J BIOL CHEM, V282, P2646, DOI 10.1074/jbc.M606202200; YANAGISAWA K, 1995, NAT MED, V1, P1062, DOI 10.1038/nm1095-1062; Yip CM, 2001, J MOL BIOL, V311, P723, DOI 10.1006/jmbi.2001.4881	40	99	102	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1552	1559		10.1096/fj.07-9766com	http://dx.doi.org/10.1096/fj.07-9766com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18096814				2022-12-25	WOS:000255898700027
J	Ginger, RS; Askew, SE; Ogborne, RM; Wilson, S; Ferdinando, D; Dadd, T; Smith, AM; Kazi, S; Szerencsei, RT; Winkfein, RJ; Schnetkamp, PPM; Green, MR				Ginger, Rebecca S.; Askew, Sarah E.; Ogborne, Richard M.; Wilson, Stephen; Ferdinando, Dudley; Dadd, Tony; Smith, Adrian M.; Kazi, Shubana; Szerencsei, Robert T.; Winkfein, Robert J.; Schnetkamp, Paul P. M.; Green, Martin R.			SLC24A5 encodes a trans-golgi network protein with potassium-dependent sodium-calcium exchange activity that regulates human epidermal melanogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ BINDING POCKET; SKIN PIGMENTATION; RETINAL CONE; FUNCTIONAL-PROPERTIES; MOLECULAR-CLONING; TYROSINASE; CA2+; EXPRESSION; NCKX2; RESIDUES	A non-synonymous single nucleotide polymorphism in the human SLC24A5 gene is associated with natural human skin color variation. Multiple sequence alignments predict that this gene encodes a member of the potassium-dependent sodium-calcium exchanger family denoted NCKX5. In cultured human epidermal melanocytes we show using affinity-purified antisera that native human NCKX5 runs as a triplet of similar to 43 kDa on SDS-PAGE and is partially localized to the trans-Golgi network. Removal of the NCKX5 protein through small interfering RNA-mediated knockdown disrupts melanogenesis in human and murine melanocytes, causing a significant reduction in melanin pigment production. Using a heterologous expression system, we confirm for the first time that NCKX5 possesses the predicted exchanger activity. Site-directed mutagenesis of NCKX5 and NCKX2 in this system reveals that the non-synonymous single nucleotide polymorphism in SLC24A5 alters a residue that is important for NCKX5 and NCKX2 activity. We suggest that NCKX5 directly regulates human epidermal melanogenesis and natural skin color through its intracellular potassium-dependent exchanger activity.	[Ginger, Rebecca S.; Askew, Sarah E.; Ogborne, Richard M.; Wilson, Stephen; Ferdinando, Dudley; Dadd, Tony; Smith, Adrian M.; Kazi, Shubana; Green, Martin R.] Unilever Res Labs Colworth, Colworth Sci Parks, Sharnbrook MK44 1LQ, Beds, England; [Szerencsei, Robert T.; Winkfein, Robert J.; Schnetkamp, Paul P. M.] Univ Calgary, Hotchkiss Brain Inst, Dept Phys & Biophys, Calgary, AB T2N 4N1, Canada	Unilever; University of Calgary	Ginger, RS (corresponding author), Unilever Res Labs Colworth, Colworth Sci Parks, Sharnbrook MK44 1LQ, Beds, England.	rebecca.ginger@unilever.com		Smith, Adrian/0000-0001-8833-2330				Altimimi HF, 2007, CHANNELS, V1, P62, DOI 10.4161/chan.4366; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Annunziato L, 2007, ANN NY ACAD SCI, V1099, P413, DOI 10.1196/annals.1387.050; Barsh GS, 2003, PLOS BIOL, V1, P19, DOI 10.1371/journal.pbio.0000027; Cai XJ, 2004, MOL BIOL EVOL, V21, P1692, DOI 10.1093/molbev/msh177; Chen K, 2004, PIGM CELL RES, V17, P36, DOI 10.1046/j.1600-0749.2003.00106.x; Chen K, 2002, MOL BIOL CELL, V13, P1953, DOI 10.1091/mbc.02-02-0022; Chi A, 2006, J PROTEOME RES, V5, P3135, DOI 10.1021/pr060363j; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Cook AL, 2003, J INVEST DERMATOL, V121, P1150, DOI 10.1046/j.1523-1747.2003.12562.x; Dolman NJ, 2006, CELL CALCIUM, V40, P505, DOI 10.1016/j.ceca.2006.08.012; Fuller BB, 2001, EXP CELL RES, V262, P197, DOI 10.1006/excr.2000.5092; Halaban R, 2002, J BIOL CHEM, V277, P14821, DOI 10.1074/jbc.M111497200; Hall AM, 2005, PIGM CELL RES, V18, P122, DOI 10.1111/j.1600-0749.2005.00213.x; Hu ZL, 2000, NAT GENET, V24, P61, DOI 10.1038/71701; HUNT MW, 1995, ADV MATER PROCESS, V147, P4; IOZUMI K, 1993, J INVEST DERMATOL, V100, P806, DOI 10.1111/1523-1747.ep12476630; Izagirre N, 2006, MOL BIOL EVOL, V23, P1697, DOI 10.1093/molbev/msl030; Jackson IJ, 2006, EUR J HUM GENET, V14, P978, DOI 10.1038/sj.ejhg.5201659; Kang HY, 1998, PFLUG ARCH EUR J PHY, V435, P350, DOI 10.1007/s004240050522; Kang KJ, 2005, J BIOL CHEM, V280, P6823, DOI 10.1074/jbc.M407933200; Kinjo TG, 2005, BIOCHEMISTRY-US, V44, P7787, DOI 10.1021/bi0502442; Kinjo TG, 2003, BIOCHEMISTRY-US, V42, P2485, DOI 10.1021/bi0270788; Lamason RL, 2005, SCIENCE, V310, P1782, DOI 10.1126/science.1116238; LASKIN JD, 1982, J CELL PHYSIOL, V113, P481, DOI 10.1002/jcp.1041130318; MAYORGA LS, 1994, J BIOL CHEM, V269, P30927; Myles S, 2007, HUM GENET, V120, P613, DOI 10.1007/s00439-006-0256-4; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; NIKOMATSU L, 2007, IN PRESS J INVESTIG; Norton HL, 2007, MOL BIOL EVOL, V24, P710, DOI 10.1093/molbev/msl203; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Pinton P, 1998, EMBO J, V17, P5298, DOI 10.1093/emboj/17.18.5298; Prinsen CFM, 2000, J NEUROSCI, V20, P1424; Pryor PR, 2000, J CELL BIOL, V149, P1053, DOI 10.1083/jcb.149.5.1053; Raposo G, 2001, J CELL BIOL, V152, P809, DOI 10.1083/jcb.152.4.809; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Schallreuter KU, 1999, BIOCHEM BIOPH RES CO, V262, P423, DOI 10.1006/bbrc.1999.1241; Schallreuter KU, 2001, J PHOTOCH PHOTOBIO B, V64, P179, DOI 10.1016/S1011-1344(01)00235-4; Sheng JZ, 2000, BIOPHYS J, V79, P1945, DOI 10.1016/S0006-3495(00)76443-5; Shriver MD, 2003, HUM GENET, V112, P387, DOI 10.1007/s00439-002-0896-y; Smith DR, 2004, EXP CELL RES, V298, P521, DOI 10.1016/j.yexcr.2004.04.033; Soejima M, 2007, INT J LEGAL MED, V121, P36, DOI 10.1007/s00414-006-0112-z; Stokowski RP, 2007, AM J HUM GENET, V81, P1119, DOI 10.1086/522235; Sturm RA, 2001, GENE, V277, P49, DOI 10.1016/S0378-1119(01)00694-1; Sudbrak R, 2000, HUM MOL GENET, V9, P1131, DOI 10.1093/hmg/9.7.1131; Szerencsei RT, 2000, J BIOL CHEM, V275, P669, DOI 10.1074/jbc.275.1.669; Valencia JC, 2007, J BIOL CHEM, V282, P11266, DOI 10.1074/jbc.M608449200; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; Visser F, 2007, J BIOL CHEM, V282, P4453, DOI 10.1074/jbc.M610582200; Wang N, 2006, PIGM CELL RES, V19, P3, DOI 10.1111/j.1600-0749.2005.00288.x; Winkfein RJ, 2003, BIOCHEMISTRY-US, V42, P543, DOI 10.1021/bi026982x	51	97	105	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5486	5495		10.1074/jbc.M707521200	http://dx.doi.org/10.1074/jbc.M707521200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18166528				2022-12-25	WOS:000253426700029
J	Kienesberger, PC; Lass, A; Preiss-Landl, K; Wolinski, H; Kohlwein, SD; Zimmermann, R; Zechner, R				Kienesberger, Petra C.; Lass, Achim; Preiss-Landl, Karina; Wolinski, Heimo; Kohlwein, Sepp D.; Zimmermann, Robert; Zechner, Rudolf			Identification of an insulin-regulated lysophospholipase with homology to neuropathy target esterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID; EXPRESSION; PROTEIN; CELLS; DOMAIN; GLYCEROPHOSPHOCHOLINE; PHOSPHATIDYLCHOLINE; NEURODEGENERATION; PROLIFERATION; TRANSACYLASE	Neuropathy target esterase (NTE) is a member of the family of patatin domain-containing proteins and exhibits phospholipase activity in brain and cultured cells. NTE was originally identified as target enzyme for organophosphorus compounds that cause a delayed paralyzing syndrome with degeneration of nerve axons. Here we show that the structurally related murine protein NTE-related esterase (NRE) is a potent lysophospholipase. The enzyme efficiently hydrolyzes sn-1 esters in lysophosphatidylcholine and lysophosphatidic acid. No lipase activity was observed when triacylglycerols, cholesteryl esters, retinyl esters, phosphatidylcholine, or monoacylglycerol were used as substrates. Although NTE is predominantly expressed in the nervous system, we found the highest NRE mRNA levels in testes, skeletal muscle, cardiac muscle, and adipose tissue. Induction of NRE mRNA concentrations in these tissues during fasting suggested a nutritional regulation of enzyme expression and, in accordance with this observation, insulin reduced NRE mRNA levels in a dose-dependent manner in 3T3-L1 adipocytes. A green fluorescent protein-NRE fusion protein colocalized to the endoplasmic reticulum and lipid droplets. Thus, NRE is a previously unrecognized ER- and lipid droplet-associated lysophospholipase. Regulation of enzyme expression by the nutritional status and insulin suggests a role of NRE in the catabolism of lipid precursors and/or mediators that affect energy metabolism in mammals.	[Kienesberger, Petra C.; Lass, Achim; Preiss-Landl, Karina; Wolinski, Heimo; Kohlwein, Sepp D.; Zimmermann, Robert; Zechner, Rudolf] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria	University of Graz	Zechner, R (corresponding author), Graz Univ, Inst Mol Biosci, Heinrichstr 31, A-8010 Graz, Austria.	rudolf.zechner@uni-graz.at	Lass, Achim/C-3332-2008	Lass, Achim/0000-0002-8190-7151; Wolinski, Heimo/0000-0002-1583-6092; Kohlwein, Sepp Dieter/0000-0002-1030-0598; Zechner, Rudolf/0000-0001-5483-1182; Kienesberger, Petra/0000-0001-9643-8338; Zimmermann, Robert/0000-0002-7354-870X	Austrian Science Fund FWF [F 3002, F 3005, W 901] Funding Source: Medline; Austrian Science Fund (FWF) [Z 136, F 3002, F 3005, W 901] Funding Source: researchfish	Austrian Science Fund FWF(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))		Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; Atkins J, 2000, J BIOL CHEM, V275, P24477, DOI 10.1074/jbc.M002921200; Bajpai M, 1998, ANDROLOGIA, V30, P311; Boechzelt H, 1998, J LIPID RES, V39, P1503; Drecktrah D, 2003, MOL BIOL CELL, V14, P3459, DOI 10.1091/mbc.E02-11-0711; ESTIVILLTORRUS G, 2007, IN PRESS CEREB CORTE; Ferry G, 2003, J BIOL CHEM, V278, P18162, DOI 10.1074/jbc.M301158200; Gallazzini M, 2006, P NATL ACAD SCI USA, V103, P15260, DOI 10.1073/pnas.0607133103; Gao J, 2005, J INVEST DERMATOL, V124, P1259, DOI 10.1111/j.0022-202X.2005.23761.x; Glynn P, 1999, BIOCHEM J, V344, P625, DOI 10.1042/0264-6021:3440625; Glynn P, 2000, PROG NEUROBIOL, V61, P61, DOI 10.1016/S0301-0082(99)00043-X; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; JOHNSON MK, 1977, ARCH TOXICOL, V37, P113, DOI 10.1007/BF00293860; JOHNSON MK, 1975, ARCH TOXICOL, V34, P259, DOI 10.1007/BF00353848; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; KUME N, 1992, J CLIN INVEST, V90, P1138, DOI 10.1172/JCI115932; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lake AC, 2005, J LIPID RES, V46, P2477, DOI 10.1194/jlr.M500290-JLR200; Leslie CC, 2004, BIOCHEM CELL BIOL, V82, P1, DOI 10.1139/o03-080; Li Y, 2003, J BIOL CHEM, V278, P8820, DOI 10.1074/jbc.M210743200; Lush MJ, 1998, BIOCHEM J, V332, P1; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; MOOLENAAR WH, 1995, J BIOL CHEM, V270, P12949, DOI 10.1074/jbc.270.22.12949; Moser M, 2004, MOL CELL BIOL, V24, P1667, DOI 10.1128/MCB.24.4.1667-1679.2004; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Murugesan G, 2003, J MOL CELL CARDIOL, V35, P1375, DOI 10.1016/j.yjmcc.2003.08.004; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Quistad GB, 2003, P NATL ACAD SCI USA, V100, P7983, DOI 10.1073/pnas.1232473100; Shewry PR, 2003, ANN BOT-LONDON, V91, P755, DOI 10.1093/aob/mcg084; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Soga T, 2005, BIOCHEM BIOPH RES CO, V326, P744, DOI 10.1016/j.bbrc.2004.11.120; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Toyoda T, 1999, BBA-MOL CELL BIOL L, V1437, P182, DOI 10.1016/S1388-1981(99)00007-4; van Tienhoven M, 2002, J BIOL CHEM, V277, P20942, DOI 10.1074/jbc.M200330200; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang AJ, 1999, BBA-MOL CELL BIOL L, V1439, P1, DOI 10.1016/S1388-1981(99)00063-3; Wang AJ, 1997, J BIOL CHEM, V272, P12723, DOI 10.1074/jbc.272.19.12723; Wilson PA, 2006, J LIPID RES, V47, P1940, DOI 10.1194/jlr.M600185-JLR200; Winrow CJ, 2003, NAT GENET, V33, P477, DOI 10.1038/ng1131; Wolins NE, 2006, J LIPID RES, V47, P450, DOI 10.1194/jlr.D500037-JLR200; Xie MX, 2003, ARCH BIOCHEM BIOPHYS, V416, P137, DOI 10.1016/S0003-9861(03)00264-9; YAMAMOTO N, 1987, CANCER RES, V47, P2008; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zhang HC, 2007, J BIOL CHEM, V282, P15541, DOI 10.1074/jbc.M700702200; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	48	45	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5908	5917		10.1074/jbc.M709598200	http://dx.doi.org/10.1074/jbc.M709598200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086666	hybrid			2022-12-25	WOS:000253426700069
J	Rouget, R; Auclair, Y; Loignon, M; Affar, EB; Drobetsky, EA				Rouget, Raphael; Auclair, Yannick; Loignon, Martin; Affar, El Bachir; Drobetsky, Elliot A.			A sensitive flow Cytometry-based nucleotide excision repair assay unexpectedly reveals that mitogen-activated protein kinase signaling does not regulate the removal of UV-induced DNA damage in human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; XERODERMA-PIGMENTOSUM; C-JUN; INDUCED PHOSPHORYLATION; MAPKAP KINASE-2; JNK ACTIVATION; P53 PROTEIN; EXPRESSION; APOPTOSIS; PATHWAY	In response to diverse genotoxic stimuli ( e. g. UV and cisplatin), the mitogen-activated protein kinases ERK1/2, JNK1/2, and p38 alpha/beta become rapidly phosphorylated and in turn activate multiple downstream effectors that modulate apoptosis and/or growth arrest. Furthermore, previous lines of evidence have strongly suggested that ERK1/2 and JNK1/2 participate in global-genomic nucleotide excision repair, a critical antineoplastic pathway that removes helix-distorting DNA adducts induced by a variety of mutagenic agents, including UV. To rigorously evaluate the potential role of mitogen-activated protein kinases in global-genomic nucleotide excision repair, various human cell strains ( primary skin fibroblasts, primary lung fibroblasts, and HCT116 colon carcinoma cells) were treated with highly specific chemical inhibitors, which, following UV exposure, (i) abrogated the capacities of ERK1/2, JNK1/2, or p38 alpha/beta to phosphorylate specific downstream effectors and (ii) characteristically modulated cellular proliferation, clonogenic survival, and/or apoptosis. A highly sensitive flow cytometry-based nucleotide excision repair assay recently optimized and validated in our laboratory was then employed to directly demonstrate that the kinetics of UV DNA photoadduct repair are highly similar in mock-treated versus mitogen-activated protein kinase inhibitor-treated cells. These data on primary and tumor cells treated with pharmacological inhibitors were fully corroborated by repair studies using ( i) short hairpin RNA-mediated knockdown of ERK1/2 or JNK1/2 in human U2OS osteosarcoma cells and ( ii) expression of a dominant negative p38 alpha mutant in human primary lung fibroblasts. Our results provide solid evidence for the first time, in disaccord with a burgeoning perception, that mitogen-activated protein kinase signaling does not influence the efficiency of human global-genomic nucleotide excision repair.	[Rouget, Raphael; Auclair, Yannick; Loignon, Martin; Affar, El Bachir; Drobetsky, Elliot A.] Univ Montreal, Hop Maison Neuve Rosemont, Res Ctr, Fac Med,Dept Immunol & Oncol, Montreal, PQ H1T 2M4, Canada	Universite de Montreal	Drobetsky, EA (corresponding author), Maisonneuve Rosemont Hosp Res Ctr, 5415 Boul Assomption, Montreal, PQ H1T 2M4, Canada.	elliot.drobetsky@umontreal.ca						ABOUSSEKHRA A, 1995, CELL, V80, P859, DOI 10.1016/0092-8674(95)90289-9; Adimoolam S, 2002, P NATL ACAD SCI USA, V99, P12985, DOI 10.1073/pnas.202485699; Andrieux LO, 2007, CANCER RES, V67, P2114, DOI 10.1158/0008-5472.CAN-06-3821; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; BERG RJW, 1993, CARCINOGENESIS, V14, P103, DOI 10.1093/carcin/14.1.103; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Buschmann T, 2001, MOL CELL BIOL, V21, P2743, DOI 10.1128/MCB.21.8.2743-2754.2001; Christmann M, 2007, CARCINOGENESIS, V28, P183, DOI 10.1093/carcin/bgl119; Christmann M, 2006, NUCLEIC ACIDS RES, V34, P6530, DOI 10.1093/nar/gkl895; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Clifton AD, 1996, FEBS LETT, V392, P209, DOI 10.1016/0014-5793(96)00816-2; Du LH, 2004, J BIOL CHEM, V279, P11957, DOI 10.1074/jbc.M304935200; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; FORD JM, 1995, P NATL ACAD SCI USA, V92, P8876, DOI 10.1073/pnas.92.19.8876; Gjerset RA, 1999, CELL GROWTH DIFFER, V10, P545; Gururajan M, 2005, BLOOD, V106, P1382, DOI 10.1182/blood-2004-10-3819; Hanawalt PC, 2001, ENVIRON MOL MUTAGEN, V38, P89, DOI 10.1002/em.1057; Hayakawa J, 2003, J BIOL CHEM, V278, P20582, DOI 10.1074/jbc.M210992200; Hildesheim J, 2004, DNA REPAIR, V3, P567, DOI 10.1016/j.dnarep.2004.02.012; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Hwang BJ, 1999, P NATL ACAD SCI USA, V96, P424, DOI 10.1073/pnas.96.2.424; Johnson GL, 2007, BBA-MOL CELL RES, V1773, P1341, DOI 10.1016/j.bbamcr.2006.12.009; Kraemer KH, 2007, NEUROSCIENCE, V145, P1388, DOI 10.1016/j.neuroscience.2006.12.020; LEE JC, 1994, NATURE, V372, P739, DOI 10.1038/372739a0; Li JL, 2007, J BIOMED SCI, V14, P303, DOI 10.1007/s11373-007-9148-4; Liu J, 2005, CELL RES, V15, P36, DOI 10.1038/sj.cr.7290262; Loignon M, 2002, CARCINOGENESIS, V23, P35, DOI 10.1093/carcin/23.1.35; Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021; Mathonnet R, 2003, P NATL ACAD SCI USA, V100, P7219, DOI 10.1073/pnas.123216100; Melnikova VO, 2005, MUTAT RES-FUND MOL M, V571, P91, DOI 10.1016/j.mrfmmm.2004.11.015; MITCHELL DL, 1985, MUTAT RES, V143, P109, DOI 10.1016/S0165-7992(85)80018-X; Nojima K, 2005, CANCER RES, V65, P11704, DOI 10.1158/0008-5472.CAN-05-1214; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Potapova O, 2001, J BIOL CHEM, V276, P28546, DOI 10.1074/jbc.M102075200; Potapova O, 1997, J BIOL CHEM, V272, P14041, DOI 10.1074/jbc.272.22.14041; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rubbi CP, 2003, EMBO J, V22, P975, DOI 10.1093/emboj/cdg082; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; She QB, 2000, J BIOL CHEM, V275, P20444, DOI 10.1074/jbc.M001020200; She QB, 2002, ONCOGENE, V21, P1580, DOI 10.1038/sj.onc.1205239; Smith ML, 2000, MOL CELL BIOL, V20, P3705, DOI 10.1128/MCB.20.10.3705-3714.2000; Therrien JP, 1999, P NATL ACAD SCI USA, V96, P15038, DOI 10.1073/pnas.96.26.15038; Ussar S, 2004, J BIOL CHEM, V279, P43861, DOI 10.1074/jbc.M406240200	43	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5533	5541		10.1074/jbc.M706257200	http://dx.doi.org/10.1074/jbc.M706257200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093981	hybrid			2022-12-25	WOS:000253426700034
J	Petropoulos, AD; Kouvela, EC; Dinos, GP; Kalpaxis, DL				Petropoulos, Alexandros D.; Kouvela, Ekaterini C.; Dinos, George P.; Kalpaxis, Dimitrios L.			Stepwise binding of tylosin and erythromycin to Escherichia coli ribosomes, characterized by kinetic and footprinting analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYL TRANSFERASE CENTER; MACROLIDE ANTIBIOTICS; RESISTANCE MUTATION; PROTEIN-SYNTHESIS; STRUCTURAL BASIS; BOND FORMATION; BLASTICIDIN-S; RNA; SITE; SUBUNIT	Erythromycin and tylosin are 14- and 16-membered lactone ring macrolides, respectively. The current work shows by means of kinetic and chemical footprinting analysis that both antibiotics bind to Escherichia coli ribosomes in a two-step process. The first step established rapidly, involves a low-affinity binding site placed at the entrance of the exit tunnel in the large ribosomal subunit, where macrolides bind primarily through their hydrophobic portions. Subsequently, slow conformational changes mediated by the antibiotic hydrophilic portion push the drugs deeper into the tunnel, in a high-affinity site. Compared with erythromycin, tylosin shifts to the high-affinity site more rapidly, due to the interaction of the mycinose sugar of the drug with the loop of H35 in domain II of 23 S rRNA. Consistently, mutations of nucleosides U2609 and U754 implicated in the high-affinity site reduce the shift of tylosin to this site and destabilize, respectively, the final drug-ribosome complex. The weak interaction between tylosin and the ribosome is Mg2+ independent, unlike the tight binding. In contrast, both interactions between erythromycin and the ribosome are reduced by increasing concentrations of Mg2+ ions. Polyamines attenuate erythromycin affinity for the ribosome at both sequential steps of binding. In contrast, polyamines facilitate the initial binding of tylosin, but exert a detrimental, more pronounced, effect on the drug accommodation at its final position. Our results emphasize the role of the particular interactions that side chains of tylosin and erythromycin establish with 23 S rRNA, which govern the exact binding process of each drug and its response to the ionic environment.	[Petropoulos, Alexandros D.; Kouvela, Ekaterini C.; Dinos, George P.; Kalpaxis, Dimitrios L.] Univ Patras, Sch Med, Biochem Lab, Patras 26500, Greece	University of Patras	Kalpaxis, DL (corresponding author), Univ Patras, Sch Med, Biochem Lab, Patras 26500, Greece.	dimkal@med.upatras.gr	Dinos, George/AAR-8444-2020	Dinos, George/0000-0003-3914-7408				Amarantos I, 2001, BIOCHEMISTRY-US, V40, P7641, DOI 10.1021/bi010010s; Berisio R, 2006, ANTIMICROB AGENTS CH, V50, P3816, DOI 10.1128/AAC.00767-06; Bertho G, 1998, BIOORGAN MED CHEM, V6, P209, DOI 10.1016/S0968-0896(97)10028-1; Braga PC, 2004, INT J ANTIMICROB AG, V24, P254, DOI 10.1016/j.ijantimicag.2004.02.031; Champney W. S., 2001, Current Drug Targets - Infectious Disorders, V1, P19, DOI 10.2174/1568005013343281; Davydova N, 2002, J MOL BIOL, V322, P635, DOI 10.1016/S0022-2836(02)00772-6; DIGIAMBATTISTA M, 1987, J BIOL CHEM, V262, P8591; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; Dinos GP, 2000, BIOCHEMISTRY-US, V39, P11621, DOI 10.1021/bi000811f; DOUTHWAITE S, 1993, J MOL BIOL, V232, P725, DOI 10.1006/jmbi.1993.1426; EHRESMANN C, 1987, NUCLEIC ACIDS RES, V15, P9109, DOI 10.1093/nar/15.22.9109; FERNANDEZMUNOZ R, 1973, J ANTIBIOT, V26, P107, DOI 10.7164/antibiotics.26.107; Garza-Ramos G, 2001, J BACTERIOL, V183, P6898, DOI 10.1128/JB.183.23.6898-6907.2001; GOLDMAN RC, 1990, ANTIMICROB AGENTS CH, V34, P426, DOI 10.1128/AAC.34.3.426; Hansen JL, 2002, MOL CELL, V10, P117, DOI 10.1016/S1097-2765(02)00570-1; Hansen LH, 1999, MOL MICROBIOL, V31, P623, DOI 10.1046/j.1365-2958.1999.01202.x; Hennelly SP, 2005, J MOL BIOL, V346, P1243, DOI 10.1016/j.jmb.2004.12.054; KALPAXIS DL, 1986, EUR J BIOCHEM, V154, P267, DOI 10.1111/j.1432-1033.1986.tb09392.x; Katz L, 2005, CHEM REV, V105, P499, DOI 10.1021/cr030107f; Kirillov SV, 1999, RNA, V5, P1003, DOI 10.1017/S1355838299990568; Liu MF, 2002, P NATL ACAD SCI USA, V99, P14658, DOI 10.1073/pnas.232580599; Lovmar M, 2004, J BIOL CHEM, V279, P53506, DOI 10.1074/jbc.M401625200; MOAZED D, 1987, BIOCHIMIE, V69, P879, DOI 10.1016/0300-9084(87)90215-X; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Nanavaty J, 1998, CURR MICROBIOL, V36, P212; Petropoulos AD, 2004, J BIOL CHEM, V279, P26518, DOI 10.1074/jbc.M313634200; Pfister P, 2005, P NATL ACAD SCI USA, V102, P5180, DOI 10.1073/pnas.0501598102; Pfister P, 2004, J MOL BIOL, V342, P1569, DOI 10.1016/j.jmb.2004.07.095; Poulsen SM, 2000, J MOL BIOL, V304, P471, DOI 10.1006/jmbi.2000.4229; RODRIGUEZFONSECA C, 1995, J MOL BIOL, V247, P224, DOI 10.1006/jmbi.1994.0135; Schlunzen F, 2001, NATURE, V413, P814, DOI 10.1038/35101544; STERN S, 1988, METHOD ENZYMOL, V164, P481; TEJEDOR F, 1986, BIOCHEMISTRY-US, V25, P7725, DOI 10.1021/bi00371a066; TERAOKA H, 1973, EUR J BIOCHEM, V33, P578, DOI 10.1111/j.1432-1033.1973.tb02718.x; Thompson J, 2004, ANTIMICROB AGENTS CH, V48, P4889, DOI 10.1128/AAC.48.12.4889-4891.2004; Tu D, 2005, CELL, V121, P257, DOI 10.1016/j.cell.2005.02.005; Vazquez D, 1979, MOL BIOL BIOCH BIOPH, V30, P1, DOI 10.1007/978-3-642-81309-2; Vester B, 2001, ANTIMICROB AGENTS CH, V45, P1, DOI 10.1128/AAC.45.1.1-12.2001; VOGEL Z, 1971, J MOL BIOL, V60, P339, DOI 10.1016/0022-2836(71)90298-1; WEISBLUM B, 1995, ANTIMICROB AGENTS CH, V39, P797, DOI 10.1128/AAC.39.4.797; Wilson DN, 2005, BIOL CHEM, V386, P1239, DOI 10.1515/BC.2005.141; Xaplanteri MA, 2005, NUCLEIC ACIDS RES, V33, P2792, DOI 10.1093/nar/gki557; Yan K, 2005, ANTIMICROB AGENTS CH, V49, P3367, DOI 10.1128/AAC.49.8.3367-3372.2005; Zhong P, 1999, MICROB DRUG RESIST, V5, P183, DOI 10.1089/mdr.1999.5.183	44	21	22	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4756	4765		10.1074/jbc.M708371200	http://dx.doi.org/10.1074/jbc.M708371200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18079110	hybrid			2022-12-25	WOS:000253426500033
J	Seino, Y; Miki, T; Kiyonari, H; Abe, T; Fujimoto, W; Kimura, K; Takeuchi, A; Takahashi, Y; Oiso, Y; Iwanaga, T; Seino, S				Seino, Yusuke; Miki, Takashi; Kiyonari, Hiroshi; Abe, Takaya; Fujimoto, Wakako; Kimura, Keita; Takeuchi, Ayako; Takahashi, Yoshihisa; Oiso, Yutaka; Iwanaga, Toshihiko; Seino, Susumu			Isx participates in the maintenance of vitamin A metabolism by regulation of beta-carotene 15,15 '-Monooxygenase (Bcmo1) expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B SCAVENGER RECEPTOR; I SR-BI; CDX2 MUTANT MICE; BETA,BETA-CAROTENE 15,15'-MONOOXYGENASE; STEM-CELLS; IDENTIFICATION; INTESTINE; GENE; DIFFERENTIATION; ABSORPTION	Isx (intestine specific homeobox) is an intestine-specific transcription factor. To elucidate its physiological function, we generated Isx-deficient mice by knocking in the beta-galactosidase gene (LacZ) in the Isx locus (Isx(LacZ/ LacZ) mice). LacZ staining of heterozygous (Isx(LacZ/+)) mice revealed that Isx was expressed abundantly in intestinal epithelial cells from duodenum to proximal colon. Quantitative mRNA expression profiling of duodenum and jejunum showed that beta-carotene 15,15 '-monooxygenase (EC1.14.99.36 Bcmo1) and the class B type I scavenger receptor, which are involved in vitamin A synthesis and carotenoid uptake, respectively, were drastically increased in Isx(LacZ/LacZ) mice. Although mild vitamin A deficiency decreased Isx expression in duodenum of wild-type (Isx(+/+)) mice, severe vitamin A deficiency decreased Isx mRNA expression in both duodenum and jejunum of Isx(+/+) mice. On the other hand, vitamin A deficiency increased Bcmo1 expression in both duodenum and jejunum of Isx(+/+) mice. However, Bcmo1 expression was not increased in duodenum of Isx(LacZ/LacZ) mice by mild vitamin A deficiency. These data suggest that Isx participates in the maintenance of vitamin A metabolism by regulating Bcmo1 expression in the intestine.	[Seino, Yusuke; Miki, Takashi; Fujimoto, Wakako; Kimura, Keita; Takahashi, Yoshihisa; Seino, Susumu] Kobe Univ, Grad Sch Med, Div Cellular & Mol Med, Kobe, Hyogo 6500017, Japan; [Seino, Yusuke; Oiso, Yutaka] Nagoya Univ, Grad Sch Med, Div Endocrinol & Diabet, Nagoya, Aichi 4668550, Japan; [Kiyonari, Hiroshi; Abe, Takaya] RIKEN, Ctr Dev Biol, Lab Anim Resources & Genet Engn, Kobe, Aichi 6500047, Japan; [Fujimoto, Wakako] Hokkaido Univ, Grad Sch Med, Lab Histol & Cytol, Kobe, Hyogo 6500017, Japan	Kobe University; Nagoya University; RIKEN; Hokkaido University	Seino, S (corresponding author), 7-5-1 Kusunoki,Chuo Ku, Kobe, Hyogo 6500017, Japan.	seino@med.kobe-u.ac.jp	Kiyonari, Hiroshi/N-7936-2015; MIKI, Takashi/ABD-3995-2020	MIKI, Takashi/0000-0001-5741-1626				ACTON SL, 1994, J BIOL CHEM, V269, P21003; Bach SP, 2000, CARCINOGENESIS, V21, P469, DOI 10.1093/carcin/21.3.469; Bachmann H, 2002, J NUTR, V132, P3616, DOI 10.1093/jn/132.12.3616; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Beck F, 1999, P NATL ACAD SCI USA, V96, P7318, DOI 10.1073/pnas.96.13.7318; Bietrix F, 2006, J BIOL CHEM, V281, P7214, DOI 10.1074/jbc.M508868200; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Cai SF, 2001, J LIPID RES, V42, P902; CALVO D, 1993, J BIOL CHEM, V268, P18929; Chawengsaksophak K, 1997, NATURE, V386, P84, DOI 10.1038/386084a0; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Choi MY, 2006, DEVELOPMENT, V133, P4119, DOI 10.1242/dev.02537; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; During A, 2005, J NUTR, V135, P2305, DOI 10.1093/jn/135.10.2305; Fujimoto W, 2007, P NATL ACAD SCI USA, V104, P15514, DOI 10.1073/pnas.0707328104; GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.biochem.63.1.487; Gong XM, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-7; GOODMAN DS, 1965, SCIENCE, V149, P879, DOI 10.1126/science.149.3686.879; GORDON JI, 1992, FASEB J, V6, P3039, DOI 10.1096/fasebj.6.12.1521737; Hauser H, 1998, BIOCHEMISTRY-US, V37, P17843, DOI 10.1021/bi982404y; HERMISTON ML, 1995, AM J PHYSIOL-GASTR L, V268, pG813, DOI 10.1152/ajpgi.1995.268.5.G813; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kiefer C, 2002, P NATL ACAD SCI USA, V99, P10581, DOI 10.1073/pnas.162182899; Mardones P, 2002, J NUTR, V132, P443, DOI 10.1093/jn/132.3.443; OLSON JA, 1965, P NATL ACAD SCI USA, V54, P1364, DOI 10.1073/pnas.54.5.1364; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Reboul E, 2006, J BIOL CHEM, V281, P4739, DOI 10.1074/jbc.M509042200; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Sakai K, 1997, BIOCHEM BIOPH RES CO, V237, P318, DOI 10.1006/bbrc.1997.7111; SUBRAMANIAN V, 1995, CELL, V83, P641, DOI 10.1016/0092-8674(95)90104-3; van Bennekum A, 2005, BIOCHEMISTRY-US, V44, P4517, DOI 10.1021/bi0484320; Wyss A, 2004, J NUTR, V134, p246S, DOI 10.1093/jn/134.1.246S; YAGI T, 1993, ANAL BIOCHEM, V214, P68; Zhang Y, 2002, J BIOL CHEM, V277, P28065, DOI 10.1074/jbc.C100767200	35	60	68	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4905	4911		10.1074/jbc.M707928200	http://dx.doi.org/10.1074/jbc.M707928200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093975	hybrid			2022-12-25	WOS:000253426500048
J	Liu, ZJ; Zheng, XL; Wang, J; Wang, EK				Liu, Zuojia; Zheng, Xiliang; Wang, Jin; Wang, Erkang			Molecular Analysis of Thymopentin Binding to HLA-DR Molecules	PLOS ONE			English	Article								Thymopentin (TP5) triggers an immune response by contacting with T cells; however the molecular basis of how TP5 achieves this process remains incompletely understood. According to the main idea of immunomodulation, we suppose that it would be necessary for TP5 to form complex with human class II major histocompatibility complex DR molecules (HLA-DR) before TP5 interacts with T cells. The uptake of TP5 by EBV-transformed B cells expressing HLA-DR molecules and the histogram of fluorescence intensities were observed by using fluorescent-labeled TP5, testifying the direct binding of TP5 to HLA-DR. The binding specificity was confirmed by the inhibition with unlabeled TP5, suggesting the recognition of TP5 by HLA-DR. To confirm the interaction between TP5 and HLA-DR, the complex formation was predicted by using various modeling strategies including six groups of trials with different parameters, alanine substitutions of TP5, and the mutants of HLA-DR. The results demonstrated that TP5 and its alanine substitutions assumed distinct conformations when they bound to HLA-DR. The observation further showed that there was flexibility in how the peptide bound within the binding cleft. Also, the molecular analysis supplemented a newly important discovery to the effect of Val anchor on TP5 binding HLA-DR, and revealed the important effects of Glu11 and Asn62 on the recognition of TP5. These results demonstrated the capability of TP5 to associate with HLA-DR in living antigen presenting cells (APC), thereby providing a new and promising strategy to understand the immunomodulation mechanism induced by TP5 and to design potential immunoregulatory polypeptides.	[Liu, Zuojia; Zheng, Xiliang; Wang, Jin; Wang, Erkang] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China; [Wang, Jin] SUNY Stony Brook, Dept Chem & Phys, Stony Brook, NY 11794 USA	Chinese Academy of Sciences; Changchun Institute of Applied Chemistry, CAS; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wang, EK (corresponding author), Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Electroanalyt Chem, Changchun 130022, Jilin, Peoples R China.	ekwang@ciac.jl.cn	, 汪尔康/P-1748-2019		National Natural Science Foundation of China [20575063, 90713022, 20735003]; Chinese Academy of Sciences [KJCX2.YW.H09]; National Science Foundation Career Award; American Chemical Society Petroleum Research Fund	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); National Science Foundation Career Award(National Science Foundation (NSF)); American Chemical Society Petroleum Research Fund(American Chemical Society)	Funding: This work was supported by the National Natural Science Foundation of China with the Grant No. 20575063, 90713022, 20735003 and Chinese Academy of Sciences KJCX2.YW.H09. J.W thanks National Science Foundation Career Award and American Chemical Society Petroleum Research Fund for financial supports. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARVINTE T, 1993, J BIOL CHEM, V268, P6415; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; Bodey B, 2000, INT J IMMUNOPHARMACO, V22, P261, DOI 10.1016/S0192-0561(99)00084-3; Bouvier M, 1998, PROTEINS, V33, P97, DOI 10.1002/(SICI)1097-0134(19981001)33:1<97::AID-PROT9>3.0.CO;2-I; BUUS S, 1987, SCIENCE, V235, P1353, DOI 10.1126/science.2435001; CEPELLINI R, 1989, NATURE, V339, P392; CLARE BA, 2006, J IMMUNOL, V176, P4622; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Feig M, 2004, J MOL GRAPH MODEL, V22, P377, DOI 10.1016/j.jmgm.2003.12.005; GEORGE AH, 1985, ARCH BIOCHEM BIOPHYS, V242, P248; GOLDSTEIN G, 1979, SCIENCE, V204, P1309, DOI 10.1126/science.451537; GREY HM, 1985, IMMUNOL TODAY, V6, P101, DOI 10.1016/0167-5699(85)90025-8; GUILLET JG, 1986, NATURE, V324, P260, DOI 10.1038/324260a0; HAMMER J, 1995, J EXP MED, V181, P1847, DOI 10.1084/jem.181.5.1847; HAWARD W, 1991, CELL, V67, P105; JENSEN PE, 1991, J EXP MED, V174, P111; JENSEN PE, 1990, J EXP MED, V171, P779; KAI W, 1995, P NATL ACAD SCI USA, V92, P11935; Krebs S, 1998, Pharm Acta Helv, V73, P173, DOI 10.1016/S0031-6865(98)00021-1; Lazavecchia AA, 1992, NATURE, V357, P249; Liu S, 2004, PROTEINS, V56, P93, DOI 10.1002/prot.20019; LUESCHER IF, 1988, P NATL ACAD SCI USA, V85, P871, DOI 10.1073/pnas.85.3.871; MASHA FH, 1998, J IMMUNOL, V160, P4386; MASHA HA, 1994, P NATI ACAD SCI US, V91, P4872; McFarland BJ, 1999, BIOCHEMISTRY-US, V38, P16663, DOI 10.1021/bi991393l; MEHLER EL, 1991, PROTEIN ENG, V4, P903, DOI 10.1093/protein/4.8.903; MERRIFIELD RB, 1963, J AM CHEM SOC, V85, P2149, DOI 10.1021/ja00897a025; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; RAMMENSEE HG, 1995, IMMUNOGENETICS, V41, P178, DOI 10.1007/BF00172063; ROBERT B, 1990, INT IMMUNOL, V2, P443; Robertson JM, 2000, J IMMUNOL, V164, P4706, DOI 10.4049/jimmunol.164.9.4706; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Santambrogio L, 1999, P NATL ACAD SCI USA, V96, P15050, DOI 10.1073/pnas.96.26.15050; Sherman MA, 1997, CELL IMMUNOL, V182, P1, DOI 10.1006/cimm.1997.1219; Singh VK, 1998, IMMUNOL RES, V17, P345, DOI 10.1007/BF02786456; Solmajer T, 1990, Drug Des Deliv, V6, P213; SPECK SH, 1987, PROG NUCLEIC ACID RE, V34, P189, DOI 10.1016/S0079-6603(08)60496-1; SUNDAL E, 1994, ARZNEIMITTEL-FORSCH, V44-2, P866; TARA MCH, 2001, J IMMUNOL, V167, P4207; THEODORE S, 1996, P NATL ACAD SCI USA, V93, P734; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; WATTS TH, 1986, P NATL ACAD SCI USA, V83, P9660, DOI 10.1073/pnas.83.24.9660	42	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1348	10.1371/journal.pone.0001348	http://dx.doi.org/10.1371/journal.pone.0001348			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159232	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459700006
J	Finkelman, BS; Viboud, C; Koelle, K; Ferrari, MJ; Bharti, N; Grenfell, BT				Finkelman, Brian S.; Viboud, Cecile; Koelle, Katia; Ferrari, Matthew J.; Bharti, Nita; Grenfell, Bryan T.			Global Patterns in Seasonal Activity of Influenza A/H3N2, A/H1N1, and B from 1997 to 2005: Viral Coexistence and Latitudinal Gradients	PLOS ONE			English	Article							EVOLUTION; H3N2; EPIDEMIOLOGY; SUBTYPE	Despite a mass of research on the epidemiology of seasonal influenza, overall patterns of infection have not been fully described on broad geographic scales and for specific types and subtypes of the influenza virus. Here we provide a descriptive analysis of laboratory-confirmed influenza surveillance data by type and subtype (A/H3N2, A/H1N1, and B) for 19 temperate countries in the Northern and Southern hemispheres from 1997 to 2005, compiled from a public database maintained by WHO (FluNet). Key findings include patterns of large scale co-occurrence of influenza type A and B, interhemispheric synchrony for subtype A/H3N2, and latitudinal gradients in epidemic timing for type A. These findings highlight the need for more countries to conduct year-round viral surveillance and report reliable incidence data at the type and subtype level, especially in the Tropics.	[Finkelman, Brian S.; Ferrari, Matthew J.; Bharti, Nita; Grenfell, Bryan T.] Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, Eberly Coll Sci, University Pk, PA 16802 USA; [Viboud, Cecile; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [Koelle, Katia] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); University of Michigan System; University of Michigan	Finkelman, BS (corresponding author), Penn State Univ, Dept Biol, Ctr Infect Dis Dynam, Eberly Coll Sci, University Pk, PA 16802 USA.	bsf143@psu.edu		Bharti, Nita/0000-0003-1940-7794; Finkelman, Brian/0000-0002-4348-8208	Schreyer Honors College Summer 2007 Research Scholarship	Schreyer Honors College Summer 2007 Research Scholarship	Funding for this work was provided by the Schreyer Honors College Summer 2007 Research Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Bjornstad ON, 1999, TRENDS ECOL EVOL, V14, P427, DOI 10.1016/S0169-5347(99)01677-8; Cannell JJ, 2006, EPIDEMIOL INFECT, V134, P1129, DOI 10.1017/S0950268806007175; Cox NJ, 2000, ANNU REV MED, V51, P407, DOI 10.1146/annurev.med.51.1.407; Dushoff J, 2004, P NATL ACAD SCI USA, V101, P16915, DOI 10.1073/pnas.0407293101; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; FOUCHIER R, 2007, RECOMMENDED LAB TEST; Greene SK, 2006, AM J EPIDEMIOL, V163, P316, DOI 10.1093/aje/kwj040; HOPESIMPSON RE, 1981, J HYG-CAMBRIDGE, V86, P35, DOI 10.1017/S0022172400068728; KILBOURNE ED, 1961, NATURE, V195, P1129; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Lin YP, 2004, VIRUS RES, V103, P47, DOI 10.1016/j.virusres.2004.02.011; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nguyen-Van-Tam JS, 1998, TXB INFLUENZA, P181; Roberts MG, 2001, ECOLOGY WILDLIFE DIS, P63; Simonsen L, 1999, VACCINE, V17, pS3, DOI 10.1016/S0264-410X(99)00099-7; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; SONOGUCHI T, 1986, J INFECT DIS, V153, P33, DOI 10.1093/infdis/153.1.33; SONOGUCHI T, 1985, J INFECT DIS, V151, P81, DOI 10.1093/infdis/151.1.81; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Xia YC, 2005, J R STAT SOC C-APPL, V54, P659, DOI 10.1111/j.1467-9876.2005.05383.x	23	161	165	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1296	10.1371/journal.pone.0001296	http://dx.doi.org/10.1371/journal.pone.0001296			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074020	gold, Green Published			2022-12-25	WOS:000207459500015
J	Benayoun, B; Baghdiguian, S; Lajmanovich, A; Bartoli, M; Daniele, N; Gicquel, E; Bourg, N; Raynaud, F; Pasquier, MA; Suel, L; Lochmuller, H; Lefranc, G; Richard, I				Benayoun, Beatrice; Baghdiguian, Stephen; Lajmanovich, Alicia; Bartoli, Marc; Daniele, Nathalie; Gicquel, Evelyne; Bourg, Nathalie; Raynaud, Fabrice; Pasquier, Marie-Anne; Suel, Laurence; Lochmuller, Hanns; Lefranc, Gerard; Richard, Isabelle			NF-kappa B-dependent expression of the antiapoptotic factor c-FLIP is regulated by calpain 3, the protein involved in limb-girdle muscular dystrophy type 2A	FASEB JOURNAL			English	Article						muscle; apoptosis; FLICE; inhibitary protein; lgmd2A	SKELETAL-MUSCLE ATROPHY; SIGNALING MODULE; MESSENGER-RNA; CELL-DEATH; APOPTOSIS; ACTIVATION; PATHWAY; ALPHA; INSIGHTS; DETERMINANTS	Limb-girdle muscular dystrophy type 2A (LGMD2A) is a recessive genetic disorder caused by mutations in the cysteine protease calpain 3 (CAPN3) that leads to selective muscle wasting. We previously showed that CAPN3 deficiency is associated with a profound perturbation of the NF-kappa B/I kappa B alpha survival pathway. In this study, the consequences of altered NF-kappa B/I kappa B alpha pathway were investigated using biological materials from LGMD2A patients. We first show that die antiapoptotic factor cellular-FUCE inhibitory protein (c-FLIP), which is dependent on the NF-kappa B pathway in normal muscle cells, is down-regulated in LGMD2A biopsies. In muscle cells isolated from LGMD2A patients, NF-kappa B is readily activated on cytokine induction as shown by an increase in its DNA binding activity. However, we observed discrepant transcriptional responses depending on the NF-kappa B target genes. I kappa B alpha is expressed following NF-kappa B activation independent of the CAPN3 status, whereas expression of c-FLIP is obtained only when CAPN3 is present. These data lead us to postulate that CAPN3 intervenes in the regulation of the expression of NF-kappa B-dependent survival genes to prevent apoptosis in skeletal muscle. Deregulations in the NF-kappa B pathway could be part of the mechanism responsible for the muscle wasting resulting from CAPN3 deficiency.	[Benayoun, Beatrice; Bartoli, Marc; Daniele, Nathalie; Gicquel, Evelyne; Bourg, Nathalie; Suel, Laurence; Richard, Isabelle] CNRS, Genethon FRE 3018, F-91000 Evry, France; [Baghdiguian, Stephen; Lefranc, Gerard] Univ Montpellier 2, CNRS, UMR 5554, Montpellier, France; [Lajmanovich, Alicia; Pasquier, Marie-Anne] INSERM, Albert Bonniot Inst, EMI 353, Res Grp Lymphoma, La Tronche, France; [Raynaud, Fabrice] IGF, UMR 5203, Dept Neurosci, Montpellier, France; [Lochmuller, Hanns] Univ Munich, Friedrich Baur Inst, Munich, Germany; [Lochmuller, Hanns] Univ Munich, Dept Neurol, D-8000 Munich, Germany; [Lefranc, Gerard] CNRS, UPR 1142, Inst Genet Humaine, Lab Immunol Mol, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of Munich; University of Munich; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier	Richard, I (corresponding author), CNRS, Genethon FRE 3018, 1 Rue Int, F-91000 Evry, France.	richard@genethon.fr	Danièle, Nathalie/J-7432-2013; Bartoli, Marc/O-8893-2016; Richard, isabelle/J-8298-2013; Bartoli, Marc/Q-5979-2017	Bartoli, Marc/0000-0003-3339-9858; Bartoli, Marc/0000-0003-3339-9858; Lochmuller, Hanns/0000-0003-2324-8001; Raynaud, Fabrice/0000-0003-3055-0524; Daniele, Nathalie/0000-0002-7985-2788; Baghdiguian, Stephen/0000-0002-2992-9708	Medical Research Council [G0601943B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Baghdiguian S, 2001, J MOL MED, V79, P254, DOI 10.1007/s001090100225; Baghdiguian S, 1999, NAT MED, V5, P503, DOI 10.1038/8385; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bullani RR, 2001, J INVEST DERMATOL, V117, P360, DOI 10.1046/j.0022-202x.2001.01418.x; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Campbell KJ, 2006, CANCER RES, V66, P929, DOI 10.1158/0008-5472.CAN-05-2234; Chae J, 2001, NEUROMUSCULAR DISORD, V11, P547, DOI 10.1016/S0960-8966(01)00197-3; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Fardeau M, 1996, NEUROMUSCULAR DISORD, V6, P447, DOI 10.1016/S0960-8966(96)00387-2; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; HIRAI S, 1991, FEBS LETT, V287, P57, DOI 10.1016/0014-5793(91)80015-U; Ho RC, 2005, AM J PHYSIOL-CELL PH, V289, pC794, DOI 10.1152/ajpcell.00632.2004; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Hoffmann A, 2002, SCIENCE, V298, P1241, DOI 10.1126/science.1071914; Hunter RB, 2004, J CLIN INVEST, V114, P1504, DOI 10.1172/JCI200421696; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Jovanovic M, 2006, ONCOGENE, V25, P6176, DOI 10.1038/sj.onc.1209912; Judge AR, 2007, AM J PHYSIOL-CELL PH, V292, pC372, DOI 10.1152/ajpcell.00293.2006; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kramerova I, 2004, HUM MOL GENET, V13, P1373, DOI 10.1093/hmg/ddh153; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; Luo GJ, 2003, AM J PHYSIOL-REG I, V284, pR1249, DOI 10.1152/ajpregu.00490.2002; Marcilhac A, 2006, INT J BIOCHEM CELL B, V38, P2128, DOI 10.1016/j.biocel.2006.06.005; Martin M, 1997, MOL BIOL CELL, V8, P1543, DOI 10.1091/mbc.8.8.1543; Mitsiades CS, 2002, ONCOGENE, V21, P5673, DOI 10.1038/sj.onc.1205664; Mourkioti F, 2006, J CLIN INVEST, V116, P2945, DOI 10.1172/JCI28721; Nagaraju K, 2000, J IMMUNOL, V164, P5459, DOI 10.4049/jimmunol.164.10.5459; Oda A, 2002, BLOOD, V99, P1850, DOI 10.1182/blood.V99.5.1850; Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029; Phillips T, 2005, FASEB J, V19, P668, DOI 10.1096/fj.04-2870fje; PONS F, 1993, NEUROMUSCULAR DISORD, V3, P507, DOI 10.1016/0960-8966(93)90106-T; Ricci MS, 2004, MOL CELL BIOL, V24, P8541, DOI 10.1128/MCB.24.19.8541-8555.2004; RICHARD I, 1995, CELL, V81, P27, DOI 10.1016/0092-8674(95)90368-2; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; Turco MC, 2004, LEUKEMIA, V18, P11, DOI 10.1038/sj.leu.2403171; Valnet-Rabier MB, 2005, BRIT J HAEMATOL, V128, P767, DOI 10.1111/j.1365-2141.2005.05378.x; VAN AD, 1996, SCIENCE, V274, P787; Vermeulen L, 2002, BIOCHEM PHARMACOL, V64, P963, DOI 10.1016/S0006-2952(02)01161-9; Wahl C, 1998, J CLIN INVEST, V101, P1163, DOI 10.1172/JCI992; Welm AL, 2002, J BIOL CHEM, V277, P33848, DOI 10.1074/jbc.M204096200; Zhou XD, 2004, CLIN SCI, V106, P397, DOI 10.1042/CS20030238	44	44	45	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1521	1529		10.1096/fj.07-8701com	http://dx.doi.org/10.1096/fj.07-8701com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18073330				2022-12-25	WOS:000255898700024
J	Hudson, BI; Carter, AM; Harja, E; Kalea, AZ; Arriero, M; Yang, HJ; Grant, PJ; Schmidt, AM				Hudson, Barry I.; Carter, Angela M.; Harja, Evis; Kalea, Anastasia Z.; Arriero, Maria; Yang, Hojin; Grant, Peter J.; Schmidt, Ann Marie			Identification, classification, and expression of RAGE gene splice variants	FASEB JOURNAL			English	Article						RNA splicing; DNA cloning	GLYCATION END-PRODUCTS; TYPE-1 DIABETIC-PATIENTS; CORONARY-ARTERY-DISEASE; CELL-SURFACE RECEPTOR; SOLUBLE RECEPTOR; PLASMA-LEVELS; HUMAN BRAIN; PROTEIN; ATHEROSCLEROSIS; ENDPRODUCTS	The receptor for advanced glycation end-products (RAGE) is a single-transmembrane, multiligand receptor of the immunoglobulin superfamily. RAGE up-regulation is implicated in numerous pathological states including vascular disease, diabetes, cancer, and neurodegeneration. The understanding of the regulation of RAGE is important in both disease pathogenesis and normal homeostasis. Here, we demonstrate the characterization and identification of human RAGE splice variants by analysis of RAGE cDNA from tissue and cells. We identified a vast range of splice forms that lead to changes in the protein coding region of RAGE, which we have classified according to the Human Gene Nomenclature Committee (HGNC). These resulted in protein changes in the ligand-binding domain of RAGE or the removal of the transmembrane domain and cytosolic tail. Analysis of splice variants for premature termination codons reveals similar to 50% of identified variants are targeted to the nonsense-mediated mRNA decay pathway. Expression analysis revealed the RAGE_v1 variant to be the primary secreted soluble isoform of RAGE. Taken together, identification of functional splice variants of RAGE underscores the biological diversity of the RAGE gene and will aid in the understanding of the gene in the normal and pathological state.	[Hudson, Barry I.; Harja, Evis; Kalea, Anastasia Z.; Arriero, Maria; Yang, Hojin; Schmidt, Ann Marie] Columbia Univ, Coll Phys & Surg, Div Surg Sci, Dept Surg, New York, NY 10032 USA; [Carter, Angela M.; Grant, Peter J.] Univ Leeds, Leeds Inst Genet Hlth & Therapeut, Acad Unit Mol Vasc Med, Leeds, W Yorkshire, England	Columbia University; University of Leeds	Hudson, BI (corresponding author), Columbia Univ, Coll Phys & Surg, Div Surg Sci, Dept Surg, 630 W 168th St,PS 17-401, New York, NY 10032 USA.	bh202l@columbia.edu	Kalea, Anastasia Z./G-4053-2010; Hudson, Barry/B-3122-2009	Hudson, Barry/0000-0001-7647-8121; Kalea, Anastasia Z./0000-0001-5775-3984				Ayoubi TAY, 1996, FASEB J, V10, P453, DOI 10.1096/fasebj.10.4.8647344; BARTOLAZZI A, 1995, J CELL SCI, V108, P1723; Basta G, 2006, J CLIN ENDOCR METAB, V91, P4628, DOI 10.1210/jc.2005-2559; Ding QX, 2005, NEUROSCI LETT, V373, P67, DOI 10.1016/j.neulet.2004.09.059; Emanuele E, 2005, ARCH NEUROL-CHICAGO, V62, P1734, DOI 10.1001/archneur.62.11.1734; Falcone C, 2005, ARTERIOSCL THROM VAS, V25, P1032, DOI 10.1161/01.ATV.0000160342.20342.00; Geroldi D, 2005, J HYPERTENS, V23, P1725, DOI 10.1097/01.hjh.0000177535.45785.64; Geroldi D, 2006, CURR MED CHEM, V13, P1971, DOI 10.2174/092986706777585013; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Holbrook JA, 2004, NAT GENET, V36, P801, DOI 10.1038/ng1403; HORI O, 1995, J BIOL CHEM, V270, P25752, DOI 10.1074/jbc.270.43.25752; Hudson BI, 2005, ARTERIOSCL THROM VAS, V25, P879, DOI 10.1161/01.ATV.0000164804.05324.8b; Hudson BI, 2004, PHARM RES-DORDR, V21, P1079, DOI 10.1023/B:PHAM.0000032992.75423.9b; Jang JH, 2002, BLOOD CELL MOL DIS, V29, P133, DOI 10.1006/bcmd.2002.0548; Katakami N, 2005, DIABETES CARE, V28, P2716, DOI 10.2337/diacare.28.11.2716; KISSLINGER, 1999, J BIOL CHEM, V274, P31740; Koyama H, 2005, ARTERIOSCL THROM VAS, V25, P2587, DOI 10.1161/01.ATV.0000190660.32863.cd; Koyama H, 2007, MOL MED, V13, P625, DOI 10.2119/2007-00087.Koyama; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; Malherbe P, 1999, MOL BRAIN RES, V71, P159, DOI 10.1016/S0169-328X(99)00174-6; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Park IH, 2004, MOL IMMUNOL, V40, P1203, DOI 10.1016/j.molimm.2003.11.027; Park' L, 1998, NAT MED, V4, P1025, DOI 10.1038/2012; Sakurai S, 2006, DIABETES RES CLIN PR, V73, P158, DOI 10.1016/j.diabres.2005.12.013; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; SUGAYA K, 1994, GENOMICS, V23, P408, DOI 10.1006/geno.1994.1517; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748; Wendt TM, 2003, AM J PATHOL, V162, P1123, DOI 10.1016/S0002-9440(10)63909-0; Yonekura H, 2003, BIOCHEM J, V370, P1097, DOI 10.1042/BJ20021371	29	271	281	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1572	1580		10.1096/fj.07-9909com	http://dx.doi.org/10.1096/fj.07-9909com			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18089847				2022-12-25	WOS:000255898700029
J	Wooten, MW; Geetha, T; Babu, JR; Seibenhener, ML; Peng, JM; Cox, N; Diaz-Meco, MT; Moscat, J				Wooten, Marie W.; Geetha, Thangiah; Babu, J. Ramesh; Seibenhener, M. Lamar; Peng, Junmin; Cox, Nancy; Diaz-Meco, Maria-T.; Moscat, Jorge			Essential role of sequestosome 1/p62 in regulating accumulation of Lys(63)-ubiquitinated proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P62; UBIQUITIN; PROTEASOME; DISEASE; POLYUBIQUITINATION; NEURODEGENERATION; DEGRADATION; AGGREGATION; INCLUSIONS; HYDROLASE	Sequestosome 1 (SQSTM1)/p62 is an interacting partner of the atypical protein kinase C zeta/i and serves as a scaffold for cell signaling and ubiquitin binding, which is critical for several cell functions in vivo such as osteoclastogenesis, adipogenesis, and T cell activation. Here we report that in neurons of p62(-/-) mouse brain there is a detectable increase in ubiquitin staining paralleled by accumulation of insoluble ubiquitinated proteins. The absolute amount of each ubiquitin chain linkage measured by quantitative mass spectrometry demonstrated hyperaccumulation of Lys(63) chains in the insoluble fraction recovered from the brain of p62(-/-) mice, which correlated with increased levels of Lys(63)-ubiquitinated TrkA receptor. The increase in Lys(63) chains was attributed in part to diminished activity of the TRAF6-interacting the Lys(63)-deubiquitinating enzyme (DUB), cylindromatosis tumor suppressor (CYLD). The interaction of CYLD with TRAF6 was dependent upon p62, thus defining a mechanism that accounts for decreased activity of CYLD in the absence of p62. These findings reveal that p62 serves as an adapter for the formation of this complex, thereby regulating the DUB activity of CYLD by TRAF6 interaction. Thus, p62 has a bifunctional role in regulation of an E3 ubiquitin-protein ligase, TRAF6, and a DUB, CYLD, to balance the turnover of Lys(63)-polyubiquitinated proteins such as TrkA.	[Wooten, Marie W.; Geetha, Thangiah; Babu, J. Ramesh; Seibenhener, M. Lamar] Auburn Univ, Dept Biol Sci, Program Cell & Mol Biosci, Auburn, AL 36849 USA; [Peng, Junmin] Emory Univ, Alzheimer Dis Res Ctr, Atlanta, GA 30322 USA; [Cox, Nancy] Auburn Univ, Coll Vet Med, Scott Ritchey Res Ctr, Auburn, AL 36849 USA; [Diaz-Meco, Maria-T.; Moscat, Jorge] Univ Cincinnati, Genome Res Inst, Dept Genome Sci, Cincinnati, OH 45237 USA	Auburn University System; Auburn University; Emory University; Auburn University System; Auburn University; University System of Ohio; University of Cincinnati	Wooten, MW (corresponding author), Auburn Univ, Dept Biol Sci, Program Cell & Mol Biosci, 331 Funchess Hall, Auburn, AL 36849 USA.	wootemw@auburn.edu	Thangiah, Geetha/W-6796-2019; Peng, Junmin/N-2614-2018; Moscat, Jorge/A-7011-2009	Peng, Junmin/0000-0003-0472-7648; Diaz-Meco, Maria/0000-0003-0147-0998; Ramesh Babu, Jeganathan/0000-0002-3719-932X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033661] Funding Source: NIH RePORTER; NINDS NIH HHS [NS-33661] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Arai T, 2003, NEUROSCI LETT, V342, P41, DOI 10.1016/S0304-3940(03)00216-7; Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Capsoni S, 2000, P NATL ACAD SCI USA, V97, P6826, DOI 10.1073/pnas.97.12.6826; Dawbarn D, 2003, NEUROPATH APPL NEURO, V29, P211, DOI 10.1046/j.1365-2990.2003.00487.x; Donaldson KM, 2003, P NATL ACAD SCI USA, V100, P8892, DOI 10.1073/pnas.1530212100; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Geetha T, 2003, J BIOL CHEM, V278, P4730, DOI 10.1074/jbc.M208468200; HUANG F, 2006, MOL CELL, V21, P1; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Liu YC, 2002, CELL, V111, P209, DOI 10.1016/S0092-8674(02)01012-7; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Rodriguez A, 2006, CELL METAB, V3, P211, DOI 10.1016/j.cmet.2006.01.011; Sanchez P, 1998, MOL CELL BIOL, V18, P3069, DOI 10.1128/MCB.18.5.3069; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Tanemura K, 2002, J NEUROSCI, V22, P133, DOI 10.1523/JNEUROSCI.22-01-00133.2002; Vigouroux S, 2003, J NEUROCHEM, V84, P392, DOI 10.1046/j.1471-4159.2003.01534.x; Wang ZY, 2005, MOL CELL NEUROSCI, V29, P222, DOI 10.1016/j.mcn.2005.02.011; WILKINSON KD, 1989, SCIENCE, V246, P670, DOI 10.1126/science.2530630; Wooten MW, 2005, J BIOL CHEM, V280, P35625, DOI 10.1074/jbc.C500237200; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6	28	140	147	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6783	6789		10.1074/jbc.M709496200	http://dx.doi.org/10.1074/jbc.M709496200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18174161	hybrid			2022-12-25	WOS:000253779600020
J	Saito, S; Matsui, H; Kawano, M; Kumagai, K; Tomishige, N; Hanada, K; Echigo, S; Tamura, S; Kobayashi, T				Saito, Satoko; Matsui, Hiroyuki; Kawano, Miyuki; Kumagai, Keigo; Tomishige, Nario; Hanada, Kentaro; Echigo, Seishi; Tamura, Shinri; Kobayashi, Takayasu			Protein phosphatase 2C epsilon is an endoplasmic reticulum integral membrane protein that dephosphorylates the ceramide transport protein CERT to enhance its association with organelle membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYSTEROL-BINDING PROTEIN; FFAT MOTIF; INTRACELLULAR TRAFFICKING; MOLECULAR MACHINERY; GENE-PRODUCT; VAP; PHOSPHORYLATION; APOPTOSIS; SURVIVAL; COMPLEX	Protein phosphatase 2C epsilon(PP2C epsilon), a mammalian PP2C family member, is expressed in various tissues and is implicated in the negative regulation of stress-activated protein kinase pathways. We show that PP2C epsilon is an endoplasmic reticulum (ER) transmembrane protein with a transmembrane domain at the amino terminus and the catalytic domain facing the cytoplasm. Yeast two-hybrid screening of a human brain library using PP2C epsilon as bait resulted in the isolation of a cDNA that encoded vesicle-associated membrane protein-associated protein A (VAPA). VAPA is an ER resident integral membrane protein involved in recruiting lipid-binding proteins such as the ceramide transport protein CERT to the ER membrane. Expression of PP2C epsilon resulted in dephosphorylation of CERT in a VAPA expression-dependent manner, which was accompanied by redistribution of CERT from the cytoplasm to the Golgi apparatus. The expression of PP2C epsilon also enhanced the association between CERT and VAPA. In addition, knockdown of PP2C epsilon expression by short interference RNA attenuated the interaction between CERT and VAPA and the sphingomyelin synthesis. These results suggest that CERT is a physiological substrate of PP2C epsilon and that dephosphorylation of CERT by PP2C epsilon may play an important role in the regulation of ceramide trafficking from the ER to the Golgi apparatus.	[Saito, Satoko; Matsui, Hiroyuki; Tamura, Shinri; Kobayashi, Takayasu] Tohoku Univ, Dept Biochem, Inst Dev Aging & Canc, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Saito, Satoko; Echigo, Seishi] Tohoku Univ, Div Oral Surg, Grad Sch Dent, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Kawano, Miyuki; Kumagai, Keigo; Tomishige, Nario; Hanada, Kentaro] Natl Inst Infect Dis, Dept Biochem & Cell Biol, Shinjuku Ku, Tokyo 1628640, Japan	Tohoku University; Tohoku University; National Institute of Infectious Diseases (NIID)	Tamura, S (corresponding author), Tohoku Univ, Dept Biochem, Inst Dev Aging & Canc, Aoba Ku, 4-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	tamura@idac.tohoku.ac.jp; takayasu@idac.tohoku.ac.jp	Kumagai, Keigo/AAG-1385-2021	KAWANO-KAWADA, Miyuki/0000-0002-1168-9291; Kumagai, Keigo/0000-0002-1663-2905; Hanada, Kentaro/0000-0003-1383-2781				Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Foster LJ, 2000, TRAFFIC, V1, P512, DOI 10.1034/j.1600-0854.2000.010609.x; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2007, BBA-MOL CELL BIOL L, V1771, P644, DOI 10.1016/j.bbalip.2007.01.009; Hanada K, 2006, MOL CELL BIOCHEM, V286, P23, DOI 10.1007/s11010-005-9044-z; Joshi M, 2007, BIOCHEM BIOPH RES CO, V356, P38, DOI 10.1016/j.bbrc.2007.02.108; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Levine T, 2004, TRENDS CELL BIOL, V14, P483, DOI 10.1016/j.tcb.2004.07.017; Li MG, 2003, J BIOL CHEM, V278, P12013, DOI 10.1074/jbc.M211474200; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Lu G, 2007, GENE DEV, V21, P784, DOI 10.1101/gad.1499107; Neddermann P, 2004, J VIROL, V78, P13306, DOI 10.1128/JVI.78.23.13306-13314.2004; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Saito J, 2007, BIOCHEM J, V405, P591, DOI 10.1042/BJ20070231; Shimizu K, 1999, FEBS LETT, V458, P363, DOI 10.1016/S0014-5793(99)01190-4; SKEHEL PA, 1995, SCIENCE, V269, P1580, DOI 10.1126/science.7667638; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Tamura S, 2004, TOP CURR GENET, V5, P91; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Tu H, 1999, VIROLOGY, V263, P30, DOI 10.1006/viro.1999.9893; Walter DM, 1998, J BIOL CHEM, V273, P29565, DOI 10.1074/jbc.273.45.29565; Weir ML, 2001, BIOCHEM BIOPH RES CO, V286, P616, DOI 10.1006/bbrc.2001.5437; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Wyles JP, 2004, EXP CELL RES, V297, P533, DOI 10.1016/j.yexcr.2004.03.052	33	69	72	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6584	6593		10.1074/jbc.M707691200	http://dx.doi.org/10.1074/jbc.M707691200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165232	hybrid			2022-12-25	WOS:000253779500064
J	Terao, Y; Mori, Y; Yamaguchi, M; Shimizu, Y; Ooe, K; Hamada, S; Kawabata, S				Terao, Yutaka; Mori, Yuka; Yamaguchi, Masaya; Shimizu, Yoshikata; Ooe, Kenji; Hamada, Shigeyuki; Kawabata, Shigetada			Group A streptococcal cysteine protease degrades C3 (C3b) and contributes to evasion of innate immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIBRONECTIN-BINDING PROTEIN; ALTERNATIVE COMPLEMENT PATHWAY; SHOCK-LIKE SYNDROME; H-LIKE PROTEIN-1; EPITHELIAL-CELLS; PYOGENES; GENE; SPEB; INACTIVATION; ACTIVATION	A relative lack of neutrophils around Streptococcus pyogenes is observed in streptococcal toxic shock syndrome (STSS). Because the bacteria spread rapidly into various organs in STSS, we speculated that S. pyogenes is equipped with molecules to evade the host innate immune system. Complement C3b opsonizes the pathogen to facilitate phagocytosis, and a complex of C3b converts C5 into anaphylatoxin. Because we found that C3 (C3b) is degraded in sera from patients with STSS, we investigated the mechanism of C3 (C3b) degradation by S. pyogenes. We incubated human C3b or serum with recombinant SpeB (rSpeB), a wild-type S. pyogenes strain isolated from an STSS patient or its isogenic Delta speB mutant and examined the supernatant by Western blotting with anti-human C3b. Western blot and Biacore analyses revealed that rSpeB and wild-type S. pyogenes rapidly degrade C3b. Additionally, C3 (C3b) was not detected in sera collected from infected areas of STSS patients. Furthermore, the survival rate in human blood and in mice was lower for the Delta speB mutant than the wild-type strain. Histopathological observations demonstrated that neutrophils were recruited toandphagocytosedthe Delta speB mutant, whereas with the wild-type strain, few neutrophils migrated to the site of infection, and the bacteria spread along the fascia. We observed the degradation of C3 (C3b) in sera from STSS patients and the degradation of C3 (C3b) by rSpeB. This suggests that SpeB contributes to the escape of S. pyogenes from phagocytosis at the site of initial infection, allowing it to invade host tissues during severe infections.	[Terao, Yutaka; Mori, Yuka; Yamaguchi, Masaya; Kawabata, Shigetada] Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, Suita, Osaka 5650871, Japan; [Shimizu, Yoshikata] Asahi Gen Hosp, Dept Anaesthesia, Chiba 2892511, Japan; [Ooe, Kenji] Asahi Gen Hosp, Dept Pathol & Lab Med, Chiba 2892511, Japan; [Hamada, Shigeyuki] Nihon Univ Adv Res Inst Sci & Human, Dept Life Sci, Tokyo 1020073, Japan	Osaka University; Nihon University	Kawabata, S (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral & Mol Microbiol, 1-8 Yamadaoka, Suita, Osaka 5650871, Japan.	kawabata@dent.osaka-u.ac.jp	Yamaguchi, Masaya/I-8156-2019	Yamaguchi, Masaya/0000-0001-6218-7112; Terao, Yutaka/0000-0002-4450-5583				Andre I, 2006, BIOCHEMISTRY-US, V45, P4559, DOI 10.1021/bi052455c; BOHACH GA, 1988, INFECT IMMUN, V56, P1665, DOI 10.1128/IAI.56.6.1665-1667.1988; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; CHEN CC, 1990, J BIOL CHEM, V265, P3161; Cockerill FR, 1998, CLIN INFECT DIS, V26, P1448, DOI 10.1086/516376; Cue D, 2000, P NATL ACAD SCI USA, V97, P2858, DOI 10.1073/pnas.050587897; DEBRUIJN MHL, 1985, P NATL ACAD SCI USA, V82, P708; Edwards RJ, 2005, J INFECT DIS, V192, P783, DOI 10.1086/432485; Felto MJ, 2007, MOL IMMUNOL, V44, P3571, DOI 10.1016/j.molimm.2007.03.012; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; HANSKI E, 1992, P NATL ACAD SCI USA, V89, P6172, DOI 10.1073/pnas.89.13.6172; Hidalgo-Grass C, 2004, LANCET, V363, P696, DOI 10.1016/S0140-6736(04)15643-2; Hidalgo-Grass C, 2006, EMBO J, V25, P4628, DOI 10.1038/sj.emboj.7601327; HORSTMANN RD, 1988, P NATL ACAD SCI USA, V85, P1657, DOI 10.1073/pnas.85.5.1657; Kuo CF, 2004, MICROB PATHOGENESIS, V36, P273, DOI 10.1016/j.micpath.2004.01.003; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; Loughman JA, 2006, J BACTERIOL, V188, P399, DOI 10.1128/JB.188.2.399-408.2006; Lukomski S, 1998, INFECT IMMUN, V66, P771, DOI 10.1128/IAI.66.2.771-776.1998; Lukomski S, 1997, J CLIN INVEST, V99, P2574, DOI 10.1172/JCI119445; Lukomski S, 1999, INFECT IMMUN, V67, P1779; Muller-Eberhard H J, 1980, Adv Immunol, V29, P1, DOI 10.1016/S0065-2776(08)60042-5; Nilsson M, 2005, EUR J IMMUNOL, V35, P1472, DOI 10.1002/eji.200424850; Nyberg P, 2004, MICROBIOL-SGM, V150, P1559, DOI 10.1099/mic.0.27076-0; Okamoto S, 2004, INFECT IMMUN, V72, P6068, DOI 10.1128/IAI.72.10.6068-6075.2004; Pandiripally V, 2003, INFECT IMMUN, V71, P7119, DOI 10.1128/IAI.71.12.7119-7128.2003; Pandiripally V, 2002, INFECT IMMUN, V70, P6206, DOI 10.1128/IAI.70.11.6206-6214.2002; PANGBURN MK, 1980, J IMMUNOL, V124, P977; Raeder R, 1998, RES MICROBIOL, V149, P539, DOI 10.1016/S0923-2508(99)80001-1; Steinrucke P, 2000, ANAL BIOCHEM, V286, P26, DOI 10.1006/abio.2000.4780; STENBERG E, 1991, J COLLOID INTERF SCI, V143, P513, DOI 10.1016/0021-9797(91)90284-F; STEVENS DL, 1989, NEW ENGL J MED, V321, P1, DOI 10.1056/NEJM198907063210101; TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I; Terao Y, 2005, J INFECT DIS, V192, P2081, DOI 10.1086/498162; Terao Y, 2002, J BIOL CHEM, V277, P47428, DOI 10.1074/jbc.M209133200; Terao Y, 2001, MOL MICROBIOL, V42, P75, DOI 10.1046/j.1365-2958.2001.02579.x; Terao Y, 2006, J BIOL CHEM, V281, P14215, DOI 10.1074/jbc.M513408200; Wei L, 2005, INFECT IMMUN, V73, P2040, DOI 10.1128/IAI.73.4.2040-2050.2005; Yuste J, 2006, J IMMUNOL, V176, P6112, DOI 10.4049/jimmunol.176.10.6112	39	80	83	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6253	6260		10.1074/jbc.M704821200	http://dx.doi.org/10.1074/jbc.M704821200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18160402	hybrid			2022-12-25	WOS:000253779500032
J	Oxley, CL; Anthis, NJ; Lowe, ED; Vakonakis, I; Campbell, ID; Wegener, KL				Oxley, Camilla L.; Anthis, Nicholas J.; Lowe, Edward D.; Vakonakis, Ioannis; Campbell, Iain D.; Wegener, Kate L.			An integrin phosphorylation switch - The effect of beta 3 integrin tail phosphorylation on Dok1 and talin binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; BETA(3) TYROSINE PHOSPHORYLATION; STRUCTURAL BASIS; PTB DOMAINS; PROTEIN; ACTIVATION; ADHESION; RECEPTOR; INSULIN; RECOGNITION	Integrins play a fundamental role in cell migration and adhesion; knowledge of how they are regulated and controlled is vital for understanding these processes. Recent work showed that Dok1 negatively regulates integrin activation, presumably by competition with talin. To understand how this occurs, we used NMR spectroscopy and x-ray crystallography to investigate the molecular details of interactions with integrins. The binding affinities of beta 3 integrin tails for the Dok1 and talin phosphotyrosine binding domains were quantified using N-15-H-1 heteronuclear single quantum correlation titrations, revealing that the unphosphorylated integrin tail binds more strongly to talin than Dok1. Chemical shift mapping showed that unlike talin, Dok1 exclusively interacts with the canonical NPXY motif of the beta 3 integrin tail. Upon phosphorylation of Tyr(747) in the beta 3 integrin tail, however, Dok1 then binds much more strongly than talin. Thus, we show that phosphorylation of Tyr(747) provides a switch for integrin ligand binding. This switch may represent an in vivo mechanism for control of integrin receptor activation. These results have implications for the control of integrin signaling by proteins containing phosphotyrosine binding domains.	[Oxley, Camilla L.; Anthis, Nicholas J.; Lowe, Edward D.; Vakonakis, Ioannis; Campbell, Iain D.; Wegener, Kate L.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Oxford	Wegener, KL (corresponding author), Univ Oxford, Dept Biochem, S Pk Rd, Oxford OX1 3QU, England.	kate.wegener@bioch.ox.ac.uk	Wegener, Kate/E-5077-2010; Lowe, Edward/AAP-5381-2021	Wegener, Kate/0000-0002-1562-6060; Lowe, Edward/0000-0002-1757-0208; Anthis, Nicholas/0000-0002-1881-450X	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Blystone SD, 1997, J BIOL CHEM, V272, P28757, DOI 10.1074/jbc.272.45.28757; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chandhoke SK, 2004, J CELL SCI, V117, P1431, DOI 10.1242/jcs.00987; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Czuchra A, 2006, J CELL BIOL, V174, P889, DOI 10.1083/jcb.200604060; Datta A, 2002, J BIOL CHEM, V277, P3943, DOI 10.1074/jbc.M109536200; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eck MJ, 1996, CELL, V85, P695, DOI 10.1016/S0092-8674(00)81236-2; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forman-Kay JD, 1999, CURR OPIN STRUC BIOL, V9, P690, DOI 10.1016/S0959-440X(99)00031-7; Gao CL, 2005, J BIOL CHEM, V280, P15422, DOI 10.1074/jbc.M414457200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Law DA, 1999, NATURE, V401, P808, DOI 10.1038/44599; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling Y, 2005, J BIOL CHEM, V280, P3151, DOI 10.1074/jbc.M411035200; Liu SC, 2000, J CELL SCI, V113, P3563; Noguchi T, 1999, EMBO J, V18, P1748, DOI 10.1093/emboj/18.7.1748; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Shi N, 2004, J BIOL CHEM, V279, P4962, DOI 10.1074/jbc.M311030200; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; TAPLEY P, 1989, ONCOGENE, V4, P325; Uhlik MT, 2005, J MOL BIOL, V345, P1, DOI 10.1016/j.jmb.2004.10.038; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3; Yasuda T, 2004, J EXP MED, V200, P1681, DOI 10.1084/jem.20041247; Yasuda T, 2007, INT IMMUNOL, V19, P487, DOI 10.1093/intimm/dxm015	39	88	91	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5420	5426		10.1074/jbc.M709435200	http://dx.doi.org/10.1074/jbc.M709435200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18156175	hybrid			2022-12-25	WOS:000253426700022
J	Moncoq, K; Kemp, G; Li, XJ; Fliegel, L; Young, HS				Moncoq, Karine; Kemp, Grant; Li, Xiuju; Fliegel, Larry; Young, Howard S.			Dimeric structure of human Na+/H+ exchanger isoform 1 overproduced in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROLOGOUS EXPRESSION; FUNCTIONAL-CHARACTERIZATION; PROTEIN; NHE1; PURIFICATION; ANTIPORTER; TRANSPORT; YEAST; CRYSTALLIZATION; IDENTIFICATION	The Na+/H+ exchanger isoform 1 (NHE1) is an integral membrane protein that regulates intracellular pH by extruding an intracellular H+ in exchange for one extracellular Na+. The human NHE1 isoform is involved in heart disease and cell growth and proliferation. Although details of NHE1 regulation and transport are being revealed, there is little information available on the structure of the intact protein. In this report, we demonstrate overexpression, purification, and characterization of the human NHE1 (hNHE1) protein in Saccharomyces cerevisiae. Overproduction of the His-tagged protein followed by purification via nickel-nitrilotriacetic acid-agarose chromatography yielded 0.2 mg of pure protein/liter of cell culture. Reconstitution of hNHE1 in proteoliposomes demonstrated that the protein was active and responsive to an NHE1-specific inhibitor. Circular dichroism spectroscopy of purified hNHE1 revealed that the protein contains 41% alpha-helix, 23% beta-sheet, and 36% random coil. Size exclusion chromatography indicated that the protein-detergent micelle was in excess of 200 kDa, consistent with an hNHE1 dimer. Electron microscopy and single particle reconstruction of negatively stained hNHE1 confirmed that the protein was a dimer, with a compact globular domain assigned to the transmembrane region and an apical ridge assigned to the cytoplasmic domain. The transmembrane domain of the hNHE1 reconstruction was clearly dimeric, where each monomer had a size and shape consistent with the predicted 12 membrane-spanning segments for hNHE1.	[Moncoq, Karine; Kemp, Grant; Li, Xiuju; Fliegel, Larry; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada	University of Alberta	Young, HS (corresponding author), Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada.	hyoung@ualberta.ca	Kemp, Grant/AAF-6735-2019	Kemp, Grant/0000-0001-5125-2740; Young, Howard/0000-0002-5990-8422				Avkiran M, 2001, BASIC RES CARDIOL, V96, P306, DOI 10.1007/s003950170037; Avkiran M, 2002, J AM COLL CARDIOL, V39, P747, DOI 10.1016/S0735-1097(02)01693-5; BERTRAND B, 1994, J BIOL CHEM, V269, P13703; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; COUNILLON L, 1994, BIOCHEMISTRY-US, V33, P10463, DOI 10.1021/bi00200a030; Dibrov P, 1998, MOL CELL BIOCHEM, V183, P125, DOI 10.1023/A:1006801104502; Ding J, 2006, J BIOL CHEM, V281, P29817, DOI 10.1074/jbc.M606152200; FAFOURNOUX P, 1994, J BIOL CHEM, V269, P2589; Flegelova H, 2006, BBA-GEN SUBJECTS, V1760, P504, DOI 10.1016/j.bbagen.2006.01.014; Flegelova H, 2005, FEBS LETT, V579, P4733, DOI 10.1016/j.febslet.2005.07.046; Fliegel L, 2005, INT J BIOCHEM CELL B, V37, P33, DOI 10.1016/j.biocel.2004.02.006; FLIEGEL L, 1993, BIOCHEM J, V289, P101, DOI 10.1042/bj2890101; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gebreselassie D, 1998, BIOCHEM CELL BIOL, V76, P837, DOI 10.1139/bcb-76-5-837; HAWORTH RS, 1993, BIOCHEM J, V289, P637, DOI 10.1042/bj2890637; Hilger D, 2007, BIOPHYS J, V93, P3675, DOI 10.1529/biophysj.107.109769; Hisamitsu T, 2004, BIOCHEMISTRY-US, V43, P11135, DOI 10.1021/bi049367x; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jahn T, 2001, J MOL BIOL, V309, P465, DOI 10.1006/jmbi.2001.4688; JEAN T, 1985, J BIOL CHEM, V260, P9678; Jidenko M, 2005, P NATL ACAD SCI USA, V102, P11687, DOI 10.1073/pnas.0503986102; KAPLAN RS, 1985, ANAL BIOCHEM, V150, P97, DOI 10.1016/0003-2697(85)90445-2; Karmazyn M., 2005, Current Drug Targets - Cardiovascular & Haematological Disorders, V5, P323, DOI 10.2174/1568006054553417; KLEINMAN JG, 1988, AM J PHYSIOL, V255, pG206, DOI 10.1152/ajpgi.1988.255.2.G206; Landau M, 2007, J BIOL CHEM, V282, P37854, DOI 10.1074/jbc.M705460200; LAZDUNSKI M, 1985, J MOL CELL CARDIOL, V17, P1029, DOI 10.1016/S0022-2828(85)80119-X; Lenoir G, 2002, BBA-BIOMEMBRANES, V1560, P67, DOI 10.1016/S0005-2736(01)00458-8; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mentzer RM, 2003, CIRCULATION, V108; Montero-Lomeli M, 1999, BIOCHEM CELL BIOL, V77, P25, DOI 10.1139/bcb-77-1-25; Moor AN, 1999, J BIOL CHEM, V274, P22985, DOI 10.1074/jbc.274.33.22985; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Parcej DN, 2003, J MOL BIOL, V333, P103, DOI 10.1016/j.jmb.2003.07.009; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Rieder CV, 2002, AM J PHYSIOL-HEART C, V283, pH273, DOI 10.1152/ajpheart.00042.2002; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7; SAXENA VP, 1971, P NATL ACAD SCI USA, V68, P969, DOI 10.1073/pnas.68.5.969; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; SEKLER I, 1995, J BIOL CHEM, V270, P21028, DOI 10.1074/jbc.270.36.21028; Slepkov ER, 2007, BIOCHEM J, V401, P623, DOI 10.1042/BJ20061062; Slepkov ER, 2005, J BIOL CHEM, V280, P17863, DOI 10.1074/jbc.M409608200; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sreerama N, 2004, PROTEIN SCI, V13, P100, DOI 10.1110/ps.03258404; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; VENEMA K, 1993, BIOCHIM BIOPHYS ACTA, V1146, P87, DOI 10.1016/0005-2736(93)90342-W; Vinothkumar KR, 2005, EMBO J, V24, P2720, DOI 10.1038/sj.emboj.7600727; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; WAKABAYASHI S, 1994, J BIOL CHEM, V269, P5583; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558; Williams KA, 2000, NATURE, V403, P112, DOI 10.1038/47534; Zeymer U, 2001, J AM COLL CARDIOL, V38, P1644	54	38	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4145	4154		10.1074/jbc.M704844200	http://dx.doi.org/10.1074/jbc.M704844200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077454	hybrid			2022-12-25	WOS:000253083500050
J	Roose, JL; Pakrasi, HB				Roose, Johnna L.; Pakrasi, Himadri B.			The Psb27 protein facilitates manganese cluster assembly in photosystem II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCYSTIS SP PCC-6803; ARABIDOPSIS-THALIANA; STABILIZING PROTEIN; CRYSTAL-STRUCTURE; IN-VIVO; RESOLUTION; COMPLEXES; BINDING; PHOTOINACTIVATION; BIOGENESIS	Photosystem II (PSII) is a large membrane protein complex that uses light energy to convert water to molecular oxygen. This enzyme undergoes an intricate assembly process to ensure accurate and efficient positioning of its many components. It has been proposed that the Psb27 protein, a lumenal extrinsic subunit, serves as a PSII assembly factor. Using a psb27 genetic deletion strain (Delta psb27) of the cyanobacterium Synechocystis sp. PCC 6803, we have defined the role of the Psb27 protein in PSII biogenesis. While the Psb27 protein was not essential for photosynthetic activity, various PSII assembly assays revealed that the Delta psb27 mutant was defective in integration of the Mn4Ca1Clx cluster, the catalytic core of the oxygen-evolving machinery within the PSII complex. The other lumenal extrinsic proteins (PsbO, PsbU, PsbV, and PsbQ) are key components of the fully assembled PSII complex and are important for the water oxidation reaction, but we propose that the Psb27 protein has a distinct function separate from these subunits. We show that the Psb27 protein facilitates Mn4Ca1Clx cluster assembly in PSII at least in part by preventing the premature association of the other extrinsic proteins. Thus, we propose an exchange of lumenal subunits and cofactors during PSII assembly, in that the Psb27 protein is replaced by the other extrinsic proteins upon assembly of the Mn4Ca1Clx cluster. Furthermore, we show that the Psb27 protein provides a selective advantage for cyanobacterial cells under conditions such as nutrient deprivation where Mn4Ca1Clx cluster assembly efficiency is critical for survival.	[Roose, Johnna L.; Pakrasi, Himadri B.] Washington Univ, Dept Biol, St Louis, MO 63130 USA	Washington University (WUSTL)	Pakrasi, HB (corresponding author), Washington Univ, Dept Biol, Campus Box 1137,1 Brookings Dr, St Louis, MO 63130 USA.	Pakrasi@wustl.edu						ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Andersson B, 2001, ADV PHOTOSYNTH, V11, P377; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; Baena-Gonzalez E, 2002, PHILOS T R SOC B, V357, P1451, DOI 10.1098/rstb.2002.1141; Burnap RL, 1996, BIOCHEMISTRY-US, V35, P874, DOI 10.1021/bi951964j; Burnap RL, 2004, PHYS CHEM CHEM PHYS, V6, P4803, DOI 10.1039/b407094a; Chandler LE, 2003, BIOCHEMISTRY-US, V42, P5508, DOI 10.1021/bi027113a; Chen H, 2006, PLANT MOL BIOL, V61, P567, DOI 10.1007/s11103-006-0031-x; CHU HA, 1994, BIOCHEMISTRY-US, V33, P6150, DOI 10.1021/bi00186a014; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; Ivleva NB, 2000, PLANT PHYSIOL, V124, P1403, DOI 10.1104/pp.124.3.1403; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; Keren N, 2004, PLANT PHYSIOL, V135, P1666, DOI 10.1104/pp.104.042770; KLIMOV VV, 1990, PHOTOSYNTH RES, V23, P59, DOI 10.1007/BF00030063; Klinkert B, 2004, J BIOL CHEM, V279, P44639, DOI 10.1074/jbc.M405393200; Kufryk GI, 2003, J BACTERIOL, V185, P6615, DOI 10.1128/JB.185.22.6615-6623.2003; Kufryk GI, 2001, BIOCHEMISTRY-US, V40, P9247, DOI 10.1021/bi0026526; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Ma JF, 2007, PLANT CELL, V19, P1980, DOI 10.1105/tpc.107.050526; Mamedov F, 2007, BIOCHEMISTRY-US, V46, P5542, DOI 10.1021/bi7000399; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Peltier JB, 2002, PLANT CELL, V14, P211, DOI 10.1105/tpc.010304; Peng LW, 2006, PLANT CELL, V18, P955, DOI 10.1105/tpc.105.037689; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Qian M, 1997, BIOCHEMISTRY-US, V36, P15244, DOI 10.1021/bi9713198; Rajalahti T, 2007, J PROTEOME RES, V6, P2420, DOI 10.1021/pr0605973; Rokka A, 2005, BIOCHEM J, V388, P159, DOI 10.1042/BJ20042098; Roose JL, 2004, J BIOL CHEM, V279, P45417, DOI 10.1074/jbc.M408458200; Roose JL, 2007, PHOTOSYNTH RES, V92, P369, DOI 10.1007/s11120-006-9117-1; Roose JL, 2007, P NATL ACAD SCI USA, V104, P2548, DOI 10.1073/pnas.0609337104; THEG SM, 1986, BIOCHIM BIOPHYS ACTA, V849, P104, DOI 10.1016/0005-2728(86)90101-5; Wang HL, 2002, BIOTECHNIQUES, V33, P26, DOI 10.2144/02331bm02; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	35	87	89	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4044	4050		10.1074/jbc.M708960200	http://dx.doi.org/10.1074/jbc.M708960200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18089572	Green Published, hybrid			2022-12-25	WOS:000253083500039
J	Datta, K; von Hippel, PH				Datta, Kausiki; von Hippel, Peter H.			Direct spectroscopic study of reconstituted transcription complexes reveals that intrinsic termination is driven primarily by thermodynamic destabilization of the nucleic acid framework	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T7 RNA-POLYMERASE; LOW-ENERGY CD; ELONGATION COMPLEXES; ESCHERICHIA-COLI; NASCENT RNA; 3 END; DNA; HAIRPIN; CONFORMATION; BUBBLE	Changes in near UV circular dichroism (CD) and fluorescence spectra of site-specifically placed pairs of 2-aminopurine residues have been used to probe the roles of the RNA hairpin and the RNA-DNA hybrid in controlling intrinsic termination of transcription. Functional transcription complexes were assembled directly by mixing preformed nucleic acid scaffolds of defined sequence with T7 RNA polymerase (RNAP). Scaffolds containing RNA hairpins immediately upstream of a GC-rich hybrid formed complexes of reduced stability, whereas the same hairpins adjacent to a hybrid of rU-dA base pairs triggered complex dissociation and transcript release. 2-Aminopurine probes at the upstream ends of the hairpin stems show that the hairpins open on RNAP binding and that stem re-formation begins after one or two RNA bases on the downstream side of the stem have emerged from the RNAP exit tunnel. Hairpins directly adjacent to the RNA-DNA hybrid weaken RNAP binding, decrease elongation efficiency, and disrupt the upstream end of the hybrid as well as interfere with the movement of the template base at the RNAP active site. Probing the edges of the DNA transcription bubble demonstrates that termination hairpins prevent translocation of the RNAP, suggesting that they transiently "lock" the polymerase to the nucleic acid scaffold and, thus, hold the RNA-DNA hybrid "in frame." At intrinsic terminators the weak rU-dA hybrid and the adjacent termination hairpin combine to destabilize the elongation complex sufficiently to permit significant transcript release, whereas hairpin-dependent pausing provides time for the process to go to completion.	[Datta, Kausiki; von Hippel, Peter H.] Univ Oregon, Inst Mol Biol, Eugene, OR 97403 USA; [Datta, Kausiki; von Hippel, Peter H.] Univ Oregon, Dept Chem, Eugene, OR 97403 USA	University of Oregon; University of Oregon	von Hippel, PH (corresponding author), Amer Canc Soc, Atlanta, GA 30329 USA.	petevh@molbio.uoregon.edu		von Hippel, Peter H./0000-0003-2512-8097	NIGMS NIH HHS [R01 GM029158, GM-29158, GM-15792, R01 GM015792, R01 GM015792-42] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM015792, R01GM015792, R01GM029158] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ARNDT KM, 1990, J MOL BIOL, V213, P79, DOI 10.1016/S0022-2836(05)80123-8; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Chan CL, 1997, J MOL BIOL, V268, P54, DOI 10.1006/jmbi.1997.0935; Datta K, 2006, J MOL BIOL, V360, P800, DOI 10.1016/j.jmb.2006.05.053; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; DORVAL BC, 1991, J MOL BIOL, V221, P837, DOI 10.1016/0022-2836(91)80179-X; Ebright RH, 2000, J MOL BIOL, V304, P687, DOI 10.1006/jmbi.2000.4309; FENG GH, 1994, J BIOL CHEM, V269, P22282; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; Greive SJ, 2005, NAT REV MOL CELL BIO, V6, P221, DOI 10.1038/nrm1588; Hartvig L, 1996, EMBO J, V15, P4767, DOI 10.1002/j.1460-2075.1996.tb00854.x; He B, 1997, PROTEIN EXPRES PURIF, V9, P142, DOI 10.1006/prep.1996.0663; JENG ST, 1992, J BIOL CHEM, V267, P19306; Johnson NP, 2005, J BIOL CHEM, V280, P32177, DOI 10.1074/jbc.M504619200; Johnson NP, 2004, P NATL ACAD SCI USA, V101, P3426, DOI 10.1073/pnas.0400591101; Komissarova N, 1997, P NATL ACAD SCI USA, V94, P1755, DOI 10.1073/pnas.94.5.1755; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Ma KY, 2005, P NATL ACAD SCI USA, V102, P17612, DOI 10.1073/pnas.0508865102; MACDONALD LE, 1993, J MOL BIOL, V232, P1030, DOI 10.1006/jmbi.1993.1458; PLATT T, 1986, ANNU REV BIOCHEM, V55, P339, DOI 10.1146/annurev.bi.55.070186.002011; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; WILSON KS, 1995, P NATL ACAD SCI USA, V92, P8793, DOI 10.1073/pnas.92.19.8793; Wilson KS, 1999, J MOL BIOL, V289, P1179, DOI 10.1006/jmbi.1999.2814; YAGER TD, 1991, BIOCHEMISTRY-US, V30, P1097, DOI 10.1021/bi00218a032; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464; Zhou Y, 2007, P NATL ACAD SCI USA, V104, P10352, DOI 10.1073/pnas.0606306104	31	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3537	3549		10.1074/jbc.M707998200	http://dx.doi.org/10.1074/jbc.M707998200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070878	Green Accepted, hybrid			2022-12-25	WOS:000253083000059
J	Hinney, A; Nguyen, TT; Scherag, A; Friedel, S; Bronner, G; Muller, TD; Grallert, H; Illig, T; Wichmann, HE; Rief, W; Schafer, H; Hebebrand, J				Hinney, Anke; Nguyen, Thuy Trang; Scherag, Andre; Friedel, Susann; Broenner, Guenter; Mueller, Timo Dirk; Grallert, Harald; Illig, Thomas; Wichmann, H. -Erich; Rief, Winfried; Schaefer, Helmut; Hebebrand, Johannes			Genome Wide Association (GWA) Study for Early Onset Extreme Obesity Supports the Role of Fat Mass and Obesity Associated Gene (FTO) Variants	PLOS ONE			English	Article							LIPOPROTEIN RECEPTOR GENE; CHILDHOOD OBESITY; ADULT OBESITY; INDEX	Background. Obesity is a major health problem. Although heritability is substantial, genetic mechanisms predisposing to obesity are not very well understood. We have performed a genome wide association study (GWA) for early onset (extreme) obesity. Methodology/Principal Findings. a) GWA (Genome-Wide Human SNP Array 5.0 comprising 440,794 single nucleotide polymorphisms) for early onset extreme obesity based on 487 extremely obese young German individuals and 442 healthy lean German controls; b) confirmatory analyses on 644 independent families with at least one obese offspring and both parents. We aimed to identify and subsequently confirm the 15 SNPs (minor allele frequency >= 10%) with the lowest p-values of the GWA by four genetic models: additive, recessive, dominant and allelic. Six single nucleotide polymorphisms (SNPs) in FTO ( fat mass and obesity associated gene) within one linkage disequilibrium (LD) block including the GWA SNP rendering the lowest p-value (rs1121980; log-additive model: nominal p = 1.13x10(-7), corrected p = 0.0494; odds ratio (OR)(CT) 1.67, 95% confidence interval (CI) 1.22-2.27; OR(TT) 2.76, 95% CI 1.88-4.03) belonged to the 15 SNPs showing the strongest evidence for association with obesity. For confirmation we genotyped 11 of these in the 644 independent families (of the six FTO SNPs we chose only two representing the LD bock). For both FTO SNPs the initial association was confirmed (both Bonferroni corrected p<0.01). However, none of the nine non-FTO SNPs revealed significant transmission disequilibrium. Conclusions/Significance. Our GWA for extreme early onset obesity substantiates that variation in FTO strongly contributes to early onset obesity. This is a further proof of concept for GWA to detect genes relevant for highly complex phenotypes. We concurrently show that nine additional SNPs with initially low p-values in the GWA were not confirmed in our family study, thus suggesting that of the best 15 SNPs in the GWA only the FTO SNPs represent true positive findings.	[Hinney, Anke; Friedel, Susann; Broenner, Guenter; Mueller, Timo Dirk; Hebebrand, Johannes] Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Nguyen, Thuy Trang; Schaefer, Helmut] Univ Marburg, Inst Med Biometry & Epidemiol, Marburg, Germany; [Scherag, Andre] Univ Duisburg Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Grallert, Harald; Illig, Thomas; Wichmann, H. -Erich] GSF Forschungszentrum Umwelt & Gesundheit, Inst Epidemiol, Munich, Germany; [Rief, Winfried] Univ Marburg, Dept Clin Psychol & Psychotherapy, Marburg, Germany	University of Duisburg Essen; Philipps University Marburg; University of Duisburg Essen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Philipps University Marburg	Hinney, A (corresponding author), Univ Duisburg Essen, Dept Child & Adolescent Psychiat, Essen, Germany.	anke.hinney@uni-due.de	Müller, Timo D./AAZ-4445-2020; Rief, Winfried/ABD-4994-2021; Wichmann, Heinz Erich/AAA-5695-2022; Grallert, Harald/B-3424-2013; Scherag, Andre/B-3805-2014; Hinney, Anke/D-6953-2011	Rief, Winfried/0000-0002-7019-2250; Hinney, Anke/0000-0001-5659-0706; Muller, Timo/0000-0002-0624-9339; Scherag, Andre/0000-0002-9406-4704	Bundesministerium fur Bildung und Forschung [NGFN2 01GS0482, 01GS0483, 01GP0259, 01GP0209]; Deutsche Forschungsgemeinschaft [HE 1446/4-1]; European Union [FP6 LSHMCT-2003-503041]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	Funding: This work was supported by grants from the Bundesministerium fur Bildung und Forschung (NGFN2 01GS0482, 01GS0483 and 01GP0259, 01GP0209), the Deutsche Forschungsgemeinschaft (HE 1446/4-1) and the European Union (FP6 LSHMCT-2003-503041). The funding organizations had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Christensen K, 2007, NEW ENGL J MED, V356, P1094, DOI 10.1056/NEJMp068126; Deng HW, 2000, J CLIN ENDOCR METAB, V85, P2748, DOI 10.1210/jc.85.8.2748; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Edwards BJ, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-18; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Garner C, 2007, GENET EPIDEMIOL, V31, P288, DOI 10.1002/gepi.20209; Herbert A, 2006, SCIENCE, V312, P279, DOI 10.1126/science.1124779; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Mattevi VS, 2000, HUM GENET, V106, P546, DOI 10.1007/s004390050023; Okura T, 2003, INT J OBESITY, V27, P1020, DOI 10.1038/sj.ijo.0802378; Rankinen T, 2006, OBESITY, V14, P529, DOI 10.1038/oby.2006.71; Scott WJ, 2007, RES J BIOTECHNOL, V2, P5; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Vollmert C, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.040931; ZEE RYL, 1995, CLIN GENET, V47, P118	17	400	420	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1361	10.1371/journal.pone.0001361	http://dx.doi.org/10.1371/journal.pone.0001361			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159244	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459700018
J	Steinfartz, S; Glaberman, S; Lanterbecq, D; Marquez, C; Rassmann, K; Caccone, A				Steinfartz, Sebastian; Glaberman, Scott; Lanterbecq, Deborah; Marquez, Cruz; Rassmann, Kornelia; Caccone, Adalgisa			Genetic Impact of a Severe El Nino Event on Galapagos Marine Iguanas (Amblyrhynchus cristatus)	PLOS ONE			English	Article								The El Nino-Southern Oscillation (ENSO) is a major source of climatic disturbance, impacting the dynamics of ecosystems worldwide. Recent models predict that human-generated rises in green-house gas levels will cause an increase in the strength and frequency of El Nino warming events in the next several decades, highlighting the need to understand the potential biological consequences of increased ENSO activity. Studies have focused on the ecological and demographic implications of El Nino in a range of organisms, but there have been few systematic attempts to measure the impact of these processes on genetic diversity in populations. Here, we evaluate whether the 1997-1998 El Nino altered the genetic composition of Galapagos marine iguana populations from eleven islands, some of which experienced mortality rates of up to 90% as a result of El Nino warming. Specifically, we measured the temporal variation in microsatellite allele frequencies and mitochondrial DNA diversity (mtDNA) in samples collected before (1991/1993) and after (2004) the El Nino event. Based on microsatellite data, only one island (Marchena) showed signatures of a genetic bottleneck, where the harmonic mean of the effective population size (N(e)) was estimated to be less than 50 individuals during the period between samplings. Substantial decreases in mtDNA variation between time points were observed in populations from just two islands (Marchena and Genovesa). Our results suggests that, for the majority of islands, a single, intense El Nino event did not reduce marine iguana populations to the point where substantial neutral genetic diversity was lost. In the case of Marchena, simultaneous changes to both nuclear and mitochondrial DNA variation may also be the result of a volcanic eruption on the island in 1991. Therefore, studies that seek to evaluate the genetic impact of El Nino must also consider the confounding or potentially synergistic effect of other environmental and biological forces shaping populations.	[Steinfartz, Sebastian; Glaberman, Scott; Lanterbecq, Deborah; Caccone, Adalgisa] Yale Univ, Dept Ecol & Evolutionary Biol, Yale Inst Biospher Studies, New Haven, CT 06520 USA; [Marquez, Cruz] Charles Darwin Res Stn, Santa Cruz, Galapagos, Ecuador	Yale University	Steinfartz, S (corresponding author), Univ Bielefeld, Unit Mol Ecol & Behav, Bielefeld, Germany.	sebastian.steinfartz@uni-bielefeld.de; scott.glaberman@gmail.com	Lanterbecq, Deborah/ABD-4115-2021; Caccone, Adalgisa/AAE-4238-2021	Caccone, Adalgisa/0000-0002-8949-9260; Steinfartz, Sebastian/0000-0001-5347-3969; Glaberman, Scott/0000-0003-0594-4732; Lanterbecq, Deborah/0000-0002-1104-9227	German Research Community [STE 1130/2-1, STE 1130/2-2]; Belgian American Educational Foundation; The Yale Institute for Biospheric studies	German Research Community(German Research Foundation (DFG)); Belgian American Educational Foundation; The Yale Institute for Biospheric studies	Sampling was made possible through a grant from the National Geographic Society to AC. SS has been supported by a fellowship of the German Research Community ( DFG; STE 1130/2-1 and STE 1130/2-2). DL has been supported by a postdoctoral fellowship of the Belgian American Educational Foundation. The Yale Institute for Biospheric studies supported this project through funds to AC.	Akst EP, 2002, CONSERV GENET, V3, P375, DOI 10.1023/A:1020555303124; Allendorf F., 2007, CONSERVATION GENETIC; BARBER RT, 1986, NATURE, V319, P279, DOI 10.1038/319279a0; BARBER RT, 1983, SCIENCE, V222, P1203, DOI 10.1126/science.222.4629.1203; Beheregaray LB, 2003, SCIENCE, V302, P75, DOI 10.1126/science.1087486; Berthier P, 2002, GENETICS, V160, P741; Chavez FP, 1999, SCIENCE, V286, P2126, DOI 10.1126/science.286.5447.2126; Depaulis F, 1998, MOL BIOL EVOL, V15, P1788, DOI 10.1093/oxfordjournals.molbev.a025905; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fauvelot C, 2006, J HERED, V97, P367, DOI 10.1093/jhered/esl010; Frankham R, 1995, ANNU REV GENET, V29, P305, DOI 10.1146/annurev.ge.29.120195.001513; Frankham R., 2002, INTRO CONSERVATION G; FREELAND JR, 2005, MOL BIOL; Glynn P.W., 1988, Annual Review of Ecology and Systematics, V19, P309, DOI 10.1146/annurev.es.19.110188.001521; Hale KA, 2007, ANIM CONSERV, V10, P2, DOI 10.1111/j.1469-1795.2006.00059.x; Hanley TC, 2005, MOL ECOL NOTES, V5, P599, DOI 10.1111/j.1471-8286.2005.01004.x; Hansen MM, 1996, EVOLUTION, V50, P454, DOI [10.2307/2410816, 10.1111/j.1558-5646.1996.tb04508.x]; Holmgren M, 2001, TRENDS ECOL EVOL, V16, P89, DOI 10.1016/S0169-5347(00)02052-8; LANDE R, 1994, EVOLUTION, V48, P1460, DOI [10.2307/2410240, 10.1111/j.1558-5646.1994.tb02188.x]; LAURIE WA, 1990, J ANIM ECOL, V59, P515, DOI 10.2307/4878; Luikart G, 1998, MOL ECOL, V7, P963, DOI 10.1046/j.1365-294x.1998.00414.x; Mackie RI, 2004, PHYSIOL BIOCHEM ZOOL, V77, P127, DOI 10.1086/383498; Martinez EA, 2003, J PHYCOL, V39, P504, DOI 10.1046/j.1529-8817.2003.02191.x; NEI M, 1981, GENETICS, V98, P625; Nei M., 1987, MOL EVOLUTIONARY GEN; Peel D., 2004, NEESTIMATOR SOFTWARE; PHILANDER SGH, 1983, NATURE, V302, P295, DOI 10.1038/302295a0; Rassmann K, 1997, MOL ECOL, V6, P437, DOI 10.1046/j.1365-294X.1997.00209.x; Richards C, 1996, CONSERV BIOL, V10, P832, DOI 10.1046/j.1523-1739.1996.10030832.x; Riedinger MA, 2002, J PALEOLIMNOL, V27, P1, DOI 10.1023/A:1013514408468; Romero LM, 2001, P NATL ACAD SCI USA, V98, P7366, DOI 10.1073/pnas.131091498; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; *SMITHS I, 1991, LAVA CIRCUMFERENTIAL; Spencer CC, 2000, MOL ECOL, V9, P1517, DOI 10.1046/j.1365-294x.2000.01031.x; Steinfartz S, 2006, MOL ECOL NOTES, V6, P927, DOI 10.1111/j.1471-8286.2006.01402.x; Tessier N, 1999, MOL ECOL, V8, P169, DOI 10.1046/j.1365-294X.1999.00547.x; Timmermann A, 1999, NATURE, V398, P694, DOI 10.1038/19505; Trenberth KE, 1997, B AM METEOROL SOC, V78, P2771, DOI 10.1175/1520-0477(1997)078<2771:TDOENO>2.0.CO;2; TRILLMICH F, 1985, OECOLOGIA, V67, P19, DOI 10.1007/BF00378445; Vargas FH, 2006, BIOL CONSERV, V127, P107, DOI 10.1016/j.biocon.2005.08.001; Wang CZ, 2006, PROG OCEANOGR, V69, P239, DOI 10.1016/j.pocean.2006.03.004; WAPLES RS, 1989, GENETICS, V121, P379; Wikelski M, 2003, INTEGR COMP BIOL, V43, P376, DOI 10.1093/icb/43.3.376; Wikelski M, 2002, NATURE, V417, P607, DOI 10.1038/417607a; Wikelski M, 1997, EVOLUTION, V51, P922, DOI 10.1111/j.1558-5646.1997.tb03673.x; Wikelski M, 1996, ANIM BEHAV, V52, P581, DOI 10.1006/anbe.1996.0199; Wikelski M., 2004, IGUANA, V11, P191	47	23	24	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1285	10.1371/journal.pone.0001285	http://dx.doi.org/10.1371/journal.pone.0001285			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074011	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459500004
J	Szabova, L; Chrysovergis, K; Yamada, SS; Holmbeck, K				Szabova, L.; Chrysovergis, K.; Yamada, S. S.; Holmbeck, K.			MT1-MMP is required for efficient tumor dissemination in experimental metastatic disease	ONCOGENE			English	Article						MT1-MMP; PyMT; mammary cancer; metastasis; collagen; proteolysis	MATRIX METALLOPROTEINASES; PERICELLULAR PROTEOLYSIS; EXTRACELLULAR-MATRIX; BREAST CARCINOMAS; CANCER INVASION; DEFICIENT MICE; MEMBRANE; EXPRESSION; CELLS; ANGIOGENESIS	Membrane-type I matrix metalloproteinase (MT1-MMP) is associated with multiple forms of cancer including mammary cancer. To directly evaluate the significance of MT1-MMP expression in tumor progression and metastasis using a genetically induced cancer model, we crossed MT1-MMP-deficient mice to MMTV-polyoma virus middle T-antigen (PyMT) mice. Expression of PyMT in the MT1-MMP-deficient background consistently resulted in hyperplasia of the mammary gland as seen in wild-type PyMT littermates. Following orthotopic transplantation of PyMT + glands into the cleared mammary fat pad of syngeneic recipient mice, MT1-MMP-deficient tumors were palpable earlier than wild-type tumors. Moreover, MT1-MMP-deficient tumors grew to the experimental end point size quicker than control tumors, but demonstrated markedly reduced ability to metastasize to the lungs of recipient mice. Accordingly, MT1-MMP deficient mice displayed an overall reduction in metastasis count of 50%. MT1-MMP was expressed solely in the stroma of PyMT-induced tumors and those metastatic nodules that formed in the lungs were devoid of MT1-MMP expression. Stromal fibbroblasts isolated from MT1-MMP-deficient tumors did not degrade type I collagen suggesting that efficient dissemination of tumor cells is dependent on stromal cell remodeling of the tumor environment. The data demonstrate directly that MT1-MMP-mediated proteolysis by stromal cells is important in the metastatic process.	[Szabova, L.; Chrysovergis, K.; Yamada, S. S.; Holmbeck, K.] Natl Inst Dent & Craniofacial Res, Matrix Metalloproteinase Unit, Craniofacial & Skeletal Dis Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Holmbeck, K (corresponding author), Natl Inst Dent & Craniofacial Res, Matrix Metalloproteinase Unit, Craniofacial & Skeletal Dis Branch, NIH, Bldg 30,Room 125,30 Convent Dr,MSC 4380, Bethesda, MD 20892 USA.	kenn.holmbeck@nih.gov		Holmbeck, Kenn/0000-0002-4472-3257	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000676] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000676] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Andarawewa KL, 2003, CANCER RES, V63, P5844; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Bisson C, 2003, INT J CANCER, V105, P7, DOI 10.1002/ijc.11012; Blavier L, 2001, MOL BIOL CELL, V12, P1457, DOI 10.1091/mbc.12.5.1457; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Bugge TH, 1998, ONCOGENE, V16, P3097, DOI 10.1038/sj.onc.1201869; Coussens LM, 2000, CELL, V103, P481, DOI 10.1016/S0092-8674(00)00139-2; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; Deryugina EI, 2006, CANCER METAST REV, V25, P9, DOI 10.1007/s10555-006-7886-9; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Holmbeck K, 2003, J CELL BIOL, V163, P661, DOI 10.1083/jcb.200307061; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Hotary KB, 2003, CELL, V114, P33, DOI 10.1016/S0092-8674(03)00513-0; Hotary K, 2006, GENE DEV, V20, P2673, DOI 10.1101/gad.1451806; Itoh T, 1998, CANCER RES, V58, P1048; Kalluri R, 2006, NAT REV CANCER, V6, P392, DOI 10.1038/nrc1877; Masson R, 1998, J CELL BIOL, V140, P1535, DOI 10.1083/jcb.140.6.1535; McCawley LJ, 2004, CANCER RES, V64, P6965, DOI 10.1158/0008-5472.CAN-04-0910; Murphy G, 2002, ARTHRITIS RES THER, V4, DOI 10.1186/ar572; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Pedersen TX, 2005, CARCINOGENESIS, V26, P1233, DOI 10.1093/carcin/bgi065; Pendas AM, 2004, MOL CELL BIOL, V24, P5304, DOI 10.1128/MCB.24.12.5304-5313.2004; Polette M, 1996, VIRCHOWS ARCH, V428, P29; Polette M, 1997, CLIN EXP METASTAS, V15, P157, DOI 10.1023/A:1018404927753; Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024; Rosenthal EL, 2004, ARCH OTOLARYNGOL, V130, P943, DOI 10.1001/archotol.130.8.943; Seiki M, 2003, CANCER SCI, V94, P569, DOI 10.1111/j.1349-7006.2003.tb01484.x; Stetler-Stevenson WG, 2001, SEMIN CANCER BIOL, V11, P143, DOI 10.1006/scbi.2000.0365; Szabova L, 2005, J CELL PHYSIOL, V205, P123, DOI 10.1002/jcp.20385; Tran KT, 2005, J DERMATOL SCI, V40, P11, DOI 10.1016/j.jdermsci.2005.05.001; Ueno H, 1997, CANCER RES, V57, P2055; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Wilson CL, 1997, P NATL ACAD SCI USA, V94, P1402, DOI 10.1073/pnas.94.4.1402; Winkler MK, 2002, AM J PHYSIOL-LUNG C, V283, pL1, DOI 10.1152/ajplung.00489.2001; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Zatterstrom UK, 2000, CELL STRUCT FUNCT, V25, P97	38	64	66	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2008	27	23					3274	3281		10.1038/sj.onc.1210982	http://dx.doi.org/10.1038/sj.onc.1210982			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	304LQ	18071307				2022-12-25	WOS:000256111400006
J	Koshkin, V; Dai, FF; Robson-Doucette, CA; Chan, CB; Wheeler, MB				Koshkin, Vasilij; Dai, Feihan F.; Robson-Doucette, Christine A.; Chan, Catherine B.; Wheeler, Michael B.			Limited mitochondrial permeabilization is an early manifestation of palmitate-induced lipotoxicity in pancreatic beta-cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RAT-LIVER MITOCHONDRIA; MONOUNSATURATED FATTY-ACIDS; GLUCOSE-STIMULATED EFFLUX; TRANSITION PORE; OXIDATIVE STRESS; CYCLOSPORINE-A; INSULIN-SECRETION; PROTEIN-KINASE; INDUCED APOPTOSIS; NITRIC-OXIDE	Involvement o(f) the mitochondrial permeability transition (MPT) pore in early stages of lipotoxic stress in the pancreatic beta-cell lines MIN6 and INS-1 was the focus of this study. Both long term (indirect) and acute (direct) effects of fatty acid (FA) application on beta-cell susceptibility to Ca2+- induced MPT induction were examined using both permeabilized and intact beta-cells. Long term exposure to moderate (i.e. below cytotoxic) levels of the saturated FA palmitate sensitized beta-cell mitochondria to MPT induced by Ca2+. Long term exposure to palmitate was significantly a more efficient inducer of MPT than the unsaturated FA oleate, although upon acute application both caused similar MPT activation. Application of antioxidants, inhibitors of the ceramide pathway, or modifiers of membrane fluidity did not protect beta-cell mitochondria from FA exposure. However, significant protection was provided by co-application of the unsaturated FA oleate in a phosphatidylinositol 3-kinase-dependent manner. Characterization of MPT pore opening in response to moderate palmitate treatment revealed the opening of a unique form of MPT in beta-cells as it encompassed features of both low and high conductance MPT states. Specifically, this MPT showed solute selectivity, characteristic of a low conductance MPT; however, it affected mitochondrial respiration and membrane potential in a way typical of a high conductance MPT. Activation of the full-size/high conductance form of MPT required application of high levels of FA that reduced growth and initiated apoptosis. These findings suggest that in the beta-cell, MPTs can act as both initiators of cell death and as versatile modulators of cell metabolism, depending on the mode of the MPT pore induced.	[Koshkin, Vasilij; Dai, Feihan F.; Robson-Doucette, Christine A.; Wheeler, Michael B.] Univ Toronto, Dept Physiol, Toronto, ON M5S 1A8, Canada; [Koshkin, Vasilij; Dai, Feihan F.; Robson-Doucette, Christine A.; Wheeler, Michael B.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; [Chan, Catherine B.] Univ Alberta, Dept Physiol & Agr, Edmonton, AB T6G 2H7, Canada	University of Toronto; University of Toronto; University of Alberta	Wheeler, MB (corresponding author), Univ Toronto, Dept Physiol, 1 Kings Coll Circle, Toronto, ON M5S 1A8, Canada.	michael.wheeler@utoronto.ca	Chan, Catherine/C-1162-2011	Chan, Catherine/0000-0003-3882-0592; Wheeler, Michael B./0000-0002-7480-7267; Doucette, Christine/0000-0002-5070-2639				Aikawa R, 2000, CIRCULATION, V102, P2873; Aikin R, 2006, DIABETOLOGIA, V49, P2900, DOI 10.1007/s00125-006-0476-0; AKERMAN KEO, 1976, FEBS LETT, V68, P191, DOI 10.1016/0014-5793(76)80434-6; ALNASSER I, 1986, BIOCHEM J, V239, P19, DOI 10.1042/bj2390019; ARKHAMMAR P, 1989, BIOCHEM BIOPH RES CO, V159, P223, DOI 10.1016/0006-291X(89)92426-1; ARKHAMMAR P, 1990, FEBS LETT, V273, P182, DOI 10.1016/0014-5793(90)81079-4; Asghar Z, 2006, DIABETOLOGIA, V49, P90, DOI 10.1007/s00125-005-0045-y; Barbu A, 2002, MOL CELL ENDOCRINOL, V190, P75, DOI 10.1016/S0303-7207(02)00009-6; Barrand MA, 1997, GEN PHARMACOL, V28, P639, DOI 10.1016/S0306-3623(96)00284-4; Beeharry N, 2004, APOPTOSIS, V9, P599, DOI 10.1023/B:APPT.0000038039.82506.0c; Belosludtsev KN, 2005, BIOCHEMISTRY-MOSCOW+, V70, P815, DOI 10.1007/s10541-005-0189-x; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 2002, VITAM HORM, V65, P97, DOI 10.1016/S0083-6729(02)65061-7; Bernardi P, 1999, EUR J BIOCHEM, V264, P687, DOI 10.1046/j.1432-1327.1999.00725.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Biden TJ, 2004, DIABETES, V53, pS159, DOI 10.2337/diabetes.53.2007.S159; Bodrova ME, 2003, BIOCHEMISTRY-MOSCOW+, V68, P391, DOI 10.1023/A:1023691628110; Bodrova ME, 2000, IUBMB LIFE, V50, P189; Broekemeier KM, 1998, BIOCHEMISTRY-US, V37, P13059, DOI 10.1021/bi980820c; Brustovetsky N, 2000, J NEUROSCI, V20, P103, DOI 10.1523/JNEUROSCI.20-01-00103.2000; Busch AK, 2005, DIABETES, V54, P2917, DOI 10.2337/diabetes.54.10.2917; Busch AK, 2002, DIABETES, V51, P977, DOI 10.2337/diabetes.51.4.977; Buteau J, 2004, DIABETOLOGIA, V47, P806, DOI 10.1007/s00125-004-1379-6; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Civelek VN, 1996, BIOCHEM J, V318, P615, DOI 10.1042/bj3180615; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Dai FHF, 2006, J BIOL CHEM, V281, P21942, DOI 10.1074/jbc.M512924200; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Di Paola M, 2006, BBA-BIOENERGETICS, V1757, P1330, DOI 10.1016/j.bbabio.2006.03.024; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Dufer M, 2001, MOL PHARMACOL, V60, P873; Dymkowska D, 2006, BBA-MOL CELL RES, V1763, P152, DOI 10.1016/j.bbamcr.2005.12.009; El-Kholy W, 2003, FASEB J, V17, P720, DOI 10.1096/fj.02-0802fje; ELLIOTT JI, 1980, J INORG BIOCHEM, V12, P323; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; FRY JR, 1976, ANAL BIOCHEM, V71, P341, DOI 10.1016/S0003-2697(76)80003-6; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GUNTER TE, 1990, AM J PHYSIOL, V258, pC755, DOI 10.1152/ajpcell.1990.258.5.C755; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; Hardy S, 2000, CANCER RES, V60, P6353; Hausenloy D, 2004, CIRCULATION, V109, P1714, DOI 10.1161/01.CIR.0000126294.81407.7D; HOEK JB, 1995, BBA-MOL BASIS DIS, V1271, P93, DOI 10.1016/0925-4439(95)00015-V; Ichas F, 1998, BBA-BIOENERGETICS, V1366, P33, DOI 10.1016/S0005-2728(98)00119-4; Inoguchi T, 2000, DIABETES, V49, P1939, DOI 10.2337/diabetes.49.11.1939; Jimenez-Chillaron JC, 2005, DIABETES, V54, P702, DOI 10.2337/diabetes.54.3.702; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Joshi MS, 2006, AM J RESP CRIT CARE, V173, P999, DOI 10.1164/rccm.200411-1507OC; Kong JY, 2000, BBA-MOL CELL BIOL L, V1485, P45, DOI 10.1016/S1388-1981(00)00028-7; Korge P, 1999, EUR J BIOCHEM, V265, P273, DOI 10.1046/j.1432-1327.1999.00724.x; Koshkin V, 2004, J BIOL CHEM, V279, P41368, DOI 10.1074/jbc.M406914200; Koshkin V, 2003, J BIOL CHEM, V278, P19709, DOI 10.1074/jbc.M209709200; Kowaltowski AJ, 2000, AM J PHYSIOL-CELL PH, V279, pC852, DOI 10.1152/ajpcell.2000.279.3.C852; Kowaltowski AJ, 2001, FEBS LETT, V495, P12, DOI 10.1016/S0014-5793(01)02316-X; Krasnikov BF, 2005, BBA-BIOENERGETICS, V1708, P375, DOI 10.1016/j.bbabio.2005.05.009; Kristal BS, 1996, J BIOL CHEM, V271, P6033, DOI 10.1074/jbc.271.11.6033; Kushnareva YE, 2000, ARCH BIOCHEM BIOPHYS, V376, P377, DOI 10.1006/abbi.2000.1730; Lecoeur H, 2001, CYTOMETRY, V44, P65, DOI 10.1002/1097-0320(20010501)44:1<65::AID-CYTO1083>3.0.CO;2-Q; LeRoith D, 2002, AM J MED, V113, p3S; LOTSCHER HR, 1979, P NATL ACAD SCI USA, V76, P4340, DOI 10.1073/pnas.76.9.4340; Lukowiak B, 2001, J HISTOCHEM CYTOCHEM, V49, P519, DOI 10.1177/002215540104900412; MACDONALD MJ, 1981, J BIOL CHEM, V256, P8287; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Maedler K, 2001, DIABETES, V50, P69, DOI 10.2337/diabetes.50.1.69; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; MERRITT JE, 1990, BIOCHEM J, V269, P513, DOI 10.1042/bj2690513; Migita K, 2003, IMMUNOL LETT, V90, P87, DOI 10.1016/j.imlet.2003.07.003; Moore PC, 2004, DIABETES, V53, P2610, DOI 10.2337/diabetes.53.10.2610; Novgorodov SA, 1996, J BIOENERG BIOMEMBR, V28, P139, DOI 10.1007/BF02110644; Pacher P, 2001, EMBO J, V20, P4107, DOI 10.1093/emboj/20.15.4107; Panaretakis T, 2001, TOXICOL APPL PHARM, V173, P56, DOI 10.1006/taap.2001.9159; Park SY, 2005, APOPTOSIS, V10, P537, DOI 10.1007/s10495-005-1884-1; Penzo D, 2004, J BIOL CHEM, V279, P25219, DOI 10.1074/jbc.M310381200; Penzo D, 2002, BBA-BIOENERGETICS, V1555, P160, DOI 10.1016/S0005-2728(02)00272-4; QUINLAN PT, 1983, BIOCHEM J, V214, P395, DOI 10.1042/bj2140395; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; Rello S, 2005, APOPTOSIS, V10, P201, DOI 10.1007/s10495-005-6075-6; REYNAFARJE B, 1985, ANAL BIOCHEM, V145, P406, DOI 10.1016/0003-2697(85)90381-1; RILEY WW, 1985, J BIOL CHEM, V260, P2416; Rosenstock TR, 2004, J NEUROCHEM, V88, P1220, DOI 10.1046/j.1471-4159.2003.02250.x; Sabin MA, 2007, J CELL PHYSIOL, V211, P244, DOI 10.1002/jcp.20922; SCHONFELD P, 1990, FEBS LETT, V264, P246, DOI 10.1016/0014-5793(90)80259-L; Shimabukuro M, 1998, J BIOL CHEM, V273, P32487, DOI 10.1074/jbc.273.49.32487; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Silva JP, 2000, NAT GENET, V26, P336, DOI 10.1038/81649; Smaili SS, 1999, CELL CALCIUM, V26, P121, DOI 10.1054/ceca.1999.0061; Smaili SS, 2001, J BIOL CHEM, V276, P23329, DOI 10.1074/jbc.M100989200; Smart N, 2006, CARDIOVASC RES, V69, P164, DOI 10.1016/j.cardiores.2005.08.017; Sparagna GC, 2000, AM J PHYSIOL-HEART C, V279, pH2124, DOI 10.1152/ajpheart.2000.279.5.H2124; Stavrovskaya IG, 2005, FREE RADICAL BIO MED, V38, P687, DOI 10.1016/j.freeradbiomed.2004.11.032; Takuma K, 2001, J BIOL CHEM, V276, P48093, DOI 10.1074/jbc.M108622200; Thomas A.P., 1991, CELLULAR CALCIUM PRA, P1; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; VERCESI AE, 1991, J BIOL CHEM, V266, P14431; Vieira HLA, 2001, ONCOGENE, V20, P4305, DOI 10.1038/sj.onc.1204575; Wang XL, 2004, DIABETES, V53, P129, DOI 10.2337/diabetes.53.1.129; Ward MW, 2000, J NEUROSCI, V20, P7208; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Wieckowski MR, 1998, FEBS LETT, V423, P339, DOI 10.1016/S0014-5793(98)00118-5; WOITCZAK L, 1993, BIOCHIM BIOPHYS ACTA, V1183, P41, DOI 10.1016/0005-2728(93)90004-Y; Xia SH, 2007, J BIOL CHEM, V282, P13199, DOI 10.1074/jbc.M610225200; Zago EB, 2000, FEBS LETT, V478, P29, DOI 10.1016/S0014-5793(00)01815-9; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	104	62	63	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7936	7948		10.1074/jbc.M705652200	http://dx.doi.org/10.1074/jbc.M705652200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18162472	hybrid			2022-12-25	WOS:000253997900069
J	Doi, H; Okamura, K; Bauer, PO; Furukawa, Y; Shimizu, H; Kurosawa, M; Machida, Y; Miyazaki, H; Mitsui, K; Kuroiwa, Y; Nukina, N				Doi, Hiroshi; Okamura, Kazumasa; Bauer, Peter O.; Furukawa, Yoshiaki; Shimizu, Hideaki; Kurosawa, Masaru; Machida, Yoko; Miyazaki, Haruko; Mitsui, Kenichi; Kuroiwa, Yoshiyuki; Nukina, Nobuyuki			RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE TRANSGENIC MICE; STRIATAL SPINY NEURONS; N-TERMINAL HUNTINGTIN; CELLULAR TOXICITY; IN-VITRO; INTRANUCLEAR INCLUSIONS; CASPASE ACTIVATION; DENDRITIC SPINES; POLYMERASE-II; MOUSE MODEL	Formation of intracellular aggregates is the hallmark of polyglutamine (polyQ) diseases. We analyzed the components of purified nuclear polyQ aggregates by mass spectrometry. As a result, we found that the RNA-binding protein translocated in liposarcoma (TLS) was one of the major components of nuclear polyQ aggregate-interacting proteins in a Huntington disease cell model and was also associated with neuronal intranuclear inclusions of R6/2 mice. In vitro study revealed that TLS could directly bind to truncated N-terminal huntingtin (tNhtt) aggregates but could not bind to monomer GST-tNhtt with 18, 42, or 62Q, indicating that the tNhtt protein acquired the ability to sequester TLS after forming aggregates. Thioflavin T assay and electron microscopic study further supported the idea that TLS bound to tNhtt-42Q aggregates at the early stage of tNhtt-42Q amyloid formation. Immunohistochemistry showed that TLS was associated with neuronal intranuclear inclusions of Huntington disease human brain. Because TLS has a variety of functional roles, the sequestration of TLS to polyQ aggregates may play a role in diverse pathological changes in the brains of patients with polyQ diseases.	[Doi, Hiroshi; Okamura, Kazumasa; Bauer, Peter O.; Furukawa, Yoshiaki; Shimizu, Hideaki; Kurosawa, Masaru; Machida, Yoko; Miyazaki, Haruko; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan; [Mitsui, Kenichi] RIKEN, Brain Sci Inst, Res Resource Ctr, Wako, Saitama 3510198, Japan; [Doi, Hiroshi; Kuroiwa, Yoshiyuki] Yokohama City Univ, Grad Sch Med, Dept Neurol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan	RIKEN; RIKEN; Yokohama City University	Nukina, N (corresponding author), 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nukina@brain.riken.jp	Furukawa, Yoshiaki/F-2871-2014; Nukina, Nobuyuki/GPP-6265-2022; Shimizu, Hideaki/C-4142-2017; Longo, Kenneth A/A-5631-2010; Bauer, Peter O./AAD-6502-2022	Furukawa, Yoshiaki/0000-0002-1918-372X; Shimizu, Hideaki/0000-0003-0174-5947; Bauer, Peter O./0000-0003-2811-1354				Bertolotti A, 1996, EMBO J, V15, P5022, DOI 10.1002/j.1460-2075.1996.tb00882.x; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Chai YH, 1999, HUM MOL GENET, V8, P673, DOI 10.1093/hmg/8.4.673; Chien P, 2003, NATURE, V424, P948, DOI 10.1038/nature01894; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Delva L, 2004, ONCOGENE, V23, P4389, DOI 10.1038/sj.onc.1207578; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; Fujii R, 2005, J CELL SCI, V118, P5755, DOI 10.1242/jcs.02692; Fujii R, 2005, CURR BIOL, V15, P587, DOI 10.1016/j.cub.2005.01.058; Jana NR, 2000, HUM MOL GENET, V9, P2009, DOI 10.1093/hmg/9.13.2009; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Katsuno M, 2003, NAT MED, V9, P768, DOI 10.1038/nm878; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Klapstein GJ, 2001, J NEUROPHYSIOL, V86, P2667, DOI 10.1152/jn.2001.86.6.2667; Kuhn A, 2007, HUM MOL GENET, V16, P1845, DOI 10.1093/hmg/ddm133; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Michalik A, 2003, HUM MOL GENET, V12, pR173, DOI 10.1093/hmg/ddg295; Mitsui K, 2002, J NEUROSCI, V22, P9267; Mitsui K, 2006, METHOD ENZYMOL, V412, P63, DOI 10.1016/S0076-6879(06)12005-4; Nagai Y, 2003, HUM MOL GENET, V12, P1253, DOI 10.1093/hmg/ddg144; Nagai Y, 2007, NAT STRUCT MOL BIOL, V14, P332, DOI 10.1038/nsmb1215; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Oyama F, 2006, J NEUROCHEM, V98, P518, DOI 10.1111/j.1471-4159.2006.03893.x; Perez MK, 1998, J CELL BIOL, V143, P1457, DOI 10.1083/jcb.143.6.1457; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sanchez I, 2003, NATURE, V421, P373, DOI 10.1038/nature01301; Schaffar G, 2004, MOL CELL, V15, P95, DOI 10.1016/j.molcel.2004.06.029; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schilling G, 2004, HUM MOL GENET, V13, P1599, DOI 10.1093/hmg/ddh175; Serio TR, 2000, SCIENCE, V289, P1317, DOI 10.1126/science.289.5483.1317; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tanaka M, 2003, J BIOL CHEM, V278, P34717, DOI 10.1074/jbc.M209852200; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Wang GH, 1999, NEUROREPORT, V10, P2435, DOI 10.1097/00001756-199908200-00001; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yang L, 1998, J BIOL CHEM, V273, P27761, DOI 10.1074/jbc.273.43.27761; Zemskov EA, 2003, J NEUROCHEM, V87, P395, DOI 10.1046/j.1471-4159.2003.02002.x; Zinszner H, 1997, J CELL SCI, V110, P1741	48	91	95	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6489	6500		10.1074/jbc.M705306200	http://dx.doi.org/10.1074/jbc.M705306200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167354	hybrid			2022-12-25	WOS:000253779500056
J	Gao, T; Brognard, J; Newton, AC				Gao, Tianyan; Brognard, John; Newton, Alexandra C.			The phosphatase PHLPP controls the cellular levels of protein kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOINOSITIDE-DEPENDENT KINASE; DOWN-REGULATION; IN-VIVO; BETA-II; COLON CARCINOGENESIS; PHOSPHORYLATION; DEPHOSPHORYLATION; ALPHA; AUTOPHOSPHORYLATION; CONTRIBUTES	The life cycle of protein kinase C (PKC) is controlled by multiple phosphorylation and dephosphorylation steps. The maturation of PKC requires three ordered phosphorylations, one at the activation loop and two at COOH-terminal sites, the turn motif and the hydrophobic motif, to yield a stable and signaling-competent enzyme. Dephosphorylation of the enzyme leads to protein degradation. We have recently discovered a novel family of protein phosphatases named PH domain leucine-rich repeat protein phosphatase (PHLPP) whose members terminate Akt signaling by dephosphorylating the hydrophobic motif on Akt. Here we show that the two PHLPP isoforms, PHLPP1 and PHLPP2, also dephosphorylate the hydrophobic motif on PKC beta II, an event that shunts PKC to the detergent-insoluble fraction, effectively terminating its life cycle. Deletion mutagenesis reveals that the PH domain is necessary for the effective dephosphorylation of PKC beta II by PHLPP in cells, whereas the PDZ-binding motif, required for Akt regulation, is dispensable. The phorbol ester-mediated dephosphorylation of the hydrophobic site, but not the turn motif or activation loop, is insensitive to okadaic acid, consistent with PHLPP, a PP2C family member, controlling the hydrophobic site. In addition, knockdown of PHLPP expression reduces the rate of phorbol ester-triggered dephosphorylation of the hydrophobic motif, but not turn motif, of PKC alpha. Last, we show that depletion of PHLPP in colon cancer and normal breast epithelial cells results in an increase in conventional and novel PKC levels. These data reveal that PHLPP controls the cellular levels of PKC by specifically dephosphorylating the hydrophobic motif, thus destabilizing the enzyme and promoting its degradation.	[Gao, Tianyan; Newton, Alexandra C.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Brognard, John] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu	Brognard, John/T-5099-2019	Brognard, John/0000-0002-9243-6615	NATIONAL CANCER INSTITUTE [K01CA102098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043154, R01GM067946] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA 10209-03] Funding Source: Medline; NIGMS NIH HHS [GM 067946, R01 GM043154, R01 GM067946, R01 GM 43154] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alessi DR, 1998, CURR BIOL, V8, P69, DOI 10.1016/S0960-9822(98)70037-5; Balendran A, 2000, FEBS LETT, V484, P217, DOI 10.1016/S0014-5793(00)02162-1; Behn-Krappa A, 1999, CURR BIOL, V9, P728, DOI 10.1016/S0960-9822(99)80332-7; Bornancin F, 1997, J BIOL CHEM, V272, P3544, DOI 10.1074/jbc.272.6.3544; BORNER C, 1988, P NATL ACAD SCI USA, V85, P2110, DOI 10.1073/pnas.85.7.2110; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; COHEN P, 1989, J BIOL CHEM, V264, P21435; Cohen PTW, 2002, J CELL SCI, V115, P241; DUTIL EM, 1994, J BIOL CHEM, V269, P29359; Dutil EM, 1998, CURR BIOL, V8, P1366, DOI 10.1016/S0960-9822(98)00017-7; Edwards AS, 1997, J BIOL CHEM, V272, P18382, DOI 10.1074/jbc.272.29.18382; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Gao TY, 2001, J BIOL CHEM, V276, P19588, DOI 10.1074/jbc.M101357200; Gokmen-Polar Y, 2001, CANCER RES, V61, P1375; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; Gysin S, 1997, EUR J BIOCHEM, V249, P156, DOI 10.1111/j.1432-1033.1997.t01-2-00156.x; Gysin S, 1996, EUR J BIOCHEM, V240, P747, DOI 10.1111/j.1432-1033.1996.0747h.x; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hansra G, 1996, J BIOL CHEM, V271, P32785, DOI 10.1074/jbc.271.51.32785; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Hill MM, 2001, J BIOL CHEM, V276, P25643, DOI 10.1074/jbc.C100174200; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; KILEY SC, 1991, J BIOL CHEM, V266, P23761; Lee HW, 1996, AM J PHYSIOL-CELL PH, V271, pC304, DOI 10.1152/ajpcell.1996.271.1.C304; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; MURRAY NR, 1993, J BIOL CHEM, V268, P15847; Murray NR, 1999, J CELL BIOL, V145, P699, DOI 10.1083/jcb.145.4.699; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; NEWTON AC, 1987, J BIOL CHEM, V262, P10185; Parker PJ, 2001, BIOCHEM SOC T, V29, P860, DOI 10.1042/0300-5127:0290860; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710	33	150	155	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6300	6311		10.1074/jbc.M707319200	http://dx.doi.org/10.1074/jbc.M707319200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18162466	hybrid			2022-12-25	WOS:000253779500037
J	D'Costa, SM; Bainbridge, TW; Condit, RC				D'Costa, Susan M.; Bainbridge, Travis W.; Condit, Richard C.			Purification and properties of the vaccinia virus mRNA processing factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPHOSPHATE PHOSPHOHYDROLASE I; TRANSCRIPTION ELONGATION-FACTOR; TEMPERATURE-SENSITIVE MUTANTS; A18R DNA HELICASE; EXONUCLEASE XRN2; J3 PROTEIN; GENE G2R; H5R GENE; POLYMERASE; TERMINATION	The mRNAs encoding the vaccinia virus F17 protein and the cowpox A-type inclusion protein are known to possess sequence-homogeneous 3' ends, generated by a post-transcriptional cleavage event. By using partially purified extracts, we have previously shown that the same factor probably cleaves both the F17 and A-type inclusion protein transcripts and that the cleavage factor is either virus-coded or virus-induced during the post-replicative phase of virus replication. In this study, we have purified the cleavage factor from vaccinia-infected HeLa cells using column chromatography and gel filtration. The factor eluted from the gel filtration column with an apparent molecular mass of similar to 440 kDa. Mass spectrometric analyses of the proteins present in the peak active fractions revealed the presence of at least one vaccinia protein with a high degree of certainty, the H5R gene product. To extend this finding, extracts were prepared from HeLa cells infected with vaccinia virus over-expressing His-tagged H5, chromatographed on a nickel affinity column, and eluted using an imidazole gradient. Cleavage activity eluted with the peak of His-tagged H5. Gel filtration of the affinity-purified material further demonstrated that cleavage activity and His-tagged H5 co-chromatographed with an apparent molecular mass of 463 kDa. We therefore conclude that H5 is specifically associated with post-transcriptional cleavage of F17R transcripts. In addition, we show that dephosphorylation of a cleavage competent extract with a nonspecific phosphatase abolishes cleavage activity implying a role for phosphorylation in cleavage activity.	[D'Costa, Susan M.; Bainbridge, Travis W.; Condit, Richard C.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	D'Costa, SM (corresponding author), Univ Florida, J Hillis Miller Hlth Ctr, PO Box 100266, Gainesville, FL 32610 USA.	ihssd@ufl.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018094] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI18094] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANTCZAK JB, 1992, P NATL ACAD SCI USA, V89, P12033, DOI 10.1073/pnas.89.24.12033; BAYLISS CD, 1995, J BIOL CHEM, V270, P1550, DOI 10.1074/jbc.270.4.1550; BEAUD G, 1995, J VIROL, V69, P1819, DOI 10.1128/JVI.69.3.1819-1826.1995; Beaud G, 1997, J GEN VIROL, V78, P3297, DOI 10.1099/0022-1317-78-12-3297; Black EP, 1996, J VIROL, V70, P47, DOI 10.1128/JVI.70.1.47-54.1996; Black EP, 1998, VIROLOGY, V245, P313, DOI 10.1006/viro.1998.9166; Brown N G, 2000, BMC Biochem, V1, P2, DOI 10.1186/1471-2091-1-2; Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003; Christen LM, 1998, VIROLOGY, V245, P360, DOI 10.1006/viro.1998.9177; CONDIT RC, 1983, VIROLOGY, V128, P429, DOI 10.1016/0042-6822(83)90268-4; CONDIT RC, 1981, VIROLOGY, V113, P224, DOI 10.1016/0042-6822(81)90150-1; Condit RC, 1996, VIROLOGY, V218, P169, DOI 10.1006/viro.1996.0177; Condit RC, 1996, VIROLOGY, V220, P10, DOI 10.1006/viro.1996.0280; CONDIT RC, 1991, VIROLOGY, V185, P857, DOI 10.1016/0042-6822(91)90559-T; Condit RC, 2002, BBA-GENE STRUCT EXPR, V1577, P325, DOI 10.1016/S0167-4781(02)00461-X; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; Cresawn SG, 2007, VIROLOGY, V363, P319, DOI 10.1016/j.virol.2007.02.005; Cresawn SG, 2007, VIROLOGY, V363, P333, DOI 10.1016/j.virol.2007.02.016; D'Costa SM, 2004, VIROLOGY, V319, P1, DOI 10.1016/j.virol.2003.09.041; Dellis S, 2004, VIROLOGY, V329, P328, DOI 10.1016/j.virol.2004.08.017; DeMasi J, 2000, J VIROL, V74, P2393, DOI 10.1128/JVI.74.5.2393-2405.2000; Deng L, 1998, GENE DEV, V12, P538, DOI 10.1101/gad.12.4.538; Domi A, 2000, J GEN VIROL, V81, P1231, DOI 10.1099/0022-1317-81-5-1231; FUERST TR, 1986, P NATL ACAD SCI USA, V83, P8122, DOI 10.1073/pnas.83.21.8122; GORDON J, 1991, VIROLOGY, V181, P671, DOI 10.1016/0042-6822(91)90901-M; Ishii K, 2001, J VIROL, V75, P1656, DOI 10.1128/JVI.75.4.1656-1663.2001; Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207; Kovacs GR, 1996, J VIROL, V70, P6796, DOI 10.1128/JVI.70.10.6796-6802.1996; Lackner CA, 2000, J BIOL CHEM, V275, P1485, DOI 10.1074/jbc.275.2.1485; Lackner CA, 2003, VIROLOGY, V305, P240, DOI 10.1006/viro.2002.1745; Latner DR, 2000, VIROLOGY, V269, P345, DOI 10.1006/viro.2000.0243; Latner DR, 2002, VIROLOGY, V301, P64, DOI 10.1006/viro.2002.1538; Luo WF, 2004, CELL, V119, P911, DOI 10.1016/j.cell.2004.11.041; MAHR A, 1984, J VIROL, V49, P510, DOI 10.1128/JVI.49.2.510-520.1984; McCraith S, 2000, P NATL ACAD SCI USA, V97, P4879, DOI 10.1073/pnas.080078197; MEIS RJ, 1991, VIROLOGY, V182, P442, DOI 10.1016/0042-6822(91)90585-Y; Mohamed MR, 2000, J BIOL CHEM, V275, P25798, DOI 10.1074/jbc.M002250200; Moss B, 2001, FIELDS VIROLOGY, P2849; NOWAKOWSKI M, 1978, VIROLOGY, V86, P217, DOI 10.1016/0042-6822(78)90022-3; PARSONS BL, 1990, VIROLOGY, V175, P69, DOI 10.1016/0042-6822(90)90187-V; PATEL DD, 1989, J VIROL, V63, P1076, DOI 10.1128/JVI.63.3.1076-1086.1989; PATEL DD, 1988, P NATL ACAD SCI USA, V85, P9431, DOI 10.1073/pnas.85.24.9431; Rodgers ND, 2002, J BIOL CHEM, V277, P2597, DOI 10.1074/jbc.M108330200; ROHRMANN G, 1986, CELL, V46, P1029, DOI 10.1016/0092-8674(86)90702-6; ROSEL JL, 1986, J VIROL, V60, P436, DOI 10.1128/JVI.60.2.436-449.1986; Shav-Tal Y, 2002, FEBS LETT, V531, P109, DOI 10.1016/S0014-5793(02)03447-6; SHUMAN S, 1987, J BIOL CHEM, V262, P12372; SHUMAN S, 1988, J BIOL CHEM, V263, P6220; Teixeira A, 2004, NATURE, V432, P526, DOI 10.1038/nature03032; Turner PC, 1999, J VIROL, V73, P6394, DOI 10.1128/JVI.73.8.6394-6404.1999; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Xiang Y, 2000, VIROLOGY, V269, P356, DOI 10.1006/viro.2000.0242; Xiang Y, 1998, J VIROL, V72, P7012, DOI 10.1128/JVI.72.9.7012-7023.1998; YUEN L, 1987, P NATL ACAD SCI USA, V84, P6417, DOI 10.1073/pnas.84.18.6417	54	9	10	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5267	5275		10.1074/jbc.M709258200	http://dx.doi.org/10.1074/jbc.M709258200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18089571	hybrid			2022-12-25	WOS:000253426700006
J	Zhang, HM; Hamdane, D; Im, SC; Waskell, L				Zhang, Haoming; Hamdane, Djemel; Im, Sang-Choul; Waskell, Lucy			Cytochrome b(5) inhibits electron transfer from NADPH-cytochrome P450 reductase to ferric cytochrome P4502B4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER MICROSOMAL CYTOCHROME-P-450; P450 REDUCTASE; PROTEIN INTERACTIONS; P-450 REDUCTASE; ENZYME-SYSTEM; BINDING-SITE; B(5); NADPH; OXIDATION; 2B4	Experiments demonstrating that cytochrome (cyt) b(5) inhibits the activity of cytochrome P450 2B4 ( cyt P450 2B4) at higher concentrations suggested that cyt b(5) was occupying the cyt P450 reductase-binding site on cyt P450 2B4 and preventing the reduction of ferric cyt P450 (Zhang, H., Im, S.-C., and Waskell, L. (2007) J. Biol. Chem. 282, 29766-29776). In this work experiments were undertaken with manganese-containing cyt b(5) (Mn-cyt b(5)) to test this hypothesis. Because Mn-cyt b(5) does not undergo oxidation state changes under our experimental conditions, interpretation of the experimental results was unambiguous. The rate of electron transfer from cyt P450 reductase to ferric cyt P450 2B4 was decreased by Mn-cyt b(5) in a concentration-dependent manner. Moreover, reduction of cyt P450 2B4 by cyt P450 reductase was incomplete in the presence of Mn-cyt b5. At a Mn-cyt b5: cyt P450 2B4: cyt P450 reductase molar ratio of 5: 1: 1, the rate of reduction of ferric cyt P450 was decreased by 10-fold, and only 30% of the cyt P450 was reduced, whereas 70% remained oxidized. It could be demonstrated that Mn-cyt b(5) had its effect by acting on cyt P450, not the reductase, because the reduction of cyt c by cyt P450 reductase in the presence of Mn-cyt b(5) was not effected. Furthermore, under steady-state conditions in the cyt P450 reconstituted system, Mn-cyt b(5), which lacks the ability to reduce oxyferrous cyt P450 2B4, was unable to stimulate the activity of cyt P450. Mn-cyt b(5) only inhibited the cyt P450 2B4 activity. In conjunction with site-directed mutagenesis studies and experiments that strongly suggested that cyt b(5) competed with cyt P450 reductase for binding to cyt P450, the current investigation demonstrates unequivocally that cyt b(5) inhibits the activity of cyt P450 2B4 by preventing cyt P450 reductase from binding to cyt P450, a prerequisite for electron transfer from cyt P450 reductase to cyt P450 and catalysis.	[Zhang, Haoming; Hamdane, Djemel; Im, Sang-Choul; Waskell, Lucy] Univ Michigan, Sch Med, Vet Affairs Med Ctr, Dept Anesthesiol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Waskell, L (corresponding author), Univ Michigan, Dept Anesthesiol, Res Serv, 2215 Fuller Rd, Ann Arbor, MI 48105 USA.	waskell@umich.edu	Zhang, Haoming/AAE-3749-2020	Zhang, Haoming/0000-0002-8765-4394	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM035533] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM35533] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BACKES WL, 1989, J BIOL CHEM, V264, P6252; BACKES WL, 1988, J BIOL CHEM, V263, P247; BONFILS C, 1981, J BIOL CHEM, V256, P9457; BOSTERLING B, 1982, J BIOL CHEM, V257, P4375; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; CANOVADAVIS E, 1985, BIOCHEM PHARMACOL, V34, P1907, DOI 10.1016/0006-2952(85)90307-7; CANOVADAVIS E, 1984, J BIOL CHEM, V259, P2541; Davydov DR, 2000, BIOCHEMISTRY-US, V39, P6489, DOI 10.1021/bi992936u; DAVYDOV DR, 1992, ARCH BIOCHEM BIOPHYS, V297, P304, DOI 10.1016/0003-9861(92)90677-O; Davydov DR, 1996, BIOCHIMIE, V78, P734, DOI 10.1016/S0300-9084(97)82531-X; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Estabrook R W, 1978, Methods Enzymol, V52, P212; FRENCH JS, 1980, J BIOL CHEM, V255, P4112; GRAY RD, 1978, J BIOL CHEM, V253, P4364; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Gruenke LD, 1997, BIOCHEMISTRY-US, V36, P7114, DOI 10.1021/bi970407p; GUENGERICH FP, 1975, J BIOL CHEM, V250, P7405; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Guengerich FP, 1997, BIOCHEMISTRY-US, V36, P14741, DOI 10.1021/bi9719399; Guryev OL, 2001, BIOCHEMISTRY-US, V40, P5018, DOI 10.1021/bi002305w; Ivanov YD, 1999, ARCH BIOCHEM BIOPHYS, V362, P87, DOI 10.1006/abbi.1998.0981; Locuson CW, 2007, DRUG METAB DISPOS, V35, P1174, DOI 10.1124/dmd.107.014910; MAYUZUMI H, 1994, ARCH BIOCHEM BIOPHYS, V310, P367, DOI 10.1006/abbi.1994.1180; MIWA GT, 1979, J BIOL CHEM, V254, P5695; Mokashi V, 2003, ARCH BIOCHEM BIOPHYS, V412, P147, DOI 10.1016/S0003-9861(03)00040-7; MORGAN ET, 1984, DRUG METAB DISPOS, V12, P358; NASH T, 1953, BIOCHEM J, V55, P416, DOI 10.1042/bj0550416; OMURA T, 1964, J BIOL CHEM, V239, P2379; OPRIAN DD, 1982, J BIOL CHEM, V257, P8935; PETERSON JA, 1977, J BIOL CHEM, V252, P4431; POMPON D, 1984, J BIOL CHEM, V259, P5377; Reed JR, 2003, J INORG BIOCHEM, V97, P265, DOI 10.1016/S0162-0134(03)00275-7; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Shimada T, 2005, ARCH BIOCHEM BIOPHYS, V435, P207, DOI 10.1016/j.abb.2004.12.008; SPATZ L, 1971, P NATL ACAD SCI USA, V68, P1042, DOI 10.1073/pnas.68.5.1042; TAMBURINI PP, 1986, MOL PHARMACOL, V30, P178; TAMBURINI PP, 1987, P NATL ACAD SCI USA, V84, P11, DOI 10.1073/pnas.84.1.11; TAMBURINI PP, 1985, J BIOL CHEM, V260, P4007; VAN GB, 1962, BIOCHIM BIOPHYS ACTA, V58, P593; VATSIS KP, 1979, ACTA BIOL MED GER, V38, P459; VERMILION JL, 1978, J BIOL CHEM, V253, P2694; WU FF, 1994, ARCH BIOCHEM BIOPHYS, V308, P380, DOI 10.1006/abbi.1994.1054; Yamaori S, 2003, BIOCHEM PHARMACOL, V66, P2333, DOI 10.1016/j.bcp.2003.08.004; Yamazaki H, 1997, ARCH BIOCHEM BIOPHYS, V342, P329, DOI 10.1006/abbi.1997.0125; Yamazaki H, 1996, J BIOL CHEM, V271, P27438, DOI 10.1074/jbc.271.44.27438; Yamazaki H, 2002, PROTEIN EXPRES PURIF, V24, P329, DOI 10.1006/prep.2001.1578; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P11594, DOI 10.1021/bi034968u; Zhang HM, 2005, BIOCHEM BIOPH RES CO, V338, P499, DOI 10.1016/j.bbrc.2005.09.022	49	44	44	3	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5217	5225		10.1074/jbc.M709094200	http://dx.doi.org/10.1074/jbc.M709094200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086668	hybrid			2022-12-25	WOS:000253426700001
J	Choi, DW; Seo, YM; Kim, EA; Sung, KS; Ahn, JW; Park, SJ; Lee, SR; Choi, CY				Choi, Dong Wook; Seo, Yu-Mi; Kim, Eun-A; Sung, Ki Sa; Ahn, Jang Won; Park, Sang-Joon; Lee, Seung-Rock; Choi, Cheol Yong			Ubiquitination and degradation of homeodomain-interacting protein kinase 2 by WD40 repeat/SOCS box protein WSB-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; SOCS-BOX; CELL-CYCLE; TRANSCRIPTIONAL REPRESSION; P53 PHOSPHORYLATION; WD-REPEAT; HIPK2; KINASE-2; APOPTOSIS; LIGASE	Homeodomain-interacting protein kinase 2 (HIPK2) is a member of the nuclear protein kinase family, which induces both p53- and CtBP-mediated apoptosis. Levels of HIPK2 were increased by UV irradiation and cisplatin treatment, thereby implying the degradation of HIPK2 in cells under normal conditions. Here, we indicate that HIPK2 is ubiquitinated and degraded by the WD40-repeat/SOCS box protein WSB-1, a process that is blocked under DNA damage conditions. Yeast two-hybrid screening was conducted to identify the proteins that interact with HIPK2. WSB-1, an E3 ubiquitin ligase, was characterized as an HIPK2-interacting protein. The coexpression of WSB-1 resulted in the degradation of HIPK2 via its C-terminal region. Domain analysis of WSB-1 showed that WD40-repeats and the SOCS box were required for its interaction with and degradation of HIPK2, respectively. In support of the degradation of HIPK2 by WSB-1, HIPK2 was polyubiquitinated by WSB-1 in vitro and in vivo. The knockdown of endogenous WSB-1 with the expression of short hairpin RNA against WSB-1 increases the stability of endogenous HIPK2 and resulted in the accumulation of HIPK2. The ubiquitination and degradation of HIPK2 by WSB-1 was inhibited completely via the administration of DNA damage reagents, including Adriamycin and cisplatin. These findings effectively illustrate the regulatory mechanisms by which HIPK2 is maintained at a low level, by WSB-1 in cells under normal conditions, and stabilized by genotoxic stresses.	[Choi, Dong Wook; Seo, Yu-Mi; Kim, Eun-A; Sung, Ki Sa; Ahn, Jang Won; Choi, Cheol Yong] Sungkyunkwan Univ, Dept Biol Sci, Suwon 440746, South Korea; [Park, Sang-Joon] Korea Res Inst Chem Technol, Korea Inst Toxicol, Taejon 305600, South Korea; [Lee, Seung-Rock] Chonnam Natl Univ, Sch Med, Ctr Aging & Geriatr, Dept Biochem, Kwangju 501746, South Korea	Sungkyunkwan University (SKKU); Korea Institute of Toxicology; Korea Research Institute of Chemical Technology (KRICT); Chonnam National University	Choi, CY (corresponding author), Sungkyunkwan Univ, Dept Biol Sci, 300 Chunchundong, Suwon 440746, South Korea.	choicy@skku.ac.kr		Choi, Dong Wook/0000-0002-5729-2273				Aikawa Y, 2006, EMBO J, V25, P3955, DOI 10.1038/sj.emboj.7601273; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Castro A, 2005, ONCOGENE, V24, P314, DOI 10.1038/sj.onc.1207973; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Choi CY, 1999, J BIOL CHEM, V274, P31543, DOI 10.1074/jbc.274.44.31543; Choi CY, 2005, J BIOL CHEM, V280, P21427, DOI 10.1074/jbc.M500496200; Choi CY, 1999, J BIOL CHEM, V274, P33194, DOI 10.1074/jbc.274.47.33194; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; D'Orazi G, 2002, NAT CELL BIOL, V4, P11, DOI 10.1038/ncb714; Dentice M, 2005, NAT CELL BIOL, V7, P698, DOI 10.1038/ncb1272; Di Stefano V, 2004, ONCOGENE, V23, P5185, DOI 10.1038/sj.onc.1207656; Di Stefano V, 2004, EXP CELL RES, V293, P311, DOI 10.1016/j.yexcr.2003.09.032; Doxakis E, 2004, CURR BIOL, V14, P1761, DOI 10.1016/j.cub.2004.09.050; Erkeland SJ, 2007, ONCOGENE, V26, P1985, DOI 10.1038/sj.onc.1210004; Harper JW, 2002, GENE DEV, V16, P2179, DOI 10.1101/gad.1013102; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Heuze ML, 2005, J BIOL CHEM, V280, P5468, DOI 10.1074/jbc.M413040200; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hilioti Z, 2001, CURR BIOL, V11, P1347, DOI 10.1016/S0960-9822(01)00399-2; Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Isono K, 2006, MOL CELL BIOL, V26, P2758, DOI 10.1128/MCB.26.7.2758-2771.2006; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Kanei-Ishii C, 2004, GENE DEV, V18, P816, DOI 10.1101/gad.1170604; Kile BT, 2002, TRENDS BIOCHEM SCI, V27, P235, DOI 10.1016/S0968-0004(02)02085-6; Kim EA, 2006, J BIOL CHEM, V281, P7489, DOI 10.1074/jbc.M507227200; Kim EJ, 2002, J BIOL CHEM, V277, P32020, DOI 10.1074/jbc.M200153200; Kim YH, 1998, J BIOL CHEM, V273, P25875, DOI 10.1074/jbc.273.40.25875; Kim YH, 1999, P NATL ACAD SCI USA, V96, P12350, DOI 10.1073/pnas.96.22.12350; Moilanen AM, 1998, MOL BIOL CELL, V9, P2527, DOI 10.1091/mbc.9.9.2527; Moller A, 2003, ONCOGENE, V22, P8731, DOI 10.1038/sj.onc.1207079; Moller A, 2003, CANCER RES, V63, P4310; Nakayama KI, 2005, SEMIN CELL DEV BIOL, V16, P323, DOI 10.1016/j.semcdb.2005.02.010; NEER EJ, 1994, NATURE, V371, P297, DOI 10.1038/371297a0; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Pfleger CM, 2001, GENE DEV, V15, P2396, DOI 10.1101/gad.918201; Rui YN, 2004, EMBO J, V23, P4583, DOI 10.1038/sj.emboj.7600475; Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5; Sutterluty H, 1999, NAT CELL BIOL, V1, P207, DOI 10.1038/12027; Tomasini R, 2003, J BIOL CHEM, V278, P37722, DOI 10.1074/jbc.M301979200; Vasiliauskas D, 1999, MECH DEVELOP, V82, P79, DOI 10.1016/S0925-4773(99)00014-3; Vodermaier HC, 2004, CURR BIOL, V14, pR787, DOI 10.1016/j.cub.2004.09.020; Wang Y, 2001, BBA-GENE STRUCT EXPR, V1518, P168, DOI 10.1016/S0167-4781(00)00308-0; Wiggins AK, 2004, J CELL BIOL, V167, P257, DOI 10.1083/jcb.200406131; Willems AR, 2004, BBA-MOL CELL RES, V1695, P133, DOI 10.1016/j.bbamcr.2004.09.027; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Zeold A, 2006, J BIOL CHEM, V281, P31538, DOI 10.1074/jbc.M604728200; Zhang OH, 2003, CELL, V115, P177, DOI 10.1016/S0092-8674(03)00802-X; Zhang QH, 2005, P NATL ACAD SCI USA, V102, P2802, DOI 10.1073/pnas.0409373102	52	87	93	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4682	4689		10.1074/jbc.M708873200	http://dx.doi.org/10.1074/jbc.M708873200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093972	hybrid			2022-12-25	WOS:000253426500026
J	Nakamura, T; de Vega, S; Fukumoto, S; Jimenez, L; Unda, F; Yamada, Y				Nakamura, Takashi; de Vega, Susana; Fukumoto, Satoshi; Jimenez, Lucia; Unda, Fernando; Yamada, Yoshihiko			Transcription factor epiprofin is essential for tooth morphogenesis by regulating epithelial cell fate and tooth number	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPING MOUSE TOOTH; EPIDERMAL MORPHOGENESIS; MICE; LIMB; PROLIFERATION; EXPRESSION; GROWTH; GENE; ABNORMALITIES; AMELOBLASTIN	In tooth morphogenesis, the dental epithelium and mesenchyme interact reciprocally for growth and differentiation to form the proper number and shapes of teeth. We previously identified epiprofin (Epfn), a gene preferentially expressed in dental epithelia, differentiated ameloblasts, and certain ectodermal organs. To identify the role of Epfn in tooth development, we created Epfn-deficient mice (Epfn(-/-)). Epfn(-/-) mice developed an excess number of teeth, enamel deficiency, defects in cusp and root formation, and abnormal dentin structure. Mutant tooth germs formed multiple dental epithelial buds into the mesenchyme. In Epfn(-/-) molars, rapid proliferation and differentiation of the inner dental epithelium were inhibited, and the dental epithelium retained the progenitor phenotype. Formation of the enamel knot, a signaling center for cusps, whose cells differentiate from the dental epithelium, was also inhibited. However, multiple premature nonproliferating enamel knot-like structures were formed ectopically. These dental epithelial abnormalities were accompanied by dysregulation of Lef-1, which is required for the normal transition from the bud to cap stage. Transfection of an Epfn vector promoted dental epithelial cell differentiation into ameloblasts and activated promoter activity of the enamel matrix ameloblastin gene. Our results suggest that in Epfn-deficient teeth, ectopic nonproliferating regions likely bud off from the self-renewable dental epithelium, form multiple branches, and eventually develop into supernumerary teeth. Thus, Epfn has multiple functions for cell fate determination of the dental epithelium by regulating both proliferation and differentiation, preventing continuous tooth budding and generation.	[Nakamura, Takashi; de Vega, Susana; Fukumoto, Satoshi; Yamada, Yoshihiko] NIDCR, Lab Cell & Dev Biol, Bethesda, MD 20892 USA; [Fukumoto, Satoshi] Kyushu Univ, Fac Dent Sci, Dept Pediat Dent, Fukuoka 8128582, Japan; [Jimenez, Lucia; Unda, Fernando] Univ Basque Country, Fac Med & Dent, Dept Cell Biol & Histol, Vizcaya 48940, Spain	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Kyushu University; University of Basque Country	Yamada, Y (corresponding author), NIDCR, Lab Cell & Dev Biol, Bldg 30,Rm 407,30 Convent Dr,MSC 4370, Bethesda, MD 20892 USA.	yoshi.yamada@nih.gov	de Vega, Susana/AAH-4775-2020; Unda, Fernando/AAF-9128-2019; Nakamura, Takashi/A-8931-2012; Jimenez, Lucia/AAG-1367-2019; Nakamura, Takashi/P-7796-2016; Jimenez, Lucia/K-3377-2012	Nakamura, Takashi/0000-0001-9904-1037; Jimenez, Lucia/0000-0003-1699-8437; Nakamura, Takashi/0000-0001-9904-1037; Fukumoto, Satoshi/0000-0002-5046-6891	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000720] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [Z01DE000720] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Aberg T, 2004, J HISTOCHEM CYTOCHEM, V52, P131, DOI 10.1177/002215540405200113; Bouwman P, 2000, EMBO J, V19, P655, DOI 10.1093/emboj/19.4.655; Dassule HR, 2000, DEVELOPMENT, V127, P4775; Fjeld K, 2005, DEV DYNAM, V233, P161, DOI 10.1002/dvdy.20285; Fuchs E, 2002, NAT REV GENET, V3, P199, DOI 10.1038/nrg758; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; Galderisi U, 2006, ONCOGENE, V25, P5250, DOI 10.1038/sj.onc.1209736; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Gritli-Linde A, 2002, DEVELOPMENT, V129, P5323, DOI 10.1242/dev.00100; JARVINEN E, 2006, P NATL ACAD SCI US; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; Kawano S, 2002, CONNECT TISSUE RES, V43, P409, DOI 10.1080/03008200290000637; Kratochwil K, 1996, GENE DEV, V10, P1382, DOI 10.1101/gad.10.11.1382; Krebsbach PH, 1996, J BIOL CHEM, V271, P4431; Li FQ, 2000, MOL CELL BIOL, V20, P5129, DOI 10.1128/MCB.20.14.5129-5139.2000; Miletich I, 2003, HUM MOL GENET, V12, pR69, DOI 10.1093/hmg/ddg085; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Nakamura T, 2004, J BIOL CHEM, V279, P626, DOI 10.1074/jbc.M307502200; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Peters H, 1998, GENE DEV, V12, P2735, DOI 10.1101/gad.12.17.2735; Pispa J, 2003, DEV BIOL, V262, P195, DOI 10.1016/S0012-1606(03)00325-7; QIN XQ, 1992, GENE DEV, V6, P953, DOI 10.1101/gad.6.6.953; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Thesleff I, 2006, AM J MED GENET A, V140A, P2530, DOI 10.1002/ajmg.a.31360; Vaahtokari A, 1996, MECH DEVELOP, V54, P39, DOI 10.1016/0925-4773(95)00459-9; VANGENDEREN C, 1994, GENE DEV, V8, P2691, DOI 10.1101/gad.8.22.2691; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; ZHOU PB, 1995, GENE DEV, V9, P700, DOI 10.1101/gad.9.6.700	32	86	88	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4825	4833		10.1074/jbc.M708388200	http://dx.doi.org/10.1074/jbc.M708388200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156176	hybrid			2022-12-25	WOS:000253426500040
J	Hu, Z; Shanker, S; MacLean, JA; Ackerman, SL; Wilkinson, MF				Hu, Zhiying; Shanker, Sreenath; MacLean, James A., II; Ackerman, Susan L.; Wilkinson, Miles F.			The RHOX5 homeodomain protein mediates transcriptional repression of the netrin-1 receptor gene Unc5c	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE SERTOLI-CELLS; HOMEOBOX GENES; RAT TESTIS; SEX DETERMINATION; DEFICIENT MICE; MUTANT MICE; DNA COMPLEX; C-ELEGANS; HOX; CLUSTER	The X-linked mouse Rhox gene cluster contains more than 30 homeobox genes that are candidates to regulate multiple steps in male and female gametogenesis. The founding member of the Rhox gene cluster, Rhox5, is an androgen-dependent gene expressed in Sertoli cells that promotes the survival and differentiation of the adjacent male germ cells. Here, we report the first identification and characterization of a Rhox5-regulated gene. This gene, Unc5c, encodes a pro-apoptotic receptor with tumor suppressor activity that we found is negatively regulated by Rhox5 in the testis in vivo. Transfection analyses in cell lines of different origin indicated that Rhox5-dependent down-regulation of Unc5c requires another Sertoli cell-specific cofactor. Examination of other mouse Rhox family members revealed that mouse RHOX2 and RHOX3 also have the ability to down-regulate Unc5c expression. The human RHOX protein PEPP2 (RHOXF2) also had this ability, indicating that Unc5c repression is a conserved RHOX-dependent response. Deletion analysis identified a Rhox5-responsive element in the Unc5c 5'-untranslated region. Although 5'-untranslated regions typically house post-transcriptional elements, several lines of evidence indicated that Rhox5 down-regulates Unc5c at the transcriptional level. The repression of Unc5c expression by Rhox5 may, in part, mediate the pro-survival function of Rhox5 in the testis, as we found that Unc5c mutant mice have decreased germ cell apoptosis in the testis. Along with our other data, these findings led us to propose a model in which Rhox5 is a negative regulator upstream of Unc5c in a Sertoli-cell pathway that promotes germ-cell survival.	[Hu, Zhiying; Shanker, Sreenath; MacLean, James A., II; Wilkinson, Miles F.] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Ackerman, Susan L.] Jackson Lab, Bar Harbor, ME 04609 USA; [Hu, Zhiying] Univ Texas Houston, Grad Sch Biomed Sci, Grad Training Program Genes & Dev, Houston, TX 77225 USA	University of Texas System; UTMD Anderson Cancer Center; Jackson Laboratory; University of Texas System; University of Texas Health Science Center Houston	Wilkinson, MF (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	mwilkins@mdanderson.org			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD045595] Funding Source: NIH RePORTER; NICHD NIH HHS [HD45595, R01 HD045595] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Ackerman SL, 1997, NATURE, V386, P838, DOI 10.1038/386838a0; Ackerman SL, 1998, GENOMICS, V52, P205, DOI 10.1006/geno.1998.5425; ADES SE, 1995, BIOCHEMISTRY-US, V34, P14601, DOI 10.1021/bi00044a040; Anway MD, 2003, BIOL REPROD, V68, P996, DOI 10.1095/biolreprod.102.008045; Arakawa H, 2004, NAT REV CANCER, V4, P978, DOI 10.1038/nrc1504; Awgulewitsch A, 2003, NATURWISSENSCHAFTEN, V90, P193, DOI 10.1007/s00114-003-0417-4; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Benson GV, 1996, DEVELOPMENT, V122, P2687; Biggin MD, 1997, DEVELOPMENT, V124, P4425; Chan SK, 1996, P NATL ACAD SCI USA, V93, P5223, DOI 10.1073/pnas.93.11.5223; Chang CP, 1996, MOL CELL BIOL, V16, P1734; Chiba S, 1998, INT J HEMATOL, V68, P343; Darbinian N, 2006, J CELL BIOCHEM, V99, P1052, DOI 10.1002/jcb.20872; Di Rocco G, 2001, J BIOL CHEM, V276, P20506, DOI 10.1074/jbc.M011175200; Ebner A, 2005, DEVELOPMENT, V132, P1591, DOI 10.1242/dev.01721; Fohn LE, 2001, GENOMICS, V74, P105, DOI 10.1006/geno.2001.6532; GEHRING WJ, 1993, GENE, V135, P215, DOI 10.1016/0378-1119(93)90068-E; GEHRING WJ, 1990, TRENDS GENET, V6, P323, DOI 10.1016/0168-9525(90)90253-3; Geisbrecht BV, 2003, J BIOL CHEM, V278, P32561, DOI 10.1074/jbc.M302943200; Geserick C, 2002, BIOCHEM J, V366, P367, DOI 10.1042/bj20020399; Guo F, 2005, ACTA BIOCH BIOPH SIN, V37, P784, DOI 10.1111/j.1745-7270.2005.00102.x; Guo Fen, 2007, Journal of Genetics and Genomics, V34, P392, DOI 10.1016/S1673-8527(07)60042-3; Hombria JCG, 2003, DIFFERENTIATION, V71, P461, DOI 10.1046/j.1432-0436.2003.7108004.x; Hueber SD, 2007, DEVELOPMENT, V134, P381, DOI 10.1242/dev.02746; INGHAM PW, 1992, CELL, V68, P221, DOI 10.1016/0092-8674(92)90467-Q; Jackson M, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-212; Jahnukainen K, 2004, BIOL REPROD, V70, P290, DOI 10.1095/biolreprod.103.018390; Kappen C, 2000, P NATL ACAD SCI USA, V97, P4481, DOI 10.1073/pnas.97.9.4481; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; KNUDSON CM, 1995, SCIENCE, V270, P96, DOI 10.1126/science.270.5233.96; Kruger RP, 2004, J NEUROSCI, V24, P10826, DOI 10.1523/JNEUROSCI.3715-04.2004; Lee CS, 2004, BEST PRACT RES CL EN, V18, P453, DOI 10.1016/j.beem.2004.08.008; Lemmens IH, 2001, BIOCHEM BIOPH RES CO, V286, P426, DOI 10.1006/bbrc.2001.5405; Leonardo ED, 1997, NATURE, V386, P833, DOI 10.1038/386833a0; LEPESANT JA, 1990, REPROD NUTR DEV, pS9, DOI 10.1051/rnd:19900702; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Li YH, 1998, NAT GENET, V20, P309, DOI 10.1038/3129; Lin CJ, 2001, J IMMUNOL, V166, P6134, DOI 10.4049/jimmunol.166.10.6134; Lindsey JS, 1996, DEV BIOL, V179, P471, DOI 10.1006/dbio.1996.0276; Lindsey JS, 1996, BIOL REPROD, V55, P975, DOI 10.1095/biolreprod55.5.975; Lindsey S, 1996, J ASSIST REPROD GEN, V13, P182, DOI 10.1007/BF02072542; Livesey FJ, 1999, CELL MOL LIFE SCI, V56, P62, DOI 10.1007/s000180050006; Llambi F, 2001, EMBO J, V20, P2715, DOI 10.1093/emboj/20.11.2715; Luo Zhi-Wen, 2006, Sheng Wu Gong Cheng Xue Bao, V22, P125; MacLaughlin DT, 2004, NEW ENGL J MED, V350, P367, DOI 10.1056/NEJMra022784; MacLean JA, 2005, CELL, V120, P369, DOI 10.1016/j.cell.2004.12.022; MacLean JA, 2006, GENESIS, V44, P122, DOI 10.1002/gene.20193; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; MACLEOD CL, 1990, CELL GROWTH DIFFER, V1, P271; Morris L, 2006, MAMM GENOME, V17, P178, DOI 10.1007/s00335-005-0138-4; Oda M, 2006, GENE DEV, V20, P3382, DOI 10.1101/gad.1470906; ORTH JM, 1982, ANAT REC, V203, P485, DOI 10.1002/ar.1092030408; Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726; Pitman JL, 1998, DEV BIOL, V202, P196, DOI 10.1006/dbio.1998.8978; Porter AG, 2004, BIOESSAYS, V26, P656, DOI 10.1002/bies.20037; Przyborski SA, 1998, DEVELOPMENT, V125, P41; Rao M, 2002, EPIDIDYMIS MOL CLIN, P269, DOI 10.1007/978-1-4615-0679-9_15; Rodriguez I, 1997, EMBO J, V16, P2262, DOI 10.1093/emboj/16.9.2262; Round J, 2007, CURR OPIN NEUROBIOL, V17, P15, DOI 10.1016/j.conb.2007.01.003; STEINBERGER A, 1971, BIOL REPROD, V4, P84, DOI 10.1093/biolreprod/4.1.84; Sutton KA, 1998, J ANDROL, V19, P21; Suzuki M, 2003, J BIOL CHEM, V278, P30148, DOI 10.1074/jbc.M303932200; Thiebault K, 2003, P NATL ACAD SCI USA, V100, P4173, DOI 10.1073/pnas.0738063100; Vagner S, 2001, EMBO REP, V2, P893, DOI 10.1093/embo-reports/kve208; WAGLE JR, 1986, IN VITRO CELL DEV B, V22, P325; Wang J, 2001, BIOTECHNIQUES, V31, P722, DOI 10.2144/01314bm01; Wang XX, 2006, GENOMICS, V88, P34, DOI 10.1016/j.ygeno.2006.02.007; Wayne CM, 2002, GENE, V301, P1, DOI 10.1016/S0378-1119(02)01087-9; Wilhelm D, 2007, PHYSIOL REV, V87, P1, DOI 10.1152/physrev.00009.2006; WILKINSON M, 1991, ESSENTIAL MOL BIOL, V1, P69; WILKINSON MF, 1990, DEV BIOL, V141, P451, DOI 10.1016/0012-1606(90)90400-D; YOMOGIDA K, 1994, DEVELOPMENT, V120, P1759	72	25	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3866	3876		10.1074/jbc.M706717200	http://dx.doi.org/10.1074/jbc.M706717200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077458	hybrid			2022-12-25	WOS:000253083500021
J	Kim, EJ; Kim, JS; Lee, IH; Rhee, HJ; Lee, JK				Kim, Eui-Jin; Kim, Ju-Sim; Lee, Il-Han; Rhee, Hae J.; Lee, Jeong K.			Superoxide generation by chlorophyllide a reductase of Rhodobacter sphaeroides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATIVE PROTOCHLOROPHYLLIDE REDUCTASE; IRON-SULFUR PROTEINS; ESCHERICHIA-COLI; BACTERIOCHLOROPHYLL BIOSYNTHESIS; GENETIC-ANALYSIS; RHODOPSEUDOMONAS-SPHAEROIDES; OXIDATIVE STRESS; CAPSULATUS; EXPRESSION; NITROGENASE	Chlorophyllide a reductase of Rhodobacter sphaeroides, which were reconstituted with the purified subunits of BchX, BchY, and BchZ, reduced ring B of chlorophyllide a using NADH under anaerobic conditions. Interestingly, suppressor mutations rescuing the inability of R. sphaeroides Fe-SOD mutant to grow in succinate-based minimal medium were predominantly mapped to BchZ subunit of chlorophyllide a reductase. The enzyme is labile in the presence of O-2. However, it generates superoxide at low O-2. The enzymes reconstituted with BchX, BchY, and the mutein subunit of BchZ from suppressor mutants showed less activity not only for chlorophyllide a reduction but also for superoxide generation compared with the enzyme reconstituted with the wild-type subunits. BchX, which contains FMN, and BchY are iron-sulfur proteins, whereas BchZ is a hemoprotein containing b-type heme. Neither chlorophyllide a reduction nor superoxide generation was observed with the enzyme reconstituted with the wild-type subunits of BchX and BchY, and the apo-subunit of BchZ that had been refolded without heme, in which FMN of BchX was fully reduced. Thus, superoxide is generated not from FMN of BchX but from heme of BchZ. Consistently, the heme of BchZ muteins was half-reduced in its redox state compared with that of wild-type BchZ.	[Kim, Eui-Jin; Kim, Ju-Sim; Lee, Il-Han; Rhee, Hae J.; Lee, Jeong K.] Sogang Univ, Dept Life Sci, Interdisciplinary Program Integrated Biol, Seoul 121742, South Korea	Sogang University	Lee, JK (corresponding author), Sogang Univ, Dept Life Sci, Interdisciplinary Program Integrated Biol, Seoul 121742, South Korea.	jgklee@sogang.ac.kr	lee, jeong/HGD-9839-2022					Abada EM, 2002, MOL GENET GENOMICS, V267, P202, DOI 10.1007/s00438-002-0652-y; Anthony JR, 2005, P NATL ACAD SCI USA, V102, P6502, DOI 10.1073/pnas.0502225102; ARMSTRONG GA, 1993, J GEN MICROBIOL, V139, P897, DOI 10.1099/00221287-139-5-897; Barquera B, 2006, J BIOL CHEM, V281, P36482, DOI 10.1074/jbc.M605765200; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BEINERT H, 1983, ANAL BIOCHEM, V131, P373, DOI 10.1016/0003-2697(83)90186-0; Benov L, 1999, J BIOL CHEM, V274, P4202, DOI 10.1074/jbc.274.7.4202; Benov L, 1996, J BIOL CHEM, V271, P21037, DOI 10.1074/jbc.271.35.21037; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; BRIGLE KE, 1987, J BACTERIOL, V169, P1547, DOI 10.1128/jb.169.4.1547-1553.1987; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; Caldinelli L, 2005, J BIOL CHEM, V280, P22572, DOI 10.1074/jbc.M500549200; Cortez N, 1998, J BACTERIOL, V180, P5413, DOI 10.1128/JB.180.20.5413-5420.1998; Crouse BR, 1996, BIOCHEMISTRY-US, V35, P16222, DOI 10.1021/bi9620114; DAILEY HA, 1982, J BIOL CHEM, V257, P4714; DAVIS J, 1988, J BACTERIOL, V170, P320, DOI 10.1128/jb.170.1.320-329.1988; Des Marais DJ, 2000, SCIENCE, V289, P1703; Dikalov S, 1997, BIOCHEM BIOPH RES CO, V230, P54, DOI 10.1006/bbrc.1996.5880; DONOHUE TJ, 1986, J BACTERIOL, V168, P962, DOI 10.1128/jb.168.2.962-972.1986; DRYDEN SC, 1990, NUCLEIC ACIDS RES, V18, P7267, DOI 10.1093/nar/18.24.7267; FAEDER EJ, 1973, ANAL BIOCHEM, V53, P332, DOI 10.1016/0003-2697(73)90442-9; FINKELSTEIN E, 1980, J AM CHEM SOC, V102, P4994, DOI 10.1021/ja00535a029; Frank HA, 2004, BIOCHEMISTRY-US, V43, P8607, DOI 10.1021/bi0492096; FUHRHOP JH, 1975, LAB METHODS, P804; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; GAUDU P, 1994, J BIOL CHEM, V269, P8182; Gibson LCD, 1999, BIOCHEM J, V337, P243, DOI 10.1042/0264-6021:3370243; Glaeser J, 2005, MICROBIOL-SGM, V151, P1927, DOI 10.1099/mic.0.27789-0; GOMELSKY M, 1995, J BACTERIOL, V177, P1634, DOI 10.1128/jb.177.6.1634-1637.1995; Gomelsky M, 1997, J BACTERIOL, V179, P128, DOI 10.1128/jb.179.1.128-134.1997; Goodwin PJ, 1998, BIOCHEMISTRY-US, V37, P10420, DOI 10.1021/bi980435n; Guigliarelli B, 1999, ADV INORG CHEM, V47, P421, DOI 10.1016/S0898-8838(08)60084-7; Han YC, 2007, MOL MICROBIOL, V64, P1090, DOI 10.1111/j.1365-2958.2007.05724.x; HOLMGREN A, 1972, J BIOL CHEM, V247, P1992; JOHNSON MK, 1988, J BIOL CHEM, V263, P14732; KEARNEY EB, 1960, J BIOL CHEM, V235, P865; Kho DH, 2004, FEMS MICROBIOL LETT, V234, P261, DOI 10.1111/j.1574-6968.2004.tb09542.x; Kim JS, 2003, J BIOL CHEM, V278, P18455, DOI 10.1074/jbc.M211740200; Kim JS, 2006, J BACTERIOL, V188, P8586, DOI 10.1128/JB.01084-06; Kimmich N, 2007, J BIOL CHEM, V282, P27006, DOI 10.1074/jbc.M703790200; Klatt P, 1996, J BIOL CHEM, V271, P7336, DOI 10.1074/jbc.271.13.7336; Kroliczewski J, 2005, BIOCHEMISTRY-US, V44, P7570, DOI 10.1021/bi047422w; Latimer MT, 1996, J BIOL CHEM, V271, P24023, DOI 10.1074/jbc.271.39.24023; Lee IH, 2002, APPL MICROBIOL BIOT, V60, P147, DOI 10.1007/s00253-002-1097-2; LEE JK, 1992, J BACTERIOL, V174, P1146, DOI 10.1128/jb.174.4.1146-1157.1992; LENZ O, 1994, J BACTERIOL, V176, P4385, DOI 10.1128/jb.176.14.4385-4393.1994; Li KY, 2004, J BACTERIOL, V186, P6800, DOI 10.1128/JB.186.20.6800-6808.2004; Mackenzie C, 2007, ANNU REV MICROBIOL, V61, P283, DOI 10.1146/annurev.micro.61.080706.093402; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; MASSEY V, 1959, BIOCHIM BIOPHYS ACTA, V34, P255, DOI 10.1016/0006-3002(59)90259-8; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; MCGLYNN P, 1993, MOL GEN GENET, V236, P227, DOI 10.1007/BF00277117; MEINHARDT SW, 1985, ARCH BIOCHEM BIOPHYS, V236, P130, DOI 10.1016/0003-9861(85)90612-5; Moskvin OV, 2007, J BIOL CHEM, V282, P28740, DOI 10.1074/jbc.M703261200; Nomata J, 2005, BBA-BIOENERGETICS, V1708, P229, DOI 10.1016/j.bbabio.2005.02.002; Nomata J, 2006, FEBS LETT, V580, P6151, DOI 10.1016/j.febslet.2006.10.014; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; Oh JI, 2001, MOL MICROBIOL, V39, P1116, DOI 10.1046/j.1365-2958.2001.02299.x; OHNISHI T, 1981, J BIOL CHEM, V256, P5577; Pasternak C, 1999, J BACTERIOL, V181, P100, DOI 10.1128/JB.181.1.100-106.1999; Ponnampalam SN, 1998, J BIOL CHEM, V273, P30757, DOI 10.1074/jbc.273.46.30757; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; Rhee HJ, 2007, J CELL MOL MED, V11, P685, DOI 10.1111/j.1582-4934.2007.00077.x; Roubaud V, 1998, ANAL BIOCHEM, V257, P210, DOI 10.1006/abio.1997.2542; Sambrook J, 2001, MOL CLONING LAB MANU; SIMON R, 1986, METHOD ENZYMOL, V118, P640; SIMONS RW, 1987, GENE, V53, P85, DOI 10.1016/0378-1119(87)90095-3; SISTROM WR, 1962, J GEN MICROBIOL, V28, P607, DOI 10.1099/00221287-28-4-607; Tabares LC, 2003, J BACTERIOL, V185, P3223, DOI 10.1128/JB.185.10.3223-3227.2003; TAI TN, 1988, PLASMID, V19, P175, DOI 10.1016/0147-619X(88)90037-6; Tehrani A, 2003, BIOCHEMISTRY-US, V42, P8919, DOI 10.1021/bi0346650; Tiwari BS, 2002, PLANT PHYSIOL, V128, P1271, DOI 10.1104/pp.010999; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Willett J, 2007, J BACTERIOL, V189, P7765, DOI 10.1128/JB.00853-07	74	14	15	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3718	3730		10.1074/jbc.M707774200	http://dx.doi.org/10.1074/jbc.M707774200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079120	hybrid			2022-12-25	WOS:000253083500005
J	Badugu, R; Garcia, M; Bondada, V; Joshi, A; Geddes, JW				Badugu, RamaKrishna; Garcia, Matthew; Bondada, Vimala; Joshi, Aashish; Geddes, James W.			N terminus of calpain 1 is a mitochondrial targeting sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS-INDUCING FACTOR; SMALL-SUBUNIT GENE; MU-CALPAIN; CALPAIN/CALPASTATIN NETWORK; EMBRYONIC-DEVELOPMENT; INTERMEMBRANE SPACE; BINDING PROTEIN; CALPASTATIN; ASSOCIATION; IMPORT	The ubiquitous m- and mu-calpains are thought to be localized in the cytosolic compartment, as is their endogenous inhibitor calpastatin. Previously, mu-calpain was found to be enriched in mitochondrial fractions isolated from rat cerebral cortex and SH-SY5Y neuroblastoma cells, but the submitochondrial localization of mu-calpain was not determined. In the present study, submitochondrial fractionation and digitonin permeabilization studies indicated that both calpain 1 and calpain small subunit 1, which together form mu-calpain, are present in the mitochondrial intermembrane space. The N terminus of calpain 1 contains an amphipathic alpha-helical domain, and is distinct from the N terminus of calpain 2. Calpain 1, but not calpain 2, was imported into mitochondria. Removal of the N-terminal 22 amino acids of calpain 1 blocked the mitochondrial calpain import, while addition of this N-terminal region to calpain 2 or green fluorescent protein enabled mitochondrial import. The N terminus of calpain 1 was not processed following mitochondrial import, but was removed by autolysis following calpain activation. Calpain small subunit 1 was not directly imported into mitochondria, but was imported in the presence of calpain 1. The presence of a mitochondrial targeting sequence in the N-terminal region of calpain 1 is consistent with the localization of mu-calpain to the mitochondrial intermembrane space and provides new insight into the possible functions of this cysteine protease.	[Badugu, RamaKrishna; Bondada, Vimala] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA; [Garcia, Matthew; Joshi, Aashish; Geddes, James W.] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Geddes, JW (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, B477 BBSRB, Lexington, KY 40536 USA.	jgeddes@uky.edu	Badugu, RamaKrishna/A-8572-2008		NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045726, P01NS058484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010836] Funding Source: NIH RePORTER; NIA NIH HHS [P01AG010836] Funding Source: Medline; NINDS NIH HHS [R01NS045726, P01NS058484] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADACHI Y, 1991, J BIOL CHEM, V266, P3968; Arrington DD, 2006, AM J PHYSIOL-CELL PH, V291, pC1159, DOI 10.1152/ajpcell.00207.2006; Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Azam M, 2001, MOL CELL BIOL, V21, P2213, DOI 10.1128/MCB.21.6.2213-2220.2001; BAUDRY M, 1987, SYNAPSE, V1, P506, DOI 10.1002/syn.890010603; BEER DG, 1982, BIOCHEM BIOPH RES CO, V109, P1276, DOI 10.1016/0006-291X(82)91915-5; Bernardi P, 1998, BIOFACTORS, V8, P273, DOI 10.1002/biof.5520080315; BOLLIGER L, 1994, EMBO J, V13, P1998, DOI 10.1002/j.1460-2075.1994.tb06469.x; Cao GD, 2007, J NEUROSCI, V27, P9278, DOI 10.1523/JNEUROSCI.2826-07.2007; Carragher NO, 2006, CURR PHARM DESIGN, V12, P615, DOI 10.2174/138161206775474314; CHAKRABARTI AK, 1988, J NEUROSCI RES, V20, P351, DOI 10.1002/jnr.490200309; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CONG JY, 1989, J BIOL CHEM, V264, P10096; CROALL DE, 1991, PHYSIOL REV, V71, P813, DOI 10.1152/physrev.1991.71.3.813; Diekert K, 1999, P NATL ACAD SCI USA, V96, P11752, DOI 10.1073/pnas.96.21.11752; Duret L, 1996, COMPUT APPL BIOSCI, V12, P507; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Elce JS, 1997, BIOCHEM J, V326, P31, DOI 10.1042/bj3260031; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Fan ACY, 2006, J BIOL CHEM, V281, P33313, DOI 10.1074/jbc.M605250200; Friedrich P, 2005, BIOL CHEM, V386, P609, DOI 10.1515/BC.2005.071; Friedrich P, 2004, EUR J NEUROSCI, V19, P1819, DOI 10.1111/j.1460-9568.2004.03313.x; Garcia M, 2005, BIOCHEM BIOPH RES CO, V338, P1241, DOI 10.1016/j.bbrc.2005.10.081; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; GOPALAKRISHNA R, 1986, J BIOL CHEM, V261, P13936; GRAHAMSIEGENTHALER K, 1994, J BIOL CHEM, V269, P30457; Griparic L, 2005, METHOD ENZYMOL, V404, P620, DOI 10.1016/S0076-6879(05)04054-1; Herrmann JM, 2005, TRENDS BIOCHEM SCI, V30, P205, DOI 10.1016/j.tibs.2005.02.005; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Hood JL, 2004, J BIOL CHEM, V279, P43126, DOI 10.1074/jbc.M408100200; Hood JL, 2003, BIOCHEM BIOPH RES CO, V310, P1200, DOI 10.1016/j.bbrc.2003.09.142; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; HUANG XQ, 1991, ADV APPL MATH, V12, P337, DOI 10.1016/0196-8858(91)90017-D; Huang YH, 2001, TRENDS MOL MED, V7, P355, DOI 10.1016/S1471-4914(01)02049-4; Kar P, 2007, ARCH BIOCHEM BIOPHYS, V466, P290, DOI 10.1016/j.abb.2007.07.022; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kumar M, 2006, J BIOL CHEM, V281, P5357, DOI 10.1074/jbc.M511061200; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Melloni E, 2000, J BIOL CHEM, V275, P82, DOI 10.1074/jbc.275.1.82; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Molinari M, 1997, J MEMBRANE BIOL, V156, P1, DOI 10.1007/s002329900181; Moubarak RS, 2007, MOL CELL BIOL, V27, P4844, DOI 10.1128/MCB.02141-06; MURAKAMI T, 1981, J BIOCHEM-TOKYO, V90, P1809, DOI 10.1093/oxfordjournals.jbchem.a133659; Naga KK, 2007, J NEUROSCI, V27, P7469, DOI 10.1523/JNEUROSCI.0646-07.2007; Neupert W, 2002, NAT REV MOL CELL BIO, V3, P555, DOI 10.1038/nrm878; Ohsato T, 2002, EUR J BIOCHEM, V269, P5765, DOI 10.1046/j.1432-1033.2002.03238.x; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Ozaki T, 2007, J BIOCHEM, V142, P365, DOI 10.1093/jb/mvm143; Pang Z, 2003, J NEUROPATH EXP NEUR, V62, P633, DOI 10.1093/jnen/62.6.633; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Raynaud F, 2006, FEBS J, V273, P3437, DOI 10.1111/j.1742-4658.2006.05352.x; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; ROISE D, 1986, EMBO J, V5, P1327, DOI 10.1002/j.1460-2075.1986.tb04363.x; Saga Kenji, 2005, Medical Molecular Morphology, V38, P155, DOI 10.1007/s00795-005-0287-2; Shulga N, 2006, J BIOL CHEM, V281, P30824, DOI 10.1074/jbc.M602503200; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Suzuki K, 2004, DIABETES, V53, pS12, DOI 10.2337/diabetes.53.2007.S12; Syntichaki P, 2002, NATURE, V419, P939, DOI 10.1038/nature01108; Szabadkai G, 2006, BBA-MOL CELL RES, V1763, P442, DOI 10.1016/j.bbamcr.2006.04.002; TAKANO E, 1982, J BIOCHEM-TOKYO, V92, P2021, DOI 10.1093/oxfordjournals.jbchem.a134134; TAVARES A, 1991, BIOMED BIOCHIM ACTA, V50, P523; TAYLOR RG, 1991, BIOMED BIOCHIM ACTA, V50, P491; Thompson VF, 2000, METH MOL B, V144, P3; TULLIO RD, 1999, BIOCHEM J, V343, P467; VONHEIJNE G, 1986, EMBO J, V5, P1335, DOI 10.1002/j.1460-2075.1986.tb04364.x; Weil R, 1999, MOL CELL BIOL, V19, P6345; Yermovsky-Kammerer AE, 1999, MOL CELL BIOL, V19, P6253; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63; ZIMMERMAN UJP, 1991, BIOCHIM BIOPHYS ACTA, V1078, P192, DOI 10.1016/0167-4838(91)99009-H	72	55	56	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3409	3417		10.1074/jbc.M706851200	http://dx.doi.org/10.1074/jbc.M706851200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070881	hybrid			2022-12-25	WOS:000253083000046
J	Kuhlicke, J; Frick, JS; Morote-Garcia, JC; Rosenberger, P; Eltzschig, HK				Kuhlicke, Johannes; Frick, Julia S.; Morote-Garcia, Julio C.; Rosenberger, Peter; Eltzschig, Holger K.			Hypoxia Inducible Factor (HIF)-1 Coordinates Induction of Toll-Like Receptors TLR2 and TLR6 during Hypoxia	PLOS ONE			English	Article							ECTO-5'-NUCLEOTIDASE CD73; NEUTROPHIL ACCUMULATION; DENDRITIC CELLS; FACTOR-I; ADENOSINE; RECOGNITION; ACTIVATION; EXPRESSION; HIF-1-ALPHA; COOPERATION	Background. During acute infection and inflammation, dramatic shifts in tissue metabolism are typical, thereby resulting in profound tissue hypoxia. Therefore, we pursued the hypothesis, that tissue hypoxia may influence innate immune responses by transcriptional modulation of Toll-like receptor (TLRs) expression and function. Methodology/Principal Findings. We gained first insight from transcriptional profiling of murine dendritic cells exposed to hypoxia (2% oxygen for 24 h). While transcript levels of other TLRs remained unchanged, we found a robust induction of TLR2 (2.3 +/- 60.7-fold; P<0.05) and TLR6 (3.46 +/- 1.56-fold; P<0.05). Additional studies in different cells types and cell-lines including human dendritic cells, monocytic cells (MM6), endothelia (HMEC-1) or intestinal epithelia (Caco-2) confirmed TLR2 and TLR6 induction of transcript, protein and function during hypoxia. Furthermore, analysis of the putative TLR2 and TLR6 promoters revealed previously unrecognized binding sites for HIF-1, which were shown by chromatin immunoprecipitation to bind the pivotal hypoxia-regulating transcription factor HIF-1alpha. Studies using loss and gain of function of HIF-1 confirmed a critical role of HIF-1alpha in coordinating TLR2 and TLR6 induction. Moreover, studies of murine hypoxia (8% oxygen over 6 h) showed TLR2 and TLR 6 induction in mucosal organs in vivo. In contrast, hypoxia induction of TLR2 and TLR6 was abolished in conditional HIF-1 alpha mutant mice. Conclusions/Significance. Taking together, these studies reveal coordinated induction of TLR2 and TLR6 during hypoxia and suggest tissue hypoxia in transcriptional adaptation of innate immune responses during acute infection or inflammation.	[Kuhlicke, Johannes; Morote-Garcia, Julio C.; Rosenberger, Peter; Eltzschig, Holger K.] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Frick, Julia S.] Univ Tubingen Hosp, Dept Microbiol, Tubingen, Germany; [Eltzschig, Holger K.] Univ Colorado, Hlth Sci Ctr, Dept Anesthesiol & Perioperat Med, Mucosal Inflammat Program, Denver, CO USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Eltzschig, HK (corresponding author), Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany.	holger.eltzschig@uchsc.edu		Frick, Julia-Stefanie/0000-0002-7662-7956	Deutsche Forschungsgemeinschaft (DFG) Graduate College [685]; German Research Foundation (DFG) [EL274/2-2]; Foundation for Anesthesia Research and Education (FAER)	Deutsche Forschungsgemeinschaft (DFG) Graduate College(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Foundation for Anesthesia Research and Education (FAER)	Funding: This work was supported by Deutsche Forschungsgemeinschaft (DFG) Graduate College 685 to JK, a German Research Foundation (DFG) grant EL274/2-2 and a Foundation for Anesthesia Research and Education (FAER) to HKE.	Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Asikainen TM, 2005, P NATL ACAD SCI USA, V102, P10212, DOI 10.1073/pnas.0504520102; Asikainen TM, 2005, FREE RADICAL BIO MED, V38, P1002, DOI 10.1016/j.freeradbiomed.2004.12.004; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; DHARMSATHAPHORN K, 1990, METHOD ENZYMOL, V192, P354; Dieterich HJ, 2006, CRIT CARE MED, V34, P1775, DOI 10.1097/01.CCM.0000218814.77568.BC; ECKLE T, 2007, BLOOD; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2004, BLOOD, V104, P3986, DOI 10.1182/blood-2004-06-2066; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2006, BLOOD, V108, P1602, DOI 10.1182/blood-2006-02-001016; Evans SM, 2000, CANCER RES, V60, P2018; Geisel J, 2007, J IMMUNOL, V179, P5811, DOI 10.4049/jimmunol.179.9.5811; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Haddad JJ, 2003, CRIT CARE, V7, P47, DOI 10.1186/cc1840; Hasan U, 2005, J IMMUNOL, V174, P2942, DOI 10.4049/jimmunol.174.5.2942; Hatoum OA, 2003, GASTROENTEROLOGY, V125, P58, DOI 10.1016/S0016-5085(03)00699-1; HAUSER CJ, 1988, J LAB CLIN MED, V112, P68; Johnson CM, 2007, J BIOL CHEM, V282, P31197, DOI 10.1074/jbc.M705151200; Karhausen J, 2005, CELL CYCLE, V4, P256; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kokura S, 2002, FREE RADICAL BIO MED, V33, P427, DOI 10.1016/S0891-5849(02)00852-3; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kong TQ, 2004, P NATL ACAD SCI USA, V101, P10440, DOI 10.1073/pnas.0401339101; Kruschewski M, 2001, DIGEST DIS SCI, V46, P2336, DOI 10.1023/A:1012334727509; Lando D, 2002, SCIENCE, V295, P858, DOI 10.1126/science.1068592; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nakao Y, 2005, J IMMUNOL, V174, P1566, DOI 10.4049/jimmunol.174.3.1566; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Saadi S, 2002, FASEB J, V16, DOI 10.1096/fj.01-0690hyp; Schaefer TM, 2004, IMMUNOLOGY, V112, P428, DOI 10.1111/j.1365-2567.2004.01898.x; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; Semenza GL, 2001, CELL, V107, P1, DOI 10.1016/S0092-8674(01)00518-9; Semenza GL, 2000, ADV EXP MED BIOL, V475, P123; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Tamura DY, 2002, SHOCK, V17, P269, DOI 10.1097/00024382-200204000-00005; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Yano K, 2006, J EXP MED, V203, P1447, DOI 10.1084/jem.20060375; Yokoyama K, 2001, HEPATO-GASTROENTEROL, V48, P401; ZIEGLERHEITBROCK HWL, 1988, INT J CANCER, V41, P456, DOI 10.1002/ijc.2910410324	55	143	148	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1364	10.1371/journal.pone.0001364	http://dx.doi.org/10.1371/journal.pone.0001364			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159247	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459700021
J	Miralves, J; Magdeleine, E; Kaddoum, L; Brun, H; Peries, S; Joly, E				Miralves, Julie; Magdeleine, Eddy; Kaddoum, Lara; Brun, Helene; Peries, Sophie; Joly, Etienne			High Levels of MeCP2 Depress MHC Class I Expression in Neuronal Cells	PLOS ONE			English	Article							CPG-BINDING-PROTEIN; SEVERE MENTAL-RETARDATION; RETT-SYNDROME BRAIN; DNA METHYLATION; MOUSE MODEL; TRANSCRIPTIONAL REPRESSOR; CELLULAR-DIFFERENTIATION; NEUROLOGICAL SYMPTOMS; CHROMOSOMAL-PROTEIN; GENE-EXPRESSION	Background. The expression of MHC class I genes is repressed in mature neurons. The molecular basis of this regulation is poorly understood, but the genes are particularly rich in CpG islands. MeCP2 is a transcriptional repressor that binds to methylated CpG dinucleotides; mutations in this protein also cause the neurodevelopmental disease called Rett syndrome. Because MHC class I molecules play a role in neuronal connectivity, we hypothesised that MeCP2 might repress MHC class I expression in the CNS and that this might play a role in the pathology of Rett syndrome. Methodology. We show here that transiently transfected cells expressing high levels of MeCP2 specifically downregulate cell-surface expression of MHC class I molecules in the neuronal cell line N2A and they prevent the induction of MHC class I expression in response to interferon in these cells, supporting our first hypothesis. Surprisingly, however, overexpression of the mutated forms of MeCP2 that cause Rett syndrome had a similar effect on MHC class I expression as the wild-type protein. Immunohistological analyses of brain slices from MECP2 knockout mice (the MeCP2(tm1.1Bird) strain) demonstrated a small but reproducible increase in MHC class I when compared to their wild type littermates, but we found no difference in MHC class I expression in primary cultures of mixed glial cells (mainly neurons and astrocytes) from the knockout and wild-type mice. Conclusion. These data suggest that high levels of MeCP2, such as those found in mature neurons, may contribute to the repression of MHC expression, but we find no evidence that MeCP2 regulation of MHC class I is important for the pathogenesis of Rett syndrome.	[Miralves, Julie; Magdeleine, Eddy; Kaddoum, Lara; Peries, Sophie; Joly, Etienne] CNRS, Inst Pharmacol & Biol Struct, Toulouse, France; [Brun, Helene] Fac Med Toulouse, INSERM, Ctr Physiopathol Toulouse Purpan, F-31073 Toulouse, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Joly, E (corresponding author), CNRS, Inst Pharmacol & Biol Struct, Toulouse, France.	atn@cict.fr	Joly, Etienne/A-5644-2009	Joly, Etienne/0000-0002-7264-2681	Association Francaise du Syndrome de Rett (AFSR); CNRS	Association Francaise du Syndrome de Rett (AFSR); CNRS(Centre National de la Recherche Scientifique (CNRS))	Funding: This work was funded mostly by Association Francaise du Syndrome de Rett (AFSR), as well as core funds from CNRS, salaries were from MRT and FRM for JM, ITAV for EM and INSERM for EJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Ariani F, 2004, HUM MUTAT, V24, P172, DOI 10.1002/humu.20065; Balmer D, 2003, J MOL MED-JMM, V81, P61, DOI 10.1007/s00109-002-0396-5; Beyer KS, 2002, HUM GENET, V111, P305, DOI 10.1007/s00439-002-0786-3; Bienvenu T, 2000, HUM MOL GENET, V9, P1377, DOI 10.1093/hmg/9.9.1377; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Chen RZ, 2001, NAT GENET, V27, P327, DOI 10.1038/85906; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Clayton-Smith J, 2000, LANCET, V356, P830, DOI 10.1016/S0140-6736(00)02661-1; Cohen DRS, 2003, MOL CELL NEUROSCI, V22, P417, DOI 10.1016/S1044-7431(03)00026-5; Colantuoni C, 2001, NEUROBIOL DIS, V8, P847, DOI 10.1006/nbdi.2001.0428; Collins AL, 2004, HUM MOL GENET, V13, P2679, DOI 10.1093/hmg/ddh282; Corriveau RA, 1998, NEURON, V21, P505, DOI 10.1016/S0896-6273(00)80562-0; Couvert P, 2001, HUM MOL GENET, V10, P941, DOI 10.1093/hmg/10.9.941; DEsposito M, 1996, MAMM GENOME, V7, P533, DOI 10.1007/s003359900157; Fuks F, 2003, J BIOL CHEM, V278, P4035, DOI 10.1074/jbc.M210256200; Gemelli T, 2006, BIOL PSYCHIAT, V59, P468, DOI 10.1016/j.biopsych.2005.07.025; Georgel PT, 2003, J BIOL CHEM, V278, P32181, DOI 10.1074/jbc.M305308200; Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104; Gobin SJP, 1999, J IMMUNOL, V163, P1428; GODDARD CA, 2007, P NATL ACAD SCI US; Guy J, 2001, NAT GENET, V27, P322, DOI 10.1038/85899; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; HAGBERG B, 1983, ANN NEUROL, V14, P471, DOI 10.1002/ana.410140412; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Ishii T, 2003, CURR BIOL, V13, P394, DOI 10.1016/S0960-9822(03)00092-7; Jeffery L, 2004, J BIOL CHEM, V279, P49479, DOI 10.1074/jbc.M409070200; Jones PL, 1998, NAT GENET, V19, P187, DOI 10.1038/561; Jung BP, 2003, J NEUROBIOL, V55, P86, DOI 10.1002/neu.10201; Kaludov NK, 2000, NUCLEIC ACIDS RES, V28, P1921, DOI 10.1093/nar/28.9.1921; Kimura H, 2003, J BIOL CHEM, V278, P4806, DOI 10.1074/jbc.M209923200; Kirsch RD, 1998, NUCLEIC ACIDS RES, V26, P1848, DOI 10.1093/nar/26.7.1848; Kishi N, 2004, MOL CELL NEUROSCI, V27, P306, DOI 10.1016/j.mcn.2004.07.006; Klose RJ, 2005, MOL CELL, V19, P667, DOI 10.1016/j.molcel.2005.07.021; Kokura K, 2001, J BIOL CHEM, V276, P34115, DOI 10.1074/jbc.M105747200; Kriaucionis S, 2004, NUCLEIC ACIDS RES, V32, P1818, DOI 10.1093/nar/gkh349; Lam C W, 2000, J Med Genet, V37, pE41, DOI 10.1136/jmg.37.12.e41; LaSalle JM, 2001, HUM MOL GENET, V10, P1729, DOI 10.1093/hmg/10.17.1729; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Loconto J, 2003, CELL, V112, P607, DOI 10.1016/S0092-8674(03)00153-3; Lugtenberg D, 2006, J MED GENET, V43, P362, DOI 10.1136/jmg.2005.036178; Luikenhuis S, 2004, P NATL ACAD SCI USA, V101, P6033, DOI 10.1073/pnas.0401626101; Martinowich K, 2003, SCIENCE, V302, P890, DOI 10.1126/science.1090842; McLaren FH, 2001, J NEUROIMMUNOL, V112, P35, DOI 10.1016/S0165-5728(00)00410-0; Meins M, 2005, J MED GENET, V42, DOI 10.1136/jmg.2004.023804; Miralves J, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-16; Mnatzakanian GN, 2004, NAT GENET, V36, P339, DOI 10.1038/ng1327; Mullaney BC, 2004, NEUROSCIENCE, V123, P939, DOI 10.1016/j.neuroscience.2003.11.025; Nan XS, 1996, MOL CELL BIOL, V16, P414; NAN XS, 1993, NUCLEIC ACIDS RES, V21, P4886, DOI 10.1093/nar/21.21.4886; Nan XS, 1997, CELL, V88, P471, DOI 10.1016/S0092-8674(00)81887-5; Nan XS, 1998, NATURE, V393, P386, DOI 10.1038/30764; Neul JL, 2004, NEUROSCIENTIST, V10, P118, DOI 10.1177/1073858403260995; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; NIKITINA T, 2007, J BIOL CHEM; Nikitina T, 2007, MOL CELL BIOL, V27, P864, DOI 10.1128/MCB.01593-06; Nuber UA, 2005, HUM MOL GENET, V14, P2247, DOI 10.1093/hmg/ddi229; Orrico A, 2000, FEBS LETT, V481, P285, DOI 10.1016/S0014-5793(00)01994-3; Peddada S, 2006, HUM MOL GENET, V15, P2003, DOI 10.1093/hmg/ddl124; Pelka GJ, 2006, BRAIN, V129, P887, DOI 10.1093/brain/awl022; Percy AK, 2002, NEUROL CLIN, V20, P1125, DOI 10.1016/S0733-8619(02)00022-1; QUADERI NA, 1994, GENOMICS, V22, P648, DOI 10.1006/geno.1994.1442; Ritz U, 2001, MOL MED, V7, P149, DOI 10.1007/BF03401948; Shahbazian MD, 2002, NEURON, V35, P243, DOI 10.1016/S0896-6273(02)00768-7; Shahbazian MD, 2002, HUM MOL GENET, V11, P115, DOI 10.1093/hmg/11.2.115; Shahbazian MD, 2001, CURR OPIN NEUROL, V14, P171, DOI 10.1097/00019052-200104000-00006; Sirianni N, 1998, AM J HUM GENET, V63, P1552, DOI 10.1086/302105; Syken J, 2003, P NATL ACAD SCI USA, V100, P13048, DOI 10.1073/pnas.1735415100; Traynor Jeff, 2002, BMC Med Genet, V3, P12, DOI 10.1186/1471-2350-3-12; Tudor M, 2002, P NATL ACAD SCI USA, V99, P15536, DOI 10.1073/pnas.242566899; TYKOCINSKI ML, 1984, NUCLEIC ACIDS RES, V12, P4385, DOI 10.1093/nar/12.10.4385; Van Esch H, 2005, AM J HUM GENET, V77, P442, DOI 10.1086/444549; Villard L, 2000, NEUROLOGY, V55, P1188, DOI 10.1212/WNL.55.8.1188; Watson P, 2001, J MED GENET, V38, P224, DOI 10.1136/jmg.38.4.224; York IA, 1996, ANNU REV IMMUNOL, V14, P369, DOI 10.1146/annurev.immunol.14.1.369; Young JI, 2005, P NATL ACAD SCI USA, V102, P17551, DOI 10.1073/pnas.0507856102; Zoghbi HY, 2005, J CHILD NEUROL, V20, P736, DOI 10.1177/08830738050200090701	80	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1354	10.1371/journal.pone.0001354	http://dx.doi.org/10.1371/journal.pone.0001354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159237	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459700011
J	Cangiano, L; Gargini, C; Della Santina, L; Demontis, GC; Cervetto, L				Cangiano, Lorenzo; Gargini, Claudia; Della Santina, Luca; Demontis, Gian Carlo; Cervetto, Luigi			High-Pass Filtering of Input Signals by the I(h) Current in a Non-Spiking Neuron, the Retinal Rod Bipolar Cell	PLOS ONE			English	Article								Hyperpolarization-activated cyclic nucleotide-sensitive (HCN) channels mediate the I(f) current in heart and I(h) throughout the nervous system. In spiking neurons I(h) participates primarily in different forms of rhythmic activity. Little is known, however, about its role in neurons operating with graded potentials as in the retina, where all four channel isoforms are expressed. Intriguing evidence for an involvement of I(h) in early visual processing are the side effects reported, in dim light or darkness, by cardiac patients treated with HCN inhibitors. Moreover, electroretinographic recordings indicate that these drugs affect temporal processing in the outer retina. Here we analyzed the functional role of HCN channels in rod bipolar cells (RBCs) of the mouse. Perforated-patch recordings in the dark-adapted slice found that RBCs exhibit I(h), and that this is sensitive to the specific blocker ZD7288. RBC input impedance, explored by sinusoidal frequency-modulated current stimuli (0.1-30 Hz), displays band-pass behavior in the range of I(h) activation. Theoretical modeling and pharmacological blockade demonstrate that high-pass filtering of input signals by I(h), in combination with low-pass filtering by passive properties, fully accounts for this frequency-tuning. Correcting for the depolarization introduced by shunting through the pipette-membrane seal, leads to predict that in darkness I(h) is tonically active in RBCs and quickens their responses to dim light stimuli. Immunohistochemistry targeting candidate subunit isoforms HCN1-2, in combination with markers of RBCs (PKC) and rod-RBC synaptic contacts (bassoon, mGluR6, Kv1.3), suggests that RBCs express HCN2 on the tip of their dendrites. The functional properties conferred by I(h) onto RBCs may contribute to shape the retina's light response and explain the visual side effects of HCN inhibitors.	[Cangiano, Lorenzo; Gargini, Claudia; Demontis, Gian Carlo] Univ Pisa, Dipartimento Psichiat & Neurobiol, Pisa, Italy; [Della Santina, Luca; Cervetto, Luigi] Univ Pisa, Dipartimento Fisiol Umana G Moruzzi, Pisa, Italy	University of Pisa; University of Pisa	Cangiano, L (corresponding author), Univ Pisa, Dipartimento Psichiat & Neurobiol, Pisa, Italy.	lorenzo.cangiano@farm.unipi.it	Cangiano, Lorenzo/F-1482-2019; Demontis, Gian Carlo A.G./K-6963-2016; Della Santina, Luca/J-9795-2016	Cangiano, Lorenzo/0000-0001-7145-1288; Demontis, Gian Carlo A.G./0000-0001-7641-0426; Della Santina, Luca/0000-0001-6036-1295; GARGINI, MARIA CLAUDIA/0000-0002-4992-9086	Italian Ministry of Research (PRIN-Cofin, MiUR)	Italian Ministry of Research (PRIN-Cofin, MiUR)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	support was provided by the Italian Ministry of Research (PRIN-Cofin, MiUR).	BADER CR, 1979, J PHYSIOL-LONDON, V296, P1; BARRY PH, 1991, J MEMBRANE BIOL, V121, P101, DOI 10.1007/BF01870526; BEECH DJ, 1989, NEURON, V3, P573, DOI 10.1016/0896-6273(89)90267-5; Berntson A, 2004, VISUAL NEUROSCI, V21, P693, DOI 10.1017/S0952523804215048; BIALEK W, 1990, BIOPHYS J, V58, P1227, DOI 10.1016/S0006-3495(90)82463-2; Brandstatter JH, 1999, EUR J NEUROSCI, V11, P3683, DOI 10.1046/j.1460-9568.1999.00793.x; Cervetto L, 2007, BRIT J PHARMACOL, V150, P383, DOI 10.1038/sj.bjp.0706998; Chavas J, 2003, J NEUROSCI, V23, P2019; Craven KB, 2006, ANNU REV PHYSIOL, V68, P375, DOI 10.1146/annurev.physiol.68.040104.134728; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Demontis GC, 2002, J PHYSIOL-LONDON, V542, P89, DOI 10.1113/jphysiol.2002.017640; Demontis GC, 2002, NEWS PHYSIOL SCI, V17, P110, DOI 10.1152/nips.01364.2001; Demontis GC, 1999, J PHYSIOL-LONDON, V515, P813, DOI 10.1111/j.1469-7793.1999.813ab.x; DETWILER PB, 1980, J PHYSIOL-LONDON, V300, P213, DOI 10.1113/jphysiol.1980.sp013159; DIFRANCESCO D, 1993, ANNU REV PHYSIOL, V55, P455, DOI 10.1146/annurev.physiol.55.1.455; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Dong CJ, 2003, J NEUROPHYSIOL, V89, P2159, DOI 10.1152/jn.01008.2002; Dunn FA, 2006, J NEUROSCI, V26, P3959, DOI 10.1523/JNEUROSCI.5148-05.2006; Euler T, 2000, J NEUROPHYSIOL, V83, P1817, DOI 10.1152/jn.2000.83.4.1817; Field GD, 2005, ANNU REV PHYSIOL, V67, P491, DOI 10.1146/annurev.physiol.67.031103.151256; FISCHMEISTER R, 1986, PFLUG ARCH EUR J PHY, V406, P73, DOI 10.1007/BF00582957; Fyk-Kolodziej B, 2007, J COMP NEUROL, V501, P891, DOI 10.1002/cne.21287; Gargini C, 1999, VISION RES, V39, P1767, DOI 10.1016/S0042-6989(98)00282-X; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; GOLD CEA, 2003, J NEUROSCI, V23, P3796; Harris NC, 1995, J NEUROPHYSIOL, V74, P2366, DOI 10.1152/jn.1995.74.6.2366; Hartveit E, 1999, J NEUROPHYSIOL, V81, P2923, DOI 10.1152/jn.1999.81.6.2923; Hutcheon B, 2000, TRENDS NEUROSCI, V23, P216, DOI 10.1016/S0166-2236(00)01547-2; HUTCHEON B, 1994, J NEUROPHYSIOL, V71, P583, DOI 10.1152/jn.1994.71.2.583; Hutcheon B, 1996, J NEUROPHYSIOL, V76, P698, DOI 10.1152/jn.1996.76.2.698; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; Jackson HA, 2007, PHYSIOL GENOMICS, V29, P231, DOI 10.1152/physiolgenomics.00142.2006; Kim IB, 2003, J COMP NEUROL, V467, P389, DOI 10.1002/cne.10957; KLUMPP DJ, 1995, J NEUROSCI, V15, P5004; Koizumi A, 2004, MOL VIS, V10, P328; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7; Ma YP, 2003, J NEUROPHYSIOL, V90, P3479, DOI 10.1152/jn.00426.2003; Magee JC, 2000, NAT NEUROSCI, V3, P895, DOI 10.1038/78800; Magee JC, 1998, J NEUROSCI, V18, P7613; Mao BQ, 2003, BIOPHYS J, V84, P2756, DOI 10.1016/S0006-3495(03)75080-2; Maric D, 1998, EUR J NEUROSCI, V10, P2532, DOI 10.1046/j.1460-9568.1998.00284.x; Meuth SG, 2006, J NEUROPHYSIOL, V96, P1517, DOI 10.1152/jn.01212.2005; Mistrik P, 2005, J BIOL CHEM, V280, P27056, DOI 10.1074/jbc.M502696200; Moosmang S, 2001, EUR J BIOCHEM, V268, P1646, DOI 10.1046/j.1432-1327.2001.02036.x; Muller F, 2003, EUR J NEUROSCI, V17, P2084, DOI 10.1046/j.1460-9568.2003.02634.x; Nolan MF, 2004, CELL, V119, P719, DOI 10.1016/S0092-8674(04)01055-4; NOMURA A, 1994, CELL, V77, P361, DOI 10.1016/0092-8674(94)90151-1; Pan ZH, 2000, J NEUROPHYSIOL, V83, P513, DOI 10.1152/jn.2000.83.1.513; Pan ZH, 2001, NEURON, V32, P89, DOI 10.1016/S0896-6273(01)00454-8; PAPE HC, 1989, NATURE, V340, P715, DOI 10.1038/340715a0; Poolos NP, 2006, J NEUROSCI, V26, P7995, DOI 10.1523/JNEUROSCI.2069-06.2006; PUIL E, 1986, J NEUROPHYSIOL, V55, P995, DOI 10.1152/jn.1986.55.5.995; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; Robinson RB, 2003, ANNU REV PHYSIOL, V65, P453, DOI 10.1146/annurev.physiol.65.092101.142734; Sampath AP, 2004, NEURON, V41, P431, DOI 10.1016/S0896-6273(04)00005-4; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Satoh TO, 2000, NEUROPHARMACOLOGY, V39, P1284, DOI 10.1016/S0028-3908(99)00207-5; Singer JH, 2003, J NEUROSCI, V23, P10923; Tabata T, 1996, J NEUROPHYSIOL, V75, P1932, DOI 10.1152/jn.1996.75.5.1932; TESSIERLAVIGNE M, 1988, J GEN PHYSIOL, V91, P49, DOI 10.1085/jgp.91.1.49; Tyzio R, 2003, J NEUROPHYSIOL, V90, P2964, DOI 10.1152/jn.00172.2003; Ulrich D, 2002, J NEUROPHYSIOL, V87, P2753, DOI 10.1152/jn.2002.87.6.2753; Williams SR, 2003, J NEUROSCI, V23, P7358; Williams SR, 2002, J PHYSIOL-LONDON, V539, P469, DOI 10.1113/jphysiol.2001.013136; Witkovsky P, 2004, DOC OPHTHALMOL, V108, P17, DOI 10.1023/B:DOOP.0000019487.88486.0a; WOLLMUTH LP, 1992, J GEN PHYSIOL, V100, P749, DOI 10.1085/jgp.100.5.749; Wu SM, 2004, VISION RES, V44, P3277, DOI 10.1016/j.visres.2004.07.045; Xue T, 2002, CIRC RES, V90, P1267, DOI 10.1161/01.RES.0000024390.97889.C6; Ying SW, 2007, J NEUROSCI, V27, P8719, DOI 10.1523/JNEUROSCI.1630-07.2007; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zhou ZY, 2006, J NEUROPHYSIOL, V96, P2539, DOI 10.1152/jn.00688.2006; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	73	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1327	10.1371/journal.pone.0001327	http://dx.doi.org/10.1371/journal.pone.0001327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091997	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459600015
J	Sayer, EJ; Powers, JS; Tanner, EVJ				Sayer, Emma J.; Powers, Jennifer S.; Tanner, Edmund V. J.			Increased Litterfall in Tropical Forests Boosts the Transfer of Soil CO2 to the Atmosphere	PLOS ONE			English	Article							GROUND CARBON ALLOCATION; MICROBIAL BIOMASS; ROOT RESPIRATION; ORGANIC-CARBON; RAIN-FORESTS; DECOMPOSITION; NITROGEN; ECOSYSTEMS; CLIMATE; MANIPULATION	Aboveground litter production in forests is likely to increase as a consequence of elevated atmospheric carbon dioxide (CO2) concentrations, rising temperatures, and shifting rainfall patterns. As litterfall represents a major flux of carbon from vegetation to soil, changes in litter inputs are likely to have wide-reaching consequences for soil carbon dynamics. Such disturbances to the carbon balance may be particularly important in the tropics because tropical forests store almost 30% of the global soil carbon, making them a critical component of the global carbon cycle; nevertheless, the effects of increasing aboveground litter production on belowground carbon dynamics are poorly understood. We used long-term, large-scale monthly litter removal and addition treatments in a lowland tropical forest to assess the consequences of increased litterfall on belowground CO2 production. Over the second to the fifth year of treatments, litter addition increased soil respiration more than litter removal decreased it; soil respiration was on average 20% lower in the litter removal and 43% higher in the litter addition treatment compared to the controls but litter addition did not change microbial biomass. We predicted a 9% increase in soil respiration in the litter addition plots, based on the 20% decrease in the litter removal plots and an 11% reduction due to lower fine root biomass in the litter addition plots. The 43% measured increase in soil respiration was therefore 34% higher than predicted and it is possible that this 'extra' CO2 was a result of priming effects, i.e. stimulation of the decomposition of older soil organic matter by the addition of fresh organic matter. Our results show that increases in aboveground litter production as a result of global change have the potential to cause considerable losses of soil carbon to the atmosphere in tropical forests.	[Sayer, Emma J.; Tanner, Edmund V. J.] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Sayer, Emma J.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Powers, Jennifer S.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA; [Powers, Jennifer S.] Univ Minnesota, Dept Plant Biol, St Paul, MN 55108 USA; [Powers, Jennifer S.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA	University of Cambridge; Smithsonian Institution; Smithsonian Tropical Research Institute; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Sayer, EJ (corresponding author), Univ Cambridge, Dept Plant Sci, Cambridge, England.	ejs44@cam.ac.uk	Sayer, Emma/B-2514-2010	Sayer, Emma/0000-0002-3322-4487	Mellon Foundation; Smithsonian Tropical Research Institute; Cambridge Philosophical Society; Drummond Fund; Gonville and Caius College, Cambridge; Gates Cambridge Scholarship; European Union Marie Curie Outgoing International Fellowship; NSF ADVANCE Fellowship [DBI0338143]	Mellon Foundation; Smithsonian Tropical Research Institute(Smithsonian InstitutionSmithsonian Tropical Research Institute); Cambridge Philosophical Society; Drummond Fund; Gonville and Caius College, Cambridge; Gates Cambridge Scholarship; European Union Marie Curie Outgoing International Fellowship(European Commission); NSF ADVANCE Fellowship	This study was funded by the Mellon Foundation, the Smithsonian Tropical Research Institute, the Cambridge Philosophical Society, and the Drummond Fund, Gonville and Caius College, Cambridge. EJS was supported by a Gates Cambridge Scholarship and a European Union Marie Curie Outgoing International Fellowship; JSP was supported by an NSF ADVANCE Fellowship ( DBI0338143). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AS, 2000, ECOL APPL, V10, P437, DOI 10.1890/1051-0761(2000)010[0437:EOFACE]2.0.CO;2; ANDERSON JM, 1983, J ECOL, V71, P503, DOI 10.2307/2259731; Bardgett RD, 2003, ECOLOGY, V84, P2258, DOI 10.1890/02-0274; Beck T, 1997, SOIL BIOL BIOCHEM, V29, P1023, DOI 10.1016/S0038-0717(97)00030-8; Bernoux M, 2002, SOIL SCI SOC AM J, V66, P888, DOI 10.2136/sssaj2002.0888; BINGEMAN C. W., 1953, Proceedings. Soil Science Society of America, V17, P34; BROOKES PC, 1985, SOIL BIOL BIOCHEM, V17, P837, DOI 10.1016/0038-0717(85)90144-0; CAVELIER J, 1992, PLANT SOIL, V142, P187, DOI 10.1007/BF00010965; Clark DA, 2004, PHILOS T R SOC B, V359, P477, DOI 10.1098/rstb.2003.1426; Cleveland CC, 2006, P NATL ACAD SCI USA, V103, P10316, DOI 10.1073/pnas.0600989103; CORNEJO FH, 1994, OIKOS, V70, P183, DOI 10.2307/3545629; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2002, AGR FOREST METEOROL, V113, P39, DOI 10.1016/S0168-1923(02)00101-6; De Nobili M, 2001, SOIL BIOL BIOCHEM, V33, P1163, DOI 10.1016/S0038-0717(01)00020-7; DeLucia EH, 1999, SCIENCE, V284, P1177, DOI 10.1126/science.284.5417.1177; Desrochers A, 2002, TREE PHYSIOL, V22, P725, DOI 10.1093/treephys/22.10.725; DIXON RK, 1994, SCIENCE, V263, P185, DOI 10.1126/science.263.5144.185; Finzi AC, 2001, ECOLOGY, V82, P470, DOI 10.1890/0012-9658(2001)082[0470:FLPCAD]2.0.CO;2; Fontaine S, 2004, ECOL LETT, V7, P314, DOI 10.1111/j.1461-0248.2004.00579.x; Hamer U, 2005, GEODERMA, V128, P38, DOI 10.1016/j.geoderma.2004.12.014; Jobbagy EG, 2000, ECOL APPL, V10, P423, DOI 10.1890/1051-0761(2000)010[0423:TVDOSO]2.0.CO;2; Kirschbaum MUF, 2000, BIOGEOCHEMISTRY, V48, P21, DOI 10.1023/A:1006238902976; Kuzyakov Y, 2000, SOIL BIOL BIOCHEM, V32, P1485, DOI 10.1016/S0038-0717(00)00084-5; Leigh E.G., 1999, TROPICAL FOREST ECOL, P245; Leigh E.G. Jr, 1990, P28; Li YQ, 2004, SOIL BIOL BIOCHEM, V36, P2111, DOI 10.1016/j.soilbio.2004.06.003; Metcalfe DB, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000443; Neff JC, 2002, NATURE, V419, P915, DOI 10.1038/nature01136; Palmroth S, 2006, P NATL ACAD SCI USA, V103, P19362, DOI 10.1073/pnas.0609492103; Powers JS, 2005, NEW PHYTOL, V165, P913, DOI 10.1111/j.1469-8137.2004.01279.x; Pregitzer KS, 1998, TREE PHYSIOL, V18, P665; Priess JA, 2001, SOIL BIOL BIOCHEM, V33, P503, DOI 10.1016/S0038-0717(00)00191-7; Raich JW, 2006, ECOLOGY, V87, P76, DOI 10.1890/05-0023; RAICH JW, 1989, ECOLOGY, V70, P1346, DOI 10.2307/1938194; Raich JW, 2002, GLOBAL CHANGE BIOL, V8, P800, DOI 10.1046/j.1365-2486.2002.00511.x; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; ROUT SK, 1989, ACTA OECOL-OEC PLANT, V10, P229; Sayer EJ, 2006, FOREST ECOL MANAG, V229, P285, DOI 10.1016/j.foreco.2006.04.007; Sayer EJ, 2006, PLANT SOIL, V281, P5, DOI 10.1007/s11104-005-6334-x; Sayer EJ, 2006, BIOL REV, V81, P1, DOI 10.1017/S1464793105006846; Schlesinger WH, 2001, NATURE, V411, P466, DOI 10.1038/35078060; SINGH JS, 1977, BOT REV, V43, P499, DOI 10.1007/BF02860844; Vasconcelos SS, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002210; Zak DR, 2003, ECOL APPL, V13, P1508, DOI 10.1890/03-5055; Zhang XB, 2007, NATURE, V448, P461, DOI 10.1038/nature06025	45	103	125	6	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1299	10.1371/journal.pone.0001299	http://dx.doi.org/10.1371/journal.pone.0001299			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074023	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000207459500018
J	Schnitzler, MMY; Waring, J; Gudermann, T; Chubanov, V				Schnitzler, Michael Mederos y; Waering, Janine; Gudermann, Thomas; Chubanov, Vladimir			Evolutionary determinants of divergent calcium selectivity of TRPM channels	FASEB JOURNAL			English	Article						transient receptor potential; TRPM2; TRPM7; TRPM8; nudix	CATION CHANNEL; ION-CHANNEL; ADP-RIBOSE; FUNCTIONAL-CHARACTERIZATION; MOLECULAR DETERMINANTS; SECONDARY HYPOCALCEMIA; CRYSTAL-STRUCTURE; KINASE DOMAIN; PROTEIN; IDENTIFICATION	The mammalian TRPM gene family can be subdivided into distinct categories of cation channels that are either highly permeable for Ca(2+) (TRPM3/6/7), nonselective (TRPM2/8), or even Ca(2+) impermeable (TRPM4/5). TRPM6/7 are fused to alpha-kinase domains, whereas TRPM2 is linked to an ADPribose phosphohydrolase (Nudix domain). At a molecular level, the evolutionary steps that gave rise to the structural and functional TRPM channel diversity remain elusive. Here, we provide phylogenetic evidence that Nudix-linked channels represent an ancestral type of TRPMs that is present in various phyla, ranging from protists to humans. Surprisingly, the pore-forming segments of invertebrate TRPM2-like proteins display high sequence similarity to those of Ca(2+)-selective TRPMs, while human TPPM2 is characterized by a loss of several conserved residues. Using the patch-clamp technique, Ca(2+) imaging, and site-directed mutagenesis, we demonstrate that restoration of only two "ancient" pore residues in human TRPM2 (Q981E/P983Y) significantly increased (similar to 4-fold) its permeability for Ca(2+) Conversely, introduction of a "modern" sequence motif into mouse TRPM7 (EI047Q/YI049P) resulted in the loss of Ca(2+) permeation and a linear TRPM2-like current-voltage relationship. Overall, our findings provide an integrative view on the evolution of the domain architecture and the structural basis of the distinct ion permeation profiles of TRPM channels.	[Schnitzler, Michael Mederos y; Waering, Janine; Gudermann, Thomas; Chubanov, Vladimir] Univ Marburg, Inst Pharmakol & Toxikol, D-35043 Marburg, Germany	Philipps University Marburg	Chubanov, V (corresponding author), Univ Marburg, Inst Pharmakol & Toxikol, Karl Von Frisch Str 1, D-35043 Marburg, Germany.	chubanov@staff.uni-marburg.de						Baubet V, 2000, P NATL ACAD SCI USA, V97, P7260, DOI 10.1073/pnas.97.13.7260; Chubanov V, 2005, N-S ARCH PHARMACOL, V371, P334, DOI 10.1007/s00210-005-1056-4; Chubanov V, 2004, P NATL ACAD SCI USA, V101, P2894, DOI 10.1073/pnas.0305252101; Chubanov V, 2007, J BIOL CHEM, V282, P7656, DOI 10.1074/jbc.M611117200; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Estevez AY, 2003, J GEN PHYSIOL, V122, P207, DOI 10.1085/jgp.200308804; Garcia-Martinez C, 2000, J BIOL CHEM, V275, P32552, DOI 10.1074/jbc.M002391200; Grimm C, 2003, J BIOL CHEM, V278, P21493, DOI 10.1074/jbc.M300945200; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; Harteneck C, 2000, TRENDS NEUROSCI, V23, P159, DOI 10.1016/S0166-2236(99)01532-5; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jung S, 2003, J BIOL CHEM, V278, P3562, DOI 10.1074/jbc.M211484200; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Kozak JA, 2005, J GEN PHYSIOL, V126, P499, DOI 10.1085/jgp.200509324; Kozak JA, 2003, BIOPHYS J, V84, P922, DOI 10.1016/S0006-3495(03)74909-1; KUHN FJ, 2007, J BIOL CHEM, V277, P23150; Kuhn FJP, 2004, J BIOL CHEM, V279, P46431, DOI 10.1074/jbc.M407263200; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; LEWIS CA, 1979, J PHYSIOL-LONDON, V286, P417, DOI 10.1113/jphysiol.1979.sp012629; Li M, 2006, J GEN PHYSIOL, V127, P525, DOI 10.1085/jgp.200609502; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Liu CH, 2007, J NEUROSCI, V27, P604, DOI 10.1523/JNEUROSCI.4099-06.2007; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Liu XB, 2003, J BIOL CHEM, V278, P11337, DOI 10.1074/jbc.M213271200; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Monteilh-Zoller MK, 2003, J GEN PHYSIOL, V121, P49, DOI 10.1085/jgp.20028740; Nadler MJS, 2001, NATURE, V411, P590, DOI 10.1038/35079092; Nilius B, 2001, J BIOL CHEM, V276, P1020, DOI 10.1074/jbc.M006184200; Nilius B, 2007, BBA-MOL BASIS DIS, V1772, P805, DOI 10.1016/j.bbadis.2007.02.002; Oberwinkler J, 2005, J BIOL CHEM, V280, P22540, DOI 10.1074/jbc.M503092200; Owsianik G, 2006, ANNU REV PHYSIOL, V68, P685, DOI 10.1146/annurev.physiol.68.040204.101406; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Perraud AL, 2005, J BIOL CHEM, V280, P6138, DOI 10.1074/jbc.M411446200; Perraud AL, 2001, NATURE, V411, P595, DOI 10.1038/35079100; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Saito S, 2006, PHYSIOL GENOMICS, V27, P219, DOI 10.1152/physiolgenomics.00322.2005; Sano Y, 2001, SCIENCE, V293, P1327, DOI 10.1126/science.1062473; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; Shen BW, 2003, J MOL BIOL, V332, P385, DOI 10.1016/S0022-2836(03)00954-9; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; Teramoto T, 2005, CELL METAB, V1, P343, DOI 10.1016/j.cmet.2005.04.007; Topala CN, 2007, CELL CALCIUM, V41, P513, DOI 10.1016/j.ceca.2006.10.003; Venkatachalam K, 2007, ANNU REV BIOCHEM, V76, P387, DOI 10.1146/annurev.biochem.75.103004.142819; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Voets T, 2003, J GEN PHYSIOL, V121, P245, DOI 10.1085/jgp.20028752; Voets T, 2002, J BIOL CHEM, V277, P33704, DOI 10.1074/jbc.M204828200; Vriens J, 2004, PFLUG ARCH EUR J PHY, V449, P213, DOI 10.1007/s00424-004-1314-1; West RJ, 2001, GENE, V266, P103, DOI 10.1016/S0378-1119(01)00373-0; Wilding M, 1998, AM J PHYSIOL-CELL PH, V275, pC1277, DOI 10.1152/ajpcell.1998.275.5.C1277; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8	56	55	55	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2008	22	5					1540	1551		10.1096/fj.07-9694com	http://dx.doi.org/10.1096/fj.07-9694com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18073331				2022-12-25	WOS:000255898700026
J	Bansal, PS; Torres, AM; Crossett, B; Wong, KKY; Koh, JMS; Geraghty, DP; Vandenberg, JI; Kuchel, PW				Bansal, Paramjit S.; Torres, Allan M.; Crossett, Ben; Wong, Karen K. Y.; Koh, Jennifer M. S.; Geraghty, Dominic P.; Vandenberg, Jamie I.; Kuchel, Philip W.			Substrate specificity of platypus venom L-to-D-peptide isomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							D-AMINO-ACID; ENZYME-CATALYZED REACTIONS; CARBON ACIDS; RESIDUE; SKIN; ISOMERIZATION; DERMORPHIN	The L-to-D-peptide isomerase from the venom of the platypus ( Ornithorhyncus anatinus) is the first such enzyme to be reported for a mammal. In delineating its catalytic mechanism and broader roles in the animal, its substrate specificity was explored. We used N-terminal segments of defensin-like peptides DLP-2 and DLP-4 and natriuretic peptide OvCNP from the venom as substrates. The DLP analogues IMFsrs and ImFsrs ( srs is a solubilizing chain; lowercase letters denote D-amino acid) were effective substrates for the isomerase; it appears to recognize the N-terminal tripeptide sequence Ile-Xaa-Phe-.Asuite of 26 mutants of these hexapeptides was synthesized by replacing the second residue ( Met) with another amino acid, viz. Ala, alpha-aminobutyric acid, Ile, Leu, Lys, norleucine, Phe, Tyr, and Val. It was shown that mutant peptides incorporating norleucine and Phe are substrates and exhibit L-or D-amino acid isomerization, but mutant peptides that contain residues with shorter, beta-branched or long side chains with polar terminal groups, viz. Ala, alpha-aminobutyric acid, Ile, Val, Leu, Lys, and Tyr, respectively, are not substrates. It was demonstrated that at least three N-terminal amino acid residues are absolutely essential for L-to D-isomerization; furthermore, the third amino acid must be a Phe residue. None of the hexapeptides based on LLH, the first three residues of OvCNP, were substrates. A consistent 2-base mechanism is proposed for the isomerization; abstraction of a proton by 1 base is concomitant with delivery of a proton by the conjugate acid of a second base.	[Bansal, Paramjit S.; Crossett, Ben; Wong, Karen K. Y.; Koh, Jennifer M. S.; Kuchel, Philip W.] Univ Sydney, Sch Mol & Microbial Biosci, Sydney, NSW 2006, Australia; [Torres, Allan M.] Univ Western Sydney, Coll Hlth & Sci, Nanoscale Org & Dynam Grp, Penrith, NSW 1797, Australia; [Geraghty, Dominic P.] Univ Tasmania, Sch Human Life Sci, Launceston, Tas 7250, Australia; [Vandenberg, Jamie I.] Victor Chang Cardiac Res Inst, Mark Cowley Lidwill Cardiac Electrophysiol & Biop, Darlinghurst, NSW 2010, Australia	University of Sydney; Western Sydney University; University of Tasmania; Victor Chang Cardiac Research Institute	Kuchel, PW (corresponding author), Univ Sydney, Sch Mol & Microbial Biosci, Bldg G08, Sydney, NSW 2006, Australia.	p.kuchel@mmb.usyd.edu.au	Vandenberg, Jamie I/B-6608-2013; Geraghty, Dominic P/A-4362-2013; Torres, Allan/GSN-4624-2022; Crossett, Ben/G-2316-2011	Vandenberg, Jamie I/0000-0002-3859-3716; Koh, Jennifer/0000-0003-2140-3151; Geraghty, Dominic (Dom)/0000-0001-8968-5912; Kuchel, Philip/0000-0003-4100-7332				CLELAND WW, 1994, SCIENCE, V264, P1887, DOI 10.1126/science.8009219; DOOLEY CT, 1994, SCIENCE, V266, P2019, DOI 10.1126/science.7801131; GERLT JA, 1991, J AM CHEM SOC, V113, P9667, DOI 10.1021/ja00025a039; GERLT JA, 1993, BIOCHEMISTRY-US, V32, P11943, DOI 10.1021/bi00096a001; Heck SD, 1996, P NATL ACAD SCI USA, V93, P4036, DOI 10.1073/pnas.93.9.4036; HECK SD, 1994, SCIENCE, V266, P1065, DOI 10.1126/science.7973665; Jacobsen RB, 1999, J PEPT RES, V54, P93, DOI 10.1034/j.1399-3011.1999.00093.x; Jilek A, 2005, P NATL ACAD SCI USA, V102, P4235, DOI 10.1073/pnas.0500789102; KAMATANI Y, 1989, BIOCHEM BIOPH RES CO, V160, P1015, DOI 10.1016/S0006-291X(89)80103-2; Kreil G, 1997, ANNU REV BIOCHEM, V66, P337, DOI 10.1146/annurev.biochem.66.1.337; MONTECUCCHI PC, 1981, INT J PEPT PROT RES, V17, P275; RICHTER K, 1987, SCIENCE, V238, P200, DOI 10.1126/science.3659910; SHIKATA Y, 1995, J BIOL CHEM, V270, P16719, DOI 10.1074/jbc.270.28.16719; SOYEZ D, 1994, J BIOL CHEM, V269, P18295; Torres AM, 2007, AMINO ACIDS, V32, P63, DOI 10.1007/s00726-006-0346-6; Torres AM, 2006, FEBS LETT, V580, P1587, DOI 10.1016/j.febslet.2006.01.089; Torres AM, 2005, BIOCHEM J, V391, P215, DOI 10.1042/BJ20050900; Torres AM, 2002, FEBS LETT, V524, P172, DOI 10.1016/S0014-5793(02)03050-8; VOLKMANN RA, 1998, D AMINOACIDS INSEQUE, P57	19	42	44	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 4	2008	283	14					8969	8975		10.1074/jbc.M709762200	http://dx.doi.org/10.1074/jbc.M709762200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	280ZO	18158286	hybrid			2022-12-25	WOS:000254465800026
J	Giorgini, F; Moller, T; Kwan, W; Zwilling, D; Wacker, JL; Hong, S; Tsai, LCL; Cheah, CS; Schwarcz, R; Guidetti, P; Muchowski, PJ				Giorgini, Flaviano; Moller, Thomas; Kwan, Wanda; Zwilling, Daniel; Wacker, Jennifer L.; Hong, Soyon; Tsai, Li-Chun L.; Cheah, Christine S.; Schwarcz, Robert; Guidetti, Paolo; Muchowski, Paul J.			Histone deacetylase inhibition modulates kynurenine pathway activation in yeast, microglia, and mice expressing a mutant huntingtin fragment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBEROYLANILIDE HYDROXAMIC ACID; MOUSE MODEL; QUINOLINIC ACID; DISEASE GENE; DEPENDENT NEURODEGENERATION; POLYGLUTAMINE; BRAIN; HD; 3-HYDROXYKYNURENINE; DYSREGULATION	The kynurenine pathway of tryptophan degradation is hypothesized to play an important role in Huntington disease, a neurodegenerative disorder caused by a polyglutamine expansion in the protein huntingtin. Neurotoxic metabolites of the kynurenine pathway, generated in microglia and macrophages, are present at increased levels in the brains of patients and mouse models during early stages of disease, but the mechanism by which kynurenine pathway up-regulation occurs in Huntington disease is unknown. Here we report that expression of a mutant huntingtin fragment was sufficient to induce transcription of the kynurenine pathway in yeast and that this induction was abrogated by impairing the activity of the histone deacetylase Rpd3. Moreover, numerous genetic suppressors of mutant huntingtin toxicity that are functionally unrelated converged unexpectedly on the kynurenine pathway, supporting a critical role for the kynurenine pathway in mediating mutant huntingtin toxicity in yeast. Histone deacetylase-dependent regulation of the kynurenine pathway was also observed in a mouse model of Huntington disease, in which treatment with a neuroprotective histone deacetylase inhibitor blocked activation of the kynurenine pathway in microglia expressing a mutant huntingtin fragment in vitro and in vivo. These findings suggest that a mutant huntingtin fragment can perturb transcriptional programs in microglia, and thus implicate these cells as potential modulators of neurodegeneration in Huntington disease that are worthy of further investigation.	[Giorgini, Flaviano; Wacker, Jennifer L.; Tsai, Li-Chun L.; Cheah, Christine S.; Muchowski, Paul J.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Giorgini, Flaviano; Wacker, Jennifer L.; Tsai, Li-Chun L.; Cheah, Christine S.; Muchowski, Paul J.] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Kwan, Wanda; Zwilling, Daniel; Muchowski, Paul J.] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Schwarcz, Robert; Guidetti, Paolo] Univ Maryland, Sch Med, Maryland Psychiat Res Ctr, Catonsville, MD 21228 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Muchowski, PJ (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.	pmuchowski@gladstone.ucsf.edu	Schwarcz, Robert/P-3134-2018; Hong, Soyon/AAE-9662-2021	Hong, Soyon/0000-0002-5744-4871; Giorgini, Flaviano/0000-0001-7881-9508	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057715] Funding Source: NIH RePORTER; Medical Research Council Funding Source: Medline; NINDS NIH HHS [R01 NS057715] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; BEAL MF, 1986, NATURE, V321, P168, DOI 10.1038/321168a0; Beers DR, 2006, P NATL ACAD SCI USA, V103, P16021, DOI 10.1073/pnas.0607423103; Bernstein BE, 2000, P NATL ACAD SCI USA, V97, P13708, DOI 10.1073/pnas.250477697; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; BURACZYNSKA MJ, 1995, CYTOGENET CELL GENET, V71, P197, DOI 10.1159/000134106; Cha JHJ, 1999, PHILOS T R SOC B, V354, P981, DOI 10.1098/rstb.1999.0449; Cha JHJ, 2000, TRENDS NEUROSCI, V23, P387, DOI 10.1016/S0166-2236(00)01609-X; Custer SK, 2006, NAT NEUROSCI, V9, P1302, DOI 10.1038/nn1750; DAVIES SW, 1988, SCIENCE, V241, P474, DOI 10.1126/science.2969147; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Ferrante RJ, 2003, J NEUROSCI, V23, P9418; Gardian G, 2005, J BIOL CHEM, V280, P556, DOI 10.1074/jbc.M410210200; Giorgini F, 2005, NAT GENET, V37, P526, DOI 10.1038/ng1542; GRAVELAND GA, 1985, SCIENCE, V227, P770, DOI 10.1126/science.3155875; Guidetti P, 2000, NEUROSCI LETT, V283, P233, DOI 10.1016/S0304-3940(00)00956-3; Guidetti P, 2004, NEUROBIOL DIS, V17, P455, DOI 10.1016/j.nbd.2004.07.006; Guidetti P, 2006, NEUROBIOL DIS, V23, P190, DOI 10.1016/j.nbd.2006.02.011; Guillemin GJ, 1999, ADV EXP MED BIOL, V467, P125; Guillemin GJ, 2001, J NEUROCHEM, V78, P842, DOI 10.1046/j.1471-4159.2001.00498.x; Heyes MP, 1996, BIOCHEM J, V320, P595, DOI 10.1042/bj3200595; Hockly E, 2003, P NATL ACAD SCI USA, V100, P2041, DOI 10.1073/pnas.0437870100; Kiss C, 2003, J NEURAL TRANSM, V110, P1, DOI 10.1007/s00702-002-0770-z; Kurdistani SK, 2002, NAT GENET, V31, P248, DOI 10.1038/ng907; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; LI SH, 1993, NEURON, V11, P985, DOI 10.1016/0896-6273(93)90127-D; Luthi-Carter R, 2000, HUM MOL GENET, V9, P1259, DOI 10.1093/hmg/9.9.1259; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1927, DOI 10.1093/hmg/11.17.1927; Luthi-Carter R, 2002, HUM MOL GENET, V11, P1911, DOI 10.1093/hmg/11.17.1911; Ma L, 2003, GLIA, V43, P274, DOI 10.1002/glia.10261; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mallory MJ, 2003, J BIOL CHEM, V278, P44727, DOI 10.1074/jbc.M308632200; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MARTIN JB, 1986, NEW ENGL J MED, V315, P1267; Meriin AB, 2002, J CELL BIOL, V157, P997, DOI 10.1083/jcb.200112104; MYERS RH, 1991, J NEUROPATH EXP NEUR, V50, P729, DOI 10.1097/00005072-199111000-00005; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; PEARSON SJ, 1992, NEUROSCI LETT, V144, P199, DOI 10.1016/0304-3940(92)90749-W; Reddy PH, 1998, NAT GENET, V20, P198, DOI 10.1038/2510; Rover S, 1997, J MED CHEM, V40, P4378, DOI 10.1021/jm970467t; SAITO K, 1992, NEUROSCIENCE, V51, P25, DOI 10.1016/0306-4522(92)90467-G; Sapp E, 2001, J NEUROPATH EXP NEUR, V60, P161, DOI 10.1093/jnen/60.2.161; Schuettengruber B, 2003, J BIOL CHEM, V278, P1784, DOI 10.1074/jbc.M204843200; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Schwarcz R, 2002, J PHARMACOL EXP THER, V303, P1, DOI 10.1124/jpet.102.034439; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Simmons DA, 2007, GLIA, V55, P1074, DOI 10.1002/glia.20526; Singhrao SK, 1999, EXP NEUROL, V159, P362, DOI 10.1006/exnr.1999.7170; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Streit WJ, 2005, NEUROL RES, V27, P685, DOI 10.1179/016164105X49463; STRONG TV, 1993, NAT GENET, V5, P259, DOI 10.1038/ng1193-259; Sugars KL, 2003, TRENDS GENET, V19, P233, DOI 10.1016/S0168-9525(03)00074-X; Tai YF, 2007, BRAIN, V130, P1759, DOI 10.1093/brain/awm044; TOPPER R, 1993, EXP NEUROL, V123, P271, DOI 10.1006/exnr.1993.1159; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Weydt P, 2004, GLIA, V48, P179, DOI 10.1002/glia.20062; Willingham S, 2003, SCIENCE, V302, P1769, DOI 10.1126/science.1090389; Yu ZX, 2003, J NEUROSCI, V23, P2193	59	78	79	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7390	7400		10.1074/jbc.M708192200	http://dx.doi.org/10.1074/jbc.M708192200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18079112	hybrid			2022-12-25	WOS:000253997900013
J	Bai, S; Kopan, R; Zou, W; Hilton, MJ; Ong, CT; Long, FX; Ross, FP; Teitelbaum, SL				Bai, Shuting; Kopan, Raphael; Zou, Wei; Hilton, Matthew J.; Ong, Chin-tong; Long, Fanxin; Ross, F. Patrick; Teitelbaum, Steven L.			NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC LETHALITY; MUTANT MICE; LIGAND; DIFFERENTIATION; GENE; ACTIVATION; DEFECTS; EXPRESSION; SKELETAL; HOMOLOG	NOTCH signaling is a key regulator of cell fate decisions in prenatal skeletal development and is active during adult tissue renewal. In addition, its association with neoplasia suggests that it is a candidate therapeutic target. We find that attenuated NOTCH signaling enhances osteoclastogenesis and bone resorption in vitro and in vivo by a combination of molecular mechanisms. First, deletion of Notch1-3 in bone marrow macrophages directly promotes their commitment to the osteoclast phenotype. These osteoclast precursors proliferate more rapidly than the wild type in response to macrophage colony-stimulating factor and are sensitized to RANKL and macrophage colony-stimulating factor, undergoing enhanced differentiation in response to low doses of either cytokine. Conforming with a role for NOTCH in this process, presentation of the NOTCH ligand JAGGED1 blunts the capacity of wild-type bone marrow macrophages to become osteoclasts. Combined, these data establish that NOTCH suppresses osteoclastogenesis via ligand-mediated receptor activation. Although NOTCH1 and NOTCH3 collaborate in regulating osteoclast formation, NOTCH1 is the dominant paralog. In addition, NOTCH1 deficiency promotes osteoclastogenesis indirectly by enhancing the ability of osteoblast lineage cells to stimulate osteoclastogenesis. This is achieved by decreasing the osteoprotegerin/RANKL expression ratio. Thus, NOTCH1 acts as a net inhibitor of bone resorption, exerting its effect both directly in osteoclast precursors and indirectly via osteoblast lineage cells. These observations raise caution that therapeutic inhibition of NOTCH signaling may adversely accelerate bone loss in humans.	[Bai, Shuting; Zou, Wei; Ross, F. Patrick; Teitelbaum, Steven L.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA; [Kopan, Raphael; Ong, Chin-tong] Washington Univ, Sch Med, Dept Mol Biol & Pharmacol, St Louis, MO 63110 USA; [Hilton, Matthew J.; Long, Fanxin] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Teitelbaum, SL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	teitelbs@wustl.edu	Kopan, Raphael/AFG-3275-2022; Kopan, Raphael/AAF-1357-2022	Hilton, Matthew/0000-0003-3165-267X; Zou, Wei/0000-0001-8081-268X; Teitelbaum, Steven/0000-0002-4054-6679; Kopan, Raphael/0000-0002-0350-2730; Ong, Chin-Tong/0000-0002-5450-4760	NIAMS NIH HHS [AR 32788, AR 46523, AR 48812, AR 46852, AR 48853] Funding Source: Medline; NICHD NIH HHS [HD 044056] Funding Source: Medline; NIDDK NIH HHS [P30 DK056341-07, DK 065789, P30 DK056341] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD044056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032788, R01AR048853, R37AR046523, R01AR048812, R01AR046852, R01AR046523] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK065789, P30DK056341] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Ball Douglas W, 2003, Cancer Treat Res, V115, P95; Bolos V, 2007, ENDOCR REV, V28, P339, DOI 10.1210/er.2006-0046; Bulman MP, 2000, NAT GENET, V24, P438, DOI 10.1038/74307; Callahan R, 2004, J MAMMARY GLAND BIOL, V9, P145, DOI 10.1023/B:JOMG.0000037159.63644.81; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; CONLON RA, 1995, DEVELOPMENT, V121, P1533; Costa RM, 2003, CURR BIOL, V13, P1348, DOI 10.1016/S0960-9822(03)00492-5; Deregowski V, 2006, J BIOL CHEM, V281, P6203, DOI 10.1074/jbc.M508370200; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; ELLISEN LW, 1991, CELL, V66, P649, DOI 10.1016/0092-8674(91)90111-B; Fischer A, 2003, TRENDS CARDIOVAS MED, V13, P221, DOI 10.1016/S1050-1738(03)00082-3; Gordon WR, 2007, NAT STRUCT MOL BIOL, V14, P295, DOI 10.1038/nsmb1227; Gridley T, 2006, DEV DYNAM, V235, P2330, DOI 10.1002/dvdy.20850; Hamada Y, 1999, DEVELOPMENT, V126, P3415; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Huppert SS, 2000, NATURE, V405, P966, DOI 10.1038/35016111; ILAGAN MX, 2007, CELL, V128, pE2; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang RL, 1998, GENE DEV, V12, P1046, DOI 10.1101/gad.12.7.1046; Kitaura H, 2005, J CLIN INVEST, V115, P3418, DOI 10.1172/JCI26132; KOPAN R, 1994, DEVELOPMENT, V120, P2385; Lee J, 2007, DEVELOPMENT, V134, P2795, DOI 10.1242/dev.02868; Lubman OY, 2004, MOL CELL, V13, P619, DOI 10.1016/S1097-2765(04)00120-0; Maillard I, 2003, IMMUNITY, V18, P587, DOI 10.1016/S1074-7613(03)00119-5; Maillard I, 2007, SCIENCE, V316, P840, DOI 10.1126/science.1143336; McHugh KP, 2000, J CLIN INVEST, V105, P433, DOI 10.1172/JCI8905; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Monsalve E, 2006, J IMMUNOL, V176, P5362, DOI 10.4049/jimmunol.176.9.5362; Nam Y, 2002, CURR OPIN CHEM BIOL, V6, P501, DOI 10.1016/S1367-5931(02)00346-0; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Nobta M, 2005, J BIOL CHEM, V280, P15842, DOI 10.1074/jbc.M412891200; Ohishi K, 2001, BLOOD, V98, P1402, DOI 10.1182/blood.V98.5.1402; Pan YH, 2004, DEV CELL, V7, P731, DOI 10.1016/j.devcel.2004.09.014; Parks AL, 2000, DEVELOPMENT, V127, P1373; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Teitelbaum SL, 2007, AM J PATHOL, V170, P427, DOI 10.2353/ajpath.2007.060834; Tezuka K, 2002, J BONE MINER RES, V17, P231, DOI 10.1359/jbmr.2002.17.2.231; van Es JH, 2005, TRENDS MOL MED, V11, P496, DOI 10.1016/j.molmed.2005.09.008; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang MWH, 2004, J CLIN INVEST, V114, P206, DOI 10.1172/JCI200415797; Weber JM, 2006, BONE, V39, P485, DOI 10.1016/j.bone.2006.03.002; Yamada T, 2003, BLOOD, V101, P2227, DOI 10.1182/blood-2002-06-1740; Zamurovic N, 2004, J BIOL CHEM, V279, P37704, DOI 10.1074/jbc.M403813200; Zou W, 2007, J CELL BIOL, V176, P877, DOI 10.1083/jcb.200611083	47	164	186	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6509	6518		10.1074/jbc.M707000200	http://dx.doi.org/10.1074/jbc.M707000200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18156632	hybrid			2022-12-25	WOS:000253779500058
J	Caldara, M; Dupont, G; Leroy, F; Goldbeter, A; De Vuyst, L; Cunin, R				Caldara, Marina; Dupont, Genevieve; Leroy, Frederic; Goldbeter, Albert; De Vuyst, Luc; Cunin, Raymond			Arginine biosynthesis in Escherichia coli - Experimental perturbation and mathematical modeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBAMOYL-PHOSPHATE SYNTHETASE; N-ACETYLGLUTAMATE SYNTHETASE; ASPARTATE-TRANSCARBAMYLASE; ALLOSTERIC REGULATION; INTRAMOLECULAR TRANSMISSION; FEEDBACK INHIBITION; SYNTHASE; PATHWAY; PYRIMIDINE; ENZYME	A basic challenge in cell biology is to understand how interconnected metabolic pathways are regulated to provide the adequate cellular outcome when changing levels of metabolites and enzyme expression. In Escherichia coli, the arginine and pyrimidine biosynthetic pathways are connected through a common metabolite provided by a single enzyme. The different elements of the arginine biosynthetic system of Escherichia coli, including the connection with pyrimidine biosynthesis, and the principal regulatory mechanisms operating at genetic and enzymatic levels were integrated in a mathematical model using a molecular kinetic approach combined with a modular description of the system. The model was then used to simulate a set of perturbed conditions as follows: genetic derepression, feedback resistance of the first enzymatic step, and low constitutive synthesis of the intermediate carbamyl phosphate. In all cases, an excellent quantitative agreement between simulations and experimental results was found. The model was used to gain further insight into the function of the system, including the synergy between the different regulations. The outcome of combinations of perturbations on cellular arginine concentration was predicted accurately, establishing the model as a powerful tool for the design of arginine-overproducing strains.	[Caldara, Marina; Cunin, Raymond] Vrije Univ Brussel, Lab Microbiol & Genet, B-1050 Brussels, Belgium; [Dupont, Genevieve; Goldbeter, Albert] Univ Libre Bruxelles, Fac Sci, Unite Chronbiol Theor, B-1050 Brussels, Belgium; [Goldbeter, Albert; Cunin, Raymond] Vrije Univ Brussel, Lab Ind Microbiol & Food Biotechnol, B-1050 Brussels, Belgium	Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Cunin, R (corresponding author), Vrije Univ Brussel, Lab Microbiol & Genet, Pleinplaan 2, B-1050 Brussels, Belgium.	rcunin@vub.ac.be	Leroy, Frédéric/D-2424-2009	Leroy, Frédéric/0000-0001-8682-9626; De Vuyst, Luc/0000-0002-7534-7186				Abadjieva A, 2001, J BIOL CHEM, V276, P42869, DOI 10.1074/jbc.M103732200; ANDERSON PM, 1965, BIOCHEMISTRY-US, V4, P2803, DOI 10.1021/bi00888a034; ANDERSON PM, 1966, BIOCHEMISTRY-US, V5, P3164, DOI 10.1021/bi00874a013; Bachmann B.J., 1987, ESCHERICHIA COLI SAL, P1190; Bruggeman FJ, 2002, J THEOR BIOL, V218, P507, DOI 10.1006/jtbi.2002.3096; Bruggeman FJ, 2002, MOL BIOL REP, V29, P57, DOI 10.1023/A:1020354302260; Bruggeman FJ, 2007, TRENDS MICROBIOL, V15, P45, DOI 10.1016/j.tim.2006.11.003; CALDARA M, 2007, THESIS VRIJE U BRUSS; Caldara M, 2006, MICROBIOL-SGM, V152, P3343, DOI 10.1099/mic.0.29088-0; Castellanos M, 2004, P NATL ACAD SCI USA, V101, P6681, DOI 10.1073/pnas.0400962101; CHARLIER D, 2004, BIOSYNTHESIS ARGININ; Chassagnole C, 2001, BIOCHEM J, V356, P415, DOI 10.1042/0264-6021:3560415; CUNIN R, 1986, MICROBIOL REV, V50, P314, DOI 10.1128/MMBR.50.3.314-352.1986; Cunin R, 1996, J MOL BIOL, V262, P258, DOI 10.1006/jmbi.1996.0511; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Delannay S, 1999, J MOL BIOL, V286, P1217, DOI 10.1006/jmbi.1999.2561; DESTAERCKE C, 1995, J MOL BIOL, V246, P132, DOI 10.1006/jmbi.1994.0072; ELSEVIERS D, 1972, MOL GEN GENET, V117, P349, DOI 10.1007/BF00333028; ENGLAND P, 1992, BIOCHEMISTRY-US, V31, P9725, DOI 10.1021/bi00155a028; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; GERHART JC, 1962, J BIOL CHEM, V237, P891; GLANSDOR.N, 1965, BIOCHIM BIOPHYS ACTA, V108, P308, DOI 10.1016/0005-2787(65)90016-X; GLANSDORFF N, 1965, GENETICS, V51, P167; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; GOLDBETER A, 1973, THESIS U LIBRE BRUXE; HAAS D, 1972, EUR J BIOCHEM, V31, P290, DOI 10.1111/j.1432-1033.1972.tb02531.x; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; HERVE G, 1989, ALLOSTERIC ENZYMES, P61; HESS B, 1971, ANNU REV BIOCHEM, V40, P237, DOI 10.1146/annurev.bi.40.070171.001321; Kafri R, 2005, NAT GENET, V37, P295, DOI 10.1038/ng1523; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kumari S, 2000, J BACTERIOL, V182, P4173, DOI 10.1128/JB.182.15.4173-4179.2000; Lauffenburger DA, 2000, P NATL ACAD SCI USA, V97, P5031, DOI 10.1073/pnas.97.10.5031; LEGRAIN C, 1972, EUR J BIOCHEM, V27, P93, DOI 10.1111/j.1432-1033.1972.tb01814.x; LEISINGER T, 1975, J BIOL CHEM, V250, P1690; LIM D, 1987, P NATL ACAD SCI USA, V84, P6697, DOI 10.1073/pnas.84.19.6697; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu CD, 2006, APPL MICROBIOL BIOT, V70, P261, DOI 10.1007/s00253-005-0308-z; MAAS WK, 1994, MICROBIOL REV, V58, P631, DOI 10.1128/MMBR.58.4.631-640.1994; MARVIL DK, 1977, J BIOL CHEM, V252, P3295; MERGEAY M, 1974, MOL GEN GENET, V133, P299, DOI 10.1007/BF00332706; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nandineni MR, 2004, J BACTERIOL, V186, P3539, DOI 10.1128/JB.186.11.3539-3546.2004; NEUHARD J, 1996, BIOSYNTHESIS ARGININ; PIERARD A, 1965, J MOL BIOL, V14, P23, DOI 10.1016/S0022-2836(65)80226-1; PIERARD A, 1966, SCIENCE, V154, P1572, DOI 10.1126/science.154.3756.1572; PIETTE J, 1984, P NATL ACAD SCI-BIOL, V81, P4134, DOI 10.1073/pnas.81.13.4134; PRESCOTT LM, 1969, ANAL BIOCHEM, V32, P408, DOI 10.1016/S0003-2697(69)80008-4; Qi YA, 2006, PLOS COMPUT BIOL, V2, P1502, DOI 10.1371/journal.pcbi.0020174; Rajagopal BS, 1998, APPL ENVIRON MICROB, V64, P1805; Ravasz E, 2002, SCIENCE, V297, P1551, DOI 10.1126/science.1073374; Reitzer L, 2003, ANNU REV MICROBIOL, V57, P155, DOI 10.1146/annurev.micro.57.030502.090820; ROBIN JP, 1989, EUR J BIOCHEM, V183, P519, DOI 10.1111/j.1432-1033.1989.tb21080.x; Rodriguez M, 2005, J THEOR BIOL, V234, P299, DOI 10.1016/j.jtbi.2004.11.023; RUBIO V, 1991, BIOCHEMISTRY-US, V30, P1068, DOI 10.1021/bi00218a027; Schneider BL, 1998, J BACTERIOL, V180, P4278, DOI 10.1128/JB.180.16.4278-4286.1998; Segel I.H, 1993, ENZYME KINETICS; Shi DS, 2005, J BIOL CHEM, V280, P14366, DOI 10.1074/jbc.C500005200; Stelling J, 2004, IEEE T NANOBIOSCI, V3, P172, DOI 10.1109/TNB.2004.833688; Sundararaj S, 2004, NUCLEIC ACIDS RES, V32, pD293, DOI 10.1093/nar/gkh108; VYAS S, 1963, ARCH BIOCHEM BIOPHYS, V100, P542, DOI 10.1016/0003-9861(63)90124-3; WALES ME, 1999, ENCY MOL BIOL, P196; WEBER K, 1968, J BIOL CHEM, V243, P543; WILD JR, 1989, P NATL ACAD SCI USA, V86, P46, DOI 10.1073/pnas.86.1.46; Xu Y, 2007, MICROBIOL MOL BIOL R, V71, P36, DOI 10.1128/MMBR.00032-06; Yang CR, 2005, J BIOL CHEM, V280, P11224, DOI 10.1074/jbc.M411471200; Yu YG, 1996, MOL MICROBIOL, V22, P545, DOI 10.1046/j.1365-2958.1996.1321494.x	67	44	49	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6347	6358		10.1074/jbc.M705884200	http://dx.doi.org/10.1074/jbc.M705884200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165237	Green Submitted, hybrid			2022-12-25	WOS:000253779500042
J	Rontein, D; Onillon, S; Herbette, G; Lesot, A; Werck-Reichhart, D; Sallaud, C; Tissier, A				Rontein, Denis; Onillon, Sandrine; Herbette, Gaetan; Lesot, Agnes; Werck-Reichhart, Daniele; Sallaud, Christophe; Tissier, Alain			CYP725A4 from yew catalyzes complex structural rearrangement of taxa-4(5),11(12)-diene into the cyclic ether 5(12)-oxa-3(11)-cyclotaxane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TAXUS-CANADENSIS NEEDLES; 1ST OXYGENATION STEP; TAXOL BIOSYNTHESIS; TAXADIENE SYNTHASE; YEAST EXPRESSION; METABOLISM; GENES; DITERPENOIDS; ARABIDOPSIS; ANTICANCER	Taxa-4(5),11(12)-diene is the first committed precursor of functionalized taxanes such as paclitaxel, a successful anticancer drug. Biosynthesis of taxanes in yew involves several oxidations, a number of which have been shown to be catalyzed by cytochrome P-450 oxygenases. Hydroxylation of the C-5 alpha of taxa-4(5),11(12)-diene is believed to be the first of these oxidations, and a gene encoding a taxa-4(5),11(12)-diene 5 alpha-hydroxylase (CYP725A4) was recently described (Jennewein, S., Long, R. M., Williams, R. M., and Croteau, R. (2004) Chem. Biol. 11, 379-387). In an attempt to produce the early components of the paclitaxel pathway by a metabolic engineering approach, cDNAs encoding taxa-4(5),11(12)-diene synthase and CYP725A4 were introduced in Nicotiana sylvestris for specific expression in trichome cells. Their co-expression did not lead to the production of the expected 5 alpha-hydroxytaxa-4(20),11(12)-diene. Instead, taxa-4(5),11(12)-diene was quantitatively converted to a novel taxane that was purified and characterized. Its structure was determined by NMR analysis and found to be that of 5(12)-oxa-3(11)-cyclotaxane (OCT) in which the eight-carbon B-ring from taxa-4(5), 11(12)-diene is divided into two fused five-carbon rings. In addition, OCT contains an ether bridge linking C-5 and C-12 from opposite sides of the molecule. OCT was also the sole major product obtained after incubation of taxa-4(5),11(12)-diene with NADPH and microsomes prepared from recombinant yeast expressing CYP725A4. The rearrangement of the taxa-4(5),11(12)-diene ring system is thus mediated by CYP725A4 only and does not rely on additional enzymes or factors present in the plant. The complex structure of OCT led us to propose a reaction mechanism involving a sequence of events so far unknown in P-450 catalysis.	[Rontein, Denis; Onillon, Sandrine; Sallaud, Christophe; Tissier, Alain] Ctr Cadarache, Librophyt, F-13115 St Paul Les Durance, France; [Herbette, Gaetan] Spectropole, F-13397 Marseille 20, France; [Lesot, Agnes; Werck-Reichhart, Daniele] Univ Strasbourg, CNRS UPR2357, Inst Plant Mol Biol, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Rontein, D (corresponding author), Ctr Cadarache, Librophyt, Batiment 185, F-13115 St Paul Les Durance, France.	denis.rontein@librophyt.com	WERCK-REICHHART, Danièle/U-3713-2019; Tissier, Alain F/B-2108-2017	WERCK-REICHHART, Danièle/0000-0003-2869-4262; Tissier, Alain F/0000-0002-9406-4245; RONTEIN, Denis/0000-0002-3288-3800; HERBETTE, Gaetan/0000-0002-3374-2508				APPENDINO G, 1992, PHYTOCHEMISTRY, V31, P4259, DOI 10.1016/0031-9422(92)80455-N; Baloglu E, 1999, J NAT PROD, V62, P1448, DOI 10.1021/np990176i; Besumbes O, 2004, BIOTECHNOL BIOENG, V88, P168, DOI 10.1002/bit.20237; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BORMAN S, 1994, CHEM ENG NEWS, V72, P32, DOI 10.1021/cen-v072n008.p032; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; COMMERCON A, 1995, ACS SYM SER, V583, P233; CRAGG GM, 1993, J NAT PROD, V56, P1657, DOI 10.1021/np50100a001; DeJong JM, 2006, BIOTECHNOL BIOENG, V93, P212, DOI 10.1002/bit.20694; Goldspiel BR, 1997, PHARMACOTHERAPY, V17, pS110; Guengerich FP, 2001, CHEM RES TOXICOL, V14, P611, DOI 10.1021/tx0002583; Hanson JR, 2001, NAT PROD REP, V18, P88, DOI 10.1039/b007477m; Hefner J, 1996, CHEM BIOL, V3, P479, DOI 10.1016/S1074-5521(96)90096-4; Hezari M, 1997, ARCH BIOCHEM BIOPHYS, V337, P185, DOI 10.1006/abbi.1996.9772; HORSCH RB, 1985, SCIENCE, V227, P1229, DOI 10.1126/science.227.4691.1229; Isin EM, 2007, BBA-GEN SUBJECTS, V1770, P314, DOI 10.1016/j.bbagen.2006.07.003; Jennewein S, 2004, P NATL ACAD SCI USA, V101, P9149, DOI 10.1073/pnas.0403009101; Jennewein S, 2004, CHEM BIOL, V11, P379, DOI 10.1016/j.chembiol.2004.02.022; Jennewein S, 2001, APPL MICROBIOL BIOT, V57, P13; Kovacs K, 2007, TRANSGENIC RES, V16, P121, DOI 10.1007/s11248-006-9039-x; KURONO M, 1963, TETRAHEDRON LETT, P2153; Meesters RJW, 2007, XENOBIOTICA, V37, P604, DOI 10.1080/00498250701393191; Nelson SD, 2003, DRUG METAB DISPOS, V31, P1481, DOI 10.1124/dmd.31.12.1481; NICOLAOU KC, 1994, NATURE, V367, P630, DOI 10.1038/367630a0; Petzke TL, 2004, J NAT PROD, V67, P1864, DOI 10.1021/np049836w; Pompon D, 1996, METHOD ENZYMOL, V272, P51, DOI 10.1016/S0076-6879(96)72008-6; Reilly CA, 2006, DRUG METAB REV, V38, P685, DOI 10.1080/03602530600959557; SALLAUD C, 2004, Patent No. 2005002530; SEVERSON RF, 1984, J AGR FOOD CHEM, V32, P566, DOI 10.1021/jf00123a037; Shi QW, 2004, CHEM COMMUN, P544, DOI 10.1039/b316051c; Shi QW, 2003, CHEM COMMUN, P68, DOI 10.1039/b209312j; SUFFNESS M, 1995, ACS SYM SER, V583, P1; TISSIER A, 2006, Patent No. 2006000188; Urban P, 1997, J BIOL CHEM, V272, P19176, DOI 10.1074/jbc.272.31.19176; Walker K, 2001, PHYTOCHEMISTRY, V58, P1, DOI 10.1016/S0031-9422(01)00160-1; Wang EM, 2003, PLANTA, V216, P686, DOI 10.1007/s00425-002-0904-4; Wang EM, 2002, J EXP BOT, V53, P1891, DOI 10.1093/jxb/erf054; Wang EM, 2001, NAT BIOTECHNOL, V19, P371, DOI 10.1038/86770; Watson C, 2004, ENVIRON SCI TECHNOL, V38, P248, DOI 10.1021/es034535e; Wildung MR, 1996, J BIOL CHEM, V271, P9201, DOI 10.1074/jbc.271.16.9201; WOOLHOUSE HW, 1966, NEW PHYTOL, V65, P518, DOI 10.1111/j.1469-8137.1966.tb05975.x	41	61	69	2	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6067	6075		10.1074/jbc.M708950200	http://dx.doi.org/10.1074/jbc.M708950200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167342	hybrid			2022-12-25	WOS:000253779500012
J	Caillet-Saguy, C; Turano, P; Piccioli, M; Lukat-Rodgers, GS; Czjzek, M; Guigliarelli, B; Izadi-Pruneyre, N; Rodgers, KR; Delepierre, M; Lecroisey, A				Caillet-Saguy, Celia; Turano, Paola; Piccioli, Mario; Lukat-Rodgers, Gudrun S.; Czjzek, Mirjam; Guigliarelli, Bruno; Izadi-Pruneyre, Nadia; Rodgers, Kenton R.; Delepierre, Muriel; Lecroisey, Anne			Deciphering the structural role of histidine 83 for heme binding in hemophore HasA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-MAGNETIC-RESONANCE; LOW-SPIN STATES; ELECTRONIC-STRUCTURE; SPECTROSCOPIC CHARACTERIZATION; THERMAL-EQUILIBRIUM; ACQUISITION-SYSTEM; PROXIMAL HISTIDINE; PROTEIN; NMR; LIGAND	Heme carrier HasA has a unique type of histidine/ tyrosine heme iron ligation in which the iron ion is in a thermally driven two spin states equilibrium. We recently suggested that the H-bonding between Tyr(75) and the invariantly conserved residue His(83) modulates the strength of the iron-Tyr(75) bond. To unravel the role of His(83), we characterize the iron ligation and the electronic properties of both wild type and H83A mutant by a variety of spectroscopic techniques. Although His(83) in wild type modulates the strength of the Tyr-iron bond, its removal causes detachment of the tyrosine ligand, thus giving rise to a series of pH-dependent equilibria among species with different axial ligation. The five coordinated species detected at physiological pH may represent a possible intermediate of the heme transfer mechanism to the receptor.	[Caillet-Saguy, Celia; Turano, Paola; Piccioli, Mario; Lukat-Rodgers, Gudrun S.; Czjzek, Mirjam; Guigliarelli, Bruno; Izadi-Pruneyre, Nadia; Rodgers, Kenton R.; Delepierre, Muriel; Lecroisey, Anne] CNRS, Inst Pasteur, URA 2185, Unite RMN Biomol, Paris, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Caillet-Saguy, C (corresponding author), CNRS, Inst Pasteur, URA 2185, Unite RMN Biomol, Paris, France.	ccaillet@pasteur.fr	Piccioli, Mario/M-1994-2015; Caillet-Saguy, Célia/AAC-1249-2022; Turano, Paola/F-9089-2011	Piccioli, Mario/0000-0001-9882-9754; Turano, Paola/0000-0002-7683-8614; Izadi-Pruneyre, Nadia/0000-0002-6864-2961	NCRR NIH HHS [P20RR15556] Funding Source: Medline; NIAID NIH HHS [1R15AI072719-01, R15 AI072719] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R15AI072719] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADACHI S, 1993, BIOCHEMISTRY-US, V32, P241, DOI 10.1021/bi00052a031; ANTONINI E, 1971, EUR J BIOCHEM, V23, P396, DOI 10.1111/j.1432-1033.1971.tb01633.x; Arnesano F, 2005, Q REV BIOPHYS, V38, P167, DOI 10.1017/S0033583506004161; Arnoux P, 1999, NAT STRUCT BIOL, V6, P516; Arnoux P, 2000, PROTEINS, V41, P202, DOI 10.1002/1097-0134(20001101)41:2<202::AID-PROT50>3.0.CO;2-8; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BANCI L, 1995, CHEM BIOL, V2, P377, DOI 10.1016/1074-5521(95)90218-X; BANCI L, 1993, BIOPHYS J, V65, P806, DOI 10.1016/S0006-3495(93)81122-6; BERTINI I, 1990, ARCH BIOCHEM BIOPHYS, V282, P84, DOI 10.1016/0003-9861(90)90090-L; Bertini I, 2005, J AM CHEM SOC, V127, P12216, DOI 10.1021/ja051058m; BERTINI I, 1993, CHEM REV, V93, P2833, DOI 10.1021/cr00024a009; BERTINI I, 1986, NMR PARAMAGNETIC MOL; BETTLESTONE J, 1964, BIOCHEMISTRY-US, V3, P707; Caillet-Saguy C, 2006, J AM CHEM SOC, V128, P150, DOI 10.1021/ja054902h; Chain PSG, 2004, P NATL ACAD SCI USA, V101, P13826, DOI 10.1073/pnas.0404012101; Chu GC, 1999, J BIOL CHEM, V274, P24490, DOI 10.1074/jbc.274.35.24490; Das TK, 1999, BIOCHEMISTRY-US, V38, P15360, DOI 10.1021/bi991237e; Deniau C, 2003, BIOCHEMISTRY-US, V42, P10627, DOI 10.1021/bi030015k; Ghigo JM, 1997, J BACTERIOL, V179, P3572, DOI 10.1128/jb.179.11.3572-3579.1997; Heering HA, 2001, BIOCHEMISTRY-US, V40, P10360, DOI 10.1021/bi0106033; Howes BD, 1997, BIOCHEMISTRY-US, V36, P1532, DOI 10.1021/bi962502o; IIZUKA T, 1969, BIOCHIM BIOPHYS ACTA, V194, P351, DOI 10.1016/0005-2795(69)90096-8; IIZUKA T, 1969, BIOCHIM BIOPHYS ACTA, V181, P275, DOI 10.1016/0005-2795(69)90250-5; Indiani C, 2000, J AM CHEM SOC, V122, P7368, DOI 10.1021/ja000587h; ISHIKAWA K, 1995, J BIOL CHEM, V270, P6345, DOI 10.1074/jbc.270.11.6345; Izadi N, 1997, BIOCHEMISTRY-US, V36, P7050, DOI 10.1021/bi962577s; Izadi-Pruneyre N, 1999, EUR J BIOCHEM, V261, P562, DOI 10.1046/j.1432-1327.1999.00305.x; Izadi-Pruneyre N, 1999, J BIOMOL NMR, V14, P193, DOI 10.1023/A:1008308802821; Izadi-Pruneyre N, 2006, J BIOL CHEM, V281, P25541, DOI 10.1074/jbc.M603698200; Jin YY, 2004, BIOCHEMISTRY-US, V43, P8517, DOI 10.1021/bi036170g; KELLER RM, 1972, P NATL ACAD SCI USA, V69, P2073, DOI 10.1073/pnas.69.8.2073; KRAUS DW, 1990, J BIOL CHEM, V265, P16054; LAMAR GN, 1980, J AM CHEM SOC, V102, P1822, DOI 10.1021/ja00526a011; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LECOMTE JTJ, 1989, J MOL BIOL, V209, P235, DOI 10.1016/0022-2836(89)90275-1; LESLIE AGW, 1990, CRYSTALLOGRAPHIC COM, P50; LETOFFE S, 1994, P NATL ACAD SCI USA, V91, P9876, DOI 10.1073/pnas.91.21.9876; Letoffe S, 2003, MOL MICROBIOL, V50, P77, DOI 10.1046/j.1365-2958.2003.03686.x; Letoffe S, 1998, MOL MICROBIOL, V28, P1223, DOI 10.1046/j.1365-2958.1998.00885.x; Letoffe S, 2001, MOL MICROBIOL, V41, P439, DOI 10.1046/j.1365-2958.2001.02530.x; Letoffe S, 2000, J BACTERIOL, V182, P4401, DOI 10.1128/JB.182.16.4401-4405.2000; Liu Y, 1999, BIOCHEMISTRY-US, V38, P3733, DOI 10.1021/bi982707s; Lukat-Rodgers GS, 1998, J BIOL INORG CHEM, V3, P274, DOI 10.1007/s007750050232; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; MAURUS R, 1994, J BIOL CHEM, V269, P12606; MOTIE M, 1990, BIOCHEMISTRY-US, V29, P1932, DOI 10.1021/bi00459a038; Nagatomo S, 2002, BIOPHYS CHEM, V98, P217, DOI 10.1016/S0301-4622(02)00103-5; PANDE U, 1986, BIOCHEMISTRY-US, V25, P5638, DOI 10.1021/bi00367a044; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Pond AE, 1999, BIOCHEMISTRY-US, V38, P7601, DOI 10.1021/bi9825448; QIN J, 1994, J BIOL CHEM, V269, P1083; Rossi MS, 2001, INFECT IMMUN, V69, P6707, DOI 10.1128/IAI.69.11.6707-6717.2001; SHARMA KD, 1989, J BIOL CHEM, V264, P12772; SONG SH, 1993, BIOCHEMISTRY-US, V32, P6330, DOI 10.1021/bi00076a005; Uchida T, 2004, J BIOL CHEM, V279, P51981, DOI 10.1074/jbc.M408963200; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811; Williams PA, 1997, NATURE, V389, P406, DOI 10.1038/38775; Wolff N, 2002, PROTEIN SCI, V11, P757, DOI 10.1110/ps.3630102; WU JZ, 1991, BIOCHEMISTRY-US, V30, P2156, DOI 10.1021/bi00222a020; YAMAMOTO Y, 1993, BIOCHIM BIOPHYS ACTA, V1203, P267, DOI 10.1016/0167-4838(93)90093-7; Yeh SR, 2000, J BIOL CHEM, V275, P1679, DOI 10.1074/jbc.275.3.1679	61	45	46	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5960	5970		10.1074/jbc.M703795200	http://dx.doi.org/10.1074/jbc.M703795200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18162469	hybrid			2022-12-25	WOS:000253426700074
J	Fukami, M; Wada, Y; Okada, M; Kato, F; Katsumata, N; Baba, T; Morohashi, K; Laporte, J; Kitagawa, M; Ogata, T				Fukami, Maki; Wada, Yuka; Okada, Michiyo; Kato, Fumiko; Katsumata, Noriyuki; Baba, Takashi; Morohashi, Ken-ichirou; Laporte, Jocelyn; Kitagawa, Motoo; Ogata, Tsutomu			Mastermind-like domain-containing 1 (MAMLD1 or CXorf6) transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTIGUOUS GENE SYNDROME; NOTCH SIGNALING PATHWAY; MYOTUBULAR MYOPATHY; STEROIDOGENIC FACTOR-1; REPRODUCTIVE FUNCTION; DROSOPHILA-HAIRY; TRANSCRIPTION; MASTERMIND; IDENTIFICATION; EXPRESSION	Although chromosome X open reading frame 6 (CXorf6) has been shown to be a causative gene for hypospadias, its molecular function remains unknown. To clarify this, we first examined CXorf6 protein structure, identifying homology to mastermind-like 2 (MAML2) protein, which functions as a co-activator in canonical Notch signaling. Transactivation analysis for wildtype CXorf6 protein by luciferase assays showed that CXorf6 significantly transactivated the promoter of a noncanonical Notch target gene hairy/enhancer of split 3 (Hes3) without demonstrable DNA-binding capacity. Transactivation analysis was also performed for the previously described three apparently pathologic nonsense mutations, indicating that E124X and Q197X proteins had no transactivation function, whereas R653X protein retained a nearly normal transactivation function. Subcellular localization analysis revealed that wild-type and R653X proteins co-localized with MAML2 protein in nuclear bodies, whereas E124X and Q197X proteins were incapable of localizing to nuclear bodies. Thus, further studies were performed for R653X, revealing the occurrence of nonsense mediated mRNA decay in vivo. Next, transient knockdown of CXorf6 was performed using small interfering RNA, showing reduced testosterone production in mouse Leydig tumor cells. Furthermore, steroidogenic factor 1 (SF1) protein bound to a specific sequence in the upstream of the CXorf6 coding region and exerted a transactivation activity. These results suggest that CXorf6 transactivates the Hes3 promoter, augments testosterone production, and contains the SF1 target sequence, thereby providing the first clue to clarify the biological role of CXorf6. We designate CXorf6 as MAMLD1 (mastermind-like domain-containing 1) based on its characteristic structure.	[Fukami, Maki; Wada, Yuka; Okada, Michiyo; Kato, Fumiko; Katsumata, Noriyuki; Ogata, Tsutomu] Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo 1578535, Japan; [Baba, Takashi; Morohashi, Ken-ichirou] Natl Inst Basic Biol, Div Sex Differentiat, Okazaki, Aichi 4448787, Japan; [Laporte, Jocelyn] Inst Genet & Biol Mol & Cellulaire, Dept Mol Pathol, F-67404 Illkirch Graffenstaden, France; [Kitagawa, Motoo] Chiba Univ, Grad Sch Med, Dept Mol & Tumor Pathol, Chiba 260, Japan	National Center for Child Health & Development - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Chiba University	Fukami, M (corresponding author), Natl Res Inst Child Hlth & Dev, Dept Endocrinol & Metab, Tokyo 1578535, Japan.	mfukami@nch.go.jp	Fukami, Maki/ABE-4694-2020; laporte, jocelyn/J-7008-2012; Baba, Takashi/ABI-2727-2020; laporte, jocelyn/O-4888-2019; Kitagawa, Motoo/W-8468-2019; Laporte, Jocelyn/H-6801-2016	Fukami, Maki/0000-0001-9971-4035; Kitagawa, Motoo/0000-0003-1036-840X; Ogata, Tsutomu/0000-0001-7178-9991				Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Bartsch O, 1999, CYTOGENET CELL GENET, V85, P310, DOI 10.1159/000015284; Baskin LS, 2006, J PEDIATR SURG, V41, P463, DOI 10.1016/j.jpedsurg.2005.11.059; Freddi S, 2000, AM J MED GENET, V90, P398, DOI 10.1002/(SICI)1096-8628(20000228)90:5<398::AID-AJMG10>3.3.CO;2-Z; Fukami M, 2006, NAT GENET, V38, P1369, DOI 10.1038/ng1900; Grumbach M. M., 2002, WILLIAMS TXB ENDOCRI, P842; Hu LJ, 1996, HUM MOL GENET, V5, P139, DOI 10.1093/hmg/5.1.139; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Laporte J, 1997, GENOMICS, V41, P458, DOI 10.1006/geno.1997.4662; Lin SE, 2002, J BIOL CHEM, V277, P50612, DOI 10.1074/jbc.M209529200; Liu Z, 1997, MOL ENDOCRINOL, V11, P127, DOI 10.1210/me.11.2.127; Minoguchi S, 1997, MOL CELL BIOL, V17, P2679, DOI 10.1128/MCB.17.5.2679; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Mizutani T, 2001, P NATL ACAD SCI USA, V98, P9026, DOI 10.1073/pnas.161269998; Morohashi KI, 1996, FASEB J, V10, P1569, DOI 10.1096/fasebj.10.14.9002548; Muroya K, 1999, AM J MED GENET, V84, P384, DOI 10.1002/(SICI)1096-8628(19990604)84:4<384::AID-AJMG17>3.0.CO;2-T; Murphy K, 2005, GENE EXPR PATTERNS, V5, P475, DOI 10.1016/j.modgep.2004.12.007; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nishimura M, 1998, GENOMICS, V49, P69, DOI 10.1006/geno.1998.5213; Nowling TK, 2000, J BIOL CHEM, V275, P3810, DOI 10.1074/jbc.275.6.3810; Ozisik G, 2002, MOL GENET METAB, V76, P85, DOI 10.1016/S1096-7192(02)00032-X; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Panesar NS, 2003, STEROIDS, V68, P245, DOI 10.1016/S0039-128X(02)00183-6; Parker KL, 1997, ENDOCR REV, V18, P361, DOI 10.1210/er.18.3.361; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Shimizu K, 2002, BIOCHEM BIOPH RES CO, V291, P775, DOI 10.1006/bbrc.2002.6528; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tonon G, 2003, NAT GENET, V33, P208, DOI 10.1038/ng1083; Wilson JJ, 2006, CELL, V124, P985, DOI 10.1016/j.cell.2006.01.035; Wu L, 2002, MOL CELL BIOL, V22, P7688, DOI 10.1128/MCB.22.21.7688-7700.2002; Wu LZ, 2000, NAT GENET, V26, P484, DOI 10.1038/82644; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	34	54	58	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5525	5532		10.1074/jbc.M703289200	http://dx.doi.org/10.1074/jbc.M703289200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18162467	hybrid			2022-12-25	WOS:000253426700033
J	Ricotta, D; Hansen, J; Preiss, C; Teichert, D; Honing, S				Ricotta, Doris; Hansen, Jens; Preiss, Carolin; Teichert, Dominic; Hoening, Stefan			Characterization of a protein phosphatase 2A holoenzyme that dephosphorylates the clathrin adaptors AP-1 and AP-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-ASSOCIATED KINASE; COATED VESICLES; MEDIATED ENDOCYTOSIS; SORTING SIGNALS; PHOSPHORYLATION; SUBUNIT; COMPLEX; BINDING; AAK1; AP2	The AP-2 complex is a key factor in the formation of endocytic clathrin-coated vesicles (CCVs). AP-2 sorts and packages cargo membrane proteins into CCVs, binds the coat protein clathrin, and recruits numerous other factors to the site of vesicle formation. Structural information on the AP-2 complex and biochemical work have allowed understanding its function on the molecular level, and recent studies showed that cycles of phosphorylation are key steps in the regulation of AP-2 function. The complex is phosphorylated on both large subunits (alpha- and beta 2- adaptins) as well as at a single threonine residue (Thr-156) of the medium subunit mu 2. Phosphorylation of mu 2 is necessary for efficient cargo recruitment, whereas the functional context of the large subunit phosphorylation is unknown. Here, we show that the subunit phosphorylation of AP-2 exhibits striking differences, with calculated half-lives of < 1 min for mu 2, similar to 25 min for beta 2, and similar to 70 min for alpha. We were also able to purify a phosphatase that dephosphorylates the mu 2 subunit. The enzyme is a member of the protein phosphatase 2A family and composed of a catalytic C beta subunit, a scaffolding A beta subunit, and a regulatory B alpha subunit. RNA interference knock down of the latter subunit in HeLa cells resulted in increased levels of phosphorylated adaptors and altered endocytosis, showing that a specific PP2A holoenzyme is an important regulatory enzyme in CCV-mediated transport.	[Teichert, Dominic] Univ Cologne, Inst Biochem 1, D-50931 Cologne, Germany; [Ricotta, Doris] Univ Brescia, Dept Biomed Sci & Biotechnol, I-25100 Brescia, Italy; [Hansen, Jens; Preiss, Carolin; Hoening, Stefan] Univ Gottingen, Inst Biochem 2, D-37073 Gottingen, Germany	University of Cologne; University of Brescia; University of Gottingen	Honing, S (corresponding author), Univ Cologne, Inst Biochem 1, Joseph Stelzman Str 52, D-50931 Cologne, Germany.	shoening@unikoeln.de						AHLE S, 1986, EMBO J, V5, P3143, DOI 10.1002/j.1460-2075.1986.tb04621.x; Blondeau F, 2004, P NATL ACAD SCI USA, V101, P3833, DOI 10.1073/pnas.0308186101; Borner GHH, 2006, J CELL BIOL, V175, P571, DOI 10.1083/jcb.200607164; Buss F, 2001, EMBO J, V20, P3676, DOI 10.1093/emboj/20.14.3676; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Conner SD, 2005, J BIOL CHEM, V280, P21539, DOI 10.1074/jbc.M502462200; Conner SD, 2002, J CELL BIOL, V156, P921, DOI 10.1083/jcb.200108123; Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5; Ehrlich M, 2004, CELL, V118, P591, DOI 10.1016/j.cell.2004.08.017; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; Fingerhut A, 2001, J BIOL CHEM, V276, P5476, DOI 10.1074/jbc.M009516200; Flett A, 2005, BIOCHEM SOC SYMP, V72, P65, DOI 10.1042/bss0720065; Ghosh P, 2003, J CELL BIOL, V160, P699, DOI 10.1083/jcb.200211080; Goldberg Y, 1999, BIOCHEM PHARMACOL, V57, P321, DOI 10.1016/S0006-2952(98)00245-7; Greener T, 2000, J BIOL CHEM, V275, P1365, DOI 10.1074/jbc.275.2.1365; Henderson DM, 2007, MOL BIOL CELL, V18, P2698, DOI 10.1091/mbc.E06-09-0831; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Huang FT, 2003, J BIOL CHEM, V278, P43411, DOI 10.1074/jbc.M306072200; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Korolchuk V, 2003, BIOCHEM SOC T, V31, P857, DOI 10.1042/BST0310857; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Lee DW, 2005, J CELL SCI, V118, P4311, DOI 10.1242/jcs.02548; Longin S, 2007, J BIOL CHEM, V282, P26971, DOI 10.1074/jbc.M704059200; Motley AM, 2006, MOL BIOL CELL, V17, P5298, DOI 10.1091/mbc.E06-05-0452; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; PAULOIN A, 1984, BIOCHIM BIOPHYS ACTA, V799, P238, DOI 10.1016/0304-4165(84)90266-6; Ricotta D, 2002, J CELL BIOL, V156, P791, DOI 10.1083/jcb.200111068; Shevchenko A, 1996, BIOCHEM SOC T, V24, P893, DOI 10.1042/bst0240893; Umeda A, 2000, EUR J CELL BIOL, V79, P336, DOI 10.1078/S0171-9335(04)70037-0; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Virshup DM, 2000, CURR OPIN CELL BIOL, V12, P180, DOI 10.1016/S0955-0674(99)00074-5; Wilde A, 1996, J CELL BIOL, V135, P635, DOI 10.1083/jcb.135.3.635; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Zhang CX, 2005, TRAFFIC, V6, P1103, DOI 10.1111/j.1600-0854.2005.00346.x; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	36	21	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5510	5517		10.1074/jbc.M707166200	http://dx.doi.org/10.1074/jbc.M707166200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18158287	hybrid			2022-12-25	WOS:000253426700031
J	Vodnala, M; Fijolek, A; Rofougaran, R; Mosimann, M; Maser, P; Hofer, A				Vodnala, Munender; Fijolek, Artur; Rofougaran, Reza; Mosimann, Marc; Maser, Pascal; Hofer, Anders			Adenosine kinase mediates high affinity adenosine salvage in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-STREAM FORMS; TOXOPLASMA-GONDII; RIBONUCLEOTIDE REDUCTION; AFRICAN TRYPANOSOMES; DEAMINASE INHIBITORS; KINETIC MECHANISM; PURINE METABOLISM; PENTAVALENT IONS; N-RIBOHYDROLASE; IN-VITRO	African sleeping sickness is caused by Trypanosoma brucei. This extracellular parasite lacks de novo purine biosynthesis, and it is therefore dependent on exogenous purines such as adenosine that is taken up from the blood and other body fluids by high affinity transporters. The general belief is that adenosine needs to be cleaved to adenine inside the parasites in order to be used for purine nucleotide synthesis. We have found that T. brucei also can salvage this nucleoside by adenosine kinase (AK), which has a higher affinity to adenosine than the cleavage-dependent pathway. The recombinant T. brucei AK (TbAK) preferably used ATP or GTP to phosphorylate both natural and synthetic nucleosides in the following order of catalytic efficiencies: adenosine > cordycepin > deoxyadenosine > adenine arabinoside (Ara-A) > inosine > fludarabine (F-Ara-A). TbAK differed from the AK of the related intracellular parasite Leishmania donovani by having a high affinity to adenosine (K-m = 0.04-0.08 mu M depending on [phosphate]) and by being negatively regulated by adenosine (K-i = 8-14 mu M). These properties make the enzyme functionally related to the mammalian AKs, although a phylogenetic analysis grouped it together with the L. donovani enzyme. The combination of a high affinity AK and efficient adenosine transporters yields a strong salvage system in T. brucei, a potential Achilles' heel making the parasites more sensitive than mammalian cells to adenosine analogs such as Ara-A. Studies of wild-type and AK knockdown trypanosomes showed that Ara-A inhibited parasite proliferation and survival in an AK-dependent manner by affecting nucleotide levels and by inhibiting nucleic acid biosynthesis.	[Vodnala, Munender; Fijolek, Artur; Rofougaran, Reza; Hofer, Anders] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Mosimann, Marc; Maser, Pascal] Univ Bern, Inst Cell Biol, CH-3012 Bern, Switzerland	Umea University; University of Bern	Hofer, A (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	anders.hofer@medchem.umu.se		Hofer, Anders/0000-0003-2890-2957; Vodnala, Munender/0000-0002-6219-6243; Maser, Pascal/0000-0003-3122-1941				ANDRES CM, 1979, J BIOL CHEM, V254, P1388; Barrett MP, 2006, LANCET, V367, P1377, DOI 10.1016/S0140-6736(06)68591-7; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; BLATT J, 1982, J NATL CANCER I, V68, P391; BRUN R, 1999, KARGER GAZETTE, V63, P5; CARTER NS, 1993, NATURE, V361, P173, DOI 10.1038/361173a0; CASS CE, 1979, CANCER RES, V39, P1563; CASS CE, 1983, CANCER RES, V43, P4791; CHAN VL, 1981, SOMAT CELL GENET, V7, P147; Darling JA, 1999, MOL BIOCHEM PARASIT, V103, P15, DOI 10.1016/S0166-6851(99)00109-7; DATTA AK, 1987, J BIOL CHEM, V262, P5515; DAVIES MJ, 1983, PARASITOLOGY, V87, P211, DOI 10.1017/S0031182000052574; de Koning HP, 1998, J BIOL CHEM, V273, P9486, DOI 10.1074/jbc.273.16.9486; el Kouni MH, 2003, PHARMACOL THERAPEUT, V99, P283, DOI 10.1016/S0163-7258(03)00071-8; Hakansson P, 2006, J BIOL CHEM, V281, P7834, DOI 10.1074/jbc.M512894200; HASSAN HF, 1986, COMP BIOCHEM PHYS B, V84, P217, DOI 10.1016/0305-0491(86)90209-9; HIRUMI H, 1980, PARASITOLOGY, V80, P371, DOI 10.1017/S0031182000000822; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; Hofer A, 1997, P NATL ACAD SCI USA, V94, P6959, DOI 10.1073/pnas.94.13.6959; Hofer A, 1998, J BIOL CHEM, V273, P34098, DOI 10.1074/jbc.273.51.34098; HURLEY MC, 1985, J BIOL CHEM, V260, P5675; IVES DH, 1969, ANAL BIOCHEM, V28, P192, DOI 10.1016/0003-2697(69)90170-5; JABS CM, 1990, CLIN CHEM, V36, P81; Johnson SA, 2000, CLIN PHARMACOKINET, V39, P5, DOI 10.2165/00003088-200039010-00002; KUFE DW, 1983, CANCER RES, V43, P2000; Luscher A, 2007, ANTIMICROB AGENTS CH, V51, P3895, DOI 10.1128/AAC.00458-07; Maj M, 2000, BBA-PROTEIN STRUCT M, V1476, P33, DOI 10.1016/S0167-4838(99)00220-4; Maj MC, 2002, BIOCHEMISTRY-US, V41, P4059, DOI 10.1021/bi0119161; MOORE EC, 1967, J BIOL CHEM, V242, P2116; NICANDER B, 1985, J BIOL CHEM, V260, P5376; OGBUNUDE POJ, 1983, MOL BIOCHEM PARASIT, V9, P279, DOI 10.1016/0166-6851(83)90084-1; ONTYD J, 1984, J CHROMATOGR, V307, P404, DOI 10.1016/S0378-4347(00)84113-4; PALELLA TD, 1980, J BIOL CHEM, V255, P5264; Park J, 2004, PROTEIN J, V23, P167, DOI 10.1023/B:JOPC.0000020083.81718.55; Parkin DW, 1996, J BIOL CHEM, V271, P21713, DOI 10.1074/jbc.271.36.21713; Pelle R, 1998, J BIOL CHEM, V273, P2118, DOI 10.1074/jbc.273.4.2118; PFEFFERKORN ER, 1976, J PARASITOL, V62, P993, DOI 10.2307/3279197; PFEFFERKORN ER, 1978, J PARASITOL, V64, P486, DOI 10.2307/3279789; Raz B, 1997, ACTA TROP, V68, P139, DOI 10.1016/S0001-706X(97)00079-X; Rottenberg ME, 2005, J INFECT DIS, V192, P1658, DOI 10.1086/496896; Sahin B, 2004, EUR J BIOCHEM, V271, P3547, DOI 10.1111/j.1432-1033.2004.04291.x; SARUP JC, 1987, BIOCHEMISTRY-US, V26, P590, DOI 10.1021/bi00376a034; SLOWIACZEK P, 1982, ANAL BIOCHEM, V125, P6, DOI 10.1016/0003-2697(82)90376-1; Spychala J, 1996, P NATL ACAD SCI USA, V93, P1232, DOI 10.1073/pnas.93.3.1232; Thorn JA, 1996, GEN PHARMACOL, V27, P613, DOI 10.1016/0306-3623(95)02053-5; VERHOEF V, 1981, CANCER RES, V41, P4478; WHITLEY R, 1981, ANNU REV MED, V32, P335, DOI 10.1146/annurev.me.32.020181.002003	47	38	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5380	5388		10.1074/jbc.M705603200	http://dx.doi.org/10.1074/jbc.M705603200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167353	hybrid			2022-12-25	WOS:000253426700018
J	Werther, T; Spinka, M; Tittmann, K; Schutz, A; Golbik, R; Mrestani-Klaus, C; Hubner, G; Konig, S				Werther, Tobias; Spinka, Michael; Tittmann, Kai; Schuetz, Anja; Golbik, Ralph; Mrestani-Klaus, Carmen; Huebner, Gerhard; Koenig, Stephan			Amino acids allosterically regulate the thiamine diphosphate-dependent alpha-keto acid decarboxylase from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST PYRUVATE-DECARBOXYLASE; SUBSTRATE ACTIVATION BEHAVIOR; SACCHAROMYCES-CEREVISIAE; INDOLE-3-ACETIC-ACID BIOSYNTHESIS; INDOLEPYRUVATE DECARBOXYLASE; KLUYVEROMYCES-LACTIS; KEY ENZYME; PHENYLPYRUVATE DECARBOXYLASE; AZOSPIRILLUM-BRASILENSE; ENTEROBACTER-CLOACAE	The gene rv0853c from Mycobacterium tuberculosis strain H37Rv codes for a thiamine diphosphate-dependent alpha-keto acid decarboxylase (MtKDC), an enzyme involved in the amino acid degradation via the Ehrlich pathway. Steady state kinetic experiments were performed to determine the substrate specificity of MtKDC. The mycobacterial enzyme was found to convert a broad spectrum of branched-chain and aromatic alpha-keto acids. Stopped-flow kinetics showed that MtKDC is allosterically activated by alpha-keto acids. Even more, we demonstrate that also amino acids are potent activators of this thiamine diphosphate-dependent enzyme. Thus, metabolic flow through the Ehrlich pathway can be directly regulated at the decarboxylation step. The influence of amino acids on MtKDC catalysis was investigated, and implications for other thiamine diphosphate-dependent enzymes are discussed.	[Werther, Tobias; Spinka, Michael; Tittmann, Kai; Schuetz, Anja; Golbik, Ralph; Mrestani-Klaus, Carmen; Huebner, Gerhard; Koenig, Stephan] Univ Halle Wittenberg, Fac Biol Sci, Inst Biochem & Biotechnol, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Konig, S (corresponding author), Univ Halle Wittenberg, Fac Biol Sci, Inst Biochem & Biotechnol, D-06120 Halle, Germany.	stephan.koenig@biochemtech.uni-halle.de	Koenig, Stephan/GRX-2480-2022	Schutz, Anja/0000-0002-0606-2574				Acar S, 2007, ENZYME MICROB TECH, V40, P675, DOI 10.1016/j.enzmictec.2006.05.028; ALVAREZ FJ, 1991, J AM CHEM SOC, V113, P8402, DOI 10.1021/ja00022a030; Arjunan P, 1996, J MOL BIOL, V256, P590, DOI 10.1006/jmbi.1996.0111; Baburina I, 1998, BIOCHEMISTRY-US, V37, P1235, DOI 10.1021/bi970990+; Baburina I, 1998, BIOCHEMISTRY-US, V37, P1245, DOI 10.1021/bi9709912; Baburina I, 1996, BIOCHEMISTRY-US, V35, P10249, DOI 10.1021/bi961141+; BABURINA I, 1994, BIOCHEMISTRY-US, V33, P5630, DOI 10.1021/bi00184a035; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Breunig KD, 2000, ENZYME MICROB TECH, V26, P771, DOI 10.1016/S0141-0229(00)00170-8; BRINGERMEYER S, 1986, ARCH MICROBIOL, V146, P105, DOI 10.1007/BF00402334; CROSBY J, 1970, J AM CHEM SOC, V92, P5707, DOI 10.1021/ja00722a027; DAVIES DD, 1967, P BIOCH SOC, V104; Dickinson JR, 2003, J BIOL CHEM, V278, P8028, DOI 10.1074/jbc.M211914200; Dietrich A, 1997, FEBS LETT, V400, P42, DOI 10.1016/S0014-5793(96)01326-9; DYDA F, 1993, BIOCHEMISTRY-US, V32, P6165, DOI 10.1021/bi00075a008; FISCHER G, 1971, INVESTIGATIONS STRUC; Frank RAW, 2004, SCIENCE, V306, P872, DOI 10.1126/science.1101030; Furey W, 1998, BBA-PROTEIN STRUCT M, V1385, P253, DOI 10.1016/S0167-4838(98)00073-9; HEGEMAN GD, 1966, J BACTERIOL, V91, P1140, DOI 10.1128/JB.91.3.1140-1154.1966; HOLZER H, 1956, BIOCHEM Z, V327, P331; HUBNER G, 1978, EUR J BIOCHEM, V92, P175, DOI 10.1111/j.1432-1033.1978.tb12735.x; HUBNER G, 1986, BIOCHEM INT, V13, P767; Jordan F, 2005, ACCOUNTS CHEM RES, V38, P755, DOI 10.1021/ar040244e; Jordan F, 1999, BIOCHEMISTRY-US, V38, P6369, DOI 10.1021/bi990373g; Joseph E, 2006, BIOCHEMISTRY-US, V45, P13517, DOI 10.1021/bi0615588; Kern D, 1997, SCIENCE, V275, P67, DOI 10.1126/science.275.5296.67; Kiers J, 1998, YEAST, V14, P459, DOI 10.1002/(SICI)1097-0061(19980330)14:5<459::AID-YEA248>3.0.CO;2-O; KOGA J, 1992, J BIOL CHEM, V267, P15823; KOGA J, 1995, BBA-PROTEIN STRUCT M, V1249, P1, DOI 10.1016/0167-4838(95)00011-I; Krieger F, 2002, EUR J BIOCHEM, V269, P3256, DOI 10.1046/j.1432-1033.2002.03006.x; LEHMANN H, 1973, EUR J BIOCHEM, V32, P83, DOI 10.1111/j.1432-1033.1973.tb02582.x; Li H, 1999, BIOCHEMISTRY-US, V38, P10004, DOI 10.1021/bi9902440; Li HJ, 1999, BIOCHEMISTRY-US, V38, P9992, DOI 10.1021/bi9902438; Lu GG, 1997, FEBS LETT, V403, P249, DOI 10.1016/S0014-5793(97)00057-4; Lu GG, 2000, EUR J BIOCHEM, V267, P861, DOI 10.1046/j.1432-1327.2000.01070.x; Neuberg C, 1911, BIOCHEM Z, V36, P68; Neuser F, 2000, BIOL CHEM, V381, P349, DOI 10.1515/BC.2000.046; RUDOLPH R, 1997, PROTEIN FUNCTION PRA, P55; Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x; Schellenberger A, 1998, BBA-PROTEIN STRUCT M, V1385, P177, DOI 10.1016/S0167-4838(98)00067-3; Schowen RL, 2007, ISOT ENVIRON HEALT S, V43, P1, DOI 10.1080/10256010600990393; Schutz A, 2003, EUR J BIOCHEM, V270, P2322, DOI 10.1046/j.1432-1033.2003.03602.x; Sergienko EA, 2002, BIOCHEMISTRY-US, V41, P3952, DOI 10.1021/bi011860a; Sergienko EA, 2001, BIOCHEMISTRY-US, V40, P7382, DOI 10.1021/bi002857e; Smit BA, 2005, APPL ENVIRON MICROB, V71, P303, DOI 10.1128/AEM.71.1.303-311.2005; Somers E, 2005, APPL ENVIRON MICROB, V71, P1803, DOI 10.1128/AEM.71.4.1803-1810.2005; Tittmann K, 2003, BIOCHEMISTRY-US, V42, P7885, DOI 10.1021/bi034465o; Versees W, 2007, J BIOL CHEM, V282, P35269, DOI 10.1074/jbc.M706048200; Versees W, 2007, FEBS J, V274, P2363, DOI 10.1111/j.1742-4658.2007.05771.x; Vuralhan Z, 2005, APPL ENVIRON MICROB, V71, P3276, DOI 10.1128/AEM.71.6.3276-3284.2005; Vuralhan Z, 2003, APPL ENVIRON MICROB, V69, P4534, DOI 10.1128/AEM.69.8.4534-4541.2003; Wang J, 2001, BIOCHEMISTRY-US, V40, P1755, DOI 10.1021/bi001003r; WEISS PM, 1988, BIOCHEMISTRY-US, V27, P2197, DOI 10.1021/bi00406a058; WERTHER T, 2006, HASYLAB ANN REPORT, P361; Yep A, 2006, BIOORG CHEM, V34, P325, DOI 10.1016/j.bioorg.2006.08.005; ZEHENDER H, 1987, EUR J BIOCHEM, V167, P149, DOI 10.1111/j.1432-1033.1987.tb13316.x; Zhang S, 2005, BIOCHEMISTRY-US, V44, P2237, DOI 10.1021/bi047696j	57	12	18	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5344	5354		10.1074/jbc.M706569200	http://dx.doi.org/10.1074/jbc.M706569200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086676	hybrid			2022-12-25	WOS:000253426700014
J	Hochbaum, D; Hong, K; Barila, G; Ribeiro-Neto, F; Altschuler, DL				Hochbaum, Daniel; Hong, Kyoungja; Barila, Guillermo; Ribeiro-Neto, Fernando; Altschuler, Daniel L.			Epac, in synergy with cAMP-dependent protein kinase (PKA), is required for cAMP-mediated mitogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXCHANGE FACTOR EPAC; DOG THYROID-CELLS; CYCLIC-AMP; SIGNALING PATHWAYS; DEP DOMAIN; RAP1; PROLIFERATION; ACTIVATION; FAMILY	cAMP stimulates proliferation in many cell types. For many years, cAMP-dependent protein kinase (PKA) represented the only known cAMP effector. PKA, however, does not fully mimic the action of cAMP, indicating the existence of a PKA-independent component. Since cAMP-mediated activation of the G-protein Rap1 and its phosphorylation by PKA are strictly required for the effects of cAMP on mitogenesis, we hypothesized that the Rap1 activator Epac might represent the PKA-independent factor. Here we report that Epac acts synergistically with PKA in cAMP-mediated mitogenesis. We have generated a new dominant negative Epac mutant that revealed that activation of Epac is required for thyroid-stimulating hormone or cAMP stimulation of DNA synthesis. We demonstrate that Epac's action on cAMP-mediated activation of Rap1 and cAMP-mediated mitogenesis depends on the subcellular localization of Epac via its DEP domain. Disruption of the DEP-dependent subcellular targeting of Epac abolished cAMP-Epac-mediated Rap1 activation and thyroid-stimulating hormone-mediated cell proliferation, indicating that an Epac-Rap-PKA signaling unit is critical for the mitogenic action of cAMP.	[Hochbaum, Daniel; Hong, Kyoungja; Barila, Guillermo; Ribeiro-Neto, Fernando; Altschuler, Daniel L.] Univ Pittsburgh, Dept Pharmacol, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Altschuler, DL (corresponding author), Univ Pittsburgh, Dept Pharmacol, Sch Med, 200 Lothrop St,W1316 BSTWR, Pittsburgh, PA 15261 USA.	altschul@pitt.edu		Hochbaum, Daniel/0000-0001-6387-7529	NCATS NIH HHS [UL1 TR000005] Funding Source: Medline; NCI NIH HHS [CA071649] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA071649, R29CA071649] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		ALTSCHULER D, 1993, J BIOL CHEM, V268, P7527; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Cass LA, 1999, MOL CELL BIOL, V19, P5882; Christensen AE, 2003, J BIOL CHEM, V278, P35394, DOI 10.1074/jbc.M302179200; Civera C, 2005, PROTEINS, V58, P354, DOI 10.1002/prot.20320; De Falco V, 2007, CANCER RES, V67, P381, DOI 10.1158/0008-5472.CAN-06-0981; de Rooij J, 2000, J BIOL CHEM, V275, P20829, DOI 10.1074/jbc.M001113200; de Rooij J, 1998, NATURE, V396, P474, DOI 10.1038/24884; Dodge-Kafka KL, 2006, EUR J CELL BIOL, V85, P593, DOI 10.1016/j.ejcb.2006.01.007; Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966; Dremier S, 1997, MOL CELL BIOL, V17, P6717, DOI 10.1128/MCB.17.11.6717; Dremier S, 2000, BIOCHEM BIOPH RES CO, V267, P7, DOI 10.1006/bbrc.1999.1919; Dremier S, 2007, ENDOCRINOLOGY, V148, P4612, DOI 10.1210/en.2007-0540; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Holz GG, 2006, J PHYSIOL-LONDON, V577, P5, DOI 10.1113/jphysiol.2006.119644; Iacovelli L, 2001, MOL PHARMACOL, V60, P924, DOI 10.1124/mol.60.5.924; Kawasaki H, 1998, SCIENCE, V282, P2275, DOI 10.1126/science.282.5397.2275; Kimura T, 2001, ENDOCR REV, V22, P631, DOI 10.1210/er.22.5.631; Kopperud R, 2003, FEBS LETT, V546, P121, DOI 10.1016/S0014-5793(03)00563-5; Kraemer A, 2001, J MOL BIOL, V306, P1167, DOI 10.1006/jmbi.2001.4444; Medina DL, 2000, EUR J ENDOCRINOL, V143, P161, DOI 10.1530/eje.0.1430161; Ponting CP, 1996, TRENDS BIOCHEM SCI, V21, P245, DOI 10.1016/S0968-0004(96)30027-3; Qiao JB, 2002, J BIOL CHEM, V277, P26581, DOI 10.1074/jbc.M203571200; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Ribeiro-Neto F, 2004, J BIOL CHEM, V279, P46868, DOI 10.1074/jbc.M406858200; Ribeiro-Neto F, 2002, P NATL ACAD SCI USA, V99, P5418, DOI 10.1073/pnas.082122499; Richards JS, 2001, MOL ENDOCRINOL, V15, P209, DOI 10.1210/me.15.2.209; Roger PP, 1995, VITAM HORM, V51, P59, DOI 10.1016/S0083-6729(08)61038-9; Spiegel AM, 2004, ANNU REV MED, V55, P27, DOI 10.1146/annurev.med.55.091902.103843; Tsygankova OM, 2001, MOL CELL BIOL, V21, P1921, DOI 10.1128/MCB.21.6.1921-1929.2001; Weinstein LS, 2006, TRENDS PHARMACOL SCI, V27, P260, DOI 10.1016/j.tips.2006.03.005; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178	36	67	68	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4464	4468		10.1074/jbc.C700171200	http://dx.doi.org/10.1074/jbc.C700171200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18063584	hybrid			2022-12-25	WOS:000253426500002
J	Nelson, LD; Johnson, AE; London, E				Nelson, Lindsay D.; Johnson, Arthur E.; London, Erwin			How interaction of perfringolysin O with membranes is controlled by sterol structure, lipid structure, and physiological low pH - Insights into the origin of perfringolysin O-lipid raft interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; TRANSMEMBRANE BETA-HAIRPINS; STREPTOLYSIN-O; PORE FORMATION; BINDING CYTOLYSIN; DIPHTHERIA-TOXIN; DOMAIN FORMATION; LISTERIOLYSIN-O; CLOSTRIDIUM-PERFRINGENS; ACTIVATED TOXIN	Perfringolysin O (PFO) is a sterol-dependent, pore-forming cytolysin. To understand the molecular basis of PFO membrane interaction, we studied its dependence upon sterol and lipid structure and aqueous environment. PFO interacted with diverse sterols, although binding was affected by double bond location in the sterol rings, sterol side chain structure, and sterol polar group structure. Importantly, a sterol structure promoting formation of ordered membrane domains ( lipid rafts) was not critical for interaction. PFO membrane interaction was also affected by phospholipid acyl chain structure, being inversely related to tight acyl chain packing with cholesterol. Experiments using the pre-pore Y181A mutant demonstrated that sterol binding strength and specificity was not affected by whether PFO forms a transmembrane beta-barrel. Combined, these observations are consistent with a model in which the strength and specificity of sterol interaction arises from both sterol interactions with domain 4 and sterol chemical activity within membranes. The lipid raft-binding portions of sterol bound to PFO may remain largely exposed to the lipid bilayer. These results place important constraints upon the origin of PFO raft affinity. Additional experiments demonstrated that the structure of membrane-inserted PFO at low and neutral pH was similar as judged by the effect of phospholipid and sterol structure upon PFO properties and membrane interaction. However, low pH enhanced PFO membrane binding, oligomerization, and pore formation. In lipid vesicles mimicking the exofacial ( outer) membrane leaflet, PFO-membrane binding was maximal at pH 5.5-6. This is consistent with the hypothesis that PFO function involves acidic vacuoles.	[Nelson, Lindsay D.; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Johnson, Arthur E.] Texas A&M Univ, Syst Hlth Sci Ctr, Dept Mol & Cellular Biol, College Stn, TX 77843 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	erwin.london@stonybrook.edu	Johnson, Arthur E/G-3457-2012		NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007539, R01AI037657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048596] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007539, AI 37657] Funding Source: Medline; NIGMS NIH HHS [GM 48596] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALOUF JE, 1984, EUR J BIOCHEM, V141, P205, DOI 10.1111/j.1432-1033.1984.tb08176.x; Bakht O, 2007, BIOPHYS J, V93, P4307, DOI 10.1529/biophysj.107.114967; Bavdek A, 2007, BIOCHEMISTRY-US, V46, P4425, DOI 10.1021/bi602497g; Beattie ME, 2005, BIOPHYS J, V89, P1760, DOI 10.1529/biophysj.104.049635; CHUNG LA, 1988, BIOCHEMISTRY-US, V27, P1245, DOI 10.1021/bi00404a026; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; EMANS N, 1995, BIOPHYS J, V69, P716, DOI 10.1016/S0006-3495(95)79947-7; Fastenberg ME, 2003, BIOCHEMISTRY-US, V42, P12376, DOI 10.1021/bi034718d; GEISOW MJ, 1981, J CELL BIOL, V89, P645, DOI 10.1083/jcb.89.3.645; GEOFFROY C, 1987, INFECT IMMUN, V55, P1641, DOI 10.1128/IAI.55.7.1641-1646.1987; GEOFFROY C, 1983, J BIOL CHEM, V258, P9968; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gilbert RJC, 1999, CELL, V97, P647, DOI 10.1016/S0092-8674(00)80775-8; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Heuck AP, 2007, J BIOL CHEM, V282, P22629, DOI 10.1074/jbc.M703207200; Hotze EM, 2002, J BIOL CHEM, V277, P11597, DOI 10.1074/jbc.M111039200; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; JOHNSON MK, 1980, INFECT IMMUN, V27, P97, DOI 10.1128/IAI.27.1.97-101.1980; Lafont F, 2005, CELL MICROBIOL, V7, P613, DOI 10.1111/j.1462-5822.2005.00515.x; Leventis R, 2001, BIOPHYS J, V81, P2257, DOI 10.1016/S0006-3495(01)75873-0; LONDON E, 1992, MOL MICROBIOL, V6, P3277, DOI 10.1111/j.1365-2958.1992.tb02195.x; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200; Megha M, 2006, J BIOL CHEM, V281, P21903, DOI 10.1074/jbc.M600395200; NAKAMURA M, 1995, BIOCHEMISTRY-US, V34, P6513, DOI 10.1021/bi00019a032; Nicol F, 1999, BIOPHYS J, V76, P2121, DOI 10.1016/S0006-3495(99)77368-6; Nir S, 1999, MOL MEMBR BIOL, V16, P95, DOI 10.1080/096876899294814; Niu SL, 2002, BIOPHYS J, V83, P3408, DOI 10.1016/S0006-3495(02)75340-X; O'Brien DK, 2004, INFECT IMMUN, V72, P5204, DOI 10.1128/IAI.72.9.5204-5215.2004; Ohno-Iwashita Y, 2004, ANAEROBE, V10, P125, DOI 10.1016/j.anaerobe.2003.09.003; OHNOIWASHITA Y, 1992, BIOCHIM BIOPHYS ACTA, V1109, P81, DOI 10.1016/0005-2736(92)90190-W; Petit L, 1999, TRENDS MICROBIOL, V7, P104, DOI 10.1016/S0966-842X(98)01430-9; PINKNEY M, 1989, INFECT IMMUN, V57, P2553, DOI 10.1128/IAI.57.8.2553-2558.1989; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; PORTNOY DA, 1992, INFECT IMMUN, V60, P2710, DOI 10.1128/IAI.60.7.2710-2717.1992; PRIGENT D, 1976, BIOCHIM BIOPHYS ACTA, V443, P288, DOI 10.1016/0005-2736(76)90511-3; Ramachandran R, 2005, P NATL ACAD SCI USA, V102, P7139, DOI 10.1073/pnas.0500556102; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Rebolj K, 2006, BBA-BIOMEMBRANES, V1758, P1662, DOI 10.1016/j.bbamem.2006.06.003; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; Shepard LA, 2000, BIOCHEMISTRY-US, V39, P10284, DOI 10.1021/bi000436r; Shimada Y, 2002, EUR J BIOCHEM, V269, P6195, DOI 10.1046/j.1432-1033.2002.03338.x; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; Tweten RK, 2001, CURR TOP MICROBIOL, V257, P15; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; Wang J, 2006, BIOCHEMISTRY-US, V45, P8124, DOI 10.1021/bi060587f; Wang JW, 2004, BIOCHEMISTRY-US, V43, P1010, DOI 10.1021/bi035696y; WATSON KC, 1974, BIOCHEM J, V140, P95, DOI 10.1042/bj1400095; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Xu XL, 2000, BIOCHEMISTRY-US, V39, P843, DOI 10.1021/bi992543v; ZHAO JM, 1986, P NATL ACAD SCI USA, V83, P2002, DOI 10.1073/pnas.83.7.2002; Zitzer A, 2001, J BIOL CHEM, V276, P14628, DOI 10.1074/jbc.M100241200	53	93	93	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4632	4642		10.1074/jbc.M709483200	http://dx.doi.org/10.1074/jbc.M709483200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089559	hybrid			2022-12-25	WOS:000253426500020
J	Maiti, SN; Balasubramanian, K; Ramoth, JA; Schroit, AJ				Maiti, Sourindra N.; Balasubramanian, Krishnakumar; Ramoth, Johanna A.; Schroit, Alan J.			beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells - Binding to lipoprotein receptor-related protein receptor family members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; ADP-INDUCED AGGREGATION; BETA(2)-GLYCOPROTEIN I; APOLIPOPROTEIN-H; ANTIPHOSPHOLIPID ANTIBODIES; ANTICARDIOLIPIN ANTIBODIES; PHOSPHOLIPID-VESICLES; SURFACE CALRETICULIN; IMMUNE CLEARANCE; HUMAN-PLATELETS	The recognition and removal of apoptotic cells is critical to development, tissue homeostasis, and the resolution of inflammation. Many studies have shown that phagocytosis is regulated by signaling mechanisms that involve distinct ligand-receptor interactions that drive the engulfment of apoptotic cells. Studies from our laboratory have shown that the plasma protein beta-2glycoprotein 1 (beta 2GP1), a member of the short consensus repeat superfamily, binds phosphatidylserine-containing vesicles and apoptotic cells and promotes their bridging and subsequent engulfment by phagocytes. The phagocyte receptor for the protein/apoptotic cell complex, however, is unknown. Here we report that a member of the low density lipoprotein receptor-related protein family on phagocytes binds and facilitates engulfment of beta 2GP1-phosphatidylserine and beta 2GP1-apoptotic cell complexes. Using recombinant beta 2GP1, we also show that beta 2GP1-dependent uptake is mediated by bridging of the target cell to the phagocyte through the protein C- and N-terminal domains, respectively.	[Maiti, Sourindra N.; Balasubramanian, Krishnakumar; Ramoth, Johanna A.; Schroit, Alan J.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center	Schroit, AJ (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	aschroit@mdanderson.org			NIGMS NIH HHS [GM70964] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Anderson HA, 2003, NAT IMMUNOL, V4, P87, DOI 10.1038/ni871; Atsumi T, 2005, AUTOIMMUNITY, V38, P377, DOI 10.1080/08916930500124312; Balasubramanian K, 2005, APOPTOSIS, V10, P439, DOI 10.1007/s10495-005-0817-3; Balasubramanian K, 2003, ANNU REV PHYSIOL, V65, P701, DOI 10.1146/annurev.physiol.65.092101.142459; Balasubramanian K, 1997, J BIOL CHEM, V272, P31113, DOI 10.1074/jbc.272.49.31113; Balasubramanian K, 1998, J BIOL CHEM, V273, P29272, DOI 10.1074/jbc.273.44.29272; Bartl MM, 2001, EXP CELL RES, V271, P130, DOI 10.1006/excr.2001.5358; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; Bu GJ, 2001, INT REV CYTOL, V209, P79; Bu GJ, 2000, TRENDS CARDIOVAS MED, V10, P148, DOI 10.1016/S1050-1738(00)00045-1; CHONN A, 1995, J BIOL CHEM, V270, P25845, DOI 10.1074/jbc.270.43.25845; DELPAPA N, 1995, CLIN EXP RHEUMATOL, V13, P179; Fadok VA, 2000, NATURE, V405, P85, DOI 10.1038/35011084; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; GOLDSMITH GH, 1994, BRIT J HAEMATOL, V87, P548, DOI 10.1111/j.1365-2141.1994.tb08311.x; Grimsley C, 2003, TRENDS CELL BIOL, V13, P648, DOI 10.1016/j.tcb.2003.10.004; HAGIHARA Y, 1995, J BIOCHEM-TOKYO, V118, P129, DOI 10.1093/oxfordjournals.jbchem.a124867; Hamdan R, 2007, BIOCHEMISTRY-US, V46, P10612, DOI 10.1021/bi700621j; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Henson PM, 2006, TRENDS IMMUNOL, V27, P244, DOI 10.1016/j.it.2006.03.005; HERZ J, 1991, J BIOL CHEM, V266, P21232; Hong DP, 2001, BIOCHEMISTRY-US, V40, P8092, DOI 10.1021/bi010196v; HUNT J, 1994, J IMMUNOL, V152, P653; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; KRISTENSEN T, 1986, J IMMUNOL, V136, P3407; KRISTENSEN T, 1991, FEBS LETT, V289, P183, DOI 10.1016/0014-5793(91)81065-G; Lee AT, 2000, BBA-BIOMEMBRANES, V1509, P475, DOI 10.1016/S0005-2736(00)00329-1; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Liu SG, 1997, CLIN BIOCHEM, V30, P455, DOI 10.1016/S0009-9120(97)00049-0; Luster TA, 2006, J BIOL CHEM, V281, P29863, DOI 10.1074/jbc.M605252200; Lutters BCH, 2003, J BIOL CHEM, V278, P33831, DOI 10.1074/jbc.M212655200; Matsuura E, 2006, PROG LIPID RES, V45, P466, DOI 10.1016/j.plipres.2006.05.001; Matsuura Eiji, 2004, Clin Dev Immunol, V11, P103, DOI 10.1080/10446670410001722186; Moestrup SK, 1998, J CLIN INVEST, V102, P902, DOI 10.1172/JCI3772; NIMPF J, 1987, ATHEROSCLEROSIS, V63, P109, DOI 10.1016/0021-9150(87)90110-9; NIMPF J, 1985, THROMB HAEMOSTASIS, V54, P397; NIMPF J, 1986, BIOCHIM BIOPHYS ACTA, V884, P142, DOI 10.1016/0304-4165(86)90237-0; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Patel M, 2003, J BIOL CHEM, V278, P44799, DOI 10.1074/jbc.M308982200; POLZ E, 1979, FEBS LETT, V102, P183, DOI 10.1016/0014-5793(79)80955-2; Ravichandran KS, 2003, CELL, V113, P817, DOI 10.1016/S0092-8674(03)00471-9; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Shi T, 2004, P NATL ACAD SCI USA, V101, P3939, DOI 10.1073/pnas.0400281101; SHI W, 1993, BLOOD, V81, P1255; Shoenfeld Y, 2000, J AUTOIMMUN, V15, P199, DOI 10.1006/jaut.2000.0393; Wang SX, 1999, BIOCHEMISTRY-US, V38, P9477, DOI 10.1021/bi990084s; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; WURM H, 1984, INT J BIOCHEM, V16, P511, DOI 10.1016/0020-711X(84)90168-X	51	46	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3761	3766		10.1074/jbc.M704990200	http://dx.doi.org/10.1074/jbc.M704990200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073216	hybrid			2022-12-25	WOS:000253083500009
J	Noriega, VM; Tortorella, D				Noriega, Vanessa M.; Tortorella, Domenico			A bipartite trigger for dislocation directs the proteasomal degradation of an endoplasmic reticulum membrane glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; CELL RECEPTOR-CD3 COMPLEX; MHC CLASS-I; HEAVY-CHAINS; ANTIGEN PRESENTATION; CHARGED RESIDUES; SIGNAL PEPTIDE; PROTEIN; US2; ER	Polypeptides are organized into distinct substructures, termed protein domains, that are often associated with diverse functions. These modular units can act as binding sites, areas of post-translational modification, and sites of complex multimerization. The human cytomegalovirus US2 gene product is organized into discrete domains that together catalyze the proteasome-dependent degradation of class I major histocompatibility complex heavy chains. US2 co-opts the endogenous ER quality control pathway in order to dispose of class I. The US2 endoplasmic reticulum (ER)-lumenal region is the class I binding domain, whereas the carboxyl terminus can be referred to as the degradation domain. In the present study, we examined the role of the US2 transmembrane domain in virus-mediated class I degradation. Replacement of the US2 transmembrane domain with that of the CD4 glycoprotein completely blocked the ability of US2 to induce class I destruction. A more precise mutagenesis revealed that subregions of the US2 transmembrane domain differ in their ability to trigger class I degradation. Collectively, the data support a model in which US2-mediated class I degradation occurs as a highly regulated process where the US2 transmembrane domain and cytoplasmic tail work in concert to eliminate class I molecules. Host factors, including a signal peptidase complex, probably associate with the US2 molecule in a coordinated fashion to create a predislocation complex to promote the extraction of class I out of the ER. The results imply that the ER quality control machinery may recognize and eliminate misfolded proteins using a similar multistep regulated process.	[Noriega, Vanessa M.; Tortorella, Domenico] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Tortorella, D (corresponding author), Mt Sinai Sch Med, Dept Microbiol, 1 Gustave L Levy Pl,Box 1124, New York, NY 10029 USA.	Domenico.Tortorella@mssm.edu		Tortorella, Domenico/0000-0003-0961-3535	NIAID NIH HHS [T32 AI007647, R01 AI060905-03S1, R01 AI060905, AI07647, AI060905, AI060905-S1, T32 AI007647-03, R01 AI060905-04, R01 AI060905-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060905, T32AI007647] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Ahn KS, 1996, P NATL ACAD SCI USA, V93, P10990, DOI 10.1073/pnas.93.20.10990; BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Boppana SB, 1996, VIROLOGY, V222, P293, DOI 10.1006/viro.1996.0424; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Call ME, 2004, MOL IMMUNOL, V40, P1295, DOI 10.1016/j.molimm.2003.11.017; Chevalier MS, 2002, J VIROL, V76, P8265, DOI 10.1128/JVI.76.16.8265-8275.2002; Ciczora Y, 2005, J GEN VIROL, V86, P2793, DOI 10.1099/vir.0.81140-0; Cocquerel L, 2000, J VIROL, V74, P3623, DOI 10.1128/JVI.74.8.3623-3633.2000; COSSON P, 1991, NATURE, V351, P414, DOI 10.1038/351414a0; Fiebiger E, 2002, EMBO J, V21, P1041, DOI 10.1093/emboj/21.5.1041; Furman MH, 2003, J BIOL CHEM, V278, P34804, DOI 10.1074/jbc.M300913200; Furman MH, 2002, J VIROL, V76, P11753, DOI 10.1128/JVI.76.22.11753-11756.2002; Furman MH, 2002, J BIOL CHEM, V277, P3258, DOI 10.1074/jbc.M109765200; Gewurz BE, 2002, J BIOL CHEM, V277, P11306, DOI 10.1074/jbc.M107904200; Gewurz BE, 2001, P NATL ACAD SCI USA, V98, P6794, DOI 10.1073/pnas.121172898; Gewurz BE, 2001, J VIROL, V75, P5197, DOI 10.1128/JVI.75.11.5197-5204.2001; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; Hendrickson WA, 2005, Q REV BIOPHYS, V38, P321, DOI 10.1017/S0033583506004136; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Jones TR, 1997, J VIROL, V71, P2970, DOI 10.1128/JVI.71.4.2970-2979.1997; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Lilley BN, 2003, MOL BIOL CELL, V14, P3690, DOI 10.1091/mbc.E03-03-0192; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mocarski E, 1996, FIELDS VIROLOGY, P2447; Oresic K, 2006, J BIOL CHEM, V281, P19395, DOI 10.1074/jbc.M601026200; Pamer E, 1998, ANNU REV IMMUNOL, V16, P323, DOI 10.1146/annurev.immunol.16.1.323; PARHAM P, 1979, J IMMUNOL, V123, P342; Popot JL, 2000, ANNU REV BIOCHEM, V69, P881, DOI 10.1146/annurev.biochem.69.1.881; Reddehase MJ, 2000, CURR OPIN IMMUNOL, V12, P390, DOI 10.1016/S0952-7915(00)00106-0; Sayeed A, 2005, CRIT REV BIOCHEM MOL, V40, P75, DOI 10.1080/10409230590918685; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0	39	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4031	4043		10.1074/jbc.M706283200	http://dx.doi.org/10.1074/jbc.M706283200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18086679	Green Accepted, hybrid			2022-12-25	WOS:000253083500038
J	van de Graaf, SFJ; Rescher, U; Hoenderop, JGJ; Verkaart, S; Bindels, RJM; Gerke, V				van de Graaf, Stan F. J.; Rescher, Ursula; Hoenderop, Joost G. J.; Verkaart, Sjoerd; Bindels, Rene J. M.; Gerke, Volker			TRPV5 is internalized via clathrin-dependent endocytosis to enter a Ca2+-controlled recycling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ CHANNELS TRPV5; PLASMA-MEMBRANE; MEDIATED ENDOCYTOSIS; TRAFFICKING; EXPRESSION; RECEPTORS; INSERTION; TRANSLOCATION; CONTRIBUTES; INCREASES	The epithelial Ca2+ channel TRPV5 plays an essential role in transcellular Ca2+ transport and is one of the most Ca2+-selective members of the transient receptor potential superfamily. Regulation of the abundance of TRPV5 at the cell surface is critical in body Ca2+ homeostasis. However, little is known about the mechanisms underlying TRPV5 endo- and exocytosis. Here, we show that TRPV5 is constitutively internalized in a dynamin and clathrin-dependent manner. Internalized TRPV5 first appears in small vesicular structures and then localizes to perinuclear structures positive for Rab11a. TRPV5 has a half-life of more than 8 h and is stable even after internalization from the cell surface for more than 3 h. Disruption of cell surface delivery of newly synthesized TRPV5 by brefeldin A does not reduce TRPV5-mediated Ca2+ influx in cells, suggesting the presence of a stable intracellular pool of the channel capable of recycling back to the surface. Furthermore, the endocytic recycling kinetics is decreased upon treatment with Ca2+ chelator BAPTA-AM, indicating that the channel's trafficking pathways are dynamically controlled by Ca2+.	[van de Graaf, Stan F. J.; Rescher, Ursula; Gerke, Volker] Univ Munster, Ctr Mol Biol Inflammat, Inst Med Biochem, D-48149 Munster, Germany; [Hoenderop, Joost G. J.; Verkaart, Sjoerd; Bindels, Rene J. M.] Radboud Univ Nijmegen, Nijmegan Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Physiol, NL-6500 HB Nijmegen, Netherlands	University of Munster; Radboud University Nijmegen	van de Graaf, SFJ (corresponding author), UMC Utrecht, Wilhelmina Childrens Hosp, Dept Metab & Endocrine Dis, Lundlaan 6, NL-3584 EA Utrecht, Netherlands.	S.vandeGraaf-4@umcutrecht.nl	Hoenderop, Joost G.J./H-8047-2014; Bindels, René JM/B-9824-2013	Hoenderop, Joost G.J./0000-0002-1816-8544; Bindels, René JM/0000-0003-1167-1339; van de Graaf, Stan/0000-0003-4238-4359				Ambudkar I. S., 2007, V179, P541; Bao J, 2000, J BIOL CHEM, V275, P26178, DOI 10.1074/jbc.M002367200; BASU SK, 1981, CELL, V24, P493, DOI 10.1016/0092-8674(81)90340-8; Bezzerides VJ, 2004, NAT CELL BIOL, V6, P709, DOI 10.1038/ncb1150; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Cayouette S, 2007, CELL CALCIUM, V42, P225, DOI 10.1016/j.ceca.2007.01.014; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; den Dekker E, 2005, PFLUG ARCH EUR J PHY, V450, P236, DOI 10.1007/s00424-005-1409-3; Gkika D, 2006, EMBO J, V25, P4707, DOI 10.1038/sj.emboj.7601357; Hellwig N, 2005, J CELL SCI, V118, P917, DOI 10.1242/jcs.01675; HEUSER JE, 1989, J CELL BIOL, V108, P389, DOI 10.1083/jcb.108.2.389; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hoenderop JGJ, 2005, PHYSIOL REV, V85, P373, DOI 10.1152/physrev.00003.2004; Hoenderop JGJ, 2003, J CLIN INVEST, V112, P1906, DOI 10.1172/JCI200319826; Hoenderop JGJ, 2003, EMBO J, V22, P776, DOI 10.1093/emboj/cdg080; Itagaki K, 2004, J IMMUNOL, V172, P601, DOI 10.4049/jimmunol.172.1.601; Knight DE, 2002, TRAFFIC, V3, P298, DOI 10.1034/j.1600-0854.2002.030407.x; Koenig JA, 1997, TRENDS PHARMACOL SCI, V18, P276, DOI 10.1016/S0165-6147(97)01091-2; Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038; Lambers TT, 2006, EMBO J, V25, P2978, DOI 10.1038/sj.emboj.7601186; Le TL, 2002, AM J PHYSIOL-CELL PH, V283, pC489, DOI 10.1152/ajpcell.00566.2001; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Lockwich T, 2001, J BIOL CHEM, V276, P42401, DOI 10.1074/jbc.M106956200; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Montell C, 2002, CELL, V108, P595, DOI 10.1016/S0092-8674(02)00670-0; Morenilla-Palao C, 2004, J BIOL CHEM, V279, P25665, DOI 10.1074/jbc.M311515200; Nilius B, 2001, CELL CALCIUM, V29, P417, DOI 10.1054/ceca.2001.0201; Oancea E, 2006, CIRC RES, V98, P245, DOI 10.1161/01.RES.0000200179.29375.cc; Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035; QUON MJ, 1994, P NATL ACAD SCI USA, V91, P5587, DOI 10.1073/pnas.91.12.5587; Sainte-Marie J, 1997, EUR J BIOCHEM, V250, P689, DOI 10.1111/j.1432-1033.1997.00689.x; Singh BB, 2004, MOL CELL, V15, P635, DOI 10.1016/j.molcel.2004.07.010; Staub O, 1997, EMBO J, V16, P6325, DOI 10.1093/emboj/16.21.6325; van de Graaf SFJ, 2006, MOL CELL BIOL, V26, P303, DOI 10.1128/MCB.26.1.303-312.2006; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; van der Eerden BCJ, 2005, P NATL ACAD SCI USA, V102, P17507, DOI 10.1073/pnas.0505789102; Vennekens R, 2000, J BIOL CHEM, V275, P3963, DOI 10.1074/jbc.275.6.3963; Wegierski T, 2006, EMBO J, V25, P5659, DOI 10.1038/sj.emboj.7601429; Xu XZS, 2003, CELL, V114, P285, DOI 10.1016/S0092-8674(03)00565-8; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V283, pF630, DOI 10.1152/ajprenal.00378.2001; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893	43	32	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4077	4086		10.1074/jbc.M706959200	http://dx.doi.org/10.1074/jbc.M706959200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077461	hybrid, Green Published			2022-12-25	WOS:000253083500043
J	Edwin, F; Patel, TB				Edwin, Francis; Patel, Tarun B.			A novel role of sprouty 2 in regulating cellular apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; TYROSINE PHOSPHORYLATION; C-CBL; BIOLOGICAL ACTIONS; KIDNEY DEVELOPMENT; LIGASE ACTIVITY; DOWN-REGULATION; PROTEIN-KINASE; ACTIVATION; MIGRATION	Sprouty (SPRY) proteins modulate receptor-tyrosine kinase signaling and, thereby, regulate cell migration and proliferation. Here, we have examined the role of endogenous human SPRY2 (hSPRY2) in the regulation of cellular apoptosis. Small inhibitory RNA-mediated silencing of hSPRY2 abolished the anti-apoptotic action of serum in adrenal cortex adenocarcinoma (SW13) cells. Silencing of hSPRY2 decreased serum- or epidermal growth factor (EGF)-elicited activation of AKT and ERK1/2 and reduced the levels of EGF receptor. Silencing of hSPRY2 also inhibited serum- induced activation of p90RSK and decreased phosphorylation of pro-apoptotic protein BAD (BCL2-antagonist of cell death) by p90RSK. Inhibiting both the ERK1/2 and AKT pathways abolished the ability of serum to protect against apoptosis, mimicking the effects of silencing hSPRY2. Serum transactivated the EGF receptor ( EGFR), and inhibition of the EGFR by a neutralizing antibody attenuated the anti-apoptotic actions of serum. Consistent with the role of EGFR and perhaps other growth factor receptors in the antiapoptotic actions of serum, the tyrosine kinase binding domain of c-Cbl (Cbl-TKB) protected against down-regulation of the growth factor receptors such as EGFR and preserved the antiapoptotic actions of serum when hSpry2 was silenced. Additionally, silencing of Spry2 in c-Cbl null cells did not alter the ability of serum to promote cell survival. Moreover, reintroduction of wild type hSPRY2, but not its mutants that do not bind c-Cbl or CIN85 into SW13 cells after endogenous hSPRY2 had been silenced, restored the anti-apoptotic actions of serum. Overall, we conclude that endogenous hSPRY2-mediated regulation of apoptosis requires c-Cbl and is manifested by the ability of hSPRY2 to sequester c-Cbl and thereby augment signaling via growth factor receptors.	[Edwin, Francis; Patel, Tarun B.] Loyola Univ, Stritch Sch Med, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA	Loyola University Chicago	Patel, TB (corresponding author), Loyola Univ, Stritch Sch Med, Dept Pharmacol, 2160 S 1st Ave, Maywood, IL 60153 USA.	tpatel7@lumc.edu			NIGMS NIH HHS [GM073181, R01 GM073181-03S1, R01 GM073181] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073181] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Cabrita MA, 2006, J BIOL CHEM, V281, P29201, DOI 10.1074/jbc.M603921200; Chambers D, 2000, MECH DEVELOP, V91, P361, DOI 10.1016/S0925-4773(99)00288-9; Chaturvedi D, 2006, MOL CELL BIOL, V26, P4586, DOI 10.1128/MCB.01422-05; Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200; Christofori G, 2003, NAT CELL BIOL, V5, P377, DOI 10.1038/ncb0503-377; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Deng WL, 2004, J BIOL CHEM, V279, P47871, DOI 10.1074/jbc.M405443200; Edwin F, 2006, J BIOL CHEM, V281, P4816, DOI 10.1074/jbc.M508300200; Egan JE, 2002, P NATL ACAD SCI USA, V99, P6041, DOI 10.1073/pnas.052090899; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Fong CW, 2003, J BIOL CHEM, V278, P33456, DOI 10.1074/jbc.M301317200; Furthauer M, 2001, DEVELOPMENT, V128, P2175; Gross I, 2003, J BIOL CHEM, V278, P41420, DOI 10.1074/jbc.M306425200; Gross I, 2001, J BIOL CHEM, V276, P46460, DOI 10.1074/jbc.M108234200; Grovdal LM, 2004, EXP CELL RES, V300, P388, DOI 10.1016/j.yexcr.2004.07.003; Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8; Haglund K, 2005, EMBO REP, V6, P635, DOI 10.1038/sj.embor.7400453; Hall AB, 2003, CURR BIOL, V13, P308, DOI 10.1016/S0960-9822(03)00086-1; Impagnatiello MA, 2001, J CELL BIOL, V152, P1087, DOI 10.1083/jcb.152.5.1087; Kassenbrock CK, 2004, J BIOL CHEM, V279, P28017, DOI 10.1074/jbc.M404114200; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kowanetz K, 2003, J BIOL CHEM, V278, P39735, DOI 10.1074/jbc.M304541200; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lao DH, 2006, J BIOL CHEM, V281, P29993, DOI 10.1074/jbc.M604044200; Lee CC, 2004, ONCOGENE, V23, P5193, DOI 10.1038/sj.onc.1207646; Lee SH, 2001, J BIOL CHEM, V276, P4128, DOI 10.1074/jbc.M006922200; Levkowitz G, 1999, MOL CELL, V4, P1029, DOI 10.1016/S1097-2765(00)80231-2; Li X, 2003, BIOCHEM SOC T, V31, P1445; Lim J, 2000, J BIOL CHEM, V275, P32837, DOI 10.1074/jbc.M002156200; Mason JM, 2004, MOL BIOL CELL, V15, P2176, DOI 10.1091/mbc.E03-07-0503; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Minowada G, 1999, DEVELOPMENT, V126, P4465; Moolenaar Wouter H., 1994, Trends in Cell Biology, V4, P213, DOI 10.1016/0962-8924(94)90144-9; Perl AKT, 2003, DEV BIOL, V258, P154, DOI 10.1016/S0012-1606(03)00106-4; Poppleton HM, 2004, BIOCHEM BIOPH RES CO, V323, P98, DOI 10.1016/j.bbrc.2004.08.070; Reich A, 1999, DEVELOPMENT, V126, P4139; Richards SA, 1999, CURR BIOL, V9, P810, DOI 10.1016/S0960-9822(99)80364-9; Rubin C, 2003, CURR BIOL, V13, P297, DOI 10.1016/S0960-9822(03)00053-8; Sasaki A, 2001, J BIOL CHEM, V276, P36804, DOI 10.1074/jbc.C100386200; Shim K, 2005, DEV CELL, V8, P553, DOI 10.1016/j.devcel.2005.02.009; Taketomi T, 2005, NAT NEUROSCI, V8, P855, DOI 10.1038/nn1485; Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3; TIGYI G, 1992, J BIOL CHEM, V267, P21360; Waterman H, 1999, J BIOL CHEM, V274, P22151, DOI 10.1074/jbc.274.32.22151; Wong ESM, 2002, EMBO J, V21, P4796, DOI 10.1093/emboj/cdf493; Wong ESM, 2001, J BIOL CHEM, V276, P5866, DOI 10.1074/jbc.M006945200; Yigzaw Y, 2003, J BIOL CHEM, V278, P284, DOI 10.1074/jbc.M210359200; Yigzaw Y, 2001, J BIOL CHEM, V276, P22742, DOI 10.1074/jbc.M100123200; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang CX, 2005, ARTERIOSCL THROM VAS, V25, P533, DOI 10.1161/01.ATV.0000155461.50450.5a	50	27	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3181	3190		10.1074/jbc.M706567200	http://dx.doi.org/10.1074/jbc.M706567200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070883	Green Accepted, hybrid			2022-12-25	WOS:000253083000021
J	Goldman, B; Bhat, S; Shimkets, LJ				Goldman, Barry; Bhat, Swapna; Shimkets, Lawrence J.			Genome Evolution and the Emergence of Fruiting Body Development in Myxococcus xanthus	PLOS ONE			English	Article								Background. Lateral gene transfer (LGT) is thought to promote speciation in bacteria, though well-defined examples have not been put forward. Methodology/Principle Findings. We examined the evolutionary history of the genes essential for a trait that defines a phylogenetic order, namely fruiting body development of the Myxococcales. Seventy-eight genes that are essential for Myxococcus xanthus development were examined for LGT. About 73% of the genes exhibit a phylogeny similar to that of the 16S rDNA gene and a codon bias consistent with other M. xanthus genes suggesting vertical transmission. About 22% have an altered codon bias and/or phylogeny suggestive of LGT. The remaining 5% are unique. Genes encoding signal production and sensory transduction were more likely to be transmitted vertically with clear examples of duplication and divergence into multigene families. Genes encoding metabolic enzymes were frequently acquired by LGT. Myxobacteria exhibit aerobic respiration unlike most of the delta Proteobacteria. M. xanthus contains a unique electron transport pathway shaped by LGT of genes for succinate dehydrogenase and three cytochrome oxidase complexes. Conclusions/Significance. Fruiting body development depends on genes acquired by LGT, particularly those involved in polysaccharide production. We suggest that aerobic growth fostered innovation necessary for development by allowing myxobacteria access to a different gene pool from anaerobic members of the delta Proteobacteria. Habitat destruction and loss of species diversity could restrict the evolution of new bacterial groups by limiting the size of the prospective gene pool.	[Bhat, Swapna; Shimkets, Lawrence J.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Goldman, Barry] Monsanto Co, Appl Bioinformat, St Louis, MO USA	University System of Georgia; University of Georgia; Monsanto	Shimkets, LJ (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	shimkets@uga.edu			National Science Foundation [0343874]	National Science Foundation(National Science Foundation (NSF))	Funding: This work was supported by National Science Foundation grant 0343874.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102; Boucher Y, 2003, ANNU REV GENET, V37, P283, DOI 10.1146/annurev.genet.37.050503.084247; BRETON AM, 1985, J BACTERIOL, V161, P523, DOI 10.1128/JB.161.2.523-528.1985; Bull AT, 2000, MICROBIOL MOL BIOL R, V64, P573, DOI 10.1128/MMBR.64.3.573-606.2000; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; Cecchini G, 2002, BBA-BIOENERGETICS, V1553, P140, DOI 10.1016/S0005-2728(01)00238-9; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; CHENG Y, 1989, J BACTERIOL, V171, P3727, DOI 10.1128/jb.171.7.3727-3731.1989; CHENG YL, 1994, J BACTERIOL, V176, P1427, DOI 10.1128/jb.176.5.1427-1433.1994; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; de la Cruz F, 2000, TRENDS MICROBIOL, V8, P128, DOI 10.1016/S0966-842X(00)01703-0; Dolla A, 2006, J BIOTECHNOL, V126, P87, DOI 10.1016/j.jbiotec.2006.03.041; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Gevers D, 2004, TRENDS MICROBIOL, V12, P148, DOI 10.1016/j.tim.2004.02.007; Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103; Gophna U, 2006, TRENDS MICROBIOL, V14, P64, DOI 10.1016/j.tim.2005.12.008; KALMAN LV, 1994, J BACTERIOL, V176, P1434, DOI 10.1128/jb.176.5.1434-1442.1994; Karlin S, 2000, J BACTERIOL, V182, P5238, DOI 10.1128/JB.182.18.5238-5250.2000; KASHEFI K, 1995, MOL MICROBIOL, V15, P483, DOI 10.1111/j.1365-2958.1995.tb02262.x; KLEINIG H, 1974, ARCH MICROBIOL, V101, P91, DOI 10.1007/BF00455928; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lawrence JG, 1997, J MOL EVOL, V44, P383, DOI 10.1007/PL00006158; Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130; Lueders T, 2006, APPL ENVIRON MICROB, V72, P5342, DOI 10.1128/AEM.00400-06; Medrano-Soto A, 2004, MOL BIOL EVOL, V21, P1884, DOI 10.1093/molbev/msh202; Mrazek J, 1999, ANN NY ACAD SCI, V870, P314, DOI 10.1111/j.1749-6632.1999.tb08893.x; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686; Quaiser A, 2003, MOL MICROBIOL, V50, P563, DOI 10.1046/j.1365-2958.2003.03707.x; Rubin EJ, 1999, P NATL ACAD SCI USA, V96, P1645, DOI 10.1073/pnas.96.4.1645; SHIMKETS LJ, 1983, P NATL ACAD SCI-BIOL, V80, P1406, DOI 10.1073/pnas.80.5.1406; SHIMKETS LJ, 2007, HDB BIOL BACTERIA, V7, P31; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Vlamakis HC, 2004, MOL MICROBIOL, V52, P1799, DOI 10.1111/j.1365-2958.2004.04098.x; von Mering C, 2007, SCIENCE, V315, P1126, DOI 10.1126/science.1133420; YAMANAKA S, 1987, J GEN APPL MICROBIOL, V33, P247, DOI 10.2323/jgam.33.247; Yanyushin MF, 2005, BIOCHEMISTRY-US, V44, P10037, DOI 10.1021/bi047267l; Youderian P, 2006, GENETICS, V172, P1397, DOI 10.1534/genetics.105.050542; Youderian P, 2003, MOL MICROBIOL, V49, P555, DOI 10.1046/j.1365-2958.2003.03582.x; Yu R, 2007, MOL MICROBIOL, V63, P454, DOI 10.1111/j.1365-2958.2006.05536.x	41	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1329	10.1371/journal.pone.0001329	http://dx.doi.org/10.1371/journal.pone.0001329			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159227	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459700001
J	Sonderby, IE; Hansen, BG; Bjarnholt, N; Ticconi, C; Halkier, BA; Kliebenstein, DJ				Sonderby, Ida Elken; Hansen, Bjarne Gram; Bjarnholt, Nanna; Ticconi, Carla; Halkier, Barbara Ann; Kliebenstein, Daniel J.			A Systems Biology Approach Identifies a R2R3 MYB Gene Subfamily with Distinct and Overlapping Functions in Regulation of Aliphatic Glucosinolates	PLOS ONE			English	Article								Background. Glucosinolates are natural metabolites in the order Brassicales that defend plants against both herbivores and pathogens and can attract specialized insects. Knowledge about the genes controlling glucosinolate regulation is limited. Here, we identify three R2R3 MYB transcription factors regulating aliphatic glucosinolate biosynthesis in Arabidopsis by combining several systems biology tools. Methodology/Principal Findings. MYB28 was identified as a candidate regulator of aliphatic glucosinolates based on its co-localization within a genomic region controlling variation both in aliphatic glucosinolate content (metabolite QTL) and in transcript level for genes involved in the biosynthesis of aliphatic glucosinolates (expression QTL), as well as its co-expression with genes in aliphatic glucosinolate biosynthesis. A phylogenetic analysis with the R2R3 motif of MYB28 showed that it and two homologues, MYB29 and MYB76, were members of an Arabidopsis-specific clade that included three characterized regulators of indole glucosinolates. Over-expression of the individual MYB genes showed that they all had the capacity to increase the production of aliphatic glucosinolates in leaves and seeds and induce gene expression of aliphatic biosynthetic genes within leaves. Analysis of leaves and seeds of single knockout mutants showed that mutants of MYB29 and MYB76 have reductions in only short-chained aliphatic glucosinolates whereas a mutant in MYB28 has reductions in both short- and long-chained aliphatic glucosinolates. Furthermore, analysis of a double knockout in MYB28 and MYB29 identified an emergent property of the system since the absence of aliphatic glucosinolates in these plants could not be predicted by the chemotype of the single knockouts. Conclusions/Significance. It seems that these cruciferous-specific MYB regulatory genes have evolved both overlapping and specific regulatory capacities. This provides a unique system within which to study the evolution of MYB regulatory factors and their downstream targets.	[Ticconi, Carla; Kliebenstein, Daniel J.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Sonderby, Ida Elken; Hansen, Bjarne Gram; Bjarnholt, Nanna; Halkier, Barbara Ann] Univ Copenhagen, Plant Biochem Lab, Dept Plant Biol, Ctr Mol Plant Physiol PlaCe,Fac Life Sci, Copenhagen, Denmark	University of California System; University of California Davis; University of Copenhagen	Kliebenstein, DJ (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	kliebenstein@ucdavis.edu	Bjarnholt, Nanna/F-5137-2017; Halkier, Barbara A/H-3196-2014	Bjarnholt, Nanna/0000-0002-5301-5885; Halkier, Barbara A/0000-0002-3742-702X; Kliebenstein, Daniel/0000-0001-5759-3175	The Danish National Research Foundation; PlaCe (Center for Molecular Plant Physiology); NSF [DBI 0642481]; FOBI (Graduate School in Biotechnology); Faculty of Life Sciences (Copenhagen University)	The Danish National Research Foundation(Danmarks Grundforskningsfond); PlaCe (Center for Molecular Plant Physiology); NSF(National Science Foundation (NSF)); FOBI (Graduate School in Biotechnology); Faculty of Life Sciences (Copenhagen University)	The presented work was supported by The Danish National Research Foundation through its support to PlaCe (Center for Molecular Plant Physiology) (Barbara Ann Halkier) and by NSF grants DBI# 0642481 to Dan J. Kliebenstein. The PhD stipends of Bjarne Gram Hansen and Ida Elken Sonderby were funded by FOBI (Graduate School in Biotechnology) and Faculty of Life Sciences (Copenhagen University), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal M, 2006, J BIOL CHEM, V281, P37636, DOI 10.1074/jbc.M605895200; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Basten CJ, 1999, QTL CARTOGRAPHER VER; Bender J, 1998, P NATL ACAD SCI USA, V95, P5655, DOI 10.1073/pnas.95.10.5655; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bennett RN, 2005, PLANT BIOLOGY, V7, P348, DOI 10.1055/s-2005-837634; Brader G, 2001, PLANT PHYSIOL, V126, P849, DOI 10.1104/pp.126.2.849; Brem RB, 2002, SCIENCE, V296, P752, DOI 10.1126/science.1069516; Brown PD, 2003, PHYTOCHEMISTRY, V62, P471, DOI 10.1016/S0031-9422(02)00549-6; Celenza JL, 2005, PLANT PHYSIOL, V137, P253, DOI 10.1104/pp.104.054395; CHURCHILL GA, 1994, GENETICS, V138, P963; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Doerge RW, 1996, GENETICS, V142, P285; Doerge RW, 2002, NAT REV GENET, V3, P43, DOI 10.1038/nrg703; Field B, 2004, PLANT PHYSIOL, V135, P828, DOI 10.1104/pp.104.039347; Gigolashvili T, 2007, PLANT J, V51, P247, DOI 10.1111/j.1365-313X.2007.03133.x; Gigolashvili T, 2007, PLANT J, V50, P886, DOI 10.1111/j.1365-313X.2007.03099.x; Gray J, 2005, CURR BIOL, V15, pR593, DOI 10.1016/j.cub.2005.07.039; Grubb CD, 2006, TRENDS PLANT SCI, V11, P89, DOI 10.1016/j.tplants.2005.12.006; Halkier BA, 2006, ANNU REV PLANT BIOL, V57, P303, DOI 10.1146/annurev.arplant.57.032905.105228; Hansen BG, 2007, PLANT J, V50, P902, DOI 10.1111/j.1365-313X.2007.03101.x; Hemm MR, 2003, PLANT CELL, V15, P179, DOI 10.1105/tpc.006544; Hirai MY, 2007, P NATL ACAD SCI USA, V104, P6478, DOI 10.1073/pnas.0611629104; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jansen RC, 2004, TRENDS GENET, V20, P223, DOI 10.1016/j.tig.2004.03.002; Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1; Jin HL, 2000, EMBO J, V19, P6150, DOI 10.1093/emboj/19.22.6150; Kim JH, 2004, PLANT MOL BIOL, V54, P671, DOI 10.1023/B:PLAN.0000040897.49151.98; Kliebenstein D, 2002, GENETICS, V161, P325; Kliebenstein DJ, 2007, PLANT J, V51, P1062, DOI 10.1111/j.1365-313X.2007.03205.x; Kliebenstein DJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-308; Kliebenstein DJ, 2005, CURR OPIN PLANT BIOL, V8, P264, DOI 10.1016/j.pbi.2005.03.002; Kliebenstein DJ, 2006, GENETICS, V172, P1179, DOI 10.1534/genetics.105.049353; Kliebenstein DJ, 2005, PLANT J, V44, P25, DOI 10.1111/j.1365-313X.2005.02508.x; Kliebenstein DJ, 2001, GENETICS, V159, P359; Kliebenstein DJ, 2001, PLANT CELL, V13, P681, DOI 10.1105/tpc.13.3.681; Kliebenstein DJ, 2001, PLANT PHYSIOL, V126, P811, DOI 10.1104/pp.126.2.811; Lehfeldt C, 2000, PLANT CELL, V12, P1295, DOI 10.1105/tpc.12.8.1295; Levy M, 2005, PLANT J, V43, P79, DOI 10.1111/j.1365-313X.2005.02435.x; Loudet O, 2002, THEOR APPL GENET, V104, P1173, DOI 10.1007/s00122-001-0825-9; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Martin C, 2002, PHILOS T ROY SOC B, V357, P809, DOI 10.1098/rstb.2002.1089; Mewis I, 2005, PLANT PHYSIOL, V138, P1149, DOI 10.1104/pp.104.053389; Mikkelsen MD, 2003, PLANT PHYSIOL, V131, P298, DOI 10.1104/pp.011015; Mithen R, 2003, THEOR APPL GENET, V106, P727, DOI 10.1007/s00122-002-1123-x; Nour-Eldin HH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl635; Petersen BL, 2002, PLANTA, V214, P562, DOI 10.1007/s004250100659; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01434; Sinlapadech T, 2007, PLANT J, V49, P655, DOI 10.1111/j.1365-313X.2006.02984.x; Skirycz A, 2006, PLANT J, V47, P10, DOI 10.1111/j.1365-313X.2006.02767.x; Stracke R, 2001, CURR OPIN PLANT BIOL, V4, P447, DOI 10.1016/S1369-5266(00)00199-0; Textor S, 2004, PLANTA, V218, P1026, DOI 10.1007/s00425-003-1184-3; Textor S, 2007, PLANT PHYSIOL, V144, P60, DOI 10.1104/pp.106.091579; Tissier AF, 1999, PLANT CELL, V11, P1841, DOI 10.1105/tpc.11.10.1841; Wang S, 2012, WINDOWS QTL CARTOGRA; Wentzell AM, 2007, PLOS GENET, V3, P1687, DOI 10.1371/journal.pgen.0030162; West MAL, 2007, GENETICS, V175, P1441, DOI 10.1534/genetics.106.064972; West MAL, 2006, GENOME RES, V16, P787, DOI 10.1101/gr.5011206; ZAMBRYSKI P, 1983, EMBO J, V2, P2143, DOI 10.1002/j.1460-2075.1983.tb01715.x; Zeng ZB, 1999, GENET RES, V74, P279, DOI 10.1017/S0016672399004255; Zhu JH, 2005, P NATL ACAD SCI USA, V102, P9966, DOI 10.1073/pnas.0503960102	63	253	263	4	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1322	10.1371/journal.pone.0001322	http://dx.doi.org/10.1371/journal.pone.0001322			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094747	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459600010
J	Iwamoto, K; Bundo, M; Ueda, J; Nakano, Y; Ukai, W; Hashimoto, E; Saito, T; Kato, T				Iwamoto, Kazuya; Bundo, Miki; Ueda, Junko; Nakano, Yoko; Ukai, Wataru; Hashimoto, Eri; Saito, Toshikazu; Kato, Tadafumi			Detection of Chromosomal Structural Alterations in Single Cells by SNP Arrays: A Systematic Survey of Amplification Bias and Optimized Workflow	PLOS ONE			English	Article								Background. In single-cell human genome analysis using whole-genome amplified product, a strong amplification bias involving allele dropout and preferential amplification hampers the quality of results. Using an oligonucleotide single nucleotide polymorphism (SNP) array, we systematically examined the nature of this amplification bias, including frequency, degree, and preference for genomic location, and we assessed the effects of this amplification bias on subsequent genotype and chromosomal copy number analyses. Methodology/Principal Findings. We found a large variability in amplification bias among the amplified products obtained by multiple displacement amplification (MDA), and this bias had a severe effect on the genotype and chromosomal copy number analyses. We established optimal experimental conditions for pre-screening for high-quality amplified products, processing array data, and analyzing chromosomal structural alterations. Using this optimized protocol, we successfully detected previously unidentified chromosomal structural alterations in single cells from a lymphoblastoid cell line. These alterations were subsequently confirmed by karyotype analysis. In addition, we successfully obtained reproducible chromosomal copy number profiles of single cells from the cell line with a complex karyotype, indicating the applicability and potential of our optimized workflow. Conclusions/Significance. Our results suggest that the quality of amplification products should be critically assessed before using them for genomic analyses. The method of MDA-based whole-genome amplification followed by SNP array analysis described here will be useful for exploring chromosomal alterations in single cells.	[Iwamoto, Kazuya; Bundo, Miki; Ueda, Junko; Nakano, Yoko; Kato, Tadafumi] RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Saitama, Japan; [Ukai, Wataru; Hashimoto, Eri; Saito, Toshikazu] Sapporo Med Univ, Dept Neuropsychiat, Chuo Ku, Sapporo, Hokkaido, Japan	RIKEN; Sapporo Medical University	Iwamoto, K (corresponding author), RIKEN Brain Sci Inst, Lab Mol Dynam Mental Disorders, Saitama, Japan.	kaziwamoto@brain.riken.jp	Kato, Tadafumi/J-3583-2014	Kato, Tadafumi/0000-0001-7856-3952	Japanese Ministry of Health, Welfare, and Labor	Japanese Ministry of Health, Welfare, and Labor(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a Grant-in-Aid from the Japanese Ministry of Health, Welfare, and Labor.	Arriola E, 2007, LAB INVEST, V87, P75, DOI 10.1038/labinvest.3700495; Cardoso J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh142; Cheung VG, 1996, P NATL ACAD SCI USA, V93, P14676, DOI 10.1073/pnas.93.25.14676; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Dietmaier W, 1999, AM J PATHOL, V154, P83, DOI 10.1016/S0002-9440(10)65254-6; Fiegler H, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1030; Grant SFA, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf125; Handyside AH, 2004, MOL HUM REPROD, V10, P767, DOI 10.1093/molehr/gah101; Harada T, 2002, ONCOLOGY-BASEL, V62, P251, DOI 10.1159/000059573; Hellani A, 2004, MOL HUM REPROD, V10, P847, DOI 10.1093/molehr/gah114; Hu DG, 2004, MOL HUM REPROD, V10, P283, DOI 10.1093/humrep/gah038; Hughes S, 2005, PROG BIOPHYS MOL BIO, V88, P173, DOI 10.1016/j.pbiomolbio.2004.01.007; Hughes S, 2004, CYTOGENET GENOME RES, V105, P18, DOI 10.1159/000078004; Iourov IY, 2006, INT REV CYTOL, V249, P143, DOI 10.1016/S0074-7696(06)49003-3; Iwamoto K, 2007, J NEUROSCI METH, V165, P104, DOI 10.1016/j.jneumeth.2007.05.029; Johnson NA, 2006, LAB INVEST, V86, P968, DOI 10.1038/labinvest.3700441; Kato T, 2002, LIFE SCI, V71, P581, DOI 10.1016/S0024-3205(02)01725-3; Kingsbury MA, 2006, CELL MOL LIFE SCI, V63, P2626, DOI 10.1007/s00018-006-6169-5; Klein CA, 1999, P NATL ACAD SCI USA, V96, P4494, DOI 10.1073/pnas.96.8.4494; Langmore JP, 2002, PHARMACOGENOMICS, V3, P557, DOI 10.1517/14622416.3.4.557; Lasken RS, 2003, TRENDS BIOTECHNOL, V21, P531, DOI 10.1016/j.tibtech.2003.09.010; Le Caignec C, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl336; Lovmar L, 2006, HUM MUTAT, V27, P603, DOI 10.1002/humu.20341; Marcy Y, 2007, PLOS GENET, V3, P1702, DOI 10.1371/journal.pgen.0030155; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Paez JG, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh069; Rook MS, 2004, AM J PATHOL, V164, P23, DOI 10.1016/S0002-9440(10)63092-1; SATO T, 1989, BRIT J HAEMATOL, V72, P184, DOI 10.1111/j.1365-2141.1989.tb07681.x; Sermon K, 1996, MOL HUM REPROD, V2, P209, DOI 10.1093/molehr/2.3.209; Spits C, 2006, HUM MUTAT, V27, P496, DOI 10.1002/humu.20324; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; Stoecklein NH, 2002, AM J PATHOL, V161, P43, DOI 10.1016/S0002-9440(10)64155-7; TELENIUS H, 1992, GENOMICS, V13, P718, DOI 10.1016/0888-7543(92)90147-K; Wang VW, 2001, CANCER RES, V61, P4169; ZHANG L, 1992, P NATL ACAD SCI USA, V89, P5847, DOI 10.1073/pnas.89.13.5847	35	32	36	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1306	10.1371/journal.pone.0001306	http://dx.doi.org/10.1371/journal.pone.0001306			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074030	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459500025
J	McCracken, SRC; Ramsay, A; Heer, R; Mathers, ME; Jenkins, BL; Edwards, J; Robson, CN; Marquez, R; Cohen, P; Leung, HY				McCracken, S. R. C.; Ramsay, A.; Heer, R.; Mathers, M. E.; Jenkins, B. L.; Edwards, J.; Robson, C. N.; Marquez, R.; Cohen, P.; Leung, H. Y.			Aberrant expression of extracellular signal-regulated kinase 5 in human prostate cancer	ONCOGENE			English	Article						prostate cancer; ERK5; MEK5	ACTIVATED PROTEIN-KINASE; RECEPTOR TYROSINE KINASES; MAP KINASE; DIFFERENTIAL EXPRESSION; ERK5; PROLIFERATION; MEK5; OVEREXPRESSION; IDENTIFICATION; BMK1/ERK5	Abnormal intracellular signaling contributes to carcinogenesis and may represent novel therapeutic targets. mitogen/extracellular signal-regulated kinase kinase-5 (MEK5) overexpression is associated with aggressive prostate cancer. In this study, we examined the role of extracellular signal-regulated kinase (ERK5, an MAPK and specific substrate for MEK5) in prostate cancer. ERK5 immunoreactivity was significantly upregulated in high-grade prostate cancer when compared to benign prostatic hyperplasia (P < 0.0001). Increased ERK5 cytoplasmic signals correlated closely with Gleason sum score (P < 0.0001), bony metastases (P = 0.0044) and locally advanced disease at diagnosis (P = 0.0023), with a weak association with shorter disease-specific survival (P = 0.036). A subgroup of patients showed strong nuclear ERK5 localization, which correlated with poor diseasespecific survival and, on multivariant analysis, was an independent prognostic factor (P < 0.0001). Analysis of ERK5 expression in matched tumor pairs (before and after hormone relapse, n = 26) revealed ERK5 nuclear expression was significantly associated with hormone-insensitive disease (P = 0.0078). Similarly, ERK5 protein expression was increased in an androgen-independent LNCaP subline. We obtained the following in vitro and in vivo evidence to support the above expression data: (1) cotransfection of ERK5wt and MEK5D constructs in PC3 cells results in predominant ERK5 nuclear localization, similar to that observed in aggressive clinical disease; (2) ERK5-overexpressing PC3 cells have enhanced proliferative, migrative and invasive capabilities in vitro (P < 0.0001), and were dramatically more efficient in forming tumors, with a shorter mean time for tumors to reach a critical volume of 1000 mm(3), in vivo (P < 0.0001); (3) the MEK1 inhibitor, PD184352, blocking ERK1/2 activation at low dose, did not suppress proliferation but did significantly decrease proliferation at a higher dose required to inhibit ERK5 activation. Taken together, our results establish the potential importance of ERK5 in aggressive prostate cancer.	[McCracken, S. R. C.; Heer, R.; Jenkins, B. L.; Robson, C. N.; Leung, H. Y.] Univ Newcastle, No Inst Canc Res, Urol Res Grp, Newcastle Upon Tyne, Tyne & Wear, England; [Ramsay, A.; Leung, H. Y.] Beatson Inst Canc Res, Canc Res UK Labs, Glasgow G61 1BD, Lanark, Scotland; [Ramsay, A.; Edwards, J.; Leung, H. Y.] Univ Glasgow, Sect Surg & Translat Res, Div Canc Sci & Mol Pathol, Glasgow, Lanark, Scotland; [Mathers, M. E.] Royal Victoria Infirm, Dept Cellular Pathol, Newcastle Upon Tyne, Tyne & Wear, England; [Marquez, R.; Cohen, P.] Univ Dundee, Med Res Council Protein, Phosphorylat Unit, Sch Life Sci, Dundee, Scotland	Newcastle University - UK; Beatson Institute; University of Glasgow; Newcastle University - UK; University of Dundee	Leung, HY (corresponding author), Glasgow Royal Infirm, Univ Sect Surg, Univ Tower Level 2, Glasgow G31 2ER, Lanark, Scotland.	h.leung@beatson.gla.ac.uk	Edwards, Joanne/J-1903-2015; Marquez, Rudi/F-4045-2014	Edwards, Joanne/0000-0002-7192-6906; Marquez, Rudi/0000-0001-9777-2012; Leung, Hing Y./0000-0002-3933-3975	Medical Research Council [MC_U127084348, G0500966] Funding Source: Medline; MRC [MC_U127084348, G0500966] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Adler HL, 1999, J UROLOGY, V161, P182, DOI 10.1016/S0022-5347(01)62092-5; Armes JE, 1999, CANCER RES, V59, P2011; Barros JC, 2005, J CELL SCI, V118, P1663, DOI 10.1242/jcs.02308; Bartlett JMS, 2005, J PATHOL, V205, P522, DOI 10.1002/path.1735; Bouras T, 2001, CANCER RES, V61, P903; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Buschbeck M, 2005, J BIOL CHEM, V280, P2659, DOI 10.1074/jbc.M412599200; Cameron SJ, 2003, J BIOL CHEM, V278, P18682, DOI 10.1074/jbc.M213283200; Carvajal-Vergara X, 2005, BLOOD, V105, P4492, DOI 10.1182/blood-2004-08-2985; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; Dudderidge TJ, 2007, BRIT J CANCER, V96, P1384, DOI 10.1038/sj.bjc.6603718; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; ENGLISH JM, 1995, J BIOL CHEM, V270, P28897, DOI 10.1074/jbc.270.48.28897; Gnanapragasam V, 2003, BRIT J CANCER, V88, P1432, DOI 10.1038/sj.bjc.6600875; Hayashi M, 2005, CANCER RES, V65, P7699, DOI 10.1158/0008-5472.CAN-04-4540; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Kamakura S, 1999, J BIOL CHEM, V274, P26563, DOI 10.1074/jbc.274.37.26563; Kasler HG, 2000, MOL CELL BIOL, V20, P8382, DOI 10.1128/MCB.20.22.8382-8389.2000; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kato Y, 1998, NATURE, V395, P713, DOI 10.1038/27234; Kondoh K, 2006, MOL CELL BIOL, V26, P1679, DOI 10.1128/MCB.26.5.1679-1690.2006; Mehta PB, 2003, ONCOGENE, V22, P1381, DOI 10.1038/sj.onc.1206154; Mody N, 2003, BIOCHEM J, V372, P567, DOI 10.1042/BJ20030193; Mody N, 2001, FEBS LETT, V502, P21, DOI 10.1016/S0014-5793(01)02651-5; Okamoto M, 1997, ENDOCRINOLOGY, V138, P5071, DOI 10.1210/en.138.11.5071; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Regan CP, 2002, P NATL ACAD SCI USA, V99, P9248, DOI 10.1073/pnas.142293999; Rubin MA, 2000, CLIN CANCER RES, V6, P1038; Selcher JC, 2001, LEARN MEMORY, V8, P11, DOI 10.1101/lm.37001; Sohn SJ, 2002, J BIOL CHEM, V277, P43344, DOI 10.1074/jbc.M207573200; Terasawa K, 2003, GENES CELLS, V8, P263, DOI 10.1046/j.1365-2443.2003.00631.x; Uzgare AR, 2003, PROSTATE, V55, P128, DOI 10.1002/pros.10212; Wang X, 2005, MOL CELL BIOL, V25, P336, DOI 10.1128/MCB.25.1.336-345.2005; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	34	68	72	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2008	27	21					2978	2988		10.1038/sj.onc.1210963	http://dx.doi.org/10.1038/sj.onc.1210963			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18071319	Green Accepted			2022-12-25	WOS:000255681700005
J	Odgerel, T; Kikuchi, J; Wada, T; Shimizu, R; Futaki, K; Kano, Y; Furukawa, Y				Odgerel, T.; Kikuchi, J.; Wada, T.; Shimizu, R.; Futaki, K.; Kano, Y.; Furukawa, Y.			The FLT3 inhibitor PKC412 exerts differential cell cycle effects on leukemic cells depending on the presence of FLT3 mutations	ONCOGENE			English	Article						FLT3 inhibitor; leukemia; cell cycle; CDC2; CDC25; bad	INTERNAL TANDEM DUPLICATION; TYROSINE KINASE INHIBITOR; ACUTE MYELOID-LEUKEMIA; SIGNAL-TRANSDUCTION; DEATH MACHINERY; BAD; PHOSPHORYLATION; PROTEIN; STAUROSPORINE; ACTIVATION	PKC412 is a staurosporine derivative that inhibits several protein kinases including FLT3, and is highly anticipated as a novel therapeutic agent for acute myeloblastic leukemia (AML) carrying FLT3 mutations. In this study, we show that PKC412 exerts differential cell cycle effects on AML cells depending on the presence of FLT3 mutations. PKC412 elicits massive apoptosis without markedly affecting cell cycle patterns in AML cell lines with FLT3 mutations (MV4-11 and MOLM13), whereas it induces G(2) arrest but not apoptosis in AML cell lines without FLT3 mutations (THP-1 and U937). In MV4-11 and MOLM13 cells, PKC412 inactivates Myt-1 and activates CDC25c, leading to the activation of CDC2. Activated CDC2 phosphorylates Bad at serine-128 and facilitates its translocation to the mitochondria, where Bad triggers apoptosis. In contrast, PKC412 inactivates CDC2 by inducing serine-216 phosphorylation and subsequent cytoplasmic sequestration of CDC25c in THP-1 and U937 cells. As a result, cells are arrested in the G2 phase of the cell cycle, but do not undergo apoptosis because Bad is not activated. The FLT3 mutation-dependent differential cell cycle effect of PKC412 is considered an important factor when PKC412 is combined with cell cycle-specific anticancer drugs in the treatment of cancer and leukemia.	[Odgerel, T.; Kikuchi, J.; Wada, T.; Shimizu, R.; Futaki, K.; Furukawa, Y.] Ctr Mol Med, Jichi Med Sch, Div Stem Cell Regulat, Shimotsuke, Tochigi 3290498, Japan	Jichi Medical University	Furukawa, Y (corresponding author), Ctr Mol Med, Jichi Med Sch, Div Stem Cell Regulat, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	furuyu@jichi.ac.jp	Furukawa, Yusuke/Y-1342-2018	Furukawa, Yusuke/0000-0002-7249-6418				Begemann M, 1998, ANTICANCER RES, V18, P2275; Donovan N, 2002, J BIOL CHEM, V277, P40944, DOI 10.1074/jbc.M206113200; Furukawa Y, 2007, LEUKEMIA, V21, P1005, DOI 10.1038/sj.leu.2404593; GALAKTIONOV K, 1995, GENE DEV, V9, P1046, DOI 10.1101/gad.9.9.1046; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Gilliland DG, 2002, BLOOD, V100, P1532, DOI 10.1182/blood-2002-02-0492; Green DR, 2006, CANCER CELL, V9, P328, DOI 10.1016/j.ccr.2006.05.004; Griffin JD, 2004, HEMATOL J, V5, pS188, DOI 10.1038/sj.thj.6200450; Ikegami Y, 1996, ARZNEIMITTEL-FORSCH, V46, P201; Kelly LM, 2002, BLOOD, V99, P310, DOI 10.1182/blood.V99.1.310; Kim KT, 2006, BRIT J HAEMATOL, V134, P500, DOI 10.1111/j.1365-2141.2006.06225.x; Kiyoi H, 1997, LEUKEMIA, V11, P1447, DOI 10.1038/sj.leu.2400756; Konishi Y, 2002, MOL CELL, V9, P1005, DOI 10.1016/S1097-2765(02)00524-5; Levis M, 2005, INT J HEMATOL, V82, P100, DOI 10.1532/IJH97.05079; Levis M, 2004, BLOOD, V104, P1145, DOI 10.1182/blood-2004-01-0388; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; LYMAN SD, 1993, CELL, V75, P1157, DOI 10.1016/0092-8674(93)90325-K; Neben K, 2005, ONCOGENE, V24, P1580, DOI 10.1038/sj.onc.1208344; Propper DJ, 2001, J CLIN ONCOL, V19, P1485, DOI 10.1200/JCO.2001.19.5.1485; Quentmeier H, 2003, LEUKEMIA, V17, P120, DOI 10.1038/sj.leu.2402740; Schmitt E, 2007, ONCOGENE, V26, P5851, DOI 10.1038/sj.onc.1210396; SMALL D, 1994, P NATL ACAD SCI USA, V91, P459, DOI 10.1073/pnas.91.2.459; Stone RM, 2005, BLOOD, V105, P54, DOI 10.1182/blood-2004-03-0891; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Weisberg E, 2002, CANCER CELL, V1, P433, DOI 10.1016/S1535-6108(02)00069-7; Yang XP, 2005, CANCER RES, V65, P7338, DOI 10.1158/0008-5472.CAN-04-2263; Yao Q, 2003, CLIN CANCER RES, V9, P4483; Yee KWH, 2004, BLOOD, V104, P4202, DOI 10.1182/blood-2003-10-3381; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3	29	23	24	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	22					3102	3110		10.1038/sj.onc.1210980	http://dx.doi.org/10.1038/sj.onc.1210980			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	301LL	18071308				2022-12-25	WOS:000255897600003
J	Stack, CM; Caffrey, CR; Donnelly, SM; Seshaadri, A; Lowther, J; Tort, JF; Collins, PR; Robinson, MW; Xu, W; McKerrow, JH; Craik, CS; Geiger, SR; Marion, R; Brinen, LS; Dalton, JP				Stack, Colin M.; Caffrey, Conor R.; Donnelly, Sheila M.; Seshaadri, Amritha; Lowther, Jonathan; Tort, Jose F.; Collins, Peter R.; Robinson, Mark W.; Xu, Weibo; McKerrow, James H.; Craik, Charles S.; Geiger, Sebastian R.; Marion, Rachel; Brinen, Linda S.; Dalton, John P.			Structural and functional relationships in the virulence-associated cathepsin L proteases of the parasitic liver fluke, Fasciola hepatica	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEAVAGE SITES; CYSTEINE PROTEASES; PROTEINASES; SPECIFICITY; INHIBITION; AUTOACTIVATION; DETERMINANTS; COLLAGEN; REVEALS; DEGRADE	The helminth parasite Fasciola hepatica secretes cysteine proteases to facilitate tissue invasion, migration, and development within the mammalian host. The major proteases cathepsin L1 (FheCL1) and cathepsin L2 (FheCL2) were recombinantly produced and biochemically characterized. By using site-directed mutagenesis, we show that residues at position 67 and 205, which lie within the S2 pocket of the active site, are critical in determining the substrate and inhibitor specificity. FheCL1 exhibits a broader specificity and a higher substrate turnover rate compared with FheCL2. However, FheCL2 can efficiently cleave substrates with a Pro in the P2 position and degrade collagen within the triple helices at physiological pH, an activity that among cysteine proteases has only been reported for human cathepsin K. The 1.4-angstrom three-dimensional structure of the FheCL1 was determined by x-ray crystallography, and the three-dimensional structure of FheCL2 was constructed via homology-based modeling. Analysis and comparison of these structures and our biochemical data with those of human cathepsins L and K provided an interpretation of the substrate-recognition mechanisms of these major parasite proteases. Furthermore, our studies suggest that a configuration involving residue 67 and the "gatekeeper" residues 157 and 158 situated at the entrance of the active site pocket create a topology that endows FheCL2 with its unusual collagenolytic activity. The emergence of a specialized collagenolytic function in Fasciola likely contributes to the success of this tissue-invasive parasite.	[Stack, Colin M.; Donnelly, Sheila M.; Lowther, Jonathan; Tort, Jose F.; Collins, Peter R.; Robinson, Mark W.; Xu, Weibo; Dalton, John P.] Univ Technol Sydney, Inst Biotechnol Infect Dis, Sydney, NSW 2007, Australia; [Caffrey, Conor R.; Seshaadri, Amritha; McKerrow, James H.] Univ Calif San Francisco, Sandler Ctr Basic Res Parasit Dis, San Francisco, CA 94158 USA; [Tort, Jose F.] Univ Repub, Fac Med, Dept Genet, Montevideo 11800, Uruguay; [Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Craik, Charles S.] Univ Calif San Francisco, Dept Pharmacol, San Francisco, CA 94158 USA; [Craik, Charles S.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Geiger, Sebastian R.; Marion, Rachel; Brinen, Linda S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA	University of Technology Sydney; University of California System; University of California San Francisco; Universidad de la Republica, Uruguay; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Dalton, JP (corresponding author), Univ Technol Sydney, Inst Biotechnol Infect Dis, Level 6 Bldg 4 Cornor Thomas & Harris St, Sydney, NSW 2007, Australia.	john.dalton@uts.edu.au	Donnelly, Sheila/H-7733-2014; Dalton, John/K-4457-2014; Stack, Colin M/D-4601-2009; Tort, Jose/AAF-2423-2020	Tort, Jose/0000-0003-3950-9982; Robinson, Mark/0000-0001-7191-0034; Donnelly, Sheila/0000-0003-2005-3698; Stack, Colin/0000-0002-7539-7677	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053247] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI053247, AI 053247] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abdulla MH, 2007, PLOS MED, V4, P130, DOI 10.1371/journal.pmed.0040014; Arnold, 2001, CRYSTALLOGRAPHY BIOL, P720; Atley LM, 2000, BONE, V26, P241, DOI 10.1016/S8756-3282(99)00270-7; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beckham SA, 2006, BIOL CHEM, V387, P1053, DOI 10.1515/BC.2006.130; Berasain P, 1997, J PARASITOL, V83, P1, DOI 10.2307/3284308; Berasain P, 2000, EXP PARASITOL, V94, P99, DOI 10.1006/expr.1999.4479; Borgsteede FHM, 2005, VET REC, V156, P350, DOI 10.1136/vr.156.11.350; Brinen LS, 2000, STRUCT FOLD DES, V8, P831, DOI 10.1016/S0969-2126(00)00173-8; BROMME D, 1994, J BIOL CHEM, V269, P30238; Buhling F, 2001, J PATHOL, V195, P375; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; CHOTHIA C, 1974, NATURE, V248, P338, DOI 10.1038/248338a0; Collins PR, 2004, J BIOL CHEM, V279, P17038, DOI 10.1074/jbc.M308831200; Coulombe R, 1996, EMBO J, V15, P5492, DOI 10.1002/j.1460-2075.1996.tb00934.x; Dalton JP, 2006, PARASITIC FLATWORMS: MOLECULAR BIOLOGY, BIOCHEMISTRY, IMMUNOLOGY AND PHYSIOLOGY, P348, DOI 10.1079/9780851990279.0348; Dalton JP, 2003, INT J PARASITOL, V33, P1173, DOI 10.1016/S0020-7519(03)00171-1; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; DOWD AJ, 1995, EUR J BIOCHEM, V232, P241, DOI 10.1111/j.1432-1033.1995.tb20805.x; DOWD AJ, 1994, EUR J BIOCHEM, V223, P91, DOI 10.1111/j.1432-1033.1994.tb18969.x; Dowd AJ, 1997, MOL BIOCHEM PARASIT, V88, P163, DOI 10.1016/S0166-6851(97)00090-X; Drake FH, 1996, J BIOL CHEM, V271, P12511, DOI 10.1074/jbc.271.21.12511; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Gillmor SA, 1997, PROTEIN SCI, V6, P1603, DOI 10.1002/pro.5560060801; GREEN GDJ, 1981, J BIOL CHEM, V256, P1923; HANNA REB, 1983, PARASITE IMMUNOL, V5, P409, DOI 10.1111/j.1365-3024.1983.tb00756.x; Irving JA, 2003, J MOL EVOL, V57, P1, DOI 10.1007/s00239-002-2434-x; Ishidoh K, 1998, BIOL CHEM, V379, P131; KIRSCHKE H, 1988, FEBS LETT, V228, P128, DOI 10.1016/0014-5793(88)80600-8; KIRSCHKE H, 1981, BIOCHEM BIOPH RES CO, V101, P454, DOI 10.1016/0006-291X(81)91281-X; Kumar S, 2001, BIOINFORMATICS, V17, P1244, DOI 10.1093/bioinformatics/17.12.1244; Lecaille F, 2002, BIOCHEMISTRY-US, V41, P8447, DOI 10.1021/bi025638x; Lecaille F, 2007, PROTEIN SCI, V16, P662, DOI 10.1110/ps.062666607; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LI Z, 1994, J BIOL CHEM, V279, P5470; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Mas-Coma S, 2005, INT J PARASITOL, V35, P1255, DOI 10.1016/j.ijpara.2005.07.010; McManus DP, 2006, PARASITOLOGY, V133, pS43, DOI 10.1017/S0031182006001806; Mitchell GBB, 1998, VET REC, V143, P399; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Perrakis A, 1997, ACTA CRYSTALLOGR D, V53, P448, DOI 10.1107/S0907444997005696; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; ROCHE L, 1997, EUR J BIOCHEM, V232, P241; Sajid M, 2002, MOL BIOCHEM PARASIT, V120, P1, DOI 10.1016/S0166-6851(01)00438-8; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Smooker PM, 2000, PROTEIN SCI, V9, P2567, DOI 10.1110/ps.9.12.2567; Stack CM, 2007, J BIOL CHEM, V282, P16532, DOI 10.1074/jbc.M611501200; TIAN WX, 1982, BIOCHEMISTRY-US, V21, P1028, DOI 10.1021/bi00534a031; Tort J, 1999, ADV PARASIT, V43, P161, DOI 10.1016/S0065-308X(08)60243-2; van den Bedem H, 2005, ACTA CRYSTALLOGR D, V61, P2, DOI 10.1107/S0907444904025697; Wang D, 2002, BIOCHEMISTRY-US, V41, P8849, DOI 10.1021/bi0257080; Wasilewski MM, 1996, MOL BIOCHEM PARASIT, V81, P179, DOI 10.1016/0166-6851(96)02703-X; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	57	78	79	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 11	2008	283	15					9896	9908		10.1074/jbc.M708521200	http://dx.doi.org/10.1074/jbc.M708521200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	283YE	18160404	Green Published, hybrid			2022-12-25	WOS:000254671600046
J	Hernandez-Deviez, DJ; Howes, MT; Laval, SH; Bushby, K; Hancock, JF; Parton, RG				Hernandez-Deviez, Delia J.; Howes, Mark T.; Laval, Steven H.; Bushby, Kate; Hancock, John F.; Parton, Robert G.			Caveolin regulates endocytosis of the muscle repair protein, dysferlin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIRDLE MUSCULAR-DYSTROPHY; TRANS-GOLGI-NETWORK; MIYOSHI MYOPATHY; PLASMA-MEMBRANE; SKELETAL-MUSCLE; LIPID RAFTS; PHENOTYPIC BEHAVIOR; FER-1-LIKE PROTEIN; TARGETING DOMAIN; DISTAL MYOPATHY	Dysferlin and Caveolin-3 are plasma membrane proteins associated with muscular dystrophy. Patients with mutations in the CAV3 gene show dysferlin mislocalization in muscle cells. By utilizing caveolin-null cells, expression of caveolin mutants, and different mutants of dysferlin, we have dissected the site of action of caveolin with respect to dysferlin trafficking pathways. We now show that Caveolin-1 or -3 can facilitate exit of a dysferlin mutant that accumulates in the Golgi complex of Cav1(-/-) cells. In contrast, wild type dysferlin reaches the plasma membrane but is rapidly endocytosed in Cav1(-/-) cells. We demonstrate that the primary effect of caveolin is to cause surface retention of dysferlin. Caveolin-1 or Caveolin-3, but not specific caveolin mutants, inhibit endocytosis of dysferlin through a clathrin-independent pathway colocalizing with internalized glycosylphosphatidylinositol-anchored proteins. Our results provide new insights into the role of this endocytic pathway in surface remodeling of specific surface components. In addition, they highlight a novel mechanism of action of caveolins relevant to the pathogenic mechanisms underlying caveolin-associated disease.	[Hernandez-Deviez, Delia J.; Howes, Mark T.; Hancock, John F.; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Laval, Steven H.; Bushby, Kate] Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	University of Queensland; University of Queensland; Newcastle University - UK	Parton, RG (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.	R.Parton@imb.uq.edu.au	Parton, Robert G/C-5673-2009	Parton, Robert G/0000-0002-7494-5248; Hancock, John/0000-0003-0542-4710; Howes, Mark/0000-0002-9666-3364	MRC [G0601943] Funding Source: UKRI; Medical Research Council [G0601943] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aoki M, 2001, NEUROLOGY, V57, P271, DOI 10.1212/WNL.57.2.271; Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Bashir R, 1998, NAT GENET, V20, P37, DOI 10.1038/1689; Betz RC, 2001, NAT GENET, V28, P218, DOI 10.1038/90050; Borgonovo B, 2002, NAT CELL BIOL, V4, P955, DOI 10.1038/ncb888; Brazer SCW, 2003, J BIOL CHEM, V278, P27208, DOI 10.1074/jbc.M301118200; Britton S, 2000, GENOMICS, V68, P313, DOI 10.1006/geno.2000.6290; Capanni C, 2003, EXP MOL MED, V35, P538, DOI 10.1038/emm.2003.70; Carbone I, 2000, NEUROLOGY, V54, P1373, DOI 10.1212/WNL.54.6.1373; Carozzi AJ, 2002, J BIOL CHEM, V277, P17944, DOI 10.1074/jbc.M110879200; Cheng ZJ, 2006, MOL MEMBR BIOL, V23, P101, DOI 10.1080/09687860500460041; Cocucci E, 2004, MOL BIOL CELL, V15, P5356, DOI 10.1091/mbc.E04-07-0577; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Davis DB, 2000, HUM MOL GENET, V9, P217, DOI 10.1093/hmg/9.2.217; de Paula F, 2001, AM J MED GENET, V99, P303, DOI 10.1002/1096-8628(2001)9999:9999<::AID-AJMG1168>3.0.CO;2-O; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Doyle DD, 2003, BIOCHEM BIOPH RES CO, V304, P22, DOI 10.1016/S0006-291X(03)00528-X; Draviam RA, 2006, TRAFFIC, V7, P793, DOI 10.1111/j.1600-0854.2006.00433.x; DUPREE P, 1993, EMBO J, V12, P1597, DOI 10.1002/j.1460-2075.1993.tb05804.x; Fanin M, 1997, J MED GENET, V34, P973, DOI 10.1136/jmg.34.12.973; Figarella-Branger D, 2003, NEUROLOGY, V61, P562, DOI 10.1212/01.WNL.0000076486.57572.5C; Fischer D, 2003, ANN NEUROL, V53, P233, DOI 10.1002/ana.10442; Galbiati F, 1999, J BIOL CHEM, V274, P25632, DOI 10.1074/jbc.274.36.25632; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Huang YC, 2007, FASEB J, V21, P732, DOI 10.1096/fj.06-6628com; Ikonen E, 2004, BIOCHEM SOC T, V32, P121, DOI 10.1042/BST0320121; Illa I, 2001, ANN NEUROL, V49, P130, DOI 10.1002/1531-8249(200101)49:1<130::AID-ANA22>3.0.CO;2-0; Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Kubisch C, 2003, ANN NEUROL, V53, P512, DOI 10.1002/ana.10501; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Le PU, 2002, J BIOL CHEM, V277, P3371, DOI 10.1074/jbc.M111240200; Liu J, 1998, NAT GENET, V20, P31, DOI 10.1038/1682; Luetterforst R, 1999, J CELL BIOL, V145, P1443, DOI 10.1083/jcb.145.7.1443; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Matsuda C, 1999, NEUROLOGY, V53, P1119, DOI 10.1212/WNL.53.5.1119; Matsuda C, 2001, HUM MOL GENET, V10, P1761, DOI 10.1093/hmg/10.17.1761; MCNALLY EM, 1994, P NATL ACAD SCI USA, V91, P9690, DOI 10.1073/pnas.91.21.9690; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; Merlini L, 2002, J NEUROL NEUROSUR PS, V73, P65, DOI 10.1136/jnnp.73.1.65; Mikoshiba K, 1999, CHEM PHYS LIPIDS, V98, P59, DOI 10.1016/S0009-3084(99)00018-3; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; MONIER S, 1995, MOL BIOL CELL, V6, P911, DOI 10.1091/mbc.6.7.911; Morrow IC, 2002, J BIOL CHEM, V277, P48834, DOI 10.1074/jbc.M209082200; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; Nalefski EA, 1996, PROTEIN SCI, V5, P2375, DOI 10.1002/pro.5560051201; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Newton AJ, 2006, P NATL ACAD SCI USA, V103, P17955, DOI 10.1073/pnas.0606212103; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Pallanck L, 2003, TRENDS NEUROSCI, V26, P2, DOI 10.1016/S0166-2236(02)00007-3; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2001, NAT CELL BIOL, V3, P473, DOI 10.1038/35074539; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Razani B, 2001, J BIOL CHEM, V276, P38121; Razani B, 2000, J CELL SCI, V113, P2103; Ren XY, 2004, MOL BIOL CELL, V15, P4556, DOI 10.1091/mbc.E04-06-0480; Rizo J, 1998, J BIOL CHEM, V273, P15879, DOI 10.1074/jbc.273.26.15879; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Scherer PE, 1997, J BIOL CHEM, V272, P29337, DOI 10.1074/jbc.272.46.29337; Sharma DK, 2004, MOL BIOL CELL, V15, P3114, DOI 10.1091/mbc.E04-03-0189; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Sotgia F, 2002, MOL CELL BIOL, V22, P3905, DOI 10.1128/MCB.22.11.3905-3926.2002; Sotgia F, 2003, AM J PHYSIOL-CELL PH, V285, pC1150, DOI 10.1152/ajpcell.00166.2003; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Tang ZL, 1996, J BIOL CHEM, V271, P2255, DOI 10.1074/jbc.271.4.2255; Tateyama M, 2002, NEUROLOGY, V58, P323, DOI 10.1212/WNL.58.2.323; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Vorgerd M, 2001, NEUROLOGY, V57, P2273, DOI 10.1212/WNL.57.12.2273; WAY M, 1995, FEBS LETT, V376, P108, DOI 10.1016/0014-5793(95)01256-7; Weiler T, 1999, HUM MOL GENET, V8, P871, DOI 10.1093/hmg/8.5.871; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Wyse BD, 2003, J BIOL CHEM, V278, P23738, DOI 10.1074/jbc.M212892200; Yabe I, 2003, ACTA NEUROL SCAND, V108, P47, DOI 10.1034/j.1600-0404.2003.00083.x; Yasunaga S, 1999, NAT GENET, V21, P363, DOI 10.1038/7693	80	70	72	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6476	6488		10.1074/jbc.M708776200	http://dx.doi.org/10.1074/jbc.M708776200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18096699	hybrid			2022-12-25	WOS:000253779500055
J	Kowieski, TM; Lee, S; Denu, JM				Kowieski, Terri M.; Lee, Susan; Denu, John M.			Acetylation-dependent ADP-ribosylation by Trypanosoma brucei Sir2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SILENCING PROTEIN SIR2; PANCREATIC BETA-CELLS; HISTONE/PROTEIN DEACETYLASES; CALORIE RESTRICTION; NAD(+)-DEPENDENT DEACETYLASES; TRANSCRIPTION FACTORS; HISTONE DEACETYLASE; SIR2-LIKE PROTEINS; INSULIN-SECRETION; INCREASED DOSAGE	Sirtuins are a highly conserved family of proteins implicated in diverse cellular processes such as gene silencing, aging, and metabolic regulation. Although many sirtuins catalyze a well characterized protein/histone deacetylation reaction, there are a number of reports that suggest protein ADP-ribosyltransferase activity. Here we explored the mechanisms of ADP-ribosylation using the Trypanosoma brucei Sir2 homologue TbSIR2rp1 as a model for sirtuins that reportedly display both activities. Steady-state kinetic analysis revealed a highly active histone deacetylase (k(cat) = 0.1 s(-1), with K-m values of 42 mu M and for NAD(+) and 65 mu M for acetylated substrate). A series of biochemical assays revealed that TbSIR2rp1 ADP-ribosylation of protein/histone requires an acetylated substrate. The data are consistent with two distinct ADP-ribosylation pathways that involve an acetylated substrate, NAD(+) and TbSIR2rp1 as follows: 1) a noncatalytic reaction between the deacetylation product O-acetyl-ADP-ribose (or its hydrolysis product ADP-ribose) and histones, and 2) a more efficient mechanism involving interception of an ADP-ribose-acetylpeptide-enzyme intermediate by a side-chain nucleophile from bound histone. However, the sum of both ADP-ribosylation reactions was similar to 5 orders of magnitude slower than histone deacetylation under identical conditions. The biological implications of these results are discussed.	[Kowieski, Terri M.; Lee, Susan; Denu, John M.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Denu, JM (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Biomol Chem, 1300 Univ Ave, Madison, WI 53706 USA.	jmdenu@wisc.edu						Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Alsford S, 2007, MOL MICROBIOL, V63, P724, DOI 10.1111/j.1365-2958.2006.05553.x; Berndsen CE, 2007, BIOCHEMISTRY-US, V46, P623, DOI 10.1021/bi602513x; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Borra MT, 2004, METHOD ENZYMOL, V376, P171; Borra MT, 2004, BIOCHEMISTRY-US, V43, P9877, DOI 10.1021/bi049592e; Borra MT, 2002, J BIOL CHEM, V277, P12632, DOI 10.1074/jbc.M111830200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; CervantesLaurean D, 1996, J BIOL CHEM, V271, P10461, DOI 10.1074/jbc.271.18.10461; CERVANTESLAUREAN D, 1993, BIOCHEMISTRY-US, V32, P1528, DOI 10.1021/bi00057a017; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Denu JM, 2005, CURR OPIN CHEM BIOL, V9, P431, DOI 10.1016/j.cbpa.2005.08.010; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Garcia-Salcedo JA, 2003, EMBO J, V22, P5851, DOI 10.1093/emboj/cdg553; Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jackson MD, 2003, J BIOL CHEM, V278, P50985, DOI 10.1074/jbc.M306552200; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Luger K, 1999, METH MOL B, V119, P1; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Moynihan KA, 2005, CELL METAB, V2, P105, DOI 10.1016/j.cmet.2005.07.001; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Pagans S, 2005, PLOS BIOL, V3, P210, DOI 10.1371/journal.pbio.0030041; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rafty LA, 2002, J BIOL CHEM, V277, P47114, DOI 10.1074/jbc.M208997200; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sauve AA, 2001, BIOCHEMISTRY-US, V40, P15456, DOI 10.1021/bi011858j; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Sereno D, 2006, PARASITOL RES, V100, P1, DOI 10.1007/s00436-006-0280-2; SHAH GM, 1995, ANAL BIOCHEM, V227, P1, DOI 10.1006/abio.1995.1245; Smith BC, 2006, BIOCHEMISTRY-US, V45, P272, DOI 10.1021/bi052014t; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tanner KG, 2000, P NATL ACAD SCI USA, V97, P14178, DOI 10.1073/pnas.250422697; Tanny JC, 2001, P NATL ACAD SCI USA, V98, P415, DOI 10.1073/pnas.031563798; Tanny JC, 1999, CELL, V99, P735, DOI 10.1016/S0092-8674(00)81671-2; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tsang AW, 1998, J BIOL CHEM, V273, P31788, DOI 10.1074/jbc.273.48.31788; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Zhang J, 1997, METHOD ENZYMOL, V280, P255; ZHANG J, 1993, BIOCHEMISTRY-US, V32, P2228, DOI 10.1021/bi00060a014; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005	56	50	51	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5317	5326		10.1074/jbc.M707613200	http://dx.doi.org/10.1074/jbc.M707613200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165239	hybrid			2022-12-25	WOS:000253426700011
J	't Hoen, PAC; de Meijer, EJ; Boer, JM; Vossen, RHAM; Turk, R; Maatman, RGHJ; Davies, KE; van Ommen, GJB; van Deutekom, JCT; den Dunnen, JT				't Hoen, Peter A. C.; de Meijer, Emile J.; Boer, Judith M.; Vossen, Rolf H. A. M.; Turk, Rolf; Maatman, Ronald G. H. J.; Davies, Kay E.; van Ommen, Gert-Jan B.; van Deutekom, Judith C. T.; den Dunnen, Johan T.			Generation and characterization of transgenic mice with the full-length human DMD gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; DEFICIENT MDX MICE; GLYCOPROTEIN COMPLEX; SKELETAL-MUSCLE; SYSTEMIC DELIVERY; MOUSE MUSCLE; IN-VITRO; EXPRESSION; UTROPHIN; PROTEIN	We report the generation of mice with an intact and functional copy of the 2.3-megabase human dystrophin gene (hDMD), the largest functional stretch of human DNA thus far integrated into a mouse chromosome. Yeast spheroplasts containing an artificial chromosome with the full-length hDMD gene were fused with mouse embryonic stem cells and were subsequently injected into mouse blastocysts to produce transgenic hDMD mice. Human-specific PCR, Southern blotting, and fluorescent in situ hybridization techniques demonstrated the intactness and stable chromosomal integration of the hDMD gene on mouse chromosome 5. Expression of the transgene was confirmed by RT-PCR and Western blotting. The tissue-specific expression pattern of the different DMD transcripts was maintained. However, the human Dp427p and Dp427m transcripts were expressed at 2-fold higher levels and human Dp427c and Dp260 transcripts were expressed at 2- and 4-fold lower levels than their endogenous counterparts. Ultimate functional proof of the hDMD transgene was obtained by crossing of hDMD mice with dystrophin-deficient mdx mice and dystrophin and utrophin-deficient mdx x Utrn(-/-) mice. The hDMD transgene rescued the lethal dystrophic phenotype of the mdx x Utrn(-/-) mice. All signs of muscular dystrophy disappeared in the rescued mice, as demonstrated by histological staining of muscle sections and gene expression profiling experiments. Currently, hDMD mice are extensively used for preclinical testing of sequence-specific therapeutics for the treatment of Duchenne muscular dystrophy. In addition, the hDMD mouse can be used to study the influence of the genomic context on deletion and recombination frequencies, genome stability, and gene expression regulation.	['t Hoen, Peter A. C.; de Meijer, Emile J.; Boer, Judith M.; Vossen, Rolf H. A. M.; Turk, Rolf; Maatman, Ronald G. H. J.; van Ommen, Gert-Jan B.; van Deutekom, Judith C. T.; den Dunnen, Johan T.] Leiden Univ, Med Ctr, Ctr Human & Clin Genet, NL-2300 RC Leiden, Netherlands; [Davies, Kay E.] MRC, Dept Physiol Anat & Genet, Funct Genet Unit, Oxford OX1 3QX, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	't Hoen, PAC (corresponding author), Leiden Univ, Med Ctr, Ctr Human & Clin Genet, Postal Zone S4-P, NL-2300 RC Leiden, Netherlands.	p.a.c.hoen@lumc.nl	Hoen, Peter A 't/D-3950-2018; 't Hoen, Peter/A-4857-2012; dunnen, johan den/ABH-4228-2020; Boer, Judith/A-7546-2010; Turk, Rolf/E-7832-2010	Hoen, Peter A 't/0000-0003-4450-3112; dunnen, johan den/0000-0002-6304-1710; Turk, Rolf/0000-0003-1283-9594; Boer, Judith/0000-0003-4848-7789	Medical Research Council [MC_U137761449] Funding Source: Medline; MRC [MC_U137761449] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Alter J, 2006, NAT MED, V12, P175, DOI 10.1038/nm1345; Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Bertoni C, 2002, HUM GENE THER, V13, P707, DOI 10.1089/104303402317322276; Boer JM, 2002, NEUROMUSCULAR DISORD, V12, pS118, DOI 10.1016/S0960-8966(02)00092-5; Bremmer-Bout M, 2004, MOL THER, V10, P232, DOI 10.1016/j.ymthe.2004.05.031; Chen YW, 2000, J CELL BIOL, V151, P1321, DOI 10.1083/jcb.151.6.1321; Clemens PR, 1996, GENE THER, V3, P965; COULTON GR, 1988, NEUROPATH APPL NEURO, V14, P53, DOI 10.1111/j.1365-2990.1988.tb00866.x; Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2; DelloRusso C, 2002, P NATL ACAD SCI USA, V99, P12979, DOI 10.1073/pnas.202300099; DENDUNNEN IT, 1989, BR MED B, V45, P644; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; DENDUNNEN JT, 1992, HUM MOL GENET, V1, P19; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; Ferrer A, 2004, GENE THER, V11, P884, DOI 10.1038/sj.gt.3302242; Fisher LW, 1995, ACTA ORTHOP SCAND, V66, P61, DOI 10.3109/17453679509157649; Gilbert T, 1999, HUM GENE THER, V10, P1299, DOI 10.1089/10430349950017987; Goyenvalle A, 2004, SCIENCE, V306, P1796, DOI 10.1126/science.1104297; Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4; GUTH L, 1969, EXP NEUROL, V25, P138, DOI 10.1016/0014-4886(69)90077-6; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; LOVE DR, 1991, GENOMICS, V10, P57, DOI 10.1016/0888-7543(91)90484-V; Lu QL, 2005, P NATL ACAD SCI USA, V102, P198, DOI 10.1073/pnas.0406700102; Mann CJ, 2001, P NATL ACAD SCI USA, V98, P42, DOI 10.1073/pnas.011408598; MATSUMURA K, 1992, NATURE, V360, P588, DOI 10.1038/360588a0; McClorey G, 2006, GENE THER, V13, P1373, DOI 10.1038/sj.gt.3302800; Michele DE, 2003, J BIOL CHEM, V278, P15457, DOI 10.1074/jbc.R200031200; O'Doherty A, 2005, SCIENCE, V309, P2033, DOI 10.1126/science.1114535; Porter JD, 2003, HUM MOL GENET, V12, P1813, DOI 10.1093/hmg/ddg197; Rando TA, 2001, MUSCLE NERVE, V24, P1575, DOI 10.1002/mus.1192; Sironi M, 2003, HUM GENET, V112, P272, DOI 10.1007/s00439-002-0881-5; Szuhai K, 2006, NAT PROTOC, V1, P264, DOI 10.1038/nprot.2006.41; Taylor SS, 1996, CHROMOSOMA, V105, P70, DOI 10.1007/BF02509516; Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033; TINSLEY JM, 1992, NATURE, V360, P591, DOI 10.1038/360591a0; Turk R, 2005, FASEB J, V19, P127, DOI 10.1096/fj.05-4678fje; Turk R, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-98; van Deutekom JCT, 2003, NAT REV GENET, V4, P774, DOI 10.1038/nrg1180	42	55	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5899	5907		10.1074/jbc.M709410200	http://dx.doi.org/10.1074/jbc.M709410200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18083704	hybrid			2022-12-25	WOS:000253426700068
J	Thangasamy, A; Rogge, J; Ammanamanchi, S				Thangasamy, Amalraj; Rogge, Jessica; Ammanamanchi, Sudhakar			Regulation of RON tyrosine kinase-mediated invasion of breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MACROPHAGE-STIMULATING PROTEIN; TRANSCRIPTIONAL REPRESSION; RECEPTOR; CARCINOMA; MET; COEXPRESSION; OVEREXPRESSION; IDENTIFICATION; PROGRESSION; ACTIVATION	RON (recepteur d'origine nantais), a tyrosine kinase receptor for macrophage-stimulating protein (MSP) was implicated in tumor progression. However, it was not investigated how this important oncogene is regulated. We show that MSP promotes invasion of MDA MB 231 and MDA MB 468 but not MCF-7 breast cancer cells. Reverse transcription-PCR and Western analysis indicated the expression of RON message and protein, respectively, in MDA MB 231 and MDA MB 468 cells but not in MCF-7 cells. RON expression correlated with Sp1 expression. Initial analysis of a 1.2-kb and 400-bp RON promoter in MDA MB 231 and MDA MB 468 cells suggested the presence of all the necessary regulatory elements within 400 bp from the transcription start site. Site-directed mutagenesis of the 400-bp RON promoter revealed that the overlapping Sp1 sites at -94 (Sp1-3/4) and Sp1 site at -113 (Sp1-5) are essential for RON gene transcription. Electrophoretic mobility shift assays and chromatin immunoprecipitation analysis indicated that Sp1 binding to these sites is required for RON promoter activity. Ectopic Sp1 expression in Sp1 null SL2 cells confirmed the involvement of these Sp1 sites in the regulation of oncogenic RON tyrosine kinase. Treatment of MDA MB 231 cells with mithramycin A, an inhibitor of Sp1 binding, or siRNA knockdown of Sp1 blocked RON gene expression and MSP-mediated invasion of MDA MB 231 cells. This is the first report demonstrating a clear link between Sp1-dependent RON tyrosine kinase expression and invasion of breast carcinoma cells.	[Thangasamy, Amalraj; Rogge, Jessica; Ammanamanchi, Sudhakar] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Med Oncol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Ammanamanchi, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Med Oncol, San Antonio, TX 78229 USA.	ammanamanchi@uthscsa.edu						Ammanamanchi S, 2004, J BIOL CHEM, V279, P32620, DOI 10.1074/jbc.M402691200; Ammanamanchi S, 2001, J BIOL CHEM, V276, P3348, DOI 10.1074/jbc.M002462200; Bardella C, 2004, CANCER RES, V64, P5154, DOI 10.1158/0008-5472.CAN-04-0600; Bezerra JA, 1998, J CLIN INVEST, V101, P1175, DOI 10.1172/JCI1744; Camp ER, 2005, ANN SURG ONCOL, V12, P273, DOI 10.1245/ASO.2005.08.013; Chen QY, 1997, HEPATOLOGY, V26, P59; Chen YQ, 2000, EXP CELL RES, V261, P229, DOI 10.1006/excr.2000.5012; Cheng HL, 2005, BRIT J CANCER, V92, P1906, DOI 10.1038/sj.bjc.6602593; DELGATTO F, 1995, BBA-GENE STRUCT EXPR, V1263, P93, DOI 10.1016/0167-4781(95)00082-R; Lee TJ, 2006, MOL CANCER THER, V5, P2737, DOI 10.1158/1535-7163.MCT-06-0426; Lee WY, 2005, CLIN CANCER RES, V11, P2222, DOI 10.1158/1078-0432.CCR-04-1761; Lin HS, 2004, ARCH OTOLARYNGOL, V130, P311, DOI 10.1001/archotol.130.3.311; Maggiora P, 2003, EXP CELL RES, V288, P382, DOI 10.1016/S0014-4827(03)00250-7; Muraoka RS, 1999, J CLIN INVEST, V103, P1277, DOI 10.1172/JCI6091; Peace BE, 2003, EXP CELL RES, V289, P317, DOI 10.1016/S0014-4827(03)00280-5; Penengo L, 2003, ONCOGENE, V22, P3669, DOI 10.1038/sj.onc.1206585; Suske G, 1999, GENE, V238, P291, DOI 10.1016/S0378-1119(99)00357-1; Venkatasubbarao K, 2001, CANCER RES, V61, P6239; Waltz SE, 2001, J CLIN INVEST, V108, P567, DOI 10.1172/JCI11881; Wang MH, 2000, CARCINOGENESIS, V21, P1507, DOI 10.1093/carcin/21.8.1507; Wang MH, 2006, ACTA PHARMACOL SIN, V27, P641, DOI 10.1111/j.1745-7254.2006.00361.x; Willett CG, 1998, AM J RESP CELL MOL, V18, P489, DOI 10.1165/ajrcmb.18.4.2978; Yokoyama N, 2005, J BIOL CHEM, V280, P8893, DOI 10.1074/jbc.M412623200; Zhou YQ, 2003, ONCOGENE, V22, P186, DOI 10.1038/sj.onc.1206075; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	25	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5335	5343		10.1074/jbc.M706957200	http://dx.doi.org/10.1074/jbc.M706957200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165235	hybrid			2022-12-25	WOS:000253426700013
J	Zhao, Z; Mckee, CJ; Kessl, JJ; Santos, WL; Daigle, JE; Engelman, A; Verdine, G; Kvaratskhelia, M				Zhao, Zhuojun; McKee, Christopher J.; Kessl, Jacques J.; Santos, Webster L.; Daigle, Janet E.; Engelman, Alan; Verdine, Gregory; Kvaratskhelia, Mamuka			Subunit-specific protein footprinting reveals significant structural Rearrangements and a role for N-terminal Lys-14 of HIV-1 integrase during viral DNA binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; PHOTO-CROSS-LINKING; INDUCED CONFORMATIONAL-CHANGE; REVERSE-TRANSCRIPTASE; STRAND TRANSFER; RETROVIRAL DNA; NUCLEOCAPSID PROTEIN; CRYSTAL-STRUCTURE; CATALYTIC CORE; ACTIVE-SITE	To identify functional contacts between HIV-1 integrase ( IN) and its viral DNA substrate, we devised a new experimental strategy combining the following two methodologies. First, disulfide-mediated cross-linking was used to site-specifically link select core and C-terminal domain amino acids to respective positions in viral DNA. Next, surface topologies of free IN and IN-DNA complexes were compared using Lys-and Arg-selective small chemical modifiers and mass spectrometric analysis. This approach enabled us to dissect specific contacts made by different monomers within the multimeric complex. The footprinting studies for the first time revealed the importance of a specific N-terminal domain residue, Lys-14, in viral DNA binding. In addition, a DNA-induced conformational change involving the connection between the core and C-terminal domains was observed. Site-directed mutagenesis experiments confirmed the importance of the identified contacts for recombinant IN activities and virus infection. These new findings provided major constraints, enabling us to identify the viral DNA binding channel in the active full-length IN multimer. The experimental approach described here has general application to mapping interactions within functional nucleoprotein complexes.	[Zhao, Zhuojun; McKee, Christopher J.; Kessl, Jacques J.; Verdine, Gregory; Kvaratskhelia, Mamuka] Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Santos, Webster L.; Verdine, Gregory] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Daigle, Janet E.; Engelman, Alan] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Immunol & AIDS,Div AIDS, Boston, MA 02115 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Kvaratskhelia, M (corresponding author), Ohio State Univ, Coll Pharm, Ctr Retrovirus Res, Ctr Comprehens Canc, Columbus, OH 43210 USA.	kvaratskhelia.1@osu.edu	Kessl, Jacques/AAV-2526-2021; Kessl, Jacques/J-6073-2015	Santos, Webster/0000-0002-4731-8548	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062520, R37AI039394, R01AI039394] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM067380, R01GM044853] Funding Source: NIH RePORTER; NIAID NIH HHS [AI062520, R01 AI039394, AI039394, R37 AI039394, R01 AI062520] Funding Source: Medline; NIGMS NIH HHS [R01 GM044853-15, R01 GM044853, F32 GM067380, F32 GM067380-03] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AsanteAppiah E, 1997, J BIOL CHEM, V272, P16196, DOI 10.1074/jbc.272.26.16196; Brown P. O., 1997, P161; Buckman JS, 2003, J VIROL, V77, P1469, DOI 10.1128/JVI.77.2.1469-1480.2003; BUKRINSKY MI, 1993, P NATL ACAD SCI USA, V90, P6125, DOI 10.1073/pnas.90.13.6125; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Carteau S, 1999, J VIROL, V73, P6670, DOI 10.1128/JVI.73.8.6670-6679.1999; Carteau S, 1997, J VIROL, V71, P6225, DOI 10.1128/JVI.71.8.6225-6229.1997; Chen AP, 2006, J BIOL CHEM, V281, P4173, DOI 10.1074/jbc.M510628200; Chen HM, 1998, P NATL ACAD SCI USA, V95, P15270, DOI 10.1073/pnas.95.26.15270; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Cherepanov P, 2005, NAT STRUCT MOL BIOL, V12, P526, DOI 10.1038/nsmb937; Cherepanov P, 2003, J BIOL CHEM, V278, P372, DOI 10.1074/jbc.M209278200; Datta SAK, 2007, J MOL BIOL, V365, P799, DOI 10.1016/j.jmb.2006.10.072; De Luca L, 2005, BIOCHEM BIOPH RES CO, V336, P1010, DOI 10.1016/j.bbrc.2005.08.211; Di Santo R, 2006, J MED CHEM, V49, P1939, DOI 10.1021/jm0511583; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; ENGELMAN A, 1993, EMBO J, V12, P3269, DOI 10.1002/j.1460-2075.1993.tb05996.x; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; ENGELMAN A, 2007, FUTURE HIV THER, V1, P415; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; FARNET CM, 1990, P NATL ACAD SCI USA, V87, P4164, DOI 10.1073/pnas.87.11.4164; Gao K, 2001, EMBO J, V20, P3565, DOI 10.1093/emboj/20.13.3565; Goldgur Y, 1998, P NATL ACAD SCI USA, V95, P9150, DOI 10.1073/pnas.95.16.9150; Grobler JA, 2002, P NATL ACAD SCI USA, V99, P6661, DOI 10.1073/pnas.092056199; Guiot E, 2006, J BIOL CHEM, V281, P22707, DOI 10.1074/jbc.M602198200; Hayouka Z, 2007, P NATL ACAD SCI USA, V104, P8316, DOI 10.1073/pnas.0700781104; Hazuda DJ, 2004, P NATL ACAD SCI USA, V101, P11233, DOI 10.1073/pnas.0402357101; Hazuda DJ, 2000, SCIENCE, V287, P646, DOI 10.1126/science.287.5453.646; Heuer TS, 1998, BIOCHEMISTRY-US, V37, P6667, DOI 10.1021/bi972949c; Heuer TS, 1997, BIOCHEMISTRY-US, V36, P10655, DOI 10.1021/bi970782h; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Johnson AA, 2006, J BIOL CHEM, V281, P461, DOI 10.1074/jbc.M511348200; Karki RG, 2004, J COMPUT AID MOL DES, V18, P739, DOI 10.1007/s10822-005-0365-5; Kvaratskhelia M, 2002, P NATL ACAD SCI USA, V99, P15988, DOI 10.1073/pnas.252550199; LEE MS, 1994, P NATL ACAD SCI USA, V91, P9823, DOI 10.1073/pnas.91.21.9823; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Lewinski MK, 2006, PLOS PATHOG, V2, P611, DOI 10.1371/journal.ppat.0020060; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Liu YY, 2005, J BIOL CHEM, V280, P32775, DOI 10.1074/jbc.M505705200; Llano M, 2004, J VIROL, V78, P9524, DOI 10.1128/JVI.78.17.9524-9537.2004; Llano M, 2006, SCIENCE, V314, P461, DOI 10.1126/science.1132319; LODI PJ, 1995, BIOCHEMISTRY-US, V34, P9826, DOI 10.1021/bi00031a002; Lu R, 2005, J VIROL, V79, P2493, DOI 10.1128/JVI.79.4.2493-2505.2005; Lu R, 2004, J VIROL, V78, P12735, DOI 10.1128/JVI.78.23.12735-12746.2004; Marchand C, 2006, NUCLEIC ACIDS RES, V34, P5157, DOI 10.1093/nar/gkl667; Mazumder A, 1996, J BIOL CHEM, V271, P27330, DOI 10.1074/jbc.271.44.27330; Podtelezhnikov AA, 2003, BIOPOLYMERS, V68, P110, DOI 10.1002/bip.10217; Pommier Y, 2005, NAT REV DRUG DISCOV, V4, P236, DOI 10.1038/nrd1660; Puglia J, 2006, J VIROL, V80, P9497, DOI 10.1128/JVI.00856-06; Shell SM, 2005, BIOCHEMISTRY-US, V44, P971, DOI 10.1021/bi048208a; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Shun MC, 2007, GENE DEV, V21, P1767, DOI 10.1101/gad.1565107; Sinha S, 2002, J VIROL, V76, P3105, DOI 10.1128/JVI.76.7.3105-3113.2002; van den Ent FMI, 1999, J VIROL, V73, P3176, DOI 10.1128/JVI.73.4.3176-3183.1999; VANGENT DC, 1993, EMBO J, V12, P3261, DOI 10.1002/j.1460-2075.1993.tb05995.x; Verdine GL, 2003, ANNU REV BIOCHEM, V72, P337, DOI 10.1146/annurev.biochem.72.121801.161447; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Wielens J, 2005, J COMPUT AID MOL DES, V19, P301, DOI 10.1007/s10822-005-5256-2	61	46	47	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5632	5641		10.1074/jbc.M705241200	http://dx.doi.org/10.1074/jbc.M705241200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093980	Green Accepted, hybrid, Green Published			2022-12-25	WOS:000253426700043
J	Grechez-Cassiau, A; Rayet, B; Guillaumond, F; Teboul, M; Delaunay, F				Grechez-Cassiau, Aline; Rayet, Beatrice; Guillaumond, Fabienne; Teboul, Michele; Delaunay, Franck			The circadian clock component BMAL1 is a critical regulator of p21(WAF1/CIP1) expression and hepatocyte proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION; BONE-MARROW; GENE; RHYTHMS; P21; DIFFERENTIATION; INHIBITORS; PACEMAKER; MUCOSA; PLAYS	Most living organisms show circadian (similar to 24 h) rhythms in physiology and behavior. These oscillations are generated by endogenous circadian clocks, present in virtually all cells where they control key biological processes. Although circadian gating of mitosis has been reported for many years in some peripheral tissues, the underlying molecular mechanisms have remained poorly understood. Here we show that the cell cycle inhibitor p21(WAF1/CIP1) is rhythmically expressed in mouse peripheral organs. This rhythmic pattern of mRNA and protein expression was recapitulated in vitro in serum-shocked differentiated skeletal muscle cells. p21(WAF1/CIP1) circadian expression is dramatically increased and no longer rhythmic in clock-deficient Bmal1(-/-) knock-out mice. Biochemical and genetic data show that oscillation of p21(WAF1/CIP1) gene transcription is regulated by the antagonistic activities of the orphan nuclear receptors REV-ERB alpha/beta and ROR alpha 4/gamma, which are core clock regulators. Importantly, p21(WAF1/CIP1) overexpressing Bmal1(-/-) primary hepatocytes exhibit a decreased proliferation rate. This phenotype could be reversed using small interfering RNA-mediated knockdown of p21(WAF1/CIP1). These data establish a novel molecular link between clock and cell cycle genes and suggest that the G(1) progression phase is a target of the circadian clock during liver cell proliferation.	[Grechez-Cassiau, Aline; Rayet, Beatrice; Guillaumond, Fabienne; Teboul, Michele; Delaunay, Franck] Univ Nice Sophia Antipolis, CNRS, FRE 3094, Lab Biol & Physiopathol Syst Integres, F-06108 Nice 2, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur	Delaunay, F (corresponding author), Univ Nice Sophia Antipolis, CNRS, FRE 3094, Lab Biol & Physiopathol Syst Integres, 28 Ave Valrose, F-06108 Nice 2, France.	delaunay@unice.fr	Guillaumond, Fabienne/E-8265-2017	Guillaumond, Fabienne/0000-0001-7456-7315; Delaunay, Franck/0000-0003-4927-1701; Teboul, Michele/0000-0002-3418-4384				Biederbick A, 1998, CELL TISSUE RES, V291, P277, DOI 10.1007/s004410050997; Bjarnason GA, 1999, AM J PATHOL, V154, P613, DOI 10.1016/S0002-9440(10)65306-0; Bjarnason GA, 2002, CHRONOBIOL INT, V19, P129, DOI 10.1081/CBI-120002595; Bjarnason GA, 2001, AM J PATHOL, V158, P1793, DOI 10.1016/S0002-9440(10)64135-1; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Bunger MK, 2005, GENESIS, V41, P122, DOI 10.1002/gene.20102; Burke L, 1996, NUCLEIC ACIDS RES, V24, P3481, DOI 10.1093/nar/24.18.3481; Delaunay F, 2002, TRENDS GENET, V18, P595, DOI 10.1016/S0168-9525(02)02794-4; Di Cunto F, 1998, SCIENCE, V280, P1069, DOI 10.1126/science.280.5366.1069; Diehl AM, 2002, FRONT BIOSCI-LANDMRK, V7, pE301, DOI 10.2741/diehl; DOTTO GP, 2000, BIOCHIM BIOPHYS ACTA, V1471, P43; EDMUNDS LN, 1969, SCIENCE, V165, P500, DOI 10.1126/science.165.3892.500; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Filipski E, 2002, J NATL CANCER I, V94, P690; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gery S, 2006, MOL CELL, V22, P375, DOI 10.1016/j.molcel.2006.03.038; Granda TG, 2004, FASEB J, V18, P304, DOI 10.1096/fj.04-2665fje; Grechez-Cassiau A, 2004, J BIOL CHEM, V279, P1141, DOI 10.1074/jbc.M305369200; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; GUO K, 1995, MOL CELL BIOL, V15, P3823; Harms E, 2004, J BIOL RHYTHM, V19, P361, DOI 10.1177/0748730404268111; Hirayama J, 2005, P NATL ACAD SCI USA, V102, P10194, DOI 10.1073/pnas.0502610102; Ilyin GP, 2003, AM J PHYSIOL-GASTR L, V285, pG115, DOI 10.1152/ajpgi.00309.2002; Jascur T, 2005, MOL CELL, V17, P237, DOI 10.1016/j.molcel.2004.11.049; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Miller BH, 2007, P NATL ACAD SCI USA, V104, P3342, DOI 10.1073/pnas.0611724104; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Panda S, 2002, NATURE, V417, P329, DOI 10.1038/417329a; Pei XH, 2005, ONCOGENE, V24, P2787, DOI 10.1038/sj.onc.1208611; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rudic RD, 2004, PLOS BIOL, V2, P1893, DOI 10.1371/journal.pbio.0020377; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; SCHEVING LE, 1972, AM J ANAT, V135, P311, DOI 10.1002/aja.1001350302; SCHEVING LE, 1978, ANAT REC, V191, P479, DOI 10.1002/ar.1091910407; Smaaland R, 2002, CHRONOBIOL INT, V19, P101, DOI 10.1081/CBI-120002594; Triqueneaux G, 2004, J MOL ENDOCRINOL, V33, P585, DOI 10.1677/jme.1.01554; Ueda HR, 2005, NAT GENET, V37, P187, DOI 10.1038/ng1504	44	219	231	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4535	4542		10.1074/jbc.M705576200	http://dx.doi.org/10.1074/jbc.M705576200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086663	hybrid			2022-12-25	WOS:000253426500010
J	Umekawa, M; Huang, W; Li, B; Fujita, K; Ashida, H; Wang, LX; Yamamoto, K				Umekawa, Midori; Huang, Wei; Li, Bing; Fujita, Kiyotaka; Ashida, Hisashi; Wang, Lai-Xi; Yamamoto, Kenji			Mutants of Mucor hiemalis endo-beta-N-acetylglucosaminidase show enhanced transglycosylation and glycosynthase-like activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOENZYMATIC SYNTHESIS; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; SUBSTRATE; COMPLEX; OLIGOSACCHARIDES; GLYCOPEPTIDES; ENDOGLYCOSIDASE; IDENTIFICATION; GLYCOSYLATION	Endo-beta-N-acetylglucosaminidase from Mucor hiemalis(Endo-M), a family 85 glycoside hydrolase, acts on the beta 1,4 linkage of N,N'-diacetylchitobiose moiety in the N-linked glycans of glycoproteins and catalyzes not only the hydrolysis reaction but also the transglycosylation reaction that transfers the releasing sugar chain to an acceptor other than water to form a new glycosidic linkage. The transglycosylation activity of Endo-M holds a great promise for the chemo-enzymatic synthesis and glyco-engineering of glycoproteins, but the inherent hydrolytic activity for product hydrolysis and low transglycosylation have hampered its broad applications. This paper describes the site-directed mutagenesis on residues in the putative catalytic region of Endo-M to generate mutants with superior transglycosylation activity. Two interesting mutants were discovered. The Y217F mutant was found to possess much enhanced transglycosylation activity and yet much diminished hydrolytic activity in comparison with the wild-type Endo-M. Kinetic analyses revealed that the K-m value of Y217F for an acceptor substrate 4-methylumbel-liferyl-beta-D-N-acetylglucosaminide was only one-tenth of that of the wild-type, implicating a much higher affinity of Y217F for the acceptor substrate than the wild-type. The other mutant, N175A, acts like a glycosynthase. It was found that mutation at Asn175"knocked out" the hydrolytic activity, but the mutant was able to take the highly active sugar oxazolines ( the transition state mimics) as donor substrates for transglycosylation. This is the first glycosynthase derived from endo-beta-N-acetylglucosaminidases that proceed via a substrate-assisted mechanism. Our findings provide further insights on the substrate-assisted mechanism of GH85. The usefulness of the novel glycosynthase was exemplified by the efficient synthesis of a human immunodeficiency deficiency virus, type 1 (HIV-1) glycopeptide with potent anti-HIV activity.	[Huang, Wei; Li, Bing; Wang, Lai-Xi] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Huang, Wei; Li, Bing; Wang, Lai-Xi] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Umekawa, Midori; Ashida, Hisashi; Yamamoto, Kenji] Kyoto Univ, Div Integrated Life Sci, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068502, Japan; [Fujita, Kiyotaka] Kagoshima Univ, Dept Biochem Sci & Technol, Fac Agr, Kagoshima 8900065, Japan	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Kyoto University; Kagoshima University	Wang, LX (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, 725 W Lombard St, Baltimore, MD 21201 USA.	lwang3@ihv.umaryland.edu	Wang, Lai-Xi/E-8790-2019; Ashida, Hisashi/HCI-0293-2022; Wang, Lai-Xi/E-8755-2019; wang, xl/Y-8251-2019; Huang, Wei/A-2167-2011; Huang, Wei/P-9631-2017	Wang, Lai-Xi/0000-0003-4293-5819; Huang, Wei/0000-0001-6432-1848; Ashida, Hisashi/0000-0001-5844-4075; Fujita, Kiyotaka/0000-0002-3780-3750; Umekawa, Midori/0000-0002-8071-3902	NIGMS NIH HHS [R01 GM080374, R01 GM 073717] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080374, R01GM073717] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akaike E, 2004, CARBOHYD RES, V339, P719, DOI 10.1016/j.carres.2003.12.007; Fujita K, 2004, ARCH BIOCHEM BIOPHYS, V432, P41, DOI 10.1016/j.abb.2004.09.013; Fujita K, 2004, BIOSCI BIOTECH BIOCH, V68, P1059, DOI 10.1271/bbb.68.1059; Fujita K, 2001, BIOCHEM BIOPH RES CO, V283, P680, DOI 10.1006/bbrc.2001.4836; Fujita K, 2007, J BIOCHEM, V142, P301, DOI 10.1093/jb/mvm124; Fujita K, 2006, BBA-GEN SUBJECTS, V1760, P1631, DOI 10.1016/j.bbagen.2006.09.003; Fujita M, 2001, BBA-GEN SUBJECTS, V1528, P9, DOI 10.1016/S0304-4165(01)00164-7; Gray W.R., 1967, METHODS ENZYMOL, V11, P139, DOI [10.1016/S0076-6879(67)11014-8, DOI 10.1016/S0076-6879(67)11014-8]; Hancock SM, 2006, CURR OPIN CHEM BIOL, V10, P509, DOI 10.1016/j.cbpa.2006.07.015; Haneda K, 1996, CARBOHYD RES, V292, P61; Hauser S, 2005, BIOCHEM BIOPH RES CO, V328, P580, DOI 10.1016/j.bbrc.2005.01.012; Kato T, 2002, GLYCOBIOLOGY, V12, P581, DOI 10.1093/glycob/cwf073; Li B, 2005, J AM CHEM SOC, V127, P9692, DOI 10.1021/ja051715a; Li B, 2006, ORG LETT, V8, P3081, DOI 10.1021/ol061056m; Li HG, 2005, J ORG CHEM, V70, P9990, DOI 10.1021/jo051729z; Li HG, 2005, BIOORG MED CHEM LETT, V15, P895, DOI 10.1016/j.bmcl.2004.12.066; Mizuno M, 1999, J AM CHEM SOC, V121, P284, DOI 10.1021/ja9831305; Perugino G, 2004, TRENDS BIOTECHNOL, V22, P31, DOI 10.1016/j.tibtech.2003.10.008; RAO VH, 1995, STRUCTURE, V3, P449, DOI 10.1016/S0969-2126(01)00178-2; Rising TWDF, 2006, CARBOHYD RES, V341, P1574, DOI 10.1016/j.carres.2006.03.007; Rising TWDF, 2006, CHEMBIOCHEM, V7, P1177, DOI 10.1002/cbic.200600183; ROBBINS PW, 1984, J BIOL CHEM, V259, P7577; Seko A, 1997, BBA-GEN SUBJECTS, V1335, P23, DOI 10.1016/S0304-4165(96)00118-3; Takegawa K, 1997, ARCH BIOCHEM BIOPHYS, V338, P22, DOI 10.1006/abbi.1996.9803; TARENTINO AL, 1992, J BIOL CHEM, V267, P3868; Vaaje-Kolstad G, 2004, BBA-PROTEINS PROTEOM, V1696, P103, DOI 10.1016/j.bbapap.2003.09.014; VANROEY P, 1994, BIOCHEMISTRY-US, V33, P13989, DOI 10.1021/bi00251a005; VANSCHELTINGA ACT, 1995, BIOCHEMISTRY-US, V34, P15619, DOI 10.1021/bi00048a003; Waddling CA, 2000, BIOCHEMISTRY-US, V39, P7878, DOI 10.1021/bi0001731; Wang LX, 2005, CHEMBIOCHEM, V6, P1068, DOI 10.1002/cbic.200400440; Wang LX, 2004, ACS SYM SER, V873, P73; Wang LX, 2004, CHEM BIOL, V11, P127, DOI 10.1016/j.chembiol.2003.12.020; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Yamamoto K, 1997, CARBOHYD RES, V305, P415, DOI 10.1016/S0008-6215(97)10018-0; Yamamoto K, 1997, TRENDS GLYCOSCI GLYC, V9, P339, DOI 10.4052/tigg.9.339; Yamamoto K, 2006, ENDOGLYCOSIDASES BIO, P129; YAMAMOTO KJ, 1994, BIOCHEM BIOPH RES CO, V203, P244, DOI 10.1006/bbrc.1994.2174; Zeng Y, 2006, CHEM-EUR J, V12, P3355, DOI 10.1002/chem.200501196	38	188	198	0	43	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4469	4479		10.1074/jbc.M707137200	http://dx.doi.org/10.1074/jbc.M707137200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18096701	hybrid			2022-12-25	WOS:000253426500003
J	Perez-Garcia, MJ; Gou-Fabregas, M; de Pablo, Y; Llovera, M; Comella, JX; Soler, RM				Perez-Garcia, M. Jose; Gou-Fabregas, Myriam; de Pablo, Yolanda; Llovera, Marta; Comella, Joan X.; Soler, Rosa M.			Neuroprotection by neurotrophic factors and membrane depolarization is regulated by calmodulin kinase IV	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3-KINASE; AUTONOMOUS ACTIVITY; NEURONAL SURVIVAL; CELL-SURVIVAL; ACTIVATION; CALCIUM/CALMODULIN; GROWTH; MECHANISM; DEATH	Neurotrophic factors promote motoneuron (MN) survival through increased intracellular calcium (Ca2+) and regulation of the phosphatidylinositol (PI) 3-kinase/protein kinase B(PKB) pathway by calmodulin (CaM). Activation of the PI 3-kinase/PKB pathway is one of the well established mechanisms involved in MN survival. The Ca2+/CaM complex interacts with and modulates the functionality of a large number of proteins, including serine/threonine protein kinases such as Ca2+/CaM-dependent protein kinases (CaMKs). Using a primary culture of embryonic chicken spinal cord MNs, we investigated the role of CaMKIV in mediating this process. We cloned chicken CaMKIV and demonstrated its expression in purified MNs by means of reverse transcription-PCR, Western blot, and immunofluorescence. Using RNA interference, we show that endogenous CaMKIV mediates cell survival induced by neurotrophic factors or membrane depolarization. The survival effect is independent of CaMKIV kinase activity; however, CaMKIV functionality depends on the presence of Ca2+/CaM. Finally, CaMKIV associates to the p85 subunit of PI 3- kinase in a Ca2+-dependent manner, suggesting a role in regulating PI 3-kinase/PKB activation.	[Perez-Garcia, M. Jose; Gou-Fabregas, Myriam; de Pablo, Yolanda; Llovera, Marta; Comella, Joan X.; Soler, Rosa M.] Univ Lleida, Cell Signaling & Apoptosis Grp, Dept Ciencies Med Bas, Fac Med, Lleida 25008, Spain; [Perez-Garcia, M. Jose; de Pablo, Yolanda; Llovera, Marta; Comella, Joan X.] Univ Lleida, Hosp Univ Arnau Vilanova, Lab Recerca, Inst Recerca Biomed, Lleida 25008, Spain	Universitat de Lleida; Institut de Recerca Biomedica - IRB Lleida; Universitat de Lleida; University Hospital Arnau de Vilanova	Soler, RM (corresponding author), Univ Lleida, Cell Signaling & Apoptosis Grp, Dept Ciencies Med Bas, Fac Med, Montserrat Roig 2, Lleida 25008, Spain.	rosa.soler@cmb.udl.es	Gou-Fabregas, Myriam/G-6803-2012; de Pablo, Yolanda/AAD-1642-2019; Llovera, Marta/B-5585-2009; Tatche, Rosa M Soler/AAJ-6721-2021; Gou-Fabregas, Myriam/K-1899-2016; Comella, Joan/GQA-4279-2022; Llovera, Marta/AAE-4230-2021; Soler, Rosa M/A-7361-2010; Comella, Joan X/D-7333-2012	Gou-Fabregas, Myriam/0000-0002-5329-7640; de Pablo, Yolanda/0000-0001-5208-2114; Llovera, Marta/0000-0001-8399-6867; Tatche, Rosa M Soler/0000-0003-0528-3102; Gou-Fabregas, Myriam/0000-0002-5329-7640; Soler, Rosa M/0000-0003-0528-3102; Comella, Joan X/0000-0002-6218-0786				Airaksinen MS, 2002, NAT REV NEUROSCI, V3, P383, DOI 10.1038/nrn812; Anderson KA, 1998, BIOMETALS, V11, P331, DOI 10.1023/A:1009276932076; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Brunet A, 2001, CURR OPIN NEUROBIOL, V11, P297, DOI 10.1016/S0959-4388(00)00211-7; Chow FA, 2005, J BIOL CHEM, V280, P20530, DOI 10.1074/jbc.M500067200; COMELLA JX, 1994, J NEUROSCI, V14, P2674; Crowder RJ, 1998, J NEUROSCI, V18, P2933; DeBernardi MA, 1996, J BIOL CHEM, V271, P6092, DOI 10.1074/jbc.271.11.6092; Dolcet X, 1999, J NEUROCHEM, V73, P521, DOI 10.1046/j.1471-4159.1999.0730521.x; Dong B, 2007, J BIOL CHEM, V282, P25131, DOI 10.1074/jbc.M702123200; EDWARDS SN, 1994, J CELL BIOL, V124, P537, DOI 10.1083/jcb.124.4.537; Egea J, 2001, J CELL BIOL, V154, P585, DOI 10.1083/jcb.200101023; ENSLEN H, 1994, J BIOL CHEM, V269, P15520; FRANKLIN JL, 1992, TRENDS NEUROSCI, V15, P501, DOI 10.1016/0166-2236(92)90103-F; GALLO V, 1987, J NEUROSCI, V7, P2203; Gradin HM, 1997, MOL CELL BIOL, V17, P3459, DOI 10.1128/MCB.17.6.3459; Hansen MR, 2003, J NEUROSCI RES, V72, P169, DOI 10.1002/jnr.10551; Ho N, 2000, J NEUROSCI, V20, P6459, DOI 10.1523/JNEUROSCI.20-17-06459.2000; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063; JENSEN KF, 1991, P NATL ACAD SCI USA, V88, P2850, DOI 10.1073/pnas.88.7.2850; Johnson K, 2005, J NEUROSCI RES, V79, P809, DOI 10.1002/jnr.20415; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; Llovera M, 2004, J NEUROCHEM, V88, P422, DOI 10.1046/j.1471-4159.2003.02178.x; Matsushita M, 1998, J BIOL CHEM, V273, P21473, DOI 10.1074/jbc.273.34.21473; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Perez-Garcia MJ, 2004, J BIOL CHEM, V279, P6132, DOI 10.1074/jbc.M308367200; Ribar TJ, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-22-j0004.2000; See V, 2001, FASEB J, V15, P134, DOI 10.1096/fj.00-0106com; Soderling TR, 1999, TRENDS BIOCHEM SCI, V24, P232, DOI 10.1016/S0968-0004(99)01383-3; Soderling TR, 2001, CHEM REV, V101, P2341, DOI 10.1021/cr0002386; Sole C, 2004, J CELL BIOL, V167, P479, DOI 10.1083/jcb.200403093; Soler RM, 1999, J NEUROSCI, V19, P9160; Soler RM, 1998, J NEUROSCI, V18, P1230; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Sun PQ, 1996, J BIOL CHEM, V271, P3066, DOI 10.1074/jbc.271.6.3066; Tokumitsu H, 2004, J BIOL CHEM, V279, P40296, DOI 10.1074/jbc.M406534200; TOKUMITSU H, 1994, J BIOL CHEM, V269, P28640; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Wang SL, 2001, CELL GROWTH DIFFER, V12, P351; Yano S, 1998, NATURE, V396, P584, DOI 10.1038/25147; Yap Kyoko L., 2000, Journal of Structural and Functional Genomics, V1, P8, DOI 10.1023/A:1011320027914; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	44	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4133	4144		10.1074/jbc.M705477200	http://dx.doi.org/10.1074/jbc.M705477200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079114	hybrid, Green Published			2022-12-25	WOS:000253083500049
J	Benner, EJ; Banerjee, R; Reynolds, AD; Sherman, S; Pisarev, VM; Tsiperson, V; Nemachek, C; Ciborowski, P; Przedborski, S; Mosley, RL; Gendelman, HE				Benner, Eric J.; Banerjee, Rebecca; Reynolds, Ashley D.; Sherman, Simon; Pisarev, Vladimir M.; Tsiperson, Vladislav; Nemachek, Craig; Ciborowski, Pawel; Przedborski, Serge; Mosley, R. Lee; Gendelman, Howard E.			Nitrated alpha-Synuclein Immunity Accelerates Degeneration of Nigral Dopaminergic Neurons	PLOS ONE			English	Article							POSTTRANSLATIONAL PROTEIN MODIFICATIONS; AMYLOID-BETA-PEPTIDE; BLOOD-BRAIN-BARRIER; PARKINSONS-DISEASE; FIBRIL FORMATION; MOUSE MODEL; ALZHEIMER-DISEASE; SUBSTANTIA-NIGRA; T-CELLS; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP	Background. The neuropathology of Parkinson's disease (PD) includes loss of dopaminergic neurons in the substantia nigra, nitrated alpha-synuclein (N-alpha-Syn) enriched intraneuronal inclusions or Lewy bodies and neuroinflammation. While the contribution of innate microglial inflammatory activities to disease are known, evidence for how adaptive immune mechanisms may affect the course of PD remains obscure. We reasoned that PD-associated oxidative protein modifications create novel antigenic epitopes capable of peripheral adaptive T cell responses that could affect nigrostriatal degeneration. Methods and Findings. Nitrotyrosine (NT)-modified alpha-Syn was detected readily in cervical lymph nodes (CLN) from 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine ( MPTP) intoxicated mice. Antigen-presenting cells within the CLN showed increased surface expression of major histocompatibility complex class II, initiating the molecular machinery necessary for efficient antigen presentation. MPTP-treated mice produced antibodies to native and nitrated alpha-Syn. Mice immunized with the NT-modified C-terminal tail fragment of alpha-Syn, but not native protein, generated robust T cell proliferative and pro-inflammatory secretory responses specific only for the modified antigen. T cells generated against the nitrated epitope do not respond to the unmodified protein. Mice deficient in T and B lymphocytes were resistant to MPTP-induced neurodegeneration. Transfer of T cells from mice immunized with N-alpha-Syn led to a robust neuroinflammatory response with accelerated dopaminergic cell loss. Conclusions. These data show that NT modifications within alpha-Syn, can bypass or break immunological tolerance and activate peripheral leukocytes in draining lymphoid tissue. A novel mechanism for disease is made in that NT modifications in alpha-Syn induce adaptive immune responses that exacerbate PD pathobiology. These results have implications for both the pathogenesis and treatment of this disabling neurodegenerative disease.	[Przedborski, Serge] Columbia Univ, Ctr Motor Neuron Biol & Dis, Dept Neurol & Cell Biol, New York, NY 10027 USA; [Benner, Eric J.; Banerjee, Rebecca; Reynolds, Ashley D.; Tsiperson, Vladislav; Nemachek, Craig; Ciborowski, Pawel; Mosley, R. Lee; Gendelman, Howard E.] Univ Nebraska, Med Ctr, Ctr Neurovirol & Neurodegen Dis, Dept Pharmacol & Exptl Neurosci, Omaha, NE USA; [Benner, Eric J.; Mosley, R. Lee] Univ Nebraska, Med Ctr, Dept Pathol & Microbiol, Omaha, NE USA; [Gendelman, Howard E.] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE USA; [Sherman, Simon; Pisarev, Vladimir M.] Univ Nebraska, Med Ctr, Nebraska Inf Ctr Life Sci, Eppley Canc Inst, Omaha, NE USA; [Przedborski, Serge] Columbia Univ, Ctr Motor Neuron Biol & Dis, Dept Pathol & Cell Biol, New York, NY USA	Columbia University; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Columbia University	Przedborski, S (corresponding author), Columbia Univ, Ctr Motor Neuron Biol & Dis, Dept Neurol & Cell Biol, New York, NY 10027 USA.	SP30@Columbia.edu; rlmosley@unmc.edu; hegendel@unmc.edu	Gendelman, Howard E/G-8242-2012; Pisarev, Vladimir M./E-1373-2012	Pisarev, Vladimir M./0000-0002-5729-9846	National Institute of Neurological Disorders and Stroke [NS36136, NS43985, NS007488, NS42269, NS38370, NS11766, NS049264]; National Institute of Mental Health [MH64570]; National Institute of Aging [AG021617]; National Institute of Environmental Health Sciences [ES013177]; U.S. Department of Defense [17-03-1]; Parkinson's Disease Foundation [CU51523606]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES013177] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P01MH064570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS011766, P50NS011766, T32NS007488, P01NS043985, P50NS038370, R21NS049264, R01NS042269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021617] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Department of Defense(United States Department of Defense); Parkinson's Disease Foundation; Michael J. Fox Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was funded by grants from the National Institute of Neurological Disorders and Stroke Grants (NS36136, NS43985, NS007488, NS42269, NS38370, NS11766 and NS049264); National Institute of Mental Health (MH64570); National Institute of Aging (AG021617); National Institute of Environmental Health Sciences (ES013177); U.S. Department of Defense Grant (17-03-1); the Parkinson's Disease Foundation (CU51523606) and the Michael J. Fox Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoura Z, 1999, ARTHRITIS RHEUM, V42, P833, DOI 10.1002/1529-0131(199905)42:5<833::AID-ANR1>3.3.CO;2-K; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Benner EJ, 2004, P NATL ACAD SCI USA, V101, P9435, DOI 10.1073/pnas.0400569101; Birnboim HC, 2003, J IMMUNOL, V171, P528, DOI 10.4049/jimmunol.171.2.528; Burkhardt Harald, 2001, Trends in Immunology, V22, P291, DOI 10.1016/S1471-4906(01)01935-4; CasciolaRosen L, 1997, J EXP MED, V185, P71, DOI 10.1084/jem.185.1.71; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Check E, 2002, NATURE, V415, P462, DOI 10.1038/415462a; Ciborowski P, 2004, J NEUROIMMUNOL, V157, P11, DOI 10.1016/j.jneuroim.2004.08.033; Ciborowski P, 2007, VIROLOGY, V363, P198, DOI 10.1016/j.virol.2007.01.013; Conway KA, 1998, NAT MED, V4, P1318, DOI 10.1038/3311; Croisier E, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-14; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Di Monte DA, 2002, NEUROTOXICOLOGY, V23, P487, DOI 10.1016/S0161-813X(02)00099-2; Doyle HA, 2001, TRENDS IMMUNOL, V22, P443, DOI 10.1016/S1471-4906(01)01976-7; Dringen R, 2005, ANTIOXID REDOX SIGN, V7, P1223, DOI 10.1089/ars.2005.7.1223; Dufty BM, 2007, AM J PATHOL, V170, P1725, DOI 10.2353/ajpath.2007.061232; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 1998, FEBS LETT, V440, P71, DOI 10.1016/S0014-5793(98)01418-5; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Enose Y, 2005, GLIA, V51, P161, DOI 10.1002/glia.20193; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; FISZER U, 1994, ACTA NEUROL SCAND, V90, P160; Fiszer U, 1996, J NEUROL SCI, V139, P66, DOI 10.1016/S0022-510X(96)00002-0; FISZER U, 1994, J NEUROL SCI, V121, P39, DOI 10.1016/0022-510X(94)90154-6; Gendelman HE, 2002, J NEUROVIROL, V8, P474, DOI 10.1080/13550280290168631; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; GLANZER JG, 2007, J NEUROCHEM; Guan Pingping, 2003, Appl Bioinformatics, V2, P63; Guan PP, 2003, NUCLEIC ACIDS RES, V31, P3621, DOI 10.1093/nar/gkg510; Hasegawa M, 2002, J BIOL CHEM, V277, P49071, DOI 10.1074/jbc.M208046200; Hisanaga K, 2001, ARCH NEUROL-CHICAGO, V58, P1580, DOI 10.1001/archneur.58.10.1580; Hodara R, 2004, J BIOL CHEM, V279, P47746, DOI 10.1074/jbc.M408906200; Imamura K, 2003, ACTA NEUROPATHOL, V106, P518, DOI 10.1007/s00401-003-0766-2; Ischiropoulos H, 2003, J CLIN INVEST, V111, P163, DOI 10.1172/JCI200317638; JACKSONLEWIS V, 1995, NEURODEGENERATION, V4, P257, DOI 10.1016/1055-8330(95)90015-2; Kadin I, 2007, J IMMUNOL, V178, P6404, DOI 10.4049/jimmunol.178.10.6404; KAPLAN HJ, 1977, J IMMUNOL, V118, P809; Kipnis J, 2002, J NEUROIMMUNOL, V130, P78, DOI 10.1016/S0165-5728(02)00219-9; Klockgether T, 2004, CELL TISSUE RES, V318, P115, DOI 10.1007/s00441-004-0975-6; Kosiewicz MM, 1996, J IMMUNOL, V157, P1905; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lampe JB, 2003, EUR NEUROL, V50, P64, DOI 10.1159/000072500; Langston JW, 1999, ANN NEUROL, V46, P598, DOI 10.1002/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F; LE WD, 1995, J NEUROIMMUNOL, V57, P45, DOI 10.1016/0165-5728(94)00160-P; Liberatore GT, 1999, NAT MED, V5, P1403; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; MCGEER PL, 1988, NEUROLOGY, V38, P1285, DOI 10.1212/WNL.38.8.1285; Mevorach D, 1998, J EXP MED, V188, P387, DOI 10.1084/jem.188.2.387; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Ohmori H, 2005, AUTOIMMUN REV, V4, P224, DOI 10.1016/j.autrev.2004.11.011; Orgogozo JM, 2003, NEUROLOGY, V61, P46, DOI 10.1212/01.WNL.0000073623.84147.A8; Paxinou E, 2001, J NEUROSCI, V21, P8053, DOI 10.1523/JNEUROSCI.21-20-08053.2001; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Przedborski S, 2001, J NEUROCHEM, V76, P1265, DOI 10.1046/j.1471-4159.2001.00183.x; Przedborski S, 2001, J NEUROCHEM, V76, P637, DOI 10.1046/j.1471-4159.2001.00174.x; Ricardo-Dukelow M, 2007, J NEUROIMMUNOL, V185, P37, DOI 10.1016/j.jneuroim.2007.01.004; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Sacksteder CA, 2006, BIOCHEMISTRY-US, V45, P8009, DOI 10.1021/bi060474w; Schenk D, 1999, NATURE, V400, P173, DOI 10.1038/22124; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Shin EC, 2000, MOL CELLS, V10, P65, DOI 10.1007/s100590070011; Sidhu A, 2004, FASEB J, V18, P637, DOI 10.1096/fj.03-1112rev; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Souza JM, 1999, ARCH BIOCHEM BIOPHYS, V371, P169, DOI 10.1006/abbi.1999.1480; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; TANNER CM, 1992, OCCUP MED, V7, P503; Tillerson JL, 2002, EXP NEUROL, V178, P80, DOI 10.1006/exnr.2002.8021; Utz PJ, 1998, ARTHRITIS RHEUM, V41, P1152, DOI 10.1002/1529-0131(199807)41:7<1152::AID-ART3>3.0.CO;2-L; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2005, MOL BRAIN RES, V134, P84, DOI 10.1016/j.molbrainres.2004.11.014; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Volles MJ, 2002, BIOCHEMISTRY-US, V41, P4595, DOI 10.1021/bi0121353; Weiner HL, 2001, MICROBES INFECT, V3, P947, DOI 10.1016/S1286-4579(01)01456-3; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wenkel H, 2000, J IMMUNOL, V164, P5125, DOI 10.4049/jimmunol.164.10.5125; Wersinger C, 2006, CURR MED CHEM, V13, P591, DOI 10.2174/092986706776055760; Wu DC, 2002, J NEUROSCI, V22, P1763, DOI 10.1523/JNEUROSCI.22-05-01763.2002; Wu DC, 2003, P NATL ACAD SCI USA, V100, P6145, DOI 10.1073/pnas.0937239100; Yamin G, 2003, FEBS LETT, V542, P147, DOI 10.1016/S0014-5793(03)00367-3; YOUNG IT, 1977, J HISTOCHEM CYTOCHEM, V25, P935, DOI 10.1177/25.7.894009; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zhang W, 2005, FASEB J, V19, P533, DOI 10.1096/fj.04-2751com; Zhu M, 2003, J BIOL CHEM, V278, P16873, DOI 10.1074/jbc.M210136200; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	88	249	265	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1376	10.1371/journal.pone.0001376	http://dx.doi.org/10.1371/journal.pone.0001376			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167537	gold, Green Published, Green Submitted			2022-12-25	WOS:000260468900005
J	Gao, P; Xin, ZY; Zheng, ZL				Gao, Peng; Xin, Zeyu; Zheng, Zhi-Liang			The OSU1/QUA2/TSD2-Encoded Putative Methyltransferase Is a Critical Modulator of Carbon and Nitrogen Nutrient Balance Response in Arabidopsis	PLOS ONE			English	Article							LATERAL ROOT INITIATION; ROP10 SMALL GTPASE; ABSCISIC-ACID; GENE-EXPRESSION; AMINO-ACIDS; ASPARAGINE SYNTHETASE; GLUTAMINE-SYNTHETASE; SIGNAL-TRANSDUCTION; PROTEIN; PLANTS	The balance between carbon (C) and nitrogen (N) nutrients must be tightly coordinated so that cells can optimize their opportunity for metabolism, growth and development. However, the C and N nutrient balance perception and signaling mechanism remains poorly understood. Here, we report the isolation and characterization of two allelic oversensitive to sugar1 mutants (osu1-1, osu1-2) in Arabidopsis thaliana. Using the cotyledon anthocyanin accumulation and root growth inhibition assays, we show that the osu1 mutants are more sensitive than wild-type to both of the imbalanced C/N conditions, high C/low N and low C/high N. However, under the balanced C/N conditions (low C/low N or high C/high N), the osu1 mutants have similar anthocyanin levels and root lengths as wild-type. Consistently, the genes encoding two MYB transcription factors (MYB75 and MYB90) and an Asn synthetase isoform (ASN1) are strongly up-regulated by the OSU1 mutation in response to high C/low N and low C/high N, respectively. Furthermore, the enhanced sensitivity of osu1-1 to high C/low N with respect to anthocyanin accumulation but not root growth inhibition can be suppressed by co-suppression of MYB75, indicating that MYB75 acts downstream of OSU1 in the high C/low N imbalance response. Map-based cloning reveals that OSU1 encodes a member of a large family of putative methyltransferases and is allelic to the recently reported QUA2/TSD2 locus identified in genetic screens for cell-adhesion-defective mutants. Accumulation of OSU1/QUA2/TSD2 transcript was not regulated by C and N balance, but the OSU1 promoter was slightly more active in the vascular system. Taken together, our results show that the OSU1/QUA2/TSD2-encoded putative methyltransferase is required for normal C/N nutrient balance response in plants.	[Gao, Peng; Xin, Zeyu; Zheng, Zhi-Liang] CUNY, Dept Biol Sci, Lehman Coll, Bronx, NY USA; [Zheng, Zhi-Liang] CUNY, Grad Sch & Univ Ctr, Plant Sci PhD Subprog, New York, NY USA	City University of New York (CUNY) System; Lehman College (CUNY); City University of New York (CUNY) System	Zheng, ZL (corresponding author), CUNY, Dept Biol Sci, Lehman Coll, Bronx, NY USA.	zhiliang.zheng@lehman.cuny.edu			NIH [S06GM008225]; City University of New York PSC-CUNY program [68436-00-37]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008225] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); City University of New York PSC-CUNY program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by an NIH-SCORE grant (S06GM008225, Project Number 12 to Z-LZ) and in part by the City University of New York PSC-CUNY program (68436-00-37 to Z-LZ).	Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12; Avonce N, 2004, PLANT PHYSIOL, V136, P3649, DOI 10.1104/pp.104.052084; Avruch J, 2005, CURR OPIN CLIN NUTR, V8, P67, DOI 10.1097/00075197-200501000-00010; Bertram PG, 2002, MOL CELL BIOL, V22, P1246, DOI 10.1128/MCB.22.4.1246-1252.2002; Borevitz JO, 2000, PLANT CELL, V12, P2383, DOI 10.1105/tpc.12.12.2383; Cho YH, 2006, CELL, V127, P579, DOI 10.1016/j.cell.2006.09.028; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Commichau FM, 2006, CURR OPIN MICROBIOL, V9, P167, DOI 10.1016/j.mib.2006.01.001; Coruzzi G, 2001, PLANT PHYSIOL, V125, P61, DOI 10.1104/pp.125.1.61; Coruzzi GM, 2001, CURR OPIN PLANT BIOL, V4, P247, DOI 10.1016/S1369-5266(00)00168-0; Dan H, 2007, PLANT MOL BIOL, V63, P221, DOI 10.1007/s11103-006-9084-0; Ferrario-Mery S, 2005, PLANTA, V223, P28, DOI 10.1007/s00425-005-0063-5; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; Forde BG, 2002, ANNU REV PLANT BIOL, V53, P203, DOI 10.1146/annurev.arplant.53.100301.135256; Gutierrez RA, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r7; Hiratsu K, 2003, PLANT J, V34, P733, DOI 10.1046/j.1365-313X.2003.01759.x; Hsieh MH, 1998, P NATL ACAD SCI USA, V95, P13965, DOI 10.1073/pnas.95.23.13965; Huang J, 2006, PLANT CELL, V18, P1226, DOI 10.1105/tpc.105.037259; Ishiyama K, 2004, J BIOL CHEM, V279, P16598, DOI 10.1074/jbc.M313710200; Jang JC, 1997, PLANT CELL, V9, P5, DOI 10.1105/tpc.9.1.5; JEFFERSON RA, 1987, EMBO J, V6, P3901; Karthikeyan AS, 2007, PLANTA, V225, P907, DOI 10.1007/s00425-006-0408-8; KIYOSUE T, 1994, PLANT MOL BIOL, V25, P791, DOI 10.1007/BF00028874; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Krupkova E, 2007, PLANT J, V50, P735, DOI 10.1111/j.1365-313X.2007.03123.x; Lam HM, 1998, PLANT J, V16, P345, DOI 10.1046/j.1365-313x.1998.00302.x; Lam HM, 2003, PLANT PHYSIOL, V132, P926, DOI 10.1104/pp.103.020123; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; LAM HM, 1994, PLANT PHYSIOL, V106, P1347, DOI 10.1104/pp.106.4.1347; Lea US, 2007, PLANTA, V225, P1245, DOI 10.1007/s00425-006-0414-x; Little DY, 2005, P NATL ACAD SCI USA, V102, P13693, DOI 10.1073/pnas.0504219102; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931; Malamy JE, 2001, PLANT PHYSIOL, V127, P899, DOI 10.1104/pp.010406; Marshall Stephen, 2006, Sci STKE, V2006, pre7; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Martin T, 2002, PLANT PHYSIOL, V128, P472, DOI 10.1104/pp.010475; Matsui K, 2004, PLANT BIOTECHNOL J, V2, P487, DOI 10.1111/j.1467-7652.2004.00094.x; MeloOliveira R, 1996, P NATL ACAD SCI USA, V93, P4718, DOI 10.1073/pnas.93.10.4718; Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Moorhead GBG, 2003, PLANT PHYSIOL, V133, P492, DOI 10.1104/pp.103.025627; Mouille G, 2007, PLANT J, V50, P605, DOI 10.1111/j.1365-313X.2007.03086.x; Oliveira IC, 1999, PLANT PHYSIOL, V121, P301, DOI 10.1104/pp.121.1.301; Palenchar PM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r91; Peter GJ, 2006, J BIOL CHEM, V281, P5546, DOI 10.1074/jbc.M513842200; Price J, 2004, PLANT CELL, V16, P2128, DOI 10.1105/tpc.104.022616; Qin GJ, 2005, PLANT CELL, V17, P2693, DOI 10.1105/tpc.105.034959; Rolland F, 2006, ANNU REV PLANT BIOL, V57, P675, DOI 10.1146/annurev.arplant.57.032905.105441; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Rubio V, 2001, GENE DEV, V15, P2122, DOI 10.1101/gad.204401; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schneper L, 2004, CURR OPIN MICROBIOL, V7, P624, DOI 10.1016/j.mib.2004.10.002; Smeekens S, 2000, ANNU REV PLANT PHYS, V51, P49, DOI 10.1146/annurev.arplant.51.1.49; Sun CW, 1997, PLANT J, V11, P1017, DOI 10.1046/j.1365-313X.1997.11051017.x; Teng S, 2005, PLANT PHYSIOL, V139, P1840, DOI 10.1104/pp.105.066688; Tohge T, 2005, PLANT J, V42, P218, DOI 10.1111/j.1365-313X.2005.02371.x; Wang RC, 2003, PLANT PHYSIOL, V132, P556, DOI 10.1104/pp.103.021253; Xin ZY, 2005, PLANT PHYSIOL, V139, P1350, DOI 10.1104/pp.105.068064; Xue CY, 2006, MOL BIOL CELL, V17, P667, DOI 10.1091/mbc.E05-07-0699; Zhang HM, 1998, SCIENCE, V279, P407, DOI 10.1126/science.279.5349.407; Zheng ZL, 2002, PLANT CELL, V14, P2787, DOI 10.1105/tpc.005611	62	35	37	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1387	10.1371/journal.pone.0001387	http://dx.doi.org/10.1371/journal.pone.0001387			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167546	gold, Green Published			2022-12-25	WOS:000260468900015
J	Shaykhiev, R; Behr, J; Bals, R				Shaykhiev, Renat; Behr, Juergen; Bals, Robert			Microbial Patterns Signaling via Toll-Like Receptors 2 and 5 Contribute to Epithelial Repair, Growth and Survival	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; STAPHYLOCOCCUS-AUREUS; CELL-PROLIFERATION; WOUND REPAIR; INNATE IMMUNITY; CUTTING EDGE; HOST-DEFENSE; LIPOPOLYSACCHARIDE; INFLAMMATION; RECOGNITION	Epithelial cells (ECs) continuously interact with microorganisms and detect their presence via different pattern-recognition receptors (PRRs) including Toll-like receptors (TLRs). Ligation of epithelial TLRs by pathogens is usually associated with the induction of pro-inflammatory mediators and antimicrobial factors. In this study, using human airway ECs as a model, we found that detection of microbial patterns via epithelial TLRs directly regulates tissue homeostasis. Staphylococcus aureus(S. aureus) and microbial patterns signaling via TLR2 and TLR5 induce a set of non-immune epithelial responses including cell migration, wound repair, proliferation, and survival of primary and cancerous ECs. Using small interfering RNA (siRNA) gene targeting, receptor-tyrosine kinase microarray and inhibition studies, we determined that TLR and the epidermal growth factor receptor (EGFR) mediate the stimulating effect of microbial patterns on epithelial repair. Microbial patterns signaling via Toll-like receptors 2 and 5 contribute to epithelial repair, growth and survival. This effect is independent of hematopoietic and other cells as well as inflammatory cytokines suggesting that epithelia are able to regulate their integrity in an autonomous non-inflammatory manner by sensing microbes directly via TLRs.	[Shaykhiev, Renat; Bals, Robert] Univ Marburg, Dept Internal Med, Div Pulm Dis, D-3550 Marburg, Germany; [Behr, Juergen] Univ Munich, Dept Intern Med, Div Pulmonary Dis, Munich, Germany	Philipps University Marburg; University of Munich	Bals, R (corresponding author), Univ Marburg, Dept Internal Med, Div Pulm Dis, D-3550 Marburg, Germany.	bals@staff.uni-marburg.de	Shaykhiev, Renat/D-2855-2011		Deutsche Forschungsgemeinschaft Ba [1641/7, SFB/TR22]; Wilhelm Sander Stiftung	Deutsche Forschungsgemeinschaft Ba(German Research Foundation (DFG)); Wilhelm Sander Stiftung	This study was supported by the Deutsche Forschungsgemeinschaft Ba 1641/7, SFB/TR22 (A8) and the Wilhelm Sander Stiftung to Robert Bals. The sponsors were not involved in collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2000, J ENDOTOXIN RES, V6, P383, DOI 10.1177/09680519000060050901; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Brown SL, 2007, J CLIN INVEST, V117, P258, DOI 10.1172/JCI29159; Cario E, 2004, GASTROENTEROLOGY, V127, P224, DOI 10.1053/j.gastro.2004.04.015; CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; DIGNASS A, 1994, J CLIN INVEST, V94, P376, DOI 10.1172/JCI117332; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017; Geiser T, 2000, AM J PHYSIOL-LUNG C, V279, pL1184, DOI 10.1152/ajplung.2000.279.6.L1184; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Giri D, 2001, AM J PATHOL, V159, P2159, DOI 10.1016/S0002-9440(10)63067-2; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Greten FR, 2004, CELL, V118, P285, DOI 10.1016/j.cell.2004.07.013; Hafner C, 2005, WORLD J GASTROENTERO, V11, P4024, DOI 10.3748/wjg.v11.i26.4024; Hasan UA, 2007, P NATL ACAD SCI USA, V104, P8047, DOI 10.1073/pnas.0700664104; Haugwitz U, 2006, CELL MICROBIOL, V8, P1591, DOI 10.1111/j.1462-5822.2006.00733.x; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hornef MW, 2005, J ENDOTOXIN RES, V11, P124, DOI 10.1179/096805105X35224; Hornef MW, 2002, J EXP MED, V195, P559, DOI 10.1084/jem.20011788; Hou YF, 2006, MOL IMMUNOL, V43, P1982, DOI 10.1016/j.molimm.2005.11.013; Itoh Y, 2005, CYTOKINE, V29, P275, DOI 10.1016/j.cyto.2004.11.005; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; KANG YH, 1995, SHOCK, V4, P441; Kelly MG, 2006, CANCER RES, V66, P3859, DOI 10.1158/0008-5472.CAN-05-3948; Koff JL, 2006, J IMMUNOL, V177, P8693, DOI 10.4049/jimmunol.177.12.8693; Kojima M, 2000, ONCOGENE, V19, P1225, DOI 10.1038/sj.onc.1203427; Lambiase A, 2000, INVEST OPHTH VIS SCI, V41, P1063; Lemjabbar H, 2002, NAT MED, V8, P41, DOI 10.1038/nm0102-41; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; NUSRAT A, 1994, J CLIN INVEST, V93, P2056, DOI 10.1172/JCI117200; Podolsky DK, 1999, AM J PHYSIOL-GASTR L, V277, pG495, DOI 10.1152/ajpgi.1999.277.3.G495; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Sansonetti PJ, 2004, NAT REV IMMUNOL, V4, P953, DOI 10.1038/nri1499; Sato A, 2006, J GASTROEN HEPATOL, V21, P521, DOI 10.1111/j.1440-1746.2005.03977.x; Shaykhiev R, 2005, AM J PHYSIOL-LUNG C, V289, pL842, DOI 10.1152/ajplung.00286.2004; Sousa S, 2005, CURR OPIN CELL BIOL, V17, P489, DOI 10.1016/j.ceb.2005.08.013; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; Togbe D, 2006, J LEUKOCYTE BIOL, V80, P451, DOI 10.1189/jlb.0206099; Valverde P, 2004, EXP EYE RES, V78, P27, DOI 10.1016/j.exer.2003.10.002; Vermeer PD, 2003, NATURE, V422, P322, DOI 10.1038/nature01440; Vijay-Kumar M, 2006, AM J PATHOL, V169, P1686, DOI 10.2353/ajpath.2006.060345; Whitsett JA, 2002, J CLIN INVEST, V109, P565, DOI 10.1172/JCI200215209; Xiao H, 2007, IMMUNITY, V26, P461, DOI 10.1016/j.immuni.2007.02.012; Yoshimura A, 1999, J IMMUNOL, V163, P1	50	69	71	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1393	10.1371/journal.pone.0001393	http://dx.doi.org/10.1371/journal.pone.0001393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167552	Green Published, gold, Green Submitted			2022-12-25	WOS:000260468900021
J	Lamm, C; Nusbaum, HC; Meltzoff, AN; Decety, J				Lamm, Claus; Nusbaum, Howard C.; Meltzoff, Andrew N.; Decety, Jean			What Are You Feeling? Using Functional Magnetic Resonance Imaging to Assess the Modulation of Sensory and Affective Responses during Empathy for Pain	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; NEURAL RESPONSES; OTHERS PAIN; EXPERIENCE; SELF; REPRESENTATIONS; PERCEPTION; MECHANISMS; SIMULATION; COMPONENTS	Background. Recent neuroscientific evidence suggests that empathy for pain activates similar neural representations as the first-hand experience of pain. However, empathy is not an all-or-none phenomenon but it is strongly malleable by interpersonal, intrapersonal and situational factors. This study investigated how two different top-down mechanisms attention and cognitive appraisal - affect the perception of pain in others and its neural underpinnings. Methodology/Principal Findings. We performed one behavioral (N = 23) and two functional magnetic resonance imaging (fMRI) experiments (N = 18). In the first fMRI experiment, participants watched photographs displaying painful needle injections, and were asked to evaluate either the sensory or the affective consequences of these injections. The role of cognitive appraisal was examined in a second fMRI experiment in which participants watched injections that only appeared to be painful as they were performed on an anesthetized hand. Perceiving pain in others activated the affective-motivational and sensory-discriminative aspects of the pain matrix. Activity in the somatosensory areas was specifically enhanced when participants evaluated the sensory consequences of pain. Perceiving non-painful injections into the anesthetized hand also led to signal increase in large parts of the pain matrix, suggesting an automatic affective response to the putatively harmful stimulus. This automatic response was modulated by areas involved in self/other distinction and valence attribution - including the temporo-parietal junction and medial orbitofrontal cortex. Conclusions/Significance. Our findings elucidate how top-down control mechanisms and automatic bottom-up processes interact to generate and modulate other-oriented responses. They stress the role of cognitive processing in empathy, and shed light on how emotional and bodily awareness enable us to evaluate the sensory and affective states of others.	[Lamm, Claus; Nusbaum, Howard C.; Decety, Jean] Univ Chicago, Dept Psychol, Chicago, IL 60637 USA; [Lamm, Claus; Nusbaum, Howard C.; Decety, Jean] Univ Chicago, Ctr Cognit & Social Neurosci, Chicago, IL 60637 USA; [Meltzoff, Andrew N.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA	University of Chicago; University of Chicago; University of Washington; University of Washington Seattle	Decety, J (corresponding author), Univ Chicago, Dept Psychol, 5848 S Univ Ave, Chicago, IL 60637 USA.	decety@uchicago.edu	Meltzoff, Andrew N/GPC-8807-2022; Lamm, Claus/B-3357-2014	Meltzoff, Andrew N/0000-0001-8683-0547; Lamm, Claus/0000-0002-5422-0653	NSF [BCS 0718480, SBE-0354453]	NSF(National Science Foundation (NSF))	NSF grants ( BCS 0718480 and SBE-0354453)	Avenanti A, 2005, NAT NEUROSCI, V8, P955, DOI 10.1038/nn1481; Avenanti A, 2006, NEUROIMAGE, V32, P316, DOI 10.1016/j.neuroimage.2006.03.010; Bingel U, 2002, PAIN, V99, P313, DOI 10.1016/S0304-3959(02)00157-4; Blanke O, 2005, NEUROSCIENTIST, V11, P16, DOI 10.1177/1073858404270885; BLUM JS, 1950, J COMP NEUROL, V93, P53, DOI 10.1002/cne.900930105; BOIK RJ, 1981, PSYCHOMETRIKA, V46, P241, DOI 10.1007/BF02293733; Botvinick M, 2005, NEUROIMAGE, V25, P312, DOI 10.1016/j.neuroimage.2004.11.043; Buchel C, 2002, J NEUROSCI, V22, P970, DOI 10.1523/JNEUROSCI.22-03-00970.2002; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; BUFALARI I, 2007, CEREB CORTEX; Carlsson K, 2006, NEUROIMAGE, V32, P1804, DOI 10.1016/j.neuroimage.2006.05.027; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; CHENG Y, 2007, 13 ANN M ORG HUM BRA; CLARKE FJJ, 1983, LIGHTING RES TECHNOL, V15, P25; Cooke DF, 2003, J NEUROPHYSIOL, V90, P3317, DOI 10.1152/jn.00513.2003; Craig AD, 2002, NAT REV NEUROSCI, V3, P655, DOI 10.1038/nrn894; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Danziger N, 2006, BRAIN, V129, P2494, DOI 10.1093/brain/awl155; Davis M. H., 1994, EMPATHY SOCIAL PSYCH; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Decety J, 2006, BRAIN RES, V1079, P4, DOI 10.1016/j.brainres.2005.12.115; DECETY J, 2007, NEUROSCIENT IN PRESS; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Decety Jean, 2004, Behav Cogn Neurosci Rev, V3, P71, DOI 10.1177/1534582304267187; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Derbyshire S W, 2000, Curr Rev Pain, V4, P467; DERRYBERRY D, 1988, J PERS SOC PSYCHOL, V55, P958, DOI 10.1037/0022-3514.55.6.958; Doherty RW, 1997, J NONVERBAL BEHAV, V21, P131, DOI 10.1023/A:1024956003661; Donaldson D., 2001, FUNCTIONAL MRI INTRO, P177; Duvernoy H. M., 1991, HUMAN BRAIN SURFACE; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eisenberg N, 2006, HANDBOOK OF MORAL DEVELOPMENT, P517; FAN Y, 2007, NEUROPSYCHO IN PRESS; FERNANDEZ E, 1992, PSYCHOL BULL, V112, P205, DOI 10.1037/0033-2909.112.2.205; Field DT, 2005, CURR BIOL, V15, P453, DOI 10.1016/j.cub.2004.12.081; Fischer A.H., 2001, APPRAISAL PROCESSES, P221; Gallagher S, 2007, SOC NEUROSCI-UK, V2, P353, DOI 10.1080/17470910601183549; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; GEORGE MS, 1995, AM J PSYCHIAT, V152, P341; Goubert L, 2005, PAIN, V118, P285, DOI 10.1016/j.pain.2005.10.025; Gu XS, 2007, NEUROIMAGE, V36, P256, DOI 10.1016/j.neuroimage.2007.02.025; Jackson PL, 2006, PAIN, V125, P5, DOI 10.1016/j.pain.2006.09.013; Jackson PL, 2006, NEUROPSYCHOLOGIA, V44, P752, DOI 10.1016/j.neuropsychologia.2005.07.015; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; JACKSON PL, 2007, 13 ANN M ORG HUM BRA; Kalisch R, 2005, J COGNITIVE NEUROSCI, V17, P874, DOI 10.1162/0898929054021184; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kulkarni B, 2005, EUR J NEUROSCI, V21, P3133, DOI 10.1111/j.1460-9568.2005.04098.x; Lamm C, 2007, NEUROPSYCHOLOGIA, V45, P2480, DOI 10.1016/j.neuropsychologia.2007.03.024; Lamm C, 2007, J COGNITIVE NEUROSCI, V19, P42, DOI 10.1162/jocn.2007.19.1.42; Langford DJ, 2006, SCIENCE, V312, P1967, DOI 10.1126/science.1128322; Lloyd D, 2006, J NEUROPHYSIOL, V95, P205, DOI 10.1152/jn.00614.2005; Morrison I, 2007, CEREB CORTEX, V17, P2214, DOI 10.1093/cercor/bhl129; Morrison I, 2004, COGN AFFECT BEHAV NE, V4, P270, DOI 10.3758/CABN.4.2.270; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2007, HDB EMOTION REGULATI, P135; Ogino Y, 2007, CEREB CORTEX, V17, P1139, DOI 10.1093/cercor/bhl023; Olson IR, 2007, BRAIN, V130, P1718, DOI 10.1093/brain/awm052; Ostrowsky K, 2002, CEREB CORTEX, V12, P376, DOI 10.1093/cercor/12.4.376; Peyron R, 2000, NEUROPHYSIOL CLIN, V30, P263, DOI 10.1016/S0987-7053(00)00227-6; Porro CA, 2003, NEUROSCIENTIST, V9, P354, DOI 10.1177/1073858403253660; Porro CA, 2002, J NEUROSCI, V22, P3206, DOI 10.1523/JNEUROSCI.22-08-03206.2002; Preston SD, 2002, BEHAV BRAIN SCI, V25, P1, DOI 10.1017/S0140525X02000018; Prinz, 2004, GUT REACTIONS PERCEP; Prinz W., 2003, AGENCY SELF AWARENES, P165; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rainville P, 1999, PAIN, V82, P159, DOI 10.1016/S0304-3959(99)00048-2; Rainville P, 2002, CURR OPIN NEUROBIOL, V12, P195, DOI 10.1016/S0959-4388(02)00313-6; Saarela MV, 2007, CEREB CORTEX, V17, P230, DOI 10.1093/cercor/bhj141; Schubotz RI, 2003, NEUROIMAGE, V20, pS120, DOI 10.1016/j.neuroimage.2003.09.014; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wager TD, 2004, AFFECT CONTROL FUNCT	75	248	253	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1292	10.1371/journal.pone.0001292	http://dx.doi.org/10.1371/journal.pone.0001292			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18091986	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459500011
J	Lu, M; Miller, DR; Sun, JH				Lu, Min; Miller, Daniel R.; Sun, Jiang-Hua			Cross-Attraction between an Exotic and a Native Pine Bark Beetle: A Novel Invasion Mechanism?	PLOS ONE			English	Article							RED TURPENTINE BEETLE; DENDROCTONUS-VALENS; COLEOPTERA; SCOLYTIDAE; COLONIZATION; BEHAVIOR; FUNGI	Background. Aside from the ecological impacts, invasive species fascinate ecologists because of the unique opportunities that invasives offer in the study of community ecology. Some hypotheses have been proposed to illustrate the mechanisms that allow exotics to become invasive. However, positive interactions between exotic and native insects are rarely utilized to explain invasiveness of pests. Methodology/Principal Findings. Here, we present information on a recently formed association between a native and an exotic bark beetle on their shared host, Pinus tabuliformis, in China. In field examinations, we found that 35-40% of P. tabuliformis attacked by an exotic bark beetle, Dendroctonus valens, were also attacked by a native pine bark beetle, Hylastes parallelus. In the laboratory, we found that the antennal and walking responses of H. parallelus to host- and beetle-produced compounds were similar to those of the exotic D. valens in China. In addition, D. valens was attracted to volatiles produced by the native H. parallelus. Conclusions/Significance. We report, for the first time, facilitation between an exotic and a native bark beetle seems to involve overlap in the use of host attractants and pheromones, which is cross-attraction. The concept of this interspecific facilitation could be explored as a novel invasive mechanism which helps explain invasiveness of not only exotic bark beetles but also other introduced pests in principle. The results reported here also have particularly important implications for risk assessments and management strategies for invasive species.	[Lu, Min; Sun, Jiang-Hua] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China; [Miller, Daniel R.] US Forest Serv, So Res Stn, USDA, Athens, GA USA; [Lu, Min] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; United States Department of Agriculture (USDA); United States Forest Service; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, JH (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing, Peoples R China.	sunjh@ioz.ac.cn		sun, jianghua/0000-0002-9465-3672	National Nature Science Foundation of China [30525009, 30621003]; National Key RD Program [2006BAD08A17]; USDA Forest Service	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key RD Program; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	The research was supported by the National Nature Science Foundation of China ( 30525009 and 30621003), National Key R&D Program ( 2006BAD08A17), and the USDA Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARN H, 1975, Z NATURFORSCH C, V30, P722; ATKINS MD, 1966, CAN ENTOMOL, V98, P285, DOI 10.4039/Ent98285-3; BIRCH MC, 1980, J CHEM ECOL, V6, P395, DOI 10.1007/BF01402917; BLOSSEY B, 1995, J ECOL, V83, P887, DOI 10.2307/2261425; Blum MS, 1996, ANNU REV ENTOMOL, V41, P353, DOI 10.1146/annurev.en.41.010196.002033; Borden J.H., 1982, P74; Bruno JF, 2003, TRENDS ECOL EVOL, V18, P119, DOI 10.1016/S0169-5347(02)00045-9; BYERS JA, 1989, HOLARCTIC ECOL, V12, P466; Cognato AI, 2005, AGR FOREST ENTOMOL, V7, P87, DOI 10.1111/j.1461-9555.2005.00243.x; DeBach P, 1991, BIOL CONTROL NATURAL; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; FRAEDRICH SW, 2008, PLANT DIS IN PRESS; Furniss RL, 1977, MISCELLANEOUS PUBLIC, V1339, P1, DOI [10.5962/bhl.title.131875, DOI 10.5962/BHL.TITLE.131875]; HUFBAUER RA, 2007, BIOL INVASIONS, P79; Keane RM, 2002, TRENDS ECOL EVOL, V17, P164, DOI 10.1016/S0169-5347(02)02499-0; KLEPZIG KD, 1991, FOREST SCI, V37, P1119; KO J-H, 1985, Esakia, P151; Li J.S., 2001, FOREST PEST DIS, V4, P41; Lieutier F, 2002, MECHANISMS AND DEPLOYMENT OF RESISTANCE IN TREES TO INSECTS, P31, DOI 10.1007/0-306-47596-0_2; MACARTHUR R, 1970, Theoretical Population Biology, V1, P1, DOI 10.1016/0040-5809(70)90039-0; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Miao Z.W., 2001, SHANXI FOR SCI TECH, V1, P34; Mondor EB, 2007, BIOL INVASIONS, V9, P623, DOI 10.1007/s10530-006-9062-0; OWEN DR, 1987, PHYTOPATHOLOGY, V77, P631, DOI 10.1094/Phyto-77-631; PAINE TD, 1981, OECOLOGIA, V48, P1, DOI 10.1007/BF00346980; Paine TD, 1997, ANNU REV ENTOMOL, V42, P179, DOI 10.1146/annurev.ento.42.1.179; PARMETER JR, 1989, PHYTOPATHOLOGY, V79, P768, DOI 10.1094/Phyto-79-768; Redmer JS, 2001, J ECON ENTOMOL, V94, P844, DOI 10.1603/0022-0493-94.4.844; Rejmanek M, 2001, TRENDS ECOL EVOL, V16, P545, DOI 10.1016/S0169-5347(01)02273-X; Simberloff D, 2006, ECOL LETT, V9, P912, DOI 10.1111/j.1461-0248.2006.00939.x; Simberloff Daniel, 1999, Biological Invasions, V1, P21, DOI 10.1023/A:1010086329619; SMITH MT, 1990, J CHEM ECOL, V16, P3317, DOI 10.1007/BF00982101; SPSS Inc, 2001, SPSS 11 WIND; Sun JH, 2004, ENVIRON ENTOMOL, V33, P206, DOI 10.1603/0046-225X-33.2.206; SVIHRA P, 1980, NATURWISSENSCHAFTEN, V67, P518, DOI 10.1007/BF01047641; WOOD DL, 1982, ANNU REV ENTOMOL, V27, P411, DOI 10.1146/annurev.en.27.010182.002211; Wood S. L., 1982, Great Basin Naturalist Memoirs; WU JG, 2002, FOR PEST DIS, V3, P38; Yan ZL, 2005, BIODIVERS CONSERV, V14, P1735, DOI 10.1007/s10531-004-0697-9; YIN HF, 1984, EDITORIAL COMMITTEE; Zhang Liyan, 2002, Scientia Silvae Sinicae, V38, P95; Zhang LW, 2006, ENVIRON ENTOMOL, V35, P1232, DOI 10.1603/0046-225X(2006)35[1232:EABROD]2.0.CO;2	42	12	14	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1302	10.1371/journal.pone.0001302	http://dx.doi.org/10.1371/journal.pone.0001302			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074026	Green Published, gold			2022-12-25	WOS:000207459500021
J	Buttigieg, J; Brown, S; Zhang, M; Lowe, M; Holloway, AC; Nurse, CA				Buttigieg, Josef; Brown, Stephen; Zhang, Min; Lowe, Michael; Holloway, Alison C.; Nurse, Colin A.			Chronic nicotine in utero selectively suppresses hypoxic sensitivity in neonatal rat adrenal chromaffin cells	FASEB JOURNAL			English	Article						catecholamine; nAChR; SIDS; fetus; asphyxia	INFANT-DEATH-SYNDROME; CATECHOLAMINE SECRETION; EXPOSURE; FETAL; CHANNELS; INCREASE; MEDULLA; RELEASE; NEWBORN; STRESS	Nicotine in cigarette smoke has been linked to several deleterious side effects on the offspring of smoking mothers, including impaired development of the sympathoadrenal system, abnormal arousal reflexes, and sudden infant death syndrome. Catecholamine (CA) release from adrenomedullary chromaffin cells (AMCs) in response to asphyxial stressors, e.g., low O-2 (hypoxia) and elevated CO2 (hypercapnia), is critical for adaptation to extrauterine life and occurs before splanchnic innervation. Here, we investigated the effects of prenatal nicotine bitartrate exposure on the ability of neonatal (PO) rat AMCs to respond appropriately to asphyxial stressors. Control AMCs isolated from pups born to saline-treated dams displayed typical responses to hypoxia and hypercapnia, including inhibition of outward K+ current, membrane depolarization, increased cytosolic calcium, and CA secretion. In contrast, PO AMCs from pups born to nicotine-treated dams showed a marked suppression or loss of hypoxic sensitivity, although hypercapnic sensitivity and the expression of CO2 markers (i.e., carbonic anhydrase I and II) appeared normal. Moreover, isolated saline-treated PO AMCs lost their hypoxic sensitivity when grown in culture for similar to 1 wk in the presence of a subsaturating concentration of nicotine base (50 mu M), and this effect was abolished by the nicotinic acetylcholine receptor (nAChR) blocker mecamylamine (100 mu M). Taken together, these data suggest that the adverse effects of maternal smoking on sympathoadrenal function in the offspring are due in part to a loss or suppression of acute hypoxic sensitivity in adrenal chromaffin cells, triggered by the direct action of nicotine on endogenous nicotinic acetylcholine receptors.	[Buttigieg, Josef; Brown, Stephen; Zhang, Min; Lowe, Michael; Nurse, Colin A.] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada; [Holloway, Alison C.] McMaster Univ, Dept Obstet & Gynecol, Hamilton, ON L8S 4K1, Canada	McMaster University; McMaster University	Nurse, CA (corresponding author), McMaster Univ, Dept Biol, 1280 Main St W, Hamilton, ON L8S 4K1, Canada.	nursec@mcmaster.ca						Bournaud R, 2007, PFLUG ARCH EUR J PHY, V454, P83, DOI 10.1007/s00424-006-0185-z; Cohen G, 2005, P NATL ACAD SCI USA, V102, P3817, DOI 10.1073/pnas.0409782102; Garcia-Fernandez M, 2007, PFLUG ARCH EUR J PHY, V454, P93, DOI 10.1007/s00424-006-0186-y; GIEGERICH R, 1996, P INT C INT SYST MOL, V4, P58; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HAGLUND B, 1990, AM J PUBLIC HEALTH, V80, P29, DOI 10.2105/AJPH.80.1.29; Holloway AC, 2005, DIABETOLOGIA, V48, P2661, DOI 10.1007/s00125-005-0022-5; Keating DJ, 2001, AM J PHYSIOL-CELL PH, V281, pC1434, DOI 10.1152/ajpcell.2001.281.5.C1434; LAGERCRANTZ H, 1986, SCI AM, V254, P100, DOI 10.1038/scientificamerican0486-100; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; MochizukiOda N, 1997, J NEUROCHEM, V69, P377; Mojet MH, 1997, J PHYSIOL-LONDON, V504, P175, DOI 10.1111/j.1469-7793.1997.175bf.x; Munoz-Cabello AM, 2005, J NEUROSCI, V25, P6631, DOI 10.1523/JNEUROSCI.1139-05.2005; Rico AJ, 2005, AM J PHYSIOL-CELL PH, V289, pC1417, DOI 10.1152/ajpcell.00023.2005; SEIDLER FJ, 1985, J PHYSL, V385, P1; Slotkin TA, 1998, J PHARMACOL EXP THER, V285, P931; SLOTKIN TA, 1988, J DEV PHYSIOL, V10, P1; SLOTKIN TA, 1995, BRAIN RES BULL, V38, P69, DOI 10.1016/0361-9230(95)00073-N; Thompson RJ, 2007, NEUROSCIENCE, V145, P130, DOI 10.1016/j.neuroscience.2006.11.040; Thompson RJ, 1997, J PHYSIOL-LONDON, V498, P503, DOI 10.1113/jphysiol.1997.sp021876; Thompson RJ, 1998, J PHYSIOL-LONDON, V512, P421, DOI 10.1111/j.1469-7793.1998.421be.x; Thompson RJ, 2002, PFLUG ARCH EUR J PHY, V444, P539, DOI 10.1007/s00424-002-0853-6; Zhang M, 2000, J PHYSIOL-LONDON, V525, P143, DOI 10.1111/j.1469-7793.2000.t01-1-00143.x	24	29	31	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2008	22	5					1317	1326		10.1096/fj.07-9194com	http://dx.doi.org/10.1096/fj.07-9194com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18070822				2022-12-25	WOS:000255898700005
J	Hajji, N; Wallenborg, K; Vlachos, P; Nyman, U; Hermanson, O; Joseph, B				Hajji, N.; Wallenborg, K.; Vlachos, P.; Nyman, U.; Hermanson, O.; Joseph, B.			Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells	ONCOGENE			English	Article						NSCLC; apoptosis; HDAC inhibitor; AIF; Bcl-xL	HISTONE DEACETYLASE INHIBITORS; CANCER CELLS; ANTICANCER AGENTS; EXPRESSION; RESISTANT; BCL-2; AMPLIFICATION; THERAPY; PROTEIN; POINT	Commonly used regimens in cancer therapy rely on the induction of apoptotic cell death, and drug resistance can be attributed, at least in part, to a disabled apoptotic program. Non-small cell lung carcinomas (NSCLC), exhibit an intrinsic resistance to chemotherapy. Here, we show that co-treatment with etoposide (VP16) and the pan-histone deacetylase (HDAC) inhibitor trichostatin A (TSA), but not valproic acid (VPA), induced apoptotic cell death in drug-resistant NSCLC cells. Co-treatment, but not single treatment, with VP16 and TSA induced apoptosis in a caspase-dependent manner accompanied by a crucial decrease in Bcl-xL expression allowing Bax activation and subsequent initiation of the apoptosis inducingfactor (AIF)-dependent death pathway. Importantly, AIF proved to be required for the effects of TSA/VP16 as RNA knockdown of AIF resulted in a complete abolishment of TSA/VP16-induced apoptotic cell death in drug-resistant NSCLC cells. Our results thus provide evidence for the requirement of both caspase-dependent and caspase-independent apoptotic pathways in TSA/VP16-mediated death of drug-resistant NSCLC cells, and extend previous suggestions that HDAC inhibitors in combination with conventional chemotherapeutic drugs could be valuable in the treatment of NSCLC cancer and other malignancies in which Bcl-xL is overexpressed.	[Hajji, N.; Vlachos, P.; Nyman, U.; Joseph, B.] Karolinska Inst, Inst Environm Med, Div Toxicol & Neurotoxicol, SE-17177 Stockholm, Sweden; [Wallenborg, K.; Hermanson, O.] Karolinska Inst, Dept Neurosci, SE-17177 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Joseph, B (corresponding author), Karolinska Inst, Inst Environm Med, Div Toxicol & Neurotoxicol, Box 210, SE-17177 Stockholm, Sweden.	bertrand.joseph@ki.se	hajji, nabil/AAV-1435-2020; Nyman, Ulrika/D-3708-2013; , Ola/AAF-5126-2021	Hermanson, Ola/0000-0001-9320-7921				Cande C, 2004, CELL DEATH DIFFER, V11, P591, DOI 10.1038/sj.cdd.4401400; Choi YH, 2005, INT J ONCOL, V27, P473; Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1; Drummond DC, 2005, ANNU REV PHARMACOL, V45, P495, DOI 10.1146/annurev.pharmtox.45.120403.095825; Gallego MA, 2004, ONCOGENE, V23, P6282, DOI 10.1038/sj.onc.1207835; Geng L, 2006, CANCER RES, V66, P11298, DOI 10.1158/0008-5472.CAN-06-0049; Gottlicher M, 2001, EMBO J, V20, P6969, DOI 10.1093/emboj/20.24.6969; Henderson C, 2003, DRUG RESIST UPDATE, V6, P247, DOI 10.1016/S1368-7646(03)00067-0; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Joseph B, 2002, ONCOGENE, V21, P65, DOI 10.1038/sj/onc/1205018; Joseph B, 2001, ONCOGENE, V20, P2877, DOI 10.1038/sj.onc.1204402; Karczmarek-Borowska B, 2006, LUNG CANCER, V51, P61, DOI 10.1016/j.lungcan.2005.08.010; Komatsu N, 2006, ONCOL REP, V15, P187; Kruidering M, 2000, IUBMB LIFE, V50, P85, DOI 10.1080/15216540050212088; La Thangue NB, 2004, J CHEMOTHERAPY, V16, P64, DOI 10.1179/joc.2004.16.Supplement-1.64; Lei XY, 2007, ACTA BIOCH BIOPH SIN, V39, P344, DOI 10.1111/j.1745-7270.2007.00286.x; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Marks PA, 2005, CELL CYCLE, V4, P549, DOI 10.4161/cc.4.4.1564; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Martinou JC, 2001, NAT REV MOL CELL BIO, V2, P63, DOI 10.1038/35048069; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Peart MJ, 2005, P NATL ACAD SCI USA, V102, P3697, DOI 10.1073/pnas.0500369102; Pham NA, 2001, EXP CELL RES, V264, P345, DOI 10.1006/excr.2000.5148; Roucou X, 2002, BIOCHEM J, V368, P915, DOI 10.1042/BJ20020972; Rundall BK, 2005, SURGERY, V138, P360, DOI 10.1016/j.surg.2005.06.016; Schniewind Bodo, 2006, J Carcinog, V5, P25, DOI 10.1186/1477-3163-5-25; Shimizu S, 2000, P NATL ACAD SCI USA, V97, P3100, DOI 10.1073/pnas.97.7.3100; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Villar-Garea A, 2004, INT J CANCER, V112, P171, DOI 10.1002/ijc.20372; von Haefen C, 2003, ONCOGENE, V22, P2236, DOI 10.1038/sj.onc.1206280; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Yu XD, 2002, J NATL CANCER I, V94, P504; Zamzami N, 2001, NAT REV MOL CELL BIO, V2, P67, DOI 10.1038/35048073; Zangemeister-Wittke U, 2000, CLIN CANCER RES, V6, P2547; ZHIVOTOVSKY B, 1994, FEBS LETT, V351, P150, DOI 10.1016/0014-5793(94)00827-2; Zhivotovsky B, 1999, EXP CELL RES, V248, P10, DOI 10.1006/excr.1999.4452	36	50	52	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2008	27	22					3134	3144		10.1038/sj.onc.1210976	http://dx.doi.org/10.1038/sj.onc.1210976			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	301LL	18071312				2022-12-25	WOS:000255897600006
J	Shimazoe, T; Morita, M; Ogiwara, S; Kojiya, T; Goto, J; Kamakura, M; Moriya, T; Shinohara, K; Takiguchi, S; Kono, A; Miyasaka, K; Funakoshi, A; Ikeda, M				Shimazoe, Takao; Morita, Mitsutaka; Ogiwara, Shinichiro; Kojiya, Tomoyoshi; Goto, Junpei; Kamakura, Masaki; Moriya, Takahiro; Shinohara, Kazuyuki; Takiguchi, Soichi; Kono, Akira; Miyasaka, Kyoko; Funakoshi, Akihiro; Ikeda, Masayuki			Cholecystokinin-A receptors regulate photic input pathways to the circadian clock	FASEB JOURNAL			English	Article						cholecystokinin-A receptor mutant mice; glycinergic amacrine cells; melanopsin retinal ganglion cells; suprachiasmatic nucleus neurons	RETINAL GANGLION-CELLS; AMACRINE CELLS; SUPRACHIASMATIC NUCLEUS; GENE-EXPRESSION; RAT RETINA; MELANOPSIN; RHYTHMS; NEUROTRANSMITTERS; IMMUNOREACTIVITY; LOCALIZATION	Daily behaviors are strongly dominated by internally generated circadian rhythms, but the underlying mechanisms remain unclear. In mammals, photoentrainment of behaviors to light-dark cycles involves signaling from both intrinsically photosensitive retinal ganglion cells and classic photoreceptor pathways to the suprachiasmatic nucleus (SCN). How classic photoreceptor pathways work with the photosensitive ganglion cells, however, is not fully understood. Although cholecystokinin (CCK) peptide has been shown to be present in a variety of vertebrate retinas, its function at a systems level is also unknown. In the present study we examined a possible role of CCK-A receptors in photoentrainment using CCK-A receptor knockout mice. The lacZ reporter gene within a gene-knockout cassette revealed precise localization of CCK-A receptors in the circadian clock system. We demonstrated that CCK-A receptors were located predominately on glycinergic amacrine cells but were rarely found on SCN neurons. Moreover, Ca2+ imaging analysis demonstrated that the CCK-A agonist, CCK-8 sulfate (CCK-8s), mobilized intracellular Ca2+ in amacrine cells but not glutamate-receptive SCN neurons. Furthermore, light pulse-induced mPer1/mPer2 gene expression in SCN, behavioral phase shifts, and the pupillary reflex were significantly reduced in CCK-A receptor knockout mice. These data indicate a novel function of CCK-A receptors in the nonimage-forming photoreception presumably via amacrine cell-mediated signal transduction pathways.	[Ogiwara, Shinichiro; Kojiya, Tomoyoshi; Goto, Junpei; Ikeda, Masayuki] Toyama Univ, Fac Sci, Dept Biol, Grad Sch Sci & Engn, Toyama 9308555, Japan; [Shimazoe, Takao; Morita, Mitsutaka] Kyushu Univ, Grad Sch Pharmaceut Sci, Fukuoka, Japan; [Kamakura, Masaki] Toyama Prefectural Univ, Fac Engn, Biotechnol Res Ctr, Toyama, Japan; [Moriya, Takahiro; Shinohara, Kazuyuki] Nagasaki Univ, Grad Sch Biomed Sci, Course Med & Dent Sci, Dept Translat Med Sci, Nagasaki, Japan; [Takiguchi, Soichi; Kono, Akira; Funakoshi, Akihiro] Kyushu Natl Canc Ctr, Fukuoka, Japan; [Miyasaka, Kyoko] Tokyo Metropolitan Inst Gerontol, Dept Translat Med Sci, Tokyo, Japan; [Ikeda, Masayuki] Waseda Univ, Adv Inst Biol Sci, Tokyo, Japan	University of Toyama; Kyushu University; Toyama Prefectural University; Nagasaki University; Tokyo Metropolitan Institute of Gerontology; Waseda University	Ikeda, M (corresponding author), Toyama Univ, Fac Sci, Dept Biol, Grad Sch Sci & Engn, Rm B214,3190 Gofuku, Toyama 9308555, Japan.	msikeda@sci.u-toyama.ac.jp	Kamakura, Masaki/E-7954-2011	Ikeda, Masayuki/0000-0002-6833-9495				Belenky MA, 2003, J COMP NEUROL, V460, P380, DOI 10.1002/cne.10652; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bi S, 2004, ENDOCRINOLOGY, V145, P3873, DOI 10.1210/en.2004-0284; Bragado MJ, 2003, NEUROPEPTIDES, V37, P374, DOI 10.1016/j.npep.2003.10.004; Correia SS, 2003, J BIOL CHEM, V278, P6307, DOI 10.1074/jbc.M205587200; DAVIDOWA H, 1995, BRAIN RES BULL, V36, P533, DOI 10.1016/0361-9230(94)00238-V; DING JM, 1994, SCIENCE, V266, P1713, DOI 10.1126/science.7527589; Dkhissi-Benyahya O, 2007, NEURON, V53, P677, DOI 10.1016/j.neuron.2007.02.005; Dumitrescu ON, 2006, VISUAL NEUROSCI, V23, P79, DOI 10.1017/S0952523806231079; ESKAY RL, 1982, BRAIN RES, V246, P315, DOI 10.1016/0006-8993(82)91183-0; Firth SI, 2002, VISUAL NEUROSCI, V19, P531, DOI 10.1017/S0952523802194156; Freedman MS, 1999, SCIENCE, V284, P502, DOI 10.1126/science.284.5413.502; Fry M, 2007, EXP BIOL MED, V232, P14; FUNAKOSHI A, 1995, BIOCHEM BIOPH RES CO, V210, P787, DOI 10.1006/bbrc.1995.1728; Gabriel R, 2004, CELL TISSUE RES, V315, P181, DOI 10.1007/s00441-003-0785-2; Gooley JJ, 2001, NAT NEUROSCI, V4, P1165, DOI 10.1038/nn768; Hannibal J, 2002, CELL TISSUE RES, V309, P73, DOI 10.1007/s00441-002-0574-3; Hatakeyama J, 2002, METHODS, V28, P387, DOI 10.1016/S1046-2023(02)00257-8; Herness S, 2002, J NEUROSCI, V22, P10018; Ikeda M, 2004, NEUROSCIENTIST, V10, P315, DOI 10.1177/10738584031262149; Ikeda M, 2003, NEURON, V38, P253, DOI 10.1016/S0896-6273(03)00164-8; Jobst EE, 2004, TRENDS ENDOCRIN MET, V15, P488, DOI 10.1016/j.tem.2004.10.007; Kopin AS, 1999, J CLIN INVEST, V103, P383, DOI 10.1172/JCI4901; Lagnado L, 1998, CURR BIOL, V8, pR598, DOI 10.1016/S0960-9822(98)70385-9; Lesauter J, 2002, NEUROSCIENCE, V111, P575, DOI 10.1016/S0306-4522(01)00604-2; Lucas RJ, 2003, SCIENCE, V299, P245, DOI 10.1126/science.1077293; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; MARSHAK DW, 1990, J NEUROSCI, V10, P3045; Moldavan MG, 2006, J NEUROPHYSIOL, V95, P3727, DOI 10.1152/jn.00909.2005; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Morin LP, 2006, BRAIN RES REV, V51, P1, DOI 10.1016/j.brainresrev.2005.08.003; Muramatsu Y, 2005, BIOCHEM BIOPH RES CO, V331, P1270, DOI 10.1016/j.bbrc.2005.04.040; Nirenberg S, 1997, NEURON, V18, P637, DOI 10.1016/S0896-6273(00)80304-9; Ogino T, 2000, GENOMICS, V70, P19, DOI 10.1006/geno.2000.6349; OSBORNE NN, 1981, NEUROSCI LETT, V26, P31, DOI 10.1016/0304-3940(81)90421-3; OSBORNE NN, 1982, EXP EYE RES, V34, P639, DOI 10.1016/0014-4835(82)90038-0; Panda S, 2003, SCIENCE, V301, P525, DOI 10.1126/science.1086179; Pickard GE, 1999, J NEUROSCI, V19, P4034; Shearman LP, 1997, NEURON, V19, P1261, DOI 10.1016/S0896-6273(00)80417-1; Shimazoe T, 1999, JPN J PHARMACOL, V80, P85, DOI 10.1254/jjp.80.85; Silver R, 1999, NEUROREPORT, V10, P3165, DOI 10.1097/00001756-199910190-00008; Simasko SM, 2002, AM J PHYSIOL-REG I, V283, pR1303, DOI 10.1152/ajpregu.00050.2002; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; Takiguchi S, 2002, PANCREAS, V24, P276, DOI 10.1097/00006676-200204000-00011; Takiguchi S, 1997, GENE, V197, P169, DOI 10.1016/S0378-1119(97)00259-X; VANDENPOL AN, 1985, NEUROSCIENCE, V15, P1049, DOI 10.1016/0306-4522(85)90254-4; WASSLE H, 1991, PHYSIOL REV, V71, P447, DOI 10.1152/physrev.1991.71.2.447; Williams JA, 2001, ANNU REV PHYSIOL, V63, P77, DOI 10.1146/annurev.physiol.63.1.77; Yamanouchi S, 1997, NEUROSCI LETT, V227, P103, DOI 10.1016/S0304-3940(97)00324-8; Zhang DQ, 2005, BRAIN RES, V1050, P101, DOI 10.1016/j.brainres.2005.05.042	50	14	14	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1479	1490		10.1096/fj.07-9372com	http://dx.doi.org/10.1096/fj.07-9372com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18073333				2022-12-25	WOS:000255898700020
J	Ramachandran, B; Yu, GS; Li, SG; Zhu, B; Gulick, T				Ramachandran, Bindu; Yu, Gengsheng; Li, Shiguang; Zhu, Bangmin; Gulick, Tod			Myocyte enhancer factor 2A is transcriptionally autoregulated	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE DIFFERENTIATION; SIGNAL-REGULATED KINASE-5; MEF2 PROTEIN FAMILY; GENE-EXPRESSION; MADS-BOX; HISTONE DEACETYLASES; MOUSE EMBRYOGENESIS; NEURONAL SURVIVAL; STRIATED-MUSCLE; NERVOUS-SYSTEM	MEF2 (myocyte enhancer factor 2) proteins are a small family of transcription factors that play pivotal roles in striated muscle differentiation, development, and metabolism, in neuron survival and synaptic formation, and in lymphocyte selection and activation. Products of the four mammalian MEF2 genes, MEF2A, MEF2B, MEF2C, and MEF2D, are expressed with overlapping but distinct temporospatial patterns. Toward analysis of MEF2A functions and the determinants of its regulated expression, we have mapped and begun studies of the transcriptional control regions of this gene. Heterogeneous 5'-untranslated regions of MEF2A mRNAs result from use of alternative promoters and splicing patterns. The two closely approximated TATA-less promoters are similar to 65 kb upstream of the exon containing the sole initiation codon. Ribonuclease protection and primer extension assays show that each promoter is active in various adult tissues. A canonical MEF2 site overlies the major promoter 1 transcription start site. This element specifically binds MEF2 factors, including endogenous nuclear MEF2A according to chromatin immunoprecipitation studies, and is critical to MEF2A transcription in myocytes. The site exerts reciprocal control of the alternative promoters, silencing promoter 1 and activating promoter 2 under some conditions. Erk5 and p38 MAPK signaling stimulate MEF2A expression by activating both promoters from the MEF2 element. MEF2A transcription is therefore subject to positive or negative regulation by its protein products, depending on signaling activities that influence MEF2 factor trans-activity. The sole MEF2 gene of the cephalochordate amphioxus has a similar regulatory region structure, suggesting that this mode of autoregulatory control is conserved among higher metazoan MEF2 genes.	[Ramachandran, Bindu; Yu, Gengsheng; Li, Shiguang; Zhu, Bangmin; Gulick, Tod] Massachusetts Gen Hosp, Diabet Res Lab, Dept Med, Charlestown, MA 02129 USA; [Yu, Gengsheng; Zhu, Bangmin; Gulick, Tod] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Gulick, T (corresponding author), Massachusetts Gen Hosp, Diabet Res Lab, Dept Med, CNY 149 8219, Charlestown, MA 02129 USA.	gulick@helix.mgh.harvard.edu			NHLBI NIH HHS [HL72713] Funding Source: Medline; NIDDK NIH HHS [DK55875, DK02461, P30-DK40561] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072713] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK040561, K02DK002461, R01DK055875] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ausubel FM, 1998, CURRENT PROTOCOLS MO; Beals CR, 1997, GENE DEV, V11, P824, DOI 10.1101/gad.11.7.824; Bergstrom DA, 2002, MOL CELL, V9, P587, DOI 10.1016/S1097-2765(02)00481-1; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bi WZ, 1999, DEV BIOL, V211, P255, DOI 10.1006/dbio.1999.9307; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Black BL, 1997, MOL CELL BIOL, V17, P2756, DOI 10.1128/MCB.17.5.2756; Black BL, 1996, J BIOL CHEM, V271, P26659, DOI 10.1074/jbc.271.43.26659; BLACK BL, 1995, J BIOL CHEM, V270, P2889, DOI 10.1074/jbc.270.7.2889; BREITBART RE, 1993, DEVELOPMENT, V118, P1095; Cavanaugh JE, 2004, EUR J BIOCHEM, V271, P2056, DOI 10.1111/j.1432-1033.2004.04131.x; Cripps RM, 2004, DEV BIOL, V267, P536, DOI 10.1016/j.ydbio.2003.12.004; De Val S, 2004, DEV BIOL, V275, P424, DOI 10.1016/j.ydbio.2004.08.016; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; Dodou E, 2003, MECH DEVELOP, V120, P1021, DOI 10.1016/S0925-4773(03)00178-3; EDMONDSON DG, 1994, DEVELOPMENT, V120, P1251; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Friday BB, 2000, J CELL BIOL, V149, P657, DOI 10.1083/jcb.149.3.657; Gaudilliere B, 2002, J BIOL CHEM, V277, P46442, DOI 10.1074/jbc.M206653200; Gong XM, 2003, NEURON, V38, P33, DOI 10.1016/S0896-6273(03)00191-0; Grayson J, 1998, J CELL BIOCHEM, V70, P366, DOI 10.1002/(SICI)1097-4644(19980901)70:3<366::AID-JCB10>3.3.CO;2-T; Gregoire S, 2006, J BIOL CHEM, V281, P4423, DOI 10.1074/jbc.M509471200; Han AD, 2005, J MOL BIOL, V345, P91, DOI 10.1016/j.jmb.2004.10.033; Han AD, 2003, NATURE, V422, P730, DOI 10.1038/nature01555; Han J, 1997, NATURE, V386, P296, DOI 10.1038/386296a0; HAN TH, 1995, MOL CELL BIOL, V15, P2907; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Ichijo H, 1997, SCIENCE, V275, P90, DOI 10.1126/science.275.5296.90; Junion G, 2005, P NATL ACAD SCI USA, V102, P18479, DOI 10.1073/pnas.0507030102; Kang Jungseog, 2006, BMC Biochemistry, V7, DOI 10.1186/1471-2091-7-5; Kato Y, 2000, J BIOL CHEM, V275, P18534, DOI 10.1074/jbc.M001573200; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kolodziejczyk SM, 1999, CURR BIOL, V9, P1203, DOI 10.1016/S0960-9822(00)80027-5; Lazaro JB, 2002, GENE DEV, V16, P1792, DOI 10.1101/gad.U-9988R; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lin Q, 1997, SCIENCE, V276, P1404, DOI 10.1126/science.276.5317.1404; Liu SF, 1997, EMBO J, V16, P143, DOI 10.1093/emboj/16.1.143; Liu Y., 2005, J MUSCLE RES CELL M, P1; Lluis F, 2006, TRENDS CELL BIOL, V16, P36, DOI 10.1016/j.tcb.2005.11.002; LYONS GE, 1995, J NEUROSCI, V15, P5727, DOI 10.1523/jneurosci.15-08-05727.1995; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; McKinsey TA, 2002, TRENDS BIOCHEM SCI, V27, P40, DOI 10.1016/S0968-0004(01)02031-X; Molkentin JD, 1995, CELL, V83, P1125, DOI 10.1016/0092-8674(95)90139-6; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Morin S, 2000, EMBO J, V19, P2046, DOI 10.1093/emboj/19.9.2046; NAIDU PS, 1995, MOL CELL BIOL, V15, P2707; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Naya FJ, 2002, NAT MED, V8, P1303, DOI 10.1038/nm789; Nguyen HT, 1998, DEV BIOL, V204, P550, DOI 10.1006/dbio.1998.9081; NURRISH SJ, 1995, MOL CELL BIOL, V15, P4076; Okamoto S, 2000, P NATL ACAD SCI USA, V97, P7561, DOI 10.1073/pnas.130502697; Pan F, 2004, J BIOL CHEM, V279, P14477, DOI 10.1074/jbc.C300487200; Penn BH, 2004, GENE DEV, V18, P2348, DOI 10.1101/gad.1234304; POLLOCK R, 1991, GENE DEV, V5, P2327, DOI 10.1101/gad.5.12a.2327; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Puri PL, 2000, GENE DEV, V14, P574; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Ridgeway AG, 2000, J BIOL CHEM, V275, P41, DOI 10.1074/jbc.275.1.41; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; Shalizi AK, 2005, CURR TOP DEV BIOL, V69, P239, DOI 10.1016/S0070-2153(05)69009-6; Sharp PA, 2005, TRENDS BIOCHEM SCI, V30, P279, DOI 10.1016/j.tibs.2005.04.002; Subramanian SV, 1996, MECH DEVELOP, V57, P103, DOI 10.1016/0925-4773(96)00542-4; Sugahara Y, 2001, GENE, V263, P93, DOI 10.1016/S0378-1119(00)00557-6; Suzuki E, 1996, CYTOGENET CELL GENET, V73, P244, DOI 10.1159/000134348; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Wang DZ, 2001, DEVELOPMENT, V128, P4623; WONG MW, 1994, DEV BIOL, V166, P683, DOI 10.1006/dbio.1994.1347; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Youn HD, 2000, IMMUNITY, V13, P85, DOI 10.1016/S1074-7613(00)00010-8; Yu GS, 2007, MODERN PATHOL, V20, p310A; Yu GS, 1998, J BIOL CHEM, V273, P32901, DOI 10.1074/jbc.273.49.32901; YU YT, 1992, GENE DEV, V6, P1783, DOI 10.1101/gad.6.9.1783; Zetser A, 1999, J BIOL CHEM, V274, P5193, DOI 10.1074/jbc.274.8.5193; Zhao M, 2002, ARCH BIOCHEM BIOPHYS, V400, P199, DOI 10.1016/S0003-9861(02)00028-0; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zhao X, 2005, MOL CELL BIOL, V25, P8456, DOI 10.1128/MCB.25.19.8456-8464.2005; Zhu BM, 2005, J BIOL CHEM, V280, P28749, DOI 10.1074/jbc.M502491200; Zhu BM, 2004, MOL CELL BIOL, V24, P8264, DOI 10.1128/MCB.24.18.8264-8275.2004	83	24	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10318	10329		10.1074/jbc.M707623200	http://dx.doi.org/10.1074/jbc.M707623200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18073218	Green Published, hybrid			2022-12-25	WOS:000254894700012
J	Madsen, L; Pedersen, LM; Liaset, B; Ma, T; Petersen, RK; van den Berg, S; Pan, J; Muller-Decker, K; Dulsner, ED; Kleemann, R; Kooistra, T; Doskeland, SO; Kristiansen, K				Madsen, Lise; Pedersen, Lone Moller; Liaset, Bjorn; Ma, Tao; Petersen, Rasmus Koefoed; van den Berg, Sjoerd; Pan, Jie; Mueller-Decker, Karin; Duelsner, Erik D.; Kleemann, Robert; Kooistra, Teake; Doskeland, Stein Ove; Kristiansen, Karsten			cAMP-dependent signaling regulates the adipogenic effect of n-6 polyunsaturated fatty acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE DEVELOPMENT; ADIPOCYTE DIFFERENTIATION; HEPATIC GLUCONEOGENESIS; ARACHIDONIC-ACID; COACTIVATOR PGC-1; RATS; DIET; INSULIN; LIVER; GENE	The effect of n-6 polyunsaturated fatty acids ( n-6 PUFAs) on adipogenesis and obesity is controversial. Using in vitro cell culture models, we show that n-6 PUFAs was pro-adipogenic under conditions with base-line levels of cAMP, but anti-adipogenic when the levels of cAMP were elevated. The anti-adipogenic action of n-6 PUFAs was dependent on a cAMP-dependent protein kinase-mediated induction of cyclooxygenase expression and activity. We show that n-6 PUFAs were pro-adipogenic when combined with a high carbohydrate diet, but non-adipogenic when combined with a high protein diet in mice. The high protein diet increased the glucagon/ insulin ratio, leading to elevated cAMP-dependent signaling and induction of cyclooxygenase-mediated prostaglandin synthesis. Mice fed the high protein diet had a markedly lower feed efficiency than mice fed the high carbohydrate diet. Yet, oxygen consumption and apparent heat production were similar. Mice on a high protein diet had increased hepatic expression of PGC-1 alpha(peroxisome proliferator-activated receptor gamma coactivator 1 alpha) and genes involved in energy-demanding processes like urea synthesis and gluconeogenesis. We conclude that cAMP signaling is pivotal in regulating the adipogenic effect of n-6 PUFAs and that diet-induced differences in cAMP levels may explain the ability of n-6 PUFAs to either enhance or counteract adipogenesis and obesity.	[Madsen, Lise; Liaset, Bjorn] Natl Inst Nutr & Seafood Res, N-5817 Bergen, Norway; [Madsen, Lise; Pedersen, Lone Moller; Ma, Tao; Petersen, Rasmus Koefoed; Kristiansen, Karsten] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [van den Berg, Sjoerd] Leiden Univ, Med Ctr, Dept Human Genet, NL-2300 RC Leiden, Netherlands; [Pan, Jie] Shandong Normal Univ, Coll Life Sci, Key Lab Anti Morbid Anim Biol, Jinan 250014, Peoples R China; [Mueller-Decker, Karin; Duelsner, Erik D.] Deutsch Krebsforschungszentrum, Core Facil Tumor Models, D-69120 Heidelberg, Germany; [Kleemann, Robert; Kooistra, Teake] TNO, Dept Biosci, NL-2301 CE Leiden, Netherlands; [Doskeland, Stein Ove] Univ Bergen, Dept Biomed, N-5097 Bergen, Norway	University of Southern Denmark; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Shandong Normal University; Helmholtz Association; German Cancer Research Center (DKFZ); Netherlands Organization Applied Science Research; University of Bergen	Madsen, L (corresponding author), Natl Inst Nutr & Seafood Res, Postboks 2029, N-5817 Bergen, Norway.	lise.madsen@bmb.sdu.dk; kak@bmb.sdu.dk	Kristiansen, Karsten/J-5148-2014; van den Berg, Sjoerd A/R-9541-2018; Madsen, Lise/C-6246-2012; van den Berg, Sjoerd AA/B-1994-2009	Kristiansen, Karsten/0000-0002-6024-0917; Madsen, Lise/0000-0003-4468-1947; van den Berg, Sjoerd/0000-0001-8967-376X; Doskeland, Stein Ove/0000-0002-4009-4756; van den Berg, Sjoerd/0000-0001-5937-7505; Liaset, Bjorn/0000-0002-8652-7801				Ailhaud G, 2006, PROG LIPID RES, V45, P203, DOI 10.1016/j.plipres.2006.01.003; Arslan G, 2002, LIPIDS, V37, P935, DOI 10.1007/s11745-006-0983-2; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cleary MP, 1999, P SOC EXP BIOL MED, V220, P153, DOI 10.1046/j.1525-1373.1999.d01-23.x; Cordain L, 2005, AM J CLIN NUTR, V81, P341, DOI 10.1093/ajcn.81.2.341; CRAWFORD M, 1968, LANCET, V291, P1329; FAUST IM, 1978, AM J PHYSIOL, V235, pE279, DOI 10.1152/ajpendo.1978.235.3.E279; Fine Eugene J, 2004, Nutr Metab (Lond), V1, P15, DOI 10.1186/1743-7075-1-15; GAILLARD D, 1989, BIOCHEM J, V257, P389, DOI 10.1042/bj2570389; HAHN P, 1980, J NUTR, V110, P330, DOI 10.1093/jn/110.2.330; Halton TL, 2004, J AM COLL NUTR, V23, P373, DOI 10.1080/07315724.2004.10719381; Hansen JB, 2001, J BIOL CHEM, V276, P3175, DOI 10.1074/jbc.M005567200; Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131; HYMAN BT, 1982, BIOCHIM BIOPHYS ACTA, V713, P375, DOI 10.1016/0005-2760(82)90256-9; ILLIANO G, 1972, SCIENCE, V175, P906, DOI 10.1126/science.175.4024.906; IP MM, 1977, J NUTR, V107, P746, DOI 10.1093/jn/107.5.746; Jump DB, 2005, J NUTR, V135, P2503, DOI 10.1093/jn/135.11.2503; LACEY JH, 1981, BIOCHEM J, V194, P29, DOI 10.1042/bj1940029; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; MANGANIELLO VC, 1971, J BIOL CHEM, V246, P2195; Massiera F, 2003, J LIPID RES, V44, P271, DOI 10.1194/jlr.M200346-JLR200; Matsuo T, 2002, ASIA PAC J CLIN NUTR, V11, P302, DOI 10.1046/j.1440-6047.2002.00299.x; Miller CW, 1996, ENDOCRINOLOGY, V137, P5641, DOI 10.1210/en.137.12.5641; MULLERDECKER K, 1994, TOXICOL APPL PHARM, V127, P99, DOI 10.1006/taap.1994.1144; Neufang G, 2001, P NATL ACAD SCI USA, V98, P7629, DOI 10.1073/pnas.121574098; Okuno M, 1997, J NUTR, V127, P1752, DOI 10.1093/jn/127.9.1752; Petersen RK, 2003, J LIPID RES, V44, P2320, DOI 10.1194/jlr.M300192-JLR200; Prentice AM, 2001, OBES RES, V9, p234S, DOI 10.1038/oby.2001.124; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; SERRERO G, 1992, ENDOCRINOLOGY, V131, P2545, DOI 10.1210/en.131.6.2545; SERRERO G, 1992, BIOCHEM BIOPH RES CO, V183, P438, DOI 10.1016/0006-291X(92)90500-K; Simopoulos AP, 2002, BIOMED PHARMACOTHER, V56, P365, DOI 10.1016/S0753-3322(02)00253-6; SPITZER JA, 1990, AGENTS ACTIONS, V31, P341, DOI 10.1007/BF01997629; van den Hoek AM, 2007, AM J PHYSIOL-ENDOC M, V292, pE238, DOI 10.1152/ajpendo.00239.2006; Wadleigh DJ, 2000, J BIOL CHEM, V275, P6259, DOI 10.1074/jbc.275.9.6259; Watson PM, 2000, AM J PHYSIOL-ENDOC M, V279, pE356, DOI 10.1152/ajpendo.2000.279.2.E356; Westerterp-Plantenga MS, 2005, APPETITE, V45, P187, DOI 10.1016/j.appet.2005.02.005; XIE WL, 1994, MOL CELL BIOL, V14, P6531, DOI 10.1128/MCB.14.10.6531; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhou L, 2001, J LIPID RES, V42, P1521	40	63	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7196	7205		10.1074/jbc.M707775200	http://dx.doi.org/10.1074/jbc.M707775200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18070879	hybrid, Green Published			2022-12-25	WOS:000253779600065
J	Estrella, LA; Krishnamurthy, S; Timme, CR; Hampsey, M				Estrella, Luis A.; Krishnamurthy, Shankarling; Timme, Cindy R.; Hampsey, Michael			The Rsp5 E3 ligase mediates turnover of low affinity phosphate transporters in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST URACIL PERMEASE; UBIQUITIN-PROTEIN LIGASE; GLUCOSE-INDUCED PROTEOLYSIS; PEST-LIKE SEQUENCE; GALACTOSE TRANSPORTER; ACTIN CYTOSKELETON; MALTOSE PERMEASE; DOWN-REGULATION; IN-VIVO; GENE	In an effort to identify novel components of the PHO regulon in Saccharomyces cerevisiae, we have isolated and characterized suppressors of the Pho(-) phenotype associated with deletion of the Pho4 transcriptional activator. Here we report that either a defective form of the Rsp5 E3 ubiquitin ligase or deletion of the End3 component of the endocytic pathway restores growth of the pho4 Delta mutant in the presence of limiting inorganic phosphate (P-i). The spa1-1 suppressor allele of RSP5 encodes a phenylalanine-to-valine replacement at position 748 (F748V) within the catalytic HECT domain of Rsp5. Consistent with suppression due to impaired ubiquitin ligase activity, the heat-sensitive growth defect of the spa1-1 mutant is suppressed either by overexpression of ubiquitin or by osmotic stabilization. Western blot analyses revealed that the cellular levels of the Pho87 and Pho91 low affinity P-i are markedly increased in the spa1-1 mutant, yet Pho84 high affinity P-i transporter levels are unaffected. Furthermore, Pho87 and Pho91 are ubiquitinated in vivo in an Rsp5-dependent manner, and the Pho(-) phenotype of the spa1-1 suppressor is dependent upon Pho87 and Pho91. We conclude that turnover of the low affinity P-i transporters is initiated by Rsp5-mediated ubiquitination followed by internalization and degradation by the endocytic pathway.	[Estrella, Luis A.; Krishnamurthy, Shankarling; Timme, Cindy R.; Hampsey, Michael] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, Div Nucleic Acids Enzymol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Hampsey, M (corresponding author), Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Biochem, 683 Hoes Lane W, Piscataway, NJ 08854 USA.	michael.hampsey@umdnj.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM055145, F31GM067388, T32GM008360, R01GM039484] Funding Source: NIH RePORTER; NIGMS NIH HHS [F31 GM67388, R25 GM55145, R01 GM39484, T32 GM08360] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Almaguer C, 2003, EUKARYOT CELL, V2, P729, DOI 10.1128/EC.2.4.729-736.2003; Auesukaree C, 2003, BIOCHEM BIOPH RES CO, V306, P843, DOI 10.1016/S0006-291X(03)01068-4; Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227; Blondel MO, 2004, MOL BIOL CELL, V15, P883, DOI 10.1091/mbc.E03-04-0202; BUNYA M, 1991, MOL CELL BIOL, V11, P3229, DOI 10.1128/MCB.11.6.3229; Cross FR, 1997, YEAST, V13, P647, DOI 10.1002/(SICI)1097-0061(19970615)13:7<647::AID-YEA115>3.0.CO;2-#; Deutschbauer AM, 2005, GENETICS, V169, P1915, DOI 10.1534/genetics.104.036871; Fisk HA, 1999, J CELL BIOL, V145, P1199, DOI 10.1083/jcb.145.6.1199; Galan JM, 1996, J BIOL CHEM, V271, P10946, DOI 10.1074/jbc.271.18.10946; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hicke L, 2003, ANNU REV CELL DEV BI, V19, P141, DOI 10.1146/annurev.cellbio.19.110701.154617; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; Horak J, 1997, J BACTERIOL, V179, P1541, DOI 10.1128/jb.179.5.1541-1549.1997; Horak J, 2001, J BACTERIOL, V183, P3083, DOI 10.1128/JB.183.10.3083-3088.2001; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Kaffman A, 1998, NATURE, V396, P482, DOI 10.1038/24898; Kaminska J, 2002, MOL CELL BIOL, V22, P6946, DOI 10.1128/MCB.22.20.6946-6958.2002; Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kee Y, 2007, BIOCHEM BIOPH RES CO, V354, P329, DOI 10.1016/j.bbrc.2007.01.025; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Krishnamurthy S, 2004, MOL CELL, V14, P387, DOI 10.1016/S1097-2765(04)00235-7; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Marchal C, 2000, J BIOL CHEM, V275, P23608, DOI 10.1074/jbc.M001735200; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Medintz I, 2000, BIOCHEMISTRY-US, V39, P4518, DOI 10.1021/bi992455a; Medintz I, 1998, J BIOL CHEM, V273, P34454, DOI 10.1074/jbc.273.51.34454; Mouillon JM, 2005, CURR GENET, V48, P226, DOI 10.1007/s00294-005-0019-0; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Petersson J, 1999, FEBS LETT, V462, P37, DOI 10.1016/S0014-5793(99)01471-4; Pinson B, 2004, J BIOL CHEM, V279, P35273, DOI 10.1074/jbc.M405398200; PRELICH G, 1993, GENETICS, V135, P665; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROTHSTEIN R, 1991, METHOD ENZYMOL, V194, P281; RUBIN GM, 1974, EUR J BIOCHEM, V41, P197, DOI 10.1111/j.1432-1033.1974.tb03260.x; Seron K, 1999, J BACTERIOL, V181, P1793; Shearwin-Whyatt L, 2006, BIOESSAYS, V28, P617, DOI 10.1002/bies.20422; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; TAMAI Y, 1985, J BACTERIOL, V164, P964, DOI 10.1128/JB.164.2.964-968.1985; Tang HY, 2000, MOL CELL BIOL, V20, P12, DOI 10.1128/MCB.20.1.12-25.2000; THIELE DJ, 1986, MOL CELL BIOL, V6, P1158, DOI 10.1128/MCB.6.4.1158; THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9; VOLLAND C, 1992, J BIOL CHEM, V267, P23767; Wang GL, 1999, MOL CELL BIOL, V19, P342; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; YAFFE MP, 1984, P NATL ACAD SCI-BIOL, V81, P4819, DOI 10.1073/pnas.81.15.4819; Yashiroda H, 1996, MOL CELL BIOL, V16, P3255	51	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5327	5334		10.1074/jbc.M703630200	http://dx.doi.org/10.1074/jbc.M703630200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165238	hybrid			2022-12-25	WOS:000253426700012
J	Alioua, A; Lu, R; Kumar, Y; Eghbali, M; Kundu, P; Toro, L; Stefani, E				Alioua, Abderrahmane; Lu, Rong; Kumar, Yogesh; Eghbali, Mansoureh; Kundu, Pallob; Toro, Ligia; Stefani, Enrico			Slo1 caveolin-binding motif, a mechanism of caveolin-1-Slo1 interaction regulating Slo1 surface expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; CA2+-ACTIVATED K+ CHANNEL; C-TERMINUS; SCAFFOLDING DOMAIN; PLASMA-MEMBRANE; BK CHANNELS; RECEPTOR; PROTEINS; VOLTAGE; ALPHA	The large conductance, voltage- and Ca2+- activated potassium (MaxiK, BK) channel and caveolin-1 play important roles in regulating vascular contractility. Here, we hypothesized that the MaxiK alpha-subunit (Slo1) and caveolin-1 may interact with each other. Slo1 and caveolin-1 physiological association in native vascular tissue is strongly supported by (i) detergent-free purification of caveolin-1-rich domains demonstrating a pool of aortic Slo1 co-migrating with caveolin-1 to light density sucrose fractions, (ii) reverse co-immunoprecipitation, and (iii) double immunolabeling of freshly isolated myocytes revealing caveolin-1 and Slo1 proximity at the plasmalemma. In HEK293T cells, Slo1-caveolin-1 association was unaffected by the smooth muscle MaxiK beta 1-subunit. Sequence analysis revealed two potential caveolin-binding motifs along the Slo1 C terminus, one equivalent, (1007)YNMLCFGIY(1015), and another mirror image, (537)YTEYLSSAF(545), to the consensus sequence, phi XXXX phi XX phi. Deletion of 1007YNMLCFGIY1015 caused similar to 80% loss of Slo1-caveolin-1 association while preserving channel normal folding and overall Slo1 and caveolin-1 intracellular distribution patterns. (537)YTEYLSSAF(545) deletion had an insignificant dissociative effect. Interestingly, caveolin-1 coexpression reduced Slo1 surface and functional expression near 70% without affecting channel voltage sensitivity, and deletion of (1007)YNMLCFGIY(1015) motif obliterated channel surface expression. The results suggest (1007)YNMLCFGIY(1015) possible participation in Slo1 plasmalemmal targeting and demonstrate its role as a main mechanism for caveolin-1 association with Slo1 potentially serving a dual role: (i) maintaining channels in intracellular compartments down sizing their surface expression and/or (ii) serving as anchor of plasma membrane resident channels to caveolin-1-rich membranes. Because the caveolin-1 scaffolding domain is juxtamembrane, it is tempting to suggest that Slo1-caveolin-1 interaction facilitates the tethering of the Slo1 C-terminal end to the membrane.	[Alioua, Abderrahmane; Lu, Rong; Kumar, Yogesh; Eghbali, Mansoureh; Kundu, Pallob; Toro, Ligia; Stefani, Enrico] Univ Calif Los Angeles, Dept Anesthesiol, Los Angeles, CA 90095 USA; [Toro, Ligia] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Stefani, Enrico] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Toro, Ligia; Stefani, Enrico] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Toro, Ligia; Stefani, Enrico] Univ Calif Los Angeles, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Alioua, A (corresponding author), Univ Calif Los Angeles, Dept Anesthesiol, BH-509A CHS, Los Angeles, CA 90095 USA.	aalioua@ucla.edu	KUMAR, YOGESH/GXN-1220-2022		NHLBI NIH HHS [HL54970, HL77705, P01-HL080111] Funding Source: Medline; NICHD NIH HHS [HD046510] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD046510] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL080111, R01HL054970, R01HL077705] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Brainard AM, 2005, AM J PHYSIOL-CELL PH, V289, pC49, DOI 10.1152/ajpcell.00399.2004; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; Cheng XY, 2006, AM J PHYSIOL-HEART C, V290, pH2309, DOI 10.1152/ajpheart.01226.2005; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Couet J, 1997, J BIOL CHEM, V272, P30429, DOI 10.1074/jbc.272.48.30429; Couet J, 1997, J BIOL CHEM, V272, P6525, DOI 10.1074/jbc.272.10.6525; Daniel EE, 2001, AM J PHYSIOL-GASTR L, V281, pG1101, DOI 10.1152/ajpgi.2001.281.4.G1101; Drab M, 2001, SCIENCE, V293, P2449, DOI 10.1126/science.1062688; Gang L, 2006, J BIOL CHEM, V281, P6087, DOI 10.1074/jbc.M507610200; Jiang Z, 1999, GENOMICS, V55, P57, DOI 10.1006/geno.1998.5627; Kwon SH, 2004, P NATL ACAD SCI USA, V101, P15237, DOI 10.1073/pnas.0404877101; Lam RS, 2004, BBA-BIOMEMBRANES, V1667, P241, DOI 10.1016/j.bbamem.2004.11.004; LAU YH, 1979, J GEN PHYSIOL, V74, P335, DOI 10.1085/jgp.74.3.335; Liou JY, 2001, J BIOL CHEM, V276, P34975, DOI 10.1074/jbc.M105946200; Liu LJ, 2004, AM J PHYSIOL-HEART C, V287, pH2173, DOI 10.1152/ajpheart.00352.2004; Liu PS, 2002, J BIOL CHEM, V277, P41295, DOI 10.1074/jbc.R200020200; Lu R, 2006, J PHYSIOL-LONDON, V570, P65, DOI 10.1113/jphysiol.2005.098913; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Marks MS, 1997, TRENDS CELL BIOL, V7, P124, DOI 10.1016/S0962-8924(96)10057-X; Meera P, 1997, P NATL ACAD SCI USA, V94, P14066, DOI 10.1073/pnas.94.25.14066; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Pany S, 2004, BIOCHEM BIOPH RES CO, V322, P29, DOI 10.1016/j.bbrc.2004.07.073; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; SARGIACOMO M, 1993, J CELL BIOL, V122, P789, DOI 10.1083/jcb.122.4.789; Schmalhofer WA, 2005, BIOCHEMISTRY-US, V44, P10135, DOI 10.1021/bi050527u; Schuck S, 2003, P NATL ACAD SCI USA, V100, P5795, DOI 10.1073/pnas.0631579100; Song KS, 1996, J BIOL CHEM, V271, P15160, DOI 10.1074/jbc.271.25.15160; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; Taggart MJ, 2000, EXP CELL RES, V258, P72, DOI 10.1006/excr.2000.4891; Tanaka Y, 1997, J PHYSIOL-LONDON, V502, P545, DOI 10.1111/j.1469-7793.1997.545bj.x; Thyberg J, 2002, J HISTOCHEM CYTOCHEM, V50, P185, DOI 10.1177/002215540205000206; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; VILLASCHI S, 1994, IN VITRO CELL DEV-AN, V30A, P589; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Wood LS, 1997, BIOCHEM BIOPH RES CO, V240, P623, DOI 10.1006/bbrc.1997.7714; Wyse BD, 2003, J BIOL CHEM, V278, P23738, DOI 10.1074/jbc.M212892200; Yamamoto M, 1998, J BIOL CHEM, V273, P26962, DOI 10.1074/jbc.273.41.26962; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101	40	58	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4808	4817		10.1074/jbc.M709802200	http://dx.doi.org/10.1074/jbc.M709802200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18079116	hybrid			2022-12-25	WOS:000253426500038
J	Knierim, B; Hofmann, KP; Gartner, W; Hubbell, WL; Ernst, OP				Knierim, Bernhard; Hofmann, Klaus Peter; Gaertner, Wolfgang; Hubbell, Wayne L.; Ernst, Oliver P.			Rhodopsin and 9-demethyl-retinal analog - Effect of a partial agonist on displacement of transmembrane helix 6 in class A G protein-coupled receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							METARHODOPSIN-II; TRANSDUCIN ACTIVATION; BOVINE RHODOPSIN; 9-METHYL GROUP; PROTON UPTAKE; STATE; PHOTOINTERMEDIATE; DYNAMICS; LINKING; REGION	Rhodopsin is the visual pigment of rod cells and a prototypical G protein-coupled receptor. It is activated by cis -> trans photoisomerization of the covalently bound chromophore 11-cis-retinal, which acts in the cis configuration as an inverse agonist. Light-induced formation of the full agonist all-trans-retinal in situ triggers conformational changes in the protein moiety. Partial agonists of rhodopsin include a retinal analog lacking the methyl group at C-9, termed 9-demethyl-retinal (9-dm-retinal). Rhodopsin reconstituted with this retinal (9-dm-rhodopsin) activates G protein poorly. Here we investigated the molecular nature of the partial agonism in 9-dm-rhodopsin using site-directed spin labeling. Earlier site-directed spin labeling studies of rhodopsin identified a rigid-body tilt of the cytoplasmic segment of helix transmembrane helix 6 (TM6) by similar to 6 angstrom as a central event in rhodopsin activation. Data presented here provide additional evidence for this mechanism. Only a small fraction of photoexcited 9-dm pigments reaches the TM6-tilted conformation. This fraction can be increased by increasing proton concentration by anticipation of the activating protonation step by the mutation E134Q in 9-dm-rhodopsin. These results on protein conformation are in complete accord with previous findings regarding the biological activity of the 9-dm pigments. When the proton concentration is further increased, a new state arises in 9-dm pigments that is linked to direct proton uptake at the retinal Schiff base. This state apparently has a conformation distinguishable from the active state.	[Hubbell, Wayne L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Hubbell, Wayne L.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Knierim, Bernhard; Hofmann, Klaus Peter; Ernst, Oliver P.] Charite Univ Med Berlin, Inst Med Phys & Biophys CCM, D-10117 Berlin, Germany; [Hofmann, Klaus Peter] Humboldt Univ, Zentrum Biophys & Bioinformat, D-10015 Berlin, Germany; [Gaertner, Wolfgang] Max Planck Inst Bioanorgan Chem, D-45470 Mulheim, Germany	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Humboldt University of Berlin; Max Planck Society	Hubbell, WL (corresponding author), Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA.	hubbellw@jsei.ucla.edu; oliver.ernst@charite.de		Gartner, Wolfgang/0000-0002-6898-7011	NATIONAL EYE INSTITUTE [R01EY005216, R37EY005216] Funding Source: NIH RePORTER; NEI NIH HHS [EY05216] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l; ARNIS S, 1993, P NATL ACAD SCI USA, V90, P7849, DOI 10.1073/pnas.90.16.7849; ARNIS S, 1994, J BIOL CHEM, V269, P23879; Bartl FJ, 2005, J BIOL CHEM, V280, P34259, DOI 10.1074/jbc.M505260200; Das J, 2004, BIOCHEMISTRY-US, V43, P5532, DOI 10.1021/bi036097u; Ernst OP, 2007, P NATL ACAD SCI USA, V104, P10859, DOI 10.1073/pnas.0701967104; Fahmy K, 2000, BIOCHEMISTRY-US, V39, P10607, DOI 10.1021/bi000912d; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; FRANKE RR, 1988, J BIOL CHEM, V263, P2119; Fritze O, 2003, P NATL ACAD SCI USA, V100, P2290, DOI 10.1073/pnas.0435715100; Hofmann K. P., 2000, HDB BIOL PHYSICS, P91, DOI 10.1016/s1383-8121(00)80006-8; Hubbell WL, 2003, ADV PROTEIN CHEM, V63, P243; Hubbell WL, 1998, CURR OPIN STRUC BIOL, V8, P649, DOI 10.1016/S0959-440X(98)80158-9; Hubbell WL, 1996, STRUCTURE, V4, P779, DOI 10.1016/S0969-2126(96)00085-8; JAGER F, 1994, BIOCHEMISTRY-US, V33, P10878; Knierim B, 2007, P NATL ACAD SCI USA, V104, P20290, DOI 10.1073/pnas.0710393104; Kusnetzow AK, 2006, BIOCHEMISTRY-US, V45, P5538, DOI 10.1021/bi060101v; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Meyer CK, 2000, J BIOL CHEM, V275, P19713, DOI 10.1074/jbc.M000603200; Morizumi T, 2005, BIOCHEMISTRY-US, V44, P9936, DOI 10.1021/bi0504512; Morizumi T, 2003, J BIOCHEM, V134, P259, DOI 10.1093/jb/mvg139; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Okada T, 2001, TRENDS BIOCHEM SCI, V26, P318, DOI 10.1016/S0968-0004(01)01799-6; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; PARKES JH, 1984, BIOCHEMISTRY-US, V23, P5054, DOI 10.1021/bi00316a035; RESEK JF, 1993, BIOCHEMISTRY-US, V32, P12025, DOI 10.1021/bi00096a012; SAKMAR TP, 1989, P NATL ACAD SCI USA, V86, P8309, DOI 10.1073/pnas.86.21.8309; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Sheikh SP, 1996, NATURE, V383, P347, DOI 10.1038/383347a0; Tachibanaki S, 1997, BIOCHEMISTRY-US, V36, P14173, DOI 10.1021/bi970932o; Vogel R, 2006, BIOCHEMISTRY-US, V45, P1640, DOI 10.1021/bi052196r; Vogel R, 2000, BIOCHEMISTRY-US, V39, P8895, DOI 10.1021/bi000852b; ZVYAGA TA, 1994, BIOCHEMISTRY-US, V33, P9753, DOI 10.1021/bi00198a046	34	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4967	4974		10.1074/jbc.M703059200	http://dx.doi.org/10.1074/jbc.M703059200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18063586	hybrid			2022-12-25	WOS:000253426500054
J	Wang, YJ; Singh, R; Massey, AC; Kane, SS; Kaushik, S; Grant, T; Xiang, YQ; Cuervo, AM; Czaja, MJ				Wang, Yongjun; Singh, Rajat; Massey, Ashish C.; Kane, Saul S.; Kaushik, Susmita; Grant, Taneisha; Xiang, Youqing; Cuervo, Ana Maria; Czaja, Mark J.			Loss of macroautophagy promotes or prevents fibroblast apoptosis depending on the death stimulus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; ENDOPLASMIC-RETICULUM STRESS; CHAPERONE-MEDIATED AUTOPHAGY; BCL-2 FAMILY PROTEINS; TUMOR-NECROSIS; CELL-DEATH; LIPID-PEROXIDATION; C-MYC; KINASE; DEGRADATION	Macroautophagy has been implicated as a mechanism of cell death. However, the relationship between this degradative pathway and cell death is unclear as macroautophagy has been shown recently to protect against apoptosis. To better define the interplay between these two critical cellular processes, we determined whether inhibition of macroautophagy could have both pro-apoptotic and anti-apoptotic effects in the same cell. Embryonic fibroblasts from mice with a knock-out of the essential macroautophagy gene atg5 were treated with activators of the extrinsic and intrinsic death pathways. Loss of macroautophagy sensitized these cells to caspase-dependent apoptosis from the death receptor ligands Fas and tumor necrosis factor-alpha (TNF-alpha). Atg5(-/-) mouse embryonic fibroblasts had increased activation of the mitochondrial death pathway in response to Fas/TNF-alpha in concert with decreased ATP levels. Fas/TNF-alpha treatment failed to up-regulate macroautophagy, and in fact, decreased activity at late time points. In contrast to their sensitization to Fas/TNF-alpha, Atg5(-/-) cells were resistant to death from menadione and UV light. In the absence of macroautophagy, an up-regulation of chaperone-mediated autophagy induced resistance to these stressors. These results demonstrate that inhibition of macroautophagy can promote or prevent apoptosis in the same cell and that the response is governed by the nature of the death stimulus and compensatory changes in other forms of autophagy. Experimental findings that an inhibition of macroautophagy blocks apoptosis do not prove that autophagy mediates cell death as this effect may result from the protective up-regulation of other autophagic pathways such as chaperone-mediated autophagy.	[Wang, Yongjun; Singh, Rajat; Massey, Ashish C.; Kane, Saul S.; Kaushik, Susmita; Grant, Taneisha; Xiang, Youqing; Cuervo, Ana Maria; Czaja, Mark J.] Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA; [Wang, Yongjun; Singh, Rajat; Kane, Saul S.; Grant, Taneisha; Xiang, Youqing; Cuervo, Ana Maria; Czaja, Mark J.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Massey, Ashish C.; Kaushik, Susmita; Cuervo, Ana Maria] Albert Einstein Coll Med, Dept Anat & Struct Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Czaja, MJ (corresponding author), Albert Einstein Coll Med, Marion Bessin Liver Res Ctr, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	czaja@aecom.yu.edu	Kaushik, Susmita/GVS-3186-2022	Kaushik, Susmita/0000-0002-6096-5387; Cuervo, Ana Maria/0000-0002-0771-700X	NIA NIH HHS [R01 AG021904-06, R01 AG021904-07, R37 AG021904, AG021904, T32 AG023475, T32AG023475, R01 AG021904] Funding Source: Medline; NIDDK NIH HHS [R01 DK044234-15, P01 DK041918-16, DK041918, R01 DK044234, R01 DK044234-16, P01 DK041918, P01 DK041918-17, DK044234] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK041918, R01DK044234] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021904, T32AG023475, R37AG021904] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Abedin MJ, 2007, CELL DEATH DIFFER, V14, P500, DOI 10.1038/sj.cdd.4402039; AUTERI JS, 1983, J CELL PHYSIOL, V115, P167, DOI 10.1002/jcp.1041150210; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Bradham CA, 1998, MOL CELL BIOL, V18, P6353, DOI 10.1128/MCB.18.11.6353; Canu N, 2005, J NEUROCHEM, V92, P1228, DOI 10.1111/j.1471-4159.2004.02956.x; Condorelli F, 2001, MOL CELL BIOL, V21, P3025, DOI 10.1128/MCB.21.9.3025-3036.2001; Cuervo AM, 2000, J CELL SCI, V113, P4441; Cuervo AM, 1996, SCIENCE, V273, P501, DOI 10.1126/science.273.5274.501; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Duke RC, 1992, CURR PROT IMMUNOL S3, V17, P1; Elmore SP, 2001, FASEB J, V15, P2286, DOI 10.1096/fj.01-0206fje; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; Gozuacik D, 2004, ONCOGENE, V23, P2891, DOI 10.1038/sj.onc.1207521; Hamacher-Brady A, 2006, J BIOL CHEM, V281, P29776, DOI 10.1074/jbc.M603783200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hatano E, 2000, J BIOL CHEM, V275, P11814, DOI 10.1074/jbc.275.16.11814; Iimuro Y, 1998, J CLIN INVEST, V101, P802, DOI 10.1172/JCI483; Jia GH, 2006, IMMUNOL CELL BIOL, V84, P448, DOI 10.1111/j.1440-1711.2006.01454.x; Jia L, 1997, BRIT J HAEMATOL, V98, P673, DOI 10.1046/j.1365-2141.1997.2623081.x; Jones BE, 2000, J BIOL CHEM, V275, P705, DOI 10.1074/jbc.275.1.705; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kanzawa T, 2004, CELL DEATH DIFFER, V11, P448, DOI 10.1038/sj.cdd.4401359; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; Liedtke C, 2002, HEPATOLOGY, V36, P315, DOI 10.1053/jhep.2002.34615; Liu HL, 2000, J BIOL CHEM, V275, P40155, DOI 10.1074/jbc.M001565200; Madrid LV, 2000, MOL CELL BIOL, V20, P1626, DOI 10.1128/MCB.20.5.1626-1638.2000; Martinet W, 2005, BIOTECHNOL LETT, V27, P1157, DOI 10.1007/s10529-005-0007-y; Massey AC, 2006, P NATL ACAD SCI USA, V103, P5805, DOI 10.1073/pnas.0507436103; Massey AC, 2006, CURR TOP DEV BIOL, V73, P205, DOI 10.1016/S0070-2153(05)73007-6; Mills KR, 2004, P NATL ACAD SCI USA, V101, P3438, DOI 10.1073/pnas.0400443101; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; MONKS TJ, 1992, TOXICOL APPL PHARM, V112, P2, DOI 10.1016/0041-008X(92)90273-U; MORLIERE P, 1995, FREE RADICAL BIO MED, V19, P365, DOI 10.1016/0891-5849(95)00043-W; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Nieminen AI, 2007, CELL CYCLE, V6, P2464, DOI 10.4161/cc.6.20.4917; Noda T, 1998, J BIOL CHEM, V273, P3963, DOI 10.1074/jbc.273.7.3963; Ogata M, 2006, MOL CELL BIOL, V26, P9220, DOI 10.1128/MCB.01453-06; Paglin S, 2001, CANCER RES, V61, P439; Pinkoski MJ, 2000, AM J PHYSIOL-GASTR L, V278, pG354, DOI 10.1152/ajpgi.2000.278.3.G354; Przybyszewski WM, 2002, TERATOGEN CARCIN MUT, V22, P93, DOI 10.1002/tcm.10006; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Schattenberg JRM, 2005, J BIOL CHEM, V280, P9887, DOI 10.1074/jbc.M410310200; Shimizu S, 2004, NAT CELL BIOL, V6, P1221, DOI 10.1038/ncb1192; Shinoura N, 2000, HUM GENE THER, V11, P1123, DOI 10.1089/10430340050015185; Slee EA, 2000, CELL DEATH DIFFER, V7, P556, DOI 10.1038/sj.cdd.4400689; Sohn D, 2005, J BIOL CHEM, V280, P5267, DOI 10.1074/jbc.M408585200; Suhara T, 2002, MOL CELL BIOL, V22, P680, DOI 10.1128/MCB.22.2.680-691.2002; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Terman A, 2005, CARDIOVASC RES, V68, P355, DOI 10.1016/j.cardiores.2005.08.014; Terman A, 1999, EXP GERONTOL, V34, P943, DOI 10.1016/S0531-5565(99)00070-4; THOR H, 1982, J BIOL CHEM, V257, P2419; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Xu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC1058, DOI 10.1152/ajpcell.1998.275.4.C1058; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Yousefi S, 2006, NAT CELL BIOL, V8, P1124, DOI 10.1038/ncb1482; Yu L, 2004, SCIENCE, V304, P1500, DOI 10.1126/science.1096645; Zhao YG, 2001, J BIOL CHEM, V276, P27432, DOI 10.1074/jbc.M102465200	67	112	121	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4766	4777		10.1074/jbc.M706666200	http://dx.doi.org/10.1074/jbc.M706666200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18073215	hybrid, Green Accepted			2022-12-25	WOS:000253426500034
J	Tian, W; Wijewickrama, GT; Kim, JH; Das, S; Tun, MP; Gokhale, N; Jung, JW; Kim, KP; Cho, W				Tian, Wen; Wijewickrama, Gihani T.; Kim, Jung Hwan; Das, Sudipto; Tun, Moe P.; Gokhale, Nikhil; Jung, Jin Woo; Kim, Kwang Pyo; Cho, Wonhwa			Mechanism of regulation of group IVA phospholipase A(2) activity by Ser(727) phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GASTRIC EPITHELIAL-CELLS; ARACHIDONIC-ACID RELEASE; LIPID-BINDING DOMAIN; C2 DOMAIN; GROWTH-FACTOR; PROSTAGLANDIN GENERATION; LEUKOTRIENE BIOSYNTHESIS; CERAMIDE 1-PHOSPHATE; HUMAN NEUTROPHILS; CRYSTAL-STRUCTURE	Although group IVA cytosolic phospholipase A(2) (cPLA(2)alpha) has been reported to be phosphorylated at multiple Ser residues, the mechanisms by which phosphorylation at different sites regulates cPLA(2)alpha activities are not fully understood. To explore the possibility that phosphorylation of Ser(727) modulates cellular protein-protein interactions, we measured the effect of Ser(727) mutations on the interaction of cPLA(2)alpha with a reported cPLA(2)alpha-binding protein, p11. In vitro activity assays and membrane binding measurements by surface plasmon resonance analysis showed that a heterotetramer (A2t) of p11 and annexin A2, but not p11 or annexin A2 alone, directly binds cPLA(2)alpha via Ser(727), which keeps the enzyme from binding the membrane and catalyzing the phospholipid hydrolysis. Phosphorylation of Ser(727) disrupts this inhibitory cPLA(2)alpha-A2t interaction, thereby activating cPLA(2)alpha. Subcellular translocation and activity measurements in HEK293 cells cotransfected with cPLA(2)alpha and p11 also showed that p11, in the form of A2t, inhibits cPLA(2)alpha by the same mechanism and that phosphorylation of Ser(727) activates cPLA(2)alpha by interfering with the inhibitory cPLA(2)alpha-A2t interaction. Collectively, these studies provide new insight into the regulatory mechanism of cPLA(2)alpha through Ser(727) phosphorylation.	[Tian, Wen; Wijewickrama, Gihani T.; Kim, Jung Hwan; Das, Sudipto; Tun, Moe P.; Gokhale, Nikhil; Cho, Wonhwa] Univ Illinois, Dept Chem, Chicago, IL 60607 USA; [Kim, Kwang Pyo] Konkuk Univ, Inst Biomed Sci & Technol, Seoul 143701, South Korea; [Jung, Jin Woo; Kim, Kwang Pyo] Konkuk Univ, Dept Mol Biotechnol, Seoul 143701, South Korea	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Konkuk University; Konkuk University	Cho, W (corresponding author), Univ Illinois, Dept Chem, M-C 111,845 W Taylor St, Chicago, IL 60607 USA.	wcho@uic.edu	Kim, Kwang Pyo/AAG-1815-2020	Kim, Jung Hwan/0000-0001-8548-4435	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052598] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM52598] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akiba S, 2000, BRIT J PHARMACOL, V131, P1004, DOI 10.1038/sj.bjp.0703637; Akiba S, 2001, J BIOL CHEM, V276, P21854, DOI 10.1074/jbc.M010201200; Balsinde J, 1997, J BIOL CHEM, V272, P16069, DOI 10.1074/jbc.272.26.16069; BERS DM, 1982, AM J PHYSIOL, V242, P404; Bittova L, 1999, J BIOL CHEM, V274, P9665, DOI 10.1074/jbc.274.14.9665; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Borsch-Haubold AG, 1998, J BIOL CHEM, V273, P4449, DOI 10.1074/jbc.273.8.4449; CLARK JD, 1991, CELL, V65, P1043, DOI 10.1016/0092-8674(91)90556-E; CLARK JD, 1995, J LIPID MEDIAT CELL, V12, P83, DOI 10.1016/0929-7855(95)00012-F; Das S, 2003, J BIOL CHEM, V278, P41431, DOI 10.1074/jbc.M304897200; Das S, 2002, J BIOL CHEM, V277, P23838, DOI 10.1074/jbc.M202322200; deCarvalho MGS, 1996, J BIOL CHEM, V271, P6987, DOI 10.1074/jbc.271.12.6987; Dessen A, 1999, CELL, V97, P349, DOI 10.1016/S0092-8674(00)80744-8; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Evans JH, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-30; Gee KR, 2000, CELL CALCIUM, V27, P97, DOI 10.1054/ceca.1999.0095; GERKE V, 1985, EMBO J, V4, P2917, DOI 10.1002/j.1460-2075.1985.tb04023.x; GERKE V, 1984, EMBO J, V3, P227, DOI 10.1002/j.1460-2075.1984.tb01789.x; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Gokhale NA, 2005, J BIOL CHEM, V280, P42831, DOI 10.1074/jbc.M508129200; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Hirabayashi T, 2000, BBA-MOL CELL BIOL L, V1488, P124, DOI 10.1016/S1388-1981(00)00115-3; Huang XL, 2002, J BIOL CHEM, V277, P38431, DOI 10.1074/jbc.M207406200; Kim KP, 2001, J BIOL CHEM, V276, P11126, DOI 10.1074/jbc.M004604200; Kim YJ, 2002, J BIOL CHEM, V277, P36479, DOI 10.1074/jbc.M205399200; KLIGMAN D, 1988, TRENDS BIOCHEM SCI, V13, P437, DOI 10.1016/0968-0004(88)90218-6; Leslie CC, 1997, J BIOL CHEM, V272, P16709, DOI 10.1074/jbc.272.27.16709; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Mosior M, 1998, J BIOL CHEM, V273, P2184, DOI 10.1074/jbc.273.4.2184; Muthalif MM, 2001, J BIOL CHEM, V276, P39653, DOI 10.1074/jbc.M103136200; Nakatani Y, 2000, J BIOL CHEM, V275, P1161, DOI 10.1074/jbc.275.2.1161; Nakatani Y, 2002, ADV EXP MED BIOL, V507, P21; Nalefski EA, 1998, J BIOL CHEM, V273, P1365, DOI 10.1074/jbc.273.3.1365; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Nalefski EA, 1997, BIOCHEMISTRY-US, V36, P12011, DOI 10.1021/bi9717340; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Rety S, 1999, NAT STRUCT BIOL, V6, P89; SHARP JD, 1991, J BIOL CHEM, V266, P14850; Sheridan AM, 2001, MOL CELL BIOL, V21, P4470, DOI 10.1128/MCB.21.14.4470-4481.2001; Shmelzer Z, 2003, J CELL BIOL, V162, P683, DOI 10.1083/jcb.200211056; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Stahelin RV, 2007, J BIOL CHEM, V282, P20467, DOI 10.1074/jbc.M701396200; Stahelin RV, 2001, BIOCHEMISTRY-US, V40, P4672, DOI 10.1021/bi0020325; Subramanian P, 2005, J BIOL CHEM, V280, P17601, DOI 10.1074/jbc.M414173200; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Valentin E, 2000, BBA-MOL CELL BIOL L, V1488, P59, DOI 10.1016/S1388-1981(00)00110-4; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Yao XL, 1999, J BIOL CHEM, V274, P17202, DOI 10.1074/jbc.274.24.17202	51	38	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3960	3971		10.1074/jbc.M707345200	http://dx.doi.org/10.1074/jbc.M707345200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18065419	hybrid			2022-12-25	WOS:000253083500030
J	Molina-Cruz, A; Dejong, RJ; Charles, B; Gupta, L; Kumar, S; Jaramillo-Gutierrez, G; Barillas-Mury, C				Molina-Cruz, Alvaro; Dejong, Randall J.; Charles, Bradley; Gupta, Lalita; Kumar, Sanjeev; Jaramillo-Gutierrez, Giovanna; Barillas-Mury, Carolina			Reactive oxygen species modulate anopheles gambiae immunity against bacteria and plasmodium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALARIA PARASITE; GENE-EXPRESSION; INNATE IMMUNITY; MIDGUT CELLS; MOSQUITO; VECTOR; PROTEIN; BERGHEI; DETERMINANT; NITRATION	The involvement of reactive oxygen species (ROS) in mosquito immunity against bacteria and Plasmodium was investigated in the malaria vector Anopheles gambiae. Strains of An. gambiae with higher systemic levels of ROS survive a bacterial challenge better, whereas reduction of ROS by dietary administration of antioxidants significantly decreases survival, indicating that ROS are required to mount effective antibacterial responses. Expression of several ROS detoxification enzymes increases in the midgut and fat body after a blood meal. Furthermore, expression of several of these enzymes increases to even higher levels when mosquitoes are fed a Plasmodium berghei-infected meal, indicating that the oxidative stress after a blood meal is exacerbated by Plasmodium infection. Paradoxically, a complete lack of induction of catalase mRNA and lower catalase activity were observed in P. berghei-infected midguts. This suppression of midgut catalase expression is a specific response to ookinete midgut invasion and is expected to lead to higher local levels of hydrogen peroxide. Further reduction of catalase expression by double-stranded RNA-mediated gene silencing promoted parasite clearance by a lytic mechanism and reduced infection significantly. High mosquito mortality is often observed after P. berghei infection. Death appears to result in part from excess production of ROS, as mortality can be decreased by oral administration of uric acid, a strong antioxidant. We conclude that ROS modulate An. gambiae immunity and that the mosquito response to P. berghei involves a local reduction of detoxification of hydrogen peroxide in the midgut that contributes to limit Plasmodium infection through a lytic mechanism.	[Molina-Cruz, Alvaro; Dejong, Randall J.; Gupta, Lalita; Kumar, Sanjeev; Jaramillo-Gutierrez, Giovanna; Barillas-Mury, Carolina] NIAID, NIH, LMVR, Bethesda, MD 20892 USA; [Charles, Bradley] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Colorado State University	Molina-Cruz, A (corresponding author), NIAID, NIH, LMVR, Twinbrook 3,MSC 8130,12735 Twinbrook Pkwy,Rm 2E-2, Bethesda, MD 20892 USA.	amolina-cruz@niaid.nih.gov	Gupta, Lalita/R-1111-2019	Kumar, Sanjeev/0000-0003-3866-4593; GUPTA, LALITA/0000-0002-0712-8512	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947, Z01AI000947] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Billker O, 1997, PARASITOLOGY, V115, P1, DOI 10.1017/S0031182097008895; Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; BRIEGEL H, 1975, J INSECT PHYSIOL, V21, P1597, DOI 10.1016/0022-1910(75)90197-3; COLLINS FH, 1986, SCIENCE, V234, P607, DOI 10.1126/science.3532325; Dana AN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-119; DeJong RJ, 2007, P NATL ACAD SCI USA, V104, P2121, DOI 10.1073/pnas.0608407104; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Dong YM, 2006, PLOS PATHOG, V2, P513, DOI 10.1371/journal.ppat.0020052; de Munoz FGG, 2007, ARCH INSECT BIOCHEM, V65, P20, DOI 10.1002/arch.20174; Ghosh A, 2000, PARASITOL TODAY, V16, P196, DOI 10.1016/S0169-4758(99)01626-9; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Han YS, 2000, EMBO J, V19, P6030, DOI 10.1093/emboj/19.22.6030; Iwanaga S, 2005, J BIOCHEM MOL BIOL, V38, P128; Kumar S, 2003, P NATL ACAD SCI USA, V100, P14139, DOI 10.1073/pnas.2036262100; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; Pereira LS, 2001, EXP PARASITOL, V99, P66, DOI 10.1006/expr.2001.4657; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Peterson TML, 2006, FREE RADICAL BIO MED, V40, P1067, DOI 10.1016/j.freeradbiomed.2005.10.059; Pfeiffer S, 2001, J BIOL CHEM, V276, P34051, DOI 10.1074/jbc.M100585200; RAIKHEL AS, 1992, ANNU REV ENTOMOL, V37, P217, DOI 10.1146/annurev.en.37.010192.001245; Ribeiro JMC, 2003, INSECT BIOCHEM MOLEC, V33, P865, DOI 10.1016/S0965-1748(03)00080-8; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Vlachou D, 2005, CURR OPIN MICROBIOL, V8, P415, DOI 10.1016/j.mib.2005.06.013; Vlachou D, 2005, CURR BIOL, V15, P1185, DOI 10.1016/j.cub.2005.06.044; Whitten MMA, 2006, PARASITE IMMUNOL, V28, P121, DOI 10.1111/j.1365-3024.2006.00804.x; Whitten MMA, 1999, J INSECT PHYSIOL, V45, P667, DOI 10.1016/S0022-1910(99)00039-6; *WHO, 2005, GLOB MAL REP 2005; Zheng LB, 1997, SCIENCE, V276, P425, DOI 10.1126/science.276.5311.425	34	199	205	1	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3217	3223		10.1074/jbc.M705873200	http://dx.doi.org/10.1074/jbc.M705873200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065421	hybrid			2022-12-25	WOS:000253083000025
J	Ciarrocchi, A; Jankovic, V; Shaked, Y; Nolan, DJ; Mittal, V; Kerbel, RS; Nimer, SD; Benezra, R				Ciarrocchi, Alessia; Jankovic, Vladimir; Shaked, Yuval; Nolan, Daniel J.; Mittal, Vivek; Kerbel, Robert S.; Nimer, Stephen D.; Benezra, Robert			Id1 Restrains p21 Expression to Control Endothelial Progenitor Cell Formation	PLOS ONE			English	Article								Loss of Id1 in the bone marrow (BM) severely impairs tumor angiogenesis resulting in significant inhibition of tumor growth. This phenotype has been associated with the absence of circulating endothelial progenitor cells (EPCs) in the peripheral blood of Id1 mutant mice. However, the manner in which Id1 loss in the BM controls EPC generation or mobilization is largely unknown. Using genetically modified mouse models we demonstrate here that the generation of EPCs in the BM depends on the ability of Id1 to restrain the expression of its target gene p21. Through a series of cellular and functional studies we show that the increased myeloid commitment of BM stem cells and the absence of EPCs in Id1 knockout mice are associated with elevated p21 expression. Genetic ablation of p21 rescues the EPC population in the Id1 null animals, re-establishing functional BM-derived angiogenesis and restoring normal tumor growth. These results demonstrate that the restraint of p21 expression by Id1 is one key element of its activity in facilitating the generation of EPCs in the BM and highlight the critical role these cells play in tumor angiogenesis.	[Jankovic, Vladimir; Nimer, Stephen D.] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10021 USA; [Ciarrocchi, Alessia; Benezra, Robert] Mem Sloan Kettering Canc Ctr, Program Canc Biol & Genet, New York, NY 10021 USA; [Shaked, Yuval; Kerbel, Robert S.] Sunnybrook Hlth Sci Ctr, Toronto, ON M4N 3M5, Canada; [Nolan, Daniel J.; Mittal, Vivek] Cold Spring Harbor Lab, Canc Genome Res Ctr, Woodbury, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Cold Spring Harbor Laboratory	Nimer, SD (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, 1275 York Ave, New York, NY 10021 USA.	nimers@mskcc.org; r-benezra@ski.mskcc.org	Ciarrocchi, Alessia/AAA-1130-2019	Ciarrocchi, Alessia/0000-0002-5541-2075	National Institute of Health; Breast Cancer Research Foundation (RB); Leukemia Lymphoma Society (SDN); American-Italian Cancer Foundation	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Breast Cancer Research Foundation (RB); Leukemia Lymphoma Society (SDN)(Leukemia and Lymphoma Society); American-Italian Cancer Foundation	This work was supported by grants from National Institute of Health to RB and SDN, by the Breast Cancer Research Foundation (RB) and by the Leukemia Lymphoma Society (SDN). AC was supported by a postdoctoral fellowship from the American-Italian Cancer Foundation.	Bailey AS, 2004, BLOOD, V103, P13, DOI 10.1182/blood-2003-05-1684; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bertolini F, 2003, CANCER RES, V63, P4342; Bertolini F, 2006, NAT REV CANCER, V6, P833, DOI 10.1039/nrc1971; Braun SE, 1998, BLOOD CELL MOL DIS, V24, P138, DOI 10.1006/bcmd.1998.0181; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Coukos G, 2005, BRIT J CANCER, V92, P1182, DOI 10.1038/sj.bjc.6602476; Coussens LM, 1999, GENE DEV, V13, P1382, DOI 10.1101/gad.13.11.1382; De Palma M, 2005, CANCER CELL, V8, P211, DOI 10.1016/j.ccr.2005.08.002; Dong Y, 2004, CELL SIGNAL, V16, P263, DOI 10.1016/S0898-6568(03)00136-0; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Fraidenraich D, 2004, SCIENCE, V306, P247, DOI 10.1126/science.1102612; Grant MB, 2002, NAT MED, V8, P607, DOI 10.1038/nm0602-607; HIRSCH S, 1983, IMMUNOGENETICS, V18, P229, DOI 10.1007/BF00952962; Jaggi JS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000267; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Lyden D, 1999, NATURE, V401, P670, DOI 10.1038/44334; Lyden D, 2001, NAT MED, V7, P1194, DOI 10.1038/nm1101-1194; LYONS AB, 1994, J IMMUNOL METHODS, V171, P131, DOI 10.1016/0022-1759(94)90236-4; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Peters BA, 2005, NAT MED, V11, P261, DOI 10.1038/nm1200; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Ruzinova MB, 2003, TRENDS CELL BIOL, V13, P410, DOI 10.1016/S0962-8924(03)00147-8; Ruzinova MB, 2003, CANCER CELL, V4, P277, DOI 10.1016/S1535-6108(03)00240-X; Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007; Shaked Y, 2006, SCIENCE, V313, P1785, DOI 10.1126/science.1127592; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Topley GI, 1999, P NATL ACAD SCI USA, V96, P9089, DOI 10.1073/pnas.96.16.9089; Yaroslavskiy B, 1999, BLOOD, V93, P2907; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; ZHANG DE, 1994, MOL CELL BIOL, V14, P373, DOI 10.1128/MCB.14.1.373; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang P, 2004, IMMUNITY, V21, P853, DOI 10.1016/j.immuni.2004.11.006	43	65	66	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1338	10.1371/journal.pone.0001338	http://dx.doi.org/10.1371/journal.pone.0001338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092003	gold, Green Submitted, Green Accepted, Green Published			2022-12-25	WOS:000207459600021
J	Dubois, V; Debreyer, C; Litvak, S; Quentin, C; Parissi, V				Dubois, Veronique; Debreyer, Carole; Litvak, Simon; Quentin, Claudine; Parissi, Vincent			A New In Vitro Strand Transfer Assay for Monitoring Bacterial Class 1 Integron Recombinase Intl1 Activity	PLOS ONE			English	Article								Intl1 integrase is a tyrosine recombinase involved in the mobility of antibiotic resistance gene cassettes within bacterial class 1 integrons. Recent data have shown that its recombination specifically involves the bottom strand of the attC site, but the exact mechanism of the reaction is still unclear. An efficient in vitro assay is still required to better characterize the biochemical properties of the enzyme. In this report we describe for the first time an in vitro system partially reproducing the activity of a recombinant pure Intl1. This new assay, which constitutes the only available in vitro model of recombination by Intl1, was used to determine whether this enzyme might be the sole bacterial protein required for the recombination process. Results show that Intl1 possesses all the features needed for performing recombination between attl and attC sites. However, differences in the in vitro intermolecular recombination efficiencies were found according to the target sites and were correlated with DNA affinities of the enzyme but not with in vivo data. The differential affinity of the enzyme for each site, its capacity to bind to a single-stranded structure at the attC site and the recombination observed with single-stranded substrates unambiguously confirm that it constitutes an important intermediary in the reaction. Our data strongly suggest that the enzyme possesses all the functions for generating and/or recognizing this structure even in the absence of other cellular factors. Furthermore, the in vitro assay reported here constitutes a powerful tool for the analysis of the recombination steps catalyzed by Intl1, its structure-function studies and the search for specific inhibitors.	[Dubois, Veronique; Debreyer, Carole; Litvak, Simon; Quentin, Claudine; Parissi, Vincent] Univ Bordeaux 2, Lab Cellular & Mol Microbiol & Pathogen, CNRS, UMR 5097, F-33076 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux	Parissi, V (corresponding author), Univ Bordeaux 2, Lab Cellular & Mol Microbiol & Pathogen, CNRS, UMR 5097, F-33076 Bordeaux, France.	vincent.parissi@reger.u-bordeaux2.fr	QUENTIN, Claudine/A-9701-2012; Dubois, Veronique/F-9378-2011		CNRS; University of Bordeaux 2	CNRS(Centre National de la Recherche Scientifique (CNRS)); University of Bordeaux 2	This work was supported by the CNRS and the University of Bordeaux 2.	BABINEAU D, 1985, J BIOL CHEM, V260, P2313; BALL CA, 1991, J BACTERIOL, V173, P4027, DOI 10.1128/jb.173.13.4027-4031.1991; Biswas T, 2005, NATURE, V435, P1059, DOI 10.1038/nature03657; Bouvier M, 2005, EMBO J, V24, P4356, DOI 10.1038/sj.emboj.7600898; Collis CM, 1998, MOL MICROBIOL, V29, P477, DOI 10.1046/j.1365-2958.1998.00936.x; COLLIS CM, 1995, ANTIMICROB AGENTS CH, V39, P155, DOI 10.1128/AAC.39.1.155; Collis CM, 2002, MOL MICROBIOL, V46, P1415, DOI 10.1046/j.1365-2958.2002.03260.x; Collis CM, 2001, J BACTERIOL, V183, P2535, DOI 10.1128/JB.183.8.2535-2542.2001; Dubois W, 2002, ANTIMICROB AGENTS CH, V46, P638, DOI 10.1128/AAC.46.3.638-645.2002; FRANCIA MV, 1993, MOL MICROBIOL, V10, P823, DOI 10.1111/j.1365-2958.1993.tb00952.x; Francia MV, 1999, J BACTERIOL, V181, P6844, DOI 10.1128/JB.181.21.6844-6849.1999; Grainge I, 1999, MOL MICROBIOL, V33, P449, DOI 10.1046/j.1365-2958.1999.01493.x; Gravel A, 1998, J BACTERIOL, V180, P5437, DOI 10.1128/JB.180.20.5437-5442.1998; Gravel A, 1998, NUCLEIC ACIDS RES, V26, P4347, DOI 10.1093/nar/26.19.4347; GRONOSTAJSKI RM, 1985, J BIOL CHEM, V260, P2328; HALL RM, 1991, MOL MICROBIOL, V5, P1941, DOI 10.1111/j.1365-2958.1991.tb00817.x; HALL RM, 1995, MOL MICROBIOL, V15, P593, DOI 10.1111/j.1365-2958.1995.tb02368.x; HALL RM, 1999, ANN N Y ACAD SCI, V870; Hansson K, 1997, MOL MICROBIOL, V26, P441, DOI 10.1046/j.1365-2958.1997.5401964.x; Jahnz M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni060; Johansson C, 2004, NUCLEIC ACIDS RES, V32, P4033, DOI 10.1093/nar/gkh730; Klemm M, 2000, J MOL BIOL, V299, P1203, DOI 10.1006/jmbi.2000.3829; MacDonald D, 2006, NATURE, V440, P1157, DOI 10.1038/nature04643; Partridge SR, 2000, MICROBIOL-UK, V146, P2855, DOI 10.1099/00221287-146-11-2855; RECCHIA GD, 1994, NUCLEIC ACIDS RES, V22, P2071, DOI 10.1093/nar/22.11.2071; Ringrose L, 1998, J MOL BIOL, V284, P363, DOI 10.1006/jmbi.1998.2149; Segall AM, 1998, J BIOL CHEM, V273, P24258, DOI 10.1074/jbc.273.37.24258; Stokes HW, 1997, MOL MICROBIOL, V26, P731, DOI 10.1046/j.1365-2958.1997.6091980.x	28	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1315	10.1371/journal.pone.0001315	http://dx.doi.org/10.1371/journal.pone.0001315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091989	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459600003
J	Carmeli, C; Lopez-Aguado, L; Schmidt, KE; De Feo, O; Innocenti, GM				Carmeli, Cristian; Lopez-Aguado, Laura; Schmidt, Kerstin E.; De Feo, Oscar; Innocenti, Giorgio M.			A Novel Interhemispheric Interaction: Modulation of Neuronal Cooperativity in the Visual Areas	PLOS ONE			English	Article							STIMULUS-DEPENDENT CHANGES; CORPUS-CALLOSUM; EEG COHERENCE; SYNCHRONIZATION; CORTEX; CONNECTIONS; SPECIFICITY; RESPONSES	Background. The cortical representation of the visual field is split along the vertical midline, with the left and the right hemi-fields projecting to separate hemispheres. Connections between the visual areas of the two hemispheres are abundant near the representation of the visual midline. It was suggested that they re-establish the functional continuity of the visual field by controlling the dynamics of the responses in the two hemispheres. Methods/Principal Findings. To understand if and how the interactions between the two hemispheres participate in processing visual stimuli, the synchronization of responses to identical or different moving gratings in the two hemi-fields were studied in anesthetized ferrets. The responses were recorded by multiple electrodes in the primary visual areas and the synchronization of local field potentials across the electrodes were analyzed with a recent method derived from dynamical system theory. Inactivating the visual areas of one hemisphere modulated the synchronization of the stimulus-driven activity in the other hemisphere. The modulation was stimulus-specific and was consistent with the fine morphology of callosal axons in particular with the spatio-temporal pattern of activity that axonal geometry can generate. Conclusions/Significance. These findings describe a new kind of interaction between the cerebral hemispheres and highlight the role of axonal geometry in modulating aspects of cortical dynamics responsible for stimulus detection and/or categorization.	[Innocenti, Giorgio M.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Carmeli, Cristian; De Feo, Oscar] Swiss Fed Inst Technol Lausanne EPFL, Lab Nonlinear Syst LANOS, I&C Schools Comp & Commun Sci, CH-1015 Lausanne, Switzerland; [Lopez-Aguado, Laura] Univ Complutense Madrid, Dept Appl Math, Sch Opt, Madrid, Spain; [Schmidt, Kerstin E.] Max Planck Inst Brain Res, D-60496 Frankfurt, Germany; [De Feo, Oscar] Univ Coll Cork, Dept Microelect, Cork, Ireland	Karolinska Institutet; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Complutense University of Madrid; Max Planck Society; University College Cork	Innocenti, GM (corresponding author), Karolinska Inst, Dept Neurosci, Stockholm, Sweden.	giorgio.innocenti@ki.se		Carmeli, Cristian/0000-0002-1463-4587	European Community [IST-2001-34893]	European Community(European Commission)	Supported by European Community grant IST-2001-34893 ( APEREST).	ABOITIZ F, 1992, BRAIN RES, V598, P143, DOI 10.1016/0006-8993(92)90178-C; BERBEL P, 1988, J COMP NEUROL, V276, P132, DOI 10.1002/cne.902760109; BERLUCCHI G, 1968, SCIENCE, V159, P308, DOI 10.1126/science.159.3812.308; Boccaletti S, 2002, PHYS REP, V366, P1, DOI 10.1016/S0370-1573(02)00137-0; Brown R, 2000, CHAOS, V10, P344, DOI 10.1063/1.166500; Carmeli C, 2005, NEUROIMAGE, V25, P339, DOI 10.1016/j.neuroimage.2004.11.049; DESIMONE R, 1993, VISUAL NEUROSCI, V10, P159, DOI 10.1017/S095252380000328X; Engel AK, 2001, NAT REV NEUROSCI, V2, P704, DOI 10.1038/35094565; ENGEL AK, 1991, SCIENCE, V252, P1177, DOI 10.1126/science.252.5009.1177; Gazzaniga MS, 2005, NAT REV NEUROSCI, V6, P653, DOI 10.1038/nrn1723; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GRAY CM, 1989, NATURE, V338, P334, DOI 10.1038/338334a0; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; INNOCENTI GM, 1995, NEUROPSYCHOLOGIA, V33, P961, DOI 10.1016/0028-3932(95)00033-Y; INNOCENTI GM, 1994, EUR J NEUROSCI, V6, P918, DOI 10.1111/j.1460-9568.1994.tb00586.x; Innocenti GM., 1986, GEN ORG CALLOSAL CON, P291, DOI [10.1007/978-1-4613-2149-1_9, DOI 10.1007/978-1-4613-2149-1_9]; Kiper DC, 1999, J NEUROPHYSIOL, V82, P3082, DOI 10.1152/jn.1999.82.6.3082; Knyazeva MG, 1999, J NEUROPHYSIOL, V82, P3095, DOI 10.1152/jn.1999.82.6.3095; LAMANTIA AS, 1990, J COMP NEUROL, V291, P520, DOI 10.1002/cne.902910404; Li L, 2006, EXP BRAIN RES, V172, P397, DOI 10.1007/s00221-005-0337-y; Lomber SG, 1999, J NEUROSCI METH, V86, P179, DOI 10.1016/S0165-0270(98)00165-4; MAKAROV VA, 2007, CEREBRAL CO IN PRESS, P18; Manger PR, 2002, CEREB CORTEX, V12, P423, DOI 10.1093/cercor/12.4.423; MARZI CA, 1982, BEHAV BRAIN RES, V4, P155, DOI 10.1016/0166-4328(82)90070-5; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; PAYNE BR, 1991, VISUAL NEUROSCI, V6, P283, DOI 10.1017/S0952523800006283; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Ptito D, 2002, IS CL CO NE, P139; Romo R, 2003, NEURON, V38, P649, DOI 10.1016/S0896-6273(03)00287-3; Schmidt KE, 1997, J NEUROSCI, V17, P5480; SPERRY R, 1982, SCIENCE, V217, P1223, DOI 10.1126/science.7112125; Strang G, 1988, LINEAR ALGEBRA ITS A; Strogatz SH, 2000, PHYSICA D, V143, P1, DOI 10.1016/S0167-2789(00)00094-4; Tettoni L, 1998, CEREB CORTEX, V8, P543, DOI 10.1093/cercor/8.6.543; WAXMAN SG, 1976, EXP NEUROL, V53, P115, DOI 10.1016/0014-4886(76)90287-9; Womelsdorf T, 2006, NATURE, V439, P733, DOI 10.1038/nature04258	36	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1287	10.1371/journal.pone.0001287	http://dx.doi.org/10.1371/journal.pone.0001287			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074012	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459500006
J	Lopez-Fernandez, H; Bolnick, DI				Lopez-Fernandez, Hernan; Bolnick, Daniel I.			What Causes Partial F1 Hybrid Viability? Incomplete Penetrance versus Genetic Variation	PLOS ONE			English	Article								Background. Interspecific hybrid crosses often produce offspring with reduced but non-zero survivorship. In this paper we ask why such partial inviability occurs. This partial inviability could arise from incomplete penetrance of lethal Dobzhansky-Muller incompatibilities (DMIs) shared by all members of a hybrid cross. Alternatively, siblings may differ with respect to the presence or number of DMIs, leading to genotype-dependent variation in viability and hence non-Mendelian segregation of parental alleles in surviving F1 hybrids. Methodology/Principal Findings. We used amplified fragment length polymorphisms (AFLPs) to test for segregation distortion in one hybrid cross between green and longear sunfish (Lepomis cyanellus and L. megalotis). Hybrids showed partial viability, and twice as much segregation distortion (36.8%) of AFLPs as an intraspecific control cross (18.8%). Incomplete penetrance of DMIs, which should cause genotype-independent mortality, is insufficient to explain the observed segregation distortion. Conclusions/Significance. We conclude that F1 hybrid sunfish are polymorphic for DMIs, either due to sex-linked DMI loci (causing Haldane's Rule), or polymorphic autosomal DMI loci. Because few AFLP markers were sex-linked (2%), the most parsimonious conclusion is that parents may have been heterozygous for loci causing hybrid inviability.	[Bolnick, Daniel I.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA; [Lopez-Fernandez, Hernan] Texas A&M Univ, Dept Wildlife & Fisheries Sci, Sect Ecol Evolutionary Biol & Systemat, College Stn, TX 77843 USA	University of Texas System; University of Texas Austin; Texas A&M University System; Texas A&M University College Station	Bolnick, DI (corresponding author), Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.	danbolnick@mail.utexas.edu	Bolnick, Daniel I./G-4440-2015	Bolnick, Daniel I./0000-0003-3148-6296; Lopez-Fernandez, Hernan/0000-0003-0270-1671	The University of Texas at Austin; National Science Foundation [DEB 0516831]; Texas AM University	The University of Texas at Austin; National Science Foundation(National Science Foundation (NSF)); Texas AM University	The University of Texas at Austin funded DIB as assistant professor, HLF as a postdoctoral researcher at DIB's lab, and all experimental work. The National Science Foundation grant DEB 0516831 supported HLF as a postdoctoral researcher at Texas A&M University during the writing phase of this project.	Bailey R. M., 2004, MISCELLANEOUS PUBLIC, V192; Barbash DA, 2003, P NATL ACAD SCI USA, V100, P5302, DOI 10.1073/pnas.0836927100; Bolnick DI, 2006, EVOL ECOL RES, V8, P903; Bolnick DI, 2005, EVOLUTION, V59, P1754, DOI 10.1111/j.0014-3820.2005.tb01824.x; Bordenstein SR, 2000, EVOLUTION, V54, P567, DOI 10.1111/j.0014-3820.2000.tb00059.x; Brideau NJ, 2006, SCIENCE, V314, P1292, DOI 10.1126/science.1133953; Burton RS, 2006, AM NAT, V168, pS14, DOI 10.1086/509046; CHILDERS WILLIAM F., 1967, ILL NAT HIST SURV BULL, V29, P159; CLARK JM, 1988, NUCLEIC ACIDS RES, V16, P9677, DOI 10.1093/nar/16.20.9677; Coyne J.A., 1989, P180; COYNE JA, 1989, EVOLUTION, V43, P362, DOI 10.1111/j.1558-5646.1989.tb04233.x; Coyne JA, 1997, EVOLUTION, V51, P295, DOI 10.1111/j.1558-5646.1997.tb02412.x; Coyne JA, 2004, SPECIATION; Devlin RH, 2002, AQUACULTURE, V208, P191, DOI 10.1016/S0044-8486(02)00057-1; Fishman L, 2001, GENETICS, V159, P1701; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Gadau J, 1999, GENETICS, V153, P1731; Garrity DM, 2002, DEVELOPMENT, V129, P4635; Gomelsky B, 2002, N AM J AQUACULT, V64, P66, DOI 10.1577/1548-8454(2002)064&lt;0066:HSRAEO&gt;2.0.CO;2; Hall MC, 2005, GENETICS, V170, P375, DOI 10.1534/genetics.104.038653; Harushima Y, 2001, GENETICS, V159, P883; HOLLINGSHEAD L, 1930, GENETICS, V15, P116; Jenczewski E, 1997, THEOR APPL GENET, V94, P682, DOI 10.1007/s001220050466; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Laurie CC, 1997, GENETICS, V147, P937; Lerceteau E, 1999, HEREDITY, V82, P252, DOI 10.1038/sj.hdy.6884720; Masly JP, 2007, PLOS BIOL, V5, P1890, DOI 10.1371/journal.pbio.0050243; Moyle LC, 2005, GENETICS, V169, P355, DOI 10.1534/genetics.104.029546; Myburg AA, 2004, GENETICS, V166, P1405, DOI 10.1534/genetics.166.3.1405; Near TJ, 2005, EVOLUTION, V59, P1768, DOI 10.1111/j.0014-3820.2005.tb01825.x; ORR HA, 1995, GENETICS, V139, P1805; Orr HA, 2001, EVOLUTION, V55, P1085; Orr HA, 2001, TRENDS ECOL EVOL, V16, P343; Orr HA, 1997, ANNU REV ECOL SYST, V28, P195, DOI 10.1146/annurev.ecolsys.28.1.195; PAABO S, 1990, J BIOL CHEM, V265, P4718; PARKER HR, 1985, J EXP ZOOL, V233, P451, DOI 10.1002/jez.1402330314; Patterson JT, 1952, EVOLUTION GENUS DROS, P610; Presgraves DC, 2003, NATURE, V423, P715, DOI 10.1038/nature01679; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Price TD, 2002, EVOLUTION, V56, P2083; Reed LK, 2004, P NATL ACAD SCI USA, V101, P9009, DOI 10.1073/pnas.0403106101; Rieseberg LH, 1996, SCIENCE, V272, P741, DOI 10.1126/science.272.5262.741; ROBERTS FL, 1964, J MORPHOL, V115, P401, DOI 10.1002/jmor.1051150305; Sasa MM, 1998, EVOLUTION, V52, P1811, DOI 10.1111/j.1558-5646.1998.tb02258.x; Shuker DM, 2005, P ROY SOC B-BIOL SCI, V272, P2491, DOI 10.1098/rspb.2005.3242; Ting CT, 1998, SCIENCE, V282, P1501, DOI 10.1126/science.282.5393.1501; Ting CT, 2001, P NATL ACAD SCI USA, V98, P6709, DOI 10.1073/pnas.121418898; Turelli M, 2000, GENETICS, V154, P1663; Turelli M, 1997, GENETICS, V147, P1799; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wade MJ, 1997, GENETICS, V147, P1235; WADE MJ, 1994, GENETICS, V138, P791; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; Zar J.H., 1996, BIOSTAT ANAL, V5th	54	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1294	10.1371/journal.pone.0001294	http://dx.doi.org/10.1371/journal.pone.0001294			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074018	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459500013
J	Abdulhussein, R; Koo, DHH; Vogel, WF				Abdulhussein, Rahim; Koo, Diana H. H.; Vogel, Wolfgang F.			Identification of disulfide-linked dimers of the receptor tyrosine kinase DDR1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISCOIDIN DOMAIN RECEPTOR-1; GROWTH-FACTOR RECEPTOR; HUMAN INSULIN-RECEPTOR; COLLAGEN-BINDING; ACTIVATION; DIMERIZATION; EXPRESSION; CANCER; CELLS; MIGRATION	Discoidin domain receptor 1 (DDR1) is a transmembrane receptor tyrosine kinase activated by triple-helical collagen. So far six different isoforms of DDR1 have been described. Aberrant expression and signaling of DDR1 have been implicated in several human diseases linked to accelerated matrix degradation and remodeling, including tumor invasion, atherosclerosis, and lung fibrosis. Here we show that DDR1 exists as a disulfide-linked dimer in transfected as well as endogenously expressing cells. This dimer formation occurred irrespective of its kinase domain, as dimers were also found for the truncated DDR1d isoform. A deletion analysis of the extracellular domain showed that DDR1 mutants lacking the stalk region failed to form dimers, whereas deletion of the discoidin domain did not prevent dimerization. Point mutagenesis within the stalk region suggested that cysteines 303 and 348 are necessary for dimerization, collagen binding, and activation of kinase function. The identification of DDR1 dimers provides new insights into the molecular structure of receptor tyrosine kinases and suggests distinct signaling mechanisms of each receptor subfamily.	[Abdulhussein, Rahim; Koo, Diana H. H.; Vogel, Wolfgang F.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5S 1A8, Canada	University of Toronto	Abdulhussein, R (corresponding author), Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Banting Inst, 100 Coll St,Rm 110, Toronto, ON M5G 1L5, Canada.	rahim.abdulhussein@utoronto.ca						Abdulhussein R, 2004, J BIOL CHEM, V279, P31462, DOI 10.1074/jbc.M400651200; ALVES F, 1995, ONCOGENE, V10, P609; Alves F, 2001, FASEB J, V15, P1321, DOI 10.1096/fj.00-0626fje; Avivi-Green C, 2006, AM J RESP CRIT CARE, V174, P420, DOI 10.1164/rccm.200603-333OC; Bass J, 1998, J CELL BIOL, V141, P637, DOI 10.1083/jcb.141.3.637; BONISCHNETZLER M, 1986, J BIOL CHEM, V261, P5281; Curat CA, 2001, J BIOL CHEM, V276, P45952, DOI 10.1074/jbc.M104360200; Dawson JP, 2005, MOL CELL BIOL, V25, P7734, DOI 10.1128/MCB.25.17.7734-7742.2005; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; Faraci-Orf E, 2006, J CELL BIOCHEM, V97, P109, DOI 10.1002/jcb.20618; Ferri N, 2004, AM J PATHOL, V164, P1575, DOI 10.1016/S0002-9440(10)63716-9; Franco-Pons N, 2006, NEUROSCIENCE, V140, P463, DOI 10.1016/j.neuroscience.2006.02.033; Fruehauf J, 2006, J EXP THER ONCOL, V5, P231; Gan HK, 2007, J BIOL CHEM, V282, P2840, DOI 10.1074/jbc.M605136200; Gross O, 2004, KIDNEY INT, V66, P102, DOI 10.1111/j.1523-1755.2004.00712.x; Hou GP, 2001, J CLIN INVEST, V107, P727, DOI 10.1172/JCI10720; Ichikawa O, 2007, EMBO J, V26, P4168, DOI 10.1038/sj.emboj.7601833; JOHNSON JD, 1993, P NATL ACAD SCI USA, V90, P5677, DOI 10.1073/pnas.90.12.5677; Kamohara H, 2001, FASEB J, V15, P2724, DOI 10.1096/fj.01-0359fje; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Koo DHH, 2006, FEBS LETT, V580, P15, DOI 10.1016/j.febslet.2005.11.035; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Li E, 2006, BIOCHEMISTRY-US, V45, P6241, DOI 10.1021/bi060609y; Lu KH, 1996, MOL BIOL CELL, V7, P679, DOI 10.1091/mbc.7.5.679; Mullenbach E, 2006, GENE, V372, P53, DOI 10.1016/j.gene.2005.12.004; Noordeen NA, 2006, J BIOL CHEM, V281, P22744, DOI 10.1074/jbc.M603233200; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; Playford MP, 1996, GENOME RES, V6, P620, DOI 10.1101/gr.6.7.620; Schlessinger J, 1997, CELL, V91, P869, DOI 10.1016/S0092-8674(00)80477-8; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Sparrow LG, 1997, J BIOL CHEM, V272, P29460, DOI 10.1074/jbc.272.47.29460; TKACZ JS, 1975, BIOCHEM BIOPH RES CO, V65, P248, DOI 10.1016/S0006-291X(75)80086-6; Vogel W, 2000, J BIOL CHEM, V275, P5779, DOI 10.1074/jbc.275.8.5779; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel WF, 2001, MOL CELL BIOL, V21, P2906, DOI 10.1128/MCB.21.8.2906-2917.2001; Vogel WF, 2006, CELL SIGNAL, V18, P1108, DOI 10.1016/j.cellsig.2006.02.012; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; Wang CZ, 2006, MOL BIOL CELL, V17, P2839, DOI 10.1091/mbc.E05-11-1068; Wang CZ, 2005, J CELL PHYSIOL, V203, P295, DOI 10.1002/jcp.20227; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; Wu JJP, 2004, J BIOL CHEM, V279, P25765, DOI 10.1074/jbc.M314281200; Wu JJP, 2002, J BIOL CHEM, V277, P27809, DOI 10.1074/jbc.M200367200; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	44	32	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 2	2008	283	18					12026	12033		10.1074/jbc.M704592200	http://dx.doi.org/10.1074/jbc.M704592200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	293MS	18065762	Green Published, hybrid			2022-12-25	WOS:000255340000018
J	Mathieu, J; Flexor, M; Lanotte, M; Besancon, F				Mathieu, J.; Flexor, M.; Lanotte, M.; Besancon, F.			A PARP-1/JNK1 cascade participates in the synergistic apoptotic effect of TNF alpha and all-trans retinoic acid in APL cells	ONCOGENE			English	Article						TNF alpha; apoptosis; ATRA; PARP-1	NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; EWING SARCOMA-CELLS; POLY(ADP-RIBOSE) POLYMERASE; INDUCED ACTIVATION; JNK ACTIVATION; TUMOR-CELLS; IFN-GAMMA; DEATH; INDUCTION	When administrated by isolated limb perfusion, tumor necrosis factor alpha (TNF alpha) is an efficient antitumor agent that improves drug penetration and destroys angiogenic vessels. Moreover, the pronounced potentiation of TNF alpha-induced apoptosis by NF-kappa B inhibitors suggest that these compounds could enhance TNF alpha antitumor efficacy through direct induction of tumor cell apoptosis. Therefore, attempts at amplifying signaling pathways that mediate TNF alpha antitumor effects could help to design combination therapies improving its efficiency. We report that nanomolar concentrations of all-trans retinoic acid (ATRA) amplify TNF alpha-induced apoptosis in APL cells expressing a specific repressor of NF-kappa B activation. This effect is abolished by the pan-caspase inhibitor, Z-V AD-fmk and by caspase-8 and -9 inhibitors. Cell death is accompanied by a drop of mitochondrial potential and by poly (ADP-ribose) polymerase (PARP) activation. Using specific PARP-1 inhibitors and siRNAs, we show that PARP-1 is essential for the synergistic apoptotic effect and c-Jun N-terminal kinase 1 (JNK1) activation triggered by the ATRA/TNF alpha combination. JNK1 siRNAs reduce ATRA/TNF alpha-induced apoptosis, mitochondrial release of cytochrome c and caspase-9 activation. Altogether, these results identify a novel mechanism of PARP-1-induced apoptosis, in which JNK1 provides a link between PARP-1 activation and mitochondrial pathway of caspase-9 activation. This study also suggests that inclusion of nanomolar doses of ATRA could be clinically beneficial in amplifying TNF alpha-induced antitumor signals.	[Mathieu, J.; Lanotte, M.; Besancon, F.] Hop St Louis, INSERM, Unite 685, Inst Univ Hematol, F-75475 Paris 10, France; [Flexor, M.] Hop St Louis, AP HP, F-75475 Paris 10, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP	Besancon, F (corresponding author), Hop St Louis, INSERM, Unite 685, Inst Univ Hematol, 1 Ave Claude Vellefaux, F-75475 Paris 10, France.	Francoise.Besancon@stlouis.inserm.fr						Abadie A, 2004, ONCOGENE, V23, P4911, DOI 10.1038/sj.onc.1207614; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Adrain C, 2001, EMBO J, V20, P6627, DOI 10.1093/emboj/20.23.6627; AMRAN D, 2007, BIOCHIM BIOPHYS ACTA, V1173, P1653; Boulares AH, 2001, J BIOL CHEM, V276, P38185; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; De Smaele E, 2001, NATURE, V414, P308, DOI 10.1038/35104560; Dutta J, 2006, ONCOGENE, V25, P6800, DOI 10.1038/sj.onc.1209938; Garrido C, 2006, CELL DEATH DIFFER, V13, P1423, DOI 10.1038/sj.cdd.4401950; Javelaud D, 2000, ONCOGENE, V19, P61, DOI 10.1038/sj.onc.1203246; Javelaud D, 2001, ONCOGENE, V20, P4365, DOI 10.1038/sj.onc.1204570; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kukekov NV, 2006, J BIOL CHEM, V281, P15517, DOI 10.1074/jbc.M601056200; LAINE A, 2005, SCI STKE, V281, pRE5; LANOTTE M, 1991, BLOOD, V77, P1080; Lejeune FJ, 2006, B CANC, V93, pE90; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Manna SK, 2000, ONCOGENE, V19, P2110, DOI 10.1038/sj.onc.1203547; Mathieu J, 2005, ONCOGENE, V24, P7145, DOI 10.1038/sj.onc.1208889; Mathieu J, 2006, INT J CANCER, V119, P1723, DOI 10.1002/ijc.21970; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; NAKAMURA J, 2003, NUCLEIC ACIDS RES, V31, P1; Nguewa PA, 2003, MOL PHARMACOL, V64, P1007, DOI 10.1124/mol.64.5.1007; Ruegg C, 1998, NAT MED, V4, P408, DOI 10.1038/nm0498-408; Schreiber V, 2006, NAT REV MOL CELL BIO, V7, P517, DOI 10.1038/nrm1963; Suk K, 2001, J BIOL CHEM, V276, P13153, DOI 10.1074/jbc.M007646200; Tang GL, 2001, NATURE, V414, P313, DOI 10.1038/35104568; TOBLER A, 1987, BLOOD, V70, P1940; TRAENCKNER EBM, 1995, EMBO J, V14, P2876, DOI 10.1002/j.1460-2075.1995.tb07287.x; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Van Molle W, 2002, IMMUNITY, V16, P685, DOI 10.1016/S1074-7613(02)00310-2; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Whitmarsh AJ, 1998, SCIENCE, V281, P1671, DOI 10.1126/science.281.5383.1671; Witcher M, 2003, BLOOD, V102, P237, DOI 10.1182/blood-2002-09-2725; Xu Y, 2006, J BIOL CHEM, V281, P8788, DOI 10.1074/jbc.M508135200; Yu SW, 2002, SCIENCE, V297, P259, DOI 10.1126/science.1072221	36	15	17	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2008	27	24					3361	3370		10.1038/sj.onc.1210997	http://dx.doi.org/10.1038/sj.onc.1210997			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	307HL	18084321				2022-12-25	WOS:000256309900001
J	Watanabe, S; Watanabe, TM; Sato, O; Awata, J; Homma, K; Umeki, N; Higuchi, H; Ikebe, R; Ikebe, M				Watanabe, Shinya; Watanabe, Tomonobu M.; Sato, Osamu; Awata, Junya; Homma, Kazuaki; Umeki, Nobuhisa; Higuchi, Hideo; Ikebe, Reiko; Ikebe, Mitsuo			Human myosin Vc is a low duty ratio nonprocessive motor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE MYOSIN; KINETIC MECHANISM; LIGHT-CHAIN; SACCHAROMYCES-CEREVISIAE; FLUORESCENT-PROBE; ATPASE MECHANISMS; MESSENGER-RNA; ACTIN; ACTOMYOSIN; YEAST	There are three distinct members of the myosin V family in vertebrates, and each isoform is involved in different membrane trafficking pathways. Both myosin Va and Vb have demonstrated that they are high duty ratio motors that are consistent with the processive nature of these motors. Here we report that the ATPase cycle mechanism of the single-headed construct of myosin Vc is quite different from those of other vertebrate myosin Visoforms. K-ATPase of the actin-activated ATPase was 62 mu M, which is much higher than that of myosin Va (similar to 1 mu M). The rate of ADP release from actomyosin Vc was 12.7 s(-1), which was 2 times greater than the entire ATPase cycle rate, 6.5 s(-1). Pi burst size was 0.31, indicating that the equilibrium of the ATP hydrolysis step is shifted to the prehydrolysis form. Our kinetic model, based on all kinetic data we determined in this study, suggests that myosin Vc spends the majority of the ATPase cycle time in the weak actin binding state in contrast to myosin Va and Vb. Consistently, the two-headed myosin Vc construct did not show processive movement in total internal reflection fluorescence microscope analysis, demonstrating that myosin Vc is a non-processive motor. Our findings suggest that myosin Vc fulfills its function as a cargo transporter by different mechanisms from other myosin V isoforms.	[Watanabe, Shinya; Watanabe, Tomonobu M.; Sato, Osamu; Awata, Junya; Homma, Kazuaki; Umeki, Nobuhisa; Ikebe, Reiko; Ikebe, Mitsuo] Univ Massachusetts, Sch Med, Dept Physiol, Worcester, MA 01655 USA; [Higuchi, Hideo] Tohoku Univ, Biomed Res Org, Sendai, Miyagi 981, Japan	University of Massachusetts System; University of Massachusetts Worcester; Tohoku University	Ikebe, M (corresponding author), Univ Massachusetts, Sch Med, Dept Physiol, 55 Lake Ave N, Worcester, MA 01655 USA.	Mitsuo.lkebe@umassmed.edu	Watanabe, Tomonobu/J-4812-2013	Watanabe, Tomonobu/0000-0002-2420-4230	NIAMS NIH HHS [AR41653, AR048898, AR048526] Funding Source: Medline; NIDCD NIH HHS [DC006103] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048526, R01AR041653, R01AR048898] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006103] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Ajtai K, 2004, J BIOL CHEM, V279, P23415, DOI 10.1074/jbc.M310775200; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; Bridgman PC, 1999, J CELL BIOL, V146, P1045, DOI 10.1083/jcb.146.5.1045; BRUNE M, 1994, BIOCHEMISTRY-US, V33, P8262, DOI 10.1021/bi00193a013; De la Cruz EM, 2000, BIOCHEMISTRY-US, V39, P14196, DOI 10.1021/bi001701b; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Espindola FS, 2000, CELL MOTIL CYTOSKEL, V47, P269, DOI 10.1002/1097-0169(200012)47:4<269::AID-CM2>3.3.CO;2-7; Fan GH, 2004, MOL BIOL CELL, V15, P2456, DOI 10.1091/mbc.E03-09-0706; Hill KL, 1996, J CELL BIOL, V135, P1535, DOI 10.1083/jcb.135.6.1535; Homma K, 2005, J BIOL CHEM, V280, P29381, DOI 10.1074/jbc.M504779200; Ikebe M, 1998, J BIOL CHEM, V273, P17702, DOI 10.1074/jbc.273.28.17702; IKEBE M, 1988, J BIOL CHEM, V263, P6432; Kambara T, 1999, J BIOL CHEM, V274, P16400, DOI 10.1074/jbc.274.23.16400; KODAMA T, 1985, PHYSIOL REV, V65, P467, DOI 10.1152/physrev.1985.65.2.467; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Krementsova EB, 2006, J BIOL CHEM, V281, P6079, DOI 10.1074/jbc.M510041200; Lapierre LA, 2001, MOL BIOL CELL, V12, P1843, DOI 10.1091/mbc.12.6.1843; MARSTON SB, 1980, J MOL BIOL, V139, P573, DOI 10.1016/0022-2836(80)90050-9; Mehta AD, 1999, NATURE, V400, P590, DOI 10.1038/23072; Munchow S, 1999, J CELL SCI, V112, P1511; Nascimento AAC, 1997, MOL BIOL CELL, V8, P1971, DOI 10.1091/mbc.8.10.1971; Nishikawa S, 2002, BIOCHEM BIOPH RES CO, V290, P311, DOI 10.1006/bbrc.2001.6142; Prekeris R, 1997, J CELL BIOL, V137, P1589, DOI 10.1083/jcb.137.7.1589; Reck-Peterson SL, 2001, J CELL BIOL, V153, P1121, DOI 10.1083/jcb.153.5.1121; REYNARD AM, 1961, J BIOL CHEM, V236, P2277; Rodriguez OC, 2002, J CELL SCI, V115, P991; Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47; Sakamoto T, 2000, BIOCHEM BIOPH RES CO, V272, P586, DOI 10.1006/bbrc.2000.2819; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Schott D, 1999, J CELL BIOL, V147, P791, DOI 10.1083/jcb.147.4.791; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Takagishi Y, 1996, NEUROSCI LETT, V215, P169, DOI 10.1016/S0304-3940(96)12967-0; TAYLOR EW, 1991, J BIOL CHEM, V266, P294; Tilelli CQ, 2003, NEUROSCIENCE, V121, P573, DOI 10.1016/S0306-4522(03)00546-3; Toth J, 2005, J BIOL CHEM, V280, P30594, DOI 10.1074/jbc.M505209200; Volpicelli LA, 2002, J NEUROSCI, V22, P9776, DOI 10.1523/jneurosci.22-22-09776.2002; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wang F, 2000, J BIOL CHEM, V275, P4329, DOI 10.1074/jbc.275.6.4329; Watanabe S, 2006, J BIOL CHEM, V281, P7151, DOI 10.1074/jbc.M511592200; Watanabe S, 2006, BIOCHEMISTRY-US, V45, P2729, DOI 10.1021/bi051682b; Watanabe TM, 2004, P NATL ACAD SCI USA, V101, P9630, DOI 10.1073/pnas.0402914101; White HD, 1997, BIOCHEMISTRY-US, V36, P11828, DOI 10.1021/bi970540h; Wu XF, 1997, J CELL SCI, V110, P847; Yengo CM, 2004, BIOCHEMISTRY-US, V43, P2605, DOI 10.1021/bi035510v; Yengo CM, 2002, BIOCHEMISTRY-US, V41, P8508, DOI 10.1021/bi015969u	47	27	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 18	2008	283	16					10581	10592		10.1074/jbc.M707657200	http://dx.doi.org/10.1074/jbc.M707657200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	287CQ	18079121	hybrid, Green Published			2022-12-25	WOS:000254894700040
J	Ueyama, M; Takemae, H; Ohmae, Y; Yoshida, H; Toyoda, H; Ueda, R; Nishihara, S				Ueyama, Morio; Takemae, Hitoshi; Ohmae, Yoshiko; Yoshida, Hideki; Toyoda, Hidenao; Ueda, Ryu; Nishihara, Shoko			Functional analysis of proteoglycan galactosyltransferase II RNA interference mutant flies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; PROTEIN LINKAGE REGION; FALCIPARUM-INFECTED ERYTHROCYTES; BETA-D-XYLOSYLTRANSFERASE; DALLY-LIKE PROTEIN; UDP-D-XYLOSE; CAENORHABDITIS-ELEGANS; DROSOPHILA-MELANOGASTER; 5'-PHOSPHOSULFATE TRANSPORTER; CHONDROITINASE ABC	Heparan sulfate proteoglycan plays an important role in developmental processes by modulating the distribution and stability of the morphogens Wingless, Hedgehog, and Decapentaplegic. Heparan and chondroitin sulfates share a common linkage tetrasaccharide structure, GlcA beta 1, 3Gal beta 1, 3Gal beta 1, 4Xyl beta-O-Ser. In the present study, we identified Drosophila proteoglycan galactosyltransferase II (d beta 3GalTII), determined its substrate specificity, and performed its functional analysis by using RNA interference (RNAi) mutant flies. The enzyme transferred a galactose to Gal beta 1,4Xyl-pMph, confirming that it is the Drosophila ortholog of human proteoglycan galactosyltransferase II. Real-time PCR analyses revealed that d beta 3GalTII is expressed in various tissues and throughout development. The d beta 3GalTII RNAi mutant flies showed decreased amounts of heparan sulfate proteoglycans. A genetic interaction of d beta 3GalTII with Drosophila beta 1,4-galactoslyltransferase 7 (d beta 4GalT7) or with six genes that encode enzymes contributing to the synthesis of glycosaminoglycans indicated that d beta 3GalTII is involved in heparan sulfate synthesis for wing and eye development. Moreover, d beta 3GalTII knockdown caused a decrease in extracellular Wingless in the wing imaginal disc of the third instar larvae. These results demonstrated that d beta 3GalTII contributes to heparan sulfate proteoglycan synthesis in vitro and in vivo and also modulates Wingless distribution.	[Ueyama, Morio; Takemae, Hitoshi; Ohmae, Yoshiko; Yoshida, Hideki; Ueda, Ryu; Nishihara, Shoko] Soka Univ, Dept Bioinformat, Cell Biol Lab, Fac Engn, Hachioji, Tokyo 1928577, Japan; [Ueyama, Morio; Yoshida, Hideki; Toyoda, Hidenao; Nishihara, Shoko] Japan Sci & Technol Agcy, Kawaguchi Ctr Bldg, CREST, Kawaguchi, Saitama 3320012, Japan; [Toyoda, Hidenao] Chiba Univ, Fac Pharmaceut Sci, Dept Analyt Chem, Chiba 2638522, Japan; [Ueda, Ryu] Natl Inst Genet, Invertebrate Genet Lab, Mishima, Shizuoka 4418540, Japan	Soka University; Japan Science & Technology Agency (JST); Chiba University; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Nishihara, S (corresponding author), Soka Univ, Dept Bioinformat, Cell Biol Lab, Fac Engn, 1-236 Tangi Cho, Hachioji, Tokyo 1928577, Japan.	shoko@t.soka.ac.jp	Takemae, Hitoshi/AEP-5503-2022	Nishihara, Shoko/0000-0002-1668-2603; Ueyama, Morio/0000-0002-2950-7361				Almeida R, 1999, J BIOL CHEM, V274, P26165, DOI 10.1074/jbc.274.37.26165; Baeg GH, 2001, DEVELOPMENT, V128, P87; Bai XM, 2001, J BIOL CHEM, V276, P48189, DOI 10.1074/jbc.M107339200; Bao XF, 2005, J BIOL CHEM, V280, P35318, DOI 10.1074/jbc.M507304200; Bao XF, 2005, J BIOL CHEM, V280, P23184, DOI 10.1074/jbc.M503036200; BERNFIELD M, 1992, ANNU REV CELL BIOL, V8, P365, DOI 10.1146/annurev.cb.08.110192.002053; Bornemann DJ, 2004, DEVELOPMENT, V131, P1927, DOI 10.1242/dev.01061; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Bulik DA, 2000, P NATL ACAD SCI USA, V97, P10838, DOI 10.1073/pnas.97.20.10838; Fu WM, 2003, DEVELOPMENT, V130, P5229, DOI 10.1242/dev.00764; Goda E, 2006, J BIOL CHEM, V281, P28508, DOI 10.1074/jbc.M605045200; Goto S, 2001, NAT CELL BIOL, V3, P816, DOI 10.1038/ncb0901-816; Gotting C, 2000, J MOL BIOL, V304, P517, DOI 10.1006/jmbi.2000.4261; Gowda ASP, 2007, J BIOL CHEM, V282, P916, DOI 10.1074/jbc.M604741200; Han C, 2004, DEVELOPMENT, V131, P1563, DOI 10.1242/dev.01051; HASSELL JR, 1980, P NATL ACAD SCI-BIOL, V77, P4494, DOI 10.1073/pnas.77.8.4494; HEBERLEIN U, 1993, CELL, V75, P913, DOI 10.1016/0092-8674(93)90535-X; Herman T, 1999, P NATL ACAD SCI USA, V96, P968, DOI 10.1073/pnas.96.3.968; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Hwang HY, 2003, J BIOL CHEM, V278, P11735, DOI 10.1074/jbc.C200518200; Ichimiya T, 2004, J BIOL CHEM, V279, P42638, DOI 10.1074/jbc.M404900200; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Kamimura K, 2001, J BIOL CHEM, V276, P17014, DOI 10.1074/jbc.M011354200; Kamimura K, 2004, J CELL BIOL, V166, P1069, DOI 10.1083/jcb.200403077; Kamiyama S, 2003, J BIOL CHEM, V278, P25958, DOI 10.1074/jbc.M302439200; Khare N, 2000, MECH DEVELOP, V99, P199, DOI 10.1016/S0925-4773(00)00502-5; Kim BT, 2003, J BIOL CHEM, V278, P9116, DOI 10.1074/jbc.M209344200; Kirkpatrick CA, 2004, DEV CELL, V7, P513, DOI 10.1016/j.devcel.2004.08.004; Kitagawa H, 1998, J BIOL CHEM, V273, P6615, DOI 10.1074/jbc.273.12.6615; Kuhn J, 2001, J BIOL CHEM, V276, P4940, DOI 10.1074/jbc.M005111200; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lin XH, 2002, GLYCOCONJUGATE J, V19, P363, DOI 10.1023/A:1025329323438; Luders F, 2003, EMBO J, V22, P3635, DOI 10.1093/emboj/cdg345; Mizuguchi S, 2003, NATURE, V423, P443, DOI 10.1038/nature01635; Moon LDF, 2001, NAT NEUROSCI, V4, P465, DOI 10.1038/87415; Muller R, 2002, J BIOL CHEM, V277, P32417, DOI 10.1074/jbc.C200381200; Muthusamy A, 2004, GLYCOBIOLOGY, V14, P635, DOI 10.1093/glycob/cwh077; Nakamura Y, 2002, J BIOL CHEM, V277, P46280, DOI 10.1074/jbc.M203873200; NAKATO H, 1995, DEVELOPMENT, V121, P3687; Nakato H, 2002, BBA-GEN SUBJECTS, V1573, P312, DOI 10.1016/S0304-4165(02)00398-7; Nishihara S, 2004, GLYCOCONJUGATE J, V21, P63, DOI 10.1023/B:GLYC.0000043750.80389.14; Okajima T, 1999, J BIOL CHEM, V274, P22915, DOI 10.1074/jbc.274.33.22915; Olson SK, 2006, J CELL BIOL, V173, P985, DOI 10.1083/jcb.200603003; Perrimon N, 2000, NATURE, V404, P725, DOI 10.1038/35008000; Persson U, 1998, FEBS LETT, V434, P83, DOI 10.1016/S0014-5793(98)00954-5; Pinto DO, 2004, GLYCOBIOLOGY, V14, P529, DOI 10.1093/glycob/cwh070; Properzi F, 2005, EUR J NEUROSCI, V21, P378, DOI 10.1111/j.1460-9568.2005.03876.x; Rawson JM, 2005, CURR BIOL, V15, P833, DOI 10.1016/j.cub.2005.03.039; Rhodes KE, 2004, J ANAT, V204, P33, DOI 10.1111/j.1469-7580.2004.00261.x; Sango K, 2003, EXP NEUROL, V182, P1, DOI 10.1016/S0014-4886(03)00090-6; Schwientek T, 2002, J BIOL CHEM, V277, P32421, DOI 10.1074/jbc.M206213200; Selleck SB, 2001, SEMIN CELL DEV BIOL, V12, P127, DOI 10.1006/scdb.2000.0242; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Shipp EL, 2007, CHEM BIOL, V14, P195, DOI 10.1016/j.chembiol.2006.12.009; Shiraishi N, 2001, J BIOL CHEM, V276, P3498, DOI 10.1074/jbc.M004800200; SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435; SPRING J, 1994, P NATL ACAD SCI USA, V91, P3334, DOI 10.1073/pnas.91.8.3334; Staatz W D, 2001, Methods Mol Biol, V171, P41; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Tabata T, 2004, DEVELOPMENT, V131, P703, DOI 10.1242/dev.01043; Takei Y, 2004, DEVELOPMENT, V131, P73, DOI 10.1242/dev.00913; Takemae H, 2003, J BIOL CHEM, V278, P15571, DOI 10.1074/jbc.M301123200; The I, 1999, MOL CELL, V4, P633, DOI 10.1016/S1097-2765(00)80214-2; Toyoda H, 2000, J BIOL CHEM, V275, P2269, DOI 10.1074/jbc.275.4.2269; Toyoda H, 2000, J BIOL CHEM, V275, P21856, DOI 10.1074/jbc.M003540200; Tropea D, 2003, J NEUROSCI, V23, P7034, DOI 10.1523/JNEUROSCI.23-18-07034.2003; Vadaie N, 2002, GLYCOBIOLOGY, V12, P589, DOI 10.1093/glycob/cwf074; Voigt A, 2002, DEV DYNAM, V224, P403, DOI 10.1002/dvdy.10120; Wilson IBH, 2002, J BIOL CHEM, V277, P21207, DOI 10.1074/jbc.M201634200; Yamada S, 2002, J BIOL CHEM, V277, P31877, DOI 10.1074/jbc.M205078200	70	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6076	6084		10.1074/jbc.M709189200	http://dx.doi.org/10.1074/jbc.M709189200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165227	hybrid			2022-12-25	WOS:000253779500013
J	Ganichkin, OM; Xu, XM; Carlson, BA; Mix, H; Hatfield, DL; Gladyshev, VN; Wahl, MC				Ganichkin, Oleg M.; Xu, Xue-Ming; Carlson, Bradley A.; Mix, Heiko; Hatfield, Dolph L.; Gladyshev, Vadim N.; Wahl, Markus C.			Structure and catalytic mechanism of eukaryotic selenocysteine synthase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERINE TRANSFER-RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; SELENOPROTEIN SYNTHESIS; SECONDARY-STRUCTURE; TARGET ANTIGEN; PROTEIN; IDENTIFICATION; HOMOLOG; LYASE	In eukaryotes and Archaea, selenocysteine synthase (SecS) converts O-phospho-L-seryl-tRNA([Ser]Sec) into selenocysteyl-tRNA([Ser]Sec) using selenophosphate as the selenium donor compound. The molecular mechanisms underlying SecS activity are presently unknown. We have delineated a 450-residue core of mouse SecS, which retained full selenocysteyl-tRNA([Ser]Sec) synthesis activity, and determined its crystal structure at 1.65 angstrom resolution. SecS exhibits three domains that place it in the fold type I family of pyridoxal phosphate (PLP)-dependent enzymes. Two SecS monomers interact intimately and together build up two identical active sites around PLP in a Schiff-base linkage with lysine 284. Two SecS dimers further associate to form a homotetramer. The N terminus, which mediates tetramer formation, and a large insertion that remodels the active site set SecS aside from other members of the family. The active site insertion contributes to PLP binding and positions a glutamate next to the PLP, where it could repel substrates with a free alpha-carboxyl group, suggesting why SecS does not act on free O-phospho-L-serine. Upon soaking crystals in phosphate buffer, a previously disordered loop within the active site insertion contracted to form a phosphate binding site. Residues that are strictly conserved in SecS orthologs but variant in related enzymes coordinate the phosphate and upon mutation corrupt SecS activity. Modeling suggested that the phosphate loop accommodates the gamma-phosphate moiety of O-phospho-L-seryl-tRNA([Ser]Sec) and, after phosphate elimination, binds selenophosphate to initiate attack on the proposed aminoacrylyl-tRNA([Ser]Sec) intermediate. Based on these results and on the activity profiles of mechanism-based inhibitors, we offer a detailed reaction mechanism for the enzyme.	[Ganichkin, Oleg M.; Wahl, Markus C.] Max Planck Inst Biophys Chem, Zellulare Biochem Makromol Rontgenkristallog, D-37077 Gottingen, Germany; [Xu, Xue-Ming; Carlson, Bradley A.; Hatfield, Dolph L.] NIH, NCI, Canc Res Ctr, Lab Canc Prevent Mol Biol Selenium Sect, Bethesda, MD 20892 USA; [Mix, Heiko; Gladyshev, Vadim N.] Univ Nebraska, Dept Biochem, Lincoln, NE 68588 USA	Max Planck Society; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Nebraska System; University of Nebraska Lincoln	Wahl, MC (corresponding author), Max Planck Inst Biophys Chem, Zellulare Biochem Makromol Rontgenkristallog, Am Fassberg 11, D-37077 Gottingen, Germany.	mwahl@gwdg.de	Gladyshev, Vadim N/A-9894-2013; Wahl, Markus C./D-6365-2017; Gladyshev, Vadim N/J-6187-2013	Wahl, Markus C./0000-0002-2811-5307; Gladyshev, Vadim/0000-0002-0372-7016	Intramural NIH HHS Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010767, Z01BC010767] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Allmang C, 2006, BIOCHIMIE, V88, P1561, DOI 10.1016/j.biochi.2006.04.015; BARON C, 1991, J BIOL CHEM, V266, P20375; BERRY MJ, 1993, EMBO J, V12, P3315, DOI 10.1002/j.1460-2075.1993.tb06001.x; BOCK A, 1991, TRENDS BIOCHEM SCI, V16, P463, DOI 10.1016/0968-0004(91)90180-4; Carlson BA, 2004, P NATL ACAD SCI USA, V101, P12848, DOI 10.1073/pnas.0402636101; Chavatte L, 2005, NAT STRUCT MOL BIOL, V12, P408, DOI 10.1038/nsmb922; Clausen T, 1998, EMBO J, V17, P6827, DOI 10.1093/emboj/17.23.6827; Clausen T, 2000, P NATL ACAD SCI USA, V97, P3856, DOI 10.1073/pnas.97.8.3856; Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508; Commans S, 1999, FEMS MICROBIOL REV, V23, P335, DOI 10.1111/j.1574-6976.1999.tb00403.x; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; DWIVEDI CM, 1982, BIOCHEMISTRY-US, V21, P3064, DOI 10.1021/bi00256a005; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; FORCHHAMMER K, 1989, NATURE, V342, P453, DOI 10.1038/342453a0; FORCHHAMMER K, 1991, J BIOL CHEM, V266, P6324; Fujii T, 2000, BIOCHEMISTRY-US, V39, P1263, DOI 10.1021/bi991732a; Fukunaga R, 2007, J MOL BIOL, V370, P128, DOI 10.1016/j.jmb.2007.04.050; GELPI C, 1992, P NATL ACAD SCI USA, V89, P9739, DOI 10.1073/pnas.89.20.9739; Guimaraes MJ, 1996, P NATL ACAD SCI USA, V93, P15086, DOI 10.1073/pnas.93.26.15086; Hartmuth K, 2002, P NATL ACAD SCI USA, V99, P16719, DOI 10.1073/pnas.262483899; Hatfield DL, 2006, PROG NUCLEIC ACID RE, V81, P97, DOI 10.1016/S0079-6603(06)81003-2; HEIDER J, 1992, EMBO J, V11, P3759, DOI 10.1002/j.1460-2075.1992.tb05461.x; Hendrickson TL, 2007, NAT STRUCT MOL BIOL, V14, P100, DOI 10.1038/nsmb0207-100; Hester G, 1999, J MOL BIOL, V286, P829, DOI 10.1006/jmbi.1998.2506; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Hubert N, 1998, RNA, V4, P1029, DOI 10.1017/S1355838298980888; Kaiser JT, 2005, BIOCHEMISTRY-US, V44, P13315, DOI 10.1021/bi051110r; Kaiser JT, 2000, J MOL BIOL, V297, P451, DOI 10.1006/jmbi.2000.3581; Kernebeck T, 2001, HEPATOLOGY, V34, P230, DOI 10.1053/jhep.2001.26632; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Lacourciere GM, 1998, J BIOL CHEM, V273, P30921, DOI 10.1074/jbc.273.47.30921; LEE BJ, 1989, J BIOL CHEM, V264, P9724; LEINFELDER W, 1990, P NATL ACAD SCI USA, V87, P543, DOI 10.1073/pnas.87.2.543; LEINFELDER W, 1988, NATURE, V331, P723, DOI 10.1038/331723a0; Lima CD, 2002, J MOL BIOL, V315, P1199, DOI 10.1006/jmbi.2001.5308; Mihara H, 2002, J BIOCHEM, V131, P679, DOI 10.1093/oxfordjournals.jbchem.a003151; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OHAMA T, 1994, ARCH BIOCHEM BIOPHYS, V315, P293, DOI 10.1006/abbi.1994.1503; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Rother M, 2001, BIOFACTORS, V14, P75, DOI 10.1002/biof.5520140111; Sauerwald A, 2005, SCIENCE, V307, P1969, DOI 10.1126/science.1108329; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Small-Howard A, 2006, MOL CELL BIOL, V26, P2337, DOI 10.1128/MCB.26.6.2337-2346.2006; Steegborn C, 1999, J BIOL CHEM, V274, P12675, DOI 10.1074/jbc.274.18.12675; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tujebajeva RM, 2000, EMBO REP, V1, P158, DOI 10.1093/embo-reports/kvd033; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Wies I, 2000, LANCET, V355, P1510, DOI 10.1016/S0140-6736(00)02166-8; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xu XM, 2005, J BIOL CHEM, V280, P41568, DOI 10.1074/jbc.M506696200; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Xu XM, 2007, BIOCHEM J, V404, P115, DOI 10.1042/BJ20070165; YUAN J, 2006, P NATL ACAD SCI USA, V103, P1893	59	42	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5849	5865		10.1074/jbc.M709342200	http://dx.doi.org/10.1074/jbc.M709342200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093968	hybrid, Green Submitted			2022-12-25	WOS:000253426700064
J	Lee, JY; Urbatsch, IL; Senior, AE; Wilkens, S				Lee, Jyh-Yeuan; Urbatsch, Ina L.; Senior, Alan E.; Wilkens, Stephan			Nucleotide-induced structural changes in P-glycoprotein observed by electron microscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIDRUG-RESISTANCE; ABC TRANSPORTER; ATP-BINDING; PROJECTION STRUCTURE; CATALYTIC CYCLE; ESCHERICHIA-COLI; CONFORMATION; PURIFICATION; MECHANISM; AFFINITY	P-glycoprotein (Pgp) is an ATP hydrolysis driven multidrug efflux pump, which, when overexpressed in the plasma membrane of certain cancers, can lead to the failure of chemotherapy. Previously, we have presented a projection structure of nucleotide-free mouse Pgp from electron microscopic images of lipid monolayer-generated two-dimensional crystals (Lee, J. Y., Urbatsch, I. L., Senior, A. E., and Wilkens, S. (2002) J. Biol. Chem. 277, 40125-40131). Here we have analyzed the structure of cysteine-free human Pgp from two-dimensional crystals that were generated with the same lipid-monolayer technique in the absence and presence of various nucleotides. The images show that human Pgp has a similar structure to the mouse protein. Furthermore, the analysis of projection structures obtained under different nucleotide conditions suggests that Pgp can exist in at least two major conformations, one of which shows a central cavity between the N-and C-terminal halves of the molecule and another in which the two halves have moved sideways, thereby closing the central cavity. Intermediate conformations were observed for some nucleotide/vanadate combinations. A low-resolution, three-dimensional model of human Pgp was calculated from tilted specimen crystallized in the presence of the non-hydrolyzable nucleotide analog, adenosine 5'-O-(thiotriphosphate). The structural analysis presented here adds to the emerging picture that multidrug ABC transporters function by switching between two major conformations in a nucleotide-dependent manner.	[Lee, Jyh-Yeuan] Univ Calif Riverside, Dept Biochem, Riverside, CA 92521 USA; [Urbatsch, Ina L.] Texas Tech Univ, Hlth Sci Ctr, Dept Cell Biol & Biochem, Lubbock, TX 79430 USA; [Senior, Alan E.] Univ Rochester, Med Ctr, Dept Biochem & Biophys, New York, NY 14642 USA; [Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	University of California System; University of California Riverside; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; University of Rochester; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Wilkens, S (corresponding author), 750 E Adams St, Syracuse, NY 13210 USA.	wilkenss@upstate.edu	Lee, Jyh-Yeuan/ACA-2717-2022	Lee, Jyh-Yeuan/0000-0003-1799-2416	NATIONAL CANCER INSTITUTE [R01CA100246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050156] Funding Source: NIH RePORTER; NCI NIH HHS [CA100246] Funding Source: Medline; NIGMS NIH HHS [GM50156] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Campbell JD, 2005, FEBS LETT, V579, P4193, DOI 10.1016/j.febslet.2005.06.027; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x; Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626; KESSEL M, 1985, J MICROSC-OXFORD, V139, P63, DOI 10.1111/j.1365-2818.1985.tb04662.x; Lee JY, 2002, J BIOL CHEM, V277, P40125, DOI 10.1074/jbc.M206871200; Lerner-Marmarosh N, 1999, J BIOL CHEM, V274, P34711, DOI 10.1074/jbc.274.49.34711; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Loo TW, 1999, BBA-BIOMEMBRANES, V1461, P315, DOI 10.1016/S0005-2736(99)00165-0; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; Loo TW, 2002, J BIOL CHEM, V277, P41303, DOI 10.1074/jbc.C200484200; Martin C, 2001, BIOCHEMISTRY-US, V40, P15733, DOI 10.1021/bi011211z; Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200; O'Mara ML, 2007, FEBS LETT, V581, P4217, DOI 10.1016/j.febslet.2007.07.069; Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Qu Q, 2003, BIOCHEMISTRY-US, V42, P1170, DOI 10.1021/bi026555j; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8; Sharom FJ, 2006, BIOCHEM CELL BIOL, V84, P979, DOI 10.1139/O06-199; Sherman MB, 1998, ULTRAMICROSCOPY, V74, P179, DOI 10.1016/S0304-3991(98)00041-2; Smith JM, 1999, J STRUCT BIOL, V125, P223, DOI 10.1006/jsbi.1998.4073; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Tombline G, 2005, J BIOENERG BIOMEMBR, V37, P497, DOI [10.1007/s10863-005-9498-4, 10.1007/s10863-005-9498/4]; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Unger VM, 2000, ACTA CRYSTALLOGR D, V56, P1259, DOI 10.1107/S0907444900011252; Unger VM, 1997, NAT STRUCT BIOL, V4, P39, DOI 10.1038/nsb0197-39; Urbatsch IL, 2003, J BIOL CHEM, V278, P23171, DOI 10.1074/jbc.M301957200; Urbatsch IL, 2001, J BIOL CHEM, V276, P26980, DOI 10.1074/jbc.M010829200; van Veen HW, 2001, SEMIN CELL DEV BIOL, V12, P239, DOI 10.1006/scdb.2000.0249; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Wang CY, 2004, J MOL BIOL, V342, P525, DOI 10.1016/j.jmb.2004.07.001; Williams KA, 1999, EMBO J, V18, P3558, DOI 10.1093/emboj/18.13.3558	47	64	66	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5769	5779		10.1074/jbc.M707028200	http://dx.doi.org/10.1074/jbc.M707028200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093977	hybrid			2022-12-25	WOS:000253426700058
J	Ruiz, S; Castro-Castro, A; Bustelo, XR				Ruiz, Sergio; Castro-Castro, Antonio; Bustelo, Xose R.			CD147 inhibits the nuclear factor of activated T-cells by impairing vav1 and rac1 downstream signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX METALLOPROTEINASE INDUCER; GDP/GTP EXCHANGE FACTOR; BLOOD-BRAIN-BARRIER; IMMUNOGLOBULIN SUPERFAMILY; RHEUMATOID-ARTHRITIS; BASIGIN GENE; MICE LACKING; TYROSINE PHOSPHORYLATION; BIOLOGICAL-ACTIVITY; RECEPTOR SIGNALS	CD147 is a transmembrane protein that plays crucial roles in the development and function of the reproductive, visual, and nervous systems. CD147 also exerts positive and negative actions in T-cells by still obscure mechanisms. In this study, we have analyzed the expression, localization, and function of CD147 during T-cell receptor signaling responses. We show here that CD147 is an integral component of the T-cell immune synapse and that its overexpression leads to the inhibition of NF-AT ( nuclear factor of activated T-cells) activity induced by Vav1, a Rac1 exchange factor. This inhibitory activity is mediated by the CD147 intracellular tail and is totally independent of its extracellular or transmembrane regions. The molecular dissection of the influence of CD147 on the Vav1 pathway indicates that its inhibitory action takes place downstream of Vav1 and Rac1 but upstream of the serine/threonine kinases JNK and Pak1. The interference of CD147 with these pathways is highly specific because the overexpression of CD147 does not affect the activity of other GDP/GTP exchange factors or the stimulation of the ERK cascade. Finally, we show that the CD147 knockdown in Jurkat cells promotes higher levels of NF-AT stimulation and Pak1 phosphorylation upon T-cell receptor cross-linking. Instead, the lack of CD147 does not affect other signaling cascades that participate in the same cellular response. Taken together, these results indicate that CD147, via the selective inhibition of specific downstream elements of the Vav1/Rac1 route, contributes to the negative regulation of T-cell responses.	[Ruiz, Sergio; Castro-Castro, Antonio; Bustelo, Xose R.] Univ Salamanca, Ctr Invest Canc, Inst Biol Mol & Celular Canc, Consejo Super Invest Cient, E-37007 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion del Cancer (CIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Bustelo, XR (corresponding author), Univ Salamanca, Ctr Invest Canc, CSIC, Campus Unamuno, E-37007 Salamanca, Spain.	xbustelo@usal.es	Ruiz, Sergio/G-1561-2016; Bustelo, Xose R./AAD-2081-2022; Bustelo, Xose R./A-9526-2010	Ruiz, Sergio/0000-0002-0177-6965; Bustelo, Xose R./0000-0001-9398-6072; Bustelo, Xose R./0000-0001-9398-6072	NCI NIH HHS [5R01-CA73735-11] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA073735] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Acuto O, 2003, NAT REV IMMUNOL, V3, P939, DOI 10.1038/nri1248; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; ALTRUDA F, 1989, GENE, V85, P445, DOI 10.1016/0378-1119(89)90438-1; Arora K, 2005, J IMMUNOL, V175, P517, DOI 10.4049/jimmunol.175.1.517; Besse F, 2007, J CELL BIOL, V177, P843, DOI 10.1083/jcb.200701111; Boulos S, 2007, NEUROBIOL DIS, V25, P54, DOI 10.1016/j.nbd.2006.08.012; Bustelo XR, 2007, BIOESSAYS, V29, P356, DOI 10.1002/bies.20558; Bustelo XR, 2000, MOL CELL BIOL, V20, P1461, DOI 10.1128/MCB.20.5.1461-1477.2000; BUSTELO XR, 1994, ONCOGENE, V9, P2405; Bustelo XR, 2002, FRONT BIOSCI, V7, pD24, DOI 10.2741/bustelo; BUSTELO XR, 1993, CELL GROWTH DIFFER, V4, P297; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Caloca MJ, 2003, J BIOL CHEM, V278, P33465, DOI 10.1074/jbc.M302807200; Caloca MJ, 2003, EMBO J, V22, P3326, DOI 10.1093/emboj/cdg316; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chen S, 2004, BIOCHEM BIOPH RES CO, V324, P147, DOI 10.1016/j.bbrc.2004.08.232; Chen ZN, 2005, J INFECT DIS, V191, P755, DOI 10.1086/427811; Costello PS, 1999, P NATL ACAD SCI USA, V96, P3035, DOI 10.1073/pnas.96.6.3035; Crespo P, 1996, ONCOGENE, V13, P455; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; Curtin KD, 2007, GLIA, V55, P1542, DOI 10.1002/glia.20568; Egawa N, 2006, J BIOL CHEM, V281, P37576, DOI 10.1074/jbc.M606993200; FOSSUM S, 1991, EUR J IMMUNOL, V21, P671, DOI 10.1002/eji.1830210320; Gabison EE, 2005, BIOCHIMIE, V87, P361, DOI 10.1016/j.biochi.2004.09.023; Genot E, 1996, EMBO J, V15, P3923, DOI 10.1002/j.1460-2075.1996.tb00766.x; Green DR, 2003, IMMUNOL REV, V193, P70, DOI 10.1034/j.1600-065X.2003.00051.x; Guillot S, 2006, EXP LUNG RES, V32, P81, DOI 10.1080/01902140600710512; Gwinn WM, 2006, J IMMUNOL, V177, P4870, DOI 10.4049/jimmunol.177.7.4870; Harrod TP, 2002, IMMUNOL RES, V26, P153, DOI 10.1385/IR:26:1-3:153; Hemenway Charles S., 1999, Cell Biochemistry and Biophysics, V30, P115, DOI 10.1007/BF02737887; Hori K, 2000, INVEST OPHTH VIS SCI, V41, P3128; Igakura T, 1996, BIOCHEM BIOPH RES CO, V224, P33, DOI 10.1006/bbrc.1996.0980; Igakura T, 1998, DEV BIOL, V194, P152, DOI 10.1006/dbio.1997.8819; Jiang Jian-Li, 2007, Shengli Xuebao, V59, P517; KANEKURA T, 1991, CELL STRUCT FUNCT, V16, P23, DOI 10.1247/csf.16.23; Koch C, 1999, INT IMMUNOL, V11, P777, DOI 10.1093/intimm/11.5.777; Konttinen YT, 2000, ARTHRITIS RHEUM, V43, P275, DOI 10.1002/1529-0131(200002)43:2<275::AID-ANR6>3.0.CO;2-#; Kuno N, 1998, FEBS LETT, V425, P191, DOI 10.1016/S0014-5793(98)00213-0; Lim M, 1998, FEBS LETT, V441, P88, DOI 10.1016/S0014-5793(98)01474-4; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; MIYAUCHI T, 1990, J BIOCHEM-TOKYO, V107, P316, DOI 10.1093/oxfordjournals.jbchem.a123045; Muramatsu T, 2003, HISTOL HISTOPATHOL, V18, P981, DOI 10.14670/HH-18.981; Nabeshima K, 2004, J PATHOL, V202, P341, DOI 10.1002/path.1518; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Naruhashi K, 1997, BIOCHEM BIOPH RES CO, V236, P733, DOI 10.1006/bbrc.1997.6993; Ochrietor JD, 2002, VISION RES, V42, P447, DOI 10.1016/S0042-6989(01)00236-X; Ochrietor JD, 2001, EXP EYE RES, V72, P467, DOI 10.1006/exer.2000.0974; Pistol G, 2007, J CELL MOL MED, V11, P339, DOI 10.1111/j.1582-4934.2007.00022.x; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Renno T, 2002, J IMMUNOL, V168, P4946, DOI 10.4049/jimmunol.168.10.4946; Reynolds LF, 2004, J BIOL CHEM, V279, P18239, DOI 10.1074/jbc.M400257200; Ruiz S, 2007, MOL CELL BIOL, V27, P8127, DOI 10.1128/MCB.00912-07; Schreiner A, 2007, MOL BIOL CELL, V18, P1272, DOI 10.1091/mbc.E06-07-0637; Serfling E, 2000, BBA-MOL CELL RES, V1498, P1, DOI 10.1016/S0167-4889(00)00082-3; SEULBERGER H, 1990, EMBO J, V9, P2151, DOI 10.1002/j.1460-2075.1990.tb07384.x; Spinale FG, 2000, CIRCULATION, V102, P1944, DOI 10.1161/01.CIR.102.16.1944; Staffler G, 2003, J IMMUNOL, V171, P1707, DOI 10.4049/jimmunol.171.4.1707; Tang Y, 2006, MOL CANCER RES, V4, P371, DOI 10.1158/1541-7786.MCR-06-0042; Taylor PM, 2002, ONCOGENE, V21, P5765, DOI 10.1038/sj.onc.1205702; Teft WA, 2006, ANNU REV IMMUNOL, V24, P65, DOI 10.1146/annurev.immunol.24.021605.090535; Tomita T, 2002, ARTHRITIS RHEUM, V46, P373, DOI 10.1002/art.10050; Toyama Y, 1999, ANAT HISTOL EMBRYOL, V28, P205, DOI 10.1046/j.1439-0264.1999.00194.x; Vivier E, 2004, NAT REV IMMUNOL, V4, P190, DOI 10.1038/nri1306; WOODROW M, 1993, J EXP MED, V178, P1517, DOI 10.1084/jem.178.5.1517; WOODROW MA, 1993, J IMMUNOL, V150, P3853; WU J, 1995, MOL CELL BIOL, V15, P4337; Xu DS, 2005, MOL CELL PROTEOMICS, V4, P1061, DOI 10.1074/mcp.M400207-MCP200; Yablonski D, 1998, EMBO J, V17, P5647, DOI 10.1093/emboj/17.19.5647; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536; Yang JM, 2006, J BIOL CHEM, V281, P9719, DOI 10.1074/jbc.M508421200; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102; Zhu P, 2005, ARTHRITIS RES THER, V7, pR1023, DOI 10.1186/ar1778; Zhu P, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1899; Zugaza JL, 2004, ONCOGENE, V23, P5823, DOI 10.1038/sj.onc.1207768; Zugaza JL, 2002, J BIOL CHEM, V277, P45377, DOI 10.1074/jbc.M208039200	78	35	37	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5554	5566		10.1074/jbc.M708566200	http://dx.doi.org/10.1074/jbc.M708566200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18160397	hybrid			2022-12-25	WOS:000253426700036
J	Nomura, R; Suzuki, Y; Kakizuka, A; Jingami, H				Nomura, Rei; Suzuki, Yoshikazu; Kakizuka, Akira; Jingami, Hisato			Direct detection of the interaction between recombinant soluble extracellular regions in the heterodimeric metabotropic gamma-aminobutyric acid receptor.	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; GABA-B RECEPTOR; LIGAND-BINDING; GLUTAMATE-RECEPTOR; NEGATIVE COOPERATIVITY; DIMER INTERFACE; GB2 SUBUNITS; SUBTYPE 1; DOMAIN; TRAFFICKING	The gamma-aminobutyric acid, type B (GABA(B)) receptor is a heterodimeric receptor consisting of two complementary subunits, GABA(B1) receptor (GBR1) and GABA(B2) receptor (GBR2). GBR1 is responsible for GABA binding, whereas GBR2 is considered to perform a critical role in signal transduction toward downstream targets. Therefore, precise communication between GBR1 and GBR2 is thought to be essential for the proper signal transduction process. However, biochemical data describing the interaction of the two subunits, especially for the extracellular regions, are not sufficient. Thus we began by developing a protein expression system of the soluble extracellular regions. One of the soluble recombinant GBR1 proteins exhibited a ligand binding ability, which is similar to that of the full-length GBR1, and thus the ligand-binding domain was determined. Direct interaction between GBR1 and GBR2 extracellular soluble fragments was confirmed by co-expression followed by affinity column chromatography and a sucrose density gradient sedimentation. In addition, we also found homo-oligomeric states of these soluble extracellular regions. The interaction between the two soluble extracellular regions caused the enhancement of the agonist affinity for GBR1 as previously reported in a cell-based assay. These results not only open the way to future structural studies but also highlight the role of the interaction between the extracellular regions, which controls agonist affinity to the heterodimeric receptor.	[Nomura, Rei; Suzuki, Yoshikazu; Jingami, Hisato] Biomol Engn Res Inst, Dept Mol Biol, Osaka 5650874, Japan; [Nomura, Rei; Kakizuka, Akira] Kyoto Univ, Grad Sch Biostudies & Solut Oriented Res Sci & Te, JST,Lab Funct Biol, Sakyo Ku, Kyoto 6068501, Japan; [Jingami, Hisato] Kyoto Univ, Grad Courses Integrated Res Training, Fac Med, Sakyo Ku, Kyoto 6068501, Japan	Japan Science & Technology Agency (JST); Kyoto University; Kyoto University	Jingami, H (corresponding author), Biomol Engn Res Inst, Dept Mol Biol, 6-2-3 Furuedai, Osaka 5650874, Japan.	jingami@mfour.med.kyoto-u.ac.jp						Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; BOWERY NG, 1980, NATURE, V283, P92, DOI 10.1038/283092a0; Calver AR, 2001, J NEUROSCI, V21, P1203; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Deriu D, 2005, BIOCHEM J, V386, P423, DOI 10.1042/BJ20040804; Devi LA, 2001, TRENDS PHARMACOL SCI, V22, P532, DOI 10.1016/S0165-6147(00)01799-5; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Froestl W, 1999, NEUROPHARMACOLOGY, V38, P1641, DOI 10.1016/S0028-3908(99)00134-3; Galvez T, 2001, EMBO J, V20, P2152, DOI 10.1093/emboj/20.9.2152; Galvez T, 1999, J BIOL CHEM, V274, P13362, DOI 10.1074/jbc.274.19.13362; Green A, 2000, BRIT J PHARMACOL, V131, P1766, DOI 10.1038/sj.bjp.0703755; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0; Kniazeff J, 2002, J NEUROSCI, V22, P7352; Kniazeff J, 2004, NAT STRUCT MOL BIOL, V11, P706, DOI 10.1038/nsmb794; Kuner R, 1999, SCIENCE, V283, P74, DOI 10.1126/science.283.5398.74; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; Levoye A, 2006, EMBO REP, V7, P1094, DOI 10.1038/sj.embor.7400838; Liu JF, 2004, J BIOL CHEM, V279, P15824, DOI 10.1074/jbc.M313639200; Malitschek B, 1999, MOL PHARMACOL, V56, P448, DOI 10.1124/mol.56.2.448; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Margeta-Mitrovic M, 2001, P NATL ACAD SCI USA, V98, P14649, DOI 10.1073/pnas.251554498; Milligan G, 2004, MOL PHARMACOL, V66, P1, DOI 10.1124/mol.104.000497.; Muto T, 2007, P NATL ACAD SCI USA, V104, P3759, DOI 10.1073/pnas.0611577104; Okamoto T, 1998, J BIOL CHEM, V273, P13089, DOI 10.1074/jbc.273.21.13089; Pagano A, 2001, J NEUROSCI, V21, P1189; Prinster SC, 2005, PHARMACOL REV, V57, P289, DOI 10.1124/pr.57.3.1; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Sato T, 2003, J BIOL CHEM, V278, P4314, DOI 10.1074/jbc.M210278200; Suzuki Y, 2004, J BIOL CHEM, V279, P35526, DOI 10.1074/jbc.M404831200; Tsuchiya D, 2002, P NATL ACAD SCI USA, V99, P2660, DOI 10.1073/pnas.052708599; Tsuji Y, 2000, J BIOL CHEM, V275, P28144; Urizar E, 2005, EMBO J, V24, P1954, DOI 10.1038/sj.emboj.7600686; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; White JH, 1998, NATURE, V396, P679, DOI 10.1038/25354	36	17	20	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4665	4673		10.1074/jbc.M705202200	http://dx.doi.org/10.1074/jbc.M705202200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18165688	hybrid			2022-12-25	WOS:000253426500024
J	Yuan, C; O'Connell, RJ; Wilson, A; Pietrzykowski, AZ; Treistman, SN				Yuan, Chunbo; O'Connell, Robert J.; Wilson, Andrew; Pietrzykowski, Andrzej Z.; Treistman, Steven N.			Acute alcohol tolerance is intrinsic to the BKCa protein, but is modulated by the lipid environment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED POTASSIUM CHANNELS; PHOSPHOLIPID SURFACE-CHARGE; CA2+-ACTIVATED K+ CHANNELS; LARGE-CONDUCTANCE; SMOOTH-MUSCLE; ETHANOL POTENTIATION; BILAYER THICKNESS; NEUROHYPOPHYSEAL TERMINALS; ANESTHETIC ACTION; BINDING-SITE	Ethanol tolerance, in which exposure leads to reduced sensitivity, is an important component of alcohol abuse and addiction. The molecular mechanisms underlying this process remain poorly understood. The BKCa channel plays a central role in the behavioral response to ethanol in Caenorhabditis elegans (Davies, A. G., Pierce-Shimomura, J.T., Kim, H., VanHoven, M. K., Thiele, T. R., Bonci, A., Bargmann, C.I., and McIntire, S. L. (2003) Cell 115, 655 666) and Drosophila (Cowmeadow, R. B., Krishnan, H.R., and Atkinson, N.S. (2005) Alcohol. Clin. Exp. Res. 29, 1777-1786). In neurons, ethanol tolerance in BKCa channels has two components: a reduced number of membrane channels and decreased potentiation of the remaining channels (Pietrzykowski, A.Z., Martin, G.E., Puig, S.I., Knott, T.K., Lemos, J.R., and Treistman, S.N. (2004) J. Neurosci. 24, 8322-8332). Here, heterologous expression coupled with planar bilayer techniques examines two additional aspects of tolerance in human BKCa channels. 1) Is acute tolerance observed in a single channel protein complex within a lipid environment reduced to only two lipids? 2) Does lipid bilayer composition affect the appearance of acute tolerance? We found that tolerance was observable in BKCa channels in membrane patches pulled from HEK cells and when they are placed into reconstituted1-palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylethanolamine/1palmitoyl-2-oleoyl-sn-glycero-3-phosphatidylserine membranes. Furthermore, altering bilayer thickness by incorporating the channel into lipid mixtures of 1,2-dioleoyl-3-phosphatidylethanolamine with phosphatidylcholines of increasing chain length, or with sphingomyelin, strongly affected the sensitivity of the channel, as well as the time course of the acute response. Ethanol sensitivity changed from a strong potentiation in thin bilayers to inhibition in thick sphingomyelin/1,2-dioleoyl-3-phosphatidylethanolamine bilayers. Thus, tolerance can be an intrinsic property of the channel protein-lipid complex, and bilayer thickness plays an important role in shaping the pattern of response to ethanol. As a consequence of these findings the protein-lipid complex should be treated as a unit when studying ethanol action.	[Yuan, Chunbo; O'Connell, Robert J.; Wilson, Andrew; Pietrzykowski, Andrzej Z.; Treistman, Steven N.] Univ Massachusetts, Sch Med, Brudnic Neuropsychiat Res Inst, Worcester, MA 01604 USA	University of Massachusetts System; University of Massachusetts Worcester	Treistman, SN (corresponding author), Univ Massachusetts, Sch Med, Brudnic Neuropsychiat Res Inst, Worcester, MA 01604 USA.		Yuan, Chunbo/E-9627-2011		NIAAA NIH HHS [R37 AA012054-10, R37 AA012054, AA12054, R01 AA018038, R01 AA018038-02] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R37AA012054, R01AA018038] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Ahring PK, 1997, FEBS LETT, V415, P67, DOI 10.1016/S0014-5793(97)01096-X; Alvarez O., 1986, ION CHANNEL RECONSTI, P115; Andersen OS, 2007, ANNU REV BIOPH BIOM, V36, P107, DOI 10.1146/annurev.biophys.36.040306.132643; BARRY JA, 1995, BIOCHEMISTRY-US, V34, P8852, DOI 10.1021/bi00027a037; BARRY JA, 1994, BIOCHEMISTRY-US, V33, P8082, DOI 10.1021/bi00192a013; BELL JE, 1984, BIOPHYS J, V45, P279, DOI 10.1016/S0006-3495(84)84154-5; Blevins T, 1997, J NEUROCHEM, V69, P2345; Boesze-Battaglia K, 1997, J EXP BIOL, V200, P2927; BOLOTINA V, 1989, PFLUG ARCH EUR J PHY, V415, P262, DOI 10.1007/BF00370875; Bravo-Zehnder M, 2000, P NATL ACAD SCI USA, V97, P13114, DOI 10.1073/pnas.240455697; Brodie MS, 2007, ALCOHOL CLIN EXP RES, V31, P1625, DOI 10.1111/j.1530-0277.2007.00469.x; Carpenter-Hyland EP, 2004, J NEUROSCI, V24, P7859, DOI 10.1523/JNEUROSCI.1902-04.2004; CHANG HM, 1995, J MEMBRANE BIOL, V143, P51; Chu BS, 1998, MOL PHARMACOL, V54, P397, DOI 10.1124/mol.54.2.397; Cowmeadow RB, 2006, ALCOHOL CLIN EXP RES, V30, P745, DOI 10.1111/j.1530-0277.2006.00087.x; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; Crowley JJ, 2005, MOL PHARMACOL, V68, P4, DOI 10.1124/mol.105.012971; Crowley JJ, 2003, MOL PHARMACOL, V64, P365, DOI 10.1124/mol.64.2.365; Davies AG, 2003, CELL, V115, P655, DOI 10.1016/S0092-8674(03)00979-6; Dopico AM, 2003, AM J PHYSIOL-CELL PH, V284, pC1468, DOI 10.1152/ajpcell.00421.2002; Dopico AM, 1996, MOL PHARMACOL, V49, P40; Dopico AM, 1999, J PHYSIOL-LONDON, V519, P101, DOI 10.1111/j.1469-7793.1999.0101o.x; EWALD DA, 1985, NATURE, V315, P503, DOI 10.1038/315503a0; Ghezzi A, 2004, P NATL ACAD SCI USA, V101, P17276, DOI 10.1073/pnas.0405584101; Gillis KD, 2000, PFLUG ARCH EUR J PHY, V439, P655, DOI 10.1007/s004240050990; Gribkoff V K, 1997, Adv Pharmacol, V37, P319; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harris T, 2000, J BIOL CHEM, V275, P4928, DOI 10.1074/jbc.275.7.4928; HAUSDORFF WP, 1989, J BIOL CHEM, V264, P12657; Hering H, 2003, J NEUROSCI, V23, P3262; Jakab M, 2006, ACTA PHYSIOL, V187, P51, DOI 10.1111/j.1748-1716.2006.01544.x; Jakab M, 1997, J MEMBRANE BIOL, V157, P237, DOI 10.1007/PL00005895; Knott TK, 2002, MOL PHARMACOL, V62, P135, DOI 10.1124/mol.62.1.135; Kruse SW, 2003, NAT STRUCT BIOL, V10, P694, DOI 10.1038/nsb960; Latorre R, 2006, BIOL RES, V39, P385, DOI 10.4067/S0716-97602006000300003; Liu JX, 2006, NAT NEUROSCI, V9, P41, DOI 10.1038/nn1602; Liu PC, 2004, P NATL ACAD SCI USA, V101, P18217, DOI 10.1073/pnas.0406096102; Liu PC, 2003, ALCOHOL CLIN EXP RES, V27, P1640, DOI 10.1097/01.ALC.0000094756.41638.5D; LOVINGER DM, 1989, SCIENCE, V243, P1721, DOI 10.1126/science.2467382; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; Ly HV, 2004, BIOPHYS J, V87, P1013, DOI 10.1529/biophysj.103.034280; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; Martin G, 2004, J NEUROSCI, V24, P6563, DOI 10.1523/JNEUROSCI.0684-04.2004; Mascia MP, 2000, P NATL ACAD SCI USA, V97, P9305, DOI 10.1073/pnas.160128797; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; MOCZYDLOWSKI E, 1985, J MEMBRANE BIOL, V83, P273, DOI 10.1007/BF01868701; Peoples RW, 1996, ANNU REV PHARMACOL, V36, P185, DOI 10.1146/annurev.pa.36.040196.001153; Pietrzykowski AZ, 2004, J NEUROSCI, V24, P8322, DOI 10.1523/JNEUROSCI.1536-04.2004; REINHART PH, 1991, J NEUROSCI, V11, P1627; Sansom MSP, 2002, BBA-BIOMEMBRANES, V1565, P294, DOI 10.1016/S0005-2736(02)00576-X; Schuckit M A, 1993, Alcohol Alcohol Suppl, V2, P91; Shahidullah M, 2003, BIOCHEMISTRY-US, V42, P11243, DOI 10.1021/bi034738f; Vergara C, 1998, CURR OPIN NEUROBIOL, V8, P321, DOI 10.1016/S0959-4388(98)80056-1; Walters FS, 2000, AM J PHYSIOL-CELL PH, V279, pC1107, DOI 10.1152/ajpcell.2000.279.4.C1107; Yuan CB, 2004, BIOPHYS J, V86, P3620, DOI 10.1529/biophysj.103.029678; Yuan CB, 2007, J BIOL CHEM, V282, P7276, DOI 10.1074/jbc.M607593200; Zhou Y, 2002, J NEUROSCI, V22, P3855, DOI 10.1523/JNEUROSCI.22-10-03855.2002	58	34	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5090	5098		10.1074/jbc.M708214200	http://dx.doi.org/10.1074/jbc.M708214200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18084004	hybrid, Green Published, Green Accepted			2022-12-25	WOS:000253426500066
J	Sadikovic, B; Andrews, J; Carter, D; Robinson, J; Rodenhiser, DI				Sadikovic, Bekim; Andrews, Joseph; Carter, David; Robinson, John; Rodenhiser, David I.			Genome-wide H3K9 histone acetylation profiles are altered in benzopyrene-treated MCF7 breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA METHYLATION; GENE-EXPRESSION; DIOL EPOXIDE; EPIGENETICS; EXPOSURE; IMPACT; SITES; LUNG; HYPERMETHYLATION; HYPOMETHYLATION	Current toxicogenomic approaches generate transcriptional profiles that can identify functional gene expression signatures of environmental toxicants. However, the intricate processes governing transcription are overlaid with a complex set of molecular instructions involving epigenetic modifications. These commands regulate both gene expression and chromatin organization through coordinated sets of histone modifications and heritable DNA methylation patterns. Although the effects of specific environmental toxicants on gene expression are the subject of much study, the epigenetic effects of such compounds are poorly understood. Here we have used human promoter tiling arrays along with chromatin immunoprecipitation to identify changes in histone acetylation profiles because of chemical exposure. Chromatin from cells exposed to the polyaromatic hydrocarbon benzo(a) pyrene was immunoprecipitated with antibodies against acetylated histones. Affymetrix promoter tiling microarrays were probed to generate epigenomic profiles of hypo-and hyperacetylated chromatin localized to gene promoter regions. Statistical analyses, data mining, and expression studies revealed that treated cells possessed differentially acetylated gene promoter regions and gene-specific expression changes. This chromatin immunoprecipitation-on-chip approach permits genome-wide profiling of histone acetylation patterns that can identify chromatin-related signatures of environmental toxicants and potentially determine the molecular pathways these changes target. This approach also has potential applications for profiling histone modifications and DNA methylation changes during embryonic development, in cancer biology, and in the development and assessment of cancer therapeutics.	[Sadikovic, Bekim; Andrews, Joseph; Rodenhiser, David I.] London Hlth Sci Ctr, London Reg Canc Program, London, ON N6A 4L6, Canada; [Carter, David; Robinson, John; Rodenhiser, David I.] Univ Western Ontario, Childrens Hlth Res Inst, EpiGenWestern Res Grp, London, ON N6A 4L6, Canada; [Carter, David; Robinson, John] Univ Western Ontario, Robarts Res Inst, London, ON N6A 4L6, Canada; [Sadikovic, Bekim; Rodenhiser, David I.] Univ Western Ontario, Dept Biochem, London, ON N6A 4L6, Canada; [Sadikovic, Bekim; Rodenhiser, David I.] Univ Western Ontario, Dept Oncol, London, ON N6A 4L6, Canada; [Sadikovic, Bekim; Rodenhiser, David I.] Univ Western Ontario, Dept Paediat, London, ON N6A 4L6, Canada	London Health Sciences Centre; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Rodenhiser, DI (corresponding author), London Hlth Sci Ctr, London Reg Canc Program, A4-134 Victroria Res Labs,790 Commiss Rd E, London, ON N6A 4L6, Canada.	drodenhi@uwo.ca						Baskunov VB, 2005, BIOCHEMISTRY-US, V44, P1054, DOI 10.1021/bi048130y; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Butcher DT, 2004, INT J CANCER, V111, P669, DOI 10.1002/ijc.20324; Chen H, 2004, CARCINOGENESIS, V25, P1779, DOI 10.1093/carcin/bgh161; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; DIPPLE A, 1991, MUTAT RES, V259, P263, DOI 10.1016/0165-1218(91)90122-3; Esteller M, 2001, CANCER RES, V61, P3225; Esteller M, 2007, NAT REV GENET, V8, P286, DOI 10.1038/nrg2005; Fahrner JA, 2002, CANCER RES, V62, P7213; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Ghoshal K, 2006, J NUTR, V136, P1522, DOI 10.1093/jn/136.6.1522; Herceg Z, 2007, MUTAGENESIS, V22, P91, DOI 10.1093/mutage/gel068; Hu WW, 2003, BIOCHEMISTRY-US, V42, P10012, DOI 10.1021/bi034631s; Iguchi T, 2006, ENVIRON HEALTH PERSP, V114, P101, DOI 10.1289/ehp.8061; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irwin Richard D, 2004, Toxicol Pathol, V32 Suppl 1, P72, DOI 10.1080/01926230490424752; Jhaveri MS, 2001, MOL PHARMACOL, V60, P1288, DOI 10.1124/mol.60.6.1288; Jin SG, 2005, J BIOL CHEM, V280, P12700, DOI 10.1074/jbc.M413492200; Kim YI, 2005, J NUTR, V135, P2703, DOI 10.1093/jn/135.11.2703; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lettieri T, 2006, ENVIRON HEALTH PERSP, V114, P4, DOI 10.1289/ehp.8194; Mahadevan B, 2005, CANCER RES, V65, P1251, DOI 10.1158/0008-5472.CAN-04-2357; Mann DB, 1997, P NATL ACAD SCI USA, V94, P2215, DOI 10.1073/pnas.94.6.2215; Myers FA, 2001, J BIOL CHEM, V276, P20197, DOI 10.1074/jbc.M009472200; Neumann NF, 2002, BIOTECHNOL ADV, V20, P391, DOI 10.1016/S0734-9750(02)00025-3; Revel A, 2003, J APPL TOXICOL, V23, P255, DOI 10.1002/jat.916; Rodenhiser D, 2006, CAN MED ASSOC J, V174, P341, DOI 10.1503/cmaj.050774; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806; Sadikovic B, 2004, BREAST CANCER RES, V6, pR329, DOI 10.1186/bcr799; Sadikovic B, 2006, TOXICOL APPL PHARM, V216, P458, DOI 10.1016/j.taap.2006.06.012; Scherer G, 2000, CANCER EPIDEM BIOMAR, V9, P373; Schmidt CW, 2002, ENVIRON HEALTH PERSP, V110, pA750, DOI 10.1289/ehp.110-a750; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weisenberger DJ, 1999, J BIOL CHEM, V274, P23948, DOI 10.1074/jbc.274.34.23948; WILSON VL, 1983, CELL, V32, P239, DOI 10.1016/0092-8674(83)90514-7; WILSON VL, 1984, CARCINOGENESIS, V5, P1027, DOI 10.1093/carcin/5.8.1027; Yoon JH, 2001, CANCER RES, V61, P7110; Zhang N, 2005, J MOL BIOL, V346, P951, DOI 10.1016/j.jmb.2004.12.027	41	60	63	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4051	4060		10.1074/jbc.M707506200	http://dx.doi.org/10.1074/jbc.M707506200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18065415	hybrid			2022-12-25	WOS:000253083500040
J	Tan, K; Duquette, M; Liu, JH; Shanmugasundaram, K; Joachimiak, A; Gallagher, JT; Rigby, AC; Wang, JH; Lawler, J				Tan, Kemin; Duquette, Mark; Liu, Jin-huan; Shanmugasundaram, Kumaran; Joachimiak, Andrzej; Gallagher, John T.; Rigby, Alan C.; Wang, Jia-huai; Lawler, Jack			Heparin-induced cis- and trans-dimerization modes of the thrombospondin-1 N-terminal domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; MOLECULAR DIPOLE; TERNARY COMPLEX; BINDING; RECOGNITION; PROTEINS; REVEALS; GLYCOSAMINOGLYCANS; ANTITHROMBIN; INTEGRIN	Through its interactions with proteins and proteoglycans, thrombospondin-1 (TSP-1) functions at the interface of the cell membrane and the extracellular matrix to regulate matrix structure and cellular phenotype. We have previously determined the structure of the high affinity heparin-binding domain of TSP-1, designated TSPN-1, in association with the synthetic heparin, Arixtra. To establish that the binding of TSPN-1 to Arixtra is representative of the association with naturally occurring heparins, we have determined the structures of TSPN-1 in complex with heparin oligosaccharides containing eight (dp8) and ten (dp10) subunits, by x-ray crystallography. We have found that dp8 and dp10 bind to TSPN-1 in a manner similar to Arixtra and that dp8 and dp10 induce the formation of trans and cis TSPN-1 dimers, respectively. In silico docking calculations partnered with our crystal structures support the importance of arginine residues in positions 29, 42, and 77 in binding sulfate groups of the dp8 and dp10 forms of heparin. The ability of several TSPN-1 domains to bind to glycosaminoglycans simultaneously probably increases the affinity of binding through multivalent interactions. The formation of cis and trans dimers of the TSPN-1 domain with relatively short segments of heparin further enhances the ability of TSP-1 to participate in high affinity binding to glycosaminoglycans. Dimer formation may also involve TSPN-1 domains from two separate TSP-1 molecules. This association would enable glycosaminoglycans to cluster TSP-1.	[Wang, Jia-huai] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr,Dept Med,Div Mol & Vasc Med, Boston, MA 02215 USA; [Tan, Kemin; Liu, Jin-huan; Wang, Jia-huai] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Duquette, Mark; Lawler, Jack] Beth Israel Deaconess Med Ctr, Dept Pathol, Div Canc Biol & Angiogenesis, Boston, MA 02215 USA; [Tan, Kemin; Liu, Jin-huan] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lawler, Jack] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Wang, Jia-huai] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Wang, Jia-huai] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Tan, Kemin; Joachimiak, Andrzej] Argonne Natl Lab, Midwest Ctr Struct Gem & Struct Biol Ctr, Biosci Div, Argonne, IL 60439 USA; [Gallagher, John T.] Univ Manchester, Christie Hosp NHS Trust, Dept Med Oncol, Manchester M20 4BX, Lancs, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; United States Department of Energy (DOE); Argonne National Laboratory; Christie NHS Foundation Trust; Christie Hospital; University of Manchester	Rigby, AC (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Vasc Biol Res Ctr,Dept Med,Div Mol & Vasc Med, 330 Brookline Ave, Boston, MA 02215 USA.	arigby@bidmc.harvard.edu; jwang@red.dfci.harvard.edu; jlawler@bidmc.harvard.edu	Lawler, Jack/AAJ-1379-2020		NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049081, P01HL048675, R01HL068003] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL068003, HL68003, HL48675, R01 HL049081, HL49081, P01 HL048675, R01 HL049081-10] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bauer KA, 2003, CHEST, V124, p364S, DOI 10.1378/chest.124.6_suppl.364S; Bitomsky W, 1999, J AM CHEM SOC, V121, P3004, DOI 10.1021/ja983319g; Bornstein P, 2004, INT J BIOCHEM CELL B, V36, P1115, DOI 10.1016/j.biocel.2004.01.012; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Calzada MJ, 2004, CIRC RES, V94, P462, DOI 10.1161/01.RES.0000115555.05668.93; Calzada MJ, 2003, J BIOL CHEM, V278, P40679, DOI 10.1074/jbc.M302014200; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; Chen H, 2000, MATRIX BIOL, V19, P597, DOI 10.1016/S0945-053X(00)00107-4; Dementiev A, 2004, NAT STRUCT MOL BIOL, V11, P863, DOI 10.1038/nsmb810; DEPASCALIS AR, 1993, PROTEIN SCI, V2, P1126, DOI 10.1002/pro.5560020707; DiGabriele AD, 1998, NATURE, V393, P812, DOI 10.1038/31741; do Outeiro-Bernstein MAF, 2002, MATRIX BIOL, V21, P311, DOI 10.1016/S0945-053X(02)00010-0; Elzie CA, 2004, INT J BIOCHEM CELL B, V36, P1090, DOI 10.1016/j.biocel.2003.12.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 1998, CURR OPIN STRUC BIOL, V8, P578, DOI 10.1016/S0959-440X(98)80147-4; Goger B, 2002, BIOCHEMISTRY-US, V41, P1640, DOI 10.1021/bi011944j; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Greenaway J, 2007, J CELL PHYSIOL, V210, P807, DOI 10.1002/jcp.20904; Herndon ME, 1999, GLYCOBIOLOGY, V9, P143, DOI 10.1093/glycob/9.2.143; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KOPPENOL WH, 1980, BIOPHYS J, V29, P493, DOI 10.1016/S0006-3495(80)85148-4; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krieger E, 2004, PROTEINS, V54, P768, DOI 10.1002/prot.10590; Krutzsch HC, 1999, J BIOL CHEM, V274, P24080, DOI 10.1074/jbc.274.34.24080; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; LAWLER J, 1992, BIOCHEMISTRY-US, V31, P1173, DOI 10.1021/bi00119a029; Li W, 2004, NAT STRUCT MOL BIOL, V11, P857, DOI 10.1038/nsmb811; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Morris GM, 1996, J COMPUT AID MOL DES, V10, P293, DOI 10.1007/BF00124499; MULATERO C, 2003, P AM ASSOC CANC RES, V44, P1430; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; SANANTONIO JD, 1993, BIOCHEMISTRY-US, V32, P4746, DOI 10.1021/bi00069a008; Sarai A, 2005, ANNU REV BIOPH BIOM, V34, P379, DOI 10.1146/annurev.biophys.34.040204.144537; Sargiannidou I, 2004, SEMIN THROMB HEMOST, V30, P127; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Sergeev YV, 2000, BIOCHEMISTRY-US, V39, P15799, DOI 10.1021/bi001882h; Shaw JP, 2004, STRUCTURE, V12, P2081, DOI 10.1016/j.str.2004.08.014; Sinha D, 2005, BIOCHEMISTRY-US, V44, P10416, DOI 10.1021/bi050361x; Staniszewska I, 2007, CIRC RES, V100, P1308, DOI 10.1161/01.RES.0000266662.98355.66; Tan K, 2006, STRUCTURE, V14, P33, DOI 10.1016/j.str.2005.09.017; Taraboletti G, 2000, FASEB J, V14, P1674; Vives RR, 2002, BIOCHEMISTRY-US, V41, P14779, DOI 10.1021/bi026459i; Voland C, 2000, J BONE MINER RES, V15, P361, DOI 10.1359/jbmr.2000.15.2.361; Wang SX, 2004, J CELL BIOCHEM, V91, P766, DOI 10.1002/jcb.10781; WINNEMOLLER M, 1992, EUR J CELL BIOL, V59, P47; Yu HN, 2000, ARCH BIOCHEM BIOPHYS, V374, P13, DOI 10.1006/abbi.1999.1597	51	25	26	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3932	3941		10.1074/jbc.M705203200	http://dx.doi.org/10.1074/jbc.M705203200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18065761	Green Submitted, Green Accepted, hybrid			2022-12-25	WOS:000253083500027
J	Dhar, SS; Ongwijitwat, S; Wong-Riley, MTT				Dhar, Shilpa S.; Ongwijitwat, Sakkapol; Wong-Riley, Margaret T. T.			Nuclear respiratory factor 1 regulates all ten nuclear-encoded Subunits of cytochrome c oxidase in neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONTROLLING MITOCHONDRIAL BIOGENESIS; ACTIVITY-DEPENDENT REGULATION; TISSUE-SPECIFIC EXPRESSION; SPECIFYING 2 ISOFORMS; RESPIRATORY FACTOR-I; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ALZHEIMERS-DISEASE; PROMOTER ANALYSIS; FACTOR-2	Cytochrome c oxidase (COX) is one of only four bigenomic proteins in mammalian cells, having ten subunits encoded in the nuclear genome and three in the mitochondrial DNA. The mechanism of its bigenomic control is not well understood. The ten nuclear subunits are on different chromosomes, and the possibility of their coordinate regulation by the same transcription factor(s) deserves serious consideration. The present study tested our hypothesis that nuclear respiratory factor 1 (NRF-1) serves such a role in subunit coordination. Following in silico analysis of murine nuclear-encoded COX subunit promoters, electrophoretic mobility shift and supershift assays indicated NRF-1 binding to all ten promoters. In vivo chromatin immuno-precipitation assays also showed NRF-1 binding to all ten promoters in murine neuroblastoma cells. Site-directed mutagenesis of putative NRF-1 binding sites confirmed the functionality of NRF-1 binding on all ten COX promoters. These sites are highly conserved among mice, rats, and humans. Silencing of NRF-1 with RNA interference reduced all ten COX subunit mRNAs and mRNAs of other genes involved in mitochondrial biogenesis. We conclude that NRF-1 plays a significant role in coordinating the transcriptional regulation of all ten nuclear-encoded COX subunits in neurons. Moreover, NRF-1 is known to activate mitochondrial transcription factors A and B, thereby indirectly regulating the expressions of the three mitochondrial-encoded COX subunits. Thus, NRF-1 and our previously described NRF-2 prove to be the two key bigenomic coordinators for transcriptional regulation of all cytochrome c oxidase subunits in neurons. Possible interactions between the NRFs will be investigated in the future.	[Dhar, Shilpa S.; Ongwijitwat, Sakkapol; Wong-Riley, Margaret T. T.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Wong-Riley, MTT (corresponding author), Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA.	mwr@mcw.edu	Wong-Riley, Margaret/AGM-6202-2022		NATIONAL EYE INSTITUTE [R01EY005439, R01EY018441] Funding Source: NIH RePORTER; NEI NIH HHS [R01 EY05439, R01 EY018441-02, R01 EY018441, R01 EY005439] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		ARNAUDO E, 1992, GENE, V119, P299, DOI 10.1016/0378-1119(92)90287-Y; Arnold S, 1998, EUR J BIOCHEM, V252, P325, DOI 10.1046/j.1432-1327.1998.2520325.x; Arnold S, 1999, FEBS LETT, V443, P105, DOI 10.1016/S0014-5793(98)01694-9; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Bachman NJ, 1996, ARCH BIOCHEM BIOPHYS, V333, P152, DOI 10.1006/abbi.1996.0376; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; FABRIZI GM, 1992, GENE, V119, P307, DOI 10.1016/0378-1119(92)90288-Z; Frank V, 1996, FEBS LETT, V382, P121, DOI 10.1016/0014-5793(96)00096-8; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Grossman LI, 1997, BBA-GENE STRUCT EXPR, V1352, P174, DOI 10.1016/S0167-4781(97)00025-0; GUNTER TE, 1994, AM J PHYSIOL, V267, pC313, DOI 10.1152/ajpcell.1994.267.2.C313; Guo AL, 2000, J COMP NEUROL, V417, P221, DOI 10.1002/(SICI)1096-9861(20000207)417:2<221::AID-CNE7>3.0.CO;2-4; Huttemann M, 2000, BBA-GENE STRUCT EXPR, V1492, P252, DOI 10.1016/S0167-4781(00)00087-7; Huttemann M, 2003, MOL REPROD DEV, V66, P8, DOI 10.1002/mrd.10327; Huttemann M, 2003, GENE, V312, P95, DOI 10.1016/S0378-1119(03)00604-8; Huttemann M, 2001, GENE, V267, P111, DOI 10.1016/S0378-1119(01)00385-7; Jaradat SA, 1998, GENOMICS, V49, P363, DOI 10.1006/geno.1998.5279; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; KADENBACH B, 1983, ANAL BIOCHEM, V129, P517, DOI 10.1016/0003-2697(83)90586-9; Kelly DP, 2004, GENE DEV, V18, P357, DOI 10.1101/gad.1177604; Lee I, 2001, EUR J BIOCHEM, V268, P6329, DOI 10.1046/j.0014-2956.2001.02602.x; Lerman-Sagie T, 2005, MOL GENET METAB, V84, P127, DOI 10.1016/j.ymgme.2004.09.008; Li YF, 2006, J BIOENERG BIOMEMBR, V38, P283, DOI 10.1007/s10863-006-9052-z; Liang HL, 2006, NEUROSCIENCE, V140, P177, DOI 10.1016/j.neuroscience.2006.01.056; Liang HL, 2006, NEUROREPORT, V17, P401, DOI 10.1097/01.wnr.0000204980.98876.11; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig B, 2001, CHEMBIOCHEM, V2, P392, DOI 10.1002/1439-7633(20010601)2:6<392::AID-CBIC392>3.3.CO;2-E; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Napiwotzki J, 1997, BIOL CHEM, V378, P1013, DOI 10.1515/bchm.1997.378.9.1013; Nie F, 1999, J COMP NEUROL, V404, P310, DOI 10.1002/(SICI)1096-9861(19990215)404:3<310::AID-CNE3>3.0.CO;2-4; Ongwijitwat S, 2005, GENE, V360, P65, DOI 10.1016/j.gene.2005.06.015; Ongwijitwat S, 2004, GENE, V337, P163, DOI 10.1016/j.gene.2004.04.024; Ongwijitwat S, 2006, GENE, V374, P39, DOI 10.1016/j.gene.2006.01.009; Rahman S, 2001, ANN NEUROL, V49, P797, DOI 10.1002/ana.1060; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Scarpulla RC, 2002, BBA-GENE STRUCT EXPR, V1576, P1, DOI 10.1016/S0167-4781(02)00343-3; Scarpulla RC, 2006, J CELL BIOCHEM, V97, P673, DOI 10.1002/jcb.20743; Scarpulla RC, 1997, J BIOENERG BIOMEMBR, V29, P109, DOI 10.1023/A:1022681828846; Scarpulla RC, 2002, GENE, V286, P81, DOI 10.1016/S0378-1119(01)00809-5; Schmidt TR, 1997, MOL BIOL EVOL, V14, P595, DOI 10.1093/oxfordjournals.molbev.a025798; Seelan RS, 1997, J BIOL CHEM, V272, P10175, DOI 10.1074/jbc.272.15.10175; Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000; Vercauteren K, 2006, MOL CELL BIOL, V26, P7409, DOI 10.1128/MCB.00585-06; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; Wong-Riley M, 2000, GENE, V247, P63, DOI 10.1016/S0378-1119(00)00121-9; Wong-Riley M, 1997, VISION RES, V37, P3593, DOI 10.1016/S0042-6989(96)00210-6; Wong-Riley MTT, 2005, VISUAL NEUROSCI, V22, P1, DOI 10.1017/S0952523805221016; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yang SJ, 2006, NEUROSCIENCE, V141, P1181, DOI 10.1016/j.neuroscience.2006.04.063; Yang SJ, 2004, EUR J NEUROSCI, V19, P1153, DOI 10.1111/j.1460-9568.2004.03250.x; Yu M, 2002, BBA-GENE STRUCT EXPR, V1574, P345, DOI 10.1016/S0167-4781(02)00228-2; Zhang CY, 2000, EUR J NEUROSCI, V12, P1013, DOI 10.1046/j.1460-9568.2000.00997.x	55	124	131	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3120	3129		10.1074/jbc.M707587200	http://dx.doi.org/10.1074/jbc.M707587200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18077450	Green Accepted, hybrid			2022-12-25	WOS:000253083000015
J	Tu, CL; Chang, WH; Xie, ZJ; Bikle, DD				Tu, Chia-Ling; Chang, Wenhan; Xie, Zhongjian; Bikle, Daniel D.			Inactivation of the calcium sensing receptor inhibits E-cadherin-mediated cell-cell adhesion and calcium-induced differentiation in human epidermal keratinocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR-FREE CALCIUM; FYN TYROSINE KINASE; EXTRACELLULAR CALCIUM; CA2+-SENSING RECEPTOR; PHOSPHOLIPASE C-GAMMA-1; ADHERENS JUNCTIONS; FILAMIN-A; ACTIVATION; CA2+; ACTIN	Extracellular Ca2+ (Ca-o(2+)) is a critical regulator that promotes differentiation in epidermal keratinocytes. The calcium sensing receptor (CaR) is essential for mediating Ca2+ signaling during Ca-o(2+)-induced differentiation. Inactivation of the endogenous CaR-encoding gene CASR by adenoviral expression of a CaR antisense cDNA inhibited the Ca-o(2+)-induced increase in intracellular free calcium (Ca-i(2+)) and expression of terminal differentiation genes, while promoting apoptosis. Ca-o(2+) also instigates E-cadherin-mediated cell-cell adhesion, which plays a critical role in orchestrating cellular signals mediating cell survival and differentiation. Raising Ca-o(2+) concentration ([ Ca2+](o)) from 0.03 to 2 mM rapidly induced the co-localization of alpha-, beta-, and p120-catenin with E-cadherin in the intercellular adherens junctions (AJs). To assess whether CaR is required for the Ca-o(2+)-induced activation of E-cadherin signaling, we examined the impact of CaR inactivation on AJ formation. Decreased CaR expression suppressed the Ca-o(2+)-induced AJ formation, membrane translocation, and the complex formation of E-cadherin, catenins, and the phosphatidylinositol 3-kinase (PI3K), although the expression of these proteins was not affected. The assembly of the E-cadherin-catenin-PI3K complex was sensitive to the pharmacologic inhibition of Src family tyrosine kinases but was not affected by inhibition of Ca-o(2+)-induced rise in Ca-i(2+). Inhibition of CaR expression blocked the Ca-o(2+)-induced tyrosine phosphorylation of beta-, gamma-, and p120-catenin, PI3K, and the tyrosine kinase Fyn and the association of Fyn with E-cadherin and PI3K. Our results indicate that the CaR regulates cell survival and Ca-o(2+)-induced differentiation in keratinocytes at least in part by activating the E-cadherin/PI3K pathway through a Src family tyrosine kinase-mediated signaling.	[Tu, Chia-Ling; Chang, Wenhan; Xie, Zhongjian; Bikle, Daniel D.] Vet Adm Med Ctr, Endocrine Unit 111N, San Francisco, CA 94121 USA; [Tu, Chia-Ling; Chang, Wenhan; Bikle, Daniel D.] Univ Calif San Francisco, San Francisco, CA 94121 USA; [Xie, Zhongjian] No Calif Inst Res & Educ, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; Northern California Institute for Research & Education	Tu, CL (corresponding author), Vet Adm Med Ctr, Endocrine Unit 111N, 4150 Clement St, San Francisco, CA 94121 USA.	chia-ling.tu@ucsf.edu		Tu, Chia-Ling/0000-0002-7323-7733	NIAMS NIH HHS [R01-AR38386, P01-AR39448] Funding Source: Medline; NIA NIH HHS [R01-AG21353] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR039448, R01AR038386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG021353] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Awata H, 2001, J BIOL CHEM, V276, P34871, DOI 10.1074/jbc.M100775200; Bellanger JM, 2000, NAT CELL BIOL, V2, P888, DOI 10.1038/35046533; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; CALAUTTI E, 1995, GENE DEV, V9, P2279, DOI 10.1101/gad.9.18.2279; Calautti E, 1998, J CELL BIOL, V141, P1449, DOI 10.1083/jcb.141.6.1449; Eckert RL, 1997, PHYSIOL REV, V77, P397, DOI 10.1152/physrev.1997.77.2.397; Ferreira MCD, 1998, J BIOL CHEM, V273, P15192, DOI 10.1074/jbc.273.24.15192; FILVAROFF E, 1994, J BIOL CHEM, V269, P21735; Furukawa F, 1997, MICROSC RES TECHNIQ, V38, P343; FURUKAWA F, 1994, JOURNAL OF DERMATOLOGY, VOL 21, NO 11, NOVEMBER 1994, P802, DOI 10.1111/j.1346-8138.1994.tb03294.x; Handlogten ME, 2001, J BIOL CHEM, V276, P13941, DOI 10.1074/jbc.M007306200; Hjalm G, 2001, J BIOL CHEM, V276, P34880, DOI 10.1074/jbc.M100784200; Huang WT, 2004, J RARE EARTH, V22, P30; Kifor O, 2001, AM J PHYSIOL-RENAL, V280, pF291, DOI 10.1152/ajprenal.2001.280.2.F291; Komuves L, 2002, J CELL PHYSIOL, V192, P45, DOI 10.1002/jcp.10107; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; LI LW, 1995, J CELL PHYSIOL, V163, P105, DOI 10.1002/jcp.1041630112; LI LW, 1995, CELL GROWTH DIFFER, V6, P1171; Liu KP, 2003, J NEUROSCI, V23, P2049; McLachlan RW, 2007, J MOL MED-JMM, V85, P545, DOI 10.1007/s00109-007-0198-x; Oda Y, 2000, J BIOL CHEM, V275, P1183, DOI 10.1074/jbc.275.2.1183; Pang JH, 2005, J BIOL CHEM, V280, P3043, DOI 10.1074/jbc.M412148200; Perez-Moreno M, 2003, CELL, V112, P535, DOI 10.1016/S0092-8674(03)00108-9; Pi M, 2002, ENDOCRINOLOGY, V143, P3830, DOI 10.1210/en.2002-220240; PILLAI S, 1991, J CELL PHYSIOL, V146, P94, DOI 10.1002/jcp.1041460113; Pokutta S, 2007, ANNU REV CELL DEV BI, V23, P237, DOI 10.1146/annurev.cellbio.22.010305.104241; Rey O, 2005, J BIOL CHEM, V280, P22875, DOI 10.1074/jbc.M503455200; Sagi SA, 2001, J BIOL CHEM, V276, P15445, DOI 10.1074/jbc.M008961200; SHARPE GR, 1993, ARCH DERMATOL RES, V284, P445, DOI 10.1007/BF00373354; Tinkle CL, 2004, P NATL ACAD SCI USA, V101, P552, DOI 10.1073/pnas.0307437100; Tu CL, 2007, J INVEST DERMATOL, V127, P1074, DOI 10.1038/sj.jid.5700633; Tu CL, 2001, J BIOL CHEM, V276, P41079, DOI 10.1074/jbc.M107122200; Vaezi A, 2002, DEV CELL, V3, P367, DOI 10.1016/S1534-5807(02)00259-9; Wheelock MJ, 2003, CURR OPIN CELL BIOL, V15, P509, DOI 10.1016/S0955-0674(03)00101-7; Xie ZJ, 2007, J BIOL CHEM, V282, P8695, DOI 10.1074/jbc.M609135200; Xie ZJ, 2005, MOL BIOL CELL, V16, P3236, DOI 10.1091/mbc.E05-02-0109; Xie ZJ, 1999, J BIOL CHEM, V274, P20421, DOI 10.1074/jbc.274.29.20421; Young P, 2003, EMBO J, V22, P5723, DOI 10.1093/emboj/cdg560	41	100	102	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3519	3528		10.1074/jbc.M708318200	http://dx.doi.org/10.1074/jbc.M708318200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065418	Green Submitted, hybrid			2022-12-25	WOS:000253083000057
J	Garcia-Gonzalo, FR; Belmonte, JCI				Garcia-Gonzalo, Francesc R.; Izpisua Belmonte, Juan Carlos			Albumin-Associated Lipids Regulate Human Embryonic Stem Cell Self-Renewal	PLOS ONE			English	Article							DEFINED CULTURE-CONDITIONS; FIBROBLAST-GROWTH-FACTOR; PHOSPHATIDIC-ACID; DERIVATION; DIFFERENTIATION; PLURIPOTENCY; PROLIFERATION; MAINTENANCE; PATHWAYS; SURVIVAL	Background. Although human embryonic stem cells (hESCs) hold great promise as a source of differentiated cells to treat several human diseases, many obstacles still need to be surmounted before this can become a reality. First among these, a robust chemically-defined system to expand hESCs in culture is still unavailable despite recent advances in the understanding of factors controlling hESC self-renewal. Methodology/Principal Findings. In this study, we attempted to find new molecules that stimulate long term hESC self-renewal. In order to do this, we started from the observation that a commercially available serum replacement product has a strong positive effect on the expansion of undifferentiated hESCs when added to a previously reported chemically-defined medium. Subsequent experiments demonstrated that the active ingredient within the serum replacement is lipid-rich albumin. Furthermore, we show that this activity is trypsin-resistant, strongly suggesting that lipids and not albumin are responsible for the effect. Consistent with this, lipid-poor albumin shows no detectable activity. Finally, we identified the major lipids bound to the lipid-rich albumin and tested several lipid candidates for the effect. Conclusions/Significance. Our discovery of the role played by albumin-associated lipids in stimulating hESC self-renewal constitutes a significant advance in the knowledge of how hESC pluripotency is maintained by extracellular factors and has important applications in the development of increasingly chemically defined hESC culture systems.	[Garcia-Gonzalo, Francesc R.; Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Izpisua Belmonte, Juan Carlos] Ctr Regen Med Barcelona, Barcelona, Spain	Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona	Belmonte, JCI (corresponding author), Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	belmonte@salk.edu	Garcia-Gonzalo, Francesc/W-2639-2017	Garcia-Gonzalo, Francesc/0000-0002-9152-2191	Spanish Ministry of Education and Science [postdoctoral fellowship]; National Institutes of Health; G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Cellex	Spanish Ministry of Education and Science(Spanish Government); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); G. Harold and Leila Y. Mathers Charitable Foundation; Fundacion Cellex(Foundation CELLEX)	FRG-G has been supported by a postdoctoral fellowship from the Spanish Ministry of Education and Science. Work in the laboratory of JCIB was supported by grants from the National Institutes of Health, G. Harold and Leila Y. Mathers Charitable Foundation, and Fundacion Cellex.	Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brown AJ, 2005, DNA CELL BIOL, V24, P54, DOI 10.1089/dna.2005.24.54; Chase LG, 2007, CURR OPIN CHEM BIOL, V11, P367, DOI 10.1016/j.cbpa.2007.06.421; Christoforou N, 2007, PROG CARDIOVASC DIS, V49, P396, DOI 10.1016/j.pcad.2007.02.006; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Fletcher JM, 2006, CLONING STEM CELLS, V8, P319, DOI 10.1089/clo.2006.8.319; Gangaram-Panday ST, 2007, TRENDS MOL MED, V13, P164, DOI 10.1016/j.molmed.2007.02.002; Gibbons GF, 2000, BBA-MOL CELL BIOL L, V1483, P37, DOI 10.1016/S1388-1981(99)00182-1; HERINGDORF DM, 2006, BIOCHIM BIOPHYS ACTA, V1768, P923; Inniss K, 2006, STEM CELLS DEV, V15, P789, DOI 10.1089/scd.2006.15.789; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kee K, 2006, STEM CELLS DEV, V15, P831, DOI 10.1089/scd.2006.15.831; Kent C, 1999, TRENDS BIOCHEM SCI, V24, P146, DOI 10.1016/S0968-0004(99)01365-1; Kim DS, 2007, CELL TRANSPLANT, V16, P117; Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Lei T, 2007, CELL RES, V17, P682, DOI 10.1038/cr.2007.61; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; PRICE PJ, 1998, Patent No. 9830679; Pyle AD, 2006, NAT BIOTECHNOL, V24, P344, DOI 10.1038/nbt1189; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Singh AM, 2007, TRENDS CARDIOVAS MED, V17, P96, DOI 10.1016/j.tcm.2007.02.003; Skottman H, 2007, REGEN MED, V2, P265, DOI 10.2217/17460751.2.3.265; Stace CL, 2006, BBA-MOL CELL BIOL L, V1761, P913, DOI 10.1016/j.bbalip.2006.03.006; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; WANG L, 2007, BLOOD           0829; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu DC, 2007, FRONT BIOSCI-LANDMRK, V12, P4525, DOI 10.2741/2407; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103	47	114	137	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1384	10.1371/journal.pone.0001384	http://dx.doi.org/10.1371/journal.pone.0001384			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167543	Green Submitted, Green Published, gold			2022-12-25	WOS:000260468900012
J	Pai, JK; Mukamal, KJ; Rexrode, KM; Rimm, EB				Pai, Jennifer K.; Mukamal, Kenneth J.; Rexrode, Kathryn M.; Rimm, Eric B.			C-Reactive Protein (CRP) Gene Polymorphisms, CRP Levels, and Risk of Incident Coronary Heart Disease in Two Nested Case-Control Studies	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; PROMOTER REGION; BASE-LINE; INFLAMMATION; ASSOCIATION; MARKERS; PREDICTION; HAPLOTYPES; HEALTH	Background. C-reactive protein (CRP), an acute phase reactant and marker of inflammation, has been shown to predict risk of incident cardiovascular events. However, few studies have comprehensively examined six common single-nucleotide polymorphisms (SNPs) in the CRP gene, haplotypes, and plasma CRP levels with risk of coronary heart disease (CHD). Methods and Findings. We conducted parallel nested case-control studies within two ongoing, prospective cohort studies of U. S. women (Nurses' Health Study) and men (Health Professionals Follow-up Study). Blood samples were available in a subset of 32,826 women and 18,225 men for biomarker and DNA analyses. During 8 and 6 years of follow-up, 249 women and 266 men developed incident nonfatal myocardial infarction or fatal CHD, and controls (498 women, 531 men) were matched 2: 1 on age, smoking, and date of blood draw from participants free of cardiovascular disease at the time the case was diagnosed. Among both women and men, minor alleles were significantly associated with higher CRP levels for SNPs 1919A>T and 4741G>C, but associated with lower CRP levels for SNPs 2667G>C and 3872C>T. SNP 2667G>C was individually associated with increased risk of CHD in both women [OR 1.57 (95% CI 1.01-2.44); p = 0.047] and men [1.93 (95% CI 1.30-2.88); p = 0.001]. Two of the five common haplotypes were associated with lower CRP levels, and Haplotype 4 which included minor alleles for 2667 and 3872 was associated with significantly lower CRP levels and an elevated risk of CHD. The remaining SNPs or haplotypes were not associated with CHD in both populations. Conclusions. Common variation in the CRP gene was significantly associated with plasma CRP levels; however, the association between common SNPs and CRP levels did not correspond to a predicted change in CHD risk. The underlying inflammatory processes which predict coronary events cannot be captured solely by variation in the CRP gene.	[Pai, Jennifer K.; Rimm, Eric B.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Pai, Jennifer K.; Rimm, Eric B.] Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Channing Lab, Boston, MA USA; [Mukamal, Kenneth J.] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA USA; [Rexrode, Kathryn M.] Brigham & Womens Hosp, Harvard Med Sch, Dept Med, Div Prevent Med, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Pai, JK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA.	jpai@hsph.harvard.edu	Rexrode, Kathryn M/I-1177-2018; Mukamal, Kenneth/GVR-7978-2022	Rexrode, Kathryn/0000-0003-3387-8429	National Institutes of Health [HL35464, CA55075, HL34594]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034594, R01HL035464] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This study was supported by grants (HL35464, CA55075, and HL34594) from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Brull DJ, 2003, ARTERIOSCL THROM VAS, V23, P2063, DOI 10.1161/01.ATV.0000084640.21712.9C; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Colditz G A, 1995, J Am Med Womens Assoc (1972), V50, P40; Crawford DC, 2006, CIRCULATION, V114, P2458, DOI 10.1161/CIRCULATIONAHA.106.615740; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Danik JS, 2006, ANN HUM GENET, V70, P705, DOI 10.1111/j.1469-1809.2006.00272.x; de Maat MPM, 2004, CURR OPIN LIPIDOL, V15, P651, DOI 10.1097/00041433-200412000-00005; Dupuis J, 2005, ATHEROSCLEROSIS, V182, P307, DOI 10.1016/j.atherosclerosis.2005.02.015; Ford ES, 2004, CLIN CHEM, V50, P574, DOI 10.1373/clinchem.2003.027359; GABH Rose, 1982, WHO MONOGRAPH SERIES; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Kathiresan S, 2006, CIRCULATION, V113, P1415, DOI 10.1161/CIRCULATIONAHA.105.591271; Kovacs A, 2005, ATHEROSCLEROSIS, V178, P193, DOI 10.1016/j.atherosclerosis.2004.08.018; Kraft P, 2005, GENET EPIDEMIOL, V28, P261, DOI 10.1002/gepi.20061; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Ledue TB, 2003, CLIN CHEM, V49, P1258, DOI 10.1373/49.8.1258; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Luepker RV, 2003, CIRCULATION, V108, P2543, DOI 10.1161/01.CIR.0000100560.46946.EA; Miller DT, 2005, ANN HUM GENET, V69, P623, DOI 10.1111/j.1529-8817.2005.00210.x; Obisesan TO, 2004, ARTERIOSCL THROM VAS, V24, P1874, DOI 10.1161/01.ATV.0000140060.13203.22; Pai JK, 2002, CLIN CHEM, V48, P1781; Pai JK, 2004, NEW ENGL J MED, V351, P2599, DOI 10.1056/NEJMoa040967; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Pischon T, 2003, OBES RES, V11, P1055, DOI 10.1038/oby.2003.145; PRENTICE RL, 1978, BIOMETRIKA, V65, P153, DOI 10.2307/2335290; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; Russell AI, 2004, HUM MOL GENET, V13, P137, DOI 10.1093/hmg/ddh021; Suk HJ, 2005, ATHEROSCLEROSIS, V178, P139, DOI 10.1016/j.atherosclerosis.2004.07.033; Szalai AJ, 2005, J MOL MED, V83, P440, DOI 10.1007/s00109-005-0658-0; Szalai AJ, 2002, VASC PHARMACOL, V39, P105, DOI 10.1016/S1537-1891(02)00294-X; Wang QW, 2006, AM J PHYSIOL-HEART C, V291, pH2752, DOI 10.1152/ajpheart.01164.2005; Zaykin DV, 2002, HUM HERED, V53, P79, DOI 10.1159/000057986; Zee RYL, 2002, ATHEROSCLEROSIS, V162, P217, DOI 10.1016/S0021-9150(01)00703-1	37	72	81	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1395	10.1371/journal.pone.0001395	http://dx.doi.org/10.1371/journal.pone.0001395			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167554	Green Submitted, Green Published, gold			2022-12-25	WOS:000260468900023
J	Roussarie, JP; Ruffie, C; Edgar, JM; Griffiths, I; Brahic, M				Roussarie, Jean-Pierre; Ruffie, Claude; Edgar, Julia M.; Griffiths, Ian; Brahic, Michel			Axon Myelin Transfer of a Non-Enveloped Virus	PLOS ONE			English	Article								We showed previously that Theiler's virus, a neurotropic non-enveloped picornavirus of mouse, traffics from the axon of infected neurons into the surrounding myelin. When this traffic is interrupted, as in the shiverer mouse which bears a mutation in the myelin basic protein gene, the virus is unable to persist in the central nervous system. In the present work, we used the Wld(5) mutant mouse, a strain in which axonal degeneration is considerably slowed down, to show that axon to myelin traffic takes place in the absence of axon degeneration. Our results suggest the existence of a mechanism of transfer of axonal cytoplasm into the myelin which Theiler's virus might exploit to ensure its persistence.	[Roussarie, Jean-Pierre; Ruffie, Claude; Brahic, Michel] Inst Pasteur, CNRS, URA3015, Dept Virol, Paris, France; [Edgar, Julia M.; Griffiths, Ian] Univ Glasgow, Inst Comparat Med, Appl Neurobiol Grp, Glasgow, Lanark, Scotland	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Glasgow	Brahic, M (corresponding author), Stanford Univ, Sch Med, Dept Microbiol Immunol, Stanford, CA 94305 USA.	mbrahic@stanford.edu	Edgar, Julia M/U-8456-2019	Edgar, Julia M/0000-0002-3869-0962; roussarie, jean-pierre/0000-0003-2644-6046	Institut Pasteur; CNRS; ARSEP; FRM; MSS (Scotland)	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); ARSEP; FRM(Fondation pour la Recherche Medicale); MSS (Scotland)	Funding: The work was funded by the Institut Pasteur, the CNRS, the ARSEP, the FRM, the MSS (Scotland). These funders did not play any role in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Bihl F, 1997, J VIROL, V71, P5025, DOI 10.1128/JVI.71.7.5025-5030.1997; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Edgar JM, 2004, J NEUROSCI RES, V76, P593, DOI 10.1002/jnr.20063; Gatzinsky KP, 1997, GLIA, V20, P115, DOI 10.1002/(SICI)1098-1136(199706)20:2<115::AID-GLIA3>3.0.CO;2-8; GRIFFITHS IR, 1981, J NEUROCYTOL, V10, P847, DOI 10.1007/BF01262657; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Kirkegaard K, 2005, AUTOPHAGY, V1, P182, DOI 10.4161/auto.1.3.2065; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Li YC, 2005, NEUROSCI RES, V53, P298, DOI 10.1016/j.neures.2005.07.006; NOVOTNY GEK, 1984, ACTA ANAT, V119, P106; Roussarie JP, 2007, PLOS PATHOG, V3, P212, DOI 10.1371/journal.ppat.0030023; SPENCER PS, 1974, J NEUROCYTOL, V3, P763, DOI 10.1007/BF01097197	13	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1331	10.1371/journal.pone.0001331	http://dx.doi.org/10.1371/journal.pone.0001331			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159229	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459700003
J	Vitale, I; Galluzzi, L; Vivet, S; Nanty, L; Dessen, P; Senovilla, L; Olaussen, KA; Lazar, V; Prudhomme, M; Golsteyn, RM; Castedo, M; Kroemer, G				Vitale, Ilio; Galluzzi, Lorenzo; Vivet, Sonia; Nanty, Lisa; Dessen, Philippe; Senovilla, Laura; Olaussen, Ken A.; Lazar, Vladimir; Prudhomme, Michelle; Golsteyn, Roy M.; Castedo, Maria; Kroemer, Guido			Inhibition of Chk1 Kills Tetraploid Tumor Cells through a p53-Dependent Pathway	PLOS ONE			English	Article								Tetraploidy constitutes an adaptation to stress and an intermediate step between euploidy and aneuploidy in oncogenesis. Tetraploid cells are particularly resistant against genotoxic stress including radiotherapy and chemotherapy. Here, we designed a strategy to preferentially kill tetraploid tumor cells. Depletion of checkpoint kinase-1 (Chk1) by siRNAs, transfection with dominant-negative Chk1 mutants or pharmacological Chk1 inhibition killed tetraploid colon cancer cells yet had minor effects on their diploid counterparts. Chk1 inhibition abolished the spindle assembly checkpoint and caused premature and abnormal mitoses that led to p53 activation and cell death at a higher frequency in tetraploid than in diploid cells. Similarly, abolition of the spindle checkpoint by knockdown of Bub1, BubR1 or Mad2 induced p53- dependent apoptosis of tetraploid cells. Chk1 inhibition reversed the cisplatin resistance of tetraploid cells in vitro and in vivo, in xenografted human cancers. Chk1 inhibition activated p53-regulated transcripts including Puma/BBC3 in tetraploid but not in diploid tumor cells. Altogether, our results demonstrate that, in tetraploid tumor cells, the inhibition of Chk1 sequentially triggers aberrant mitosis, p53 activation and Puma/BBC3-dependent mitochondrial apoptosis.	[Vitale, Ilio; Galluzzi, Lorenzo; Vivet, Sonia; Nanty, Lisa; Senovilla, Laura; Olaussen, Ken A.; Castedo, Maria; Kroemer, Guido] INSERM, U848, Villejuif, France; [Dessen, Philippe; Lazar, Vladimir] Inst Gustave Roussy, Unite Genom Fonct, Villejuif, France; [Vitale, Ilio; Galluzzi, Lorenzo; Vivet, Sonia; Dessen, Philippe; Senovilla, Laura; Olaussen, Ken A.; Lazar, Vladimir; Castedo, Maria; Kroemer, Guido] Univ Paris Sud, Villejuif, France; [Dessen, Philippe; Lazar, Vladimir] CNRS, FRE2939, Villejuif, France; [Prudhomme, Michelle] Univ Clermont Ferrand, CNRS, UMR 6504, Aubiere, France; [Golsteyn, Roy M.] Inst Rech Servier, Croissy Sur Seine, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Servier; Institut de Recherches Internationales Servier	Kroemer, G (corresponding author), INSERM, U848, Villejuif, France.	kroemer@igr.fr	Lazar, Vladimir/AAQ-2086-2020; Galluzzi, Lorenzo/AAG-6294-2019; Galluzzi, Lorenzo/AAH-3286-2021; Galluzzi, Lorenzo/K-2709-2012; Vitale, Ilio/M-3960-2017; Lazar, Vladimir/AAV-2087-2020; Kroemer, Guido/AAY-9859-2020; Senovilla, Laura/AAX-5599-2021; Galluzzi, Lorenzo/AAG-6432-2019; KROEMER, Guido/B-4263-2013	Galluzzi, Lorenzo/0000-0003-2257-8500; Vitale, Ilio/0000-0002-5918-1841; KROEMER, Guido/0000-0002-9334-4405; Senovilla, Laura/0000-0001-6887-2436; Olaussen, Ken/0000-0002-3115-8914	Association pour la Recherche sur le Cancer; Ligue Nationale contre le cancer, Institut National du Cancer [PL06_086]; European Community; Institut Gustave Roussy	Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale contre le cancer, Institut National du Cancer(Institut National du Cancer (INCA) France); European Community(European Commission); Institut Gustave Roussy	Funding: MC is supported by Association pour la Recherche sur le Cancer. GK is supported by Ligue Nationale contre le cancer, Institut National du Cancer (N degrees PL06_086), European Community (Active p53 EC FP6 funding, RIGHT, TransDeath, Death-Train, CHEMORES), and Institut Gustave Roussy.	Andreassen PR, 2001, MOL BIOL CELL, V12, P1315, DOI 10.1091/mbc.12.5.1315; Asher G, 2003, P NATL ACAD SCI USA, V100, P15065, DOI 10.1073/pnas.2436329100; Aylon Y, 2006, GENE DEV, V20, P2687, DOI 10.1101/gad.1447006; BARRES DR, 1985, ANAL QUANT CYTOL, V7, P320; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; BJELKENKRANTZ K, 1983, ANAL QUANT CYTOL, V5, P184; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; Buhmeida A, 2002, ANTICANCER RES, V22, P2397; Castedo M, 2004, ONCOGENE, V23, P2825, DOI 10.1038/sj.onc.1207528; Castedo M, 2002, EMBO J, V21, P4070, DOI 10.1093/emboj/cdf391; Castedo M, 2006, ANN NY ACAD SCI, V1090, P35, DOI 10.1196/annals.1378.004; Castedo M, 2006, EMBO J, V25, P2584, DOI 10.1038/sj.emboj.7601127; Chen ZH, 2006, INT J CANCER, V119, P2784, DOI 10.1002/ijc.22198; Criollo A, 2007, APOPTOSIS, V12, P3, DOI 10.1007/s10495-006-0328-x; CUVELIER CA, 1987, HISTOPATHOLOGY, V11, P927, DOI 10.1111/j.1365-2559.1987.tb01899.x; Damia G, 2001, NEOPLASIA, V3, P10, DOI 10.1038/sj.neo.7900122; Duelli D, 2003, CANCER CELL, V3, P445, DOI 10.1016/S1535-6108(03)00114-4; Duelli DM, 2005, J CELL BIOL, V171, P493, DOI 10.1083/jcb.200507069; Durkin SG, 2006, ONCOGENE, V25, P4381, DOI 10.1038/sj.onc.1209466; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Furuta T, 2006, ONCOGENE, V25, P2839, DOI 10.1038/sj.onc.1209313; GALLUZZI L, 2007, APOPTOSIS; Gatei M, 2003, J BIOL CHEM, V278, P14806, DOI 10.1074/jbc.M210862200; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guerra S, 2006, J BIOL CHEM, V281, P18734, DOI 10.1074/jbc.M511983200; Heselmeyer K, 1996, P NATL ACAD SCI USA, V93, P479, DOI 10.1073/pnas.93.1.479; Incassati A, 2006, ONCOGENE, V25, P2444, DOI 10.1038/sj.onc.1209276; Lara PN, 2005, CLIN CANCER RES, V11, P4444, DOI 10.1158/1078-0432.CCR-04-2602; Levesque AA, 2005, ONCOGENE, V24, P3786, DOI 10.1038/sj.onc.1208451; Maley CC, 2004, CANCER RES, V64, P7629, DOI 10.1158/0008-5472.CAN-04-1738; Margolis RL, 2005, CANCER CELL, V8, P353, DOI 10.1016/j.ccr.2005.10.017; Nelson DA, 2004, GENE DEV, V18, P2095, DOI 10.1101/gad.1204904; Nevanlinna H, 2006, ONCOGENE, V25, P5912, DOI 10.1038/sj.onc.1209877; Niida H, 2005, J BIOL CHEM, V280, P39246, DOI 10.1074/jbc.M505009200; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Pawelek JM, 2005, LANCET ONCOL, V6, P988, DOI 10.1016/S1470-2045(05)70466-6; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Reinhardt HC, 2007, CANCER CELL, V11, P175, DOI 10.1016/j.ccr.2006.11.024; Sampath D, 2006, BLOOD, V107, P2517, DOI 10.1182/blood-2005-08-3351; Shi QH, 2005, NATURE, V437, P1038, DOI 10.1038/nature03958; Shieh SY, 2000, GENE DEV, V14, P289; Stevens C, 2003, NAT CELL BIOL, V5, P401, DOI 10.1038/ncb974; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Sugimoto M, 2006, MOL CELL BIOL, V26, P502, DOI 10.1128/MCB.26.2.502-512.2006; Syljuasen RG, 2004, CANCER RES, V64, P9035, DOI 10.1158/0008-5472.CAN-04-2434; Tang JB, 2006, P NATL ACAD SCI USA, V103, P11964, DOI 10.1073/pnas.0604987103; Tao Zhi-Fu, 2006, Anti-Cancer Agents in Medicinal Chemistry, V6, P377, DOI 10.2174/187152006777698132; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Tsuchihara K, 2005, CANCER RES, V65, P6685, DOI 10.1158/0008-5472.CAN-04-4223; VANDYKE DL, 1994, GENE CHROMOSOME CANC, V9, P192, DOI 10.1002/gcc.2870090308; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Wang X, 2006, ONCOGENE, V25, P7148, DOI 10.1038/sj.onc.1209707; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003; ZERMATI Y, 2007, MOL CELL IN PRESS; Zhao H, 2001, MOL CELL BIOL, V21, P4129, DOI 10.1128/MCB.21.13.4129-4139.2001; Zhou Bin-Bing S, 2003, Prog Cell Cycle Res, V5, P413	60	66	69	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1337	10.1371/journal.pone.0001337	http://dx.doi.org/10.1371/journal.pone.0001337			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159231	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459700005
J	Camargo, A; Azuaje, F				Camargo, Anyela; Azuaje, Francisco			Linking Gene Expression and Functional Network Data in Human Heart Failure	PLOS ONE			English	Article								Background. Gene expression profiling and the analysis of protein-protein interaction (PPI) networks may support the identification of disease bio-markers and potential drug targets. Thus, a step forward in the development of systems approaches to medicine is the integrative analysis of these data sources in specific pathological conditions. We report such an integrative bioinformatics analysis in human heart failure (HF). A global PPI network in HF was assembled, which by itself represents a useful compendium of the current status of human HF-relevant interactions. This provided the basis for the analysis of interaction connectivity patterns in relation to a HF gene expression data set. Results. Relationships between the significance of the differentiation of gene expression and connectivity degrees in the PPI network were established. In addition, relationships between gene co-expression and PPI network connectivity were analysed. Highly-connected proteins are not necessarily encoded by genes significantly differentially expressed. Genes that are not significantly differentially expressed may encode proteins that exhibit diverse network connectivity patterns. Furthermore, genes that were not defined as significantly differentially expressed may encode proteins with many interacting partners. Genes encoding network hubs may exhibit weak co-expression with the genes encoding their interacting protein partners. We also found that hubs and superhubs display a significant diversity of co-expression patterns in comparison to peripheral nodes. Gene Ontology ( GO) analysis established that highly-connected proteins are likely to be engaged in higher level GO biological process terms, while low-connectivity proteins tend to be engaged in more specific disease-related processes. Conclusion. This investigation supports the hypothesis that the integrative analysis of differential gene expression and PPI network analysis may facilitate a better understanding of functional roles and the identification of potential drug targets in human heart failure.	[Camargo, Anyela; Azuaje, Francisco] Univ Ulster, Sch Comp & Math, Jordanstown, Newtownabbey, North Ireland	Ulster University	Azuaje, F (corresponding author), Univ Ulster, Sch Comp & Math, Jordanstown, Newtownabbey, North Ireland.	fj.azuaje@ieee.org			European Union	European Union(European Commission)	This work was supported in part by a grant from the European Union (FP6), CARDIOWORKBENCH project, to FA. Public data and methodologies were used. Funders did not have any role in the design and conduct of this study.	*AHA, 2007, HEART DIS STROK STAT; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8; Fischer P, 2007, BASIC RES CARDIOL, V102, P393, DOI 10.1007/s00395-007-0674-z; Kang PM, 2000, CIRC RES, V86, P1107; KANN MG, 2007, BRIEF BIOINFORM; King JY, 2005, PHYSIOL GENOMICS, V23, P103, DOI 10.1152/physiolgenomics.00101.2005; KITTLESON MM, 2005, PHYSIOL GENOMICS, V3, P99; Lu X, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100138; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19; Niu J, 2006, CARDIOVASC RES, V71, P139, DOI 10.1016/j.cardiores.2006.03.008; Oti M, 2006, J MED GENET, V43, DOI 10.1136/jmg.2006.041376; Peri S, 2003, GENOME RES, V13, P2363, DOI 10.1101/gr.1680803; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Tan FL, 2002, P NATL ACAD SCI USA, V99, P11387, DOI 10.1073/pnas.162370099; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wang MJ, 2007, AM J PHYSIOL-HEART C, V292, pH1694, DOI 10.1152/ajpheart.01063.2006; Watanabe Tetsuya, 2004, Nihon Rinsho, V62, P2337; Wittchen F, 2007, J MOL MED, V85, P253, DOI 10.1007/s00109-006-0122-9; Xu JZ, 2006, BIOINFORMATICS, V22, P2800, DOI 10.1093/bioinformatics/btl467	22	33	35	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1347	10.1371/journal.pone.0001347	http://dx.doi.org/10.1371/journal.pone.0001347			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094754	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459600029
J	Spassova, MA; Hewavitharana, T; Fandino, RA; Kaya, A; Tanaka, J; Gill, DL				Spassova, Maria A.; Hewavitharana, Tharnara; Fandino, Richard A.; Kaya, Asli; Tanaka, Jacqueline; Gill, Donald L.			Voltage gating at the selectivity filter of the Ca2+ release-activated Ca2+ channel induced by mutation of the orai1 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STROMAL INTERACTION MOLECULE-1; CURRENT I-CRAC; CA2+-SELECTIVE ARC CHANNELS; BASOPHILIC LEUKEMIA-CELLS; OPERATED CALCIUM-CHANNEL; RECTIFIER K+ CHANNEL; PLASMA-MEMBRANE; STORE DEPLETION; STIM1; ENTRY	The Ca2+ release-activated Ca2+ (CRAC) channel is a plasma membrane (PM) channel that is uniquely activated when free Ca2+ level in the endoplasmic reticulum (ER) is substantially reduced. Several small interfering RNA screens identified two membrane proteins, Orai1 and STIM1, to be essential for the CRAC channel function. STIM1 appears to function in the PM and as the Ca2+ sensor in the ER. Orai1 is forming the pore of the CRAC channel. Despite the recent breakthroughs, a mechanistic understanding of the CRAC channel gating is still lacking. Here we reveal new insights on the structure-function relationship of STIM1 and Orai1. Our data suggest that the cytoplasmic coiled-coil region of STIM1 provides structural means for coupling of the ER membrane to the PM to activate the CRAC channel. We mutated two hydrophobic residues in this region to proline (L286P/L292P) to introduce a kink in the first a-helix of the coiled-coil domain. This STIM1 mutant caused a dramatic inhibition of the CRAC channel gating compared with the wild type. Structure-function analysis of the Orai1 protein revealed the presence of intrinsic voltage gating of the CRAC channel. A mutation of Orai1 (V102I) close to the selectivity filter modified CRAC channel voltage sensitivity. Expression of the Orai1(VI02I) mutant resulted in slow voltage gating of the CRAC channel by negative potentials. The results revealed that the alteration of Val(102) develops voltage gating in the CRAC channel. Our data strongly suggest the presence of a novel voltage gating mechanism at the selectivity filter of the CRAC channel.	[Spassova, Maria A.; Fandino, Richard A.; Kaya, Asli; Tanaka, Jacqueline] Temple Univ, Dept Biol, Coll Sci & Technol, Philadelphia, PA 19122 USA; [Hewavitharana, Tharnara; Gill, Donald L.] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University System of Maryland; University of Maryland Baltimore	Spassova, MA (corresponding author), Temple Univ, Dept Biol, Coll Sci & Technol, 1900 N 12th St, Philadelphia, PA 19122 USA.	spassova@temple.edu		Fandino, Richard A./0000-0003-2442-2681	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI058173] Funding Source: NIH RePORTER; NIAID NIH HHS [AI 058173] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bakowski D, 2002, PFLUG ARCH EUR J PHY, V443, P892, DOI 10.1007/s00424-001-0775-8; Bakowski D, 2000, J PHYSIOL-LONDON, V529, P295, DOI 10.1111/j.1469-7793.2000.00295.x; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P319, DOI 10.1038/nsmb1070; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Guo DL, 2000, J GEN PHYSIOL, V116, P561, DOI 10.1085/jgp.116.4.561; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hauser CT, 2007, P NATL ACAD SCI USA, V104, P3693, DOI 10.1073/pnas.0611713104; Hermosura MC, 2002, J PHYSIOL-LONDON, V539, P445, DOI 10.1113/jphysiol.2001.013361; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liou J, 2007, P NATL ACAD SCI USA, V104, P9301, DOI 10.1073/pnas.0702866104; Lis A, 2007, CURR BIOL, V17, P794, DOI 10.1016/j.cub.2007.03.065; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Mignen O, 2008, J PHYSIOL-LONDON, V586, P185, DOI 10.1113/jphysiol.2007.146258; Mignen O, 2007, J PHYSIOL-LONDON, V579, P703, DOI 10.1113/jphysiol.2006.122432; NEHER E, 1992, METHOD ENZYMOL, V207, P123; Parekh AB, 1997, PHYSIOL REV, V77, P901, DOI 10.1152/physrev.1997.77.4.901; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Patel KA, 2005, INVEST OPHTH VIS SCI, V46, P2282, DOI 10.1167/iovs.05-0179; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Prakriya M, 2003, CELL CALCIUM, V33, P311, DOI 10.1016/S0143-4160(03)00045-9; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Talley EM, 2003, NEUROSCIENTIST, V9, P46, DOI 10.1177/1073858402239590; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2002, BBA-PROTEIN STRUCT M, V1596, P131, DOI 10.1016/S0167-4838(02)00211-X; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yeromin AV, 2004, J GEN PHYSIOL, V123, P167, DOI 10.1085/jgp.200308982; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1995, J GEN PHYSIOL, V105, P209, DOI 10.1085/jgp.105.2.209	41	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 30	2008	283	22					14938	14945		10.1074/jbc.M702208200	http://dx.doi.org/10.1074/jbc.M702208200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	306EV	18096706	Green Published, hybrid			2022-12-25	WOS:000256232000005
J	Karcher, A; Schele, A; Hopfner, KP				Karcher, Annette; Schele, Alexandra; Hopfner, Karl-Peter			X-ray structure of the complete ABC enzyme ABCE1 from Pyrococcus abyssi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPAIR PROTEIN MUTS; RNASE-L-INHIBITOR; ATP-BINDING; CRYSTAL-STRUCTURE; RESOLUTION STRUCTURES; BIOGENESIS; MISMATCH; TRANSLATION; FERREDOXIN; MECHANISM	The ATP binding cassette enzyme ABCE1 (also known as RNase-L (ribonuclease L) inhibitor, Pixie, and HP68), one of the evolutionary most sequence-conserved enzymes, functions in translation initiation, ribosome biogenesis, and human immunodeficiency virus capsid assembly. However, its structural mechanism and biochemical role in these processes have not been revealed. We determined the crystal structure of Pyrococcus abyssi ABCE1 in complex with Mg2+ and ADP to 2.8 angstrom resolution. ABCE1 consists of four structural domains. Two nucleotide binding domains are arranged in a head-to-tail orientation by a hinge domain, suggesting that these domains undergo the characteristic tweezers-like powerstroke of ABC enzymes. In contrast to all other known ABC enzymes, ABCE1 has a N-terminal iron-sulfur-cluster (FeS) domain. The FeS domain contains two [4Fe-4S] clusters and is structurally highly related to bacterial-type ferredoxins. However, one cluster is coordinated by an unusual CX4CX3/4C triad. Surprisingly, intimate interactions of the FeS domain with the adenine and ribose binding Y-loop on nucleotide binding domain 1 suggest a linkage between FeS domain function and ATP-induced conformational control of the ABC tandem cassette. The structure substantially expands the functional architecture of ABC enzymes and raises the possibility that ABCE1 is a chemomechanical engine linked to a redox process.	[Karcher, Annette; Schele, Alexandra; Hopfner, Karl-Peter] Univ Munich, Ctr Integrated Prot Sci, D-81377 Munich, Germany; Univ Munich, Ctr Adv Photon Gene Ctr, D-81377 Munich, Germany	University of Munich; University of Munich	Hopfner, KP (corresponding author), Univ Munich, Ctr Integrated Prot Sci, Feodor Lynen Str 25, D-81377 Munich, Germany.	hopfner@lmb.uni-muenchen.de	Hopfner, Karl-Peter/B-6864-2014	Hopfner, Karl-Peter/0000-0002-4528-8357				Acharya S, 2003, MOL CELL, V12, P233, DOI 10.1016/S1097-2765(03)00219-3; Andersen CBF, 2006, NATURE, V443, P663, DOI 10.1038/nature05126; Andersen DS, 2007, J BIOL CHEM, V282, P14752, DOI 10.1074/jbc.M701361200; [Anonymous], 2003, ABC PROTEINS BACTERI; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barthelme D, 2007, J BIOL CHEM, V282, P14598, DOI 10.1074/jbc.M700825200; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; Bisbal C, 2000, METH MOL B, V160, P183; Boal AK, 2005, BIOCHEMISTRY-US, V44, P8397, DOI 10.1021/bi047494n; Braz ASK, 2004, J MOL EVOL, V59, P20, DOI 10.1007/s00239-004-2600-4; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen J, 2003, MOL CELL, V12, P651, DOI 10.1016/j.molcel.2003.08.004; Chen ZQ, 2006, J BIOL CHEM, V281, P7452, DOI 10.1074/jbc.M510603200; Coelho CMA, 2005, DEVELOPMENT, V132, P5411, DOI 10.1242/dev.02148; Cupp-Vickery JR, 2003, J MOL BIOL, V330, P1049, DOI 10.1016/S0022-2836(03)00690-9; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dobritzsch D, 2001, EMBO J, V20, P650, DOI 10.1093/emboj/20.4.650; Dong JS, 2004, J BIOL CHEM, V279, P42157, DOI 10.1074/jbc.M404502200; Estevez AM, 2004, MOL BIOCHEM PARASIT, V133, P137, DOI 10.1016/j.molbiopara.2003.09.009; Fritz G, 2002, P NATL ACAD SCI USA, V99, P1836, DOI 10.1073/pnas.042664399; Fukuyama K, 2002, J MOL BIOL, V315, P1155, DOI 10.1006/jmbi.2001.5292; Giastas P, 2006, J BIOL INORG CHEM, V11, P445, DOI 10.1007/s00775-006-0094-9; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993; Hopfner KP, 2000, CELL, V101, P789, DOI 10.1016/S0092-8674(00)80890-9; Hopfner KP, 2003, CURR OPIN STRUC BIOL, V13, P249, DOI 10.1016/S0959-440X(03)00037-X; Hung LW, 1998, NATURE, V396, P703, DOI 10.1038/25393; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Junop MS, 2001, MOL CELL, V7, P1, DOI 10.1016/S1097-2765(01)00149-6; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Karcher A, 2005, STRUCTURE, V13, P649, DOI 10.1016/j.str.2005.02.008; Kerr ID, 2004, BIOCHEM BIOPH RES CO, V315, P166, DOI 10.1016/j.bbrc.2004.01.044; Kispal G, 2005, EMBO J, V24, P589, DOI 10.1038/sj.emboj.7600541; Kriek M, 2003, PROTEIN EXPRES PURIF, V28, P241, DOI 10.1016/S1046-5928(02)00680-0; KUO CF, 1992, SCIENCE, V258, P434, DOI 10.1126/science.1411536; Kyritsis P, 1998, J BIOL CHEM, V273, P15404, DOI 10.1074/jbc.273.25.15404; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142; Locher KP, 2004, CURR OPIN STRUC BIOL, V14, P426, DOI 10.1016/j.sbi.2004.06.005; Obmolova G, 2000, NATURE, V407, P703, DOI 10.1038/35037509; Porello SL, 1998, BIOCHEMISTRY-US, V37, P6465, DOI 10.1021/bi972433t; Rees DC, 2003, SCIENCE, V300, P929, DOI 10.1126/science.1083075; Schmitt L, 2002, CURR OPIN STRUC BIOL, V12, P754, DOI 10.1016/S0959-440X(02)00399-8; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Sticht H, 1998, PROG BIOPHYS MOL BIO, V70, P95, DOI 10.1016/S0079-6107(98)00027-3; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; TURCK D, 1992, THESIS TECHNICAL U M; Tyzack JK, 2000, J BIOL CHEM, V275, P34131, DOI 10.1074/jbc.M002868200; van der Does C, 2004, BIOL CHEM, V385, P927, DOI 10.1515/BC.2004.121; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Yarunin A, 2005, EMBO J, V24, P580, DOI 10.1038/sj.emboj.7600540; Zhao ZY, 2004, BIOCHEM BIOPH RES CO, V323, P104, DOI 10.1016/j.bbrc.2004.08.068; Zimmerman C, 2002, NATURE, V415, P88, DOI 10.1038/415088a	54	68	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7962	7971		10.1074/jbc.M707347200	http://dx.doi.org/10.1074/jbc.M707347200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18160405	hybrid, Green Published			2022-12-25	WOS:000253997900071
J	Cunningham, LA; Kahn, RA				Cunningham, Leslie A.; Kahn, Richard A.			Cofactor D functions as a centrosomal protein and is required for the recruitment of the gamma-tubulin ring complex at centrosomes and organization of the mitotic spindle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FISSION YEAST; BETA-TUBULIN; MICROTUBULE CYTOSKELETON; CENTRIOLE DUPLICATION; MAMMALIAN-CELLS; ANIMAL-CELLS; MITOSIS; ARL2; MUTANTS; PATHWAY	Microtubules are highly dynamic structures, composed of alpha/beta-tubulin heterodimers. Biosynthesis of the functional dimer involves the participation of several chaperones, termed cofactors A-E, that act on folding intermediates downstream of the cytosolic chaperonin CCT ( 1, 2). We show that cofactor D is also a centrosomal protein and that overexpression of either the full-length protein or either of two centrosome localization domains leads to the loss of anchoring of the gamma-tubulin ring complex and of nucleation of microtubule growth at centrosomes. In contrast, depletion of cofactor D by short interfering RNA results in mitotic spindle defects. Because none of these changes in cofactor D activity produced a change in the levels of alpha- or beta-tubulin, we conclude that these newly discovered functions for cofactor D are distinct from its previously described role in tubulin folding. Thus, we describe a new role for cofactor D at centrosomes that is important to its function in polymerization of tubulin and organization of the mitotic spindle.	[Kahn, Richard A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Biochem Cell & Dev Biol Program, Atlanta, GA 30322 USA	Emory University; Emory University	Kahn, RA (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd, Atlanta, GA 30322 USA.	rkahn@emory.edu	Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601	NIGMS NIH HHS [GM-68029, R01 GM090158] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068029] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abal M, 2005, BIOL CELL, V97, P425, DOI 10.1042/BC20040112; BARON AT, 1992, BIOL CELL, V76, P383, DOI 10.1016/0248-4900(92)90442-4; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bicknell AB, 2001, CELL, V105, P903, DOI 10.1016/S0092-8674(01)00403-2; Blagden SP, 2003, NAT CELL BIOL, V5, P505, DOI 10.1038/ncb0603-505; DIRKSEN ER, 1991, BIOL CELL, V72, P31, DOI 10.1016/0248-4900(91)90075-X; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Efimov A, 2007, DEV CELL, V12, P917, DOI 10.1016/j.devcel.2007.04.002; Ehrhardt AG, 2005, J CELL PHYSIOL, V204, P808, DOI 10.1002/jcp.20335; Fava F, 1999, J CELL BIOL, V147, P857, DOI 10.1083/jcb.147.4.857; Fedyanina OS, 2006, CURR GENET, V50, P281, DOI 10.1007/s00294-006-0095-9; Follit JA, 2006, MOL BIOL CELL, V17, P3781, DOI 10.1091/mbc.E06-02-0133; GAO YI, 1993, MOL CELL BIOL, V13, P2478, DOI 10.1128/MCB.13.4.2478; Gonzalez MA, 2006, GENE DEV, V20, P1880, DOI 10.1101/gad.379706; Grishchuk EL, 1998, GENETICS, V149, P1251; Grynberg M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-46; Hannak E, 2002, J CELL BIOL, V157, P591, DOI 10.1083/jcb.200202047; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Hirata D, 1998, EMBO J, V17, P658, DOI 10.1093/emboj/17.3.658; HOYT MA, 1990, MOL CELL BIOL, V10, P223, DOI 10.1128/MCB.10.1.223; Hsu LC, 1998, P NATL ACAD SCI USA, V95, P12983, DOI 10.1073/pnas.95.22.12983; Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Kojima SI, 2004, BIOTECHNIQUES, V36, P74, DOI 10.2144/04361ST02; Li YW, 2004, FASEB J, V18, P1834, DOI 10.1096/fj.04-2273com; Liu CM, 1998, PLANT J, V16, P21, DOI 10.1046/j.1365-313x.1998.00268.x; Liu LA, 1999, J BIOL CHEM, V274, P38171, DOI 10.1074/jbc.274.53.38171; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Martin L, 2000, FEBS LETT, V470, P93, DOI 10.1016/S0014-5793(00)01293-X; Mayer U, 1999, EUR J CELL BIOL, V78, P100, DOI 10.1016/S0171-9335(99)80011-9; Meraldi P, 2002, EMBO J, V21, P483, DOI 10.1093/emboj/21.4.483; Murphy SM, 2001, MOL BIOL CELL, V12, P3340, DOI 10.1091/mbc.12.11.3340; Murphy SM, 1998, J CELL BIOL, V141, P663, DOI 10.1083/jcb.141.3.663; Nolasco S, 2005, FEBS LETT, V579, P3515, DOI 10.1016/j.febslet.2005.05.022; Oshimori N, 2006, NAT CELL BIOL, V8, P1095, DOI 10.1038/ncb1474; Paoletti A, 1996, J CELL SCI, V109, P3089; Piel M, 2001, SCIENCE, V291, P1550, DOI 10.1126/science.1057330; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; Shultz T, 2008, FASEB J, V22, P168, DOI 10.1096/fj.06-7786com; STEARNS T, 1990, GENETICS, V124, P251; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1996, CELL, V86, P287, DOI 10.1016/S0092-8674(00)80100-2; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; Volpicelli-Daley LA, 2005, MOL BIOL CELL, V16, P4495, DOI 10.1091/mbc.E04-12-1042; Zhou CJ, 2006, MOL BIOL CELL, V17, P2476, DOI 10.1091/mbc.E05-10-0929; Zimmerman WC, 2004, MOL BIOL CELL, V15, P3642, DOI 10.1091/mbc.E03-11-0796	51	30	30	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7155	7165		10.1074/jbc.M706753200	http://dx.doi.org/10.1074/jbc.M706753200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18171676	hybrid			2022-12-25	WOS:000253779600061
J	Dutertre, S; Croker, D; Daly, NL; Andersson, A; Muttenthaler, M; Lumsden, NG; Craik, DJ; Alewood, PF; Guillon, G; Lewis, RJ				Dutertre, Sebastien; Croker, Daniel; Daly, Norelle L.; Andersson, Asa; Muttenthaler, Markus; Lumsden, Natalie G.; Craik, David J.; Alewood, Paul F.; Guillon, Gilles; Lewis, Richard J.			Conopressin-T from Conus tulipa reveals an antagonist switch in vasopressin-like peptides	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-VASOPRESSIN; OXYTOCIN RECEPTOR; VASOTOCIN; VENOM; CONOTOXINS; PHYSIOLOGY; EVOLUTION; HORMONE; PROGRAM; AGONIST	We report the discovery of conopressin-T, a novel bioactive peptide isolated from Conus tulipa venom. Conopressin-T belongs to the vasopressin- like peptide family and displays high sequence homology to the mammalian hormone oxytocin ( OT) and to vasotocin, the endogenous vasopressin analogue found in teleost fish, the cone snail's prey. Conopressin-T was found to act as a selective antagonist at the human V-1a receptor. All peptides in this family contain two conserved amino acids within the exocyclic tripeptide ( Pro(7) and Gly(9)), which are replaced with Leu(7) and Val(9) in conopressin-T. Whereas conopressin-T binds only to OT and V-1a receptors, an L7P analogue had increased affinity for the V-1a receptor and weak V-2 receptor binding. Surprisingly, replacing Gly(9) with Val(9) in OT and vasopressin revealed that this position can function as an agonist/ antagonist switch at the V-1a receptor. NMR structures of both conopressin-T and L7P analogue revealed a marked difference in the orientation of the exocyclic tripeptide that may serve as templates for the design of novel ligands with enhanced affinity for the V-1a receptor.	[Dutertre, Sebastien; Daly, Norelle L.; Muttenthaler, Markus; Lumsden, Natalie G.; Craik, David J.; Alewood, Paul F.; Lewis, Richard J.] Univ Queensland, Inst Mol Biol, Brisbane, Qld 4072, Australia; [Croker, Daniel; Andersson, Asa] Xenome Ltd, Brisbane, Qld 4072, Australia; [Guillon, Gilles] CNRS, UMR 5203, F-34094 Montpellier, France; [Guillon, Gilles] Inst Genom Fonctionnelle, Dept Endocrinol, F-34094 Montpellier, France; [Guillon, Gilles] INSERM, U 661, F-34094 Montpellier, France; [Guillon, Gilles] Univ Montpellier, F-34094 Montpellier, France	University of Queensland; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Lewis, RJ (corresponding author), Univ Queensland, Inst Mol Biol, Brisbane, Qld 4072, Australia.	r.lewis@imb.uq.edu.au	Lewis, Richard/T-8763-2019; Craik, David/B-1695-2010; Lewis, Richard J/E-8674-2013; Daly, Norelle L/D-4302-2013; Muttenthaler, Markus/AAF-5944-2021; Alewood, Paul F/J-2412-2014; Muttenthaler, Markus/B-4944-2017; Croker, Daniel/N-7134-2013	Lewis, Richard/0000-0003-3470-923X; Craik, David/0000-0003-0007-6796; Lewis, Richard J/0000-0003-3470-923X; Daly, Norelle L/0000-0002-4697-6602; Muttenthaler, Markus/0000-0003-1996-4646; Muttenthaler, Markus/0000-0003-1996-4646; Croker, Daniel/0000-0001-9533-4019; Dutertre, Sebastien/0000-0002-2945-1484; Alewood, Paul/0000-0001-7454-6522				ADEYEMO OM, 1991, TOXICOL APPL PHARM, V108, P489, DOI 10.1016/0041-008X(91)90095-V; Balment RJ, 2006, GEN COMP ENDOCR, V147, P9, DOI 10.1016/j.ygcen.2005.12.022; Barberis C, 1998, J ENDOCRINOL, V156, P223, DOI 10.1677/joe.0.1560223; Birnbaumer M, 2000, TRENDS ENDOCRIN MET, V11, P406, DOI 10.1016/S1043-2760(00)00304-0; Brunger AT, 1997, STRUCTURE, V5, P325, DOI 10.1016/S0969-2126(97)00190-1; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Chini B, 1996, FEBS LETT, V397, P201, DOI 10.1016/S0014-5793(96)01135-0; CRUZ LJ, 1987, J BIOL CHEM, V262, P15821; Daly NL, 2004, J BIOL CHEM, V279, P25774, DOI 10.1074/jbc.M313002200; Derick S, 2002, ENDOCRINOLOGY, V143, P4655, DOI 10.1210/en.2002-220363; Dutertre S, 2006, FEBS LETT, V580, P3860, DOI 10.1016/j.febslet.2006.06.011; Egashira N, 2004, NEUROSCI LETT, V356, P195, DOI 10.1016/j.neulet.2003.11.050; ELANDS J, 1988, EUR J PHARMACOL, V147, P197, DOI 10.1016/0014-2999(88)90778-9; Febo M, 2005, J NEUROSCI, V25, P11637, DOI 10.1523/JNEUROSCI.3604-05.2005; Ferris CF, 2006, PHARMACOL BIOCHEM BE, V83, P169, DOI 10.1016/j.pbb.2006.01.001; Fry BG, 2005, GENOME RES, V15, P403, DOI 10.1101/gr.3228405; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Hiroyama M, 2007, EUR J PHARMACOL, V559, P89, DOI 10.1016/j.ejphar.2006.12.010; Hoyle CHV, 1999, BRAIN RES, V848, P1, DOI 10.1016/S0006-8993(99)01975-7; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; Kozorovitskiy Y, 2006, NAT NEUROSCI, V9, P1094, DOI 10.1038/nn1753; KRUSZYNSKI M, 1990, EXPERIENTIA, V46, P771, DOI 10.1007/BF01939964; LARIVE CK, 1992, J AM CHEM SOC, V114, P7331, DOI 10.1021/ja00045a001; Larson ET, 2006, BEHAV BRAIN RES, V167, P94, DOI 10.1016/j.bbr.2005.08.020; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lewis RJ, 2000, J BIOL CHEM, V275, P35335, DOI 10.1074/jbc.M002252200; Linge JP, 1999, J BIOMOL NMR, V13, P51, DOI 10.1023/A:1008365802830; MAHLMANN S, 1994, P NATL ACAD SCI USA, V91, P1342, DOI 10.1073/pnas.91.4.1342; MCMASTER D, 1992, PEPTIDES, V13, P413, DOI 10.1016/0196-9781(92)90069-F; Moller C, 2007, BIOCHEM J, V404, P413, DOI 10.1042/BJ20061480; NIELSEN DB, 1994, TOXICON, V32, P845, DOI 10.1016/0041-0101(94)90009-4; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; SALZET M, 1993, EUR J BIOCHEM, V217, P897, DOI 10.1111/j.1432-1033.1993.tb18319.x; SCHNOLZER M, 1992, INT J PEPT PROT RES, V40, P180; Treschan TA, 2006, ANESTHESIOLOGY, V105, P599, DOI 10.1097/00000542-200609000-00026; VANKESTEREN RE, 1995, J NEUROSCI, V15, P5989; Windt WAKM, 2006, J RENIN-ANGIO-ALDO S, V7, P217, DOI 10.3317/jraas.2006.041; Wittelsberger A, 2005, J MED CHEM, V48, P6553, DOI 10.1021/jm049205z; Wuthrich K, 1986, NMR PROTEINS NUCL AC	39	65	73	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7100	7108		10.1074/jbc.M706477200	http://dx.doi.org/10.1074/jbc.M706477200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18174156	Green Published, hybrid			2022-12-25	WOS:000253779600055
J	Kruit, JK; Drayer, AL; Bloks, VW; Blom, N; Olthof, SG; Sauer, PJJ; De Haan, G; Kema, IP; Vellenga, E; Kuipers, F				Kruit, Janine K.; Drayer, A. Lyndsay; Bloks, Vincent W.; Blom, Nel; Olthof, Sandra G.; Sauer, Pieter J. J.; De Haan, Gerald; Kema, Ido P.; Vellenga, Edo; Kuipers, Folkert			Plant sterols cause macrothrombocytopenia in a mouse model of sitosterolemia	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVER-X-RECEPTOR; CHOLESTEROL ABSORPTION; DIETARY-CHOLESTEROL; BETA-SITOSTEROLEMIA; ABCG5; MICE; ACTIVATION; XANTHOMATOSIS; TRANSPORTER; EZETIMIBE	Mutations in either ABCG5 or ABCG8 cause sitosterolemia, an inborn error of metabolism characterized by high plasma plant sterol concentrations. Recently, macrothrombocytopenia was described in a number of sitosterolemia patients, linking hematological dysfunction to disturbed sterol metabolism. Here, we demonstrate that macrothrombocytopenia is an intrinsic feature of murine sitosterolemia. Abcg5-deficient (Abcg5(-/-)) mice showed a 68% reduction in platelet count, and platelets were enlarged compared with wild-type controls. Macrothrombocytopenia was not due to decreased numbers of megakaryocytes or their progenitors, but defective megakaryocyte development with deterioration of the demarcation membrane system was evident. Lethally irradiated wild-type mice transplanted with bone marrow from Abcg5(-/-) mice displayed normal platelets, whereas Abcg5(-/-) mice transplanted with wild-type bone marrow still showed macrothrombocytopenia. Treatment with the sterol absorption inhibitor ezetimibe rapidly reversed macrothrombocytopenia in Abcg5(-/-) mice concomitant with a strong decrease in plasma plant sterols. Thus, accumulation of plant sterols is responsible for development of macrothrombocytopenia in sitosterolemia, and blocking intestinal plant sterol absorption provides an effective means of treatment.	[Kruit, Janine K.; Bloks, Vincent W.; Sauer, Pieter J. J.; Kuipers, Folkert] Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9713 GZ Groningen, Netherlands; [Drayer, A. Lyndsay] Sanquin Blood Bank, NL-9713 GZ Groningen, Netherlands; [Kema, Ido P.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, NL-9713 GZ Groningen, Netherlands; [De Haan, Gerald] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Stem Cell Biol, NL-9713 GZ Groningen, Netherlands; [Blom, Nel; Olthof, Sandra G.; Vellenga, Edo] Univ Groningen, Univ Med Ctr Groningen, Dept Hematol, NL-9713 GZ Groningen, Netherlands; [Blom, Nel] Univ Groningen, Univ Med Ctr Groningen, Dept Cell Biol, Sect Elect Microscopy, NL-9713 GZ Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; University of Groningen	Kuipers, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Liver Digest & Metab Dis, Dept Pediat, NL-9713 GZ Groningen, Netherlands.	kuipers@med.umcg.nl	de Haan, Gerald/AAF-8963-2019; Kruit, Janine/AGI-8582-2022; Bloks, Vincent/A-7609-2012; de Haan, Gerald/D-2081-2015	de Haan, Gerald/0000-0001-9706-0138; Kruit, Janine/0000-0002-5414-0485; Bloks, Vincent/0000-0001-6493-7482; de Haan, Gerald/0000-0001-9706-0138; Kuipers, Folkert/0000-0003-2518-737X				Berge KE, 2000, SCIENCE, V290, P1771, DOI 10.1126/science.290.5497.1771; BERGER GMB, 1994, POSTGRAD MED J, V70, P631, DOI 10.1136/pgmj.70.827.631; BHATTACHARYYA AK, 1974, J CLIN INVEST, V53, P1033, DOI 10.1172/JCI107640; CLAYTON PT, 1993, GASTROENTEROLOGY, V105, P1806, DOI 10.1016/0016-5085(93)91079-W; Davis HR, 2004, J BIOL CHEM, V279, P33586, DOI 10.1074/jbc.M405817200; Dieter MZ, 2004, COMP BIOCHEM PHYS C, V139, P209, DOI 10.1016/j.cca.2004.11.002; GOULET O, 1986, JPEN-PARENTER ENTER, V10, P284, DOI 10.1177/0148607186010003284; Graf GA, 2002, J CLIN INVEST, V110, P659, DOI 10.1172/JCI200216000; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Halling KK, 2004, BBA-BIOMEMBRANES, V1664, P161, DOI 10.1016/j.bbamem.2004.05.006; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Houwerzijl EJ, 2004, BLOOD, V103, P500, DOI 10.1182/blood-2003-01-0275; Igel M, 2003, J LIPID RES, V44, P533, DOI 10.1194/jlr.M200393-JLR200; ISCOVE NN, 1975, EXP HEMATOL, V3, P32; Kaushansky K, 2002, ONCOGENE, V21, P3359, DOI 10.1038/sj.onc.1205323; Kruit JK, 2005, GASTROENTEROLOGY, V128, P147, DOI 10.1053/j.gastro.2004.10.006; KUKSIS A, 1976, LIPIDS, V11, P581, DOI 10.1007/BF02532869; Lee MH, 2001, NAT GENET, V27, P79, DOI 10.1038/83799; LEIKIN AI, 1989, BIOCHIM BIOPHYS ACTA, V1005, P187, DOI 10.1016/0005-2760(89)90186-0; Louwes H, 1999, AM J MED, V106, P430, DOI 10.1016/S0002-9343(99)00054-6; Lu KM, 2001, AM J HUM GENET, V69, P278, DOI 10.1086/321294; Mahaut-Smith MP, 2003, BIOPHYS J, V84, P2646, DOI 10.1016/S0006-3495(03)75070-X; Manning KL, 1996, LAB ANIM SCI, V46, P545; MIETTINEN TA, 1995, NEW ENGL J MED, V333, P1308, DOI 10.1056/NEJM199511163332002; MIETTINEN TA, 1980, EUR J CLIN INVEST, V10, P27, DOI 10.1111/j.1365-2362.1980.tb00006.x; ORCUTT RH, 1995, J PHARMACOL TOXICOL, V34, P169, DOI 10.1016/1056-8719(95)00081-5; Plat J, 2005, J LIPID RES, V46, P68, DOI 10.1194/jlr.M400210-JLR200; Plosch T, 2004, GASTROENTEROLOGY, V126, P290, DOI 10.1053/j.gastro.2003.10.074; Plosch T, 2002, J BIOL CHEM, V277, P33870, DOI 10.1074/jbc.M206522200; Plosch T, 2006, J NUTR, V136, P2135, DOI 10.1093/jn/136.8.2135; Rees DC, 2005, BRIT J HAEMATOL, V130, P297, DOI 10.1111/j.1365-2141.2005.05599.x; Salen G, 2006, GASTROENTEROLOGY, V130, P1853, DOI 10.1053/j.gastro.2006.02.027; Salen G, 2004, CIRCULATION, V109, P966, DOI 10.1161/01.CIR.0000116766.31036.03; SALEN G, 1992, J LIPID RES, V33, P945; Saubion JL, 1998, NUTRITION, V14, P477, DOI 10.1016/S0899-9007(98)00025-2; SCHULER I, 1990, BIOCHIM BIOPHYS ACTA, V1028, P82, DOI 10.1016/0005-2736(90)90268-S; SHULMAN RS, 1976, NEW ENGL J MED, V294, P482, DOI 10.1056/NEJM197602262940907; Su YH, 2006, HAEMATOLOGICA, V91, P1392; Temel RE, 2003, J BIOL CHEM, V278, P47594, DOI 10.1074/jbc.M308235200; VANDERMEER R, 1991, AM J PHYSIOL, V260, pG142, DOI 10.1152/ajpgi.1991.260.1.G142; WANG C, 1981, AM J MED, V71, P313, DOI 10.1016/0002-9343(81)90134-0; WEIHRAUCH JL, 1978, J AM DIET ASSOC, V73, P39; Xu XL, 2001, J BIOL CHEM, V276, P33540, DOI 10.1074/jbc.M104776200; Yang CD, 2004, J CLIN INVEST, V114, P813, DOI 10.1172/JCI200422186; Yu LQ, 2002, P NATL ACAD SCI USA, V99, P16237, DOI 10.1073/pnas.252582399; Yu LQ, 2005, J LIPID RES, V46, P1739, DOI 10.1194/jlr.M500124-JLR200; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]	47	29	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6281	6287		10.1074/jbc.M706689200	http://dx.doi.org/10.1074/jbc.M706689200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18156627	Green Published, hybrid			2022-12-25	WOS:000253779500035
J	Park, KY; Russo, AF				Park, Ki-Youb; Russo, Andrew F.			Control of the calcitonin gene-related peptide enhancer by upstream stimulatory factor in trigeminal ganglion neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HELIX-LOOP-HELIX; TRANSCRIPTION FACTOR USF; PROMOTER ACTIVITY; EXPRESSION; MIGRAINE; BINDING; ACTIVATION; CONTRIBUTE; PROTEIN; CGRP	The neuropeptide calcitonin gene-related peptide (CGRP) is a key player in migraine. However, the transcription factors controlling CGRP expression in the migraine-relevant trigeminal ganglion neurons are unknown. Previous in vitro studies demonstrated that upstream stimulatory factor (USF) 1 and USF2 bind to the CGRP neuroendocrine-specific 18-bp enhancer, yet discrepant overexpression results in cell lines, and the ubiquitous nature of the USF cast doubts about its role. To test the functional role of USF, we first demonstrated that small interfering RNAs directed against USF1 and USF2 reduced endogenous CGRP RNA and preferentially targeted the USF binding site at the 18-bp enhancer in the neuronal-like CA77 cell line. In cultured rat trigeminal ganglion neurons, knockdown of either USF1 or USF2 reduced CGRP promoter activity. Conversely, overexpression of USF1 or USF2 increased promoter activity. The activation was even greater upon cotransfection with an upstream activator of mitogen-activated protein kinases and was synergistic in a heterologous cell line. To begin to address the paradox of how ubiquitous USF proteins might direct neuronal-specific activity, we examined USF expression and used a series of adenoviral reporters in the cultured ganglia. Unexpectedly, there was more intense USF immunostaining in neurons than nonneuronal cells. Importantly, the 18-bp USF enhancer driving a minimal promoter was sufficient for neuronal specificity, although it was not the only site that directed neuronal expression. These results demonstrate that USF1 and USF2 are important contributors to neuronal-specific and mitogen-activated protein kinase regulation of the CGRP gene in trigeminal ganglion neurons.	[Russo, Andrew F.] Univ Iowa, Dept Physiol & Mol Biophys, Iowa City, IA 52242 USA; [Park, Ki-Youb] Univ Iowa, Program Mol & Cell Biol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Russo, AF (corresponding author), Univ Iowa, Dept Physiol & Mol Biophys, Iowa City, IA 52242 USA.	Andrew-russo@uiowa.edu		Russo, Andrew/0000-0002-8156-5649	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE016511] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NIDCR NIH HHS [R01 DE016511, DE016511] Funding Source: Medline; NIDDK NIH HHS [DK54759, P30 DK054759] Funding Source: Medline	NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Bowen EJ, 2006, J NEUROCHEM, V96, P65, DOI 10.1111/j.1471-4159.2005.03524.x; Brain SD, 2004, PHYSIOL REV, V84, P903, DOI 10.1152/physrev.00037.2003; Chen JG, 2005, J VIROL, V79, P4396, DOI 10.1128/JVI.79.7.4396-4406.2005; Chen WG, 2003, J NEUROSCI, V23, P2572; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; COTE GJ, 1986, J BIOL CHEM, V261, P5524; Coulson JM, 1999, BIOCHEM J, V344, P961, DOI 10.1042/0264-6021:3440961; Coulson JM, 2003, BIOCHEM J, V369, P549, DOI 10.1042/BJ20021176; Durham PL, 2006, HEADACHE, V46, pS3, DOI 10.1111/j.1526-4610.2006.00483.x; Durham PL, 2004, BRAIN RES, V997, P103, DOI 10.1016/j.brainres.2003.11.005; Durham PL, 2003, J NEUROSCI, V23, P807; FEINMAN R, 1994, EMBO J, V13, P3852, DOI 10.1002/j.1460-2075.1994.tb06696.x; Frenkel S, 1998, J IMMUNOL, V161, P2881; Fujii G, 2006, BIOCHEM J, V395, P203, DOI 10.1042/BJ20051802; Galibert MD, 2001, EMBO J, V20, P5022, DOI 10.1093/emboj/20.17.5022; Gerrard L, 2005, NEUROPEPTIDES, V39, P475, DOI 10.1016/j.npep.2005.08.004; Goadsby Peter J, 2006, Expert Opin Emerg Drugs, V11, P419, DOI 10.1517/14728214.11.3.419; GOADSBY PJ, 1990, ANN NEUROL, V28, P183, DOI 10.1002/ana.410280213; Goadsby PJ, 2002, NEW ENGL J MED, V346, P257, DOI 10.1056/NEJMra010917; HOUGH PVC, 1987, P NATL ACAD SCI USA, V84, P4826, DOI 10.1073/pnas.84.14.4826; JESSEN KR, 1984, J NEUROCYTOL, V13, P187, DOI 10.1007/BF01148114; Juhasz G, 2005, CEPHALALGIA, V25, P179, DOI 10.1111/j.1468-2982.2005.00836.x; Juttner S, 2003, CELL MICROBIOL, V5, P821, DOI 10.1046/j.1462-5822.2003.00324.x; Kutz SM, 2006, EXP CELL RES, V312, P1093, DOI 10.1016/j.yexcr.2005.12.027; Lanigan TM, 1997, J BIOL CHEM, V272, P18316, DOI 10.1074/jbc.272.29.18316; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo X, 1996, P NATL ACAD SCI USA, V93, P1308, DOI 10.1073/pnas.93.3.1308; Luo X, 1996, MOL CELL BIOL, V16, P1367; Martin CC, 2003, BIOCHEM J, V371, P675, DOI 10.1042/BJ20021585; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; MONCOLLIN V, 1986, EMBO J, V5, P2577, DOI 10.1002/j.1460-2075.1986.tb04537.x; Nagavarapu U, 2001, J BIOL CHEM, V276, P16749, DOI 10.1074/jbc.M009712200; Olesen J, 2004, NEW ENGL J MED, V350, P1104, DOI 10.1056/NEJMoa030505; Pietrobon D, 2003, NAT REV NEUROSCI, V4, P386, DOI 10.1038/nrn1102; Qyang YB, 1999, MOL CELL BIOL, V19, P1508; READ ML, 1993, BIOCHEM J, V295, P233, DOI 10.1042/bj2950233; Ribeiro A, 1999, J BIOL CHEM, V274, P1216, DOI 10.1074/jbc.274.3.1216; Sayasith K, 2005, J BIOL CHEM, V280, P28885, DOI 10.1074/jbc.M413434200; SCHWARTZ ML, 1992, J BIOL CHEM, V267, P24596; Sirito M, 1998, P NATL ACAD SCI USA, V95, P3758, DOI 10.1073/pnas.95.7.3758; SIRITO M, 1994, NUCLEIC ACIDS RES, V22, P427, DOI 10.1093/nar/22.3.427; Sun P, 2001, J BIOL CHEM, V276, P45462, DOI 10.1074/jbc.M104793200; TVERBERG LA, 1993, J BIOL CHEM, V268, P15965; Viney TJ, 2004, J BIOL CHEM, V279, P49948, DOI 10.1074/jbc.M406659200; Viollet B, 1996, J BIOL CHEM, V271, P1405, DOI 10.1074/jbc.271.3.1405; Waeber C, 2005, NEUROLOGY, V64, pS9, DOI 10.1212/WNL.64.10_suppl_2.S9; Wood JL, 2001, J BIOL CHEM, V276, P21262, DOI 10.1074/jbc.M007520200; Zhang ZM, 2007, J NEUROSCI, V27, P2693, DOI 10.1523/JNEUROSCI.4542-06.2007	50	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5441	5451		10.1074/jbc.M708662200	http://dx.doi.org/10.1074/jbc.M708662200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167349	hybrid			2022-12-25	WOS:000253426700024
J	Peter, C; Waibel, M; Radu, CG; Yang, LV; Witte, ON; Schulze-Osthoff, K; Wesselborg, S; Lauber, K				Peter, Christoph; Waibel, Michaela; Radu, Caius G.; Yang, Li V.; Witte, Owen N.; Schulze-Osthoff, Klaus; Wesselborg, Sebastian; Lauber, Kirsten			Migration to apoptotic "Find-me" signals is mediated via the phagocyte receptor G2A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETRACTED ARTICLE. SEE; LYSOPHOSPHATIDYLCHOLINE; CELLS; CLEARANCE; COMPLEMENT; ACID; IDENTIFICATION; CALRETICULIN; CHEMOTAXIS; LIGANDS	Phagocytosis of apoptotic cells is fundamentally important throughout life, because non-cleared cells become secondarily necrotic and release intracellular contents, thus instigating inflammatory and autoimmune responses. Secreted "find-me" and exposed "eat-me" signals displayed by the dying cell in concert with the phagocyte receptors comprise the phagocytic synapse of apoptotic cell clearance. In this scenario, lysophospholipids (lysoPLs) are assumed to act as find-me signals for the attraction of phagocytes. However, both the identity of the lysoPLs released from apoptotic cells and the nature of the phagocyte receptor are largely unknown. By a detailed analysis of the structural requirements we show here that lysophosphatidylcholine (lysoPC), but none of the lysoPC metabolites or other lysoPLs, represents the essential apoptotic attraction signal able to trigger a phagocyte chemotactic response. Furthermore, using RNA interference and expression studies, we demonstrate that the G-protein-coupled receptor G2A, unlike its relative GPR4, is involved in the chemotaxis of monocytic cells. Thus, our study identifies lysoPC and G2A as the crucial receptor/ligand system for the attraction of phagocytes to apoptotic cells and the prevention of autoimmunity.	[Peter, Christoph; Waibel, Michaela; Wesselborg, Sebastian; Lauber, Kirsten] Univ Tubingen, Dept Internal Med, D-72076 Tubingen, Germany; [Radu, Caius G.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Yang, Li V.; Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Schulze-Osthoff, Klaus] Univ Dusseldorf, Inst Mol Med, D-40225 Dusseldorf, Germany	Eberhard Karls University of Tubingen; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; Heinrich Heine University Dusseldorf	Wesselborg, S (corresponding author), Univ Tubingen, Dept Internal Med, Otfried-Muller-Str 10, D-72076 Tubingen, Germany.	sebastian.wesselborg@uni-tuebingen.de	Schulze-Osthoff, Klaus/N-9025-2013; Peter, Christoph/ABB-4684-2020; Radu, Caius/D-3936-2013	Schulze-Osthoff, Klaus/0000-0003-1443-2720; Peter, Christoph/0000-0002-0048-2279; Radu, Caius/0000-0002-9338-5397; Wesselborg, Sebastian/0000-0002-5236-942X; Yang, Li/0000-0002-8654-4927				Botto M, 1998, EXP CLIN IMMUNOGENET, V15, P231, DOI 10.1159/000019076; Gaipl Udo S, 2004, Curr Rheumatol Rep, V6, P401, DOI 10.1007/s11926-004-0016-1; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; HENRICKS PAJ, 1991, PROSTAGLANDINS, V41, P21, DOI 10.1016/0090-6980(91)90101-K; Horino K, 1998, LAB INVEST, V78, P603; Huber J, 2002, ARTERIOSCL THROM VAS, V22, P101, DOI 10.1161/hq0102.101525; Ishii S, 2005, J BIOL CHEM, V280, P9083, DOI 10.1074/jbc.M407832200; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Kim K, 2005, FASEB J, V19, P819, DOI 10.1096/fj.04-2988fje; Kim SJ, 2002, J EXP MED, V196, P655, DOI 10.1084/jem.20020542; Lauber K, 2004, MOL CELL, V14, P277, DOI 10.1016/S1097-2765(04)00237-0; Lauber K, 2003, CELL, V113, P717, DOI 10.1016/S0092-8674(03)00422-7; Le LQ, 2001, IMMUNITY, V14, P561, DOI 10.1016/S1074-7613(01)00145-5; Ludwig MG, 2003, NATURE, V425, P93, DOI 10.1038/nature01905; Moodley Y, 2003, AM J PATHOL, V162, P771, DOI 10.1016/S0002-9440(10)63874-6; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Qiao J, 2006, AM J PHYSIOL-LUNG C, V291, pL91, DOI 10.1152/ajplung.00508.2005; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Radu CG, 2004, P NATL ACAD SCI USA, V101, P245, DOI 10.1073/pnas.2536801100; Tang J, 1997, J BIOL CHEM, V272, P8567, DOI 10.1074/jbc.272.13.8567; Vandivier RW, 2002, J IMMUNOL, V169, P3978, DOI 10.4049/jimmunol.169.7.3978; Wakasugi K, 1999, J BIOL CHEM, V274, P23155, DOI 10.1074/jbc.274.33.23155; Wang JQ, 2004, J BIOL CHEM, V279, P45626, DOI 10.1074/jbc.M406966200; Wang L, 2005, MOL BIOL CELL, V16, P2234, DOI 10.1091/mbc.E04-12-1044; Witte Owen N, 2005, Science, V307, P206; Yang LV, 2005, BLOOD, V105, P1127, DOI 10.1182/blood-2004-05-1916; Zhu K, 2005, J BIOL CHEM, V280, P43280; Zhu K, 2001, J BIOL CHEM, V276, P41325, DOI 10.1074/jbc.M008057200	32	165	171	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5296	5305		10.1074/jbc.M706586200	http://dx.doi.org/10.1074/jbc.M706586200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18089568	hybrid			2022-12-25	WOS:000253426700009
J	Di Matteo, A; Scandurra, FM; Testa, F; Forte, E; Sarti, P; Brunori, M; Giuffre, A				Di Matteo, Adele; Scandurra, Francesca Maria; Testa, Fabrizio; Forte, Elena; Sarti, Paolo; Brunori, Maurizio; Giuffre, Alessandro			The O-2-scavenging flavodiiron protein in the human parasite Giardia intestinalis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE REDUCTASE; ESCHERICHIA-COLI; DESULFOVIBRIO-GIGAS; MOORELLA-THERMOACETICA; ELECTRON-TRANSFER; IN-VIVO; FLAVORUBREDOXIN; DETOXIFICATION; DUODENALIS; LAMBLIA	The flavodiiron proteins (FDP) are widespread among strict or facultative anaerobic prokaryotes, where they are involved in the response to nitrosative and/or oxidative stress. Unexpectedly, FDPs were fairly recently identified in a restricted group of microaerobic protozoa, including Giardia intestinalis, the causative agent of the human infectious disease giardiasis. The FDP from Giardia was expressed, purified, and extensively characterized by x-ray crystallography, stopped-flow spectroscopy, respirometry, and NO amperometry. Contrary to flavorubredoxin, the FDP from Escherichia coli, the enzyme from Giardia has high O-2-reductase activity (>40 s(-1)), but very low NO-reductase activity (similar to 0.2 s(-1)); O-2 reacts with the reduced protein quite rapidly (milliseconds) and with high affinity (K-m <= 2 mu M), producing H2O. The three-dimensional structure of the oxidized protein determined at 1.9 angstrom resolution shows remarkable similarities with prokaryotic FDPs. Consistent with HPLC analysis, the enzyme is a dimer of dimers with FMN and the non-heme di-iron site topologically close at the monomer-monomer interface. Unlike the FDP from Desulfovibrio gigas, the residue His-90 is a ligand of the di-iron site, in contrast with the proposal that ligation of this histidine is crucial for a preferential specificity for NO. We propose that in G. intestinalis the primary function of FDP is to efficiently scavenge O-2, allowing this microaerobic parasite to survive in the human small intestine, thus promoting its pathogenicity.	Univ Roma La Sapienza, Dept Biochem Sci, CNR, Inst Mol Biol & Pathol, I-00185 Rome, Italy; Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome	Giuffre, A (corresponding author), Univ Roma La Sapienza, Dipartimento Sci Biochim, Ist Biol & Patol Mol, CNR, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	alessandro.giuffre@uniroma1.it	Forte, Elena/K-6015-2015; Giuffrè, Alessandro/K-4341-2015; Di Matteo, Adele/AAC-8338-2019; Sarti, Paolo/D-2946-2009	Giuffrè, Alessandro/0000-0001-5301-0681; Di Matteo, Adele/0000-0002-5921-7365; FORTE, Elena/0000-0001-9049-6916; Brunori, Maurizio/0000-0002-7795-1635; Sarti, Paolo/0000-0002-8219-4827				Andersson JO, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148/6/27; Andersson JO, 2003, CURR BIOL, V13, P94, DOI 10.1016/S0960-9822(03)00003-4; Brown DM, 1998, INT J PARASITOL, V28, P149, DOI 10.1016/S0020-7519(97)00172-0; BROWN DM, 1995, MOL BIOCHEM PARASIT, V72, P47, DOI 10.1016/0166-6851(95)00065-9; Brown DM, 1996, EUR J BIOCHEM, V241, P155, DOI 10.1111/j.1432-1033.1996.0155t.x; CHEN L, 1993, BIOCHEM BIOPH RES CO, V193, P100, DOI 10.1006/bbrc.1993.1595; Eckmann L, 2000, J IMMUNOL, V164, P1478, DOI 10.4049/jimmunol.164.3.1478; ELLIS JE, 1993, INT J PARASITOL, V23, P35, DOI 10.1016/0020-7519(93)90095-G; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fang FC, 1997, J CLIN INVEST, V99, P2818, DOI 10.1172/JCI119473; Frazao C, 2000, NAT STRUCT BIOL, V7, P1041; Gardner AM, 2002, J BIOL CHEM, V277, P8172, DOI 10.1074/jbc.M110471200; Gomes CM, 1997, J BIOL CHEM, V272, P22502, DOI 10.1074/jbc.272.36.22502; Gomes CM, 2002, J BIOL CHEM, V277, P25273, DOI 10.1074/jbc.M203886200; Gomes CM, 2000, BIOCHEMISTRY-US, V39, P16230, DOI 10.1021/bi001844y; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Li EQ, 2006, J IMMUNOL, V176, P516, DOI 10.4049/jimmunol.176.1.516; Li L, 2006, MOL MICROBIOL, V59, P202, DOI 10.1111/j.1365-2958.2005.04896.x; Lloyd D, 2000, MICROBIOL-UK, V146, P3109, DOI 10.1099/00221287-146-12-3109; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAGET TA, 1989, J GEN MICROBIOL, V135, P145; Rodrigues R, 2006, J BACTERIOL, V188, P2745, DOI 10.1128/JB.188.8.2745-2751.2006; Roxstrom-Lindquist K, 2006, TRENDS PARASITOL, V22, P26, DOI 10.1016/j.pt.2005.11.005; Saraiva LM, 2004, ADV MICROB PHYSIOL, V49, P77, DOI 10.1016/S0065-2911(04)49002-X; Sarti P, 2004, CELL MOL LIFE SCI, V61, P618, DOI 10.1007/s00018-003-3413-8; Seedorf H, 2004, ARCH MICROBIOL, V182, P126, DOI 10.1007/s00203-004-0675-3; Seedorf H, 2007, FEBS J, V274, P1588, DOI 10.1111/j.1742-4658.2007.05706.x; SHERIDAN WG, 1990, AM J SURG, V159, P314, DOI 10.1016/S0002-9610(05)81226-7; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P6492, DOI 10.1021/bi0473049; Silaghi-Dumitrescu R, 2003, BIOCHEMISTRY-US, V42, P2806, DOI 10.1021/bi027253k; Silaghi-Dumitrescu R, 2005, BIOCHEMISTRY-US, V44, P3572, DOI 10.1021/bi0477337; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; Solomon EI, 2000, CHEM REV, V100, P235, DOI 10.1021/cr9900275; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; SUSIN S, 1993, J BIOL CHEM, V268, P20958; Townson SM, 1996, MOL BIOCHEM PARASIT, V79, P183, DOI 10.1016/0166-6851(96)02661-8; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vicente JB, 2005, J BIOL CHEM, V280, P34599, DOI 10.1074/jbc.M506349200; Vicente JB, 2007, FEBS J, V274, P677, DOI 10.1111/j.1742-4658.2006.05612.x; Wasserfallen A, 1998, EUR J BIOCHEM, V254, P325, DOI 10.1046/j.1432-1327.1998.2540325.x	47	84	85	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4061	4068		10.1074/jbc.M705605200	http://dx.doi.org/10.1074/jbc.M705605200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077462	hybrid			2022-12-25	WOS:000253083500041
J	Fekete, Z; Ellis, TP; Schonauer, MS; Dieckmann, CL				Fekete, Zsuzsanna; Ellis, Timothy P.; Schonauer, Melissa S.; Dieckmann, Carol L.			Pet127 Governs a 5 ' -> 3 '-exonuclease important in maturation of apocytochrome b mRNA in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL CYTOCHROME-B; YEAST MITOCHONDRIA; 5'-UNTRANSLATED REGION; ESCHERICHIA-COLI; MEMBRANE SYSTEM; CBP1; GENE; DEGRADOSOME; DECAY; EXORIBONUCLEASE	The details of mRNA maturation in Saccharomyces mitochondria are not well understood. All seven mRNAs are transcribed as part of multigenic units. The mRNAs are processed at a common 3'-dodecamer sequence, but the 5'-ends have seven different sequences. To investigate whether apocytochrome b (COB) mRNA is processed at the 5'-end from a longer precursor by an endonuclease or an exonuclease, a 64-nucleotide sequence, which is required for the protection of COB mRNA by the Cbp1 protein and is found at the 5'-end of the processed COB mRNA, was duplicated in tandem. The wild-type 64-nucleotide element functioned in either the upstream or downstream position when paired with a mutant element. In the tandem wild-type strain, the 5'-end of the mRNA was at the 5'-end of the upstream unit, demonstrating that the mRNA is processed by an exonuclease. Accumulation of precursor COB RNA in single and double element strains with a deletion of PET127 demonstrated that the encoded protein governs the 5'-exonuclease responsible for processing the precursor to the mature form.	[Schonauer, Melissa S.; Dieckmann, Carol L.] Univ Arizona, Dept Biochem & Biophys, Tucson, AZ 85721 USA; [Fekete, Zsuzsanna] Univ Pecs, Sch Med, Dept Med Biol, H-7624 Pecs, Hungary; [Fekete, Zsuzsanna; Ellis, Timothy P.; Dieckmann, Carol L.] Univ Arizona, Dept Biochem & Mol Biol, Tucson, AZ 85721 USA	University of Arizona; University of Pecs; University of Arizona	Dieckmann, CL (corresponding author), Univ Arizona, Dept Biochem & Biophys, PO Box 210106, Tucson, AZ 85721 USA.	dieckman@u.arizona.edu		Fekete, Zsuzsanna/0000-0002-4264-2365	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034893] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34893] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADAMS A, 1997, METHODS YEAST GENETI, P145; BONITZ SG, 1982, J BIOL CHEM, V257, P6268; Burger G, 2003, TRENDS GENET, V19, P709, DOI 10.1016/j.tig.2003.10.012; CAPONIGRO G, 1993, MOL CELL BIOL, V13, P5141, DOI 10.1128/MCB.13.9.5141; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; CHEN JY, 1988, J BIOL CHEM, V263, P13677; CHEN W, 1994, J BIOL CHEM, V269, P16574; Chen W, 1999, GENETICS, V151, P1315; Chen W, 1997, MOL CELL BIOL, V17, P6203, DOI 10.1128/MCB.17.11.6203; CHRISTIANSON T, 1983, P NATL ACAD SCI-BIOL, V80, P5564, DOI 10.1073/pnas.80.18.5564; DIECKMANN CL, 1984, J BIOL CHEM, V259, P4722; DIECKMANN CL, 1982, P NATL ACAD SCI-BIOL, V79, P1805, DOI 10.1073/pnas.79.6.1805; Dziembowski A, 2003, J BIOL CHEM, V278, P1603, DOI 10.1074/jbc.M208287200; Dziembowski A, 2001, METHOD ENZYMOL, V342, P367, DOI 10.1016/S0076-6879(01)42559-6; Ellis TP, 2005, GENETICS, V171, P949, DOI 10.1534/genetics.104.036467; Gagliardi D, 2004, TRENDS GENET, V20, P260, DOI 10.1016/j.tig.2004.04.006; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; He F, 2003, MOL CELL, V12, P1439, DOI 10.1016/S1097-2765(03)00446-5; HEYER WD, 1995, MOL CELL BIOL, V15, P2728; HOLLINGSWORTH MJ, 1986, MOL CELL BIOL, V6, P1058, DOI 10.1128/MCB.6.4.1058; Houalla R, 2006, YEAST, V23, P439, DOI 10.1002/yea.1369; Islas-Osuna MA, 2002, J BIOL CHEM, V277, P37987, DOI 10.1074/jbc.M206132200; Mackie GA, 1998, NATURE, V395, P720, DOI 10.1038/27246; Maniatis T, 1982, MOL CLONING LABORATO, P68; Margossian SP, 1996, CELL, V84, P199, DOI 10.1016/S0092-8674(00)80975-7; Mathy N, 2007, CELL, V129, P681, DOI 10.1016/j.cell.2007.02.051; MAYER SA, 1989, MOL CELL BIOL, V9, P4161, DOI 10.1128/MCB.9.10.4161; Miczak A, 1996, P NATL ACAD SCI USA, V93, P3865, DOI 10.1073/pnas.93.9.3865; MITTELMEIER TM, 1993, MOL CELL BIOL, V13, P4203, DOI 10.1128/MCB.13.7.4203; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Poole T L, 1995, Nucleic Acids Symp Ser, P79; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; STAPLES RR, 1993, GENETICS, V135, P981; Wegierski T, 1998, ACTA BIOCHIM POL, V45, P935, DOI 10.18388/abp.1998_4352; Wiesenberger G, 1997, MOL CELL BIOL, V17, P2816, DOI 10.1128/MCB.17.5.2816; Wiesenberger G, 2007, J MOL BIOL, V367, P681, DOI 10.1016/j.jmb.2007.01.014; Zuo YH, 2001, NUCLEIC ACIDS RES, V29, P1017, DOI 10.1093/nar/29.5.1017	37	23	23	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3767	3772		10.1074/jbc.M709617200	http://dx.doi.org/10.1074/jbc.M709617200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18086665	hybrid			2022-12-25	WOS:000253083500010
J	Vigetti, D; Viola, M; Karousou, E; Rizzi, M; Moretto, P; Genasetti, A; Clerici, M; Hascall, VC; De Luca, G; Passi, A				Vigetti, Davide; Viola, Manuela; Karousou, Eugenia; Rizzi, Manuela; Moretto, Paola; Genasetti, Anna; Clerici, Moira; Hascall, Vincent C.; De Luca, Giancarlo; Passi, Alberto			Hyaluronan-CD44-ERK1/2 regulate human aortic smooth muscle cell motility during aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGE-RELATED-CHANGES; HYALURONAN RECEPTOR; IN-VITRO; GEL-ELECTROPHORESIS; CHONDROITIN SULFATE; ENDOCYTOSIS HARE; MIGRATION; CD44; BINDING; ACID	The glycosaminoglycan hyaluronan (HA) modulates cell proliferation and migration, and it is involved in several human vascular pathologies including atherosclerosis and vascular restenosis. During intima layer thickening, HA increases dramatically in the neointima extracellular matrix. Aging is one of the major risk factors for the insurgence of vascular diseases, in which smooth muscle cells (SMCs) play a role by determining neointima formation through their migration and proliferation. Therefore, we established an in vitro aging model consisting of sequential passages of human aortic smooth muscle cells (AoSMCs). Comparing young and aged cells, we found that, during the aging process in vitro, HA synthesis significantly increases, as do HA synthetic enzymes (i.e. HAS2 and HAS3), the precursor synthetic enzyme (UDP-glucose dehydrogenase), and the HA receptor CD44. In aged cells, we also observed increased CD44 signaling that consisted of higher levels of phosphorylated MAP kinase ERK1/2. Further, aged AoSMCs migrated faster than young cells, and such migration could be modulated by HA, which alters the ERK1/2 phosphorylation. HA oligosaccharides of 6.8 kDa and an anti-CD44 blocking antibody prevented ERK1/2 phosphorylation and inhibited AoSMCs migration. These results indicate that, during aging, HA can modulate cell migration involving CD44-mediated signaling through ERK1/2. These data suggest that age-related HA accumulation could promote SMC migration and intima thickening during vascular neointima formation.	[Vigetti, Davide; Viola, Manuela; Karousou, Eugenia; Rizzi, Manuela; Moretto, Paola; Genasetti, Anna; Clerici, Moira; De Luca, Giancarlo; Passi, Alberto] Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, I-21100 Varese, Italy; [Hascall, Vincent C.] Cleveland Clin Fdn, Dept Biomed Engn, Cleveland, OH 44195 USA; [Hascall, Vincent C.] Cleveland Clin Fdn, Orthopaed Res Ctr ND20, Cleveland, OH 44195 USA	University of Insubria; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Passi, A (corresponding author), Univ Insubria, Dipartimento Sci Biomed Sperimentali & Clin, Via JH Dunant 5, I-21100 Varese, Italy.	alberto.passi@uninsubria.it	Viola, Manuela/B-7120-2011; passi, alberto g/A-1752-2018; Rizzi, Manuela/AAE-9202-2021; Vigetti, Davide/C-9861-2010	Viola, Manuela/0000-0002-0634-6390; passi, alberto g/0000-0003-3328-3089; Rizzi, Manuela/0000-0002-6174-7111; Vigetti, Davide/0000-0002-6339-8453				Arita Y, 2002, CIRCULATION, V105, P2893, DOI 10.1161/01.CIR.0000018622.84402.FF; Bourguignon LYW, 2005, J BIOL CHEM, V280, P11961, DOI 10.1074/jbc.M411985200; Chai S, 2005, CIRC RES, V96, P583, DOI 10.1161/01.RES.0000158963.37132.8b; Chajara A, 1998, ATHEROSCLEROSIS, V138, P53, DOI 10.1016/S0021-9150(98)00004-5; Clark RAF, 2004, J INVEST DERMATOL, V122, P266, DOI 10.1046/j.0022-202X.2004.22205.x; Cox BD, 2006, J CELL BIOCHEM, V99, P36, DOI 10.1002/jcb.20956; Cuff CA, 2001, J CLIN INVEST, V108, P1031, DOI 10.1172/JCI12455; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Evanko SP, 1999, J HISTOCHEM CYTOCHEM, V47, P1331, DOI 10.1177/002215549904701013; Harada H, 2007, J BIOL CHEM, V282, P5597, DOI 10.1074/jbc.M608358200; HARIRI RJ, 1986, J EXP MED, V164, P1171, DOI 10.1084/jem.164.4.1171; Harris EN, 2007, J BIOL CHEM, V282, P2785, DOI 10.1074/jbc.M607787200; Harris EN, 2004, J BIOL CHEM, V279, P36201, DOI 10.1074/jbc.M405322200; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; Heldin P, 2003, BRAZ J MED BIOL RES, V36, P967, DOI 10.1590/S0100-879X2003000800002; Isacke CM, 2002, INT J BIOCHEM CELL B, V34, P718, DOI 10.1016/S1357-2725(01)00166-2; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jiang J, 2005, EMERG INFECT DIS, V11, P1473, DOI 10.3201/eid1109.050011; Johnson LA, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702889200; Karousou EG, 2004, ELECTROPHORESIS, V25, P2919, DOI 10.1002/elps.200406034; KITAYAMA J, 1993, J IMMUNOL, V151, P1663; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Li LL, 2006, J BIOL CHEM, V281, P26512, DOI 10.1074/jbc.M605607200; Li ZH, 1997, EXP MOL PATHOL, V64, P1, DOI 10.1006/exmp.1997.2204; LIAO HX, 1995, J IMMUNOL, V155, P3938; Lokeshwar VB, 2002, J BIOL CHEM, V277, P33654, DOI 10.1074/jbc.M203821200; Lundberg MS, 1999, EXP GERONTOL, V34, P549, DOI 10.1016/S0531-5565(99)00036-4; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; MARTIN GM, 1983, AM J PATHOL, V110, P236; MIURA RO, 1995, ANAL BIOCHEM, V225, P333, DOI 10.1006/abio.1995.1163; MURATA K, 1989, ATHEROSCLEROSIS, V78, P69, DOI 10.1016/0021-9150(89)90160-3; Nedvetzki S, 2004, P NATL ACAD SCI USA, V101, P18081, DOI 10.1073/pnas.0407378102; Plaas AHK, 1997, J BIOL CHEM, V272, P20603, DOI 10.1074/jbc.272.33.20603; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Raio L, 2005, MATRIX BIOL, V24, P166, DOI 10.1016/j.matbio.2005.01.006; Riessen R, 1996, CIRCULATION, V93, P1141, DOI 10.1161/01.CIR.93.6.1141; Ruiz-Torres A, 2003, J GERONTOL A-BIOL, V58, P1074; Slevin M, 2002, J BIOL CHEM, V277, P41046, DOI 10.1074/jbc.M109443200; SPAGNOLI LG, 1991, ATHEROSCLEROSIS, V89, P11, DOI 10.1016/0021-9150(91)90003-L; STUHLSATZ HW, 1982, J CLIN CHEM CLIN BIO, V20, P713; Tawada A, 2002, GLYCOBIOLOGY, V12, P421, DOI 10.1093/glycob/cwf048; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Tien JYL, 2005, DEV DYNAM, V233, P130, DOI 10.1002/dvdy.20328; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Toole BP, 2002, J BIOL CHEM, V277, P4593, DOI 10.1074/jbc.R100039200; Tovar AMF, 1998, ARTERIOSCL THROM VAS, V18, P604, DOI 10.1161/01.ATV.18.4.604; Turley EA, 2002, J BIOL CHEM, V277, P4589, DOI 10.1074/jbc.R100038200; Tzircotis G, 2005, J CELL SCI, V118, P5119, DOI 10.1242/jcs.02629; van den Boom M, 2006, CIRC RES, V98, P36, DOI 10.1161/01.RES.0000199263.67107.c0; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Vigetti D, 2006, J BIOL CHEM, V281, P8254, DOI 10.1074/jbc.M508516200; Vigetti D, 2006, FASEB J, V20, P1118, DOI 10.1096/fj.05-4504com; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085	55	79	82	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4448	4458		10.1074/jbc.M709051200	http://dx.doi.org/10.1074/jbc.M709051200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077444	Green Published, hybrid			2022-12-25	WOS:000253083500079
J	Anil, VS; Rajkumar, P; Kumar, P; Mathew, MK				Anil, Veena S.; Rajkumar, Premraj; Kumar, Pavan; Mathew, M. K.			A plant Ca2+ pump, ACA2, relieves salt hypersensitivity in yeast - Modulation of cytosolic calcium signature and activation of adaptive Na+ homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TERMINAL AUTOINHIBITORY DOMAIN; DEPENDENT PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; ION HOMEOSTASIS; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; TRANSCRIPTIONAL RESPONSE; HYPERTONIC SHOCK	Stress responses in both plants and yeast utilize calcium-mediated signaling. A yeast strain, K616, which lacks Ca2+ pumps, requires micromolar Ca(2+)for growth. In medium containing 100 mu M Ca2+, K616 can withstand osmotic stress (750 mM sorbitol) and ionic stress (300 mM KCl) but not hypersodic stress (300 mM NaCl). Heterologous expression of the endoplasmic reticulum-located Arabidopsis thaliana Ca2+-ATPase, ACA2, permits K616 to grow under NaCl stress even in Ca2+-depleted medium. All stresses tested generated transient elevation of cytosolic Ca2+ in wild type yeast, K601, whereas NaCl alone induced prolonged elevation of cytosolic Ca2+ in K616. Both the Ca2+ transient and survival of cultures subjected to NaCl stress was similar for the ACA2 transformant and K601. However, whereas K601 maintained low cytosolic Na+ predominantly by pumping it out across the plasma membrane, the transformant sequestered Na+ in internal organelles. This sequestration requires the presence of an endomembrane Na+/H+-antiporter, NHX1, which does not play a significant role in salt tolerance of wild type yeast except at acidic pH. Transcript levels of the plasma membrane Na+-ATPase, ENA1, were strongly induced only in K601, whereas NHX1 was strongly induced in both K601 and the ACA2 transformant. The calmodulin kinase inhibitor KN62 significantly reduced the salt tolerance of the ACA2 transformant and the transcriptional induction of NHX1. Thus, the heterologous expression of a plant endomembrane Ca2+ pump results in the rapid depletion of cytosolic Ca2+ and the activation of an alternate mechanism for surviving saline stress.	[Anil, Veena S.; Rajkumar, Premraj; Kumar, Pavan; Mathew, M. K.] Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Mathew, MK (corresponding author), Natl Ctr Biol Sci, UAS GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India.	mathew@ncbs.res.in	Anil, Veena/ABI-3683-2020	Mathew, M K/0000-0002-5932-3598; Anil, Veena/0000-0002-7404-7683				ALLEN GJ, 1995, SCIENCE, V268, P735, DOI 10.1126/science.7732384; Anil Veena S., 2007, Proceedings of the Indian National Science Academy, V73, P43; Anil VS, 2007, PHYSIOL PLANTARUM, V129, P607, DOI 10.1111/j.1399-3054.2006.00854.x; Anil VS, 2005, PHYSIOL PLANTARUM, V124, P451, DOI 10.1111/j.1399-3054.2005.00529.x; Anil VS, 2001, J PLANT PHYSIOL, V158, P1237, DOI 10.1078/0176-1617-00550; Anil VS, 2000, PLANT PHYSIOL, V123, P1301, DOI 10.1104/pp.123.4.1301; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Banuelos MA, 1998, MICROBIOL-UK, V144, P2749, DOI 10.1099/00221287-144-10-2749; Bowers K, 2004, TRAFFIC, V5, P194, DOI 10.1111/j.1600-0854.2004.00169.x; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Cessna SG, 1998, J BIOL CHEM, V273, P27286, DOI 10.1074/jbc.273.42.27286; Crespo JL, 2001, J BIOL CHEM, V276, P34441, DOI 10.1074/jbc.M103601200; Cui JJ, 2006, CELL CALCIUM, V39, P337, DOI 10.1016/j.ceca.2005.12.001; CUNNINGHAM KW, 1994, J CELL BIOL, V124, P351, DOI 10.1083/jcb.124.3.351; Darley CP, 2000, BIOCHEM J, V351, P241, DOI 10.1042/0264-6021:3510241; Denis V, 2002, J CELL BIOL, V156, P29, DOI 10.1083/jcb.200111004; Elbe R, 1992, BIOTECHNIQUES, V13, P18; Epstein E, 1998, SCIENCE, V280, P1906, DOI 10.1126/science.280.5371.1906; Evans NH, 2001, CURR OPIN PLANT BIOL, V4, P415, DOI 10.1016/S1369-5266(00)00194-1; Flowers TJ, 2004, J EXP BOT, V55, P307, DOI 10.1093/jxb/erh003; Fukuda A, 2004, PLANT CELL PHYSIOL, V45, P146, DOI 10.1093/pcp/pch014; Geisler M, 2000, PLANT PHYSIOL, V124, P1814, DOI 10.1104/pp.124.4.1814; Halperin SJ, 2003, J EXP BOT, V54, P2035, DOI 10.1093/jxb/erg219; Haro R, 2002, BBA-BIOMEMBRANES, V1564, P114, DOI 10.1016/S0005-2736(02)00408-X; Harper JF, 1998, J BIOL CHEM, V273, P1099, DOI 10.1074/jbc.273.2.1099; HARTENECK C, 2007, DRUG REV, V25, P61; HIRATA D, 1995, MOL GEN GENET, V249, P257, DOI 10.1007/BF00290525; Hirschi K, 2001, TRENDS PLANT SCI, V6, P100, DOI 10.1016/S1360-1385(00)01863-X; Hwang I, 2000, PLANT PHYSIOL, V122, P157, DOI 10.1104/pp.122.1.157; Hwang I, 2000, P NATL ACAD SCI USA, V97, P6224, DOI 10.1073/pnas.97.11.6224; Kawasaki S, 2001, PLANT CELL, V13, P889, DOI 10.1105/tpc.13.4.889; Kellermayer R, 2003, J CELL SCI, V116, P1637, DOI 10.1242/jcs.00372; KLUSENER B, 1995, EMBO J, V14, P2708, DOI 10.1002/j.1460-2075.1995.tb07271.x; Knight H, 1997, PLANT J, V12, P1067, DOI 10.1046/j.1365-313X.1997.12051067.x; Maas E.V., 1990, ASCE MANUALS REPORTS, P262; Malho R, 1996, PLANT CELL, V8, P1935, DOI 10.1105/tpc.8.11.1935; Matheos DP, 1997, GENE DEV, V11, P3445, DOI 10.1101/gad.11.24.3445; Matsumoto TK, 2002, J BIOL CHEM, V277, P33075, DOI 10.1074/jbc.M205037200; Melcher ML, 1996, J BIOL CHEM, V271, P29958, DOI 10.1074/jbc.271.47.29958; Nass R, 1999, MICROBIOL-SGM, V145, P3221, DOI 10.1099/00221287-145-11-3221; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; NIU XM, 1995, PLANT PHYSIOL, V109, P735, DOI 10.1104/pp.109.3.735; OHSUMI Y, 1988, J BACTERIOL, V170, P2676, DOI 10.1128/jb.170.6.2676-2682.1988; PEREZPRAT E, 1992, PLANT PHYSIOL, V100, P1471, DOI 10.1104/pp.100.3.1471; Phean-O-pas S, 2005, J BIOCHEM MOL BIOL, V38, P432; Platara M, 2006, J BIOL CHEM, V281, P36632, DOI 10.1074/jbc.M606483200; Posas F, 2000, J BIOL CHEM, V275, P17249, DOI 10.1074/jbc.M910016199; Proft M, 2004, CELL, V118, P351, DOI 10.1016/j.cell.2004.07.016; Proft M, 1999, MOL CELL BIOL, V19, P537; Saijo Y, 2000, PLANT J, V23, P319, DOI 10.1046/j.1365-313x.2000.00787.x; Sanders D, 2002, PLANT CELL, V14, pS401, DOI 10.1105/tpc.002899; Sen Gupta S, 2003, J BIOL CHEM, V278, P28831, DOI 10.1074/jbc.M303300200; Serrano R, 1999, J EXP BOT, V50, P1023, DOI 10.1093/jexbot/50.suppl_1.1023; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Sze H, 2000, ANNU REV PLANT PHYS, V51, P433, DOI 10.1146/annurev.arplant.51.1.433; WIMMERS LE, 1992, P NATL ACAD SCI USA, V89, P9205, DOI 10.1073/pnas.89.19.9205; YEO AR, 1982, PHYSIOL PLANTARUM, V56, P343, DOI 10.1111/j.1399-3054.1982.tb00350.x; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329	60	42	46	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3497	3506		10.1074/jbc.M700766200	http://dx.doi.org/10.1074/jbc.M700766200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18073213	hybrid			2022-12-25	WOS:000253083000055
J	Klinke, DJ				Klinke, David J., II			Extent of Beta Cell Destruction Is Important but Insufficient to Predict the Onset of Type 1 Diabetes Mellitus	PLOS ONE			English	Article							INSULIN-SECRETION; PANCREAS; INTERVENTION; PREVENTION; MOLECULES; PATTERNS; CHILDREN; ANTIBODY; ISLETS	Background. Type 1 diabetes mellitus is characterized by an inability to produce insulin endogenously. Based on a series of histopathology studies of patients with recent onset of the disease, it is commonly stated that the onset of clinical symptoms corresponds to an 80-95% reduction in beta cell mass. Motivated by the clinical importance of the degree of beta cell destruction at onset, a meta-analysis was used to determine the validity of this common wisdom. Methods and Findings. The histopathology results identifying insulin containing islets in patients younger than 20 years of age were extracted from three different studies. The results for 105 patients were stratified by duration of diabetic symptoms and age at onset. Linear regression and a non-parametric bootstrap approach were used to determine the dependence of residual beta cell mass to age at onset. The percentage reduction in beta cell mass was highly correlated (p < 0.001) with the age of onset with the greatest reduction in beta cell mass in the youngest patients. As this trend had not been previously observed, an alternative physiology-based model is proposed that captures this age-dependence. Conclusions. The severity in beta cell reduction at onset decreased with age where, on average, a 40% reduction in beta cell mass was sufficient to precipitate clinical symptoms at 20 years of age. The observed trend was consistent with a physiology-based model where the threshold for onset is based upon a dynamic balance between insulin-production capacity, which is proportional to beta cell mass, and insulin demand, which is proportional to body weight.	[Klinke, David J., II] W Virginia Univ, Dept Chem Engn, Morgantown, WV 26506 USA; [Klinke, David J., II] West Virginia Univ, Dept Microbiol Immunol & Cell Biol, Morgantown, WV USA	West Virginia University; West Virginia University	Klinke, DJ (corresponding author), W Virginia Univ, Dept Chem Engn, Morgantown, WV 26506 USA.	david.klinke@mail.wvu.edu		Klinke, David/0000-0003-3299-4938	West Virginia University Research Corporation	West Virginia University Research Corporation	This work was supported by the West Virginia University Research Corporation.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; ARMITAGE P, 2002, STAT METHODS MED RES, P102; Atkinson MA, 2005, DIABETES, V54, P1253, DOI 10.2337/diabetes.54.5.1253; Atkinson MA, 2001, LANCET, V358, P221, DOI 10.1016/S0140-6736(01)05415-0; Barker JM, 2007, J PEDIATR-US, V150, P31, DOI 10.1016/j.jpeds.2006.09.033; Beers KJ, 2007, NUMERICAL METHODS FOR CHEMICAL ENGINEERING: APPLICATIONS IN MATLAB, P372; CHERNICK MR, 1999, BOOTSTRAP METHODS PR, P150; Daaboul J, 2003, REV ENDOCR METAB DIS, V4, P317, DOI 10.1023/A:1027308310837; DONIACH I, 1973, Clinical Endocrinology, V2, P233, DOI 10.1111/j.1365-2265.1973.tb00425.x; Efron B, 1986, STAT SCI, V1, P54, DOI DOI 10.1214/SS/1177013815; FOULIS AK, 1987, DIABETOLOGIA, V30, P333, DOI 10.1007/BF00299027; FOULIS AK, 1986, DIABETOLOGIA, V29, P267, DOI 10.1007/BF00452061; Gale EAM, 2002, NEW ENGL J MED, V346, P1740, DOI 10.1056/NEJM200205303462211; Genuth S, 2002, JAMA-J AM MED ASSOC, V287, P2563; GEPTS W, 1965, DIABETES, V14, P619, DOI 10.2337/diab.14.10.619; Green A, 2000, LANCET, V355, P873; Greenbaum CJ, 2002, DIABETES, V51, P951, DOI 10.2337/diabetes.51.4.951; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Herold KC, 2002, NEW ENGL J MED, V346, P1692, DOI 10.1056/NEJMoa012864; Hinke SA, 2004, J PHYSIOL-LONDON, V558, P369, DOI 10.1113/jphysiol.2004.064881; HORN R, 1987, BIOPHYS J, V51, P255, DOI 10.1016/S0006-3495(87)83331-3; Kloppel G, 1984, Behring Inst Mitt, P42; Kolb H, 2001, DIABETOLOGIA, V44, P1349, DOI 10.1007/s001250100636; Komulainen J, 1997, DIABETIC MED, V14, P532, DOI 10.1002/(SICI)1096-9136(199707)14:7<532::AID-DIA403>3.0.CO;2-6; Kuczmarski RJ, 2000, ADV DATA, V314, P1; LERNMARK A, 1995, VIRCHOWS ARCH, V425, P631; Marchetti P, 2000, DIABETES CARE, V23, P701, DOI 10.2337/diacare.23.5.701; Onkamo P, 1999, DIABETOLOGIA, V42, P1395, DOI 10.1007/s001250051309; SCIBILIA J, 1986, ACTA ENDOCRINOL-COP, V113, P326; Sherry NA, 2005, DIABETES, V54, pS32, DOI 10.2337/diabetes.54.suppl_2.S32; Silverstein J, 2005, DIABETES CARE, V28, P186, DOI 10.2337/diacare.28.1.186; SOCHETT EB, 1987, DIABETOLOGIA, V30, P453, DOI 10.1007/BF00279611; SOMOZA N, 1994, J IMMUNOL, V153, P1360; Sosenko JM, 2006, DIABETES CARE, V29, P643, DOI 10.2337/diacare.29.03.06.dc05-1006; SRIKANTA S, 1984, DIABETES, V33, P717, DOI 10.2337/diabetes.33.8.717; Steele C, 2004, DIABETES, V53, P426, DOI 10.2337/diabetes.53.2.426; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; VARDI P, 1991, DIABETOLOGIA, V34, P93, DOI 10.1007/BF00500379; WEIBEL ER, 1962, J APPL PHYSIOL, V17, P343, DOI 10.1152/jappl.1962.17.2.343; World Health Organization, 1999, REP WHO CONS 1; YAMAOKA K, 1978, J PHARMACOKINET BIOP, V6, P165, DOI 10.1007/BF01117450	41	64	65	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1374	10.1371/journal.pone.0001374	http://dx.doi.org/10.1371/journal.pone.0001374			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167535	Green Published, gold, Green Submitted			2022-12-25	WOS:000260468900003
J	Li, YF; Maedler, K; Shu, L; Haataja, L				Li, Yunfeng; Maedler, Kathrin; Shu, Luan; Haataja, Leena			UCP-2 and UCP-3 Proteins Are Differentially Regulated in Pancreatic Beta-Cells	PLOS ONE			English	Article							STIMULATED INSULIN-SECRETION; OXYGEN SPECIES PRODUCTION; TYPE-2 DIABETIC-PATIENTS; FREE FATTY-ACIDS; UNCOUPLING PROTEIN-2; SKELETAL-MUSCLE; HIGH GLUCOSE; PROLONGED EXPOSURE; MESSENGER-RNA; KNOCKOUT MICE	Background. Increased uncoupling protein-2 (UCP-2) expression has been associated with impaired insulin secretion, whereas UCP-3 protein levels are decreased in the skeleton muscle of type-2 diabetic subjects. In the present studies we hypothesize an opposing effect of glucose on the regulation of UCP-2 and UCP-3 in pancreatic islets. Methodology. Dominant negative UCP-2 and wild type UCP-3 adenoviruses were generated, and insulin release by transduced human islets was measured. UCP-2 and UCP-3 mRNA levels were determined using quantitative PCR. UCP-2 and UCP-3 protein expression was investigated in human islets cultured in the presence of different glucose concentrations. Human pancreatic sections were analyzed for subcellular localization of UCP-3 using immunohistochemistry. Principal Findings. Dominant negative UCP-2 expression in human islets increased insulin secretion compared to control islets (p<0.05). UCP-3 mRNA is expressed in human islets, but the relative abundance of UCP-2 mRNA was 8.1-fold higher (p<0.05). Immunohistochemical analysis confirmed co-localization of UCP-3 protein with mitochondria in human beta-cells. UCP-2 protein expression in human islets was increased similar to 2-fold after high glucose exposure, whereas UCP-3 protein expression was decreased by similar to 40% (p<0.05). UCP-3 overexpression improved glucose-stimulated insulin secretion. Conclusions. UCP-2 and UCP-3 may have distinct roles in regulating beta-cell function. Increased expression of UCP-2 and decreased expression of UCP-3 in humans with chronic hyperglycemia may contribute to impaired glucose-stimulated insulin secretion. These data imply that mechanisms that suppress UCP-2 or mechanisms that increase UCP-3 expression and/or function are potential therapeutic targets to offset defects of insulin secretion in humans with type-2 diabetes.	[Li, Yunfeng; Maedler, Kathrin; Shu, Luan; Haataja, Leena] Univ Calif Los Angeles, David Geffen Sch Med, Larry L Hillblom Islet Res Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Haataja, L (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Larry L Hillblom Islet Res Ctr, Los Angeles, CA 90095 USA.	lhaataja@mednet.ucla.edu	Maedler, Kathrin/ABE-3022-2021	Maedler, Kathrin/0000-0002-7436-1197	Larry L. Hillblom Foundation [2003/1Mc, 2005/1C]; American Diabetes Association [706JF41]	Larry L. Hillblom Foundation; American Diabetes Association(American Diabetes Association)	Larry L. Hillblom Foundation 2003/1Mc (LH), 2005/1C (KM) and American Diabetes Association 706JF41 (KM)	Anello M, 2005, DIABETOLOGIA, V48, P282, DOI 10.1007/s00125-004-1627-9; Argyropoulos G, 2002, J APPL PHYSIOL, V92, P2187, DOI 10.1152/japplphysiol.00994.2001; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Ashcroft FM, 1999, DIABETOLOGIA, V42, P903, DOI 10.1007/s001250051247; Beattie GM, 1997, J CLIN ENDOCR METAB, V82, P1852, DOI 10.1210/jc.82.6.1852; Briaud I, 2002, DIABETES, V51, P662, DOI 10.2337/diabetes.51.3.662; Brown JEP, 2002, FEBS LETT, V513, P189, DOI 10.1016/S0014-5793(02)02296-2; Chan CB, 2004, DIABETES, V53, pS136, DOI 10.2337/diabetes.53.2007.S136; Chan CB, 2001, DIABETES, V50, P1302, DOI 10.2337/diabetes.50.6.1302; Chan CB, 1999, DIABETES, V48, P1482, DOI 10.2337/diabetes.48.7.1482; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; De Souza CT, 2007, FASEB J, V21, P1153, DOI 10.1096/fj.06-7148com; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; EIZIRIK DL, 1992, J CLIN INVEST, V90, P1263, DOI 10.1172/JCI115989; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Feeney CJ, 2003, J NEUROSCI METH, V125, P13, DOI 10.1016/S0165-0270(03)00027-X; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Gong DW, 2000, J BIOL CHEM, V275, P16251, DOI 10.1074/jbc.M910177199; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hesselink MKC, 2005, HORM METAB RES, V37, P550, DOI 10.1055/s-2005-870421; Hong Y, 2001, ENDOCRINOLOGY, V142, P249, DOI 10.1210/en.142.1.249; Jimenez M, 2002, EUR J BIOCHEM, V269, P2878, DOI 10.1046/j.1432-1033.2002.02953.x; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Lameloise N, 2001, DIABETES, V50, P803, DOI 10.2337/diabetes.50.4.803; Langin D, 2001, NEW ENGL J MED, V345, P1772, DOI 10.1056/NEJM200112133452412; Laybutt DR, 2002, J BIOL CHEM, V277, P10912, DOI 10.1074/jbc.M111751200; Li LX, 2002, ENDOCRINOLOGY, V143, P1371, DOI 10.1210/en.143.4.1371; Lingohr MK, 2003, MOL CELL ENDOCRINOL, V204, P85, DOI 10.1016/S0303-7207(03)00124-2; Lingohr MK, 2002, DIABETES, V51, P966, DOI 10.2337/diabetes.51.4.966; Lupi R, 2002, DIABETES, V51, P1437, DOI 10.2337/diabetes.51.5.1437; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; Maedler K, 2003, DIABETES, V52, P726, DOI 10.2337/diabetes.52.3.726; Mattson MP, 2003, BIOCHEM BIOPH RES CO, V304, P539, DOI 10.1016/S0006-291X(03)00627-2; Medvedev AV, 2002, J BIOL CHEM, V277, P42639, DOI 10.1074/jbc.M208645200; Mills EM, 2002, J BIOL CHEM, V277, P27385, DOI 10.1074/jbc.M111860200; Patane G, 2002, DIABETES, V51, P2749, DOI 10.2337/diabetes.51.9.2749; Pecqueur C, 2001, J BIOL CHEM, V276, P8705, DOI 10.1074/jbc.M006938200; Poitout V, 2002, ENDOCRINOLOGY, V143, P339, DOI 10.1210/en.143.2.339; REERS M, 1991, BIOCHEMISTRY-US, V30, P4480, DOI 10.1021/bi00232a015; Ritzel RA, 2003, J CLIN ENDOCR METAB, V88, P742, DOI 10.1210/jc.2002-021250; Robertson RP, 2003, DIABETES, V52, P581, DOI 10.2337/diabetes.52.3.581; Schrauwen P, 2004, DIABETES, V53, P1412, DOI 10.2337/diabetes.53.6.1412; Schrauwen P, 2006, J CLIN ENDOCR METAB, V91, P1520, DOI 10.1210/jc.2005-1572; Schrauwen P, 2001, DIABETES, V50, P2870, DOI 10.2337/diabetes.50.12.2870; Son C, 2004, DIABETOLOGIA, V47, P47, DOI 10.1007/s00125-003-1272-8; Song SH, 2002, J CLIN ENDOCR METAB, V87, P213, DOI 10.1210/jc.87.1.213; UNGER RH, 1995, DIABETES, V44, P863, DOI 10.2337/diabetes.44.8.863; Vidal-Puig AJ, 2000, J BIOL CHEM, V275, P16258, DOI 10.1074/jbc.M910179199; VidalPuig A, 1997, BIOCHEM BIOPH RES CO, V235, P79, DOI 10.1006/bbrc.1997.6740; Zhang CY, 2001, CELL, V105, P745, DOI 10.1016/S0092-8674(01)00378-6	54	29	31	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1397	10.1371/journal.pone.0001397	http://dx.doi.org/10.1371/journal.pone.0001397			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167556	Green Submitted, Green Published, gold			2022-12-25	WOS:000260468900025
J	Singer-Lahat, D; Chikvashvili, D; Lotan, I				Singer-Lahat, Dafna; Chikvashvili, Dodo; Lotan, Ilana			Direct Interaction of Endogenous Kv Channels with Syntaxin Enhances Exocytosis by Neuroendocrine Cells	PLOS ONE			English	Article							DEPENDENT K+ CHANNELS; BOTULINUM TOXIN C1; N-TERMINUS; RAT-BRAIN; POTASSIUM CHANNELS; INSULIN-SECRETION; FUNCTIONAL IMPACT; CALCIUM-CHANNELS; SNARE COMPLEXES; MEMBRANE-FUSION	K+ efflux through voltage-gated K+ (Kv) channels can attenuate the release of neurotransmitters, neuropeptides and hormones by hyperpolarizing the membrane potential and attenuating Ca2+ influx. Notably, direct interaction between Kv2.1 channels overexpressed in PC12 cells and syntaxin has recently been shown to facilitate dense core vesicle (DCV)-mediated release. Here, we focus on endogenous Kv2.1 channels and show that disruption of their interaction with native syntaxin after ATP-dependent priming of the vesicles by Kv2.1 syntaxin-binding peptides inhibits Ca2+ - triggered exocytosis of DCVs from cracked PC12 cells in a specific and dose-dependent manner. The inhibition cannot simply be explained by the impairment of the interaction of syntaxin with its SNARE cognates. Thus, direct association between endogenous Kv2.1 and syntaxin enhances exocytosis and in combination with the Kv2.1 inhibitory effect to hyperpolarize the membrane potential, could contribute to the known activity dependence of DCV release in neuroendocrine cells and in dendrites where Kv2.1 commonly expresses and influences release.	[Singer-Lahat, Dafna; Chikvashvili, Dodo; Lotan, Ilana] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Lotan, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, Ramat Aviv, Israel.	ilotan@post.tau.ac.il			Israel Science Foundation [640/02]	Israel Science Foundation(Israel Science Foundation)	This research was supported by the Israel Science Foundation grant 640/02 (to IL).	BENNETT MK, 1992, J CELL BIOL, V116, P761, DOI 10.1083/jcb.116.3.761; BENNETT MK, 1992, SCIENCE, V257, P255, DOI 10.1126/science.1321498; BENNETT MK, 1995, CURR OPIN CELL BIOL, V7, P581, DOI 10.1016/0955-0674(95)80016-6; Bergsman JB, 2000, J NEUROSCI, V20, P4368, DOI 10.1523/JNEUROSCI.20-12-04368.2000; Betz A, 1997, J BIOL CHEM, V272, P2520; BEZPROZVANNY I, 1995, NATURE, V378, P623, DOI 10.1038/378623a0; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Du J, 1998, NEUROSCIENCE, V84, P37, DOI 10.1016/S0306-4522(97)00519-8; Fili O, 2001, J NEUROSCI, V21, P1964, DOI 10.1523/JNEUROSCI.21-06-01964.2001; Hanson PI, 1997, CURR OPIN NEUROBIOL, V7, P310, DOI 10.1016/S0959-4388(97)80057-8; HAY JC, 1992, J CELL BIOL, V119, P139, DOI 10.1083/jcb.119.1.139; Hay JC, 1997, CURR OPIN CELL BIOL, V9, P505, DOI 10.1016/S0955-0674(97)80026-9; Hua YY, 2001, P NATL ACAD SCI USA, V98, P8065, DOI 10.1073/pnas.131214798; HWANG PM, 1993, J NEUROSCI, V13, P1569; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jing J, 1999, EMBO J, V18, P1245, DOI 10.1093/emboj/18.5.1245; Khvotchev M, 2007, J NEUROSCI, V27, P12147, DOI 10.1523/JNEUROSCI.3655-07.2007; Leung YM, 2005, BIOCHEM J, V387, P195, DOI 10.1042/BJ20041625; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; MacDonald PE, 2002, J BIOL CHEM, V277, P44938, DOI 10.1074/jbc.M205532200; MacDonald PE, 2002, MOL ENDOCRINOL, V16, P2452, DOI 10.1210/me.2002-0058; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; MARTIN TFJ, 1989, J BIOL CHEM, V264, P10299; MARTIN TFJ, 1989, METHOD ENZYMOL, V168, P225; Meir A, 1999, PHYSIOL REV, V79, P1019, DOI 10.1152/physrev.1999.79.3.1019; Michaelevski I, 2003, J BIOL CHEM, V278, P34320, DOI 10.1074/jbc.M304943200; Murakoshi H, 1999, J NEUROSCI, V19, P1728; RHODES KJ, 1995, J NEUROSCI, V15, P5360; Richmond JE, 2001, NATURE, V412, P338, DOI 10.1038/35085583; Roeper J, 1996, CURR OPIN NEUROBIOL, V6, P338, DOI 10.1016/S0959-4388(96)80117-6; Singer-Lahat D, 2007, J NEUROSCI, V27, P1651, DOI 10.1523/JNEUROSCI.4006-06.2007; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Spafford JD, 2003, J BIOL CHEM, V278, P4258, DOI 10.1074/jbc.M211076200; Stanley EF, 2003, EUR J NEUROSCI, V17, P1303, DOI 10.1046/j.1460-9568.2003.02536.x; TRIMMER JS, 1993, FEBS LETT, V324, P205, DOI 10.1016/0014-5793(93)81394-F; Tsuk S, 2005, MOL PHARMACOL, V67, P480, DOI 10.1124/mol.104.005314; Wiser O, 1996, EMBO J, V15, P4100, DOI 10.1002/j.1460-2075.1996.tb00785.x; Wolf-Goldberg T, 2006, MOL PHARMACOL, V70, P818, DOI 10.1124/mol.105.021717; Yan LZ, 2004, DIABETES, V53, P597, DOI 10.2337/diabetes.53.3.597	39	26	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1381	10.1371/journal.pone.0001381	http://dx.doi.org/10.1371/journal.pone.0001381			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167541	Green Submitted, Green Published, gold			2022-12-25	WOS:000260468900009
J	McGovern, G; Jeffrey, M				McGovern, Gillian; Jeffrey, Martin			Scrapie-Specific Pathology of Sheep Lymphoid Tissues	PLOS ONE			English	Article								Transmissible spongiform encephalopathies (TSEs) or prion diseases often result in accumulation of disease-associated PrP (PrP(d)) in the lymphoreticular system (LRS), specifically in association with follicular dendritic cells (FDCs) and tingible body macrophages (TBMs) of secondary follicles. We studied the effects of sheep scrapie on lymphoid tissue in tonsils and lymph nodes by light and electron microscopy. FDCs of sheep were grouped according to morphology as immature, mature or regressing. Scrapie was associated with FDC dendrite hypertrophy and electron dense deposit or vesicles. PrP(d) was located using immunogold labelling at the plasmalemma of FDC dendrites and, infrequently, mature B cells. Abnormal electron dense deposits surrounding FDC dendrites were identified as immunoglobulins suggesting that excess immune complexes are retained and are indicative of an FDC dysfunction. Within scrapie-affected lymph nodes, macrophages outside the follicle and a proportion of germinal centre TBMs accumulated PrP(d) within endosomes and lysosomes. In addition, TBMs showed PrP(d) in association with the cell membrane, non-coated pits and vesicles, and also with discrete, large and random endoplasmic reticulum networks, which co-localised with ubiquitin. These observations suggest that PrP(d) is internalised via the caveolin-mediated pathway, and causes an abnormal disease-related alteration in endoplasmic reticulum structure. In contrast to current dogma, this study shows that sheep scrapie is associated with cytopathology of germinal centres, which we attribute to abnormal antigen complex trapping by FDCs and abnormal endocytic events in TBMs. The nature of the sub-cellular changes in FDCs and TBMs differs from those of scrapie infected neurones and glial cells suggesting that different PrP(d)/cell membrane interactions occur in different cell types.	[McGovern, Gillian; Jeffrey, Martin] Vet Labs Agcy Lasswade, Penicuik, Midlothian, Scotland		McGovern, G (corresponding author), Vet Labs Agcy Lasswade, Pentlands Sci Pk, Penicuik, Midlothian, Scotland.	g.mcgovern@vla.defra.gsi.gov.uk	Jeffrey, Martin/D-2251-2009; McGOVERN, GILLIAN/C-3441-2011	McGOVERN, GILLIAN/0000-0001-5344-5909	Department for Environment, Food and Rural Affairs [Se1940, Se1955]	Department for Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA))	This work was supported by funding from Department for Environment, Food and Rural Affairs projects Se1940 and Se1955.	BENLIMAME N, 1995, J CELL BIOL, V129, P459, DOI 10.1083/jcb.129.2.459; BOSSELOIR A, 1995, FOLLICULAR DENDRITIC, P53; Brown KL, 1999, NAT MED, V5, P1308, DOI 10.1038/15264; CARP RI, 1994, ARCH VIROL, V136, P255, DOI 10.1007/BF01321056; CAUGHEY B, 1991, J BIOL CHEM, V266, P18217; Denzer K, 2000, J IMMUNOL, V165, P1259, DOI 10.4049/jimmunol.165.3.1259; Denzer K, 2000, J CELL SCI, V113, P3365; Ersdal C, 2003, ACTA NEUROPATHOL, V106, P17, DOI 10.1007/s00401-003-0690-5; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Gonzalez L, 2006, VET REC, V158, P325, DOI 10.1136/vr.158.10.325; Gonzalez L, 2002, J COMP PATHOL, V126, P17, DOI 10.1053/jcpa.2001.0516; Gonzalez L, 2001, J COMP PATHOL, V125, P41, DOI 10.1053/jcpa.2001.0475; GONZALEZ L, 2007, VET REC IN PRESS; Heggebo R, 2002, J GEN VIROL, V83, P479, DOI 10.1099/0022-1317-83-2-479; Heinen E, 1995, CURR TOP MICROBIOL, V201, P15; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Jeffrey M, 2000, J PATHOL, V191, P323, DOI 10.1002/1096-9896(200007)191:3&lt;323::AID-PATH629&gt;3.0.CO;2-Z; Jeffrey M, 2004, ANN NEUROL, V55, P781, DOI 10.1002/ana.20093; Jeffrey M, 2003, J GEN VIROL, V84, P1033, DOI 10.1099/vir.0.18825-0; JEFFREY M, 1994, NEUROSCI LETT, V174, P39, DOI 10.1016/0304-3940(94)90113-9; Jeffrey M, 2001, J COMP PATHOL, V125, P271, DOI 10.1053/jcpa.2001.0499; Jeffrey M, 2001, J COMP PATHOL, V125, P48, DOI 10.1053/jcpa.2001.0476; Jeffrey M, 1996, PRION DIS, P301; KARTENBECK J, 1989, J CELL BIOL, V109, P2721, DOI 10.1083/jcb.109.6.2721; Liu T, 2002, J BIOL CHEM, V277, P47671, DOI 10.1074/jbc.M207458200; MAUL GG, 1978, J VIROL, V28, P936, DOI 10.1128/JVI.28.3.936-944.1978; McGovern G, 2004, J COMP PATHOL, V130, P181, DOI 10.1016/j.jcpa.2003.11.001; Nielsen CH, 2000, IMMUNOLOGY, V100, P4, DOI 10.1046/j.1365-2567.2000.00009.x; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Press CM, 2004, ADV DRUG DELIVER REV, V56, P885, DOI 10.1016/j.addr.2003.09.008; RADEMAKERS LHPM, 1992, CELL TISSUE RES, V269, P359, DOI 10.1007/BF00319629; RADOUX D, 1985, ADV EXP MED BIOL, V186, P185; REYNOLDS JD, 1983, EUR J IMMUNOL, V13, P627, DOI 10.1002/eji.1830130805; SHYNG SL, 1994, J CELL BIOL, V125, P1239, DOI 10.1083/jcb.125.6.1239; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Smith J P, 1998, Dev Immunol, V6, P285, DOI 10.1155/1998/38923; Sprocati T, 2006, J CELL SCI, V119, P3249, DOI 10.1242/jcs.03058; St Rose SG, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-5; SZAKAL AK, 1990, ANAT REC, V227, P475, DOI 10.1002/ar.1092270411; Szakal AK, 2002, SEMIN IMMUNOL, V14, P267, DOI 10.1016/S1044-5323(02)00059-3; THORBECKE GJ, 1994, FASEB J, V8, P832, DOI 10.1096/fasebj.8.11.8070632; vanKeulen LJM, 1996, J CLIN MICROBIOL, V34, P1228, DOI 10.1128/JCM.34.5.1228-1231.1996	42	26	26	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1304	10.1371/journal.pone.0001304	http://dx.doi.org/10.1371/journal.pone.0001304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074028	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459500023
J	Kim, JM; Kakusho, N; Yamada, M; Kanoh, Y; Takemoto, N; Masai, H				Kim, J. M.; Kakusho, N.; Yamada, M.; Kanoh, Y.; Takemoto, N.; Masai, H.			Cdc7 kinase mediates Claspin phosphorylation in DNA replication checkpoint	ONCOGENE			English	Article						Cdc7; DNA replication checkpoint; hydroxyurea; Chk1	HUMAN CDC7-RELATED KINASE; FORK PROTECTION COMPLEX; S-PHASE ARREST; FISSION YEAST; CELL-CYCLE; GENOTOXIC STRESS; SCHIZOSACCHAROMYCES-POMBE; EFFICIENT PROGRESSION; DAMAGE RESPONSE; PROTEIN-KINASE	Cdc7 kinase is evolutionarily conserved and is involved in initiation and progression of DNA replication. However, roles of Cdc7 in checkpoint responses remain largely unknown. In this study, we show that deletion of the Cdc7 genes in mouse embryonic stem (ES) cells abrogates hydroxyurea (HU)- or UV-induced activation of Chk1. HU-induced Chk1 activation is also impaired in human cancer cell lines in which Cdc7 is depleted by siRNA, and Cdc7-depleted cells are more sensitive to HU treatment. In contrast, ATR and Rad17 are relocated to chromatin in these cells following HU treatment, indicating that stalled DNA replication forks are detected normally. Cdc7-depleted cells exhibit defects in chromatin association and phosphorylation of Claspin, suggesting that Cdc7 exerts its effect at least partially through Claspin. Consistent with this prediction, Cdc7 interacts with and phosphorylates Claspin. We propose that Cdc7 is required for activation of the ATR-Chk1 checkpoint pathway through regulation of Cl aspin.	[Kim, J. M.; Kakusho, N.; Yamada, M.; Kanoh, Y.; Masai, H.] Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, Tokyo 1138613, Japan; [Takemoto, N.] Tokyo Metropolitan Inst Med Sci, Cytokine Project, Bunkyo Ku, Tokyo 1138613, Japan	Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science	Masai, H (corresponding author), Tokyo Metropolitan Inst Med Sci, Genome Dynam Project, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo 1138613, Japan.	hmasai@rinshoken.or.jp						Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bao SD, 2001, NATURE, V411, P969, DOI 10.1038/35082110; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Brown GW, 1999, P NATL ACAD SCI USA, V96, P8443, DOI 10.1073/pnas.96.15.8443; Chen YH, 2004, DNA REPAIR, V3, P1025, DOI 10.1016/j.dnarep.2004.03.003; Christiano C, 2003, J BIOL CHEM, V278, P30057, DOI 10.1074/jbc.M301136200; Clarke CAL, 2005, J BIOL CHEM, V280, P35337, DOI 10.1074/jbc.M506460200; Cortez D, 2004, P NATL ACAD SCI USA, V101, P10078, DOI 10.1073/pnas.0403410101; Costanzo V, 2003, MOL CELL, V11, P203, DOI 10.1016/S1097-2765(02)00799-2; Duncker BP, 2002, P NATL ACAD SCI USA, V99, P16087, DOI 10.1073/pnas.252093999; Jeong SY, 2003, J BIOL CHEM, V278, P46782, DOI 10.1074/jbc.M304551200; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kihara M, 2000, J BIOL CHEM, V275, P35051, DOI 10.1074/jbc.M003491200; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(00)00082-4; Kumagai A, 2003, NAT CELL BIOL, V5, P161, DOI 10.1038/ncb921; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Lee J, 2005, MOL BIOL CELL, V16, P5269, DOI 10.1091/mbc.E05-07-0671; Lee J, 2003, MOL CELL, V11, P329, DOI 10.1016/S1097-2765(03)00045-5; Lin SY, 2004, P NATL ACAD SCI USA, V101, P6484, DOI 10.1073/pnas.0401847101; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Matsumoto S, 2005, J BIOL CHEM, V280, P42536, DOI 10.1074/jbc.M510575200; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Montagnoli A, 2004, CANCER RES, V64, P7110, DOI 10.1158/0008-5472.CAN-04-1547; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Robison JG, 2004, J BIOL CHEM, V279, P34802, DOI 10.1074/jbc.M404750200; Sclafani RA, 2000, J CELL SCI, V113, P2111; Shechter D, 2004, DNA REPAIR, V3, P901, DOI 10.1016/j.dnarep.2004.03.020; Sommariva E, 2005, MOL CELL BIOL, V25, P2770, DOI 10.1128/MCB.25.7.2770-2784.2005; Stiff T, 2005, EMBO J, V24, P199, DOI 10.1038/sj.emboj.7600504; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Takeda T, 2001, MOL BIOL CELL, V12, P1257, DOI 10.1091/mbc.12.5.1257; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tenca P, 2007, J BIOL CHEM, V282, P208, DOI 10.1074/jbc.M604457200; Tibbetts RS, 2000, GENE DEV, V14, P2989, DOI 10.1101/gad.851000; Wang X, 2003, GENE DEV, V17, P965, DOI 10.1101/gad.1065103; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Yanow SK, 2003, J BIOL CHEM, V278, P41083, DOI 10.1074/jbc.M307144200; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhao H, 2003, MOL CELL BIOL, V23, P8395, DOI 10.1128/MCB.23.22.8395-8403.2003; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	51	74	77	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2008	27	24					3475	3482		10.1038/sj.onc.1210994	http://dx.doi.org/10.1038/sj.onc.1210994			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	307HL	18084324				2022-12-25	WOS:000256309900012
J	Germain, M; Milburn, J; Duronio, V				Germain, Marc; Milburn, Jocelyn; Duronio, Vincent			MCL-1 inhibits BAX in the absence of MCL-1/BAX interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BH3-ONLY PROTEINS; MITOCHONDRIAL-MEMBRANE; BCL-2 FAMILY; ENDOPLASMIC-RETICULUM; CYTOCHROME-C; BH3 DOMAINS; CELL-DEATH; APOPTOSIS; INITIATION; FISSION	The BCL-2 family of proteins plays a major role in the control of apoptosis as the primary regulator of mitochondrial permeability. The pro-apoptotic BCL-2 homologues BAX and BAK are activated following the induction of apoptosis and induce cytochrome c release from mitochondria. A second class of BCL-2 homologues, the BH3-only proteins, is required for the activation of BAX and BAK. The activity of both BAX/BAK and BH3-only proteins is opposed by anti-apoptotic BCL-2 homologues such as BCL-2 and MCL-1. Here we show that anti-apoptotic MCL-1 inhibits the function of BAX downstream of its initial activation and translocation to mitochondria. Although MCL-1 interacted with BAK and inhibited its activation, the activity of MCL-1 against BAX was independent of an interaction between the two proteins. However, the anti-apoptotic function of MCL-1 required the presence of BAX. These results suggest that the pro-survival activity of MCL-1 proceeds via inhibition of BAX function at mitochondria, downstream of its activation and translocation to this organelle.	Univ British Columbia, Dept Med, Vancouver, BC V6H 3Z6, Canada; Jack Bell Res Ctr, Vancouver Coastal Hlth Res Inst, Vancouver, BC V6H 3Z6, Canada	University of British Columbia; University of British Columbia; Vancouver Coastal Health Research Institute	Germain, M (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC V6H 3Z6, Canada.							Antonsson B, 2001, J BIOL CHEM, V276, P11615, DOI 10.1074/jbc.M010810200; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Germain M, 2005, EMBO J, V24, P1546, DOI 10.1038/sj.emboj.7600592; Germain M, 2002, J BIOL CHEM, V277, P18053, DOI 10.1074/jbc.M201235200; Germain M, 2007, J BIOL CHEM, V282, P32233, DOI 10.1074/jbc.M706408200; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Leber B, 2007, APOPTOSIS, V12, P897, DOI 10.1007/s10495-007-0746-4; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Ruffolo SC, 2003, J BIOL CHEM, V278, P25039, DOI 10.1074/jbc.M302930200; Takahashi Y, 2005, MOL CELL BIOL, V25, P9369, DOI 10.1128/MCB.25.21.9369-9382.2005; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wei MC, 2000, GENE DEV, V14, P2060; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001	26	42	44	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6384	6392		10.1074/jbc.M707762200	http://dx.doi.org/10.1074/jbc.M707762200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18089567	hybrid			2022-12-25	WOS:000253779500046
J	Li, H; Wang, Y; Liu, X				Li, Hongchang; Wang, Yun; Liu, Xiaoqi			Plk1-dependent phosphorylation regulates functions of DNA topoisomerase II alpha in cell cycle progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE KINASE; REPLICATION CHECKPOINT RESPONSE; SPINDLE CHECKPOINT; BETA; APOPTOSIS; RECOVERY; CLASPIN; COHESIN; YEAST; PLK1	Plk1 (Polo-like kinase 1) has been documented as a critical regulator of many mitotic events. However, increasing evidence supports the notion that Plk1 might also have functions outside of mitosis. Using biochemical fractionation and RNA interference approaches, we found that Plk1 was required for both G(1)/S and G(2)/M phases and that DNA topoisomerase II alpha (topoII alpha) was a potential target for Plk1 in both interphase and mitosis. Plk1 phosphorylates Ser(1337) and Ser(1524) of topoII alpha. Overexpression of an unphosphorylatable topoII alpha mutant led to S phase arrest, suggesting that Plk1-associated phosphorylation first occurs in S phase. Moreover, overexpression of the unphosphorylatable topoII alpha mutant activated the ATM/R-dependent DNA damage checkpoint, probably due to reduced catalytic activity of topoII alpha, and resulted in accumulation of catenated DNA. Finally, we showed that wild type topoII alpha, but not the unphosphorylatable mutant, was able to rescue topoII alpha depletion-induced defects in sister chromatid segregation, indicating that Plk1-associated phosphorylation is essential for the functions of topoII alpha in mitosis.	Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; Purdue Univ, Ctr Canc, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Li, H (corresponding author), Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA.				NATIONAL CANCER INSTITUTE [K01CA114401] Funding Source: NIH RePORTER; NCI NIH HHS [K01 CA 114401] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexandru G, 2001, CELL, V105, P459, DOI 10.1016/S0092-8674(01)00362-2; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; BURDEN DA, 1994, BIOCHEMISTRY-US, V33, P14651, DOI 10.1021/bi00253a001; CARDENAS ME, 1993, J CELL SCI, V104, P219; Chang CJ, 2003, J CELL SCI, V116, P4715, DOI 10.1242/jcs.00797; Chikamori K, 2003, J BIOL CHEM, V278, P12696, DOI 10.1074/jbc.M300837200; Christensen MO, 2002, J CELL BIOL, V157, P31, DOI 10.1083/jcb.200112023; CORBETT AH, 1993, BIOCHEMISTRY-US, V32, P2090, DOI 10.1021/bi00059a029; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Escargueil AE, 2000, J BIOL CHEM, V275, P34710, DOI 10.1074/jbc.M005179200; GERDES J, 1984, J IMMUNOL, V133, P1710; GOLSTEYN RM, 1994, J CELL SCI, V107, P1509; Ishida R, 1996, J BIOL CHEM, V271, P30077, DOI 10.1074/jbc.271.47.30077; Issacs R. J., 1998, BIOCHIM BIOPHYS ACTA, V1400, P121; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; McPherson JP, 1998, CANCER RES, V58, P4519; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; NITISS JL, 1998, BIOCHIM BIOPHYS ACTA, V1400, P121; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590; ROCA J, 1994, P NATL ACAD SCI USA, V91, P1781, DOI 10.1073/pnas.91.5.1781; Sakaguchi A, 2004, J CELL SCI, V117, P1047, DOI 10.1242/jcs.00977; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Shapiro PS, 1999, MOL CELL BIOL, V19, P3551; Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2; Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; van Vugt MATM, 2004, MOL CELL, V15, P799, DOI 10.1016/j.molcel.2004.07.015; WELLS NJ, 1994, J BIOL CHEM, V269, P29746; Yoo HY, 2004, CELL, V117, P575, DOI 10.1016/S0092-8674(04)00417-9	33	84	86	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6209	6221		10.1074/jbc.M709007200	http://dx.doi.org/10.1074/jbc.M709007200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171681	hybrid			2022-12-25	WOS:000253779500028
J	Hao, YW; Chun, A; Cheung, K; Rashidi, B; Yang, XL				Hao, Yawei; Chun, Alex; Cheung, Kevin; Rashidi, Babak; Yang, Xiaolong			Tumor suppressor LATS1 is a negative regulator of oncogene YAP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YES-ASSOCIATED PROTEIN; CELL-PROLIFERATION; HUMAN HOMOLOG; SIGNALING PATHWAY; DROSOPHILA LATS; HIPPO PATHWAY; GROWTH; APOPTOSIS; KINASE; PROMOTES	LATS ((la) under bar rge (t) under bar umor (s) under bar uppressor) or warts is a Ser/Thr kinase that belongs to the Ndr/LATS subfamily of AGC ( protein kinase (A) under bar /PK (G) under bar /PK (C) under bar) kinases. It is a tumor suppressor gene originally isolated from Drosophila and recently isolated from mice and humans. Drosophila or mice mutant for LATS develop tumors in various tissues. Recent studies in Drosophila demonstrate that LATS is a central player of an emerging tumor suppressor pathway called the Hippo-LATS/Warts pathway that suppresses tumor growth by regulating cell proliferation, cell growth, and cell death. Although tremendous progress has been made toward understanding the roles of LATS in tumorigenesis, the kinase substrates of LATS or downstream target proteins mediating LATS function remain largely unknown. In this study, we have provided convincing evidence that the LATS1 tumor suppressor can bind to and phosphorylate transcription regulator and oncogene YAP in vitro and in vivo. We have also identified HX(R/H/K)XX(S/T) as the consensus phosphorylation sequence for LATS/Ndr kinase substrates. Significantly, we have discovered that LATS1 inactivates YAP oncogenic function by suppressing its transcription regulation of cellular genes via sequestration of YAP in the cytoplasm after phosphorylation of YAP. Finally, by using microarray analysis, we have also identified many oncogenes or tumor suppressor genes up-regulated or down-regulated by YAP. These research findings will have profound impacts on our understanding of the molecular mechanism of the LATS tumor suppressor and the emerging Hippo-LATS/Warts pathway.	[Hao, Yawei; Chun, Alex; Cheung, Kevin; Rashidi, Babak; Yang, Xiaolong] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	McMaster University; Queens University - Canada	Yang, XL (corresponding author), Richard Lab 201,88 Stuart St, Kingston, ON K7L 3N6, Canada.	yang@cliff.path.queensu.ca		Rashidi, Babak/0000-0001-7273-8686				Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Bertotti A, 2005, CANCER RES, V65, P10674, DOI 10.1158/0008-5472.CAN-05-2827; Board R, 2005, DRUG RESIST UPDATE, V8, P75, DOI 10.1016/j.drup.2005.03.004; Chan EH, 2005, ONCOGENE, V24, P2076, DOI 10.1038/sj.onc.1208445; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Danen EHJ, 2003, J PATHOL, V200, P471, DOI 10.1002/path.1416; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Eckfeld K, 2004, CANCER RES, V64, P8688, DOI 10.1158/0008-5472.CAN-04-2065; Emoto K, 2004, CELL, V119, P245, DOI 10.1016/j.cell.2004.09.036; Espanel X, 2001, J BIOL CHEM, V276, P14514, DOI 10.1074/jbc.M008568200; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Guo C, 2007, CURR BIOL, V17, P700, DOI 10.1016/j.cub.2007.02.055; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; HERGOVICH A, 2007, BIOCH BIOPHYS ACTA; Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ingham RJ, 2005, MOL CELL BIOL, V25, P7092, DOI 10.1128/MCB.25.16.7092-7106.2005; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kamikubo Y, 2003, J BIOL CHEM, V278, P17609, DOI 10.1074/jbc.M211974200; Ke HN, 2004, EXP CELL RES, V298, P329, DOI 10.1016/j.yexcr.2004.04.031; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lee MH, 2001, CELL MOL LIFE SCI, V58, P1907, DOI 10.1007/PL00000826; Li YF, 2003, ONCOGENE, V22, P4398, DOI 10.1038/sj.onc.1206603; Mah Angie S., 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-22; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Nouhi Z, 2006, CANCER RES, V66, P1824, DOI 10.1158/0008-5472.CAN-05-2292; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Polesello C, 2006, CURR BIOL, V16, P2459, DOI 10.1016/j.cub.2006.10.060; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004; St John MAR, 1999, NAT GENET, V21, P182, DOI 10.1038/5965; Strano S, 2001, J BIOL CHEM, V276, P15164, DOI 10.1074/jbc.M010484200; Tao WF, 1999, NAT GENET, V21, P177, DOI 10.1038/5960; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Virdee K, 2007, FEBS LETT, V581, P2657, DOI 10.1016/j.febslet.2007.05.009; Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X; XU TA, 1995, DEVELOPMENT, V121, P1053; Yabuta N, 2000, GENOMICS, V63, P263, DOI 10.1006/geno.1999.6065; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yang XL, 2004, NAT CELL BIOL, V6, P609, DOI 10.1038/ncb1140; Yang XL, 1998, ONCOGENE, V17, P981, DOI 10.1038/sj.onc.1202032; Yang XL, 2001, ONCOGENE, V20, P6516, DOI 10.1038/sj.onc.1204817; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907	54	594	620	0	46	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5496	5509		10.1074/jbc.M709037200	http://dx.doi.org/10.1074/jbc.M709037200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18158288	hybrid			2022-12-25	WOS:000253426700030
J	Kim, YK; Wassef, L; Hamberger, L; Piantedosi, R; Palczewski, K; Blaner, WS; Quadro, L				Kim, Youn-Kyung; Wassef, Lesley; Hamberger, Leora; Piantedosi, Roseann; Palczewski, Krzysztof; Blaner, William S.; Quadro, Loredana			Retinyl ester formation by lecithin: Retinol acyltransferase is a key regulator of retinoid Homeostasis in mouse embryogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A-DEFICIENCY; BINDING-PROTEIN; EMBRYONIC-DEVELOPMENT; DIFFERENTIAL EXPRESSION; HUMAN CYTOCHROME-P450; MEMBRANE-RECEPTOR; ZEBRAFISH EMBRYO; CELLULAR UPTAKE; RAT-LIVER; ACID	The developing mammalian embryo is entirely dependent on the maternal circulation for its supply of retinoids ( vitamin A and its metabolites). The mechanisms through which mammalian developing tissues maintain adequate retinoid levels in the face of suboptimal or excessive maternal dietary vitamin A intake have not been established. We investigated the role of retinyl ester formation catalyzed by lecithin: retinol acyltransferase (LRAT) in regulating retinoid homeostasis during embryogenesis. Dams lacking both LRAT and retinol-binding protein (RBP), the sole specific carrier for retinol in serum, were maintained on diets containing different amounts of vitamin A during pregnancy. We hypothesized that the lack of both proteins would make the embryo more vulnerable to changes in maternal dietary vitamin A intake. Our data demonstrate that maternal dietary vitamin A deprivation during pregnancy generates a severe retinoid-deficient phenotype of the embryo due to the severe retinoid- deficient status of the double mutant dams rather than to the lack of LRAT in the developing tissues. Moreover, in the case of excessive maternal dietary vitamin A intake, LRAT acts together with Cyp26A1, one of the enzymes that catalyze the degradation of retinoic acid, and possibly with STRA6, the recently identified cell surface receptor for retinol-RBP, in maintaining adequate levels of retinoids in embryonic and extraembryonic tissues. In contrast, the pathway of retinoic acid synthesis does not contribute significantly to regulating retinoid homeostasis during mammalian development except under conditions of severe maternal retinoid deficiency.	[Kim, Youn-Kyung; Wassef, Lesley; Hamberger, Leora; Quadro, Loredana] Rutgers State Univ, Rutgers Ctr Lipid Res, Dept Food Sci, New Brunswick, NJ 08901 USA; [Piantedosi, Roseann; Blaner, William S.] Columbia Univ Coll Phys & Surg, Dept Med, New York, NY 10032 USA; [Palczewski, Krzysztof] Case Western Reserve Univ, Case Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Rutgers State University New Brunswick; Columbia University; Case Western Reserve University	Quadro, L (corresponding author), Rutgers State Univ, Rutgers Ctr Lipid Res, Dept Food Sci, 65 Dudley Rd, New Brunswick, NJ 08901 USA.	quadro@aesop.rutgers.edu			NEI NIH HHS [R01 EY009339, EY09339] Funding Source: Medline; NICHD NIH HHS [R01 HD057493] Funding Source: Medline; NIDDK NIH HHS [DK068437, R01 DK079221, DK079221, R56 DK068437, R01 DK061310, R01 DK068437, DK061310] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057493] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY009339] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK068437, R01DK079221, R01DK061310, R01DK068437] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Balmer JE, 2002, J LIPID RES, V43, P1773, DOI 10.1194/jlr.R100015-JLR200; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Blaner WS, 2007, CELL METAB, V5, P164, DOI 10.1016/j.cmet.2007.02.006; BLANER WS, 1994, J BIOL CHEM, V269, P16559; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Chambon Pierre, 1994, Seminars in Cell Biology, V5, P115, DOI 10.1006/scel.1994.1015; Clagett-Dame M, 2002, ANNU REV NUTR, V22, P347, DOI 10.1146/annurev.nutr.22.010402.102745E; Cross JC, 2006, REPROD FERT DEVELOP, V18, P71, DOI 10.1071/RD05121; DELIGDISH L, 1992, HORMONES FETAL PATHO; Dobbs-McAuliffe B, 2004, MECH DEVELOP, V121, P339, DOI 10.1016/j.mod.2004.02.008; Duester G, 2000, EUR J BIOCHEM, V267, P4315, DOI 10.1046/j.1432-1327.2000.01497.x; Guo XJ, 2002, CANCER RES, V62, P1654; HERR FM, 1992, BIOCHEMISTRY-US, V31, P6748, DOI 10.1021/bi00144a014; Isken A, 2007, J BIOL CHEM, V282, P1144, DOI 10.1074/jbc.M609109200; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kurlandsky SB, 1996, J BIOL CHEM, V271, P15346, DOI 10.1074/jbc.271.26.15346; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; LOHNES D, 1994, DEVELOPMENT, V120, P2723; Loudig O, 2005, BIOCHEM J, V392, P241, DOI 10.1042/BJ20050874; MacLean G, 2001, MECH DEVELOP, V107, P195, DOI 10.1016/S0925-4773(01)00463-4; Marceau G, 2007, VITAM HORM, V75, P97, DOI 10.1016/S0083-6729(06)75004-X; MENDELSOHN C, 1991, DEVELOPMENT, V113, P723; Morriss-Kay GM, 1999, INT REV CYTOL, V188, P73; *NAT RES COUNC, 1996, GUID CAR US LAB AN; Niederreither K, 1997, MECH DEVELOP, V62, P67, DOI 10.1016/S0925-4773(96)00653-3; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; OSMOND MK, 1991, DEVELOPMENT, V113, P1405; Quadro L, 2005, ENDOCRINOLOGY, V146, P4479, DOI 10.1210/en.2005-0158; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Quadro L, 2004, AM J PHYSIOL-ENDOC M, V286, pE844, DOI 10.1152/ajpendo.00556.2003; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reijntjes S, 2005, DEV BIOL, V285, P224, DOI 10.1016/j.ydbio.2005.06.019; ROSS AC, 2003, J NUTR, V133, P291; Ross SA, 2000, PHYSIOL REV, V80, P1021, DOI 10.1152/physrev.2000.80.3.1021; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; SAARI JC, 1989, J BIOL CHEM, V264, P8636; Sapin V, 2000, MECH DEVELOP, V92, P295, DOI 10.1016/S0925-4773(00)00241-0; SATRE MA, 1992, BIOL REPROD, V46, P802, DOI 10.1095/biolreprod46.5.802; Taimi M, 2004, J BIOL CHEM, V279, P77, DOI 10.1074/jbc.M308337200; TANEJA R, 1995, P NATL ACAD SCI USA, V92, P7854, DOI 10.1073/pnas.92.17.7854; VOGEL S, 1999, HANDB EXP PHARM, V139, P31; Wang XS, 2001, GENOMICS, V74, P245, DOI 10.1006/geno.2001.6546; WARKANY J, 1946, ARCH OPHTHALMOL-CHIC, V35, P150, DOI 10.1001/archopht.1946.00890200155008; White JA, 1996, J BIOL CHEM, V271, P29922, DOI 10.1074/jbc.271.47.29922; White JA, 2000, P NATL ACAD SCI USA, V97, P6403, DOI 10.1073/pnas.120161397; *WHO, 1998, MICR SER WHO; WILSON JG, 1953, AM J ANAT, V92, P189, DOI 10.1002/aja.1000920202; WOLBACH SB, 1947, J BONE JOINT SURG, V29, P171; Wolf G, 2007, NUTR REV, V65, P385, DOI 10.1301/nr.2007.aug.385-388; YOST RW, 1988, J BIOL CHEM, V263, P18693; Zile MH, 2001, J NUTR, V131, P705, DOI 10.1093/jn/131.3.705; Zolfaghari R, 2000, J LIPID RES, V41, P2024	54	59	61	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5611	5621		10.1074/jbc.M708885200	http://dx.doi.org/10.1074/jbc.M708885200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093970	Green Accepted, hybrid			2022-12-25	WOS:000253426700041
J	Yang, HJ; Xia, YY; Lu, SQ; Soong, TW; Feng, ZW				Yang, Haijie; Xia, Yinyan; Lu, Song Qing; Soong, Tuck Wah; Feng, Zhi Wei			Basic fibroblast growth factor-induced neuronal differentiation of mouse bone marrow stromal cells requires FGFR-1, MAPK/ERK, and transcription factor AP-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCTION PATHWAYS; RETINAL-PIGMENT EPITHELIUM; MESENCHYMAL STEM-CELLS; FACTOR RECEPTORS; FACTOR (FGF)-2; NEURAL RETINA; KINASE; PROTEIN; TRANSDIFFERENTIATION; EXPRESSION	It has been reported recently that bone marrow stromal cells (BMSCs) are able to differentiate into various neural cells both in vivo and in vitro (Egusa, H., Schweizer, F. E., Wang, C. C., Matsuka, Y., and Nishimura, I. (2005) J. Biol. Chem. 280, 23691 23697). However, the underlying mechanisms remain largely unknown. In this report, we have demonstrated that basic fibroblast growth factor (bFGF) alone effectively induces mouse BMSC neuronal differentiation. These differentiated neuronal cells exhibit characteristic electrophysiological properties and elevated levels of the neuronal differentiation marker, growth-associated protein-43 (GAP-43). To explore possible signaling pathways, we first analyzed the expression of various FGF receptors in mouse BMSCs. FGF receptor-1, -2, and -3 were detected, but only FGFR-1 was shown to be activated by bFGF. Small interfering RNA knock down of FGFR-1 in BMSCs significantly inhibited neuronal differentiation. Moreover, we have shown that the mitogen-activated protein kinase (ERK1/2) is persistently activated and blockage of ERK activity with the ERK-specific inhibitor U0126 prevents neuronal differentiation. It appears that activation of ERK cascade and neuronal differentiation of BMSCs induced by bFGF are independent of Ras activity but require functions of phospholipase C-gamma pathway. Lastly, we examined the role of the immediate-early transcription factors AP-1 and NF-kappa B and have found that phospholipase C-gamma-dependent c-Jun and ERK-dependent c-fos, but not the NF-kappa B, are strongly activated by bFGF, which in turn regulates the neuronal differentiation of BMSCs.	[Yang, Haijie; Xia, Yinyan; Lu, Song Qing; Soong, Tuck Wah; Feng, Zhi Wei] Natl Inst Neurosci, Res Labs, Singapore 308433, Singapore	National Neuroscience Institute (NNI)	Feng, ZW (corresponding author), NNI Res, 11 Jalan Tan Tock Seng, Singapore, Singapore.	Zhi_Wei_Feng@nni.com.sg		Soong, Tuck Wah/0000-0002-0876-0325				Abe K, 2000, DEV BRAIN RES, V122, P81, DOI 10.1016/S0165-3806(00)00054-7; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; BROWN PH, 1994, ONCOGENE, V9, P791; BURRY RW, 1992, J NEUROCYTOL, V21, P413, DOI 10.1007/BF01191506; Chen Y, 2000, ONCOGENE, V19, P3750, DOI 10.1038/sj.onc.1203726; Chiba S, 2005, EXP BRAIN RES, V163, P86, DOI 10.1007/s00221-004-2148-y; Chikazu D, 2000, J BIOL CHEM, V275, P31444, DOI 10.1074/jbc.M910132199; Choi DY, 2001, J BIOL CHEM, V276, P5116, DOI 10.1074/jbc.M002959200; Corti S, 2004, J CELL MOL MED, V8, P329, DOI 10.1111/j.1582-4934.2004.tb00322.x; DAVIS RJ, 1995, MOL REPROD DEV, V42, P459, DOI 10.1002/mrd.1080420414; DEXTER TM, 1977, J CELL PHYSIOL, V91, P335, DOI 10.1002/jcp.1040910303; Dimitropoulou A, 2000, BRAIN RES, V858, P205, DOI 10.1016/S0006-8993(00)01946-6; Doniach T, 1995, CELL, V83, P1067, DOI 10.1016/0092-8674(95)90133-7; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Feng ZW, 1999, J BIOL CHEM, V274, P30341, DOI 10.1074/jbc.274.43.30341; Galy A, 2002, DEV BIOL, V248, P251, DOI 10.1006/dbio.2002.0736; Herdegen T, 2001, ONCOGENE, V20, P2424, DOI 10.1038/sj.onc.1204387; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Jin K, 2003, EXP NEUROL, V183, P255, DOI 10.1016/S0014-4886(03)00220-6; JOHNSON DE, 1993, ADV CANCER RES, V60, P1; King AJ, 1998, NATURE, V396, P180, DOI 10.1038/24184; Klint P, 1999, ONCOGENE, V18, P3354, DOI 10.1038/sj.onc.1202680; Kopen GC, 1999, P NATL ACAD SCI USA, V96, P10711, DOI 10.1073/pnas.96.19.10711; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Leppa S, 2001, MOL CELL BIOL, V21, P4369, DOI 10.1128/MCB.21.13.4369-4378.2001; LERNER EC, 1995, J BIOL CHEM, V270, P26770, DOI 10.1074/jbc.270.45.26770; Lu P, 2004, J NEUROSCI RES, V77, P174, DOI 10.1002/jnr.20148; Ma QF, 2006, J PHYSIOL-LONDON, V575, P379, DOI 10.1113/jphysiol.2006.113449; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; McKeehan WL, 1998, PROG NUCLEIC ACID RE, V59, P135; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; MOHAMMADI M, 1991, MOL CELL BIOL, V11, P5068, DOI 10.1128/MCB.11.10.5068; O'Neill E, 2004, BRIT J CANCER, V90, P283, DOI 10.1038/sj.bjc.6601488; Pirvola U, 2002, NEURON, V35, P671, DOI 10.1016/S0896-6273(02)00824-3; PITTACK C, 1991, DEVELOPMENT, V113, P577; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Powers CJ, 2000, ENDOCR-RELAT CANCER, V7, P165, DOI 10.1677/erc.0.0070165; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reuss B, 2003, CELL TISSUE RES, V313, P139, DOI 10.1007/s00441-003-0756-7; Sakaguchi DS, 1997, DEV DYNAM, V209, P387, DOI 10.1002/(SICI)1097-0177(199708)209:4<387::AID-AJA6>3.0.CO;2-E; Sanchez-Ramos JR, 2002, J NEUROSCI RES, V69, P880, DOI 10.1002/jnr.10337; Schaeffer HJ, 1999, MOL CELL BIOL, V19, P2435; Tohjima E, 2003, J BONE MINER RES, V18, P1461, DOI 10.1359/jbmr.2003.18.8.1461; Walsh S, 2000, BONE, V27, P185, DOI 10.1016/S8756-3282(00)00319-7; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; Weinstein DC, 1998, NATURE, V394, P904, DOI 10.1038/29808; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Woodbury D, 2000, J NEUROSCI RES, V61, P364, DOI 10.1002/1097-4547(20000815)61:4<364::AID-JNR2>3.0.CO;2-C; WOODGETT JR, 1994, PIGM CELL RES, V7, P96, DOI 10.1111/j.1600-0749.1994.tb00027.x; Xu YX, 1998, HEMATOPATHOL MOL HEM, V11, P49; YANG Q, 2005, AHONGGUO ZHONG XI YI, V25, P248	51	69	77	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5287	5295		10.1074/jbc.M706917200	http://dx.doi.org/10.1074/jbc.M706917200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18171671	hybrid			2022-12-25	WOS:000253426700008
J	Zou, YL; Wu, J; Giannone, RJ; Boucher, L; Du, HS; Huang, Y; Johnson, DK; Liu, Y; Wang, YS				Zou, Yonglong; Wu, Jun; Giannone, Richard J.; Boucher, Lorrie; Du, Hansen; Huang, Ying; Johnson, Dabney K.; Liu, Yie; Wang, Yisong			Nucleophosmin/B23 negatively regulates GCN5-dependent histone acetylation and transactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLTRANSFERASE ACTIVITY; DEPENDENT KINASE; PROTEIN; PHOSPHORYLATION; TRANSCRIPTION; GENE; GCN5; IDENTIFICATION; CHROMATIN; H3	Nucleophosmin/B23 is a multifunctional phosphoprotein that is overexpressed in cancer cells and has been shown to be involved in both positive and negative regulation of transcription. In this study, we first identified GCN5 acetyltransferase as a B23-interacting protein by mass spectrometry, which was then confirmed by in vivo co-immunoprecipitation. An in vitro assay demonstrated that B23 bound the PCAF-N domain of GCN5 and inhibited GCN5-mediated acetylation of both free and mononucleosomal histones, probably through interfering with GCN5 and masking histones from being acetylated. Mitotic B23 exhibited higher inhibitory activity on GCN5-mediated histone acetylation than interphase B23. Immunodepletion experiments of mitotic extracts revealed that phosphorylation of B23 at Thr(199) enhanced the inhibition of GCN5-mediated histone acetylation. Moreover, luciferase reporter and microarray analyses suggested that B23 attenuated GCN5-mediated transactivation in vivo. Taken together, our studies suggest a molecular mechanism of B23 in the mitotic inhibition of GCN5-mediated histone acetylation and transactivation.	[Zou, Yonglong; Wu, Jun; Giannone, Richard J.; Huang, Ying; Johnson, Dabney K.; Wang, Yisong] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37831 USA; [Boucher, Lorrie] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Du, Hansen; Liu, Yie] NIH, NIA, Ctr Gerontol Res, Baltimore, MD 21224 USA	United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Wang, YS (corresponding author), Oak Ridge Natl Lab, Biosci Div, Bethel Valley Rd, Oak Ridge, TN 37831 USA.	ywa@ornl.gov	Giannone, Richard/ABC-8247-2020; Wu, Jun/AAF-1830-2019; Liu, Yie/AAO-2092-2020	Giannone, Richard/0000-0001-8551-0138; Wu, Jun/0000-0001-9863-1668; 	NATIONAL INSTITUTE ON AGING [ZIAAG000748, Z01AG000748] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Barlev NA, 1998, MOL CELL BIOL, V18, P1349, DOI 10.1128/MCB.18.3.1349; BIEMANN K, 1990, METHOD ENZYMOL, V193, P886, DOI 10.1016/0076-6879(90)93460-3; Boyer LA, 2002, MOL CELL, V10, P935, DOI 10.1016/S1097-2765(02)00634-2; Brown CE, 2000, TRENDS BIOCHEM SCI, V25, P15, DOI 10.1016/S0968-0004(99)01516-9; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; Candau R, 1997, EMBO J, V16, P555, DOI 10.1093/emboj/16.3.555; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cho HP, 2005, MOL CELL BIOL, V25, P4541, DOI 10.1128/MCB.25.11.4541-4551.2005; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Falini B, 2007, HAEMATOLOGICA, V92, P519, DOI 10.3324/haematol.11007; Fang JY, 2002, WORLD J GASTROENTERO, V8, P400, DOI 10.3748/wjg.v8.i3.400; Frehlick LJ, 2007, BIOESSAYS, V29, P49, DOI 10.1002/bies.20512; Giannone RJ, 2007, BIOTECHNIQUES, V43, P296, DOI 10.2144/000112550; Gomez M, 2006, MOL BIOL CELL, V17, P1686, DOI 10.1091/mbc.E05-07-0672; Gregory PD, 1998, MOL CELL, V1, P495, DOI 10.1016/S1097-2765(00)80050-7; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Hsu CY, 2000, INT J CANCER, V88, P392, DOI 10.1002/1097-0215(20001101)88:3<392::AID-IJC11>3.0.CO;2-7; INOUYE CJ, 1994, J BIOL CHEM, V269, P6506; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kobayashi H, 2004, INT J CANCER, V109, P207, DOI 10.1002/ijc.11697; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Kuo MH, 1996, NATURE, V383, P269, DOI 10.1038/383269a0; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Liu H, 2007, EMBO REP, V8, P394, DOI 10.1038/sj.embor.7400909; Lo WS, 2000, MOL CELL, V5, P917, DOI 10.1016/S1097-2765(00)80257-9; Lu YY, 1996, BIOCHEM J, V317, P321, DOI 10.1042/bj3170321; Maiguel DA, 2004, MOL CELL BIOL, V24, P3703, DOI 10.1128/MCB.24.9.3703-3711.2004; Negi SS, 2006, J CELL SCI, V119, P3676, DOI 10.1242/jcs.03090; OCHS R, 1983, EXP CELL RES, V146, P139, DOI 10.1016/0014-4827(83)90332-4; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2002, MOL BIOL CELL, V13, P2016, DOI 10.1091/mbc.02-03-0036; Okuwaki M, 2001, FEBS LETT, V506, P272, DOI 10.1016/S0014-5793(01)02939-8; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; Redner RL, 2000, BLOOD, V95, P2683; Santos-Rosa H, 2003, NUCLEIC ACIDS RES, V31, P4285, DOI 10.1093/nar/gkg655; Sekiguchi T, 2006, NUCLEIC ACIDS RES, V34, P4593, DOI 10.1093/nar/gkl603; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Sowa Y, 1997, BIOCHEM BIOPH RES CO, V241, P142, DOI 10.1006/bbrc.1997.7786; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sterner DE, 2006, BIOCHEMISTRY-US, V45, P1035, DOI 10.1021/bi051624q; Swaminathan V, 2005, MOL CELL BIOL, V25, P7534, DOI 10.1128/MCB.25.17.7534-7545.2005; Tabb DL, 2005, ANAL CHEM, V77, P2464, DOI 10.1021/ac0487000; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tarapore P, 2006, FEBS LETT, V580, P399, DOI 10.1016/j.febslet.2005.12.022; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Xu WT, 1998, MOL CELL BIOL, V18, P5659, DOI 10.1128/MCB.18.10.5659	52	10	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5728	5737		10.1074/jbc.M709932200	http://dx.doi.org/10.1074/jbc.M709932200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165222	hybrid			2022-12-25	WOS:000253426700054
J	Chang, WC; Di Capite, J; Singaravelu, K; Nelson, C; Halse, V; Parekh, AB				Chang, Wei-Chiao; Di Capite, Joseph; Singaravelu, Karthika; Nelson, Charmaine; Halse, Victoria; Parekh, Anant B.			Local Ca2+ influx through Ca2+ release-activated Ca2+ (CRAC) channels stimulates production of an intracellular messenger and an intercellular pro-inflammatory signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-DEPENDENT ACTIVATION; LEUKOTRIENE C-4 SECRETION; MAST-CELLS; PLASMA-MEMBRANE; TRPC3 CHANNELS; RBL-1 CELLS; T-CELLS; ENTRY; MICRODOMAINS; DEPLETION	Ca2+ entry through store-operated Ca2+ channels drives the production of the pro-inflammatory molecule leukotriene C-4 (LTC4) from mast cells through a pathway involving Ca2+-dependent protein kinase C, mitogen-activated protein kinases ERK1/2, phospholipase A(2), and 5-lipoxygenase. Here we examine whether local Ca2+ influx through store-operated Ca2+ release-activated Ca2+ (CRAC) channels in the plasma membrane stimulates this signaling pathway. Manipulating the amplitude and spatial extent of Ca2+ entry by altering chemical and electrical gradients for Ca2+ influx or changing the Ca2+ buffering of the cytoplasm all impacted on protein kinase C and ERK activation, generation of arachidonic acid and LTC4 secretion, with little change in the bulk cytoplasmic Ca2+ rise. Similar bulk cytoplasmic Ca2+ concentrations were achieved when CRAC channels were activated in 0.25 mM external Ca2+ versus 2 mM Ca2+ and 100 nM La3+, an inhibitor of CRAC channels. However, despite similar bulk cytoplasmic Ca2+, protein kinase C activation and LTC4 secretion were larger in 2 mM Ca2+ and La3+ than in 0.25 mM Ca2+, consistent with the central involvement of a subplasmalemmal Ca2+ rise. The nonreceptor tyrosine kinase Syk coupled CRAC channel opening to protein kinase C and ERK activation. Recombinant TRPC3 channels also activated protein kinase C, suggesting that subplasmalemmal Ca2+ rather than a microdomain exclusive to CRAC channels is the trigger. Hence a subplasmalemmal Ca2+ increase in mast cells is highly versatile in that it triggers cytoplasmic responses through generation of intracellular messengers as well as long distance changes through increased secretion of paracrine signals.	[Chang, Wei-Chiao; Di Capite, Joseph; Singaravelu, Karthika; Nelson, Charmaine; Halse, Victoria; Parekh, Anant B.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3PT, England	University of Oxford	Parekh, AB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Pk Rd, Oxford OX1 3PT, England.	anant.parekh@dpag.ox.ac.uk		Chang, Wei-Chiao/0000-0002-8573-5924	Medical Research Council [G0200218] Funding Source: Medline; MRC [G0200218] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BADING H, 1993, SCIENCE, V260, P181, DOI 10.1126/science.8097060; Bakowski D, 2001, J PHYSIOL-LONDON, V532, P55, DOI 10.1111/j.1469-7793.2001.0055g.x; Bautista DM, 2004, J PHYSIOL-LONDON, V556, P805, DOI 10.1113/jphysiol.2003.060004; Berkefeld H, 2006, SCIENCE, V314, P615, DOI 10.1126/science.1132915; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bird GS, 2005, J PHYSIOL-LONDON, V562, P697, DOI 10.1113/jphysiol.2004.077289; Carafoli E, 2002, P NATL ACAD SCI USA, V99, P1115, DOI 10.1073/pnas.032427999; CARAFOLI E, 1991, PHYSIOL REV, V71, P129, DOI 10.1152/physrev.1991.71.1.129; Chang WC, 2004, J BIOL CHEM, V279, P29994, DOI 10.1074/jbc.M403969200; Chang WC, 2007, J IMMUNOL, V179, P5255, DOI 10.4049/jimmunol.179.8.5255; Chang WC, 2006, FASEB J, V20, P2381, DOI 10.1096/fj.06-6016fje; Fagan KA, 1998, J BIOL CHEM, V273, P9297, DOI 10.1074/jbc.273.15.9297; Fierro L, 2000, J PHYSIOL-LONDON, V522, P247, DOI 10.1111/j.1469-7793.2000.t01-1-00247.x; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Herrington J, 1996, NEURON, V16, P219, DOI 10.1016/S0896-6273(00)80038-0; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; HOTH M, 1993, J PHYSIOL-LONDON, V465, P359, DOI 10.1113/jphysiol.1993.sp019681; Kamouchi M, 1999, J PHYSIOL-LONDON, V518, P345, DOI 10.1111/j.1469-7793.1999.0345p.x; Kawakami Y, 2003, P NATL ACAD SCI USA, V100, P9470, DOI 10.1073/pnas.1633695100; LANSMAN JB, 1986, J GEN PHYSIOL, V88, P321, DOI 10.1085/jgp.88.3.321; Lin S, 2000, J BIOL CHEM, V275, P17979, DOI 10.1074/jbc.275.24.17979; MCCLOSKEY MA, 1990, J GEN PHYSIOL, V95, P205, DOI 10.1085/jgp.95.2.205; Moreau B, 2005, J BIOL CHEM, V280, P8776, DOI 10.1074/jbc.M409619200; Neher E, 1998, NEURON, V20, P389, DOI 10.1016/S0896-6273(00)80983-6; Neher E., 1986, EXPT BRAIN RES SERIE, P80; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Peters-Golden M, 2006, CLIN EXP ALLERGY, V36, P689, DOI 10.1111/j.1365-2222.2006.02498.x; Prakriya M, 2002, J GEN PHYSIOL, V119, P487, DOI 10.1085/jgp.20028551; Prakriya M, 2006, J GEN PHYSIOL, V128, P373, DOI 10.1085/jgp.200609588; PREMACK BA, 1994, J IMMUNOL, V152, P5226; Reeves JP, 2003, AM J PHYSIOL-CELL PH, V285, pC763, DOI 10.1152/ajpcell.00168.2003; Rezaul K, 1997, BIOCHEM BIOPH RES CO, V239, P23, DOI 10.1006/bbrc.1997.7419; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Seabold GK, 2003, J BIOL CHEM, V278, P15040, DOI 10.1074/jbc.M212825200; Straube S, 2002, PFLUG ARCH EUR J PHY, V444, P389, DOI 10.1007/s00424-002-0812-2; Trebak M, 2003, CELL CALCIUM, V33, P451, DOI 10.1016/S0143-4160(03)00056-3; Trebak M, 2003, J BIOL CHEM, V278, P16244, DOI 10.1074/jbc.M300544200; WANG XY, 1994, J BIOCHEM-TOKYO, V116, P858, DOI 10.1093/oxfordjournals.jbchem.a124607; Zenisek D, 2000, NEURON, V25, P229, DOI 10.1016/S0896-6273(00)80885-5; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	40	72	72	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4622	4631		10.1074/jbc.M705002200	http://dx.doi.org/10.1074/jbc.M705002200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156181	hybrid			2022-12-25	WOS:000253426500019
J	Donnelly, PS; Caragounis, A; Du, T; Laughton, KM; Volitakis, I; Cherny, RA; Sharples, RA; Hill, AF; Li, QX; Masters, CL; Barnham, KJ; White, AR				Donnelly, Paul S.; Caragounis, Aphrodite; Du, Tai; Laughton, Katrina M.; Volitakis, Irene; Cherny, Robert A.; Sharples, Robyn A.; Hill, Andrew F.; Li, Qiao-Xin; Masters, Colin L.; Barnham, Kevin J.; White, Anthony R.			Selective intracellular release of copper and zinc ions from bis( thiosemicarbazonato) complexes reduces levels of Alzheimer disease amyloid-beta peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIS(THIOSEMICARBAZONE) COMPLEXES; TRANSGENIC MICE; METAL-COMPLEXES; BINDING; BRAIN; NEURODEGENERATION; ACCUMULATION; CU(II); AGENTS; CELLS	Copper and zinc play important roles in Alzheimer disease pathology with recent reports describing potential therapeutics based on modulation of metal bioavailability. We examined the ability of a range of metal bis( thiosemicarbazonato) complexes (M-II(btsc), where M = Cu-II or Zn-II) to increase intracellular metal levels in Chinese hamster ovary cells overexpressing amyloid precursor protein (APP-CHO) and the subsequent effect on extracellular levels of amyloid-beta peptide (A beta). The Cu-II( btsc) complexes were engineered to be either stable to both a change in oxidation state and dissociation of metal or susceptible to intracellular reduction and dissociation of metal. Treatment of APP-CHO cells with stable complexes resulted in elevated levels of intracellular copper with no effect on the detected levels of A beta. Treatment with complexes susceptible to intracellular reduction increased intracellular copper levels but also resulted in a dose-dependent reduction in the levels of monomeric A beta. Treatment with less stable Zn-II( btsc) complexes increased intracellular zinc levels with a subsequent dose-dependent depletion of monomeric A beta levels. The increased levels of intracellular bioavailable copper and zinc initiated a signaling cascade involving activation of phosphoinositol 3-kinase and c-Jun N-terminal kinase. Inhibition of these enzymes prevented A beta depletion induced by the M-II( btsc) complexes. Inhibition of metalloproteases also partially restored A beta levels, implicating metal-driven metalloprotease activation in the extracellular monomeric A beta depletion. However, a role for alternative metal-induced A beta metabolism has not been ruled out. These studies demonstrate that MII( btsc) complexes have potential for Alzheimer disease therapy.	[Donnelly, Paul S.; Sharples, Robyn A.; Barnham, Kevin J.] Univ Melbourne, Sch Chem, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia; [Caragounis, Aphrodite; Du, Tai; Laughton, Katrina M.; Volitakis, Irene; Cherny, Robert A.; Sharples, Robyn A.; Hill, Andrew F.; Li, Qiao-Xin; Masters, Colin L.; Barnham, Kevin J.; White, Anthony R.] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia; [Caragounis, Aphrodite; Du, Tai; Laughton, Katrina M.; Volitakis, Irene; Cherny, Robert A.; Sharples, Robyn A.; Hill, Andrew F.; Li, Qiao-Xin; Masters, Colin L.; Barnham, Kevin J.; White, Anthony R.] Mental Hlth Res Inst, Parkville, Vic 3052, Australia; [Caragounis, Aphrodite; Du, Tai; Masters, Colin L.; White, Anthony R.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia; [Sharples, Robyn A.; Hill, Andrew F.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia	University of Melbourne; University of Melbourne; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne	Donnelly, PS (corresponding author), Univ Melbourne, Sch Chem, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia.	pauld@unimelb.edu.au; arwhite@unimelb.edu.au	Hill, Andrew F./GZL-4124-2022; Hill, Andrew F./AAH-2854-2020; Hill, Andrew F/B-4527-2009; White, Anthony/P-5596-2016	Hill, Andrew F./0000-0001-5581-2354; Hill, Andrew F/0000-0001-5581-2354; White, Anthony/0000-0003-1802-9891; Volitakis, Irene/0000-0003-0766-817X				Adonai N, 2002, P NATL ACAD SCI USA, V99, P3030, DOI 10.1073/pnas.052709599; Ali FEA, 2004, AUST J CHEM, V57, P511, DOI 10.1071/CH04026; Alsop L, 2005, INORG CHIM ACTA, V358, P2770, DOI 10.1016/j.ica.2005.03.027; Anderson CJ, 1999, CHEM REV, V99, P2219, DOI 10.1021/cr980451q; Backstrom JR, 1996, J NEUROSCI, V16, P7910; Barnham K.J., 2004, DRUG DES REV ONLINE, V1, P75, DOI DOI 10.2174/1567269043480690; Bayer TA, 2003, P NATL ACAD SCI USA, V100, P14187, DOI 10.1073/pnas.2332818100; Beraldo H, 2004, MINI-REV MED CHEM, V4, P31, DOI 10.2174/1389557043487484; Blower PJ, 2003, DALTON T, P4416, DOI 10.1039/b307499d; Brown DR, 2004, DALTON T, P1907, DOI 10.1039/b401985g; Burdette SC, 2003, P NATL ACAD SCI USA, V100, P3605, DOI 10.1073/pnas.0637711100; Caragounis A, 2007, BIOCHEM J, V407, P435, DOI 10.1042/BJ20070579; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; Ciuculescu ED, 2005, CHEM-EUR J, V11, P903, DOI 10.1002/chem.200400786; Cowley AR, 2002, J AM CHEM SOC, V124, P5270, DOI 10.1021/ja012668z; Cowley AR, 2005, CHEM COMMUN, P845, DOI 10.1039/b417206j; Curtain Cyril C., 2003, Current Medicinal Chemistry - Immunology Endocrine & Metabolic Agents, V3, P309, DOI 10.2174/1568013033483276; Dearling JLJ, 1998, CHEM COMMUN, P2531, DOI 10.1039/a805957h; Dearling JLJ, 2002, J BIOL INORG CHEM, V7, P249, DOI 10.1007/s007750100291; Donnelly PS, 2007, CURR OPIN CHEM BIOL, V11, P128, DOI 10.1016/j.cbpa.2007.01.678; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Fujibayashi Y, 1997, J NUCL MED, V38, P1155; GREEN MA, 1988, J NUCL MED, V29, P1549; KRAKER A, 1985, J BIOL CHEM, V260, P3710; Lewis JS, 2001, P NATL ACAD SCI USA, V98, P1206, DOI 10.1073/pnas.98.3.1206; Lewis JS, 2001, J NUCL MED, V42, P655; Mocchegiani E, 2005, PROG NEUROBIOL, V75, P367, DOI 10.1016/j.pneurobio.2005.04.005; Pajonk FG, 2005, J ALZHEIMERS DIS, V8, P23; PETERING DH, 1974, BIOCHEM PHARMACOL, V23, P567, DOI 10.1016/0006-2952(74)90621-2; Phinney AL, 2003, P NATL ACAD SCI USA, V100, P14193, DOI 10.1073/pnas.2332851100; Ritchie CW, 2003, ARCH NEUROL-CHICAGO, V60, P1685, DOI 10.1001/archneur.60.12.1685; ROHER AE, 1994, BIOCHEM BIOPH RES CO, V205, P1755, DOI 10.1006/bbrc.1994.2872; Sparks DL, 2003, P NATL ACAD SCI USA, V100, P11065, DOI 10.1073/pnas.1832769100; WADA K, 1994, ARCH BIOCHEM BIOPHYS, V310, P1, DOI 10.1006/abbi.1994.1132; WEST DX, 1993, COORDIN CHEM REV, V123, P49, DOI 10.1016/0010-8545(93)85052-6; White AR, 2006, J BIOL CHEM, V281, P17670, DOI 10.1074/jbc.M602487200; Wu WD, 2004, AM J RESP CELL MOL, V30, P540, DOI 10.1165/rcmb.2003-0233OC	37	157	157	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4568	4577		10.1074/jbc.M705957200	http://dx.doi.org/10.1074/jbc.M705957200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086681	hybrid			2022-12-25	WOS:000253426500013
J	Kelber, JA; Shani, G; Booker, EC; Vale, WW; Gray, PC				Kelber, Jonathan A.; Shani, Gidi; Booker, Evan C.; Vale, Wylie W.; Gray, Peter C.			Cripto is a noncompetitive activin antagonist that forms analogous signaling complexes with activin and nodal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; EMBRYONIC STEM-CELLS; TGF-BETA; VERTEBRATE DEVELOPMENT; MESODERM INDUCTION; XENOPUS EMBRYOS; BINDING-SITE; I RECEPTORS; MECHANISMS; PATHWAY	Cripto plays critical roles during embryogenesis and has been implicated in promoting the growth and spread of tumors. Cripto is required for signaling by certain transforming growth factor-beta superfamily members, such as Nodal, but also antagonizes others, such as activin. The opposing effects of Cripto on Nodal and activin signaling seem contradictory, however, because these closely related ligands utilize the same type I (ALK4) and type II (ActRII/IIB) receptors. Here, we have addressed this apparent paradox by demonstrating that Cripto forms analogous receptor complexes with Nodal and activin and functions as a noncompetitive activin antagonist. Our results show that activin-A and Nodal elicit similar maximal signaling responses in the presence of Cripto that are substantially lower than that of activin-A in the absence of Cripto. In addition, we provide biochemical evidence for complexes containing activin-A, Cripto, and both receptor types and show that the assembly of such complexes is competitively inhibited by Nodal. We further demonstrate that Nodal and activin-A share the same binding site on ActRII and that ALK4 has distinct and separable binding sites for activin-A and Cripto. Finally, we show that ALK4 mutants with disrupted activin-A binding retain Cripto binding and prevent the effects of Cripto on both activin-A and Nodal signaling. Together, our data indicate that Cripto facilitates Nodal signaling and inhibits activin signaling by forming receptor complexes with these ligands that are structurally and functionally similar.	[Kelber, Jonathan A.; Shani, Gidi; Booker, Evan C.; Vale, Wylie W.; Gray, Peter C.] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA; [Kelber, Jonathan A.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92037 USA; [Booker, Evan C.] Univ Calif San Diego, Dept Biol, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Gray, PC (corresponding author), Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, La Jolla, CA 92037 USA.	gray@salk.edu		Kelber, Jonathan/0000-0002-4606-1445	NCI NIH HHS [R01CA107420] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA107420] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Adkins HB, 2003, J CLIN INVEST, V112, P575, DOI 10.1172/JCI200317788; Allendorph GP, 2006, P NATL ACAD SCI USA, V103, P7643, DOI 10.1073/pnas.0602558103; ATTISANO L, 1992, CELL, V68, P97, DOI 10.1016/0092-8674(92)90209-U; CARCAMO J, 1994, MOL CELL BIOL, V14, P3810, DOI 10.1128/MCB.14.6.3810; Chen CH, 2006, DEVELOPMENT, V133, P319, DOI 10.1242/dev.02210; CHEN RH, 1993, SCIENCE, V260, P1335, DOI 10.1126/science.8388126; Cheng SK, 2004, PLOS BIOL, V2, P215, DOI 10.1371/journal.pbio.0020030; Cheng SK, 2003, GENE DEV, V17, P31, DOI 10.1101/gad.1041203; Gray PC, 2000, J BIOL CHEM, V275, P3206, DOI 10.1074/jbc.275.5.3206; Gray PC, 2003, P NATL ACAD SCI USA, V100, P5193, DOI 10.1073/pnas.0531290100; Gray PC, 2006, MOL CELL BIOL, V26, P9268, DOI 10.1128/MCB.01168-06; Greenwald J, 2004, MOL CELL, V15, P485, DOI 10.1016/j.molcel.2004.07.011; Harms PW, 2003, GENE DEV, V17, P2624, DOI 10.1101/gad.1127703; Harrison CA, 2005, TRENDS ENDOCRIN MET, V16, P73, DOI 10.1016/j.tem.2005.01.003; Harrison CA, 2003, J BIOL CHEM, V278, P21129, DOI 10.1074/jbc.M302015200; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; MATHEWS LS, 1992, SCIENCE, V255, P1702, DOI 10.1126/science.1313188; MATHEWS LS, 1991, CELL, V65, P973, DOI 10.1016/0092-8674(91)90549-E; McDowell N, 1999, SEMIN CELL DEV BIOL, V10, P311, DOI 10.1006/scdb.1999.0307; Minchiotti G, 2001, DEVELOPMENT, V128, P4501; Nicolas FJ, 2003, ONCOGENE, V22, P3698, DOI 10.1038/sj.onc.1206420; Pardali K, 2007, BBA-REV CANCER, V1775, P21, DOI 10.1016/j.bbcan.2006.06.004; Parish CL, 2005, STEM CELLS, V23, P471, DOI 10.1634/stemcells.2004-0294; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Piek E, 1999, INT J CANCER, V80, P756, DOI 10.1002/(SICI)1097-0215(19990301)80:5<756::AID-IJC21>3.0.CO;2-N; Piepenburg O, 2004, DEVELOPMENT, V131, P4977, DOI 10.1242/dev.01323; Ramis JM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000213; Schier AF, 2003, ANNU REV CELL DEV BI, V19, P589, DOI 10.1146/annurev.cellbio.19.041603.094522; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shen MM, 2000, TRENDS GENET, V16, P303, DOI 10.1016/S0168-9525(00)02006-0; Shen MM, 2003, J CLIN INVEST, V112, P500, DOI 10.1172/JCI200319546; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Strizzi L, 2005, ONCOGENE, V24, P5731, DOI 10.1038/sj.onc.1208918; TENDIJKE P, 1994, SCIENCE, V264, P101, DOI 10.1126/science.8140412; Thompson TB, 2003, EMBO J, V22, P1555, DOI 10.1093/emboj/cdg156; Topczewska JM, 2006, NAT MED, V12, P925, DOI 10.1038/nm1448; TSUCHIDA K, 1995, ENDOCRINOLOGY, V136, P5493, DOI 10.1210/en.136.12.5493; VAUGHAN JM, 1993, ENDOCRINOLOGY, V132, P2038, DOI 10.1210/en.132.5.2038; Xu CH, 1998, DEV BIOL, V196, P237, DOI 10.1006/dbio.1998.8862; Yan YT, 2002, MOL CELL BIOL, V22, P4439, DOI 10.1128/MCB.22.13.4439-4449.2002; Yeo CY, 2001, MOL CELL, V7, P949, DOI 10.1016/S1097-2765(01)00249-0	44	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4490	4500		10.1074/jbc.M704960200	http://dx.doi.org/10.1074/jbc.M704960200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089557	hybrid			2022-12-25	WOS:000253426500005
J	Taguchi, H; Planque, S; Nishiyama, Y; Symersky, J; Boivin, S; Szabo, P; Friedland, RP; Ramsland, PA; Edmundson, AB; Weksler, ME; Paul, S				Taguchi, Hiroaki; Planque, Stephanie; Nishiyama, Yasuhiro; Symersky, Jindrich; Boivin, Stephane; Szabo, Paul; Friedland, Robert P.; Ramsland, Paul A.; Edmundson, Allen B.; Weksler, Marc E.; Paul, Sudhir			Autoantibody-catalyzed hydrolysis of amyloid beta peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BLOOD-BRAIN-BARRIER; VASOACTIVE-INTESTINAL-PEPTIDE; ALZHEIMERS-DISEASE; A-BETA; MOUSE MODEL; IMMUNE-RESPONSE; ANTIBODY; PROTEIN; CLEARANCE; IMMUNOTHERAPY	We describe IgM class human autoantibodies that hydrolyze amyloid beta peptide 1-40 (A beta 40). A monoclonal IgM from a patient with Waldenstrom's macroglobulinemia hydrolyzed A beta 40 at the Lys-28 -Gly-29 bond and Lys-16 - Ala-17 bonds. The catalytic activity was inhibited stoichiometrically by an electrophilic serine protease inhibitor. Treatment with the catalytic IgM blocked the aggregation and toxicity of A beta 40 in neuronal cell cultures. IgMs purified from the sera of patients with Alzheimer disease (AD) hydrolyzed A beta 40 at rates superior to IgMs from age-matched humans without dementia. IgMs from non-elderly humans expressed the least catalytic activity. The reaction rate was sufficient to afford appreciable degradation at physiological A beta and IgM concentrations found in peripheral circulation. Increased A beta concentrations in the AD brain are thought to induce neurodegenerative effects. Peripheral administration of A beta binding antibodies has been suggested as a potential treatment of AD. Our results suggest that catalytic IgM autoantibodies can help clear A beta, and they open the possibility of using catalytic Abs for AD immunotherapy.	[Taguchi, Hiroaki; Planque, Stephanie; Nishiyama, Yasuhiro; Symersky, Jindrich; Boivin, Stephane; Paul, Sudhir] Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Chem Immunol Res Ctr, Houston, TX 77030 USA; [Szabo, Paul; Weksler, Marc E.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA; [Friedland, Robert P.] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Ramsland, Paul A.] Macfarlane Burnet Inst Med Res Fdn, Struct Immunol Lab, Heidelberg, Vic 3084, Australia; [Edmundson, Allen B.] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	University of Texas System; University of Texas Health Science Center Houston; Cornell University; Case Western Reserve University; Burnet Institute; Oklahoma Medical Research Foundation	Paul, S (corresponding author), Univ Texas Houston, Sch Med, Dept Pathol & Lab Med, Chem Immunol Res Ctr, 6431 Fannin, Houston, TX 77030 USA.	Sudhir.Paul@uth.tmc.edu	Friedland, Robert/A-2834-2010; Boivin, Stephane/K-4018-2012	Friedland, Robert/0000-0001-5721-1843; Boivin, Stephane/0000-0003-1460-326X; Ramsland, Paul/0000-0002-2107-2738	NIA NIH HHS [1R01AG025304, R01AG017173] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG025304, R01AG017173] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Banks WA, 2007, EXP NEUROL, V206, P248, DOI 10.1016/j.expneurol.2007.05.005; Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682; Berisha HI, 2002, PULM PHARMACOL THER, V15, P121, DOI 10.1006/pupt.2001.0337; BLACK RS, 2006, 9 INT GEN SPR S ADV, P21; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Burbach GJ, 2007, NEUROBIOL AGING, V28, P202, DOI 10.1016/j.neurobiolaging.2005.12.003; Chander H, 2006, BRAIN RES, V1082, P173, DOI 10.1016/j.brainres.2006.01.079; Chauhan V, 2005, J ALZHEIMERS DIS, V7, P37; Chen R, 2003, PROTEINS, V52, P68, DOI 10.1002/prot.10388; Coles M, 1998, BIOCHEMISTRY-US, V37, P11064, DOI 10.1021/bi972979f; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Deane R, 2005, J NEUROSCI, V25, P11495, DOI 10.1523/JNEUROSCI.3697-05.2005; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodel RC, 2004, J NEUROL NEUROSUR PS, V75, P1472, DOI 10.1136/jnnp.2003.033399; ELOVAARA I, 1985, J NEUROL SCI, V70, P73, DOI 10.1016/0022-510X(85)90189-3; Ferrer I, 2004, BRAIN PATHOL, V14, P11, DOI 10.1111/j.1750-3639.2004.tb00493.x; Friedland RP, 2001, P NATL ACAD SCI USA, V98, P3440, DOI 10.1073/pnas.061002998; GAO QS, 1995, J MOL BIOL, V253, P658, DOI 10.1006/jmbi.1995.0580; Geylis V, 2006, AUTOIMMUN REV, V5, P33, DOI 10.1016/j.autrev.2005.06.007; Hifumi E, 2005, FEBS J, V272, P4497, DOI 10.1111/j.1742-4658.2005.04869.x; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Howe CL, 2006, NEUROBIOL DIS, V23, P731, DOI 10.1016/j.nbd.2006.06.012; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Knobloch M, 2007, J NEUROSCI, V27, P7648, DOI 10.1523/JNEUROSCI.0395-07.2007; KOO EH, 1993, P NATL ACAD SCI USA, V90, P4748, DOI 10.1073/pnas.90.10.4748; Lacroix-Desmazes S, 2005, P NATL ACAD SCI USA, V102, P4109, DOI 10.1073/pnas.0500586102; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Liu R, 2004, BIOCHEMISTRY-US, V43, P9999, DOI 10.1021/bi0492354; Lue LF, 2002, J NEUROSCI RES, V70, P599, DOI 10.1002/jnr.10422; Matsuoka Y, 2003, J NEUROSCI, V23, P29; MEI S, 1991, J BIOL CHEM, V266, P15571; Mirshahi M, 2006, IMMUNOL LETT, V106, P57, DOI 10.1016/j.imlet.2006.04.008; Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200; Morgan D, 2005, NEURODEGENER DIS, V2, P261, DOI 10.1159/000090366; Mruthinti S, 2004, NEUROBIOL AGING, V25, P1023, DOI 10.1016/j.neurobiolaging.2003.11.001; Nath A, 2003, NEUROMOL MED, V3, P29, DOI 10.1385/NMM:3:1:29; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nishiyama Y, 2002, ARCH BIOCHEM BIOPHYS, V402, P281, DOI 10.1016/S0003-9861(02)00087-5; Nishiyama Y, 2007, J BIOL CHEM, V282, P31250, DOI 10.1074/jbc.M706471200; OLEKSYSZYN J, 1994, METHOD ENZYMOL, V244, P423; Palop JJ, 2006, NATURE, V443, P768, DOI 10.1038/nature05289; Paul S, 2005, SPRINGER SEMIN IMMUN, V26, P485, DOI 10.1007/s00281-004-0191-1; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Paul S, 2003, J BIOL CHEM, V278, P20429, DOI 10.1074/jbc.M300870200; PAUL S, 1989, SCIENCE, V244, P1158, DOI 10.1126/science.2727702; Paul S, 2001, J BIOL CHEM, V276, P28314, DOI 10.1074/jbc.M102530200; Planque S, 2004, J BIOL CHEM, V279, P14024, DOI 10.1074/jbc.M312152200; Ponomarenko NA, 2006, P NATL ACAD SCI USA, V103, P281, DOI 10.1073/pnas.0509849103; Qiu WQ, 1998, J BIOL CHEM, V273, P32730, DOI 10.1074/jbc.273.49.32730; Ramsland PA, 2006, BIOCHEM J, V395, P473, DOI 10.1042/BJ20051739; Rangan SK, 2003, BIOCHEMISTRY-US, V42, P14328, DOI 10.1021/bi035038d; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; SAXON A, 1989, B LYMPHOCYTE SYSTEM; Schenk D, 2004, CURR OPIN IMMUNOL, V16, P599, DOI 10.1016/j.coi.2004.07.012; Sigurdsson EM, 2004, J NEUROSCI, V24, P6277, DOI 10.1523/JNEUROSCI.1344-04.2004; SOHN J, 1993, J EXP MED, V177, P493, DOI 10.1084/jem.177.2.493; Stine WB, 2003, J BIOL CHEM, V278, P11612, DOI 10.1074/jbc.M210207200; Vos Q, 2000, IMMUNOL REV, V176, P154; Walsh DM, 2007, J NEUROCHEM, V101, P1172, DOI 10.1111/j.1471-4159.2006.04426.x; Weksler ME, 2002, EXP GERONTOL, V37, P943, DOI 10.1016/S0531-5565(02)00029-3; White AR, 2003, J NEUROCHEM, V87, P801, DOI 10.1046/j.1471-4159.2003.02064.x; Wilcock DM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-24; Wolfe Michael S., 2002, Current Topics in Medicinal Chemistry, V2, P371, DOI 10.2174/1568026024607535; Xu JL, 2000, IMMUNITY, V13, P37, DOI 10.1016/S1074-7613(00)00006-6; YANKNER BA, 1990, SCIENCE, V250, P279, DOI 10.1126/science.2218531	66	64	70	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4714	4722		10.1074/jbc.M707983200	http://dx.doi.org/10.1074/jbc.M707983200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086674	hybrid			2022-12-25	WOS:000253426500029
J	Zheng, YX; Boeglin, WE; Schneider, C; Brash, AR				Zheng, Yuxiang; Boeglin, William E.; Schneider, Claus; Brash, Alan R.			A 49-kDa mini-lipoxygenase from Anabaena sp PCC 7120 retains catalytically complete functionality	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORAL PLEXAURA-HOMOMALLA; FATTY-ACID-COMPOSITION; N-TERMINAL DOMAIN; BLUE-GREEN-ALGAE; SOYBEAN LIPOXYGENASE-1; FUSION PROTEIN; CYCLOOXYGENASE CATALYSIS; NOSTOC-PUNCTIFORME; MOLECULAR-CLONING; CRYSTAL-STRUCTURE	Anabaena sp. PCC 7120 is one of the few prokaryotes harboring a lipoxygenase (LOX) gene. The sequence resides in an open reading frame encoding a fusion protein of a catalase-like hemoprotein with an unusually short LOX (similar to 49 kDa) at the C terminus. The recombinant mini-LOX contains a non-heme iron in the active site and is highly active with linoleic and alpha-linolenic acids (which occur naturally in Anabaena) giving the respective 9R-hydroperoxides, the mirror image of the 9S-LOX products of plants. Using stereospecifically labeled [11-H-3] linoleic acids we show that reaction is catalyzed via a typical antarafacial relationship of initial hydrogen abstraction and oxygenation. The mini-LOX oxygenated C-16/C-18:2-phosphatidylcholine with 9R specificity, suggesting a '' tail first '' mode of fatty acid binding. Site-directed mutagenesis of an active site Ala (Ala(215)), typically conserved as Gly in R-LOX, revealed that substitution with Gly retained 9R specificity, whereas the larger Val substitution switched oxygenation to 13S, implying that Ala(215) represents the functional equivalent of the Gly in other R-LOX. Metabolism studies using a synthetic fatty acid with extended double bond conjugation, 9E, 11Z, 14Z-20:3 omega 6, showed that the mini-LOX can control oxygenation two positions further along the fatty acid carbon chain. We conclude that the mini-LOX, despite lacking the beta-barrel domain and much additional sequence, is catalytically complete. Interestingly, animal and plant LOX, which undoubtedly share a common ancestor, are related in sequence only in the catalytic domain; it is possible that the prokaryotic LOX represents a common link and that the beta-barrel domain was then acquired independently in the animal and plant kingdoms.	[Zheng, Yuxiang; Boeglin, William E.; Schneider, Claus; Brash, Alan R.] Vanderbilt Univ, Sch Med, Dept Pharmacol, Nashville, TN 37232 USA	Vanderbilt University	Brash, AR (corresponding author), Vanderbilt Univ, Sch Med, Dept Pharmacol, 23rd Ave S, Nashville, TN 37232 USA.	brash@vanderbilt.edu			NIGMS NIH HHS [GM-074888] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074888] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BILD GS, 1977, LIPIDS, V12, P732, DOI 10.1007/BF02570904; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boeglin WE, 1998, P NATL ACAD SCI USA, V95, P6744, DOI 10.1073/pnas.95.12.6744; BOEYNAEMS JM, 1980, ANAL BIOCHEM, V104, P259, DOI 10.1016/0003-2697(80)90073-1; Boutaud O, 1999, J BIOL CHEM, V274, P33764, DOI 10.1074/jbc.274.47.33764; BOYINGTON JC, 1993, SCIENCE, V260, P1482, DOI 10.1126/science.8502991; Brash AR, 1999, J BIOL CHEM, V274, P23679, DOI 10.1074/jbc.274.34.23679; Brash AR, 1996, J BIOL CHEM, V271, P20949, DOI 10.1074/jbc.271.34.20949; BRASH AR, 1987, BIOCHEMISTRY-US, V26, P5465, DOI 10.1021/bi00391a038; Chen XS, 2001, J BIOL CHEM, V276, P811, DOI 10.1074/jbc.M008203200; Coffa G, 2005, J BIOL CHEM, V280, P38756, DOI 10.1074/jbc.M504870200; Coffa G, 2005, BIOCHEM BIOPH RES CO, V338, P87, DOI 10.1016/j.bbrc.2005.07.185; Coffa G, 2004, P NATL ACAD SCI USA, V101, P15579, DOI 10.1073/pnas.0406727101; COREY EJ, 1987, TETRAHEDRON LETT, V28, P5391, DOI 10.1016/S0040-4039(00)96736-4; Feussner I, 2002, ANNU REV PLANT BIOL, V53, P275, DOI 10.1146/annurev.arplant.53.100301.135248; Funk CD, 2002, PROSTAG OTH LIPID M, V68-9, P303, DOI 10.1016/S0090-6980(02)00036-9; Gillmor SA, 1997, NAT STRUCT BIOL, V4, P1003, DOI 10.1038/nsb1297-1003; GLICKMAN MH, 1995, BIOCHEMISTRY-US, V34, P14077, DOI 10.1021/bi00043a013; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; GREELEY RH, 1974, J CHROMATOGR, V88, P229; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; Hamberg M, 1998, J BIOL CHEM, V273, P13080, DOI 10.1074/jbc.273.21.13080; Hammarberg T, 2000, J BIOL CHEM, V275, P38787, DOI 10.1074/jbc.M006136200; Knapp MJ, 2003, BIOCHEMISTRY-US, V42, P11466, DOI 10.1021/bi0300884; Koeduka T, 2007, CURR MICROBIOL, V54, P315, DOI 10.1007/s00284-006-0512-9; Koljak R, 1997, SCIENCE, V277, P1994, DOI 10.1126/science.277.5334.1994; Kuhn H, 2005, BIOCHEM BIOPH RES CO, V338, P93, DOI 10.1016/j.bbrc.2005.08.238; LABELLE M, 1990, TETRAHEDRON, V46, P6301, DOI 10.1016/S0040-4020(01)96002-8; Lang I, 2007, PHYTOCHEMISTRY, V68, P1120, DOI 10.1016/j.phytochem.2007.02.028; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Li RH, 2004, CURR MICROBIOL, V49, P376, DOI 10.1007/s00284-004-4380-x; Maccarrone M, 2001, BIOCHEMISTRY-US, V40, P6819, DOI 10.1021/bi010187m; Minor W, 1996, BIOCHEMISTRY-US, V35, P10687, DOI 10.1021/bi960576u; MURAKAMI N, 1992, LIPIDS, V27, P776, DOI 10.1007/BF02535848; Oldham ML, 2005, J BIOL CHEM, V280, P39545, DOI 10.1074/jbc.M506675200; Oldham ML, 2005, P NATL ACAD SCI USA, V102, P297, DOI 10.1073/pnas.0406352102; Oliw EH, 2002, PROSTAG OTH LIPID M, V68-9, P313, DOI 10.1016/S0090-6980(02)00037-0; PARKER PL, 1967, SCIENCE, V155, P707, DOI 10.1126/science.155.3763.707; PERCIVAL MD, 1991, J BIOL CHEM, V266, P10058; Porta H, 2001, MICROBIOL-SGM, V147, P3199, DOI 10.1099/00221287-147-12-3199; Rector CL, 2007, CHEM RES TOXICOL, V20, P1582, DOI 10.1021/tx700120r; SATO N, 1979, BIOCHIM BIOPHYS ACTA, V572, P19; Schneider C, 1997, CHIRALITY, V9, P563, DOI 10.1002/(SICI)1520-636X(1997)9:5/6<563::AID-CHIR25>3.0.CO;2-L; Schneider C, 2000, ANAL BIOCHEM, V284, P125, DOI 10.1006/abio.2000.4670; Schneider C, 2002, PROSTAG OTH LIPID M, V68-9, P291, DOI 10.1016/S0090-6980(02)00041-2; Schneider C, 2007, P NATL ACAD SCI USA, V104, P18941, DOI 10.1073/pnas.0707148104; Schneider C, 2007, CHEM BIOL, V14, P473, DOI 10.1016/j.chembiol.2007.04.007; TSUZUKI M, 1990, PLANT PHYSIOL, V93, P851, DOI 10.1104/pp.93.3.851; Vance RE, 2004, P NATL ACAD SCI USA, V101, P2135, DOI 10.1073/pnas.0307308101; Walther M, 2002, J BIOL CHEM, V277, P27360, DOI 10.1074/jbc.M203234200	50	45	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5138	5147		10.1074/jbc.M705780200	http://dx.doi.org/10.1074/jbc.M705780200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18070874	hybrid			2022-12-25	WOS:000253426500071
J	Chernyavsky, AI; Arredondo, J; Piser, T; Karlsson, E; Grando, SA				Chernyavsky, Alex I.; Arredondo, Juan; Piser, Timothy; Karlsson, Evert; Grando, Sergei A.			Differential coupling of M-1 muscarinic and alpha 7 nicotinic receptors to inhibition of pemphigus acantholysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KERATINOCYTE ACETYLCHOLINE-RECEPTORS; TYROSINE PHOSPHORYLATION; BETA-CATENIN; E-CADHERIN; VULGARIS-IGG; PROTEIN-PHOSPHORYLATION; PATHWAYS DOWNSTREAM; CHOLINERGIC CONTROL; CELLS; MECHANISMS	The mechanisms mediating and regulating assembly and disassembly of intercellular junctions is a subject of intensive research. The IgG autoantibodies produced in patients with the immunoblistering skin disease pemphigus vulgaris (PV) can induce keratinocyte (KC) dyshesion (acantholysis) via mechanisms that involve signaling kinases targeting intercellular adhesion molecules, thus providing a useful model to study the physiologic regulation of KC cohesion. Previous studies showed that activation of Src and protein kinase C are the earliest events in the PV IgG-induced intracellular phosphorylation cascades and that cholinergic agonists are effective for treating patients with pemphigus. In this study, we sought to elucidate the molecular mechanisms allowing cholinergic agonists to inhibit PV IgG-induced acantholysis and phosphorylation of KC adhesion molecules. The extent of acantholysis in KC monolayers correlated closely with the degree of PV IgG-induced phosphorylation of p120- and beta-catenins, with classic isoforms of protein kinase C mediating serine phosphorylation of beta-catenin and Src-tyrosine phosphorylation of p120-catenin. The M-1 muscarinic agonist pilocarpine blocked phosphorylation of both catenins, which could be abolised by the M-1 antagonist MT7. The alpha 7 nicotinic agonist AR-R17779 inhibited phosphorylation of P120-cateinin. The alpha 7 antagonist methyllycaconitine abolished the effect of AR-R17779. Okadaic acid abrogated protective effects of agonists on phosphorylation of alpha-catenin, and pervanadate, on that of p120-catenin. Stimulation of KCs with pilocarpine significantly (p < 0.05) elevated both serine/threonine and tyrosine phosphatase activities in KCs. AR-R17779 both stimulated tyrosine phosphatase and decreased PV IgG-induced Src activity. Methyllycaconitine released Src activity in intact KCs and caused acantholysis. Thus, downstream signaling from M-1 abolished PV IgG-dependent catenin phosphorylation due to activation of both serine/threonine and tyrosine phosphatases, whereas alpha 7 action involved both activation of tyrosine phosphatase and inhibition of Src. These findings identified novel paradigm of regulation of signaling kinases associated with cholinergic receptors and provided mechanistic explanation of therapeutic activity of cholinomimetics in PV patients.	[Chernyavsky, Alex I.; Arredondo, Juan; Grando, Sergei A.] Univ Calif Irvine, Dept Dermatol, Irvine, CA 92697 USA; [Piser, Timothy] AstraZeneca, Wilmington, DE 19850 USA; [Karlsson, Evert] Karolinska Inst, S-75240 Uppsala, Sweden	University of California System; University of California Irvine; AstraZeneca; Karolinska Institutet	Grando, SA (corresponding author), Univ Calif Irvine, Dept Dermatol, C340 Med Sci 1, Irvine, CA 92697 USA.	sgrando@uci.edu			NIGMS NIH HHS [GM62136] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062136] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Alema S, 2007, BBA-MOL CELL RES, V1773, P47, DOI 10.1016/j.bbamcr.2006.06.001; Amar LS, 1999, CELL ADHES COMMUN, V7, P125, DOI 10.3109/15419069909034396; Aoyama Y, 1999, EUR J IMMUNOL, V29, P2233, DOI 10.1002/(SICI)1521-4141(199907)29:07<2233::AID-IMMU2233>3.0.CO;2-4; Arredondo J, 2005, AM J PATHOL, V167, P1531, DOI 10.1016/S0002-9440(10)61239-4; Arredondo J, 2006, FASEB J, V20, P2093, DOI 10.1096/fj.06-6191com; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Billet SE, 2006, AUTOIMMUNITY, V39, P617, DOI 10.1080/08916930600972099; BOYER B, 1989, J CELL BIOL, V109, P1495, DOI 10.1083/jcb.109.4.1495; Bystryn JC, 2006, J AM ACAD DERMATOL, V54, P513, DOI 10.1016/j.jaad.2005.12.003; Calautti E, 2002, J CELL BIOL, V156, P137, DOI 10.1083/jcb.200105140; CHAFFINS ML, 1993, J AM ACAD DERMATOL, V28, P998, DOI 10.1016/S0190-9622(08)80651-2; Charpantier E, 2005, J NEUROSCI, V25, P9836, DOI 10.1523/JNEUROSCI.3497-05.2005; Chernyavsky AI, 2005, J BIOL CHEM, V280, P39220, DOI 10.1074/jbc.M504407200; Chernyavsky AI, 2007, J BIOL CHEM, V282, P13804, DOI 10.1074/jbc.M611365200; Chilton M, 2004, LIFE SCI, V74, P3133, DOI 10.1016/j.lfs.2003.11.012; Damaj MI, 1999, J PHARMACOL EXP THER, V291, P1284; Dupre-Crochet S, 2007, MOL CELL BIOL, V27, P3804, DOI 10.1128/MCB.01590-06; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; Gerthoffer WT, 2005, AM J PHYSIOL-GASTR L, V288, pG849, DOI 10.1152/ajpgi.00530.2004; Grando S. A., 1993, J EUR ACAD DERMATOL, V2, P72; Grando SA, 2006, EXP DERMATOL, V15, P265, DOI 10.1111/j.0906-6705.2006.00410.x; GRANDO SA, 1993, J INVEST DERMATOL, V101, P32, DOI 10.1111/1523-1747.ep12358588; Grando SA, 2004, J INVEST DERM SYMP P, V9, P84, DOI 10.1111/j.1087-0024.2004.00826.x; Grando SA, 2000, DERMATOLOGY, V201, P290, DOI 10.1159/000051540; Grando SA, 2006, J INVEST DERMATOL, V126, P1948, DOI 10.1038/sj.jid.5700151; Grishin AA, 2005, NEUROPHARMACOLOGY, V49, P328, DOI 10.1016/j.neuropharm.2005.03.019; Hu PQ, 2001, J INVEST DERMATOL, V117, P1059, DOI 10.1046/j.0022-202x.2001.01523.x; Iraji F, 2006, INT J DERMATOL, V45, P743, DOI 10.1111/j.1365-4632.2006.02766.x; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; KARLSSON E, 1994, ANN NY ACAD SCI, V710, P153, DOI 10.1111/j.1749-6632.1994.tb26623.x; Karlsson E, 2000, BIOCHIMIE, V82, P793, DOI 10.1016/S0300-9084(00)01176-7; Kawasaki Y, 2006, AUTOIMMUNITY, V39, P587, DOI 10.1080/08916930600971943; Kebabian J.W., 1994, RBI HDB RECEPTOR CLA; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kitajima Y, 1999, J INVEST DERM SYMP P, V4, P137, DOI 10.1038/sj.jidsp.5640197; Kitajima Y, 1995, EPITHELIAL CELL BIOL, V4, P70; Klapproth H, 1997, N-S ARCH PHARMACOL, V355, P515, DOI 10.1007/PL00004977; Koppen A, 1997, J PHARMACOL EXP THER, V282, P1139; Kumar P, 2005, J BIOL CHEM, V280, P25928, DOI 10.1074/jbc.M502435200; Kurzen H, 2006, J INVEST DERMATOL, V126, P2458, DOI 10.1038/sj.jid.5700443; Levin ED, 1999, BEHAV PHARMACOL, V10, P675, DOI 10.1097/00008877-199911000-00014; Lilien J, 2002, DEV DYNAM, V224, P18, DOI 10.1002/dvdy.10087; Matsuoka Y, 2001, J DERMATOL SCI, V27, P206, DOI 10.1016/S0923-1811(01)00137-2; Mehta JN, 2000, ARCH DERMATOL, V136, P15, DOI 10.1001/archderm.136.1.15; Moon HS, 2001, GYNECOL ONCOL, V81, P355, DOI 10.1006/gyno.2001.6163; MUELLER H, 1983, J MOL BIOL, V163, P647, DOI 10.1016/0022-2836(83)90116-X; Namazi M R, 2004, J Drugs Dermatol, V3, P484; Nguyen VT, 2004, ARCH DERMATOL, V140, P327, DOI 10.1001/archderm.140.3.327; Nguyen VT, 2004, EXP CELL RES, V294, P534, DOI 10.1016/j.yexcr.2003.12.010; Nguyen VT, 2004, J BIOL CHEM, V279, P2135, DOI 10.1074/jbc.M309000200; Nguyen VT, 2003, LIFE SCI, V72, P2081, DOI 10.1016/S0024-3205(03)00087-0; Pasdar M, 1997, CELL GROWTH DIFFER, V8, P451; PASDAR M, 1995, CELL MOTIL CYTOSKEL, V30, P108, DOI 10.1002/cm.970300203; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; ROMANENKO AV, 1987, FIZIOL ZH SSSR, V33, P51; Rubenstein DS, 2006, AUTOIMMUNITY, V39, P577, DOI 10.1080/08916930600971885; Sanchez-Carpintero I, 2004, BRIT J DERMATOL, V151, P565, DOI 10.1111/j.1365-2133.2004.06147.x; Seishima M, 1999, ARCH DERMATOL RES, V291, P606, DOI 10.1007/s004030050462; Serres M, 2000, EXP CELL RES, V257, P255, DOI 10.1006/excr.2000.4895; Shelden E, 1996, CELL MOTIL CYTOSKEL, V35, P24, DOI 10.1002/(SICI)1097-0169(1996)35:1<24::AID-CM2>3.0.CO;2-I; Stoytcheva M, 1996, ELECTROANAL, V8, P676, DOI 10.1002/elan.1140080714; Tsai W, 1999, EMBO J, V18, P109, DOI 10.1093/emboj/18.1.109; VANDERMEERS A, 1995, TOXICON, V33, P1171, DOI 10.1016/0041-0101(95)00057-S; vanHoek ML, 1997, BIOCHEM J, V326, P271, DOI 10.1042/bj3260271; VOLBERG T, 1992, EMBO J, V11, P1733, DOI 10.1002/j.1460-2075.1992.tb05225.x; Wakita H, 1997, INT J CANCER, V73, P432, DOI 10.1002/(SICI)1097-0215(19971104)73:3<432::AID-IJC19>3.0.CO;2-E; Wang K, 2004, J BIOL CHEM, V279, P8779, DOI 10.1074/jbc.M309652200; Xie ZJ, 2003, ANN NY ACAD SCI, V986, P497, DOI 10.1111/j.1749-6632.2003.tb07234.x; Yin TF, 2005, J BIOL CHEM, V280, P40355, DOI 10.1074/jbc.M506692200	71	32	33	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3401	3408		10.1074/jbc.M704956200	http://dx.doi.org/10.1074/jbc.M704956200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18073210	hybrid			2022-12-25	WOS:000253083000045
J	Iberg, AN; Espejo, A; Cheng, D; Kim, D; Michaud-Levesque, J; Richard, S; Bedford, MT				Iberg, Aimee N.; Espejo, Alexsandra; Cheng, Donghang; Kim, Daehoon; Michaud-Levesque, Jonathan; Richard, Stephane; Bedford, Mark T.			Arginine methylation of the histone H3 tail impedes effector binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHD FINGER; LYSINE-4 TRIMETHYLATION; DYNAMIC REGULATION; PLANT HOMEODOMAIN; RECOGNITION; COMPLEX; WDR5; TRANSCRIPTION; H3K4ME3; DOMAIN	Histone tail post-translational modification results in changes in cellular processes, either by generating or blocking docking sites for histone code readers or by altering the higher order chromatin structure. H3K4me3 is known to mark the promoter regions of active transcription. Proteins bind H3K4 in a methyl-dependent manner and aid in the recruitment of histone-remodeling enzymes and transcriptional cofactors. The H3K4me3 binders harbor methyl-specific chromatin binding domains, including plant homeodomain, Chromo, and tudor domains. Structural analysis of the plant homeodomains present in effector proteins, as well as the WD40 repeats of WDR5, reveals critical contacts between residues in these domains and H3R2. The intimate contact between H3R2 and these domain types leads to the hypothesis that methylation of this arginine residue antagonizes the binding of effector proteins to the N-terminal tail of H3. Here we show that H3 tail binding effector proteins are indeed sensitive to H3R2 methylation and that PRMT6, not CARM1/PRMT4, is the primary methyltransferase acting on this site. We have tested the expression of a select group of H3K4 effector-regulated genes in PRMT6 knockdown cells and found that their levels are altered. Thus, PRMT6 methylates H3R2 and is a negative regulator of N-terminal H3 tail binding.	[Iberg, Aimee N.; Espejo, Alexsandra; Cheng, Donghang; Kim, Daehoon; Bedford, Mark T.] Univ Texas Dallas, MD Anderson Canc Ctr, Div Res, Smithville, TX 78957 USA; [Michaud-Levesque, Jonathan; Richard, Stephane] McGill Univ, Terry Fox Mol Oncol Grp, Montreal, PQ H3T 1E2, Canada	University of Texas System; University of Texas Dallas; UTMD Anderson Cancer Center; McGill University	Bedford, MT (corresponding author), Univ Texas Dallas, MD Anderson Canc Ctr, Div Res, Sci Pk,POB 389, Smithville, TX 78957 USA.	mtbedford@mdanderson.org	Bedford, Mark T/E-7856-2011	Espejo, Alexsandra/0000-0002-8841-7219	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062248, R56DK062248] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA023449] Funding Source: NIH RePORTER; NIDA NIH HHS [DA023449] Funding Source: Medline; NIDDK NIH HHS [DK62248] Funding Source: Medline; NIEHS NIH HHS [ES07784] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Couture JF, 2006, NAT STRUCT MOL BIOL, V13, P698, DOI 10.1038/nsmb1116; Dormann HL, 2006, CELL CYCLE, V5, P2842, DOI 10.4161/cc.5.24.3540; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Frankel A, 2002, J BIOL CHEM, V277, P3537, DOI 10.1074/jbc.M108786200; Guccione E, 2007, NATURE, V449, P933, DOI 10.1038/nature06166; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Huang Y, 2006, SCIENCE, V312, P748, DOI 10.1126/science.1125162; Ito T, 2007, J BIOCHEM, V141, P609, DOI 10.1093/jb/mvm091; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Matthews AGW, 2007, NATURE, V450, P1106, DOI 10.1038/nature06431; Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814; Ramon-Maiques S, 2007, P NATL ACAD SCI USA, V104, P18993, DOI 10.1073/pnas.0709170104; Ruthenburg AJ, 2006, NAT STRUCT MOL BIOL, V13, P704, DOI 10.1038/nsmb1119; Schurter BT, 2001, BIOCHEMISTRY-US, V40, P5747, DOI 10.1021/bi002631b; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815	24	146	152	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3006	3010		10.1074/jbc.C700192200	http://dx.doi.org/10.1074/jbc.C700192200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18077460	hybrid			2022-12-25	WOS:000253083000003
J	Masquelier, T; Guyonneau, R; Thorpe, SJ				Masquelier, Timothee; Guyonneau, Rudy; Thorpe, Simon J.			Spike Timing Dependent Plasticity Finds the Start of Repeating Patterns in Continuous Spike Trains	PLOS ONE			English	Article							DEVELOPING RETINOTECTAL SYSTEM; RECURRING DISCHARGE PATTERNS; RETINAL GANGLION-CELLS; VISUAL-CORTEX; COINCIDENCE DETECTOR; NEURONAL RESPONSES; RECEPTIVE-FIELDS; CORTICAL NEURON; BARREL CORTEX; PRECISION	Experimental studies have observed Long Term synaptic Potentiation (LTP) when a presynaptic neuron fires shortly before a postsynaptic neuron, and Long Term Depression (LTD) when the presynaptic neuron fires shortly after, a phenomenon known as Spike Timing Dependant Plasticity (STDP). When a neuron is presented successively with discrete volleys of input spikes STDP has been shown to learn 'early spike patterns', that is to concentrate synaptic weights on afferents that consistently fire early, with the result that the postsynaptic spike latency decreases, until it reaches a minimal and stable value. Here, we show that these results still stand in a continuous regime where afferents fire continuously with a constant population rate. As such, STDP is able to solve a very difficult computational problem: to localize a repeating spatio-temporal spike pattern embedded in equally dense 'distractor' spike trains. STDP thus enables some form of temporal coding, even in the absence of an explicit time reference. Given that the mechanism exposed here is simple and cheap it is hard to believe that the brain did not evolve to use it.	[Masquelier, Timothee; Guyonneau, Rudy; Thorpe, Simon J.] Univ Toulouse 3, Ctr Rech Cerveau & Cognit, CNRS, Fac Med Rangueil, F-31062 Toulouse, France; [Masquelier, Timothee; Guyonneau, Rudy; Thorpe, Simon J.] SpikeNet Technol SARL, Prologue 1 La Pyreneenne, Labege, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Masquelier, T (corresponding author), Univ Toulouse 3, Ctr Rech Cerveau & Cognit, CNRS, Fac Med Rangueil, F-31062 Toulouse, France.	timothee.masquelier@alum.mit.edu	THORPE, Simon J/A-5661-2008; Masquelier, Timothee/F-1159-2010	THORPE, Simon J/0000-0003-4997-3367; Masquelier, Timothee/0000-0001-8629-9506; Guyonneau, Rudy/0000-0002-2013-5872	CNRS [IST-027198]; ANR	CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR))	This project was supported by the CNRS, STREP Decisions-in-Motion (IST-027198), ANR projects Natstats and Hearing in Time, and SpikeNet Technology SARL.	Abeles M, 2004, SCIENCE, V304, P523, DOI 10.1126/science.1097725; ABELES M, 1982, ISRAEL J MED SCI, V18, P83; Abeles M, 2001, J NEUROSCI METH, V107, P141, DOI 10.1016/S0165-0270(01)00364-8; Abeles M., 1991, CORTICONICS NEURAL C, pxiv; Bair W, 1996, NEURAL COMPUT, V8, P1185, DOI 10.1162/neco.1996.8.6.1185; Barlow H B, 1972, Perception, V1, P371, DOI 10.1068/p010371; Berry MJ, 1998, J NEUROSCI, V18, P2200; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Boloori AR, 2006, J NEUROSCI, V26, P3767, DOI 10.1523/JNEUROSCI.4056-05.2006; Buracas GT, 1998, NEURON, V20, P959, DOI 10.1016/S0896-6273(00)80477-8; CASSENAER S, 2007, NATURE; Feldman DE, 2000, NEURON, V27, P45, DOI 10.1016/S0896-6273(00)00008-8; Fellous JM, 2004, J NEUROSCI, V24, P2989, DOI 10.1523/JNEUROSCI.4649-03.2004; Fries P, 2007, TRENDS NEUROSCI, V30, P309, DOI 10.1016/j.tins.2007.05.005; FROSTIG RD, 1990, BIOL CYBERN, V62, P495, DOI 10.1007/BF00205111; FROSTIG RD, 1990, BIOL CYBERN, V62, P487, DOI 10.1007/BF00205110; GERSTNER W, 1995, PHYS REV E, V51, P738, DOI 10.1103/PhysRevE.51.738; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Gerstner W., 2002, SPIKING NEURON MODEL; Gutig R, 2006, NAT NEUROSCI, V9, P420, DOI 10.1038/nn1643; Guyonneau R, 2004, J PHYSIOL-PARIS, V98, P487, DOI 10.1016/j.jphysparis.2005.09.004; Guyonneau R, 2005, NEURAL COMPUT, V17, P859, DOI 10.1162/0899766053429390; HOPFIELD JJ, 1995, NATURE, V376, P33, DOI 10.1038/376033a0; Innocenti GM, 2005, NAT REV NEUROSCI, V6, P955, DOI 10.1038/nrn1790; Jacob V, 2007, J NEUROSCI, V27, P1271, DOI 10.1523/JNEUROSCI.4264-06.2007; Johansson RS, 2004, NAT NEUROSCI, V7, P170, DOI 10.1038/nn1177; Konig P, 1996, TRENDS NEUROSCI, V19, P130, DOI 10.1016/S0166-2236(96)80019-1; Liu RC, 2001, J NEUROPHYSIOL, V86, P2789, DOI 10.1152/jn.2001.86.6.2789; MAINEN ZF, 1995, SCIENCE, V268, P1503, DOI 10.1126/science.7770778; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Masquelier T, 2007, PLOS COMPUT BIOL, V3, P247, DOI 10.1371/journal.pcbi.0030031; Mehta MR, 2000, NEURON, V25, P707, DOI 10.1016/S0896-6273(00)81072-7; Meliza CD, 2006, NEURON, V49, P183, DOI 10.1016/j.neuron.2005.12.009; Movshon JA, 2000, NEURON, V27, P412, DOI 10.1016/S0896-6273(00)00049-0; Mu Y, 2006, NEURON, V50, P115, DOI 10.1016/j.neuron.2006.03.009; Pfister JP, 2006, J NEUROSCI, V26, P9673, DOI 10.1523/JNEUROSCI.1425-06.2006; Prut Y, 1998, J NEUROPHYSIOL, V79, P2857, DOI 10.1152/jn.1998.79.6.2857; Reinagel P, 2000, J NEUROSCI, V20, P5392, DOI 10.1523/JNEUROSCI.20-14-05392.2000; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Stein RB, 2005, NAT REV NEUROSCI, V6, P389, DOI 10.1038/nrn1668; Uchida N, 2006, NAT REV NEUROSCI, V7, P485, DOI 10.1038/nrn1933; Uzzell VJ, 2004, J NEUROPHYSIOL, V92, P780, DOI 10.1152/jn.01171.2003; van Rossum MCW, 2000, J NEUROSCI, V20, P8812; Van Rullen R, 2001, NEURAL COMPUT, V13, P1255, DOI 10.1162/08997660152002852; VanRullen R, 2005, TRENDS NEUROSCI, V28, P1, DOI 10.1016/j.tins.2004.10.010; Vislay-Meltzer R, 2006, NEURON, V50, P101, DOI 10.1016/j.neuron.2006.02.016; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Young JM, 2007, NAT NEUROSCI, V10, P887, DOI 10.1038/nn1913; Zhang LI, 1998, NATURE, V395, P37, DOI 10.1038/25665	50	190	197	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1377	10.1371/journal.pone.0001377	http://dx.doi.org/10.1371/journal.pone.0001377			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167538	Green Published, gold			2022-12-25	WOS:000260468900006
J	Rubio, D; Garcia, S; Paz, MF; De la Cueva, T; Lopez-Fernandez, LA; Lloyd, AC; Garcia-Castro, J; Bernad, A				Rubio, Daniel; Garcia, Silvia; Paz, Maria F.; De la Cueva, Teresa; Lopez-Fernandez, Luis A.; Lloyd, Alison C.; Garcia-Castro, Javier; Bernad, Antonio			Molecular Characterization of Spontaneous Mesenchymal Stem Cell Transformation	PLOS ONE			English	Article							TELOMERASE; CANCER; GENE; IMMORTALIZATION; METHYLATION; P16(INK4A); MLL; P53; ASSOCIATION; INK4A/ARF	Background. We previously reported the in vitro spontaneous transformation of human mesenchymal stem cells (MSC) generating a population with tumorigenic potential, that we termed transformed mesenchymal cells (TMC). Methodology/Principal Findings. Here we have characterized the molecular changes associated with TMC generation. Using microarrays techniques we identified a set of altered pathways and a greater number of downregulated than upregulated genes during MSC transformation, in part due to the expression of many untranslated RNAs in MSC. Microarray results were validated by qRT-PCR and protein detection. Conclusions/Significance. In our model, the transformation process takes place through two sequential steps; first MSC bypass senescence by upregulating c-myc and repressing p16 levels. The cells then bypass cell crisis with acquisition of telomerase activity, Ink4a/Arf locus deletion and Rb hyperphosphorylation. Other transformation-associated changes include modulation of mitochondrial metabolism, DNA damage-repair proteins and cell cycle regulators. In this work we have characterized the molecular mechanisms implicated in TMC generation and we propose a two-stage model by which a human MSC becomes a tumor cell.	[Rubio, Daniel; Garcia, Silvia; Paz, Maria F.; De la Cueva, Teresa; Garcia-Castro, Javier; Bernad, Antonio] CNIC, Dept Regenerat Cardiol, Madrid, Spain; [Rubio, Daniel; Garcia, Silvia; Paz, Maria F.; De la Cueva, Teresa; Garcia-Castro, Javier; Bernad, Antonio] Univ Autonoma Madrid, CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Lopez-Fernandez, Luis A.] Hosp Gen Univ Gregorio Maranon, Serv Farm, Madrid, Spain; [Lloyd, Alison C.] UCL, Lab Mol Cell Biol, London, England; [Garcia-Castro, Javier] Andalusian Stem Cell Bank, Granada, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); General University Gregorio Maranon Hospital; University of London; University College London	Bernad, A (corresponding author), CNIC, Dept Regenerat Cardiol, Madrid, Spain.	abernad@cnic.es	Lopez-Fernandez, Luis A/I-9679-2019; Lopez-Fernandez, Luis/AAV-2580-2021; Garcia-Castro, Javier/H-5274-2011; Lopez-Fernandez, Luis A/B-7330-2011; Bernad, Antonio/P-8573-2017; Garcia-Castro, Javier/ABC-9741-2021	Lopez-Fernandez, Luis A/0000-0003-3964-5837; Lopez-Fernandez, Luis/0000-0003-3964-5837; Garcia-Castro, Javier/0000-0001-7604-1640; Lopez-Fernandez, Luis A/0000-0003-3964-5837; Garcia-Castro, Javier/0000-0001-7604-1640	Spanish Ministry of Education and Science [predoctoral fellowships]; Ministry of Science and Technology [CP03/0031]; Ministerio de Sanidad y Consumo [CP06/0267]; Spanish Ministry of Science and Technology (CICYT) [SAF2001-2262, SAF2005-0864, GEN2001-4856-C13-02]	Spanish Ministry of Education and Science(Spanish Government); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Spanish Ministry of Science and Technology (CICYT)(Consejo Interinstitucional de Ciencia y Tecnologia (CICYT)Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	DR and SG received predoctoral fellowships from the Spanish Ministry of Education and Science, JG-C and L L-F received postdoctoral fellowships from the Ministry of Science and Technology and the Ministerio de Sanidad y Consumo (FIS; CP03/0031 and CP06/0267). This work was partially supported by Spanish Ministry of Science and Technology (CICYT) grants SAF2001-2262, SAF2005-0864 and GEN2001-4856-C13-02 to AB. The Department of Immunology and Oncology was founded and is supported by the Spanish National Research Council (CSIC) and by Pfizer.	BENANTI JA, 2007, MOL CANCER RES, V5, pOF1; Burns JS, 2005, CANCER RES, V65, P3126, DOI 10.1158/0008-5472.CAN-04-2218; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Daibata M, 2000, CANCER GENET CYTOGEN, V117, P28, DOI 10.1016/S0165-4608(99)00083-7; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Daser A, 2004, GENE DEV, V18, P965, DOI 10.1101/gad.1195504; Funes JM, 2007, P NATL ACAD SCI USA, V104, P6223, DOI 10.1073/pnas.0700690104; Gil J, 2005, CANCER RES, V65, P2179, DOI 10.1158/0008-5472.CAN-03-4030; Gorgoulis VG, 1998, AM J PATHOL, V153, P1749, DOI 10.1016/S0002-9440(10)65690-8; Hahn WC, 2002, NAT REV CANCER, V2, P331, DOI 10.1038/nrc795; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; KIM NW, 1994, SCIENCE, V266, P2011, DOI 10.1126/science.7605428; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Li H, 2007, CANCER RES, V67, P10889, DOI 10.1158/0008-5472.CAN-07-2665; Matheu A, 2004, GENE DEV, V18, P2736, DOI 10.1101/gad.310304; Milyavsky M, 2003, CANCER RES, V63, P7147; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Mund C, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni072; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Pegram LD, 2000, BLOOD, V96, P4360; Prockop DJ, 2007, BLOOD, V109, P3147, DOI 10.1182/blood-2006-03-013433; Rea MA, 2006, J INVEST DERMATOL, V126, P2507, DOI 10.1038/sj.jid.5700424; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Rubio D, 2005, CANCER RES, V65, P3035, DOI 10.1158/0008-5472.CAN-04-4194; Ruiz JF, 2004, NUCLEIC ACIDS RES, V32, P5861, DOI 10.1093/nar/gkh929; Serakinci N, 2004, ONCOGENE, V23, P5095, DOI 10.1038/sj.onc.1207651; Serakinci N, 2006, REGEN MED, V1, P125, DOI 10.2217/17460751.1.1.125; Sharpless NE, 2005, MUTAT RES-FUND MOL M, V576, P22, DOI 10.1016/j.mrfmmm.2004.08.021; Shay Jerry W., 1996, Current Opinion in Oncology, V8, P66, DOI 10.1097/00001622-199601000-00012; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Sherr CJ, 2002, CANCER CELL, V2, P103, DOI 10.1016/S1535-6108(02)00102-2; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Tremain N, 2001, STEM CELLS, V19, P408, DOI 10.1634/stemcells.19-5-408; Tsutsui T, 2002, CARCINOGENESIS, V23, P2111, DOI 10.1093/carcin/23.12.2111; Wang Y, 2005, CYTOTHERAPY, V7, P509, DOI 10.1080/14653240500363216; Weinberg RA., 2002, NEW ENGL J MED, V347, P1593, DOI [DOI 10.1056/NEJMRA021902, 10.1056/NEJMra021902]; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xing EP, 1999, CARCINOGENESIS, V20, P77, DOI 10.1093/carcin/20.1.77; Yeh E, 2004, NAT CELL BIOL, V6, P308, DOI 10.1038/ncb1110; Zhou YF, 2006, CANCER RES, V66, P10849, DOI 10.1158/0008-5472.CAN-06-2146; Zongaro S, 2005, CANCER RES, V65, P11411, DOI 10.1158/0008-5472.CAN-05-1140	43	128	144	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1398	10.1371/journal.pone.0001398	http://dx.doi.org/10.1371/journal.pone.0001398			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167557	Green Published, Green Submitted, gold			2022-12-25	WOS:000260468900026
J	Lenka, N; Ramasamy, SK				Lenka, Nibedita; Ramasamy, Saravana Kumar			Neural Induction from ES Cells Portrays Default Commitment but Instructive Maturation	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; IN-VITRO; NESTIN ENHANCER; PRECURSOR CELLS; FATE; HEDGEHOG; NEURONS; PROTEIN; DIFFERENTIATION	The neural induction has remained a debatable issue pertaining to whether it is a mere default process or it involves precise instructive cues. We have chosen the embryonic stem (ES) cell model to address this issue. In a devised monoculture strategy, the cell-cell interaction availed through optimum cell plating density could define the niche for the attainment of efficient in vitro neurogenesis from the ES cells. The medium plating density was found ideal in generating optimum number of progenitors and also yielded about 80% mature neurons in a serum free culture set up barring any exogenous inducers. We could also demarcate and quantify the neural stem cells/progenitors among the heterogeneous cell population of differentiating ES cells using nestin intron II driven EGFP expression as a tool. The one week post-plating was determined to be the critical time window for optimum neural progenitor generation from ES cells that helped us further in purifying these cells and in demonstrating their proliferation and multipotent differentiation potential. Seeding cells at varying densities, we could decipher an interesting paradoxical scenario that interlinked both commitment and maturation with the initial plating density having a vital influence on neuronal maturation but not specification and the secretory factors were apparently playing a key role during this process. Thus it was comprehended that, the neural specification was a default process independent of exogenous factors and cellular interaction. Conversely, a defined number of cells at the specification stage itself seemed critical to provide an auto-/paracrine means of signaling threshold for the maturation process to materialize.	[Lenka, Nibedita; Ramasamy, Saravana Kumar] Natl Ctr Cell Sci, Pune, Maharashtra, India	Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS)	Lenka, N (corresponding author), Natl Ctr Cell Sci, Pune, Maharashtra, India.	nibedita@nccs.res.in	Lenka, Nibedita/ABX-3824-2022	Ramasamy, Saravana/0000-0003-2658-2945	Department of Biotechnology (DBT); Govt. of India [BT/PR2993/MED/14/399/2002]; Council of Scientific and Industrial Research (CSIR), India	Department of Biotechnology (DBT); Govt. of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Part of this work was supported by a project grant from Department of Biotechnology (DBT); Govt. of India (BT/PR2993/MED/14/399/2002) to NL. SKR is a Senior Research fellow, Council of Scientific and Industrial Research (CSIR), India pursuing his Ph. D. The funding agencies have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andressen C, 2001, STEM CELLS, V19, P419, DOI 10.1634/stemcells.19-5-419; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; Bainter JJ, 2001, DEV DYNAM, V222, P315, DOI 10.1002/dvdy.1210; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Cayuso J, 2006, DEVELOPMENT, V133, P517, DOI 10.1242/dev.02228; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Clarke DL, 2000, SCIENCE, V288, P1660, DOI 10.1126/science.288.5471.1660; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Goodrich LV, 1998, NEURON, V21, P1243, DOI 10.1016/S0896-6273(00)80645-5; HemmatiBrivanlou A, 1997, CELL, V88, P13, DOI 10.1016/S0092-8674(00)81853-X; Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601; Irioka T, 2005, DEV BRAIN RES, V154, P63, DOI 10.1016/j.devbrainres.2004.10.004; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kim T, 2007, IET ELECTR POWER APP, V1, P557, DOI 10.1049/iet-epa:20060358; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; LAMB TM, 1995, DEVELOPMENT, V121, P3627; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lenka N, 2002, J CELL SCI, V115, P1471; Lenka Nibedita, 2006, V330, P33; Linker C, 2004, DEVELOPMENT, V131, P5671, DOI 10.1242/dev.01445; Lothian C, 1997, EUR J NEUROSCI, V9, P452, DOI 10.1111/j.1460-9568.1997.tb01622.x; Lothian C, 1999, EXP CELL RES, V248, P509, DOI 10.1006/excr.1999.4417; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Moreau M, 2004, INT J DEV BIOL, V48, P75, DOI 10.1387/ijdb.15272372; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Otero JJ, 2004, DEVELOPMENT, V131, P3545, DOI 10.1242/dev.01218; Qi XX, 2004, P NATL ACAD SCI USA, V101, P6027, DOI 10.1073/pnas.0401367101; Ribes V, 2006, DEVELOPMENT, V133, P351, DOI 10.1242/dev.02204; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; Streit A, 2000, NATURE, V406, P74, DOI 10.1038/35017617; Streit A, 1999, TRENDS GENET, V15, P20, DOI 10.1016/S0168-9525(98)01620-5; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tropepe V, 2001, NEURON, V30, P65, DOI 10.1016/S0896-6273(01)00263-X; Wilson L, 2005, DEV BIOL, V282, P1, DOI 10.1016/j.ydbio.2005.02.027; Wilson PA, 1997, NEURON, V18, P699, DOI 10.1016/S0896-6273(00)80311-6; WILSON PA, 1995, NATURE, V376, P331, DOI 10.1038/376331a0; Yamazoe H, 2006, CELL TRANSPLANT, V15, P135, DOI 10.3727/000000006783982061; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	48	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1349	10.1371/journal.pone.0001349	http://dx.doi.org/10.1371/journal.pone.0001349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092007	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459600030
J	Rischitor, PE; May, KM; Hardwick, KG				Rischitor, Patricia E.; May, Karen M.; Hardwick, Kevin G.			Bub1 Is a Fission Yeast Kinetochore Scaffold Protein, and Is Sufficient to Recruit other Spindle Checkpoint Proteins to Ectopic Sites on Chromosomes	PLOS ONE			English	Article								The spindle checkpoint delays anaphase onset until all chromosomes have attached in a bi-polar manner to the mitotic spindle. Mad and Bub proteins are recruited to unattached kinetochores, and generate diffusible anaphase inhibitors. Checkpoint models propose that Mad1 and Bub1 act as stable kinetochore-bound scaffolds, to enhance recruitment of Mad2 and Mad3/BubR1, but this remains untested for Bub1. Here, fission yeast FRAP experiments confirm that Bub1 stably binds kinetochores, and by tethering Bub1 to telomeres we demonstrate that it is sufficient to recruit anaphase inhibitors in a kinase-independent manner. We propose that the major checkpoint role for Bub1 is as a signalling scaffold.	[Rischitor, Patricia E.; May, Karen M.; Hardwick, Kevin G.] Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland	University of Edinburgh	Hardwick, KG (corresponding author), Univ Edinburgh, Inst Cell Biol, Wellcome Trust Ctr Cell Biol, Edinburgh, Midlothian, Scotland.	Kevin.Hardwick@ed.ac.uk	Pillay, Nischalan/F-9536-2012	Hardwick, Kevin/0000-0002-6462-1047	HFSP Programme; Wellcome Trust Senior Research Fellowship	HFSP Programme; Wellcome Trust Senior Research Fellowship(Wellcome Trust)	This work was supported by an HFSP Programme Grant (PR and KM) and a Wellcome Trust Senior Research Fellowship (KGH). The sponsors had no role in design or conduct of these studies, or in preparation or approval of the manuscript.	Acquaviva C, 2004, NAT CELL BIOL, V6, P892, DOI 10.1038/ncb1167; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Chikashige Y, 2001, CURR BIOL, V11, P1618, DOI 10.1016/S0960-9822(01)00457-2; Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; HARDWICK KG, 1995, J CELL BIOL, V131, P709, DOI 10.1083/jcb.131.3.709; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; HIRAOKA Y, 1984, CELL, V39, P349, DOI 10.1016/0092-8674(84)90013-8; Howell BJ, 2000, J CELL BIOL, V150, P1233, DOI 10.1083/jcb.150.6.1233; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kadura S, 2005, MOL BIOL CELL, V16, P385, DOI 10.1091/mbc.E04-07-0558; Kallio MJ, 2002, J CELL BIOL, V158, P841, DOI 10.1083/jcb.200201135; KEENEY JB, 1994, GENETICS, V136, P849; Kim SH, 1998, SCIENCE, V279, P1045, DOI 10.1126/science.279.5353.1045; King EMJ, 2007, GENE DEV, V21, P1163, DOI 10.1101/gad.431507; Kitazono AA, 2003, MOL GENET GENOMICS, V269, P672, DOI 10.1007/s00438-003-0870-y; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Liu XK, 2005, EMBO J, V24, P2919, DOI 10.1038/sj.emboj.7600762; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Molk JN, 2004, MOL BIOL CELL, V15, P1519, DOI 10.1091/mbc.E03-09-0708; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; RIEDER CL, 1995, J CELL BIOL, V130, P941, DOI 10.1083/jcb.130.4.941; Shah JV, 2004, CURR BIOL, V14, P942, DOI 10.1016/j.cub.2004.05.046; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Snaith HA, 2005, EMBO J, V24, P3690, DOI 10.1038/sj.emboj.7600838; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2004, MOL CELL, V16, P387, DOI 10.1016/j.molcel.2004.09.031; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Taylor SS, 2004, CHROMOSOME RES, V12, P599, DOI 10.1023/B:CHRO.0000036610.78380.51; Vanoosthuyse V, 2004, MOL CELL BIOL, V24, P9786, DOI 10.1128/MCB.24.22.9786-9801.2004; Vink M, 2006, CURR BIOL, V16, P755, DOI 10.1016/j.cub.2006.03.057; Yamaguchi S, 2003, EMBO J, V22, P1075, DOI 10.1093/emboj/cdg100; Yu HT, 2006, J CELL BIOL, V173, P153, DOI 10.1083/jcb.200601172; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	38	37	39	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1342	10.1371/journal.pone.0001342	http://dx.doi.org/10.1371/journal.pone.0001342			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094750	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459600025
J	Okitsu, SL; Silvie, O; Westerfeld, N; Curcic, M; Kammer, AR; Mueller, MS; Sauerwein, RW; Robinson, JA; Genton, B; Mazier, D; Zurbriggen, R; Pluschke, G				Okitsu, Shinji L.; Silvie, Olivier; Westerfeld, Nicole; Curcic, Marija; Kammer, Andreas R.; Mueller, Markus S.; Sauerwein, Robert W.; Robinson, John A.; Genton, Blaise; Mazier, Dominique; Zurbriggen, Rinaldo; Pluschke, Gerd			A Virosomal Malaria Peptide Vaccine Elicits a Long-Lasting Sporozoite-Inhibitory Antibody Response in a Phase 1a Clinical Trial	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM; CIRCUMSPOROZOITE PROTEIN; INFLUENZA VIROSOMES; DELIVERY-SYSTEM; CHILDREN; INDUCTION; IMMUNITY; DISEASE; DESIGN; MEMORY	Objectives. Peptides delivered on the surface of influenza virosomes have been shown to induce solid humoral immune responses in experimental animals. High titers of peptide-specific antibodies were also induced in a phase 1a clinical trial in volunteers immunized with virosomal formulations of two peptides derived from the circumsporozoite protein (CSP) and the apical membrane antigen 1 (AMA-1) of Plasmodium falciparum. The main objective of this study was to perform a detailed immunological and functional analysis of the CSP-specific antibodies elicited in this phase 1a trial. Methodology/Principal Findings. 46 healthy malaria-naive adults were immunized with virosomal formulations of two peptide-phosphatidylethanolamine conjugates, one derived from the NANP repeat region of P. falciparum CSP ( designated UK-39) the other from P. falciparum AMA-1 ( designated AMA49-C1). The two antigens were delivered in two different concentrations, alone and in combination. One group was immunized with empty virosomes as control. In this report we show a detailed analysis of the antibody response against UK-39. Three vaccinations with a 10 mg dose of UK-39 induced high titers of sporozoite-binding antibodies in all volunteers. This IgG response was affinity maturated and long-lived. Co-administration of UK-39 and AMA49-C1 loaded virosomes did not interfere with the immunogenicity of UK-39. Purified total IgG from UK-39 immunized volunteers inhibited sporozoite migration and invasion of hepatocytes in vitro. Sporozoite inhibition closely correlated with titers measured in immunogenicity assays. Conclusions. Virosomal delivery of a short, conformationally constrained peptide derived from P. falciparum CSP induced a long-lived parasite-inhibitory antibody response in humans. Combination with a second virosomally-formulated peptide derived from P. falciparum AMA-1 did not interfere with the immunogenicity of either peptide, demonstrating the potential of influenza virosomes as a versatile, human-compatible antigen delivery platform for the development of multivalent subunit vaccines.	[Okitsu, Shinji L.; Curcic, Marija; Mueller, Markus S.; Genton, Blaise; Pluschke, Gerd] Swiss Trop Inst, CH-4002 Basel, Switzerland; [Silvie, Olivier; Mazier, Dominique] CHU Pitie Salpetriere, Fac Med Pierre & Marie Curie, UPMC, INSERM,UMR S Immunobiol Cellulaire & Mol Infect P, Paris, France; [Westerfeld, Nicole; Kammer, Andreas R.; Zurbriggen, Rinaldo] Pevion Biotech, Basel, Switzerland; [Sauerwein, Robert W.] Radboud Univ Nijmegen Med Ctr, Dept Med Microbiol, Nijmegen, Netherlands; [Robinson, John A.] Univ Zurich, Inst Organ Chem, Zurich, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Radboud University Nijmegen; University of Zurich	Pluschke, G (corresponding author), Swiss Trop Inst, CH-4002 Basel, Switzerland.	Gerd.Pluschke@unibas.ch	Silvie, Olivier/AAF-5437-2021; Sauerwein, Robert/C-8519-2013; Silvie, Olivier/K-7290-2017	Silvie, Olivier/0000-0002-0525-6940; Silvie, Olivier/0000-0002-0525-6940	Pevion Biotech, Switzerland	Pevion Biotech, Switzerland	This study was supported by Pevion Biotech, Switzerland.	Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Amacker M, 2005, INT IMMUNOL, V17, P695, DOI 10.1093/intimm/dxh249; Bachmann MF, 1997, ANNU REV IMMUNOL, V15, P235, DOI 10.1146/annurev.immunol.15.1.235; Bisang C, 1998, J AM CHEM SOC, V120, P7439, DOI 10.1021/ja980444j; CLYDE DF, 1973, AM J MED SCI, V266, P169, DOI 10.1097/00000441-197309000-00002; FERREIRA MU, 1995, J IMMUNOL METHODS, V187, P297, DOI 10.1016/0022-1759(95)00186-4; Genton B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001018; Ghasparian A, 2006, CHEM COMMUN, P174, DOI 10.1039/b510812h; Good MF, 2005, TRENDS PARASITOL, V21, P29, DOI 10.1016/j.pt.2004.10.006; Greenwood B, 2005, ACTA TROP, V95, P298, DOI 10.1016/j.actatropica.2005.04.017; Greenwood BM, 2005, LANCET, V365, P1487, DOI 10.1016/S0140-6736(05)66420-3; Huckriede A, 2003, VACCINE, V21, P925, DOI 10.1016/S0264-410X(02)00542-X; James WPT, 2006, INT J PEDIATR OBES, V1, P7, DOI 10.1080/17477160600630404; Kappe SHI, 2004, TRENDS PARASITOL, V20, P13, DOI 10.1016/j.pt.2003.10.011; MAZIER D, 1986, SCIENCE, V231, P156, DOI 10.1126/science.3510455; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; MOORTHY VS, 2005, PROGR DEV VACCINE AI; Moreno R, 2001, CHEMBIOCHEM, V2, P838, DOI 10.1002/1439-7633(20011105)2:11<838::AID-CBIC838>3.0.CO;2-4; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Mueller MS, 2003, INFECT IMMUN, V71, P4749, DOI 10.1128/IAI.71.8.4749-4758.2003; Nevill CG, 1996, TROP MED INT HEALTH, V1, P139; Okitsu SL, 2007, CHEM BIOL, V14, P577, DOI 10.1016/j.chembiol.2007.04.008; OKITSU SL, 2007, PEPTIDES; Pfeiffer B, 2003, ANGEW CHEM INT EDIT, V42, P2368, DOI 10.1002/anie.200250348; Poltl-Frank F, 1999, CLIN EXP IMMUNOL, V117, P496; Pulendran B, 2006, CELL, V124, P849, DOI 10.1016/j.cell.2006.02.019; Silvie O, 2003, NAT MED, V9, P93, DOI 10.1038/nm808; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Targett GA, 2005, TRENDS PARASITOL, V21, P499, DOI 10.1016/j.pt.2005.08.018; Tongren JE, 2004, TRENDS PARASITOL, V20, P604, DOI 10.1016/j.pt.2004.09.005; Vanderberg JP, 2004, INT J PARASITOL, V34, P991, DOI 10.1016/j.ijpara.2004.05.005; Waters A, 2006, CELL, V124, P689, DOI 10.1016/j.cell.2006.02.011; Zurbriggen R, 2003, VACCINE, V21, P921, DOI 10.1016/S0264-410X(02)00541-8	34	44	47	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1278	10.1371/journal.pone.0001278	http://dx.doi.org/10.1371/journal.pone.0001278			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060072	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459400025
J	Frech, MS; Torre, KM; Robinson, GW; Furth, PA				Frech, M. S.; Torre, K. M.; Robinson, G. W.; Furth, P. A.			Loss of cyclin D1 in concert with deregulated estrogen receptor a expression induces DNA damage response activation and interrupts mammary gland morphogenesis	ONCOGENE			English	Article						ER alpha; cyclin D1; cyclin E; DNA damage; mammary gland	CARCINOMA IN-SITU; BREAST-CANCER; PRECANCEROUS BREAST; INSTABILITY; LESIONS; CELLS	We have previously shown that increased and deregulated estrogen receptor alpha expression in the mammary gland leads to the development of proliferative disease and cancer. To address the importance of cyclin D1 in ER alpha-mediated mammary tumorigenesis, we crossed ER alpha-overexpressing mice with cyclin D1 knockout mice. Mammary gland morphogenesis was completely interrupted in the ER alpha-overexpressing cyclin D1-deficient triple transgenic mice. In addition to a highly significant reduction in mammary epithelial cell proliferation, cyclin E was upregulated resulting in DNA damage checkpoint activation and apoptosis. This imbalance between proliferative and apoptotic rates in conjunction with remarkable structural defects and cellular disorganization in the terminal end buds interrupted ductal morphogenesis. Interestingly, the structure of the mammary fat pad was fundamentally altered by the consequences of overexpressing ERa in the epithelial cells in the absence of cyclin D1 illustrating how alterations in the epithelial compartment can impact surrounding stromal composition. Transplantation of embryonic ER alpha-overexpressing and cyclin D1-deficient mammary epithelium into the cleared fat pad of wild-type mice did not rescue the aberrant mammary gland phenotype indicating that it was intrinsic to the mammary epithelial cells. In conclusion, although cyclin D1 is not essential for proliferation of normal mammary epithelial cells, ER alpha-overexpressing cells are absolutely dependent on cyclin D1 for proliferation. This differential requirement for cyclin D1 in normal vs abnormal mammary epithelial cells supports the application of cyclin D1 inhibitors as therapeutic interventions in ER alpha-overexpressing breast cancers.	[Frech, M. S.; Torre, K. M.; Furth, P. A.] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Robinson, G. W.] NIDDKD, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA	Georgetown University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Frech, MS (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA.	msf25@georgetown.edu	Robinson, Gertraud/I-2136-2012		NATIONAL CANCER INSTITUTE [R01CA112176] Funding Source: NIH RePORTER; NCI NIH HHS [1R01CA112176, R01 CA112176, R01 CA112176-05] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Carthon BC, 2005, MOL CELL BIOL, V25, P1081, DOI 10.1128/MCB.25.3.1081-1088.2005; DANIEL CW, 1995, DEV BIOL, V169, P511, DOI 10.1006/dbio.1995.1165; Deugnier MA, 2002, BREAST CANCER RES, V4, P224, DOI 10.1186/bcr459; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Frech MS, 2005, CANCER RES, V65, P681; Geng Y, 1999, CELL, V97, P767, DOI 10.1016/S0092-8674(00)80788-6; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Hinck L, 2005, BREAST CANCER RES, V7, P245, DOI 10.1186/bcr1331; Keyomarsi K, 2002, NEW ENGL J MED, V347, P1566, DOI 10.1056/NEJMoa021153; Minella AC, 2007, ONCOGENE, V26, P6948, DOI 10.1038/sj.onc.1210518; Oh YL, 2001, PATHOL INT, V51, P94, DOI 10.1046/j.1440-1827.2001.01173.x; Peng SY, 1998, J HEPATOL, V29, P281, DOI 10.1016/S0168-8278(98)80014-7; ROBINSON GW, 2000, METHODS MAMMARY GLAN, P301; Shoker BS, 1999, J PATHOL, V188, P237; Shoker BS, 2001, BRIT J CANCER, V84, P1064, DOI 10.1054/bjoc.2001.1705; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Silberstein GB, 2001, BREAST CANCER RES, V3, P218, DOI 10.1186/bcr299; Spruck CH, 1999, NATURE, V401, P297, DOI 10.1038/45836; Sutherland RL, 2004, J MAMMARY GLAND BIOL, V9, P95, DOI 10.1023/B:JOMG.0000023591.45568.77; Wiseman BS, 2002, SCIENCE, V296, P1046, DOI 10.1126/science.1067431; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500	23	12	12	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	22					3186	3193		10.1038/sj.onc.1210974	http://dx.doi.org/10.1038/sj.onc.1210974			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	301LL	18071314	Green Accepted			2022-12-25	WOS:000255897600011
J	Fuchs, J; Tichopad, A; Golub, Y; Munz, M; Schweitzer, KJ; Wolf, B; Berg, D; Mueller, JC; Gasser, T				Fuchs, Julia; Tichopad, Ales; Golub, Yulia; Munz, Marita; Schweitzer, Katherine J.; Wolf, Bjoern; Berg, Daniela; Mueller, Jakob C.; Gasser, Thomas			Genetic variability in the SNCA gene influences alpha-synuclein levels in the blood and brain	FASEB JOURNAL			English	Article						Parkinson's disease; SNP; NACP-Rep1; substantia nigra; gene expression; real-time RT-PCR; ELISA	FAMILIAL PARKINSONS-DISEASE; MESSENGER-RNA EXPRESSION; HUMAN PLASMA; LYMPHOCYTES; DUPLICATION; DOPAMINE; SUSCEPTIBILITY; TRIPLICATION; HAPLOTYPES; MUTATION	Genetic variability in the promoter and 3' region of the SNCA gene coding alpha-synuclein modulates the risk to develop sporadic Parkinson's disease (PD). Whether this is mediated by regulating alpha-synuclein expression levels remains unknown. Therefore, we analyzed levels of alpha-synuclein in blood and human post mortem brain tissue including the substantia nigra using quantitative real-time reverse transcriptase-polymerase chain reaction and enzyme linked immunosorbent assay in vivo. Single nucleotide polymorphism (SNP) rs356219, a tagging SNP for a disease-associated haplotype in the 3' region of the SNCA gene, has a significant effect on SNCA mRNA levels in the substantia nigra and the cerebellum. Further, the "protective" genotype 259/259 of the PD-associated promoter repeat NACP-Rep1 is associated with lower protein levels in blood than genotypes 261/261, 259/261, and 259/263. In conclusion, we provide evidence that alpha-synuclei levels are influenced by genetic variability in the promoter and 3' region of the SNCA gene in vivo.	[Fuchs, Julia; Golub, Yulia; Munz, Marita; Schweitzer, Katherine J.; Wolf, Bjoern; Berg, Daniela; Mueller, Jakob C.; Gasser, Thomas] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, D-72076 Tubingen, Germany; [Tichopad, Ales] Tech Univ Munich, Freising Weihenstephan, Germany; [Mueller, Jakob C.] Max Planck Inst Ornithol, Dept Behav Ecol & Evolut Genet, Seewiesen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Max Planck Society	Gasser, T (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Hoppe Seyler Str 3, D-72076 Tubingen, Germany.	thomas.gasser@med.uni-tuebingen.de	Fuchs, Julia/M-7529-2017; Gasser, Thomas/GNH-5293-2022	Fuchs, Julia/0000-0002-3045-0470; Gasser, Thomas/0000-0002-1069-1146	NATIONAL INSTITUTE OF MENTAL HEALTH [R24MH068855] Funding Source: NIH RePORTER; NIMH NIH HHS [R24 MH068855] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Barbanti P, 1999, MOVEMENT DISORD, V14, P764, DOI 10.1002/1531-8257(199909)14:5<764::AID-MDS1008>3.0.CO;2-W; Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Caronti B, 1999, NEUROREPORT, V10, P2907, DOI 10.1097/00001756-199909290-00006; Caronti B, 2001, J NEURAL TRANSM, V108, P803, DOI 10.1007/s007020170030; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kim S, 2004, FASEB J, V18, P1615, DOI 10.1096/fj.04-1917fje; Kingsbury AE, 2004, MOVEMENT DISORD, V19, P162, DOI 10.1002/mds.10683; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; MCCuLLAGH P., 1989, GEN LINEAR MODELS, V37; Michell AW, 2005, NEUROSCI LETT, V381, P294, DOI 10.1016/j.neulet.2005.02.030; Mizuta I, 2006, HUM MOL GENET, V15, P1151, DOI 10.1093/hmg/ddl030; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Nagai Y, 1996, NEUROLOGY, V46, P791, DOI 10.1212/WNL.46.3.791; Neystat M, 1999, MOVEMENT DISORD, V14, P417, DOI 10.1002/1531-8257(199905)14:3<417::AID-MDS1005>3.0.CO;2-X; Nishioka K, 2006, ANN NEUROL, V59, P298, DOI 10.1002/ana.20753; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Petrozzi L, 2001, NEUROL SCI, V22, P83, DOI 10.1007/s100720170058; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tan EK, 2004, NEUROLOGY, V62, P128, DOI 10.1212/01.WNL.0000101721.25345.DC; Xia Y, 1996, ANN NEUROL, V40, P207, DOI 10.1002/ana.410400212	32	195	202	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2008	22	5					1327	1334		10.1096/fj.07-9348com	http://dx.doi.org/10.1096/fj.07-9348com			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18162487				2022-12-25	WOS:000255898700006
J	Beltzner, CC; Pollard, TD				Beltzner, Christopher C.; Pollard, Thomas D.			Pathway of actin filament branch formation by Arp2/3 complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WASP/SCAR PROTEINS; FISSION YEAST; ADP-ACTIN; NUCLEATION; POLYMERIZATION; WASP; IDENTIFICATION; ACTIVATION; ENERGETICS; MECHANISM	A spectroscopic assay using pyrene-labeled fission yeast Arp2/3 complex revealed that the complex binds to and dissociates from actin filaments extremely slowly with or without the nucleation-promoting factor fission yeast Wsp1-VCA. Wsp1-VCA binds both Arp2/3 complex and actin monomers with high affinity. These two ligands have only modest impacts on the interaction of the other ligand with VCA. Simulations of a mathematical model based on the kinetic parameters determined in this study and elsewhere account for the full time course of actin polymerization in the presence of Arp2/3 complex and Wsp1-VCA and show that an activation step, postulated to follow binding of a ternary complex of Arp2/ 3 complex, a bound nucleation-promoting factor, and an actin monomer to an actin filament, has a rate constant at least 0.15 s(-1). Kinetic parameters determined in this study constrain the process of actin filament branch formation during cellular motility to one main pathway.	[Beltzner, Christopher C.; Pollard, Thomas D.] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Cell Biol, New Haven, CT 06520 USA; [Pollard, Thomas D.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Pollard, TD (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, 219 Prospect St,KBT-548,POB 208103, New Haven, CT 06520 USA.	thomas.pollard@yale.edu			NIGMS NIH HHS [GM-26338] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM026338] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abraham VC, 1999, BIOPHYS J, V77, P1721, DOI 10.1016/S0006-3495(99)77018-9; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beltzner CC, 2004, J MOL BIOL, V336, P551, DOI 10.1016/j.jmb.2003.12.017; Blanchoin L, 1999, J BIOL CHEM, V274, P15538, DOI 10.1074/jbc.274.22.15538; Cao WX, 2006, J MOL BIOL, V361, P257, DOI 10.1016/j.jmb.2006.06.019; De La Cruz EM, 1996, BIOCHEMISTRY-US, V35, P14054, DOI 10.1021/bi961047t; Egile C, 2005, PLOS BIOL, V3, P1902, DOI 10.1371/journal.pbio.0030383; Egile C, 1999, J CELL BIOL, V146, P1319, DOI 10.1083/jcb.146.6.1319; Gournier H, 2001, MOL CELL, V8, P1041, DOI 10.1016/S1097-2765(01)00393-8; Higgs HN, 1999, J BIOL CHEM, V274, P32531, DOI 10.1074/jbc.274.46.32531; Higgs HN, 1999, BIOCHEMISTRY-US, V38, P15212, DOI 10.1021/bi991843+; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kelly AE, 2006, J BIOL CHEM, V281, P10589, DOI 10.1074/jbc.M507470200; Kovar DR, 2005, MOL BIOL CELL, V16, P2313, DOI 10.1091/mbc.E04-09-0781; MACLEANFLETCHER S, 1980, BIOCHEM BIOPH RES CO, V96, P18, DOI 10.1016/0006-291X(80)91175-4; Marchand JB, 2001, NAT CELL BIOL, V3, P76, DOI 10.1038/35050590; Mogilner A, 2002, BIOPHYS J, V83, P1237, DOI 10.1016/S0006-3495(02)73897-6; Mullins RD, 1998, P NATL ACAD SCI USA, V95, P6181, DOI 10.1073/pnas.95.11.6181; Mullins RD, 1998, MOL BIOL CELL, V9, P841, DOI 10.1091/mbc.9.4.841; Nolen BJ, 2007, MOL CELL, V26, P449, DOI 10.1016/j.molcel.2007.04.017; POLLARD TD, 1986, J CELL BIOL, V103, P2747, DOI 10.1083/jcb.103.6.2747; POLLARD TD, 1984, J CELL BIOL, V99, P769, DOI 10.1083/jcb.99.3.769; Pollard TD, 2007, ANNU REV BIOPH BIOM, V36, P451, DOI 10.1146/annurev.biophys.35.040405.101936; Rodal AA, 2005, NAT STRUCT MOL BIOL, V12, P26, DOI 10.1038/nsmb870; Sirotkin V, 2005, J CELL BIOL, V170, P637, DOI 10.1083/jcb.200502053; Volkmann N, 2001, SCIENCE, V293, P2456, DOI 10.1126/science.1063025; Welch MD, 2002, ANNU REV CELL DEV BI, V18, P247, DOI 10.1146/annurev.cellbio.18.040202.112133; WHITE HD, 1976, BIOCHEMISTRY-US, V15, P5818, DOI 10.1021/bi00671a020	28	71	71	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7135	7144		10.1074/jbc.M705894200	http://dx.doi.org/10.1074/jbc.M705894200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18165685	hybrid			2022-12-25	WOS:000253779600059
J	Ruggiero, AM; Liu, Y; Vidensky, S; Maier, S; Jung, E; Farhan, H; Robinson, MB; Sitte, HH; Rothstein, JD				Ruggiero, Alicia M.; Liu, Yiting; Vidensky, Svetlana; Maier, Susanne; Jung, Elizabeth; Farhan, Hesso; Robinson, Michael B.; Sitte, Harald H.; Rothstein, Jeffrey D.			The endoplasmic reticulum exit of glutamate transporter is regulated by the inducible mammalian Yip6b/GTRAP3-18 protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAB; OLIGOMERIZATION; IDENTIFICATION; TRAFFICKING; MODULATION; EXPRESSION; SUBTYPE; CELLS; ER	GTRAP3-18 interacts with and reduces the activity of the neuronal specific Na+/K+ glutamate transporter, EAAC1 both in vitro and in vivo. GTRAP3-18 and the related isoform, JM4, are distant relatives of the Rab GTPase-interacting factor PRA1, and share a topology of four transmembrane domains and cytosolic termini. GTRAP3-18 and JM4 are resident endoplasmic reticulum ( ER) proteins. The physiological role of GTRAP3-18 is poorly understood. We demonstrate for the first time that GTRAP3-18 is a regulator of ER protein trafficking. Expression of GTRAP3-18 delays the ER exit of EAAC1, as well as other members of the excitatory amino acid transporter family. GTRAP3-18 uses hydrophobic domain interactions in the ER membrane to self-associate and cytoplasmic interactions at the C terminus to regulate trafficking. The features of GTRAP3-18 activity are consistent with recent phylogenic sequence analyses suggesting GTRAP3-18 and JM4 be reclassified as mammalian isoforms of the yeast protein family Yip, Yip6b, and Yip6a, respectively.	[Ruggiero, Alicia M.; Rothstein, Jeffrey D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA; [Maier, Susanne; Farhan, Hesso; Sitte, Harald H.] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria; [Robinson, Michael B.] Univ Penn, Childrens Hosp Philadelphia, Dept Pediat & Pharmacol, Philadelphia, PA 19104 USA	Johns Hopkins University; Medical University of Vienna; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Rothstein, JD (corresponding author), Johns Hopkins Univ, Dept Neurol, Meyer 6-109,625 N Wolfe St, Baltimore, MD 21287 USA.	jrothstein@jhmi.edu	Sitte, Harald/O-7025-2019; Sitte, Harald/N-2681-2013; rothstein, jeffrey d/C-9470-2013; Farhan, Hesso/C-7997-2012	Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444; Farhan, Hesso/0000-0002-0889-8463	Austrian Science Fund FWF [P 18706] Funding Source: Medline; NINDS NIH HHS [R01 NS036465, NS 36465, NS 40151, R01 NS040151] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS036465, R01NS040151] Funding Source: NIH RePORTER	Austrian Science Fund FWF(Austrian Science Fund (FWF)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200; ARRIZA JL, 1994, J NEUROSCI, V14, P5559; Calero M, 2002, BIOCHEM BIOPH RES CO, V290, P676, DOI 10.1006/bbrc.2001.6242; Cheng CL, 2002, J NEUROSCI, V22, P10643; Collins RN, 2003, MOL MEMBR BIOL, V20, P105, DOI 10.1080/0968768031000085892; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Davis KE, 1998, J NEUROSCI, V18, P2475; Diamond JS, 2001, J NEUROSCI, V21, P8328, DOI 10.1523/JNEUROSCI.21-21-08328.2001; Dowd LA, 1996, J NEUROCHEM, V67, P508, DOI 10.1046/j.1471-4159.1996.67020508.x; Gonzalez MI, 2003, J NEUROSCI, V23, P5589; Ikemoto MJ, 2002, NEUROREPORT, V13, P2079, DOI 10.1097/00001756-200211150-00018; Jackson M, 2001, NATURE, V410, P89, DOI 10.1038/35065091; Kalandadze A, 2004, J NEUROSCI, V24, P5183, DOI 10.1523/JNEUROSCI.0839-04.2004; Lee SP, 2003, LIFE SCI, V74, P173, DOI 10.1016/j.lfs.2003.09.028; Li HW, 2004, P NATL ACAD SCI USA, V101, P647, DOI 10.1073/pnas.0305145101; Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084; Lin CLG, 1998, NEURON, V20, P589, DOI 10.1016/S0896-6273(00)80997-6; Mao Wen-ge, 2004, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V22, P60; Mathews GC, 2003, J NEUROSCI, V23, P2040; Melikian HE, 1996, MOL PHARMACOL, V50, P266; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pfeffer S, 2005, BIOCHEM SOC T, V33, P627, DOI 10.1042/BST0330627; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Pfeffer SR, 2005, J BIOL CHEM, V280, P15485, DOI 10.1074/jbc.R500003200; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; Rothstein JD, 1999, J NEUROCHEM, V72, P422, DOI 10.1046/j.1471-4159.1999.0720422.x; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200; Seal RP, 2001, P NATL ACAD SCI USA, V98, P15324, DOI 10.1073/pnas.011400198; Sepkuty JP, 2002, J NEUROSCI, V22, P6372; Sitte HH, 2004, MOL INTERV, V4, P38, DOI 10.1124/mi.4.1.38; Sivars U, 2003, NATURE, V425, P856, DOI 10.1038/nature02057; Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27; Trombetta ES, 2003, GLYCOBIOLOGY, V13, p77R, DOI 10.1093/glycob/cwg075; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Wang H, 2003, INT J ADV MANUF TECH, V21, P215, DOI 10.1007/s001700300024; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; YANG W, 2002, J BIOL CHEM, V31, P31; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018	39	57	58	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6175	6183		10.1074/jbc.M701008200	http://dx.doi.org/10.1074/jbc.M701008200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167356	Green Accepted, hybrid			2022-12-25	WOS:000253779500024
J	Sundaram, S; Rathinasabapathi, B; Ma, LQ; Rosen, BP				Sundaram, Sabarinath; Rathinasabapathi, Bala; Ma, Lena Q.; Rosen, Barry P.			An arsenate-activated glutaredoxin from the arsenic hyperaccumulator fern Pteris vittata L. regulates intracellular arsenite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; TRANSPORT; THIOREDOXIN; PROTECTION; STRESS	To elucidate the mechanisms of arsenic resistance in the arsenic hyperaccumulator fern Pteris vittata L., a cDNA for a glutaredoxin (Grx) Pv5-6 was isolated from a frond expression cDNA library based on the ability of the cDNA to increase arsenic resistance in Escherichia coli. The deduced amino acid sequence of Pv5-6 showed high homology with an Arabidopsis chloroplastic Grx and contained two CXXS putative catalytic motifs. Purified recombinant Pv5-6 exhibited glutaredoxin activity that was increased 1.6-fold by 10mM arsenate. Site-specific mutation of Cys(67) to Ala(67) resulted in the loss of both GRX activity and arsenic resistance. PvGrx5 was expressed in E. coli mutants in which the arsenic resistance genes of the ars operon were deleted (strain AW3110), a deletion of the gene for the ArsC arsenate reductase (strain WC3110), and a strain in which the ars operon was deleted and the gene for the GlpF aquaglyceroporin was disrupted (strain OSBR1). Expression of PvGrx5 increased arsenic tolerance in strains AW3110 and WC3110, but not in OSBR1, suggesting that PvGrx5 had a role in cellular arsenic resistance independent of the ars operon genes but dependent on GlpF. AW3110 cells expressing PvGrx5 had significantly lower levels of arsenite when compared with vector controls when cultured in medium containing 2.5 mM arsenate. Our results are consistent with PvGrx5 having a role in regulating intracellular arsenite levels, by either directly or indirectly modulating the aquaglyceroporin. To our knowledge, PvGrx5 is the first plant Grx implicated in arsenic metabolism.	[Sundaram, Sabarinath; Rathinasabapathi, Bala] Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA; [Ma, Lena Q.] Univ Florida, Dept Soil & Water Sci, Gainesville, FL 32611 USA; [Rosen, Barry P.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; Wayne State University	Rathinasabapathi, B (corresponding author), Univ Florida, Dept Hort Sci, Plant Mol & Cellular Biol Program, Gainesville, FL 32611 USA.	brath@ufl.edu	Ma, Lena Q/E-5854-2010; Rathinasabapathi, Bala/I-5811-2019; sundaram, sabarinath/E-2405-2011; sundaram, sabarinath/A-8806-2012	Ma, Lena Q/0000-0002-8463-9957; Rathinasabapathi, Bala/0000-0002-7867-465X; Rosen, Barry P./0000-0002-5230-4271	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052216] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM 52216] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caille N, 2004, ENVIRON POLLUT, V132, P113, DOI 10.1016/j.envpol.2004.03.018; CARLIN A, 1995, J BACTERIOL, V177, P981, DOI 10.1128/jb.177.4.981-986.1995; Chen M, 1998, J ENVIRON QUAL, V27, P1294, DOI 10.2134/jeq1998.00472425002700060004x; Cheng NH, 2005, PLANT PHYSIOL, V138, P2048, DOI 10.1104/pp.105.061218; Cheng NH, 2003, J BIOL CHEM, V278, P6503, DOI 10.1074/jbc.M210883200; Cheng NH, 2006, J BIOL CHEM, V281, P26280, DOI 10.1074/jbc.M601354200; Elless MP, 2005, WATER RES, V39, P3863, DOI 10.1016/j.watres.2005.07.029; Ellis DR, 2006, PLANT PHYSIOL, V141, P1544, DOI 10.1104/pp.106.084079; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Fouad WM, 2006, PLANT MOL BIOL, V60, P495, DOI 10.1007/s11103-005-4844-9; Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; Johanson U, 2002, MOL BIOL EVOL, V19, P456, DOI 10.1093/oxfordjournals.molbev.a004101; Kertulis GM, 2005, ENVIRON EXP BOT, V54, P239, DOI 10.1016/j.envexpbot.2004.09.001; Lillig CH, 2004, P NATL ACAD SCI USA, V101, P13227, DOI 10.1073/pnas.0401896101; Liu ZJ, 2006, ENVIRON HEALTH PERSP, V114, P527, DOI 10.1289/ehp.8600; Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899; Ma LQ, 2001, NATURE, V409, P579, DOI 10.1038/35054664; Meyer AJ, 2005, PHOTOSYNTH RES, V86, P435, DOI 10.1007/s11120-005-8425-1; Mukhopadhyay R, 2000, J BIOL CHEM, V275, P21149, DOI 10.1074/jbc.M910401199; Oremland RS, 2005, TRENDS MICROBIOL, V13, P45, DOI 10.1016/j.tim.2004.12.002; Pickering IJ, 2006, ENVIRON SCI TECHNOL, V40, P5010, DOI 10.1021/es052559a; Poynton CY, 2004, PLANTA, V219, P1080, DOI 10.1007/s00425-004-1304-8; Rathinasabapathi B, 2006, PLANT MOL BIOL, V62, P845, DOI 10.1007/s11103-006-9060-8; Rathinasabapathi B, 2006, NEW PHYTOL, V172, P385, DOI 10.1111/j.1469-8137.2006.01889.x; Rodriguez-Manzaneque MT, 1999, MOL CELL BIOL, V19, P8180; Rosen BP, 2002, FEBS LETT, V529, P86, DOI 10.1016/S0014-5793(02)03186-1; Rouhier N, 2004, CELL MOL LIFE SCI, V61, P1266, DOI 10.1007/s00018-004-3410-y; Rouhier N, 2006, J EXP BOT, V57, P1685, DOI 10.1093/jxb/erl001; Sanders OI, 1997, J BACTERIOL, V179, P3365, DOI 10.1128/jb.179.10.3365-3367.1997; Shi HL, 2004, MOL CELL BIOCHEM, V255, P67, DOI 10.1023/B:MCBI.0000007262.26044.e8; Shi J, 1999, J BIOL CHEM, V274, P36039, DOI 10.1074/jbc.274.51.36039; Singh N, 2006, PLANT SCI, V170, P274, DOI 10.1016/j.plantsci.2005.08.013; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; Srivastava M, 2005, J EXP BOT, V56, P1335, DOI 10.1093/jxb/eri134; Starke DW, 2003, J BIOL CHEM, V278, P14607, DOI 10.1074/jbc.M210434200; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tu C, 2002, J ENVIRON QUAL, V31, P1671, DOI 10.2134/jeq2002.1671; Tu S, 2004, INT J PHYTOREMEDIAT, V6, P35, DOI 10.1080/16226510490439972; WANG J, 2002, PLANT PHYSIOL, V130, P1; Xing SP, 2005, DEVELOPMENT, V132, P1555, DOI 10.1242/dev.01725; Yang HC, 2005, J BACTERIOL, V187, P6991, DOI 10.1128/JB.187.20.6991-6997.2005	47	66	72	2	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6095	6101		10.1074/jbc.M704149200	http://dx.doi.org/10.1074/jbc.M704149200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18156657	hybrid			2022-12-25	WOS:000253779500015
J	Ren, Y; Xu, HW; Davey, F; Taylor, M; Aiton, J; Coote, P; Fang, F; Yao, J; Chen, D; Chen, JX; Yan, SD; Gunn-Moore, FJ				Ren, Yimin; Xu, Hong Wei; Davey, Fleur; Taylor, Margaret; Aiton, Jim; Coote, Peter; Fang, Fang; Yao, Jun; Chen, Doris; Chen, John Xi; Yan, Shi Du; Gunn-Moore, Frank J.			Endophilin I expression is increased in the brains of Alzheimer disease patients	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL KINASE; AMYLOID-BETA-PEPTIDE; BINDING ALCOHOL-DEHYDROGENASE; ACTIVATED PROTEIN-KINASES; A-BETA; MITOCHONDRIAL DYSFUNCTION; NEURONAL APOPTOSIS; TRANSGENIC MICE; ABAD; STRESS	Alzheimer patients have increased levels of both the 42 amyloid-beta-peptide(A beta) and the amyloid binding alcohol dehydrogenase (ABAD), which is an intracellular binding site for A beta. The overexpression of A beta and ABAD in transgenic mice has shown that the binding of A beta to ABAD results in amplified neuronal stress and impairment of learning and memory. From a proteomic analysis of the brains from these animals, we have identified for the first time that the protein endophilin I increases in Alzheimer diseased brain. The increase in endophilin I levels in neurons is linked to an increase in the activation of the stress kinase c-Jun N-terminal kinase with the subsequent death of the neurons. We also demonstrate in living animals that the expression level of endophilin I is an indicator for the interaction of ABAD and A beta as its expression levels return to normal if this interaction is perturbed. Therefore this identifies endophilin I as a new indicator of the progression of Alzheimer disease.	[Ren, Yimin; Davey, Fleur; Taylor, Margaret; Aiton, Jim; Coote, Peter; Gunn-Moore, Frank J.] Univ St Andrews, Sch Biol & Med, St Andrews KY16 9TS, Fife, Scotland; [Xu, Hong Wei; Fang, Fang; Yao, Jun; Chen, John Xi; Yan, Shi Du] Columbia Univ Coll Phys & Surg, Dept Surg Pathol, New York, NY 10032 USA; [Chen, John Xi] Harvey Cushing Inst Neurosci, N Shore Long Island Jewish Hlth System, New York 11021, NY USA	University of St Andrews; Columbia University; Northwell Health	Gunn-Moore, FJ (corresponding author), Univ St Andrews, Sch Biol & Med, St Andrews KY16 9TS, Fife, Scotland.	sdy1@columbia.edu; fjg1@st-and.ac.uk		Xu, Hongwei/0000-0001-5763-3894; Coote, Peter John/0000-0001-5190-805X; Gunn-Moore, Francis James/0000-0003-3422-3387	MRC [G0400930] Funding Source: UKRI; Alzheimers Research UK [ART-PhD2004-3, ART-EG2005A-2] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P50AG008702, P01AG017490] Funding Source: NIH RePORTER; Medical Research Council [G0400930] Funding Source: Medline; NIA NIH HHS [P01 AG17490, P050 AG08702] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arancio O, 2004, EMBO J, V23, P4096, DOI 10.1038/sj.emboj.7600415; Bozyczko-Coyne D, 2001, J NEUROCHEM, V77, P849, DOI 10.1046/j.1471-4159.2001.00294.x; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Dickens M, 1997, SCIENCE, V277, P693, DOI 10.1126/science.277.5326.693; Du Yan S, 1999, J BIOL CHEM, V274, P2145, DOI 10.1074/jbc.274.4.2145; Ferrer I., 2005, Current Alzheimer Research, V2, P3, DOI 10.2174/1567205052772713; Goedert M, 1997, FEBS LETT, V409, P57, DOI 10.1016/S0014-5793(97)00483-3; He XY, 1999, J BIOL CHEM, V274, P15014, DOI 10.1074/jbc.274.21.15014; Howard L, 1999, J BIOL CHEM, V274, P31693, DOI 10.1074/jbc.274.44.31693; Kissinger CR, 2004, J MOL BIOL, V342, P943, DOI 10.1016/j.jmb.2004.07.071; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lustbader JW, 2004, SCIENCE, V304, P448, DOI 10.1126/science.1091230; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Minogue AM, 2003, J BIOL CHEM, V278, P27971, DOI 10.1074/jbc.M302530200; Morishima Y, 2001, J NEUROSCI, V21, P7551, DOI 10.1523/JNEUROSCI.21-19-07551.2001; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Powell AJ, 2000, J MOL BIOL, V303, P311, DOI 10.1006/jmbi.2000.4139; Ramjaun AR, 2001, J BIOL CHEM, V276, P28913, DOI 10.1074/jbc.M103198200; Reutens AT, 2002, INT J BIOCHEM CELL B, V34, P1173, DOI 10.1016/S1357-2725(02)00063-8; Reynolds CH, 2000, J NEUROCHEM, V74, P1587, DOI 10.1046/j.1471-4159.2000.0741587.x; Schobel S, 2006, INT J DEV NEUROSCI, V24, P141, DOI 10.1016/j.ijdevneu.2005.11.003; SHOJI M, 2001, BRAIN RES MOL BRAIN, V85, P221; Takuma K, 2005, FASEB J, V19, P597, DOI 10.1096/fj.04-2582fje; Thakur A, 2007, J NEUROSCI RES, V85, P1668, DOI 10.1002/jnr.21298; Trevaskis J, 2005, ENDOCRINOLOGY, V146, P3757, DOI 10.1210/en.2005-0282; Troy CM, 2001, J NEUROCHEM, V77, P157, DOI 10.1046/j.1471-4159.2001.00218.x; Wei WL, 2002, BRAIN, V125, P2036, DOI 10.1093/brain/awf205; Xie YL, 2006, BIOORG MED CHEM LETT, V16, P4657, DOI 10.1016/j.bmcl.2006.05.099; Yan SD, 2005, INT J EXP PATHOL, V86, P161, DOI 10.1111/j.0959-9673.2005.00427.x; Yan SD, 1997, NATURE, V389, P689; Yan SD, 2000, J BIOL CHEM, V275, P27100; YAO J, 2004, 2004 ABSTR VIEW IT P; Yao J, 2007, MOL CELL NEUROSCI, V35, P377, DOI 10.1016/j.mcn.2007.03.013; Zhu XW, 2001, MECH AGEING DEV, V123, P39, DOI 10.1016/S0047-6374(01)00342-6	35	41	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5685	5691		10.1074/jbc.M707932200	http://dx.doi.org/10.1074/jbc.M707932200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167351	hybrid			2022-12-25	WOS:000253426700049
J	Urs, NM; Kowalczyk, AP; Radhakrishna, H				Urs, Nikhil M.; Kowalczyk, Andrew P.; Radhakrishna, Harish			Different mechanisms regulate lysophosphatidic acid (LPA)-dependent versus phorbol ester-dependent internalization of the LPA(1) receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CLATHRIN-MEDIATED ENDOCYTOSIS; KINASE-C; BETA-ARRESTIN; ACTIVATED RECEPTOR-1; CARBOXYL-TERMINUS; TRAFFICKING; CELLS; PHOSPHORYLATION; DESENSITIZATION	Lysophosphatidic acid (LPA) stimulates cells by activation of five G-protein-coupled receptors, termed LPA(1-5). The LPA(1) receptor is the most widely expressed and is a major regulator of cell migration. In this study, we show that phorbol ester (PMA)-induced internalization of the LPA(1) receptor requires clathrin AP-2 complexes, protein kinase C, and a distal dileucine motif (amino acids 352 and 353) in the cytoplasmic tail but not beta-arrestin. Agonist-dependent internalization of LPA(1), however, requires a cluster of serine residues (amino acids 341-347) located proximal to the dileucine motif, beta-arrestin, and to a lesser extent clathrin AP-2. The serine cluster of LPA(1) is required for beta-arrestin2-GFP translocation to the plasma membrane and signal desensitization. In contrast, the dileucine motif (IL) is required for both basal and PMA-induced internalization. Evidence for the beta-arrestin independence of PMA-induced internalization of LPA(1) comes from the observations that beta-arrestin2-GFP is not recruited to the plasma membrane upon PMA treatment and that LPA(1) is readily internalized in beta-arrestin1/2 knock-out mouse embryonic fibroblasts. These results indicate that distinct molecular mechanisms regulate agonist-dependent and PMA-dependent internalization of the LPA(1) receptor.	[Urs, Nikhil M.; Radhakrishna, Harish] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Kowalczyk, Andrew P.] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA	University System of Georgia; Georgia Institute of Technology; Emory University	Radhakrishna, H (corresponding author), Coca Cola Co, One Coca-Cola Plaza,TEC-437, Atlanta, GA 30301 USA.	hradha@earthlink.net			NHLBI NIH HHS [HL 67314] Funding Source: Medline; NIAMS NIH HHS [AR 050501] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL067314] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050501] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Ally RA, 2003, MOL PHARMACOL, V64, P890, DOI 10.1124/mol.64.4.890; Anliker B, 2004, SEMIN CELL DEV BIOL, V15, P457, DOI 10.1016/j.semcdb.2004.05.005; Avendano-Vazquez SEA, 2005, BIOCHEM J, V385, P677, DOI 10.1042/BJ20040891; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Diviani D, 2003, J BIOL CHEM, V278, P19331, DOI 10.1074/jbc.M302110200; Drake MT, 2006, CIRC RES, V99, P570, DOI 10.1161/01.RES.0000242563.47507.ce; Droese J, 2004, BIOCHEM BIOPH RES CO, V322, P42, DOI 10.1016/j.bbrc.2004.07.076; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Futahashi Y, 2007, CANCER SCI, V98, P373, DOI 10.1111/j.1349-7006.2007.00388.x; Gage RM, 2005, J BIOL CHEM, V280, P3305, DOI 10.1074/jbc.M406934200; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Kirchhausen T, 1997, CURR OPIN CELL BIOL, V9, P488, DOI 10.1016/S0955-0674(97)80024-5; Laporte SA, 1999, P NATL ACAD SCI USA, V96, P3712, DOI 10.1073/pnas.96.7.3712; Lasley RD, 2000, J BIOL CHEM, V275, P4417, DOI 10.1074/jbc.275.6.4417; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Marchese A, 2003, TRENDS BIOCHEM SCI, V28, P369, DOI 10.1016/S0968-0004(03)00134-8; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Mundell SJ, 2006, MOL PHARMACOL, V70, P1132, DOI 10.1124/mol.106.023549; Murph MM, 2003, J CELL SCI, V116, P1969, DOI 10.1242/jcs.00397; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Oakley RH, 2001, J BIOL CHEM, V276, P19452, DOI 10.1074/jbc.M101450200; Oakley RH, 1999, J BIOL CHEM, V274, P32248, DOI 10.1074/jbc.274.45.32248; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Paing MM, 2006, MOL CELL BIOL, V26, P3231, DOI 10.1128/MCB.26.8.3231-3242.2006; Paing MM, 2004, J BIOL CHEM, V279, P21938, DOI 10.1074/jbc.M401672200; Paing MM, 2002, J BIOL CHEM, V277, P1292, DOI 10.1074/jbc.M109160200; Parent JL, 2001, J BIOL CHEM, V276, P7079, DOI 10.1074/jbc.M009375200; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Schulein R, 1998, MOL PHARMACOL, V54, P525, DOI 10.1124/mol.54.3.525; Scott MGH, 2002, J BIOL CHEM, V277, P3552, DOI 10.1074/jbc.M106586200; Shen ZZ, 1998, GYNECOL ONCOL, V71, P364, DOI 10.1006/gyno.1998.5193; Signoret N, 1997, J CELL BIOL, V139, P651, DOI 10.1083/jcb.139.3.651; Urs NM, 2005, J CELL SCI, V118, P5291, DOI 10.1242/jcs.02634; van Leeuwen FN, 2003, BIOCHEM SOC T, V31, P1209; Wang QMJ, 2006, TRENDS PHARMACOL SCI, V27, P317, DOI 10.1016/j.tips.2006.04.003; Watterson KR, 2002, J BIOL CHEM, V277, P5767, DOI 10.1074/jbc.M110647200; Xiang B, 2001, J BIOL CHEM, V276, P4709, DOI 10.1074/jbc.M006187200; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440	45	15	15	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5249	5257		10.1074/jbc.M710003200	http://dx.doi.org/10.1074/jbc.M710003200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18089565	hybrid			2022-12-25	WOS:000253426700004
J	Campo, N; Marquis, KA; Rudner, DZ				Campo, Nathalie; Marquis, Kathleen A.; Rudner, David Z.			SpoIIQ anchors membrane proteins on both sides of the sporulation septum in Bacillus subtilis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPMENTAL TRANSCRIPTION FACTOR; CELL-SPECIFIC TRANSCRIPTION; SUBCELLULAR-LOCALIZATION; ASYMMETRIC DIVISION; GENE-EXPRESSION; ACTIVATION; FTSZ; PHOSPHATASE; ENGULFMENT; FORESPORE	During the process of spore formation in Bacillus subtilis, many membrane proteins localize to the polar septum where they participate in morphogenesis and signal transduction. The forespore membrane protein SpoIIQ plays a central role in anchoring several mother-cell membrane proteins in the septal membrane. Here, we report that SpoIIQ is also responsible for anchoring a membrane protein on the forespore side of the sporulation septum. Co-immunoprecipitation experiments reveal that SpoIIQ resides in a complex with the polytopic membrane protein SpoIIE. During the early stages of sporulation, SpoIIE participates in the switch from medial to polar division and co-localizes with FtsZ at the polar septum. We show that after cytokinesis, SpoIIE is released from the septum and transiently localizes to all membranes in the forespore compartment. Upon the initiation of engulfment, it specifically re-localizes to the septal membrane on the forespore side. Importantly, the re-localization of SpoIIE to the engulfing septum requires SpoIIQ. These results indicate that SpoIIQ is required to anchor membrane proteins on both sides of the division septum. Moreover, our data suggest that forespore membrane proteins can localize to the septal membrane by diffusion-and-capture as has been described for membrane proteins in the mother cell. Finally, our results raise the intriguing possibility that SpoIIE has an uncharacterized function at a late stage of sporulation.	[Campo, Nathalie; Marquis, Kathleen A.; Rudner, David Z.] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Rudner, DZ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, 200 Longwood Ave, Boston, MA 02115 USA.	rudner@hms.harvard.edu	Campo, Nathalie/GYU-6339-2022		NIGMS NIH HHS [GM073831-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073831] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abanes-De Mello A, 2002, GENE DEV, V16, P3253, DOI 10.1101/gad.1039902; Adler E, 1997, MOL MICROBIOL, V23, P57, DOI 10.1046/j.1365-2958.1997.1801552.x; Arigoni F, 1999, MOL MICROBIOL, V31, P1407, DOI 10.1046/j.1365-2958.1999.01282.x; ARIGONI F, 1995, SCIENCE, V270, P637, DOI 10.1126/science.270.5236.637; Arigoni F, 1996, P NATL ACAD SCI USA, V93, P3238, DOI 10.1073/pnas.93.8.3238; Barak I, 1996, MOL MICROBIOL, V19, P1047, DOI 10.1046/j.1365-2958.1996.433963.x; Barak I, 2007, FEMS MICROBIOL REV, V31, P311, DOI 10.1111/j.1574-6976.2007.00067.x; Ben-Yehuda S, 2002, CELL, V109, P257, DOI 10.1016/S0092-8674(02)00698-0; Blaylock B, 2004, GENE DEV, V18, P2916, DOI 10.1101/gad.1252704; Campo N, 2004, MOL MICROBIOL, V53, P1583, DOI 10.1111/j.1365-2958.2004.04278.x; Campo N, 2007, J BACTERIOL, V189, P6021, DOI 10.1128/JB.00399-07; Campo N, 2006, MOL CELL, V23, P25, DOI 10.1016/j.molcel.2006.05.019; Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06; Doan T, 2005, MOL MICROBIOL, V55, P1767, DOI 10.1111/j.1365-2958.2005.04501.x; Doan T, 2007, MOL MICROBIOL, V64, P500, DOI 10.1111/j.1365-2958.2007.05677.x; DUNCAN L, 1995, SCIENCE, V270, P641, DOI 10.1126/science.270.5236.641; Errington J, 2003, MICROBIOL MOL BIOL R, V67, P52, DOI 10.1128/MMBR.67.1.52-65.2003; Feucht A, 1996, GENE DEV, V10, P794, DOI 10.1101/gad.10.7.794; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Harwood C.R., 1990, MOL BIOL METHODS BAC; Jiang X, 2005, MOL MICROBIOL, V58, P102, DOI 10.1111/j.1365-2958.2005.04811.x; Kentner D, 2006, CURR OPIN MICROBIOL, V9, P619, DOI 10.1016/j.mib.2006.10.012; Khvorova A, 1998, J BACTERIOL, V180, P1256, DOI 10.1128/JB.180.5.1256-1260.1998; King N, 1999, GENE DEV, V13, P1156, DOI 10.1101/gad.13.9.1156; Levin PA, 1997, MOL MICROBIOL, V25, P839; Levin PA, 1996, GENE DEV, V10, P478, DOI 10.1101/gad.10.4.478; Lewis PJ, 1998, J BACTERIOL, V180, P3276, DOI 10.1128/JB.180.13.3276-3284.1998; Resnekov O, 1998, P NATL ACAD SCI USA, V95, P3162, DOI 10.1073/pnas.95.6.3162; Rosch J, 2004, SCIENCE, V304, P1513, DOI 10.1126/science.1097404; Rubio A, 2004, EMBO J, V23, P1636, DOI 10.1038/sj.emboj.7600171; Rudner AD, 2005, MOL CELL BIOL, V25, P4514, DOI 10.1128/MCB.25.11.4514-4528.2005; Rudner DZ, 2001, DEV CELL, V1, P733, DOI 10.1016/S1534-5807(01)00094-6; Rudner DZ, 2002, P NATL ACAD SCI USA, V99, P8701, DOI 10.1073/pnas.132235899; Rudner DZ, 2002, GENE DEV, V16, P1007, DOI 10.1101/gad.977702; Shiomi D, 2006, MOL MICROBIOL, V60, P894, DOI 10.1111/j.1365-2958.2006.05145.x; Stragier P, 1996, ANNU REV GENET, V30, P297, DOI 10.1146/annurev.genet.30.1.297; van Ooij C, 2003, J BACTERIOL, V185, P1391, DOI 10.1128/JB.185.4.1391-1398.2003; Vicente M, 2006, J BACTERIOL, V188, P19, DOI 10.1128/JB.188.1.19-27.2006; Wu LJ, 1998, GENE DEV, V12, P1371, DOI 10.1101/gad.12.9.1371; YORK K, 1992, J BACTERIOL, V174, P2648, DOI 10.1128/jb.174.8.2648-2658.1992; YOUNGMAN PJ, 1983, P NATL ACAD SCI-BIOL, V80, P2305, DOI 10.1073/pnas.80.8.2305	41	33	36	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4975	4982		10.1074/jbc.M708024200	http://dx.doi.org/10.1074/jbc.M708024200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18077456	hybrid			2022-12-25	WOS:000253426500055
J	Jarboe, LR; Hyduke, DR; Tran, LM; Chou, KJY; Liao, JC				Jarboe, Laura R.; Hyduke, Daniel R.; Tran, Linh M.; Chou, Katherine J. Y.; Liao, James C.			Determination of the Escherichia coli S-nitrosoglutathione response network using integrated biochemical and systems analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE; SALMONELLA-TYPHIMURIUM; TRANSCRIPTIONAL NETWORKS; METHIONINE BIOSYNTHESIS; REGULATORY ACTIVITIES; COMPONENT ANALYSIS; GROWTH-CONDITIONS; NITROGEN-OXIDES; GENE-EXPRESSION; IN-VIVO	During infection or denitrification, bacteria encounter reactive nitrogen species. Although the molecular targets of and defensive response against nitric oxide (NO) in Escherichia coli are well studied, the response elements specific to S-nitrosothiols are less clear. Previously, we employed an integrated systems biology approach to unravel the E. coli NO-response network. Here we use a similar approach to confirm that S-nitrosoglutathione (GSNO) primarily impacts the metabolic and regulatory programs of E. coli in minimal medium by reaction with homocysteine and cysteine and subsequent disruption of the methionine biosynthesis pathway. Targeting of homocysteine and cysteine results in altered regulatory activity of MetJ, MetR, and CysB, activation of the stringent response and growth inhibition. Deletion of metJ or supplementation with methionine strongly attenuated the effect of GSNO on growth and gene expression. Furthermore, GSNO inhibited the ArcAB two-component system. Consistent with the underlying nitrosative and thiol-oxidative chemistry, growth inhibition and the majority of the regulatory perturbations were dependent upon GSNO internalization by the Dpp dipeptide transporter. Contrastingly, perturbation of NsrR appeared to be a result of the submicromolar levels of NO released from GSNO and did not require GSNO internalization.	[Jarboe, Laura R.; Hyduke, Daniel R.; Tran, Linh M.; Chou, Katherine J. Y.; Liao, James C.] Univ Calif Los Angeles, Dept Chem & Biomol Engn, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Liao, JC (corresponding author), 5531 Boelter Hall,420 Westwood Plaza, Los Angeles, CA 90095 USA.	liaoj@ucla.edu		Liao, James/0000-0002-4580-7276	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076143] Funding Source: NIH RePORTER; NIGMS NIH HHS [1R01GM076143] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABOUHAMAD WN, 1991, MOL MICROBIOL, V5, P1035, DOI 10.1111/j.1365-2958.1991.tb01876.x; Bodenmiller DM, 2006, J BACTERIOL, V188, P874, DOI 10.1128/JB.188.3.874-881.2006; COTTER PA, 1992, FEMS MICROBIOL LETT, V91, P31; D'Autreaux B, 2005, NATURE, V437, P769, DOI 10.1038/nature03953; da Costa PN, 2003, FEMS MICROBIOL LETT, V218, P385, DOI 10.1016/S0378-1097(02)01186-2; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DEGROOTE MA, 1995, P NATL ACAD SCI USA, V92, P6399, DOI 10.1073/pnas.92.14.6399; DeGroote MA, 1996, SCIENCE, V272, P414, DOI 10.1126/science.272.5260.414; Dicks A.P., 1996, J CHEM SOC PERK T, V4, P481; Drapier JC, 1996, BIOESSAYS, V18, P549, DOI 10.1002/bies.950180706; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Flatley J, 2005, J BIOL CHEM, V280, P10065, DOI 10.1074/jbc.M410393200; Galbraith SJ, 2006, BIOINFORMATICS, V22, P1886, DOI 10.1093/bioinformatics/btl279; Gao F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-31; Gardner AM, 2003, J BIOL CHEM, V278, P10081, DOI 10.1074/jbc.M212462200; Gilberthorpe NJ, 2007, MICROBIOL-SGM, V153, P1756, DOI 10.1099/mic.0.2006/003731-0; Gladwin MT, 2002, J BIOL CHEM, V277, P27818, DOI 10.1074/jbc.M203236200; Gow AJ, 1997, J BIOL CHEM, V272, P2841, DOI 10.1074/jbc.272.5.2841; Hogg N, 2002, ANNU REV PHARMACOL, V42, P585, DOI 10.1146/annurev.pharmtox.42.092501.104328; Hooton TM, 1997, INFECT DIS CLIN N AM, V11, P551, DOI 10.1016/S0891-5520(05)70373-1; Hutchings MI, 2002, J BACTERIOL, V184, P4640, DOI 10.1128/JB.184.16.4640-4643.2002; Hyduke DR, 2007, P NATL ACAD SCI USA, V104, P8484, DOI 10.1073/pnas.0610888104; Inoue K, 1999, J BIOL CHEM, V274, P27069, DOI 10.1074/jbc.274.38.27069; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; KREDICH NM, 1966, J BIOL CHEM, V241, P4955; KREDICH NM, 1992, MOL MICROBIOL, V6, P2747, DOI 10.1111/j.1365-2958.1992.tb01453.x; LEE LW, 1966, J BIOL CHEM, V241, P5479; Liao JC, 2003, P NATL ACAD SCI USA, V100, P15522, DOI 10.1073/pnas.2136632100; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; MALOY S, 1989, EXPT TECHNIQUES BACT; Malpica R, 2006, ANTIOXID REDOX SIGN, V8, P781, DOI 10.1089/ars.2006.8.781; Mancardi D, 2004, CURR MOL MED, V4, P723, DOI 10.2174/1566524043359854; Membrillo-Hernandez J, 1998, MOL MICROBIOL, V29, P1101, DOI 10.1046/j.1365-2958.1998.01000.x; Mukhopadhyay P, 2004, P NATL ACAD SCI USA, V101, P745, DOI 10.1073/pnas.0307741100; OLSON ER, 1991, J BACTERIOL, V173, P234, DOI 10.1128/jb.173.1.234-244.1991; Pullan ST, 2007, J BACTERIOL, V189, P1845, DOI 10.1128/JB.01354-06; Rodionov DA, 2005, PLOS COMPUT BIOL, V1, P415, DOI 10.1371/journal.pcbi.0010055; Salgado H, 2004, NUCLEIC ACIDS RES, V32, pD303, DOI 10.1093/nar/gkh140; SHOEMAN R, 1985, P NATL ACAD SCI USA, V82, P3601, DOI 10.1073/pnas.82.11.3601; Singh RJ, 1996, J BIOL CHEM, V271, P18596, DOI 10.1074/jbc.271.31.18596; Stamler JS, 1999, CORONARY ARTERY DIS, V10, P273, DOI 10.1097/00019501-199907000-00001; Stevanin TM, 2000, J BIOL CHEM, V275, P35868, DOI 10.1074/jbc.M002471200; Talan DA, 2000, JAMA-J AM MED ASSOC, V283, P1583, DOI 10.1001/jama.283.12.1583; TAUXE RV, 1991, LAB MED, V22, P55; Tran LM, 2005, METAB ENG, V7, P128, DOI 10.1016/j.ymben.2004.12.001; Tseng CP, 1996, J BACTERIOL, V178, P1094, DOI 10.1128/jb.178.4.1094-1098.1996; Tsikas D, 1999, ANAL BIOCHEM, V270, P231, DOI 10.1006/abio.1999.4084; URBANOWSKI ML, 1989, J BACTERIOL, V171, P3277, DOI 10.1128/jb.171.6.3277-3281.1989; Wang SY, 2006, J MOL BIOL, V355, P798, DOI 10.1016/j.jmb.2005.11.020; Wanner B.L., 1994, METH MOL G, V3, P291; Wasser IM, 2002, CHEM REV, V102, P1201, DOI 10.1021/cr0006627; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6	53	31	31	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5148	5157		10.1074/jbc.M706018200	http://dx.doi.org/10.1074/jbc.M706018200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18070885	hybrid			2022-12-25	WOS:000253426500072
J	Noor, S; Goldfine, H; Tucker, DE; Suram, S; Lenz, LL; Akira, S; Uematsu, S; Girotti, M; Bonventre, JV; Breuel, K; Williams, DL; Leslie, CC				Noor, Shahid; Goldfine, Howard; Tucker, Dawn E.; Suram, Saritha; Lenz, Laurel L.; Akira, Shizuo; Uematsu, Satoshi; Girotti, Milena; Bonventre, Joseph V.; Breuel, Kevin; Williams, David L.; Leslie, Christina C.			Activation of cytosolic phospholipase A(2)alpha in resident peritoneal macrophages by Listeria monocytogenes involves listeriolysin O and TLR2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID RELEASE; NECROSIS-FACTOR-ALPHA; PROTEIN-KINASE-A; TNF-ALPHA; PHOSPHOINOSITIDE 3-KINASE; INTRACELLULAR GROWTH; DIFFERENTIAL ROLES; CYTOKINE RELEASE; GENE-EXPRESSION; CELL ACTIVATION	Eicosanoid production by macrophages is an early response to microbial infection that promotes acute inflammation. The intracellular pathogen Listeria monocytogenes stimulates arachidonic acid release and eicosanoid production from resident mouse peritoneal macrophages through activation of group IVA cytosolic phospholipase A(2) (cPLA(2)alpha). The ability of wild type L. monocytogenes (WTLM) to stimulate arachidonic acid release is partially dependent on the virulence factor listeriolysin O; however, WTLM and L. monocytogenes lacking listeriolysin O (Delta hlyLM) induce similar levels of cyclooxygenase 2. Arachidonic acid release requires activation of MAPKs by WTLM and Delta hlyLM. The attenuated release of arachidonic acid that is observed in TLR2(-/-) and MyD88(-/-) macrophages infected with WTLM and Delta hlyLM correlates with diminished MAPK activation. WTLM but not Delta hlyLM increases intracellular calcium, which is implicated in regulation of cPLA(2)alpha. Prostaglandin E-2, prostaglandin I-2, and leukotriene C-4 are produced by cPLA(2)alpha(+/+) but not cPLA(2)alpha(-/-) macrophages in response to WTLM and Delta hlyLM. Tumor necrosis factor (TNF)-alpha production is significantly lower in cPLA(2)alpha(+/+) than in cPLA(2)alpha(-/-) macrophages infected with WTLM and Delta hlyLM. Treatment of infected cPLA(2)alpha(+/+) macrophages with the cyclooxygenase inhibitor indomethacin increases TNF alpha production to the level produced by cPLA(2)alpha(-/-) macrophages implicating prostaglandins in TNF alpha down-regulation. Therefore activation of cPLA(2)alpha in macrophages may impact immune responses to L. monocytogenes.	[Noor, Shahid; Tucker, Dawn E.; Suram, Saritha; Leslie, Christina C.] Natl Jewish Med & Res Ctr, Dept Pediat, Denver, CO 80206 USA; [Lenz, Laurel L.] Natl Jewish Med & Res Ctr, Dept Immunol, Denver, CO 80206 USA; [Goldfine, Howard] Univ Penn, Sch Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Akira, Shizuo; Uematsu, Satoshi] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Girotti, Milena] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Bonventre, Joseph V.] Brigham & Womens Hosp, Div Renal, Boston, MA 02115 USA; [Breuel, Kevin] ETSU Phys & Assoc, ETSU Clin Labs, Johnson City, TN 37604 USA; [Williams, David L.] James H Quillen Coll Med, Dept Surg, Johnson City, TN 37614 USA; [Leslie, Christina C.] Univ Colorado, Sch Med, Dept Pathol & Pharmacol, Aurora, CO 80045 USA	National Jewish Health; National Jewish Health; University of Pennsylvania; Osaka University; University of Colorado System; University of Colorado Boulder; Harvard University; Brigham & Women's Hospital; East Tennessee State University; East Tennessee State University; University of Colorado System; University of Colorado Anschutz Medical Campus	Leslie, CC (corresponding author), Natl Jewish Med & Res Ctr, Dept Pediat, 1400 Jackson St, Denver, CO 80206 USA.	lesliec@njc.org	Akira, Shizuo/C-3134-2009; Goldfine, Howard/AAB-8097-2020	Lenz, Laurel/0000-0002-4933-8913	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034303] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065638, R56AI065638] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL34303, P01 HL034303] Funding Source: Medline; NIAID NIH HHS [AI065638, R56 AI065638, R01 AI065638, R01 AI065638-03] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Akaogi J, 2004, J LEUKOCYTE BIOL, V76, P227, DOI 10.1189/jlb.1203627; Alberti-Segui C, 2007, CELL MICROBIOL, V9, P179, DOI 10.1111/j.1462-5822.2006.00780.x; Aronoff DM, 2005, J IMMUNOL, V174, P595, DOI 10.4049/jimmunol.174.2.595; Aronoff DM, 2004, J IMMUNOL, V173, P559, DOI 10.4049/jimmunol.173.1.559; Bavdek A, 2007, BIOCHEMISTRY-US, V46, P4425, DOI 10.1021/bi602497g; Bonventre JV, 1997, NATURE, V390, P622, DOI 10.1038/37635; Braun L, 2000, EMBO J, V19, P1458, DOI 10.1093/emboj/19.7.1458; CAMILLI A, 1993, MOL MICROBIOL, V8, P143, DOI 10.1111/j.1365-2958.1993.tb01211.x; Chen BC, 2006, J IMMUNOL, V177, P681, DOI 10.4049/jimmunol.177.1.681; Cousens LP, 2000, IMMUNOL REV, V174, P150, DOI 10.1034/j.1600-0528.2002.017407.x; DECARVALHO MS, 1993, ARCH BIOCHEM BIOPHYS, V306, P534, DOI 10.1006/abbi.1993.1549; Dramsi S, 2003, INFECT IMMUN, V71, P3614, DOI 10.1128/IAI.71.6.3614-3618.2003; DREVETS DA, 1994, INFECT IMMUN, V62, P2222, DOI 10.1128/IAI.62.6.2222-2228.1994; DUSSURGET O, 2004, ANNU REV MICROBIOL, V58, P611; Edelson BT, 2002, J IMMUNOL, V169, P3869, DOI 10.4049/jimmunol.169.7.3869; Evans JH, 2001, J BIOL CHEM, V276, P30150, DOI 10.1074/jbc.M100943200; Evans JH, 2002, BMC BIOCHEM, V3, DOI 10.1186/1471-2091-3-30; FARBER JM, 1991, MICROBIOL REV, V55, P476, DOI 10.1128/MMBR.55.3.476-511.1991; Fennekohl A, 2002, J HEPATOL, V36, P328, DOI 10.1016/S0168-8278(01)00277-X; FIEREN MWJA, 1992, IMMUNOL LETT, V31, P85, DOI 10.1016/0165-2478(92)90015-G; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; GAILLARD JL, 1987, INFECT IMMUN, V55, P2822, DOI 10.1128/IAI.55.11.2822-2829.1987; Gekara NO, 2005, CELL MICROBIOL, V7, P1345, DOI 10.1111/j.1462-5822.2005.00561.x; Ghosh M, 2006, PROG LIPID RES, V45, P487, DOI 10.1016/j.plipres.2006.05.003; Gijon MA, 2000, J BIOL CHEM, V275, P20146, DOI 10.1074/jbc.M908941199; Gijon MA, 1999, J CELL BIOL, V145, P1219, DOI 10.1083/jcb.145.6.1219; Gijon MA, 1999, J LEUKOCYTE BIOL, V65, P330, DOI 10.1002/jlb.65.3.330; Girotti M, 2004, J BIOL CHEM, V279, P19113, DOI 10.1074/jbc.M313867200; Goldfine H, 2000, INFECT IMMUN, V68, P5735, DOI 10.1128/IAI.68.10.5735-5741.2000; Goldfine H, 2002, MICROBES INFECT, V4, P1335, DOI 10.1016/S1286-4579(02)00011-4; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Harizi H, 2005, TISSUE ANTIGENS, V65, P507, DOI 10.1111/j.1399-0039.2005.00394.x; Hefner Y, 2000, J BIOL CHEM, V275, P37542, DOI 10.1074/jbc.M003395200; Humann J, 2007, J IMMUNOL, V178, P2407, DOI 10.4049/jimmunol.178.4.2407; HUTCHISON DL, 1987, CELL IMMUNOL, V110, P68, DOI 10.1016/0008-8749(87)90102-X; Ireton K, 1996, SCIENCE, V274, P780, DOI 10.1126/science.274.5288.780; Kayal S, 2006, FEMS MICROBIOL REV, V30, P514, DOI 10.1111/j.1574-6976.2006.00021.x; KOCKS C, 1992, CELL, V68, P521, DOI 10.1016/0092-8674(92)90188-I; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; KUNKEL SL, 1988, J BIOL CHEM, V263, P5380; Lehner MD, 2002, J IMMUNOL, V168, P4667, DOI 10.4049/jimmunol.168.9.4667; Lenz LL, 2003, P NATL ACAD SCI USA, V100, P12432, DOI 10.1073/pnas.2133653100; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Mancuso P, 1998, INFECT IMMUN, V66, P5140, DOI 10.1128/IAI.66.11.5140-5146.1998; Mansell A, 2001, J BIOL CHEM, V276, P43597, DOI 10.1074/jbc.M105202200; MARCINKIEWICZ J, 1991, CYTOKINE, V3, P327, DOI 10.1016/1043-4666(91)90501-4; McCaffrey RL, 2004, P NATL ACAD SCI USA, V101, P11386, DOI 10.1073/pnas.0403215101; Mengaud J, 1996, CELL, V84, P923, DOI 10.1016/S0092-8674(00)81070-3; NALEFSKI EA, 1994, J BIOL CHEM, V269, P18239; Natarajan M, 2006, NAT CELL BIOL, V8, P571, DOI 10.1038/ncb1418; O'Riordan M, 2002, P NATL ACAD SCI USA, V99, P13861, DOI 10.1073/pnas.202476699; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Perisic O, 1999, J BIOL CHEM, V274, P14979, DOI 10.1074/jbc.274.21.14979; PETIT JC, 1985, INFECT IMMUN, V49, P383, DOI 10.1128/IAI.49.2.383-388.1985; PFEFFER K, 1993, CELL, V73, P457, DOI 10.1016/0092-8674(93)90134-C; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Portnoy DA, 2002, J CELL BIOL, V158, P409, DOI 10.1083/jcb.200205009; Qiu ZH, 1998, J BIOL CHEM, V273, P8203, DOI 10.1074/jbc.273.14.8203; Repp H, 2002, CELL MICROBIOL, V4, P483, DOI 10.1046/j.1462-5822.2002.00207.x; Rocca B, 2002, INT IMMUNOPHARMACOL, V2, P603, DOI 10.1016/S1567-5769(01)00204-1; ROLAND CR, 1994, ANN SURG, V219, P389, DOI 10.1097/00000658-199404000-00010; Rose F, 2001, INFECT IMMUN, V69, P897, DOI 10.1128/IAI.69.2.897-905.2001; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Rouzer CA, 2004, J BIOL CHEM, V279, P34256, DOI 10.1074/jbc.M402594200; Sawyer RT, 1996, J LEUKOCYTE BIOL, V60, P603, DOI 10.1002/jlb.60.5.603; Seki E, 2002, J IMMUNOL, V169, P3863, DOI 10.4049/jimmunol.169.7.3863; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; Shen Y, 2000, CELL, V103, P501, DOI 10.1016/S0092-8674(00)00141-0; Shinomiya S, 2001, BIOCHEM PHARMACOL, V61, P1153, DOI 10.1016/S0006-2952(01)00586-X; Sibelius U, 1999, INFECT IMMUN, V67, P1125, DOI 10.1128/IAI.67.3.1125-1130.1999; SMITH GA, 1995, INFECT IMMUN, V63, P4231, DOI 10.1128/IAI.63.11.4231-4237.1995; SMITH GA, 1995, MOL MICROBIOL, V17, P945, DOI 10.1111/j.1365-2958.1995.mmi_17050945.x; Suram S, 2006, J BIOL CHEM, V281, P5506, DOI 10.1074/jbc.M509824200; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tang P, 1996, INFECT IMMUN, V64, P2359, DOI 10.1128/IAI.64.6.2359-2361.1996; Tang P, 1998, INFECT IMMUN, V66, P1106, DOI 10.1128/IAI.66.3.1106-1112.1998; Tilley SL, 2001, J CLIN INVEST, V108, P15, DOI 10.1172/JCI200113416; Torres D, 2004, INFECT IMMUN, V72, P2131, DOI 10.1128/IAI.72.4.2131-2139.2004; TRIPP CS, 1987, J CLIN INVEST, V79, P399, DOI 10.1172/JCI112825; Tsuchiya K, 2005, INFECT IMMUN, V73, P3869, DOI 10.1128/IAI.73.7.3869-3877.2005; Vazquez-Boland JA, 2001, CLIN MICROBIOL REV, V14, P584, DOI 10.1128/CMR.14.3.584-640.2001; VAZQUEZBOLAND JA, 1992, INFECT IMMUN, V60, P219, DOI 10.1128/IAI.60.1.219-230.1992; Wadsworth SJ, 1999, INFECT IMMUN, V67, P1770; Weiglein I, 1997, FEMS MICROBIOL LETT, V148, P189, DOI 10.1016/S0378-1097(97)00032-3; Wing MG, 1999, J NEUROIMMUNOL, V94, P74, DOI 10.1016/S0165-5728(98)00227-6; ZHONG WW, 1995, IMMUNOLOGY, V84, P446	86	21	21	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4744	4755		10.1074/jbc.M709956200	http://dx.doi.org/10.1074/jbc.M709956200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18083708	Green Published, Green Accepted, hybrid			2022-12-25	WOS:000253426500032
J	Pham, LV; Zhou, HJ; Lin-Lee, YC; Tamayo, AT; Yoshimura, LC; Fu, LC; Darnay, BG; Ford, RJ				Pham, Lan V.; Zhou, Hai-Jun; Lin-Lee, Yen-Chiu; Tamayo, Archito T.; Yoshimura, Linda C.; Fu, Lingchen; Darnay, Bryant G.; Ford, Richard J.			Nuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively regulates c-myb-mediated transactivation through small ubiquitin-related modifier-1 modification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; SUMO MODIFICATION; EXPORT SIGNAL; LOCALIZATION; PROTEIN; TRAF6; ACTIVATION; TRANSCRIPTION; STIMULATION; MECHANISMS	Tumor necrosis factor receptor-associated factor 6 (TRAF6) is an adaptor/scaffold protein that mediates several important signaling pathways, including the tumor necrosis factor-R:NF-kappa B pathway, involved in immune surveillance, inflammation, etc. Because most studies of TRAF6 function have focused primarily on its role as an adaptor molecule in signaling pathways in the cytoplasm, the potential functions of TRAF6 in other cellular compartments has not been previously investigated. Here, we demonstrate that TRAF6 resides not only in the cellular cytoplasm but is also found in the nuclei of both normal and malignant B lymphocytes. TRAF6 does not possess a nuclear localization signal but enters the nucleus through the nuclear pore complex containing RanGap1. Chromatin immunoprecipitation cloning experiments demonstrated that nuclear TRAF6 associates with c-Myb within the 5'-end of the c-Myb promoter. Further analysis showed that nuclear TRAF6 is modified by small ubiquitin-related modifier-1, interacts with histone deacetylase 1, and represses c-Myb-mediated transactivation. Thus, TRAF6negatively regulates c-Myb through a novel repressor function in the nuclei of both normal and malignant B-lymphocytes that could represent a novel control mechanism that maintains cell homeostasis and immune surveillance.	[Pham, Lan V.; Zhou, Hai-Jun; Lin-Lee, Yen-Chiu; Tamayo, Archito T.; Yoshimura, Linda C.; Fu, Lingchen; Ford, Richard J.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Hematol, Houston, TX 77030 USA; [Darnay, Bryant G.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Expt Therapeut, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Ford, RJ (corresponding author), Univ Texas Houston, MD Anderson Canc Ctr, Dept Hematol, Box 54,1515 Holcombe Blvd, Houston, TX 77030 USA.	rford@mdanderson.org			NATIONAL CANCER INSTITUTE [R01CA100836, P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA-16672-26, CA-R01-100836] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Birbach A, 2002, J BIOL CHEM, V277, P10842, DOI 10.1074/jbc.M112475200; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Bradley JR, 2001, ONCOGENE, V20, P6482, DOI 10.1038/sj.onc.1204788; Bryant DM, 2005, TRAFFIC, V6, P947, DOI 10.1111/j.1600-0854.2005.00332.x; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Choi YW, 2005, ADV EXP MED BIOL, V560, P77; Chung JY, 2002, J CELL SCI, V115, P679; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Emambokus N, 2003, EMBO J, V22, P4478, DOI 10.1093/emboj/cdg434; Fu LC, 2006, BLOOD, V107, P4540, DOI 10.1182/blood-2005-10-4042; Fu SL, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-54; Gill G, 2005, CURR OPIN GENET DEV, V15, P536, DOI 10.1016/j.gde.2005.07.004; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Glauner H, 2002, EUR J BIOCHEM, V269, P4819, DOI 10.1046/j.1432-1033.2002.03180.x; Gonda TJ, 1996, CURR TOP MICROBIOL, V211, P99; Huang TT, 2000, P NATL ACAD SCI USA, V97, P1014, DOI 10.1073/pnas.97.3.1014; Huang TT, 2003, CELL, V115, P565, DOI 10.1016/S0092-8674(03)00895-X; Ishida T, 1996, J BIOL CHEM, V271, P28745, DOI 10.1074/jbc.271.46.28745; Johnson C, 1999, EMBO J, V18, P6682, DOI 10.1093/emboj/18.23.6682; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Johnson HM, 2004, BIOESSAYS, V26, P993, DOI 10.1002/bies.20086; King CG, 2006, NAT MED, V12, P1088, DOI 10.1038/nm1449; Lamothe B, 2007, BIOCHEM BIOPH RES CO, V359, P1044, DOI 10.1016/j.bbrc.2007.06.017; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lauder A, 2001, MOL CELL BIOL, V21, P5797, DOI 10.1128/MCB.21.17.5797-5805.2001; Lian ZL, 2005, ONCOGENE, V24, P7394, DOI 10.1038/sj.onc.1209089; Lin DY, 2006, MOL CELL, V24, P341, DOI 10.1016/j.molcel.2006.10.019; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lin-Lee YC, 2006, J BIOL CHEM, V281, P18878, DOI 10.1074/jbc.M513315200; Liu BH, 2007, BIOCHEM BIOPH RES CO, V358, P136, DOI 10.1016/j.bbrc.2007.04.097; Mabb AM, 2007, CELL MOL LIFE SCI, V64, P1979, DOI 10.1007/s00018-007-7005-2; Min W, 1998, J IMMUNOL, V161, P319; Morita Y, 2005, MOL BIOL CELL, V16, P5433, DOI 10.1091/mbc.E05-08-0731; NICOLAIDES NC, 1991, MOL CELL BIOL, V11, P6166, DOI 10.1128/MCB.11.12.6166; Pham LV, 2003, J IMMUNOL, V171, P88, DOI 10.4049/jimmunol.171.1.88; Pham LV, 2002, IMMUNITY, V16, P37, DOI 10.1016/S1074-7613(01)00258-8; Pichler A, 2002, TRAFFIC, V3, P381, DOI 10.1034/j.1600-0854.2002.30601.x; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Sternsdorf T, 1999, J BIOL CHEM, V274, P12555, DOI 10.1074/jbc.274.18.12555; Verger A, 2003, EMBO REP, V4, P137, DOI 10.1038/sj.embor.embor738; Weston K, 1999, ONCOGENE, V18, P3034, DOI 10.1038/sj.onc.1202728; Zhou HJ, 2007, BLOOD, V110, P2121, DOI 10.1182/blood-2007-02-073080	44	22	29	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5081	5089		10.1074/jbc.M706307200	http://dx.doi.org/10.1074/jbc.M706307200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093978	hybrid			2022-12-25	WOS:000253426500065
J	Bessiere, D; Lacroix, C; Campagne, S; Ecochard, V; Guillet, V; Mourey, L; Lopez, F; Czaplicki, J; Demange, P; Milon, A; Girard, JP; Gervais, V				Bessiere, Damien; Lacroix, Chrystelle; Campagne, Sebastien; Ecochard, Vincent; Guillet, Valerie; Mourey, Lionel; Lopez, Frederic; Czaplicki, Jerzy; Demange, Pascal; Milon, Alain; Girard, Jean-Philippe; Gervais, Virginie			Structure-function analysis of the THAP zinc finger of THAP1, a large C2CH DNA-binding module linked to Rb/E2F pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-ELEMENT TRANSPOSASE; SYNTHETIC MULTIVULVA GENES; CAENORHABDITIS-ELEGANS; C-ELEGANS; CLASS-B; CELL-PROLIFERATION; CHEMICAL-SHIFT; TARGET GENES; PROTEIN; DOMAIN	THAP1, the founding member of a previously uncharacterized large family of cellular proteins (THAP proteins), is a sequence-specific DNA-binding factor that has recently been shown to regulate cell proliferation through modulation of pRb/ E2F cell cycle target genes. THAP1 shares its DNA-binding THAP zinc finger domain with Drosophila P element transposase, zebrafish E2F6, and several nematode proteins interacting genetically with the retinoblastoma protein pRb. In this study, we report the three-dimensional structure and structure-function relationships of the THAP zinc finger of human THAP1. Deletion mutagenesis and multidimensional NMR spectroscopy revealed that the THAP domain of THAP1 is an atypical zinc finger of similar to 80 residues, distinguished by the presence between the C2CH zinc coordinating residues of a short antiparallel beta-sheet interspersed by a long loop-helix-loop insertion. Alanine scanning mutagenesis of this loop-helix-loop motif resulted in the identification of a number of critical residues for DNA recognition. NMR chemical shift perturbation analysis was used to further characterize the residues involved in DNA binding. The combination of the mutagenesis and NMR data allowed the mapping of the DNA binding interface of the THAP zinc finger to a highly positively charged area harboring multiple lysine and arginine residues. Together, these data represent the first structure-function analysis of a functional THAP domain, with demonstrated sequence-specific DNA binding activity. They also provide a structural framework for understanding DNA recognition by this atypical zinc finger, which defines a novel family of cellular factors linked to cell proliferation and pRb/E2F cell cycle pathways in humans, fish, and nematodes.	[Bessiere, Damien; Lacroix, Chrystelle; Campagne, Sebastien; Ecochard, Vincent; Guillet, Valerie; Mourey, Lionel; Czaplicki, Jerzy; Demange, Pascal; Milon, Alain; Girard, Jean-Philippe; Gervais, Virginie] Univ Toulouse, Inst Pharmacol & Struct Biol, CNRS, F-31077 Toulouse, France; [Bessiere, Damien; Campagne, Sebastien; Czaplicki, Jerzy; Demange, Pascal; Milon, Alain; Gervais, Virginie] IPBS CNRS UPS, Lab NMR & Prot Membrane Interact, F-31077 Toulouse, France; [Lacroix, Chrystelle; Ecochard, Vincent; Girard, Jean-Philippe] IPBS CNRS UPS, Lab Vasc Biol, F-31077 Toulouse, France; [Guillet, Valerie; Mourey, Lionel] IPBS CNRS UPS, Lab Struct Biophys, F-31077 Toulouse, France; [Lopez, Frederic] CHU Rangueil, INSERM, IFR 31, F-31059 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm)	Girard, JP (corresponding author), Univ Toulouse, Inst Pharmacol & Struct Biol, CNRS, F-31077 Toulouse, France.	jean-philippe.girard@ipbs.fr; virginie.gervais@ipbs.fr	MILON, Alain/B-3767-2010; GIRARD, Jean-Philippe/F-5229-2010; Czaplicki, Georges/ABC-7047-2020; demange, pascal JP/U-3561-2018; Mourey, Lionel/B-5662-2009; Guillet, Valérie/C-6058-2011	MILON, Alain/0000-0001-5692-8201; GIRARD, Jean-Philippe/0000-0002-9154-1691; Czaplicki, Georges/0000-0001-5348-4107; demange, pascal JP/0000-0002-9572-9990; Mourey, Lionel/0000-0002-8259-1259; Sebastien, Campagne/0000-0002-0094-4760; Gervais, Virginie/0000-0002-1144-6185				Auguin D, 2004, J BIOMOL NMR, V28, P137, DOI 10.1023/B:JNMR.0000013836.62154.c2; Billeter M, 1995, J BIOMOL NMR, V5, P1; Boxem M, 2002, CURR BIOL, V12, P906, DOI 10.1016/S0960-9822(02)00844-8; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Ceol CJ, 2004, DEV CELL, V6, P563, DOI 10.1016/S1534-5807(04)00065-6; Chesney MA, 2006, GENETICS, V172, P915, DOI 10.1534/genetics.105.048751; Clouaire T, 2005, P NATL ACAD SCI USA, V102, P6907, DOI 10.1073/pnas.0406882102; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DAIKUN GP, 1986, NATURE, V324, P688; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fay DS, 2002, GENE DEV, V16, P503, DOI 10.1101/gad.952302; FERGUSON EL, 1989, GENETICS, V123, P109; Garvie CW, 2001, MOL CELL, V8, P937, DOI 10.1016/S1097-2765(01)00392-6; Giangrande PH, 2004, GENE DEV, V18, P2941, DOI 10.1101/gad.1239304; Hammer SE, 2005, MOL BIOL EVOL, V22, P833, DOI 10.1093/molbev/msi068; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; Jauch R, 2003, STRUCTURE, V11, P1393, DOI 10.1016/j.str.2003.09.015; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; KAUFMAN PD, 1989, CELL, V59, P359, DOI 10.1016/0092-8674(89)90297-3; Klug A, 1999, J MOL BIOL, V293, P215, DOI 10.1006/jmbi.1999.3007; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Koreth J, 2005, ONCOGENE, V24, P2756, DOI 10.1038/sj.onc.1208607; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee CC, 1998, EMBO J, V17, P4166, DOI 10.1093/emboj/17.14.4166; LEE MS, 1989, SCIENCE, V245, P635, DOI 10.1126/science.2503871; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Liew CK, 2007, J MOL BIOL, V366, P382, DOI 10.1016/j.jmb.2006.11.058; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Macfarlan T, 2005, J BIOL CHEM, V280, P7346, DOI 10.1074/jbc.M411675200; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Ponstingl H, 1998, J BIOMOL NMR, V12, P319, DOI 10.1023/A:1008293016073; Poulin G, 2005, EMBO J, V24, P2613, DOI 10.1038/sj.emboj.7600726; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; Reddy KC, 2004, CELL, V118, P439, DOI 10.1016/j.cell.2004.07.026; Roussigne M, 2003, ONCOGENE, V22, P2432, DOI 10.1038/sj.onc.1206271; Roussigne M, 2003, TRENDS BIOCHEM SCI, V28, P66, DOI 10.1016/S0968-0004(02)00013-0; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schubert M, 2002, J BIOMOL NMR, V24, P149, DOI 10.1023/A:1020997118364; SCHWABE JWR, 1990, NATURE, V348, P458, DOI 10.1038/348458a0; Thomas JH, 1999, DEVELOPMENT, V126, P3449; WUTHRICH K, 1986, NMR PROTEINS NUCLEIC, P122	45	62	65	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4352	4363		10.1074/jbc.M707537200	http://dx.doi.org/10.1074/jbc.M707537200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073205	Green Published, hybrid			2022-12-25	WOS:000253083500070
J	Russell, TV; Do, AN; Setik, E; Sullivan, PS; Rayle, VD; Fridlund, CA; Quan, VM; Voetsch, AC; Fleming, PL				Russell, Toya V.; Do, Ann N.; Setik, Eleanor; Sullivan, Patrick S.; Rayle, Victoria D.; Fridlund, Carol A.; Quan, Vu M.; Voetsch, Andrew C.; Fleming, Patricia L.			Sexual Risk Behaviors for HIV/AIDS in Chuuk State, Micronesia: The Case for HIV Prevention in Vulnerable Remote Populations	PLOS ONE			English	Article								Background. After the first two cases of locally-acquired HIV infection were recognized in Chuuk State, Federated States of Micronesia (FSM), a public health response was initiated. The purpose of the response was to assess the need for HIV education and prevention services, to develop recommendations for controlling further spread of HIV in Chuuk, and to initiate some of the prevention measures. Methodology/Principal Findings. A public health team conducted a survey and rapid HIV testing among a sample of residents on the outer islands in Chuuk. Local public health officials conducted contact tracing and testing of sex partners of the two locally-acquired cases of HIV infection. A total of 333 persons completed the survey. The majority knew that HIV is transmitted through unprotected sexual contact (81%), injection drug use (61%), or blood transfusion (64%). Sexual activity in the past 12 months was reported among 159 participants, including 90 females and 69 males. Compared to women, men were more likely to have had multiple sex partners, to have been drunk during sex, but less likely to have used a condom in the past 12 months. The two men with locally acquired HIV infection had unprotected anal sex with a third Chuukese man who likely contracted HIV while outside of Chuuk. All 370 persons who received voluntary, confidential HIV counseling and testing had HIV negative test results. Conclusions/Significance. Despite the low HIV seroprevalence, risky sexual behaviors in this small isolated population raise concerns about the potential for rapid spread of HIV. The lack of knowledge about risks, along with stigmatizing attitudes towards persons infected with HIV and high risk sexual behaviors indicate the need for resources to be directed toward HIV prevention in Chuuk and on other Pacific Islands.	[Do, Ann N.; Sullivan, Patrick S.; Rayle, Victoria D.; Voetsch, Andrew C.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA; [Russell, Toya V.] Uniformed Serv Univ Hlth Sci, Res Off, Rockville, MD USA; [Setik, Eleanor] Chuuk State Dept Hlth & Hosp, Chuuk, Micronesia; [Fridlund, Carol A.] Ctr Dis Control & Prevent, Global AIDS Program, Natl Ctr HIV STD & TB Prevent, Atlanta, GA USA; [Quan, Vu M.] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Fleming, Patricia L.] Univ Med & Dent New Jersey, New Jersey Med Sch, Dept Prevent Med & Community Hlth, Newark, NJ 07103 USA	Centers for Disease Control & Prevention - USA; Uniformed Services University of the Health Sciences - USA; Centers for Disease Control & Prevention - USA; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Rutgers State University New Brunswick; Rutgers State University Medical Center	Do, AN (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV STD & TB Prevent, Atlanta, GA 30333 USA.	aad9@cdc.gov	Voetsch, Andrew/CAF-1978-2022	Sullivan, Patrick Sean/0000-0002-7728-0587; Voetsch, Andrew/0000-0002-0783-1312	National Center for STD, TB, and HIV Prevention	National Center for STD, TB, and HIV Prevention	This project was funded by the National Center for STD, TB, and HIV Prevention, CDC. The CDC was the employer of 8 of the 9 co-authors at the time of this project, and has no other specific role in the project, besides providing the funding, material support, personnel and technical support for the project, which was essentially a public health response to the first cases of locally-acquired HIV infection in Chuuk.	*CDCP, 2003, MMWR-MORBID MORTAL W, V52, P329; *CDCP, 2001, HIV AIDS SURVEILLANC, V13, P7; Centers for Disease Control and Prevention (CDC), 1998, MMWR Morb Mortal Wkly Rep, V47, P211; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P434; Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1051; Holtgrave DR, 2000, AIDS PUBLIC POLICY J, V15, P75; Michael RT, 1998, AM J PUBLIC HEALTH, V88, P749, DOI 10.2105/AJPH.88.5.749; *POP REF BUR, 2006, 2006 WORLD POP DAT S; Stetler HC, 1997, AIDS, V11, P369, DOI 10.1097/00002030-199703110-00015; Sullivan EA, 2003, SEX TRANSM DIS, V30, P362, DOI 10.1097/00007435-200304000-00017; *UNAIDS WHO, 2001, GUID US HIV TEST TEC	11	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1283	10.1371/journal.pone.0001283	http://dx.doi.org/10.1371/journal.pone.0001283			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074009	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459500002
J	Yates, A; Graw, F; Barber, DL; Ahmed, R; Regoes, RR; Antia, R				Yates, Andrew; Graw, Frederik; Barber, Daniel L.; Ahmed, Rafi; Regoes, Roland R.; Antia, Rustom			Revisiting Estimates of CTL Killing Rates In Vivo	PLOS ONE			English	Article								Recent experimental advances have allowed the estimation of the in vivo rates of killing of infected target cells by cytotoxic T lymphocytes (CTL). We present several refinements to a method applied previously to quantify killing of targets in the spleen using a dynamical model. We reanalyse data previously used to estimate killing rates of CTL specific for two epitopes of lymphocytic choriomeningitis virus (LCMV) in mice and show that, contrary to previous estimates the "killing rate'' of effector CTL is approximately twice that of memory CTL. Further, our method allows the fits to be visualized, and reveals one potentially interesting discrepancy between fits and data. We discuss extensions to the basic CTL killing model to explain this discrepancy and propose experimental tests to distinguish between them.	[Yates, Andrew; Antia, Rustom] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Graw, Frederik; Regoes, Roland R.] ETH, Inst Integrat Biol, Zurich, Switzerland; [Barber, Daniel L.] NIAID, Bethesda, MD 20892 USA; [Ahmed, Rafi] Emory Univ, Sch Med, Emory Vaccine Ctr, Atlanta, GA USA	Emory University; Swiss Federal Institutes of Technology Domain; ETH Zurich; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Emory University	Yates, A (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	ayates2@emory.edu	Regoes, Roland R/A-6538-2008; Barber, Daniel L./V-1190-2019	Regoes, Roland R/0000-0001-8319-5293; 	Swiss National Science Foundation; NIH [RO1 AI 49334]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049334] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	RRR and FG gratefully acknowledge the financial support of the Swiss National Science Foundation. AY and Rustom Antia were supported by NIH grant RO1 AI 49334 to Rustom Antia. The funders played no other role in the study.	Asquith B, 2006, PLOS BIOL, V4, P583, DOI 10.1371/journal.pbio.0040090; Asquith B, 2007, P NATL ACAD SCI USA, V104, P6365, DOI 10.1073/pnas.0700666104; Barber DL, 2003, J IMMUNOL, V171, P27, DOI 10.4049/jimmunol.171.1.27; Barchet W, 2000, EUR J IMMUNOL, V30, P1356, DOI 10.1002/(SICI)1521-4141(200005)30:5<1356::AID-IMMU1356>3.0.CO;2-K; Boissonnas A, 2007, J EXP MED, V204, P345, DOI 10.1084/jem.20061890; Fernandez CS, 2005, J VIROL, V79, P5721, DOI 10.1128/JVI.79.9.5721-5731.2005; GRIMM EA, 1979, J IMMUNOL, V123, P2870; LEBOW LT, 1986, NAT IMMUN CELL GROW, V5, P221; Ludewig B, 2001, EUR J IMMUNOL, V31, P1772, DOI 10.1002/1521-4141(200106)31:6<1772::AID-IMMU1772>3.3.CO;2-#; MACKEN CA, 1984, J IMMUNOL, V132, P1614; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; PERELSON AS, 1985, ADV EXP MED BIOL, V184, P551; PERELSON AS, 1982, J IMMUNOL, V129, P2796; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; PERELSON AS, 1984, J IMMUNOL, V132, P2190; R Development Core Team, 2007, R LANG ENV STAT COMP; Regoes RR, 2007, P NATL ACAD SCI USA, V104, P1599, DOI 10.1073/pnas.0508830104; Regoes RR, 2007, IMMUNOL CELL BIOL, V85, P274, DOI 10.1038/sj.icb.7100053; Regoes RR, 2004, J VIROL, V78, P4866, DOI 10.1128/JVI.78.9.4866-4875.2004; ROTHSTEIN TL, 1978, J IMMUNOL, V121, P1652; SLATE EH, 1994, J AM STAT ASSOC, V89, P1471, DOI 10.2307/2291009; van der Most RG, 1998, VIROLOGY, V240, P158, DOI 10.1006/viro.1997.8934; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wick WD, 2005, J VIROL, V79, P13579, DOI 10.1128/JVI.79.21.13579-13586.2005; ZAGURY D, 1979, J IMMUNOL, V123, P1604	25	40	40	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1301	10.1371/journal.pone.0001301	http://dx.doi.org/10.1371/journal.pone.0001301			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074025	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000207459500020
J	Corradi, N; Akiyoshi, DE; Morrison, HG; Feng, XC; Weiss, LM; Tzipori, S; Keeling, PJ				Corradi, Nicolas; Akiyoshi, Donna E.; Morrison, Hilary G.; Feng, Xiaochuan; Weiss, Louis M.; Tzipori, Saul; Keeling, Patrick J.			Patterns of Genome Evolution among the Microsporidian Parasites Encephalitozoon cuniculi, Antonospora locustae and Enterocytozoon bieneusi	PLOS ONE			English	Article							GENE ORDER; NOSEMA-LOCUSTAE; HIGH-FREQUENCY; ALPHA-TUBULIN; REARRANGEMENT; SEQUENCE; IDENTIFICATION; INVERSIONS; COMPACTION; PHYLOGENY	Background. Microsporidia are intracellular parasites that are highly-derived relatives of fungi. They have compacted genomes and, despite a high rate of sequence evolution, distantly related species can share high levels of gene order conservation. To date, only two species have been analysed in detail, and data from one of these largely consists of short genomic fragments. It is therefore difficult to determine how conservation has been maintained through microsporidian evolution, and impossible to identify whether certain regions are more prone to genomic stasis. Principal Findings. Here, we analyse three large fragments of the Enterocytozoon bieneusi genome ( in total 429 kbp), a species of medical significance. A total of 296 ORFs were identified, annotated and their context compared with Encephalitozoon cuniculi and Antonospora locustae. Overall, a high degree of conservation was found between all three species, and interestingly the level of conservation was similar in all three pairwise comparisons, despite the fact that A. locustae is more distantly related to E. cuniculi and E. bieneusi than either are to each other. Conclusions/Significance. Any two genes that are found together in any pair of genomes are more likely to be conserved in the third genome as well, suggesting that a core of genes tends to be conserved across the entire group. The mechanisms of rearrangments identified among microsporidian genomes were consistent with a very slow evolution of their architecture, as opposed to the very rapid sequence evolution reported for these parasites.	[Corradi, Nicolas; Keeling, Patrick J.] Univ British Columbia, Dept Bot, Canadian Inst Adv Res, Vancouver, BC, Canada; [Akiyoshi, Donna E.; Feng, Xiaochuan; Tzipori, Saul] Tufts Cummings Sch Vet Med, Div Infect Dis, North Grafton, MA USA; [Morrison, Hilary G.] Josephine Bay Paul Ctr Comparat Mol Biol & Evolut, Marine Biol Lab, Woods Hole, MA USA; [Weiss, Louis M.] Montefiore Med Ctr, Albert Einstein Coll Med, Dept Med, Bronx, NY 10467 USA	Canadian Institute for Advanced Research (CIFAR); University of British Columbia; Marine Biological Laboratory - Woods Hole; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Keeling, PJ (corresponding author), Univ British Columbia, Dept Bot, Canadian Inst Adv Res, Vancouver, BC, Canada.	pkeeling@interchange.ubc.ca		Keeling, Patrick/0000-0002-7644-0745; Morrison, Hilary/0000-0003-0281-326X; Corradi, Nicolas/0000-0002-7932-7932	National Institutes of Health [R21 AI52792, R21 AI064118]; Canadian Institutes for Heath Research [MOP-84265]; NSF [0135272]; Swiss National Science Foundation [PBLAA-114238]; Canadian Institute for Advanced Research; Michael Smith Foundation for Health Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI064118, R01AI031788, R21AI052792] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes for Heath Research(Canadian Institutes of Health Research (CIHR)); NSF(National Science Foundation (NSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The Enterocytozoon bieneusi genome sequence survey was supported by National Institutes of Health grants R21 AI52792 and R21 AI064118 and analysis was supported by a grant from the Canadian Institutes for Heath Research (MOP-84265). We acknowledge the Josephine Bay Paul Center for Comparative Molecular Biology and Evolution for the use of data included in the Antonospora locustae Genome Project funded by NSF award number 0135272. NC is supported by a fellowship from the Swiss National Science Foundation (PBLAA-114238). PJK is a fellow of the Canadian Institute for Advanced Research and the Michael Smith Foundation for Health Research. None of these institutions played a role in the design and conduct of the study, in the collection, analysis and interpretation of the data and in the preparation, review or approval of this manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bennetzen JL, 2002, PLANT MOL BIOL, V48, P821, DOI 10.1023/A:1014841515249; Burt DW, 1999, NATURE, V402, P411, DOI 10.1038/46555; Coghlan A, 2002, GENOME RES, V12, P857, DOI 10.1101/gr.172702; DESPORTES I, 1985, J PROTOZOOL, V32, P250; Fast NM, 2003, EUKARYOT CELL, V2, P1069, DOI 10.1128/EC.2.5.1069-1075.2003; Franzen C, 2001, MICROBES INFECT, V3, P389, DOI 10.1016/S1286-4579(01)01395-8; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Hinkle G, 1997, BIOL BULL, V193, P250, DOI 10.1086/BBLv193n2p250; Hurst LD, 2002, TRENDS GENET, V18, P604, DOI 10.1016/S0168-9525(02)02813-5; Huynen MA, 2001, TRENDS GENET, V17, P304, DOI 10.1016/S0168-9525(01)02302-2; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Keeling PJ, 2003, FUNGAL GENET BIOL, V38, P298, DOI 10.1016/S1087-1845(02)00537-6; Keeling PJ, 2005, CURR OPIN GENET DEV, V15, P601, DOI 10.1016/j.gde.2005.09.003; Keeling PJ, 1996, MOL BIOL EVOL, V13, P1297, DOI 10.1093/oxfordjournals.molbev.a025576; Keeling PJ, 2000, MOL BIOL EVOL, V17, P23, DOI 10.1093/oxfordjournals.molbev.a026235; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kent WJ, 2003, P NATL ACAD SCI USA, V100, P11484, DOI 10.1073/pnas.1932072100; Keogh RS, 1998, YEAST, V14, P443, DOI 10.1002/(SICI)1097-0061(19980330)14:5<443::AID-YEA243>3.0.CO;2-L; Larsson JIR, 1999, ACTA PROTOZOOL, V38, P161; Mittleider D, 2002, J EUKARYOT MICROBIOL, V49, P393, DOI 10.1111/j.1550-7408.2002.tb00218.x; Nilsen F, 1998, J EUKARYOT MICROBIOL, V45, P535, DOI 10.1111/j.1550-7408.1998.tb05113.x; Notermans DW, 2005, J CLIN MICROBIOL, V43, P610, DOI 10.1128/JCM.43.2.610-614.2005; Pal C, 2003, NAT GENET, V33, P392, DOI 10.1038/ng1111; Peyretaillade E, 1998, NUCLEIC ACIDS RES, V26, P3513, DOI 10.1093/nar/26.15.3513; Ranz JM, 2001, GENOME RES, V11, P230, DOI 10.1101/gr.162901; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Seoighe C, 2000, P NATL ACAD SCI USA, V97, P14433, DOI 10.1073/pnas.240462997; Slamovits CH, 2004, J EUKARYOT MICROBIOL, V51, P207, DOI 10.1111/j.1550-7408.2004.tb00547.x; Slamovits CH, 2004, CURR BIOL, V14, P891, DOI 10.1016/j.cub.2004.04.041; Slamovits CH, 2006, J MOL BIOL, V359, P1196, DOI 10.1016/j.jmb.2006.04.028; Suyama M, 2001, TRENDS GENET, V17, P10, DOI 10.1016/S0168-9525(00)02159-4; Tamames J, 2001, GENOME BIOL, V2; Thomarat F, 2004, J MOL EVOL, V59, P780, DOI 10.1007/s00239-004-2673-0; Van de Peer Y, 2000, GENE, V246, P1, DOI 10.1016/S0378-1119(00)00063-9; Vivares CP, 2000, CURR OPIN MICROBIOL, V3, P463, DOI 10.1016/S1369-5274(00)00123-5; Williams BAP, 2005, P NATL ACAD SCI USA, V102, P10936, DOI 10.1073/pnas.0501321102; Xu JS, 2006, INT J PARASITOL, V36, P1049, DOI [10.1016/j.ijpara.2006.04.010, 10.1016/j.ijpara.2006.09.010]; Zdobnov EM, 2002, SCIENCE, V298, P149, DOI 10.1126/science.1077061; Zhang QS, 2005, INFECT IMMUN, V73, P5166, DOI 10.1128/IAI.73.8.5166-5172.2005	41	41	71	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1277	10.1371/journal.pone.0001277	http://dx.doi.org/10.1371/journal.pone.0001277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060071	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459400024
J	Spreafico, A; Schenone, S; Serchi, T; Orlandini, M; Angelucci, A; Magrini, D; Bernardini, G; Collodel, G; Di Stefano, A; Tintori, C; Bologna, M; Manetti, F; Botta, M; Santucci, A				Spreafico, Adriano; Schenone, Silvia; Serchi, Tommaso; Orlandini, Maurizio; Angelucci, Adriano; Magrini, David; Bernardini, Giulia; Collodel, Giulia; Di Stefano, Anna; Tintori, Cristina; Bologna, Mauro; Manetti, Fabrizio; Botta, Maurizio; Santucci, Annalisa			Antiproliferative and proapoptotic activities of new pyrazolo [3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells	FASEB JOURNAL			English	Article						bone cells; apoptosis; bone cancer; osteoblast; tyrosine kinase	FOCAL ADHESION KINASE; C-SRC; TYROSINE KINASE; IN-VITRO; OSTEOGENIC-SARCOMA; ESTROGEN-RECEPTOR; CARCINOMA-CELLS; DEFICIENT MICE; CANCER-CELLS; CODON 531	Osteosarcoma is the most frequent primitive malignant tumor of the skeletal system, characterized by an extremely aggressive clinical course that still lacks an effective treatment. Src kinase seems to be involved in the osteosarcoma malignant phenotype. We show that the treatment of human osteosarcoma cell lines with a new pyrazolo[3,4-d]pyrimidine derivative Src inhibitor, namely SI-83, impaired cell viability, with a half-maximal inhibitory concentration of 12 mu M in nonstarved cells and a kinetic different from that known for the Src inhibitor PP2. Analysis by terminal deoxynucleotidyl transferase-mediated nick end labeling, Hoechst, and flow cytometric assay showed that SI-83 induced apoptosis in SaOS-2 cells. Moreover, SI-83, by inhibiting Src phosphorylation, decreased in vivo osteosarcoma tumor mass in a mouse model. Finally, SI-83 showed selectivity for osteosarcoma, since it had a far lower effect in primary human osteoblasts. These results show that human osteosarcoma. had Src-dependent proliferation and that modulation of Src activity may be a therapeutic target of this new compound with low toxicity for nonneoplastic cells.	[Spreafico, Adriano; Serchi, Tommaso; Orlandini, Maurizio; Magrini, David; Bernardini, Giulia; Di Stefano, Anna; Santucci, Annalisa] Univ Siena, Dipartimento Biol Mol, I-53100 Siena, Italy; [Spreafico, Adriano] Univ Siena, Dipartimento Med Clin & Sci Immunol, Policlin Le Scotte, I-53100 Siena, Italy; [Tintori, Cristina; Manetti, Fabrizio; Botta, Maurizio] Univ Siena, Dipartimento Farmaco Chim Tecnol, I-53100 Siena, Italy; [Collodel, Giulia] Univ Siena, Dipartimento Chirurg Sez Biol Applicat, Policlin Le Scotte, I-53100 Siena, Italy; [Schenone, Silvia] Univ Genoa, Dipartimento Sci Farmaceut, Genoa, Italy; [Angelucci, Adriano; Bologna, Mauro] Univ Aquila, Dipartimento Biol Base & Applicata, Coppito, Italy	University of Siena; University of Siena; University of Siena; University of Siena; University of Genoa; University of L'Aquila	Santucci, A (corresponding author), Univ Siena, Dipartimento Biol Mol, Via Fiorienta 1, I-53100 Siena, Italy.	santucci@unisi.it; botta@unisi.it; santucci@unisi.it	Orlandini, Maurizio/AAF-8247-2020; Bernardini, Giulia/ABG-2209-2020; Manetti, Fabrizio/Q-9412-2019; spreafico, adriano/AAL-6492-2020; collodel, giulia/AAW-5217-2021; Santucci, Annalisa/K-1932-2018; Spreafico, Adriano/K-2397-2018; Angelucci, Adriano/B-7134-2013	Orlandini, Maurizio/0000-0002-6112-4889; Bernardini, Giulia/0000-0003-0016-0728; Manetti, Fabrizio/0000-0002-9598-2339; collodel, giulia/0000-0003-1587-0159; Santucci, Annalisa/0000-0001-6976-9086; Spreafico, Adriano/0000-0002-8047-8666; Angelucci, Adriano/0000-0002-8755-1889; Serchi, Tommaso/0000-0003-2386-3514; BOLOGNA, Mauro/0000-0002-6306-6897	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Amling M, 2000, BONE, V27, P603, DOI 10.1016/S8756-3282(00)00373-2; Angelucci A, 2006, EUR J CANCER, V42, P2838, DOI 10.1016/j.ejca.2006.06.024; Angers-Loustau A, 2004, MOL CANCER RES, V2, P595; Azuma K, 2005, ONCOGENE, V24, P4754, DOI 10.1038/sj.onc.1208654; Bacci G, 2000, J CLIN ONCOL, V18, P4016, DOI 10.1200/JCO.2000.18.24.4016; Bondavalli F, 2002, J MED CHEM, V45, P4875, DOI 10.1021/jm0209580; Boyd DD, 2004, CLIN CANCER RES, V10, P1545, DOI 10.1158/1078-0432.CCR-1565-02; Bruland OS, 1997, EUR J CANCER, V33, P1725, DOI 10.1016/S0959-8049(97)00252-9; Brunton VG, 2005, CANCER RES, V65, P1335, DOI 10.1158/0008-5472.CAN-04-1949; Carraro F, 2006, J MED CHEM, V49, P1549, DOI 10.1021/jm050603r; Carraro F, 2004, J MED CHEM, V47, P1595, DOI 10.1021/jm034257u; Casas-Ganem J, 2005, CURR OPIN RHEUMATOL, V17, P79, DOI 10.1097/01.bor.0000146608.03927.16; Contri A, 2005, J CLIN INVEST, V115, P369, DOI 10.1172/JC1200522094; Daigo Y, 1999, CANCER RES, V59, P4222; Dass CR, 2006, CLIN EXP METASTAS, V23, P367, DOI 10.1007/s10585-006-9046-6; Diaz-Montero CM, 2006, EUR J CANCER, V42, P1491, DOI 10.1016/j.ejca.2006.03.007; Donnini S, 2007, INT J CANCER, V120, P995, DOI 10.1002/ijc.22410; Frediani B, 2004, BONE, V35, P859, DOI 10.1016/j.bone.2004.06.001; Fuchs B, 2007, GENE, V399, P137, DOI 10.1016/j.gene.2007.05.003; Golubovskaya VM, 2003, MOL CANCER RES, V1, P755; Gorlick R, 2003, CLIN CANCER RES, V9, P5442; Grimer RJ, 2005, LANCET ONCOL, V6, P85, DOI 10.1016/S1470-2045(05)01734-1; Hayden JB, 2006, ORTHOP CLIN N AM, V37, P1, DOI 10.1016/j.ocl.2005.06.004; KAOLAN KB, 1995, GENE DEV, V9, P1505; Lee M, 2004, J CELL BIOCHEM, V93, P629, DOI 10.1002/jcb.20215; Liu ZJ, 2004, J CLIN ENDOCR METAB, V89, P3503, DOI 10.1210/jc.2003-031917; Longhi A, 2006, CANCER TREAT REV, V32, P423, DOI 10.1016/j.ctrv.2006.05.005; Longo M, 2004, BONE, V34, P100, DOI 10.1016/j.bone.2003.09.007; Longo M, 2006, J MOL ENDOCRINOL, V37, P489, DOI 10.1677/jme.1.02055; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; Luu HH, 2005, CLIN EXP METASTAS, V22, P319, DOI 10.1007/s10585-005-0365-9; Manara MC, 2006, MOL BIOL CELL, V17, P1910, DOI 10.1091/mbc.E05-10-0971; Manetti F, 2007, CHEMMEDCHEM, V2, P343, DOI 10.1002/cmdc.200600214; Marina N, 2004, ONCOLOGIST, V9, P422, DOI 10.1634/theoncologist.9-4-422; Marzia M, 2000, J CELL BIOL, V151, P311, DOI 10.1083/jcb.151.2.311; MCALLISTER RM, 1971, CANCER-AM CANCER SOC, V27, P397, DOI 10.1002/1097-0142(197102)27:2<397::AID-CNCR2820270224>3.0.CO;2-X; Missbach M, 1999, BONE, V24, P437, DOI 10.1016/S8756-3282(99)00020-4; Moasser MM, 1999, CANCER RES, V59, P6145; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Nilbert M, 2000, CANCER GENET CYTOGEN, V121, P94, DOI 10.1016/S0165-4608(00)00226-0; Orimo H, 2006, MOL CELL BIOCHEM, V282, P101, DOI 10.1007/s11010-006-1520-6; Perez M, 2001, EUR J CANCER, V37, P629, DOI 10.1016/S0959-8049(00)00436-6; Recchia I, 2004, BONE, V34, P65, DOI 10.1016/j.bone.2003.06.004; Ren S, 2003, BIOCHEM BIOPH RES CO, V308, P120, DOI 10.1016/S0006-291X(03)01309-3; Schenone S, 2004, EUR J MED CHEM, V39, P939, DOI 10.1016/j.ejmech.2004.07.010; Schenone S, 2004, EUR J MED CHEM, V39, P153, DOI 10.1016/j.ejmech.2003.11.007; Schenone S, 2004, BIOORG MED CHEM LETT, V14, P2511, DOI 10.1016/j.bmcl.2004.03.013; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; Shor AC, 2007, CANCER RES, V67, P2800, DOI 10.1158/0008-5472.CAN-06-3469; Spreafico A, 2006, PROTEOMICS, V6, P3520, DOI 10.1002/pmic.200500858; Susa M, 2000, DRUG NEWS PERSPECT, V13, P169, DOI 10.1358/dnp.2000.13.3.566664; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073	53	59	60	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1560	1571		10.1096/fj.07-9873com	http://dx.doi.org/10.1096/fj.07-9873com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18171692				2022-12-25	WOS:000255898700028
J	Talavera, K; Yasumatsu, K; Yoshida, R; Margolskee, RF; Voets, T; Ninomiya, Y; Nilius, B				Talavera, Karel; Yasumatsu, Keiko; Yoshida, Ryusuke; Margolskee, Robert F.; Voets, Thomas; Ninomiya, Yuzo; Nilius, Bernd			The taste transduction channel TRPM5 is a locus for bitter-sweet taste interactions	FASEB JOURNAL			English	Article						quinine; quinidine; taste mixture; gustatory nerve; sensary interaction	NONSELECTIVE CATION CHANNEL; CHORDA TYMPANI NERVE; RECEPTOR-CELLS; MIXTURE INTERACTIONS; SIGNAL-TRANSDUCTION; ION-CHANNEL; RAPID ENTRY; RESPONSES; SUPPRESSION; STIMULI	Ordinary gustatory experiences, which are usually evoked by taste mixtures, are determined by multiple interactions between different taste stimuli. The most studied model for these gustatory interactions is the suppression of the responses to sweeteners by the prototype bitter compound quinine. Here we report that TRPM5, a cation channel involved in sweet taste transduction, is inhibited by quinine (EC50=50 mu M at -50 mV) owing to a decrease in the maximal whole-cell TRPM5 conductance and an acceleration of channel closure. Notably, quinine inhibits the gustatory responses of sweet-sensitive gustatory nerves in wildtype (EC50=similar to 1.6 mM) but not in Trpm5 knockout mice. Quinine induces a dose- and time-dependent inhibition of TRPM5-dependent responses of single sweet-sensitive fibers to sucrose, according to the restricted diffusion of the drug into the taste tissue. Quinidine, the stereoisomer of quinine, has similar effects on TRPM5 currents and on sweet-induced gustatory responses. In contrast, the chemically unrelated bitter compound denatonium benzoate has an similar to 100-fold weaker effect on TRPM5 currents and, accordingly, at 10 mM it does not alter gustatory responses to sucrose. The inhibition of TRPM5 by bitter compounds constitutes the molecular basis of a novel mechanism of taste interactions, whereby the bitter tastant inhibits directly the sweet transduction pathway.	[Talavera, Karel; Voets, Thomas; Nilius, Bernd] Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Ion Channel Res, B-3000 Louvain, Belgium; [Yasumatsu, Keiko; Yoshida, Ryusuke; Ninomiya, Yuzo] Kyushu Univ, Grad Sch Dent Sci, Sect Oral Neurosci, Fukuoka 812, Japan; [Margolskee, Robert F.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA	KU Leuven; Kyushu University; Icahn School of Medicine at Mount Sinai	Talavera, K (corresponding author), Katholieke Univ Leuven, Dept Mol Cell Biol, Lab Ion Channel Res, Herests 49,Campus Gasthuisberg,O&N1, B-3000 Louvain, Belgium.	karel.talavera@med.kuleuven.be	Voets, Thomas/AAD-4389-2019; Talavera, Karel/K-7990-2014; Voets, Thomas/E-2466-2012	Voets, Thomas/0000-0001-5526-5821; Talavera, Karel/0000-0002-3124-138X; Voets, Thomas/0000-0001-5526-5821; Margolskee, Robert/0000-0002-9572-2887				BARTOSHUK LM, 1975, PHYSIOL BEHAV, V14, P643, DOI 10.1016/0031-9384(75)90193-6; CALVINO AM, 1986, PHYSIOL BEHAV, V36, P1021, DOI 10.1016/0031-9384(86)90474-9; CALVINO AM, 1991, PERCEPT MOTOR SKILL, V73, P1216, DOI 10.2466/PMS.73.8.1216-1216; COOK DI, 1990, J MEMBRANE BIOL, V114, P37, DOI 10.1007/BF01869383; Damak S, 2006, CHEM SENSES, V31, P253, DOI 10.1093/chemse/bjj027; DeSimone JA, 2000, AM J PHYSIOL-CELL PH, V278, pC13, DOI 10.1152/ajpcell.2000.278.1.C13; Dinehart ME, 2006, PHYSIOL BEHAV, V87, P304, DOI 10.1016/j.physbeh.2005.10.018; Formaker BK, 1997, BRAIN RES, V772, P239, DOI 10.1016/S0006-8993(97)00845-7; Formaker BK, 1996, BRAIN RES, V727, P79; Frank ME, 2005, BRAIN RES BULL, V66, P70, DOI 10.1016/j.brainresbull.2005.04.004; Frank ME, 2003, BEHAV NEUROSCI, V117, P228, DOI 10.1037/0735-7044.117.2.228; Hofmann T, 2003, CURR BIOL, V13, P1153, DOI 10.1016/S0960-9822(03)00431-7; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P6436, DOI 10.1073/pnas.0611280104; Kaske S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-49; Kawai K, 2000, P NATL ACAD SCI USA, V97, P11044, DOI 10.1073/pnas.190066697; Keast RSJ, 2007, CHEM SENSES, V32, P245, DOI 10.1093/chemse/bjl052; LAWLESS H, 1982, PHYSIOL BEHAV, V29, P149, DOI 10.1016/0031-9384(82)90379-1; LAWLESS HT, 1979, J COMP PHYSIOL PSYCH, V93, P538, DOI 10.1037/h0077582; LAWLESS HT, 1977, SENS PROCESS, V1, P227; Liman E. R., 2007, V179, P287; Lin W, 2007, P NATL ACAD SCI USA, V104, P2471, DOI 10.1073/pnas.0610201104; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Liu D, 2003, P NATL ACAD SCI USA, V100, P15160, DOI 10.1073/pnas.2334159100; Liu D, 2005, J BIOL CHEM, V280, P20691, DOI 10.1074/jbc.M414072200; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Margolskee RF, 2002, J BIOL CHEM, V277, P1, DOI 10.1074/jbc.R100054200; MOSKOWITZ HR, 1972, PERCEPT PSYCHOPHYS, V11, P257, DOI 10.3758/BF03210374; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Nilius B, 2004, J PHYSIOL-LONDON, V560, P753, DOI 10.1113/jphysiol.2004.070839; Ogawa K, 1997, BRAIN RES, V769, P263, DOI 10.1016/S0006-8993(97)00729-4; OHRWALL H, 2006, SKAND ARCH PHYSL, V2, P1; Oike H, 2006, BBA-MOL CELL BIOL L, V1761, P1078, DOI 10.1016/j.bbalip.2006.07.005; Perez CA, 2002, NAT NEUROSCI, V5, P1169, DOI 10.1038/nn952; Peri I, 2000, AM J PHYSIOL-CELL PH, V278, pC17, DOI 10.1152/ajpcell.2000.278.1.C17; Prawitt D, 2003, P NATL ACAD SCI USA, V100, P15166, DOI 10.1073/pnas.2334624100; Prescott J, 2001, CHEM SENSES, V26, P993, DOI 10.1093/chemse/26.8.993; Romanov RA, 2007, EMBO J, V26, P657, DOI 10.1038/sj.emboj.7601526; Sanchez-Chapula JA, 2003, MOL PHARMACOL, V63, P1051, DOI 10.1124/mol.63.5.1051; SCHIFFERSTEIN HN, 2003, HDB OLFACTION GUSTAT; SCHLICHTER LC, 1992, CAN J PHYSIOL PHARM, V70, P247, DOI 10.1139/y92-031; Simon SA, 2006, NAT REV NEUROSCI, V7, P890, DOI 10.1038/nrn2006; SMITH DV, 1994, PHYSIOL BEHAV, V56, P1189, DOI 10.1016/0031-9384(94)90365-4; SPIELMAN AI, 1992, SOC GEN PHY, V47, P307; STEVENS JC, 1995, PERCEPT PSYCHOPHYS, V57, P18, DOI 10.3758/BF03211846; Stevens JC, 1996, CHEM SENSES, V21, P211, DOI 10.1093/chemse/21.2.211; STURGESS NC, 1987, PFLUG ARCH EUR J PHY, V409, P607, DOI 10.1007/BF00584661; Sugita M, 2006, CELL MOL LIFE SCI, V63, P2000, DOI 10.1007/s00018-006-6100-0; Talavera K, 2005, NATURE, V438, P1022, DOI 10.1038/nature04248; TRAVERS SP, 1984, J GEN PHYSIOL, V84, P221, DOI 10.1085/jgp.84.2.221; Ullrich ND, 2005, CELL CALCIUM, V37, P267, DOI 10.1016/j.ceca.2004.11.001; Vandenbeuch A, 2004, NEUROSCI LETT, V358, P137, DOI 10.1016/j.neulet.2004.01.013; VOGT MB, 1993, J NEUROPHYSIOL, V69, P658, DOI 10.1152/jn.1993.69.3.658; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhang Z, 2007, J NEUROSCI, V27, P5777, DOI 10.1523/JNEUROSCI.4973-06.2007	54	65	66	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1343	1355		10.1096/fj.07-9591com	http://dx.doi.org/10.1096/fj.07-9591com			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18070821	Green Accepted			2022-12-25	WOS:000255898700008
J	Fushimi, K; Troeberg, L; Nakamura, H; Lim, NH; Nagase, H				Fushimi, Kazunari; Troeberg, Linda; Nakamura, Hiroyuki; Lim, Ngee Han; Nagase, Hideaki			Functional differences of the catalytic and non-catalytic domains in human ADAMTS-4 and ADAMTS-5 in aggrecanolytic activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SYNOVIAL-FLUID; CARTILAGE EXPLANTS; MATRIX-METALLOPROTEINASE; CHONDROITIN SULFATE; ARTICULAR-CARTILAGE; AGGRECANASE; CLEAVAGE; OSTEOARTHRITIS; DEGRADATION; BINDING	ADAMTS-4 (aggrecanase-1) and ADAMTS-5 (aggrecanase2) are multidomain metalloproteinases belonging to the ADAMTS family. We have previously reported that human ADAMTS-5 has much higher aggrecanolytic activity than human ADAMTS-4. To investigate the different proteolytic activity of the two enzymes, we generated a series of chimeras by exchanging various non-catalytic domains of the two proteinases. We found that the catalytic domain of ADAMTS-5 has higher intrinsic catalytic ability than that of ADAMTS-4. The studies also demonstrated that the non-catalytic domains of ADAMTS-5 are more effective modifiers than those of ADAMTS-4, making both catalytic domains more active against aggrecan, an Escherichia coli-expressed interglobular domain of aggrecan and fibromodulin. Addition of the C-terminal thrombospondin type I motif of ADAMTS-5 to the C terminus of ADAMTS-4 increased the activity of ADAMTS-4 against aggrecan and fibromodulin severalfold. In contrast to previous reports (Kashiwagi, M., Enghild, J. J., Gendron, C., Hughes, C., Caterson, B., Itoh, Y., and Nagase, H. ( 2004) J. Biol. Chem. 279, 10109-10119 and Gao, G., Plaas, A., Thompson, V. P., Jin, S., Zuo, F., and Sandy, J. D. ( 2004) J. Biol. Chem. 279, 10042 10051), our detailed investigation of the role of the C-terminal spacer domain of ADAMTS-4 indicated that full-length ADAMTS-4 is similar to 20-times more active against aggrecan than its spacer domain deletion mutant, even at the Glu(373)-Ala(374) site of the interglobular domain. This discrepancy is most likely due to selective inhibition of full-length ADAMTS-4 by heparin, particularly for cleavage at the Glu(373)-Ala(374) bond. However, removal of the spacer domain from ADAMTS-4 greatly enhanced more general proteolytic activity against non-aggrecan substrates, e. g. E. coli-expressed interglobular domain, fibromodulin, and carboxymethylated transferrin.	[Fushimi, Kazunari; Troeberg, Linda; Nakamura, Hiroyuki; Lim, Ngee Han; Nagase, Hideaki] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, London W6 8LH, England	Imperial College London; University of Oxford	Nagase, H (corresponding author), Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, 1 Aspenlea Rd, London W6 8LH, England.	h.nagase@imperial.ac.uk	nakamura, hiroyuki/A-2953-2013; Fushimi, Kazunari/AAN-8382-2021; Lim, Ngee Han/B-4226-2011	nakamura, hiroyuki/0000-0002-2524-3063; Lim, Ngee Han/0000-0002-8520-7857; /0000-0003-0939-4651; Fushimi, Kazunari/0000-0003-0884-1990	NIAMS NIH HHS [AR40994] Funding Source: Medline; Wellcome Trust Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR040994] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; DOEGE KJ, 1991, J BIOL CHEM, V266, P894; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Gao G, 2004, J BIOL CHEM, V279, P10042, DOI 10.1074/jbc.M312100200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gendron C, 2003, FEBS LETT, V555, P431, DOI 10.1016/S0014-5793(03)01295-X; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2004, ARTHRITIS RHEUM-US, V50, P2547, DOI 10.1002/art.20558; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; HASCALL VC, 1969, J BIOL CHEM, V244, P2384; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kashiwagi M, 2001, J BIOL CHEM, V276, P12501, DOI 10.1074/jbc.C000848200; Lark MW, 1997, J CLIN INVEST, V100, P93, DOI 10.1172/JCI119526; Little CB, 2005, ARTHRITIS RHEUM-US, V52, P1461, DOI 10.1002/art.21022; LOHMANDER LS, 1993, ARTHRITIS RHEUM, V36, P1214; MANKIN HJ, 1970, J BONE JOINT SURG AM, VA 52, P424, DOI 10.2106/00004623-197052030-00002; Melching LI, 2006, OSTEOARTHR CARTILAGE, V14, P1147, DOI 10.1016/j.joca.2006.05.014; Miwa HE, 2006, MATRIX BIOL, V25, P534, DOI 10.1016/j.matbio.2006.07.004; NAGASE H, 1995, METHOD ENZYMOL, V248, P449; Nagase H, 2003, ARTHRITIS RES THER, V5, P94, DOI 10.1186/ar630; Patwari P, 2005, OSTEOARTHR CARTILAGE, V13, P269, DOI 10.1016/j.joca.2004.10.023; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Pratta MA, 2000, J BIOL CHEM, V275, P39096, DOI 10.1074/jbc.M006201200; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; SANDY JD, 1992, J CLIN INVEST, V89, P1512, DOI 10.1172/JCI115742; SANDY JD, 1991, J BIOL CHEM, V266, P8683; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018; Tortorella M, 2000, J BIOL CHEM, V275, P25791, DOI 10.1074/jbc.M001065200; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; WYCKOFF M, 1977, ANAL BIOCHEM, V78, P459, DOI 10.1016/0003-2697(77)90107-5; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013	36	67	69	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6706	6716		10.1074/jbc.M708647200	http://dx.doi.org/10.1074/jbc.M708647200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18156631	hybrid			2022-12-25	WOS:000253779600012
J	Muchowski, PJ; Ramsden, R; Nguyen, Q; Arnett, EE; Greiling, TM; Anderson, SK; Clark, JI				Muchowski, Paul J.; Ramsden, Richard; Nguyen, QuangVu; Arnett, Ernest E.; Greiling, Teri M.; Anderson, Susan K.; Clark, John I.			Noninvasive measurement of protein aggregation by mutant huntingtin fragments or alpha-synuclein in the lens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; TRANSGENIC MICE; CATARACT; CELLS; OPACIFICATION; POLYGLUTAMINE; GENE; FORM	Many diverse human diseases are associated with protein aggregation in ordered fibrillar structures called amyloid. Amyloid formation may mediate aberrant protein interactions that culminate in neurodegeneration in Alzheimer, Huntington, and Parkinson diseases and in prion encephalopathies. Studies of protein aggregation in the brain are hampered by limitations in imaging techniques and often require invasive methods that can only be performed postmortem. Here we describe transgenic mice in which aggregation-prone proteins that cause Huntington and Parkinson disease are expressed in the ocular lens. Expression of a mutant huntingtin fragment or alpha-synuclein in the lens leads to protein aggregation and cataract formation, which can be monitored in real time by noninvasive, highly sensitive optical techniques. Expression of a mutant huntingtin fragment in mice lacking the major lens chaperone, alpha B-crystallin, markedly accelerated the onset and severity of aggregation, demonstrating that the endogenous chaperone activity of alpha B-crystallin suppresses aggregation in vivo. These novel mouse models will facilitate the characterization of protein aggregation in vivo and are being used in efficient and economical screens for chemical and genetic modifiers of disease-relevant protein aggregation.	[Muchowski, Paul J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Muchowski, Paul J.; Ramsden, Richard; Nguyen, QuangVu] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Arnett, Ernest E.; Greiling, Teri M.; Anderson, Susan K.; Clark, John I.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Clark, John I.] Univ Washington, Dept Ophthalmol, Seattle, WA 98195 USA	University of California System; University of California San Francisco; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Muchowski, PJ (corresponding author), Univ Calif San Francisco, Dept Biochem, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	pmuchowski@gladstone.ucsf.edu	Greiling, Teri M./AAL-8924-2020	Greiling, Teri M./0000-0002-0028-8986	NATIONAL EYE INSTITUTE [R01EY004542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054753] Funding Source: NIH RePORTER; NEI NIH HHS [EY 04552, R01 EY004542] Funding Source: Medline; NINDS NIH HHS [R01 NS054753, R01 NS054753-03] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ansari RR, 2003, P SOC PHOTO-OPT INS, V4951, P168, DOI 10.1117/12.479478; Brady JP, 2001, INVEST OPHTH VIS SCI, V42, P2924; BURKE JR, 1996, NAT MED, V347, P350; Clark JI, 2000, CURR OPIN STRUC BIOL, V10, P52, DOI 10.1016/S0959-440X(99)00048-2; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; HIRAOKA T, 1995, INVEST OPHTH VIS SCI, V36, P2550; Hiraoka T, 1996, EXP EYE RES, V62, P11, DOI 10.1006/exer.1996.0002; Kazantsev A, 1999, P NATL ACAD SCI USA, V96, P11404, DOI 10.1073/pnas.96.20.11404; Kruger R, 2004, J NEUROL, V251, P2, DOI 10.1007/s00415-004-1602-x; Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAHON KA, 1987, SCIENCE, V235, P1622, DOI 10.1126/science.3029873; Outeiro TF, 2003, SCIENCE, V302, P1772, DOI 10.1126/science.1090439; Rochet JC, 2004, J MOL NEUROSCI, V23, P23, DOI 10.1385/JMN:23:1-2:023; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Seeberger TM, 2004, J BIOMED OPT, V9, P116, DOI 10.1117/1.1630034; Taube JR, 2002, TRANSGENIC RES, V11, P397, DOI 10.1023/A:1016364001095; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122	21	17	17	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6330	6336		10.1074/jbc.M709678200	http://dx.doi.org/10.1074/jbc.M709678200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167346	hybrid, Green Accepted			2022-12-25	WOS:000253779500040
J	Ozog, MA; Modha, G; Church, J; Reilly, R; Naus, CC				Ozog, Mark A.; Modha, Geetanjalee; Church, John; Reilly, Rayne; Naus, Christian C.			Co-administration of ciliary neurotrophic factor with its soluble receptor protects against neuronal death and enhances neurite outgrowth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; LEUKEMIA INHIBITORY FACTOR; ENTORHINAL CORTEX LESION; ADULT-RAT BRAIN; PC12 CELLS; SYMPATHETIC NEURONS; MESSENGER-RNA; CNTF RECEPTOR; DIFFERENTIAL EXPRESSION; SULFATE PROTEOGLYCANS	Attempts to promote neuronal survival and repair with ciliary neurotrophic factor (CNTF) have met with limited success. The variability of results obtained with CNTF may, in part, reflect the fact that some of the biological actions of the cytokine are mediated by a complex formed between CNTF and its specific receptor, CNTFR alpha, which exists in both membrane-bound and soluble forms. In this study, we compared the actions of CNTF alone and CNTF complexed with soluble CNTFR alpha (hereafter termed "Complex") on neuronal survival and growth. Although CNTF alone produced limited effects, Complex protected against glutamate-mediated excitotoxicity via gap junction-dependent and -independent mechanisms. Further examination revealed that only Complex promoted neurite outgrowth. Differential gene expression analysis revealed that, compared with CNTF alone, Complex differentially regulates several neuroprotective and neurotrophic genes. Collectively, these findings indicate that CNTF exerts more robust effects on neuronal survival and growth when applied in combination with its soluble receptor.	[Ozog, Mark A.; Modha, Geetanjalee; Church, John; Reilly, Rayne; Naus, Christian C.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Naus, CC (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	cnaus@interchange.ubc.ca						ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; Alonzi T, 2001, MOL CELL NEUROSCI, V18, P270, DOI 10.1006/mcne.2001.1018; Avwenagha O, 2003, J NEUROCYTOL, V32, P1055, DOI 10.1023/B:NEUR.0000021902.65233.8d; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Belloir B, 2001, J NEUROSCI RES, V64, P61, DOI 10.1002/jnr.1054; Blanc EM, 1998, J NEUROCHEM, V70, P958; Bloch J, 2004, HUM GENE THER, V15, P968, DOI 10.1089/hum.2004.15.968; Bonnet D, 2004, BRAIN RES, V1007, P142, DOI 10.1016/j.brainres.2004.02.023; Burdick JA, 2006, BIOMATERIALS, V27, P452, DOI 10.1016/j.biomaterials.2005.06.034; Cui Q, 2003, MOL CELL NEUROSCI, V22, P49, DOI 10.1016/S1044-7431(02)00037-4; Cushing P, 2005, J NEUROSCI RES, V82, P788, DOI 10.1002/jnr.20689; Davies JE, 2004, EUR J NEUROSCI, V19, P1226, DOI 10.1111/j.1460-9568.2004.03184.x; DAVIS S, 1993, SCIENCE, V259, P1736, DOI 10.1126/science.7681218; DAVIS S, 1991, SCIENCE, V253, P59, DOI 10.1126/science.1648265; Dehmelt L, 2004, J NEUROBIOL, V58, P18, DOI 10.1002/neu.10284; DELS, 2006, EUR J NEUROSCI, V23, P65; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Dirnagl U, 1999, TRENDS NEUROSCI, V22, P391, DOI 10.1016/S0166-2236(99)01401-0; DUGAN LL, 1995, J NEUROSCI, V15, P4545; Emerich DF, 2004, CELL TRANSPLANT, V13, P253, DOI 10.3727/000000004783983981; Emsley JG, 2003, EXP NEUROL, V183, P298, DOI 10.1016/S0014-4886(03)00129-8; FAISSNER A, 1994, J CELL BIOL, V126, P783, DOI 10.1083/jcb.126.3.783; GEARING DP, 1994, P NATL ACAD SCI USA, V91, P1119, DOI 10.1073/pnas.91.3.1119; Gerecke KM, 2004, MOL CELL NEUROSCI, V27, P379, DOI 10.1016/j.mcn.2004.08.001; Guo X, 1997, DEV BRAIN RES, V104, P101, DOI 10.1016/S0165-3806(97)00142-9; GUPTA SK, 1993, EUR J NEUROSCI, V5, P977, DOI 10.1111/j.1460-9568.1993.tb00949.x; Hartwig C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-53; HEYMANNS J, 1987, P NATL ACAD SCI USA, V84, P7758, DOI 10.1073/pnas.84.21.7758; Higuchi M, 2003, GENES CELLS, V8, P657, DOI 10.1046/j.1365-2443.2003.00663.x; Hirota H, 1996, J EXP MED, V183, P2627, DOI 10.1084/jem.183.6.2627; Holm NR, 2002, J NEUROCHEM, V82, P495, DOI 10.1046/j.1471-4159.2002.00963.x; IMAIZUMI K, 1994, MOL BRAIN RES, V26, P189, DOI 10.1016/0169-328X(94)90090-6; Ip Nancy Y., 1992, Progress in Growth Factor Research, V4, P139, DOI 10.1016/0955-2235(92)90028-G; IP NY, 1991, J NEUROSCI, V11, P3124; IP NY, 1993, EUR J NEUROSCI, V5, P25, DOI 10.1111/j.1460-9568.1993.tb00201.x; IP NY, 1993, NEURON, V10, P89, DOI 10.1016/0896-6273(93)90245-M; James CG, 2005, MOL BIOL CELL, V16, P5316, DOI 10.1091/mbc.E05-01-0084; Kelleher MO, 2006, ACTA NEUROCHIR, V148, P55, DOI 10.1007/s00701-005-0631-2; Kim BJ, 2004, INVEST OPHTH VIS SCI, V45, P3170, DOI 10.1167/iovs.03-0919; Kim IJ, 2004, J NEUROSCI, V24, P3304, DOI 10.1523/JNEUROSCI.3286-03.2004; LAWRANCE G, 1995, J NEUROCHEM, V64, P1483; Lee MY, 1997, J NEUROSCI, V17, P1137; Lee N, 2005, NEUROSCI LETT, V374, P161, DOI 10.1016/j.neulet.2004.10.048; Lin JHC, 2003, J NEUROSCI, V23, P430, DOI 10.1523/JNEUROSCI.23-02-00430.2003; MacLennan AJ, 1996, J NEUROSCI, V16, P621; Malgrange B, 1998, NEUROCHEM RES, V23, P1133, DOI 10.1023/A:1020724506337; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Matsui F, 2005, J NEUROSCI RES, V81, P837, DOI 10.1002/jnr.20603; McCallister WV, 2004, J RECONSTR MICROSURG, V20, P473, DOI 10.1055/s-2004-833499; Nagai N, 1999, CIRCULATION, V99, P2440, DOI 10.1161/01.CIR.99.18.2440; NAGATA K, 1993, INT J DEV NEUROSCI, V11, P227, DOI 10.1016/0736-5748(93)90081-N; Nakase T, 2004, AM J PATHOL, V164, P2067, DOI 10.1016/S0002-9440(10)63765-0; Nakase T, 2003, STROKE, V34, P1987, DOI 10.1161/01.STR.0000079814.72027.34; Nakashima K, 1999, FEBS LETT, V457, P43, DOI 10.1016/S0014-5793(99)00997-7; Ng YP, 2003, J BIOL CHEM, V278, P38731, DOI 10.1074/jbc.M304623200; NIETOSAMPEDRO M, 1982, SCIENCE, V217, P860, DOI 10.1126/science.7100931; Ogata N, 1996, ACTA NEUROCHIR, V138, P580, DOI 10.1007/BF01411179; Ozog MA, 2002, CANCER RES, V62, P3544; Ozog MA, 2004, MOL BIOL CELL, V15, P4761, DOI 10.1091/mbc.E04-03-0271; Ozog MA, 2002, J NEUROPATH EXP NEUR, V61, P132, DOI 10.1093/jnen/61.2.132; Park CK, 2000, BRAIN RES, V861, P345, DOI 10.1016/S0006-8993(00)02045-X; Qiu J, 2005, J NEUROSCI, V25, P1645, DOI 10.1523/JNEUROSCI.3269-04.2005; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; RUDGE JS, 1995, J NEUROSCI, V15, P6856; RUDGE JS, 1992, EUR J NEUROSCI, V4, P459, DOI 10.1111/j.1460-9568.1992.tb00896.x; RUDGE JS, 1994, EUR J NEUROSCI, V6, P693, DOI 10.1111/j.1460-9568.1994.tb00981.x; SAGGIO I, 1995, EMBO J, V14, P3045, DOI 10.1002/j.1460-2075.1995.tb07307.x; Shuto T, 2001, NEUROREPORT, V12, P1081, DOI 10.1097/00001756-200104170-00043; Simon R, 1995, NEUROREPORT, V7, P153, DOI 10.1097/00001756-199512000-00037; Smit M, 2003, BIOTECHNIQUES, V35, P254, DOI 10.2144/03352bm01; Sterneck E, 1996, J NEUROCHEM, V67, P1365; Stichel CC, 1995, BRAIN RES, V704, P263, DOI 10.1016/0006-8993(95)01131-5; STOCKLI KA, 1989, NATURE, V342, P920, DOI 10.1038/342920a0; Takeda K, 1998, J IMMUNOL, V161, P4652; Theis M, 2003, J NEUROSCI, V23, P766; Thompson J, 2004, MOL CELL NEUROSCI, V27, P441, DOI 10.1016/j.mcn.2004.07.007; Treister NS, 2005, J DENT RES, V84, P160, DOI 10.1177/154405910508400210; Tu YH, 1998, J CEREBR BLOOD F MET, V18, P658, DOI 10.1097/00004647-199806000-00008; Wiese S, 1999, NAT NEUROSCI, V2, P978, DOI 10.1038/14777; Wu YY, 1996, J BIOL CHEM, V271, P13023, DOI 10.1074/jbc.271.22.13023; Xia XG, 2002, MOL CELL NEUROSCI, V21, P379, DOI 10.1006/mcne.2002.1180; ZAHEER A, 1995, CELL MOL NEUROBIOL, V15, P221, DOI 10.1007/BF02073330; Zhang J, 2004, J RECONSTR MICROSURG, V20, P323, DOI 10.1055/s-2004-824891; ZHONG WX, 1994, BRAIN RES, V661, P56, DOI 10.1016/0006-8993(94)91180-0	84	12	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6546	6560		10.1074/jbc.M709065200	http://dx.doi.org/10.1074/jbc.M709065200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18086669	hybrid			2022-12-25	WOS:000253779500061
J	Itoh, H; Suzuta, T; Hoshino, T; Takaya, N				Itoh, Hideomi; Suzuta, Tetsuya; Hoshino, Takayuki; Takaya, Naoki			Novel dehydrogenase catalyzes oxidative hydrolysis of carbon-nitrogen double bonds for hydrazone degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; MITOCHONDRIAL ALDEHYDE DEHYDROGENASE; SACCHAROMYCES-CEREVISIAE; RAT-LIVER; GLUTAMINE TRANSAMINASE; AGARICUS-BISPORUS; ACTIVE-SITE; METABOLISM; YEAST; PARTICIPATION	Hydrazines and their derivatives are versatile artificial and natural compounds that are metabolized by elusive biological systems. Here we identified microorganisms that assimilate hydrazones and isolated the yeast, Candida palmioleophila MK883. When cultured with adipic acid bis(ethylidene hydrazide) as the sole source of carbon, C. palmioleophila MK883 degraded hydrazones and accumulated adipic acid dihydrazide. Cytosolic NAD(+)-or NADP(+)-dependent hydrazone dehydrogenase (Hdh) activity was detectable under these conditions. The production of Hdh was inducible by adipic acid bis(ethylidene hydrazide) and the hydrazone, varelic acid ethylidene hydrazide, under the control of carbon catabolite repression. Purified Hdh oxidized and hydrated the C = N double bond of acetaldehyde hydrazones by reducing NAD(+) or NADP(+) to produce relevant hydrazides and acetate, the latter of which the yeast assimilated. The deduced amino acid sequence revealed that Hdh belongs to the aldehyde dehydrogenase (Aldh) superfamily. Kinetic and mutagenesis studies showed that Hdh formed a ternary complex with the substrates and that conserved Cys is essential for the activity. The mechanism of Hdh is similar to that of Aldh, except that it catalyzed oxidative hydrolysis of hydrazones that requires adding a water molecule to the reaction catalyzed by conventional Aldh. Surprisingly, both Hdh and Aldh from baker's yeast (Ald4p) catalyzed the Hdh reaction as well as aldehyde oxidation. Our findings are unique in that we discovered a biological mechanism for hydrazone utilization and a novel function of proteins in the Aldh family that act on C = N compounds.	[Itoh, Hideomi; Suzuta, Tetsuya; Hoshino, Takayuki; Takaya, Naoki] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba	Takaya, N (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	ntakaya@sakura.cc.tsukuba.ac.jp	Itoh, Hideomi/M-3429-2018	Itoh, Hideomi/0000-0001-5114-9268				BARRATT RW, 1965, GENETICS, V52, P233; Boubekeur S, 2001, EUR J BIOCHEM, V268, P5057, DOI 10.1046/j.1432-1327.2001.02418.x; BRADBURY AF, 1987, EUR J BIOCHEM, V169, P579, DOI 10.1111/j.1432-1033.1987.tb13648.x; BRANDRISS MC, 1983, MOL CELL BIOL, V3, P1846, DOI 10.1128/MCB.3.10.1846; Carlson M, 1999, CURR OPIN MICROBIOL, V2, P202, DOI 10.1016/S1369-5274(99)80035-6; CLELAND WW, 1963, BIOCHIM BIOPHYS ACTA, V67, P173, DOI 10.1016/0926-6569(63)90226-8; COOPER AJL, 1973, J BIOL CHEM, V248, P8489; COOPER AJL, 1972, BIOCHEMISTRY-US, V11, P661; DELONG EF, 1992, P NATL ACAD SCI USA, V89, P5685, DOI 10.1073/pnas.89.12.5685; FARRES J, 1995, BIOCHEMISTRY-US, V34, P2592, DOI 10.1021/bi00008a025; FELDMAN RI, 1972, J BIOL CHEM, V247, P267; Galkin A, 2005, J BIOL CHEM, V280, P34080, DOI 10.1074/jbc.M505471200; GIGLIOTTI HJ, 1964, J BIOL CHEM, V239, P2274; HANKINSON O, 1974, J BIOL CHEM, V249, P2344; Haslett MR, 2004, BBA-GEN SUBJECTS, V1675, P81, DOI 10.1016/j.bbagen.2004.08.008; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; JACOBSON MK, 1974, BIOCHIM BIOPHYS ACTA, V350, P277, DOI 10.1016/0005-2744(74)90502-6; Kennedy SH, 1997, J PSYCHIATR NEUROSCI, V22, P127; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liu ZJ, 1997, NAT STRUCT BIOL, V4, P317, DOI 10.1038/nsb0497-317; McCammon MT, 1996, GENETICS, V144, P57; MEDLIN L, 1988, GENE, V71, P491, DOI 10.1016/0378-1119(88)90066-2; MICHELOT D, 1989, J TOXICOL CLIN EXPER, V9, P83; NAKASE T, 1988, J GEN APPL MICROBIOL, V34, P493, DOI 10.2323/jgam.34.493; Nguyen R, 2003, CHEM COMMUN, P942, DOI 10.1039/b211645f; Oinuma KI, 2003, J BIOL CHEM, V278, P29600, DOI 10.1074/jbc.M211832200; Ono Y, 1998, BIOL PHARM BULL, V21, P421; Perozich J, 1999, PROTEIN SCI, V8, P137, DOI 10.1110/ps.8.1.137; REYNOLDS DR, 1993, FUNGAL HOLOMORPH MIT, P225; ROTHGERY EF, 2004, J TOXICOL CLIN EXP, V9, P83; Sarich TC, 1999, J PHARMACOL EXP THER, V289, P695; Shimogawa H, 2006, TETRAHEDRON LETT, V47, P1409, DOI 10.1016/j.tetlet.2005.12.087; SMITH TA, 1969, PHYTOCHEMISTRY, V8, P2111, DOI 10.1016/S0031-9422(00)88168-6; Sophos NA, 2003, CHEM-BIOL INTERACT, V143, P5, DOI 10.1016/S0009-2797(02)00163-1; STRECKER HJ, 1971, METHODS ENZYMOLOGY B, V17, P262; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; TOIDA I, 1963, J BIOCHEM-TOKYO, V53, P14, DOI 10.1093/oxfordjournals.jbchem.a127651; TOTH B, 1978, CANCER RES, V38, P177; WANG XP, 1995, BIOCHEMISTRY-US, V34, P237, DOI 10.1021/bi00001a028; Wang XP, 1998, J BACTERIOL, V180, P822, DOI 10.1128/JB.180.4.822-830.1998; Wei BX, 2003, CHEM-BIOL INTERACT, V143, P85, DOI 10.1016/S0009-2797(02)00177-1	41	13	13	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5790	5800		10.1074/jbc.M709027200	http://dx.doi.org/10.1074/jbc.M709027200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18096698	hybrid			2022-12-25	WOS:000253426700060
J	Piazzon, N; Rage, F; Schlotter, F; Moine, H; Branlant, C; Massenet, S				Piazzon, Nathalie; Rage, Florence; Schlotter, Florence; Moine, Herve; Branlant, Christiane; Massenet, Severine			In vitro and in cellulo evidences for association of the survival of motor neuron complex with the fragile x mental retardation protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SPINAL MUSCULAR-ATROPHY; RNA-BINDING PROTEIN; DETERMINING GENE-PRODUCT; SMN COMPLEX; MESSENGER-RNA; INTRACELLULAR-LOCALIZATION; FMR1 PROTEIN; RIBONUCLEOPROTEIN BIOGENESIS; CYTOPLASMIC LOCALIZATION; POLYRIBOSOMAL MRNPS	Spinal muscular atrophy (SMA) is caused by reduced levels of the survival of motor neuron (SMN) protein. Although the SMN complex is essential for assembly of spliceosomal U small nuclear RNPs, it is still not understood why reduced levels of the SMN protein specifically cause motor neuron degeneration. SMN was recently proposed to have specific functions in mRNA transport and translation regulation in neuronal processes. The defective protein in Fragile X mental retardation syndrome (FMRP) also plays a role in transport of mRNPs and in their translation. Therefore, we examined possible relationships of SMN with FMRP. We observed granules containing both transiently expressed red fluorescent protein(RFP)-tagged SMN and green fluorescent protein(GFP)-tagged FMRP in cell bodies and processes of rat primary neurons of hypothalamus in culture. By immunoprecipitation experiments, we detected an association of FMRP with the SMN complex in human neuroblastoma SH-SY5Y cells and in murine motor neuron MN-1 cells. Then, by in vitro experiments, we demonstrated that the SMN protein is essential for this association. We showed that the COOH-terminal region of FMRP, as well as the conserved YG box and the region encoded by exon 7 of SMN, are required for the interaction. Our findings suggest a link between the SMN complex and FMRP in neuronal cells.	[Piazzon, Nathalie; Schlotter, Florence; Branlant, Christiane; Massenet, Severine] CNRS, Fac Sci, Lab Maturat ARN & Enzymol Mol, UHP Nancy 1,UMR 7567, F-54506 Vandoeuvre Les Nancy, France; [Rage, Florence] Inst Genet Mol Montpellier, UMR 5535, F-34293 Montpellier, France; [Moine, Herve] CNRS, INSERM, Inst Genet & Biol Mol & Cellulaire, ULP, F-67404 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lorraine; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Massenet, S (corresponding author), CNRS, Fac Sci, Lab Maturat ARN & Enzymol Mol, UHP Nancy 1,UMR 7567, BP 239, F-54506 Vandoeuvre Les Nancy, France.	severine.massenet@maem.uhp-nancy.fr	Rage, Florence/F-4828-2016; Moine, Herve/Q-2328-2016	Moine, Herve/0000-0002-6250-7902; Rage, Florence/0000-0003-1221-3903; Severine, Massenet/0000-0001-5187-8356; Branlant, Christiane/0000-0003-4728-5499				Antar LN, 2006, MOL CELL NEUROSCI, V32, P37, DOI 10.1016/j.mcn.2006.02.001; Antar LN, 2004, J NEUROSCI, V24, P2648, DOI 10.1523/JNEUROSCI.0099-04.2004; ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bardoni B, 1999, HUM MOL GENET, V8, P2557, DOI 10.1093/hmg/8.13.2557; Bardoni B, 2003, HUM MOL GENET, V12, P1689, DOI 10.1093/hmg/ddg181; Bardoni B, 1997, NEUROBIOL DIS, V4, P329, DOI 10.1006/nbdi.1997.0142; Bardoni Barbara, 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010751; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Bechade C, 1999, EUR J NEUROSCI, V11, P293, DOI 10.1046/j.1460-9568.1999.00428.x; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; Brendel C, 2004, BIOCHEM J, V384, P239, DOI 10.1042/BJ20040812; Briese M, 2005, BIOESSAYS, V27, P946, DOI 10.1002/bies.20283; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Campbell L, 2000, HUM MOL GENET, V9, P1093, DOI 10.1093/hmg/9.7.1093; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carissimi C, 2005, FEBS LETT, V579, P2348, DOI 10.1016/j.febslet.2005.03.034; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; Carrel TL, 2006, J NEUROSCI, V26, P11014, DOI 10.1523/JNEUROSCI.1637-06.2006; Castets M, 2005, HUM MOL GENET, V14, P835, DOI 10.1093/hmg/ddi077; Ceman S, 2003, HUM MOL GENET, V12, P3295, DOI 10.1093/hmg/ddg350; Charroux B, 2000, J CELL BIOL, V148, P1177, DOI 10.1083/jcb.148.6.1177; Charroux B, 1999, J CELL BIOL, V147, P1181, DOI 10.1083/jcb.147.6.1181; Chen L, 2003, NEUROSCIENCE, V120, P1005, DOI 10.1016/S0306-4522(03)00406-8; Coovert DD, 1997, HUM MOL GENET, V6, P1205, DOI 10.1093/hmg/6.8.1205; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Darnell JC, 2005, GENE DEV, V19, P903, DOI 10.1101/gad.1276805; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Davidovic L, 2006, HUM MOL GENET, V15, P1525, DOI 10.1093/hmg/ddl074; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; DEVYS D, 1993, NAT GENET, V4, P335, DOI 10.1038/ng0893-335; Dolzhanskaya N, 2003, BIOCHEM BIOPH RES CO, V305, P434, DOI 10.1016/S0006-291X(03)00766-6; Dolzhanskaya N, 2006, BIOCHEMISTRY-US, V45, P10385, DOI 10.1021/bi0525019; DREYFUSS G, 1984, J CELL BIOL, V99, pA233, DOI 10.1083/jcb.99.6.1997; Eberhart DE, 1996, HUM MOL GENET, V5, P1083, DOI 10.1093/hmg/5.8.1083; Eggert C, 2006, TRENDS MOL MED, V12, P113, DOI 10.1016/j.molmed.2006.01.005; Elvira G, 2006, MOL CELL PROTEOMICS, V5, P635, DOI 10.1074/mcp.M500255-MCP200; Fan L, 2002, HUM MOL GENET, V11, P1605, DOI 10.1093/hmg/11.14.1605; Feng Y, 1997, J NEUROSCI, V17, P1539; Feng Y, 1997, MOL CELL, V1, P109, DOI 10.1016/S1097-2765(00)80012-X; Ferrari F, 2007, MOL CELL NEUROSCI, V34, P343, DOI 10.1016/j.mcn.2006.11.015; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fridell RA, 1996, EMBO J, V15, P5408, DOI 10.1002/j.1460-2075.1996.tb00924.x; Friesen MJ, 2000, J BIOL CHEM, V275, P26370, DOI 10.1074/jbc.M003299200; Friesen WJ, 2001, MOL CELL BIOL, V21, P8289, DOI 10.1128/MCB.21.24.8289-8300.2001; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Giesemann T, 1999, J BIOL CHEM, V274, P37908, DOI 10.1074/jbc.274.53.37908; Golembe TJ, 2005, MOL CELL BIOL, V25, P10989, DOI 10.1128/MCB.25.24.10989-11004.2005; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Gubitz AK, 2002, J BIOL CHEM, V277, P5631, DOI 10.1074/jbc.M109448200; Halpain S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-6-224; Hebert MD, 2002, DEV CELL, V3, P329, DOI 10.1016/S1534-5807(02)00222-8; Hua YM, 2004, FEBS LETT, V572, P69, DOI 10.1016/j.febslet.2004.07.010; Jablonka S, 2001, HUM MOL GENET, V10, P497, DOI 10.1093/hmg/10.5.497; Jin P, 2003, TRENDS BIOCHEM SCI, V28, P152, DOI 10.1016/S0968-0004(03)00033-1; Job C, 2001, NAT REV NEUROSCI, V2, P889, DOI 10.1038/35104069; Jonson L, 2007, MOL CELL PROTEOMICS, V6, P798, DOI 10.1074/mcp.M600346-MCP200; Kanai Y, 2004, NEURON, V43, P513, DOI 10.1016/j.neuron.2004.07.022; Kiebler MA, 2006, NEURON, V51, P685, DOI 10.1016/j.neuron.2006.08.021; Kobayashi K, 1998, J BIOL CHEM, V273, P291, DOI 10.1074/jbc.273.1.291; Laggerbauer B, 2001, HUM MOL GENET, V10, P329, DOI 10.1093/hmg/10.4.329; Lai DM, 2006, RNA, V12, P1446, DOI 10.1261/rna.94306; Lefebvre S, 1997, NAT GENET, V16, P265, DOI 10.1038/ng0797-265; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Lefebvre S, 2002, HUM MOL GENET, V11, P1017, DOI 10.1093/hmg/11.9.1017; LERNER MR, 1979, P NATL ACAD SCI USA, V76, P5495, DOI 10.1073/pnas.76.11.5495; Li ZZ, 2001, NUCLEIC ACIDS RES, V29, P2276, DOI 10.1093/nar/29.11.2276; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Lorson CL, 1998, HUM MOL GENET, V7, P1269, DOI 10.1093/hmg/7.8.1269; Ma YL, 2005, STRUCTURE, V13, P883, DOI 10.1016/j.str.2005.03.014; Massenet S, 2002, MOL CELL BIOL, V22, P6533, DOI 10.1128/MCB.22.18.6533-6541.2002; Mazroui R, 2003, HUM MOL GENET, V12, P3087, DOI 10.1093/hmg/ddg335; Mazroui R, 2002, HUM MOL GENET, V11, P3007, DOI 10.1093/hmg/11.24.3007; McWhorter ML, 2003, J CELL BIOL, V162, P919, DOI 10.1083/jcb.200303168; Meister G, 2000, HUM MOL GENET, V9, P1977, DOI 10.1093/hmg/9.13.1977; Meister G, 2002, EMBO J, V21, P5853, DOI 10.1093/emboj/cdf585; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Meister G, 2001, NAT CELL BIOL, V3, P945, DOI 10.1038/ncb1101-945; Melki J, 1997, CURR OPIN NEUROL, V10, P381, DOI 10.1097/00019052-199710000-00005; Menon RP, 2004, J MOL BIOL, V343, P43, DOI 10.1016/j.jmb.2004.08.024; Miyashiro KY, 2003, NEURON, V37, P417, DOI 10.1016/S0896-6273(03)00034-5; Monani UR, 1999, HUM MOL GENET, V8, P1177, DOI 10.1093/hmg/8.7.1177; Monani UR, 2005, NEURON, V48, P885, DOI 10.1016/j.neuron.2005.12.001; Mouaikel J, 2003, EMBO REP, V4, P616, DOI 10.1038/sj.embor.embor863; Mourelatos Z, 2001, EMBO J, V20, P5443, DOI 10.1093/emboj/20.19.5443; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Narayanan U, 2002, HUM MOL GENET, V11, P1785, DOI 10.1093/hmg/11.15.1785; Otero YD, 2002, MOL CELL BIOL, V22, P8332, DOI 10.1128/MCB.22.23.8332-8341.2002; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Pagliardini S, 2000, HUM MOL GENET, V9, P47, DOI 10.1093/hmg/9.1.47; Parker F, 1996, MOL CELL BIOL, V16, P2561; Paushkin S, 2000, J BIOL CHEM, V275, P23841, DOI 10.1074/jbc.M001441200; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pellizzoni L, 1999, P NATL ACAD SCI USA, V96, P11167, DOI 10.1073/pnas.96.20.11167; Pellizzoni L, 1998, CELL, V95, P615, DOI 10.1016/S0092-8674(00)81632-3; Pellizzoni L, 2001, J CELL BIOL, V152, P75, DOI 10.1083/jcb.152.1.75; Pellizzoni L, 2002, J BIOL CHEM, V277, P7540, DOI 10.1074/jbc.M110141200; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Pfeiffer BE, 2006, J NEUROSCI, V26, P7147, DOI 10.1523/JNEUROSCI.1797-06.2006; Pillai RS, 2003, GENE DEV, V17, P2321, DOI 10.1101/gad.274403; PINOLROMA S, 1988, GENE DEV, V2, P215, DOI 10.1101/gad.2.2.215; Rage F, 1999, ENDOCRINOLOGY, V140, P909, DOI 10.1210/en.140.2.909; Ramos A, 2006, STRUCTURE, V14, P21, DOI 10.1016/j.str.2005.09.018; Reeve SR, 2005, CURR BIOL, V15, P1156, DOI 10.1016/j.cub.2005.05.050; Rossoll W, 2002, HUM MOL GENET, V11, P93, DOI 10.1093/hmg/11.1.93; Rossoll W, 2003, J CELL BIOL, V163, P801, DOI 10.1083/jcb.200304128; SALAZARGRUESO EF, 1991, NEUROREPORT, V2, P505, DOI 10.1097/00001756-199109000-00002; Schaeffer C, 2003, BIOL CELL, V95, P221, DOI 10.1016/S0248-4900(03)00037-6; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2003, NEURON, V38, P887, DOI 10.1016/S0896-6273(03)00354-4; Schenck A, 2001, P NATL ACAD SCI USA, V98, P8844, DOI 10.1073/pnas.151231598; Sharma A, 2005, EXP CELL RES, V309, P185, DOI 10.1016/j.yexcr.2005.05.014; Siomi H, 2004, MENT RETARD DEV D R, V10, P68, DOI 10.1002/mrdd.20011; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Siomi MC, 2002, MOL CELL BIOL, V22, P8438, DOI 10.1128/MCB.22.24.8438-8447.2002; Siomi MC, 1996, MOL CELL BIOL, V16, P3825; Sittler A, 1996, HUM MOL GENET, V5, P95, DOI 10.1093/hmg/5.1.95; Stetler A, 2006, HUM MOL GENET, V15, P87, DOI 10.1093/hmg/ddi429; Steward O, 2002, CELL, V110, P537, DOI 10.1016/S0092-8674(02)00934-0; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tretyakova I, 2005, J BIOL CHEM, V280, P31981, DOI 10.1074/jbc.M502736200; Twiss JL, 2006, J NEUROTRAUM, V23, P295, DOI 10.1089/neu.2006.23.295; Villace P, 2004, NUCLEIC ACIDS RES, V32, P2411, DOI 10.1093/nar/gkh552; Watabe-Uchida M, 2006, J NEUROSCI, V26, P10633, DOI 10.1523/JNEUROSCI.4084-06.2006; Weiler IJ, 1997, P NATL ACAD SCI USA, V94, P5395, DOI 10.1073/pnas.94.10.5395; Wells DG, 2006, J NEUROSCI, V26, P7135, DOI 10.1523/JNEUROSCI.1795-06.2006; Whitehead SE, 2002, J BIOL CHEM, V277, P48087, DOI 10.1074/jbc.M204551200; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Willis DE, 2006, CURR OPIN NEUROBIOL, V16, P111, DOI 10.1016/j.conb.2006.01.002; Winkler C, 2005, GENE DEV, V19, P2320, DOI 10.1101/gad.342005; Wirth B, 2000, HUM MUTAT, V15, P228, DOI 10.1002/(SICI)1098-1004(200003)15:3<228::AID-HUMU3>3.0.CO;2-9; Xia ZG, 1996, J NEUROSCI, V16, P5425; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Yong JS, 2004, TRENDS CELL BIOL, V14, P226, DOI 10.1016/j.tcb.2004.03.010; Yong JS, 2002, EMBO J, V21, P1188, DOI 10.1093/emboj/21.5.1188; Young PJ, 2000, HUM MOL GENET, V9, P2869, DOI 10.1093/hmg/9.19.2869; Zalfa F, 2005, J BIOL CHEM, V280, P33403, DOI 10.1074/jbc.M504286200; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5; Zhang HLL, 2003, J NEUROSCI, V23, P6627; Zhang HL, 2006, J NEUROSCI, V26, P8622, DOI 10.1523/JNEUROSCI.3967-05.2006	150	71	74	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5598	5610		10.1074/jbc.M707304200	http://dx.doi.org/10.1074/jbc.M707304200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093976	hybrid, Green Published			2022-12-25	WOS:000253426700040
J	Zhang, L; Liu, WZ; Hu, TC; Du, L; Luo, C; Chen, KX; Shen, X; Jiang, HL				Zhang, Liang; Liu, Weizhi; Hu, Tiancen; Du, Li; Luo, Cheng; Chen, Kaixian; Shen, Xu; Jiang, Hualiang			Structural basis for catalytic and inhibitory mechanisms of beta-hydroxyacyl-acyl carrier protein dehydratase (FabZ)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID BIOSYNTHESIS; PLASMODIUM-FALCIPARUM; ESCHERICHIA-COLI; HELICOBACTER-PYLORI; CRYSTAL-STRUCTURE; ACP DEHYDRATASE; DISCOVERY; ISOMERASE; ALIGNMENT; TARGETS	beta-Hydroxyacyl-acyl carrier protein dehydratase (FabZ) is an important enzyme for the elongation cycles of both saturated and unsaturated fatty acids biosyntheses in the type II fatty acid biosynthesis system (FAS II) pathway. FabZ has been an essential target for the discovery of compounds effective against pathogenic microbes. In this work, to characterize the catalytic and inhibitory mechanisms of FabZ, the crystal structures of the FabZ of Helicobacter pylori (HpFabZ) and its complexes with two newly discovered inhibitors have been solved. Different from the structures of other bacterial FabZs, HpFabZ contains an extra short two-turn alpha-helix (alpha 4) between alpha 3 and beta 3, which plays an important role in shaping the substrate-binding tunnel. Residue Tyr-100 at the entrance of the tunnel adopts either an open or closed conformation in the crystal structure. The crystal structural characterization, the binding affinity determination, and the enzymatic activity assay of the HpFabZ mutant (Y100A) confirm the importance of Tyr-100 in catalytic activity and substrate binding. Residue Phe-83 at the exit tunnel was also refined in two alternative conformations, leading the tunnel to form an L-shape and U-shape. All these data thus contributed much to understanding the catalytic mechanism of HpFabZ. In addition, the co-crystal structures of HpFabZ with its inhibitors have suggested that the enzymatic activity of HpFabZ could be inhibited either by occupying the entrance of the tunnel or plugging the tunnel to prevent the substrate from accessing the active site. Our study has provided some insights into the catalytic and inhibitory mechanisms of FabZ, thus facilitating antibacterial agent development.	[Zhang, Liang; Liu, Weizhi; Hu, Tiancen; Du, Li; Luo, Cheng; Chen, Kaixian; Shen, Xu; Jiang, Hualiang] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr,State Key Lab Drug Re, Shanghai 201203, Peoples R China; [Shen, Xu; Jiang, Hualiang] E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; East China University of Science & Technology	Shen, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Drug Discovery & Design Ctr,State Key Lab Drug Re, Shanghai 201203, Peoples R China.	xshen@mail.shcnc.ac.cn	Du, Li/L-2353-2015; Zhang, Liang/F-8064-2013	Zhang, Liang/0000-0002-7672-1168				Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Chen LL, 2005, J VIROL, V79, P7095, DOI 10.1128/JVI.79.11.7095-7103.2005; DELANOUE WL, 2002, PUMOL MOL GRAPHICS S; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GARWIN JL, 1980, J BIOL CHEM, V255, P1949; Gille C, 2003, BIOINFORMATICS, V19, P2489, DOI 10.1093/bioinformatics/btg354; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kimber MS, 2004, J BIOL CHEM, V279, P52593, DOI 10.1074/jbc.M408105200; Kostrewa D, 2005, PROTEIN SCI, V14, P1570, DOI 10.1110/ps.051373005; Leesong M, 1996, STRUCTURE, V4, P253, DOI 10.1016/S0969-2126(96)00030-5; Liu WZ, 2007, PROTEIN EXPRES PURIF, V52, P74, DOI 10.1016/j.pep.2006.09.003; Liu WZ, 2005, BIOCHEM BIOPH RES CO, V333, P1078, DOI 10.1016/j.bbrc.2005.05.197; Lu YJ, 2005, J BIOL CHEM, V280, P30342, DOI 10.1074/jbc.M504637200; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rock CO, 1996, BBA-LIPID LIPID MET, V1302, P1, DOI 10.1016/0005-2760(96)00056-2; Sharma SK, 2003, J BIOL CHEM, V278, P45661, DOI 10.1074/jbc.M304283200; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Swarnamukhi PL, 2006, FEBS LETT, V580, P2653, DOI 10.1016/j.febslet.2006.04.014; Tasdemir D, 2006, J MED CHEM, V49, P3345, DOI 10.1021/jm0600545; Viola R, 2007, J APPL CRYSTALLOGR, V40, P539, DOI 10.1107/S0021889807012149; Wang HH, 2004, J BIOL CHEM, V279, P34489, DOI 10.1074/jbc.M403874200; White SW, 2005, ANNU REV BIOCHEM, V74, P791, DOI 10.1146/annurev.biochem.74.082803.133524; Wu SY, 2003, STRUCTURE, V11, P399, DOI 10.1016/S0969-2126(03)00060-1; Zhang YM, 2003, J BIOL CHEM, V278, P52935, DOI 10.1074/jbc.M309874200	27	55	72	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5370	5379		10.1074/jbc.M705566200	http://dx.doi.org/10.1074/jbc.M705566200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093984	hybrid			2022-12-25	WOS:000253426700017
J	Kizawa, K; Takahara, H; Troxler, H; Kleinert, P; Mochida, U; Heizmann, CW				Kizawa, Kenji; Takahara, Hidenari; Troxler, Heinz; Kleinert, Peter; Mochida, Urara; Heizmann, Claus W.			Specific citrullination causes assembly of a globular S100A3 homotetramer - A putative Ca2+ modulator matures human hair cuticle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING PROTEIN; EPIDERMAL DIFFERENTIATION COMPLEX; PEPTIDYLARGININE DEIMINASE; CYSTEINE-RICH; CRYSTAL-STRUCTURE; HUMAN SKIN; FOLLICLE; TRICHOHYALIN; MOUSE; GENE	S100A3 is a unique member of the Ca2+- binding S100 protein family with the highest cysteine content and affinity for Zn2+. This protein is highly expressed in the differentiating cuticular cells within the hair follicle and organized into mature hair cuticles. Previous studies suggest a close association of S100A3 with epithelial differentiation, leading to hair shaft formation, but its molecular function is still unknown. By two-dimensional PAGE-Western blot analyses using a modified citrulline antibody, we discovered that more than half of the arginine residues of native S100A3 are progressively converted to citrullines by Ca2+-dependent peptidylarginine deiminases. Confocal immunofluorescent microscopy showed that the cytoplasmic S100A3 within the cuticular layer is mostly co-localized with the type III isoform of peptidylarginine deiminase (PAD3) but not with PAD1. Recombinant PAD1 and PAD2 are capable of converting all 4 arginines in recombinant S100A3, whereas PAD3 specifically converts only Arg-51 into citrulline. Gel filtration analyses showed that either enzymatic conversion of Arg-51 in S100A3 to citrulline or its mutational substitution with alanine (R51A) promotes a homotetramer assembly. Fluorescent titration of R51A suggested that its potential Ca2+ binding property increased during tetramerization. A prototype structural model of the globular Ca2+- bound S100A3 tetramer with citrulline residues is presented. High concentrations of S100A3 homotetramer might provide the millimolar level of Ca2+ required for hair cuticular barrier formation.	[Kizawa, Kenji] Kanebo Cosmet Inc, Basic Res Lab, Odawara 2500002, Japan; [Takahara, Hidenari; Mochida, Urara] Ibaraki Univ, Sch Agr, Dept Appl Biol Resource Sci, Ibaraki 3000393, Japan; [Troxler, Heinz; Kleinert, Peter; Heizmann, Claus W.] Univ Zurich, Dept Pediat, Div Clin Chem & Biochem, CH-8032 Zurich, Switzerland	Kanebo Cosmetics Inc.; Ibaraki University; University of Zurich	Kizawa, K (corresponding author), Kanebo Cosmet Inc, Basic Res Lab, 5-3-28 Kotobuki Cho, Odawara 2500002, Japan.	kizawa.kenji@kanebocos.co.jp		Takahara, Hidenari/0000-0003-2373-8588				Chavanas S, 2004, GENE, V330, P19, DOI 10.1016/j.gene.2003.12.038; Eckert RL, 2005, J INVEST DERMATOL, V124, P481, DOI 10.1111/j.0022-202X.2005.23627.x; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; FOHR UG, 1995, J BIOL CHEM, V270, P21056, DOI 10.1074/jbc.270.36.21056; Fritz G, 1998, BBA-MOL CELL RES, V1448, P264, DOI 10.1016/S0167-4889(98)00138-4; Fritz G, 2002, J BIOL CHEM, V277, P33092, DOI 10.1074/jbc.M200574200; Huber M, 2005, J INVEST DERMATOL, V124, P998, DOI 10.1111/j.0022-202X.2005.23675.x; Kalinin AE, 2002, BIOESSAYS, V24, P789, DOI 10.1002/bies.10144; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Kiryushko D, 2006, MOL CELL BIOL, V26, P3625, DOI 10.1128/MCB.26.9.3625-3638.2006; Kizawa K, 2005, J COSMET SCI, V56, P219; Kizawa K, 2005, BRIT J DERMATOL, V152, P314, DOI 10.1111/j.1365-2133.2004.06391.x; Kizawa K, 1998, J INVEST DERMATOL, V111, P879, DOI 10.1046/j.1523-1747.1998.00385.x; Kizawa K, 2002, BIOCHEM BIOPH RES CO, V299, P857, DOI 10.1016/S0006-291X(02)02744-4; Kizawa K, 1996, BBA-MOL CELL RES, V1312, P94, DOI 10.1016/0167-4889(96)00023-7; Koch M, 2007, BBA-MOL CELL RES, V1773, P457, DOI 10.1016/j.bbamcr.2006.12.006; Korndorfer IP, 2007, J MOL BIOL, V370, P887, DOI 10.1016/j.jmb.2007.04.065; Leukert N, 2006, J MOL BIOL, V359, P961, DOI 10.1016/j.jmb.2006.04.009; Marenholz I, 2004, BIOCHEM BIOPH RES CO, V322, P1111, DOI 10.1016/j.bbrc.2004.07.096; Marenholz I, 1996, GENOMICS, V37, P295, DOI 10.1006/geno.1996.0563; Marenholz I, 2006, BBA-MOL CELL RES, V1763, P1282, DOI 10.1016/j.bbamcr.2006.07.013; Mechin MC, 2005, CELL MOL LIFE SCI, V62, P1984, DOI 10.1007/s00018-005-5196-y; Mittl PRE, 2002, ACTA CRYSTALLOGR D, V58, P1255, DOI 10.1107/S0907444902008430; Moroz OV, 2002, ACTA CRYSTALLOGR D, V58, P407, DOI 10.1107/S0907444901021278; Nachat R, 2005, J INVEST DERMATOL, V125, P34, DOI 10.1111/j.0022-202X.2005.23763.x; Nachat R, 2005, J INVEST DERMATOL, V124, P384, DOI 10.1111/j.0022-202X.2004.23568.x; Novitskaya V, 2000, J BIOL CHEM, V275, P41278, DOI 10.1074/jbc.M007058200; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Robinson NA, 1998, J BIOL CHEM, V273, P2721, DOI 10.1074/jbc.273.5.2721; Rogers GE, 2004, INT J DEV BIOL, V48, P163, DOI 10.1387/ijdb.15272381; Ruse M, 2001, BIOCHEMISTRY-US, V40, P3167, DOI 10.1021/bi0019747; Rustandi RR, 1998, BIOCHEMISTRY-US, V37, P1951, DOI 10.1021/bi972701n; SENSHU T, 1995, J INVEST DERMATOL, V105, P163, DOI 10.1111/1523-1747.ep12317070; Steinert PM, 2003, J BIOL CHEM, V278, P41409, DOI 10.1074/jbc.M302037200; TAKAHARA H, 1985, J BIOL CHEM, V260, P8378; Takizawa T, 1999, J HISTOCHEM CYTOCHEM, V47, P525, DOI 10.1177/002215549904700411; Tarcsa E, 1997, J BIOL CHEM, V272, P27893, DOI 10.1074/jbc.272.44.27893; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; TEIGELKAMP S, 1991, J BIOL CHEM, V266, P13462; Vogl T, 2006, BBA-MOL CELL RES, V1763, P1298, DOI 10.1016/j.bbamcr.2006.08.028; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200	42	46	48	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5004	5013		10.1074/jbc.M709357200	http://dx.doi.org/10.1074/jbc.M709357200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18083705	hybrid, Green Accepted			2022-12-25	WOS:000253426500058
J	Hill, PC; Jackson-Sillah, DJ; Fox, A; Brookes, RH; de Jong, BC; Lugos, MD; Adetifa, IM; Donkor, SA; Aiken, AM; Howie, SR; Corrah, T; McAdam, KP; Adegbola, RA				Hill, Philip C.; Jackson-Sillah, Dolly J.; Fox, Annette; Brookes, Roger H.; de Jong, Bouke C.; Lugos, Moses D.; Adetifa, Ifedayo M.; Donkor, Simon A.; Aiken, Alex M.; Howie, Stephen R.; Corrah, Tumani; McAdam, Keith P.; Adegbola, Richard A.			Incidence of Tuberculosis and the Predictive Value of ELISPOT and Mantoux Tests in Gambian Case Contacts	PLOS ONE			English	Article							LINKED IMMUNOSPOT ASSAY; INTERFERON-GAMMA ASSAY; HEALTH-CARE WORKERS; MYCOBACTERIUM-TUBERCULOSIS; SKIN-TEST; HOUSEHOLD CONTACTS; RISK-FACTORS; INFECTION; DIAGNOSIS; SURVEILLANCE	Background. Studies of Tuberculosis (TB) case contacts are increasingly being utilised for understanding the relationship between M. tuberculosis and the human host and for assessing new interventions and diagnostic tests. We aimed to identify the incidence rate of new TB cases among TB contacts and to relate this to their initial Mantoux and ELISPOT test results. Methods and Findings. After initial Mantoux and ELISPOT tests and exclusion of co-prevalent TB cases, we followed 2348 household contacts of sputum smear positive TB cases. We visited them at 3 months, 6 months, 12 months, 18 months and 24 months, and investigated those with symptoms consistent with TB. Those who were diagnosed separately at a government clinic had a chest x-ray. Twenty six contacts were diagnosed with definite TB over 4312 person years of follow-up (Incidence rate 603/100,000 person years; 95% Confidence Interval, 370-830). Nine index and secondary case pairs had cultured isolates available for genotyping. Of these, 6 pairs were concordant and 3 were discordant. 2.5% of non-progressors were HIV positive compared to 12% of progressors (HR 6.2; 95% CI 1.7-22.5; p = 0.010). 25 secondary cases had initial Mantoux results, 14 (56%) were positive; 21 had initial ELISPOT results, 11 (52%) were positive; 15 (71%) of 21 tested were positive by one or the other test. Of the 6 contacts who had concordant isolates with their respective index case, 4 (67%) were Mantoux positive at recruitment, 3 (50%) were ELISPOT positive; 5 (83%) were positive by one or other of the two tests. ELISPOT positive contacts, and those with discordant results, had a similar rate of progression to those who were Mantoux positive. Those negative on either or both tests had the lowest rate of progression. Conclusions. The incidence rate of TB disease in Gambian TB case contacts, after screening for co-prevalent cases, was 603/100,000 person years. Since initial ELISPOT test and Mantoux tests were each positive in only just over half of cases, but 71% were positive by one or other test, positivity by either might be the best indication for preventive treatment. These data do not support the replacement of the Mantoux test by an ELISPOT test in The Gambia or similar settings.	[Hill, Philip C.; Jackson-Sillah, Dolly J.; Fox, Annette; Brookes, Roger H.; de Jong, Bouke C.; Lugos, Moses D.; Adetifa, Ifedayo M.; Donkor, Simon A.; Aiken, Alex M.; Howie, Stephen R.; Corrah, Tumani; McAdam, Keith P.; Adegbola, Richard A.] MRC Labs, Bacterial Dis Programme, Banjul, Gambia	MRC Laboratory Molecular Biology	Hill, PC (corresponding author), MRC Labs, Bacterial Dis Programme, Banjul, Gambia.	pandmhill@hotmail.com	de Jong, Bouke/A-3636-2013; Lugos, Moses D/AAZ-5179-2020	de Jong, Bouke/0000-0002-1017-4675; Lugos, Moses D/0000-0002-4921-2691; Brookes, Roger/0000-0002-5361-0617; Fox, Annette/0000-0002-0565-7146	Medical Research Council (UK); European Commission; Medical Research Council [MC_U190088478, MC_U190071468, MC_U190081982] Funding Source: researchfish; MRC [MC_U190088478, MC_U190081982, MC_U190071468] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Medical Research Council (UK) and the European Commission. Neither funder had any role in conducting the study or preparing the manuscript.	Adegbola RA, 2003, INT J TUBERC LUNG D, V7, P390; EGSMOSE T, 1965, B WORLD HEALTH ORGAN, V33, P419; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; FEREBEE SH, 1962, AM REV RESPIR DIS, V85, P490; FEREBEE SH, 1970, BIBL TUBERC MED THOR, V17, P28; Ferrara G, 2006, LANCET, V367, P1328, DOI 10.1016/S0140-6736(06)68579-6; Guwatudde D, 2003, AM J EPIDEMIOL, V158, P887, DOI 10.1093/aje/kwg227; Hill PC, 2006, PEDIATRICS, V117, P1542, DOI 10.1542/peds.2005-2095; Hill PC, 2004, CLIN INFECT DIS, V38, P966, DOI 10.1086/382362; Hill PC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000183; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hill PC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-156; Jackson-Sillah D, 2007, T ROY SOC TROP MED H, V101, P594, DOI 10.1016/j.trstmh.2007.02.001; Jeffries DJ, 2006, INT J TUBERC LUNG D, V10, P192; Jeffries DJ, 2004, INT J TUBERC LUNG D, V8, P1095; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Kaufmann SHE, 2007, NAT MED, V13, P299, DOI 10.1038/nm0307-299; Lienhardt C, 2005, INT J EPIDEMIOL, V34, P914, DOI 10.1093/ije/dyi100; Mazurek GH, 2001, JAMA-J AM MED ASSOC, V286, P1740, DOI 10.1001/jama.286.14.1740; National Association of State Public Health Veterinarians Inc. (NASPHV), 2005, MMWR Recomm Rep, V54, P1; *NIH CLIN EXC, 2006, CLIN GUID, V33; Pai M, 2005, JAMA-J AM MED ASSOC, V293, P2746, DOI 10.1001/jama.293.22.2746; Pai M, 2006, AM J RESP CRIT CARE, V174, P349, DOI 10.1164/rccm.200604-472OC; PUFFER RR, 1952, AM REV TUBERC PULM, V65, P111; TAYLOR RE, 2007, ARCH DIS CH IN PRESS; van der Loeff MFS, 2003, AIDS, V17, P1841, DOI [10.1097/00002030-200308150-00014, 10.1097/01.aids.0000076303.76477.49]; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9	29	105	108	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1379	10.1371/journal.pone.0001379	http://dx.doi.org/10.1371/journal.pone.0001379			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167540	gold, Green Accepted, Green Published			2022-12-25	WOS:000260468900008
J	Cane, G; Lievin-Le Moal, V; Pages, G; Servin, AL; Hofman, P; Vouret-Craviari, V				Cane, Gaelle; Lievin-Le Moal, Vanessa; Pages, Gilles; Servin, Alain L.; Hofman, Paul; Vouret-Craviari, Valerie			Up-Regulation of Intestinal Vascular Endothelial Growth Factor by Afa/Dr Diffusely Adhering Escherichia coli	PLOS ONE			English	Article								Background. Angiogenesis has been recently described as a novel component of inflammatory bowel disease pathogenesis. The level of vascular endothelial growth factor (VEGF) has been found increased in Crohn's disease and ulcerative colitis mucosa. To question whether a pro-inflammatory Escherichia coli could regulate the expression of VEGF in human intestinal epithelial cells, we examine the response of cultured human colonic T84 cells to infection by E. coli strain C1845 that belongs to the typical Afa/Dr diffusely adhering E. coli family (Afa/Dr DAEC). Methodology. VEGF mRNA expression was examined by Northern blotting and q-PCR. VEGF protein levels were assayed by ELISA and its bioactivity was analysed in endothelial cells. The bacterial factor involved in VEGF induction was identified using recombinant E. coli expressing Dr adhesin, purified Dr adhesin and lipopolysaccharide. The signaling pathway activated for the up-regulation of VEGF was identified using a blocking monoclonal anti-DAF antibody, Western blot analysis and specific pharmacological inhibitors. Principal Findings. C1845 bacteria induce the production of VEGF protein which is bioactive. VEGF is induced by adhering C1845 in both a time-and bacteria concentration-dependent manner. This phenomenon is not cell line dependent since we reproduced this observation in intestinal LS174, Caco2/TC7 and INT407 cells. Up-regulation of VEGF production requires: (1) the interaction of the bacterial F1845 adhesin with the brush border-associated decay accelerating factor (DAF, CD55) acting as a bacterial receptor, and (2) the activation of a Src protein kinase upstream of the activation of the Erk and Akt signaling pathways. Conclusions. Results demonstrate that a Afa/Dr DAEC strain induces an adhesin-dependent activation of DAF signaling that leads to the up-regulation of bioactive VEGF in cultured human intestinal cells. Thus, these results suggest a link between an entero-adherent, pro-inflammatory E. coli strain and angiogenesis which appeared recently as a novel component of IBD pathogenesis.	[Cane, Gaelle; Pages, Gilles; Vouret-Craviari, Valerie] Univ Nice Sophia Antipolis, CNRS, UMR 6543, Nice, France; [Hofman, Paul] Fac Med Nice, INSERM, ERI 21, F-06034 Nice, France; [Lievin-Le Moal, Vanessa; Servin, Alain L.] INSERM, U756, Chatenay Malabry, France; [Lievin-Le Moal, Vanessa; Servin, Alain L.] Univ Paris 11, Fac Pharm, F-92290 Chatenay Malabry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; CHU Nice; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Vouret-Craviari, V (corresponding author), Univ Nice Sophia Antipolis, CNRS, UMR 6543, Nice, France.	vouret@unice.fr	Pages, Gilles/N-7135-2017; Hofman, Paul/P-7654-2018	Hofman, Paul/0000-0003-0431-9353	"Centre National de la Recherche Scientifique'' (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); "Association pour la Recherche sur le Cancer (ARC)"; Universities of Nice Sophia Antipolis" [UMR6543]; Paris-Sud 11 [UMR756]	"Centre National de la Recherche Scientifique'' (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); "Association pour la Recherche sur le Cancer (ARC)"(Fondation ARC pour la Recherche sur le Cancer); Universities of Nice Sophia Antipolis"; Paris-Sud 11	Funding: This work was supported by the "Centre National de la Recherche Scientifique'' (CNRS), the Institut National de la Sante et de la Recherche Medicale (Inserm), the "Association pour la Recherche sur le Cancer (ARC)", and the Universities of Nice Sophia Antipolis" (UMR6543) and Paris-Sud 11 (UMR756).	Alatas F, 2004, CHEST, V125, P2156, DOI 10.1378/chest.125.6.2156; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; BARBIERI B, 1981, P SOC EXP BIOL MED, V168, P204; Barnich N, 2003, MOL MICROBIOL, V48, P781, DOI 10.1046/j.1365-2958.2003.03468.x; Barnich N, 2007, CURR OPIN GASTROEN, V23, P16, DOI 10.1097/MOG.0b013e3280105a38; Beddy D, 2004, BRIT J SURG, V91, P72, DOI 10.1002/bjs.4453; Berra E, 2003, EMBO J, V22, P4082, DOI 10.1093/emboj/cdg392; Berstad AE, 1998, GUT, V42, P522, DOI 10.1136/gut.42.4.522; Betis F, 2003, INFECT IMMUN, V71, P1774, DOI 10.1128/IAI.71.4.1774-1783.2003; Betis F, 2003, INFECT IMMUN, V71, P1068, DOI 10.1128/IAI.71.3.1068-1074.2003; BILGE SS, 1989, J BACTERIOL, V171, P4281, DOI 10.1128/JB.171.8.4281-4289.1989; Blomfield IC, 2001, ADV MICROB PHYSIOL, V45, P1, DOI 10.1016/S0065-2911(01)45001-6; Botero TM, 2006, J ENDODONT, V32, P951, DOI 10.1016/j.joen.2006.03.018; Boudeau J, 2001, MOL MICROBIOL, V39, P1272, DOI 10.1046/j.1365-2958.2001.02315.x; Boudeau J, 1999, INFECT IMMUN, V67, P4499, DOI 10.1128/IAI.67.9.4499-4509.1999; Bringer MA, 2006, CELL MICROBIOL, V8, P471, DOI 10.1111/j.1462-5822.2005.00639.x; Campieri M, 2001, GUT, V48, P132, DOI 10.1136/gut.48.1.132; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carratelli CR, 2007, INT IMMUNOPHARMACOL, V7, P287, DOI 10.1016/j.intimp.2006.10.007; CHANG HR, 1994, ANN SURG ONCOL, V1, P213, DOI 10.1007/BF02303526; COYNE KE, 1992, J IMMUNOL, V149, P2906; DANESE S, 2006, GUT; Danese S, 2006, GASTROENTEROLOGY, V130, P2060, DOI 10.1053/j.gastro.2006.03.054; Darfeuille-Michaud A, 1998, GASTROENTEROLOGY, V115, P1405, DOI 10.1016/S0016-5085(98)70019-8; Desreumaux P., 2003, Annales Pharmaceutiques Francaises, V61, P276; DHARMSATHAPHORN K, 1984, AM J PHYSIOL, V246, pG204, DOI 10.1152/ajpgi.1984.246.2.G204; Ferrante M, 2006, INFLAMM BOWEL DIS, V12, P870, DOI 10.1097/01.mib.0000235095.01608.10; Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479; Glasser AL, 2001, INFECT IMMUN, V69, P5529, DOI 10.1128/IAI.69.9.5529-5537.2001; Goebel S, 2006, AM J PHYSIOL-GASTR L, V290, pG648, DOI 10.1152/ajpgi.00466.2005; Goluszko P, 1999, INFECT IMMUN, V67, P3989, DOI 10.1128/IAI.67.8.3989-3997.1999; Griga T, 1999, DIGEST DIS SCI, V44, P1196, DOI 10.1023/A:1026640610621; Griga T, 2002, HEPATO-GASTROENTEROL, V49, P116; Guignot J, 2000, INFECT IMMUN, V68, P3554, DOI 10.1128/IAI.68.6.3554-3563.2000; Guignot J, 2007, CELL MICROBIOL, V9, P204, DOI 10.1111/j.1462-5822.2006.00782.x; Harmey JH, 2002, INT J CANCER, V101, P415, DOI 10.1002/ijc.10632; Hasan RJ, 2002, INFECT IMMUN, V70, P4485, DOI 10.1128/IAI.70.8.4485-4493.2002; Heine H, 2003, EUR J IMMUNOL, V33, P1399, DOI 10.1002/eji.200323381; Hudault S, 2004, INFECT IMMUN, V72, P4859, DOI 10.1128/IAI.72.8.4859-4863.2004; Inaba T, 1998, CLIN EXP IMMUNOL, V112, P237; Kanazawa S, 2001, AM J GASTROENTEROL, V96, P822; Kansau I, 2004, INFECT IMMUN, V72, P3733, DOI 10.1128/IAI.72.7.3733-3742.2004; Kaper JB, 2004, NAT REV MICROBIOL, V2, P123, DOI 10.1038/nrmicro818; Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x; Kirby JE, 2004, INFECT IMMUN, V72, P7315, DOI 10.1128/IAI.72.12.7315-7317.2004; Kitadai Y, 2003, BIOCHEM BIOPH RES CO, V311, P809, DOI 10.1016/j.bbrc.2003.10.077; Konno S, 2004, J GASTROENTEROL, V39, P931, DOI 10.1007/s00535-004-1423-9; Kotlowski R, 2007, GUT, V56, P669, DOI 10.1136/gut.2006.099796; Koutroubakis IE, 2006, INFLAMM BOWEL DIS, V12, P515, DOI 10.1097/00054725-200606000-00012; MADARA JL, 1987, GASTROENTEROLOGY, V92, P1133, DOI 10.1016/S0016-5085(87)91069-9; Mangia A, 2006, WORLD J GASTROENTERO, V12, P5465, DOI 10.3748/wjg.v12.i34.5465; Martin HM, 2004, GASTROENTEROLOGY, V127, P80, DOI 10.1053/j.gastro.2004.03.054; Masseret E, 2001, GUT, V48, P320, DOI 10.1136/gut.48.3.320; Mazure NM, 2003, CURR PHARM DESIGN, V9, P531, DOI 10.2174/1381612033391469; Meconi S, 2007, CELL MICROBIOL, V9, P1252, DOI 10.1111/j.1462-5822.2006.00868.x; MORAN AP, 1992, J BACTERIOL, V174, P1370, DOI 10.1128/jb.174.4.1370-1377.1992; Neut C, 2002, AM J GASTROENTEROL, V97, P939, DOI 10.1111/j.1572-0241.2002.05613.x; NOWICKI B, 1993, J EXP MED, V178, P2115, DOI 10.1084/jem.178.6.2115; NOWICKI B, 1990, INFECT IMMUN, V58, P279, DOI 10.1128/IAI.58.1.279-281.1990; O'Brien DP, 2006, J BIOL CHEM, V281, P13317, DOI 10.1074/jbc.M601805200; Ohm JE, 2003, BLOOD, V101, P4878, DOI 10.1182/blood-2002-07-1956; Pages G, 2000, ANN NY ACAD SCI, V902, P187; Peeters H, 2007, INT J IMMUNOGENET, V34, P181, DOI 10.1111/j.1744-313X.2007.00670.x; Peiffer I, 1998, INFECT IMMUN, V66, P4036; Rodriguez-Martinez S, 2006, EXP EYE RES, V83, P1373, DOI 10.1016/j.exer.2006.07.015; Sato F, 2007, BIOCHEM BIOPH RES CO, V354, P608, DOI 10.1016/j.bbrc.2007.01.027; Schulte B, 2006, INFECT IMMUN, V74, P5003, DOI 10.1128/IAI.00663-06; SCHULZ R, 1994, PORTL PR P, V8, P81; Sepehri S, 2007, INFLAMM BOWEL DIS, V13, P675, DOI 10.1002/ibd.20101; Servin AL, 2005, CLIN MICROBIOL REV, V18, P264, DOI 10.1128/CMR.18.2.264-292.2005; SHENOYSCARIA AM, 1992, J IMMUNOL, V149, P3535; Swidsinski A, 2005, J CLIN MICROBIOL, V43, P3380, DOI 10.1128/JCM.43.7.3380-3389.2005; Swidsinski A, 2002, GASTROENTEROLOGY, V122, P44, DOI 10.1053/gast.2002.30294; Telles PDS, 2003, J DENT RES, V82, P466, DOI 10.1177/154405910308200612; Tieng V, 2002, P NATL ACAD SCI USA, V99, P2977, DOI 10.1073/pnas.032668099; Tiveljung A, 1999, J MED MICROBIOL, V48, P263, DOI 10.1099/00222615-48-3-263; Trisciuoglio D, 2005, MOL BIOL CELL, V16, P4153, DOI 10.1091/mbc.E04-12-1087; Tuccillo C, 2005, J PATHOL, V207, P277, DOI 10.1002/path.1844; UESU T, 1995, LAB INVEST, V72, P587; van der Flier M, 2000, INFECT IMMUN, V68, P4792, DOI 10.1128/IAI.68.8.4792-4794.2000; Wu LW, 2000, J BIOL CHEM, V275, P5096, DOI 10.1074/jbc.275.7.5096; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005	82	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1359	10.1371/journal.pone.0001359	http://dx.doi.org/10.1371/journal.pone.0001359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159242	gold, Green Submitted, Green Published			2022-12-25	WOS:000207459700016
J	Tillmann, RL; Simon, A; Muller, A; Schildgen, O				Tillmann, Ramona Liza; Simon, Arne; Mueller, Andreas; Schildgen, Oliver			Sensitive Commercial NASBA Assay for the Detection of Respiratory Syncytial Virus in Clinical Specimen	PLOS ONE			English	Article							TRACT INFECTIONS; YOUNG-CHILDREN; RAPID DETECTION; INCREASED RISK; BD DIRECTIGEN; RSV; HOSPITALIZATION; OUTBREAK; IMPACT; BINAX	The aim of the study was to evaluate the usability of three diagnostic procedures for the detection of respiratory syncytial virus in clinical samples. Therefore, the FDA cleared CE marked NOW (R) RSV ELISA, the NucliSENS (R) EasyQ RSV A+B NASBA, and a literature based inhouse RT-PCR protocol were compared for their relative sensitivities. Thereby, NASBA turned out to be the most sensitive method with a total number of 80 RSV positive samples out of a cohort of 251 nasopharyngeal washings from patients suffering from clinical symptoms, followed by the inhouse RT-PCR (62/251) and ELISA (52/251). Thus, NASBA may serve as a rapid and highly sensitive alternative for RSV diagnostics.	[Tillmann, Ramona Liza; Schildgen, Oliver] Univ Bonn, Inst Virol, D-5300 Bonn, Germany; [Simon, Arne; Mueller, Andreas] Univ Bonn, Childrens Hosp, D-5300 Bonn, Germany	University of Bonn; University of Bonn	Schildgen, O (corresponding author), Univ Bonn, Inst Virol, D-5300 Bonn, Germany.	schildgen@mibi03.meb.uni-bonn.de	Schildgen, Oliver/D-5327-2014	Schildgen, Oliver/0000-0003-4297-9627	bioMerieux, Nurtingen, Germany	bioMerieux, Nurtingen, Germany	Funding: The authors thank bioMerieux, Nurtingen, Germany for technical support and providing resources for this study.	Black Craig Patrick, 2003, Respir Care, V48, P209; Buckingham S C, 2001, Pediatr Crit Care Med, V2, P318, DOI 10.1097/00130478-200110000-00006; Cox RA, 2001, J HOSP INFECT, V48, P186, DOI 10.1053/jhin.2001.1002; Cruz AT, 2007, J CLIN MICROBIOL, V45, P1993, DOI 10.1128/JCM.00279-07; Ehlken B, 2005, EUR J PEDIATR, V164, P607, DOI 10.1007/s00431-005-1705-0; Feltes TF, 2003, J PEDIATR-US, V143, P532, DOI 10.1067/S0022-3476(03)00454-2; Fitzgerald DA, 2004, MED J AUSTRALIA, V180, P399, DOI 10.5694/j.1326-5377.2004.tb05993.x; Forster J, 2004, EUR J PEDIATR, V163, P709, DOI 10.1007/s00431-004-1523-9; Grondahl B, 2005, CLIN MICROBIOL INFEC, V11, P848, DOI 10.1111/j.1469-0691.2005.01223.x; Jennings LC, 2004, PEDIATR INFECT DIS J, V23, P1003, DOI 10.1097/01.inf.0000143648.04673.6c; MANJI R, 2006, NUCL ACID SEQUENCE B; McIntosh K, 2002, NEW ENGL J MED, V346, P429, DOI 10.1056/NEJMra011994; Meissner HC, 2003, PEDIATR INFECT DIS J, V22, pS40, DOI 10.1097/00006454-200302001-00006; Mentel R, 2003, J MED MICROBIOL, V52, P893, DOI 10.1099/jmm.0.05290-0; Moore C, 2006, EUR J CLIN MICROBIOL, V25, P167, DOI 10.1007/S10096-006-0112-4; Ohm-Smith MJ, 2004, J CLIN MICROBIOL, V42, P2996, DOI 10.1128/JCM.42.7.2996-2999.2004; Reina J, 2004, CLIN MICROBIOL INFEC, V10, P967, DOI 10.1111/j.1469-0691.2004.00986.x; Rietveld E, 2004, PEDIATR INFECT DIS J, V23, P523, DOI 10.1097/01.inf.0000129690.35341.8d; Simon A, 2006, INT J HYG ENVIR HEAL, V209, P317, DOI 10.1016/j.ijheh.2006.02.003; Terletskaia-Ladwig E, 2005, BMC INFECT DIS, V5, DOI 10.1186/1471-2334-5-20; Thorburn K, 2004, J HOSP INFECT, V57, P194, DOI 10.1016/j.jhin.2004.03.013; Wilkesmann A, 2006, EUR J PEDIATR, V165, P467, DOI 10.1007/s00431-006-0105-4; Wilkesmann A, 2007, PEDIATR INFECT DIS J, V26, P485, DOI 10.1097/INF.0b013e31805d01e3	23	16	18	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1357	10.1371/journal.pone.0001357	http://dx.doi.org/10.1371/journal.pone.0001357			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159240	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459700014
J	Alahari, A; Trivelli, X; Guerardel, Y; Dover, LG; Besra, GS; Sacchettini, JC; Reynolds, RC; Coxon, GD; Kremer, L				Alahari, Anuradha; Trivelli, Xavier; Guerardel, Yann; Dover, Lynn G.; Besra, Gurdyal S.; Sacchettini, James C.; Reynolds, Robert C.; Coxon, Geoffrey D.; Kremer, Laurent			Thiacetazone, an Antitubercular Drug that Inhibits Cyclopropanation of Cell Wall Mycolic Acids in Mycobacteria	PLOS ONE			English	Article								Background. Mycolic acids are a complex mixture of branched, long-chain fatty acids, representing key components of the highly hydrophobic mycobacterial cell wall. Pathogenic mycobacteria carry mycolic acid sub-types that contain cyclopropane rings. Double bonds at specific sites on mycolic acid precursors are modified by the action of cyclopropane mycolic acid synthases (CMASs). The latter belong to a family of S-adenosyl-methionine-dependent methyl transferases, of which several have been well studied in Mycobacterium tuberculosis, namely, MmaA1 through A4, PcaA and CmaA2. Cyclopropanated mycolic acids are key factors participating in cell envelope permeability, host immunomodulation and persistence of M. tuberculosis. While several antitubercular agents inhibit mycolic acid synthesis, to date, the CMASs have not been shown to be drug targets. Methodology/Principle Findings. We have employed various complementary approaches to show that the antitubercular drug, thiacetazone (TAC), and its chemical analogues, inhibit mycolic acid cyclopropanation. Dramatic changes in the content and ratio of mycolic acids in the vaccine strain Mycobacterium bovis BCG, as well as in the related pathogenic species Mycobacterium marinum were observed after treatment with the drugs. Combination of thin layer chromatography, mass spectrometry and Nuclear Magnetic Resonance (NMR) analyses of mycolic acids purified from drug-treated mycobacteria showed a significant loss of cyclopropanation in both the alpha- and oxygenated mycolate sub-types. Additionally, High-Resolution Magic Angle Spinning (HR-MAS) NMR analyses on whole cells was used to detect cell wall-associated mycolates and to quantify the cyclopropanation status of the cell envelope. Further, overexpression of cmaA2, mmaA2 or pcaA in mycobacteria partially reversed the effects of TAC and its analogue on mycolic acid cyclopropanation, suggesting that the drugs act directly on CMASs. Conclusions/Significance. This is a first report on the mechanism of action of TAC, demonstrating the CMASs as its cellular targets in mycobacteria. The implications of this study may be important for the design of alternative strategies for tuberculosis treatment.	[Alahari, Anuradha; Kremer, Laurent] Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, Montpellier, France; [Alahari, Anuradha; Kremer, Laurent] Univ Montpellier 1, CNRS, UMR 5235, Montpellier, France; [Kremer, Laurent] INSERM, Montpellier, France; [Trivelli, Xavier; Guerardel, Yann] Univ Sci & Technol Lille, CNRS, UMR 8576, Unite Glycobiol Struct & Fonct, Villeneuve Dascq, France; [Dover, Lynn G.] Northumbria Univ, Sch Appl Sci, Biomol & Biomed Res Ctr, Newcastle Upon Tyne NE1 8ST, Tyne & Wear, England; [Besra, Gurdyal S.] Univ Birmingham, Sch Biosci, Birmingham, W Midlands, England; [Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Reynolds, Robert C.] So Res Inst, Drug Discovery Div, Birmingham, AL 35255 USA; [Coxon, Geoffrey D.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Div Pharmaceut Sci, Glasgow, Lanark, Scotland	Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Northumbria University; University of Birmingham; Texas A&M University System; Texas A&M University College Station; University of Strathclyde	Kremer, L (corresponding author), Univ Montpellier 2, Lab Dynam Interact Membranaires Normales & Pathol, Montpellier, France.	laurent.kremer@univ-montp2.fr	Kremer, Laurent/M-4935-2017; Dover, Lynn G/F-3021-2010; Dover, Lynn George/Q-6778-2019	Kremer, Laurent/0000-0002-6604-4458; Dover, Lynn G/0000-0002-4776-2665; Dover, Lynn George/0000-0002-4776-2665; Besra, Gurdyal/0000-0002-5605-0395; Guerardel, Yann/0000-0003-4967-9512; Trivelli, Xavier/0000-0001-6775-9650	Royal Society Wolfson Research Merit Award; Lister Institute; Medical Research Council (UK); Wellcome Trust; Centre National de la Recherche Scientifique (CNRS); European Union (FEDER); Ministere Francais de l'Enseignement Superieur et de la Recherche; region Nord-Pas de Calais; Universite des Sciences et Technologies de Lille; CNRS; MRC [G0400789] Funding Source: UKRI; Medical Research Council [G0400789] Funding Source: researchfish	Royal Society Wolfson Research Merit Award(Royal Society of London); Lister Institute; Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); European Union (FEDER)(European Commission); Ministere Francais de l'Enseignement Superieur et de la Recherche; region Nord-Pas de Calais(Region Hauts-de-FranceEuropean Commission); Universite des Sciences et Technologies de Lille; CNRS(Centre National de la Recherche Scientifique (CNRS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	GSB acknowledges support from Mr. James Bardrick in the form of a Personal Chair, a Royal Society Wolfson Research Merit Award, the Lister Institute as a former Jenner Research Fellow, the Medical Research Council (UK) and the Wellcome Trust. LK is supported by a Grant from the Centre National de la Recherche Scientifique (CNRS) (Action Thematique Incitative sur Programme "Microbiologie Fondamentale''). The 800 MHz spectrometer was funded by European Union (FEDER), Ministere Francais de l'Enseignement Superieur et de la Recherche, region Nord-Pas de Calais, Universite des Sciences et Technologies de Lille and CNRS.	BANERJEE A, 1994, SCIENCE, V263, P227, DOI 10.1126/science.8284673; Behr MA, 2000, J BACTERIOL, V182, P3394, DOI 10.1128/JB.182.12.3394-3399.2000; Bermudez LE, 2004, ANTIMICROB AGENTS CH, V48, P3556, DOI 10.1128/AAC.48.9.3556-3558.2004; Bermudez LE, 2003, ANTIMICROB AGENTS CH, V47, P2685, DOI 10.1128/AAC.47.8.2685-2687.2003; BHATT A, 2007, P NATL ACAD IN PRESS; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Boissier F, 2006, J BIOL CHEM, V281, P4434, DOI 10.1074/jbc.M510250200; Collins LA, 1997, ANTIMICROB AGENTS CH, V41, P1004, DOI 10.1128/AAC.41.5.1004; DAFFE M, 1991, RES MICROBIOL, V142, P397, DOI 10.1016/0923-2508(91)90109-N; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; DAVIDSON PT, 1992, DRUGS, V43, P651, DOI 10.2165/00003495-199243050-00003; DeBarber AE, 2000, P NATL ACAD SCI USA, V97, P9677, DOI 10.1073/pnas.97.17.9677; Dinadayala P, 2003, J BIOL CHEM, V278, P7310, DOI 10.1074/jbc.M210501200; Dorman SE, 2007, NAT MED, V13, P295, DOI 10.1038/nm0307-295; Dover LG, 2007, ANTIMICROB AGENTS CH, V51, P1055, DOI 10.1128/AAC.01063-06; Dubnau E, 1997, MOL MICROBIOL, V23, P313, DOI 10.1046/j.1365-2958.1997.2301589.x; Dubnau E, 2000, MOL MICROBIOL, V36, P630, DOI 10.1046/j.1365-2958.2000.01882.x; GEORGE KM, 1995, J BIOL CHEM, V270, P27292, DOI 10.1074/jbc.270.45.27292; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Glickman MS, 2003, J BIOL CHEM, V278, P7844, DOI 10.1074/jbc.M212458200; Glickman MS, 2001, J BIOL CHEM, V276, P2228, DOI 10.1074/jbc.C000652200; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; HOUSTON S, 1994, DRUGS, V48, P689, DOI 10.2165/00003495-199448050-00004; Huang CC, 2002, J BIOL CHEM, V277, P11559, DOI 10.1074/jbc.M111698200; Kremer L, 2000, J BIOL CHEM, V275, P16857, DOI 10.1074/jbc.M000569200; Kremer L, 2002, MICROBIOL-SGM, V148, P3145, DOI 10.1099/00221287-148-10-3145; Kremer L, 2000, MOLECULAR GENETICS OF MYCOBACTERIA, P173; Laval F, 2001, ANAL CHEM, V73, P4537, DOI 10.1021/ac0105181; Lee REB, 2005, GLYCOBIOLOGY, V15, P139, DOI 10.1093/glycob/cwh150; MINNIKIN DE, 1982, J GEN MICROBIOL, V128, P817; Mitchison DA, 2004, FRONT BIOSCI-LANDMRK, V9, P1059, DOI 10.2741/1293; NUNN P, 1993, T ROY SOC TROP MED H, V87, P578, DOI 10.1016/0035-9203(93)90096-9; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; *PREV CFDCA, 2006, MMWR-MORBID MORTAL W, V55, P301; Qian L, 2006, CHEM RES TOXICOL, V19, P443, DOI 10.1021/tx050328b; Rao V, 2005, J EXP MED, V201, P535, DOI 10.1084/jem.20041668; Rao V, 2006, J CLIN INVEST, V116, P1660, DOI 10.1172/JCI27335; Raviglione MC, 2007, NEW ENGL J MED, V356, P656, DOI 10.1056/NEJMp068273; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Vilcheze C, 2006, NAT MED; Wang F, 2007, J EXP MED, V204, P73, DOI 10.1084/jem.20062100; Watanabe M, 1999, J BACTERIOL, V181, P2293, DOI 10.1128/JB.181.7.2293-2297.1999; Watkins WM, 1996, BRIT J CLIN PHARMACO, V41, P160, DOI 10.1111/j.1365-2125.1996.tb00175.x; Wieruszeski JM, 2006, J MAGN RESON, V181, P199, DOI 10.1016/j.jmr.2006.04.007; Yuan Y, 1998, MOL MICROBIOL, V29, P1449, DOI 10.1046/j.1365-2958.1998.01026.x; YUAN Y, 1995, P NATL ACAD SCI USA, V92, P6630, DOI 10.1073/pnas.92.14.6630; Yuan Y, 1996, P NATL ACAD SCI USA, V93, P12828, DOI 10.1073/pnas.93.23.12828; Yuan Y, 1997, J BIOL CHEM, V272, P10041; Zhang Y, 2006, DRUG DISCOV TODAY, V11, P21, DOI 10.1016/S1359-6446(05)03626-3	50	100	104	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1343	10.1371/journal.pone.0001343	http://dx.doi.org/10.1371/journal.pone.0001343			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18094751	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000207459600026
J	Cui, Y; Guadagno, TM				Cui, Y.; Guadagno, T. M.			B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells	ONCOGENE			English	Article						B-Raf(V600E); ERK; mps1; spindle checkpoint; melanoma	ACTIVATED PROTEIN-KINASE; B-RAF; ASSEMBLY CHECKPOINT; BRAF MUTATIONS; MAP KINASE; CENTROSOME DUPLICATION; CANCER; PATHWAY; MITOSIS; PHOSPHORYLATION	The B-Raf(V600E) mutant, found in 65% of human melanomas, drives constitutive activation of the extracellular signal-regulated kinase (ERK) pathway and is implicated in tumorigenesis. Recently, we showed that B-Raf is important for spindle formation and the mitotic spindle checkpoint arrest. In this study, we demonstrate that B-Raf(V600E) signaling deregulates the spindle checkpoint as a consequence of stabilizing monopolar spindle 1 (Mps1) levels in human melanoma cells. Upon introducing the B-Raf(V600E) mutant into wild-type B-Raf melanoma cells, Mps1 protein and activity increased 3- and 10-fold, respectively. In addition, Mps1 became hyperphosphorylated, which correlated with stabilization of Mps1 protein levels. In contrast, reduction of B-Raf by RNAi or inactivation of ERK by the MEK inhibitor U0126 resulted in a precipitous decline in Mps1 levels. Together, these results suggest that B-Raf signaling through ERK regulates the stability of Mps1. Finally, B-Raf(V600E) expression induces a mitotic delay due to promoting robust activation of the mitotic spindle checkpoint. These effects were dependent on the induction of Mps1 levels by oncogenic B-Raf(V600E) as shown by depleting Mps1 with short interfering RNA. Collectively, our findings implicate a new mechanism through which B-Raf(V600E) exerts its oncogenic effects in melanoma.	[Cui, Y.; Guadagno, T. M.] H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Div, Mol Oncol Program, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Guadagno, TM (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Cutaneous Oncol Div, Mol Oncol Program, Tampa, FL 33612 USA.	guadagnt@moffitt.usf.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062542] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM62542] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Bastian BC, 1998, CANCER RES, V58, P2170; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Bhatt KV, 2005, ONCOGENE, V24, P3459, DOI 10.1038/sj.onc.1208544; Borysov SI, 2006, J BIOL CHEM, V281, P22586, DOI 10.1074/jbc.M601432200; Calipel A, 2003, J BIOL CHEM, V278, P42409, DOI 10.1074/jbc.M308709200; Chadee DN, 2004, NAT CELL BIOL, V6, P770, DOI 10.1038/ncb1152; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Conner SR, 2003, J BIOL CHEM, V278, P34548, DOI 10.1074/jbc.M305797200; Curtin JA, 2005, NEW ENGL J MED, V353, P2135, DOI 10.1056/NEJMoa050092; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Eves EM, 2006, MOL CELL, V23, P561, DOI 10.1016/j.molcel.2006.07.015; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Fukushima T, 2003, ONCOGENE, V22, P6455, DOI 10.1038/sj.onc.1206739; Hardwick KG, 1996, SCIENCE, V273, P953, DOI 10.1126/science.273.5277.953; Hingorani SR, 2003, CANCER RES, V63, P5198; Hoeflich MP, 2006, CANCER RES, V66, P999, DOI 10.1158/0008-5472.CAN-05-2720; Horne MM, 2003, J CELL BIOL, V161, P1021, DOI 10.1083/jcb.200304144; Jallepalli PV, 2001, NAT REV CANCER, V1, P109, DOI 10.1038/35101065; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Karasarides M, 2004, ONCOGENE, V23, P6292, DOI 10.1038/sj.onc.1207785; Kimura ET, 2003, CANCER RES, V63, P1454; Knauf JA, 2006, J BIOL CHEM, V281, P3800, DOI 10.1074/jbc.M511690200; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Kumar R, 2003, CLIN CANCER RES, V9, P3362; Liu ST, 2003, MOL BIOL CELL, V14, P1638, DOI 10.1091/mbc.02-05-0074; Liu X, 2004, ONCOGENE, V23, P763, DOI 10.1038/sj.onc.1207188; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Palframan WJ, 2006, SCIENCE, V313, P680, DOI 10.1126/science.1127205; Park S, 2005, ONCOGENE, V24, P3535, DOI 10.1038/sj.onc.1208435; Peeper DS, 2002, NAT CELL BIOL, V4, P148, DOI 10.1038/ncb742; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Satyamoorthy K, 2003, CANCER RES, V63, P756; Stahl JM, 2004, CANCER RES, V64, P7002, DOI 10.1158/0008-5472.CAN-04-1399; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Takenaka K, 1997, J CELL BIOL, V136, P1091, DOI 10.1083/jcb.136.5.1091; Wang XM, 1997, J CELL BIOL, V137, P433, DOI 10.1083/jcb.137.2.433; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wright JH, 1999, P NATL ACAD SCI USA, V96, P11335, DOI 10.1073/pnas.96.20.11335; Yuen ST, 2002, CANCER RES, V62, P6451; Zhao Y, 2006, CURR BIOL, V16, P1764, DOI 10.1016/j.cub.2006.07.058	41	40	44	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	22					3122	3133		10.1038/sj.onc.1210972	http://dx.doi.org/10.1038/sj.onc.1210972			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	301LL	18071315				2022-12-25	WOS:000255897600005
J	Pan, Q; Zhu, YJ; Gu, BW; Cai, X; Bai, XT; Yun, HY; Zhu, J; Chen, B; Weng, L; Chen, Z; Xue, YQ; Chen, SJ				Pan, Q.; Zhu, Y-J; Gu, B-W; Cai, X.; Bai, X-T; Yun, H-Y; Zhu, J.; Chen, B.; Weng, L.; Chen, Z.; Xue, Y-Q; Chen, S-J			New fusion gene NUP98-IQCG identified in an acute T-lymphoid/myeloid leukemia with a t(3;11)(q29q13;p15)del(3)(q29) translocation	ONCOGENE			English	Article						NUP98-IQCG; fusion gene; acute T-lymphoid/myeloid leukemia	ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; PARTNER GENE; NUCLEAR-PORE; FG REPEATS; NUP98-HOXA9; LEUKEMOGENESIS; ABNORMALITIES; PROLIFERATION; DYSREGULATION	NUP98 has been involved in multiple recurrent chromosome rearrangements in leukemia. We identified a novel fusion between NUP98 and IQ motif containing G (IQCG) gene from a de novo acute T-lymphoid/myeloid leukemia harboring t(3;11)(q29q13;p15)del(3)(q29). IQCG has two putative coiled-coil domains and one IQ domain. The FG repeat from NUP98 and the coiled-coil domain from IQCG were retained in the fusion protein. We demonstrated that NUP98-IQCG could form homodimer, heterodimerize with NUP98 or IQCG, bind coactivators and/or co-repressors, and show transcriptional activity in vitro. Expression of NUP98-IQCG inhibited 32Dcl3 cell apoptosis induced by Ara-C, and partially blocked granulocyte differentiation induced by G-CSF. Colony-forming assay and serial replating assays indicated that NUP98-IQCG was able to stimulate proliferation, partially block differentiation of hematopoietic stem/progenitor cells but was unable to confer transformation alone. Taken together, our data indicate that newly identified NUP98-IQCG fusion protein may play an essential role in leukemogenesis, but by itself may not be sufficient to induce leukemia.	[Pan, Q.; Gu, B-W; Cai, X.; Bai, X-T; Yun, H-Y; Zhu, J.; Chen, B.; Weng, L.; Chen, Z.; Chen, S-J] Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Shanghai Inst Hematol,Ruijin Hosp, Shanghai 200030, Peoples R China; [Zhu, Y-J; Xue, Y-Q] Soochow Univ, Affiliated Hosp 1, JiangSu Inst Hematol, Leukemia Res Unit, Suzhou, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Soochow University - China	Chen, SJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, State Key Lab Med Genom, Shanghai Inst Hematol,Ruijin Hosp, 197,Ruijin Rd 2, Shanghai 200030, Peoples R China.	uujihsmc@public1.sz.js.cn; sjchen@stn.sh.cn		Yun, Haiyang/0000-0001-8714-205X				Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; Chung KY, 2006, CANCER RES, V66, P11781, DOI 10.1158/0008-5472.CAN-06-0706; Gervais C, 2005, LEUKEMIA, V19, P145, DOI 10.1038/sj.leu.2403565; Gu BW, 2003, LEUKEMIA, V17, P1858, DOI 10.1038/sj.leu.2403036; Gurevich RM, 2004, BLOOD, V104, P1127, DOI 10.1182/blood-2003-10-3550; Iwasaki M, 2005, BLOOD, V105, P784, DOI 10.1182/blood-2004-04-1508; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lin YW, 2005, BLOOD, V106, P287, DOI 10.1182/blood-2004-12-4794; Minucci S, 2000, MOL CELL, V5, P811, DOI 10.1016/S1097-2765(00)80321-4; Moore MAS, 2007, ANN NY ACAD SCI, V1106, P114, DOI 10.1196/annals.1392.019; Nakamura T, 2005, INT J HEMATOL, V82, P21, DOI 10.1532/IJH97.04160; Nebral K, 2005, CLIN CANCER RES, V11, P6489, DOI 10.1158/1078-0432.CCR-05-0150; Ohta H, 2007, EXP HEMATOL, V35, P817, DOI 10.1016/j.exphem.2007.02.012; Panagopoulos I, 2007, BRIT J HAEMATOL, V136, P294, DOI 10.1111/j.1365-2141.2006.06410.x; RADU A, 1995, CELL, V81, P215, DOI 10.1016/0092-8674(95)90331-3; Reader JC, 2007, LEUKEMIA, V21, P842, DOI 10.1038/sj.leu.2404579; Shaffer LG., 2005, INT SYSTEM HUMAN CYT; Slape C, 2004, LEUKEMIA LYMPHOMA, V45, P1341, DOI 10.1080/10428190310001659325; Takeda A, 2006, CANCER RES, V66, P6628, DOI 10.1158/0008-5472.CAN-06-0458; Tosi S, 2005, GENE CHROMOSOME CANC, V44, P225, DOI 10.1002/gcc.20233; van Zutven LJCM, 2006, GENE CHROMOSOME CANC, V45, P437, DOI 10.1002/gcc.20308; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Xu L, 2001, LEUKEMIA, V15, P1359, DOI 10.1038/sj.leu.2402205	25	23	25	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	24					3414	3423		10.1038/sj.onc.1210999	http://dx.doi.org/10.1038/sj.onc.1210999			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	307HL	18084320				2022-12-25	WOS:000256309900006
J	Castellani, LW; Nguyen, CN; Charugundla, S; Weinstein, MM; Doan, CX; Blaner, WS; Wongsiriroj, N; Lusis, AJ				Castellani, Lawrence W.; Nguyen, Cara N.; Charugundla, Sarada; Weinstein, Michael M.; Doan, Chau X.; Blaner, William S.; Wongsiriroj, Nuttaporn; Lusis, Aldons J.			Apolipoprotein AII is a regulator of very low density lipoprotein metabolism and insulin resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-II GENE; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; TRIGLYCERIDE-RICH LIPOPROTEINS; TRANSGENIC MICE; SKELETAL-MUSCLE; RISK-FACTORS; PEROXISOME PROLIFERATOR; COMBINED HYPERLIPIDEMIA; PLASMA TRIGLYCERIDES; LIPOGENIC ENZYMES	Apolipoprotein AII (apoAII) transgenic (apoAIItg) mice exhibit several traits associated with the insulin resistance (IR) syndrome, including IR, obesity, and a marked hypertriglyceridemia. Because treatment of the apoAIItg mice with rosiglitazone ameliorated the IR and hypertriglyceridemia, we hypothesized that the hypertriglyceridemia was due largely to overproduction of very low density lipoprotein ( VLDL) by the liver, a normal response to chronically elevated insulin and glucose. We now report in vivo and in vitro studies that indicate that hepatic fatty acid oxidation was reduced and lipogenesis increased, resulting in a 25% increase in triglyceride secretion in the apoAIItg mice. In addition, we observed that hydrolysis of triglycerides from both chylomicrons and VLDL was significantly reduced in the apoAIItg mice, further contributing to the hypertriglyceridemia. This is a direct, acute effect, because when mouse apoAII was injected into mice, plasma triglyceride concentrations were significantly increased within 4 h. VLDL from both control and apoAIItg mice contained significant amounts of apoAII, with similar to 4 times more apoAII on apoAIItg VLDL. ApoAII was shown to transfer spontaneously from high density lipoprotein (HDL) to VLDL in vitro, resulting in VLDL that was a poorer substrate for hydrolysis by lipoprotein lipase. These results indicate that one function of apoAII is to regulate the metabolism of triglyceride-rich lipoproteins, with HDL serving as a plasma reservoir of apoAII that is transferred to the triglyceride-rich lipoproteins in much the same way as VLDL and chylomicrons acquire most of their apoCs from HDL.	[Castellani, Lawrence W.; Nguyen, Cara N.; Charugundla, Sarada; Weinstein, Michael M.; Doan, Chau X.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Div Cardiol, Los Angeles, CA 90095 USA; [Castellani, Lawrence W.; Nguyen, Cara N.; Charugundla, Sarada; Weinstein, Michael M.; Doan, Chau X.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Med, Dept Cardiol, Los Angeles, CA 90095 USA; [Blaner, William S.; Wongsiriroj, Nuttaporn] Columbia Univ, Dept Med, New York, NY 10032 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Lusis, Aldons J.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Columbia University; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Castellani, LW (corresponding author), Univ Calif Los Angeles, Dept Med, Div Cardiol, BH-307 CHS, Los Angeles, CA 90095 USA.	lcastellani@mednet.ucla.edu			NHLBI NIH HHS [HL28481] Funding Source: Medline; NIDDK NIH HHS [DK071673] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL028481] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071673] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ALAUPOVIC P, 1991, J LIPID RES, V32, P9; Aleksandrovich OV, 2006, B EXP BIOL MED+, V141, P678, DOI 10.1007/s10517-006-0250-9; Allayee H, 2003, CIRC RES, V92, P1262, DOI 10.1161/01.RES.0000075600.87675.16; ASSIMACOPOULOSJEANNET F, 1995, METABOLISM, V44, P228, DOI 10.1016/0026-0495(95)90270-8; Baier L, 1998, DIABETES, V47, pA171; BARBARAS R, 1987, BIOCHEM BIOPH RES CO, V142, P63, DOI 10.1016/0006-291X(87)90451-7; BAZIN R, 1982, J LIPID RES, V23, P839; BLANER WS, 1994, J BIOL CHEM, V269, P16559; Boisfer E, 1999, J BIOL CHEM, V274, P11564, DOI 10.1074/jbc.274.17.11564; BORGHINI I, 1991, BIOCHIM BIOPHYS ACTA, V1083, P139, DOI 10.1016/0005-2760(91)90034-F; Brunmair B, 2001, DIABETES, V50, P2309, DOI 10.2337/diabetes.50.10.2309; Burger H, 1997, J ACQ IMMUN DEF SYND, V14, P321, DOI 10.1097/00042560-199704010-00003; Caiazza D, 2004, BIOCHEMISTRY-US, V43, P11898, DOI 10.1021/bi049776t; Castellani LW, 2004, J LIPID RES, V45, P2377, DOI 10.1194/jlr.M400345-JLR200; Castellani LW, 1997, J CLIN INVEST, V100, P464, DOI 10.1172/JCI119554; CASTELLANI LW, 1991, BIOCHIM BIOPHYS ACTA, V1086, P197, DOI 10.1016/0005-2760(91)90008-6; Castellani LW, 2001, DIABETES, V50, P643, DOI 10.2337/diabetes.50.3.643; Cerne D, 2000, RENAL FAILURE, V22, P799, DOI 10.1081/JDI-100101965; Cerne D, 2000, CLIN CHEM LAB MED, V38, P529, DOI 10.1515/CCLM.2000.078; COLBERG SR, 1995, J CLIN INVEST, V95, P1846, DOI 10.1172/JCI117864; Corella D, 2007, CLIN CHEM, V53, P1144, DOI 10.1373/clinchem.2006.084863; Delgado-Lista J, 2007, J NUTR, V137, P2024; DREXEL H, 1994, CIRCULATION, V90, P2230, DOI 10.1161/01.CIR.90.5.2230; Dugue-Pujol S, 2006, J LIPID RES, V47, P2631, DOI 10.1194/jlr.M600112-JLR200; EISENBERG S, 1979, J BIOL CHEM, V254, P2603; EKMAN R, 1975, CLIN CHIM ACTA, V63, P29, DOI 10.1016/0009-8981(75)90374-5; Elbein SC, 1998, DIABETES, V47, pA15; Escola-Gil JC, 2000, J LIPID RES, V41, P1328; Escola-Gil JC, 1998, J LIPID RES, V39, P457; Escola-Gil JC, 2002, DIABETOLOGIA, V45, P600, DOI 10.1007/s00125-002-0778-9; Escola-Gil JC, 2001, J LIPID RES, V42, P241; FAGER G, 1980, ATHEROSCLEROSIS, V36, P67, DOI 10.1016/0021-9150(80)90199-9; Ferreira LDMCB, 2001, DIABETES, V50, P1064, DOI 10.2337/diabetes.50.5.1064; FOLCH J, 1957, J BIOL CHEM, V226, P497; Ginsberg HN, 2005, ARCH MED RES, V36, P232, DOI 10.1016/j.arcmed.2005.01.005; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; HAVEL RJ, 1973, J CLIN INVEST, V52, P32, DOI 10.1172/JCI107171; HEDRICK CC, 1993, J BIOL CHEM, V268, P20676; Hedrick CC, 2001, J LIPID RES, V42, P563; Hime NJ, 2006, J LIPID RES, V47, P115, DOI 10.1194/jlr.M500284-JLR200; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; ITO Y, 1990, SCIENCE, V249, P790, DOI 10.1126/science.2167514; Julve J, 2000, BBA-MOL CELL BIOL L, V1488, P233, DOI 10.1016/S1388-1981(00)00127-X; Julve-Gil J, 1999, METABOLISM, V48, P415, DOI 10.1016/S0026-0495(99)90097-5; Kalopissis AD, 2003, CURR OPIN LIPIDOL, V14, P165, DOI 10.1097/00041433-200304000-00008; Kim S, 2004, DIABETES, V53, pS66, DOI 10.2337/diabetes.53.2007.S66; Klos KL, 2001, ARTERIOSCL THROM VAS, V21, P971, DOI 10.1161/01.ATV.21.6.971; Lara-Castro C, 2005, OBES RES, V13, P507, DOI 10.1038/oby.2005.53; LEBOEUF RC, 1983, J BIOL CHEM, V258, P5063; LEBOEUF RC, 1990, J LIPID RES, V31, P91; Lowenstein J M, 1975, Methods Enzymol, V35, P279, DOI 10.1016/0076-6879(75)35165-3; MAGILL P, 1982, EUR J CLIN INVEST, V12, P113, DOI 10.1111/j.1365-2362.1982.tb00947.x; Mahley RW, 2007, J CLIN INVEST, V117, P94, DOI 10.1172/JCI30889; MAO SJT, 1981, FEBS LETT, V132, P289, DOI 10.1016/0014-5793(81)81181-7; MarzalCasacuberta A, 1996, J BIOL CHEM, V271, P6720, DOI 10.1074/jbc.271.12.6720; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; MEHRABIAN M, 1993, ARTERIOSCLER THROMB, V13, P1, DOI 10.1161/01.ATV.13.1.1; MILLS JL, 1992, J PEDIATR-US, V120, P863, DOI 10.1016/S0022-3476(05)81951-1; MUSLINER TA, 1988, J LIPID RES, V29, P349; OLUBADEWO J, 1983, J BIOL CHEM, V258, P938; Packard CJ, 2000, J LIPID RES, V41, P305; Pajukanta P, 2004, NAT GENET, V36, P371, DOI 10.1038/ng1320; PILGER E, 1983, ARTERIOSCLEROSIS, V3, P57, DOI 10.1161/01.ATV.3.1.57; PUPPIONE DL, 1994, LIPIDS, V29, P595, DOI 10.1007/BF02536633; Redlich CA, 1996, AM J RESP CRIT CARE, V154, P1436, DOI 10.1164/ajrccm.154.5.8912761; Ribeiro A, 1999, J BIOL CHEM, V274, P1216, DOI 10.1074/jbc.274.3.1216; ROSSENEU M, 1981, ACTA CARDIOL, P11; Rye KA, 2003, J BIOL CHEM, V278, P22530, DOI 10.1074/jbc.M213250200; Savage DB, 2005, HYPERTENSION, V45, P828, DOI 10.1161/01.HYP.0000163475.04421.e4; Schernthaner GH, 2005, SCAND J CLIN LAB INV, V65, P30, DOI 10.1080/00365510500236119; SCHONFELD G, 1978, LIPIDS, V13, P951, DOI 10.1007/BF02533855; SCHULTZ JR, 1993, NATURE, V365, P762, DOI 10.1038/365762a0; Sharrett AR, 2001, CIRCULATION, V104, P1108, DOI 10.1161/hc3501.095214; SHILLABEER G, 1992, J LIPID RES, V33, P31; SOLERARGILAGA C, 1977, ARCH BIOCHEM BIOPHYS, V178, P135, DOI 10.1016/0003-9861(77)90177-1; Tailleux A, 2002, ATHEROSCLEROSIS, V164, P1, DOI 10.1016/S0021-9150(01)00751-1; Tall AR, 1998, EUR HEART J, V19, pA31; Ting HJ, 2007, CIRC RES, V100, P381, DOI 10.1161/01.RES.0000258023.76515.a3; TOZUKA M, 1992, BIOCHIM BIOPHYS ACTA, V1165, P61, DOI 10.1016/0005-2760(92)90076-8; Turpeinen AK, 1999, DIABETES, V48, P1245, DOI 10.2337/diabetes.48.6.1245; van't Hooft FM, 2001, CIRCULATION, V104, P1223, DOI 10.1161/hc3601.095709; Vohl MC, 1997, ATHEROSCLEROSIS, V128, P183, DOI 10.1016/S0021-9150(96)05985-0; WARDEN CH, 1993, SCIENCE, V261, P469, DOI 10.1126/science.8332912; WARDEN CH, 1993, P NATL ACAD SCI USA, V90, P10886, DOI 10.1073/pnas.90.22.10886; Weng W, 1996, P NATL ACAD SCI USA, V93, P14788, DOI 10.1073/pnas.93.25.14788; Zammit VA, 2002, ANN NY ACAD SCI, V967, P52; ZHONG SB, 1994, J CLIN INVEST, V94, P2457, DOI 10.1172/JCI117614	87	63	65	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11633	11644		10.1074/jbc.M708995200	http://dx.doi.org/10.1074/jbc.M708995200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18160395	Green Published, hybrid			2022-12-25	WOS:000255067400064
J	Mozzo, M; Dall'Osto, L; Hienerwadel, R; Bassi, R; Croce, R				Mozzo, Milena; Dall'Osto, Luca; Hienerwadel, Rainer; Bassi, Roberto; Croce, Roberta			Photoprotection in the antenna complexes of photosystem II - Role of individual xanthophylls in chlorophyll triplet quenching	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; NONPHOTOCHEMICAL ENERGY-DISSIPATION; FEMTOSECOND TRANSIENT ABSORPTION; HIGHER-PLANTS; BINDING-SITE; SINGLET-OXYGEN; BETA-CAROTENE; LHCII; FLUORESCENCE; ARABIDOPSIS	In this work the photoprotective role of all xanthophylls in LHCII, Lhcb4, and Lhcb5 is investigated by laser-induced Triplet-minus-Singlet (TmS) spectroscopy. The comparison of native LHCII trimeric complexes with different carotenoid composition shows that the xanthophylls in sites V1 and N1 do not directly contribute to the chlorophyll triplet quenching. The largest part of the triplets is quenched by the lutein bound in site L1, which is located in close proximity to the chlorophylls responsible for the low energy state of the complex. The lutein in the L2 site is also active in triplet quenching, and it shows a longer triplet lifetime than the lutein in the L1 site. This lifetime difference depends on the occupancy of the N1 binding site, where neoxanthin acts as an oxygen barrier, limiting the access of O-2 to the inner domain of the Lhc complex, thereby strongly contributing to the photostability. The carotenoid triplet decay of monomeric Lhcb1, Lhcb4, and Lhcb5 is mono-exponential, with shorter lifetimes than observed for trimeric LHCII, suggesting that their inner domains are more accessible for O2. As for trimeric LHCII, only the xanthophylls in sites L1 and L2 are active in triplet quenching. Although the chlorophyll to carotenoid triplet transfer is efficient (95%) in all complexes, it is not perfect, leaving 5% of the chlorophyll triplets unquenched. This effect appears to be intrinsically related to the molecular organization of the Lhcb proteins.	[Mozzo, Milena; Croce, Roberta] Univ Groningen, Groningen Bimol Sci & Biotechnol Inst, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands; [Mozzo, Milena] Ist Biofis Consiglio Nazl Ric, I-38100 Trento, Italy; [Dall'Osto, Luca; Bassi, Roberto] Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; [Hienerwadel, Rainer] Univ Aix Marseille 2, Fac Sci Luminy, LGBP Dept Biol, F-13288 Marseille, France	University of Groningen; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Verona; UDICE-French Research Universities; Aix-Marseille Universite	Croce, R (corresponding author), Univ Groningen, Groningen Bimol Sci & Biotechnol Inst, Dept Biophys Chem, NL-9747 AG Groningen, Netherlands.	R.Croce@rug.nl	Croce, Roberta/HGU-9554-2022; Croce, Roberta/F-1174-2014; Croce, Roberta/ABG-3595-2021; Croce, Roberta/N-4067-2014; Dall'Osto, Luca/A-9384-2010	Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Croce, Roberta/0000-0003-3469-834X; Dall'Osto, Luca/0000-0001-9497-5156; bassi, roberto/0000-0002-4140-8446				ANDERSSON PO, 1991, PHOTOCHEM PHOTOBIOL, V54, P353, DOI 10.1111/j.1751-1097.1991.tb02027.x; Barzda V, 1998, BIOCHEMISTRY-US, V37, P546, DOI 10.1021/bi972123a; Barzda V, 2000, BIOCHEMISTRY-US, V39, P10468, DOI 10.1021/bi992826n; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V936, P29, DOI 10.1016/0005-2728(88)90248-4; BENSASSON RV, 1983, CONTRIBUTIONS CHEM B, V21, P836; Caffarri S, 2001, J BIOL CHEM, V276, P35924, DOI 10.1074/jbc.M105199200; Caffarri S, 2007, FEBS LETT, V581, P4704, DOI 10.1016/j.febslet.2007.08.066; Carbonera D, 1992, APPL MAGN RESON, V3, P859, DOI 10.1007/BF03260117; CHAUVET JP, 1985, PHOTOCHEM PHOTOBIOL, V41, P83, DOI 10.1111/j.1751-1097.1985.tb03452.x; Connelly JP, 1997, BIOCHEMISTRY-US, V36, P281, DOI 10.1021/bi962467l; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2003, BIOPHYS J, V84, P2517, DOI 10.1016/S0006-3495(03)75057-7; Croce R, 2002, BIOCHEMISTRY-US, V41, P7334, DOI 10.1021/bi0257437; Croce R, 2000, PHOTOSYNTH RES, V64, P221, DOI 10.1023/A:1006455230379; Croce R, 2001, BIOPHYS J, V80, P901, DOI 10.1016/S0006-3495(01)76069-9; Croce R, 2007, BIOCHEMISTRY-US, V46, P3846, DOI 10.1021/bi602531k; DAINESE P, 1990, PHOTOCHEM PHOTOBIOL, V51, P693, DOI 10.1111/php.1990.51.6.693; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; Damjanovic A, 1999, PHYS REV E, V59, P3293, DOI 10.1103/PhysRevE.59.3293; Demmig-Adams B., 1989, PHOTOSYNTHESIS PLANT, V8; DEXTER DL, 1953, J CHEM PHYS, V21, P836, DOI 10.1063/1.1699044; FARMILO A, 1973, PHOTOCHEM PHOTOBIOL, V18, P447, DOI 10.1111/j.1751-1097.1973.tb06448.x; Fiore A, 2006, FEBS LETT, V580, P4718, DOI 10.1016/j.febslet.2006.07.055; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; Frank HA, 2001, BIOCHEMISTRY-US, V40, P1220, DOI 10.1021/bi001160q; FUJIMORI E, 1957, NATURE, V180, P1036, DOI 10.1038/1801036a0; Gastaldelli M, 2003, J BIOL CHEM, V278, P19190, DOI 10.1074/jbc.M212125200; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Gradinaru CC, 2000, J PHYS CHEM B, V104, P9330, DOI 10.1021/jp001752i; Havaux M, 1999, P NATL ACAD SCI USA, V96, P8762, DOI 10.1073/pnas.96.15.8762; Havaux M, 2007, PLANT PHYSIOL, V145, P1506, DOI 10.1104/pp.107.108480; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Jhutti CS, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P491; Johnson MP, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702831200; Kleima FJ, 1999, BIOCHEMISTRY-US, V38, P6587, DOI 10.1021/bi982823v; KNOX JP, 1985, PLANTA, V164, P30, DOI 10.1007/BF00391022; KOYAMA Y, 1991, J PHOTOCH PHOTOBIO B, V9, P265; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Lampoura SS, 2002, BIOCHEMISTRY-US, V41, P9139, DOI 10.1021/bi025724x; LAND EJ, 1971, PHOTOCHEM PHOTOBIOL, V13, P311, DOI 10.1111/j.1751-1097.1971.tb06119.x; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; MATHIS P, 1967, CR HEBD ACAD SCI, V15, P1903; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; NAGAI K, 1987, METHOD ENZYMOL, V153, P461; Naqvi KR, 1997, SPECTROCHIM ACTA A, V53, P2659, DOI 10.1016/S1386-1425(97)00160-1; NECHUSHTAI R, 1988, J PHYS CHEM-US, V92, P1165, DOI 10.1021/j100316a033; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Novoderezhkin VI, 2005, J PHYS CHEM B, V109, P10493, DOI 10.1021/jp044082f; PAULSEN H, 1993, EUR J BIOCHEM, V215, P809, DOI 10.1111/j.1432-1033.1993.tb18096.x; Peterman EJG, 1997, BIOCHEMISTRY-US, V36, P12208, DOI 10.1021/bi9711689; Peterman EJG, 1995, BIOPHYS J, V69, P2670, DOI 10.1016/S0006-3495(95)80138-4; Remelli R, 1999, J BIOL CHEM, V274, P33510, DOI 10.1074/jbc.274.47.33510; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Ruban AV, 1999, J BIOL CHEM, V274, P10458, DOI 10.1074/jbc.274.15.10458; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; Schodel R, 1998, BIOPHYS J, V75, P3143, DOI 10.1016/S0006-3495(98)77756-2; Schodel R, 1999, BIOPHYS J, V76, P2238, DOI 10.1016/S0006-3495(99)77380-7; Siefermann-Harms D, 1998, PHOTOSYNTH RES, V55, P83, DOI 10.1023/A:1005951307673; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Tardy F, 1996, J PHOTOCH PHOTOBIO B, V34, P87, DOI 10.1016/1011-1344(95)07272-1; VANDERVOS R, 1994, BBA-BIOENERGETICS, V1188, P243, DOI 10.1016/0005-2728(94)90042-6; Visser HM, 1996, CHEM PHYS, V210, P297, DOI 10.1016/0301-0104(96)00092-4; ZUCCHELLI G, 1988, J PHOTOCH PHOTOBIO B, V2, P483, DOI 10.1016/1011-1344(88)85077-2	66	155	155	4	44	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6184	6192		10.1074/jbc.M708961200	http://dx.doi.org/10.1074/jbc.M708961200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18079125	hybrid			2022-12-25	WOS:000253779500025
J	He, QY; Battistella, L; Morse, RH				He, Qiye; Battistella, Luisa; Morse, Randall H.			Mediator requirement downstream of chromatin remodeling during transcriptional activation of CHA1 in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; IN-VIVO TARGET; SACCHAROMYCES-CEREVISIAE; HISTONE H3; TERMINAL DOMAIN; INDEPENDENT RECRUITMENT; NUCLEOSOMAL DNA; REPEAT DOMAIN; PHO5 PROMOTER	Mediator complex is essential for transcription by RNA polymerase II in eukaryotes. Although chromatin remodeling is an integral part of transcriptional activation at many promoters, whether Mediator is required for this function has not been determined. Here we have used the yeast CHA1 gene to study the role of Mediator in chromatin remodeling and recruitment of the transcription machinery. We show by chromatin immunoprecipitation that Mediator subunits are recruited to the induced CHA1 promoter. Inactivation of Mediator at 37 degrees C in yeast harboring the srb4-138 (med17) ts mutation severely reduces CHA1 activation and prevents recruitment to the induced CHA1 promoter of Med18/Srb5, from the head module of Mediator, and Med14/Rgr1, which bridges the middle and tail modules. In contrast, recruitment of Med15/Gal11 from the tail module is unaffected in med17 ts yeast at 37 degrees C. Recruitment of TATA-binding protein (TBP) is severely compromised in the absence of functional Mediator, whereas Kin28 and polymerase II recruitment are reduced but to a lesser extent. Induced levels of histone H3K4me3 at the CHA1 promoter are not diminished by inactivation of Mediator, whereas recruitment of Paf1 and of Ser(2)- and Ser(5)- phosphorylated forms of Rbp1 are reduced but not eliminated. Loss of histone H3 from the induced CHA1 promoter is seen in wild type yeast but is greatly reduced by loss of intact Mediator. In contrast, Swi/Snf recruitment and nucleosome remodeling are unaffected by loss of Mediator function. Thus, Mediator is required for recruitment of the transcription machinery subsequent to chromatin remodeling during CHA1 induction.	[He, Qiye; Morse, Randall H.] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA; [Battistella, Luisa; Morse, Randall H.] New York State Dept Hlth, Wadsworth Ctr, Lab Dev Genet, Albany, NY 12201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; Wadsworth Center	Morse, RH (corresponding author), Wadsworth Ctr, PO Box 22002, Albany, NY 12201 USA.	randall.morse@wadsworth.org		Morse, Randall/0000-0003-0000-8718				Adkins MW, 2006, MOL CELL, V21, P405, DOI 10.1016/j.molcel.2005.12.010; Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Asturias FJ, 1999, SCIENCE, V283, P985, DOI 10.1126/science.283.5404.985; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; BORNAES C, 1993, MOL CELL BIOL, V13, P7604, DOI 10.1128/MCB.13.12.7604; BORNAES C, 1992, GENETICS, V131, P531; Boube M, 2002, CELL, V110, P143, DOI 10.1016/S0092-8674(02)00830-9; Bryant GO, 2003, MOL CELL, V11, P1301, DOI 10.1016/S1097-2765(03)00144-8; Cairns BR, 1996, CELL, V87, P1249, DOI 10.1016/S0092-8674(00)81820-6; CISMOWSKI MJ, 1995, MOL CELL BIOL, V15, P2983; Davis JA, 2002, MOL CELL, V10, P409, DOI 10.1016/S1097-2765(02)00598-1; Dotson MR, 2000, P NATL ACAD SCI USA, V97, P14307, DOI 10.1073/pnas.260489497; Erkina TY, 2006, MOL CELL BIOL, V26, P7587, DOI 10.1128/MCB.00666-06; Fan XC, 2006, NAT STRUCT MOL BIOL, V13, P117, DOI 10.1038/nsmb1049; Gaudreau L, 1997, CELL, V89, P55, DOI 10.1016/S0092-8674(00)80182-8; Gavin IM, 1997, EMBO J, V16, P6263, DOI 10.1093/emboj/16.20.6263; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; GODDE JS, 1995, NUCLEIC ACIDS RES, V23, P4557, DOI 10.1093/nar/23.22.4557; Govind CK, 2007, MOL CELL, V25, P31, DOI 10.1016/j.molcel.2006.11.020; Govind CK, 2005, MOL CELL BIOL, V25, P5626, DOI 10.1128/MCB.25.13.5626-5638.2005; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guglielmi B, 2004, NUCLEIC ACIDS RES, V32, P5379, DOI 10.1093/nar/gkh878; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Han SJ, 1999, MOL CELL BIOL, V19, P979; Hertel CB, 2005, MOL CELL BIOL, V25, P10755, DOI 10.1128/MCB.25.24.10755-10767.2005; HILL J, 1991, NUCLEIC ACIDS RES, V19, P5791, DOI 10.1093/nar/19.20.5791; Holmberg S, 1996, GENETICS, V144, P467; Holstege FCP, 1998, CELL, V95, P717, DOI 10.1016/S0092-8674(00)81641-4; IMBALZANO AN, 1994, NATURE, V370, P481, DOI 10.1038/370481a0; Jessen WJ, 2006, NAT STRUCT MOL BIOL, V13, P256, DOI 10.1038/nsmb1062; KENT NA, 1993, NUCLEIC ACIDS RES, V21, P4653, DOI 10.1093/nar/21.19.4653; Kim SJ, 2005, MOL CELL BIOL, V25, P11171, DOI 10.1128/MCB.25.24.11171-11183.2005; KIM YJ, 1994, CELL, V77, P599, DOI 10.1016/0092-8674(94)90221-6; Kim YJ, 2005, TRENDS BIOCHEM SCI, V30, P245, DOI 10.1016/j.tibs.2005.03.010; Koh SS, 1998, MOL CELL, V1, P895, DOI 10.1016/S1097-2765(00)80088-X; KOLESKE AJ, 1994, NATURE, V368, P466, DOI 10.1038/368466a0; KOLESKE AJ, 1992, CELL, V69, P883, DOI 10.1016/0092-8674(92)90298-Q; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Krebs JE, 2000, CELL, V102, P587, DOI 10.1016/S0092-8674(00)00081-7; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Kuo MH, 1999, METHODS, V19, P425, DOI 10.1006/meth.1999.0879; Kuras L, 2003, P NATL ACAD SCI USA, V100, P13887, DOI 10.1073/pnas.2036346100; Kuras L, 1999, NATURE, V399, P609, DOI 10.1038/21239; LAYBOURN PJ, 1990, J BIOL CHEM, V265, P13165; Lee D, 1998, NATURE, V393, P389, DOI 10.1038/30770; Lee DK, 1999, GENE DEV, V13, P2934, DOI 10.1101/gad.13.22.2934; Lemieux K, 2004, EMBO J, V23, P4040, DOI 10.1038/sj.emboj.7600416; Leroy C, 2006, MOL CELL BIOL, V26, P3149, DOI 10.1128/MCB.26.8.3149-3163.2006; Li XY, 1999, NATURE, V399, P605, DOI 10.1038/21232; Linder T, 2006, BIOCHEM BIOPH RES CO, V349, P948, DOI 10.1016/j.bbrc.2006.08.099; LU H, 1991, P NATL ACAD SCI USA, V88, P10004, DOI 10.1073/pnas.88.22.10004; Martens JA, 2005, GENE DEV, V19, P2695, DOI 10.1101/gad.1367605; Martens JA, 2002, GENE DEV, V16, P2231, DOI 10.1101/gad.1009902; Moreira JMA, 1999, EMBO J, V18, P2836, DOI 10.1093/emboj/18.10.2836; Moreira JMA, 1998, EMBO J, V17, P6028, DOI 10.1093/emboj/17.20.6028; Morse RH, 2003, BIOCHEM CELL BIOL, V81, P101, DOI 10.1139/o03-039; Myers LC, 1999, P NATL ACAD SCI USA, V96, P67, DOI 10.1073/pnas.96.1.67; Myers LC, 1998, GENE DEV, V12, P45, DOI 10.1101/gad.12.1.45; Natarajan K, 1999, MOL CELL, V4, P657, DOI 10.1016/S1097-2765(00)80217-8; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; NONET ML, 1989, GENETICS, V123, P715; Paule MR, 2000, NUCLEIC ACIDS RES, V28, P1283, DOI 10.1093/nar/28.6.1283; Phatnani HP, 2006, GENE DEV, V20, P2922, DOI 10.1101/gad.1477006; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Qiu HF, 2004, MOL CELL BIOL, V24, P4104, DOI 10.1128/MCB.24.10.4104-4117.2004; Reinke H, 2003, MOL CELL, V11, P1599, DOI 10.1016/S1097-2765(03)00186-2; Roeder RG, 1998, COLD SPRING HARB SYM, V63, P201, DOI 10.1101/sqb.1998.63.201; Ryan MP, 1998, MOL CELL BIOL, V18, P1774, DOI 10.1128/MCB.18.4.1774; Ryan MP, 2000, MOL CELL BIOL, V20, P5847, DOI 10.1128/MCB.20.16.5847-5857.2000; Sabet N, 2003, P NATL ACAD SCI USA, V100, P4084, DOI 10.1073/pnas.0637524100; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sato S, 2004, MOL CELL, V14, P685, DOI 10.1016/j.molcel.2004.05.006; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Sertil O, 2007, MOL CELL BIOL, V27, P2037, DOI 10.1128/MCB.02297-06; Sharma VM, 2003, GENE DEV, V17, P502, DOI 10.1101/gad.1039503; Takagi Y, 2006, J BIOL CHEM, V281, P80, DOI 10.1074/jbc.M508253200; Takagi Y, 2006, MOL CELL, V23, P355, DOI 10.1016/j.molcel.2006.06.007; THOMPSON CM, 1993, CELL, V73, P1361, DOI 10.1016/0092-8674(93)90362-T; THOMPSON CM, 1995, P NATL ACAD SCI USA, V92, P4587, DOI 10.1073/pnas.92.10.4587; TSANG SS, 1993, BIOTECHNIQUES, V14, P380; VALAY JG, 1995, J MOL BIOL, V249, P535, DOI 10.1006/jmbi.1995.0316; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Wilson CJ, 1996, CELL, V84, P235, DOI 10.1016/S0092-8674(00)80978-2; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yoon S, 2003, MOL CELL BIOL, V23, P8829, DOI 10.1128/MCB.23.23.8829-9945.2003; Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178; Zhang F, 2004, MOL CELL BIOL, V24, P6871, DOI 10.1128/mcb.24.15.6871-6886.2004	90	23	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5276	5286		10.1074/jbc.M708266200	http://dx.doi.org/10.1074/jbc.M708266200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18093974	hybrid			2022-12-25	WOS:000253426700007
J	Schubert, SW; Lamoureux, N; Kilian, K; Klein-Hitpass, L; Hashemolhosseini, S				Schubert, Steffen Wolfgang; Lamoureux, Nicolas; Kilian, Karin; Klein-Hitpass, Ludger; Hashemolhosseini, Said			Identification of integrin-alpha 4, Rb1, and syncytin a as murine placental target genes of the transcription factor GCMa/Gcm1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING DOMAIN; GLIAL PROMOTING FACTOR; CELL-DIFFERENTIATION; GCM PROTEINS; DROSOPHILA; EXPRESSION; SWITCH; MOUSE; GLIOGENESIS; GLIDE/GCM	Members of the GCM( glial cells missing) transcription factor family have been shown to act as master regulators in different cells during mammalian and fly development being responsible for processes including gliogenesis, hematopoiesis, placental formation, and development of the parathyroidea. In the central nervous system of flies, several target genes for GCM have been reported, namely repo, pointed, and tramtrack. In mammals, two GCM genes are known (GCMa and GCMb), but the knowledge of their target genes is very limited. Here, we present for the first time a global approach aimed to identify GCMa target genes. We found 66 genes up-regulated and 11 genes down-regulated in GCMa-deficient chorionic tissue of mice at embryonic day 9.5. Moreover, we verified by quantitative reverse transcription-PCR all 11 down-regulated genes. The two most strongly down-regulated genes, integrin-alpha 4 and retinoblastoma (Rb1), were further analyzed by promoter studies. Additionally, we identified down-regulation of the murine syncytin A gene, which is fundamental for syncytiotrophoblast formation. Finally, we proved strong down-regulation of integrin-alpha 4 and Rb1 transcript levels by in situ hybridization in murine GCMa-deficient placentae at embryonic day 9.5. Our data demonstrate for the first time that genes encoding key regulators of placental tissue formation and architecture are regulated by GCMa.	[Schubert, Steffen Wolfgang; Lamoureux, Nicolas; Kilian, Karin; Hashemolhosseini, Said] Univ Erlangen Nurnberg, Emil Fisher Zentrum, Inst Biochem, D-91054 Erlangen, Germany; [Klein-Hitpass, Ludger] Univ Essen Gesamthsch, Inst Zellbiol, D-45122 Essen, Germany	University of Erlangen Nuremberg; University of Duisburg Essen	Schubert, SW (corresponding author), Univ Erlangen Nurnberg, Emil Fisher Zentrum, Inst Biochem, Fahrstr 17, D-91054 Erlangen, Germany.	sh@biochem.uni-erlangen.de	Hashemolhosseini, Said/N-2464-2013	Hashemolhosseini, Said/0000-0002-6564-5649				*AFF, AFF EXPR S2 MAN; Akiyama Y, 1996, P NATL ACAD SCI USA, V93, P14912, DOI 10.1073/pnas.93.25.14912; Alfonso TB, 2002, DEV BIOL, V248, P369, DOI 10.1006/dbio.2002.0740; Anson-Cartwright L, 2000, NAT GENET, V25, P311, DOI 10.1038/77076; Chen CP, 2004, PLACENTA, V25, P413, DOI 10.1016/j.placenta.2003.10.014; Chotard C, 2005, NEURON, V48, P237, DOI 10.1016/j.neuron.2005.09.019; Cohen SX, 2003, EMBO J, V22, P1835, DOI 10.1093/emboj/cdg182; Cohen SX, 2002, FEBS LETT, V528, P95, DOI 10.1016/S0014-5793(02)03257-X; Colonques J, 2007, MECH DEVELOP, V124, P327, DOI 10.1016/j.mod.2007.01.004; Cross JC, 2002, RECENT PROG HORM RES, V57, P221, DOI 10.1210/rp.57.1.221; Dupressoir A, 2005, P NATL ACAD SCI USA, V102, P725, DOI 10.1073/pnas.0406509102; Egger B, 2002, DEVELOPMENT, V129, P3295; Fujito Naoya, 2006, Hiroshima Journal of Medical Sciences, V55, P9; Gong R, 2007, CELL PHYSIOL BIOCHEM, V20, P517, DOI 10.1159/000107535; Granderath S, 2000, MECH DEVELOP, V91, P197, DOI 10.1016/S0925-4773(99)00304-4; Gunther T, 2000, NATURE, V406, P199, DOI 10.1038/35018111; Hashemolhosseini S, 2004, J MOL BIOL, V336, P441, DOI 10.1016/j.jmb.2003.12.029; Hashemolhosseini S, 2002, MECH DEVELOP, V118, P175, DOI 10.1016/S0925-4773(02)00239-3; Hashemothosseini S, 2004, J CELL BIOL, V166, P765, DOI 10.1083/jcb.200406097; HOSOYA T, 1995, CELL, V82, P1025, DOI 10.1016/0092-8674(95)90281-3; Iwasaki Y, 2003, DEVELOPMENT, V130, P6027, DOI 10.1242/dev.00822; JONES BW, 1995, CELL, V82, P1013, DOI 10.1016/0092-8674(95)90280-5; Kammerer M, 2001, EMBO J, V20, P4664, DOI 10.1093/emboj/20.17.4664; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee BP, 2005, MECH DEVELOP, V122, P849, DOI 10.1016/j.mod.2005.01.002; Lee X, 2001, PLACENTA, V22, P808, DOI 10.1053/plac.2001.0722; Miller AA, 1998, EMBO J, V17, P6316, DOI 10.1093/emboj/17.21.6316; Schreiber J, 2000, MOL CELL BIOL, V20, P2466, DOI 10.1128/MCB.20.7.2466-2474.2000; Schreiber J, 1997, P NATL ACAD SCI USA, V94, P4739, DOI 10.1073/pnas.94.9.4739; Schreiber J, 1998, NUCLEIC ACIDS RES, V26, P2337, DOI 10.1093/nar/26.10.2337; Schubert SW, 2004, J BIOL CHEM, V279, P50358, DOI 10.1074/jbc.M404587200; Sengbusch JK, 2002, J CELL BIOL, V157, P873, DOI 10.1083/jcb.200203075; Soustelle L, 2004, DEVELOPMENT, V131, P4521, DOI 10.1242/dev.01290; Spencer C, 2005, GENE EXPR PATTERNS, V5, P687, DOI 10.1016/j.modgep.2005.02.003; Stecca B, 2002, MECH DEVELOP, V115, P27, DOI 10.1016/S0925-4773(02)00095-3; Vincent S, 1996, DEVELOPMENT, V122, P131; Wu LZ, 2003, NATURE, V421, P942, DOI 10.1038/nature01417; Yamada K, 1999, J BIOL CHEM, V274, P32279, DOI 10.1074/jbc.274.45.32279; YANG JT, 1995, DEVELOPMENT, V121, P549; Yu CC, 2002, J BIOL CHEM, V277, P50062, DOI 10.1074/jbc.M209316200; Yuasa Y, 2003, DEVELOPMENT, V130, P2419, DOI 10.1242/dev.00468	41	20	22	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5460	5465		10.1074/jbc.M710110200	http://dx.doi.org/10.1074/jbc.M710110200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167345	hybrid			2022-12-25	WOS:000253426700026
J	Chen, C; Krausz, KW; Idle, JR; Gonzalez, FJ				Chen, Chi; Krausz, Kristopher W.; Idle, Jeffrey R.; Gonzalez, Frank J.			Identification of novel toxicity-associated metabolites by metabolomics and mass isotopomer analysis of acetaminophen metabolism in wild-type and Cyp2e1-null mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PERMEABILITY TRANSITION; ALCOHOL-MEDIATED INCREASES; ACUTE LIVER-FAILURE; OXIDATIVE STRESS; RAT-LIVER; INDUCED HEPATOTOXICITY; CATECHOL METABOLITES; HEPATIC GLUTATHIONE; MOUSE HEPATOCYTES; COVALENT BINDING	CYP2E1 is recognized as the most important enzyme for initiation of acetaminophen ( APAP)-induced toxicity. In this study, the resistance of Cyp2e1-null mice to APAP treatment was confirmed by comparing serum aminotransferase activities and blood urea nitrogen levels in wild-type and Cyp2e1-null mice. However, unexpectedly, profiling of major known APAP metabolites in urine and serum revealed that the contribution of CYP2E1 to APAP metabolism decreased with increasing APAP doses administered. Measurement of hepatic glutathione and hydrogen peroxide levels exposed the importance of oxidative stress in determining the consequence of APAP overdose. Subsequent metabolomic analysis was capable of constructing a principal components analysis (PCA) model that delineated a relationship between urinary metabolomes and the responses to APAP treatment. Urinary ions high in wild-type mice treated with 400 mg/kg APAP were elucidated as 3-methoxy-APAP glucuronide (VII) and three novel APAP metabolites, including S-(5-acetylamino-2-hydroxyphenyl) mercaptopyruvic acid ( VI, formed by a Cys-APAP transamination reaction in kidney), 3,3'-biacetaminophen (VIII, an APAP dimer), and a benzothiazine compound (IX, originated from deacetylated APAP), through mass isotopomer analysis, accurate mass measurement, tandem mass spectrometry fragmentation, in vitro reactions, and chemical treatments. Dose-, time-, and genotype-dependent appearance of these minor APAP metabolites implied their association with the APAP-induced toxicity and potential biomarker application. Overall, the oxidative stress elicited by CYP2E1-mediated APAP metabolism might significantly contribute to APAP-induced toxicity. The combination of genetically modified animal models, mass isotopomer analysis, and metabolomics provides a powerful and efficient technical platform to characterize APAP-induced toxicity through identifying novel biomarkers and unraveling novel mechanisms.	[Chen, Chi; Krausz, Kristopher W.; Gonzalez, Frank J.] NCI, NIH, Lab Metab, Ctr Canc Res, Bethesda, MD 20892 USA; [Idle, Jeffrey R.] Charles Univ Prague, Inst Pharmacol, Fac Med 1, Prague 12800, Czech Republic	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Charles University Prague	Gonzalez, FJ (corresponding author), NCI, NIH, Lab Metab, Ctr Canc Res, 37 Convert Dr, Bethesda, MD 20892 USA.	fjgonz@helix.nih.gov	Chen, Chi/B-4618-2008; Chen, Chi/AAF-5343-2020; Idle, Jeff/B-1152-2012	Chen, Chi/0000-0001-9703-604X; Idle, Jeff/0000-0002-6143-1520	Intramural NIH HHS [Z01 BC005562-19] Funding Source: Medline; NATIONAL CANCER INSTITUTE [Z01BC005562, ZIABC005562] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Amacher DE, 1998, REGUL TOXICOL PHARM, V27, P119, DOI 10.1006/rtph.1998.1201; Anandatheerthavarada HK, 1997, ARCH BIOCHEM BIOPHYS, V339, P136, DOI 10.1006/abbi.1996.9855; BALES JR, 1984, CLIN CHEM, V30, P1631; Boutis K, 2001, J TOXICOL-CLIN TOXIC, V39, P441, DOI 10.1081/CLT-100105413; Chen C, 2007, DRUG METAB REV, V39, P581, DOI 10.1080/03602530701497804; Chen C, 2007, CHEM RES TOXICOL, V20, P531, DOI 10.1021/tx600320w; Chen C, 2006, J PHARMACOL EXP THER, V318, P1330, DOI 10.1124/jpet.106.105213; Chen WQ, 1998, CHEM RES TOXICOL, V11, P295, DOI 10.1021/tx9701687; Cheung C, 2005, DRUG METAB DISPOS, V33, P449, DOI 10.1124/dmd.104.002402; CHRISTEN P, 1990, ANN NY ACAD SCI, V585, P331, DOI 10.1111/j.1749-6632.1990.tb28065.x; Coen M, 2004, J PHARMACEUT BIOMED, V35, P93, DOI 10.1016/j.jpba.2003.12.019; Coen M, 2003, CHEM RES TOXICOL, V16, P295, DOI 10.1021/tx0256127; Cohen S. D., 1998, TOXICOLOGY LIVER, P159; DAHLIN DC, 1984, P NATL ACAD SCI-BIOL, V81, P1327, DOI 10.1073/pnas.81.5.1327; EKLIND KI, 1990, CARCINOGENESIS, V11, P2033, DOI 10.1093/carcin/11.11.2033; EKSTROM G, 1989, BIOCHEM PHARMACOL, V38, P1313, DOI 10.1016/0006-2952(89)90338-9; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Ferret PJ, 2001, HEPATOLOGY, V33, P1173, DOI 10.1053/jhep.2001.24267; FORTE AJ, 1984, DRUG METAB DISPOS, V12, P484; Giri S, 2006, CHEM RES TOXICOL, V19, P818, DOI 10.1021/tx0600402; GORSKY LD, 1984, J BIOL CHEM, V259, P6812; GRIFFITH OW, 1985, P NATL ACAD SCI USA, V82, P4668, DOI 10.1073/pnas.82.14.4668; Guo GL, 2004, TOXICOL SCI, V82, P374, DOI 10.1093/toxsci/kfh286; HART SGE, 1995, FUND APPL TOXICOL, V24, P260, DOI 10.1006/faat.1995.1029; HARVISON PJ, 1988, CHEM RES TOXICOL, V1, P47, DOI 10.1021/tx00001a009; Hinson JA, 2004, DRUG METAB REV, V36, P805, DOI 10.1081/DMR-200033494; HOLME JA, 1991, BIOCHEM PHARMACOL, V42, P1137, DOI 10.1016/0006-2952(91)90299-K; KAPLOWITZ N, 1985, ANNU REV PHARMACOL, V25, P715, DOI 10.1146/annurev.pa.25.040185.003435; Knight TR, 2002, J PHARMACOL EXP THER, V303, P468, DOI 10.1124/jpet.102.038968; KOOP DR, 1992, FASEB J, V6, P724, DOI 10.1096/fasebj.6.2.1537462; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lieber CS, 1997, PHYSIOL REV, V77, P517, DOI 10.1152/physrev.1997.77.2.517; MONKS TJ, 1990, MOL PHARMACOL, V38, P121; Nicholson JK, 2002, NAT REV DRUG DISCOV, V1, P153, DOI 10.1038/nrd728; Nicholson JK, 2003, NAT REV DRUG DISCOV, V2, P668, DOI 10.1038/nrd1157; Palumbo A, 2001, BIOCHEM J, V356, P105, DOI 10.1042/0264-6021:3560105; PATTEN CJ, 1993, CHEM RES TOXICOL, V6, P511, DOI 10.1021/tx00034a019; POTTER DW, 1987, J BIOL CHEM, V262, P974; POTTER DW, 1985, J BIOL CHEM, V260, P2174; POTTER WZ, 1974, PHARMACOLOGY, V12, P129, DOI 10.1159/000136531; Prota G, 2000, PIGM CELL RES, V13, P283, DOI 10.1034/j.1600-0749.2000.130412.x; RAUCY JL, 1989, ARCH BIOCHEM BIOPHYS, V271, P270, DOI 10.1016/0003-9861(89)90278-6; Reid AB, 2005, J PHARMACOL EXP THER, V312, P509, DOI 10.1124/jpet.104.075945; Shertzer HG, 2004, FREE RADICAL BIO MED, V36, P605, DOI 10.1016/j.freeradbiomed.2003.11.013; Sinclair J, 1998, BIOCHEM PHARMACOL, V55, P1557; SMILKSTEIN MJ, 1988, NEW ENGL J MED, V319, P1557, DOI 10.1056/NEJM198812153192401; SNAWDER JE, 1994, BIOCHEM BIOPH RES CO, V203, P532, DOI 10.1006/bbrc.1994.2215; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Stern ST, 2005, TOXICOL APPL PHARM, V202, P151, DOI 10.1016/j.taap.2004.06.030; TOMISAWA H, 1988, XENOBIOTICA, V18, P1015, DOI 10.3109/00498258809042224; Wolf KK, 2007, DRUG METAB DISPOS, V35, P1223, DOI 10.1124/dmd.107.014738; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501	53	104	107	0	26	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4543	4559		10.1074/jbc.M706299200	http://dx.doi.org/10.1074/jbc.M706299200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093979	hybrid, Green Accepted			2022-12-25	WOS:000253426500011
J	Iseli, TJ; Oakhill, JS; Bailey, MF; Wee, S; Walter, M; van Denderen, BJ; Castelli, LA; Katsis, F; Witters, LA; Stapleton, D; Macaulay, SL; Michell, BJ; Kemp, BE				Iseli, Tristan J.; Oakhill, Jonathan S.; Bailey, Michael F.; Wee, Sheena; Walter, Mark; van Denderen, Bryce J.; Castelli, Laura A.; Katsis, Frosa; Witters, Lee A.; Stapleton, David; Macaulay, S. Lance; Michell, Belinda J.; Kemp, Bruce E.			AMP-activated protein kinase subunit interactions - beta 1 :gamma 1 association requires beta 1 Thr-263 and Tyr-267	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SUBUNITS; POSTTRANSLATIONAL MODIFICATIONS; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; BATEMAN DOMAINS; BINDING; SEQUENCE; FORM	AMP-activated protein kinase (AMPK) plays multiple roles in the body's overall metabolic balance and response to exercise, nutritional stress, hormonal stimulation, and the glucose-lowering drugs metformin and rosiglitazone. AMPK consists of a catalytic alpha subunit and two non-catalytic subunits, beta and gamma, each with multiple isoforms that form active 1: 1: 1 heterotrimers. Here we show that recombinant human AMPK alpha 1 beta 1 gamma 1 expressed in insect cells is monomeric and displays specific activity and AMP responsiveness similar to rat liver AMPK. The previously determined crystal structure of the core of mammalian alpha beta gamma complex shows that beta binds alpha and gamma. Here we show that a beta 1(186-270)gamma 1 complex can form in the absence of detectable alpha subunit. Moreover, using alanine mutagenesis we show that beta 1 Thr-263 and Tyr-267 are required for beta gamma association but not alpha beta association.	[Iseli, Tristan J.; Oakhill, Jonathan S.; Wee, Sheena; Walter, Mark; van Denderen, Bryce J.; Katsis, Frosa; Michell, Belinda J.; Kemp, Bruce E.] St Vincents Inst, Fitzroy, Vic 3065, Australia; [Bailey, Michael F.; Stapleton, David] Univ Melbourne, Bio21 Mol Sci & Biotechnol Inst, Dept Biochem & Mol Biol, Melbourne, Vic 3010, Australia; [Witters, Lee A.] Dartmouth Med Sch, Dept Med, Endocrine Metab Div, Hanover, NH 03755 USA; [Witters, Lee A.] Dartmouth Med Sch, Dept Biochem, Endocrine Metab Div, Hanover, NH 03755 USA; [Castelli, Laura A.; Macaulay, S. Lance; Kemp, Bruce E.] CSIRO Mol Hlth Technologies, Parkville, Vic 3052, Australia	St. Vincent's Institute of Medical Research; University of Melbourne; Dartmouth College; Dartmouth College; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Oakhill, JS (corresponding author), St Vincents Inst, 41 Victoria Parade, Fitzroy, Vic 3065, Australia.	joakhill@svi.edu.au; bmichell@svi.edu.au	castelli, laura/C-5400-2013; Iseli, Tristan/A-9537-2012; van Denderen, Bryce/AAW-5454-2021; Oakhill, Jonathan S/F-5724-2011; Macaulay, Stuart Lance/A-6086-2008; Kemp, Bruce E/L-2633-2014; Kemp, Bruce/G-9602-2019	Oakhill, Jonathan S/0000-0002-9475-1440; Macaulay, Stuart Lance/0000-0001-5069-9516; Kemp, Bruce E/0000-0001-6735-5082; Kemp, Bruce/0000-0001-6735-5082; Wee, Sheena/0000-0003-2536-3433	NIDDK NIH HHS [DK35712] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK035712] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams J, 2004, PROTEIN SCI, V13, P155, DOI 10.1110/ps.03340004; Amodeo GA, 2007, NATURE, V449, P492, DOI 10.1038/nature06127; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; Chen ZP, 2003, DIABETES, V52, P2205, DOI 10.2337/diabetes.52.9.2205; Crute BE, 1998, J BIOL CHEM, V273, P35347, DOI 10.1074/jbc.273.52.35347; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hudson ER, 2003, CURR BIOL, V13, P861, DOI 10.1016/S0960-9822(03)00249-5; Iseli TJ, 2005, J BIOL CHEM, V280, P13395, DOI 10.1074/jbc.M412993200; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; Kemp BE, 2004, J CLIN INVEST, V113, P182, DOI 10.1172/JCI200420846; KEMP BE, 1977, J BIOL CHEM, V252, P4888; Kemp BE, 2007, STRUCTURE, V15, P1161, DOI 10.1016/j.str.2007.09.006; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Michell BJ, 1996, J BIOL CHEM, V271, P28445, DOI 10.1074/jbc.271.45.28445; Mitchelhill KI, 1997, J BIOL CHEM, V272, P24475, DOI 10.1074/jbc.272.39.24475; Nayak V, 2006, STRUCTURE, V14, P477, DOI 10.1016/j.str.2005.12.008; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Pang T, 2007, J BIOL CHEM, V282, P495, DOI 10.1074/jbc.M605790200; Polekhina G, 2003, CURR BIOL, V13, P867, DOI 10.1016/S0960-9822(03)00292-6; Rudolph MJ, 2005, BIOCHEM BIOPH RES CO, V337, P1224, DOI 10.1016/j.bbrc.2005.09.181; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scott JW, 2004, J CLIN INVEST, V113, P274, DOI 10.1172/JCI200419874; Stapleton D, 1996, J BIOL CHEM, V271, P611, DOI 10.1074/jbc.271.2.611; Suter M, 2006, J BIOL CHEM, V281, P32207, DOI 10.1074/jbc.M606357200; Taylor EB, 2006, AM J PHYSIOL-ENDOC M, V290, pE661, DOI 10.1152/ajpendo.00313.2005; Townley R, 2007, SCIENCE, V315, P1726, DOI 10.1126/science.1137503; Viana R, 2007, J BIOL CHEM, V282, P16117, DOI 10.1074/jbc.M611804200; Warden SM, 2001, BIOCHEM J, V354, P275, DOI 10.1042/0264-6021:3540275; Wong KA, 2006, J BIOL CHEM, V281, P36434, DOI 10.1074/jbc.M607410200; Woods A, 1996, J BIOL CHEM, V271, P10282, DOI 10.1074/jbc.271.17.10282; Woods A, 2003, J BIOL CHEM, V278, P28434, DOI 10.1074/jbc.M303946200; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	36	27	28	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4799	4807		10.1074/jbc.M708298200	http://dx.doi.org/10.1074/jbc.M708298200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18079111	hybrid			2022-12-25	WOS:000253426500037
J	Miyamoto, T; Oshiro, N; Yoshino, KI; Nakashima, A; Eguchi, S; Takahashi, M; Ono, Y; Kikkawa, U; Yonezawa, K				Miyamoto, Takafumi; Oshiro, Noriko; Yoshino, Ken-Ichi; Nakashima, Akio; Eguchi, Satoshi; Takahashi, Mikiko; Ono, Yoshitaka; Kikkawa, Ushio; Yonezawa, Kazuyoshi			AMP-activated protein kinase phosphorylates Golgi-specific brefeldin A resistance factor 1 at Thr(1337) to induce disassembly of Golgi apparatus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-EXCHANGE FACTOR; RICH AKT SUBSTRATE; MAMMALIAN TARGET; CIS-GOLGI; SIGNALING PATHWAY; CELL STRUCTURE; GBF1; RAPAMYCIN; MTOR; IDENTIFICATION	Sufficiency and depletion of nutrients regulate the cellular activities through the protein phosphorylation reaction; however, many protein substrates remain to be clarified. GBF1 (Golgi-specific brefeldin A resistance factor 1), a guanine nucleotide exchange factor for the ADP-ribosylation factor family associated with the Golgi apparatus, was isolated as a phosphoprotein from the glucose-depleted cells by using the phospho-Akt-substrate antibody, which recognizes the substrate proteins of several protein kinases. The phosphorylation of GBF1 was induced by 2-deoxyglucose (2-DG), which blocks glucose utilization and increases the intracellular AMP concentration, and by AICAR, an AMP-activated protein kinase (AMPK) activator. This phosphorylation was observed in the cells expressing the constitutively active AMPK. The 2-DG-induced phosphorylation of GBF1 was suppressed by Compound C, an AMPK inhibitor, and by the overexpression of the kinase-negative AMPK. Analysis using the deletion and point mutants identified Thr(1337) as the 2-DG-induced phosphorylation site in GBF1, which is phosphorylated by AMPK in vitro. ATP depletion is known to provoke the Golgi apparatus disassembly. Immunofluorescent microscopic analysis with the Golgi markers indicated that GBF1 associates with the fragmented Golgi apparatus in the cells treated with 2-DG and AICAR. The expression of the kinase-negative AMPK and the GBF1 mutant replacing Thr(1337) by Ala prevented the 2-DG-induced Golgi disassembly. These results indicate that GBF1 is a novel AMPK substrate and that the AMPK-mediated phosphorylation of GBF1 at Thr1337 has a critical role, presumably by attenuating the function of GBF1, in the disassembly of the Golgi apparatus induced under stress conditions that lower the intracellular ATP concentration.	[Miyamoto, Takafumi; Oshiro, Noriko; Yoshino, Ken-Ichi; Nakashima, Akio; Eguchi, Satoshi; Takahashi, Mikiko; Ono, Yoshitaka; Kikkawa, Ushio; Yonezawa, Kazuyoshi] Kobe Univ, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan	Kobe University	Kikkawa, U (corresponding author), Kobe Univ, Biosignal Res Ctr, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	ukikkawa@kobe-u.ac.jp	Takahashi, Mikiko/AAH-2345-2019; Miyamoto, Takafumi/T-6950-2019	Miyamoto, Takafumi/0000-0001-9363-2864				BANTA M, 1995, BIOCHEMISTRY-US, V34, P13359, DOI 10.1021/bi00041a012; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Claude A, 1999, J CELL BIOL, V146, P71, DOI 10.1083/jcb.146.1.71; CLUETT EB, 1993, J CELL BIOL, V120, P15, DOI 10.1083/jcb.120.1.15; Colanzi A, 2007, CURR OPIN CELL BIOL, V19, P386, DOI 10.1016/j.ceb.2007.06.002; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; del Valle M, 1999, J CELL SCI, V112, P4017; Dyck JRB, 1996, J BIOL CHEM, V271, P17798, DOI 10.1074/jbc.271.30.17798; FLOTOW H, 1992, J BIOL CHEM, V267, P3074; Fujita N, 2002, J BIOL CHEM, V277, P28706, DOI 10.1074/jbc.M203668200; Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730; Garcia-Mata R, 2003, EMBO REP, V4, P320, DOI 10.1038/sj.embor.embor762; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hara K, 1997, J BIOL CHEM, V272, P26457, DOI 10.1074/jbc.272.42.26457; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kawamoto K, 2002, TRAFFIC, V3, P483, DOI 10.1034/j.1600-0854.2002.30705.x; Kemp BE, 2003, BIOCHEM SOC T, V31, P162; KEMP BE, 1991, METHOD ENZYMOL, V200, P121; Kimura N, 2003, GENES CELLS, V8, P65, DOI 10.1046/j.1365-2443.2003.00615.x; Koh H, 2007, BIOCHEM BIOPH RES CO, V362, P789, DOI 10.1016/j.bbrc.2007.08.016; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; Lee JH, 2007, NATURE, V447, P1017, DOI 10.1038/nature05828; Mandell JW, 2003, AM J PATHOL, V163, P1687, DOI 10.1016/S0002-9440(10)63525-0; Marshall S., 2006, SCI STKE, V2006, pre7; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nave BT, 1999, BIOCHEM J, V344, P427, DOI 10.1042/0264-6021:3440427; Niu TK, 2005, MOL BIOL CELL, V16, P1213, DOI 10.1091/mbc.E04-07-0599; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; PEARSON RB, 1991, METHOD ENZYMOL, V200, P62; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; RABOUILLE C, 1995, J CELL SCI, V108, P1617; Sekulic A, 2000, CANCER RES, V60, P3504; Shin HW, 2005, METHOD ENZYMOL, V404, P206, DOI 10.1016/S0076-6879(05)04020-6; Tokunaga C, 2004, BIOCHEM BIOPH RES CO, V313, P443, DOI 10.1016/j.bbrc.2003.07.019; TOOZE SA, 1990, CELL, V60, P837, DOI 10.1016/0092-8674(90)90097-X; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; WARREN G, 1993, ANNU REV BIOCHEM, V62, P323, DOI 10.1146/annurev.bi.62.070193.001543; Wiche G, 1998, J CELL SCI, V111, P2477; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	42	34	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4430	4438		10.1074/jbc.M708296200	http://dx.doi.org/10.1074/jbc.M708296200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18063581	hybrid			2022-12-25	WOS:000253083500077
J	Neumeyer, T; Schiffler, B; Maier, E; Lang, AE; Aktories, K; Benz, R				Neumeyer, Tobias; Schiffler, Bettina; Maier, Elke; Lang, Alexander E.; Aktories, Klaus; Benz, Roland			Clostridium botulinum C2 toxin - Identification of the binding site for chloroquine and related compounds and influence of the binding site on properties of the C2II channel	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID BILAYER-MEMBRANES; PERFRINGENS IOTA-TOXIN; ANTHRAX PROTECTIVE ANTIGEN; CURRENT NOISE-ANALYSIS; ADP-RIBOSYLATES ACTIN; MATRIX PROTEIN PORIN; ENZYME COMPONENT C2I; BINARY TOXIN; PHENYLALANINE CLAMP; ESCHERICHIA-COLI	Clostridium botulinum C2 toxin belongs to the family of binary AB type toxins that are structurally organized into distinct enzyme (A, C2I) and binding (B, C2II) components. The proteolytically activated 60-kDa C2II binding component is essential for C2I transport into target cells. It oligomerizes into heptamers and forms channels in lipid bilayer membranes. The C2II channel is cation-selective and can be blocked by chloroquine and related compounds. Residues 303-330 of C2II contain a conserved pattern of alternating hydrophobic and hydrophilic residues, which has been implicated in the formation of two amphipathic beta-strands involved in membrane insertion and channel formation. In the present study, C2II mutants created by substitution of different negatively charged amino acids by alanine-scanning mutagenesis were analyzed in artificial lipid bilayer membranes. The results suggested that most of the C2II mutants formed SDS-resistant oligomers (heptamers) similar to wild type. The mutated negatively charged amino acids did not influence channel properties with the exception of Glu(399) and Asp(426), which are probably localized in the vestibule near the channel entrance. These mutants show a dramatic decrease in their affinity for binding of chloroquine and its analogues. Similarly, F428A, which represents the Phi-clamp in anthrax protective antigen, was mutated in C2II in several other amino acids. The C2II mutants F428A, F428D, F428Y, and F428W not only showed altered chloroquine binding but also had drastically changed single channel properties. The results suggest that amino acids Glu(399), Asp(426), and Phe(428) have a major impact on the function of C2II as a binding protein for C2I delivery into target cells.	[Neumeyer, Tobias; Schiffler, Bettina; Maier, Elke; Benz, Roland] Univ Wurzburg, Lehrstuhl Biotechnol, Theodor Boveri Inst, D-97074 Wurzburg, Germany; [Lang, Alexander E.; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxicol, D-79104 Freiburg, Germany	University of Wurzburg; University of Freiburg	Benz, R (corresponding author), Univ Wurzburg, Lehrstuhl Biotechnol, Theodor Boveri Inst, D-97074 Wurzburg, Germany.	roland.benz@mail.uni-wuerzburg.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Benz, Roland/0000-0002-9510-9265				AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; AKTORIES K, 1992, CURR TOP MICROBIOL, V175, P97; Bachmeyer C, 2003, J MOL BIOL, V333, P527, DOI 10.1016/j.jmb.2003.08.044; Bachmeyer C, 2001, FASEB J, V15, P1658, DOI 10.1096/fj.00-0671fje; Barth H, 2000, J BIOL CHEM, V275, P18704, DOI 10.1074/jbc.M000596200; Barth H, 2002, N-S ARCH PHARMACOL, V366, P501, DOI 10.1007/s00210-002-0626-y; Barth H, 1998, INFECT IMMUN, V66, P1364, DOI 10.1128/IAI.66.4.1364-1369.1998; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1987, J MEMBRANE BIOL, V100, P12; BLAUSTEIN RO, 1989, P NATL ACAD SCI USA, V86, P2209, DOI 10.1073/pnas.86.7.2209; Blocker D, 2000, INFECT IMMUN, V68, P4566, DOI 10.1128/IAI.68.8.4566-4573.2000; Blocker D, 2003, BIOCHEMISTRY-US, V42, P5368, DOI 10.1021/bi034199e; Blocker D, 2003, J BIOL CHEM, V278, P37360, DOI 10.1074/jbc.M305849200; Blocker D, 2001, INFECT IMMUN, V69, P2980, DOI 10.1128/IAI.69.5.2980-2987.2001; Christensen KA, 2006, BIOCHEMISTRY-US, V45, P2380, DOI 10.1021/bi051830y; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; CONSIDINE RV, 1991, TOXICON, V29, P913, DOI 10.1016/0041-0101(91)90076-4; Eckhardt M, 2000, J BIOL CHEM, V275, P2328, DOI 10.1074/jbc.275.4.2328; GEIPEL U, 1989, EUR J BIOCHEM, V179, P229, DOI 10.1111/j.1432-1033.1989.tb14545.x; Gulke I, 2001, INFECT IMMUN, V69, P6004, DOI 10.1128/IAI.69.10.6004-6011.2001; Han S, 1999, NAT STRUCT BIOL, V6, P932, DOI 10.1038/13300; Knapp O, 2002, J BIOL CHEM, V277, P6143, DOI 10.1074/jbc.M103939200; Krantz BA, 2005, SCIENCE, V309, P777, DOI 10.1126/science.1113380; Leuber M, 2006, BIOCHEMISTRY-US, V45, P283, DOI 10.1021/bi051351z; Melnyk RA, 2006, P NATL ACAD SCI USA, V103, P9802, DOI 10.1073/pnas.0604000103; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; Neumeyer T, 2006, BIOCHEMISTRY-US, V45, P3060, DOI 10.1021/bi0524316; Neumeyer T, 2006, J BIOL CHEM, V281, P32335, DOI 10.1074/jbc.M606552200; OHISHI I, 1987, INFECT IMMUN, V55, P1461, DOI 10.1128/IAI.55.6.1461-1465.1987; OHISHI I, 1980, INFECT IMMUN, V30, P668; OHISHI I, 1992, INFECT IMMUN, V60, P4648, DOI 10.1128/IAI.60.11.4648-4655.1992; Orlik F, 2005, BIOPHYS J, V88, P1715, DOI 10.1529/biophysj.104.050336; Perelle S, 1997, INFECT IMMUN, V65, P1402, DOI 10.1128/IAI.65.4.1402-1407.1997; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; POPOFF MR, 1988, INFECT IMMUN, V56, P2299, DOI 10.1128/IAI.56.9.2299-2306.1988; POPOFF MR, 1988, BIOCHEM BIOPH RES CO, V152, P1361, DOI 10.1016/S0006-291X(88)80435-2; REUNER KH, 1987, EUR J CELL BIOL, V43, P134; SCHERING B, 1988, EUR J BIOCHEM, V171, P225, DOI 10.1111/j.1432-1033.1988.tb13780.x; Schleberger C, 2006, J MOL BIOL, V364, P705, DOI 10.1016/j.jmb.2006.09.002; SCHMID A, 1994, J BIOL CHEM, V269, P16706; Sellman BR, 2001, J BIOL CHEM, V276, P8371, DOI 10.1074/jbc.M008309200; SIMPSON LI, 1989, J PHARMACOL EXP THER, V251, P1223; SIMPSON LL, 1989, INFECT IMMUN, V57, P255, DOI 10.1128/IAI.57.1.255-261.1989; SIMPSON LL, 1987, INFECT IMMUN, V55, P118, DOI 10.1128/IAI.55.1.118-122.1987; VANDEKERCKHOVE J, 1988, J BIOL CHEM, V263, P696; WIEGERS W, 1991, EUR J CELL BIOL, V54, P237; Zhang S, 2004, P NATL ACAD SCI USA, V101, P16756, DOI 10.1073/pnas.0405754101; Zhang S, 2004, BIOPHYS J, V87, P3842, DOI 10.1529/biophysj.104.050864	50	33	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3904	3914		10.1074/jbc.M709807200	http://dx.doi.org/10.1074/jbc.M709807200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077455	hybrid			2022-12-25	WOS:000253083500024
J	Song, M; Basu, VP; Hanson, MN; Roques, BP; Bambara, RA				Song, Min; Basu, Vandana P.; Hanson, Mark N.; Roques, Bernard P.; Bambara, Robert A.			Proximity and branch migration mechanisms in HIV-1 minus strand strong stop DNA transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 NUCLEOCAPSID PROTEIN; VIRUS REVERSE-TRANSCRIPTASE; ACID-CHAPERONE ACTIVITY; ZINC-FINGER STRUCTURES; HUMAN-IMMUNODEFICIENCY; RNASE-H; IN-VITRO; GENOMIC RNA; CLEAVAGE SPECIFICITY; INVASION MECHANISM	Human immunodeficiency virus type 1 minus strand transfer was measured using a genomic donor-acceptor template system in vitro. Donor RNA D199, having the minimum region required for minus strong stop DNA synthesis, was previously shown to transfer with 35% efficiency to an acceptor RNA representing the 3 ' repeat region. Donor D520, having an additional 321-nucleotide segment extending into gag, transferred at 75% efficiency. In this study each transfer step was analyzed to account for the difference. Measurement of terminal transfer indicated that the 3 ' terminus of the cDNA generated using D520 is more accessible for transfer than that of D199. Nevertheless, acceptor competition experiments demonstrated that D520 has a greater preference for invasion-driven versus terminal transfer than D199. Competition mapping showed that the base of the transactivation response element is the primary invasion site for D520, important for efficient acceptor invasion. Acceptors complementary to the invasion and terminal transfer sites, but not the region between, allowed assessment of the significance of hybrid propagation by branch migration. These bipartite acceptors showed that with D520, invasion raises the local concentration of the acceptor for efficient terminal transfer by a proximity effect. However, with D199, invasion is relatively inefficient, and the cDNA 3 ' terminus is not very accessible. For most transfers that occurred, the acceptor accessed the cDNA 3 ' end by branch migration. Results suggest that both proximity and branch migration mechanisms contribute to transfers, with the proportion determined by donor-cDNA structure. D520 transfers better because it has greater accessibility for both invasion and terminus transfer.	[Song, Min; Basu, Vandana P.; Hanson, Mark N.; Bambara, Robert A.] Univ Rochester, Ctr Med, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Roques, Bernard P.] CNRS, Fac Pharm, INSERM, Dept Pharmacochim Mol & Struct,U266,UMR 8600, F-75270 Paris, France	University of Rochester; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Bambara, RA (corresponding author), Univ Rochester, Ctr Med, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	robert_bambara@urmc.rochester.edu	so, strawberry/F-6515-2012		NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049573] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM049573] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Balakrishnan M, 2003, J VIROL, V77, P4710, DOI 10.1128/JVI.77.8.4710-4721.2003; Balakrishnan M, 2001, J BIOL CHEM, V276, P36482, DOI 10.1074/jbc.M102860200; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Brule F, 2000, NUCLEIC ACIDS RES, V28, P634, DOI 10.1093/nar/28.2.634; Chen Y, 2005, J BIOL CHEM, V280, P14443, DOI 10.1074/jbc.M412190200; Chen Y, 2003, J BIOL CHEM, V278, P38368, DOI 10.1074/jbc.M305700200; Chen Y, 2003, J BIOL CHEM, V278, P8006, DOI 10.1074/jbc.M210959200; Coffin J. M., 1990, VIROLOGY, P1437; Cristofari G, 2002, PROG NUCLEIC ACID RE, V72, P223, DOI 10.1016/S0079-6603(02)72071-0; DEROCQUIGNY H, 1991, BIOCHEM BIOPH RES CO, V180, P1010, DOI 10.1016/S0006-291X(05)81166-0; DESTEFANO JJ, 1994, NUCLEIC ACIDS RES, V22, P3793, DOI 10.1093/nar/22.18.3793; DESTEFANO JJ, 1993, NUCLEIC ACIDS RES, V21, P4330, DOI 10.1093/nar/21.18.4330; DESTEFANO JJ, 1994, J MOL BIOL, V243, P558, DOI 10.1016/0022-2836(94)90030-2; DESTEFANO JJ, 1992, J VIROL, V66, P6370, DOI 10.1128/JVI.66.11.6370-6378.1992; Driscoll MD, 2000, J VIROL, V74, P8785, DOI 10.1128/JVI.74.19.8785-8792.2000; Driscoll MD, 2001, J VIROL, V75, P672, DOI 10.1128/JVI.75.2.672-686.2001; Gao L, 2007, J BIOL CHEM, V282, P6222, DOI 10.1074/jbc.M610056200; GOPALAKRISHNAN V, 1992, P NATL ACAD SCI USA, V89, P10763, DOI 10.1073/pnas.89.22.10763; GORELICK RJ, 1993, J VIROL, V67, P4027, DOI 10.1128/JVI.67.7.4027-4036.1993; GORELICK RJ, 1990, J VIROL, V64, P3207, DOI 10.1128/JVI.64.7.3207-3211.1990; Guo JH, 2000, J VIROL, V74, P8980, DOI 10.1128/JVI.74.19.8980-8988.2000; Guo JH, 2002, J VIROL, V76, P4370, DOI 10.1128/JVI.76.9.4370-4378.2002; Guo JH, 1997, J VIROL, V71, P5178, DOI 10.1128/JVI.71.7.5178-5188.1997; Hanson MN, 2006, J MOL BIOL, V363, P878, DOI 10.1016/j.jmb.2006.08.068; Hanson MN, 2005, J MOL BIOL, V353, P772, DOI 10.1016/j.jmb.2005.08.065; Heilman-Miller SL, 2004, J BIOL CHEM, V279, P44154, DOI 10.1074/jbc.M401646200; Hong MK, 2003, J MOL BIOL, V325, P1, DOI 10.1016/S0022-2836(02)01177-4; Huthoff H, 2001, RNA, V7, P143, DOI 10.1017/S1355838201001881; JACOBOMOLINA A, 1993, P NATL ACAD SCI USA, V90, P6320, DOI 10.1073/pnas.90.13.6320; KLAVER B, 1994, NUCLEIC ACIDS RES, V22, P137, DOI 10.1093/nar/22.2.137; Kulpa D, 1997, EMBO J, V16, P856, DOI 10.1093/emboj/16.4.856; LapadatTapolsky M, 1997, J MOL BIOL, V268, P250, DOI 10.1006/jmbi.1997.0978; LEE YMH, 1991, MOL CELL BIOL, V11, P1419, DOI 10.1128/MCB.11.3.1419; Levin JG, 2005, PROG NUCLEIC ACID RE, V80, P217, DOI 10.1016/S0079-6603(05)80006-6; LOBEL LI, 1985, J VIROL, V53, P447, DOI 10.1128/JVI.53.2.447-455.1985; LUO G, 1990, J VIROL, V64, P4321, DOI 10.1128/JVI.64.9.4321-4328.1990; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Negroni M, 2000, P NATL ACAD SCI USA, V97, P6385, DOI 10.1073/pnas.120520497; Negroni M, 1999, J MOL BIOL, V286, P15, DOI 10.1006/jmbi.1998.2460; Ohi Y, 2000, J VIROL, V74, P8324, DOI 10.1128/JVI.74.18.8324-8334.2000; Ooms M, 2004, NUCLEIC ACIDS RES, V32, P819, DOI 10.1093/nar/gkh206; PAILLART JC, 1994, J BIOL CHEM, V269, P27486; Paillart JC, 1996, P NATL ACAD SCI USA, V93, P5572, DOI 10.1073/pnas.93.11.5572; Palaniappan C, 1996, J BIOL CHEM, V271, P2063, DOI 10.1074/jbc.271.47.29605; Pandey VN, 1996, BIOCHEMISTRY-US, V35, P2168, DOI 10.1021/bi9516642; PELISKA JA, 1994, BIOCHEMISTRY-US, V33, P13817, DOI 10.1021/bi00250a036; PELISKA JA, 1992, SCIENCE, V258, P1112, DOI 10.1126/science.1279806; Purohit V, 2005, J BIOL CHEM, V280, P40534, DOI 10.1074/jbc.M507839200; RAMSEY CA, 1993, J VIROL, V67, P4114, DOI 10.1128/JVI.67.7.4114-4121.1993; Rein A, 1998, TRENDS BIOCHEM SCI, V23, P297, DOI 10.1016/S0968-0004(98)01256-0; Roda RH, 2003, J BIOL CHEM, V278, P31536, DOI 10.1074/jbc.M304608200; SKRIPKIN E, 1994, P NATL ACAD SCI USA, V91, P4945, DOI 10.1073/pnas.91.11.4945; Song M, 2006, J BIOL CHEM, V281, P24227, DOI 10.1074/jbc.M603097200; Telesnitsky A., 1997, P121; Telesnitsky A, 1993, REVERSE TRANSCRIPTAS; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Topping R, 1998, J MOL BIOL, V281, P1, DOI 10.1006/jmbi.1998.1929; VARMUS H, 1989, MOBILE DNA, P53; VARMUS HE, 1978, J MOL BIOL, V120, P55, DOI 10.1016/0022-2836(78)90295-4; Wisniewski M, 2000, J BIOL CHEM, V275, P37664, DOI 10.1074/jbc.M007381200; Wu TY, 2007, NUCLEIC ACIDS RES, V35, P3974, DOI 10.1093/nar/gkm375; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; Yin PD, 1997, J VIROL, V71, P2487, DOI 10.1128/JVI.71.3.2487-2494.1997; YOU JC, 1994, J BIOL CHEM, V269, P31491; Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11	65	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3141	3150		10.1074/jbc.M707343200	http://dx.doi.org/10.1074/jbc.M707343200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18073206	hybrid			2022-12-25	WOS:000253083000017
J	Chen, K; Tu, YZ; Zhang, YJ; Blair, HC; Zhang, L; Wu, CY				Chen, Ka; Tu, Yizeng; Zhang, Yongjun; Blair, Harry C.; Zhang, Lin; Wu, Chuanyue			PINCH-1 regulates the ERK-Bim pathway and contributes to apoptosis resistance in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTEGRIN-LINKED KINASE; FOCAL ADHESION KINASE; MATRIX ADHESION; SIGNAL-TRANSDUCTION; SHAPE MODULATION; PROTEIN; PHOSPHORYLATION; PROMOTES; SRC; LOCALIZATION	Resistance to apoptosis is a hallmark of cancer cells. We report here that PINCH-1, a cytoplasmic component of cell-extracellular matrix adhesions, is required for protection of multiple types of cancer cells from apoptosis. Furthermore, using HT-1080 fibrosarcoma cells as a model system, we have investigated the signaling pathway through which PINCH-1 contributes to apoptosis resistance. Loss of PINCH-1 markedly increases the level of Bim and promotes Bim translocation to mitochondria, resulting in activation of the intrinsic apoptosis pathway. Depletion of Bim completely blocked apoptosis induced by the loss of PINCH-1.Thus, PINCH-1 contributes to apoptosis resistance through suppression of Bim. Mechanistically, PINCH-1 suppresses Bim not only transcriptionally but also post-transcriptionally. PINCH-1 promotes activating phosphorylation of Src family kinase and ERK1/2. Consistent with this, ERK1/2-mediated Ser69 phosphorylation of Bim, a key signal for turnover of Bim, is suppressed by the removal of PINCH-1. Our results demonstrate a strong dependence of multiple types of apoptosis-resistant cancer cells on PINCH-1 and provide new insights into the molecular mechanism by which cancer cells are protected from apoptosis.	[Chen, Ka; Tu, Yizeng; Zhang, Yongjun; Blair, Harry C.; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15261 USA; [Zhang, Lin] Univ Pittsburgh, Dept Pharmacol, Sch Med, Pittsburgh, PA 15261 USA; [Zhang, Lin; Wu, Chuanyue] Univ Pittsburgh, Inst Canc, Sch Med, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, 707B Scaife Hall,3550 Terrace St, Pittsburgh, PA 15261 USA.	carywu@pitt.edu	Zhang, Lin/A-7389-2009	Zhang, Lin/0000-0003-0018-3903	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054639] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065188] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 54639] Funding Source: Medline; NIGMS NIH HHS [GM 65188] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Adams JM, 2003, GENE DEV, V17, P2481, DOI 10.1101/gad.1126903; Aplin AE, 1999, CURR OPIN CELL BIOL, V11, P737, DOI 10.1016/S0955-0674(99)00045-9; Bershadsky AD, 2003, ANNU REV CELL DEV BI, V19, P677, DOI 10.1146/annurev.cellbio.19.111301.153011; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Clark KA, 2003, DEVELOPMENT, V130, P2611, DOI 10.1242/dev.00492; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dedhar S, 1996, CURR OPIN CELL BIOL, V8, P657, DOI 10.1016/S0955-0674(96)80107-4; Degterev A, 2003, ONCOGENE, V22, P8543, DOI 10.1038/sj.onc.1207107; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; ERPEL T, 1995, CURR OPIN CELL BIOL, V7, P176, DOI 10.1016/0955-0674(95)80025-5; Ewings KE, 2007, EMBO J, V26, P2856, DOI 10.1038/sj.emboj.7601723; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Glinsky GV, 1997, CANCER LETT, V115, P185, DOI 10.1016/S0304-3835(97)04738-1; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guan JL, 1997, MATRIX BIOL, V16, P195, DOI 10.1016/S0945-053X(97)90008-1; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Harada H, 2004, P NATL ACAD SCI USA, V101, P15313, DOI 10.1073/pnas.0406837101; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Howe A, 1998, CURR OPIN CELL BIOL, V10, P220, DOI 10.1016/S0955-0674(98)80144-0; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kohli M, 2004, P NATL ACAD SCI USA, V101, P16897, DOI 10.1073/pnas.0403405101; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Ley R, 2003, J BIOL CHEM, V278, P18811, DOI 10.1074/jbc.M301010200; Li FG, 1999, J CELL SCI, V112, P4589; Li SH, 2005, J CELL SCI, V118, P2913, DOI 10.1242/jcs.02422; Liang XQ, 2007, CIRC RES, V100, P527, DOI 10.1161/01.RES.0000259041.37059.8c; Liang XQ, 2005, MOL CELL BIOL, V25, P3056, DOI 10.1128/MCB.25.8.3056-3062.2005; Luciano F, 2003, ONCOGENE, V22, P6785, DOI 10.1038/sj.onc.1206792; Mackinnon AC, 2002, CURR BIOL, V12, P787, DOI 10.1016/S0960-9822(02)00810-2; MARAIS R, 1995, EMBO J, V14, P3136, DOI 10.1002/j.1460-2075.1995.tb07316.x; Martin SS, 2004, BBA-MOL CELL RES, V1692, P145, DOI 10.1016/j.bbamcr.2004.02.008; Mehlen P, 2006, NAT REV CANCER, V6, P449, DOI 10.1038/nrc1886; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Playford MP, 2004, ONCOGENE, V23, P7928, DOI 10.1038/sj.onc.1208080; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; Reddig PJ, 2005, CANCER METAST REV, V24, P425, DOI 10.1007/s10555-005-5134-3; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rogalski TM, 2000, J CELL BIOL, V150, P253, DOI 10.1083/jcb.150.1.253; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Shi XH, 2007, J BIOL CHEM, V282, P20455, DOI 10.1074/jbc.M611680200; Strasser A, 2000, ANNU REV BIOCHEM, V69, P217, DOI 10.1146/annurev.biochem.69.1.217; Tong T, 2005, MOL CELL BIOL, V25, P4488, DOI 10.1128/MCB.25.11.4488-4500.2005; Tu YZ, 2003, CELL, V113, P37, DOI 10.1016/S0092-8674(03)00163-6; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Wu CY, 2005, TRENDS CELL BIOL, V15, P460, DOI 10.1016/j.tcb.2005.07.002; Xu Z, 2005, J BIOL CHEM, V280, P27631, DOI 10.1074/jbc.M504189200; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhan Y, 2002, J BIOL CHEM, V277, P4512, DOI 10.1074/jbc.M109520200; Zhang L, 2000, SCIENCE, V290, P989, DOI 10.1126/science.290.5493.989; Zhang YJ, 2004, J BIOL CHEM, V279, P41695, DOI 10.1074/jbc.M401563200; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166	60	62	67	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 1	2008	283	5					2508	2517		10.1074/jbc.M707307200	http://dx.doi.org/10.1074/jbc.M707307200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	254XW	18063582	hybrid			2022-12-25	WOS:000252622300007
J	Peretz, A; Degani-Katzav, N; Talmon, M; Danieli, E; Gopin, A; Malka, E; Nachman, R; Raz, A; Shabat, D; Attali, B				Peretz, Asher; Degani-Katzav, Nurit; Talmon, Maya; Danieli, Eyal; Gopin, Anna; Malka, Eti; Nachman, Rachel; Raz, Amiram; Shabat, Doron; Attali, Bernard			A Tale of Switched Functions: From Cyclooxygenase Inhibition to M-Channel Modulation in New Diphenylamine Derivatives	PLOS ONE			English	Article								Cyclooxygenase (COX) enzymes are molecular targets of nonsteroidal anti-inflammatory drugs (NSAIDs), the most used medication worldwide. However, the COX enzymes are not the sole molecular targets of NSAIDs. Recently, we showed that two NSAIDs, diclofenac and meclofenamate, also act as openers of Kv7.2/3 K+ channels underlying the neuronal M-current. Here we designed new derivatives of diphenylamine carboxylate to dissociate the M-channel opener property from COX inhibition. The carboxylate moiety was derivatized into amides or esters and linked to various alkyl and ether chains. Powerful M-channel openers were generated, provided that the diphenylamine moiety and a terminal hydroxyl group are preserved. In transfected CHO cells, they activated recombinant Kv7.2/3 K+ channels, causing a hyperpolarizing shift of current activation as measured by whole-cell patch-clamp recording. In sensory dorsal root ganglion and hippocampal neurons, the openers hyperpolarized the membrane potential and robustly depressed evoked spike discharges. They also decreased hippocampal glutamate and GABA release by reducing the frequency of spontaneous excitatory and inhibitory post-synaptic currents. In vivo, the openers exhibited anti-convulsant activity, as measured in mice by the maximal electroshock seizure model. Conversion of the carboxylate function into amide abolished COX inhibition but preserved M-channel modulation. Remarkably, the very same template let us generating potent M-channel blockers. Our results reveal a new and crucial determinant of NSAID-mediated COX inhibition. They also provide a structural framework for designing novel M-channel modulators, including openers and blockers.	[Peretz, Asher; Degani-Katzav, Nurit; Malka, Eti; Nachman, Rachel; Attali, Bernard] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Talmon, Maya; Raz, Amiram] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem, IL-69978 Tel Aviv, Israel; [Danieli, Eyal; Gopin, Anna; Shabat, Doron] Tel Aviv Univ, Sch Chem, Fac Exact Sci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University	Attali, B (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel.	battali@post.tau.ac.il			Israel Science Foundation [ISF 672/05]; Keren Wolfson	Israel Science Foundation(Israel Science Foundation); Keren Wolfson	Funding: This work is supported by the Israel Science Foundation (ISF 672/05) and the Keren Wolfson funds to BA.	BARLOW RB, 1978, BRIT J PHARMACOL, V62, P39, DOI 10.1111/j.1476-5381.1978.tb07004.x; Brown D A, 1988, Ion Channels, V1, P55; Camerino DC, 2007, NEUROTHERAPEUTICS, V4, P184; Diaz A, 1998, EXP CELL RES, V241, P222, DOI 10.1006/excr.1998.4050; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Galanakis D, 2004, BIOORG MED CHEM LETT, V14, P3639, DOI 10.1016/j.bmcl.2004.05.025; Gu N, 2005, J PHYSIOL-LONDON, V566, P689, DOI 10.1113/jphysiol.2005.086835; Hoozemans JJM, 2005, CNS NEUROL DISORD-DR, V4, P307, DOI 10.2174/1568007054038201; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kalgutkar AS, 2000, P NATL ACAD SCI USA, V97, P925, DOI 10.1073/pnas.97.2.925; Kalgutkar AS, 2002, BIOORG MED CHEM LETT, V12, P521, DOI 10.1016/S0960-894X(01)00792-2; Kalgutkar AS, 2000, J MED CHEM, V43, P2860, DOI 10.1021/jm000004e; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Levin G, 2002, BIOCHEM J, V365, P489, DOI 10.1042/BJ20011798; Llorens O, 2002, J MOL GRAPH MODEL, V20, P359, DOI 10.1016/S1093-3263(01)00135-8; Luong C, 1996, NAT STRUCT BIOL, V3, P927, DOI 10.1038/nsb1196-927; MACDONALD RL, 1995, EPILEPSIA, V36, P2; Marrion NV, 1997, ANNU REV PHYSIOL, V59, P483, DOI 10.1146/annurev.physiol.59.1.483; Nerbonne JM, 2005, PHYSIOL REV, V85, P1205, DOI 10.1152/physrev.00002.2005; Passmore GM, 2003, J NEUROSCI, V23, P7227, DOI 10.1523/JNEUROSCI.23-18-07227.2003; Peretz A, 2005, MOL PHARMACOL, V67, P1053, DOI 10.1124/mol.104.007112; Peretz A, 2007, J NEUROPHYSIOL, V97, P283, DOI 10.1152/jn.00634.2006; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Pouplana R, 2002, J MOL GRAPH MODEL, V20, P329, DOI 10.1016/S1093-3263(01)00133-4; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Rowlinson SW, 2003, J BIOL CHEM, V278, P45763, DOI 10.1074/jbc.M305481200; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Selinsky BS, 2001, BIOCHEMISTRY-US, V40, P5172, DOI 10.1021/bi010045s; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Solomon DH, 2005, ARTHRITIS RHEUM, V52, P1968, DOI 10.1002/art.21132; Solomon DH, 2002, ARCH INTERN MED, V162, P1099, DOI 10.1001/archinte.162.10.1099; Sriram D, 2006, BIOORGAN MED CHEM, V14, P3113, DOI 10.1016/j.bmc.2005.12.042; Takahashi T, 2006, CANCER LETT, V231, P319, DOI 10.1016/j.canlet.2005.02.025; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Vane JR, 1998, ANNU REV PHARMACOL, V38, P97, DOI 10.1146/annurev.pharmtox.38.1.97; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Yue CY, 2004, J NEUROSCI, V24, P4614, DOI 10.1523/JNEUROSCI.0765-04.2004	38	34	38	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1332	10.1371/journal.pone.0001332	http://dx.doi.org/10.1371/journal.pone.0001332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159230	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459700004
J	Altermatt, F; Ebert, D				Altermatt, Florian; Ebert, Dieter			The Genotype Specific Competitive Ability Does Not Correlate with Infection in Natural Daphnia magna Populations	PLOS ONE			English	Article								Background. Different evolutionary hypotheses predict a correlation between the fitness of a genotype in the absence of infection and the likelihood to become infected. The cost of resistance hypothesis predicts that resistant genotypes pay a cost of being resistant and are less fit in the absence of parasites. The inbreeding-infection hypothesis predicts that the susceptible individuals are less fit due to inbreeding depression. Methods and Results. Here we tested if a host's natural infection status was associated with its fitness. First, we experimentally confirmed that cured but formerly infected Daphnia magna are genetically more susceptible to reinfections with Octosporea bayeri than naturally uninfected D. magna. We then collected from each of 22 populations both uninfected and infected D. magna genotypes. All were treated against parasites and kept in their asexual phase. We estimated their relative fitness in an experiment against a tester genotype and in another experiment in direct competition. Consistently, we found no difference in competitive abilities between uninfected and cured but formerly infected genotypes. This was the case both in the presence as well as in the absence of sympatric parasites during the competition trials. Conclusions. Our data do not support the inbreeding-infection hypothesis. They also do not support a cost of resistance, however ignoring other parasite strains or parasite species. We suggest as a possible explanation for our results that resistance genes might segregate largely independently of other fitness associated genes in this system.	[Altermatt, Florian; Ebert, Dieter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland; [Altermatt, Florian; Ebert, Dieter] Tvarminne Zool Stn, SF-10900 Hango, Finland	University of Basel	Altermatt, F (corresponding author), Univ Basel, Inst Zool, Rheinsprung 9, CH-4051 Basel, Switzerland.	florian.altermatt@unibas.ch	Ebert, Dieter/B-5502-2009; Ebert, Dieter/P-6134-2019	Ebert, Dieter/0000-0003-2653-3772; Ebert, Dieter/0000-0003-2653-3772; Altermatt, Florian/0000-0002-4831-6958	Swiss National Science Foundation; Tomcsik Foundation; Swiss Academy of Natural Sciences	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Tomcsik Foundation; Swiss Academy of Natural Sciences	The study was supported by the Swiss National Science Foundation. F. Altermatt was also supported by the Tomcsik Foundation and the Swiss Academy of Natural Sciences during the field work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altermatt F, 2007, EVOL ECOL, V21, P561, DOI 10.1007/s10682-006-9136-6; Baganz F, 1998, YEAST, V14, P1417, DOI 10.1002/(SICI)1097-0061(199811)14:15<1417::AID-YEA334>3.0.CO;2-N; Bandi C, 2001, TRENDS PARASITOL, V17, P88, DOI 10.1016/S1471-4922(00)01812-2; Bengtsson J, 1998, OECOLOGIA, V115, P213, DOI 10.1007/s004420050510; BENGTSSON J, 1993, OIKOS, V67, P451, DOI 10.2307/3545357; BENGTSSON J, 1989, NATURE, V340, P713, DOI 10.1038/340713a0; Brown MJF, 2000, OIKOS, V91, P421, DOI 10.1034/j.1600-0706.2000.910302.x; Capaul M, 2003, EVOLUTION, V57, P249, DOI 10.1111/j.0014-3820.2003.tb00260.x; Carius HJ, 2001, EVOLUTION, V55, P1136, DOI 10.1111/j.0014-3820.2001.tb00633.x; Carton Y, 2005, DEV COMP IMMUNOL, V29, P9, DOI 10.1016/j.dci.2004.05.004; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Crawley M. J, 2002, STAT COMPUTING INTRO; Duncan AB, 2006, J EVOLUTION BIOL, V19, P1183, DOI 10.1111/j.1420-9101.2006.01085.x; Ebert D, 2001, ECOLOGY, V82, P3417; Ebert D, 2002, SCIENCE, V295, P485, DOI 10.1126/science.1067485; Ebert D., 2005, ECOLOGY EPIDEMIOLOGY; Ebert D, 2007, J R SOC INTERFACE, V4, P777, DOI 10.1098/rsif.2007.0232; Fellowes MDE, 1998, P ROY SOC B-BIOL SCI, V265, P1553, DOI 10.1098/rspb.1998.0471; GROETERS FR, 1994, EVOLUTION, V48, P197, DOI 10.2307/2410015; Haag CR, 2007, J EVOLUTION BIOL, V20, P881, DOI 10.1111/j.1420-9101.2007.01313.x; Haag CR, 2006, HEREDITY, V96, P150, DOI 10.1038/sj.hdy.6800774; Haag CR, 2005, GENETICS, V170, P1809, DOI 10.1534/genetics.104.036814; Haag CR, 2003, EVOLUTION, V57, P777, DOI 10.1111/j.0014-3820.2003.tb00289.x; Haag CR, 2002, EVOLUTION, V56, P518; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Hebert P. D. N., 1993, METHODOLOGIES ALLOZY; Hudson P, 1998, TRENDS ECOL EVOL, V13, P387, DOI 10.1016/S0169-5347(98)01475-X; Jensen KH, 2006, PLOS BIOL, V4, P1265, DOI 10.1371/journal.pbio.0040197; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Kraaijeveld AR, 1997, NATURE, V389, P278, DOI 10.1038/38483; Little TJ, 2000, P ROY SOC B-BIOL SCI, V267, P2037, DOI 10.1098/rspb.2000.1246; Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5; Little TJ, 2002, J EVOLUTION BIOL, V15, P796, DOI 10.1046/j.1420-9101.2002.00436.x; LIVELY CM, 1989, EVOLUTION, V43, P1663, DOI [10.2307/2409382, 10.1111/j.1558-5646.1989.tb02616.x]; Luong LT, 2007, J EVOLUTION BIOL, V20, P79, DOI 10.1111/j.1420-9101.2006.01226.x; MINCHELLA DJ, 1991, TRENDS ECOL EVOL, V6, P250, DOI 10.1016/0169-5347(91)90071-5; Mitchell SE, 2005, EVOLUTION, V59, P70, DOI 10.1111/j.0014-3820.2005.tb00895.x; NEE S, 1989, J THEOR BIOL, V140, P499, DOI 10.1016/S0022-5193(89)80111-0; Pajunen VI, 2007, HYDROBIOLOGIA, V592, P291, DOI 10.1007/s10750-007-0769-4; Pajunen VI, 2003, ECOGRAPHY, V26, P731; POULIN R, 1998, EVOLUTIONARY ECOLOGY; R Development Core Team, 2007, R LANG ENV STAT COMP; RANTA E, 1979, ARCH HYDROBIOL, V87, P205; Rauch G, 2007, BASIC APPL ECOL, V8, P89, DOI 10.1016/j.baae.2006.03.007; REID JM, 2003, P ROYAL SOC B, V270; Salathe P, 2003, J EVOLUTION BIOL, V16, P976, DOI 10.1046/j.1420-9101.2003.00582.x; Sasaki A, 2000, P ROY SOC B-BIOL SCI, V267, P2183, DOI 10.1098/rspb.2000.1267; Vizoso DB, 2005, OECOLOGIA, V143, P157, DOI 10.1007/s00442-004-1771-4; Vizoso DB, 2004, PARASITOLOGY, V128, P31, DOI 10.1017/S0031182003004293; Zbinden M, 2005, EXP PARASITOL, V109, P58, DOI 10.1016/j.exppara.2004.11.002; ZBINDEN M, 2008, RAPID HOST ADAPTATIO	52	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1280	10.1371/journal.pone.0001280	http://dx.doi.org/10.1371/journal.pone.0001280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060074	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459400027
J	Gong, YP; Zhang, RH; Zhang, JP; Xu, L; Zhang, F; Xu, W; Wang, Y; Chu, YW; Xiong, SD				Gong, Yanping; Zhang, Ruihua; Zhang, Jinping; Xu, Lin; Zhang, Feng; Xu, Wei; Wang, Ying; Chu, Yiwei; Xiong, Sidong			alpha-Dystroglycan is involved in positive selection of thymocytes by participating in immunological synapse formation	FASEB JOURNAL			English	Article						thymic development; fetal thymus organ culture; reaggregate thymus organ culture	T-CELL DEVELOPMENT; IMMATURE CD4(+)CD8(+) THYMOCYTES; DYSTROPHIN-GLYCOPROTEIN COMPLEX; THYMUS ORGAN-CULTURES; NEGATIVE SELECTION; BETA-DYSTROGLYCAN; IN-VITRO; TYROSINE PHOSPHORYLATION; NEUROMUSCULAR-JUNCTION; EXTRACELLULAR-MATRIX	alpha-Dystroglycan has been proved to be involved in lymphocyte activation by participating in inummological synapse (IS) formation. Considering the existence of IS formation in thymic development, we questioned whether alpha-dystroglycan was expressed in thymus and influenced thymic development. In this study, we demonstrated that alpha-dystroglycan was expressed on fetal thymocytes, especially on double-positive (DP, CD4(+)CD8(+)) cells. Blocking alpha-dystroglycan by treatment of fetal thymus organ culture (FTOC) with anti-alpha-dystroglycan antibody IIH6C4 decreased the number of DP cells compared with nontreated or isotype antibody controls. Down-regulation of alpha-dystroglycan by retroviruses carrying antisense cDNA of dystroglycan in reaggregate thymus organ culture (RTOC) further confirmed these results. Enhanced apoptosis of DP cells was observed after blocking alpha-dystroglycan. Interestingly, we found that blocking alpha-dystroglycan reduced IS formation between DP cells and thymic epithelial cells. Furthermore, blocking of-dystroglycan up-regulated CD95/CD95L expression and reduced Bcl-2 expression on DP cells in the developing thymus. Finally, the increase in the apoptosis of DP cells was associated with a consequent decrease in the positive selection, as indicated by the reduction of both ERK phosphorylation in DP cells and single-positive (SP, CD4(+) or CD8(+)) cell outcome. Altogether, these results indicated that alpha-dystroglycan was involved in positive selection of thymocytes by participating in the IS formation.	[Gong, Yanping; Zhang, Ruihua; Zhang, Jinping; Xu, Lin; Zhang, Feng; Xu, Wei; Wang, Ying; Chu, Yiwei] Fudan Univ, Shanghai Med Coll, Dept Immunol, Inst Immunobiol, Shanghai 200032, Peoples R China; [Xiong, Sidong] Shanghai Univ E Inst, Div Immunol, Shanghai, Peoples R China	Fudan University	Xiong, SD (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Immunol, Inst Immunobiol, 138 Yixueyuan Rd, Shanghai 200032, Peoples R China.	sdxiongfd@126.com						Amsen D, 1999, P NATL ACAD SCI USA, V96, P622, DOI 10.1073/pnas.96.2.622; ANDERSON G, 1995, J IMMUNOL, V154, P3636; Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; ANDERSON G, 1993, NATURE, V362, P70, DOI 10.1038/362070a0; Azzam HS, 2001, J IMMUNOL, V166, P5464, DOI 10.4049/jimmunol.166.9.5464; Bedossa P, 2002, LAB INVEST, V82, P1053, DOI 10.1097/01.LAB.0000024429.73158.DE; Bousso P, 2002, SCIENCE, V296, P1876, DOI 10.1126/science.1070945; Bowe MA, 2000, J CELL BIOL, V148, P801, DOI 10.1083/jcb.148.4.801; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; CHANG AC, 1995, J IMMUNOL, V154, P500; CHANG AC, 1993, J IMMUNOL, V151, P1789; Chen YJ, 2003, BIOCHEM J, V375, P329, DOI 10.1042/BJ20030808; Cifone MG, 1999, BLOOD, V93, P2282, DOI 10.1182/blood.V93.7.2282.407a23_2282_2296; DeLuca D, 2002, DEV COMP IMMUNOL, V26, P365, DOI 10.1016/S0145-305X(01)00085-4; DELUCA D, 1995, J IMMUNOL METHODS, V178, P13, DOI 10.1016/0022-1759(94)00236-P; DELUCA D, 1986, J IMMUNOL, V136, P430; DURBEEJ M, 1995, J CELL BIOL, V130, P79, DOI 10.1083/jcb.130.1.79; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; Durbeej M, 2001, DIFFERENTIATION, V69, P121, DOI 10.1046/j.1432-0436.2001.690206.x; Durbeej M, 1998, CURR OPIN CELL BIOL, V10, P594, DOI 10.1016/S0955-0674(98)80034-3; Ebert PJR, 2000, J IMMUNOL, V165, P5435, DOI 10.4049/jimmunol.165.10.5435; Eichhorst ST, 2001, CANCER RES, V61, P243; ERVASTI JM, 1991, CELL, V66, P1121, DOI 10.1016/0092-8674(91)90035-W; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; Ferreira A, 2002, MOL NEUROBIOL, V26, P69, DOI 10.1385/MN:26:1:069; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Gesemann M, 1998, J BIOL CHEM, V273, P600, DOI 10.1074/jbc.273.1.600; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Hare KJ, 2003, J IMMUNOL, V171, P2825, DOI 10.4049/jimmunol.171.6.2825; Heaney DL, 2003, HEARING RES, V177, P12, DOI 10.1016/S0378-5955(02)00769-4; Heaney DL, 2002, HEARING RES, V174, P9, DOI 10.1016/S0378-5955(02)00611-1; Heathcote RD, 2000, DEV BIOL, V227, P595, DOI 10.1006/dbio.2000.9906; Henry MD, 2001, HUM PATHOL, V32, P791, DOI 10.1053/hupa.2001.26468; Hogquist KA, 2001, CURR OPIN IMMUNOL, V13, P225, DOI 10.1016/S0952-7915(00)00208-9; Hosokawa H, 2002, J CELL SCI, V115, P1487; Hozumi K, 2000, IMMUNOL LETT, V71, P61, DOI 10.1016/S0165-2478(99)00167-4; IBRAGHIMOVBESKROVNAYA O, 1993, HUM MOL GENET, V2, P1651, DOI 10.1093/hmg/2.10.1651; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Ilsley JL, 2001, CELL SIGNAL, V13, P625, DOI 10.1016/S0898-6568(01)00188-7; Jacobson C, 2001, J CELL BIOL, V152, P435, DOI 10.1083/jcb.152.3.435; James M, 2000, J CELL SCI, V113, P1717; JENKINSON EJ, 1992, J EXP MED, V176, P845, DOI 10.1084/jem.176.3.845; Jiang FX, 2001, MOL MED, V7, P107, DOI 10.1007/BF03401944; Kahl J, 2003, J NEUROSCI, V23, P392, DOI 10.1523/JNEUROSCI.23-02-00392.2003; Keir ME, 2005, J IMMUNOL, V175, P7372, DOI 10.4049/jimmunol.175.11.7372; Kim MG, 2000, J IMMUNOL, V165, P192, DOI 10.4049/jimmunol.165.1.192; Kulms D, 2002, CELL DEATH DIFFER, V9, P598, DOI 10.1038/sj.cdd.4401002; Kurasawa K, 1999, CELL IMMUNOL, V194, P127, DOI 10.1006/cimm.1999.1502; Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258; Lee LK, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-10; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Losasso C, 2000, FEBS LETT, V484, P194, DOI 10.1016/S0014-5793(00)02157-8; Lucas B, 2000, J IMMUNOL, V165, P1889, DOI 10.4049/jimmunol.165.4.1889; Magner W J, 2000, Dev Immunol, V7, P179, DOI 10.1155/2000/90943; Manole Emilia, 2000, J Cell Mol Med, V4, P289, DOI 10.1111/j.1582-4934.2000.tb00129.x; Mariathasan S, 2001, J IMMUNOL, V167, P4966, DOI 10.4049/jimmunol.167.9.4966; Masaki T, 2002, EXP NEUROL, V174, P109, DOI 10.1006/exnr.2001.7856; Middlebrook AJ, 2002, J IMMUNOL, V169, P2915, DOI 10.4049/jimmunol.169.6.2915; MILLER AD, 1989, BIOTECHNIQUES, V7, P980; Montanaro F, 2003, NEURON, V37, P193, DOI 10.1016/S0896-6273(03)00032-1; Montanaro F, 1999, J CELL BIOL, V145, P1325, DOI 10.1083/jcb.145.6.1325; Muschler J, 2002, CANCER RES, V62, P7102; NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; NISHIMURA Y, 1995, J IMMUNOL, V154, P4395; OGASAWARA J, 1995, J EXP MED, V181, P485, DOI 10.1084/jem.181.2.485; Peng HB, 1998, CELL ADHES COMMUN, V5, P475, DOI 10.3109/15419069809005605; Plum J, 1996, BLOOD, V88, P4239; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; PUNT JA, 1994, J EXP MED, V179, P709, DOI 10.1084/jem.179.2.709; Punt JA, 1997, J EXP MED, V186, P1911, DOI 10.1084/jem.186.11.1911; Richie LI, 2002, IMMUNITY, V16, P595, DOI 10.1016/S1074-7613(02)00299-6; Schlaepfer DD, 1999, PROG BIOPHYS MOL BIO, V71, P435, DOI 10.1016/S0079-6107(98)00052-2; Schmeissner PJ, 2001, J IMMUNOL, V167, P3715, DOI 10.4049/jimmunol.167.7.3715; Sciandra F, 2001, EUR J BIOCHEM, V268, P4590, DOI 10.1046/j.1432-1327.2001.02386.x; Sgambato A, 2003, AM J PATHOL, V162, P849, DOI 10.1016/S0002-9440(10)63881-3; Sotgia F, 2001, BIOCHEMISTRY-US, V40, P14585, DOI 10.1021/bi011247r; Spence HJ, 2004, EMBO REP, V5, P484, DOI 10.1038/sj.embor.7400140; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Sugita S, 2001, J CELL BIOL, V154, P435, DOI 10.1083/jcb.200105003; van der Merwe PA, 2000, SEMIN IMMUNOL, V12, P5, DOI 10.1006/smim.2000.0203; Varas A, 1998, Dev Immunol, V6, P141, DOI 10.1155/1998/95861; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; White SR, 2001, AM J RESP CELL MOL, V24, P179, DOI 10.1165/ajrcmb.24.2.3993; Williams O, 2001, EUR J IMMUNOL, V31, P1876, DOI 10.1002/1521-4141(200106)31:6<1876::AID-IMMU1876>3.0.CO;2-F; Williamson RA, 1997, HUM MOL GENET, V6, P831, DOI 10.1093/hmg/6.6.831; Yamada H, 1996, J BIOL CHEM, V271, P23418, DOI 10.1074/jbc.271.38.23418; YANG B, 1995, J BIOL CHEM, V270, P11711, DOI 10.1074/jbc.270.20.11711; YOSHIDA M, 1994, EUR J BIOCHEM, V222, P1055, DOI 10.1111/j.1432-1033.1994.tb18958.x; Zaccaria ML, 2001, NEUROSCIENCE, V104, P311, DOI 10.1016/S0306-4522(01)00092-6; Zhang JP, 2007, DNA CELL BIOL, V26, P19, DOI 10.1089/dna.2006.0525; Zhang JP, 2006, FASEB J, V20, P50, DOI 10.1096/fj.04-3303com	95	2	2	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1426	1439		10.1096/fj.07-9264com	http://dx.doi.org/10.1096/fj.07-9264com			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18171694				2022-12-25	WOS:000255898700015
J	Shao, C; Novakovic, VA; Head, JF; Seaton, BA; Gilbert, GE				Shao, Chenghua; Novakovic, Valerie A.; Head, James F.; Seaton, Barbara A.; Gilbert, Gary E.			Crystal structure of lactadherin C2 domain at 1.7 angstrom resolution with mutational and computational analyses of its membrane-binding motif	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; FACTOR VIIIC2 DOMAIN; AMINO-ACID-RESIDUES; FACTOR-V; PHOSPHOLIPID-MEMBRANES; BLOOD-COAGULATION; APOPTOTIC CELLS; IDENTIFICATION; PROTEIN; AFFINITY	Lactadherin is a phosphatidyl-L-serine ( Ptd-L-Ser)-binding protein that decorates membranes of milk fat globules. The major Ptd-L- Ser binding function of lactadherin has been localized to its C2 domain, which shares homology with the C2 domains of blood coagulation factor VIII and factor V. Correlating with this homology, purified lactadherin competes efficiently with factors VIII and V for Ptd-L-Ser binding sites, functioning as a potent anticoagulant. We have determined the crystal structure of the lactadherin C2 domain ( Lact-C2) at 1.7 angstrom resolution. The bovine Lact-C2 structure has a beta-barrel core that is homologous with the factor VIII C2 ( fVIII-C2) and factor V C2 ( fV-C2) domains. Two loops at the end of the beta-barrel, designated spikes 1 and 3, display four water-exposed hydrophobic amino acids, reminiscent of the membrane-interactive residues of fVIII-C2 and fV-C2. In contrast to the corresponding loops in fVIII-C2 and fV-C2, spike 1 of Lact-C2 adopts a hairpin turn in which the 7-residue loop is stabilized by internal hydrogen bonds. Further, central glycine residues in two membrane-interactive loops may enhance conformability of Lact-C2 to membrane binding sites. Mutagenesis studies confirmed a membrane-interactive role for the hydrophobic and/ or Gly residues of both spike 1 and spike 3. Substitution of spike 1 of fVIII-C2 into Lact-C2 also diminished binding. Computational ligand docking studies identified two prospective Ptd-L-Ser interaction sites. These results identify two membrane-interactive loops of Lact-C2 and provide a structural basis for the more efficient phospholipid binding of lactadherin as compared with factor VIII and factor V.	[Novakovic, Valerie A.; Gilbert, Gary E.] Brigham & Womens Hosp, Vet Affairs Boston Healthcare Syst, Dept Med, West Roxburgy, MA 02132 USA; [Novakovic, Valerie A.; Gilbert, Gary E.] Harvard Univ, Sch Med, Boston, MA 02132 USA; [Shao, Chenghua; Head, James F.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA	Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Harvard Medical School; Boston University	Gilbert, GE (corresponding author), Brigham & Womens Hosp, Vet Affairs Boston Healthcare Syst, Dept Med, 1400 VFW Pkwy, West Roxburgy, MA 02132 USA.	ggilbert@rics.bwh.harvard.edu		Head, James/0000-0002-6226-4146; Seaton, Barbara/0000-0003-4654-7709				ABBOTT AJ, 1987, BIOCHEMISTRY-US, V26, P7994, DOI 10.1021/bi00398a067; Ait-Oufella H, 2007, CIRCULATION, V115, P2168, DOI 10.1161/CIRCULATIONAHA.106.662080; Andersen MH, 2000, BIOCHEMISTRY-US, V39, P6200, DOI 10.1021/bi992221r; Andersen MH, 1997, BIOCHEMISTRY-US, V36, P5441, DOI 10.1021/bi963119m; BARENHOLZ Y, 1977, BIOCHEMISTRY-US, V16, P2806, DOI 10.1021/bi00631a035; Baumgartner S, 1998, PROTEIN SCI, V7, P1626, DOI 10.1002/pro.5560070717; Boddaert J, 2007, AM J PATHOL, V170, P921, DOI 10.2353/ajpath.2007.060664; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; BUTLER JE, 1980, DIFFERENTIATION, V17, P31, DOI 10.1111/j.1432-0436.1980.tb01079.x; Cantor RS, 1999, BIOPHYS J, V76, P2625, DOI 10.1016/S0006-3495(99)77415-1; CHEN PS, 1956, ANAL CHEM, V28, P1756, DOI 10.1021/ac60119a033; CONCHA NO, 1993, SCIENCE, V261, P1321, DOI 10.1126/science.8362244; Couto JR, 1996, DNA CELL BIOL, V15, P281, DOI 10.1089/dna.1996.15.281; Ensslin M, 1995, BIOL CHEM H-S, V376, P733, DOI 10.1515/bchm3.1995.376.12.733; Ensslin MA, 2003, CELL, V114, P405, DOI 10.1016/S0092-8674(03)00643-3; Fodor K, 2005, J MOL BIOL, V350, P156, DOI 10.1016/j.jmb.2005.04.039; GILBERT GE, 1992, J BIOL CHEM, V267, P15861; GILBERT GE, 1990, J BIOL CHEM, V265, P815; Gilbert GE, 2002, J BIOL CHEM, V277, P6374, DOI 10.1074/jbc.M104732200; GILBERT GE, 1991, J BIOL CHEM, V266, P17261; Gilbert GE, 1998, BIOCHEMISTRY-US, V37, P13526, DOI 10.1021/bi972944f; GILBERT GE, 2007, J THROMB HAEMOST S1, V5; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Haggqvist B, 1999, P NATL ACAD SCI USA, V96, P8669, DOI 10.1073/pnas.96.15.8669; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2005, P NATL ACAD SCI USA, V102, P16886, DOI 10.1073/pnas.0508599102; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; Hetenyi C, 2002, PROTEIN SCI, V11, P1729, DOI 10.1110/ps.0202302; Hvarregaard J, 1996, EUR J BIOCHEM, V240, P628, DOI 10.1111/j.1432-1033.1996.0628h.x; JOHNSON SM, 1971, BIOCHIM BIOPHYS ACTA, V233, P820, DOI 10.1016/0005-2736(71)90184-2; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kim SW, 2000, BIOCHEMISTRY-US, V39, P1951, DOI 10.1021/bi992256r; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lin L, 2007, J MOL BIOL, V371, P717, DOI 10.1016/j.jmb.2007.05.054; Macedo-Ribeiro S, 1999, NATURE, V402, P434, DOI 10.1038/46594; Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng WM, 2004, BIOCHEMISTRY-US, V43, P4385, DOI 10.1021/bi035763o; Pratt KP, 1999, NATURE, V402, P439, DOI 10.1038/46601; Saenko EL, 1998, J BIOL CHEM, V273, P27918, DOI 10.1074/jbc.273.43.27918; Saenko EL, 1999, TRENDS CARDIOVAS MED, V9, P185, DOI 10.1016/S1050-1738(00)00019-0; Saenko EL, 1996, J BIOL CHEM, V271, P27424, DOI 10.1074/jbc.271.44.27424; Saleh M, 2004, THROMB HAEMOSTASIS, V91, P16, DOI 10.1160/TH03-04-0222; Shi J, 2006, CYTOM PART A, V69A, P1193, DOI 10.1002/cyto.a.20345; Shi JL, 2003, BLOOD, V101, P2628, DOI 10.1182/blood-2002-07-1951; Shi JL, 2004, BBA-BIOMEMBRANES, V1667, P82, DOI 10.1016/j.bbamem.2004.09.006; Silvestre JS, 2005, NAT MED, V11, P499, DOI 10.1038/nm1233; SOPKOVA J, 1993, J MOL BIOL, V234, P816, DOI 10.1006/jmbi.1993.1627; Spiegel PC, 2001, BLOOD, V98, P13, DOI 10.1182/blood.V98.1.13; STUBBS JD, 1990, P NATL ACAD SCI USA, V87, P8417, DOI 10.1073/pnas.87.21.8417; Takeshima K, 2003, THROMB HAEMOSTASIS, V89, P788, DOI 10.1055/s-0037-1613463; Taylor MR, 1997, DNA CELL BIOL, V16, P861, DOI 10.1089/dna.1997.16.861; WU PG, 1994, ANAL BIOCHEM, V218, P1, DOI 10.1006/abio.1994.1134; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066	57	74	79	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					7230	7241		10.1074/jbc.M705195200	http://dx.doi.org/10.1074/jbc.M705195200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18160406	hybrid			2022-12-25	WOS:000253779600068
J	Lloyd, AJ; Gilbey, AM; Blewett, AM; De Pascale, G; El Zoeiby, A; Levesque, RC; Catherwood, AC; Tomasz, A; Bugg, TDH; Roper, DI; Dowson, CG				Lloyd, Adrian J.; Gilbey, Andrea M.; Blewett, Anne M.; De Pascale, Gianfranco; El Zoeiby, Ahmed; Levesque, Roger C.; Catherwood, Anita C.; Tomasz, Alexander; Bugg, Timothy D. H.; Roper, David I.; Dowson, Christopher G.			Characterization of tRNA-dependent peptide bond formation by MurM in the synthesis of Streptococcus pneumoniae peptidoglycan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL-CELL-WALLS; TRANSFER-RIBONUCLEIC-ACIDS; ACETYLENOLPYRUVYLGLUCOSAMINE REDUCTASE MURB; CONTINUOUS SPECTROPHOTOMETRIC ASSAY; HIGH-LEVEL PENICILLIN; INTERPEPTIDE BRIDGES; BIOSYNTHESIS; RESISTANCE; GLYCINE; BINDING	MurM is an aminoacyl ligase that adds L-serine or L-alanine as the first amino acid of a dipeptide branch to the stem peptide lysine of the pneumococcal peptidoglycan. MurM activity is essential for clinical pneumococcal penicillin resistance. Analysis of peptidoglycan from the highly penicillin-resistant Streptococcus pneumoniae strain 159 revealed that in vivo and in vitro, in the presence of the appropriate acyl-tRNA, MurM(159) alanylated the peptidoglycan epsilon-amino group of the stem peptide lysine in preference to its serylation. However, in contrast, identical analyses of the penicillin-susceptible strain Pn16 revealed that MurM(Pn16) activity supported serylation more than alanylation both in vivo and in vitro. Interestingly, both MurMPn16 acylation activities were far lower than the alanylation activity of MurM159. The resulting differing stem peptide structures of 159 and Pn16 were caused by the profoundly greater catalytic efficiency of MurM159 compared with MurMPn16 bought about by sequence variation between these enzymes and, to a lesser extent, differences in the in vivo tRNAAla: tRNASer ratio in 159 and Pn16. Kinetic analysis revealed that MurM159 acted during the lipid-linked stages of peptidoglycan synthesis, that the D-alanyl-D-alanine of the stem peptide and the lipid II N-acetylglucosaminyl group were not essential for substrate recognition, that epsilon-carboxylation of the lysine of the stem peptide was not tolerated, and that lipid II-alanine was a substrate, suggesting an evolutionary link to staphylococcal homologues of MurM such as FemA. Kinetic analysis also revealed that MurM recognized the acceptor stem and/or the T Psi C loop stem of the tRNAAla. It is anticipated that definition of the minimal structural features of MurM substrates will allow development of novel resistance inhibitors that will restore the efficacy of beta-lactams for treatment of pneumococcal infection.	[Lloyd, Adrian J.; Gilbey, Andrea M.; Blewett, Anne M.; Catherwood, Anita C.; Roper, David I.; Dowson, Christopher G.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [De Pascale, Gianfranco; Bugg, Timothy D. H.] Univ Warwick, Dept Chem, Coventry CV4 7AL, W Midlands, England; [El Zoeiby, Ahmed; Levesque, Roger C.] Univ Laval, Fac Med, Ctr Rech Fonct Struct & Ingn Prot, Ste Foy, PQ G1K 7P4, Canada; [Tomasz, Alexander] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA	University of Warwick; University of Warwick; Laval University; Rockefeller University	Lloyd, AJ (corresponding author), Univ Warwick, Dept Biol Sci, Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	adrian.lloyd@warwick.ac.uk	Levesque, Roger C./ABD-8407-2021; Dowson, Chris/N-6195-2014; Tomasz, Alexander/B-9939-2011; Roper, David I/A-2323-2011; Dowson, Christopher/ABG-5083-2021	Dowson, Chris/0000-0002-8294-8836; Roper, David I/0000-0003-0009-621X; Dowson, Christopher/0000-0002-8294-8836; Tomasz, Alexander/0000-0003-1520-1983; Levesque, Roger/0000-0001-8315-5937; Lloyd, Adrian/0000-0002-4638-4586	MRC [G0701400, G0500643, G0400848] Funding Source: UKRI; Medical Research Council [G0400848, G0500643, G0701400] Funding Source: Medline; Wellcome Trust [066443] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BARCUS VA, 1995, FEMS MICROBIOL LETT, V126, P299, DOI 10.1016/0378-1097(95)00026-2; Benson TE, 1997, BIOCHEMISTRY-US, V36, P796, DOI 10.1021/bi962220o; Bentley SD, 2002, NATURE, V417, P141, DOI 10.1038/417141a; Blewett AM, 2004, ACTA CRYSTALLOGR D, V60, P359, DOI 10.1107/S0907444903027720; Bouhss A, 2001, J BACTERIOL, V183, P5122, DOI 10.1128/JB.183.17.5122-5127.2001; BREUKINK E, 2003, J BIOL CHEM, V22, P2003; Bugg T.D.H., 1999, COMPREHENSIVE NATURA, P241; BUMSTED RM, 1968, J BIOL CHEM, V243, P779; Chesnel L, 2005, ANTIMICROB AGENTS CH, V49, P2895, DOI 10.1128/AAC.49.7.2895-2902.2005; DHALLA AM, 1995, BIOCHEMISTRY-US, V34, P5390, DOI 10.1021/bi00016a010; Dowson Christopher G., 1994, Trends in Microbiology, V2, P361, DOI 10.1016/0966-842X(94)90612-2; El Zoeiby A, 2001, FEMS MICROBIOL LETT, V201, P229, DOI 10.1016/S0378-1097(01)00268-3; El Zoeiby A, 2003, MOL MICROBIOL, V47, P1, DOI 10.1046/j.1365-2958.2003.03289.x; Filipe SR, 2000, J BIOL CHEM, V275, P27768; Filipe SR, 2000, P NATL ACAD SCI USA, V97, P4891, DOI 10.1073/pnas.080067697; Filipe SR, 2001, J BIOL CHEM, V276, P39618, DOI 10.1074/jbc.M106425200; Filipe SR, 2000, J BACTERIOL, V182, P6798, DOI 10.1128/JB.182.23.6798-6805.2000; Ganchev DN, 2006, BIOCHEMISTRY-US, V45, P6195, DOI 10.1021/bi051913e; GARCIABUSTOS J, 1990, P NATL ACAD SCI USA, V87, P5415, DOI 10.1073/pnas.87.14.5415; GARCIABUSTOS JF, 1988, J BACTERIOL, V170, P2143, DOI 10.1128/jb.170.5.2143-2147.1988; GARCIABUSTOS JF, 1987, J BACTERIOL, V169, P447, DOI 10.1128/jb.169.2.447-453.1987; Goffin C, 2002, MICROBIOL MOL BIOL R, V66, P702, DOI 10.1128/MMBR.66.4.702-738.2002; Hegde SS, 2001, J BIOL CHEM, V276, P6998, DOI 10.1074/jbc.M008591200; Hegde SS, 2003, J BIOL CHEM, V278, P22861, DOI 10.1074/jbc.M301565200; HENDERSON PJ, 1973, BIOCHEM J, V135, P101, DOI 10.1042/bj1350101; Hong HJ, 2005, J BIOL CHEM, V280, P13055, DOI 10.1074/jbc.M413801200; Hoskins J, 2001, J BACTERIOL, V183, P5709, DOI 10.1128/JB.183.19.5709-5717.2001; Jonsson M, 2003, MICROB DRUG RESIST, V9, P147, DOI 10.1089/107662903765826732; LaRiviere FJ, 2001, SCIENCE, V294, P165, DOI 10.1126/science.1064242; LINNETT PE, 1974, J BIOL CHEM, V249, P2497; LLOYD AJ, 1995, NUCLEIC ACIDS RES, V23, P2886, DOI 10.1093/nar/23.15.2886; Lloyd AJ, 2004, J BACTERIOL, V186, P1747, DOI 10.1128/JB.186.6.1747-1757.2004; Maillard AP, 2005, J BACTERIOL, V187, P3833, DOI 10.1128/JB.187.11.3833-3838.2005; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; MATSUHAS.M, 1967, J BIOL CHEM, V242, P3191; Nishida S, 2006, J BIOL CHEM, V281, P1714, DOI 10.1074/jbc.M509277200; PETIT JF, 1968, J BIOL CHEM, V243, P757; PLAPP R, 1970, J BIOL CHEM, V245, P3667; PLAPP R, 1970, J BIOL CHEM, V245, P3675; Reddy SG, 1999, J AM CHEM SOC, V121, P1175, DOI 10.1021/ja983850b; Ribas De Pouplana L, 2005, AMINOACYL TRNA SYNTH, P241; ROBERTS RJ, 1974, J BIOL CHEM, V249, P4781; ROBERTS RJ, 1974, J BIOL CHEM, V249, P4787; ROBERTS WSL, 1968, J BIOL CHEM, V243, P768; ROBERTS WSL, 1968, J BIOL CHEM, V243, P749; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schneider T, 2004, MOL MICROBIOL, V53, P675, DOI 10.1111/j.1365-2958.2004.04149.x; SEGEL IH, 1975, ENZYME KINETICS, P18; Severin A, 1996, J BACTERIOL, V178, P168, DOI 10.1128/jb.178.1.168-174.1996; Smith AM, 2001, ANTIMICROB AGENTS CH, V45, P2393, DOI 10.1128/AAC.45.8.2393-2396.2001; Sprinzl M, 2005, NUCLEIC ACIDS RES, V33, pD139, DOI 10.1093/nar/gki012; STEWART TS, 1971, NATURE, V230, P36, DOI 10.1038/230036a0; Sylvester DR, 2001, BIOCHEM J, V355, P431, DOI 10.1042/0264-6021:3550431; Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217; Villet R, 2007, NUCLEIC ACIDS RES, V35, P6870, DOI 10.1093/nar/gkm778; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; WEYGANDDURASEVI.I, 2005, AMINOACYL TRNA SYNTH, P177; Whatmore AM, 1999, J BACTERIOL, V181, P3144, DOI 10.1128/JB.181.10.3144-3154.1999; Williams KP, 2002, NUCLEIC ACIDS RES, V30, P866, DOI 10.1093/nar/30.4.866; ZHOU LX, 1995, PLASMID, V33, P127, DOI 10.1006/plas.1995.1014	61	68	68	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6402	6417		10.1074/jbc.M708105200	http://dx.doi.org/10.1074/jbc.M708105200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18077448	hybrid			2022-12-25	WOS:000253779500048
J	Porat, Z; Landau, G; Bercovich, Z; Krutauz, D; Glickman, M; Kahana, C				Porat, Ziv; Landau, Guy; Bercovich, Zippi; Krutauz, Dasha; Glickman, Michael; Kahana, Chaim			Yeast antizyme mediates degradation of yeast ornithine decarboxylase by yeast but not by mammalian proteasome - New insights on yeast antizyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; POLYAMINE METABOLISM; RETICULOCYTE LYSATE; INTRACELLULAR DEGRADATION; REGULATED DEGRADATION; REQUIRES INTERACTION; NEOPLASTIC GROWTH; IN-VIVO; CELLS; PROTEIN	Mammalian antizyme (mAz) is a central element of a feedback circuit regulating cellular polyamines by accelerating ornithine decarboxylase (ODC) degradation and inhibiting polyamine uptake. Although yeast antizyme (yAz) stimulates the degradation of yeast ODC(yODC), we show here that it has only a minor effect on polyamine uptake by yeast cells. A segment of yODC that parallels the Az binding segment of mammalian ODC (mODC) is required for its binding to yAz. Although demonstrating minimal homology to mAz, our results suggest that yAz stimulates yODC degradation via a similar mechanism of action. We demonstrate that interaction with yAz provokes degradation of yODC by yeast but not by mammalian proteasomes. This differential recognition may serve as a tool for investigating proteasome functions.	[Porat, Ziv; Landau, Guy; Bercovich, Zippi; Kahana, Chaim] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Krutauz, Dasha; Glickman, Michael] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel	Weizmann Institute of Science; Technion Israel Institute of Technology	Kahana, C (corresponding author), Weizmann Inst Sci, Dept Mol Genet, 1 Hertzel St, IL-76100 Rehovot, Israel.	chaim.kahana@weizmann.ac.il	Porat, Ziv/K-1672-2012	Porat, Ziv/0000-0003-3059-181X; Glickman, Michael/0000-0002-1222-8104				Benaroudj N, 2001, BIOCHIMIE, V83, P311, DOI 10.1016/S0300-9084(01)01244-5; BERCOVICH Z, 1989, J BIOL CHEM, V264, P15949; Chen H, 2002, J BIOL CHEM, V277, P45957, DOI 10.1074/jbc.M206799200; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Gandre S, 2002, BIOCHEM BIOPH RES CO, V293, P139, DOI 10.1016/S0006-291X(02)00194-8; GHODA L, 1989, SCIENCE, V243, P1493, DOI 10.1126/science.2928784; GHODA L, 1990, J BIOL CHEM, V265, P11823; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; Gupta R, 2001, P NATL ACAD SCI USA, V98, P10620, DOI 10.1073/pnas.181341298; HE Y, 1994, BIOCHEM BIOPH RES CO, V203, P608, DOI 10.1006/bbrc.1994.2226; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hobbs S, 1998, BIOCHEM BIOPH RES CO, V252, P368, DOI 10.1006/bbrc.1998.9646; Hoyt MA, 2003, J BIOL CHEM, V278, P12135, DOI 10.1074/jbc.M211802200; ICHIBA T, 1994, BIOCHEM BIOPH RES CO, V200, P1721, DOI 10.1006/bbrc.1994.1651; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JARIELENCONTRE I, 1995, J BIOL CHEM, V270, P11623, DOI 10.1074/jbc.270.19.11623; Krappmann D, 1996, EMBO J, V15, P6716, DOI 10.1002/j.1460-2075.1996.tb01061.x; Leggett David S., 2005, V301, P57; LI XQ, 1993, MOL CELL BIOL, V13, P2377, DOI 10.1128/MCB.13.4.2377; LI XQ, 1994, MOL CELL BIOL, V14, P87, DOI 10.1128/MCB.14.1.87; LI XQ, 1992, MOL CELL BIOL, V12, P3556, DOI 10.1128/MCB.12.8.3556; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; LOETSCHER P, 1991, J BIOL CHEM, V266, P11213; Madhubala R, 1998, Methods Mol Biol, V79, P131; MAMROUDKIDRON E, 1994, FEBS LETT, V337, P239, DOI 10.1016/0014-5793(94)80199-1; MAMROUDKIDRON E, 1994, FEBS LETT, V356, P162, DOI 10.1016/0014-5793(94)01260-1; MAMROUDKIDRON E, 1994, EUR J BIOCHEM, V226, P547, DOI 10.1111/j.1432-1033.1994.tb20079.x; MARUYAMA T, 1994, BBA-BIOMEMBRANES, V1194, P289, DOI 10.1016/0005-2736(94)90311-5; MATSUFUJI S, 1995, CELL, V80, P51, DOI 10.1016/0092-8674(95)90450-6; MITCHELL JLA, 1994, BIOCHEM J, V299, P19, DOI 10.1042/bj2990019; MITCHELL JLA, 1990, BIOCHIM BIOPHYS ACTA, V1037, P115, DOI 10.1016/0167-4838(90)90109-S; MIYAZAKI Y, 1993, EUR J BIOCHEM, V214, P837, DOI 10.1111/j.1432-1033.1993.tb17987.x; MURAKAMI Y, 1992, NATURE, V360, P597, DOI 10.1038/360597a0; Palanimurugan R, 2004, EMBO J, V23, P4857, DOI 10.1038/sj.emboj.7600473; Pegg AE, 2007, BIOCHEM SOC T, V35, P295, DOI 10.1042/BST0350295; PEGG AE, 1988, CANCER RES, V48, P759; PILLAI R, 1993, P NATL ACAD SCI USA, V90, P11970, DOI 10.1073/pnas.90.24.11970; Porat Z, 2005, CELL MOL LIFE SCI, V62, P3106, DOI 10.1007/s00018-005-5341-7; POULIN R, 1993, J BIOL CHEM, V268, P4690; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; ROM E, 1994, P NATL ACAD SCI USA, V91, P3959, DOI 10.1073/pnas.91.9.3959; ROSENBERGHASSON Y, 1989, EUR J BIOCHEM, V185, P469, DOI 10.1111/j.1432-1033.1989.tb15138.x; ROSENBERGHASSON Y, 1991, EUR J BIOCHEM, V196, P647, DOI 10.1111/j.1432-1033.1991.tb15861.x; SCHWARTZ B, 1995, BIOCHEM J, V312, P83, DOI 10.1042/bj3120083; Seiler N, 2003, CURR DRUG TARGETS, V4, P537, DOI 10.2174/1389450033490885; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; Takeuchi J, 2007, EMBO J, V26, P123, DOI 10.1038/sj.emboj.7601476; TOBIAS KE, 1995, CELL GROWTH DIFFER, V6, P1279; Toth C, 1999, J BIOL CHEM, V274, P25921, DOI 10.1074/jbc.274.36.25921; Wallace HM, 2003, BIOCHEM J, V376, P1, DOI 10.1042/BJ20031327; Wallace HM, 2004, AMINO ACIDS, V26, P353, DOI 10.1007/s00726-004-0092-6; Wallace HM, 2003, BIOCHEM SOC T, V31, P393, DOI 10.1042/BST0310393; Yu H, 1997, J BIOL CHEM, V272, P20800, DOI 10.1074/jbc.272.33.20800; Zhang MS, 2003, EMBO J, V22, P1488, DOI 10.1093/emboj/cdg158	56	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4528	4534		10.1074/jbc.M708088200	http://dx.doi.org/10.1074/jbc.M708088200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089576	hybrid			2022-12-25	WOS:000253426500009
J	Wang, Z; Ma, TH; Chi, XK; Pei, DQ				Wang, Zhe; Ma, Tianhua; Chi, Xiaoke; Pei, Duanqing			Aromatic residues in the C-terminal domain 2 are required for nanog to mediate LIF-independent self-renewal of mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLURIPOTENCY SUSTAINING FACTOR; TRANSCRIPTION; SUBDOMAINS; NETWORK	Nanog was identified by its ability to sustain the LIF-independent self-renewal of mouse embryonic stem (ES) cells and has recently been shown to play a role in reprogramming adult fibroblasts into pluripotent stem cells. However, little is known about the structural basis of these remarkable activities of Nanog. We have previously identified an unusually strong transactivator named CD2 at its C terminus. Here we demonstrate that CD2 is required for Nanog to mediate ES cell self-renewal. Furthermore, deletion and point mutation analysis revealed that CD2 relies on at least seven aromatic amino acid residues to generate its potent transactivating activity. A mutant Nanog bearing alanine substitutions for these seven residues fails to confer LIF-independent self-renewal in mouse ES cells. Substitution of CD2 by the viral transactivator VP16 gave rise to Nanog-VP16, which is 10 times more active than wild-type Nanog in ES cells. Surprisingly, the expression of Nanog-VP16 in mouse ES cells induces differentiation and is thus unable to sustain LIF-independent self-renewal for mouse ES cells. Taken together, our results demonstrate that the CD2 domain of Nanog is a unique transactivator that utilizes aromatic residues to confer specific activity absolutely required for ES self-renewal.	[Wang, Zhe; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Stem Cell & Canc Biol Grp,Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Peoples R China; [Wang, Zhe; Ma, Tianhua; Chi, Xiaoke] Tsinghua Univ, Sch Med,Inst Biomed, Lab Stem Cell Biol,Dept Biol Sci & Biotechnol, State Key Lab Biomembrane & Membrane Biotechnol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Tsinghua University	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Stem Cell & Canc Biol Grp,Lab Regenerat Biol, S China Inst Stem Cell Biol & Regenerat Med, Guangzhou 510663, Peoples R China.	pei_duanqing@gibh.ac.cn	zhou, xingru/G-4442-2012					Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Orkin SH, 2005, CELL, V122, P828, DOI 10.1016/j.cell.2005.09.002; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pan GJ, 2003, CELL RES, V13, P499, DOI 10.1038/sj.cr.7290193; Pan GJ, 2002, CELL RES, V12, P321, DOI 10.1038/sj.cr.7290134; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; REGIER JL, 1993, P NATL ACAD SCI USA, V90, P883, DOI 10.1073/pnas.90.3.883; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284	12	14	18	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4480	4489		10.1074/jbc.M706009200	http://dx.doi.org/10.1074/jbc.M706009200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086680	hybrid			2022-12-25	WOS:000253426500004
J	Amrute-Nayak, M; Antognozzi, M; Scholz, T; Kojima, H; Brenner, B				Amrute-Nayak, Mamta; Antognozzi, Massimo; Scholz, Tim; Kojima, Hiroaki; Brenner, Bernhard			Inorganic phosphate binds to the empty nucleotide binding pocket of conventional myosin II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICALLY SKINNED FIBERS; PROBES ACTOMYOSIN STATES; SKELETAL-MUSCLE FIBERS; FORCE GENERATION; ENERGY TRANSDUCTION; SINGLE-MOLECULE; ACTIN MOVEMENT; CONTRACTION; RELEASE; MECHANISM	In muscle inorganic phosphate strongly decreases force generation in the presence of millimolar MgATP, whereas phosphate slows shortening velocity only at micromolar MgATP concentrations. It is still controversial whether reduction in shortening velocity by phosphate results from phosphate binding to the nucleotide-free myosin head or from binding of phosphate to an actomyosin-ADP state as postulated for the inhibition of force generation by phosphate. Because most single-molecule studies are performed at micromolar concentrations of MgATP where phosphate effects on movement are rather prominent, clarification of the mechanisms of phosphate inhibition is essential for interpretation of data in which phosphate is used in single molecule studies to probe molecular events of force generation and movement. In in vitro assays we found that inhibition of filament gliding by inorganic phosphate was associated with increased fragmentation of actin filaments. In addition, phosphate did not extend dwell times of Cy3-EDA-ATP(2'(3')-O-[[2-[[6-[2-[3-(1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene)-1-propenyl]-3,3-dimethyl-5-sulfo-3H-indolio]-1-oxohexyl]amino] ethyl] carbamoyl] ATP) but reduced the number of Cy3-signals per field of view, approaching 50% at phosphate concentrations of 1-2mM. Apparently, inhibition of movement does not result from binding of phosphate to an actomyosin-ADP intermediate as proposed by Hooft and coworkers (Hooft, A. M., Maki, E. J., Cox, K. K., and Baker, J. E. (2007) Biochemistry 46, 3513-3520) but, rather, from forming a strong-binding actomyosin-phosphate intermediate.	[Amrute-Nayak, Mamta; Antognozzi, Massimo; Scholz, Tim; Brenner, Bernhard] Hannover Med Sch, Dept Mol & Cell Physiol, D-30625 Hannover, Germany; [Kojima, Hiroaki] Kobe Adv ICT Res Ctr, Natl Inst Informat & Commun Technol, Kobe, Hyogo 6512492, Japan	Hannover Medical School; National Institute of Information & Communications Technology (NICT) - Japan	Brenner, B (corresponding author), Hannover Med Sch, Dept Mol & Cell Physiol, D-30625 Hannover, Germany.	brenner.bernhard@mh-hannover.de	Amrute-Nayak, Mamta/P-7447-2019; Scholz, Tim/A-7798-2013	Scholz, Tim/0000-0002-2127-9843; Antognozzi, Massimo/0000-0001-5396-0564				ALTRINGHAM JD, 1985, J PHYSIOL-LONDON, V368, P491, DOI 10.1113/jphysiol.1985.sp015871; AMRUTE M, 2006, BIOPHYS J S, V90, P434; BAGSHAW CR, 1974, BIOCHEM J, V141, P331, DOI 10.1042/bj1410331; Baker JE, 2002, BIOPHYS J, V82, P2134, DOI 10.1016/S0006-3495(02)75560-4; BRENNER B, 1994, J MUSCLE RES CELL M, V15, P201; BRENNER B, 1993, P NATL ACAD SCI USA, V90, P5252, DOI 10.1073/pnas.90.11.5252; BRENNER B, 1986, BIOPHYS J, V50, P1101, DOI 10.1016/S0006-3495(86)83554-8; BRENNER B, 1995, BIOPHYS J, V68, pS106; Brenner B., 1990, MUSCLE MECH BIOLOGIC, P77; CHASE PB, 1994, J MUSCLE RES CELL M, V15, P119, DOI 10.1007/BF00130423; CHASE PB, 1988, BIOPHYS J, V53, P935, DOI 10.1016/S0006-3495(88)83174-6; Conibear PB, 1996, BIOCHEMISTRY-US, V35, P2299, DOI 10.1021/bi951824+; COOKE R, 1988, J PHYSIOL-LONDON, V395, P77, DOI 10.1113/jphysiol.1988.sp016909; DANTZIG JA, 1992, J PHYSIOL-LONDON, V451, P247, DOI 10.1113/jphysiol.1992.sp019163; EISENBERG E, 1985, SCIENCE, V227, P999, DOI 10.1126/science.3156404; GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P629; HARADA Y, 1990, J MOL BIOL, V216, P49, DOI 10.1016/S0022-2836(05)80060-9; HIBBERD MG, 1985, SCIENCE, V228, P1317, DOI 10.1126/science.3159090; Hooft AM, 2007, BIOCHEMISTRY-US, V46, P3513, DOI 10.1021/bi0614840; HUXLEY AF, 1954, NATURE, V173, P971, DOI 10.1038/173971a0; HUXLEY H, 1954, NATURE, V173, P973, DOI 10.1038/173973a0; KAWAI M, 1991, BIOPHYS J, V59, P329, DOI 10.1016/S0006-3495(91)82227-5; Kintses B, 2006, BIOPHYS J, V91, P4605, DOI 10.1529/biophysj.106.092833; Kraft T, 2005, P NATL ACAD SCI USA, V102, P13861, DOI 10.1073/pnas.0504026102; KRAFT T, 1995, BIOPHYS J, V69, P1246, DOI 10.1016/S0006-3495(95)80018-4; KRON SJ, 1991, METHOD ENZYMOL, V196, P399; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MARUTA S, 1993, J BIOL CHEM, V268, P7093; MCKILLOP DFA, 1990, BIOCHEM SOC T, V18, P585, DOI 10.1042/bst0180585; MILLAR NC, 1990, J BIOL CHEM, V265, P20234; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Oiwa K, 2000, BIOPHYS J, V78, P3048, DOI 10.1016/S0006-3495(00)76843-3; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; PATE E, 1989, PFLUG ARCH EUR J PHY, V414, P73, DOI 10.1007/BF00585629; Pate E, 1998, BIOPHYS J, V74, P369, DOI 10.1016/S0006-3495(98)77794-X; PATE E, 1989, J MUSCLE RES CELL M, V10, P181, DOI 10.1007/BF01739809; RUEGG JC, 1971, PFLUG ARCH EUR J PHY, V325, P359, DOI 10.1007/BF00592176; Takagi Y, 2004, PHILOS T R SOC B, V359, P1913, DOI 10.1098/rstb.2004.1561; Takagi Y, 2004, BIOPHYS J, V86, p54A; TESI C, 1988, FEBS LETT, V236, P256, DOI 10.1016/0014-5793(88)80326-0; Tesi C, 2002, J PHYSIOL-LONDON, V541, P187, DOI 10.1113/jphysiol.2001.013418; Thedinga E, 1999, J MUSCLE RES CELL M, V20, P785, DOI 10.1023/A:1005658825375; Tokunaga M, 1997, BIOCHEM BIOPH RES CO, V235, P47, DOI 10.1006/bbrc.1997.6732; TOYOSHIMA YY, 1989, NATURE, V341, P154, DOI 10.1038/341154a0; WARSHAW DM, 1991, J BIOL CHEM, V266, P24339; YU LC, 1989, BIOPHYS J, V55, P441, DOI 10.1016/S0006-3495(89)82838-3	46	22	22	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3773	3781		10.1074/jbc.M706779200	http://dx.doi.org/10.1074/jbc.M706779200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079122	hybrid, Green Published			2022-12-25	WOS:000253083500011
J	Detro-Dassen, S; Schanzler, M; Lauks, H; Martin, I; zu Berstenhorst, SM; Nothmann, D; Torres-Salazar, D; Hidalgo, P; Schmalzing, G; Fahlke, C				Detro-Dassen, Silvia; Schaenzler, Michael; Lauks, Heike; Martin, Ina; zu Berstenhorst, Sonja Meyer; Nothmann, Doreen; Torres-Salazar, Delany; Hidalgo, Patricia; Schmalzing, Guenther; Fahlke, Christoph			Conserved dimeric subunit stoichiometry of SLC26 multifunctional anion exchangers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOTOR PROTEIN; OLIGOMERIC STRUCTURE; CHLORIDE CHANNEL; PRESTIN; MEMBRANE; GENE; EXPRESSION; TOPOLOGY; STATE; TRANSPORTERS	The SLC26 gene family encodes multifunctional transport proteins in numerous tissues and organs. Some paralogs function as anion exchangers, others as anion channels, and one, prestin (SLC26A5), represents a membrane-bound motor protein in outer hair cells of the inner ear. At present, little is known about the molecular basis of this functional diversity. We studied the subunit stoichiometry of one bacterial, one teleost, and two mammalian SLC26 isoforms expressed in Xenopus laevis oocytes or in mammalian cells using blue native PAGE and chemical cross-linking. All tested SLC26s are assembled as dimers composed of two identical subunits. Co-expression of two mutant prestins with distinct voltage-dependent capacitances results in motor proteins with novel electrical properties, indicating that the two subunits do not function independently. Our results indicate that an evolutionarily conserved dimeric quaternary structure represents the native and functional state of SLC26 transporters.	[Detro-Dassen, Silvia; Lauks, Heike; Schmalzing, Guenther] Univ Aachen, Rhein Westfal TH Aachen, Abt Mol Pharmakol, D-52074 Aachen, Germany; [Schaenzler, Michael; Martin, Ina; zu Berstenhorst, Sonja Meyer; Nothmann, Doreen; Torres-Salazar, Delany; Hidalgo, Patricia; Fahlke, Christoph] Med Hochschule Hannover, Inst Neurophysiol, D-30625 Hannover, Germany; [Fahlke, Christoph] Zentrum System Neurowissensch Hannover, D-30625 Hannover, Germany	RWTH Aachen University; Hannover Medical School	Schmalzing, G (corresponding author), Univ Aachen, Rhein Westfal TH Aachen, Abt Mol Pharmakol, Wendlingweg 2, D-52074 Aachen, Germany.	gschmalzing@ukaachen.de; fahlke.christoph@mh-hannover.de	Fahlke, Christoph/G-3635-2013; Hidalgo, Patricia/I-7506-2013	Fahlke, Christoph/0000-0001-8602-9952; Hidalgo, Patricia/0000-0002-4162-6590; Torres-Salazar, Delany/0000-0002-6789-9810				Albert JT, 2007, J PHYSIOL-LONDON, V580, P451, DOI 10.1113/jphysiol.2007.127993; BISSIG M, 1994, J BIOL CHEM, V269, P3017; Buttner C, 2001, J BIOL CHEM, V276, P42978, DOI 10.1074/jbc.M102121200; CASEY JR, 1991, J BIOL CHEM, V266, P15726; Dallos P, 2002, NAT REV MOL CELL BIO, V3, P104, DOI 10.1038/nrm730; Dorwart MR, 2007, J PHYSIOL-LONDON, V584, P333, DOI 10.1113/jphysiol.2007.135855; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Everett LA, 1999, HUM MOL GENET, V8, P1883, DOI 10.1093/hmg/8.10.1883; Fahlke C, 1997, J GEN PHYSIOL, V109, P93, DOI 10.1085/jgp.109.1.93; Failer BU, 2003, EUR J BIOCHEM, V270, P1802, DOI 10.1046/j.1432-1033.2003.03542.x; Fernandez E, 2006, J BIOL CHEM, V281, P26552, DOI 10.1074/jbc.M604049200; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Gendreau S, 2004, J BIOL CHEM, V279, P39505, DOI 10.1074/jbc.M408038200; Greeson JN, 2006, BRAIN RES, V1091, P140, DOI 10.1016/j.brainres.2006.02.084; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Griffon N, 1999, EMBO J, V18, P4711, DOI 10.1093/emboj/18.17.4711; Hebeisen S, 2004, J BIOL CHEM, V279, P13140, DOI 10.1074/jbc.M312649200; Jiang Z, 2002, J BIOL CHEM, V277, P33963, DOI 10.1074/jbc.M202660200; Kim KH, 2005, J BIOL CHEM, V280, P6463, DOI 10.1074/jbc.M409162200; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Krause F, 2006, ELECTROPHORESIS, V27, P2759, DOI 10.1002/elps.200600049; Lieberman RL, 2003, P NATL ACAD SCI USA, V100, P3820, DOI 10.1073/pnas.0536703100; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Liu XZ, 2003, HUM MOL GENET, V12, P1155, DOI 10.1093/hmg/ddg127; Matsuda K, 2004, J NEUROCHEM, V89, P928, DOI 10.1111/j.1471-4159.2004.02377.x; Melvin JE, 1999, J BIOL CHEM, V274, P22855, DOI 10.1074/jbc.274.32.22855; MILLER C, 1982, PHILOS T ROY SOC B, V299, P401, DOI 10.1098/rstb.1982.0140; Moseley RH, 1999, AM J PHYSIOL-GASTR L, V276, pG185, DOI 10.1152/ajpgi.1999.276.1.G185; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; Navaratnam D, 2005, BIOPHYS J, V89, P3345, DOI 10.1529/biophysj.105.068759; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 2003, MOL PHARMACOL, V63, P243, DOI 10.1124/mol.63.1.243; Nicke A, 1999, J RECEPT SIGNAL TR R, V19, P493, DOI 10.3109/10799899909036667; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Sadtler S, 2003, J BIOL CHEM, V278, P16782, DOI 10.1074/jbc.M213077200; SANTOS-SACCHI J, 1991, J NEUROSCI, V11, P3096, DOI 10.1523/jneurosci.11-10-03096.1991; Santos-Sacchi J, 1998, J PHYSIOL-LONDON, V510, P225, DOI 10.1111/j.1469-7793.1998.225bz.x; Schaechinger TJ, 2007, P NATL ACAD SCI USA, V104, P7693, DOI 10.1073/pnas.0608583104; SCHMALZING G, 1992, J BIOL CHEM, V267, P20212; SchmidtRose T, 1997, P NATL ACAD SCI USA, V94, P7633, DOI 10.1073/pnas.94.14.7633; SCHWEINFEST CW, 1993, P NATL ACAD SCI USA, V90, P4166, DOI 10.1073/pnas.90.9.4166; Scott DA, 2000, AM J PHYSIOL-CELL PH, V278, pC207, DOI 10.1152/ajpcell.2000.278.1.C207; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356, DOI 10.1152/ajprenal.2001.280.2.F356; Toth T, 2007, INT J MOL MED, V20, P545; WANG DN, 1994, EMBO J, V13, P3230, DOI 10.1002/j.1460-2075.1994.tb06624.x; Weber T, 2003, P NATL ACAD SCI USA, V100, P7690, DOI 10.1073/pnas.1330557100; Wu XD, 2007, DEV NEUROBIOL, V67, P483, DOI 10.1002/dneu.20357; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002; Xu JK, 2004, J BIOL CHEM, V279, P19781, DOI 10.1074/jbc.M310785200; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2001, NEUROREPORT, V12, P1929, DOI 10.1097/00001756-200107030-00032; Zheng J, 2006, J BIOL CHEM, V281, P19916, DOI 10.1074/jbc.M513854200	55	72	72	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4177	4188		10.1074/jbc.M704924200	http://dx.doi.org/10.1074/jbc.M704924200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073211	hybrid			2022-12-25	WOS:000253083500053
J	Wu, LNY; Genge, BR; Wuthier, RE				Wu, Licia N. Y.; Genge, Brian R.; Wuthier, Roy E.			Analysis and molecular modeling of the formation, structure, and activity of the phosphatidylserine-calcium-phosphate complex associated with biomineralization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-PLATE CARTILAGE; MATRIX VESICLES INVITRO; MINERAL FORMATION; IN-VITRO; EPIPHYSEAL CARTILAGE; NUCLEATIONAL CORE; BINDING-PROTEINS; LIGHT-SCATTERING; DYNAMICS; ION	The nucleational core of matrix vesicles contains a complex (CPLX) of phosphatidylserine (PS), Ca2+, and inorganic phosphate (Pi) that is important to both normal and pathological calcification. Factors required for PS-CPLX formation and nucleational activity were studied using in vitro model systems and molecular dynamic simulations. Ca2+ levels required for and rates of PS-CPLX formation were monitored by light scattering at 340 nm, assessing changes in amount and particle size. Fourier transform infrared spectroscopy was used to explore changes in chemical structure and composition. Washing with pH 5 buffer was used to examine the role of amorphous calcium phosphate in CPLX nucleational activity, which was assessed by incubation in synthetic cartilage lymph with varied pH values. Addition of 4 Ca2+/PS was minimally required to form viable complexes. During the critical first 10-min reaction period, rapid reduction in particle size signaled changes in PS-CPLX structure. Fourier transform infrared spectroscopy revealed increasing mineral phosphate that became progressively deprotonated to PO43+. This Ca2+-mediated effect was mimicked in part by increasing the Ca2+/PS reaction ratio. Molecular dynamic simulations provided key insight into initial interactions between Ca2+ and Pi and the carboxyl, amino, and phosphodiester groups of PS. Deduced interatomic distances agreed closely with previous radial distribution function x-ray-absorption fine structure measurements, except for an elongated Ca2+-N distance, suggesting additional changes in atomic structure during the critical 10-min ripening period. These findings clarify the process of PS-CPLX formation, reveal details of its structure, and provide insight into its role as a nucleator of crystalline calcium phosphate mineral formation.	[Wuthier, Roy E.] Univ S Carolina, Dept Chem & Biochem, Grad Sci Res Ctr, Columbia, SC 29208 USA	University of South Carolina; University of South Carolina System; University of South Carolina Columbia	Wu, LNY (corresponding author), Univ S Carolina, Dept Chem & Biochem, Grad Sci Res Ctr, 631 Sumter St, Columbia, SC 29208 USA.	wuthier@mail.chem.sc.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042359, R01AR018983] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR18983, AR42359] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABRAMSON MB, 1964, J BIOL CHEM, V239, P70; Anderson HC, 2005, FRONT BIOSCI-LANDMRK, V10, P822, DOI 10.2741/1576; ANDERSON HC, 1988, RHEUM DIS CLIN N AM, V14, P303; ANGHILERI LJ, 1972, EXPERIENTIA, V28, P1086, DOI 10.1007/BF01918690; BETTS F, 1975, P NATL ACAD SCI USA, V72, P2088, DOI 10.1073/pnas.72.6.2088; Blood PD, 2006, P NATL ACAD SCI USA, V103, P15068, DOI 10.1073/pnas.0603917103; BLUMENTHAL NC, 1977, CALC TISS RES, V23, P245, DOI 10.1007/BF02012793; BOSKEY AL, 1978, P SOC EXP BIOL MED, V157, P590; BOSKEY AL, 1976, CALC TISS RES, V19, P273; BOSKEY AL, 1988, AM J PATHOL, V133, P22; BOSKEY AL, 1982, CALCIF TISSUE INT S2, V34, P1; BOYAN BD, 1984, CALCIFIED TISSUE INT, V36, P214, DOI 10.1007/BF02405320; BOYANSALYERS BD, 1980, CALCIFIED TISSUE INT, V30, P167, DOI 10.1007/BF02408622; BRECEVIC L, 1972, CALC TISS RES, V10, P82, DOI 10.1007/BF02012538; BRIGHTON CT, 1976, FED PROC, V35, P143; COTMORE JM, 1971, SCIENCE, V172, P1339, DOI 10.1126/science.172.3990.1339; EANES ED, 1970, CALC TISS RES, V5, P133, DOI 10.1007/BF02017543; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; Floris FM, 2002, J CHEM PHYS, V116, P5460, DOI 10.1063/1.1453957; Frisch M., 2016, GAUSSIAN 16 REVISION; GENGE B, 1992, BONE MINER, V17, P202, DOI 10.1016/0169-6009(92)90737-X; GENGE BR, 1992, J BONE MINER RES, V7, P807, DOI 10.1002/jbmr.5650070710; GENGE BR, 1990, J BIOL CHEM, V265, P4703; GENGE BR, 1989, J BIOL CHEM, V264, P10917; GENGE BR, 1988, J BIOL CHEM, V263, P18513; Genge BR, 2007, J BIOL CHEM, V282, P26035, DOI 10.1074/jbc.M701057200; Genge BR, 2007, ANAL BIOCHEM, V367, P159, DOI 10.1016/j.ab.2007.04.029; HOLWERDA DL, 1981, BIOCHEMISTRY-US, V20, P418, DOI 10.1021/bi00505a030; HOWELL DS, 1968, J CLIN INVEST, V47, P1121, DOI 10.1172/JCI105801; HUMPHREY W, 1996, J MOL GRAPHICS, V14, P27, DOI DOI 10.1016/0263-7855(96)00018-5; IANNOTTI JP, 1989, J ORTHOPAED RES, V7, P511, DOI 10.1002/jor.1100070408; IANNOTTI JP, 1985, J BONE JOINT SURG AM, V67A, P113, DOI 10.2106/00004623-198567010-00014; IANNOTTI JP, 1994, CLIN ORTHOP RELAT R, P222; IRVING JT, 1961, ARCH ORAL BIOL, V5, P323, DOI 10.1016/0003-9969(61)90067-X; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kale L, 1999, J COMPUT PHYS, V151, P283, DOI 10.1006/jcph.1999.6201; LATIMER P, 1982, ANNU REV BIOPHYS BIO, V11, P129, DOI 10.1146/annurev.bb.11.060182.001021; LATIMER P, 1977, ARCH BIOCHEM BIOPHYS, V180, P151; LYSTER RLJ, 1984, BIOCHIM BIOPHYS ACTA, V801, P315, DOI 10.1016/0304-4165(84)90082-5; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MAJESKA RJ, 1979, CALCIFIED TISSUE INT, V27, P41, DOI 10.1007/BF02441159; Marchand S, 1998, PROTEINS, V33, P265, DOI 10.1002/(SICI)1097-0134(19981101)33:2<265::AID-PROT10>3.3.CO;2-G; MCGANN TCA, 1983, CALCIFIED TISSUE INT, V35, P821, DOI 10.1007/BF02405131; NASH HA, 1964, P NATL ACAD SCI USA, V51, P476, DOI 10.1073/pnas.51.3.476; Pandit SA, 2002, BIOPHYS J, V82, P1818, DOI 10.1016/S0006-3495(02)75532-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PLESHKO N, 1991, BIOPHYS J, V60, P786, DOI 10.1016/S0006-3495(91)82113-0; POSNER AS, 1975, J DENT RES, V54, pB88, DOI 10.1177/00220345750540023301; POSNER AS, 1977, CALCIF TISSUE RES, V22, pS208; Pye CC, 2004, CAN J ANAL SCI SPECT, V49, P175; SAUER GR, 1988, J BIOL CHEM, V263, P13718; Taylor MG, 1998, CELL MOL LIFE SCI, V54, P196, DOI 10.1007/s000180050143; TERMINE JD, 1970, ARCH BIOCHEM BIOPHYS, V140, P318, DOI 10.1016/0003-9861(70)90072-X; TERMINE JD, 1967, P SOC EXP BIOL MED, V125, P4; TSUI FC, 1986, BIOPHYS J, V49, P459, DOI 10.1016/S0006-3495(86)83655-4; VALHMU WB, 1990, BONE MINER, V8, P195, DOI 10.1016/0169-6009(90)90105-O; Wu LNY, 1997, CLIN ORTHOP RELAT R, P310; Wu LNY, 2003, J INORG BIOCHEM, V94, P221, DOI 10.1016/S0162-0134(03)00003-5; WU LNY, 1993, J BIOL CHEM, V268, P25084; Wu LNY, 1996, CONNECT TISSUE RES, V35, P309, DOI 10.3109/03008209609029205; Wu LNY, 1997, J BIOL CHEM, V272, P4404, DOI 10.1074/jbc.272.7.4404; WUTHIER RE, 1977, CALC TISS RES, V23, P125, DOI 10.1007/BF02012777; WUTHIER RE, 1975, CALC TISS RES, V19, P197, DOI 10.1007/BF02564004; WUTHIER RE, 1968, J LIPID RES, V9, P68; WUTHIER RE, 1977, CALC TISS RES, V24, P163, DOI 10.1007/BF02223311; Zahn D, 2004, Z ANORG ALLG CHEM, V630, P1507, DOI 10.1002/zaac.200400151	66	30	31	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3827	3838		10.1074/jbc.M707653200	http://dx.doi.org/10.1074/jbc.M707653200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18077457	hybrid			2022-12-25	WOS:000253083500017
J	Kimball, SR; Do, AND; Kutzler, L; Cavener, DR; Jefferson, LS				Kimball, Scot R.; Do, A. N. Dang; Kutzler, Lydia; Cavener, Douglas R.; Jefferson, Leonard S.			Rapid turnover of the mTOR complex 1 (mTORC1) repressor REDD1 and activation of mTORC1 signaling following inhibition of protein synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; STRESS-RESPONSE GENE; P70 S6 KINASE; MAMMALIAN TARGET; SKELETAL-MUSCLE; AMINO-ACID; TRANSLATION INITIATION; CARDIAC-HYPERTROPHY; RAPAMYCIN MTOR; PHAS-I	mTORC1 is a complex of proteins that includes the mammalian target of rapamycin (mTOR) and several regulatory proteins. It is activated by a variety of hormones (e. g. insulin) and nutrients (e. g. amino acids) that act to stimulate cell growth and proliferation and repressed by hormones (e. g. glucocorticoids) that act to reduce cell growth. Curiously, mTORC1 signaling is reported to be rapidly (e. g. within 1-2 h) activated by inhibitors of protein synthesis that act on either mRNA translation elongation or gene transcription. However, the basis for the mTORC1 activation has not been satisfactorily delineated. In the present study, mTORC1 signaling was found to be activated in response to inhibition of either the initiation or elongation phases of mRNA translation. Changes in mTORC1 signaling were inversely proportional to alterations in the expression of the mTORC1 repressor, REDD1, but not the expression of TRB3 or TSC2. Moreover the cycloheximide-induced increase in mTORC1 signaling was significantly attenuated in cells lacking REDD1, showing that REDD1 plays an integral role in the response. Finally, the half-life of REDD1 was estimated to be 5 min or less. Overall, the results are consistent with a model in which inhibition of protein synthesis leads to a loss of REDD1 protein because of its rapid degradation, and in part reduced REDD1 expression subsequently leads to de-repression of mTORC1 activity.	[Kimball, Scot R.; Do, A. N. Dang; Kutzler, Lydia; Jefferson, Leonard S.] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Cavener, Douglas R.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Kimball, SR (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, H 166,500 Univ Dr, Hershey, PA 17033 USA.	skimball@psu.edu	Cavener, Douglas R/E-3524-2010		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK013499, R37DK013499] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Baar K, 1999, AM J PHYSIOL-CELL PH, V276, pC120, DOI 10.1152/ajpcell.1999.276.1.C120; Beugnet A, 2003, BIOCHEM J, V372, P555, DOI 10.1042/BJ20021266; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Corradetti MN, 2004, GENE DEV, V18, P1533, DOI 10.1101/gad.1199104; Corradetti MN, 2005, J BIOL CHEM, V280, P9769, DOI 10.1074/jbc.C400557200; Cuaz-Perolin C, 2004, ARTERIOSCL THROM VAS, V24, P1830, DOI 10.1161/01.ATV.0000142366.69080.c3; De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Earnshaw WC, 2006, CURR OPIN CELL BIOL, V18, P587, DOI 10.1016/j.ceb.2006.10.010; Ellisen LW, 2005, CELL CYCLE, V4, P1500, DOI 10.4161/cc.4.11.2139; EVERSON WV, 1989, AM J PHYSIOL, V256, pC18, DOI 10.1152/ajpcell.1989.256.1.C18; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Fox Heather L., 1998, American Journal of Physiology, V275, pC1232; Galbaugh T, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-34; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Goggin MM, 2004, HEPATOLOGY, V40, P537, DOI 10.1002/hep.20338; GRAVES LM, 1995, P NATL ACAD SCI USA, V92, P7222, DOI 10.1073/pnas.92.16.7222; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; HANSEN BS, 1972, J BIOL CHEM, V247, P3854; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Hinnebusch AG, 2000, COLD SPRING HARBOR M, V39, P185; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jones S, 2007, NAT REV MICROBIOL, V5, P331, DOI 10.1038/nrmicro1666; Kimball SR, 2006, J NUTR, V136, p227S, DOI 10.1093/jn/136.1.227S; Kimball SR, 2003, AM J PHYSIOL-ENDOC M, V285, pE637, DOI 10.1152/ajpendo.00340.2002; Kimball SR, 2002, AM J PHYSIOL-ENDOC M, V282, pE585, DOI 10.1152/ajpendo.00269.2001; Kimball SR, 1998, J BIOL CHEM, V273, P30945, DOI 10.1074/jbc.273.47.30945; Kwiatkowski DJ, 2005, HUM MOL GENET, V14, pR251, DOI 10.1093/hmg/ddi260; Lang CH, 2002, AM J PHYSIOL-ENDOC M, V282, pE336, DOI 10.1152/ajpendo.00366.2001; Lin L, 2005, BIOCHEM J, V392, P93, DOI 10.1042/BJ20050553; Lin L, 2005, BIOCHEMISTRY-US, V44, P3909, DOI 10.1021/bi047574r; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200; Loreni F, 2000, EUR J BIOCHEM, V267, P6594, DOI 10.1046/j.1432-1327.2000.01753.x; MACLEAN DA, 1991, J APPL PHYSIOL, V70, P2095, DOI 10.1152/jappl.1991.70.5.2095; MARVIN OB, 2004, CARDIOVASC DRUG THER, V18, P257; Matsushima R, 2006, J BIOL CHEM, V281, P29719, DOI 10.1074/jbc.M511636200; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; Nader GA, 2001, J APPL PHYSIOL, V90, P1936, DOI 10.1152/jappl.2001.90.5.1936; NIELSEN PJ, 1982, J BIOL CHEM, V257, P2316; Palmer LK, 2006, AM J PHYSIOL-ENDOC M, V290, pE1267, DOI 10.1152/ajpendo.00463.2005; PRICE DJ, 1989, J BIOL CHEM, V264, P13825; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Reiling JH, 2004, GENE DEV, V18, P2879, DOI 10.1101/gad.322704; Roccio M, 2006, ONCOGENE, V25, P657, DOI 10.1038/sj.onc.1209106; Safer B, 1979, Methods Enzymol, V60, P61; Schwarzer R, 2005, ONCOGENE, V24, P1138, DOI 10.1038/sj.onc.1208236; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE74, DOI 10.1152/ajpendo.2000.279.1.E74; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE76, DOI 10.1152/ajpendo.2000.278.1.E76; Shah OJ, 2000, AM J PHYSIOL-ENDOC M, V279, pE1185, DOI 10.1152/ajpendo.2000.279.5.E1185; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Shoshani T, 2002, MOL CELL BIOL, V22, P2283, DOI 10.1128/MCB.22.7.2283-2293.2002; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Sofer A, 2005, MOL CELL BIOL, V25, P5834, DOI 10.1128/MCB.25.14.5834-5845.2005; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Wang HM, 2006, J BIOL CHEM, V281, P39128, DOI 10.1074/jbc.M610023200; Wang ZQ, 2003, J BIOL CHEM, V278, P27053, DOI 10.1074/jbc.M303723200; Wasef SZY, 2006, AM J PHYSIOL-ENDOC M, V291, pE1274, DOI 10.1052/ajpendo.00117.2006; Zhang PC, 2002, MOL CELL BIOL, V22, P6681, DOI 10.1128/MCB.22.19.6681-6688.2002; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	63	81	85	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3465	3475		10.1074/jbc.M706643200	http://dx.doi.org/10.1074/jbc.M706643200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18070882	hybrid, Green Accepted			2022-12-25	WOS:000253083000052
J	Anders, CK; Acharya, CR; Hsu, DS; Broadwater, G; Garman, K; Foekens, JA; Zhang, Y; Wang, YX; Marcom, K; Marks, JR; Mukherjee, S; Nevins, JR; Blackwell, KL; Potti, A				Anders, Carey K.; Acharya, Chaitanya R.; Hsu, David S.; Broadwater, Gloria; Garman, Katherine; Foekens, John A.; Zhang, Yi; Wang, Yixin; Marcom, Kelly; Marks, Jeffrey R.; Mukherjee, Sayan; Nevins, Joseph R.; Blackwell, Kimberly L.; Potti, Anil			Age-Specific Differences in Oncogenic Pathway Deregulation Seen in Human Breast Tumors	PLOS ONE			English	Article							TRANSCRIPTION FACTOR E2F-1; EXPRESSION; CANCER; SURVIVAL; SIGNATURES; PROGNOSIS; SUBTYPES; GROWTH; GUIDE	Purpose. To define the biology driving the aggressive nature of breast cancer arising in young women. Experimental Design. Among 784 patients with early stage breast cancer, using prospectively-defined, age-specific cohorts (young <= 45 years; older <= 65 years), 411 eligible patients (n = 200 <= 45 years; n = 211 <= 65 years) with clinically-annotated Affymetrix microarray data were identified. GSEA, signatures of oncogenic pathway deregulation and predictors of chemotherapy sensitivity were evaluated within the two age-defined cohorts. Results. In comparing deregulation of oncogenic pathways between age groups, a higher probability of PI3K (p = 0.006) and Myc (p = 0.03) pathway deregulation was observed in breast tumors arising in younger women. When evaluating unique patterns of pathway deregulation, a low probability of Src and E2F deregulation in tumors of younger women, concurrent with a higher probability of PI3K, Myc, and beta-catenin, conferred a worse prognosis (HR = 4.15). In contrast, a higher probability of Src and E2F pathway activation in tumors of older women, with concurrent low probability of PI3K, Myc and beta-catenin deregulation, was associated with poorer outcome (HR = 2.7). In multivariate analyses, genomic clusters of pathway deregulation illustrate prognostic value. Conclusion. Results demonstrate that breast cancer arising in young women represents a distinct biologic entity characterized by unique patterns of deregulated signaling pathways that are prognostic, independent of currently available clinico-pathologic variables. These results should enable refinement of targeted treatment strategies in this clinically challenging situation.	[Anders, Carey K.; Hsu, David S.; Marcom, Kelly; Blackwell, Kimberly L.; Potti, Anil] Duke Univ, Dept Med, Div Med Oncol, Durham, NC 27706 USA; [Acharya, Chaitanya R.; Hsu, David S.; Garman, Katherine; Marks, Jeffrey R.; Mukherjee, Sayan; Nevins, Joseph R.; Potti, Anil] Duke Univ, Inst Genome Sci & Policy, Durham, NC USA; [Broadwater, Gloria] Duke Univ, Med Ctr, Canc Ctr Biostat, Durham, NC USA; [Foekens, John A.] Erasmus MC, Rotterdam, Netherlands; [Zhang, Yi; Wang, Yixin] Johnson & Johnson, Veridex Inc, San Diego, CA USA	Duke University; Duke University; Duke University; Erasmus University Rotterdam; Erasmus MC; Johnson & Johnson; Johnson & Johnson USA	Potti, A (corresponding author), Duke Univ, Dept Med, Div Med Oncol, Durham, NC 27706 USA.	anil.potti@duke.edu	Acharya, Chaitanya/T-3510-2019	Mukherjee, Sayan/0000-0002-6715-3920	NCI [CA093245-05]; NATIONAL CANCER INSTITUTE [T32CA093245] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research has been supported by T32 (CA093245-05) Duke Translational Research in Oncology Training Grant, provided by the NCI (CA).	ADAMI HO, 1986, NEW ENGL J MED, V315, P559, DOI 10.1056/NEJM198608283150906; Aebi S, 2000, LANCET, V355, P1869, DOI 10.1016/S0140-6736(00)02292-3; Albain K S, 1994, J Natl Cancer Inst Monogr, P35; ANDERS C, 2007, YOUNG AGE DIAG UNPUB; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bramis J, 2004, ANTICANCER RES, V24, P3041; DELAROCHEFORDIERE A, 1993, LANCET, V341, P1039, DOI 10.1016/0140-6736(93)92407-K; El Saghir NS, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-194; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Han S, 2003, BREAST CANCER RES TR, V82, P11, DOI 10.1023/B:BREA.0000003843.53726.63; Harrell FE, 2001, REGRESSION MODELING; Holli K, 1997, EUR J CANCER, V33, P425; IHAKA R, 1996, J COMPUTATIONAL GRAP, V5, P299, DOI [10.2307/1390807, DOI 10.1080/10618600.1996.10474713]; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Johnson DG, 2006, CURR MOL MED, V6, P731; Kollias J, 1997, BRIT J CANCER, V75, P1318, DOI 10.1038/bjc.1997.223; LEHRER S, 1989, MT SINAI J MED, V56, P83; NIXON AJ, 1994, J CLIN ONCOL, V12, P888, DOI 10.1200/JCO.1994.12.5.888; Pittman J, 2004, BIOSTATISTICS, V5, P587, DOI 10.1093/biostatistics/kxh011; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Rabbani F, 1999, J NATL CANCER I, V91, P874, DOI 10.1093/jnci/91.10.874; Rounbehler RJ, 2002, CANCER RES, V62, P3276; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; Vara JAF, 2004, CANCER TREAT REV, V30, P193, DOI 10.1016/j.ctrv.2003.07.007; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998	29	76	78	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1373	10.1371/journal.pone.0001373	http://dx.doi.org/10.1371/journal.pone.0001373			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167534	Green Published, gold			2022-12-25	WOS:000260468900002
J	Pandey, M; Patel, SS; Gabriel, A				Pandey, Manjula; Patel, Smita S.; Gabriel, Abram			Kinetic Pathway of Pyrophosphorolysis by a Retrotransposon Reverse Transcriptase	PLOS ONE			English	Article							DEPENDENT DNA-POLYMERASE; T7 RNA-POLYMERASE; ACTIVE-SITE ASPARTATE; PRIMER-UNBLOCKING; CATALYTIC COMPLEX; MECHANISM; VIRUS; POLYMERIZATION; TRANSLOCATION; RESISTANCE	DNA and RNA polymerases use a common phosphoryl transfer mechanism for base addition that requires two or three acidic amino acid residues at their active sites. We previously showed, for the reverse transcriptase (RT) encoded by the yeast retrotransposon Ty1, that one of the three conserved active site aspartates (D-211) can be substituted by asparagine and still retain in vitro polymerase activity, although in vivo transposition is lost. Transposition is partially restored by second site suppressor mutations in the RNAse H domain. The novel properties of this amino acid substitution led us to express the WT and D211N mutant enzymes, and study their pre-steady state kinetic parameters. We found that the k(pol) was reduced by a factor of 223 in the mutant, although the K-d for nucleotide binding was unaltered. Further, the mutant enzyme had a marked preference for Mn2+ over Mg2+. To better understand the functions of this residue within the Ty1 RT active site, we have now examined the in vitro properties of WT and D211N mutant Ty1 RTs in carrying out pyrophosphorolysis, the reverse reaction to polymerization, where pyrophosphate is the substrate and dNTPs are the product. We find that pyrophosphorolysis is efficient only when the base-paired primer template region is > 14 bases, and that activity increases when the primer end is blunt-ended or recessed by only a few bases. Using pre-steady state kinetic analysis, we find that the rate of pyrophosphorolysis (k(pyro)) in the D211N mutant is nearly 320 fold lower than the WT enzyme, and that the mutant enzyme has an similar to 170 fold lower apparent K-d for pyrophosphate. These findings indicate that subtle substrate differences can strongly affect the enzyme's ability to properly position the primer-end to carry out pyrophosphorolysis. Further the kinetic data suggests that the D-211 residue has a role in pyrophosphate binding and release, which could affect polymerase translocation, and help explain the D211N mutant's transposition defect.	[Pandey, Manjula; Gabriel, Abram] Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA; [Pandey, Manjula; Patel, Smita S.] Univ Med & Dent NJ, Dept Biochem, Piscataway, NJ USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center	Gabriel, A (corresponding author), Rutgers State Univ, Dept Mol Biol & Biochem, Piscataway, NJ 08855 USA.	gabriel@cabm.rutgers.edu			PHS [GM60534, GM55310, GM51966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055310, R01GM051966, R01GM060534, R37GM051966] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported, in part, from PHS grants GM60534 (to AG) and GM55310 and GM51966 (to SP). The sponsors or funders had no role in the design or conduct of the study, nor in the collection, analysis, or interpretation of the data, nor in the preparation, review or approval on the manuscript.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Anand VS, 2006, J BIOL CHEM, V281, P35677, DOI 10.1074/jbc.M608180200; Arion D, 1998, BIOCHEMISTRY-US, V37, P15908, DOI 10.1021/bi981200e; Arnold JJ, 2004, BIOCHEMISTRY-US, V43, P5126, DOI 10.1021/bi035212y; BALTIMORE D, 1970, NATURE, V226, P1209, DOI 10.1038/2261209a0; Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011; Beard WA, 2006, CHEM REV, V106, P361, DOI 10.1021/cr0404904; Bibillo A, 2005, NUCLEIC ACIDS RES, V33, P171, DOI 10.1093/nar/gki150; Bolton EC, 2002, MOL CELL, V9, P879, DOI 10.1016/S1097-2765(02)00495-1; D'Abramo CM, 2004, J MOL BIOL, V337, P1, DOI 10.1016/j.jmb.2004.01.030; DELARUE M, 1990, PROTEIN ENG, V3, P461, DOI 10.1093/protein/3.6.461; GILBOA E, 1979, CELL, V18, P93, DOI 10.1016/0092-8674(79)90357-X; Goldschmidt V, 2004, INT J BIOCHEM CELL B, V36, P1687, DOI 10.1016/j.biocel.2004.02.028; Guajardo R, 1997, J MOL BIOL, V265, P8, DOI 10.1006/jmbi.1996.0707; HSIEH JC, 1993, J BIOL CHEM, V268, P24607; Huang HF, 1998, SCIENCE, V282, P1669, DOI 10.1126/science.282.5394.1669; JIANG MY, 1994, BIOESSAYS, V16, P531, DOI 10.1002/bies.950160803; Johnson K. A., 1992, ENZYMES, P1; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kaushik N, 1996, BIOCHEMISTRY-US, V35, P11536, DOI 10.1021/bi960364x; LARDER BA, 1987, NATURE, V327, P716, DOI 10.1038/327716a0; LEGRICE SFJ, 1991, EMBO J, V10, P3905, DOI 10.1002/j.1460-2075.1991.tb04960.x; Lin P, 2006, P NATL ACAD SCI USA, V103, P13294, DOI 10.1073/pnas.0606006103; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; Meyer PR, 2003, J VIROL, V77, P6127, DOI 10.1128/JVI.77.11.6127-6137.2003; Meyer PR, 1998, P NATL ACAD SCI USA, V95, P13471, DOI 10.1073/pnas.95.23.13471; Pandey M, 2004, J BIOL CHEM, V279, P47840, DOI 10.1074/jbc.M406019200; Patel PH, 2000, P NATL ACAD SCI USA, V97, P5095, DOI 10.1073/pnas.97.10.5095; PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006; PATEL SS, 1991, BIOCHEMISTRY-US, V30, P511, DOI 10.1021/bi00216a029; REARDON JE, 1993, J BIOL CHEM, V268, P8743; Sarafianos SG, 2003, J BIOL CHEM, V278, P16280, DOI 10.1074/jbc.M212911200; Sarafianos SG, 2002, EMBO J, V21, P6614, DOI 10.1093/emboj/cdf637; SKALKA A, 1993, REVERSE TRANSCRIPTAS; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; TEMIN HM, 1970, NATURE, V226, P1211, DOI 10.1038/2261211a0; Urban S, 2001, P NATL ACAD SCI USA, V98, P4984, DOI 10.1073/pnas.091324398; Uzun O, 2001, J VIROL, V75, P6337, DOI 10.1128/JVI.75.14.6337-6347.2001; Wilhelm FX, 2005, CYTOGENET GENOME RES, V110, P269, DOI 10.1159/000084960; Wilhelm M, 2000, BIOCHEM J, V348, P337, DOI 10.1042/0264-6021:3480337; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464	42	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1389	10.1371/journal.pone.0001389	http://dx.doi.org/10.1371/journal.pone.0001389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167548	Green Submitted, gold, Green Published			2022-12-25	WOS:000260468900017
J	Byrd, A; Hoffmann, SC; Jarahian, M; Momburg, F; Watzl, C				Byrd, Andreina; Hoffmann, Sabrina C.; Jarahian, Mostafa; Momburg, Frank; Watzl, Carsten			Expression Analysis of the Ligands for the Natural Killer Cell Receptors NKp30 and NKp44	PLOS ONE			English	Article								Background. The natural cytotoxicity receptors (NCR) are important to stimulate the activity of Natural Killer (NK) cells against transformed cells. Identification of NCR ligands and their level of expression on normal and neoplastic cells has important implications for the rational design of immunotherapy strategies for cancer. Methodology/Principal Findings. Here we analyze the expression of NKp30 ligand and NKp44 ligand on 30 transformed or non-transformed cell lines of different origin. We find intracellular and surface expression of these two ligands on almost all cell lines tested. Expression of NKp30 and NKp44 ligands was variable and did not correlate with the origin of the cell line. Expression of NKp30 and NKp44 ligand correlated with NKp30 and NKp44-mediated NK cell lysis of tumor cells, respectively. The surface expression of NKp30 ligand and NKp44 ligand was sensitive to trypsin treatment and was reduced in cells arrested in G2/M phase. Conclusion/Significance. These data demonstrate the ubiquitous expression of the ligands for NKp30 and NKp44 and give an important insight into the regulation of these ligands.	[Byrd, Andreina; Hoffmann, Sabrina C.; Watzl, Carsten] Univ Heidelberg, Inst Immunol, D-6900 Heidelberg, Germany; [Jarahian, Mostafa; Momburg, Frank] German Canc Res Ctr, Dept Mol Immunol, D-6900 Heidelberg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Watzl, C (corresponding author), Univ Heidelberg, Inst Immunol, Neuenheimer Feld 305, D-6900 Heidelberg, Germany.	Carsten.watzl@urz.uni-heidelberg.de	Watzl, Carsten/B-4911-2013	Watzl, Carsten/0000-0001-5195-0995	Deutsche Krebshilfe [106174]	Deutsche Krebshilfe(Deutsche Krebshilfe)	This work was supported by the Deutsche Krebshilfe (grant 106174).	Arnon TI, 2006, SEMIN CANCER BIOL, V16, P348, DOI 10.1016/j.semcancer.2006.07.005; Arnon TI, 2005, NAT IMMUNOL, V6, P515, DOI 10.1038/ni1190; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Bhat R, 2006, J LEUKOCYTE BIOL, V79, P417, DOI 10.1189/jlb.0905537; Bloushtain N, 2004, J IMMUNOL, V173, P2392, DOI 10.4049/jimmunol.173.4.2392; Bottino C, 2001, J EXP MED, V194, P235, DOI 10.1084/jem.194.3.235; Bryceson YT, 2006, BLOOD, V107, P159, DOI 10.1182/blood-2005-04-1351; Chisholm SE, 2006, J VIROL, V80, P2225, DOI 10.1128/JVI.80.5.2225-2233.2006; Chisholm SE, 2007, J INFECT DIS, V195, P1160, DOI 10.1086/512862; Costello RT, 2002, BLOOD, V99, P3661, DOI 10.1182/blood.V99.10.3661; Hayakawa Y, 2006, ADV CANCER RES, V95, P293, DOI 10.1016/S0065-230X(06)95008-8; Hershkovitz O, 2007, BIOCHEMISTRY-US, V46, P7426, DOI 10.1021/bi7000455; Jarahian M, 2007, INT J CANCER, V120, P2625, DOI 10.1002/ijc.22579; Kumar V, 2005, NAT REV IMMUNOL, V5, P363, DOI 10.1038/nri1603; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lee SH, 2007, TRENDS IMMUNOL, V28, P252, DOI 10.1016/j.it.2007.04.001; Ljunggren HG, 2007, NAT REV IMMUNOL, V7, P329, DOI 10.1038/nri2073; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mavoungou E, 2007, J INFECT DIS, V195, P1521, DOI 10.1086/515579; Messmer B, 2006, J IMMUNOL, V176, P4646, DOI 10.4049/jimmunol.176.8.4646; Moretta L, 2004, CURR OPIN IMMUNOL, V16, P626, DOI 10.1016/j.coi.2004.07.010; Moretta L, 2004, EMBO J, V23, P255, DOI 10.1038/sj.emboj.7600019; Moretta L, 2006, IMMUNOL REV, V214, P219, DOI 10.1111/j.1600-065X.2006.00450.x; Newman KC, 2007, NAT REV IMMUNOL, V7, P279, DOI 10.1038/nri2057; Nolte-'t Hoen ENM, 2007, BLOOD, V109, P670, DOI 10.1182/blood-2006-07-036509; Nowbakht P, 2005, BLOOD, V105, P3615, DOI 10.1182/blood-2004-07-2585; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Ruggeri L, 2007, CURR OPIN ONCOL, V19, P142, DOI 10.1097/CCO.0b013e3280148a1a; Sivori S, 1999, EUR J IMMUNOL, V29, P1656, DOI 10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1; Sivori S, 2000, EUR J IMMUNOL, V30, P787, DOI 10.1002/1521-4141(200003)30:3<787::AID-IMMU787>3.0.CO;2-I; Stark S, 2005, J IMMUNOL METHODS, V296, P149, DOI 10.1016/j.jim.2004.11.010; Vieillard V, 2005, P NATL ACAD SCI USA, V102, P10981, DOI 10.1073/pnas.0504315102; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Warren HS, 2005, J IMMUNOL, V175, P207, DOI 10.4049/jimmunol.175.1.207; Watzl C, 2003, J EXP MED, V197, P77, DOI 10.1084/jem.20020427; Wu J, 2003, ADV CANCER RES, V90, P127, DOI 10.1016/S0065-230X(03)90004-2; Zamai L, 2007, J IMMUNOL, V178, P4011, DOI 10.4049/jimmunol.178.7.4011	39	76	77	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1339	10.1371/journal.pone.0001339	http://dx.doi.org/10.1371/journal.pone.0001339			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092004	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459600022
J	Diaz, JA; Jaramillo, NA; Murillo, MF				Diaz, Jairo A.; Jaramillo, Natalia A.; Murillo, Mauricio F.			Geometric Triangular Chiral Hexagon Crystal-Like Complexes Organization in Pathological Tissues Biological Collision Order	PLOS ONE			English	Article							STELLATE	The present study describes and documents self-assembly of geometric triangular chiral hexagon crystal like complex organizations (GTCHC) in human pathological tissues. The authors have found this architectural geometric expression at macroscopic and microscopic levels mainly in cancer processes. This study is based essentially on macroscopic and histopathologic analyses of 3000 surgical specimens: 2600 inflammatory lesions and 400 malignant tumours. Geometric complexes identified photographically at macroscopic level were located in the gross surgical specimen, and these areas were carefully dissected. Samples were taken to carry out histologic analysis. Based on the hypothesis of a collision genesis mechanism and because it is difficult to carry out an appropriate methodological observation in biological systems, the authors designed a model base on other dynamic systems to obtain indirect information in which a strong white flash wave light discharge, generated by an electronic device, hits over the lines of electrical conductance structured in helicoidal pattern. In their experimental model, the authors were able to reproduce and to predict polarity, chirality, helicoid geometry, triangular and hexagonal clusters through electromagnetic sequential collisions. They determined that similar events among constituents of extracelular matrix which drive and produce piezoelectric activity are responsible for the genesis of GTCHC complexes in pathological tissues. This research suggests that molecular crystals represented by triangular chiral hexagons derived from a collision-attraction event against collagen type I fibrils emerge at microscopic and macroscopic scales presenting a lateral assembly of each side of hypertrophy helicoid fibers, that represent energy flow in cooperative hierarchically chiral electromagnetic interaction in pathological tissues and arises as a geometry of the equilibrium in perturbed biological systems. Further interdisciplinary studies must be carried out to reproduce, manipulate and amplify their activity and probably use them as a base to develop new therapeutic strategies in cancer.	[Diaz, Jairo A.; Jaramillo, Natalia A.; Murillo, Mauricio F.] Univ Cooperativa Colombia, Sch Med, Pathol Lab, Dept Pathol,Clin Hlth Social Ent Policarpa Salava, Villavicencio, Meta, Colombia	Universidad Cooperativa de Colombia	Diaz, JA (corresponding author), Univ Cooperativa Colombia, Sch Med, Pathol Lab, Dept Pathol,Clin Hlth Social Ent Policarpa Salava, Villavicencio, Meta, Colombia.	jaditod@hotmail.com		Jaramillo Gomez, Natalia/0000-0002-0939-171X	Medicine School, Pathology Department, Cooperative University of Colombia; Clinical Carlos Hugo Estrada, State social company Policarpa Salavarrieta, Villavicencio, Colombia	Medicine School, Pathology Department, Cooperative University of Colombia; Clinical Carlos Hugo Estrada, State social company Policarpa Salavarrieta, Villavicencio, Colombia	This investigation was possible thanks to the logistical and economic support of the Medicine School, Pathology Department, Cooperative University of Colombia and the Clinical Carlos Hugo Estrada, State social company Policarpa Salavarrieta, Villavicencio, Colombia.	ADDADI L, 2007, TOPICS STEREOCHEMIST, V17; Barron LD, 2000, NATURE, V405, P895, DOI 10.1038/35016183; Brizard A, 2005, TOP CURR CHEM, V256, P167, DOI 10.1007/b107174; Cherel P, 2005, EUR J RADIOL, V54, P37, DOI 10.1016/j.ejrad.2004.11.018; Dong LF, 2006, PLASMA SOURCES SCI T, V15, P840, DOI 10.1088/0963-0252/15/4/029; He HJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.101803; Hulliger J, 2002, CHEM MATER, V14, P1523, DOI 10.1021/cm010405y; HULMES DJS, 1979, NATURE, V282, P878, DOI 10.1038/282878a0; LANYI M, 1982, FORTSCHR RONTG NEUEN, V136, P182, DOI 10.1055/s-2008-1056023; Oda R, 1996, J PHYS II, V6, P1429, DOI 10.1051/jp2:1996140; Pokorna E, 2003, FOLIA BIOL-PRAGUE, V49, P33; Prockop DJ, 1998, J STRUCT BIOL, V122, P111, DOI 10.1006/jsbi.1998.3976; Prosser RS, 1998, BIOPHYS J, V75, P2163, DOI 10.1016/S0006-3495(98)77659-3; SHAMOS MH, 1967, NATURE, V213, P267, DOI 10.1038/213267a0; Tadokoro T, 2004, J GASTROENTEROL, V39, P635, DOI 10.1007/s00535-004-1358-1; Tamura S, 2002, J GASTROENTEROL, V37, P798, DOI 10.1007/s005350200133	16	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1282	10.1371/journal.pone.0001282	http://dx.doi.org/10.1371/journal.pone.0001282			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074008	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459500001
J	Estep, AL; Palmer, C; McCormick, F; Rauen, KA				Estep, Anne L.; Palmer, Chana; McCormick, Frank; Rauen, Katherine A.			Mutation Analysis of BRAF, MEK1 and MEK2 in 15 Ovarian Cancer Cell Lines: Implications for Therapy	PLOS ONE			English	Article							KINASE GENE FAMILY; PROTEIN MAP KINASE; LOW-GRADE; SOMATIC MUTATIONS; SIGNALING PATHWAY; PIK3CA MUTATIONS; PTEN GENE; KRAS; ACTIVATION; NEOPLASMS	Background. Among gynecologic cancers, ovarian cancer is the second most common and has the highest death rate. Cancer is a genetic disorder and arises due to the accumulation of somatic mutations in critical genes. An understanding of the genetic basis of ovarian cancer has implications both for early detection and for therapeutic intervention in this population of patients. Methodology/Principal Findings. Fifteen ovarian cancer cell lines, commonly used for in vitro experiments, were screened for mutations using bidirectional direct sequencing in all coding regions of BRAF, MEK1 and MEK2. BRAF mutations were identified in four of the fifteen ovarian cancer cell lines studied. Together, these four cell lines contained four different BRAF mutations, two of which were novel. ES-2 had the common B-Raf p. V600E mutation in exon 15 and Hey contained an exon 11 missense mutation, p.G464E. The two novel B-Raf mutants identified were a 5 amino acid heterozygous deletion p.N486-P490del in OV90, and an exon 4 missense substitution p.Q201H in OVCAR 10. One of the cell lines, ES-2, contained a mutation in MEK1, specifically, a novel heterozygous missense substitution, p. D67N which resulted from a nt 199 G -> A transition. None of the cell lines contained coding region mutations in MEK2. Functional characterization of the MEK1 mutant p. D67N by transient transfection with subsequent Western blot analysis demonstrated increased ERK phosphorylation as compared to controls. Conclusions/Significance. In this study, we report novel BRAF mutations in exon 4 and exon 12 and also report the first mutation in MEK1 associated with human cancer. Functional data indicate the MEK1 mutation may confer alteration of activation through the MAPK pathway. The significance of these findings is that BRAF and MEK1/2 mutations may be more common than anticipated in ovarian cancer which could have important implications for treatment of patients with this disease and suggests potential new therapeutic avenues.	[Estep, Anne L.; McCormick, Frank; Rauen, Katherine A.] Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA; [Estep, Anne L.; McCormick, Frank; Rauen, Katherine A.] Univ Calif San Francisco, Canc Res Inst, San Francisco, CA 94143 USA; [Palmer, Chana] Canary Fdn, San Jose, CA USA; [McCormick, Frank] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Rauen, Katherine A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Rauen, KA (corresponding author), Univ Calif San Francisco, Ctr Comprehens Canc, San Francisco, CA 94143 USA.	rauen@cc.ucsf.edu			NIH [HD048502]; Canary Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD048502] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canary Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	NIH grant HD048502 (K.A.R.) provided partial funding. Canary Foundation provided partial funding. The Canary Foundation did not have a role in the collection, analysis, and interpretation of data.	Bansal A, 1997, ONCOGENE, V14, P1231, DOI 10.1038/sj.onc.1200947; Bignell G, 2006, GENE CHROMOSOME CANC, V45, P42, DOI 10.1002/gcc.20265; BUICK RN, 1985, CANCER RES, V45, P3668; Campbell IG, 2005, CLIN CANCER RES, V11, P7042, DOI 10.1158/1078-0432.CCR-05-1024; ChenevixTrench G, 1997, GENE CHROMOSOME CANC, V18, P75, DOI 10.1002/(SICI)1098-2264(199702)18:2<75::AID-GCC1>3.0.CO;2-Y; Cruz F, 2003, CANCER RES, V63, P5761; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delaney AM, 2002, MOL CELL BIOL, V22, P7593, DOI 10.1128/MCB.22.21.7593-7602.2002; Fukuda M, 1997, J BIOL CHEM, V272, P32642, DOI 10.1074/jbc.272.51.32642; Gemignani ML, 2003, GYNECOL ONCOL, V90, P378, DOI 10.1016/S0090-8258(03)00264-6; Ho CL, 2004, CANCER RES, V64, P6915, DOI 10.1158/0008-5472.CAN-04-2067; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; Hunter C, 2006, CANCER RES, V66, P3987, DOI 10.1158/0008-5472.CAN-06-0127; Ikediobi ON, 2006, MOL CANCER THER, V5, P2606, DOI 10.1158/1535-7163.MCT-06-0433; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; LAU DHM, 1991, CANCER RES, V51, P5181; Levine DA, 2005, CLIN CANCER RES, V11, P2875, DOI 10.1158/1078-0432.CCR-04-2142; MANSOUR SJ, 1994, J BIOCHEM-TOKYO, V116, P304, DOI 10.1093/oxfordjournals.jbchem.a124524; Morita K, 2000, PATHOL INT, V50, P219, DOI 10.1046/j.1440-1827.2000.01028.x; Nakayama K, 2006, CANCER BIOL THER, V5, P779, DOI 10.4161/cbt.5.7.2751; Narumi Y, 2007, AM J MED GENET A, V143A, P799, DOI 10.1002/ajmg.a.31658; NAVA C, 2007, J MED GENET; Ng PC, 2006, ANNU REV GENOM HUM G, V7, P61, DOI 10.1146/annurev.genom.7.080505.115630; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Niihori T, 2006, NAT GENET, V38, P294, DOI 10.1038/ng1749; Provencher DM, 2000, IN VITRO CELL DEV-AN, V36, P357; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; Russell SEH, 2004, J PATHOL, V203, P617, DOI 10.1002/path.1563; Saito M, 2000, INT J CANCER, V85, P160, DOI 10.1002/(SICI)1097-0215(20000115)85:2<160::AID-IJC2>3.0.CO;2-5; Schondorf T, 2000, J SOC GYNECOL INVEST, V7, P313, DOI 10.1016/S1071-5576(00)00076-9; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Sieben NLG, 2004, J PATHOL, V202, P336, DOI 10.1002/path.1521; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; Singer G, 2003, J NATL CANCER I, V95, P484, DOI 10.1093/jnci/95.6.484; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Trovisco V, 2005, HUM PATHOL, V36, P694, DOI 10.1016/j.humpath.2005.04.011; Tworek H, 1999, CANCER GENET CYTOGEN, V112, P105, DOI 10.1016/S0165-4608(98)00267-2; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang Y, 2005, HUM MUTAT, V25, DOI 10.1002/humu.9316; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218	44	65	75	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1279	10.1371/journal.pone.0001279	http://dx.doi.org/10.1371/journal.pone.0001279			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060073	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459400026
J	Dou, GR; Wang, YC; Hu, XB; Hou, LH; Wang, CM; Xu, JF; Wang, YS; Liang, YM; Yao, LB; Yang, AG; Han, H				Dou, Guo-Rui; Wang, Yao-Chun; Hu, Xing-Bin; Hou, Li-Hong; Wang, Chun-Mei; Xu, Jian-Feng; Wang, Yu-Sheng; Liang, Ying-Min; Yao, Li-Bo; Yang, An-Gang; Han, Hua			RBPJ, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice	FASEB JOURNAL			English	Article						angiogenesis; Notch signaling; endothelial cells; choroidal neovascularization	ARTERIOVENOUS-MALFORMATIONS; ACTIVATED NOTCH4; PROGENITOR CELLS; TUMOR-GROWTH; EXPRESSION; PATHWAY; ANGIOGENESIS; INHIBITION; TARGET; GENES	In adults, angiogenic abnormalities are involved in not only tumor growth but several human inherited diseases as well. It is unclear, however, concerning how the normal vascular structure is maintained and how angiogenesis is initiated in normal adults. Using the Cre-LoxP-mediated conditional gene deletion, we show in the present study that in adult mice disruption of the transcription factor recombination signal-binding protein J kappa (RBP-J) in endothelial cells strikingly induced spontaneous angiogenesis in multiple tissues, including retina and cornea, as well as in internal organs, such as liver and lung. In a choroidal neovascularization model, which mimics the angiogenic process in tumor growth and age-related macular degeneration, RBP-J deficiency induced a more intensive angiogenic response to injury. This could be transmitted by bone marrow, indicating that RBP-J could modulate bone marrow-derived endothelial progenitor cells in adult angiogenesis. In addition, in the absence of RBP-J, proliferation of endothelial cells increased significantly, leading to accumulative vessel outgrowth. These findings suggest that in adults RBP-J-mediated Notch signaling may play an essential role in the maintenance of vascular homeostasis by repressing endothelial cell proliferation.	[Dou, Guo-Rui; Wang, Yao-Chun; Hu, Xing-Bin; Hou, Li-Hong; Wang, Chun-Mei; Liang, Ying-Min; Yao, Li-Bo; Yang, An-Gang; Han, Hua] Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Xian 710032, Peoples R China; [Dou, Guo-Rui; Xu, Jian-Feng; Wang, Yu-Sheng; Liang, Ying-Min] Fourth Mil Med Univ, Xijing Hosp, Dept Ophthalmol, Xian 710032, Peoples R China; [Han, Hua] Fourth Mil Med Univ, Tangdu Hosp, Dept Hematol, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Han, H (corresponding author), Fourth Mil Med Univ, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Chang Le Xi St 17, Xian 710032, Peoples R China.	wangys@fmmu.edu.cn	Hu, XB/U-8501-2019					Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; BAILEY AM, 1995, GENE DEV, V9, P2609, DOI 10.1101/gad.9.21.2609; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Carey KA, 2007, J GERONTOL A-BIOL, V62, P9, DOI 10.1093/gerona/62.1.9; Carlson TR, 2005, P NATL ACAD SCI USA, V102, P9884, DOI 10.1073/pnas.0504391102; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; deAngelis MH, 1997, NATURE, V386, P717, DOI 10.1038/386717a0; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Fischer A, 2004, GENE DEV, V18, P901, DOI 10.1101/gad.291004; Gridley T, 2001, P NATL ACAD SCI USA, V98, P5377, DOI 10.1073/pnas.101138098; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; HANS EG, 2004, AM J OPHTHALMOL, V137, P496; HARRINGTON LS, 2007, MICROVASC RES; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; Hou HY, 2006, CURR EYE RES, V31, P1051, DOI 10.1080/02713680601100459; Iso T, 2002, J BIOL CHEM, V277, P6598, DOI 10.1074/jbc.M110495200; Joutel A, 1998, SEMIN CELL DEV BIOL, V9, P619, DOI 10.1006/scdb.1998.0261; Joutel A, 1996, NATURE, V383, P707, DOI 10.1038/383707a0; Karsan A, 2005, CAN J PHYSIOL PHARM, V83, P14, DOI 10.1139/Y04-125; Kato H, 1997, DEVELOPMENT, V124, P4133; Kokubo H, 1999, BIOCHEM BIOPH RES CO, V260, P459, DOI 10.1006/bbrc.1999.0880; Krebs LT, 2000, GENE DEV, V14, P1343; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; Lacombe P, 2005, STROKE, V36, P1053, DOI 10.1161/01.STR.0000163080.82766.eb; Lawson ND, 2002, DEV CELL, V3, P127, DOI 10.1016/S1534-5807(02)00198-3; Leong KG, 2002, MOL CELL BIOL, V22, P2830, DOI 10.1128/MCB.22.8.2830-2841.2002; Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244; Liu ZJ, 2006, FASEB J, V20, P1009, DOI 10.1096/fj.05-4880fje; Lobov IB, 2007, P NATL ACAD SCI USA, V104, P3219, DOI 10.1073/pnas.0611206104; Nakajima M, 2003, MECH DEVELOP, V120, P657, DOI 10.1016/S0925-4773(03)00064-9; Nicolas M, 2003, NAT GENET, V33, P416, DOI 10.1038/ng1099; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; Noseda M, 2004, MOL CELL BIOL, V24, P8813, DOI 10.1128/MCB.24.20.8813-8822.2004; Noseda M, 2006, CIRC RES, V98, P1468, DOI 10.1161/01.RES.0000229683.81357.26; Paris D, 2005, EUR J PHARMACOL, V514, P1, DOI 10.1016/j.ejphar.2005.02.050; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Rao PK, 2000, EXP CELL RES, V260, P379, DOI 10.1006/excr.2000.5034; Rehman AO, 2006, TRENDS CELL BIOL, V16, P293, DOI 10.1016/j.tcb.2006.04.003; Roberts N, 2005, J CELL MOL MED, V9, P583, DOI 10.1111/j.1582-4934.2005.tb00490.x; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577; SWIATEK PJ, 1994, GENE DEV, V8, P707, DOI 10.1101/gad.8.6.707; Takahashi H, 2004, BIOCHEM BIOPH RES CO, V325, P461, DOI 10.1016/j.bbrc.2004.10.054; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Uyttendaele H, 2001, P NATL ACAD SCI USA, V98, P5643, DOI 10.1073/pnas.091584598; Villa N, 2001, MECH DEVELOP, V108, P161, DOI 10.1016/S0925-4773(01)00469-5; Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000; Xue YZ, 1999, HUM MOL GENET, V8, P723, DOI 10.1093/hmg/8.5.723; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215	54	86	95	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1606	1617		10.1096/fj.07-9998com	http://dx.doi.org/10.1096/fj.07-9998com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18096813				2022-12-25	WOS:000255898700032
J	Larouche, D; Tong, XM; Fradette, J; Coulombe, PA; Germain, L				Larouche, Danielle; Tong, Xuemei; Fradette, Julie; Coulombe, Pierre A.; Germain, Lucie			Vibrissa hair bulge houses two populations of skin epithelial stem cells distinct by their keratin profile	FASEB JOURNAL			English	Article						intermediate filaments; tissue engineering; transmission electron microscopy; rodent	ROOT SHEATH-CELLS; LABEL-RETAINING CELLS; IN-VITRO; MERKEL CELLS; MAMMALIAN-TISSUES; GENE-EXPRESSION; MOUSE SKIN; FOLLICLE; MICE; CYTOKERATINS	Defining the properties of postnatal stem cells is of interest given their relevance for tissue homeostasis and therapeutic applications, such as skin tissue engineering for burn patients. In hair follicles, the bulge region of the outer root sheath houses stem cells. We show that explants from the prominent bulge area, but not the bulb, in rodent vibrissa follicles can produce epidermis in a skin model of tissue engineering. Using morphological criteria and keratin expression, we typified epithelial stem cells of vibrissa bulge. Two types of slow-cycling cells (Bb, Bs1) featuring a high colony-forming capacity occur in the bulge. Bb cells are located in the outermost basal layer, express K5, K15, K17, and K19, and feature a loosely organized keratin network. Bs1 cells localize to the suprabasal layers proximal to Bb cells and express K5/K17, correlating with a network of densely bundled filaments. These prominent bundles are missing in K17-null mice, which lack vibrissa. Atypically, both the Bb and Bs1 keratinocytes lack K14 expression. These findings show heterogeneity within the hair follicle stem cell repository, establish that a subset of slow-cycling cells are suprabasal in location, and point to a special role for K5/K17 filaments in a newly defined subset of stem cells. Our results are discussed in the context of long-term survival of engineered tissues after grafting that requires the presence of stem cells.	[Larouche, Danielle; Fradette, Julie; Germain, Lucie] Hop St Sacrement CHA, Lab Organogenese Expt LEOX, Quebec City, PQ G1S 4L8, Canada; [Larouche, Danielle; Fradette, Julie; Germain, Lucie] Univ Laval, Dept Surg, Ste Foy, PQ G1K 7P4, Canada; [Tong, Xuemei; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Tong, Xuemei; Coulombe, Pierre A.] Johns Hopkins Univ, Sch Med, Dept Dermatol, Baltimore, MD 21205 USA	Laval University; Laval University; Johns Hopkins University; Johns Hopkins University	Germain, L (corresponding author), Hop St Sacrement CHA, Lab Organogenese Expt LEOX, 1050 Chemin, Quebec City, PQ G1S 4L8, Canada.	lucic.germain@chg.ulaval.ca		Germain, Lucie/0000-0001-8883-6491; Fradette, Julie/0000-0002-1851-5112	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044232, R01AR042047, R55AR042047] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR42047, AR44232] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Bernot KM, 2002, J INVEST DERMATOL, V119, P1137, DOI 10.1046/j.1523-1747.2002.19518.x; BICKENBACH JR, 1986, CELL TISSUE KINET, V19, P325, DOI 10.1111/j.1365-2184.1986.tb00684.x; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; BLESSING M, 1993, J CELL BIOL, V120, P743, DOI 10.1083/jcb.120.3.743; BYRNE C, 1994, DEVELOPMENT, V120, P2369; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; COULOMBE PA, 1989, J CELL BIOL, V109, P2295, DOI 10.1083/jcb.109.5.2295; Daniely Y, 2004, AM J PHYSIOL-CELL PH, V287, pC171, DOI 10.1152/ajpcell.00226.2003; Fradette J, 2003, J INVEST DERMATOL, V120, P313, DOI 10.1046/j.1523-1747.2003.12024.x; FRANKE WW, 1984, CELL, V36, P813, DOI 10.1016/0092-8674(84)90031-X; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; HEID HW, 1988, DIFFERENTIATION, V37, P137, DOI 10.1111/j.1432-0436.1988.tb00805.x; HEID HW, 1988, DIFFERENTIATION, V37, P215, DOI 10.1111/j.1432-0436.1988.tb00724.x; IBRAHIM L, 1975, J EMBRYOL EXP MORPH, V33, P831; Kim S, 2006, NATURE, V441, P362, DOI 10.1038/nature04659; KOBAYASHI K, 1993, P NATL ACAD SCI USA, V90, P7391, DOI 10.1073/pnas.90.15.7391; L'Heureux N, 1998, FASEB J, V12, P47, DOI 10.1096/fasebj.12.1.47; Laplante AF, 2001, FASEB J, V15, P2377, DOI 10.1096/fj.01-0250com; LAROUCHE D, METHODS MOL MED; LENOIR MC, 1988, DEV BIOL, V130, P610, DOI 10.1016/0012-1606(88)90356-9; LIMAT A, 1991, EXP CELL RES, V194, P218, DOI 10.1016/0014-4827(91)90357-Z; Limat A, 2002, CELLS TISSUES ORGANS, V172, P79, DOI 10.1159/000065615; Lyle S, 1998, J CELL SCI, V111, P3179; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; Mazzalupo S, 2003, DEV DYNAM, V226, P356, DOI 10.1002/dvdy.10245; McGowan K, 1998, Subcell Biochem, V31, P173; McGowan KM, 1998, J CELL BIOL, V143, P469, DOI 10.1083/jcb.143.2.469; McGowan KM, 2002, GENE DEV, V16, P1412, DOI 10.1101/gad.979502; Michel M, 1996, J CELL SCI, V109, P1017; Moll I, 1996, J INVEST DERMATOL, V106, P281, DOI 10.1111/1523-1747.ep12340714; MOLL R, 1984, DIFFERENTIATION, V28, P136, DOI 10.1111/j.1432-0436.1984.tb00277.x; MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; NELSON WG, 1983, J CELL BIOL, V97, P244, DOI 10.1083/jcb.97.1.244; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Paladini RD, 1996, J CELL BIOL, V132, P381, DOI 10.1083/jcb.132.3.381; Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; ROYAL I, 1995, EXP CELL RES, V220, P171, DOI 10.1006/excr.1995.1303; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; STARK HJ, 1987, DIFFERENTIATION, V35, P236, DOI 10.1111/j.1432-0436.1987.tb00174.x; STOLER A, 1988, J CELL BIOL, V107, P427, DOI 10.1083/jcb.107.2.427; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Tong XM, 2004, J INVEST DERMATOL, V122, P965, DOI 10.1111/j.0022-202X.2004.22422.x; Tong XM, 2006, GENE DEV, V20, P1353, DOI 10.1101/gad.1387406; Troy TC, 1999, J CELL PHYSIOL, V180, P409, DOI 10.1002/(SICI)1097-4652(199909)180:3<409::AID-JCP12>3.0.CO;2-V; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wang ZL, 2003, J INVEST DERMATOL, V121, P1276, DOI 10.1111/j.1523-1747.2003.12644.x; Wawersik M, 1997, J BIOL CHEM, V272, P32557, DOI 10.1074/jbc.272.51.32557; WEINBERG WC, 1993, J INVEST DERMATOL, V100, P229, DOI 10.1111/1523-1747.ep12468971; Whitbread LA, 1998, EXP CELL RES, V244, P448, DOI 10.1006/excr.1998.4217	53	43	43	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2008	22	5					1404	1415		10.1096/fj.07-8109com	http://dx.doi.org/10.1096/fj.07-8109com			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18162489				2022-12-25	WOS:000255898700013
J	Leister, P; Felten, A; Chasan, AI; Scheidtmann, KH				Leister, P.; Felten, A.; Chasan, A. I.; Scheidtmann, K. H.			ZIP kinase plays a crucial role in androgen receptor-mediated transcription	ONCOGENE			English	Article						androgen receptor; AATF/Che-1; co-activators; ZIP kinase/DAP like kinase	PROSTATE-CANCER; DLK/ZIP KINASE; NUCLEAR RECEPTORS; GENE-REGULATION; APOPTOSIS; PHOSPHORYLATION; INTERACTS; CHE-1; GROWTH; IDENTIFICATION	The androgen receptor (AR) is a ligand-dependent transcription factor that plays a crucial role in the development and homeostasis of the prostate and in prostate cancer. The transcriptional activity of AR is mediated by interaction with multiple co-activators, which serve in chromatin modi. cation or remodeling, or provide a link between specific and general transcription factors. We have identified zipper interacting protein (ZIP) kinase as a novel transcriptional co-activator of the AR. ZIP kinase enhanced expression of AR-responsive promotor/luciferase reporter constructs in a hormone-and kinase-dependent manner. Similar results were obtained for glucocorticoid receptor but not for progesterone receptor and estrogen receptor. Following hormone treatment, AR and ZIP kinase formed physical complexes and associated with the promoter and enhancer of the prostate-specific antigen gene, as revealed by chromatin immunoprecipitation. Strikingly, depletion of ZIP kinase by siRNA led to significant reduction of AR-mediated transactivation. The interaction of ZIP kinase with AR seems to be mediated in part by apoptosis antagonizing transcription factor and in part by direct binding. Interestingly, AR was not phosphorylated by ZIP kinase in vitro, suggesting that it phosphorylates other co-activators or chromatin proteins.	[Leister, P.; Felten, A.; Chasan, A. I.; Scheidtmann, K. H.] Univ Bonn, Genet Inst, D-53117 Bonn, Germany	University of Bonn	Scheidtmann, KH (corresponding author), Univ Bonn, Genet Inst, Romerstr 164,NRW, D-53117 Bonn, Germany.	kh.scheidtmann@uni-bonn.de		Imam Chasan, Achmet/0000-0001-5137-6890				Bruno T, 2002, CANCER CELL, V2, P387, DOI 10.1016/S1535-6108(02)00182-4; Bruno T, 2006, CANCER CELL, V10, P473, DOI 10.1016/j.ccr.2006.10.012; Burgdorf S, 2004, J BIOL CHEM, V279, P17524, DOI 10.1074/jbc.M313703200; Chen SY, 2006, P NATL ACAD SCI USA, V103, P15969, DOI 10.1073/pnas.0604193103; Debes JD, 2002, CANCER LETT, V187, P1, DOI 10.1016/S0304-3835(02)00413-5; Di Padova M, 2003, J BIOL CHEM, V278, P36496, DOI 10.1074/jbc.M306694200; Engemann H, 2002, NUCLEIC ACIDS RES, V30, P1408, DOI 10.1093/nar/30.6.1408; Fanciulli M, 2000, FASEB J, V14, P904, DOI 10.1096/fasebj.14.7.904; Felten A, 2007, BIOL CHEM, V388, P569, DOI 10.1515/BC.2007.073; Gao S, 2006, J MOL ENDOCRINOL, V36, P463, DOI 10.1677/jme.1.01991; Gioeli D, 2002, J BIOL CHEM, V277, P29304, DOI 10.1074/jbc.M204131200; Haystead TAJ, 2005, CELL SIGNAL, V17, P1313, DOI 10.1016/j.cellsig.2005.05.008; Kawai T, 2003, MOL CELL BIOL, V23, P6174, DOI 10.1128/MCB.23.17.6174-6186.2003; Kawai T, 1998, MOL CELL BIOL, V18, P1642, DOI 10.1128/MCB.18.3.1642; Kim J, 2004, J CELL BIOCHEM, V93, P233, DOI 10.1002/jcb.20228; Kogel D, 2001, BIOESSAYS, V23, P352, DOI 10.1002/bies.1050; Kogel D, 1999, ONCOGENE, V18, P7212, DOI 10.1038/sj.onc.1203169; Leister P., 2003, SIGNAL TRANSDUCTION, V3, P17, DOI [10.1002/sita.200300020, DOI 10.1002/SITA.200300020]; Lohrum M, 1996, ONCOGENE, V13, P2527; Lonard DM, 2006, CELL, V125, P411, DOI 10.1016/j.cell.2006.04.021; McEwan IJ, 2004, ENDOCR-RELAT CANCER, V11, P281, DOI 10.1677/erc.0.0110281; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; Muller JM, 2000, EMBO J, V19, P359, DOI 10.1093/emboj/19.3.359; Nelson JD, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gnj004; OTTEN AD, 1988, MOL ENDOCRINOL, V2, P143, DOI 10.1210/mend-2-2-143; Page G, 1999, ONCOGENE, V18, P7265, DOI 10.1038/sj.onc.1203170; Page G, 1999, FEBS LETT, V462, P187, DOI 10.1016/S0014-5793(99)01529-X; Rosenfeld MG, 2001, J BIOL CHEM, V276, P36865, DOI 10.1074/jbc.R100041200; Sato N, 2005, INT IMMUNOL, V17, P1543, DOI 10.1093/intimm/dxh331; Scheidtmann KH, 2007, SIGNAL TRANSDUCTION, V7, P248, DOI 10.1002/sita.200600112; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Taplin ME, 2004, J CELL BIOCHEM, V91, P483, DOI 10.1002/jcb.10653; Thomas T, 2000, DEV BIOL, V227, P324, DOI 10.1006/dbio.2000.9915; Ueda T, 2002, J BIOL CHEM, V277, P7076, DOI 10.1074/jbc.M108255200; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wu RC, 2005, ENDOCR REV, V26, P393, DOI 10.1210/er.2004-0018	36	20	24	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2008	27	23					3292	3300		10.1038/sj.onc.1210995	http://dx.doi.org/10.1038/sj.onc.1210995			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	304LQ	18084323				2022-12-25	WOS:000256111400008
J	Sugimoto, K; Sasaki, M; Isobe, Y; Tsutsui, M; Suto, H; Ando, J; Tamayose, K; Ando, M; Oshimi, K				Sugimoto, K.; Sasaki, M.; Isobe, Y.; Tsutsui, M.; Suto, H.; Ando, J.; Tamayose, K.; Ando, M.; Oshimi, K.			Hsp90-inhibitor geldanamycin abrogates G(2) arrest in p53-negative leukemia cell lines through the depletion of Chk1	ONCOGENE			English	Article						Hsp90; geldanamycin; Chk1; G(2) arrest	DNA-DAMAGE; ANSAMYCINS CAUSES; PROTEIN-KINASE; TUMOR-CELLS; HSP90; CHECKPOINT; INHIBITION; APOPTOSIS; CYCLE; RADIOSENSITIZATION	Checkpoint protein Chk1 has been identified as an Hsp90 client. Treatment with 100 nM geldanamycin (GM) for 24 h markedly reduced the Chk1 amount in Jurkat and ML-1 leukemia cell lines. Because Chk1 plays a central role in G(2) checkpoint, we added GM to G(2)-arrested Jurkat and HL-60 cells pretreated with 50 nM doxorubicin for 24 h. GM slowly released both cell lines from doxorubicin-induced G(2) arrest into G(1) phase. GM also abrogated ICRF-193-induced decatenation G(2) checkpoint in Jurkat and HL-60 cells. Western blot analysis showed that addition of GM attenuates doxorubicin-and ICRF193-induced Chk1 phosphorylation at Ser345. GM, however, failed to abrogate G(2) arrest in p53-positive ML-1 cells maybe due to the p21 induction. GM released HeLa cells from doxorubicin-induced G(2) arrest but trapped them at M phase. Flow cytometric analysis showed that addition of GM converted doxorubicin-induced necrosis into apoptosis in Jurkat cells. Colony assay indicated that although GM has a weak cytotoxic effect as a single agent, it dramatically intensifies the cytotoxicity of doxorubicin and ICRF-193 in Jurkat and HL-60 cells. These results suggest that abrogation of G(2) checkpoint by GM may play a central role in sensitizing p53-negative tumor cells to DNA-damaging and decate-nation-inhibiting agents.	[Sugimoto, K.; Sasaki, M.; Isobe, Y.; Tsutsui, M.; Suto, H.; Ando, J.; Tamayose, K.; Ando, M.; Oshimi, K.] Juntendo Univ, Sch Med, Dept Internal Med, Div Hematol,Bunkyo Ku, Tokyo 1138421, Japan	Juntendo University	Sugimoto, K (corresponding author), Juntendo Univ, Sch Med, Dept Internal Med, Div Hematol,Bunkyo Ku, Hongo 2-1-1, Tokyo 1138421, Japan.	ksugimot@med.juntendo.ac.jp						ALIGUE R, 1994, EMBO J, V13, P6099, DOI 10.1002/j.1460-2075.1994.tb06956.x; Arlander SJH, 2003, J BIOL CHEM, V278, P52572, DOI 10.1074/jbc.M309054200; Bisht KS, 2003, CANCER RES, V63, P8984; Broemer M, 2004, ONCOGENE, V23, P5378, DOI 10.1038/sj.onc.1207705; Bulavin DV, 2003, NAT CELL BIOL, V5, P545, DOI 10.1038/ncb994; Bull EEA, 2004, CLIN CANCER RES, V10, P8077, DOI 10.1158/1078-0432.CCR-04-1212; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chen Q, 1998, BLOOD, V92, P4545, DOI 10.1182/blood.V92.12.4545.424k41_4545_4553; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; Deming PB, 2001, P NATL ACAD SCI USA, V98, P12044, DOI 10.1073/pnas.221430898; Descombes P, 1998, EMBO J, V17, P1328, DOI 10.1093/emboj/17.5.1328; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; FAN SJ, 1995, CANCER RES, V55, P1649; Gorre ME, 2002, BLOOD, V100, P3041, DOI 10.1182/blood-2002-05-1361; Graves PR, 2000, J BIOL CHEM, V275, P5600, DOI 10.1074/jbc.275.8.5600; Jones DT, 2004, BLOOD, V103, P1855, DOI 10.1182/blood-2003-05-1603; Kawabe T, 2004, MOL CANCER THER, V3, P513; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Kohn EA, 2003, CANCER RES, V63, P31; Lewis J, 2000, J BIOL CHEM, V275, P10519, DOI 10.1074/jbc.275.14.10519; Ling YH, 1998, J BIOL CHEM, V273, P18984, DOI 10.1074/jbc.273.30.18984; Mesa RA, 2005, BLOOD, V106, P318, DOI 10.1182/blood-2004-09-3523; Minami Y, 2002, LEUKEMIA, V16, P1535, DOI 10.1038/sj.leu.2402558; Mitsiades CS, 2006, BLOOD, V107, P1092, DOI 10.1182/blood-2005-03-1158; Munster PN, 2001, CANCER RES, V61, P2945; Neckers L, 2002, TRENDS MOL MED, V8, pS55, DOI 10.1016/S1471-4914(02)02316-X; Nimmanapalli R, 2001, CANCER RES, V61, P1799; Passalaris TM, 1999, MOL CELL BIOL, V19, P5872, DOI 10.1128/mcb.19.9.5872; Pearl LH, 2002, ADV PROTEIN CHEM, V59, P157; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; POWELL SN, 1995, CANCER RES, V55, P1643; Prodromou C, 1997, CELL, V90, P65, DOI 10.1016/S0092-8674(00)80314-1; RUSSELL KJ, 1995, CANCER RES, V55, P1639; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Sarkaria JN, 1999, CANCER RES, V59, P4375; Srethapakdi M, 2000, CANCER RES, V60, P3940; Sugimoto K, 2000, BRIT J HAEMATOL, V110, P819, DOI 10.1046/j.1365-2141.2000.02304.x; Sugimoto K, 1998, BLOOD, V91, P1407, DOI 10.1182/blood.V91.4.1407; Sugimoto K, 2002, BRIT J HAEMATOL, V118, P229, DOI 10.1046/j.1365-2141.2002.03577.x; Tse AN, 2004, CANCER RES, V64, P6635, DOI 10.1158/0008-5472.CAN-04-0841; Weinert T, 1997, SCIENCE, V277, P1450, DOI 10.1126/science.277.5331.1450; Workman P, 2004, CANCER LETT, V206, P149, DOI 10.1016/j.canlet.2003.08.032; Yao SL, 1996, NAT MED, V2, P1140, DOI 10.1038/nm1096-1140; Zhao B, 2002, J BIOL CHEM, V277, P46609, DOI 10.1074/jbc.M201233200	44	22	24	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	22					3091	3101		10.1038/sj.onc.1210978	http://dx.doi.org/10.1038/sj.onc.1210978			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	301LL	18071310				2022-12-25	WOS:000255897600002
J	Bonente, G; Howes, BD; Caffarri, S; Smulevich, G; Bassi, R				Bonente, Giulia; Howes, Barry D.; Caffarri, Stefano; Smulevich, Giulietta; Bassi, Roberto			Interactions between the photosystem II subunit PsbS and xanthophylls studied in vivo and in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-HARVESTING COMPLEX; NONPHOTOCHEMICAL ENERGY-DISSIPATION; RESOLVED FLUORESCENCE ANALYSIS; PIGMENT-PIGMENT INTERACTIONS; CAROTENOID-BINDING-SITES; HIGHER-PLANT ANTENNA; CHLOROPHYLL FLUORESCENCE; CHLOROPLAST MEMBRANES; ARABIDOPSIS-THALIANA; MOLECULAR MECHANISM	The photosystem II subunit PsbS is essential for excess energy dissipation (qE); however, both lutein and zeaxanthin are needed for its full activation. Based on previous work, two models can be proposed in which PsbS is either 1) the gene product where the quenching activity is located or 2) a proton-sensing trigger that activates the quencher molecules. The first hypothesis requires xanthophyll binding to two PsbS-binding sites, each activated by the protonation of a dicyclohexylcarbodiimide-binding lumen-exposed glutamic acid residue. To assess the existence and properties of these xanthophyll-binding sites, PsbS point mutants on each of the two Glu residues PsbS E122Q and PsbS E226Q were crossed with the npq1/npq4 and lut2/ npq4 mutants lacking zeaxanthin and lutein, respectively. Double mutants E122Q/npq1 and E226Q/npq1 had no qE, whereas E122Q/lut2 and E226Q/lut2 showed a strong qE reduction with respect to both lut2 and single glutamate mutants. These findings exclude a specific interaction between lutein or zeaxanthin and a dicyclohexylcarbodiimide-binding site and suggest that the dependence of nonphotochemical quenching on xanthophyll composition is not due to pigment binding to PsbS. To verify, in vitro, the capacity of xanthophylls to bind PsbS, we have produced recombinant PsbS refolded with purified pigments and shown that Raman signals, previously attributed to PsbS-zeaxanthin interactions, are in fact due to xanthophyll aggregation. We conclude that the xanthophyll dependence of qE is not due to PsbS but to other pigment-binding proteins, probably of the Lhcb type.	[Bonente, Giulia; Bassi, Roberto] Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; [Bonente, Giulia; Caffarri, Stefano; Bassi, Roberto] Univ Aix Marseille 2, Fac Sci Luminy, Lab Genet & Biophys Plantes, Marseille 9, France; [Howes, Barry D.; Smulevich, Giulietta] Univ Florence, Dipartimento Chim, I-50019 Florence, Italy	University of Verona; CEA; UDICE-French Research Universities; Aix-Marseille Universite; University of Florence	Bassi, R (corresponding author), Univ Verona, Dipartimento Sci & Tecnol, Strada Grazie 15, I-37134 Verona, Italy.	bassi@sci.univr.it	smulevich, giulietta/A-6510-2008; Caffarri, Stefano/AAX-8913-2021	Caffarri, Stefano/0000-0002-4729-7679; bassi, roberto/0000-0002-4140-8446; Smulevich, Giulietta/0000-0003-3021-8919				Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Aspinall-O'Dea M, 2002, P NATL ACAD SCI USA, V99, P16331, DOI 10.1073/pnas.252500999; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; BASSI R, 1987, J BIOL CHEM, V262, P13333; Bassi R, 1999, P NATL ACAD SCI USA, V96, P10056, DOI 10.1073/pnas.96.18.10056; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V936, P29, DOI 10.1016/0005-2728(88)90248-4; BASSI R, 1993, EUR J BIOCHEM, V212, P297, DOI 10.1111/j.1432-1033.1993.tb17662.x; Bassi R, 2000, PHOTOSYNTH RES, V64, P243, DOI 10.1023/A:1006409506272; BILGER W, 1994, PLANTA, V193, P238, DOI 10.1007/BF00192536; Billsten HH, 2005, J PHYS CHEM A, V109, P1521, DOI 10.1021/jp044847j; BRIANTAIS JM, 1966, CR ACAD SCI D NAT, V263, P1899; Briantais JM, 1996, PHOTOSYNTH RES, V48, P189, DOI 10.1007/BF00041008; CAMMARATA KV, 1992, PHOTOSYNTH RES, V33, P235, DOI 10.1007/BF00030034; Casazza AP, 2001, PHOTOSYNTH RES, V68, P175, DOI 10.1023/A:1011818021875; Castelletti S, 2003, BIOCHEMISTRY-US, V42, P4226, DOI 10.1021/bi027398r; Crimi M, 2001, EUR J BIOCHEM, V268, P260, DOI 10.1046/j.1432-1033.2001.01874.x; Croce R, 1999, FEBS LETT, V456, P1, DOI 10.1016/S0014-5793(99)00907-2; Croce R, 1999, J BIOL CHEM, V274, P29613, DOI 10.1074/jbc.274.42.29613; Croce R, 2003, BIOPHYS J, V84, P2517, DOI 10.1016/S0006-3495(03)75057-7; CROFTS AR, 1994, FEBS LETT, V352, P265, DOI 10.1016/0014-5793(94)00976-7; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; Dall'Osto L, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-32; Dall'Osto L, 2007, PLANT CELL, V19, P1048, DOI 10.1105/tpc.106.049114; DALLOSTO L, 2007, J BIOL CHEM; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; Elrad D, 2002, PLANT CELL, V14, P1801, DOI 10.1105/tpc.002154; Formaggio E, 2001, J MOL BIOL, V314, P1157, DOI 10.1006/jmbi.2000.5179; FUNK C, 1995, J BIOL CHEM, V270, P30141; FUNK C, 1995, BIOCHEMISTRY-US, V34, P11133, DOI 10.1021/bi00035a019; Ganeteg U, 2004, PLANT PHYSIOL, V134, P502, DOI 10.1104/pp.103.033324; Gastaldelli M, 2003, J BIOL CHEM, V278, P19190, DOI 10.1074/jbc.M212125200; Giuffra E, 1996, EUR J BIOCHEM, V238, P112, DOI 10.1111/j.1432-1033.1996.0112q.x; Grabowski B, 2001, P NATL ACAD SCI USA, V98, P2911, DOI 10.1073/pnas.031587198; Havaux M, 2004, J BIOL CHEM, V279, P13878, DOI 10.1074/jbc.M311154200; Hobe S, 2000, EUR J BIOCHEM, V267, P616, DOI 10.1046/j.1432-1327.2000.01060.x; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Holt NE, 2004, BIOCHEMISTRY-US, V43, P8281, DOI 10.1021/bi0494020; Horton P, 2000, PHILOS T R SOC B, V355, P1361, DOI 10.1098/rstb.2000.0698; HORTON P, 1991, FEBS LETT, V292, P1, DOI 10.1016/0014-5793(91)80819-O; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; JOHNSON WC, 1990, PROTEIN-STRUCT FUNCT, V7, P214; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2002, J BIOL CHEM, V277, P33590, DOI 10.1074/jbc.M204797200; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lokstein H, 2002, BBA-BIOENERGETICS, V1553, P309, DOI 10.1016/S0005-2728(02)00184-6; MEYER M, 1993, Z NATURFORSCH C, V48, P461; Morosinotto T, 2005, J BIOL CHEM, V280, P20612, DOI 10.1074/jbc.M500705200; Morosinotto T, 2003, PHYSIOL PLANTARUM, V119, P347, DOI 10.1034/j.1399-3054.2003.00213.x; Morosinotto T, 2002, J BIOL CHEM, V277, P36253, DOI 10.1074/jbc.M205062200; Morosinotto T, 2002, J BIOL CHEM, V277, P36913, DOI 10.1074/jbc.M205339200; Moya I, 2001, BIOCHEMISTRY-US, V40, P12552, DOI 10.1021/bi010342x; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 2001, PHOTOSYNTH RES, V67, P139, DOI 10.1023/A:1010661102365; PAULSEN H, 1992, EUR J BIOCHEM, V205, P71, DOI 10.1111/j.1432-1033.1992.tb16752.x; Pesaresi P, 1997, FEBS LETT, V402, P151, DOI 10.1016/S0014-5793(96)01518-9; PLUMLEY FG, 1987, P NATL ACAD SCI USA, V84, P146, DOI 10.1073/pnas.84.1.146; Pogson BJ, 1998, P NATL ACAD SCI USA, V95, P13324, DOI 10.1073/pnas.95.22.13324; Polivka T, 2002, BIOCHEMISTRY-US, V41, P439, DOI 10.1021/bi011589x; PREISS S, 1995, PLANT PHYSIOL, V107, P709, DOI 10.1104/pp.107.3.709; Ruban AV, 2002, J BIOL CHEM, V277, P7785, DOI 10.1074/jbc.M110693200; Ruban AV, 1999, PLANT PHYSIOL, V119, P531, DOI 10.1104/pp.119.2.531; RUBAN AV, 1994, BBA-BIOENERGETICS, V1186, P123, DOI 10.1016/0005-2728(94)90143-0; RUBAN AV, 1992, FEBS LETT, V309, P175, DOI 10.1016/0014-5793(92)81089-5; RUBAN AV, 1993, PLANT PHYSIOL, V102, P741, DOI 10.1104/pp.102.3.741; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P379; Schulz H, 2005, BIOPOLYMERS, V77, P212, DOI 10.1002/bip.20215	70	106	108	2	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8434	8445		10.1074/jbc.M708291200	http://dx.doi.org/10.1074/jbc.M708291200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18070876	Green Published, hybrid			2022-12-25	WOS:000254288000041
J	Koida, N; Ozaki, T; Yamamoto, H; Ono, S; Koda, T; Ando, K; Okoshi, R; Kamijo, T; Omura, K; Nakagawara, A				Koida, Nami; Ozaki, Toshinori; Yamamoto, Hideki; Ono, Sayaka; Koda, Tadayuki; Ando, Kiyohiro; Okoshi, Rintaro; Kamijo, Takehiko; Omura, Ken; Nakagawara, Akira			Inhibitory role of Plk1 in the regulation of p73-dependent apoptosis through physical interaction and phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLO-LIKE-KINASE; P53 FAMILY-MEMBER; C-ABL; P73; EXPRESSION; PROTEIN; ACTIVATION; P73-ALPHA; TARGET; DOMAIN	In response to DNA damage, p73 plays a critical role in cell fate determination. In this study, we have found that Plk1 (pololike kinase 1) associates with p73, phosphorylates p73 at Thr-27, and thereby inhibits its pro-apoptotic activity. During cisplatin-mediated apoptosis in COS7 cells in which the endogenous p53 is inactivated by SV40 large T antigen, p73 was induced to accumulate in association with a significant down-regulation of Plk1. Consistent with these observations, Plk1 reduced the stability of the endogenous p73. Immunoprecipitation and in vitro pulldown assay demonstrated that p73 binds to the kinase domain of Plk1 through its NH2-terminal region. Luciferase reporter assay and reverse transcription-PCR analysis revealed that Plk1 is able to block the p73-mediated transcriptional activation. Of note, kinase-deficient Plk1 mutant (Plk1(K82M)) retained an ability to interact with p73; however, it failed to inactivate the p73-mediated transcriptional activation, suggesting that kinase activity of Plk1 is required for the inhibition of p73. Indeed, in vitro kinase assay indicated that p73 is phosphorylated at Thr-27 by Plk1. Furthermore, small interference RNA-mediated knockdown of the endogenous Plk1 in p53-deficient H1299 cells resulted in a significant increase in the number of cells with sub-G(1) DNA content accompanied by the up-regulation of p73 and pro-apoptotic p53(AIP1) as well as the proteolytic cleavage of poly(ADP-ribose) polymerase. Thus, our present results suggest that Plk1-mediated dysfunction of p73 is one of the novel molecular mechanisms to inhibit the p53-independent apoptosis, and the inhibition of Plk1 might provide an attractive therapeutic strategy for cancer treatment.	[Koida, Nami; Ozaki, Toshinori; Yamamoto, Hideki; Ando, Kiyohiro; Okoshi, Rintaro; Kamijo, Takehiko; Nakagawara, Akira] Chiba Canc Res Inst, Div Biochem, Chiba 2608717, Japan; [Koida, Nami; Omura, Ken] Tokyo Med & Dent Univ, Dept Oral & Maxillofacial Surg, Tokyo 1138549, Japan; [Ono, Sayaka; Koda, Tadayuki] Hisamitsu Pharmaceut Co Inc, Ctr Funct Genom, Chiba 2608717, Japan	Chiba Cancer Center; Tokyo Medical & Dental University (TMDU); Hisamitsu Pharmaceutical Co Ltd	Nakagawara, A (corresponding author), Chiba Canc Res Inst, Div Biochem, Chiba 2608717, Japan.	akiranak@chiba-cc.jp						Agami R, 1999, NATURE, V399, P809; Ando K, 2004, J BIOL CHEM, V279, P25549, DOI 10.1074/jbc.M314182200; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bourdon JC, 2005, GENE DEV, V19, P2122, DOI 10.1101/gad.1339905; Chen J, 2006, FEBS LETT, V580, P3624, DOI 10.1016/j.febslet.2006.05.047; Costanzo A, 2002, MOL CELL, V9, P175, DOI 10.1016/S1097-2765(02)00431-8; Dai W, 2005, ONCOGENE, V24, P214, DOI 10.1038/sj.onc.1208270; Eckerdt F, 2005, ONCOGENE, V24, P267, DOI 10.1038/sj.onc.1208273; Elia AEH, 2003, SCIENCE, V299, P1228, DOI 10.1126/science.1079079; Gaiddon C, 2003, J BIOL CHEM, V278, P27421, DOI 10.1074/jbc.M300251200; Gong JG, 1999, NATURE, V399, P806; Gonzalez S, 2003, MOL CELL BIOL, V23, P8161, DOI 10.1128/MCB.23.22.8161-8171.2003; Hosoda M, 2005, ONCOGENE, V24, P7156, DOI 10.1038/sj.onc.1208872; Irwin MS, 2003, CANCER CELL, V3, P403, DOI 10.1016/S1535-6108(03)00078-3; Kaghad M, 1997, CELL, V90, P809, DOI 10.1016/S0092-8674(00)80540-1; Knecht R, 1999, CANCER RES, V59, P2794; Knecht R, 2000, INT J CANCER, V89, P535; Liu XQ, 2006, MOL CELL BIOL, V26, P2093, DOI 10.1128/MCB.26.6.2093-2108.2006; Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100; Liu YS, 2005, CHEM BIOL, V12, P99, DOI 10.1016/j.chembiol.2004.11.009; Melino G, 2002, NAT REV CANCER, V2, P605, DOI 10.1038/nrc861; Munarriz E, 2005, BIOCHEM BIOPH RES CO, V333, P954, DOI 10.1016/j.bbrc.2005.05.188; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Niizuma H, 2006, ONCOGENE, V25, P5046, DOI 10.1038/sj.onc.1209515; Ozaki T, 2005, CANCER SCI, V96, P729, DOI 10.1111/j.1349-7006.2005.00116.x; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Ren J, 2002, J BIOL CHEM, V277, P33758, DOI 10.1074/jbc.M110667200; Smith MR, 1997, BIOCHEM BIOPH RES CO, V234, P397, DOI 10.1006/bbrc.1997.6633; Smits VAJ, 2000, NAT CELL BIOL, V2, P672, DOI 10.1038/35023629; Spankuch-Schmitt B, 2002, JNCI-J NATL CANCER I, V94, P1863, DOI 10.1093/jnci/94.24.1863; Spankuch-Schmitt B, 2002, ONCOGENE, V21, P3162, DOI 10.1038/sj.onc.1205412; Stiewe T, 2002, CANCER RES, V62, P3598; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; Tanaka Y, 2004, BIOCHEM BIOPH RES CO, V317, P865, DOI 10.1016/j.bbrc.2004.03.124; van Vugt MATM, 2001, J BIOL CHEM, V276, P41656, DOI 10.1074/jbc.M101831200; Xie SQ, 2005, ONCOGENE, V24, P277, DOI 10.1038/sj.onc.1208218; Yuan ZM, 1999, NATURE, V399, P814, DOI 10.1038/21704; Zeng XY, 2000, MOL CELL BIOL, V20, P1299, DOI 10.1128/MCB.20.4.1299-1310.2000; Zeng XY, 1999, MOL CELL BIOL, V19, P3257	39	47	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8555	8563		10.1074/jbc.M710608200	http://dx.doi.org/10.1074/jbc.M710608200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18174154	hybrid, Green Published			2022-12-25	WOS:000254288000054
J	Raggatt, LJ; Qin, L; Tamasi, J; Jefcoat, SC; Shimizu, E; Selvamurugan, N; Liew, FY; Bevelock, L; Feyen, JHM; Partridge, NC				Raggatt, Liza J.; Qin, Ling; Tamasi, Joseph; Jefcoat, Stephen C., Jr.; Shimizu, Emi; Selvamurugan, Nagarajan; Liew, Foo Y.; Bevelock, Laura; Feyen, Jean H. M.; Partridge, Nicola C.			Interleukin-18 is regulated by parathyroid hormone and is required for its bone anabolic actions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; ELEMENT-BINDING PROTEIN; GAMMA-INDUCING FACTOR; GENE-EXPRESSION; OSTEOBLASTIC CELLS; C-FOS; OSTEOPROTEGERIN EXPRESSION; OSTEOCLAST FORMATION; SIGNALING PATHWAYS; MESSENGER-RNA	Interleukin-18 (IL-18) can regulate osteoblast and osteoclast function. We have identified, using cDNA microarray technology, that IL-18 expression is increased in UMR 106-01 rat osteoblastic cells in response to parathyroid hormone (PTH) treatment. Confirmation of these data using real-time reverse transcription-PCR showed that steady-state levels of IL-18 mRNA increased by 2 h (3-fold), peaked by 4 h (10-fold), and had diminished after 12 h (4.4-fold) and that this regulation was via the protein kinase A signaling pathway and did not involve activation of the PKC signal cascade. PTH regulation of IL-18 was confirmed at the protein level, and analysis of differentiating primary rat calvarial osteoblasts verified that both IL-18 mRNA and protein are regulated by PTH in primary rat osteoblasts. Promoter reporter assays revealed that PTH regulated the upstream IL-18 promoter and induced the exon 1 containing 1.1-kb IL-18 mRNA transcript in primary osteoblast cells. The in vivo physiological role of IL- 18 in the anabolic actions of PTH on bone was then assessed using IL- 18 knock-out mice. Female IL-18 null mice and wild-type littermate controls were injected with vehicle or 8 mu g/100 g of human 1-38 PTH for 4 weeks. In IL-18 knock-out animals the anabolic effect of PTH (determined by bone mineral density changes in the proximal tibia) was abolished in trabecular bone but not in the cortical component. These data characterize the PTH regulation of IL-18 expression in osteoblastic cells and suggest that this cytokine is involved in the anabolic actions of PTH.	[Raggatt, Liza J.; Qin, Ling; Jefcoat, Stephen C., Jr.; Shimizu, Emi; Selvamurugan, Nagarajan; Bevelock, Laura; Partridge, Nicola C.] UMDNJ, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Tamasi, Joseph; Feyen, Jean H. M.] Bristol Myers Squibb Pharmaceut Res Inst, Pennington, NJ 08534 USA; [Liew, Foo Y.] Glasgow Biomed Res Ctr, Div Immunol Infect & Inflammat, Glasgow G12 8TA, Lanark, Scotland	Rutgers State University New Brunswick; Rutgers State University Medical Center; Bristol-Myers Squibb; University of Glasgow	Partridge, NC (corresponding author), UMDNJ, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, 675 Hoes Lane, Piscataway, NJ 08854 USA.	partrinc@umdnj.edu	Raggatt, Liza-Jane/S-4530-2016; Raggatt, Liza-Jane/A-5297-2011; Selvamurugan, Nagarajan/P-7894-2016	Raggatt, Liza-Jane/0000-0002-7920-6225; Selvamurugan, Nagarajan/0000-0003-3713-1920; Partridge, Nicola/0000-0002-5406-4814	Howard Hughes Medical Institute Funding Source: Medline; Medical Research Council [G9818261] Funding Source: Medline; NIDDK NIH HHS [DK48109] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048109] Funding Source: NIH RePORTER; MRC [G9818261] Funding Source: UKRI	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ANGEL P, 1991, BIOCHIM BIOPHYS ACTA, V1072, P129, DOI 10.1016/0304-419X(91)90011-9; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bikle DD, 2002, J BONE MINER RES, V17, P1570, DOI 10.1359/jbmr.2002.17.9.1570; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Bouxsein ML, 2005, J BONE MINER RES, V20, P635, DOI 10.1359/JBMR.041204; Cornish J, 2003, ENDOCRINOLOGY, V144, P1194, DOI 10.1210/en.2002-220936; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; DOBNIG H, 1995, ENDOCRINOLOGY, V136, P3632, DOI 10.1210/en.136.8.3632; Erclik MS, 2002, AM J PHYSIOL-ENDOC M, V282, pE534, DOI 10.1152/ajpendo.00417.2001; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; HODSMAN AB, 1993, J CLIN INVEST, V91, P1138, DOI 10.1172/JCI116273; Horwood NJ, 1998, J CLIN INVEST, V101, P595, DOI 10.1172/JCI1333; Huang YF, 1998, BONE, V23, P327, DOI 10.1016/S8756-3282(98)00115-X; Iida-Klein A, 2002, J BONE MINER RES, V17, P808, DOI 10.1359/jbmr.2002.17.5.808; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; JUPPNER H, 1991, SCIENCE, V254, P1024, DOI 10.1126/science.1658941; Kawase Y, 2003, J BONE MINER RES, V18, P975, DOI 10.1359/jbmr.2003.18.6.975; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002-0225; LEAFFER D, 1995, ENDOCRINOLOGY, V136, P3624, DOI 10.1210/en.136.8.3624; Li X, 2002, BONE, V30, P567, DOI 10.1016/S8756-3282(02)00683-X; Makiishi-Shimobayashi C, 2001, BIOCHEM BIOPH RES CO, V281, P361, DOI 10.1006/bbrc.2001.4380; Miyakoshi N, 2001, ENDOCRINOLOGY, V142, P4349, DOI 10.1210/en.142.10.4349; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; Qin L, 2003, J BIOL CHEM, V278, P19723, DOI 10.1074/jbc.M212226200; Schiller PC, 1999, J BONE MINER RES, V14, P1504, DOI 10.1359/jbmr.1999.14.9.1504; Selvamurugan N, 2000, J CELL BIOCHEM, V79, P182, DOI 10.1002/1097-4644(20001101)79:2<182::AID-JCB20>3.0.CO;2-0; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Selvarnurugan N, 2007, J ORTHOP RES, V25, P1213, DOI 10.1002/jor.20409; SHALHOUB V, 1992, J CELL BIOCHEM, V50, P425, DOI 10.1002/jcb.240500411; Sims JE, 2002, CURR OPIN IMMUNOL, V14, P117, DOI 10.1016/S0952-7915(01)00306-5; Sugama S, 2000, J IMMUNOL, V165, P6287, DOI 10.4049/jimmunol.165.11.6287; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; TAM CS, 1982, ENDOCRINOLOGY, V110, P506, DOI 10.1210/endo-110-2-506; Tone M, 1997, J IMMUNOL, V159, P6156; Tsutsui H, 2004, IMMUNOL REV, V202, P115, DOI 10.1111/j.0105-2896.2004.00205.x; Tyson DR, 1999, ENDOCRINOLOGY, V140, P1255, DOI 10.1210/en.140.3.1255; Udagawa N, 1997, J EXP MED, V185, P1005, DOI 10.1084/jem.185.6.1005; Wei XQ, 2001, J IMMUNOL, V166, P517, DOI 10.4049/jimmunol.166.1.517; Wu YH, 2000, J BONE MINER RES, V15, P879, DOI 10.1359/jbmr.2000.15.5.879; Yamada N, 2002, BONE, V30, P901, DOI 10.1016/S8756-3282(02)00722-6; Yu XP, 1997, ENDOCRINOLOGY, V138, P3085, DOI 10.1210/en.138.8.3085; Zhou H, 2003, BONE, V32, P513, DOI 10.1016/S8756-3282(03)00057-7	46	36	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6790	6798		10.1074/jbc.M709909200	http://dx.doi.org/10.1074/jbc.M709909200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18165223	hybrid			2022-12-25	WOS:000253779600021
J	Siskind, LJ; Feinstein, L; Yu, TX; Davis, JS; Jones, D; Choi, J; Zuckerman, JE; Tan, WZ; Hill, RB; Hardwick, JM; Colombini, M				Siskind, Leah J.; Feinstein, Laurence; Yu, Tingxi; Davis, Joseph S.; Jones, David; Choi, Jinna; Zuckerman, Jonathan E.; Tan, Wenzhi; Hill, R. Blake; Hardwick, J. Marie; Colombini, Marco			Anti-apoptotic Bcl-2 family proteins disassemble ceramide channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DAUNORUBICIN-INDUCED APOPTOSIS; PROGRAMMED CELL-DEATH; CYTOCHROME-C RELEASE; MITOCHONDRIAL CERAMIDE; RESPIRATORY-CHAIN; WILD-TYPE; BAX; SPHINGOMYELIN; GENERATION; MEMBRANES	Early in mitochondria- mediated apoptosis, the mitochondrial outer membrane becomes permeable to proteins that, when released into the cytosol, initiate the execution phase of apoptosis. Proteins in the Bcl-2 family regulate this permeabilization, but the molecular composition of the mitochondrial outer membrane pore is under debate. We reported previously that at physiologically relevant levels, ceramides form stable channels in mitochondrial outer membranes capable of passing the largest proteins known to exit mitochondria during apoptosis (Siskind, L. J., Kolesnick, R. N., and Colombini, M. ( 2006) Mitochondrion 6, 118 - 125). Here we show that Bcl-2 proteins are not required for ceramide to form protein-permeable channels in mitochondrial outer membranes. However, both recombinant human Bcl-x(L) and CED-9, the Caenorhabditis elegans Bcl-2 homologue, disassemble ceramide channels in the mitochondrial outer membranes of isolated mitochondria from rat liver and yeast. Importantly, Bcl-xL and CED-9 disassemble ceramide channels in the defined system of solvent-free planar phospholipid membranes. Thus, ceramide channel disassembly likely results from direct interaction with these anti-apoptotic proteins. Mutants of Bcl-xL act on ceramide channels as expected from their ability to be anti-apoptotic. Thus, ceramide channels may be one mechanism for releasing pro-apoptotic proteins from mitochondria during the induction phase of apoptosis.	[Feinstein, Laurence; Davis, Joseph S.; Jones, David; Choi, Jinna; Tan, Wenzhi; Colombini, Marco] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Siskind, Leah J.] Med Univ S Carolina, Dept Gen Internal Med Geriatr, Charleston, SC 29425 USA; [Yu, Tingxi; Hardwick, J. Marie] Johns Hopkins Univ, Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Zuckerman, Jonathan E.; Hill, R. Blake] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland College Park; Medical University of South Carolina; Johns Hopkins University; Johns Hopkins University	Colombini, M (corresponding author), Univ Maryland, Dept Biol, Bldg 144, College Pk, MD 20742 USA.	colombini@umd.edu	Colombini, Marco/A-1540-2014	Siskind, Leah/0000-0001-5026-5187; Hill, Blake/0000-0001-6228-3905	NIGMS NIH HHS [R01 GM067180-04, GM067180, R01 GM067180, GM77875, R01 GM077875, R01 GM077875-03] Funding Source: Medline; NINDS NIH HHS [R01 NS037402, NS37402, NS42025, R01 NS042025] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067180, R01GM077875] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042025, R01NS037402] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Allouche M, 1997, ONCOGENE, V14, P1837, DOI 10.1038/sj.onc.1201023; Arora AS, 1997, HEPATOLOGY, V25, P958, DOI 10.1002/hep.510250428; Basanez G, 2001, J BIOL CHEM, V276, P31083, DOI 10.1074/jbc.M103879200; Bionda C, 2004, BIOCHEM J, V382, P527, DOI 10.1042/BJ20031819; Birbes H, 2005, BIOCHEM J, V386, P445, DOI 10.1042/BJ20041627; Birbes H, 2001, FASEB J, V15, P2669, DOI 10.1096/fj.01-0539com; BOSE R, 1995, CELL, V82, P405, DOI 10.1016/0092-8674(95)90429-8; Chandra D, 2005, J BIOL CHEM, V280, P19051, DOI 10.1074/jbc.M501391200; Charles AG, 2001, CANCER CHEMOTH PHARM, V47, P444, DOI 10.1007/s002800000265; Clem RJ, 1998, P NATL ACAD SCI USA, V95, P554, DOI 10.1073/pnas.95.2.554; COLOMBINI M, 1987, METHOD ENZYMOL, V148, P465; Dai Q, 2004, ONCOGENE, V23, P3650, DOI 10.1038/sj.onc.1207430; Dejean LM, 2006, CELL DEATH DIFFER, V13, P1387, DOI 10.1038/sj.cdd.4401949; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; Di Paola M, 2004, J BIOENERG BIOMEMBR, V36, P165, DOI 10.1023/B:JOBB.0000023619.97392.0c; El Bawab S, 2000, J BIOL CHEM, V275, P21508, DOI 10.1074/jbc.M002522200; Elrick MJ, 2006, BIOPHYS J, V91, P1749, DOI 10.1529/biophysj.106.088443; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ghafourifar P, 1999, J BIOL CHEM, V274, P6080, DOI 10.1074/jbc.274.10.6080; Gonzalvez F, 2005, CELL DEATH DIFFER, V12, P614, DOI 10.1038/sj.cdd.4401571; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Heiden MGV, 2001, J BIOL CHEM, V276, P19414, DOI 10.1074/jbc.M101590200; Jonas EA, 2004, P NATL ACAD SCI USA, V101, P13590, DOI 10.1073/pnas.0401372101; Kawatani M, 2003, EXP CELL RES, V286, P57, DOI 10.1016/S0014-4827(03)00098-3; Kroesen BJ, 2001, J BIOL CHEM, V276, P13606, DOI 10.1074/jbc.M009517200; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Longo VD, 1997, J CELL BIOL, V137, P1581, DOI 10.1083/jcb.137.7.1581; Matsko CM, 2001, BIOCHEM BIOPH RES CO, V287, P1112, DOI 10.1006/bbrc.2001.5696; MONTAL M, 1972, P NATL ACAD SCI USA, V69, P3561, DOI 10.1073/pnas.69.12.3561; Morizono H, 2005, MOL GENET METAB, V86, P431, DOI 10.1016/j.ymgme.2005.08.013; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; QuilletMary A, 1997, J BIOL CHEM, V272, P21388, DOI 10.1074/jbc.272.34.21388; Rodriguez-Lafrasse C, 2002, INT J CANCER, V101, P589, DOI 10.1002/ijc.10652; Rodriguez-Lafrasse C, 2001, BIOCHEM J, V357, P407, DOI 10.1042/0264-6021:3570407; Sawada M, 2000, ONCOGENE, V19, P3508, DOI 10.1038/sj.onc.1203699; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Shimeno H, 1998, LIPIDS, V33, P601, DOI 10.1007/s11745-998-0246-2; Siskind LJ, 2006, MITOCHONDRION, V6, P118, DOI 10.1016/j.mito.2006.03.002; Siskind LJ, 2005, J BIOENERG BIOMEMBR, V37, P143, DOI 10.1007/s10863-005-6567-7; Siskind LJ, 2003, BIOPHYS J, V85, P1560, DOI 10.1016/S0006-3495(03)74588-3; Siskind LJ, 2002, J BIOL CHEM, V277, P26796, DOI 10.1074/jbc.M200754200; Siskind LJ, 2000, J BIOL CHEM, V275, P38640, DOI 10.1074/jbc.C000587200; Susin SA, 1997, J EXP MED, V186, P25, DOI 10.1084/jem.186.1.25; Tepper AD, 1999, J CLIN INVEST, V103, P971, DOI 10.1172/JCI5457; Terrones O, 2004, J BIOL CHEM, V279, P30081, DOI 10.1074/jbc.M313420200; Thomas RL, 1999, J BIOL CHEM, V274, P30580, DOI 10.1074/jbc.274.43.30580; Thuduppathy GR, 2006, BIOCHEMISTRY-US, V45, P14533, DOI 10.1021/bi0616652; VANCE JE, 1990, J BIOL CHEM, V265, P7248; Wiesner DA, 1997, J BIOL CHEM, V272, P9868; Witty JP, 1996, ENDOCRINOLOGY, V137, P5269, DOI 10.1210/en.137.12.5269; ZAMZAMI N, 1995, J EXP MED, V182, P367, DOI 10.1084/jem.182.2.367; Zhang JD, 1996, P NATL ACAD SCI USA, V93, P5325, DOI 10.1073/pnas.93.11.5325	53	98	104	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6622	6630		10.1074/jbc.M706115200	http://dx.doi.org/10.1074/jbc.M706115200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18171672	hybrid, Green Accepted			2022-12-25	WOS:000253779600003
J	Churbanova, IY; Sevrioukova, IF				Churbanova, Inna Y.; Sevrioukova, Irina F.			Redox-dependent changes in molecular properties of mitochondrial apoptosis-inducing factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH OXIDASE ACTIVITY; FACTOR AIF; CRYSTAL-STRUCTURE; CELL-DEATH; PUTIDAREDOXIN REDUCTASE; PERMEABILITY TRANSITION; OXIDATIVE STRESS; DNA-DEGRADATION; MUTANT; COMPONENT	Mitochondrial apoptosis-inducing factor (AIF) is a central player in the caspase-independent cell death pathway whose normal physiological function remains unclear. Our study showed that naturally folded mouse AIF very slowly reacts with NAD(P)H (k(cat) of 0.2- 0.01 s(-1)) forming tight, dimeric, and airstable FADH(2)-NAD(P) charge-transfer complexes ineffective in electron transfer. FAD reduction is accompanied by a conformational change involving AIF-specific N-terminal and regulatory 509 - 559 peptides and the active site His(453), and it affects susceptibility of AIF to calpain and AIF-DNA interaction, the two events critical for initiating caspase-independent apoptosis. Based on our results, we propose that formation of long lived complexes with NAD(P) H and redox reorganization may be functionally important and enable AIF to act as a redox-signaling molecule linking NAD(P) H-dependent metabolic pathways to apoptosis.	[Churbanova, Inna Y.; Sevrioukova, Irina F.] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	University of California System; University of California Irvine	Sevrioukova, IF (corresponding author), Univ Calif Irvine, Dept Mol Biol & Biochem, 3205 MacGaugh Hall, Irvine, CA 92697 USA.	sevrioui@uci.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067637] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM67637] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Apostolova N, 2006, CELL DEATH DIFFER, V13, P354, DOI 10.1038/sj.cdd.4401776; Cande C, 2004, J CELL SCI, V117, P4461, DOI 10.1242/jcs.01356; Cande C, 2004, ONCOGENE, V23, P1514, DOI 10.1038/sj.onc.1207279; Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; Delettre C, 2006, J BIOL CHEM, V281, P6413, DOI 10.1074/jbc.M509884200; Delettre C, 2006, J BIOL CHEM, V281, P18507, DOI 10.1074/jbc.M601751200; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Gurbuxani S, 2003, ONCOGENE, V22, P6669, DOI 10.1038/sj.onc.1206794; Joza N, 2005, MOL CELL BIOL, V25, P10261, DOI 10.1128/MCB.25.23.10261-10272.2005; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Klein JA, 2002, NATURE, V419, P367, DOI 10.1038/nature01034; Loeffler M, 2001, FASEB J, V15, P758, DOI 10.1096/fj.00-0388com; Mannella CA, 2006, BBA-MOL CELL RES, V1763, P542, DOI 10.1016/j.bbamcr.2006.04.006; Massey V., 1991, FLAVINS FLAVOPROTEIN, P581; Mate MJ, 2002, NAT STRUCT BIOL, V9, P442, DOI 10.1038/nsb793; Mayer BJ, 2001, J CELL SCI, V114, P1253; Miramar MD, 2001, J BIOL CHEM, V276, P16391, DOI 10.1074/jbc.M010498200; Modjtahedi N, 2006, TRENDS CELL BIOL, V16, P264, DOI 10.1016/j.tcb.2006.03.008; OTERA H, 2005, EMBO J, V17, P1; Petit PX, 2001, BIOCHEM J, V353, P357, DOI 10.1042/0264-6021:3530357; Polster BM, 2005, J BIOL CHEM, V280, P6447, DOI 10.1074/jbc.M413269200; Ravagnan L, 2001, NAT CELL BIOL, V3, P839, DOI 10.1038/ncb0901-839; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rustin P, 1996, J BIOL CHEM, V271, P14785, DOI 10.1074/jbc.271.25.14785; SAKURAI T, 1966, BIOCHIM BIOPHYS ACTA, V112, P459, DOI 10.1016/0926-6585(66)90248-2; Schmitt E, 2003, CANCER RES, V63, P8233; Senda T, 2000, J MOL BIOL, V304, P397, DOI 10.1006/jmbi.2000.4200; Sevrioukova IF, 2004, J MOL BIOL, V336, P889, DOI 10.1016/j.jmb.2003.12.067; Sevrioukova IF, 2002, J BIOL CHEM, V277, P25831, DOI 10.1074/jbc.M201110200; Susin SA, 2000, J EXP MED, V192, P571, DOI 10.1084/jem.192.4.571; Susin SA, 1999, NATURE, V397, P441, DOI 10.1038/17135; Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204; Vahsen N, 2004, EMBO J, V23, P4679, DOI 10.1038/sj.emboj.7600461; Vahsen N, 2006, ONCOGENE, V25, P1763, DOI 10.1038/sj.onc.1209206; van Empel VPM, 2006, J AM COLL CARDIOL, V48, P824, DOI 10.1016/j.jacc.2006.02.075; van Empel VPM, 2005, CIRC RES, V96, pE92, DOI 10.1161/01.RES.0000172081.30327.28; Wang XC, 2002, SCIENCE, V298, P1587, DOI 10.1126/science.1076194; Wilkinson JC, 2008, MOL CELL BIOL, V28, P237, DOI 10.1128/MCB.01065-07; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Ye H, 2002, NAT STRUCT BIOL, V9, P680, DOI 10.1038/nsb836; Yuste VJ, 2005, J BIOL CHEM, V280, P35670, DOI 10.1074/jbc.M504015200; Yuste VJ, 2005, CELL DEATH DIFFER, V12, P1445, DOI 10.1038/sj.cdd.4401687; Zhu CL, 2007, J EXP MED, V204, P1741, DOI 10.1084/jem.20070193; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A	45	65	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5622	5631		10.1074/jbc.M709147200	http://dx.doi.org/10.1074/jbc.M709147200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167347	hybrid			2022-12-25	WOS:000253426700042
J	Eun, B; Lee, Y; Hong, S; Kim, J; Lee, HW; Kim, K; Sun, W; Kim, H				Eun, Bokkee; Lee, Yool; Hong, Soontaek; Kim, Jaesang; Lee, Han-Woong; Kim, Kyungjin; Sun, Woong; Kim, Hyun			Hes6 controls cell proliferation via interaction with cAMP-response element-binding protein-binding protein in the promyelocytic leukemia nuclear body	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NOTCH SIGNALING PATHWAY; LOOP-HELIX FACTORS; TRANSCRIPTIONAL REPRESSION; NEURONAL DIFFERENTIATION; BHLH PROTEINS; CYCLE ARREST; REGULATES DIFFERENTIATION; PREMATURE SENESCENCE; P53 ACETYLATION; MAMMALIAN-CELLS	Hes6 is a basic helix-loop-helix transcription factor that functions in the differentiation of pluripotent progenitor cells and during tumorigenesis. However, the molecular mechanism for its function is largely unknown. Here we show that Hes6 is a component of the promyelocytic leukemia nuclear body (PML-NB) complex in the nuclei and that Hes6 inhibits cell proliferation through induction of p21 cyclin-dependent kinase inhibitor. We further show that Hes6 directly interacts with CREB-binding protein (CBP), one of the key components of PML-NB, via its basic domain. This association is critical for p21 induction through multiple mechanisms, including chromatin remodeling and p53 acetylation. Taken together, these results suggest that the Hes6-CBP complex in PML-NB may influence the proliferation of cells via p53-dependent and -independent pathways.	[Eun, Bokkee; Hong, Soontaek; Sun, Woong; Kim, Hyun] Korea Univ, Coll Med, Seoul 136705, South Korea; [Eun, Bokkee; Lee, Yool; Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Jaesang] Ewha Womans Univ, Div Mol Life Sci, Seoul 120750, South Korea; [Lee, Han-Woong] Yonsei Univ, Coll Sci, Seoul 120749, South Korea	Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU); Ewha Womans University; Yonsei University	Kim, H (corresponding author), Korea Univ, Coll Med, Brain Korea 21, Seoul 136705, South Korea.	kimhyun@korea.ac.kr		LEE, YOOL/0000-0003-0498-3342; sun, woong/0000-0003-1792-4894; Kim, Hyun/0000-0002-7210-5798				ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Bae SK, 2000, DEVELOPMENT, V127, P2933; Barlev NA, 2001, MOL CELL, V8, P1243, DOI 10.1016/S1097-2765(01)00414-2; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Ching RW, 2005, J CELL SCI, V118, P847, DOI 10.1242/jcs.01700; Coffman FD, 1999, EXP CELL RES, V248, P58, DOI 10.1006/excr.1999.4457; Cossins J, 2002, DEVELOPMENT, V129, P2195; Davis RL, 2001, ONCOGENE, V20, P8342, DOI 10.1038/sj.onc.1205094; DAWSON SR, 1995, MOL CELL BIOL, V15, P6923; de Stanchina E, 2004, MOL CELL, V13, P523, DOI 10.1016/S1097-2765(04)00062-0; DETHE H, 1991, CELL, V66, P675, DOI 10.1016/0092-8674(91)90113-D; Farah MH, 2000, DEVELOPMENT, V127, P693; Ferbeyre G, 2000, GENE DEV, V14, P2015; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Fisher AL, 1996, MOL CELL BIOL, V16, P2670; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gartel AL, 1999, EXP CELL RES, V246, P280, DOI 10.1006/excr.1998.4319; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Georgia S, 2006, DEV BIOL, V298, P22, DOI 10.1016/j.ydbio.2006.05.036; Ghiani CA, 1999, DEVELOPMENT, V126, P1077; Gill RM, 1998, EXP CELL RES, V244, P157, DOI 10.1006/excr.1998.4197; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Guo A, 2000, NAT CELL BIOL, V2, P730, DOI 10.1038/35036365; HALEVY O, 1995, SCIENCE, V267, P1018, DOI 10.1126/science.7863327; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; Hofmann TG, 2002, NAT CELL BIOL, V4, P1, DOI 10.1038/ncb715; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Ito A, 2001, EMBO J, V20, P1331, DOI 10.1093/emboj/20.6.1331; Iyer NG, 2004, ONCOGENE, V23, P4225, DOI 10.1038/sj.onc.1207118; Kageyama R, 2000, MOL CELLS, V10, P1, DOI 10.1007/s10059-000-0001-0; Kang SA, 2005, BIOCHEM BIOPH RES CO, V332, P33, DOI 10.1016/j.bbrc.2005.04.089; Kawasaki H, 1998, NATURE, V393, P284, DOI 10.1038/30538; Kiesslich A, 2002, J STRUCT BIOL, V140, P167, DOI 10.1016/S1047-8477(02)00571-3; Kleihues P, 1999, Neuro Oncol, V1, P44, DOI 10.1093/neuonc/1.1.44; Koyano-Nakagawa N, 2000, DEVELOPMENT, V127, P4203; Lamond AI, 1998, SCIENCE, V280, P547, DOI 10.1126/science.280.5363.547; Lin HK, 2005, ONCOGENE, V24, P5693, DOI 10.1038/sj.onc.1208923; Liu H, 2006, EMBO J, V25, P1058, DOI 10.1038/sj.emboj.7601020; Murata K, 2005, MOL CELL BIOL, V25, P4262, DOI 10.1128/MCB.25.10.4262-4271.2005; Mutoh H, 1998, GENE DEV, V12, P820, DOI 10.1101/gad.12.6.820; Nguyen LA, 2005, BLOOD, V105, P292, DOI 10.1182/blood-2004-03-1185; Norton JD, 2000, J CELL SCI, V113, P3897; Ohnuma S, 2001, CURR OPIN NEUROBIOL, V11, P66, DOI 10.1016/S0959-4388(00)00175-6; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; PANDOLFI PP, 1991, ONCOGENE, V6, P1285; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Piscione TD, 2004, GENE EXPR PATTERNS, V4, P707, DOI 10.1016/j.modgep.2004.04.007; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Qi RZ, 2003, CANCER RES, V63, P8323; Ross SE, 2003, NEURON, V39, P13, DOI 10.1016/S0896-6273(03)00365-9; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Somasundaram K, 2005, ONCOGENE, V24, P7073, DOI 10.1038/sj.onc.1208865; Tomita K, 1996, NEURON, V16, P723, DOI 10.1016/S0896-6273(00)80093-8; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Wang L, 2001, ENDOCRINOLOGY, V142, P4015, DOI 10.1210/en.142.9.4015; Wang ZG, 1998, NAT GENET, V20, P266, DOI 10.1038/3073; Wu YY, 2003, DEV DYNAM, V226, P675, DOI 10.1002/dvdy.10278; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Zhong S, 2000, NAT CELL BIOL, V2, pE85, DOI 10.1038/35010583	67	9	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5939	5949		10.1074/jbc.M707683200	http://dx.doi.org/10.1074/jbc.M707683200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18160400	hybrid			2022-12-25	WOS:000253426700072
J	Hadfield, KD; Rock, CF; Inkson, CA; Dallas, SL; Sudre, L; Wallis, GA; Boot-Handford, RP; Canfield, AE				Hadfield, Kristen D.; Rock, Claire Farrington; Inkson, Colette A.; Dallas, Sarah L.; Sudre, Laure; Wallis, Gillian A.; Boot-Handford, Raymond P.; Canfield, Ann E.			HtrA1 inhibits mineral deposition by osteoblasts - Requirement for the protease and PDZ domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-GLA-PROTEIN; BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR-BETA; SERINE-PROTEASE; EXTRACELLULAR-MATRIX; TGF-BETA; INTEGRIN RECEPTORS; IN-VITRO; DIFFERENTIATION; CALCIFICATION	HtrA1 is a secreted multidomain protein with serine protease activity. In light of increasing evidence implicating this protein in the regulation of skeletal development and pathology, we investigated the role of HtrA1 in osteoblast mineralization and identified domains essential for this activity. We demonstrate increased HtrA1 expression in differentiating 2T3 osteoblasts prior to the appearance of mineralization. HtrA1 is subsequently down-regulated in fully mineralized cultures. The functional role of HtrA1 in matrix calcification was investigated using three complementary approaches. First, we transfected a full-length HtrA1 expression plasmid into 2T3 cells and showed that overexpression of HtrA1 delayed mineralization, reduced expression of Cbfa1 and collagen type I mRNA, and prevented BMP-2-induced mineralization. Second, knocking down HtrA1 expression using short interfering RNA induced mineral deposition by 2T3 cells. Third, by expressing a series of recombinant HtrA1 proteins, we demonstrated that the protease domain and the PDZ domain are essential for the inhibitory effect of HtrA1 on osteoblast mineralization. Finally, we tested whether HtrA1 cleaves specific matrix proteins that are known to regulate osteoblast differentiation, mineralization, and/or BMP-2 activity. Full-length recombinant HtrA1 cleaved recombinant decorin, fibronectin, and matrix Gla protein. Both the protease domain and the PDZ domain were necessary for the cleavage of matrix Gla protein, whereas the PDZ domain was not required for the cleavage of decorin or fibronectin. Type I collagen was not cleaved by recombinant HtrA1. These results suggest that HtrA1 may regulate matrix calcification via the inhibition of BMP-2 signaling, modulating osteoblast gene expression, and/or via the degradation of specific matrix proteins.	[Hadfield, Kristen D.; Rock, Claire Farrington; Inkson, Colette A.; Sudre, Laure; Wallis, Gillian A.; Boot-Handford, Raymond P.; Canfield, Ann E.] Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester, Lancs, England; [Canfield, Ann E.] Univ Manchester, Fac Med & Human Genet, Sch Clin & Lab Sci, Cardiovasc Res Grp, Manchester M13 9PT, Lancs, England; [Dallas, Sarah L.] Univ Missouri, Sch Dent, Dept Oral Biol, Kansas City, MO 64108 USA	University of Manchester; University of Manchester; University of Missouri System; University of Missouri Kansas City	Canfield, AE (corresponding author), Univ Manchester, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	ann.canfield@manchester.ac.uk		Boot-Handford, Raymond/0000-0002-6167-8419; Inkson, Colette/0000-0003-1215-312X; Canfield, Ann/0000-0002-8983-5674	Arthritis Research UK Funding Source: Medline; Wellcome Trust Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Wellcome Trust(Wellcome TrustEuropean Commission)		Bakay M, 2002, NEUROMUSCULAR DISORD, V12, pS125, DOI 10.1016/S0960-8966(02)00093-7; Baldi A, 2002, ONCOGENE, V21, P6684, DOI 10.1038/sj.onc.1205911; Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779; BAYLINK DJ, 1993, J BONE MINER RES, V8, pS565; Bi YM, 2005, J BIOL CHEM, V280, P30481, DOI 10.1074/jbc.M500573200; BONEWALD LF, 1990, CLIN ORTHOP RELAT R, P261; BOSKEY AL, 1984, ORTHOP CLIN N AM, V15, P597; Bostrom K, 2001, J BIOL CHEM, V276, P14044, DOI 10.1074/jbc.M008103200; Canfield AE, 2000, FEBS LETT, V487, P267, DOI 10.1016/S0014-5793(00)02363-2; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Chien J, 2004, ONCOGENE, V23, P1636, DOI 10.1038/sj.onc.1207271; Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5; Corsi A, 2002, J BONE MINER RES, V17, P1180, DOI 10.1359/jbmr.2002.17.7.1180; Dallas SL, 2005, J BIOL CHEM, V280, P18871, DOI 10.1074/jbc.M410762200; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; DOHERTY M, 1998, BIOCHEM SOC T, V26, pS410; Fischer JW, 2004, ARTERIOSCL THROM VAS, V24, P2391, DOI 10.1161/01.ATV.0000147029.63303.28; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; GhoshChoudhury N, 1996, ENDOCRINOLOGY, V137, P331, DOI 10.1210/en.137.1.331; Grau S, 2005, P NATL ACAD SCI USA, V102, P6021, DOI 10.1073/pnas.0501823102; Grau S, 2006, J BIOL CHEM, V281, P6124, DOI 10.1074/jbc.M500361200; Harris SE, 2003, FRONT BIOSCI, V8, pS1249, DOI 10.2741/1170; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hoffmann A, 2001, CRIT REV EUKAR GENE, V11, P23; Hoshi K, 1999, J BONE MINER RES, V14, P273, DOI 10.1359/jbmr.1999.14.2.273; Hoshi K, 2001, J BONE MINER RES, V16, P289, DOI 10.1359/jbmr.2001.16.2.289; Hu SI, 1998, J BIOL CHEM, V273, P34406, DOI 10.1074/jbc.273.51.34406; Jikko A, 1999, J BONE MINER RES, V14, P1075, DOI 10.1359/jbmr.1999.14.7.1075; Kirton JP, 2006, CIRC RES, V98, P1264, DOI 10.1161/01.RES.0000223056.68892.8b; Kohfeldt E, 1997, FEBS LETT, V414, P557, DOI 10.1016/S0014-5793(97)01070-3; Landis W J, 1999, Gravit Space Biol Bull, V12, P15; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; Mochida Y, 2003, BIOCHEM BIOPH RES CO, V305, P6, DOI 10.1016/S0006-291X(03)00693-4; Moursi AM, 1997, J CELL SCI, V110, P2187; Moursi AM, 1996, J CELL SCI, V109, P1369; Murshed M, 2004, J CELL BIOL, V165, P625, DOI 10.1083/jcb.200402046; Murwantoko, 2004, BIOCHEM J, V381, P895, DOI 10.1042/BJ20040435; Newman B, 2001, J CELL BIOL, V154, P659, DOI 10.1083/jcb.200106040; Nishimoto SK, 2005, MATRIX BIOL, V24, P353, DOI 10.1016/j.matbio.2005.05.004; Oka C, 2004, DEVELOPMENT, V131, P1041, DOI 10.1242/dev.00999; Pereira M, 2002, J CELL SCI, V115, P609; Price PA, 2003, J BIOL CHEM, V278, P22153, DOI 10.1074/jbc.M300739200; PRICE PA, 1985, J BIOL CHEM, V260, P4971; Rock MJ, 2004, J BIOL CHEM, V279, P23748, DOI 10.1074/jbc.M400212200; SHIOI A, 1995, ARTERIOSCL THROM VAS, V15, P2003, DOI 10.1161/01.ATV.15.11.2003; Shukunami C, 1997, J BONE MINER RES, V12, P1174, DOI 10.1359/jbmr.1997.12.8.1174; Sweatt A, 2003, J THROMB HAEMOST, V1, P178, DOI 10.1046/j.1538-7836.2003.00023.x; Tocharus J, 2004, DEV GROWTH DIFFER, V46, P257; Tsuchiya A, 2005, BONE, V37, P323, DOI 10.1016/j.bone.2005.03.015; Van Craenenbroeck K, 2000, EUR J BIOCHEM, V267, P5665, DOI 10.1046/j.1432-1327.2000.01645.x; Velling T, 2002, J BIOL CHEM, V277, P37377, DOI 10.1074/jbc.M206286200; Waddington R. J., 2003, European Cells & Materials, V6, P12; Wajih N, 2004, J BIOL CHEM, V279, P43052, DOI 10.1074/jbc.M407180200; Wallin R, 2000, THROMB HAEMOSTASIS, V84, P1039; Wu J, 2007, ARTHRITIS RHEUM-US, V56, P3675, DOI 10.1002/art.22876; Yagami K, 1999, J CELL BIOL, V147, P1097, DOI 10.1083/jcb.147.5.1097; YAMAGUCHI Y, 1990, NATURE, V346, P281, DOI 10.1038/346281a0; Yang WC, 2005, J BIOL CHEM, V280, P20680, DOI 10.1074/jbc.M500104200; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Young MF, 2003, OSTEOPOROSIS INT, V14, pS35, DOI 10.1007/s00198-002-1342-7; Zebboudj AF, 2002, J BIOL CHEM, V277, P4388, DOI 10.1074/jbc.M109683200; Zebboudj AF, 2003, J CELL BIOCHEM, V90, P756, DOI 10.1002/jcb.10669; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200; Zumbrunn J, 1996, FEBS LETT, V398, P187, DOI 10.1016/S0014-5793(96)01229-X	65	57	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5928	5938		10.1074/jbc.M709299200	http://dx.doi.org/10.1074/jbc.M709299200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18156628	hybrid			2022-12-25	WOS:000253426700071
J	Vaid, A; Thomas, DC; Sharma, P				Vaid, Ankush; Thomas, Divya C.; Sharma, Pushkar			Role of Ca2+/Calmodulin-PfPKB signaling pathway in erythrocyte invasion by Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MALARIA PARASITES; B-LIKE ENZYME; TOXOPLASMA-GONDII; CELL INVASION; MYOSIN-A; PROTEIN-KINASES; IN-VIVO; CALCIUM; INHIBIT; MEMBRANE	Molecular mechanisms by which signaling pathways operate in the malaria parasite and control its development are promiscuous. Recently, we reported the identification of a signaling pathway in Plasmodium falciparum, which involves activation of protein kinase B-like enzyme (PfPKB) by calcium/calmodulin (Vaid, A., and Sharma, P. (2006) J. Biol. Chem. 281, 27126 27133). Studies carried out to elucidate the function of this pathway suggested that it may be important for erythrocyte invasion. Blocking the function of the upstream activators of this pathway, calmodulin and phospholipase C, resulted in impaired invasion. To evaluate if this signaling cascade controls invasion by regulating PfPKB, inhibitors against this kinase were developed. PfPKB inhibitors dramatically reduced the ability of the parasite to invade erythrocytes. Furthermore, we demonstrate that PfPKB associates with actin-myosin motor and phosphorylates PfGAP45 (glideosome-associated protein 45), one of the important components of the motor complex, which may help explain its role in erythrocyte invasion.	[Vaid, Ankush; Thomas, Divya C.; Sharma, Pushkar] Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII)	Sharma, P (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India.	pushkar@nii.res.in			Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Anamika, 2005, PROTEINS, V58, P180, DOI 10.1002/prot.20278; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Bergman LW, 2003, J CELL SCI, V116, P39, DOI 10.1242/jcs.00194; BLACKMAN MJ, 1994, J EXP MED, V180, P389, DOI 10.1084/jem.180.1.389; Bosch J, 2006, P NATL ACAD SCI USA, V103, P4852, DOI 10.1073/pnas.0510907103; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Davies TG, 2007, J MOL BIOL, V367, P882, DOI 10.1016/j.jmb.2007.01.004; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; Farias SL, 2005, MOL BIOCHEM PARASIT, V141, P71, DOI 10.1016/j.molbiopara.2005.01.015; Garcia CRS, 1996, EUR J CELL BIOL, V71, P409; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gaskins E, 2004, J CELL BIOL, V165, P383, DOI 10.1083/jcb.200311137; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; Green JL, 2006, J MOL BIOL, V355, P933, DOI 10.1016/j.jmb.2005.11.027; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Hotta CT, 2003, BRAZ J MED BIOL RES, V36, P1583, DOI 10.1590/S0100-879X2003001100016; Jones ML, 2006, MOL BIOCHEM PARASIT, V147, P74, DOI 10.1016/j.molbiopara.2006.01.009; Kaidanovich-Beilin O, 2006, PHYSIOLOGY, V21, P411, DOI 10.1152/physiol.00022.2006; Kelemen BR, 2002, J BIOL CHEM, V277, P8741, DOI 10.1074/jbc.M108459200; Kumar A, 2004, J BIOL CHEM, V279, P24255, DOI 10.1074/jbc.M312855200; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Luo Y, 2004, BIOCHEMISTRY-US, V43, P1254, DOI 10.1021/bi034515p; Mamoun CB, 2001, MOL MICROBIOL, V39, P26, DOI 10.1046/j.1365-2958.2001.02222.x; MATSUMOTO Y, 1987, EUR J CELL BIOL, V45, P36; MCCALLUMDEIGHTON N, 1992, MOL BIOCHEM PARASIT, V50, P317, DOI 10.1016/0166-6851(92)90229-D; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Mohrle JJ, 1997, BIOCHEM J, V328, P677; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Pinder JC, 1998, J CELL SCI, V111, P1831; Rees-Channer RR, 2006, MOL BIOCHEM PARASIT, V149, P113, DOI 10.1016/j.molbiopara.2006.04.008; SCHEIBEL LW, 1987, P NATL ACAD SCI USA, V84, P7310, DOI 10.1073/pnas.84.20.7310; Soldati D, 2004, TRENDS PARASITOL, V20, P567, DOI 10.1016/j.pt.2004.09.009; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaid A, 2006, J BIOL CHEM, V281, P27126, DOI 10.1074/jbc.M601914200; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; WARD GE, 1994, EXP PARASITOL, V79, P480, DOI 10.1006/expr.1994.1109; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Wasserman M, 1996, PARASITOL RES, V82, P102, DOI 10.1007/s004360050078	41	76	79	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5589	5597		10.1074/jbc.M708465200	http://dx.doi.org/10.1074/jbc.M708465200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165240	hybrid			2022-12-25	WOS:000253426700039
J	Jefferies, KC; Forgac, M				Jefferies, Kevin C.; Forgac, Michael			Subunit h of the vacuolar (H+) ATPase inhibits ATP hydrolysis by the free V-1 domain by interaction with the rotary subunit F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST V-ATPASE; PROTON-TRANSLOCATING ATPASE; MEDIATED CROSS-LINKING; SACCHAROMYCES-CEREVISIAE; MUTATIONAL ANALYSIS; COMPLEX; VMA13P; V-1; ACIDIFICATION; LOCALIZATION	The vacuolar (H+) ATPases (V-ATPases) are large, multimeric proton pumps that, like the related family of F1F0 ATP synthases, employ a rotary mechanism. ATP hydrolysis by the peripheral V-1 domain drives rotation of a rotary complex (the rotor) relative to the stationary part of the enzyme (the stator), leading to proton translocation through the integral V-0 domain. One mechanism of regulating V-ATPase activity in vivo involves reversible dissociation of the V-1 and V-0 domains. Unlike the corresponding domains in F1F0, the dissociated V-1 domain does not hydrolyze ATP, and the free V0 domain does not passively conduct protons. These properties are important to avoid generation of an uncoupled ATPase activity or an unregulated proton conductance upon dissociation of the complex in vivo. Previous results (Parra, K. J., Keenan, K. L., and Kane, P. M. (2000) J. Biol. Chem. 275, 21761-21767) showed that subunit H(part of the stator) inhibits ATP hydrolysis by free V-1. To test the hypothesis that subunit H accomplishes this by bridging rotor and stator in free V-1, cysteine-mediated cross-linking studies were performed. Unique cysteine residues were introduced over the surface of subunit H from yeast by site-directed mutagenesis and used as the site of attachment of the photo-activated cross-linking reagent maleimido benzophenone. After UV-activated cross-linking, cross-linked products were identified by Western blot using subunit-specific antibodies. The results indicate that the subunit H mutant S381C shows cross-linking between subunit H and subunit F (a rotor subunit) in the free V-1 domain but not in the intact V1V0 complex. These results indicate that subunits H and F are proximal in free V-1, supporting the hypothesis that subunit H inhibits free V-1 by bridging the rotary and stator domains.	[Jefferies, Kevin C.; Forgac, Michael] Tufts Univ, Sch Med, Dept Physiol, Boston, MA 02111 USA	Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Physiol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			NIDDK NIH HHS [DK34928, P30 DK034928] Funding Source: Medline; NIGMS NIH HHS [R37 GM034478-22, R37 GM034478, R01 GM034478, R37 GM034478-21, R37 GM034478-20, GM 34478, R37 GM034478-23] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034928] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arata Y, 2002, BIOCHEMISTRY-US, V41, P11301, DOI 10.1021/bi0262449; Arata Y, 2002, J BIOL CHEM, V277, P3357, DOI 10.1074/jbc.M109967200; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Curtis KK, 2002, J BIOL CHEM, V277, P2716, DOI 10.1074/jbc.M107777200; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Geyer M, 2002, J BIOL CHEM, V277, P28521, DOI 10.1074/jbc.M200522200; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Imamura H, 2003, P NATL ACAD SCI USA, V100, P2312, DOI 10.1073/pnas.0436796100; Inoue T, 2005, J BIOENERG BIOMEMBR, V37, P393, DOI 10.1007/s10863-005-9478-8; Inoue T, 2005, J BIOL CHEM, V280, P27896, DOI 10.1074/jbc.M504890200; Jones RPO, 2005, BIOCHEMISTRY-US, V44, P3933, DOI 10.1021/bi048402x; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kato-Yamada Y, 1998, J BIOL CHEM, V273, P19375, DOI 10.1074/jbc.273.31.19375; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Liu JZ, 1996, BIOCHEMISTRY-US, V35, P10938, DOI 10.1021/bi9608065; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; MacLeod KJ, 1998, J BIOL CHEM, V273, P150, DOI 10.1074/jbc.273.1.150; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Nanda A, 1996, J BIOL CHEM, V271, P15963, DOI 10.1074/jbc.271.27.15963; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Rizzo JM, 2007, J BIOL CHEM, V282, P8521, DOI 10.1074/jbc.M607092200; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; SENNOUNE SR, 2004, AM J PHYSIOL-CELL PH, V286, P1443; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Sun-Wada GH, 2004, BBA-BIOENERGETICS, V1658, P106, DOI 10.1016/j.bbabio.2004.04.013; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vasilyeva E, 2000, J BIOL CHEM, V275, P255, DOI 10.1074/jbc.275.1.255; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zhong XT, 2000, J BIOL CHEM, V275, P35592, DOI 10.1074/jbc.M006932200	42	65	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4512	4519		10.1074/jbc.M707144200	http://dx.doi.org/10.1074/jbc.M707144200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156183	Green Accepted, hybrid			2022-12-25	WOS:000253426500007
J	Kang, S; Dong, S; Guo, A; Ruan, H; Lonial, S; Khoury, HJ; Gu, TL; Chen, J				Kang, Sumin; Dong, Shaozhong; Guo, Ailan; Ruan, Hong; Lonial, Sagar; Khoury, Hanna Jean; Gu, Ting-Lei; Chen, Jing			Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and Src-dependent tyrosine phosphorylation of RSK2 at Tyr-529	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL S6 KINASE; DOCKING SITE; SIGNAL-TRANSDUCTION; HISTONE H3; MAP	The Ser/Thr kinase ribosomal S6 kinase 2 (RSK2) has been demonstrated to phosphorylate transcription factor CREB ( cyclic AMP-responsive-binding protein) and histone H3 in response to mitogenic stimulation by epidermal growth factor (EGF). EGF activates the MEK/ERK pathway to activate RSK2. We recently reported that receptor tyrosine kinase fibroblast growth factor receptor 3 (FGFR3) directly tyrosine phosphorylates RSK2 at Tyr-529, which consequently regulates RSK2 activation by facilitating inactive ERK binding to RSK2 that is required for ERK-dependent phosphorylation and activation of RSK2 (Kang, S., Dong, S., Gu, T. L., Guo, A., Cohen, M. S., Lonial, S., Khoury, H. J., Fabbro, D., Gilliland, D. G., Bergsagel, P. L., Taunton, J., Polakiewicz, R. D., and Chen, J. ( 2007) Cancer Cell 12, 201-214). Here we report that upon treatment of EGF, RSK2 was tyrosine-phosphorylated at Tyr-529 and activated in 293T and COS7 cells that do not express FGFR3. In contrast to FGFR3, the receptor tyrosine kinase EGF receptor did not directly phosphorylate RSK2 at Tyr-529 in an in vitro kinase assay using recombinant RSK2 and active EGF receptor or FGFR3. By mass spectroscopy-based studies, we identified Src tyrosine kinase family members Src and Fyn as upstream kinases of RSK2 Tyr-529. Treatment of Src inhibitor PP2 effectively attenuated EGF-dependent activation and Tyr-529 phosphorylation of RSK2, suggesting that Src family members are the kinases that phosphorylate RSK2 at Tyr-529 in response to EGF. Src and Fyn were able to directly phosphorylate RSK2 at Tyr-529 in the in vitro kinase assay. In vitro reconstitution of Tyr-529 phosphorylation by Src in glutathione S-transferase- tagged RSK2 enhanced inactive ERK binding to RSK2 wild type, but not the Y529F mutant. Together, our findings suggest that Src-dependent phosphorylation at Tyr-529 facilitates inactive ERK binding to RSK2, which might be a general requirement for RSK2 activation by EGF through the MEK/ERK pathway.	[Kang, Sumin; Dong, Shaozhong; Lonial, Sagar; Khoury, Hanna Jean; Chen, Jing] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA; [Guo, Ailan; Ruan, Hong; Gu, Ting-Lei] Cell Signaling Technol Inc, Danvers, MA 01923 USA	Emory University	Chen, J (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA.	jchen@emory.edu			NCI NIH HHS [R01 CA120272-02, CA120272, R01 CA120272] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA120272] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BLENIS J, 1993, P NATL ACAD SCI USA, V90, P5889, DOI 10.1073/pnas.90.13.5889; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; Fisher TL, 1996, MOL CELL BIOL, V16, P1212; Frodin M, 2000, EMBO J, V19, P2924, DOI 10.1093/emboj/19.12.2924; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Jensen CJ, 1999, J BIOL CHEM, V274, P27168, DOI 10.1074/jbc.274.38.27168; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Sassone-Corsi P, 1999, SCIENCE, V285, P886, DOI 10.1126/science.285.5429.886; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Strelkov IS, 2002, CANCER RES, V62, P75; Treisman R, 1996, CURR OPIN CELL BIOL, V8, P205, DOI 10.1016/S0955-0674(96)80067-6; Xing J, 1996, SCIENCE, V273, P959, DOI 10.1126/science.273.5277.959	15	28	28	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4652	4657		10.1074/jbc.M709673200	http://dx.doi.org/10.1074/jbc.M709673200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156174	hybrid, Green Accepted			2022-12-25	WOS:000253426500022
J	Makareeva, E; Mertz, EL; Kuznetsova, NV; Sutter, MB; DeRidder, AM; Cabral, WA; Barnes, AM; McBride, DJ; Marini, JC; Leikin, S				Makareeva, Elena; Mertz, Edward L.; Kuznetsova, Natalia V.; Sutter, Mary B.; DeRidder, Angela M.; Cabral, Wayne A.; Barnes, Aileen M.; McBride, Daniel J.; Marini, Joan C.; Leikin, Sergey			Structural heterogeneity of type I collagen triple helix and its role in osteogenesis imperfecta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID-SEQUENCE; THERMAL-STABILITY; ELECTRON-MICROGRAPHS; MOLECULAR PACKING; ALPHA-1(I) CHAIN; ALPHA-2(I) CHAIN; DANLOS-SYNDROME; MODEL PEPTIDES; BINDING SITES; MURINE MODEL	We investigated regions of different helical stability within human type I collagen and discussed their role in intermolecular interactions and osteogenesis imperfecta (OI). By differential scanning calorimetry and circular dichroism, we measured and mapped changes in the collagen melting temperature (Delta T-m) for 41 different Gly substitutions from 47 OI patients. In contrast to peptides, we found no correlations of Delta T-m with the identity of the substituting residue. Instead, we observed regular variations in Delta T-m with the substitution location in different triple helix regions. To relate the Delta T-m map to peptide-based stability predictions, we extracted the activation energy of local helix unfolding (Delta G(double dagger)) from the reported peptide data. We constructed the Delta G(double dagger) map and tested it by measuring the H-D exchange rate for glycine NH residues involved in interchain hydrogen bonds. Based on the Delta T-m and Delta G(double dagger) maps, we delineated regional variations in the collagen triple helix stability. Two large, flexible regions deduced from the Delta T-m map aligned with the regions important for collagen fibril assembly and ligand binding. One of these regions also aligned with a lethal region for Gly substitutions in the alpha 1(I) chain.	[Makareeva, Elena; Mertz, Edward L.; Kuznetsova, Natalia V.; Sutter, Mary B.; DeRidder, Angela M.; Leikin, Sergey] NICHD, Sect Phys Biochem, NIH, Bethesda, MD 20892 USA; [Cabral, Wayne A.; Barnes, Aileen M.; Marini, Joan C.] NICHD, Bone & Extracellular Matrix Branch, NIH, Bethesda, MD 20892 USA; [McBride, Daniel J.] Univ Maryland, Sch Med, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University System of Maryland; University of Maryland Baltimore	Leikin, S (corresponding author), NICHD, Sect Phys Biochem, NIH, Bldg 9,Rm 1E-127, Bethesda, MD 20892 USA.	leikins@mail.nih.gov	Leikin, Sergey/A-5518-2008; Makareeva, Elena/F-5183-2011	Leikin, Sergey/0000-0001-7095-0739; Makareeva, Elena/0000-0002-5815-0760; Barnes, Aileen/0000-0001-8021-4997	Intramural NIH HHS Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008810, ZIAHD000256, ZIAHD000408] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000408, Z01HD008810, Z01HD000256] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ANDREEVA N S, 1970, Biofizika, V15, P198; Arnold WV, 1998, J BIOL CHEM, V273, P31822, DOI 10.1074/jbc.273.48.31822; BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1991, INT J BIOL MACROMOL, V13, P152, DOI 10.1016/0141-8130(91)90040-2; Beck K, 2000, P NATL ACAD SCI USA, V97, P4273, DOI 10.1073/pnas.070050097; BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699; BRADBURY EM, 1958, DISCUSS FARADAY SOC, P173; BURJANADZE TV, 1992, BIOPOLYMERS, V32, P951, DOI 10.1002/bip.360320806; Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7; Byers P, 2002, CONNECTIVE TISSUE IT, P385, DOI DOI 10.1002/0471221929.CH8; Cabral WA, 2005, J BIOL CHEM, V280, P19259, DOI 10.1074/jbc.M414698200; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; CHAPMAN JA, 1974, CONNECT TISSUE RES, V2, P137, DOI 10.3109/03008207409152099; Chu M., 2002, CONNECTIVE TISSUE IT, P223, DOI [10.1002/0471221929.ch2(ii), DOI 10.1002/0471221929.CH2(II)]; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Di Lullo GA, 2002, J BIOL CHEM, V277, P4223, DOI 10.1074/jbc.M110709200; DOYLE BB, 1975, BIOPOLYMERS, V14, P937, DOI 10.1002/bip.1975.360140505; ENGEL J, 1991, ANNU REV BIOPHYS BIO, V20, P137, DOI 10.1146/annurev.biophys.20.1.137; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; ESIPOVA N G, 1958, Biofizika, V3, P529; FERTALA A, 1993, BIOCHEM J, V289, P195, DOI 10.1042/bj2890195; Forlino A, 1999, J BIOL CHEM, V274, P37923, DOI 10.1074/jbc.274.53.37923; Forlino A, 2000, MOL GENET METAB, V71, P225, DOI 10.1006/mgme.2000.3039; Forlino A, 2007, MATRIX BIOL, V26, P604, DOI 10.1016/j.matbio.2007.06.005; Forlino A, 2007, PROTEOMICS, V7, P1877, DOI 10.1002/pmic.200600919; Fraser ROB, 1973, CONFORMATION FIBROUS, P344; Gauba V, 2007, J AM CHEM SOC, V129, P2683, DOI 10.1021/ja0683640; HOFMANN H, 1984, J MOL BIOL, V172, P325, DOI 10.1016/S0022-2836(84)80029-7; HOFMANN H, 1978, J MOL BIOL, V125, P137, DOI 10.1016/0022-2836(78)90342-X; HULMES DJS, 1977, J MOL BIOL, V110, P643, DOI 10.1016/S0022-2836(77)80082-X; HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1; Hyde TJ, 2006, J BIOL CHEM, V281, P36937, DOI 10.1074/jbc.M605135200; KADLER KE, 1988, J BIOL CHEM, V263, P10517; Koide T, 2005, CONNECT TISSUE RES, V46, P131, DOI 10.1080/03008200591008518; KUIVANIEMI H, 1991, FASEB J, V5, P2052, DOI 10.1096/fasebj.5.7.2010058; Kuznetsova NV, 2004, MATRIX BIOL, V23, P101, DOI 10.1016/j.matbio.2004.03.002; Kuznetsova NV, 2003, J MOL BIOL, V331, P191, DOI 10.1016/S0022-2836(03)00715-0; Leikina E, 2002, P NATL ACAD SCI USA, V99, P1314, DOI 10.1073/pnas.032307099; Makareeva E, 2006, J BIOL CHEM, V281, P6463, DOI 10.1074/jbc.M511830200; Makareeva E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001029; MARINI JC, 2007, NELSON TXB PEDIAT, P2887; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Mertz EL, 2004, BIOCHEMISTRY-US, V43, P14901, DOI 10.1021/bi048788b; Miles CA, 2001, MICRON, V32, P325, DOI 10.1016/S0968-4328(00)00034-2; Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103; Persikov AV, 2005, J BIOL CHEM, V280, P19343, DOI 10.1074/jbc.M501657200; Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704; PIEZ KA, 1984, EXTRACELLULAR MATRIX, P1; PRIVALOV PL, 1979, J MOL BIOL, V127, P203, DOI 10.1016/0022-2836(79)90240-7; PRIVALOV PL, 1982, ADV PROTEIN CHEM, V35, P1, DOI 10.1016/S0065-3233(08)60468-4; Radmer RJ, 2004, BIOCHEMISTRY-US, V43, P5314, DOI 10.1021/bi035676w; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; RYHANEN L, 1983, ARCH BIOCHEM BIOPHYS, V223, P562, DOI 10.1016/0003-9861(83)90621-5; TIKTOPULO E I, 1979, Molekulyarnaya Biologiya (Moscow), V13, P619; Wess TJ, 1998, J STRUCT BIOL, V122, P92, DOI 10.1006/jsbi.1998.3991; WESTERHAUSEN A, 1990, J BIOL CHEM, V265, P13995; YEE RY, 1974, J MOL BIOL, V83, P1, DOI 10.1016/0022-2836(74)90420-3; Zafarullah K, 1997, MATRIX BIOL, V16, P245, DOI 10.1016/S0945-053X(97)90013-5	58	72	75	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4787	4798		10.1074/jbc.M705773200	http://dx.doi.org/10.1074/jbc.M705773200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18073209	hybrid			2022-12-25	WOS:000253426500036
J	Prosser, BL; Wright, NT; Ndez-Ochoa, EOH; Varney, KM; Liu, Y; Olojo, RO; Zimmer, DB; Weber, DJ; Schneider, MF				Prosser, Benjamin L.; Wright, Nathan T.; Ndez-Ochoa, Erick O. Herna; Varney, Kristen M.; Liu, Yewei; Olojo, Rotimi O.; Zimmer, Danna B.; Weber, David J.; Schneider, Martin F.			S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-BINDING PROTEIN S100A1; CA2+ RELEASE CHANNEL; 3-DIMENSIONAL SOLUTION STRUCTURE; CALCIUM-BINDING; REGULATORY DOMAIN; HEART-FAILURE; C-TERMINUS; TARGET; ALPHA; C-13	S100A1, a 21-kDa dimeric Ca2+-binding protein, is an enhancer of cardiac Ca2+ release and contractility and a potential therapeutic agent for the treatment of cardiomyopathy. The role of S100A1 in skeletal muscle has been less well defined. Additionally, the precise molecular mechanism underlying S100A1 modulation of sarcoplasmic reticulum Ca2+ release in striated muscle has not been fully elucidated. Here, utilizing a genetic approach to knock out S100A1, we demonstrate a direct physiological role of S100A1 in excitation-contraction coupling in skeletal muscle. We show that the absence of S100A1 leads to decreased global myoplasmic Ca2+ transients following electrical excitation. Using high speed confocal microscopy, we demonstrate with high temporal resolution depressed activation of sarcoplasmic reticulum Ca2+ release in S100A1(-/-) muscle fibers. Through competition assays with sarcoplasmic reticulum vesicles and through tryptophan fluorescence experiments, we also identify a novel S100A1-binding site on the cytoplasmic face of the intact ryanodine receptor that is conserved throughout striated muscle and corresponds to a previously identified calmodulin-binding site. Using a 12-mer peptide of this putative binding domain, we demonstrate low micromolar binding affinity to S100A1. NMR spectroscopy reveals this peptide binds within the Ca2+ -dependent hydrophobic pocket of S100A1. Taken together, these data suggest that S100A1 plays a significant role in skeletal muscle excitation-contraction coupling, primarily through specific interactions with a conserved binding domain of the ryanodine receptor. This warrants further investigation into the use of S100A1 as a therapeutic target for the treatment of both cardiac and skeletal myopathies.	[Prosser, Benjamin L.; Wright, Nathan T.; Ndez-Ochoa, Erick O. Herna; Varney, Kristen M.; Liu, Yewei; Olojo, Rotimi O.; Weber, David J.; Schneider, Martin F.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Zimmer, Danna B.] Texas A&M Univ, Coll Vet Med, Dept Vet Pathobiol, College Stn, TX 77843 USA	University System of Maryland; University of Maryland Baltimore; Texas A&M University System; Texas A&M University College Station	Weber, DJ (corresponding author), Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA.	dweber@umaryland.edu; mschneid@umaryland.edu	Weber, David J/B-5349-2011; Tuluc, Petronel/C-2527-2011	Weber, David J/0000-0002-8824-1110; Wright, Nathan/0000-0003-0177-6129; Prosser, Benjamin/0000-0003-3696-9131	NATIONAL CANCER INSTITUTE [R01CA107331] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR010441, S10RR015741, S10RR016812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007592, R01AR055099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058888] Funding Source: NIH RePORTER; NCI NIH HHS [CA107331, R01 CA107331] Funding Source: Medline; NCRR NIH HHS [S10 RR10441, S10 RR16812] Funding Source: Medline; NIAMS NIH HHS [R01 AR055099, T32 AR007592] Funding Source: Medline; NIGMS NIH HHS [R01 GM058888, GM58888] Funding Source: Medline; PHS HHS [S10 R15741] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Baldisseri DM, 1999, J BIOMOL NMR, V14, P91, DOI 10.1023/A:1008301518346; Carlomagno T, 1997, J MAGN RESON, V126, P110, DOI 10.1006/jmre.1997.1157; CHENG H, 1993, SCIENCE, V262, P740, DOI 10.1126/science.8235594; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DiFranco M, 2005, J MEMBRANE BIOL, V208, P141, DOI 10.1007/s00232-005-0825-9; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Du XJ, 2002, MOL CELL BIOL, V22, P2821, DOI 10.1128/MCB.22.8.2821-2829.2002; EDISON AS, 1994, METHOD ENZYMOL, V239, P3; GRZESIEK S, 1993, J MAGN RESON SER B, V101, P114, DOI 10.1006/jmrb.1993.1019; HAIMOTO H, 1987, J NEUROCHEM, V48, P917, DOI 10.1111/j.1471-4159.1987.tb05604.x; IKURA M, 1990, J AM CHEM SOC, V112, P9020, DOI 10.1021/ja00180a080; Inman KG, 2002, J MOL BIOL, V324, P1003, DOI 10.1016/S0022-2836(02)01152-X; IVANENKOV VV, 1995, J BIOL CHEM, V270, P14651, DOI 10.1074/jbc.270.24.14651; KAY LE, 1990, SCIENCE, V249, P411, DOI 10.1126/science.2377896; Kettlewell S, 2005, J MOL CELL CARDIOL, V39, P900, DOI 10.1016/j.yjmcc.2005.06.018; Kiewitz R, 2003, BIOCHEM BIOPH RES CO, V306, P550, DOI 10.1016/S0006-291X(03)00987-2; KUBONIWA H, 1994, J BIOMOL NMR, V4, P871, DOI 10.1007/BF00398416; Landar A, 1998, BIOCHEMISTRY-US, V37, P17429, DOI 10.1021/bi9817921; Liu YW, 1997, AM J PHYSIOL-CELL PH, V273, pC1915, DOI 10.1152/ajpcell.1997.273.6.C1915; Liu YW, 2001, J CELL BIOL, V155, P27, DOI 10.1083/jcb.200103020; LIVE DH, 1984, J AM CHEM SOC, V106, P1939, DOI 10.1021/ja00319a006; MACLENNA.DH, 1970, J BIOL CHEM, V245, P4508; Maco B, 2001, PHYSIOL RES, V50, P567; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Markowitz J, 2005, BIOCHEMISTRY-US, V44, P7305, DOI 10.1021/bi050321t; MATISE M, 2000, GENE TARGETING PRACT; MENEGAZZI P, 1994, BIOCHEMISTRY-US, V33, P9078, DOI 10.1021/bi00197a008; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Moore CP, 1999, BIOCHEMISTRY-US, V38, P8532, DOI 10.1021/bi9907431; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; Most P, 2004, J CLIN INVEST, V114, P1550, DOI 10.1172/JCI200421454; Most P, 2003, J BIOL CHEM, V278, P33809, DOI 10.1074/jbc.M301788200; Most P, 2003, J BIOL CHEM, V278, P26356, DOI 10.1074/jbc.M303338200; Most P, 2001, P NATL ACAD SCI USA, V98, P13889, DOI 10.1073/pnas.241393598; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; MUHANDIRAM DR, 1993, J BIOMOL NMR, V3, P463; O'Connell KMS, 2002, J GEN PHYSIOL, V120, P337, DOI 10.1085/jgp.20028617; Pleger ST, 2006, EUR J MED RES, V11, P418; Pleger ST, 2005, MOL THER, V12, P1120, DOI 10.1016/j.ymthe.2005.08.002; Pleger ST, 2007, CARDIOVASC RES, V75, P1, DOI 10.1016/j.cardiores.2007.05.009; Pleger ST, 2007, CIRCULATION, V115, P2506, DOI 10.1161/CIRCULATIONAHA.106.671701; Remppis A, 1996, BBA-MOL CELL RES, V1313, P253, DOI 10.1016/0167-4889(96)00097-3; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rodney GG, 2005, J BIOL CHEM, V280, P11713, DOI 10.1074/jbc.M408189200; Rodney GG, 2003, BIOPHYS J, V85, P921, DOI 10.1016/S0006-3495(03)74531-7; Rodney GG, 2001, J BIOL CHEM, V276, P2069, DOI 10.1074/jbc.M008891200; Rustandi RR, 1999, PROTEIN SCI, V8, P1743, DOI 10.1110/ps.8.9.1743; Rustandi RR, 2002, BIOCHEMISTRY-US, V41, P788, DOI 10.1021/bi0118308; SPERA S, 1991, Journal of Biomolecular NMR, V1, P155, DOI 10.1007/BF01877227; SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071; Treves S, 1997, BIOCHEMISTRY-US, V36, P11496, DOI 10.1021/bi970160w; TRIPATHY A, 1995, BIOPHYS J, V69, P106, DOI 10.1016/S0006-3495(95)79880-0; VUISTER GW, 1992, J BIOMOL NMR, V2, P401, DOI 10.1007/BF01874818; Weber DJ, 2000, CALCIUM: THE MOLECULAR BASIS OF CALCIUM ACTION IN BIOLOGY AND MEDICINE, P521; WESTERBLAD H, 1991, J GEN PHYSIOL, V98, P615, DOI 10.1085/jgp.98.3.615; Wilder PT, 2006, BBA-MOL CELL RES, V1763, P1284, DOI 10.1016/j.bbamcr.2006.08.024; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Wright NT, 2005, J MOL BIOL, V353, P410, DOI 10.1016/j.jmb.2005.08.027; Wuthrich K, 1986, NMR PROTEINS NUCL AC, P117; Xiong LW, 2002, J BIOL CHEM, V277, P40862, DOI 10.1074/jbc.M206763200; Yamaguchi N, 2001, J BIOL CHEM, V276, P22579, DOI 10.1074/jbc.M102729200; Zhang HW, 2003, J BIOL CHEM, V278, P8348, DOI 10.1074/jbc.M209565200; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; ZIMMER DB, 1991, CELL MOTIL CYTOSKEL, V20, P325, DOI 10.1002/cm.970200408	65	79	81	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5046	5057		10.1074/jbc.M709231200	http://dx.doi.org/10.1074/jbc.M709231200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089560	hybrid, Green Accepted			2022-12-25	WOS:000253426500062
J	Severi, E; Muller, A; Potts, JR; Leech, A; Williamson, D; Wilson, KS; Thomas, GH				Severi, Emmanuele; Mueller, Axel; Potts, Jennifer R.; Leech, Andrew; Williamson, David; Wilson, Keith S.; Thomas, Gavin H.			Sialic acid mutarotation is catalyzed by the Escherichia coli beta-propeller protein YjhT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KELCH-REPEAT SUPERFAMILY; HAEMOPHILUS-INFLUENZAE; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; SERUM RESISTANCE; VIRULENCE FACTOR; NEURAMINIC ACID; LIPOPOLYSACCHARIDE; TRANSPORTER; K-12	The acquisition of host-derived sialic acid is an important virulence factor for some bacterial pathogens, but in vivo this sugar acid is sequestered in sialoconjugates as the alpha-anomer. In solution, however, sialic acid is present mainly as the beta-anomer, formed by a slow spontaneous mutarotation. We studied the Escherichia coli protein YjhT as a member of a family of uncharacterized proteins present in many sialic acid-utilizing pathogens. This protein is able to accelerate the equilibration of the alpha- and beta-anomers of the sialic acid N-acetylneuraminic acid, thus describing a novel sialic acid mutarotase activity. The structure of this periplasmic protein, solved to 1.5 A resolution, reveals a dimeric 6-bladed unclosed beta-propeller, the first of a bacterial Kelch domain protein. Mutagenesis of conserved residues in YjhT demonstrated an important role for Glu-209 and Arg-215 in mutarotase activity. We also present data suggesting that the ability to utilize alpha-N-acetylneuraminic acid released from complex sialoconjugates in vivo provides a physiological advantage to bacteria containing YjhT.	[Severi, Emmanuele; Mueller, Axel; Potts, Jennifer R.; Thomas, Gavin H.] Univ York, Dept Biol Area 10, York YO10 5YW, N Yorkshire, England; [Mueller, Axel; Potts, Jennifer R.; Williamson, David; Wilson, Keith S.] Univ York, Dept Chem, York Struct Biol Lab, York YO10 5YW, N Yorkshire, England; [Leech, Andrew] Univ York, Dept Biol Area 15, Technol Facil, York YO10 5YW, N Yorkshire, England	University of York - UK; University of York - UK; University of York - UK	Thomas, GH (corresponding author), Univ York, Dept Biol Area 10, York YO10 5YW, N Yorkshire, England.	ght2@york.ac.uk	Thomas, Gavin H/E-5753-2011	Thomas, Gavin H/0000-0002-9763-1313; Wilson, Keith/0000-0002-3581-2194	Biotechnology and Biological Sciences Research Council [BB/C509807/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Adams J, 2000, TRENDS CELL BIOL, V10, P17, DOI 10.1016/S0962-8924(99)01673-6; Allen S, 2005, INFECT IMMUN, V73, P5291, DOI 10.1128/IAI.73.9.5291-5300.2005; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Blakey D, 2002, BIOCHEM J, V364, P527, DOI 10.1042/BJ20011761; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BORK P, 1994, J MOL BIOL, V236, P1277, DOI 10.1016/0022-2836(94)90056-6; Bouchet V, 2003, P NATL ACAD SCI USA, V100, P8898, DOI 10.1073/pnas.1432026100; BOUFFARD GG, 1994, J MOL BIOL, V244, P269, DOI 10.1006/jmbi.1994.1728; BROWN EB, 1975, BIOCHIM BIOPHYS ACTA, V399, P124, DOI 10.1016/0304-4165(75)90218-4; Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101; Cioci G, 2006, J MOL BIOL, V357, P1575, DOI 10.1016/j.jmb.2006.01.066; Condemine G, 2005, J BACTERIOL, V187, P1959, DOI 10.1128/JB.187.6.1959-1965.2005; Cox AD, 2002, EUR J BIOCHEM, V269, P4009, DOI 10.1046/j.1432-1033.2002.03090.x; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Ducros VMA, 2001, J MOL BIOL, V306, P759, DOI 10.1006/jmbi.2001.4443; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FRIEBOLIN H, 1981, TETRAHEDRON LETT, V22, P1383, DOI 10.1016/S0040-4039(01)90327-2; Fulop V, 1999, CURR OPIN STRUC BIOL, V9, P715, DOI 10.1016/S0959-440X(99)00035-4; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Graille M, 2006, J BIOL CHEM, V281, P30175, DOI 10.1074/jbc.M604443200; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hood DW, 1999, MOL MICROBIOL, V33, P679, DOI 10.1046/j.1365-2958.1999.01509.x; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; ITO N, 1991, NATURE, V350, P87, DOI 10.1038/350087a0; JAQUES LW, 1977, J BIOL CHEM, V252, P4533; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Jurcisek J, 2005, INFECT IMMUN, V73, P3210, DOI 10.1128/IAI.73.6.3210-3218.2005; Kolker E, 2004, NUCLEIC ACIDS RES, V32, P2353, DOI 10.1093/nar/gkh555; Langen H, 2000, ELECTROPHORESIS, V21, P411, DOI 10.1002/(SICI)1522-2683(20000101)21:2<411::AID-ELPS411>3.3.CO;2-W; Li XC, 2004, J BIOL CHEM, V279, P54750, DOI 10.1074/jbc.M410073200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Moustafa I, 2004, J BIOL CHEM, V279, P40819, DOI 10.1074/jbc.M404965200; Muller A, 2006, J BIOL CHEM, V281, P22212, DOI 10.1074/jbc.M603463200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Newman J, 2005, ACTA CRYSTALLOGR D, V61, P1426, DOI [10.1107/S0907444905024984, 10.1107/S090744905024984]; Oh H, 1999, J BIOL CHEM, V274, P14006, DOI 10.1074/jbc.274.20.14006; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Prag S, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-42; Riley M, 2006, NUCLEIC ACIDS RES, V34, P1, DOI 10.1093/nar/gkj405; Ryu KS, 2005, J MOL BIOL, V349, P153, DOI 10.1016/j.jmb.2005.03.047; Ryu KS, 2004, J BIOL CHEM, V279, P25544, DOI 10.1074/jbc.M402016200; Saha RP, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-11; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Severi E, 2005, MOL MICROBIOL, V58, P1173, DOI 10.1111/j.1365-2958.2005.04901.x; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Snyder JA, 2004, INFECT IMMUN, V72, P6373, DOI 10.1128/IAI.72.11.6373-6381.2004; Sohanpal BK, 2004, P NATL ACAD SCI USA, V101, P16322, DOI 10.1073/pnas.0405821101; Thoden JB, 2003, PROTEIN SCI, V12, P1051, DOI 10.1110/ps.0243203; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; Vimr E, 2000, MOL MICROBIOL, V36, P1113, DOI 10.1046/j.1365-2958.2000.01925.x; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	61	39	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4841	4849		10.1074/jbc.M707822200	http://dx.doi.org/10.1074/jbc.M707822200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18063573	Green Accepted, hybrid			2022-12-25	WOS:000253426500042
J	Bento, M; Pereira, HS; Rocheta, M; Gustafson, P; Viegas, W; Silva, M				Bento, Miguel; Pereira, H. Sofia; Rocheta, Margarida; Gustafson, Perry; Viegas, Wanda; Silva, Manuela			Polyploidization as a Retraction Force in Plant Genome Evolution: Sequence Rearrangements in Triticale	PLOS ONE			English	Article							NUCLEOLAR DOMINANCE; GENE-EXPRESSION; HUBBARD POACEAE; WHEAT; RETROTRANSPOSONS; ALLOPOLYPLOIDY; ARABIDOPSIS; ACTIVATION; AEGILOPS; METHYLATION	Background. Polyploidization is a major evolutionary process in plants where hybridization and chromosome doubling induce enormous genomic stress and can generate genetic and epigenetic modifications. However, proper evaluation of DNA sequence restructuring events and the precise characterization of sequences involved are still sparse. Methodology/Principal Findings. Inter Retrotransposons Amplified Polymorphism ( IRAP), Retrotransposons Microsatellite Amplified Polymorphism (REMAP) and Inter Simple Sequence Repeat (ISSR) largely confirmed the absence of any intraspecific variation in wheat, rye and triticale. The comparative analysis of banding profiles between wheat and rye inbred lines revealed 34% of monomorphic ( common to both parental species) bands for the ten different primer combinations used. The analysis of triticale plants uncovered nearly 51% of rearranged bands in the polyploid, being the majority of these modifications, due to the loss of rye bands (83%). Sequence analysis of rye fragments absent in triticale revealed for instance homology with hydroxyproline-rich glycoproteins ( HRGP), a protein that belongs to a major family of inducible defence response proteins. Conversely, a wheat-specific band absent in triticale comprises a nested structure of copia-like retrotransposons elements, namely Claudia and Barbara. Sequencing of a polyploid-specific band ( absent in both parents) revealed a microsatellite related sequence. Cytological studies using Fluorescent In Situ Hybridization ( FISH) with REMAP products revealed a widespread distribution of retrotransposon and/or microsatellite flanking sequences on rye chromosomes, with a preferential accumulation in heterochromatic sub-telomeric domains. Conclusions/Significance.. Here, we used PCR-based molecular marker techniques involving retrotransposons and microsatellites to uncover polyploidization induced genetic restructuring in triticale. Sequence analysis of rearranged genomic fragments either from rye or wheat origin showed these to be retrotransposon-related as well as coding sequences. Further FISH analysis revealed possible chromosome hotspots for sequence rearrangements. The role of chromatin condensation on the origin of genomic rearrangements mediated by polyploidization in triticale is also discussed.	[Bento, Miguel; Pereira, H. Sofia; Rocheta, Margarida; Viegas, Wanda; Silva, Manuela] Univ Tecn Lisbon, Ctr Bot Aplicada Agr, Seccao Genet, Inst Super Agron, Lisbon, Portugal; [Gustafson, Perry] Univ Missouri, Curits Hall, Columbia, MO USA	Universidade de Lisboa; University of Missouri System; University of Missouri Columbia	Silva, M (corresponding author), Univ Tecn Lisbon, Ctr Bot Aplicada Agr, Seccao Genet, Inst Super Agron, Lisbon, Portugal.	manuelasilva@isa.utl.pt	Rocheta, Margarida/E-9156-2015; Silva, Manuela/ABF-7085-2020; Silva, Manuela/GSN-4031-2022	Rocheta, Margarida/0000-0003-3939-4564; Silva, Manuela/0000-0003-4677-870X; Bento, Miguel/0000-0002-7545-8943; Pereira, H. Sofia/0000-0002-7933-6097; Viegas, Wanda/0000-0003-4660-1226	Fundacao de Ciencias e Tecnologia, Portugal [POCI/BIA-BDE/57575/2004];  [SFRH/BD/28657/2006];  [SFRH/BPD/20320/2004];  [SFRH/BPD/14549/2003]	Fundacao de Ciencias e Tecnologia, Portugal; ; ; 	Miguel Bento is funded by a doctoral scholarship (SFRH/BD/28657/2006). Manuela Silva and H. Sofia Pereira are funded by postdoctoral fellowships (SFRH/BPD/20320/2004 and SFRH/BPD/14549/2003, respectively). This research was financed by Fundacao de Ciencias e Tecnologia, Portugal, (Project POCI/BIA-BDE/57575/2004).	Adams KL, 2005, TRENDS GENET, V21, P539, DOI 10.1016/j.tig.2005.07.009; Baumel A, 2001, MOL ECOL, V10, P1689, DOI 10.1046/j.1365-294X.2001.01299.x; Baumel A, 2002, MOL BIOL EVOL, V19, P1218, DOI 10.1093/oxfordjournals.molbev.a004182; Belyayev A, 2001, CHROMOSOME RES, V9, P129, DOI 10.1023/A:1009231019833; BENNETT MD, 1976, THEOR APPL GENET, V65, P353; BENNETT MD, 1974, MEIOTIC GAMETOPHITIC, P137; Berenyi M, 2002, THEOR APPL GENET, V105, P862, DOI 10.1007/s00122-002-1015-0; BOYKO EV, 1984, CEREAL RES COMMUN, V12, P99; Chen ZJ, 2006, BIOESSAYS, V28, P240, DOI 10.1002/bies.20374; CORBIN DR, 1987, MOL CELL BIOL, V7, P4337, DOI 10.1128/MCB.7.12.4337; Devos KM, 2000, PLANT CELL, V12, P637, DOI 10.1105/tpc.12.5.637; Feldman M, 2005, CYTOGENET GENOME RES, V109, P250, DOI 10.1159/000082407; GERLACH WL, 1979, NUCLEIC ACIDS RES, V7, P1869, DOI 10.1093/nar/7.7.1869; GUSTAFSON JP, 1976, CROP SCI, V16, P688, DOI 10.2135/cropsci1976.0011183X001600050022x; Kalendar R, 1999, THEOR APPL GENET, V98, P704, DOI 10.1007/s001220051124; Kashkush K, 2002, GENETICS, V160, P1651; Kashkush K, 2003, NAT GENET, V33, P102, DOI 10.1038/ng1063; Kumar A, 1999, ANNU REV GENET, V33, P479, DOI 10.1146/annurev.genet.33.1.479; Leitch IJ, 2004, BIOL J LINN SOC, V82, P651, DOI 10.1111/j.1095-8312.2004.00349.x; Liu B, 1998, GENOME, V41, P272, DOI 10.1139/gen-41-2-272; Ma XF, 2004, GENOME, V47, P839, DOI [10.1139/g04-051, 10.1139/G04-051]; Ma XF, 2005, CYTOGENET GENOME RES, V109, P236, DOI 10.1159/000082406; Ma XF, 2006, GENOME, V49, P950, DOI 10.1139/G06-078; Madlung A, 2005, PLANT J, V41, P221, DOI 10.1111/j.1365-313X.2004.02297.x; MERKER A, 1976, HEREDITAS, V83, P215; Neves N, 1997, CHROMOSOME RES, V5, P125, DOI 10.1023/A:1018470208730; Ozkan H, 2003, J HERED, V94, P260, DOI 10.1093/jhered/esg053; Ozkan H, 2001, PLANT CELL, V13, P1735, DOI 10.1105/tpc.13.8.1735; Peng JC, 2007, NAT CELL BIOL, V9, P25, DOI 10.1038/ncb1514; Pereira HS, 2005, THEOR APPL GENET, V111, P871, DOI 10.1007/s00122-005-0009-0; Perlman PS, 2004, SCIENCE, V303, P182, DOI 10.1126/science.1093514; Pontes O, 2004, P NATL ACAD SCI USA, V101, P18240, DOI 10.1073/pnas.0407258102; Pontes O, 2003, P NATL ACAD SCI USA, V100, P11418, DOI 10.1073/pnas.1932522100; Rocheta M, 2007, PLANTA, V225, P551, DOI 10.1007/s00425-006-0370-5; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandhu D, 2002, PLANT PHYSIOL, V128, P803, DOI 10.1104/pp.010745; Schwarzacher T., 2000, PRACTICAL SITU HYBRI; Shaked H, 2001, PLANT CELL, V13, P1749, DOI 10.1105/tpc.13.8.1749; Smykal P, 2006, J APPL GENET, V47, P221, DOI 10.1007/BF03194627; SONG KM, 1995, P NATL ACAD SCI USA, V92, P7719, DOI 10.1073/pnas.92.17.7719; SUONIEMI A, 1997, GENETICA, V100; VARMUS H, 1989, MOBILE DNA, P53; Viegas W., 2002, Current Genomics, V3, P563, DOI 10.2174/1389202023350237; Vitte C, 2005, CYTOGENET GENOME RES, V110, P91, DOI 10.1159/000084941; WYCOFF KL, 1995, PLANT PHYSIOL, V109, P41, DOI 10.1104/pp.109.1.41	46	64	68	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1402	10.1371/journal.pone.0001402	http://dx.doi.org/10.1371/journal.pone.0001402			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167561	gold, Green Published, Green Submitted			2022-12-25	WOS:000260468900030
J	Shinkareva, SV; Mason, RA; Malave, VL; Wang, W; Mitchell, TM; Just, MA				Shinkareva, Svetlana V.; Mason, Robert A.; Malave, Vicente L.; Wang, Wei; Mitchell, Tom M.; Just, Marcel Adam			Using fMRI Brain Activation to Identify Cognitive States Associated with Perception of Tools and Dwellings	PLOS ONE			English	Article							VENTRAL TEMPORAL CORTEX; CORTICAL ACTIVITY; OBJECTS; REPRESENTATIONS; PATTERNS; CLASSIFICATION; PARCELLATION; RECOGNITION; RETRIEVAL; DORSAL	Previous studies have succeeded in identifying the cognitive state corresponding to the perception of a set of depicted categories, such as tools, by analyzing the accompanying pattern of brain activity, measured with fMRI. The current research focused on identifying the cognitive state associated with a 4s viewing of an individual line drawing (1 of 10 familiar objects, 5 tools and 5 dwellings, such as a hammer or a castle). Here we demonstrate the ability to reliably (1) identify which of the 10 drawings a participant was viewing, based on that participant's characteristic whole-brain neural activation patterns, excluding visual areas; (2) identify the category of the object with even higher accuracy, based on that participant's activation; and (3) identify, for the first time, both individual objects and the category of the object the participant was viewing, based only on other participants' activation patterns. The voxels important for category identification were located similarly across participants, and distributed throughout the cortex, focused in ventral temporal perceptual areas but also including more frontal association areas (and somewhat left-lateralized). These findings indicate the presence of stable, distributed, communal, and identifiable neural states corresponding to object concepts.	[Shinkareva, Svetlana V.; Mason, Robert A.; Malave, Vicente L.; Just, Marcel Adam] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Shinkareva, Svetlana V.; Wang, Wei; Mitchell, Tom M.] Carnegie Mellon Univ, Sch Comp Sci, Machine Learn Dept, Pittsburgh, PA USA	Carnegie Mellon University; Carnegie Mellon University	Shinkareva, SV (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	shinkareva@sc.edu		Shinkareva, Svetlana/0000-0001-5112-4829; Just, Marcel/0000-0003-1245-3050	W. M. Keck Foundation; NSF [IIS-0423070]	W. M. Keck Foundation(W.M. Keck Foundation); NSF(National Science Foundation (NSF))	This research was supported by the W. M. Keck Foundation and by the National Science Foundation-Collaborative Research in Computational Neuroscience Grant IIS-0423070.	Abdi H., 2007, ENCY MEASUREMENT STA, P955; Aminoff E, 2007, CEREB CORTEX, V17, P1493, DOI 10.1093/cercor/bhl078; Carlson TA, 2003, J COGNITIVE NEUROSCI, V15, P704, DOI 10.1162/089892903322307429; Chao LL, 2000, NEUROIMAGE, V12, P478, DOI 10.1006/nimg.2000.0635; Cox DD, 2003, NEUROIMAGE, V19, P261, DOI 10.1016/S1053-8119(03)00049-1; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; Epstein R, 1999, NEURON, V23, P115, DOI 10.1016/S0896-6273(00)80758-8; Goldberg RF, 2006, J NEUROSCI, V26, P4917, DOI 10.1523/JNEUROSCI.5389-05.2006; Grill-Spector K, 1999, NEURON, V24, P187, DOI 10.1016/S0896-6273(00)80832-6; Hanson SJ, 2004, NEUROIMAGE, V23, P156, DOI 10.1016/j.neuroimage.2004.05.020; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Ishai A, 2000, J COGNITIVE NEUROSCI, V12, P35, DOI 10.1162/089892900564055; Ishai A, 1999, P NATL ACAD SCI USA, V96, P9379, DOI 10.1073/pnas.96.16.9379; James TW, 2002, NEURON, V35, P793, DOI 10.1016/S0896-6273(02)00803-6; Kherif F, 2003, NEUROIMAGE, V20, P2197, DOI 10.1016/j.neuroimage.2003.08.018; LaConte S, 2005, NEUROIMAGE, V26, P317, DOI 10.1016/j.neuroimage.2005.01.048; LAVIT C, 1994, COMPUT STAT DATA AN, V18, P97, DOI 10.1016/0167-9473(94)90134-1; MARTIN A, 2000, NEW COGNITIVE NEUROS, P1023; Mechelli A, 2004, CEREB CORTEX, V14, P1256, DOI 10.1093/cercor/bhh087; Mitchell TM, 2004, MACH LEARN, V57, P145, DOI 10.1023/B:MACH.0000035475.85309.1b; Mourao-Miranda J, 2005, NEUROIMAGE, V28, P980, DOI 10.1016/j.neuroimage.2005.06.070; O'Toole AJ, 2005, J COGNITIVE NEUROSCI, V17, P580, DOI 10.1162/0898929053467550; Phillips JA, 2002, BRAIN, V125, P2067, DOI 10.1093/brain/awf215; Polyn SM, 2005, SCIENCE, V310, P1963, DOI 10.1126/science.1117645; RADEMACHER J, 1992, J COGNITIVE NEUROSCI, V4, P352, DOI 10.1162/jocn.1992.4.4.352; Robert P., 1976, APPL STAT, P257, DOI DOI 10.2307/2347233; Rorden C, 2000, BEHAV NEUROL, V12, P191, DOI 10.1155/2000/421719; ROSCH E, 1976, COGNITIVE PSYCHOL, V8, P382, DOI 10.1016/0010-0285(76)90013-X; Shinkareva SV, 2006, NEUROIMAGE, V33, P63, DOI 10.1016/j.neuroimage.2006.06.032; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Vuilleumier P, 2002, NAT NEUROSCI, V5, P491, DOI 10.1038/nn839	32	132	134	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1394	10.1371/journal.pone.0001394	http://dx.doi.org/10.1371/journal.pone.0001394			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167553	Green Published, gold			2022-12-25	WOS:000260468900022
J	Budde, BS; Binner, P; Waldmuller, S; Hohne, W; Blankenfeldt, W; Hassfeld, S; Bromsen, J; Dermintzoglou, A; Wieczorek, M; May, E; Kirst, E; Selignow, C; Rackebrandt, K; Muller, M; Goody, RS; Vosberg, HP; Nurnberg, P; Scheffold, T				Budde, Birgit S.; Binner, Priska; Waldmueller, Stephan; Hoehne, Wolfgang; Blankenfeldt, Wulf; Hassfeld, Sabine; Broemsen, Juergen; Dermintzoglou, Anastassia; Wieczorek, Marcus; May, Erik; Kirst, Elisabeth; Selignow, Carmen; Rackebrandt, Kirsten; Mueller, Melanie; Goody, Roger S.; Vosberg, Hans-Peter; Nuernberg, Peter; Scheffold, Thomas			Noncompaction of the Ventricular Myocardium Is Associated with a De Novo Mutation in the beta-Myosin Heavy Chain Gene	PLOS ONE			English	Article							HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; CARDIAC MYOSIN; CLASSIFICATION; CARDIOLOGY	Noncompaction of the ventricular myocardium (NVM) is the morphological hallmark of a rare familial or sporadic unclassified heart disease of heterogeneous origin. NVM results presumably from a congenital developmental error and has been traced back to single point mutations in various genes. The objective of this study was to determine the underlying genetic defect in a large German family suffering from NVM. Twenty four family members were clinically assessed using advanced imaging techniques. For molecular characterization, a genome-wide linkage analysis was undertaken and the disease locus was mapped to chromosome 14ptel-14q12. Subsequently, two genes of the disease interval, MYH6 and MYH7 (encoding the alpha- and beta-myosin heavy chain, respectively) were sequenced, leading to the identification of a previously unknown de novo missense mutation, c. 842G>C, in the gene MYH7. The mutation affects a highly conserved amino acid in the myosin subfragment-1 (R281T). In silico simulations suggest that the mutation R281T prevents the formation of a salt bridge between residues R281 and D325, thereby destabilizing the myosin head. The mutation was exclusively present in morphologically affected family members. A few members of the family displayed NVM in combination with other heart defects, such as dislocation of the tricuspid valve (Ebstein's anomaly, EA) and atrial septal defect (ASD). A high degree of clinical variability was observed, ranging from the absence of symptoms in childhood to cardiac death in the third decade of life. The data presented in this report provide first evidence that a mutation in a sarcomeric protein can cause noncompaction of the ventricular myocardium.	[Binner, Priska; Waldmueller, Stephan; Rackebrandt, Kirsten; Mueller, Melanie; Vosberg, Hans-Peter; Scheffold, Thomas] Univ Witten Herdecke, Inst Herz Kreislaufforsch, Dortmund, Germany; [Budde, Birgit S.; Kirst, Elisabeth; Nuernberg, Peter] Univ Cologne, Cologne Ctr Genom, Cologne, Germany; [Budde, Birgit S.; Kirst, Elisabeth; Nuernberg, Peter] Univ Cologne, Genet Inst, Cologne, Germany; [Hoehne, Wolfgang] Charite, Inst Biochem, D-13353 Berlin, Germany; [Blankenfeldt, Wulf; Goody, Roger S.] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44139 Dortmund, Germany; [Hassfeld, Sabine] Franz Volhard Klin, Charite, Berlin, Germany; [Broemsen, Juergen; Dermintzoglou, Anastassia; Wieczorek, Marcus; May, Erik] Herzzentrum Duisburg, Duisburg, Germany; [Broemsen, Juergen] Herzklin Augustinum, Munich, Germany; [Vosberg, Hans-Peter] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Witten Herdecke University; University of Cologne; University of Cologne; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Max Planck Society; Franz-Volhard Clinical Research Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Heart Center Duisburg pediatric hospital; Max Planck Society	Scheffold, T (corresponding author), Univ Witten Herdecke, Inst Herz Kreislaufforsch, Dortmund, Germany.	scheffold@herz-kreislaufforschung.de	Goody, Roger S/J-8845-2014; Blankenfeldt, Wulf/F-8877-2010	Goody, Roger S/0000-0002-0772-0444; Blankenfeldt, Wulf/0000-0001-9886-9668; Budde, Birgit/0000-0001-9385-4168	German Federal Ministry of Science and Education (BMBF) through the National Genome Research Network [01GR0416]; Competence Network of Heart Failure [FKZ 01GI0205]	German Federal Ministry of Science and Education (BMBF) through the National Genome Research Network(Federal Ministry of Education & Research (BMBF)); Competence Network of Heart Failure	Funding: This study was supported by the German Federal Ministry of Science and Education (BMBF) through the National Genome Research Network (grant 01GR0416 to P.N.) and through the Competence Network of Heart Failure, FKZ 01GI0205.	Bleyl SB, 1997, AM J HUM GENET, V61, P868, DOI 10.1086/514879; CHIN TK, 1990, CIRCULATION, V82, P507, DOI 10.1161/01.CIR.82.2.507; Ching YH, 2005, NAT GENET, V37, P423, DOI 10.1038/ng1526; EDWARDS D, 1993, FOSS REC, V2, P15; ENGBERDING R, 1984, AM J CARDIOL, V53, P1733, DOI 10.1016/0002-9149(84)90618-0; Ichida F, 1999, J AM COLL CARDIOL, V34, P233, DOI 10.1016/S0735-1097(99)00170-9; Ichida F, 2001, CIRCULATION, V103, P1256; JAENICKE T, 1990, GENOMICS, V8, P194, DOI 10.1016/0888-7543(90)90272-V; Jenni R, 2001, HEART, V86, P666, DOI 10.1136/heart.86.6.666; Karkkainen S, 2007, ANN MED, V39, P91, DOI 10.1080/07853890601145821; KURABAYASHI M, 1988, J CLIN INVEST, V82, P524, DOI 10.1172/JCI113627; Lind Joanne M, 2006, Expert Rev Cardiovasc Ther, V4, P927, DOI 10.1586/14779072.4.6.927; Lindner TH, 2005, BIOINFORMATICS, V21, P405, DOI 10.1093/bioinformatics/bti009; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Murphy RT, 2005, EUR HEART J, V26, P187, DOI 10.1093/eurheartj/ehi025; Pauli RM, 1999, AM J MED GENET, V85, P419, DOI 10.1002/(SICI)1096-8628(19990806)85:4<419::AID-AJMG21>3.0.CO;2-S; POLYMEROPOULOS MH, 1991, NUCLEIC ACIDS RES, V19, P4019, DOI 10.1093/nar/19.14.4019-a; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; RAYMENT I, 1995, P NATL ACAD SCI USA, V92, P3864, DOI 10.1073/pnas.92.9.3864; Reiser PJ, 2001, AM J PHYSIOL-HEART C, V280, pH1814, DOI 10.1152/ajpheart.2001.280.4.H1814; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Rigopoulos A, 2002, CARDIOLOGY, V98, P25, DOI 10.1159/000064677; Sasse-Klaassen S, 2004, CIRCULATION, V109, P2720, DOI 10.1161/01.CIR.0000131865.21260.56; SCHWARTZ K, 1992, CIRC RES, V71, P3, DOI 10.1161/01.RES.71.1.3; Sedmera D, 2000, ANAT RECORD, V258, P319, DOI 10.1002/(SICI)1097-0185(20000401)258:4<319::AID-AR1>3.0.CO;2-O; Sen-Chowdhry S, 2005, J CARDIOVASC ELECTR, V16, P927, DOI 10.1111/j.1540-8167.2005.40842.x; Sobel E, 1996, AM J HUM GENET, V58, P1323; Toydemir RM, 2006, NAT GENET, V38, P561, DOI 10.1038/ng1775; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Villard E, 2005, EUR HEART J, V26, P794, DOI 10.1093/eurheartj/ehi193; Waldmuller S, 2003, J MOL CELL CARDIOL, V35, P623, DOI 10.1016/S0022-2828(03)00050-6; Woo A, 2003, HEART, V89, P1179, DOI 10.1136/heart.89.10.1179; Zhu LM, 2006, NAT GENET, V38, P343, DOI 10.1038/ng1721	33	77	80	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1362	10.1371/journal.pone.0001362	http://dx.doi.org/10.1371/journal.pone.0001362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159245	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459700019
J	Yang, H; Fung, SY; Pritzker, M; Chen, P				Yang, Hong; Fung, Shan-Yu; Pritzker, Mark; Chen, P.			Modification of Hydrophilic and Hydrophobic Surfaces Using an Ionic-Complementary Peptide	PLOS ONE			English	Article								Ionic-complementary peptides are novel nano-biomaterials with a variety of biomedical applications including potential biosurface engineering. This study presents evidence that a model ionic-complementary peptide EAK16-II is capable of assembling/coating on hydrophilic mica as well as hydrophobic highly ordered pyrolytic graphite (HOPG) surfaces with different nano-patterns. EAK16-II forms randomly oriented nanofibers or nanofiber networks on mica, while ordered nanofibers parallel or oriented 60 degrees or 120 degrees to each other on HOPG, reflecting the crystallographic symmetry of graphite (0001). The density of coated nanofibers on both surfaces can be controlled by adjusting the peptide concentration and the contact time of the peptide solution with the surface. The coated EAK16-II nanofibers alter the wettability of the two surfaces differently: the water contact angle of bare mica surface is measured to be <10 degrees, while it increases to 20.3 +/- 62.9 degrees upon 2 h modification of the surface using a 29 mu M EAK16-II solution. In contrast, the water contact angle decreases significantly from 71.2 +/- 11.1 degrees to 39.4 +/- 4.3 degrees after the HOPG surface is coated with a 29 mM peptide solution for 2 h. The stability of the EAK16-II nanofibers on both surfaces is further evaluated by immersing the surface into acidic and basic solutions and analyzing the changes in the nanofiber surface coverage. The EAK16-II nanofibers on mica remain stable in acidic solution but not in alkaline solution, while they are stable on the HOPG surface regardless of the solution pH. This work demonstrates the possibility of using self-assembling peptides for surface modification applications.	[Yang, Hong; Fung, Shan-Yu; Pritzker, Mark; Chen, P.] Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada	University of Waterloo	Pritzker, M (corresponding author), Univ Waterloo, Dept Chem Engn, Waterloo, ON N2L 3G1, Canada.	pritzker@uwaterloo.ca; p4chen@cape.uwaterloo.ca	Fung, Shan-Yu/E-3477-2014; Yang, Hong/E-3478-2014; Yang, Hong/AAZ-1061-2020	Fung, Shan-Yu/0000-0002-4547-8740; Yang, Hong/0000-0002-6707-8481; 	Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Canada Research Chairs Program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs Program(Canada Research Chairs)	Funding from the following agencies supported the work presented in this manuscript: Natural Sciences and Engineering Research Council of Canada, Canada Foundation for Innovation, Canada Research Chairs Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown CL, 2002, J AM CHEM SOC, V124, P6846, DOI 10.1021/ja0261271; Chinn JA, 1998, J BIOMED MATER RES, V39, P130, DOI 10.1002/(SICI)1097-4636(19980101)39:1<130::AID-JBM15>3.0.CO;2-J; Clare TL, 2005, LANGMUIR, V21, P6344, DOI 10.1021/la050362q; Davis ME, 2005, CIRCULATION, V111, P442, DOI 10.1161/01.CIR.0000153847.47301.80; Ellis-Behnke RG, 2006, P NATL ACAD SCI USA, V103, P5054, DOI 10.1073/pnas.0600559103; Falini G, 2002, ACTA CRYSTALLOGR D, V58, P1649, DOI 10.1107/S0907444902012763; Fung SY, 2007, COLLOID SURFACE B, V55, P200, DOI 10.1016/j.colsurfb.2006.12.002; Fung SY, 2003, BIOPHYS J, V85, P537, DOI 10.1016/S0006-3495(03)74498-1; Gettens RTT, 2005, J BIOMED MATER RES A, V72A, P246, DOI 10.1002/jbm.a.30218; He H., 2004, ENCY NANOSCIENCE NAN, V2, P755; Heller DA, 2005, BIOMATERIALS, V26, P883, DOI 10.1016/j.biomaterials.2004.03.029; Holmes TC, 2000, P NATL ACAD SCI USA, V97, P6728, DOI 10.1073/pnas.97.12.6728; Hong YS, 2003, BIOMACROMOLECULES, V4, P1433, DOI 10.1021/bm0341374; Jun S, 2004, BIOPHYS J, V87, P1249, DOI 10.1529/biophysj.103.038166; Keyes-Baig C, 2004, J AM CHEM SOC, V126, P7522, DOI 10.1021/ja0381297; Kisiday J, 2002, P NATL ACAD SCI USA, V99, P9996, DOI 10.1073/pnas.142309999; Kowalewski T, 1999, P NATL ACAD SCI USA, V96, P3688, DOI 10.1073/pnas.96.7.3688; Lahann J, 2001, BIOMATERIALS, V22, P817, DOI 10.1016/S0142-9612(00)00244-1; Larsen CC, 2006, BIOMATERIALS, V27, P4846, DOI 10.1016/j.biomaterials.2006.05.009; Long J, 2001, LANGMUIR, V17, P2965, DOI 10.1021/la001547u; Mansur HS, 2005, J MATER SCI-MATER M, V16, P333, DOI 10.1007/s10856-005-0632-y; Moulton SE, 2003, J COLLOID INTERF SCI, V261, P312, DOI 10.1016/S0021-9797(03)00073-0; NISHIMURA S, 1995, LANGMUIR, V11, P291, DOI 10.1021/la00001a049; Pallandre A, 2006, ELECTROPHORESIS, V27, P584, DOI 10.1002/elps.200500761; Patel S, 2006, BIOMATERIALS, V27, P2890, DOI 10.1016/j.biomaterials.2005.12.009; Sawant RM, 2006, BIOCONJUGATE CHEM, V17, P943, DOI 10.1021/bc060080h; SCHAMBERGER PC, 1994, COLLOID SURFACE B, V2, P209, DOI 10.1016/0927-7765(94)80036-7; Semino CE, 2003, DIFFERENTIATION, V71, P262, DOI 10.1046/j.1432-0436.2003.7104503.x; Shervedani RK, 2006, BIOELECTROCHEMISTRY, V69, P201, DOI 10.1016/j.bioelechem.2006.01.003; Toublan FJJ, 2006, J AM CHEM SOC, V128, P3472, DOI 10.1021/ja0544455; Voet D., 2005, BIOCHEMISTRY-US; Walter EC, 2002, MICROELECTRON ENG, V61-2, P555, DOI 10.1016/S0167-9317(02)00582-8; Wisniewski N, 2000, COLLOID SURFACE B, V18, P197, DOI 10.1016/S0927-7765(99)00148-4; Yang GC, 2002, J AM CHEM SOC, V124, P10648, DOI 10.1021/ja027302g; Yang H, 2007, J AM CHEM SOC, V129, P12200, DOI 10.1021/ja073168u; YE Y, 2002, SENSORS, V3, P128; Yemini M, 2005, NANO LETT, V5, P183, DOI 10.1021/nl0484189; Yemini M, 2005, ANAL CHEM, V77, P5155, DOI 10.1021/ac050414g; Ying PQ, 2004, J COLLOID INTERF SCI, V279, P95, DOI 10.1016/j.jcis.2004.06.048; ZHANG SG, 1994, BIOPOLYMERS, V34, P663, DOI 10.1002/bip.360340508; ZHANG SG, 1993, P NATL ACAD SCI USA, V90, P3334, DOI 10.1073/pnas.90.8.3334; Zhang SG, 1999, BIOMATERIALS, V20, P1213, DOI 10.1016/S0142-9612(99)00014-9; ZHANG SG, 1995, BIOMATERIALS, V16, P1385, DOI 10.1016/0142-9612(95)96874-Y; Zhang SG, 2002, BIOTECHNOL ADV, V20, P321, DOI 10.1016/S0734-9750(02)00026-5; Zhang SX, 2005, BIOELECTROCHEMISTRY, V67, P15, DOI 10.1016/j.bioelechem.2004.12.002; Zhang Y, 2005, J COLLOID INTERF SCI, V283, P352, DOI 10.1016/j.jcis.2004.09.042	46	70	71	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1325	10.1371/journal.pone.0001325	http://dx.doi.org/10.1371/journal.pone.0001325			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091996	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459600013
J	Houshdaran, S; Cortessis, VK; Siegmund, K; Yang, A; Laird, PW; Sokol, RZ				Houshdaran, Sahar; Cortessis, Victoria K.; Siegmund, Kimberly; Yang, Allen; Laird, Peter W.; Sokol, Rebecca Z.			Widespread Epigenetic Abnormalities Suggest a Broad DNA Methylation Erasure Defect in Abnormal Human Sperm	PLOS ONE			English	Article							IMPRINTED GENES; CPG ISLAND; SNURF-SNRPN; PATTERNS; ESTABLISHMENT; INHERITANCE; H19; SPECIFICATION; EXPRESSION; GERMLINE	Background. Male-factor infertility is a common condition, and etiology is unknown for a high proportion of cases. Abnormal epigenetic programming of the germline is proposed as a possible mechanism compromising spermatogenesis of some men currently diagnosed with idiopathic infertility. During germ cell maturation and gametogenesis, cells of the germ line undergo extensive epigenetic reprogramming. This process involves widespread erasure of somatic-like patterns of DNA methylation followed by establishment of sex-specific patterns by de novo DNA methylation. Incomplete reprogramming of the male germ line could, in theory, result in both altered sperm DNA methylation and compromised spermatogenesis. Methodology/Principal Finding. We determined concentration, motility and morphology of sperm in semen samples collected by male members of couples attending an infertility clinic. Using MethyLight and Illumina assays we measured methylation of DNA isolated from purified sperm from the same samples. Methylation at numerous sequences was elevated in DNA from poor quality sperm. Conclusions. This is the first report of a broad epigenetic defect associated with abnormal semen parameters. Our results suggest that the underlying mechanism for these epigenetic changes may be improper erasure of DNA methylation during epigenetic reprogramming of the male germ line.	[Cortessis, Victoria K.; Siegmund, Kimberly] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; [Houshdaran, Sahar; Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Laird, Peter W.] Univ So Calif, Keck Sch Med, Dept Surg, Los Angeles, CA 90033 USA; [Sokol, Rebecca Z.] Univ So Calif, Keck Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90033 USA; [Yang, Allen; Sokol, Rebecca Z.] Univ So Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Cortessis, VK (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	cortessis_v@ccnt.hsc.usc.edu	Laird, Peter W/G-8683-2012	Laird, Peter W/0000-0001-9117-3641; Cortessis, Victoria/0000-0002-2339-1089	National Institute of Environmental Health Sciences [5P30ES007048]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES007048] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Southern California Environmental Health Sciences Center ( grant # 5P30ES007048) funded by the National Institute of Environmental Health Sciences. The funders of this study had no role in the design or conduct of this study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Abma J C, 1997, Vital Health Stat 23, P1; Acacio BD, 2000, FERTIL STERIL, V73, P595, DOI 10.1016/S0015-0282(99)00591-9; ARIEL M, 1994, NAT GENET, V7, P59, DOI 10.1038/ng0594-59; Astuti D, 2005, BRIT J CANCER, V92, P1574, DOI 10.1038/sj.bjc.6602478; Bastepe M, 2005, NAT GENET, V37, P25, DOI 10.1038/ng1487; Bastepe M, 2003, J CLIN INVEST, V112, P1255, DOI 10.1172/JCI200319159; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Benchaib M, 2005, HUM REPROD, V20, P768, DOI 10.1093/humrep/deh684; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bestor TH, 2004, COLD SPRING HARB SYM, V69, P381, DOI 10.1101/sqb.2004.69.381; Bibikova M, 2006, GENOME RES, V16, P383, DOI 10.1101/gr.4410706; BIERMANN K, 2007, J ANDROL; Chandra A, 1998, FAM PLANN PERSPECT, V30, P34, DOI 10.2307/2991524; Chang HS, 2006, ENDOCRINOLOGY, V147, P5524, DOI 10.1210/en.2006-0987; Cui HM, 2002, CANCER RES, V62, P6442; Cupp AS, 2003, J ANDROL, V24, P736; Dale, 1997, IN VITRO FERTILIZATI; de la Puente A, 2002, GENE, V291, P287, DOI 10.1016/S0378-1119(02)00601-7; Emery BR, 2006, ASIAN J ANDROL, V8, P131, DOI 10.1111/j.1745-7262.2006.00127.x; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Gaston V, 2001, EUR J HUM GENET, V9, P409, DOI 10.1038/sj.ejhg.5200649; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hancock AL, 2007, HUM MOL GENET, V16, P343, DOI 10.1093/hmg/ddl478; Hartmann S, 2006, MOL HUM REPROD, V12, P407, DOI 10.1093/molehr/gal040; Hayashi K, 2007, SCIENCE, V316, P394, DOI 10.1126/science.1137545; Higashimoto K, 2006, CYTOGENET GENOME RES, V113, P306, DOI 10.1159/000090846; JIE X, 2007, ONCOGENE; Kearns M, 2000, NUCLEIC ACIDS RES, V28, P3301, DOI 10.1093/nar/28.17.3301; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Kim JD, 2007, GENOMICS, V89, P262, DOI 10.1016/j.ygeno.2006.09.009; LAIRD PW, 1991, NUCLEIC ACIDS RES, V19, P4293, DOI 10.1093/nar/19.15.4293; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lee J, 2002, DEVELOPMENT, V129, P1807; Lees-Murdock DJ, 2003, GENOMICS, V82, P230, DOI 10.1016/S0888-7543(03)00105-8; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li JY, 2004, GENOMICS, V84, P952, DOI 10.1016/j.ygeno.2004.08.012; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Liu J, 2005, HUM MOL GENET, V14, P95, DOI 10.1093/hmg/ddi009; Maduro MR, 2003, J ANDROL, V24, P485; Manning M, 2001, INT J ANDROL, V24, P87, DOI 10.1046/j.1365-2605.2001.00274.x; Marques CJ, 2004, LANCET, V363, P1700, DOI 10.1016/S0140-6736(04)16256-9; McElreavey K, 2000, Results Probl Cell Differ, V28, P211; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Murphy SK, 2001, GENOMICS, V71, P110, DOI 10.1006/geno.2000.6419; Murrell A, 2004, NAT GENET, V36, P889, DOI 10.1038/ng1402; Oakes CC, 2007, P NATL ACAD SCI USA, V104, P228, DOI 10.1073/pnas.0607521104; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; Rakyan VK, 2003, P NATL ACAD SCI USA, V100, P2538, DOI 10.1073/pnas.0436776100; Rousseaux S, 2005, GENE, V345, P139, DOI 10.1016/j.gene.2004.12.004; Rousseeuw P.J., 1990, FINDING GROUPS DATA; Runte M, 2004, HUM GENET, V114, P553, DOI 10.1007/s00439-004-1104-z; Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Santos F, 2004, REPRODUCTION, V127, P643, DOI 10.1530/rep.1.00221; Schaefer CB, 2007, SCIENCE, V316, P398, DOI 10.1126/science.1137544; Sharlip ID, 2002, FERTIL STERIL, V77, P873, DOI 10.1016/S0015-0282(02)03105-9; SOKOL RZ, 1997, INFERTILITY CONTRACE, P547; Sullivan MJ, 1999, ONCOGENE, V18, P7527, DOI 10.1038/sj.onc.1203096; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; SUTCLIFFE JS, 1994, NAT GENET, V8, P52, DOI 10.1038/ng0994-52; Suzuki S, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030055; Szabo PE, 2002, MECH DEVELOP, V115, P157, DOI 10.1016/S0925-4773(02)00087-4; THONNEAU P, 1991, HUM REPROD, V6, P811, DOI 10.1093/oxfordjournals.humrep.a137433; Trasler JM, 2006, REPROD FERT DEVELOP, V18, P63, DOI 10.1071/RD05118; Trasler JM, 1998, SEMIN CELL DEV BIOL, V9, P467, DOI 10.1006/scdb.1998.0225; Varrault A, 2001, J BIOL CHEM, V276, P18653, DOI 10.1074/jbc.C100095200; Ventura S J, 1999, Natl Vital Stat Rep, V47, P1; Vu TH, 2000, GENOMICS, V64, P132, DOI 10.1006/geno.1999.6094; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; *WHO, 1999, WHO LAB MAN HUM SEM; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Yun J, 2003, MAMM GENOME, V14, P376, DOI 10.1007/s00335-002-2252-x	74	201	216	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1289	10.1371/journal.pone.0001289	http://dx.doi.org/10.1371/journal.pone.0001289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074014	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459500008
J	Eichele, K; Ramer, R; Hinz, B				Eichele, K.; Ramer, R.; Hinz, B.			Decisive role of cyclooxygenase-2 and lipocalin-type prostaglandin D synthase in chemotherapeutics-induced apoptosis of human cervical carcinoma cells	ONCOGENE			English	Article						chemotherapeutics; cyclooxygenase-2; lipocalin-type prostaglandin D synthase; prostaglandins; peroxisome proliferator-activated receptor gamma; apoptosis	HUMAN NEUROGLIOMA CELLS; PHASE-II TRIAL; LUNG-CANCER; COLORECTAL-CANCER; EPITHELIAL-CELLS; UP-REGULATION; CELECOXIB; PROLIFERATION; EXPRESSION; DOCETAXEL	The role of cyclooxygenase-2 (COX-2) in cancer remains controversial. Using cervical carcinoma cells (HeLa), the present study investigates the involvement of COX-2 in apoptosis elicited by the chemotherapeutics paclitaxel, cisplatin and 5-fluorouracil. Each compound led to a profound induction of COX-2 expression and prostaglandin (PG) synthesis, accompanied by a substantial decrease of viability and enhanced apoptosis. Cells were significantly less sensitive to apoptotic death when either COX-2 expression or its activity was suppressed by smallinterfering RNA (siRNA) and by the selective COX-2 inhibitor NS-398, respectively. Experiments performed to clarify how COX-2 leads to apoptosis revealed a profound proapoptotic action of PGD2 and its dehydration product, 15-deoxy- D12,14 PGJ2 (15d-PGJ2). In line with these findings, chemotherapeutics-induced apoptosis was prevented by siRNA targeting lipocalin-type PGD synthase (L-PGDS), which catalyses the isomerization of PGH2 to PGD2. Moreover, apoptosis by chemotherapeutics, PGD2 and 15d-PGJ2 was suppressed by the peroxisome proliferator-activated receptor c (PPARc) antagonist, GW-9662 or PPARc siRNA. Finally, a COX-2-dependent apoptotic mechanism of all investigated chemotherapeutics was confirmed in human lung cancer cells (A549) as well as in another cervical carcinoma cell line (C33A). Collectively, this study suggests COX-2 induction and synthesis of L-PGDS-derived, PPARc-activating PGs as a decisive target by which several chemotherapeutics induce apoptosis. COX-2 is therefore suspected to sensitize cancer cells to apoptotic death under certain circumstances, suggesting that COX-2 inhibition during cancer therapy could diminish its efficacy.	[Eichele, K.; Ramer, R.; Hinz, B.] Univ Rostock, Inst Pharmacol & Toxicol, D-18057 Rostock, Germany	University of Rostock	Hinz, B (corresponding author), Univ Rostock, Inst Pharmacol & Toxicol, Schillingallee 70, D-18057 Rostock, Germany.	burkhard.hinz@med.uni-rostock.de						Altorki NK, 2003, J CLIN ONCOL, V21, P2645, DOI 10.1200/JCO.2003.07.127; Argiris A, 2006, INVEST NEW DRUG, V24, P203, DOI 10.1007/s10637-005-3259-4; Chen Q, 2004, ANAL BIOCHEM, V335, P253, DOI 10.1016/j.ab.2004.09.004; Chen YC, 2005, BBA-MOL CELL RES, V1743, P291, DOI 10.1016/j.bbamcr.2004.10.016; Clay CE, 1999, CARCINOGENESIS, V20, P1905, DOI 10.1093/carcin/20.10.1905; Csiki I, 2005, CLIN CANCER RES, V11, P6634, DOI 10.1158/1078-0432.CCR-05-0436; Danesi R, 2002, BRIT J CLIN PHARMACO, V53, P508, DOI 10.1046/j.1365-2125.2002.01579.x; Denkert C, 2003, ONCOGENE, V22, P8653, DOI 10.1038/sj.onc.1206920; Dommels YEM, 2003, CARCINOGENESIS, V24, P385, DOI 10.1093/carcin/24.3.385; Eichele K, 2006, PHARM RES-DORDR, V23, P90, DOI 10.1007/s11095-005-8815-2; Gupta RA, 2001, NAT REV CANCER, V1, P11, DOI 10.1038/35094017; Hinz B, 2004, MOL PHARMACOL, V66, P1643, DOI 10.1124/mol.104.002618; Hwang Daniel H., 2002, Neoplasia (New York), V4, P91, DOI 10.1038/sj.neo.7900226; Kim J, 2005, CANCER RES, V65, P6189, DOI 10.1158/0008-5472.CAN-04-4439; Lalier L, 2007, ONCOGENE, V26, P4999, DOI 10.1038/sj.onc.1210303; Maccarrone M, 2002, BIOCHEM J, V366, P137, DOI 10.1042/BJ20020438; Na HK, 2005, FEBS LETT, V579, P6279, DOI 10.1016/j.febslet.2005.09.094; Na HK, 2003, BIOCHEM PHARMACOL, V66, P1381, DOI 10.1016/S0006-2952(03)00488-X; Narko K, 1997, J BIOL CHEM, V272, P21455, DOI 10.1074/jbc.272.34.21455; Nugent FW, 2005, LUNG CANCER, V48, P267, DOI 10.1016/j.lungcan.2004.11.004; Pan CX, 2005, ONCOLOGY-BASEL, V69, P63, DOI 10.1159/000087302; Ramer R, 2003, MOL PHARMACOL, V64, P1189, DOI 10.1124/mol.64.5.1189; Shen ZN, 2005, BIOCHEM BIOPH RES CO, V328, P375, DOI 10.1016/j.bbrc.2004.12.186; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; TSUJII M, 1995, CELL, V83, P493, DOI 10.1016/0092-8674(95)90127-2; Xu Z, 2006, CANCER RES, V66, P6657, DOI 10.1158/0008-5472.CAN-05-3624; Zhang XP, 1999, J EXP MED, V190, P451, DOI 10.1084/jem.190.4.451	27	30	30	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY 8	2008	27	21					3032	3044		10.1038/sj.onc.1210962	http://dx.doi.org/10.1038/sj.onc.1210962			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18071320				2022-12-25	WOS:000255681700010
J	Yu, S; Wong, YC; Wang, XH; Ling, MT; Ng, CF; Chen, S; Chan, FL				Yu, S.; Wong, Y. C.; Wang, X. H.; Ling, M. T.; Ng, C. F.; Chen, S.; Chan, F. L.			Orphan nuclear receptor estrogen-related receptor-beta suppresses in vitro and in vivo growth of prostate cancer cells via p21(WAF1/CIP1) induction and as a potential therapeutic target in prostate cancer	ONCOGENE			English	Article						estrogen-related receptor; estrogen receptor-related; receptor; ERR beta; orphan nuclear receptor; tumor suppression; prostate cancer	PROLIFERATOR-ACTIVATED RECEPTOR; ANDROGEN RECEPTOR; GAMMA COACTIVATOR-1-ALPHA; TRANSCRIPTIONAL CONTROL; DNA-REPLICATION; MOUSE EMBRYOS; ERR-ALPHA; EXPRESSION; IDENTIFICATION; PGC-1-ALPHA	Recent studies indicate that estrogen-related receptors (ERRs) are involved in similar estrogen receptor (ER) regulatory pathways and play roles in energy and lipid metabolism. Here, we analysed the functional role of ERR beta in prostate cancer cell growth regulation in an androgen-sensitive and androgen-insensitive prostate cancer cell lines. ERR beta was expressed in normal human prostates, but exhibited a reduced expression in prostate cancer lesions. Stable ERR beta expression suppressed significantly cell proliferation and tumorigenicity of LNCaP and DU145 cells, accompanied by an S-phase suppression and increased p21 expression. Reporter and chromatin immunoprecipitation assays showed that ERRb could directly transactivate p21 gene promoter, which could be further enhanced by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha. Truncation analysis showed that ERR beta-mediated p21 transactivation and prostate cancer cell growth inhibition required intact DNA-binding domain and AF2 domains in ERR beta. Interestingly, ERR beta displayed a cell cycle associated downregulated expression pattern in ERR beta-transduced and non-transduced cells. Finally, we showed that ERR beta-mediated growth inhibition could be potentiated by an ERRb/gamma agonist DY131. Knockdown of ERR beta by RNA interference could reduce the DY131-induced growth inhibition in prostate cancer cells. Taken together, our findings indicate that ERR beta performs a tumor suppressing function in prostate cancer cells, and targeting ERR beta could be a potential therapeutic strategy for prostate cancer.	[Yu, S.; Chan, F. L.] Chinese Univ Hong Kong, Dept Anat, Shatin, Hong Kong, Peoples R China; [Wong, Y. C.; Wang, X. H.; Ling, M. T.] Univ Hong Kong, Dept Anat, Shatin, Hong Kong, Peoples R China; [Ng, C. F.] Chinese Univ Hong Kong, Dept Surg, Shatin, Hong Kong, Peoples R China; [Chen, S.] Beckman Res Inst City Hope, Dept Surg Res, Duarte, CA USA	Chinese University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; City of Hope; Beckman Research Institute of City of Hope	Chan, FL (corresponding author), Chinese Univ Hong Kong, Dept Anat, Basic Med Sci Bldg, Shatin, Hong Kong, Peoples R China.	franky-chan@cuhk.edu.hk	Ng, Chi-Fai/E-5134-2011; Chi-fai, NG/AAV-8270-2021; Chan, Franky L./M-1043-2018	Ng, Chi-Fai/0000-0002-1723-9646; Chan, Franky L./0000-0003-0567-2052				Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Castet A, 2006, MOL ENDOCRINOL, V20, P1035, DOI 10.1210/me.2005-0227; Chan PSF, 1999, PROSTATE, V41, P99; Chen F, 1999, GENE, V228, P101, DOI 10.1016/S0378-1119(98)00619-2; Cheung CP, 2005, J CLIN ENDOCR METAB, V90, P1830, DOI 10.1210/jc.2004-1421; Fujimoto J, 2005, J STEROID BIOCHEM, V94, P67, DOI 10.1016/j.jsbmb.2004.12.030; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; GIGUERE V, 1988, NATURE, V331, P91, DOI 10.1038/331091a0; Griffiths K, 2000, Prostate, V45, P87, DOI 10.1002/1097-0045(20001001)45:2<87::AID-PROS2>3.0.CO;2-G; Ho E, 2004, ARCH BIOCHEM BIOPHYS, V428, P109, DOI 10.1016/j.abb.2004.01.009; Ho SM, 2004, J CELL BIOCHEM, V91, P491, DOI 10.1002/jcb.10759; Huang CY, 2005, MOL ENDOCRINOL, V19, P2915, DOI 10.1210/me.2005-0097; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Ichida M, 2002, J BIOL CHEM, V277, P50991, DOI 10.1074/jbc.M210262200; Kamei Y, 2003, P NATL ACAD SCI USA, V100, P12378, DOI 10.1073/pnas.2135217100; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Lu DS, 2001, CANCER RES, V61, P6755; Lui K, 2006, PROSTATE, V66, P1600, DOI 10.1002/pros.20429; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Luo JM, 1997, NATURE, V388, P778, DOI 10.1038/42022; Mitsunaga K, 2004, MECH DEVELOP, V121, P237, DOI 10.1016/j.mod.2004.01.006; Pettersson K, 1996, MECH DEVELOP, V54, P211, DOI 10.1016/0925-4773(95)00479-3; Prins GS, 2006, ANN NY ACAD SCI, V1089, P1, DOI 10.1196/annals.1386.009; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Sharma MJ, 2003, EMBO J, V22, P6101, DOI 10.1093/emboj/cdg585; Sladek R, 1997, MOL CELL BIOL, V17, P5400, DOI 10.1128/MCB.17.9.5400; Soriano FX, 2006, DIABETES, V55, P1783, DOI 10.2337/db05-0509; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Trapp T, 1996, J BIOL CHEM, V271, P9879, DOI 10.1074/jbc.271.17.9879; Vanacker JM, 1999, EMBO J, V18, P4270, DOI 10.1093/emboj/18.15.4270; Vankoningsloo S, 2005, J LIPID RES, V46, P1133, DOI 10.1194/jlr.M400464-JLR200; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Wright ME, 2003, MOL ENDOCRINOL, V17, P1726, DOI 10.1210/me.2003-0031; Xie W, 1999, MOL ENDOCRINOL, V13, P2151, DOI 10.1210/me.13.12.2151; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yu DD, 2005, BIOORG MED CHEM LETT, V15, P1311, DOI 10.1016/j.bmcl.2005.01.025; Yu SA, 2007, CANCER RES, V67, P4904, DOI 10.1158/0008-5472.CAN-06-3855; Zhang WH, 2002, MOL CELL ENDOCRINOL, V193, P1, DOI 10.1016/s0303-7207(02)00089-8; Zhou W, 2006, J CLIN ENDOCR METAB, V91, P569, DOI 10.1210/jc.2004-1957	45	60	63	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	23					3313	3328		10.1038/sj.onc.1210986	http://dx.doi.org/10.1038/sj.onc.1210986			16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	304LQ	18071305				2022-12-25	WOS:000256111400010
J	Zang, Y; Yu, LF; Pang, T; Fang, LP; Feng, X; Wen, TQ; Nan, FJ; Feng, LY; Li, J				Zang, Yi; Yu, Li-Fang; Pang, Tao; Fang, Lei-Ping; Feng, Xu; Wen, Tie-Qiao; Nan, Fa-Jun; Feng, Lin-Yin; Li, Jia			AICAR induces astroglial differentiation of neural stem cells via activating the JAK/STAT3 pathway independently of AMP-activated protein kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CENTRAL-NERVOUS-SYSTEM; LEUKEMIA INHIBITORY FACTOR; IN-VIVO; 5-AMINO-4-IMIDAZOLECARBOXAMIDE RIBOSIDE; ASTROCYTE DIFFERENTIATION; NEURONAL SURVIVAL; MOUSE-BRAIN; FATTY-ACID; PROGENITOR; ASTROGLIOGENESIS	Neural stem cell differentiation and the determination of lineage decision between neuronal and glial fates have important implications in the study of developmental, pathological, and regenerative processes. Although small molecule chemicals with the ability to control neural stem cell fate are considered extremely useful tools in this field, few were reported. AICAR is an adenosine analog and extensively used to activate AMP-activated protein kinase (AMPK), a metabolic "fuel gauge" of the biological system. In the present study, we found an unrecognized astrogliogenic activity of AICAR on not only immortalized neural stem cell line C17.2 (C17.2-NSC), but also primary neural stem cells (NSCs) derived from post-natal (P0) rat hippocampus (P0-NSC) and embryonic day 14 (E14) rat embryonic cortex (E14-NSC). However, another AMPK activator, Metformin, did not alter either the C17.2-NSC or E14-NSC undifferentiated state although both Metformin and AICAR can activate the AMPK pathway in NSC. Furthermore, overexpression of dominant-negative mutants of AMPK in C17.2-NSC was unable to block the gliogenic effects of AICAR. We also found AICAR could activate the Janus kinase (JAK) STAT3 pathway in both C17.2-NSC and E14-NSC but Metformin fails. JAK inhibitor I abolished the gliogenic effects of AICAR. Taken together, these results suggest that the astroglial differentiation effect of AICAR on neural stem cells was acting independently of AMPK and that the JAK-STAT3 pathway is essential for the gliogenic effect of AICAR.	[Zang, Yi; Yu, Li-Fang; Pang, Tao; Feng, Xu; Nan, Fa-Jun; Li, Jia] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; [Fang, Lei-Ping; Feng, Lin-Yin] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai Inst Mat Med, Neurol Pharmacol Dept, Shanghai 201203, Peoples R China; [Wen, Tie-Qiao] Shanghai Univ, Sch Life Sci, Shanghai 200444, Peoples R China	Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS; Shanghai University	Li, J (corresponding author), 189 Guo Shou Jing Rd, Shanghai 201203, Peoples R China.	TUjli@mail.shcnc.ac.cnUT	Li, Jia/F-9116-2011; li, jia/GVT-7587-2022					Aberg MAI, 2001, MOL CELL NEUROSCI, V17, P426, DOI 10.1006/mcne.2000.0947; Blazquez C, 2001, FEBS LETT, V489, P149, DOI 10.1016/S0014-5793(01)02089-0; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bugga L, 1998, J NEUROBIOL, V36, P509, DOI 10.1002/(SICI)1097-4695(19980915)36:4<509::AID-NEU5>3.0.CO;2-#; Carling D, 2004, CURR BIOL, V14, pR220, DOI 10.1016/j.cub.2004.02.048; Christopher M, 2006, AM J PHYSIOL-ENDOC M, V291, pE1131, DOI 10.1152/ajpendo.00518.2005; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Culmsee C, 2001, J MOL NEUROSCI, V17, P45, DOI 10.1385/JMN:17:1:45; Favero CB, 2007, BRAIN RES, V1168, P1, DOI 10.1016/j.brainres.2007.06.087; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Ge WH, 2002, J NEUROSCI RES, V69, P848, DOI 10.1002/jnr.10364; Guigas B, 2007, BIOCHEM J, V404, P499, DOI 10.1042/BJ20070105; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Hardie DG, 2003, ENDOCRINOLOGY, V144, P5179, DOI 10.1210/en.2003-0982; He F, 2005, NAT NEUROSCI, V8, P616, DOI 10.1038/nn1440; Hu XH, 2004, J NEUROCHEM, V90, P1339, DOI 10.1111/j.1471-4159.2004.02594.x; Iglesias MA, 2004, DIABETES, V53, P1649, DOI 10.2337/diabetes.53.7.1649; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Jacobs RL, 2007, J BIOL CHEM, V282, P4516, DOI 10.1074/jbc.M605702200; Jhun BS, 2004, BIOCHEM BIOPH RES CO, V318, P372, DOI 10.1016/j.bbrc.2004.04.035; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Koblar SA, 1998, P NATL ACAD SCI USA, V95, P3178, DOI 10.1073/pnas.95.6.3178; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Longnus SL, 2003, AM J PHYSIOL-REG I, V284, pR936, DOI 10.1152/ajpregu.00319.2002; Lopez JM, 2003, BIOCHEM J, V370, P1027, DOI 10.1042/BJ20021053; Marshall CAG, 2003, GLIA, V43, P52, DOI 10.1002/glia.10213; Meley D, 2006, J BIOL CHEM, V281, P34870, DOI 10.1074/jbc.M605488200; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Molne M, 2000, J NEUROSCI RES, V59, P301, DOI 10.1002/(SICI)1097-4547(20000201)59:3<301::AID-JNR3>3.0.CO;2-H; Nakashima K, 1999, J NEUROSCI, V19, P5429; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Pencek RR, 2005, DIABETES, V54, P355, DOI 10.2337/diabetes.54.2.355; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; SABINA RL, 1985, J BIOL CHEM, V260, P6107; Shang J, 2004, J BIOL CHEM, V279, P12076, DOI 10.1074/jbc.M400431200; Skillington J, 2002, J CELL BIOL, V159, P135, DOI 10.1083/jcb.200204060; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Snyder EY, 1997, P NATL ACAD SCI USA, V94, P11663, DOI 10.1073/pnas.94.21.11663; SNYDER EY, 1995, NATURE, V374, P367, DOI 10.1038/374367a0; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; SULLIVAN JE, 1994, FEBS LETT, V353, P33, DOI 10.1016/0014-5793(94)01006-4; Taylor RM, 1997, TRANSPL P, V29, P845, DOI 10.1016/S0041-1345(96)00163-7; Vescovi AL, 1999, BRAIN PATHOL, V9, P569, DOI 10.1111/j.1750-3639.1999.tb00542.x; VINCENT MF, 1992, BIOCHEM J, V281, P267, DOI 10.1042/bj2810267; Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xiang XQ, 2004, BIOCHEM BIOPH RES CO, V321, P161, DOI 10.1016/j.bbrc.2004.06.133; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zimmermann H, 2006, PFLUG ARCH EUR J PHY, V452, P573, DOI 10.1007/s00424-006-0067-4	52	54	57	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6201	6208		10.1074/jbc.M708619200	http://dx.doi.org/10.1074/jbc.M708619200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18077446	hybrid			2022-12-25	WOS:000253779500027
J	Hamuro, J; Higuchi, O; Okada, K; Ueno, M; Iemura, SI; Natsume, T; Spearman, H; Beeson, D; Yamanashi, Y				Hamuro, Johko; Higuchi, Osamu; Okada, Kumiko; Ueno, Makiko; Iemura, Shun-Ichiro; Natsume, Tohru; Spearman, Hayley; Beeson, David; Yamanashi, Yuji			Mutations causing DOK7 congenital myasthenia ablate functional motifs in dok-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBUNIT; FAMILY; PROTEIN; DEFICIENCY; DOMAIN; MEMBER	Dok-7 is a cytoplasmic activator of muscle-specific receptor-tyrosine kinase (MuSK). Both Dok-7 and MuSK are required for neuromuscular synaptogenesis. Mutations in DOK7 underlie a congenital myasthenic syndrome (CMS) associated with small and simplified neuromuscular synapses likely due to impaired Dok-7/MuSK signaling. The overwhelming majority of patients with DOK7 CMS have at least one allele with a frameshift mutation that causes a truncation in the COOH-terminal region of Dok-7 and affects MuSK activation. Dok-7 has pleckstrin homology (PH) and phosphotyrosine binding (PTB) domains in the NH2-terminal moiety, both of which are indispensable for MuSK activation in myotubes, but little is known about additional functional elements. Here, we identify a chromosome region maintenance 1-dependent nuclear export signal (NES) in the COOH-terminal moiety and demonstrate that the NES-mediated cytoplasmic location of Dok-7 is essential for regulating the interaction with MuSK in myotubes. The NH2-terminal PH domain is responsible for the nuclear import of Dok-7. We also show that the Src homology 2 target motifs in the COOH-terminal moiety of Dok-7 are active and crucial for MuSK activation in myotubes. In addition, CMS-associated missense mutations found in the PH or PTB domain inactivate Dok-7. Together, these findings demonstrate that, in addition to the NH2-terminal PH and PTB domains, the COOH-terminal NES and Src homology 2 target motifs play key roles in Dok-7/MuSK signaling for neuromuscular synaptogenesis. Ablation or disruption of these functional elements in Dok-7 probably underlies the neuromuscular junction synaptopathy observed in DOK7 CMS.	[Hamuro, Johko; Higuchi, Osamu; Okada, Kumiko; Ueno, Makiko; Yamanashi, Yuji] Tokyo Med & Dent Univ, Inst Med Res, Dept Cell Regulat, Bunkyo Ku, Tokyo 1138510, Japan; [Iemura, Shun-Ichiro; Natsume, Tohru] Natl Inst Adv Ind Sci & Technol, Biol Informat Res Ctr, Tokyo 1350064, Japan; [Spearman, Hayley; Beeson, David] Univ Oxford, Weatherall Inst Mol Med, Neurosci Grp, Oxford OX1 2JD, England	Tokyo Medical & Dental University (TMDU); National Institute of Advanced Industrial Science & Technology (AIST); University of Oxford	Yamanashi, Y (corresponding author), Tokyo Med & Dent Univ, Inst Med Res, Dept Cell Regulat, Bunkyo Ku, Tokyo 1138510, Japan.	yamanashi.creg@mri.tmd.ac.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582	MRC [G117/490] Funding Source: UKRI; Medical Research Council [G117/490] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837; Beeson David, 2005, Neuromuscul Disord, V15, P498, DOI 10.1016/j.nmd.2005.05.001; Biswas R, 2006, DEVELOPMENT, V133, P217, DOI 10.1242/dev.02198; Cabane C, 2003, AM J PHYSIOL-CELL PH, V284, pC658, DOI 10.1152/ajpcell.00078.2002; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333; Cong F, 1999, MOL CELL BIOL, V19, P8314; Crowder RJ, 2004, J BIOL CHEM, V279, P42072, DOI 10.1074/jbc.M403726200; Di Cristofano A, 1998, J BIOL CHEM, V273, P4827, DOI 10.1074/jbc.273.9.4827; Donger C, 1998, AM J HUM GENET, V63, P967, DOI 10.1086/302059; Engel AG, 2003, NAT REV NEUROSCI, V4, P339, DOI 10.1038/nrn1101; Engel AG, 2007, NEUROTHERAPEUTICS, V4, P252, DOI 10.1016/j.nurt.2007.01.001; Engel AG, 2006, BRAIN, V129, P1938, DOI 10.1093/brain/awl198; Gomez CM, 1996, ANN NEUROL, V39, P712, DOI 10.1002/ana.410390607; Grimm J, 2001, J CELL BIOL, V154, P345, DOI 10.1083/jcb.200102032; Hoffmann K, 2006, AM J HUM GENET, V79, P303, DOI 10.1086/506257; Iwahara T, 2003, ONCOGENE, V22, P5946, DOI 10.1038/sj.onc.1206633; Morgan NV, 2006, AM J HUM GENET, V79, P390, DOI 10.1086/506256; Muller JS, 2007, BRAIN, V130, P1497, DOI 10.1093/brain/awm068; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Ohno K, 2002, AM J HUM GENET, V70, P875, DOI 10.1086/339465; OHNO K, 1995, P NATL ACAD SCI USA, V92, P758, DOI 10.1073/pnas.92.3.758; Ohno K, 2001, P NATL ACAD SCI USA, V98, P2017, DOI 10.1073/pnas.98.4.2017; Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142; Palace J, 2007, BRAIN, V130, P1507, DOI 10.1093/brain/awm072; Pawson T, 2004, CELL, V116, P191, DOI 10.1016/S0092-8674(03)01077-8; Shen XM, 2002, NEUROLOGY, V59, P1881, DOI 10.1212/01.WNL.0000042422.87384.2F; SINE SM, 1995, NEURON, V15, P229, DOI 10.1016/0896-6273(95)90080-2; Slater CR, 2006, BRAIN, V129, P2061, DOI 10.1093/brain/awl200; Tsujino A, 2003, P NATL ACAD SCI USA, V100, P7377, DOI 10.1073/pnas.1230273100; Vincent A, 2006, NEURON, V52, P123, DOI 10.1016/j.neuron.2006.09.024; Yamanashi Y, 1997, CELL, V88, P205, DOI 10.1016/S0092-8674(00)81841-3	32	46	48	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5518	5524		10.1074/jbc.M708607200	http://dx.doi.org/10.1074/jbc.M708607200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165682	hybrid			2022-12-25	WOS:000253426700032
J	Robling, AG; Niziolek, PJ; Baldridge, LA; Condon, KW; Allen, MR; Alam, I; Mantila, SM; Gluhak-Heinrich, J; Bellido, TM; Harris, SE; Turner, CH				Robling, Alexander G.; Niziolek, Paul J.; Baldridge, Lee A.; Condon, Keith W.; Allen, Matthew R.; Alam, Imranul; Mantila, Sara M.; Gluhak-Heinrich, Jelica; Bellido, Teresita M.; Harris, Stephen E.; Turner, Charles H.			Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VAN-BUCHEM-DISEASE; AFFECTED INDIVIDUALS; PARATHYROID-HORMONE; OSTEOBLASTIC CELLS; ANABOLIC RESPONSE; MINERAL DENSITY; GENE-EXPRESSION; WNT CORECEPTOR; MESSENGER-RNA; FLUID SHEAR	Sclerostin, the protein product of the Sost gene, is a potent inhibitor of bone formation. Among bone cells, sclerostin is found nearly exclusively in the osteocytes, the cell type that historically has been implicated in sensing and initiating mechanical signaling. The recent discovery of the antagonistic effects of sclerostin on Lrp5 receptor signaling, a crucial mediator of skeletal mechanotransduction, provides a potential mechanism for the osteocytes to control mechanotransduction, by adjusting their sclerostin (Wnt inhibitory) signal output to modulate Wnt signaling in the effector cell population. We investigated the mechanoregulation of Sost and sclerostin under enhanced (ulnar loading) and reduced (hindlimb unloading) loading conditions. Sost transcripts and sclerostin protein levels were dramatically reduced by ulnar loading. Portions of the ulnar cortex receiving a greater strain stimulus were associated with a greater reduction in Sost staining intensity and sclerostin-positive osteocytes (revealed via in situ hybridization and immunohistochemistry, respectively) than were lower strain portions of the tissue. Hindlimb unloading yielded a significant increase in Sost expression in the tibia. Modulation of sclerostin levels appears to be a finely tuned mechanism by which osteocytes coordinate regional and local osteogenesis in response to increased mechanical stimulation, perhaps via releasing the local inhibition of Wnt/Lrp5 signaling.	[Robling, Alexander G.; Condon, Keith W.; Allen, Matthew R.] Indiana Univ, Sch Med, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA; [Robling, Alexander G.; Niziolek, Paul J.; Alam, Imranul; Mantila, Sara M.; Turner, Charles H.] Purdue Univ, Dept Biomed Engn, W Lafayette, IN 47907 USA; [Baldridge, Lee A.] Indiana Univ, Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Harris, Stephen E.] Univ Texas Hlth Sci Ctr San Antonio, Sch Dent, Dept Periodont, San Antonio, TX 78229 USA; [Bellido, Teresita M.] Univ Arkansas Med Sci, Div Endocrinol, Little Rock, AR 72205 USA; [Turner, Charles H.] Indiana Univ, Sch Med, Dept Orthopaed Surg, Indianapolis, IN 46202 USA; [Gluhak-Heinrich, Jelica] Univ Texas Hlth Sci Ctr San Antonio, Dept Orthodont, San Antonio, TX 78229 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health San Antonio; University of Arkansas System; University of Arkansas Medical Sciences; Indiana University System; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health San Antonio	Robling, AG (corresponding author), Indiana Univ, Sch Med, Dept Anat & Cell Biol, 635 Barnhill Dr,MS 5035, Indianapolis, IN 46202 USA.	arobling@iupui.edu	Allen, Matthew/A-8799-2015	Allen, Matthew/0000-0002-1174-9004	NIAMS NIH HHS [AR46798, AR53237, AR046530] Funding Source: Medline; NIDDK NIH HHS [DK076007] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046530, R01AR053237, P01AR046798] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076007] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aguirre JI, 2006, J BONE MINER RES, V21, P605, DOI 10.1359/JBMR.060107; Ahlborg HG, 2003, NEW ENGL J MED, V349, P327, DOI 10.1056/NEJMoa022464; Balemans W, 2002, J MED GENET, V39, P91, DOI 10.1136/jmg.39.2.91; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Barou O, 1998, AM J PHYSIOL-ENDOC M, V274, pE108, DOI 10.1152/ajpendo.1998.274.1.E108; BEIGHTON P, 1976, ANN INTERN MED, V84, P393, DOI 10.7326/0003-4819-84-4-393; Bellido T, 2005, ENDOCRINOLOGY, V146, P4577, DOI 10.1210/en.2005-0239; Bex F, 2003, J BONE MINER RES, V18, pS60; Bezooijen RL, 2005, CYTOKINE GROWTH F R, V16, P319, DOI 10.1016/j.cytogfr.2005.02.005; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; BROMMAGE R, 2006, 36 INT SUN VALL WORK, P8; Cheline AJ, 2002, BONE, V31, P570, DOI 10.1016/S8756-3282(02)00865-7; COWIN SC, 1991, J BIOMECH ENG-T ASME, V113, P191, DOI 10.1115/1.2891234; Cullen DM, 2004, J BONE MINER RES, V19, pS396; Dufour C, 2007, EXP CELL RES, V313, P394, DOI 10.1016/j.yexcr.2006.10.021; Ellies DL, 2006, J BONE MINER RES, V21, P1738, DOI 10.1359/JBMR.060810; Gardner JC, 2005, J CLIN ENDOCR METAB, V90, P6392, DOI 10.1210/jc.2005-1235; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Grano M, 2002, CALCIFIED TISSUE INT, V70, P176, DOI 10.1007/s00223-001-2034-6; Hamersma H, 2003, CLIN GENET, V63, P192, DOI 10.1034/j.1399-0004.2003.00036.x; Hens JR, 2005, J BONE MINER RES, V20, P1103, DOI 10.1359/JBMR.050210; Hofmeyr Louis M, 2004, Curr Opin Otolaryngol Head Neck Surg, V12, P393, DOI 10.1097/01.moo.0000134441.84110.9e; Hsieh YF, 2001, J BONE MINER RES, V16, P2291, DOI 10.1359/jbmr.2001.16.12.2291; Kato M, 2002, J CELL BIOL, V157, P303, DOI 10.1083/jcb.200201089; Keller H, 2005, BONE, V37, P148, DOI 10.1016/j.bone.2005.03.018; Lane N, 2006, BULL HOSP JT DIS, V64, P67; LANYON LE, 1993, CALCIFIED TISSUE INT, V53, pS102, DOI 10.1007/BF01673415; Lau KHW, 2006, J BIOL CHEM, V281, P9576, DOI 10.1074/jbc.M509205200; Li J, 2006, BONE, V39, P754, DOI 10.1016/j.bone.2006.03.017; Li XF, 2005, J BIOL CHEM, V280, P19883, DOI 10.1074/jbc.M413274200; Loots GG, 2005, GENOME RES, V15, P928, DOI 10.1101/gr.3437105; MACHWATE M, 1993, AM J PHYSIOL, V264, pE790, DOI 10.1152/ajpendo.1993.264.5.E790; Mitsui N, 2006, LIFE SCI, V78, P2697, DOI 10.1016/j.lfs.2005.10.024; Morvan F, 2006, J BONE MINER RES, V21, P934, DOI 10.1359/JBMR.060311; Niikura T, 2006, J ORTHOP RES, V24, P1463, DOI 10.1002/jor.20182; Norvell SM, 2004, CALCIFIED TISSUE INT, V75, P396, DOI 10.1007/s00223-004-0213-y; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Robinson JA, 2006, J BIOL CHEM, V281, P31720, DOI 10.1074/jbc.M602308200; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Robling AG, 2006, ANNU REV BIOMED ENG, V8, P455, DOI 10.1146/annurev.bioeng.8.061505.095721; Sawakami K, 2006, J BIOL CHEM, V281, P23698, DOI 10.1074/jbc.M601000200; Semenov M, 2005, J BIOL CHEM, V280, P26770, DOI 10.1074/jbc.M504308200; Semenov MV, 2006, J BIOL CHEM, V281, P38276, DOI 10.1074/jbc.M609509200; Staehling-Hampton K, 2002, AM J MED GENET, V110, P144, DOI 10.1002/ajmg.10401; Sun N, 2003, J BONE MINER RES, V18, pS7; Sutherland MK, 2004, BONE, V35, P828, DOI 10.1016/j.bone.2004.05.023; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Turner CH, 2005, J BONE MINER METAB, V23, P16, DOI 10.1007/BF03026318; Turner CH, 2003, EXERC SPORT SCI REV, V31, P45, DOI 10.1097/00003677-200301000-00009; van Bezooijen RL, 2007, J BONE MINER RES, V22, P19, DOI 10.1359/JBMR.061002; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; Winkler DG, 2003, EMBO J, V22, P6267, DOI 10.1093/emboj/cdg599; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; ZHANG RW, 1995, J BONE MINER RES, V10, P415	55	921	959	2	95	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5866	5875		10.1074/jbc.M705092200	http://dx.doi.org/10.1074/jbc.M705092200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18089564	hybrid			2022-12-25	WOS:000253426700065
J	Scheschonka, A; Findlow, S; Schemm, R; El Far, O; Caldwell, JH; Crump, MP; Holden-Dye, K; O'Connor, V; Betz, H; Werner, JM				Scheschonka, Astrid; Findlow, Stuart; Schemm, Rudolf; El Far, Oussama; Caldwell, John H.; Crump, Matthew P.; Holden-Dye, Kate; O'Connor, Vincent; Betz, Heinrich; Werner, Joern M.			Structural determinants of calmodulin binding to the intracellular c-terminal domain of the metabotropic glutamate receptor 7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESIDUAL DIPOLAR COUPLINGS; PROTEIN-KINASE-C; TARGET RECOGNITION; PKC PHOSPHORYLATION; BACKBONE DYNAMICS; CALCIUM; COMPLEX; INACTIVATION; SPECTROSCOPY; MODULATION	Calmodulin (CaM) binds in a Ca2+-dependent manner to the intracellular C-terminal domains of most group III metabotropic glutamate receptors (mGluRs). Here we combined mutational and biophysical approaches to define the structural basis of CaM binding to mGluR 7A. Ca2+/CaM was found to interact with mGluR 7A primarily via its C-lobe at a 1:1 CaM:C-tail stoichiometry. Pulldown experiments with mutant CaM and mGluR 7A C-tail constructs and high resolution NMR with peptides corresponding to the CaM binding region of mGluR 7A allowed us to define hydrophobic and ionic interactions required for Ca2+/CaM binding and identified a 1-8-14 CaM-binding motif. The Ca2+/CaM center dot mGluR 7A peptide complex displays a classical wraparound structure that closely resembles that formed by Ca2+/CaM upon binding to smooth muscle myosin light chain kinase. Our data provide insight into how Ca2+/CaM regulates group III mGluR signaling via competition with intracellular proteins for receptor-binding sites.	[Scheschonka, Astrid; Schemm, Rudolf; El Far, Oussama; Caldwell, John H.; Betz, Heinrich] Max Planck Inst Brain Res, Dept Neurochem, D-60528 Frankfurt, Germany; [Findlow, Stuart; Crump, Matthew P.; Holden-Dye, Kate; O'Connor, Vincent; Werner, Joern M.] Univ South, Sch Biol Sci, Southampton S016 7PX, Hants, England	Max Planck Society	Betz, H (corresponding author), MPI Brain Res, Dept Neurochem, Deutschordenstr 46, D-60528 Frankfurt, Germany.	neurochemie@mpihfrankfurt.mpg.de; jmwe@soton.ac.uk	Werner, Joern/E-1148-2013; EL FAR, Oussama/P-9915-2019; Far, Oussama El/D-4225-2017	EL FAR, Oussama/0000-0002-7473-8345; Far, Oussama El/0000-0002-7473-8345; O'Connor, Vincent/0000-0003-3185-5709; Werner, Jorn/0000-0002-4712-1833; Crump, Matthew/0000-0002-7868-5818	MRC [MC_U117533887] Funding Source: UKRI; Medical Research Council [MC_U117533887] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Airas JM, 2001, FEBS LETT, V494, P60, DOI 10.1016/S0014-5793(01)02311-0; BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; BARBATO G, 1992, BIOCHEMISTRY-US, V31, P5269, DOI 10.1021/bi00138a005; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Callaerts-Vegh Z, 2006, J NEUROSCI, V26, P6573, DOI 10.1523/JNEUROSCI.1497-06.2006; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Contessa GM, 2005, J BIOMOL NMR, V31, P185, DOI 10.1007/s10858-005-0165-1; Cook AG, 2005, FEBS J, V272, P1511, DOI 10.1111/j.1742-4658.2005.04591.x; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; DAUBEROSGUTHORPE P, 1988, PROTEINS, V4, P31, DOI 10.1002/prot.340040106; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dev KK, 2001, TRENDS PHARMACOL SCI, V22, P355, DOI 10.1016/S0165-6147(00)01684-9; Dev KK, 2000, J NEUROSCI, V20, P7252; Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740; El Far O, 2002, BIOCHEM J, V365, P329, DOI 10.1042/BJ20020481; El Far O, 2001, J BIOL CHEM, V276, P30662, DOI 10.1074/jbc.M102573200; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; GEISER JR, 1991, CELL, V65, P949, DOI 10.1016/0092-8674(91)90547-C; GRZESIEK S, 1992, J AM CHEM SOC, V114, P6291, DOI 10.1021/ja00042a003; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Keen JE, 1999, J NEUROSCI, V19, P8830, DOI 10.1523/JNEUROSCI.19-20-08830.1999; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Kinoshita A, 1998, J COMP NEUROL, V393, P332; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Kunishima N, 2000, NATURE, V407, P971, DOI 10.1038/35039564; LINSE S, 1995, ADV SEC MESS PHOSPH, V30, P89; Macek TA, 1998, J NEUROSCI, V18, P6138; Mal TK, 2002, BIOCHEMISTRY-US, V41, P12899, DOI 10.1021/bi0264162; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mori MX, 2004, SCIENCE, V304, P432, DOI 10.1126/science.1093490; Nakajima Y, 1999, J BIOL CHEM, V274, P27573, DOI 10.1074/jbc.274.39.27573; NAKANISHI S, 1994, NEURON, V13, P1031, DOI 10.1016/0896-6273(94)90043-4; Nakanishi S, 1998, BRAIN RES REV, V26, P230, DOI 10.1016/S0165-0173(97)00033-7; O'Connor V, 1999, SCIENCE, V286, P1180, DOI 10.1126/science.286.5442.1180; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361; Perroy J, 2000, J NEUROSCI, V20, P7896; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; PIN JP, 1995, NEUROPHARMACOLOGY, V34, P1, DOI 10.1016/0028-3908(94)00129-G; POTTER JD, 1983, METHOD ENZYMOL, V102, P135; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; Rooney Luke M, 2004, Methods Mol Biol, V278, P123; SAIMI Y, 1994, FEBS LETT, V350, P155, DOI 10.1016/0014-5793(94)00782-9; Sansig G, 2001, J NEUROSCI, V21, P8734, DOI 10.1523/JNEUROSCI.21-22-08734.2001; Schneggenburger R, 2005, CURR OPIN NEUROBIOL, V15, P266, DOI 10.1016/j.conb.2005.05.006; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Sorensen SD, 2002, MOL PHARMACOL, V61, P1303, DOI 10.1124/mol.61.6.1303; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; Wall ME, 1997, STRUCTURE, V5, P1599, DOI 10.1016/S0969-2126(97)00308-0; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Xia XM, 1998, NATURE, V395, P503, DOI 10.1038/26758	57	12	12	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5577	5588		10.1074/jbc.M709505200	http://dx.doi.org/10.1074/jbc.M709505200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18089570	hybrid			2022-12-25	WOS:000253426700038
J	Snyder, M; Huang, XY; Zhang, JJL				Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian			Identification of novel direct Stat3 target genes for control of growth and differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EMBRYONIC STEM-CELLS; MAMMARY EPITHELIAL-CELLS; FACTOR-KAPPA-B; TRANSCRIPTIONAL ACTIVATION; SIGNAL TRANSDUCERS; MYOGENIC DIFFERENTIATION; DNA-BINDING; PROTEINS; PATHWAY; ROLES	Signal transducer and activator of transcription 3 (Stat3) is a key regulator of gene expression in response to signaling of the glycoprotein 130 (gp130) family cytokines, including interleukin 6, oncostatin M, and leukemia inhibitory factor. Many efforts have been made to identify Stat3 target genes and to understand the mechanism of how Stat3 regulates gene expression. Using the microarray technique, hundreds of genes have been documented to be potential Stat3 target genes in different cell types. However, only a small fraction of these genes have been proven to be true direct Stat3 target genes. Here we report the identification of novel direct Stat3 target genes using a genome-wide screening procedure based on the chromatin immunoprecipitation method. These novel Stat3 target genes are involved in a diverse array of biological processes such as oncogenesis, cell growth, and differentiation. We show that Stat3 can act as both a repressor and activator on its direct target genes. We further show that most of the novel Stat3 direct target genes are dependent on Stat3 for their transcriptional regulation. In addition, using a physiological cell system, we demonstrate that Stat3 is required for the transcriptional regulation of two of the newly identified direct Stat3 target genes important for muscle differentiation.	[Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian] Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA	Cornell University	Zhang, JJL (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol, New York, NY 10021 USA.	jjz2002@med.cornell.edu			NIA NIH HHS [AG023202] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [R01AG023202] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akira S, 2000, ONCOGENE, V19, P2607, DOI 10.1038/sj.onc.1203478; AKIRA S, 1994, CELL, V77, P63, DOI 10.1016/0092-8674(94)90235-6; Akira S, 1999, STEM CELLS, V17, P138, DOI 10.1002/stem.170138; Austin L, 2000, MUSCLE NERVE, V23, P1700, DOI 10.1002/1097-4598(200011)23:11<1700::AID-MUS5>3.0.CO;2-W; Azare J, 2007, MOL CELL BIOL, V27, P4444, DOI 10.1128/MCB.02404-06; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Clarkson RWE, 2006, MOL ENDOCRINOL, V20, P675, DOI 10.1210/me.2005-0392; Connor RM, 2005, J COMP NEUROL, V485, P32, DOI 10.1002/cne.20503; Darnell JE, 2005, NAT MED, V11, P595, DOI 10.1038/nm0605-595; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Dechow TN, 2004, P NATL ACAD SCI USA, V101, P10602, DOI 10.1073/pnas.0404100101; Ehret GB, 2001, J BIOL CHEM, V276, P6675, DOI 10.1074/jbc.M001748200; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Haura EB, 2005, NAT CLIN PRACT ONCOL, V2, P315, DOI 10.1038/ncponc0195; Heinrich PC, 1998, Z ERNAHRUNGSWISS, V37, P43; Huang SY, 2007, CLIN CANCER RES, V13, P1362, DOI 10.1158/1078-0432.CCR-06-2313; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Kami K, 2002, J HISTOCHEM CYTOCHEM, V50, P1579, DOI 10.1177/002215540205001202; Kang JS, 1998, J CELL BIOL, V143, P403, DOI 10.1083/jcb.143.2.403; Kang JS, 2003, P NATL ACAD SCI USA, V100, P3989, DOI 10.1073/pnas.0736565100; Kang JS, 2002, EMBO J, V21, P114, DOI 10.1093/emboj/21.1.114; Kataoka Y, 2003, J BIOL CHEM, V278, P44178, DOI 10.1074/jbc.M304884200; Kristensen DM, 2005, APMIS, V113, P756, DOI 10.1111/j.1600-0463.2005.apm_391.x; Lerner L, 2003, GENE DEV, V17, P2564, DOI 10.1101/gad.1135003; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; O'Shea JJ, 2002, CELL, V109, pS121, DOI 10.1016/S0092-8674(02)00701-8; Okada A, 2006, NATURE, V444, P369, DOI 10.1038/nature05246; Paz K, 2004, ONCOGENE, V23, P8455, DOI 10.1038/sj.onc.1207803; Raz R, 1999, P NATL ACAD SCI USA, V96, P2846, DOI 10.1073/pnas.96.6.2846; SEIDEL HM, 1995, P NATL ACAD SCI USA, V92, P3041, DOI 10.1073/pnas.92.7.3041; Sekkai D, 2005, STEM CELLS, V23, P1634, DOI 10.1634/stemcells.2005-0182; Shen YH, 2004, MOL CELL BIOL, V24, P407, DOI 10.1128/MCB.24.1.407-419.2004; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Sun W, 2006, FEBS LETT, V580, P5880, DOI 10.1016/j.febslet.2006.09.054; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Xu WF, 2005, J IMMUNOL, V175, P7419, DOI 10.4049/jimmunol.175.11.7419; Xu WF, 2005, J INTERF CYTOK RES, V25, P113, DOI 10.1089/jir.2005.25.113; Yang JB, 2007, GENE DEV, V21, P1396, DOI 10.1101/gad.1553707; Yoshida Y, 2004, J BIOL CHEM, V279, P1768, DOI 10.1074/jbc.M311498200; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang XK, 1999, MOL CELL BIOL, V19, P7138	44	84	88	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3791	3798		10.1074/jbc.M706976200	http://dx.doi.org/10.1074/jbc.M706976200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18065416	hybrid			2022-12-25	WOS:000253083500013
J	Curaba, JL; Chen, XM				Curaba, Julien; Chen, Xuemei			Biochemical activities of Arabidopsis RNA-dependent RNA polymerase 6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANS-ACTING SIRNAS; DE-NOVO INITIATION; VIRAL-RNA; TOBACCO-LEAVES; TOMATO LEAVES; C-ELEGANS; POLYMERASE; GENE; REQUIRES; PROTEIN	In Arabidopsis, genetic evidence demonstrates that RNA-dependent RNA polymerase 6 (RDR6) plays a fundamental role in at least four RNA silencing pathways whose functions range from defense against transgenes or viruses to endogene regulation in development and in stress responses. Despite its critical role in RNA silencing, the biochemical activities of RDR6 have yet to be characterized. In this study, we transiently expressed Arabidopsis RDR6 in Nicotiana benthamiana and investigated the biochemical activities of immunopurified RDR6 in vitro. We showed that RDR6 possesses terminal nucleotidyltransferase activity as well as primer-independent RNA polymerase activity on single-stranded RNAs. We found that RDR6 cannot distinguish RNAs with or without a cap or poly( A) tail. We also demonstrated that RDR6 has strong polymerase activity on single-stranded DNA. All these activities require the conserved catalytic Asp(867) residue. Our findings have important implications on the processes involving RDR6 in vivo and provide new biochemical insights into the mechanisms of RNA silencing in Arabidopsis.	[Curaba, Julien; Chen, Xuemei] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA	University of California System; University of California Riverside	Chen, XM (corresponding author), Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA.	xuemei.chen@ucr.edu		Chen, Xuemei/0000-0002-5209-1157	NIGMS NIH HHS [R01 GM061146, R01 GM061146-08] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061146] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; ASTIERMA.S, 1971, BIOCHIM BIOPHYS ACTA, V232, P484, DOI 10.1016/0005-2787(71)90602-2; ASTIERMANIFACIER S, 1978, CR ACAD SCI D NAT, V287, P1043; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Baulcombe DC, 2007, SCIENCE, V315, P199, DOI 10.1126/science.1138030; Borsani O, 2005, CELL, V123, P1279, DOI 10.1016/j.cell.2005.11.035; Chellappan P, 2004, J VIROL, V78, P7465, DOI 10.1128/JVI.78.14.7465-7477.2004; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cogoni C, 1999, NATURE, V399, P166, DOI 10.1038/20215; Dalmay T, 2000, CELL, V101, P543, DOI 10.1016/S0092-8674(00)80864-8; Dalmay T, 2001, EMBO J, V20, P2069, DOI 10.1093/emboj/20.8.2069; DUDA CT, 1979, VIROLOGY, V92, P180, DOI 10.1016/0042-6822(79)90223-X; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Elmayan T, 1998, PLANT CELL, V10, P1747, DOI 10.1105/tpc.10.10.1747; Gazzani S, 2004, SCIENCE, V306, P1046, DOI 10.1126/science.1101092; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; HONDA A, 1986, J BIOL CHEM, V261, P5987; IKEGAMI M, 1979, J BIOL CHEM, V254, P149; Kao CC, 2001, VIROLOGY, V287, P251, DOI 10.1006/viro.2001.1039; Kao CC, 1999, VIROLOGY, V253, P1, DOI 10.1006/viro.1998.9517; Katiyar-Agarwal S, 2006, P NATL ACAD SCI USA, V103, P18002, DOI 10.1073/pnas.0608258103; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Makeyev EV, 2002, MOL CELL, V10, P1417, DOI 10.1016/S1097-2765(02)00780-3; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Mourrain P, 2000, CELL, V101, P533, DOI 10.1016/S0092-8674(00)80863-6; Muangsan N, 2004, PLANT J, V38, P1004, DOI 10.1111/j.1365-313X.2004.02103.x; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Paul AV, 1998, NATURE, V393, P280, DOI 10.1038/30529; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001; Popescu SC, 2007, P NATL ACAD SCI USA, V104, P4730, DOI 10.1073/pnas.0611615104; Ranjith-Kumar CT, 2001, J VIROL, V75, P8615, DOI 10.1128/JVI.75.18.8615-8623.2001; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11851; Schiebel W, 1998, PLANT CELL, V10, P2087, DOI 10.1105/tpc.10.12.2087; SCHIEBEL W, 1993, J BIOL CHEM, V268, P11858; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Sugiyama T, 2005, P NATL ACAD SCI USA, V102, P152, DOI 10.1073/pnas.0407641102; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Vazquez F, 2004, MOL CELL, V16, P69, DOI 10.1016/j.molcel.2004.09.028; Voinnet O, 1998, CELL, V95, P177, DOI 10.1016/S0092-8674(00)81749-3; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Xie ZX, 2001, P NATL ACAD SCI USA, V98, P6516, DOI 10.1073/pnas.111440998; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605	48	83	92	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3059	3066		10.1074/jbc.M708983200	http://dx.doi.org/10.1074/jbc.M708983200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18063577	Green Accepted, hybrid			2022-12-25	WOS:000253083000009
J	Bourvis, N; Boelle, PY; Cesbron, JY; Valleron, AJ				Bourvis, Nadege; Boelle, Pierre-Yves; Cesbron, Jean-Yves; Valleron, Alain-Jacques			Risk Assessment of Transmission of Sporadic Creutzfeldt-Jakob Disease in Endodontic Practice in Absence of Adequate Prion Inactivation	PLOS ONE			English	Article								Background. Experimental results evidenced the infectious potential of the dental pulp of animals infected with transmissible spongiform encephalopathies (TSE). This route of iatrogenic transmission of sporadic Creutzfeldt- Jakob disease (sCJD) may exist in humans via reused endodontic instruments if inadequate prion decontamination procedures are used. Methodology/Principal Findings. To assess this risk, 10 critical parameters in the transmission process were identified, starting with contamination of an endodontic file during treatment of an infectious sCJD patient and ending with possible infection of a subsequent susceptible patient. It was assumed that a dose-risk response existed, with no-risk below threshold values. Plausible ranges of those parameters were obtained through literature search and expert opinions, and a sensitivity analysis was conducted. Without effective prion-deactivation procedures, the risk of being infected during endodontic treatment ranged between 3.4 and 13 per million procedures. The probability that more than one case was infected secondary to endodontic treatment of an infected sCJD patient ranged from 47% to 77% depending on the assumed quantity of infective material necessary for disease transmission. If current official recommendations on endodontic instrument decontamination were strictly followed, the risk of secondary infection would become quasi-null. Conclusion. The risk of sCJD transmission through endodontic procedure compares with other health care risks of current concern such as death after liver biopsy or during general anaesthesia. These results show that single instrument use or adequate prion-decontamination procedures like those recently implemented in dental practice must be rigorously enforced.	[Bourvis, Nadege; Boelle, Pierre-Yves; Valleron, Alain-Jacques] Univ Paris 06, Unite Rech Epidemiol Syst Informat Modelisat, UMR S 707, Paris, France; [Bourvis, Nadege; Boelle, Pierre-Yves; Valleron, Alain-Jacques] INSERM, U707, Paris, France; [Boelle, Pierre-Yves; Valleron, Alain-Jacques] Hop St Antoine, AP HP, Unite Sante Publ, F-75571 Paris, France; [Cesbron, Jean-Yves] Univ Grenoble 1, UMR 5163, Lab Adaptat & Pathogenie Microorgansimes, Grenoble, France; [Cesbron, Jean-Yves] CNRS, UMR 5163, Grenoble, France; [Cesbron, Jean-Yves] Ctr Hosp Univ Grenoble, Immunol Lab, Grenoble, France	UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA)	Valleron, AJ (corresponding author), Univ Paris 06, Unite Rech Epidemiol Syst Informat Modelisat, UMR S 707, Paris, France.	alain-jacques.valleron@upmc.fr		Boelle, Pierre-Yves/0000-0002-5367-8232	EU	EU(European Commission)	Funding: EU contract INFTRANS	*ASS MAL SAL DEP D, 2003, FREQ ACT BUCC DENT S; Bagg J, 2001, BRIT DENT J, V191, P87, DOI 10.1038/sj.bdj.4801104a; Barash PG, 2006, CLIN ANESTHESIA; BERNOULLI C, 1977, LANCET, V1, P478; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; Blanquet-Grossard F, 2000, J DENT RES, V79, P700, DOI 10.1177/00220345000790020101; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Brown P, 2000, NEUROLOGY, V55, P1075, DOI 10.1212/WNL.55.8.1075; *CCLIN SUD OUEST, 2004, AUT PRAT PREV RISQ I; *CJD INC PAN, 2005, MAN POSS EXP CJD MED; Collins S, 1999, LANCET, V353, P693, DOI 10.1016/S0140-6736(98)08138-0; CREUTZFELDT HG, 1920, NEUROL PSYCHIAT, V57, P1; CUNNIGHAM F, 2005, WILLIAMS OBSTET; d'Aignaux JH, 1999, NEUROLOGY, V53, P1197, DOI 10.1212/WNL.53.6.1197; *DEP HLTH, 2007, PREC ADV GIV DENT RE; *DEP HLTH EC RES D, 2003, RISK ASS VCJD DENT; *DEP HLTH EC RES D, 2001, RISK ASS TRANSM VCJD; *EUR ALL COUNTR CO, 2007, EUROCJD REP; Fichet G, 2004, LANCET, V364, P521, DOI 10.1016/S0140-6736(04)16810-4; Flechsig E, 2001, MOL MED, V7, P679, DOI 10.1007/BF03401958; Glatzel M, 2003, NEW ENGL J MED, V349, P1812, DOI 10.1056/NEJMoa030351; Gurevich I, 1996, J HOSP INFECT, V32, P295, DOI 10.1016/S0195-6701(96)90040-7; Herzog C, 2005, J VIROL, V79, P14339, DOI 10.1128/JVI.79.22.14339-14345.2005; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Ingle J.I., 2002, ENDODONTICS; Ingrosso L, 1999, J GEN VIROL, V80, P3043, DOI 10.1099/0022-1317-80-11-3043; Lewis V, 2002, LANCET NEUROL, V1, P470, DOI 10.1016/S1474-4422(02)00233-8; McLean AR, 2000, PHILOS T ROY SOC B, V355, P1043, DOI 10.1098/rstb.2000.0641; SANCHEZJUAN P, 2004, BR J OPHTHALMOL, V88, P446; *SEAC, 2007, 97 M SPONG ENC ADV C; Smith A, 2005, J HOSP INFECT, V61, P237, DOI 10.1016/j.jhin.2005.01.021; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Thackray AM, 2002, J VIROL, V76, P2510, DOI 10.1128/JVI.76.5.2510-2517.2002; Ward HJT, 2002, NEUROLOGY, V59, P543, DOI 10.1212/WNL.59.4.543; WILL RG, 1996, LANCET, V347, P925; Yan ZX, 2004, INFECT CONT HOSP EP, V25, P280, DOI 10.1086/502392; Zanusso G, 2003, NEW ENGL J MED, V348, P711, DOI 10.1056/NEJMoa022043; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	38	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1330	10.1371/journal.pone.0001330	http://dx.doi.org/10.1371/journal.pone.0001330			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159228	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459700002
J	Ma, X; Liu, YH; Gowen, BB; Graviss, EA; Clark, AG; Musser, JM				Ma, Xin; Liu, Yuhua; Gowen, Brian B.; Graviss, Edward A.; Clark, Andrew G.; Musser, James M.			Full-Exon Resequencing Reveals Toll-Like Receptor Variants Contribute to Human Susceptibility to Tuberculosis Disease	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; PATHOGEN RECOGNITION; CELLULAR ACTIVATION; IMMUNE-SYSTEM; CUTTING EDGE; POLYMORPHISM; GENE; PROTEIN; INFECTIONS; MUTATIONS	Tuberculosis (TB) is the leading cause of death worldwide due to an infectious agent. Data have accumulated over decades suggesting that variability in human susceptibility to TB disease has a genetic component. Toll-like receptors (TLRs) play a critical role in initiating the innate immune response to many pathogens in mouse models, but little is known about their role in human infections. Human TLRs have been reported to recognize mycobacterial antigens and initiate an immune response. We tested the hypothesis that amino acid-altering polymorphisms in five TLRs were associated with susceptibility to TB disease using a population-based case-control study with 1,312 adult TB patients and controls. Full-coding region sequencing of the five TLR genes in all 1,312 subjects yielded a data set in excess of 16 Mb. Rare nonsynonymous polymorphisms in TLR6-TLR1-TLR10 were significantly overrepresented among African-American TB cases compared with ethnically-matched control subjects. Common nonsynonymous polymorphisms in TLR6-TLR1-TLR10 also were significantly associated with TB disease in certain ethnic groups. Among African Americans, homozygotes for the common-variant haplotype TLR1-248S, TLR1-6021, and TLR6-249S had a significantly increased TB disease risk. A transmission/disequilibrium test on an independent sample found that the TLR1-248S variant was preferentially transmitted to diseased children, thereby confirming disease association. These results are consistent with recent reports implicating TLR1 variants, including TLR1-602, in significantly altered innate immune responses. Also consistent with disease association, rare TLR6 variants were defective in their ability to mediate NF-kappa B signal transduction in transfected human cells. Taken together, the data suggest that variant TLRs contribute to human susceptibility to TB disease. Extensive full-exon resequencing was critical for revealing new information about the role of TLRs in human-pathogen interactions and the genetic basis of innate immune function.	[Liu, Yuhua; Gowen, Brian B.; Musser, James M.] NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA; [Ma, Xin; Graviss, Edward A.] Baylor Coll Med, Dept Pathol, Ctr Human Bacterial Pathogenesis, Houston, TX 77030 USA; [Clark, Andrew G.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY USA; [Musser, James M.] Methodist Hosp, Res Inst, Ctr Human Mol & Translat Infect Dis Res, Houston, TX 77030 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Baylor College of Medicine; Cornell University; The Methodist Hospital System; The Methodist Hospital - Houston	Musser, JM (corresponding author), NIAID, Lab Human Bacterial Pathogenesis, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA.	jmmusser@tmhs.org		Clark, Andrew/0000-0001-7159-8511	The Division of Intramural Research; National Institute of Allergy and Infectious Diseases; National Institute of Health	The Division of Intramural Research; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institute of Health	Abel B, 2002, J IMMUNOL, V169, P3155, DOI 10.4049/jimmunol.169.6.3155; Akahoshi M, 2003, HUM GENET, V112, P237, DOI 10.1007/s00439-002-0873-5; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Arbour NC, 2000, NAT GENET, V25, P187, DOI 10.1038/76048; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Ben-Ali M, 2004, CLIN DIAGN LAB IMMUN, V11, P625, DOI 10.1128/CDLI.11.3.625-626.2004; Branger J, 2004, INT IMMUNOL, V16, P509, DOI 10.1093/intimm/dxh052; Brightbill HD, 1999, SCIENCE, V285, P732, DOI 10.1126/science.285.5428.732; Bulut Y, 2001, J IMMUNOL, V167, P987, DOI 10.4049/jimmunol.167.2.987; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; Chang JS, 2006, J IMMUNOL, V176, P3010, DOI 10.4049/jimmunol.176.5.3010; Cohen JC, 2004, SCIENCE, V305, P869, DOI 10.1126/science.1099870; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Drennan MB, 2004, AM J PATHOL, V164, P49, DOI 10.1016/S0002-9440(10)63095-7; Ferwerda B, 2007, P NATL ACAD SCI USA, V104, P16645, DOI 10.1073/pnas.0704828104; Fieschi C, 2003, J EXP MED, V197, P527, DOI 10.1084/jem.20021769; Filliol I, 2002, EMERG INFECT DIS, V8, P1347, DOI 10.3201/eid0811.020125; Flores-Villanueva PO, 2005, J EXP MED, V202, P1649, DOI 10.1084/jem.20050126; Gutacker MM, 2006, J INFECT DIS, V193, P121, DOI 10.1086/498574; Hawn TR, 2007, EUR J IMMUNOL, V37, P2280, DOI 10.1002/eji.200737034; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Heyworth PG, 2001, BLOOD CELL MOL DIS, V27, P16, DOI 10.1006/bcmd.2000.0347; Hudson RR, 2002, BIOINFORMATICS, V18, P337, DOI 10.1093/bioinformatics/18.2.337; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Johnson CM, 2007, J IMMUNOL, V178, P7520, DOI 10.4049/jimmunol.178.12.7520; KALLMANN F. J., 1943, American Review of Tuberculosis and Pulmonary Diseases, V47, P549; Khor CC, 2007, NAT GENET, V39, P523, DOI 10.1038/ng1976; Kramnik I, 2002, CURR OPIN MICROBIOL, V5, P111, DOI 10.1016/S1369-5274(02)00295-3; Lichtenauer-Kaligis EGR, 2003, EUR J IMMUNOL, V33, P59, DOI 10.1002/immu.200390008; Lopez M, 2003, J IMMUNOL, V170, P2409, DOI 10.4049/jimmunol.170.5.2409; Ma X, 2003, J INFECT DIS, V188, P349, DOI 10.1086/376559; Ma X, 2002, INT J TUBERC LUNG D, V6, P818; Malik S, 2005, P NATL ACAD SCI USA, V102, P12183, DOI 10.1073/pnas.0503368102; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Means TK, 1999, J IMMUNOL, V163, P3920; Morris RW, 2002, GENET EPIDEMIOL, V23, P221, DOI 10.1002/gepi.10200; Musser JM, 2000, GENETICS, V155, P7; Newport MJ, 2004, TUBERCULOSIS, V84, P347, DOI 10.1016/j.tube.2004.02.001; Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703; Omueti KO, 2007, J IMMUNOL, V178, P6387, DOI 10.4049/jimmunol.178.10.6387; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Pritchard JK, 2000, GENETICS, V155, P945; Reiling N, 2002, J IMMUNOL, V169, P3480, DOI 10.4049/jimmunol.169.7.3480; Remus N, 2003, IMMUNOL RES, V28, P109, DOI 10.1385/IR:28:2:109; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Roura-Mir C, 2005, J IMMUNOL, V175, P1758, DOI 10.4049/jimmunol.175.3.1758; Schroder NW, 2005, LANCET INFECT DIS, V5, P156, DOI 10.1016/S1473-3099(05)70023-2; Schumann RR, 2007, EUR J IMMUNOL, V37, P2059, DOI 10.1002/eji.200737604; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tapping RI, 2000, J IMMUNOL, V165, P5780, DOI 10.4049/jimmunol.165.10.5780; Thuong NTT, 2007, GENES IMMUN, V8, P422, DOI 10.1038/sj.gene.6364405; Topol EJ, 2007, NAT GENET, V39, P439, DOI 10.1038/ng0407-439; Tosh K, 2006, P NATL ACAD SCI USA, V103, P10364, DOI 10.1073/pnas.0603340103; Uehori J, 2005, J IMMUNOL, V174, P7096, DOI 10.4049/jimmunol.174.11.7096; Underhill DM, 1999, P NATL ACAD SCI USA, V96, P14459, DOI 10.1073/pnas.96.25.14459; Weiss KM, 2000, NAT GENET, V26, P151, DOI 10.1038/79866; *WHO, 2001, WHOCDSTB200128; Wright FA, 2001, GENOME BIOL, V2; Yu N, 2001, MOL BIOL EVOL, V18, P214, DOI 10.1093/oxfordjournals.molbev.a003795	65	158	167	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1318	10.1371/journal.pone.0001318	http://dx.doi.org/10.1371/journal.pone.0001318			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091991	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459600006
J	Bourdeaut, F; Ribeiro, A; Paris, R; Pierron, G; Couturier, J; Peuchmaur, M; Delattre, O				Bourdeaut, F.; Ribeiro, A.; Paris, R.; Pierron, G.; Couturier, J.; Peuchmaur, M.; Delattre, O.			In neuroblastic tumours, Schwann cells do not harbour the genetic alterations of neuroblasts but may nevertheless share the same clonal origin	ONCOGENE			English	Article						Schwann cell; neuroblastoma; clonality; differentiation; X inactivation	PATCH SIZE; DIFFERENTIATION; GANGLIONEUROBLASTOMA; MATURATION	Neuroblastic tumours are composed of variable proportions of neuroblasts and Schwann cells. Whether both components share a common neoplastic origin is highly debated and discrepant results have been reported about the presence of tumour-related genetic alterations in Schwann cells. We have used X-methylation analysis and array-CGH to investigate contiguous Schwannian and neuroblastic areas in tumours with a nodular pattern. A skewed X inactivation was observed in four out of five stromal components. Interestingly, in these four cases, the X-inactivation profiles of the neuroblastic components were identical to the matched stromal areas. However, whereas all neuroblastic areas displayed chromosomal imbalances, no alteration was found in any Schwann cell components. Similarly, no alteration was observed in a series of 19 tumours with a single stroma-rich component, which occasionally exhibited a skewed X-inactivation pattern (3/17 informative tumours). Altogether, this indicates that most stroma-rich tumours display a polyclonal proliferation and that Schwann cells do not derive from neuroblasts. However, in tumours with both stroma-rich and -poor components, our results suggest that cells from both areas share a common progenitor.	[Bourdeaut, F.; Delattre, O.] Inst Curie, INSERM, Unite Genet & Biol Canc, Sect Rech,U830, F-75248 Paris 05, France; [Ribeiro, A.; Pierron, G.; Delattre, O.] Inst Curie, Unite Genet Somat, Paris, France; [Paris, R.; Peuchmaur, M.] Univ Paris 07, AP HP Hop R Debre, EA3102, Serv Patol, Paris, France; [Couturier, J.] Inst Curie, Cytogenet Unit, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie	Delattre, O (corresponding author), Inst Curie, INSERM, Unite Genet & Biol Canc, Sect Rech,U830, 26 Rue Ulm, F-75248 Paris 05, France.	olivier.delattre@curie.fr	, Bourdeaut/AAG-8494-2019	delattre, olivier/0000-0002-8730-2276				Ambros IM, 1996, NEW ENGL J MED, V334, P1505, DOI 10.1056/NEJM199606063342304; Ambros IM, 2001, MED PEDIATR ONCOL, V36, P163; Bhattacharyya I, 1999, ORAL SURG ORAL MED O, V88, P586, DOI 10.1016/S1079-2104(99)70090-9; Chen GL, 2007, BLOOD, V110, P1410, DOI 10.1182/blood-2006-09-018655; Coco S, 2005, J PATHOL, V207, P346, DOI 10.1002/path.1843; DUPIN E, 1990, P NATL ACAD SCI USA, V87, P1119, DOI 10.1073/pnas.87.3.1119; HAAS D, 1988, CANCER, V62, P815; Idbaih A, 2005, ANN NEUROL, V58, P483, DOI 10.1002/ana.20607; Jovanovic L, 2003, J CLIN ENDOCR METAB, V88, P3284, DOI 10.1210/jc.2002-021552; Kubota T, 1999, HUM GENET, V104, P49, DOI 10.1007/s004390050909; La Rosa P, 2006, BIOINFORMATICS, V22, P2066, DOI 10.1093/bioinformatics/btl359; Liu SQ, 2005, AM J PATHOL, V166, P891, DOI 10.1016/S0002-9440(10)62309-7; MERLO GR, 1991, BIOTECHNIQUES, V11, P166; Mora J, 2001, CANCER RES, V61, P6892; Nishihira H, 2000, J CLIN ONCOL, V18, P3012, DOI 10.1200/JCO.2000.18.16.3012; Novelli M, 2003, P NATL ACAD SCI USA, V100, P3311, DOI 10.1073/pnas.0437825100; Peuchmaur M, 2003, CANCER, V98, P2274, DOI 10.1002/cncr.11773; RANGECROFT L, 1978, ARCH DIS CHILD, V53, P815, DOI 10.1136/adc.53.10.815; Raskind WH, 1998, LEUKEMIA, V12, P108, DOI 10.1038/sj.leu.2400934; SUGIMOTO T, 1988, CANCER RES, V48, P2531; Tsai YC, 1996, CANCER RES, V56, P402	21	25	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 8	2008	27	21					3066	3071		10.1038/sj.onc.1210965	http://dx.doi.org/10.1038/sj.onc.1210965			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	298IP	18071318				2022-12-25	WOS:000255681700014
J	Jakobsson, L; Domogatskaya, A; Tryggvason, K; Edgar, D; Claesson-Welsh, L				Jakobsson, Lars; Domogatskaya, Anna; Tryggvason, Karl; Edgar, David; Claesson-Welsh, Lena			Laminin deposition is dispensable for vasculogenesis but regulates blood vessel diameter independent of flow	FASEB JOURNAL			English	Article						angiogenesis; sprouting; basement membrane; VEGF	FIBROBLAST-GROWTH-FACTOR; BASEMENT-MEMBRANES; ENDOTHELIAL-CELLS; ALPHA-5 CHAIN; LAMC1 GENE; ANGIOGENESIS; VEGF; DIFFERENTIATION; EXPRESSION; MATURATION	Basement membranes (BMs) consisting of laminins, collagens, and heparan sulfate proteoglycans (HSPGs) are vital for proper endothelial cell function, but many aspects of their role in vascular development remain unknown. Here, we demonstrate that vascular structures within differentiating embryoid bodies are wrapped in a BM composed of alpha 4- and alpha 5-chain laminins, fibronectin, collagen IV, and HSPGs. In sprouting angiogenesis, laminins were produced by stalk cells, as well as the leading tip cell, and deposited along the sprout length, including tip cell filopodia. In embryonic stem cells deficient in laminins, due to lamc1 (laminin gamma 1) deletion, vascular development and organization were largely unaffected. However, the frequency of vessels with wide lumens was increased 4-fold. Laminin-deficient vessels were moreover characterized by increased fibronectin levels and enhanced endothelial cell proliferation. We conclude that laminins are dispensable for vascular development but that they regulate lumen formation in the absence of flow and vascular tone.	[Jakobsson, Lars; Claesson-Welsh, Lena] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Domogatskaya, Anna; Tryggvason, Karl] Karolinska Inst, Dept Med Biochem & Biophys, Stockholm, Sweden; [Edgar, David] Univ Liverpool, Dept Human Anat, Liverpool, Merseyside, England	Uppsala University; Karolinska Institutet; University of Liverpool	Claesson-Welsh, L (corresponding author), Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, Dag Hammarskjoldsv 20, SE-75185 Uppsala, Sweden.	lena.welsh@genpat.uu.se	Jakobsson, Lars/B-4200-2011; Domogatskaya, Anna/F-5794-2012	Jakobsson, Lars/0000-0001-7956-587X; Domogatskaya, Anna/0000-0002-6468-1963	BBSRC [BB/D014638/1] Funding Source: UKRI; MRC [G0300296] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/D014638/1] Funding Source: Medline; Medical Research Council [G0300296] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Benjamin LE, 1999, J CLIN INVEST, V103, P159, DOI 10.1172/JCI5028; Darland DC, 2003, DEV BIOL, V264, P275, DOI 10.1016/j.ydbio.2003.08.015; Dixelius J, 2004, J BIOL CHEM, V279, P23766, DOI 10.1074/jbc.M311675200; Doi M, 2002, J BIOL CHEM, V277, P12741, DOI 10.1074/jbc.M111228200; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Jakobsson L, 2007, J CELL BIOL, V177, P751, DOI 10.1083/jcb.200701146; Jakobsson L, 2006, DEV CELL, V10, P625, DOI 10.1016/j.devcel.2006.03.009; Kortesmaa J, 2000, J BIOL CHEM, V275, P14853, DOI 10.1074/jbc.275.20.14853; Li S, 2002, J CELL BIOL, V157, P1279, DOI 10.1083/jcb.200203073; Li XF, 2001, J CELL BIOL, V153, P811, DOI 10.1083/jcb.153.4.811; Ljubimova JY, 2001, CANCER RES, V61, P5601; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Miner JH, 2000, DEV BIOL, V217, P278, DOI 10.1006/dbio.1999.9546; Miner JH, 1997, J CELL BIOL, V137, P685, DOI 10.1083/jcb.137.3.685; Miner JH, 1998, J CELL BIOL, V143, P1713, DOI 10.1083/jcb.143.6.1713; Miner JH, 2004, DEVELOPMENT, V131, P2247, DOI 10.1242/dev.01112; Murray P, 2000, J CELL BIOL, V150, P1215, DOI 10.1083/jcb.150.5.1215; Nyberg P, 2005, CANCER RES, V65, P3967, DOI 10.1158/0008-5472.CAN-04-2427; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Parsons MJ, 2002, DEVELOPMENT, V129, P3137; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Smyth N, 1998, ANN NY ACAD SCI, V857, P283, DOI 10.1111/j.1749-6632.1998.tb10133.x; Smyth N, 1999, J CELL BIOL, V144, P151, DOI 10.1083/jcb.144.1.151; Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668; Sottile J, 2004, BBA-REV CANCER, V1654, P13, DOI 10.1016/j.bbcan.2003.07.002; Thyboll J, 2002, MOL CELL BIOL, V22, P1194, DOI 10.1128/MCB.22.4.1194-1202.2002; Vittet D, 1996, BLOOD, V88, P3424, DOI 10.1182/blood.V88.9.3424.bloodjournal8893424; Wang J, 2006, J NEUROCHEM, V96, P148, DOI 10.1111/j.1471-4159.2005.03521.x; Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435	34	45	45	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2008	22	5					1530	1539		10.1096/fj.07-9617com	http://dx.doi.org/10.1096/fj.07-9617com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18073332				2022-12-25	WOS:000255898700025
J	Kimple, ME; Joseph, JW; Bailey, CL; Fueger, PT; Hendry, IA; Newgard, CB; Casey, PJ				Kimple, Michelle E.; Joseph, Jamie W.; Bailey, Candice L.; Fueger, Patrick T.; Hendry, Ian A.; Newgard, Christopher B.; Casey, Patrick J.			G alpha(z) negatively regulates insulin secretion and glucose clearance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN ALPHA-SUBUNIT; BETA-CELLS; IN-VIVO; BIOCHEMICAL-PROPERTIES; PANCREATIC-ISLETS; CYCLIC-AMP; G(Z); ACTIVATION; MECHANISMS; EXPRESSION	Relatively little is known about the in vivo functions of the alpha subunit of the heterotrimeric G protein G(z) (G alpha(z)). Clues to one potential function recently emerged with the finding that activation of G alpha(z) inhibits glucose-stimulated insulin secretion in an insulinoma cell line (Kimple, M. E., Nixon, A. B., Kelly, P., Bailey, C. L., Young, K. H., Fields, T. A., and Casey, P. J. ( 2005) J. Biol. Chem. 280, 31708-31713). To extend this study in vivo, a G alpha(z) knock-out mouse model was utilized to determine whether G alpha(z) function plays a role in the inhibition of insulin secretion. No differences were discovered in the gross morphology of the pancreatic islets or in the islet DNA, protein, or insulin content between G alpha(z)-null and wild-type mice. There was also no difference between the insulin sensitivity of G alpha(z)-null mice and wildtype controls, as measured by insulin tolerance tests. G alpha(z)-null mice did, however, display increased plasma insulin concentrations and a corresponding increase in glucose clearance following intraperitoneal and oral glucose challenge as compared with wild-type controls. The increased plasma insulin observed in G alpha(z)-null mice is most likely a direct result of enhanced insulin secretion, since pancreatic islets isolated from G alpha(z)-null mice exhibited significantly higher glucose-stimulated insulin secretion than those of wild-type mice. Finally, the increased insulin secretion observed in G alpha(z)-null islets appears to be due to the relief of a tonic inhibition of adenylyl cyclase, as cAMP production was significantly increased in G alpha(z)-null islets in the absence of exogenous stimulation. These findings indicate that G alpha(z) may be a potential new target for therapeutics aimed at ameliorating beta-cell dysfunction in Type 2 diabetes.	[Kimple, Michelle E.; Bailey, Candice L.; Newgard, Christopher B.; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Newgard, Christopher B.; Casey, Patrick J.] Duke Univ, Med Ctr, Dept Biochem & Biophys, Durham, NC 27710 USA; [Joseph, Jamie W.; Fueger, Patrick T.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27710 USA; [Hendry, Ian A.] Australian Natl Univ, John Curtin Sch Med Res, Div Neurosci, Canberra, ACT 0200, Australia	Duke University; Duke University; Duke University; Australian National University; John Curtin School of Medical Research	Casey, PJ (corresponding author), Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Box 3813, Durham, NC 27710 USA.	casey006@mc.duke.edu		Casey, Patrick/0000-0002-7366-9309	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK080845, F32DK067799] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055717, R55GM055717] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK42583, F32 DK067799, DK67799, K01 DK080845] Funding Source: Medline; NIGMS NIH HHS [GM55717] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Arai K, 2003, MOL PHARMACOL, V63, P478, DOI 10.1124/mol.63.3.478; CASEY PJ, 1990, J BIOL CHEM, V265, P2383; Chen JF, 1997, J MOL MED, V75, P283, DOI 10.1007/s001090050113; Denker SP, 1996, J CELL BIOL, V133, P1027, DOI 10.1083/jcb.133.5.1027; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Fields TA, 1997, BIOCHEM J, V321, P561, DOI 10.1042/bj3210561; Furman B, 2006, CURR OPIN INVEST DR, V7, P898; GARIBAY JLR, 1991, BIOCHIM BIOPHYS ACTA, V1094, P193, DOI 10.1016/0167-4889(91)90008-L; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Glick JL, 1998, J BIOL CHEM, V273, P26008, DOI 10.1074/jbc.273.40.26008; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Ho MKC, 2001, ONCOGENE, V20, P1615, DOI 10.1038/sj.onc.1204190; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Joseph JW, 2002, DIABETES, V51, P3211, DOI 10.2337/diabetes.51.11.3211; Kahn SE, 2003, DIABETOLOGIA, V46, P3, DOI 10.1007/s00125-002-1009-0; KATADA T, 1979, J BIOL CHEM, V254, P469; Kelleher KL, 2001, THROMB HAEMOSTASIS, V85, P529; Kimple ME, 2005, J BIOL CHEM, V280, P31708, DOI 10.1074/jbc.M506700200; KONRAD RJ, 1995, J BIOL CHEM, V270, P12869, DOI 10.1074/jbc.270.21.12869; Kowluru A, 1996, BIOCHEM J, V313, P97, DOI 10.1042/bj3130097; Lang JC, 1999, EUR J BIOCHEM, V259, P3, DOI 10.1046/j.1432-1327.1999.00043.x; Leck KJ, 2006, NEUROPHARMACOLOGY, V51, P597, DOI 10.1016/j.neuropharm.2006.05.002; MALAISSE WJ, 1984, EXPERIENTIA, V40, P1068, DOI 10.1007/BF01971453; MATSUOKA M, 1988, P NATL ACAD SCI USA, V85, P5384, DOI 10.1073/pnas.85.15.5384; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Moxham CM, 1996, NATURE, V379, P840, DOI 10.1038/379840a0; Oleskevich S, 2005, NEUROREPORT, V16, P921, DOI 10.1097/00001756-200506210-00009; Sharp GWG, 1996, AM J PHYSIOL-CELL PH, V271, pC1781, DOI 10.1152/ajpcell.1996.271.6.C1781; Sherwood NM, 2000, ENDOCR REV, V21, P619, DOI 10.1210/er.21.6.619; Song XS, 2001, J BIOL CHEM, V276, P34651, DOI 10.1074/jbc.M105894200; Straub SG, 2002, DIABETES-METAB RES, V18, P451, DOI 10.1002/dmrr.329; Szollosi A, 2007, J BIOL CHEM, V282, P14768, DOI 10.1074/jbc.M701382200; Triplitt CL, 2007, AM J MANAG CARE, V13, pS47; Valenzuela D, 1997, P NATL ACAD SCI USA, V94, P1727, DOI 10.1073/pnas.94.5.1727; van den Buuse M, 2005, PSYCHOPHARMACOLOGY, V183, P358, DOI 10.1007/s00213-005-0181-6; Weinhaus AJ, 1998, DIABETES, V47, P1426, DOI 10.2337/diabetes.47.9.1426; Yajima H, 1999, DIABETES, V48, P1006, DOI 10.2337/diabetes.48.5.1006; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597	39	31	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4560	4567		10.1074/jbc.M706481200	http://dx.doi.org/10.1074/jbc.M706481200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18096703	hybrid			2022-12-25	WOS:000253426500012
J	Lafont, JE; Talma, S; Hopfgarten, C; Murphy, CL				Lafont, Jerome E.; Talma, Sonia; Hopfgarten, Christine; Murphy, Christopher L.			Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; OXYGEN-TENSION; CAMPOMELIC DYSPLASIA; COLLAGEN GENE; CELL-SHAPE; ACTIVIN-A; CARTILAGE; SOX9; EXPRESSION	The chondrocyte is solely responsible for synthesis and maintenance of the resilient articular cartilage matrix that gives this load-bearing tissue its mechanical integrity. When the differentiated cell phenotype is lost, the matrix becomes compromised and cartilage function begins to fail. We have recently shown that hypoxia promotes the differentiated phenotype through hypoxia-inducible factor 2 alpha (HIF-2 alpha)-mediated SOX9 induction of the main matrix genes. However, to date, only a few genes have been shown to be SOX9 targets, while little is known about SOX9-independent regulators. We therefore performed a detailed microarray study to address these issues. Analysis involved 35 arrays on chondrocytes obtained from seven healthy, non-elderly human cartilage samples. Genes were selected that were down-regulated with serial passage in culture ( as this causes loss of the differentiated phenotype) and subsequently up-regulated in hypoxia. The importance of key findings was further probed using the technique of RNA interference on these human articular chondrocytes. Our results show that hypoxia has a broader beneficial effect on the chondrocyte phenotype than has been previously described. Of especial note, we report new hypoxia-inducible and SOX9-regulated genes, Gdf10 and Chm-I. In addition, Mig6 and InhbA were induced by hypoxia, predominantly via HIF-2 alpha, but were not regulated by SOX9. Therefore, hypoxia, and more specifically HIF-2 alpha, promotes both SOX9-dependent and -independent factors important for cartilage homeostasis. HIF-2 alpha may therefore represent a new and promising therapeutic target for cartilage repair.	[Lafont, Jerome E.; Talma, Sonia; Hopfgarten, Christine; Murphy, Christopher L.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol, London W6 8LH, England	Imperial College London; University of Oxford	Murphy, CL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Kennedy Inst Rheumatol, 1 Aspenlea Rd, London W6 8LH, England.	c.murphy@imperial.ac.uk	Lafont, Jerome E/AAY-2277-2020	Lafont, Jerome E/0000-0001-8313-9873	Arthritis Research UK Funding Source: Medline; Biotechnology and Biological Sciences Research Council [bbsb0126x, BBS/B/0126X] Funding Source: Medline	Arthritis Research UK(Versus Arthritis); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Aigner T, 2007, CURR DRUG TARGETS, V8, P325, DOI 10.2174/138945007779940070; Aigner T, 2001, ARTHRITIS RHEUM-US, V44, P2777, DOI 10.1002/1529-0131(200112)44:12<2777::AID-ART465>3.0.CO;2-H; Aigner T, 2006, ARTHRITIS RHEUM-US, V54, P3533, DOI 10.1002/art.22174; Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; BENYA PD, 1978, CELL, V15, P1313, DOI 10.1016/0092-8674(78)90056-9; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; BRIGHTON CT, 1971, J BONE JOINT SURG AM, VA 53, P719, DOI 10.2106/00004623-197153040-00011; Buckwalter JA, 1998, ARTHRITIS RHEUM-US, V41, P1331, DOI 10.1002/1529-0131(199808)41:8<1331::AID-ART2>3.0.CO;2-J; Chang DM, 2007, RHEUMATOL INT, V27, P1049, DOI 10.1007/s00296-007-0350-5; Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477; Etherington P J, 2002, Clin Exp Rheumatol, V20, P799; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Francioli SE, 2007, TISSUE ENG, V13, P1227, DOI 10.1089/ten.2006.0342; GLOWACKI J, 1983, P SOC EXP BIOL MED, V172, P93; Hermansson M, 2004, J BIOL CHEM, V279, P43514, DOI 10.1074/jbc.M407041200; Jenkins E, 2005, MATRIX BIOL, V24, P177, DOI 10.1016/j.matbio.2005.02.004; Lafont JE, 2007, ARTHRITIS RHEUM, V56, P3297, DOI 10.1002/art.22878; Lefebvre V, 1997, MOL CELL BIOL, V17, P2336, DOI 10.1128/MCB.17.4.2336; Liu G, 2007, J BIOL CHEM, V282, P20407, DOI 10.1074/jbc.M608383200; Makkinje A, 2000, J BIOL CHEM, V275, P17838, DOI 10.1074/jbc.M909735199; Mandl EW, 2004, MATRIX BIOL, V23, P231, DOI 10.1016/j.matbio.2004.06.004; Meyer J, 1997, HUM MOL GENET, V6, P91, DOI 10.1093/hmg/6.1.91; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735; Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481; Saarikoski ST, 2002, FEBS LETT, V530, P186, DOI 10.1016/S0014-5793(02)03475-0; Sekiya I, 2000, J BIOL CHEM, V275, P10738, DOI 10.1074/jbc.275.15.10738; Shukunami C, 2001, OSTEOARTHR CARTILAGE, V9, pS91, DOI 10.1053/joca.2001.0450; Stokes DG, 2002, ARTHRITIS RHEUM, V46, P404, DOI 10.1002/art.10106; Verzi MP, 2007, DEV CELL, V12, P645, DOI 10.1016/j.devcel.2007.03.007; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Zhang YW, 2005, P NATL ACAD SCI USA, V102, P11740, DOI 10.1073/pnas.0505171102	34	114	123	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4778	4786		10.1074/jbc.M707729200	http://dx.doi.org/10.1074/jbc.M707729200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18077449	hybrid			2022-12-25	WOS:000253426500035
J	Oliver, DC; Paetzel, M				Oliver, David C.; Paetzel, Mark			Crystal structure of the major periplasmic domain of the bacterial membrane protein assembly facilitator YidC	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI YIDC; X-RAY-STRUCTURE; NASCENT FTSQ; INSERTION; TRANSLOCATION; PROGRAM; REGIONS; SECD; ALIGNMENT; SOFTWARE	The essential bacterial membrane protein YidC facilitates insertion and assembly of proteins destined for integration into the inner membrane. It has homologues in both mitochondria and chloroplasts. Here we report the crystal structure of the Escherichia coli YidC major periplasmic domain ( YidC(EC)P1) at 2.5 angstrom resolution. This domain is present in YidC from Gram-negative bacteria and is more than half the size of the full-length protein. The structure reveals that YidC(EC)P1 is made up of a large twisted beta-sandwich protein fold with a C-terminal alpha-helix that packs against one face of the beta-sandwich. Our structure and sequence analysis reveals that the C-terminal alpha-helix and the beta-sheet that it lays against are the most conserved regions of the domain. The region corresponding to the C-terminal alpha-helix was previously shown to be important for the protein insertase function of YidC and is conserved in other YidC-like proteins. The structure reveals that a region of YidC that was previously shown to be involved in binding to SecF maps to one edge of the beta-sandwich. Electrostatic analysis of the molecular surface for this region of YidC reveals a predominantly charged surface and suggests that the SecF-YidC interaction may be electrostatic in nature. Interestingly, YidC(EC)P1 has significant structural similarity to galactose mutarotase from Lactococcus lactis, suggesting that this domain may have another function besides its role in membrane protein assembly.	[Oliver, David C.; Paetzel, Mark] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Simon Fraser University	Paetzel, M (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, S Sci Bldg,8888 Univ Dr,Burna, Burnaby, BC V5A 1S6, Canada.	mpaetzel@sfu.ca		Paetzel, Mark/0000-0002-7408-5487				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; [Anonymous], ACTA CRYSTALLOGR D, V50, P760; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Derewenda ZS, 2006, ACTA CRYSTALLOGR D, V62, P116, DOI 10.1107/S0907444905035237; DIEDERICHS K, 1995, PROTEINS, V23, P187, DOI 10.1002/prot.340230208; Driessen AJM, 2001, NAT STRUCT BIOL, V8, P492, DOI 10.1038/88549; Duong F, 1997, EMBO J, V16, P4871, DOI 10.1093/emboj/16.16.4871; Duong F, 1997, EMBO J, V16, P2756, DOI 10.1093/emboj/16.10.2756; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fethiere J, 1999, J MOL BIOL, V288, P635, DOI 10.1006/jmbi.1999.2698; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; Froderberg L, 2004, J BIOL CHEM, V279, P31026, DOI 10.1074/jbc.M403229200; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanoulle X, 2004, J MOL BIOL, V342, P195, DOI 10.1016/j.jmb.2004.07.004; Holm L, 1998, NUCLEIC ACIDS RES, V26, P316, DOI 10.1093/nar/26.1.316; Hutchinson EG, 1996, PROTEIN SCI, V5, P212; HUTCHINSON EG, 1990, PROTEINS, V8, P203, DOI 10.1002/prot.340080303; JACOBSON RH, 1994, NATURE, V369, P761, DOI 10.1038/369761a0; Jiang FL, 2003, J BIOL CHEM, V278, P48965, DOI 10.1074/jbc.M307362200; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Liang J, 1998, PROTEIN SCI, V7, P1884, DOI 10.1002/pro.5560070905; Longenecker KL, 2001, ACTA CRYSTALLOGR D, V57, P679, DOI 10.1107/S0907444901003122; Luirink J, 2001, FEBS LETT, V501, P1, DOI 10.1016/S0014-5793(01)02616-3; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; MATSUYAMA S, 1993, EMBO J, V12, P265, DOI 10.1002/j.1460-2075.1993.tb05652.x; McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Nomen N, 2007, J MOL BIOL, V372, P422, DOI 10.1016/j.jmb.2007.07.003; Nouwen N, 2005, J BACTERIOL, V187, P5857, DOI 10.1128/JB.187.16.5857-5860.2005; Nouwen N, 2002, MOL MICROBIOL, V44, P1397, DOI 10.1046/j.1365-2958.2002.02972.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; PARSONS MR, 1995, STRUCTURE, V3, P1171, DOI 10.1016/S0969-2126(01)00253-2; Saaf A, 1998, J BIOL CHEM, V273, P30415, DOI 10.1074/jbc.273.46.30415; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Samuelson JC, 2001, J BIOL CHEM, V276, P34847, DOI 10.1074/jbc.M105793200; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Thoden JB, 2002, J BIOL CHEM, V277, P20854, DOI 10.1074/jbc.M201415200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Urbanus ML, 2001, EMBO REP, V2, P524, DOI 10.1093/embo-reports/kve108; van Bloois E, 2005, J BIOL CHEM, V280, P12996, DOI 10.1074/jbc.M414094200; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; van der Laan M, 2003, P NATL ACAD SCI USA, V100, P5801, DOI 10.1073/pnas.0636761100; van der Laan M, 2001, EMBO REP, V2, P519, DOI 10.1093/embo-reports/kve106; Vrontou E, 2004, BBA-MOL CELL RES, V1694, P67, DOI 10.1016/j.bbamcr.2004.06.003; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Xie K, 2006, BIOCHEMISTRY-US, V45, P13401, DOI 10.1021/bi060826z	59	43	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5208	5216		10.1074/jbc.M708936200	http://dx.doi.org/10.1074/jbc.M708936200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18093969	Green Published, hybrid			2022-12-25	WOS:000253426500078
J	Sammarco, MC; Ditch, S; Banerjee, A; Grabczyk, E				Sammarco, Mimi C.; Ditch, Scott; Banerjee, Ayan; Grabczyk, Ed			Ferritin L and H Subunits are differentially regulated on a post-transcriptional level	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-RESPONSIVE ELEMENT; RECEPTOR MESSENGER-RNA; TISSUE OXYGEN; HELA-CELLS; MOLECULAR CONTROL; NITRIC-OXIDE; HAIRPIN LOOP; L-CHAINS; IN-VIVO; PROTEIN	Ferritin plays an important role in the storage and release of iron, an element utilized in cellular processes such as respiration, gene regulation, and DNA replication and repair. Ferritin in animals is composed of 24 ferritin L ( FTL) and ferritin H (FTH) subunits in ratios that vary in different cell types. Because the subunits are not functionally interchangeable, both L and H units are critical for maintaining iron homeostasis and protecting against iron overload. FTL and FTH are regulated primarily at a post-transcriptional level in response to cellular iron concentrations. Individual regulation of FTL and FTH is of much interest, and although transcriptional differences between FTL and FTH have been shown, differences in their post-transcriptional regulation have not been evaluated. We report here that FTL and FTH are differentially regulated in 1% oxygen on a post-transcriptional level. We have designed a quantitative assay system sensitive enough to detect differences between FTL and FTH iron regulatory elements (IREs) that a standard electrophoretic mobility shift assay does not. The FTL IRE is the primary responder in the presence of an iron donor in hypoxic conditions, and this response is reflected in endogenous FTL protein levels. These results provide evidence that FTL and FTH subunits respond independently to cellular iron concentrations and underscore the importance of evaluating FTL and FTHIREs separately.	[Sammarco, Mimi C.; Ditch, Scott; Banerjee, Ayan; Grabczyk, Ed] Louisiana State Univ, Dept Genet, Hlth Sci Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Grabczyk, E (corresponding author), Louisiana State Univ, Dept Genet, Hlth Sci Ctr, 533 Bolivar St, New Orleans, LA 70112 USA.	egrabc@lsuhsc.edu		Sammarco, Mimi/0000-0001-9491-5735				Addess KJ, 1997, J MOL BIOL, V274, P72, DOI 10.1006/jmbi.1997.1377; AMES BN, 1993, P NATL ACAD SCI USA, V90, P7915, DOI 10.1073/pnas.90.17.7915; AROSIO P, 1991, CURR STUD HEMATOL BL, V58, P127; AROSIO P, 1976, CANCER RES, V36, P1735; BEINERT H, 1996, FEBS LETT, V382; BOMFORD A, 1981, J BIOL CHEM, V256, P948; BOYD D, 1985, J BIOL CHEM, V260, P1755; Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533, DOI 10.1152/ajpheart.2001.280.6.H2533; CAIRO G, 1985, BIOCHEM BIOPH RES CO, V133, P314, DOI 10.1016/0006-291X(85)91877-7; CASKEY JH, 1983, P NATL ACAD SCI-BIOL, V80, P482, DOI 10.1073/pnas.80.2.482; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; Chen Y, 2005, FEBS J, V272, P2088, DOI 10.1111/j.1742-4658.2005.04650.x; Christova T, 2007, MOL CELL BIOCHEM, V301, P21, DOI 10.1007/s11010-006-9393-2; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Cozzi A, 2000, J BIOL CHEM, V275, P25122, DOI 10.1074/jbc.M003797200; Cozzi A, 2004, BLOOD, V103, P2377, DOI 10.1182/blood-2003-06-1842; Curtis ARJ, 2001, NAT GENET, V28, P350, DOI 10.1038/ng571; DICKEY LF, 1987, J BIOL CHEM, V262, P7901; Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991; Erlitzki R, 2002, J BIOL CHEM, V277, P42579, DOI 10.1074/jbc.M207918200; Ferreira C, 2000, J BIOL CHEM, V275, P3021, DOI 10.1074/jbc.275.5.3021; Ferreira C, 2001, BLOOD, V98, P525, DOI 10.1182/blood.V98.3.525; GOETZE B, 2003, SCI STKE, pPL12; Han J, 2000, CELL MOL BIOL, V46, P517; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 1998, J BIOL CHEM, V273, P7588, DOI 10.1074/jbc.273.13.7588; Hanson ES, 2003, J BIOL CHEM, V278, P40337, DOI 10.1074/jbc.M302798200; HARRELL CM, 1991, P NATL ACAD SCI USA, V88, P4166, DOI 10.1073/pnas.88.10.4166; Henderson BR, 1996, BIOESSAYS, V18, P739, DOI 10.1002/bies.950180909; HENDERSON BR, 1994, J BIOL CHEM, V269, P17481; Henderson RJ, 2005, BBA-MOL CELL RES, V1743, P162, DOI 10.1016/j.bbamcr.2004.09.032; Hentze MW, 1996, P NATL ACAD SCI USA, V93, P8175, DOI 10.1073/pnas.93.16.8175; Hintze KJ, 2006, CELL MOL LIFE SCI, V63, P591, DOI 10.1007/s00018-005-5285-y; Hintze KJ, 2005, P NATL ACAD SCI USA, V102, P15048, DOI 10.1073/pnas.0505148102; Hoffman WE, 1999, SURG NEUROL, V51, P654, DOI 10.1016/S0090-3019(99)00011-7; Irace C, 2005, J NEUROCHEM, V95, P1321, DOI 10.1111/j.1471-4159.2005.03449.x; Kato J, 2001, Rinsho Ketsueki, V42, P403; Ke YH, 1998, J BIOL CHEM, V273, P23637, DOI 10.1074/jbc.273.37.23637; Ke YH, 2000, BIOCHEMISTRY-US, V39, P6235, DOI 10.1021/bi9924765; Koorts A. M., 2007, Archives of Physiology and Biochemistry, V113, P30, DOI 10.1080/13813450701318583; Kuriyama-Matsumura K, 1998, BIOCHEM BIOPH RES CO, V249, P241, DOI 10.1006/bbrc.1998.9046; LAWSON DM, 1989, FEBS LETT, V254, P207, DOI 10.1016/0014-5793(89)81040-3; LEGGETT BA, 1993, J GASTROEN HEPATOL, V8, P21, DOI 10.1111/j.1440-1746.1993.tb01170.x; LEVI S, 1992, BIOCHEM J, V288, P591, DOI 10.1042/bj2880591; Liu XB, 2002, BLOOD CELL MOL DIS, V29, P315, DOI 10.1006/bcmd.2002.0572; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Mikulits W, 1997, BIOCHEM BIOPH RES CO, V235, P212, DOI 10.1006/bbrc.1997.6647; Muckenthaler M, 2003, BLOOD, V101, P3690, DOI 10.1182/blood-2002-07-2140; Patton SM, 2005, J CELL SCI, V118, P4365, DOI 10.1242/jcs.02570; Pinero DJ, 2001, J NUTR, V131, P2831; Ponka P, 1998, SEMIN HEMATOL, V35, P35; Powell AK, 1998, MET IONS BIOL SYST, V35, P515; Roetto A, 2002, BLOOD CELL MOL DIS, V29, P532, DOI 10.1006/bcmd.2002.0590; Rouault TA, 2002, BLOOD CELL MOL DIS, V29, P309, DOI 10.1006/bcmd.2002.0571; Sammarco MC, 2005, ANAL BIOCHEM, V346, P210, DOI 10.1016/j.ab.2005.08.033; Schlegl J, 1997, RNA, V3, P1159; Schneider BD, 2003, BLOOD, V102, P3404, DOI 10.1182/blood-2003-02-0433; SIERZPUTOWSKAGRACZ H, 1995, NUCLEIC ACIDS RES, V23, P146, DOI 10.1093/nar/23.1.146; Thomson AM, 1999, INT J BIOCHEM CELL B, V31, P1139, DOI 10.1016/S1357-2725(99)00080-1; Tong WH, 2006, CELL METAB, V3, P199, DOI 10.1016/j.cmet.2006.02.003; Torti FM, 2002, BLOOD, V99, P3505, DOI 10.1182/blood.V99.10.3505; Truty J, 2001, J BIOL CHEM, V276, P48775, DOI 10.1074/jbc.M105392200; Walden WE, 2006, SCIENCE, V314, P1903, DOI 10.1126/science.1133116; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; Wang W, 2007, J BIOL CHEM, V282, P24650, DOI 10.1074/jbc.M703167200; WHITE K, 1988, J BIOL CHEM, V263, P8938; WORWOOD M, 1985, HUM GENET, V69, P371, DOI 10.1007/BF00291657; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	68	65	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4578	4587		10.1074/jbc.M703456200	http://dx.doi.org/10.1074/jbc.M703456200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18160403	hybrid			2022-12-25	WOS:000253426500014
J	Zhang, WX; Yang, NL; Shi, XM				Zhang, Weixi; Yang, Nianlan; Shi, Xing-Ming			Regulation of mesenchymal stem cell osteogenic differentiation by glucocorticoid-induced leucine zipper (GILZ)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARROW STROMAL CELLS; INHIBITION; ADIPOGENESIS; PROTEIN; GENE; LINE; CORTICOSTEROIDS; DEXAMETHASONE; OSTEOPOROSIS; OSF2/CBFA1	Mesenchymal stem cells (MSCs) can differentiate into multiple cell lineages, including osteoblasts and adipocytes. We reported previously that glucocorticoid-induced leucine zipper (GILZ) inhibits peroxisome proliferator-activated receptor gamma-2 (Ppar gamma 2) expression and blocks adipocyte differentiation. Here we show that overexpression of GILZ in mouse MSCs, but not MC3T3-E1 osteoblasts, increases alkaline phosphatase activity and enhances mineralized bone nodule formation, whereas knockdown of Gilz reduces MSC osteogenic differentiation capacity. Consistent with these observations, real-time reverse transcription-PCR analysis showed that both basal and differentiation-induced transcripts of the lineage commitment gene Runx2/Cbfa1, as well as osteoblast differentiation marker genes including alkaline phosphatase, type I collagen, and osteocalcin, were all increased in GILZ-expressing cells. In contrast, the mRNA levels of adipogenic Ppar gamma 2 and C/ebp alpha were significantly reduced in GILZ-expressing cells under both osteogenic and adipogenic conditions. Together, our results demonstrate that GILZ functions as a modulator of MSCs and that overexpression of GILZ shifts the balance between osteogenic and adipogenic differentiation of MSCs toward the osteogenic pathway. These data suggest that GILZ may have therapeutic value for stem cell-based therapies of metabolic bone diseases, such as fracture repair.	[Shi, Xing-Ming] Med Coll Georgia, Inst Mol Med & Genet, Dept Pathol, Augusta, GA 30912 USA; [Zhang, Weixi; Yang, Nianlan; Shi, Xing-Ming] Sun Yat Sen Univ, Affiliated Hosp 1, Inst Mol Med & Genet, Guangzhou, Peoples R China; [Zhang, Weixi] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Peoples R China; [Yang, Nianlan] Wuhan Univ, Renmin Hosp, Dept Hematol, Wuhan 430072, Peoples R China	University System of Georgia; Augusta University; Sun Yat Sen University; Sun Yat Sen University; Wuhan University	Shi, XM (corresponding author), Med Coll Georgia, Inst Mol Med & Genet, Dept Pathol, 1120 15th St,CB-2803, Augusta, GA 30912 USA.	xshi@mcg.edu						Ahdjoudj S, 2001, J CELL BIOCHEM, V81, P23, DOI 10.1002/1097-4644(20010401)81:1<23::AID-JCB1021>3.0.CO;2-H; Altose MD, 2000, NEW ENGL J MED, V343, P1902; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Barnes PJ, 2005, IMMUNOL ALLERGY CLIN, V25, P451, DOI 10.1016/j.iac.2005.05.003; Bazzy-Asaad A, 2001, CURR OPIN PEDIATR, V13, P523, DOI 10.1097/00008480-200112000-00005; BERESFORD JN, 1994, ARCH ORAL BIOL, V39, P941, DOI 10.1016/0003-9969(94)90077-9; BERESFORD JN, 1992, J CELL SCI, V102, P341; Bruder SP, 1997, J CELL BIOCHEM, V64, P278, DOI 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F; CHENG SL, 1994, ENDOCRINOLOGY, V134, P277, DOI 10.1210/en.134.1.277; Clowes JA, 2001, CURR OPIN RHEUMATOL, V13, P326, DOI 10.1097/00002281-200107000-00015; Conn DL, 2001, ARTHRIT RHEUM-ARTHR, V45, P462, DOI 10.1002/1529-0131(200110)45:5<462::AID-ART366>3.0.CO;2-V; Corren J, 2001, ANN ALLERG ASTHMA IM, V87, P405, DOI 10.1016/S1081-1206(10)62922-5; CRUESS RL, 1975, CLIN ORTHOP RELAT R, V113, P178; Cui Q, 1997, J BONE JOINT SURG AM, V79A, P1054, DOI 10.2106/00004623-199707000-00012; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gimble JM, 1996, MOL PHARMACOL, V50, P1087; Gori F, 1999, J BONE MINER RES, V14, P1522, DOI 10.1359/jbmr.1999.14.9.1522; HARRIS ED, 1983, HOSP PRACT, V18, P137; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Jaiswal RK, 2000, J BIOL CHEM, V275, P9645, DOI 10.1074/jbc.275.13.9645; JULIAN BA, 1991, NEW ENGL J MED, V325, P544, DOI 10.1056/NEJM199108223250804; Kirwan JR, 2000, Z RHEUMATOL, V59, P85; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; LOCASCIO V, 1990, BONE MINER, V8, P39, DOI 10.1016/0169-6009(91)90139-Q; LUKERT BP, 1990, ANN INTERN MED, V112, P352, DOI 10.7326/0003-4819-112-5-352; MEUNIER P, 1971, CLIN ORTHOP RELAT R, P147, DOI 10.1097/00003086-197110000-00021; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Park SJ, 2001, J HEART LUNG TRANSPL, V20, P304, DOI 10.1016/S1053-2498(00)00316-8; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Reichardt HM, 2000, Z RHEUMATOL, V59, P1; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Shi XM, 2003, EMBO REP, V4, P374, DOI 10.1038/sj.embor.embor805; SHIBANUMA M, 1992, J BIOL CHEM, V267, P10219; STANFORD CM, 1995, J BIOL CHEM, V270, P9420, DOI 10.1074/jbc.270.16.9420; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Tropel P, 2004, EXP CELL RES, V295, P395, DOI 10.1016/j.yexcr.2003.12.030; Tynan SH, 2004, J STEROID BIOCHEM, V91, P225, DOI 10.1016/j.jsbmb.2004.05.002; Walsh LJ, 2001, THORAX, V56, P279, DOI 10.1136/thorax.56.4.279; Weinstein RS, 1998, J CLIN INVEST, V102, P274, DOI 10.1172/JCI2799; YANG N, 2007, IN PRESS J CELL BIOC	47	118	128	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4723	4729		10.1074/jbc.M704147200	http://dx.doi.org/10.1074/jbc.M704147200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18084007	hybrid			2022-12-25	WOS:000253426500030
J	Smith, AE; Kim, SH; Liu, F; Jia, WY; Vinogradov, E; Gyles, CL; Bishop, RE				Smith, Abigail E.; Kim, Sang-Hyun; Liu, Feng; Jia, Wenyi; Vinogradov, Evgeny; Gyles, Carlton L.; Bishop, Russell E.			PagP activation in the outer membrane triggers R3 core oligosaccharide truncation in the cytoplasm of Escherichia coli O157 : H7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GRAM-NEGATIVE BACTERIA; LIPID-A; SALMONELLA-TYPHIMURIUM; ANTIMICROBIAL PEPTIDES; MOLECULAR-BASIS; UDP-GLUCOSE; POLYACRYLAMIDE GELS; SHIGELLA-FLEXNERI; HYDROCARBON RULER; ENZYME PAGP	The Escherichia coli outer membrane phospholipid: lipid A palmitoyltransferase PagP is normally a latent enzyme, but it can be directly activated in outer membranes by lipid redistribution associated with a breach in the permeability barrier. We now demonstrate that a lipid A myristate deficiency in an E. coli O157:H7 msbB mutant constitutively activates PagP in outer membranes. The lipid A myristate deficiency is associated with hydrophobic antibiotic sensitivity and, unexpectedly, with serum sensitivity, which resulted from O-antigen polysaccharide absence due to a cytoplasmically determined truncation at the first outer core glucose unit of the R3 core oligosaccharide. Mutational inactivation of pagP in the myristate-deficient lipid A background aggravated the hydrophobic antibiotic sensitivity as a result of losing a partially compensatory increase in lipid A palmitoylation while simultaneously restoring serum resistance and O-antigen attachment to intact lipopolysaccharide. Complementation with either wild-type pagP or catalytically inactive pagPSer77Ala alleles restored the R3 core truncation. However, the intact lipopolysaccharide was preserved after complementation with an internal deletion pagP Delta 5-14 allele, which mostly eliminates a periplasmic amphipathic alpha-helical domain but fully supports cell surface lipid A palmitoylation. Our findings indicate that activation of PagP not only triggers lipid A palmitoylation in the outer membrane but also separately truncates the R3 core oligosaccharide in the cytoplasm. We discuss the implication that PagP might function as an apical sensory transducer, which can be activated by a breach in the outer membrane permeability barrier.	[Smith, Abigail E.; Liu, Feng; Bishop, Russell E.] McMaster Univ, Dept Biol & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Kim, Sang-Hyun; Jia, Wenyi; Bishop, Russell E.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kim, Sang-Hyun; Jia, Wenyi; Bishop, Russell E.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Vinogradov, Evgeny] Natl Res Council Canada, Inst Biol Sci, Ottawa, ON K1A 0R6, Canada; [Gyles, Carlton L.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	McMaster University; University of Toronto; University of Toronto; National Research Council Canada; University of Guelph	Smith, AE (corresponding author), McMaster Univ, Dept Biol & Biomed Sci, Hamilton, ON L8N 3Z5, Canada.			Vinogradov, Evgeny/0000-0002-5364-1376	CIHR [84329-1] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Ahn VE, 2004, EMBO J, V23, P2931, DOI 10.1038/sj.emboj.7600320; Bader MW, 2005, CELL, V122, P461, DOI 10.1016/j.cell.2005.05.030; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Bishop RE, 2005, MOL MICROBIOL, V57, P900, DOI 10.1111/j.1365-2958.2005.04711.x; BISHOP RE, 2007, BIOCH BIOPHYS ACTA; BOHRINGER J, 1995, J BACTERIOL, V177, P413; CLARKE BR, 1992, J BACTERIOL, V174, P4614, DOI 10.1128/JB.174.14.4614-4621.1992; Clementz T, 1997, J BIOL CHEM, V272, P10353; d'Hauteville H, 2002, J IMMUNOL, V168, P5240, DOI 10.4049/jimmunol.168.10.5240; Edwards RA, 1998, GENE, V207, P149, DOI 10.1016/S0378-1119(97)00619-7; Edwards-Jones B, 2004, MICROBIOL-SGM, V150, P1079, DOI 10.1099/mic.0.26840-0; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gibbons HS, 2005, MOL MICROBIOL, V55, P425, DOI 10.1111/j.1365-2958.2004.04409.x; Grangeasse C, 2003, J BIOL CHEM, V278, P39323, DOI 10.1074/jbc.M305134200; Groisman EA, 2001, J BACTERIOL, V183, P1835, DOI 10.1128/JB.183.6.1835-1842.2001; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; HARLE C, 1995, EMBO J, V14, P1430, DOI 10.1002/j.1460-2075.1995.tb07129.x; Heinrichs DE, 1998, MOL MICROBIOL, V30, P221, DOI 10.1046/j.1365-2958.1998.01063.x; HELMUTH R, 1985, INFECT IMMUN, V48, P175, DOI 10.1128/IAI.48.1.175-182.1985; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Holden HM, 2003, J BIOL CHEM, V278, P43885, DOI 10.1074/jbc.R300025200; Huysmans GHM, 2007, J MOL BIOL, V373, P529, DOI 10.1016/j.jmb.2007.07.072; Hwang PM, 2004, P NATL ACAD SCI USA, V101, P9618, DOI 10.1073/pnas.0402324101; Hwang PM, 2002, P NATL ACAD SCI USA, V99, P13560, DOI 10.1073/pnas.212344499; Jia WY, 2004, J BIOL CHEM, V279, P44966, DOI 10.1074/jbc.M404963200; Joiner K A, 1985, Curr Top Microbiol Immunol, V121, P99; KAMIO Y, 1976, BIOCHEMISTRY-US, V15, P2561, DOI 10.1021/bi00657a012; Kanipes MI, 2001, J BIOL CHEM, V276, P1156, DOI 10.1074/jbc.M009019200; Kaniuk NA, 2004, J BIOL CHEM, V279, P31237, DOI 10.1074/jbc.M401879200; Kawasaki K, 2004, J BIOL CHEM, V279, P20044, DOI 10.1074/jbc.M401275200; Khan MA, 2007, BIOCHEMISTRY-US, V46, P4565, DOI 10.1021/bi602526k; Kim SH, 2006, MICROBIOL-SGM, V152, P657, DOI 10.1099/mic.0.28692-0; Kim SH, 2004, INFECT IMMUN, V72, P1174, DOI 10.1128/IAI.72.2.1174-1180.2004; LEIVE L, 1974, ANN NY ACAD SCI, V235, P109, DOI 10.1111/j.1749-6632.1974.tb43261.x; Marolda CL, 1996, MOL MICROBIOL, V22, P827, DOI 10.1046/j.1365-2958.1996.01531.x; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Murray SR, 2001, J BACTERIOL, V183, P5554, DOI 10.1128/JB.183.19.5554-5561.2001; *NAT COMM CLIN LAB, 2002, PERF STAND ANT DISK, V22, pM31; NIKAIDO H, 1985, MICROBIOL REV, V49, P1; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; Nikaido H, 1979, Adv Microb Physiol, V20, P163; Pilione MR, 2004, INFECT IMMUN, V72, P2837, DOI 10.1128/IAI.72.5.2837-2842.2004; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Robey M, 2001, INFECT IMMUN, V69, P4276, DOI 10.1128/IAI.69.7.4276-4286.2001; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SCHINDLER M, 1979, BIOCHEMISTRY-US, V18, P4425, DOI 10.1021/bi00587a024; SCHWEIZER HP, 1993, BIOTECHNIQUES, V15, P831; Somerville JE, 1999, INFECT IMMUN, V67, P6583; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tran AX, 2005, J BIOL CHEM, V280, P28186, DOI 10.1074/jbc.M505020200; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Vaara M, 1999, ANTIMICROB AGENTS CH, V43, P1459, DOI 10.1128/AAC.43.6.1459; West NP, 2005, SCIENCE, V307, P1313, DOI 10.1126/science.1108472; Yethon JA, 2000, J BACTERIOL, V182, P5620, DOI 10.1128/JB.182.19.5620-5623.2000; Yethon JA, 1998, J BIOL CHEM, V273, P26310, DOI 10.1074/jbc.273.41.26310; Yoon JW, 2005, INFECT IMMUN, V73, P2367, DOI 10.1128/IAI.73.4.2367-2378.2005; Zhou ZM, 1999, J BIOL CHEM, V274, P18503, DOI 10.1074/jbc.274.26.18503; Zhou ZM, 2000, J BIOL CHEM, V275, P13542, DOI 10.1074/jbc.275.18.13542	61	25	27	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4332	4343		10.1074/jbc.M708163200	http://dx.doi.org/10.1074/jbc.M708163200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18070877	Green Accepted, hybrid			2022-12-25	WOS:000253083500068
J	Wang, ZQ; Zhang, L; Qiao, AM; Watson, K; Zhang, JW; Fan, GH				Wang, Ziqing; Zhang, Li; Qiao, Aimin; Watson, Kurt; Zhang, Jingwu; Fan, Guo-Huang			Activation of CXCR4 triggers ubiquitination and down-regulation of major histocompatibility complex class I (MHC-I) on epithelioid carcinoma HeLa cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMOKINE RECEPTOR CXCR4; BREAST-CANCER; ANTIGEN PRESENTATION; INTERFERON-GAMMA; FINGER PROTEINS; GLIOMA-CELLS; LIGASE; INTERNALIZATION; EXPRESSION; MOLECULES	Many cancer cells display down-regulated major histocompatibility complex (MHC) class I antigen (MHC-I), which seems to enable them to evade immune surveillance, whereas the underlying mechanisms remain incompletely understood. Here, we demonstrate that ligand (CXCL12) stimulation of CXCR4, a major chemokine receptor expressed in many malignant cancer cells, induced MHC-I heavy chain down-regulation from the cell surface of the human epithelioid carcinoma HeLa cells, the human U251 and U87 glioblastoma cells, the human MDA-MD 231 breast cancer cells, and the human SK-N-BE (2) neuroblastoma cells. Activation of CXCR4 also induced MHC-I down-regulation in human peripheral blood mononuclear cells. The internalized MHC-I heavy chain molecules were partially co-localized with Rab7, a later endosomal marker. Activation of CXCR4 induced ubiquitination of MHC-I heavy chain, and mutation of the C-terminal two lysine residues (Lys-332, Lys337) on one of the MHC-I alleles, HLA.B7, blocked CXCR4-evoked ubiquitination and down-regulation of HLA.B7. Moreover, purified GST-conjugated CXCR4 C terminus directly associated with the purified His-tagged beta 2-microglobulin (beta 2M), and MHC-I heavy chain was co-immunoprecipitated with CXCR4 in a beta 2M-dependent manner. This interaction appears to be critical for CXCR4-evoked down-regulation of MHC-I heavy chain as evidenced by the data that MHC-I heavy chain down-regulation was inhibited by either truncation of the CXCR4 C terminus or knockdown of beta 2M. All together, these findings shed new light on the role of CXCR4 in tumor evasion of immune surveillance via inducing MHC-I down-regulation from the cell surface.	[Qiao, Aimin; Watson, Kurt; Fan, Guo-Huang] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA; [Wang, Ziqing; Zhang, Jingwu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Shanghai 200025, Peoples R China; [Wang, Ziqing; Zhang, Jingwu] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200025, Peoples R China; [Qiao, Aimin; Watson, Kurt; Fan, Guo-Huang] Meharry Med Coll, Dept Neurobiol & Neurotoxicol, Nashville, TN 37208 USA; [Zhang, Li] Vanderbilt Univ, Sch Med, Dept Pathol, Nashville, TN 37212 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; Meharry Medical College; Vanderbilt University	Fan, GH (corresponding author), Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA.	gfan@mmc.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS041071] Funding Source: NIH RePORTER; NINDS NIH HHS [U54NS41071] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akekawatchai C, 2005, J BIOL CHEM, V280, P39701, DOI 10.1074/jbc.M509829200; Balkwill F, 2004, SEMIN CANCER BIOL, V14, P171, DOI 10.1016/j.semcancer.2003.10.003; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Chang CC, 2006, SEMIN CANCER BIOL, V16, P383, DOI 10.1016/j.semcancer.2006.07.001; Chang Chien-Chung, 2003, Keio Journal of Medicine, V52, P220; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2003, TRENDS CELL BIOL, V13, P7, DOI 10.1016/S0962-8924(02)00005-3; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; FENG Y, 1995, J CELL BIOL, V131, P1435, DOI 10.1083/jcb.131.6.1435; Fruh K, 2002, VIRUS RES, V88, P55, DOI 10.1016/S0168-1702(02)00120-X; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Haque M, 2001, J GEN VIROL, V82, P1175, DOI 10.1099/0022-1317-82-5-1175; Haribabu B, 1997, J BIOL CHEM, V272, P28726, DOI 10.1074/jbc.272.45.28726; Hewitt EW, 2002, EMBO J, V21, P2418, DOI 10.1093/emboj/21.10.2418; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kucia M, 2004, J MOL HISTOL, V35, P233; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; Lehner PJ, 2005, IMMUNOL REV, V207, P112, DOI 10.1111/j.0105-2896.2005.00314.x; Li RS, 2006, J BIOL CHEM, V281, P37616, DOI 10.1074/jbc.M607266200; Liang ZX, 2004, CANCER RES, V64, P4302, DOI 10.1158/0008-5472.CAN-03-3958; Lu ZM, 2002, MOL CELL, V9, P945, DOI 10.1016/S1097-2765(02)00519-1; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mansouri M, 2003, J VIROL, V77, P1427, DOI 10.1128/JVI.77.2.1427-1440.2003; Matsui M, 2002, J GASTROEN HEPATOL, V17, P897, DOI 10.1046/j.1440-1746.2002.02837.x; Muller H, 2001, EUR J SURG ONCOL, V27, P652, DOI 10.1053/ejso.2001.1193; Murphy PM, 2001, NEW ENGL J MED, V345, P833, DOI 10.1056/NEJM200109133451113; Ochiel DO, 2005, INFECT IMMUN, V73, P4190, DOI 10.1128/IAI.73.7.4190-4197.2005; Peng SB, 2005, MOL CANCER RES, V3, P227; Phillips RJ, 2003, AM J RESP CRIT CARE, V167, P1676, DOI 10.1164/rccm.200301-071OC; Smith MCP, 2004, CANCER RES, V64, P8604, DOI 10.1158/0008-5472.CAN-04-1844; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; TATAKE RJ, 1992, TRANSPLANTATION, V54, P395, DOI 10.1097/00007890-199209000-00002; Uchida D, 2004, J EXP MED, V199, P167, DOI 10.1084/jem.20031291; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Zagzag D, 2005, LAB INVEST, V85, P328, DOI 10.1038/labinvest.3700233; Zhang LB, 2007, NEOPLASIA, V9, P36, DOI 10.1593/neo.06670; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zlotnik A, 2004, SEMIN CANCER BIOL, V14, P181, DOI 10.1016/j.semcancer.2003.10.004	39	14	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3951	3959		10.1074/jbc.M706848200	http://dx.doi.org/10.1074/jbc.M706848200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18083706	hybrid			2022-12-25	WOS:000253083500029
J	Yamano, K; Yatsukawa, YI; Esaki, M; Hobbs, AEA; Jensen, RE; Endo, T				Yamano, Koji; Yatsukawa, Yoh-Ichi; Esaki, Masatoshi; Hobbs, Alyson E. Aiken; Jensen, Robert E.; Endo, Toshiya			Tom20 and Tom22 share the common signal recognition pathway in mitochondrial protein import	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; YEAST MITOCHONDRIA; FUNCTIONAL COOPERATION; PRECURSOR BINDING; INSERTION PATHWAY; RECEPTOR COMPLEX; TRANSLOCATION; PRESEQUENCE; DOMAIN; PREPROTEIN	Precise targeting of mitochondrial precursor proteins to mitochondria requires receptor functions of Tom20, Tom22, and Tom70 on the mitochondrial surface. Tom20 is a major import receptor that recognizes preferentially mitochondrial presequences, and Tom70 is a specialized receptor that recognizes presequence-less inner membrane proteins. The cytosolic domain of Tom22 appears to function as a receptor in cooperation with Tom20, but how its substrate specificity differs from that of Tom20 remains unclear. To reveal possible differences in substrate specificities between Tom20 and Tom22, if any, we deleted the receptor domain of Tom20 or Tom22 in mitochondria in vitro by introducing cleavage sites for a tobacco etch virus protease between the receptor domains and transmembrane segments of Tom20 and Tom22. Then mitochondria without the receptor domain of Tom20 or Tom22 were analyzed for their abilities to import various mitochondrial precursor proteins targeted to different mitochondrial subcompartments in vitro. The effects of deletion of the receptor domains on the import of different mitochondrial proteins for different import pathways were quite similar between Tom20 and Tom22. Therefore Tom20 and Tom22 are apparently involved in the same step or sequential steps along the same pathway of targeting signal recognition in import.	[Yamano, Koji; Yatsukawa, Yoh-Ichi; Esaki, Masatoshi; Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Hobbs, Alyson E. Aiken; Jensen, Robert E.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA; [Endo, Toshiya] Nagoya Univ, Inst Adv Res, Nagoya, Aichi 4648602, Japan; [Endo, Toshiya] Nagoya Univ, Japan Sci & Technol Corp, Core Res Evolut Sci & Technol, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Johns Hopkins University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp	Esaki, Masatoshi/L-6591-2017; Esaki, Masatoshi/ABS-6645-2022					Abe Y, 2000, CELL, V100, P551, DOI 10.1016/S0092-8674(00)80691-1; Ahting U, 2005, J BIOL CHEM, V280, P48, DOI 10.1074/jbc.M410905200; Bolliger L, 1995, EMBO J, V14, P6318, DOI 10.1002/j.1460-2075.1995.tb00322.x; Brix J, 1999, J BIOL CHEM, V274, P16522, DOI 10.1074/jbc.274.23.16522; Davis AJ, 1998, MOL BIOL CELL, V9, P2577, DOI 10.1091/mbc.9.9.2577; Diekert K, 2001, EMBO J, V20, P5626, DOI 10.1093/emboj/20.20.5626; DOUGHERTY WG, 1993, MICROBIOL REV, V57, P781, DOI 10.1128/MMBR.57.4.781-822.1993; Endo T, 2003, J CELL SCI, V116, P3259, DOI 10.1242/jcs.00667; Endo T, 2002, BBA-MOL CELL RES, V1592, P3, DOI 10.1016/S0167-4889(02)00259-8; Esaki M, 2004, J BIOL CHEM, V279, P45701, DOI 10.1074/jbc.M404591200; HINES V, 1993, J BIOL CHEM, V268, P449; HINES V, 1990, EMBO J, V9, P3191, DOI 10.1002/j.1460-2075.1990.tb07517.x; Hulett JM, 2007, MOL BIOL EVOL, V24, P1909, DOI 10.1093/molbev/msm126; Iwahashi J, 1997, J BIOL CHEM, V272, P18467, DOI 10.1074/jbc.272.29.18467; Kanamori T, 1999, P NATL ACAD SCI USA, V96, P3634, DOI 10.1073/pnas.96.7.3634; KIEBLER M, 1993, CELL, V74, P483, DOI 10.1016/0092-8674(93)80050-O; Koehler CM, 2004, ANNU REV CELL DEV BI, V20, P309, DOI 10.1146/annurev.cellbio.20.010403.105057; Krimmer T, 2001, J CELL BIOL, V152, P289, DOI 10.1083/jcb.152.2.289; LITHGOW T, 1994, P NATL ACAD SCI USA, V91, P11973, DOI 10.1073/pnas.91.25.11973; LITHGOW T, 1995, J BIOL CHEM, V270, P14267, DOI 10.1074/jbc.270.24.14267; Lutz T, 2003, EMBO J, V22, P4400, DOI 10.1093/emboj/cdg421; MAYER A, 1995, EMBO J, V14, P4204, DOI 10.1002/j.1460-2075.1995.tb00094.x; MOCZKO M, 1993, FEBS LETT, V326, P251, DOI 10.1016/0014-5793(93)81801-6; Moczko M, 1997, MOL CELL BIOL, V17, P6574, DOI 10.1128/MCB.17.11.6574; Model K, 2001, NAT STRUCT BIOL, V8, P361, DOI 10.1038/86253; Muto T, 2001, J MOL BIOL, V306, P137, DOI 10.1006/jmbi.2000.4397; Nakai M, 1995, J BIOL CHEM, V270, P30571, DOI 10.1074/jbc.270.51.30571; NAKAI M, 1995, FEBS LETT, V357, P202; Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Obita T, 2003, J MOL BIOL, V328, P495, DOI 10.1016/S0022-2836(03)00288-2; Otera H, 2007, J CELL BIOL, V179, P1355, DOI 10.1083/jcb.200702143; PFALLER R, 1989, J BIOL CHEM, V264, P34; Pfanner N, 2000, CURR BIOL, V10, pR412, DOI 10.1016/S0960-9822(00)00507-8; Pfanner N, 2001, NAT REV MOL CELL BIO, V2, P339, DOI 10.1038/35073006; RAMAGE L, 1993, EMBO J, V12, P4115, DOI 10.1002/j.1460-2075.1993.tb06095.x; Rapaport D, 1997, J BIOL CHEM, V272, P18725, DOI 10.1074/jbc.272.30.18725; Rehling P, 2003, J MOL BIOL, V326, P639, DOI 10.1016/S0022-2836(02)01440-7; Saitoh T, 2007, EMBO J, V26, P4777, DOI 10.1038/sj.emboj.7601888; SOLLNER T, 1989, CELL, V59, P1061, DOI 10.1016/0092-8674(89)90762-9; SOLLNER T, 1990, CELL, V62, P107, DOI 10.1016/0092-8674(90)90244-9; STEGER HF, 1990, J CELL BIOL, V111, P2353, DOI 10.1083/jcb.111.6.2353; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Wiedemann N, 2004, J BIOL CHEM, V279, P14473, DOI 10.1074/jbc.R400003200; Wiedemann N, 2003, J MOL BIOL, V327, P465, DOI 10.1016/S0022-2836(03)00118-9; Yamano K, 2005, J BIOL CHEM, V280, P10011, DOI 10.1074/jbc.M413264200; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	47	102	102	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3799	3807		10.1074/jbc.M708339200	http://dx.doi.org/10.1074/jbc.M708339200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18063580	hybrid			2022-12-25	WOS:000253083500014
J	Erixon, P; Oxelman, B				Erixon, Per; Oxelman, Bengt			Whole-Gene Positive Selection, Elevated Synonymous Substitution Rates, Duplication, and Indel Evolution of the Chloroplast clpP1 Gene	PLOS ONE			English	Article							MOLECULAR ADAPTATION; GENOME SEQUENCE; MITOCHONDRIAL; NUCLEAR; FAMILY; CARYOPHYLLACEAE; PHYLOGENY; PROTEASES; PATTERNS; SEARCH	Background. Synonymous DNA substitution rates in the plant chloroplast genome are generally relatively slow and lineage dependent. Non-synonymous rates are usually even slower due to purifying selection acting on the genes. Positive selection is expected to speed up non-synonymous substitution rates, whereas synonymous rates are expected to be unaffected. Until recently, positive selection has seldom been observed in chloroplast genes, and large-scale structural rearrangements leading to gene duplications are hitherto supposed to be rare. Methodology/Principle Findings. We found high substitution rates in the exons of the plastid clpP1 gene in Oenothera(the Evening Primrose family) and three separate lineages in the tribe Sileneae (Caryophyllaceae, the Carnation family). Introns have been lost in some of the lineages, but where present, the intron sequences have substitution rates similar to those found in other introns of their genomes. The elevated substitution rates of clpP1 are associated with statistically significant whole-gene positive selection in three branches of the phylogeny. In two of the lineages we found multiple copies of the gene. Neighboring genes present in the duplicated fragments do not show signs of elevated substitution rates or positive selection. Although non-synonymous substitutions account for most of the increase in substitution rates, synonymous rates are also markedly elevated in some lineages. Whereas plant clpP1 genes experiencing negative (purifying) selection are characterized by having very conserved lengths, genes under positive selection often have large insertions of more or less repetitive amino acid sequence motifs. Conclusions/Significance. We found positive selection of the clpP1 gene in various plant lineages to correlated with repeated duplication of the clpP1 gene and surrounding regions, repetitive amino acid sequences, and increase in synonymous substitution rates. The present study sheds light on the controversial issue of whether negative or positive selection is to be expected after gene duplications by providing evidence for the latter alternative. The observed increase in synonymous substitution rates in some of the lineages indicates that the detection of positive selection may be obscured under such circumstances. Future studies are required to explore the functional significance of the large inserted repeated amino acid motifs, as well as the possibility that synonymous substitution rates may be affected by positive selection.	[Erixon, Per; Oxelman, Bengt] Uppsala Univ, Dept Systemat Bot, Evolutionary Biol Ctr, Uppsala, Sweden; [Erixon, Per; Oxelman, Bengt] Gothenburg Univ, Dept Plant & Env Sci, Gothenburg, Sweden	Uppsala University; University of Gothenburg	Erixon, P (corresponding author), Uppsala Univ, Dept Systemat Bot, Evolutionary Biol Ctr, Uppsala, Sweden.	per.erixon@ebc.uu.se	Oxelman, Bengt/F-2944-2010	Oxelman, Bengt/0000-0002-6104-4264	Linnaeus Centre for Bioinformatics; Uppsala University; Helge Ax:son Johnson foundation, the Nilsson-Ehle foundation, and the Royal Swedish Academy of Sciences; Swedish Research Council	Linnaeus Centre for Bioinformatics; Uppsala University; Helge Ax:son Johnson foundation, the Nilsson-Ehle foundation, and the Royal Swedish Academy of Sciences; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by grants from the Linnaeus Centre for Bioinformatics, Uppsala University, and by grants from the Helge Ax:son Johnson foundation, the Nilsson-Ehle foundation, and the Royal Swedish Academy of Sciences to PE and partly by a grant from the Swedish Research Council to BO	Adam Z, 2001, PLANT PHYSIOL, V125, P1912, DOI 10.1104/pp.125.4.1912; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gkw1070, 10.1093/nar/gkx1094, 10.1093/nar/gks1195, 10.1093/nar/gkr1202, 10.1093/nar/gkn723]; Cho Y, 2004, P NATL ACAD SCI USA, V101, P17741, DOI 10.1073/pnas.0408302101; Clarke AK, 1999, ANN BOT-LONDON, V83, P593, DOI 10.1006/anbo.1999.0878; CLEGG MT, 1994, P NATL ACAD SCI USA, V91, P6795, DOI 10.1073/pnas.91.15.6795; de Cambiaire JC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-37; Endo T, 1996, MOL BIOL EVOL, V13, P685, DOI 10.1093/oxfordjournals.molbev.a025629; ERIXON P, 2006, THESIS UPPSALA U; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Johnson ME, 2001, NATURE, V413, P514, DOI 10.1038/35097067; Kapralov MV, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000008; Kapralov MV, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-73; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Levin RA, 2004, SYST BOT, V29, P147, DOI 10.1600/036364404772974293; MacCallum C, 2006, PLOS BIOL, V4, P293, DOI 10.1371/journal.pbio.0040087; Muse SV, 1997, GENETICS, V146, P393; OHTA T, 1993, GENETICS, V134, P1271; OLMSTEAD RG, 1999, SOLANACEAE, V4, P111; Oxelman B, 1997, PLANT SYST EVOL, V206, P393, DOI 10.1007/BF00987959; OXELMAN B, 1995, TAXON, V44, P525, DOI 10.2307/1223498; Oxelman B, 2000, NORD J BOT, V20, P743, DOI 10.1111/j.1756-1051.2000.tb00760.x; Popp M, 2004, SYST BIOL, V53, P914, DOI 10.1080/10635150490888840; Rambaut A, 1997, COMPUT APPL BIOSCI, V13, P235; Raubeson L. A., 2005, Plant diversity and evolution: genotypic and phenotypic variation in higher plants, P45, DOI 10.1079/9780851999043.0045; Roth C, 2006, BMC PLANT BIOL, V6, DOI 10.1186/1471-2229-6-12; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shikanai T, 2001, PLANT CELL PHYSIOL, V42, P264, DOI 10.1093/pcp/pce031; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; USA The Angiosperm Phylogeny Group, 2003, Botanical Journal of the Linnean Society, V141, P399, DOI 10.1046/j.1095-8339.2003.t01-1-00158.x; Wojciechowski MF, 2004, AM J BOT, V91, P1846, DOI 10.3732/ajb.91.11.1846; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Xing Y, 2005, P NATL ACAD SCI USA, V102, P13526, DOI 10.1073/pnas.0501213102; Yang ZH, 2002, MOL BIOL EVOL, V19, P908, DOI 10.1093/oxfordjournals.molbev.a004148; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zhang JZ, 2004, MOL BIOL EVOL, V21, P1332, DOI 10.1093/molbev/msh117; Zhang JZ, 1998, P NATL ACAD SCI USA, V95, P3708, DOI 10.1073/pnas.95.7.3708	40	102	107	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1386	10.1371/journal.pone.0001386	http://dx.doi.org/10.1371/journal.pone.0001386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167545	Green Submitted, Green Published, gold			2022-12-25	WOS:000260468900014
J	Liu, CL; Xie, LX; Li, M; Durairajan, SSK; Goto, S; Huang, JD				Liu, Chen-Li; Xie, Li-Xia; Li, Min; Durairajan, Siva Sundara Kumar; Goto, Shinya; Huang, Jian-Dong			Salvianolic Acid B Inhibits Hydrogen Peroxide-Induced Endothelial Cell Apoptosis through Regulating PI3K/Akt Signaling	PLOS ONE			English	Article								Background. Salvianolic acid B (Sal B) is one of the most bioactive components of Salvia miltiorrhiza, a traditional Chinese herbal medicine that has been commonly used for prevention and treatment of cerebrovascular disorders. However, the mechanism responsible for such protective effects remains largely unknown. It has been considered that cerebral endothelium apoptosis caused by reactive oxygen species including hydrogen peroxide (H2O2) is implicated in the pathogenesis of cerebrovascular disorders. Methodology and Principal Findings. By examining the effect of Sal B on H2O2-induced apoptosis in rat cerebral microvascular endothelial cells (rCMECs), we found that Sal B pretreatment significantly attenuated H2O2-induced apoptosis in rCMECs. We next examined the signaling cascade(s) involved in Sal B-mediated anti-apoptotic effects. We showed that H2O2 induces rCMECs apoptosis mainly through the PI3K/ERK pathway, since a PI3K inhibitor (LY294002) blocked ERK activation caused by H2O2 and a specific inhibitor of MEK (U0126) protected cells from apoptosis. On the other hand, blockage of the PI3K/Akt pathway abrogated the protective effect conferred by Sal B and potentated H2O2-induced apoptosis, suggesting that Sal B prevents H2O2-induced apoptosis predominantly through the PI3K/Akt (upstream of ERK) pathway. Significance. Our findings provide the first evidence that H2O2 induces rCMECs apoptosis via the PI3K/MEK/ERK pathway and that Sal B protects rCMECs against H2O2-induced apoptosis through the PI3K/Akt/Raf/MEK/ ERK pathway.	[Liu, Chen-Li; Xie, Li-Xia; Li, Min; Durairajan, Siva Sundara Kumar] Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China; [Liu, Chen-Li; Huang, Jian-Dong] Univ Hong Kong, Dept Biochem, Li Ka Shing Fac Med, Hong Kong, Hong Kong, Peoples R China; [Goto, Shinya] Tokai Univ, Sch Med, Dept Med, Hiratsuka, Kanagawa 25912, Japan	Hong Kong Baptist University; University of Hong Kong; Tokai University	Li, M (corresponding author), Hong Kong Baptist Univ, Sch Chinese Med, Hong Kong, Hong Kong, Peoples R China.	limin@hkbu.edu.hk; jdhuang@hkucc.hku.hk	Xie, li/HGE-6052-2022; Durairajan, Siva Sundara Kumar/AAW-4617-2020; Goto, Shinya/AAU-6045-2020; /C-4277-2009	Durairajan, Siva Sundara Kumar/0000-0001-7376-7163; Goto, Shinya/0000-0002-6821-1504; /0000-0001-7531-2816; Li, Min/0000-0002-7113-2700	Research Grant Council of Hong Kong [HKU 7636/05M]; Hong Kong Baptist University [FRG/06-07/I-07, FRG/06-07/II-43]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council); Hong Kong Baptist University	This work was supported by a grant (HKU 7636/05M) from the Research Grant Council of Hong Kong awarded to Dr. J.D. Huang, and was also supported by grants (FRG/06-07/I-07 and FRG/06-07/II-43) from Hong Kong Baptist University awarded to Dr. M. Li. The funders had no roles in the design and conduct of the study, in the collection, analysis, and interpretation of the data, and in the preparation, review, or approval of the manuscript.	Abe J, 1998, TRENDS CARDIOVAS MED, V8, P59, DOI 10.1016/S1050-1738(97)00133-3; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Blanc A, 2003, INT J MOL MED, V11, P229; Boatright KM, 2003, CURR OPIN CELL BIOL, V15, P725, DOI 10.1016/j.ceb.2003.10.009; Bresgen N, 2003, J NEUROSCI RES, V72, P327, DOI 10.1002/jnr.10582; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen YH, 2000, ACTA PHARMACOL SIN, V21, P463; Chen YL, 2006, J CELL BIOCHEM, V98, P618, DOI 10.1002/jcb.20793; Cheng Yang, 2006, Chin J Integr Med, V12, P207; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Ding M, 2005, INT IMMUNOPHARMACOL, V5, P1641, DOI 10.1016/j.intimp.2005.05.005; Du GH, 2000, J ASIAN NAT PROD RES, V2, P145, DOI 10.1080/10286020008039903; Fadeel B, 2005, J INTERN MED, V258, P479, DOI 10.1111/j.1365-2796.2005.01570.x; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fischer S, 2005, EUR J CELL BIOL, V84, P687, DOI 10.1016/j.ejcb.2005.03.002; Fujimura M, 1998, J CEREBR BLOOD F MET, V18, P1239, DOI 10.1097/00004647-199811000-00010; HASHIMOTO Y, 1994, J SURG RES, V57, P693, DOI 10.1006/jsre.1994.1203; Jiang RW, 2005, CURR MED CHEM, V12, P237, DOI 10.2174/0929867053363397; Kontos CD, 2002, MOL CELL BIOL, V22, P1704, DOI 10.1128/MCB.22.6.1704-1713.2002; Lackey K, 2000, BIOORG MED CHEM LETT, V10, P223, DOI 10.1016/S0960-894X(99)00668-X; Lee JS, 2006, ARCH TOXICOL, V80, P337, DOI 10.1007/s00204-005-0052-2; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin SJ, 2007, J CELL BIOCHEM, V100, P372, DOI 10.1002/jcb.21042; Mehta SL, 2007, BRAIN RES REV, V54, P34, DOI 10.1016/j.brainresrev.2006.11.003; Nohl H, 2003, BIOCHEM SOC T, V31, P1308; Ohashi H, 2004, CIRC RES, V94, P785, DOI 10.1161/01.RES.0000121103.03275.EC; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; SAMBROOK J, 1993, MOL CLONING LAB MANU, P888; Schmidt EK, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-7; Shi LG, 2006, CHINESE MED J-PEKING, V119, P725, DOI 10.1097/00029330-200605010-00004; Sinha D, 2004, J BIOL CHEM, V279, P10962, DOI 10.1074/jbc.M312048200; Slee EA, 1996, BIOCHEM J, V315, P21, DOI 10.1042/bj3150021; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Stein RC, 2000, MOL MED TODAY, V6, P347, DOI 10.1016/S1357-4310(00)01770-6; Tang MK, 2006, BEHAV PHARMACOL, V17, P493, DOI 10.1097/00008877-200609000-00015; Tang MK, 2002, PHYTOMEDICINE, V9, P405, DOI 10.1078/09447110260571634; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang J, 2006, FEBS LETT, V580, P2779, DOI 10.1016/j.febslet.2006.04.041; Warner TD, 1999, CLIN EXP PHARMACOL P, V26, P247, DOI 10.1046/j.1440-1681.1999.03025.x; Watanabe N, 2006, AM J PATHOL, V168, P1737, DOI 10.2353/ajpath.2006.050648; Watzke A, 2006, J NAT PROD, V69, P1231, DOI 10.1021/np060136w; Xiao XQ, 2000, NEUROSCI LETT, V290, P197, DOI 10.1016/S0304-3940(00)01357-4; Yang BH, 2006, FASEB J, V20, P1501, DOI 10.1096/fj.05-5359fje; Yang JY, 2004, BIOCHEM PHARMACOL, V68, P1027, DOI 10.1016/j.bcp.2004.03.043; Zhang JJ, 2000, BRAIN RES, V877, P134, DOI 10.1016/S0006-8993(00)02666-4; Zhang YH, 2007, AM J PHYSIOL-HEART C, V292, pH2573, DOI 10.1152/ajpheart.01098.2006; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zhuang SG, 2007, AM J PHYSIOL-RENAL, V292, pF440, DOI 10.1152/ajprenal.00170.2006; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016	51	77	87	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1321	10.1371/journal.pone.0001321	http://dx.doi.org/10.1371/journal.pone.0001321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091994	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459600009
J	Ordway, JM; Budiman, MA; Korshunova, Y; Maloney, RK; Bedell, JA; Citek, RW; Bacher, B; Peterson, S; Rohlfing, T; Hall, J; Brown, R; Lakey, N; Doerge, RW; Martienssen, RA; Leon, J; McPherson, JD; Jeddeloh, JA				Ordway, Jared M.; Budiman, Muhammad A.; Korshunova, Yulia; Maloney, Rebecca K.; Bedell, Joseph A.; Citek, Robert W.; Bacher, Blaire; Peterson, Seth; Rohlfing, Tracy; Hall, Jacqueline; Brown, Robert; Lakey, Nathan; Doerge, Rebecca W.; Martienssen, Robert A.; Leon, Jorge; McPherson, John D.; Jeddeloh, Jeffrey A.			Identification of Novel High-Frequency DNA Methylation Changes in Breast Cancer	PLOS ONE			English	Article								Recent data have revealed that epigenetic alterations, including DNA methylation and chromatin structure changes, are among the earliest molecular abnormalities to occur during tumorigenesis. The inherent thermodynamic stability of cytosine methylation and the apparent high specificity of the alterations for disease may accelerate the development of powerful molecular diagnostics for cancer. We report a genome-wide analysis of DNA methylation alterations in breast cancer. The approach efficiently identified a large collection of novel differentially DNA methylated loci (, 200), a subset of which was independently validated across a panel of over 230 clinical samples. The differential cytosine methylation events were independent of patient age, tumor stage, estrogen receptor status or family history of breast cancer. The power of the global approach for discovery is underscored by the identification of a single differentially methylated locus, associated with the GHSR gene, capable of distinguishing infiltrating ductal breast carcinoma from normal and benign breast tissues with a sensitivity and specificity of 90% and 96%, respectively. Notably, the frequency of these molecular abnormalities in breast tumors substantially exceeds the frequency of any other single genetic or epigenetic change reported to date. The discovery of over 50 novel DNA methylation-based biomarkers of breast cancer may provide new routes for development of DNA methylation-based diagnostics and prognostics, as well as reveal epigenetically regulated mechanism involved in breast tumorigenesis.	[Ordway, Jared M.; Budiman, Muhammad A.; Korshunova, Yulia; Maloney, Rebecca K.; Bedell, Joseph A.; Citek, Robert W.; Bacher, Blaire; Peterson, Seth; Rohlfing, Tracy; Lakey, Nathan; Leon, Jorge; Jeddeloh, Jeffrey A.] Orion Genom, St Louis, MO USA; [Hall, Jacqueline] McGill Univ, Ctr Bioinformat, Montreal, PQ, Canada; [Brown, Robert] Univ London Imperial Coll Sci Technol & Med, Hammersmith Hosp, London, England; [Doerge, Rebecca W.] Purdue Univ, Dept Agron, Lafayette, IN USA; [Doerge, Rebecca W.] Purdue Univ, Dept Stat, Lafayette, IN USA; [Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [McPherson, John D.] Ontario Inst Canc Res, Toronto, ON, Canada	McGill University; Imperial College London; Purdue University System; Purdue University; Purdue University System; Purdue University; Cold Spring Harbor Laboratory; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Ordway, JM (corresponding author), Orion Genom, St Louis, MO USA.	jordway@oriongenomics.com	McPherson, John D/D-2633-2017	McPherson, John D/0000-0001-8049-9347; Hall, Jacqueline/0000-0003-0708-1360; Brown, Robert/0000-0001-7960-5755				Akashi M, 1998, CLIN OBSTET GYNECOL, V41, P172, DOI 10.1097/00003081-199803000-00024; Barzon L, 2005, ONCOLOGY-BASEL, V68, P414, DOI 10.1159/000086983; CHOI YC, 1991, J BIOL CHEM, V266, P20504; Chrzan P, 2001, CLIN BIOCHEM, V34, P557, DOI 10.1016/S0009-9120(01)00260-0; COLDITZ GA, 1993, JAMA-J AM MED ASSOC, V270, P338, DOI 10.1001/jama.270.3.338; COLES C, 1992, CANCER RES, V52, P5291; Deming SL, 2000, BRIT J CANCER, V83, P1688, DOI 10.1054/bjoc.2000.1522; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Fackler MJ, 2004, CANCER RES, V64, P4442, DOI 10.1158/0008-5472.CAN-03-3341; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; FROMMER M, 1992, P NATL ACAD SCI USA, V89, P1827, DOI 10.1073/pnas.89.5.1827; Grandori C, 2000, ANNU REV CELL DEV BI, V16, P653, DOI 10.1146/annurev.cellbio.16.1.653; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Hoque MO, 2006, J CLIN ONCOL, V24, P4262, DOI 10.1200/JCO.2005.01.3516; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hurlin PJ, 2006, SEMIN CANCER BIOL, V16, P265, DOI 10.1016/j.semcancer.2006.07.009; Jeffery PL, 2005, ENDOCR-RELAT CANCER, V12, P839, DOI 10.1677/erc.1.00984; Jeffery PL, 2003, CYTOKINE GROWTH F R, V14, P113, DOI 10.1016/S1359-6101(02)00089-8; JOHNSON N, 1995, FAM PRACT, V12, P287, DOI 10.1093/fampra/12.3.287; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Kerlikowske K, 1996, JAMA-J AM MED ASSOC, V276, P39, DOI 10.1001/jama.276.1.39; KORSHUNOVA K, GENOME RES IN PRESS; Kriege M, 2004, NEW ENGL J MED, V351, P427, DOI 10.1056/NEJMoa031759; Linke SP, 2006, CLIN CANCER RES, V12, P1175, DOI 10.1158/1078-0432.CCR-05-1562; Lippman Z, 2005, NAT METHODS, V2, P219, DOI 10.1038/nmeth0305-219; Lippman Z, 2004, NATURE, V430, P471, DOI 10.1038/nature02651; McKee KK, 1997, MOL ENDOCRINOL, V11, P415, DOI 10.1210/me.11.4.415; MIKI Y, 1994, SCIENCE, V266, P66, DOI 10.1126/science.7545954; Miller AB, 2002, ANN INTERN MED, V137, P305, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00005; Miyamoto K, 2005, JPN J CLIN ONCOL, V35, P293, DOI 10.1093/jjco/hyi088; Naidu R, 2002, INT J MOL MED, V9, P189; Nystrom L, 2002, LANCET, V359, P909, DOI 10.1016/S0140-6736(02)08020-0; Ogawa H, 2002, SCIENCE, V296, P1132, DOI 10.1126/science.1069861; Ordway JM, 2006, CARCINOGENESIS, V27, P2409, DOI 10.1093/carcin/bgl161; Ordway JM, 2005, BIOTECHNIQUES, V39, P464, DOI 10.2144/000112035; Petersenn S, 2001, ENDOCRINOLOGY, V142, P2649, DOI 10.1210/en.142.6.2649; Renwick A, 2006, NAT GENET, V38, P873, DOI 10.1038/ng1837; Rosenberg RD, 1998, RADIOLOGY, V209, P511, DOI 10.1148/radiology.209.2.9807581; Scorilas A, 1999, BRIT J CANCER, V81, P1385, DOI 10.1038/sj.bjc.6693404; Seal S, 2006, NAT GENET, V38, P1239, DOI 10.1038/ng1902; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; SLATTERY ML, 1993, JAMA-J AM MED ASSOC, V270, P1563, DOI 10.1001/jama.270.13.1563; Ting AH, 2006, GENE DEV, V20, P3215, DOI 10.1101/gad.1464906; Weischer M, 2007, J CLIN ONCOL, V25, P57, DOI 10.1200/JCO.2005.05.5160; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; WOOSTER R, 1995, NATURE, V378, P789, DOI 10.1038/378789a0; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zahl PH, 2004, BMJ-BRIT MED J, V328, P921, DOI 10.1136/bmj.38044.666157.63	49	84	90	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1314	10.1371/journal.pone.0001314	http://dx.doi.org/10.1371/journal.pone.0001314			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091988	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000207459600002
J	Geserick, P; Drewniok, C; Hupe, M; Haas, TL; Diessenbacher, P; Sprick, MR; Schon, MP; Henkler, F; Gollnick, H; Walczak, H; Leverkus, M				Geserick, P.; Drewniok, C.; Hupe, M.; Haas, T. L.; Diessenbacher, P.; Sprick, M. R.; Schoen, M. P.; Henkler, F.; Gollnick, H.; Walczak, H.; Leverkus, M.			Suppression of cFLIP is sufficient to sensitize human melanoma cells to TRAIL- and CD95L-mediated apoptosis	ONCOGENE			English	Article						apoptosis; TRAIL; cFLIP; TRAIL-R1; TRAIL-R2; melanoma	NF-KAPPA-B; RECEPTOR-SELECTIVE MUTANTS; DOWN-REGULATION; DEATH RECEPTORS; UP-REGULATION; BCL-2 FAMILY; LIGAND; EXPRESSION; CASPASE-8; RESISTANCE	Death ligands such as tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and certain forms of CD95L are attractive therapeutic options for metastatic melanoma. Since knowledge about the regulation of death receptor sensitivity in melanoma is sparse, we have analysed these signaling pathways in detail. The loss of CD95 or TRAIL-R1, but not of TRAIL-R2, surface expression correlated with apoptosis sensitivity in a panel of melanoma cell lines. In contrast, the expression of proteins of the apical apoptosis signaling cascade (FADD, initiator caspases-8 and cFLIP) did not predict apoptosis sensitivity. Since both TRAIL-R1 and -R2 transmit apoptotic signals, we asked whether cFLIP, highly expressed in several of the cell lines tested, is sufficient to maintain resistance to TRAIL-R2-mediated apoptosis. Downregulation of cFLIP in TRAIL-R2-positive, TRAIL-resistant IGR cells dramatically increased TRAIL sensitivity. Conversely ectopic expression of cFLIP in TRAIL-sensitive, TRAIL-R2-expressing RPM-EP melanoma cells inhibited TRAIL- and CD95L- mediated cell death. Thus, modulation of cFLIP is sufficient to sensitize TRAIL-R2-expressing cells for TRAIL. Taken together, albeit expressing all proteins necessary for death receptor-mediated apoptosis, TRAIL-R1 negative melanoma cells cannot undergo TRAIL- or CD95L-induced apoptosis due to expression of cFLIP. Hence, cFLIP represents an attractive therapeutic target for melanoma treatment, especially in combination with TRAIL receptor agonists.	[Geserick, P.; Drewniok, C.; Hupe, M.; Diessenbacher, P.; Gollnick, H.; Leverkus, M.] Otto von Guericke Univ, Lab Expt Dermatol, Dept Dermatol & Venerol, D-39120 Magdeburg, Saxonia Anhalt, Germany; [Haas, T. L.; Sprick, M. R.; Walczak, H.] German Canc Res Ctr, Dept Apoptosis Regulat, D-6900 Heidelberg, Germany; [Sprick, M. R.] Acad Med Centrum UVA, Lab Expt Oncol & Radiat, Amsterdam, Netherlands; [Schoen, M. P.] Univ Wurzburg, DFG Res Ctr Expt Biomed, Rudolf Virchow Ctr, Wurzburg, Germany; [Schoen, M. P.] Univ Wurzburg, Dept Dermatol Venerol & Allergol, Wurzburg, Germany; [Henkler, F.] Univ Wurzburg, Med Policlin, Wurzburg, Germany	Otto von Guericke University; Helmholtz Association; German Cancer Research Center (DKFZ); University of Amsterdam; Academic Medical Center Amsterdam; German Research Foundation (DFG); University of Wurzburg; University of Wurzburg; University of Wurzburg	Leverkus, M (corresponding author), Otto von Guericke Univ, Lab Expt Dermatol, Dept Dermatol & Venerol, Leipziger St 44, D-39120 Magdeburg, Saxonia Anhalt, Germany.	leverkus@medizin.uni-magdeburg.de	Sprick, Martin R./I-7995-2019; Sprick, Martin R./A-8611-2008; Walczak, Henning/AAV-2214-2020	Sprick, Martin R./0000-0001-9691-7574; Sprick, Martin R./0000-0001-9691-7574; Walczak, Henning/0000-0002-6312-4591; Hupe, Mike/0000-0002-7735-2958; Haas, Tobias/0000-0003-2336-0263				Allen JD, 2005, CELL DEATH DIFFER, V12, P680, DOI 10.1038/sj.cdd.4401634; Bae SI, 2008, ONCOGENE, V27, P490, DOI 10.1038/sj.onc.1210655; Buchsbaum Donald J, 2007, Future Oncol, V3, P405, DOI 10.2217/14796694.3.4.405; BYERS HR, 1991, AM J PATHOL, V139, P423; Chawla-Sarkar M, 2004, CELL DEATH DIFFER, V11, P915, DOI 10.1038/sj.cdd.4401416; Diessenbacher P, 2008, J INVEST DERMATOL, V128, P1134, DOI 10.1038/sj.jid.5701141; Falschlehner C, 2007, INT J BIOCHEM CELL B, V39, P1462, DOI 10.1016/j.biocel.2007.02.007; Fecker LF, 2006, J INVEST DERMATOL, V126, P1366, DOI 10.1038/sj.jid.5700192; Fulda S, 2001, ONCOGENE, V20, P5865, DOI 10.1038/sj.onc.1204750; Golks A, 2005, J BIOL CHEM, V280, P14507, DOI 10.1074/jbc.M414425200; Golks A, 2006, J EXP MED, V203, P1295, DOI 10.1084/jem.20051556; Griffith TS, 1998, J IMMUNOL, V161, P2833; Hamai A, 2006, ONCOGENE, V25, P7618, DOI 10.1038/sj.onc.1209738; Hymowitz SG, 2005, NAT CHEM BIOL, V1, P353, DOI 10.1038/nchembio1205-353; Ivanov VN, 2006, EXP CELL RES, V312, P4120, DOI 10.1016/j.yexcr.2006.09.019; Ivanov VN, 2003, ONCOGENE, V22, P3152, DOI 10.1038/sj.onc.1206456; Karst AM, 2007, CELL MOL LIFE SCI, V64, P318, DOI 10.1007/s00018-006-6364-4; Kataoka T, 2005, CRIT REV IMMUNOL, V25, P31, DOI 10.1615/CritRevImmunol.v25.i1.30; Kelley RF, 2005, J BIOL CHEM, V280, P2205, DOI 10.1074/jbc.M410660200; Kimberley FC, 2004, CELL RES, V14, P359, DOI 10.1038/sj.cr.7290236; Krueger A, 2001, J BIOL CHEM, V276, P20633, DOI 10.1074/jbc.M101780200; Kurbanov BM, 2007, ONCOGENE, V26, P3364, DOI 10.1038/sj.onc.1210134; Lavrik I, 2003, CELL DEATH DIFFER, V10, P144, DOI 10.1038/sj.cdd.4401156; Leverkus M, 2000, CANCER RES, V60, P553; Leverkus M, 2003, J INVEST DERMATOL, V121, P149, DOI 10.1046/j.1523-1747.2003.12332.x; Leverkus M, 2003, MOL CELL BIOL, V23, P777, DOI 10.1128/MCB.23.3.777-790.2003; MacFarlane M, 2005, CANCER RES, V65, P11265, DOI 10.1158/0008-5472.CAN-05-2801; Meng XW, 2006, CURR OPIN CELL BIOL, V18, P668, DOI 10.1016/j.ceb.2006.10.008; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Muhlenbeck F, 2000, J BIOL CHEM, V275, P32208, DOI 10.1074/jbc.M000482200; Naito M, 2004, MOL CELL BIOL, V24, P8418, DOI 10.1128/MCB.24.19.8418-8427.2004; Natoni A, 2007, BRIT J HAEMATOL, V139, P568, DOI 10.1111/j.1365-2141.2007.06852.x; Neise D, 2008, ONCOGENE, V27, P1387, DOI 10.1038/sj.onc.1210773; Nguyen T, 2001, CLIN CANCER RES, V7, p966S; Peltenburg LTC, 2005, CELL DEATH DIFFER, V12, P678, DOI 10.1038/sj.cdd.4401630; Peter ME, 2007, CELL, V129, P447, DOI 10.1016/j.cell.2007.04.031; Rudner J, 2005, ONCOGENE, V24, P130, DOI 10.1038/sj.onc.1208191; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Sprick MR, 2004, BBA-MOL CELL RES, V1644, P125, DOI 10.1016/j.bbamcr.2003.11.002; Takeda K, 2007, ONCOGENE, V26, P3745, DOI 10.1038/sj.onc.1210374; Trauzold A, 2006, ONCOGENE, V25, P7434, DOI 10.1038/sj.onc.1209719; Van der Sloot AM, 2006, P NATL ACAD SCI USA, V103, P8634, DOI 10.1073/pnas.0510187103; Wachter T, 2004, J BIOL CHEM, V279, P52824, DOI 10.1074/jbc.M409554200; Wendt J, 2005, ONCOGENE, V24, P4052, DOI 10.1038/sj.onc.1208580; Zhang XD, 1999, CANCER RES, V59, P2747; Zhuang LQ, 2006, HUM PATHOL, V37, P1286, DOI 10.1016/j.humpath.2006.04.026	46	82	87	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY	2008	27	22					3211	3220		10.1038/sj.onc.1210985	http://dx.doi.org/10.1038/sj.onc.1210985			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	301LL	18084329				2022-12-25	WOS:000255897600014
J	Okano, T; Shimomura, Y; Yamane, M; Suhara, Y; Kamao, M; Sugiura, M; Nakagawa, K				Okano, Toshio; Shimomura, Yuka; Yamane, Makiko; Suhara, Yoshitomo; Kamao, Maya; Sugiura, Makiko; Nakagawa, Kimie			Conversion of phylloquinone (vitamin K-1) into menaquinone-4 (vitamin K-2) in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-DEPENDENT CARBOXYLASE; BLOOD-COAGULATION; DIETARY PHYLLOQUINONE; TISSUE MENAQUINONE-4; GAMMA-CARBOXYLATION; PRIMARY CULTURES; METABOLISM; RATS; PROTEINS; ACCUMULATION	There are two forms of naturally occurring vitamin K, phylloquinone and the menaquinones. Phylloquinone (vitamin K-1) is a major type (>90%) of dietary vitamin K, but its concentrations in animal tissues are remarkably low compared with those of the menaquinones, especially menaquinone-4 (vitamin K-2), the major form (>90%) of vitamin K in tissues. Despite this great difference, the origin of tissue menaquinone-4 has yet to be exclusively defined. It is postulated that phylloquinone is converted into menaquinone-4 and accumulates in extrahepatic tissues. To clarify this, phylloquinone with a deuterium-labeled 2-methyl- 1,4-naphthoquinone ring was given orally to mice, and cerebra were collected for D NMR and liquid chromatography-tandem mass spectrometry analyses. We identified the labeled menaquinone-4 that was converted from the given phylloquinone, and this conversion occurred following an oral or enteral administration, but not parenteral or intracerebroventricular administration. By the oral route, the phylloquinone with the deuterium-labeled side chain in addition to the labeled 2-methyl- 1,4-naphthoquinone was clearly converted into a labeled menaquinone-4 with a non-deuterium-labeled side chain, implying that phylloquinone was converted into menaquinone-4 via integral side-chain removal. The conversion also occurred in cerebral slice cultures and primary cultures. Deuterium-labeled menadione was consistently converted into the labeled menaquinone-4 with all of the administration routes and the culture conditions tested. Our results suggest that cerebral menaquinone-4 originates from phylloquinone intake and that there are two routes of accumulation, one is the release of menadione from phylloquinone in the intestine followed by the prenylation of menadione into menaquinone-4 in tissues, and another is cleavage and prenylation within the cerebrum.	[Okano, Toshio; Shimomura, Yuka; Yamane, Makiko; Suhara, Yoshitomo; Kamao, Maya; Nakagawa, Kimie] Kobe Pharmaceut Univ, Dept Hygn Sci, Higashinada Ku, Kobe, Hyogo 6588558, Japan; [Sugiura, Makiko] Kobe Pharmaceut Univ, Analyt Ctr, Kobe, Hyogo 6588558, Japan	Kobe Pharmaceutical University; Kobe Pharmaceutical University	Okano, T (corresponding author), Kobe Pharmaceut Univ, Dept Hygn Sci, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	t-okano@kobepharma-u.ac.jp		Suhara, Yoshitomo/0000-0002-4770-2910				Benzakour O, 2000, BLOOD, V95, P2008, DOI 10.1182/blood.V95.6.2008; BILLETER M, 1960, BIOCHEM Z, V333, P430; Bristol JA, 1996, BLOOD, V88, P2585, DOI 10.1182/blood.V88.7.2585.bloodjournal8872585; CARLISLE TL, 1980, BIOCHEMISTRY-US, V19, P1161, DOI 10.1021/bi00547a019; Davidson RT, 1998, J NUTR, V128, P220, DOI 10.1093/jn/128.2.220; FABRE M, 1985, DEV NEUROSCI-BASEL, V7, P323, DOI 10.1159/000112300; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; FURIE B, 1992, NEW ENGL J MED, V326, P800; Huber AM, 1999, J NUTR, V129, P1039, DOI 10.1093/jn/129.5.1039; Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200; JOLLY DW, 1977, AM J PHYSIOL, V232, pH12, DOI 10.1152/ajpheart.1977.232.1.H12; LOSITO R, 1967, BIOCHEMISTRY-US, V6, P62, DOI 10.1021/bi00853a012; MAINS RE, 1973, J CELL BIOL, V59, P329, DOI 10.1083/jcb.59.2.329; MARY E, 1981, J CELL BIOL, V90, P622; METTA VC, 1960, J NUTR, V72, P455, DOI 10.1093/jn/72.4.455; PRICE PA, 1988, ANNU REV NUTR, V8, P565, DOI 10.1146/annurev.nu.08.070188.003025; RODEN JE, 1998, BIOCHIM BIOPHYS ACTA, V1379, P69; SEEGERS WH, 1965, THROMB DIATH HAEMOST, V14, P213; Servitja JM, 2000, J NEUROCHEM, V75, P788, DOI 10.1046/j.1471-4159.2000.0750788.x; Shanahan CM, 1998, CRIT REV EUKAR GENE, V8, P357, DOI 10.1615/CritRevEukarGeneExpr.v8.i3-4.60; Shearer M J, 1974, Vitam Horm, V32, P513; Stafford DW, 2005, J THROMB HAEMOST, V3, P1873, DOI 10.1111/j.1538-7836.2005.01419.x; Suhara Y, 2005, ANAL CHEM, V77, P757, DOI 10.1021/ac0489667; Suhara Y, 2006, BIOORGAN MED CHEM, V14, P6601, DOI 10.1016/j.bmc.2006.06.004; SUTTIE JW, 1995, ANNU REV NUTR, V15, P399, DOI 10.1146/annurev.nu.15.070195.002151; SUTTIE JW, 1980, CRC CR REV BIOCH MOL, V8, P191, DOI 10.3109/10409238009105469; TAGGART WV, 1969, BIOCHEMISTRY-US, V8, P1141, DOI 10.1021/bi00831a047; Thijssen HHW, 2006, BRIT J NUTR, V95, P260, DOI 10.1079/BJN20051630; Thijssen HHW, 1996, BRIT J NUTR, V75, P121, DOI 10.1079/BJN19960115; THIJSSEN HHW, 1994, BRIT J NUTR, V72, P415, DOI 10.1079/BJN19940043; Thijssen HHW, 1996, J NUTR, V126, P537, DOI 10.1093/jn/126.2.537; Tsaioun KI, 1999, NUTR REV, V57, P231, DOI 10.1111/j.1753-4887.1999.tb06950.x; Wallin R, 2004, TRENDS MOL MED, V10, P299, DOI 10.1016/j.molmed.2004.05.003; WILL BH, 1992, J NUTR, V122, P2354, DOI 10.1093/jn/122.12.2354	34	176	190	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 25	2008	283	17					11270	11279		10.1074/jbc.M702971200	http://dx.doi.org/10.1074/jbc.M702971200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	289PW	18083713	hybrid			2022-12-25	WOS:000255067400023
J	Harper, SM; Wienk, H; Wechselberger, RW; Bos, JL; Boelens, R; Rehmann, H				Harper, Shannon M.; Wienk, Hans; Wechselberger, Rainer W.; Bos, Johannes L.; Boelens, Rolf; Rehmann, Holger			Structural dynamics in the activation of Epac	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; REGULATORY SUBUNIT; CRYSTAL-STRUCTURE; BINDING DOMAINS; CHEMICAL-SHIFT; CAMP; ANCIENT; MUTANT	Epac1 is a cAMP-responsive exchange factor for the small G-protein Rap. It consists of a regulatory region containing a cyclic nucleotide binding (CNB) domain and a catalytic region that activates Rap. In the absence of cAMP, access of Rap to the catalytic site is blocked by the regulatory region. We analyzed the conformational states of the CNB domain in the absence and in the presence of cAMP and cAMP analogues by NMR spectroscopy, resulting in the first direct insights into the activation mechanism of Epac. We prove that the CNB domain exists in equilibrium between the inactive and the active conformation, which is shifted by binding of cAMP. cAMP binding results in conformational changes in both the ligand binding pocket and the outer helical segments. We used two different cAMP antagonists that block these successive changes to elucidate the steps of this process. Highlighting the role of dynamics, the superactivator 8-pCPT-'-O-Me-cAMP induces similar conformational changes as cAMP but causes different internal mobility. The results reveal the critical elements of the CNB domain of Epac required for activation and highlight the role of dynamics in this process.	[Wienk, Hans; Wechselberger, Rainer W.; Boelens, Rolf] Univ Utrecht, Bijvoet Ctr Biomol Res, NMR Spect, NL-3584 CG Utrecht, Netherlands; [Harper, Shannon M.; Bos, Johannes L.; Rehmann, Holger] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands; [Harper, Shannon M.; Bos, Johannes L.; Rehmann, Holger] Univ Med Ctr Utrecht, Ctr Biomed Genet, NL-3584 CG Utrecht, Netherlands	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Boelens, R (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, NMR Spect, Padualaan 8, NL-3584 CG Utrecht, Netherlands.	r.boelens@chem.uu.nl; h.rehmann@UMCutrecht.nl	Boelens, Rolf/B-4702-2009; Wienk, Hans/P-8929-2015	Boelens, Rolf/0000-0002-6939-8913; Wienk, Hans/0000-0001-9577-0064				Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bos JL, 2003, NAT REV MOL CELL BIO, V4, P733, DOI 10.1038/nrm1197; Bos JL, 2006, TRENDS BIOCHEM SCI, V31, P680, DOI 10.1016/j.tibs.2006.10.002; Brock M, 2007, J BIOL CHEM, V282, P32256, DOI 10.1074/jbc.M706231200; Canaves JM, 2002, J MOL EVOL, V54, P17, DOI 10.1007/s00239-001-0013-1; CAVANAGH J, 2007, PROTEIN NMR SPECTROC; Christopoulos A, 2003, J BIOL CHEM, V278, P3293, DOI 10.1074/jbc.C200629200; Clayton GM, 2004, CELL, V119, P615, DOI 10.1016/j.cell.2004.10.030; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Das R, 2007, P NATL ACAD SCI USA, V104, P93, DOI 10.1073/pnas.0609033103; Das R, 2007, J BIOL CHEM, V282, P581, DOI 10.1074/jbc.M607706200; Das R, 2006, J AM CHEM SOC, V128, P8406, DOI 10.1021/ja060046d; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; Gibson RM, 1997, J BIOL CHEM, V272, P16343, DOI 10.1074/jbc.272.26.16343; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Rehmann H, 2003, J BIOL CHEM, V278, P23508, DOI 10.1074/jbc.M301680200; Rehmann H, 2006, NATURE, V439, P625, DOI 10.1038/nature04468; Rehmann H, 2003, NAT STRUCT BIOL, V10, P26, DOI 10.1038/nsb878; Rehmann H, 2003, J BIOL CHEM, V278, P38548, DOI 10.1074/jbc.M306292200; Rehmann H, 2007, NAT REV MOL CELL BIO, V8, P63, DOI 10.1038/nrm2082; Rehmann H, 2006, METHOD ENZYMOL, V407, P159, DOI 10.1016/S0076-6879(05)07014-X; Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005; SHABB JB, 1992, J BIOL CHEM, V267, P5723; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yu SN, 2006, BIOCHEMISTRY-US, V45, P15318, DOI 10.1021/bi061701x; Zagotta WN, 2003, NATURE, V425, P200, DOI 10.1038/nature01922	30	30	32	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6501	6508		10.1074/jbc.M707849200	http://dx.doi.org/10.1074/jbc.M707849200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167352	Green Published, hybrid			2022-12-25	WOS:000253779500057
J	Paradisi, A; Pasquariello, N; Barcaroli, D; Maccarrone, M				Paradisi, Andrea; Pasquariello, Nicoletta; Barcaroli, Daniela; Maccarrone, Mauro			Anandamide regulates keratinocyte differentiation by inducing DNA methylation in a CB1 receptor-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; CANNABINOID RECEPTOR; ENDOCANNABINOID SYSTEM; CORNIFIED ENVELOPE; EPIDERMAL DIFFERENTIATION; INTERMEDIATE-FILAMENTS; GENE-EXPRESSION; TUMOR-GROWTH; METHYLTRANSFERASE; ACTIVATION	Anandamide ( arachidonoylethanolamide, AEA) belongs to an important class of endogenous lipids including amides and esters of long chain polyunsaturated fatty acids, collectively termed "endocannabinoids." Recently we have shown that AEA inhibits differentiation of human keratinocytes, by binding to type-1 cannabinoid receptors (CB1R). To further characterize the molecular mechanisms responsible for this effect, we investigated the expression of epidermal differentiation-related genes after AEA treatment. We observed that keratin 1 and 10, transglutaminase 5 and involucrin are transcriptionally down-regulated by AEA. Most importantly, we found that AEA is able to decrease differentiating gene expression by increasing DNA methylation in human keratinocytes, through a p38, and to a lesser extent p42/44, mitogen-activated protein kinase-dependent pathway triggered by CB1R. An effect of AEA on DNA methylation because of CB1R-mediated increase of methyltransferase activity is described here for the first time, and we believe that the importance of this effect clearly extends beyond the regulation of skin differentiation. In fact, the modulation of DNA methylation by endocannabinoids may affect the expression of a number of genes that regulate many cell functions in response to these substances.	[Paradisi, Andrea; Pasquariello, Nicoletta; Maccarrone, Mauro] Univ Teramo, Dept Biomed Sci, I-64100 Teramo, Italy; [Barcaroli, Daniela] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Barcaroli, Daniela; Maccarrone, Mauro] Ist Ricovero & Cura Carattere Sci St Lucia Fdn, European Ctr Brain Res CERC, I-00196 Rome, Italy	University of Teramo; University of Rome Tor Vergata	Maccarrone, M (corresponding author), Univ Teramo, Dept Biomed Sci, Piazza A Moro 45, I-64100 Teramo, Italy.	mmaccarrone@unite.it	PARADISI, Andrea/AAE-2293-2020; Maccarrone, Mauro/K-5398-2012; PARADISI, Andrea/AAN-6404-2020	PARADISI, Andrea/0000-0003-2218-3859; Maccarrone, Mauro/0000-0002-3990-2963; PARADISI, Andrea/0000-0003-2218-3859				ADAMS RLP, 1991, J BIOCHEM BIOPH METH, V22, P19, DOI 10.1016/0165-022X(91)90077-A; Aguado T, 2006, J NEUROSCI, V26, P1551, DOI 10.1523/JNEUROSCI.3101-05.2006; Bari M, 2006, MINI-REV MED CHEM, V6, P257, DOI 10.2174/138955706776073466; Battista N., 2005, THERAPY, V2, P141; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Blazquez C, 2006, FASEB J, V20, P2633, DOI 10.1096/fj.06-6638fje; BOUABOULA M, 1995, BIOCHEM J, V312, P637, DOI 10.1042/bj3120637; Bouaboula M, 1999, FEBS LETT, V449, P61, DOI 10.1016/S0014-5793(99)00395-6; Broday L, 1999, MOL CELL BIOL, V19, P3198; Calignano A, 1998, NATURE, V394, P277, DOI 10.1038/28393; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Candi E, 2002, J INVEST DERMATOL, V119, P670, DOI 10.1046/j.1523-1747.2002.01853.x; Candi E, 2001, J BIOL CHEM, V276, P35014, DOI 10.1074/jbc.M010157200; Casanova ML, 2003, J CLIN INVEST, V111, P43, DOI 10.1172/JCI200316116; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; Di Marzo V, 2006, TRENDS PHARMACOL SCI, V27, P134, DOI 10.1016/j.tips.2006.01.010; Di Marzo V, 2005, NAT NEUROSCI, V8, P585, DOI 10.1038/nn1457; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Elder JT, 2002, EXP DERMATOL, V11, P406, DOI 10.1034/j.1600-0625.2002.110503.x; ENGELKAMP D, 1993, P NATL ACAD SCI USA, V90, P6547, DOI 10.1073/pnas.90.14.6547; Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514; Glaser ST, 2005, LIFE SCI, V77, P1584, DOI 10.1016/j.lfs.2005.05.007; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hillard CJ, 1999, J PHARMACOL EXP THER, V289, P1427; Howlett AC, 2005, HANDB EXP PHARMACOL, V168, P53; Huang SM, 2002, P NATL ACAD SCI USA, V99, P8400, DOI 10.1073/pnas.122196999; JUTTERMANN R, 1994, P NATL ACAD SCI USA, V91, P11797, DOI 10.1073/pnas.91.25.11797; Kalinin A, 2001, J CELL SCI, V114, P3069; Karsak M, 2007, SCIENCE, V316, P1494, DOI 10.1126/science.1142265; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Laezza C, 2006, FEBS LETT, V580, P6076, DOI 10.1016/j.febslet.2006.09.074; LEE YW, 1995, MOL CELL BIOL, V15, P2547; LIGRESTI A, 2005, CURR DRUG TARGETS CN, V4, P615; Liu J, 2000, BIOCHEM J, V346, P835, DOI 10.1042/0264-6021:3460835; Liu J, 2006, P NATL ACAD SCI USA, V103, P13345, DOI 10.1073/pnas.0601832103; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; LYON SB, 1987, MOL CELL BIOL, V7, P1759, DOI 10.1128/MCB.7.5.1759; Maccarrone M, 2003, J BIOL CHEM, V278, P33896, DOI 10.1074/jbc.M303994200; Maccarrone M, 2006, ENDOCANNABINOIDS: THE BRAIN AND BODY'S MARIJUANA AND BEYOND, P451; Matias I, 2006, J CLIN ENDOCR METAB, V91, P3171, DOI 10.1210/jc.2005-2679; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; MING ME, 1994, J INVEST DERMATOL, V103, P780, DOI 10.1111/1523-1747.ep12413024; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Ofek O, 2006, P NATL ACAD SCI USA, V103, P696, DOI 10.1073/pnas.0504187103; Okamoto Y, 2004, J BIOL CHEM, V279, P5298, DOI 10.1074/jbc.M306642200; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Paradisi A, 2006, CURR DRUG TARGETS, V7, P1539, DOI 10.2174/1389450110607011539; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Portella G, 2003, FASEB J, V17, P1771, DOI 10.1096/fj.02-1129fje; Robertson KD, 2005, NAT REV GENET, V6, P597, DOI 10.1038/nrg1655; ROSL F, 1988, EMBO J, V7, P1321, DOI 10.1002/j.1460-2075.1988.tb02947.x; Rueda D, 2002, J BIOL CHEM, V277, P46645, DOI 10.1074/jbc.M206590200; SANTI DV, 1984, P NATL ACAD SCI-BIOL, V81, P6993, DOI 10.1073/pnas.81.22.6993; Savini I, 2002, J INVEST DERMATOL, V118, P372, DOI 10.1046/j.0022-202x.2001.01624.x; SCHMIDT R, 1989, J CELL PHYSIOL, V140, P281, DOI 10.1002/jcp.1041400213; Simon GM, 2006, J BIOL CHEM, V281, P26465, DOI 10.1074/jbc.M604660200; STAIANOCOICO L, 1989, CELL TISSUE KINET, V22, P361, DOI 10.1111/j.1365-2184.1989.tb00221.x; Sugiura T, 2000, J BIOL CHEM, V275, P605, DOI 10.1074/jbc.275.1.605; Telek A, 2007, FASEB J, V21, P3534, DOI 10.1096/fj.06-7689com; VERES DA, 1989, J INVEST DERMATOL, V93, P687, DOI 10.1111/1523-1747.ep12319883; Walker JM, 2002, PROSTAG LEUKOTR ESS, V66, P235, DOI 10.1054/plef.2001.0361; Wang J, 2006, CHAOS SOLITON FRACT, V27, P427, DOI 10.1016/j.chaos.2005.04.024; Werz O, 2002, BLOOD, V99, P1044, DOI 10.1182/blood.V99.3.1044; Xiong YN, 2005, CANCER RES, V65, P2684, DOI 10.1158/0008-5472.CAN-04-2843	69	73	75	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6005	6012		10.1074/jbc.M707964200	http://dx.doi.org/10.1074/jbc.M707964200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18165231	hybrid			2022-12-25	WOS:000253779500005
J	Ryan, KS; Balibar, CJ; Turo, KE; Walsh, CT; Drennan, CL				Ryan, Katherine S.; Balibar, Carl J.; Turo, Kaitlyn E.; Walsh, Christopher T.; Drennan, Catherine L.			The violacein Biosynthetic enzyme VioE shares a fold with lipoprotein transporter proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOPYRROLIC ACID; GENE-CLUSTER; LOLA; MECHANISM; APOPTOSIS; PIGMENT; REARRANGEMENT; CYTOTOXICITY; LOCALIZATION; REBECCAMYCIN	VioE, an unusual enzyme with no characterized homologues, plays a key role in the biosynthesis of violacein, a purple pigment with antibacterial and cytotoxic properties. Without bound cofactors or metals, VioE, from the bacterium Chromobacterium violaceum, mediates a 1,2 shift of an indole ring and oxidative chemistry to generate prodeoxyviolacein, a precursor to violacein. Our 1.21 angstrom resolution structure of VioE shows that the enzyme shares a core fold previously described for lipoprotein transporter proteins LolA and LolB. For both LolB and VioE, a bound polyethylene glycol molecule suggests the location of the binding and/or active site of the protein. Mutations of residues near the bound polyethylene glycol molecule in VioE have identified the active site and five residues important for binding or catalysis. This structural and mutagenesis study suggests that VioE acts as a catalytic chaperone, using a fold previously associated with lipoprotein transporters to catalyze the production of its prodeoxyviolacein product.	[Ryan, Katherine S.; Drennan, Catherine L.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Turo, Kaitlyn E.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Balibar, Carl J.; Walsh, Christopher T.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Harvard Medical School	Drennan, CL (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	cdrennan@mit.edu			NIEHS NIH HHS [P30 ES002109, P30 ES 002109] Funding Source: Medline; NIGMS NIH HHS [GM 20011, R01 GM020011, GM 65337, P50 GM068762, R01 GM065337, GM 68762, F32 GM020011] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES002109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM068762, R37GM020011, R01GM020011, R01GM065337] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754; Asamizu S, 2006, TETRAHEDRON LETT, V47, P473, DOI 10.1016/j.tetlet.2005.11.061; Asamizu S, 2007, TETRAHEDRON LETT, V48, P2923, DOI 10.1016/j.tetlet.2007.02.062; August PR, 2000, J MOL MICROB BIOTECH, V2, P513; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15444, DOI 10.1021/bi061998z; BALLANTINE JA, 1958, P CHEM SOC, V1, P232; Bassan A, 2003, CHEM-EUR J, V9, P4055, DOI 10.1002/chem.200304768; Brady SF, 2001, ORG LETT, V3, P1981, DOI 10.1021/ol015949k; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; de Almeida DF, 2003, P NATL ACAD SCI USA, V100, P11660, DOI 10.1073/pnas.1832124100; de Carvalho DD, 2006, TOXICOL IN VITRO, V20, P1514, DOI 10.1016/j.tiv.2006.06.007; delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7; DEMOSS RD, 1960, J BACTERIOL, V79, P729, DOI 10.1128/JB.79.5.729-733.1960; DEMOSS RD, 1959, J BACTERIOL, V78, P583, DOI 10.1128/JB.78.4.583-588.1959; Duran N, 2003, CAN J PHYSIOL PHARM, V81, P387, DOI 10.1139/Y03-033; Duran N, 2001, CRIT REV MICROBIOL, V27, P201, DOI 10.1080/20014091096747; DURAN N, 1983, AN ACAD BRAS CIENC, V55, P231; DURAN N, 1989, Anais da Academia Brasileira de Ciencias, V61, P31; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferreira CV, 2004, BLOOD, V104, P1459, DOI 10.1182/blood-2004-02-0594; Fischer G, 2000, CHEM SOC REV, V29, P119, DOI 10.1039/a803742f; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; HASHIM MF, 1990, FEBS LETT, V271, P219, DOI 10.1016/0014-5793(90)80410-K; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOSHINO T, 1987, AGR BIOL CHEM TOKYO, V51, P2733; Howard-Jones AR, 2006, J AM CHEM SOC, V128, P12289, DOI 10.1021/ja063898m; Howard-Jones AR, 2005, BIOCHEMISTRY-US, V44, P15652, DOI 10.1021/bi051706e; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kim SY, 2007, APPL MICROBIOL BIOT, V75, P1119, DOI 10.1007/s00253-007-0924-x; Kodach LL, 2006, CARCINOGENESIS, V27, P508, DOI 10.1093/carcin/bgi307; Laatsch H, 1984, J CHEM SOC P2, V8, P1331, DOI [10.1039/p29840001331, DOI 10.1039/P29840001331]; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Leon LL, 2001, J ANTIMICROB CHEMOTH, V48, P449, DOI 10.1093/jac/48.3.449; Li R, 2006, CHEM BIOL, V13, P513, DOI 10.1016/j.chembiol.2006.03.005; LICHSTEIN HC, 1946, J BACTERIOL, V52, P145, DOI 10.1128/JB.52.1.145-146.1946; Matsuyama S, 1997, EMBO J, V16, P6947, DOI 10.1093/emboj/16.23.6947; Melo PD, 2000, IN VITRO CELL DEV-AN, V36, P539, DOI 10.1290/1071-2690(2000)036<0539:VCAIOA>2.0.CO;2; Melo PS, 2003, TOXICOLOGY, V186, P217, DOI 10.1016/S0300-483X(02)00751-5; Miyamoto A, 2001, BIOCHEM BIOPH RES CO, V287, P1125, DOI 10.1006/bbrc.2001.5705; Momen AZMR, 2000, BIOSCI BIOTECH BIOCH, V64, P539, DOI 10.1271/bbb.64.539; Moran GR, 2005, ARCH BIOCHEM BIOPHYS, V433, P117, DOI 10.1016/j.abb.2004.08.015; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narita S, 2004, ARCH MICROBIOL, V182, P1, DOI 10.1007/s00203-004-0682-4; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; Reilly J, 1927, BIOCHEM J, V21, P1059, DOI 10.1042/bj0211059; Sanchez C, 2006, CHEMBIOCHEM, V7, P1231, DOI 10.1002/cbic.200600029; Saraiva VS, 2004, MELANOMA RES, V14, P421, DOI 10.1097/00008390-200410000-00014; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Strong F. M., 1944, SCIENCE, V100, P287, DOI 10.1126/science.100.2596.287; Takeda K, 2003, EMBO J, V22, P3199, DOI 10.1093/emboj/cdg324; Taniguchi N, 2005, J BIOL CHEM, V280, P34481, DOI 10.1074/jbc.M507388200; Tobie WC, 1935, J BACTERIOL, V29, P223, DOI 10.1128/JB.29.3.223-227.1935; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; Watanabe K, 2003, P NATL ACAD SCI USA, V100, P9774, DOI 10.1073/pnas.1632167100; Watanabe S, 2006, J BIOL CHEM, V281, P3335, DOI 10.1074/jbc.M509596200; Yu TW, 2001, J BIOL CHEM, V276, P12546, DOI 10.1074/jbc.M009667200	58	31	31	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6467	6475		10.1074/jbc.M708573200	http://dx.doi.org/10.1074/jbc.M708573200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171675	hybrid, Green Accepted			2022-12-25	WOS:000253779500054
J	Bhattacharyya, S; Marinic, TE; Krukovets, I; Hoppe, G; Stenina, OI				Bhattacharyya, Sanghamitra; Marinic, Tina E.; Krukovets, Irene; Hoppe, George; Stenina, Olga I.			Cell type-specific post-transcriptional regulation of production of the potent antiangiogenic and proatherogenic protein thrombospondin-1 by high glucose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR; EXTRACELLULAR-MATRIX; MESANGIAL CELLS; IN-VITRO; ANGIOGENESIS; PROLIFERATION; EXPRESSION; GENES	Hyperglycemia is an independent risk factor for development of vascular diabetic complications. Vascular dysfunction in diabetics manifests in a tissue-specific manner; macrovasculature is affected by atherosclerotic lesions, and microvascular complications are described as "aberrant angiogenesis": in the same patient angiogenesis is increased in some tissues ( e. g. retinal neovascularization) and decreased in others ( e. g. in skin). Molecular cell- and tissue-specific mechanisms regulating the response of vasculature to hyperglycemia remain unclear. Thrombospondin-1 (TSP-1), a potent antiangiogenic and proatherogenic protein, has been implicated in the development of several vascular diabetic complications ( atherosclerosis, nephropathy, and cardiomyopathy). This study examines cell type-specific regulation of production of thrombospondin-1 by high glucose. We previously reported the increased expression of TSP-1 in the large arteries of diabetic animals. mRNA and protein levels were up- regulated in response to high glucose. Unlike in macrovascular cells, TSP-1 protein levels are dramatically decreased in response to high glucose in microvascular endothelial cells and retinal pigment epithelial cells (RPE). This down-regulation is post-transcriptional; mRNA levels are increased. In situ mRNA hybridization and immunohistochemistry revealed that the level of mRNA is up- regulated in RPE of diabetic rats, whereas the protein level is decreased. This cell type-specific post-transcriptional suppression of TSP-1 production in response to high glucose in microvascular endothelial cells and RPE is controlled by untranslated regions of TSP-1 mRNA that regulate coupling of TSP-1 mRNA to polysomes and its translation. The cell specific regulation of TSP-1 suggests a potential mechanism for the aberrant angiogenesis in diabetics and TSP-1 involvement in development of various vascular diabetic complications.	[Bhattacharyya, Sanghamitra; Marinic, Tina E.; Krukovets, Irene; Stenina, Olga I.] Joseph J Jacobs Ctr Thrombosis & Vasc Biol, Dept Mol Cardiol, Cleveland, OH 44026 USA; [Hoppe, George] Cole Eye Inst, Cleveland Clin, Cleveland, OH 44026 USA	Cleveland Clinic Foundation	Stenina, OI (corresponding author), NB50,9500 Euclid Ave, Cleveland, OH 44195 USA.	stenino@ccf.org		, Olga/0000-0002-1256-0545	NATIONAL EYE INSTITUTE [P30EY001931] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL077107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK062128, R01DK067532] Funding Source: NIH RePORTER; NEI NIH HHS [P30 EY01931] Funding Source: Medline; NHLBI NIH HHS [P50 HL077107] Funding Source: Medline; NIDDK NIH HHS [R01 DK067532, K01 DK62128] Funding Source: Medline	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Armstrong LC, 2002, MOL BIOL CELL, V13, P1893, DOI 10.1091/mbc.E01-09-0066; BAYRAKTAR M, 1994, J INT MED RES, V22, P90, DOI 10.1177/030006059402200204; Belmadani S, 2007, AM J PATHOL; CANFIELD AE, 1995, J CELL SCI, V108, P797; Carpizo D, 2000, CANCER METAST REV, V19, P159, DOI 10.1023/A:1026570331022; Carron JA, 2000, INT J BIOCHEM CELL B, V32, P1137, DOI 10.1016/S1357-2725(00)00065-0; DIPIETRO LA, 1994, J VASC RES, V31, P178, DOI 10.1159/000319585; Doll JA, 2001, PROSTATE, V49, P293, DOI 10.1002/pros.10025; Hawighorst T, 2002, ONCOGENE, V21, P7945, DOI 10.1038/sj.onc.1205956; HISCOTT P, 1992, EYE, V6, P566, DOI 10.1038/eye.1992.123; Hugo CPM, 1999, KIDNEY INT, V55, P2236, DOI 10.1046/j.1523-1755.1999.00459.x; Khaw KT, 2001, BMJ-BRIT MED J, V322, P15, DOI 10.1136/bmj.322.7277.15; Lawler J, 2004, INT J BIOCHEM CELL B, V36, P1038, DOI 10.1016/j.biocel.2004.01.008; Martin A, 2003, MED RES REV, V23, P117, DOI 10.1002/med.10024; Mazumder B, 2003, TRENDS BIOCHEM SCI, V28, P91, DOI 10.1016/S0968-0004(03)00002-1; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Murphy M, 1999, J BIOL CHEM, V274, P5830, DOI 10.1074/jbc.274.9.5830; Nathan DM, 2003, NEW ENGL J MED, V348, P761; NATHAN DM, 1950, NEW ENGL J MED, V353, P2643; Peyvandi F, 2003, BLOOD, V102, p314A; Poczatek MH, 2000, AM J PATHOL, V157, P1353, DOI 10.1016/S0002-9440(10)64649-4; Raman P, 2007, J BIOL CHEM, V282, P5704, DOI 10.1074/jbc.M610965200; Riessen R, 1998, AM HEART J, V135, P357, DOI 10.1016/S0002-8703(98)70105-X; Roth JJ, 1998, J SURG RES, V74, P11, DOI 10.1006/jsre.1997.5209; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Sheibani N, 2000, BIOCHEM BIOPH RES CO, V267, P257, DOI 10.1006/bbrc.1999.1903; SHEIBANI N, 1995, P NATL ACAD SCI USA, V92, P6788, DOI 10.1073/pnas.92.15.6788; Stenina OI, 2005, CURR PHARM DESIGN, V11, P2367, DOI 10.2174/1381612054367283; Stenina OI, 2003, CIRCULATION, V107, P3209, DOI 10.1161/01.CIR.0000074223.56882.97; Tada H, 1995, TOHOKU J EXP MED, V177, P293, DOI 10.1620/tjem.177.293; Topol EJ, 2001, CIRCULATION, V104, P2641, DOI 10.1161/hc4701.100910; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang SJ, 2003, DEV DYNAM, V228, P630, DOI 10.1002/dvdy.10412; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Yevdokimova N, 2001, J AM SOC NEPHROL, V12, P703, DOI 10.1681/ASN.V124703; Zhao XM, 2001, CIRCULATION, V103, P525, DOI 10.1161/01.CIR.103.4.525	36	40	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5699	5707		10.1074/jbc.M706435200	http://dx.doi.org/10.1074/jbc.M706435200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18096704	hybrid			2022-12-25	WOS:000253426700051
J	Cifuentes, D; Martinez-Pons, C; Garcia-Rocha, M; Galina, A; de Pouplana, LR; Guinovart, JJ				Cifuentes, Daniel; Martinez-Pons, Carles; Garcia-Rocha, Mar; Galina, Antonio; de Pouplana, Lluis Ribas; Guinovart, Joan J.			Hepatic glycogen synthesis in the absence of glucokinase - The case of embryonic liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PROTEIN; RAT HEPATOCYTES; SUBCELLULAR-LOCALIZATION; GLUCOSE-HOMEOSTASIS; HEXOKINASE I; SYNTHASE; GLUCOSE-6-PHOSPHATE; METABOLISM; ACTIVATION; EXPRESSION	Glucokinase (GK, hexokinase type IV) is required for the accumulation of glycogen in adult liver and hepatoma cells. Paradoxically, mammalian embryonic livers store glycogen successfully in the absence of GK. Here we address how mammalian embryonic livers, but not adult livers or hepatoma cells, manage to accumulate glycogen in the absence of this enzyme. Hexokinase type I or II (HKI, HKII) substitutes for GK in hepatomas and in embryonic livers. We engineered FTO2B cells, a hepatoma cell line in which GK is not expressed, to unveil the modifications required to allow them to accumulate glycogen. In the light of these results, we then examined glycogen metabolism in embryonic liver. Glycogen accumulation in FTO2B cells can be triggered through elevated expression of HKI or either of the protein phosphatase 1 regulatory subunits, namely PTG or G(L). Between these two strategies to activate glycogen deposition in the absence of GK, embryonic livers choose to express massive levels of HKI and HKII. We conclude that although the GK/liver glycogen synthase tandem is ideally suited to store glycogen in liver when blood glucose is high, the substitution of HKI for GK in embryonic livers allows the HKI/liver glycogen synthase tandem to make glycogen independently of the glucose concentration in blood, although it requires huge levels of HK. Moreover, the physiological consequence of the HK isoform switch is that the embryonic liver safeguards its glycogen deposits, required as the main source of energy at birth, from maternal starvation.	[Cifuentes, Daniel; Martinez-Pons, Carles; Garcia-Rocha, Mar; Guinovart, Joan J.] Univ Barcelona, Res Inst Biomed, Barcelona 08028, Spain; [Cifuentes, Daniel; Martinez-Pons, Carles; Garcia-Rocha, Mar; Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biol, Barcelona 08028, Spain; [Galina, Antonio] Inst Catalana Rec Estud Avancats, Catalonia 08028, Spain; [de Pouplana, Lluis Ribas] Univ Fed Rio de Janeiro, Inst Bioquim Med, BR-21941590 Rio De Janeiro, Brazil	University of Barcelona; University of Barcelona; ICREA; Universidade Federal do Rio de Janeiro	Guinovart, JJ (corresponding author), Inst Res Biomed, Barcelona Sci Park,Joseph Samitier 1-5, E-08028 Barcelona, Spain.	guinovart@irbbarcelona.org	Galina, Antonio/A-9292-2008; de Pouplana, Lluis Ribas/AAA-4738-2019	de Pouplana, Lluis Ribas/0000-0002-2087-0359; Garcia-Rocha, Mar/0000-0003-2467-2090; Cifuentes Buira, Daniel/0000-0001-5442-4843	ICREA Funding Source: Custom	ICREA(ICREA)		Agius L, 1996, J BIOL CHEM, V271, P30479, DOI 10.1074/jbc.271.48.30479; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; BOSCH F, 1983, FEBS LETT, V151, P76, DOI 10.1016/0014-5793(83)80346-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSTAMANTE E, 1977, P NATL ACAD SCI USA, V74, P3735, DOI 10.1073/pnas.74.9.3735; CARABAZA A, 1986, ARCH BIOCHEM BIOPHYS, V250, P469, DOI 10.1016/0003-9861(86)90751-4; CARABAZA A, 1990, J BIOL CHEM, V265, P2724; Cardenas ML, 1997, BIOCHEM SOC T, V25, P131, DOI 10.1042/bst0250131; Cardenas ML, 1998, BBA-MOL CELL RES, V1401, P242, DOI 10.1016/S0167-4889(97)00150-X; CHAN TM, 1976, ANAL BIOCHEM, V71, P96, DOI 10.1016/0003-2697(76)90014-2; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; de la Iglesia N, 1999, FEBS LETT, V456, P332, DOI 10.1016/S0014-5793(99)00971-0; Farrelly D, 1999, P NATL ACAD SCI USA, V96, P14511, DOI 10.1073/pnas.96.25.14511; FernandezNovell JM, 1996, EUR J BIOCHEM, V238, P570, DOI 10.1111/j.1432-1033.1996.0570z.x; Ferre T, 1996, P NATL ACAD SCI USA, V93, P7225, DOI 10.1073/pnas.93.14.7225; GANCEDO JM, 1977, J BIOL CHEM, V252, P4443; Garcia-Rocha M, 2001, BIOCHEM J, V357, P17, DOI 10.1042/0264-6021:3570017; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; GIRARD J, 1992, PHYSIOL REV, V72, P507, DOI 10.1152/physrev.1992.72.2.507; Gomis RR, 2003, J BIOL CHEM, V278, P9740, DOI 10.1074/jbc.M212151200; Gomis RR, 2002, J BIOL CHEM, V277, P23246, DOI 10.1074/jbc.M111208200; Gomis RR, 2000, BIOCHEM J, V351, P811, DOI 10.1042/0264-6021:3510811; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; KUWAJIMA M, 1986, J BIOL CHEM, V261, P8849; LANG G, 1974, METHOD ENZYMAT AN, V3, P1238; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; ODoherty RM, 1996, J BIOL CHEM, V271, P20524, DOI 10.1074/jbc.271.34.20524; Penso J, 1998, EUR J PHARMACOL, V342, P113, DOI 10.1016/S0014-2999(97)01507-0; Postic C, 1999, J BIOL CHEM, V274, P305, DOI 10.1074/jbc.274.1.305; POSTIC C, 1994, AM J PHYSIOL, V266, pE548, DOI 10.1152/ajpendo.1994.266.4.E548; Printen JA, 1997, SCIENCE, V275, P1475, DOI 10.1126/science.275.5305.1475; Rodriguez A, 2001, BIOCHEM J, V355, P625, DOI 10.1042/bj3550625; SCHAMHART DHJ, 1979, CANCER RES, V39, P1051; Seoane J, 1996, J BIOL CHEM, V271, P23756, DOI 10.1074/jbc.271.39.23756; Seoane J, 1999, J BIOL CHEM, V274, P31833, DOI 10.1074/jbc.274.45.31833; Towbin H, 1992, Biotechnology, V24, P145; VALERA A, 1994, EUR J BIOCHEM, V222, P533, DOI 10.1111/j.1432-1033.1994.tb18895.x; VanSchaftingen E, 1997, BIOCHEM SOC T, V25, P136, DOI 10.1042/bst0250136; VANSCHAFTINGEN E, 1989, EUR J BIOCHEM, V179, P179; VillarPalasi C, 1997, FASEB J, V11, P544, DOI 10.1096/fasebj.11.7.9212078; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Zvibel I, 1998, DIFFERENTIATION, V63, P215, DOI 10.1111/j.1432-0436.1998.00215.x	43	12	12	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5642	5649		10.1074/jbc.M706334200	http://dx.doi.org/10.1074/jbc.M706334200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165236	hybrid			2022-12-25	WOS:000253426700044
J	VanDemark, AP; Xin, H; McCullough, L; Rawlins, R; Bentley, S; Heroux, A; Stillman, DJ; Hill, CP; Formosa, T				VanDemark, Andrew P.; Xin, Hua; McCullough, Laura; Rawlins, Robert; Bentley, Shayla; Heroux, Annie; Stillman, David J.; Hill, Christopher P.; Formosa, Tim			Structural and functional analysis of the Spt16p N-terminal domain reveals overlapping roles of yFACT subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOSOME CORE PARTICLE; DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; METHIONINE AMINOPEPTIDASE; CREATINE AMIDINOHYDROLASE; CRYSTAL-STRUCTURE; YEAST FACT; TRANSCRIPTION; COMPLEXES; BINDING	yFACT (heterodimers of Saccharomyces cerevisiae Spt16-Pob3 combined with Nhp6) binds to and alters the properties of nucleosomes. The essential function of yFACT is not disrupted by deletion of the N-terminal domain (NTD) of Spt16 or by mutation of the middle domain of Pob3, but either alteration makes yeast cells sensitive to DNA replication stress. We have determined the structure of the Spt16 NTD and find evidence for a conserved potential peptide-binding site. Pob3-M also contains a putative binding site, and we show that these two sites perform an overlapping essential function. We find that yFACT can bind the N-terminal tails of some histones and that this interaction is important for yFACT-nucleosome binding. However, neither the Spt16 NTD nor a key residue in the putative Pob3-M-binding site was required for interactions with histone N termini or for yFACT-mediated nucleosome reorganization in vitro. Instead, both potential binding sites interact functionally with the C-terminal docking domain of the histone H2A. yFACT therefore appears to make multiple contacts with different sites within nucleosomes, and these interactions are partially redundant with one another. The docking domain of H2A is identified as an important participant in maintaining stability during yFACT-mediated nucleosome reorganization, suggesting new models for the mechanism of this activity.	[VanDemark, Andrew P.; Xin, Hua; McCullough, Laura; Rawlins, Robert; Hill, Christopher P.; Formosa, Tim] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Heroux, Annie] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Bentley, Shayla; Stillman, David J.] Univ Utah, Sch Med, Dept Pathol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Brookhaven National Laboratory; Utah System of Higher Education; University of Utah	Hill, CP (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	chris@biochem.utah.edu; tim@biochem.utah.edu		Formosa, Tim/0000-0002-8477-2483; Stillman, David/0000-0002-5268-2416; VanDemark, Andrew/0000-0003-3424-4831	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076242] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM076242] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aravind L, 1998, CURR BIOL, V8, pR111, DOI 10.1016/S0960-9822(98)70982-0; ARIYOSHI M, 1994, CELL, V78, P1063, DOI 10.1016/0092-8674(94)90280-1; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Biswas D, 2005, MOL CELL BIOL, V25, P5812, DOI 10.1128/MCB.25.14.5812-5822.2005; Biswas D, 2006, EMBO J, V25, P4479, DOI 10.1038/sj.emboj.7601333; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Budd ME, 2005, PLOS GENET, V1, P634, DOI 10.1371/journal.pgen.0010061; Burke D., 2000, METHODS YEAST GENETI; COLL M, 1990, J MOL BIOL, V214, P597, DOI 10.1016/0022-2836(90)90201-V; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan HY, 2003, MOL CELL, V11, P1311, DOI 10.1016/S1097-2765(03)00192-8; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Formosa T, 2001, EMBO J, V20, P3506, DOI 10.1093/emboj/20.13.3506; Formosa T, 2002, GENETICS, V162, P1557; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Hertel L, 1999, EXP CELL RES, V250, P313, DOI 10.1006/excr.1999.4495; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kowalinski E, 2007, FEBS LETT, V581, P4450, DOI 10.1016/j.febslet.2007.08.024; Lejeune E, 2007, CURR BIOL, V17, P1219, DOI 10.1016/j.cub.2007.06.028; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Maher MJ, 2004, BIOCHEMISTRY-US, V43, P2771, DOI 10.1021/bi0356451; MALONE EA, 1991, MOL CELL BIOL, V11, P5710, DOI 10.1128/MCB.11.11.5710; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Monie TP, 2007, EMBO J, V26, P3936, DOI 10.1038/sj.emboj.7601817; O'Donnell AF, 2004, NUCLEIC ACIDS RES, V32, P5894, DOI 10.1093/nar/gkh922; Okuhara K, 1999, CURR BIOL, V9, P341, DOI 10.1016/S0960-9822(99)80160-2; Orphanides G, 1999, NATURE, V400, P284, DOI 10.1038/22350; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Padmanabhan B, 2002, ACTA CRYSTALLOGR D, V58, P1322, DOI 10.1107/S0907444902010156; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Reinberg D, 2006, J BIOL CHEM, V281, P23297, DOI 10.1074/jbc.R600007200; Rhoades AR, 2004, MOL CELL BIOL, V24, P3907, DOI 10.1128/MCB.24.9.3907-3917.2004; RODERICK SL, 1993, BIOCHEMISTRY-US, V32, P3907, DOI 10.1021/bi00066a009; ROWLEY A, 1991, MOL CELL BIOL, V11, P5718, DOI 10.1128/MCB.11.11.5718; Ruone S, 2003, J BIOL CHEM, V278, P45288, DOI 10.1074/jbc.M307291200; Schlesinger MB, 2000, GENETICS, V155, P1593; SIMCHEN G, 1984, P NATL ACAD SCI-BIOL, V81, P2431, DOI 10.1073/pnas.81.8.2431; Singer RA, 2004, BIOCHEM CELL BIOL, V82, P419, DOI 10.1139/O04-050; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; VanDemark AP, 2007, MOL CELL, V27, P171, DOI 10.1016/j.molcel.2007.06.007; VanDemark AP, 2006, MOL CELL, V22, P363, DOI 10.1016/j.molcel.2006.03.025; VANDUYNE GD, 1993, J MOL BIOL, V229, P105, DOI 10.1006/jmbi.1993.1012; White CL, 2001, EMBO J, V20, P5207, DOI 10.1093/emboj/20.18.5207; Wittmeyer J, 1999, BIOCHEMISTRY-US, V38, P8961, DOI 10.1021/bi982851d; Zhou YJ, 2004, MOL CELL BIOL, V24, P9568, DOI 10.1128/MCB.24.21.9568-9579.2004; Zipperlen P, 2001, EMBO J, V20, P3984, DOI 10.1093/emboj/20.15.3984	49	63	63	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5058	5068		10.1074/jbc.M708682200	http://dx.doi.org/10.1074/jbc.M708682200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089575	hybrid			2022-12-25	WOS:000253426500063
J	Couvreur, B; Beaufays, J; Charon, C; Lahaye, K; Gensale, F; Denis, V; Charloteaux, B; Decrem, Y; Prevot, PP; Brossard, M; Vanhamme, L; Godfroid, E				Couvreur, Bernard; Beaufays, Jerome; Charon, Cedric; Lahaye, Kathia; Gensale, Francois; Denis, Valerie; Charloteaux, Benoit; Decrem, Yves; Prevot, Pierre-Paul; Brossard, Michel; Vanhamme, Luc; Godfroid, Edmond			Variability and Action Mechanism of a Family of Anticomplement Proteins in Ixodes ricinus	PLOS ONE			English	Article							AMERICAN VISCERAL LEISHMANIASIS; HYDROPHOBIC CLUSTER-ANALYSIS; ANTI-COMPLEMENT ACTIVITY; COBRA VENOM FACTOR; X-RAY-SCATTERING; SAND FLY VECTOR; ALTERNATIVE PATHWAY; TICK SALIVA; ORNITHODOROS-MOUBATA; ACQUIRED-RESISTANCE	Background. Ticks are blood feeding arachnids that characteristically take a long blood meal. They must therefore counteract host defence mechanisms such as hemostasis, inflammation and the immune response. This is achieved by expressing batteries of salivary proteins coded by multigene families. Methodology/Principal Findings. We report the in-depth analysis of a tick multigene family and describe five new anticomplement proteins in Ixodes ricinus. Compared to previously described Ixodes anticomplement proteins, these segregated into a new phylogenetic group or subfamily. These proteins have a novel action mechanism as they specifically bind to properdin, leading to the inhibition of C3 convertase and the alternative complement pathway. An excess of non-synonymous over synonymous changes indicated that coding sequences had undergone diversifying selection. Diversification was not associated with structural, biochemical or functional diversity, adaptation to host species or stage specificity but rather to differences in antigenicity. Conclusions/Significance. Anticomplement proteins from I. ricinus are the first inhibitors that specifically target a positive regulator of complement, properdin. They may provide new tools for the investigation of role of properdin in physiological and pathophysiological mechanisms. They may also be useful in disorders affecting the alternative complement pathway. Looking for and detecting the different selection pressures involved will help in understanding the evolution of multigene families and hematophagy in arthropods.	[Couvreur, Bernard; Beaufays, Jerome; Charon, Cedric; Lahaye, Kathia; Gensale, Francois; Denis, Valerie; Decrem, Yves; Prevot, Pierre-Paul; Vanhamme, Luc; Godfroid, Edmond] Free Univ Brussels, Lab Mol Biol Ectoparasites, IBMM, Gosselies, Belgium; [Charloteaux, Benoit] Gembloux Agr Univ, Ctr Biophys Mol Numerique, Gembloux, Belgium; [Brossard, Michel] Univ Neuchatel, Inst Zool, Neuchatel, Switzerland; [Vanhamme, Luc] Free Univ Brussels, Inst Biol Med Mol IBMM, Lab Mol Parasitol, Brussels, Belgium	Universite Libre de Bruxelles; University of Liege; University of Neuchatel; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Godfroid, E (corresponding author), Free Univ Brussels, Lab Mol Biol Ectoparasites, IBMM, Gosselies, Belgium.	edmond.godfroid@ulb.ac.be			Belgian National Fund for Scientific Research; Fonds pour la Formation a la Recherche dans lIndustrie et dans lAgriculture of the Belgian Federal Governement [PhD studentship]; Ministere de la Region Wallonne in Belgium [215107, 415702]	Belgian National Fund for Scientific Research(Fonds de la Recherche Scientifique - FNRS); Fonds pour la Formation a la Recherche dans lIndustrie et dans lAgriculture of the Belgian Federal Governement(Fonds de la Recherche Scientifique - FNRS); Ministere de la Region Wallonne in Belgium	LVH is a Senior Research Associate at the Belgian National Fund for Scientific Research. CC is supported by a PhD studentship from the Fonds pour la Formation a la Recherche dans lIndustrie et dans lAgriculture of the Belgian Federal Governement. This work was supported by contracts 215107 and 415702 from the Ministere de la Region Wallonne in Belgium.	Astigarraga A, 1997, PARASITE IMMUNOL, V19, P401, DOI 10.1046/j.1365-3024.1997.d01-236.x; Cai W, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-33; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103; COLLIGAN JE, 1994, CURRENT PROTOCOLS IM; CURMAN B, 1977, BIOCHEMISTRY-US, V16, P5368, DOI 10.1021/bi00643a031; Daix V, 2007, INSECT MOL BIOL, V16, P155, DOI 10.1111/j.1365-2583.2006.00710.x; Das S, 2001, J INFECT DIS, V184, P1056, DOI 10.1086/323351; DISCIPIO RG, 1981, BIOCHEM J, V199, P485, DOI 10.1042/bj1990485; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Francischetti IMB, 2005, INSECT BIOCHEM MOLEC, V35, P1142, DOI 10.1016/j.ibmb.2005.05.007; GABORIAUD C, 1987, FEBS LETT, V224, P149, DOI 10.1016/0014-5793(87)80439-8; Giclas PC, 1997, MANUAL CLIN LAB IMMU, V5, P181; GOUNDIS D, 1988, NATURE, V335, P82, DOI 10.1038/335082a0; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gupta-Bansal R, 2000, MOL IMMUNOL, V37, P191, DOI 10.1016/S0161-5890(00)00047-X; Holers VM, 2004, MOL IMMUNOL, V41, P147, DOI 10.1016/j.molimm.2004.03.012; HOOGSTRAAL H, 1982, B SOC ENTOMOL SUISSE, V55, P5; HOURCADE D, 1989, ADV IMMUNOL, V45, P381, DOI 10.1016/S0065-2776(08)60697-5; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Hughes A.L., 1999, ADAPTIVE EVOLUTION G; Janeway CA, 2001, IMMUNOBIOLOGY; JOINER KA, 1988, ANNU REV MICROBIOL, V42, P201, DOI 10.1146/annurev.mi.42.100188.001221; Jongejan F, 2004, PARASITOLOGY, V129, pS3, DOI 10.1017/S0031182004005967; Julenius K, 2005, GLYCOBIOLOGY, V15, P153, DOI 10.1093/glycob/cwh151; Kimura Y, 2008, BLOOD, V111, P732, DOI 10.1182/blood-2007-05-089821; Kock MA, 2004, J BIOL CHEM, V279, P30836, DOI 10.1074/jbc.M403196200; Kordis D, 2000, GENE, V261, P43, DOI 10.1016/S0378-1119(00)00490-X; Kostavasil I, 1997, J IMMUNOL, V158, P1763; Kovar L, 2004, FOLIA MICROBIOL, V49, P327, DOI 10.1007/BF02931051; KOZAK M, 1989, J CELL BIOL, V108, P229, DOI 10.1083/jcb.108.2.229; Kraiczy P, 2006, MOL IMMUNOL, V43, P31, DOI 10.1016/j.molimm.2005.06.016; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lanzaro GC, 1999, INSECT MOL BIOL, V8, P267, DOI 10.1046/j.1365-2583.1999.820267.x; Lawrie CH, 1999, EXP PARASITOL, V93, P207, DOI 10.1006/expr.1999.4456; Lawrie CH, 2005, MOL IMMUNOL, V42, P31, DOI 10.1016/j.molimm.2004.07.001; Mans BJ, 2002, MOL BIOL EVOL, V19, P1695, DOI 10.1093/oxfordjournals.molbev.a003992; Mans J, 2004, PARASITOLOGY, V129, pS95, DOI 10.1017/S0031182003004670; Mejri N, 2002, PARASITOL RES, V88, P192, DOI 10.1007/s00436-001-0515-1; Milleron RS, 2004, AM J TROP MED HYG, V70, P286, DOI 10.4269/ajtmh.2004.70.286; Milleron RS, 2004, AM J TROP MED HYG, V70, P278, DOI 10.4269/ajtmh.2004.70.278; MILNE A, 1949, PARASITOLOGY, V39, P173, DOI 10.1017/S0031182000083736; Mizuno M., 2004, Current Drug Targets - Inflammation and Allergy, V3, P87, DOI 10.2174/1568010043483890; Mollnes TE, 2006, MOL IMMUNOL, V43, P107, DOI 10.1016/j.molimm.2005.06.014; Nicholas K.B., 1997, EMBNEW NEWS, V4, P14, DOI DOI 10.11118/ACTAUN201361041061; NOLAN KF, 1991, EUR J IMMUNOL, V21, P771, DOI 10.1002/eji.1830210333; NOLAN KF, 1993, METHOD ENZYMOL, V223, P35; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Nunn MA, 2005, J IMMUNOL, V174, P2084, DOI 10.4049/jimmunol.174.4.2084; Ohno S., 1970, EVOLUTION GENE DUPLI; Paesen GC, 1999, MOL CELL, V3, P661, DOI 10.1016/S1097-2765(00)80359-7; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmer M. J., 1994, Insect Molecular Biology, V3, P57, DOI 10.1111/j.1365-2583.1994.tb00151.x; PANGBURN MK, 1989, J IMMUNOL, V142, P202; PANGBURN MK, 1986, BIOCHEM J, V235, P723, DOI 10.1042/bj2350723; Prevot PP, 2006, J BIOL CHEM, V281, P26361, DOI 10.1074/jbc.M604197200; Price PW, 1980, MONOGRAPHS POPULATIO; REID KBM, 1989, IMMUNOL TODAY, V10, P177, DOI 10.1016/0167-5699(89)90317-4; Ribeiro JMC, 2006, INSECT BIOCHEM MOLEC, V36, P111, DOI 10.1016/j.ibmb.2005.11.005; RIBEIRO JMC, 1987, ANNU REV ENTOMOL, V32, P463, DOI 10.1146/annurev.en.32.010187.002335; RIBEIRO JMC, 1987, EXP PARASITOL, V64, P347, DOI 10.1016/0014-4894(87)90046-4; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ricklin D, 2007, NAT BIOTECHNOL, V25, P1265, DOI 10.1038/nbt1342; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Sacks D, 2002, NAT IMMUNOL, V3, P1041, DOI 10.1038/ni1102-1041; SCHREIBER RD, 1978, J EXP MED, V148, P1722, DOI 10.1084/jem.148.6.1722; Schroeder H, 2007, MICROBES INFECT, V9, P247, DOI 10.1016/j.micinf.2006.10.020; SMITH CA, 1984, J BIOL CHEM, V259, P4582; SMITH KF, 1991, BIOCHEMISTRY-US, V30, P8000, DOI 10.1021/bi00246a018; Soares CAG, 2005, INSECT MOL BIOL, V14, P443, DOI 10.1111/j.1365-2583.2005.00575.x; SONENSHINE B, 1991, BIOL TICKS, V1; Spitzer D, 2007, J IMMUNOL, V179, P2600, DOI 10.4049/jimmunol.179.4.2600; Sun Z, 2004, J MOL BIOL, V343, P1327, DOI 10.1016/j.jmb.2004.09.001; TACK BF, 1981, METHODS ENZYMOLOGY, V80; Taylor JS, 2004, ANNU REV GENET, V38, P615, DOI 10.1146/annurev.genet.38.072902.092831; Thomas TC, 1996, MOL IMMUNOL, V33, P1389, DOI 10.1016/S0161-5890(96)00078-8; Thurman JM, 2006, J IMMUNOL, V176, P1305, DOI 10.4049/jimmunol.176.3.1305; Tyson K, 2007, INSECT MOL BIOL, V16, P469, DOI 10.1111/j.1365-2583.2007.00742.x; Ullmann AJ, 2005, INSECT MOL BIOL, V14, P217, DOI 10.1111/j.1365-2583.2005.00551.x; Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200; Valenzuela JG, 2004, PARASITOLOGY, V129, pS83, DOI 10.1017/S0031182004005189; Valenzuela JG, 2002, J EXP BIOL, V205, P2843; Vullo A, 2004, BIOINFORMATICS, V20, P653, DOI 10.1093/bioinformatics/btg463; WEISMAN HF, 1990, T ASSOC AM PHYSICIAN, V103, P64; WIKEL SK, 1979, AM J TROP MED HYG, V28, P586, DOI 10.4269/ajtmh.1979.28.586; WIKEL SK, 1977, IMMUNOLOGY, V32, P457; Zupunski V, 2003, FEBS LETT, V547, P131, DOI 10.1016/S0014-5793(03)00693-8	90	52	56	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1400	10.1371/journal.pone.0001400	http://dx.doi.org/10.1371/journal.pone.0001400			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167559	Green Published, gold, Green Submitted			2022-12-25	WOS:000260468900028
J	Welle, S; Tawil, R; Thornton, CA				Welle, Stephen; Tawil, Rabi; Thornton, Charles A.			Sex-Related Differences in Gene Expression in Human Skeletal Muscle	PLOS ONE			English	Article							OLD HUMAN-SUBJECTS; PROTEIN-SYNTHESIS; BODY-COMPOSITION; TESTOSTERONE REPLACEMENT; POSTMENOPAUSAL WOMEN; HYPOGONADAL MEN; NEGATIVE REGULATION; GENDER-DIFFERENCES; ANDROGEN RECEPTOR; ELDERLY-MEN	There is sexual dimorphism of skeletal muscle, the most obvious feature being the larger muscle mass of men. The molecular basis for this difference has not been clearly defined. To identify genes that might contribute to the relatively greater muscularity of men, we compared skeletal muscle gene expression profiles of 15 normal men and 15 normal women by using comprehensive oligonucleotide microarrays. Although there were sex-related differences in expression of several hundred genes, very few of the differentially expressed genes have functions that are obvious candidates for explaining the larger muscle mass of men. The men tended to have higher expression of genes encoding mitochondrial proteins, ribosomal proteins, and a few translation initiation factors. The women had >2-fold greater expression than the men (P < 0.0001) of two genes that encode proteins in growth factor pathways known to be important in regulating muscle mass: growth factor receptor-bound 10 (GRB10) and activin A receptor IIB (ACVR2B). GRB10 encodes a protein that inhibits insulin-like growth factor-1 (IGF-1) signaling. ACVR2B encodes a myostatin receptor. Quantitative RT-PCR confirmed higher expression of GRB10 and ACVR2B genes in these women. In an independent microarray study of 10 men and 9 women with facioscapulohumeral dystrophy, women had higher expression of GRB10 (2.7-fold, P < 0.001) and ACVR2B (1.7-fold, P < 0.03). If these sex-related differences in mRNA expression lead to reduced IGF-1 activity and increased myostatin activity, they could contribute to the sex difference in muscle size.	Univ Rochester, Dept Med, Rochester, NY 14627 USA; [Tawil, Rabi; Thornton, Charles A.] Univ Rochester, Dept Neurol, Rochester, NY USA	University of Rochester; University of Rochester	Welle, S (corresponding author), Univ Rochester, Dept Med, Rochester, NY 14627 USA.	stephen_welle@urmc.rochester.edu			National Institutes of Health [AG17891, AG18254, AR/NS48143, RR00044]; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000044] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR048143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG018254, R01AG017891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The project was supported by grants from the National Institutes of Health (AG17891, AG18254, AR/NS48143, RR00044). The funding agency had no other role in the conduct of this study or preparation of this paper.	Bamman MM, 2003, J GERONTOL A-BIOL, V58, P108; Bhasin S, 1997, J CLIN ENDOCR METAB, V82, P407, DOI 10.1210/jc.82.2.407; Brodsky IG, 1996, J CLIN ENDOCR METAB, V81, P3469, DOI 10.1210/jc.81.10.3469; Brown CJ, 2003, TRENDS GENET, V19, P432, DOI 10.1016/S0168-9525(03)00177-X; COGGAN AR, 1992, J GERONTOL, V47, pB71, DOI 10.1093/geronj/47.3.B71; Dufresne AM, 2005, ENDOCRINOLOGY, V146, P4399, DOI 10.1210/en.2005-0150; FORSBERG AM, 1991, CLIN SCI, V81, P249, DOI 10.1042/cs0810249; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; HASSAGER C, 1989, METABOLISM, V38, P662, DOI 10.1016/0026-0495(89)90104-2; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Hunter SK, 2001, J APPL PHYSIOL, V91, P2686, DOI 10.1152/jappl.2001.91.6.2686; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jahn LA, 1999, J CLIN ENDOCR METAB, V84, P1007, DOI 10.1210/jc.84.3.1007; JENSEN J, 1986, MATURITAS, V8, P209, DOI 10.1016/0378-5122(86)90028-9; Kent-Braun JA, 2002, J APPL PHYSIOL, V93, P1813, DOI 10.1152/japplphysiol.00091.2002; Kim JS, 2005, AM J PHYSIOL-ENDOC M, V288, pE1110, DOI 10.1152/ajpendo.00464.2004; Langlais P, 2004, MOL ENDOCRINOL, V18, P350, DOI 10.1210/me.2003-0117; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Mauras N, 1998, J CLIN ENDOCR METAB, V83, P1886, DOI 10.1210/jc.83.6.1886; McClintick JN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-49; McMahon CD, 2003, AM J PHYSIOL-ENDOC M, V284, pE377, DOI 10.1152/ajpendo.00282.2002; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090; Osborne RJ, 2007, NEUROLOGY, V68, P569, DOI 10.1212/01.wnl.0000251269.31442.d9; Ramos FJ, 2006, AM J PHYSIOL-ENDOC M, V290, pE1262, DOI 10.1152/ajpendo.00609.2005; Reid KJ, 2001, J BIOL CHEM, V276, P2943, DOI 10.1074/jbc.M009170200; Roepstorff C, 2002, AM J PHYSIOL-ENDOC M, V282, pE435, DOI 10.1152/ajpendo.00266.2001; Roth SM, 2003, EXP BIOL MED, V228, P706, DOI 10.1177/153537020322800609; Roth SM, 2002, PHYSIOL GENOMICS, V10, P181, DOI 10.1152/physiolgenomics.00028.2002; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; SIMONEAU JA, 1989, AM J PHYSIOL, V257, pE567, DOI 10.1152/ajpendo.1989.257.4.E567; Sipila S, 2001, CLIN SCI, V101, P147, DOI 10.1042/CS20000271; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Smith MR, 2002, J CLIN ENDOCR METAB, V87, P599, DOI 10.1210/jc.87.2.599; Snyder PJ, 2000, J CLIN ENDOCR METAB, V85, P2670, DOI 10.1210/jc.85.8.2670; Staron RS, 2000, J HISTOCHEM CYTOCHEM, V48, P623, DOI 10.1177/002215540004800506; Steffensen CH, 2002, AM J PHYSIOL-ENDOC M, V282, pE634, DOI 10.1152/ajpendo.00078.2001; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taaffe DR, 2005, MED SCI SPORT EXER, V37, P1741, DOI 10.1249/01.mss.0000181678.28092.31; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; URBAN RJ, 1995, AM J PHYSIOL-ENDOC M, V269, pE820, DOI 10.1152/ajpendo.1995.269.5.E820; Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9; Walsh S, 2007, J APPL PHYSIOL, V102, P2142, DOI 10.1152/japplphysiol.01322.2006; Wang L, 2007, MOL CELL BIOL, V27, P6497, DOI 10.1128/MCB.00679-07; Welle S, 2004, EXP GERONTOL, V39, P369, DOI 10.1016/j.exger.2003.11.011; WELLE S, 1995, AM J PHYSIOL-ENDOC M, V268, pE422, DOI 10.1152/ajpendo.1995.268.3.E422; Welle S, 1999, J APPL PHYSIOL, V86, P1220, DOI 10.1152/jappl.1999.86.4.1220; Welle S, 2003, PHYSIOL GENOMICS, V14, P149, DOI 10.1152/physiolgenomics.00049.2003; Welle S, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-23; WELLE S, 1994, AM J PHYSIOL-ENDOC M, V267, pE599, DOI 10.1152/ajpendo.1994.267.4.E599; Welle S, 2007, AM J PHYSIOL-ENDOC M, V292, pE985, DOI 10.1152/ajpendo.00531.2006; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wu ZJ, 2004, NAT BIOTECHNOL, V22, P656, DOI 10.1038/nbt0604-656b; Yoshioka M, 2007, J MOL ENDOCRINOL, V39, P119, DOI 10.1677/JME-07-0027	56	113	115	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1385	10.1371/journal.pone.0001385	http://dx.doi.org/10.1371/journal.pone.0001385			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167544	Green Published, Green Submitted, gold			2022-12-25	WOS:000260468900013
J	Yang, L; Wong, CM; Lau, EHY; Chan, KP; Ou, CQ; Peiris, JSM				Yang, Lin; Wong, Chit Ming; Lau, Eric H. Y.; Chan, King Pan; Ou, Chun Quan; Peiris, Joseph S. M.			Synchrony of Clinical and Laboratory Surveillance for Influenza in Hong Kong	PLOS ONE			English	Article							RESPIRATORY SYNCYTIAL VIRUS; SPATIAL HIERARCHIES; WAVELET TRANSFORM; UNITED-STATES; TIME-SERIES; EPIDEMIOLOGY; MORTALITY; EVOLUTION; ILLNESS; ECOLOGY	Background. Consultation rates of influenza-like illness (ILI) in an outpatient setting have been regarded as a good indicator of influenza virus activity in the community. As ILI-like symptoms may be caused by etiologies other than influenza, and influenza virus activity in the tropics and subtropics is less predictable than in temperate regions, the correlation between of ILI and influenza virus activity in tropical and subtropical regions is less well defined. Methodology and Principal Findings. In this study, we used wavelet analysis to investigate the relationship between seasonality of influenza virus activity and consultation rates of ILI reported separately by General Out-patient Clinics (GOPC) and General Practitioners (GP). During the periods 1998-2000 and 2002-2003, influenza virus activity exhibited both annual and semiannual cycles, with one peak in the winter and another in late spring or early summer. But during 2001 and 2004-2006, only annual cycles could be clearly identified. ILI consultation rates in both GOPC and GP settings share a similar non-stationary seasonal pattern. We found high coherence between ILI in GOPC and influenza virus activity for the annual cycle, but this was only significant (p < 0.05) during the periods 1998-1999 and 2002-2006. For the semiannual cycle high coherence (p < 0.05) was also found significant during the period 1998-1999 and year 2003 when two peaks of influenza were evident. Similarly, ILI in GP setting is also associated with influenza virus activity for both the annual and semiannual cycles. On average, oscillation of ILI in GP and of ILI in GOPC preceded influenza virus isolation by approximately four and two weeks, respectively. Conclusions. Our findings suggest that consultation rates of ILI precede the oscillations of laboratory surveillance by at least two weeks and can be used as a predictor for influenza epidemics in Hong Kong. The validity of our model for other tropical regions needs to be explored.	[Yang, Lin; Wong, Chit Ming; Lau, Eric H. Y.; Chan, King Pan; Ou, Chun Quan] Univ Hong Kong, Dept Community Med, Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China; [Peiris, Joseph S. M.] Univ Hong Kong, Hong Kong Spec Admin Reg, Dept Microbiol, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wong, CM (corresponding author), Univ Hong Kong, Dept Community Med, Hong Kong Special Adm Reg, Hong Kong, Hong Kong, Peoples R China.	hrmrwcm@hkucc.hku.hk	YANG, Lin/F-9601-2014; Yang, Lin/E-5183-2011; Lau, Eric/AAJ-6588-2021	YANG, Lin/0000-0002-5964-3233; Lau, Eric/0000-0002-6688-9637; Ou, Chun-Quan/0000-0001-6866-7213	Research Fund for the Control of Infectious Disease of the Health, Welfare and Food Bureau of the Hong Kong Special Administrative Region Government [0405021]	Research Fund for the Control of Infectious Disease of the Health, Welfare and Food Bureau of the Hong Kong Special Administrative Region Government	This work was supported by the Research Fund for the Control of Infectious Disease of the Health, Welfare and Food Bureau of the Hong Kong Special Administrative Region Government (RFCID No. 0405021). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Broutin H, 2005, AM J EPIDEMIOL, V161, P1159, DOI 10.1093/aje/kwi141; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; Cazelles B, 2005, PLOS MED, V2, P313, DOI 10.1371/journal.pmed.0020106; *CENS STAT DEP, 2003, 12 CENS STAT DEP; Centers for Disease Control and Prevention (CDC), 2006, INFL FLU CLIN DESCR; Cowling BJ, 2006, INT J EPIDEMIOL, V35, P1314, DOI 10.1093/ije/dyl162; *CTR HLTH PROT, 2006, SENT SURV; Earn DJD, 2002, TRENDS ECOL EVOL, V17, P334, DOI 10.1016/S0169-5347(02)02502-8; Grenfell BT, 2001, NATURE, V414, P716, DOI 10.1038/414716a; Grinsted A, 2004, NONLINEAR PROC GEOPH, V11, P561, DOI 10.5194/npg-11-561-2004; Lau KM, 1995, B AM METEOROL SOC, V76, P2391, DOI 10.1175/1520-0477(1995)076<2391:CSDUWT>2.0.CO;2; Leung GM, 2005, SOC SCI MED, V61, P577, DOI 10.1016/j.socscimed.2004.12.029; Maraun D, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.016707; Maraun D, 2004, NONLINEAR PROC GEOPH, V11, P505, DOI 10.5194/npg-11-505-2004; MARAUN D, 2006, WAVELET SPECTRAL ANA; Meerhoff TJ, 2004, VIRUS RES, V103, P31, DOI 10.1016/j.virusres.2004.02.009; Monto AS, 2006, J INFECT DIS, V194, pS92, DOI 10.1086/507559; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; Navarro-Mari JM, 2005, J CLIN EPIDEMIOL, V58, P275, DOI 10.1016/j.jclinepi.2004.08.014; Ohmit SE, 2006, CLIN INFECT DIS, V43, P564, DOI 10.1086/506352; Shih SR, 2005, J CLIN MICROBIOL, V43, P1651, DOI 10.1128/JCM.43.4.1651-1661.2005; SHORTRIDGE KF, 1982, LANCET, V2, P812; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Thursky K, 2003, J CLIN VIROL, V27, P170, DOI 10.1016/S1386-6532(02)00172-5; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Torrence C, 1999, J CLIMATE, V12, P2679, DOI 10.1175/1520-0442(1999)012<2679:ICITEM>2.0.CO;2; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; *WHO, 2002, WKLY EPIDEMIOL REC, V77, P191; Wong CM, 2006, PLOS MED, V3, P485, DOI 10.1371/journal.pmed.0030121; Wong CM, 2004, CLIN INFECT DIS, V39, P1611, DOI 10.1086/425315; Zambon MC, 2001, LANCET, V358, P1410, DOI 10.1016/S0140-6736(01)06528-X	35	61	63	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1399	10.1371/journal.pone.0001399	http://dx.doi.org/10.1371/journal.pone.0001399			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167558	Green Submitted, Green Published, gold			2022-12-25	WOS:000260468900027
J	Dvir-Ginzberg, M; Elkayam, T; Cohen, S				Dvir-Ginzberg, Mona; Elkayam, Tsiona; Cohen, Smadar			Induced differentiation and maturation of newborn liver cells into functional hepatic tissue in macroporous alginate scaffolds	FASEB JOURNAL			English	Article						cell-to-cell contacts; spheroids; cell polarity; collagen scaffolds; tissue engineering	HEMATOPOIETIC STEM-CELLS; ONCOSTATIN-M; HEPATOCYTE SPHEROIDS; BIOARTIFICIAL LIVER; FETAL LIVER; MOUSE-LIVER; IN-VITRO; GROWTH; SURFACES; COLLAGEN	The present work explores cell cultivation in macroporous alginate scaffolds as a means to reproduce hepatocyte terminal differentiation in vitro. Newborn rat liver cell isolates, consisting of proliferating hepatocytes and progenitors, were seeded at high cell density of 125 x 10(6)/cm(3) within the scaffold and then cultivated for 6 wk in chemically defined medium. Within 3 days, the alginate-seeded cells expressed genes for mature liver enzymes, such as trypthophan oxygenase, secreted a high level of albumin, and performed phase I drug metabolism. The cells formed compacted spheroids, establishing homotypic and heterotypic cell-to-cell interactions. By 6 wk, the spheroids developed into organoids, with an external mature hepatocyte layer covered by a laminin layer encasing inner vimentin-positive cells within a laminin-rich matrix also containing collagen. The hepatocytes presented a distinct apical surface between adjacent cells and a basolateral surface with microvilli facing extracellular matrix deposits. By contrast, viable adherent cells within collagen scaffolds presenting the identical porous structure did not express adult liver enzymes or secrete albumin after 6 wk. This study thus illustrates the benefits of cell cultivation in macroporous; alginate scaffolds as an effective promoter for the maturation of newborn liver cells into functional hepatic tissue, capable of maintaining prolonged hepatoceffular functions.	[Dvir-Ginzberg, Mona; Cohen, Smadar] Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel; [Elkayam, Tsiona; Cohen, Smadar] Ben Gurion Univ Negev, Dept Biomed Engn, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University	Cohen, S (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, Bldg 39,Rm 222,POB 653, IL-84105 Beer Sheva, Israel.	scohen@bgu.ac.il	Dvir-Ginzberg, Mona/AAZ-9858-2021; COHEN, SMADAR/F-1901-2012	Dvir-Ginzberg, Mona/0000-0003-3089-6875; 				Alexander B, 1997, ANAT REC, V248, P104, DOI 10.1002/(SICI)1097-0185(199705)248:1<104::AID-AR12>3.0.CO;2-T; Beaulieu Jean-Francois, 1999, Frontiers in Bioscience, V4, pD310, DOI 10.2741/Beaulieu; Behnia K, 2000, TISSUE ENG, V6, P467, DOI 10.1089/107632700750022125; Bosman FT, 2003, J PATHOL, V200, P423, DOI 10.1002/path.1437; Brill S, 1999, DIGEST DIS SCI, V44, P364, DOI 10.1023/A:1026666820422; BRUNK CF, 1979, ANAL BIOCHEM, V92, P497, DOI 10.1016/0003-2697(79)90690-0; CLEMENT B, 1988, HEPATOLOGY, V8, P794, DOI 10.1002/hep.1840080417; Demetriou AA, 2004, ANN SURG, V239, P660, DOI 10.1097/01.sla.0000124298.74199.e5; Dvir-Ginzberg M, 2004, TISSUE ENG, V10, P1806, DOI 10.1089/ten.2004.10.1806; Ehashi T, 2005, J CELL PHYSIOL, V202, P698, DOI 10.1002/jcp.20167; Fox IJ, 2004, J HEPATOL, V40, P878, DOI 10.1016/j.jhep.2004.04.009; Fukuda J, 2006, BIOMATERIALS, V27, P5259, DOI 10.1016/j.biomaterials.2006.05.044; Glicklis R, 2004, BIOTECHNOL BIOENG, V86, P672, DOI 10.1002/bit.20086; Glicklis R, 2000, BIOTECHNOL BIOENG, V67, P344, DOI 10.1002/(SICI)1097-0290(20000205)67:3<344::AID-BIT11>3.0.CO;2-2; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; HANSEN LK, 1994, MOL BIOL CELL, V5, P967, DOI 10.1091/mbc.5.9.967; Hoshiba T, 2007, BIOCHEM BIOPH RES CO, V359, P151, DOI 10.1016/j.bbrc.2007.05.079; Jiang JL, 2004, TISSUE ENG, V10, P1577, DOI 10.1089/ten.2004.10.1577; JUNKER JL, 1987, CANCER RES, V47, P3802; Kamiya A, 2002, HEPATOLOGY, V35, P1351, DOI 10.1053/jhep.2002.33331; Kedem A, 2005, TISSUE ENG, V11, P715, DOI 10.1089/ten.2005.11.715; Krasteva N, 2004, BIOMATERIALS, V25, P2467, DOI 10.1016/j.biomaterials.2003.09.031; Lazaro CA, 2003, HEPATOLOGY, V38, P1095, DOI 10.1053/jhep.2003.50448; Lee BC, 2007, MICROSC RES TECHNIQ, V70, P34, DOI 10.1002/jemt.20383; Mahieu-Caputo D, 2004, HUM GENE THER, V15, P1219, DOI 10.1089/hum.2004.15.1219; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; MOONEY D, 1992, J CELL PHYSIOL, V151, P497, DOI 10.1002/jcp.1041510308; Ohashi K, 2007, NAT MED, V13, P880, DOI 10.1038/nm1576; OJAKIAN GK, 1994, J CELL SCI, V107, P561; Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036; Shapiro L, 1997, BIOMATERIALS, V18, P583, DOI 10.1016/S0142-9612(96)00181-0; Shimano K, 2003, AM J PATHOL, V163, P3, DOI 10.1016/S0002-9440(10)63624-3; Smith MK, 2007, J BIOMED MATER RES A, V80A, P520, DOI 10.1002/jbm.a.30930; Tsang VL, 2007, FASEB J, V21, P790, DOI 10.1096/fj.06-7117com; Uchida N, 2001, J CLIN INVEST, V108, P1071, DOI 10.1172/JCI13297; Uchida N, 2002, EXP HEMATOL, V30, P862, DOI 10.1016/S0301-472X(02)00879-2; van de Kerkhove MP, 2004, ANN SURG, V240, P216, DOI 10.1097/01.sla.0000132986.75257.19; Van Poll D, 2006, TISSUE ENG, V12, P2965; Weadock KS, 1996, J BIOMED MATER RES, V32, P221, DOI 10.1002/(SICI)1097-4636(199610)32:2<221::AID-JBM11>3.0.CO;2-M; Zinchenko YS, 2005, J BIOMED MATER RES A, V75A, P242, DOI 10.1002/jbm.a.30399; Zmora S, 2002, BIOMATERIALS, V23, P4087, DOI 10.1016/S0142-9612(02)00146-1	41	47	54	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2008	22	5					1440	1449		10.1096/fj.07-9277com	http://dx.doi.org/10.1096/fj.07-9277com			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18070820				2022-12-25	WOS:000255898700016
J	Olshavsky, NA; Groh, EM; Comstock, CES; Morey, LM; Wang, Y; Revelo, MP; Burd, C; Meller, J; Knudsen, KE				Olshavsky, N. A.; Groh, E. M.; Comstock, C. E. S.; Morey, L. M.; Wang, Y.; Revelo, M. P.; Burd, C.; Meller, J.; Knudsen, K. E.			Cyclin D3 action in androgen receptor regulation and prostate cancer	ONCOGENE			English	Article						cell cycle; prostatic adenocarcinoma; CDK; PSA and G1	VITAMIN-D-RECEPTOR; D-DEPENDENT KINASE; ESTROGEN-RECEPTOR; TRANSCRIPTIONAL ACTIVITY; CELL-LINES; D1-DEPENDENT KINASE; BINDING DOMAIN; GROWTH-FACTOR; CO-REPRESSOR; G(1) PHASE	Prostate cancer (PCa) cell proliferation is dependent on activation of the androgen receptor (AR), a ligand-dependent transcription factor. AR activation controls G1-S phase progression through fostering enhanced translation of the D-type cyclins, which promote cell cycle progression through activation of CDK4/6. However, the D-type cyclins harbor additional, CDK4/6 kinase-independent, functions through manipulation of transcription factors, including AR. It was previously established that cyclins D1 and D3 have the potential to modulate AR, and with regard to cyclin D1, disruption of this function occurs in human tumors. Therefore, it was essential to interrogate cyclin D3 function in this tumor type. Here, we show that cyclin D3 is found in association with AR in PCa cells, as mediated through a conserved motif. Cyclin D3 functions to attenuate AR activity through defined mechanisms that include modulation of ligand-dependent conformational changes and modulation of chromatin binding activity. Accumulated cyclin D3 slows cell proliferation in AR-dependent cells, thus suggesting that androgen-induced D-type cyclin production serves to temper the mitogenic response to androgen. Supporting this hypothesis, it is shown that cyclin D3 expression is reduced in primary PCas as a function of tumor grade, and inversely correlates with the proliferative index. In total, these data identify cyclin D3 as a critical modulator of the androgen response, whose deregulation may foster unchecked AR activity in PCa.	[Olshavsky, N. A.; Groh, E. M.; Comstock, C. E. S.; Morey, L. M.; Wang, Y.; Knudsen, K. E.] Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Cell & Canc Biol, Cincinnati, OH 45267 USA; [Revelo, M. P.] Univ Utah, Dept Pathol & Lab Med, Salt Lake City, UT USA; [Burd, C.] NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA; [Meller, J.; Knudsen, K. E.] Univ Cincinnati, Coll Med, UC Canc Ctr, Cincinnati, OH USA; [Meller, J.] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Knudsen, K. E.] Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati; Utah System of Higher Education; University of Utah; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Knudsen, KE (corresponding author), Univ Cincinnati, Coll Med, Vontz Ctr Mol Studies, Dept Cell & Canc Biol, 3125 Eden Ave,ML0521, Cincinnati, OH 45267 USA.	Karen.Knudsen@uc.edu	Meller, Jaroslaw/A-1971-2011; Duch, Wlodzislaw/A-2002-2011; Comstock, Clay/B-6122-2008	Meller, Jaroslaw/0000-0002-1162-8253; Duch, Wlodzislaw/0000-0001-7882-4729; Comstock, Clay/0000-0001-5867-1489; Burd, Craig/0000-0002-6899-6751; Knudsen, Karen/0000-0002-1301-890X	NATIONAL CANCER INSTITUTE [R01CA116777, T32CA117846, R01CA099996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007250] Funding Source: NIH RePORTER; NCI NIH HHS [CA099996, CA116777, T32 CA117846, T32-CA117846] Funding Source: Medline; NIEHS NIH HHS [T32-ES07250] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		ARAP W, 1995, CANCER RES, V55, P1351; Bienvenu F, 2001, J BIOL CHEM, V276, P16840, DOI 10.1074/jbc.M100795200; Braden WA, 2006, MOL CELL BIOL, V26, P7667, DOI 10.1128/MCB.00045-06; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Burd CJ, 2005, MOL ENDOCRINOL, V19, P607, DOI 10.1210/me.2004-0266; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Comstock CES, 2007, BRIT J CANCER, V96, P970, DOI 10.1038/sj.bjc.6603615; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Ewen ME, 2004, TRENDS MOL MED, V10, P158, DOI 10.1016/j.molmed.2004.02.005; EWEN ME, 1993, CELL, V73, P487, DOI 10.1016/0092-8674(93)90136-E; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Fribourg AF, 2000, CELL GROWTH DIFFER, V11, P361; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Ganter B, 1998, EMBO J, V17, P255, DOI 10.1093/emboj/17.1.255; He B, 2000, J BIOL CHEM, V275, P22986, DOI 10.1074/jbc.M002807200; Hedberg Y, 2002, ACTA ONCOL, V41, P175, DOI 10.1080/028418602753669562; HUANG HJS, 1988, SCIENCE, V242, P1563, DOI 10.1126/science.3201247; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Jian YZ, 2005, BIOCHEM BIOPH RES CO, V335, P739, DOI 10.1016/j.bbrc.2005.07.141; KAIGHN ME, 1979, INVEST UROL, V17, P16; Kato A, 1998, BIOCHEM BIOPH RES CO, V245, P70, DOI 10.1006/bbrc.1998.8377; KATO JY, 1993, P NATL ACAD SCI USA, V90, P11513, DOI 10.1073/pnas.90.24.11513; KIESS M, 1995, ONCOGENE, V10, P159; Knudsen KE, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-15; Knudsen KE, 1999, CANCER RES, V59, P2297; Knudsen KE, 2006, ONCOGENE, V25, P1620, DOI 10.1038/sj.onc.1209371; Knudsen KE, 1998, J BIOL CHEM, V273, P20213, DOI 10.1074/jbc.273.32.20213; Lamb J, 2000, MOL CELL BIOL, V20, P8667, DOI 10.1128/MCB.20.23.8667-8675.2000; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; LI J, 2007, MOL ENDOCRINOL; Lim J, 2000, MOL ENDOCRINOL, V14, P1187, DOI 10.1210/me.14.8.1187; Lim JTE, 2005, P NATL ACAD SCI USA, V102, P5156, DOI 10.1073/pnas.0501203102; Lin HM, 2002, J BIOL CHEM, V277, P28733, DOI 10.1074/jbc.M203380200; Link KA, 2005, MOL CELL BIOL, V25, P2200, DOI 10.1128/MCB.25.6.2200-2215.2005; MATSUSHIME H, 1992, CELL, V71, P323, DOI 10.1016/0092-8674(92)90360-O; McMahon C, 1999, P NATL ACAD SCI USA, V96, P5382, DOI 10.1073/pnas.96.10.5382; Miehlke S, 2002, DIGEST DIS SCI, V47, P1248, DOI 10.1023/A:1015358127751; Miller GJ, 1995, CLIN CANCER RES, V1, P997; Mittnacht S, 1998, CURR OPIN GENET DEV, V8, P21, DOI 10.1016/S0959-437X(98)80057-9; Neuman E, 1997, MOL CELL BIOL, V17, P5338, DOI 10.1128/MCB.17.9.5338; Parry D, 1999, MOL CELL BIOL, V19, P1775; Perry JE, 1998, PROSTATE, V35, P117; Peterson LF, 2005, MOL CELL BIOL, V25, P10205, DOI 10.1128/MCB.25.23.10205-10219.2005; Petre CE, 2002, J BIOL CHEM, V277, P2207, DOI 10.1074/jbc.M106399200; Petre-Draviam CE, 2005, ONCOGENE, V24, P431, DOI 10.1038/sj.onc.1208200; Petre-Draviam CE, 2003, CANCER RES, V63, P4903; QUELLE DE, 1993, GENE DEV, V7, P1559, DOI 10.1101/gad.7.8.1559; RAO SS, 1995, J BIOL CHEM, V270, P4093, DOI 10.1074/jbc.270.8.4093; Reutens AT, 2001, MOL ENDOCRINOL, V15, P797, DOI 10.1210/me.15.5.797; RUNDLETT SE, 1990, MOL ENDOCRINOL, V4, P708, DOI 10.1210/mend-4-5-708; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; SCHWARTZ GG, 1994, ANTICANCER RES, V14, P1077; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sicinska E, 2003, CANCER CELL, V4, P451, DOI 10.1016/S1535-6108(03)00301-5; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; SKAPEK SX, 1995, SCIENCE, V267, P1022, DOI 10.1126/science.7863328; SKOWRONSKI RJ, 1993, ENDOCRINOLOGY, V132, P1952, DOI 10.1210/en.132.5.1952; Timchenko LT, 2006, J BIOL CHEM, V281, P32806, DOI 10.1074/jbc.M605701200; Wang CG, 2003, MOL CELL BIOL, V23, P6159, DOI 10.1128/MCB.23.17.6159-6173.2003; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang GL, 2007, J BIOL CHEM, V282, P1468, DOI 10.1074/jbc.M608226200; Wetherill YB, 2006, MOL CANCER THER, V5, P3181, DOI 10.1158/1535-7163.MCT-06-0272; Xu YY, 2006, CANCER RES, V66, P7783, DOI 10.1158/0008-5472.CAN-05-4472; Zhuang SH, 1997, MOL CELL ENDOCRINOL, V126, P83, DOI 10.1016/S0303-7207(96)03974-3; Zong HL, 2007, MOL CELL BIOL, V27, P7125, DOI 10.1128/MCB.01753-06; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	69	23	24	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2008	27	22					3111	3121		10.1038/sj.onc.1210981	http://dx.doi.org/10.1038/sj.onc.1210981			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	301LL	18084330				2022-12-25	WOS:000255897600004
J	Fatehi, M; Linsdell, P				Fatehi, Mohammad; Linsdell, Paul			State-dependent access of anions to the cystic fibrosis transmembrane conductance regulator chloride channel pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; LINING RESIDUES; BINDING-SITE; CFTR; PERMEATION; CYSTEINE; IDENTIFICATION; PERMEABILITY; VESTIBULE; BLOCK	The cystic fibrosis transmembrane conductance regulator ( CFTR) Cl- channel is gated by intracellular factors; however, conformational changes in the channel pore associated with channel activation have not been identified. We have used patch clamp recording to investigate the state-dependent accessibility of substituted cysteine residues in the CFTR channel pore to a range of cysteine-reactive reagents applied to the extracellular side of the membrane. Using functional modification of the channel current-voltage relationship as a marker of modification, we find that several positively charged reagents are able to penetrate deeply into the pore from the outside irrespective of whether or not the channels have been activated. In contrast, access of three anionic cysteine-reactive reagents, the methanesulfonate sodium (2-sulfonatoethyl) methanesulfonate, the organic mercurial p-chloromercuriphenylsulfonic acid, and the permeant anion Au(CN)(2)(-), to several different sites in the pore is strictly limited prior to channel activation. This suggests that in nonactivated channels some ion selectivity mechanism exists to exclude anions yet permit cations into the channel pore from the extracellular solution. We suggest that activation of CFTR channels involves a conformational change in the pore that removes a strong selectivity against anion entry from the extracellular solution. We propose further that this conformational change occurs in advance of channel opening, suggesting that multiple distinct closed pore conformations exist.	[Fatehi, Mohammad; Linsdell, Paul] Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 1X5, Canada	Dalhousie University	Linsdell, P (corresponding author), Dalhousie Univ, Dept Physiol & Biophys, Halifax, NS B3H 1X5, Canada.	paul.linsdell@dal.ca		Linsdell, Paul/0000-0001-6257-6273				Aleksandrov AA, 2007, PFLUG ARCH EUR J PHY, V453, P693, DOI 10.1007/s00424-006-0140-z; Aubin CNS, 2006, J GEN PHYSIOL, V128, P535, DOI 10.1085/jgp.200609516; Cheung M, 1996, BIOPHYS J, V70, P2688, DOI 10.1016/S0006-3495(96)79838-7; Gadsby DC, 2006, NATURE, V440, P477, DOI 10.1038/nature04712; Gong XD, 2003, J GEN PHYSIOL, V122, P673, DOI 10.1085/jgp.200308889; Gong XD, 2003, J PHYSIOL-LONDON, V549, P387, DOI 10.1113/jphysiol.2002.038232; Gong XD, 2002, J PHYSIOL-LONDON, V540, P39, DOI 10.1113/jphysiol.2001.013235; Kidd JF, 2004, CURR TOP DEV BIOL, V60, P215; Linsdell P, 2006, EXP PHYSIOL, V91, P123, DOI 10.1113/expphysiol.2005.031757; Linsdell P, 2005, J BIOL CHEM, V280, P8945, DOI 10.1074/jbc.M414354200; Linsdell P, 1998, J GEN PHYSIOL, V111, P601, DOI 10.1085/jgp.111.4.601; Linsdell P, 1996, J PHYSIOL-LONDON, V496, P687, DOI 10.1113/jphysiol.1996.sp021719; Liu XH, 2004, BIOPHYS J, V87, P3826, DOI 10.1529/biophysj.104.050534; MCDONOUGH S, 1994, NEURON, V13, P623, DOI 10.1016/0896-6273(94)90030-2; RIORDAN JR, 1989, SCIENCE, V245, P1066; Rosenberg MF, 2004, J BIOL CHEM, V279, P39051, DOI 10.1074/jbc.M407434200; Serrano JR, 2006, BIOPHYS J, V91, P1737, DOI 10.1529/biophysj.105.078899; Sheppard David N., 1999, Physiological Reviews, V79, pS23; Smith SS, 2001, J GEN PHYSIOL, V118, P407, DOI 10.1085/jgp.118.4.407; Smith SS, 1999, J GEN PHYSIOL, V114, P799, DOI 10.1085/jgp.114.6.799; Zhang ZR, 2005, J BIOL CHEM, V280, P41997, DOI 10.1074/jbc.M510242200; Zhou JJ, 2007, J MEMBRANE BIOL, V216, P129, DOI 10.1007/s00232-007-9056-6	22	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6102	6109		10.1074/jbc.M707736200	http://dx.doi.org/10.1074/jbc.M707736200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167343	hybrid			2022-12-25	WOS:000253779500016
J	Horita, Y; Ohashi, K; Mukai, M; Inoue, M; Mizuno, K				Horita, Yuji; Ohashi, Kazumasa; Mukai, Mutsuko; Inoue, Masahiro; Mizuno, Kensaku			Suppression of the invasive capacity of rat ascites hepatoma cells by knockdown of slingshot or LIM kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-ASSOCIATED KINASE; MEDIATED ACTIN REORGANIZATION; COFILIN PHOSPHORYLATION; LYSOPHOSPHATIDIC-ACID; PROTEIN-KINASE; CYTOSKELETAL DYNAMICS; FILAMENT TURNOVER; CANCER INVASION; FOCAL ADHESION; TUMOR-CELLS	Actin cytoskeletal reorganization is essential for tumor cell migration, adhesion, and invasion. Cofilin and actin-depolymerizing factor (ADF) act as key regulators of actin cytoskeletal dynamics by stimulating depolymerization and severing of actin filaments. Cofilin/ADF are inactivated by phosphorylation of Ser-3 by LIM kinase-1 (LIMK1) and reactivated by dephosphorylation by Slingshot-1 (SSH1) and -2 (SSH2) protein phosphatases. In this study, we examined the roles of cofilin/ADF, LIMK1, and SSH1/SSH2 in tumor cell invasion, using an in vitro transcellular migration assay. In this assay, rat ascites hepatoma (MM1) cells were overlaid on a primary-cultured rat mesothelial cell monolayer and the number of cell foci that transmigrated underneath the monolayer in the presence of lysophosphatidic acid (LPA) was counted. The knockdown of cofilin/ADF, LIMK1, or SSH1/SSH2 expression by small interfering RNAs (siRNAs) significantly decreased the LPA-induced transcellular migration of MM1 cells and their motility in two-dimensional culture. Knockdown of LIMK1 also suppressed fibronectin-mediated cell attachment and focal adhesion formation. Our results suggest that both LIMK1-mediated phosphorylation and SSH1/SSH2-mediated dephosphorylation of cofilin/ADF are critical for the migration and invasion of tumor cells and that LIMK1 is involved in the transcellular migration of tumor cells by enhancing both adhesion and motility of the cells.	[Horita, Yuji; Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Mukai, Mutsuko; Inoue, Masahiro] Osaka Med Ctr Canc & Cardiovasc Dis, Dept Biochem, Osaka 5378511, Japan	Tohoku University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Mizuno, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan.	kmizuno@biology.tohoku.ac.jp	Ohashi, Kazumasa/U-7028-2019; Mizuno, Kensaku/G-8631-2015	Ohashi, Kazumasa/0000-0001-7617-403X; 				AKEDO H, 1986, CANCER RES, V46, P2416; Amano T, 2002, J BIOL CHEM, V277, P22093, DOI 10.1074/jbc.M201444200; Amano T, 2001, BIOCHEM J, V354, P149, DOI 10.1042/0264-6021:3540149; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Ayaki M, 2000, BBA-MOL CELL RES, V1495, P40, DOI 10.1016/S0167-4889(99)00153-6; Bagheri-Yarmand R, 2006, INT J CANCER, V118, P2703, DOI 10.1002/ijc.21650; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Davila M, 2003, J BIOL CHEM, V278, P36868, DOI 10.1074/jbc.M306196200; Dawe HR, 2003, CURR BIOL, V13, P252, DOI 10.1016/S0960-9822(03)00040-X; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Endo M, 2007, J BIOL CHEM, V282, P13692, DOI 10.1074/jbc.M610873200; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hotulainen P, 2005, MOL BIOL CELL, V16, P649, DOI 10.1091/mbc.E04-07-0555; Imamura F, 2000, JPN J CANCER RES, V91, P811, DOI 10.1111/j.1349-7006.2000.tb01018.x; Imamura F, 1996, INT J CANCER, V65, P627, DOI 10.1002/(SICI)1097-0215(19960301)65:5<627::AID-IJC12>3.0.CO;2-4; IMAMURA F, 1993, BIOCHEM BIOPH RES CO, V193, P497, DOI 10.1006/bbrc.1993.1651; Itoh K, 1999, NAT MED, V5, P221, DOI 10.1038/5587; Kiuchi T, 2007, J CELL BIOL, V177, P465, DOI 10.1083/jcb.200610005; Kobayashi M, 2006, EMBO J, V25, P713, DOI 10.1038/sj.emboj.7600973; Lappalainen P, 1997, NATURE, V388, P78, DOI 10.1038/40418; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Mouneimne G, 2006, CURR BIOL, V16, P2193, DOI 10.1016/j.cub.2006.09.016; MUKAI M, 1987, CANCER RES, V47, P2167; Nagata-Ohashi K, 2004, J CELL BIOL, V165, P465, DOI 10.1083/jcb.200401136; Nishita M, 2005, J CELL BIOL, V171, P349, DOI 10.1083/jcb.200504029; Nishita M, 2002, MOL CELL BIOL, V22, P774, DOI 10.1128/MCB.22.3.774-783.2002; Niwa R, 2002, CELL, V108, P233, DOI 10.1016/S0092-8674(01)00638-9; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ohta Y, 2003, GENES CELLS, V8, P811, DOI 10.1046/j.1365-2443.2003.00678.x; Okano I, 1995, J BIOL CHEM, V270, P31321, DOI 10.1074/jbc.270.52.31321; Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sahai E, 2001, EMBO J, V20, P755, DOI 10.1093/emboj/20.4.755; Sahai E, 2005, CURR OPIN GENET DEV, V15, P87, DOI 10.1016/j.gde.2004.12.002; Sumi T, 1999, J CELL BIOL, V147, P1519, DOI 10.1083/jcb.147.7.1519; Theriot JA, 1997, J CELL BIOL, V136, P1165, DOI 10.1083/jcb.136.6.1165; Tomiyoshi G, 2004, GENES CELLS, V9, P591, DOI 10.1111/j.1356-9597.2004.00745.x; Toshima J, 2001, MOL BIOL CELL, V12, P1131, DOI 10.1091/mbc.12.4.1131; Wang W, 2006, J CELL BIOL, V173, P395, DOI 10.1083/jcb.200510115; Wang WG, 2007, NAT REV CANCER, V7, P429, DOI 10.1038/nrc2148; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Yoshioka K, 2003, P NATL ACAD SCI USA, V100, P7247, DOI 10.1073/pnas.1232344100; Yoshioka K, 1998, J BIOL CHEM, V273, P5146, DOI 10.1074/jbc.273.9.5146; Zebda N, 2000, J CELL BIOL, V151, P1119, DOI 10.1083/jcb.151.5.1119	49	47	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6013	6021		10.1074/jbc.M706538200	http://dx.doi.org/10.1074/jbc.M706538200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171679	hybrid			2022-12-25	WOS:000253779500006
J	Paland, N; Bohme, L; Gurumurthy, RK; Maeurer, A; Szczepek, AJ; Rudel, T				Paland, Nicole; Bohme, Linda; Gurumurthy, Rajendra Kumar; Maeurer, Andre; Szczepek, Agnes J.; Rudel, Thomas			Reduced display of tumor necrosis factor receptor I at the host cell surface supports infection with Chlamydia trachomatis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-CONVERTING-ENZYME; FACTOR TNF RECEPTOR; NF-KAPPA-B; CHLAMYDOPHILA-PNEUMONIAE; GAMMA-INTERFERON; EPITHELIAL-CELLS; MOLECULAR-CLONING; INDUCED ARTHRITIS; POTENTIAL ROLE; LIPID RAFTS	The obligate intracellular human pathogenic bacterium Chlamydia trachomatis has evolved multiple mechanisms to circumvent the host immune system. Infected cells exhibit a profound resistance to the induction of apoptosis and down-regulate the expression of major histocompatibility complex class I and class II molecules to evade the cytotoxic effect of effector immune cells. Here we demonstrate the down-regulation of tumor necrosis factor receptor 1 (TNFR1) on the surface of infected cells. Interestingly, other members of the TNFR family such as TNFR2 and CD95 (Fas/Apo-1) were not modulated during infection, suggesting a selective mechanism underlying surface reduction of TNFR1. The observed effect was not due to reduced expression since the overall amount of TNFR1 protein was increased in infected cells. TNFR1 accumulated at the chlamydial inclusion and was shed by the infected cell into the culture supernatant. Receptor shedding depended on the infection-induced activation of the MEK-ERK pathway and the metalloproteinase TACE (TNF alpha converting enzyme). Our results point to a new function of TNFR1 modulation by C. trachomatis in controlling inflammatory signals during infection.	[Paland, Nicole; Bohme, Linda; Gurumurthy, Rajendra Kumar; Maeurer, Andre; Szczepek, Agnes J.; Rudel, Thomas] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Paland, Nicole; Bohme, Linda; Rudel, Thomas] Max Planck Inst Infect Biol, Res Grp Mol Infect & Tumor Biol, D-10117 Berlin, Germany	Max Planck Society; Max Planck Society	Rudel, T (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Charitepl 1, D-10117 Berlin, Germany.	rudel@mpiib-berlin.mpg.de	Szczepek, Agnieszka J./C-1434-2019; Szczepek, Agnieszka/AAK-8514-2021; Paland, Nicole/AAK-7591-2020	Szczepek, Agnieszka J./0000-0002-9292-6606; Szczepek, Agnieszka/0000-0002-9292-6606; Paland, Nicole/0000-0003-4295-1501; Gurumurthy, Rajendra Kumar/0000-0001-6479-8080				Aderka Dan, 1996, Cytokine and Growth Factor Reviews, V7, P231, DOI 10.1016/S1359-6101(96)00026-3; Al-Younes HM, 1999, CELL MICROBIOL, V1, P237, DOI 10.1046/j.1462-5822.1999.00024.x; Baillie J, 2003, J VIROL, V77, P7007, DOI 10.1128/JVI.77.12.7007-7016.2003; Balakrishnan A, 2006, J BIOL CHEM, V281, P16691, DOI 10.1074/jbc.M513648200; BEATTY WL, 1994, INFECT IMMUN, V62, P3705, DOI 10.1128/IAI.62.9.3705-3711.1994; BIGDA J, 1994, J EXP MED, V180, P445, DOI 10.1084/jem.180.2.445; Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Buxton D, 2002, J COMP PATHOL, V127, P133, DOI 10.1053/jcpa.2002.0573; Carabeo RA, 2003, P NATL ACAD SCI USA, V100, P6771, DOI 10.1073/pnas.1131289100; Conway DJ, 1997, INFECT IMMUN, V65, P1003, DOI 10.1128/IAI.65.3.1003-1006.1997; Cottin V, 1999, J BIOL CHEM, V274, P32975, DOI 10.1074/jbc.274.46.32975; Cottin V, 2002, J IMMUNOL, V168, P4095, DOI 10.4049/jimmunol.168.8.4095; Diaz-Rodriguez E, 2002, MOL BIOL CELL, V13, P2031, DOI 10.1091/mbc.01-11-0561; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; Fan T, 1998, J EXP MED, V187, P487, DOI 10.1084/jem.187.4.487; FIERS W, 1991, FEBS LETT, V285, P199, DOI 10.1016/0014-5793(91)80803-B; Fischer SF, 2001, INFECT IMMUN, V69, P7121, DOI 10.1128/IAI.69.11.7121-7129.2001; GRAY PW, 1990, P NATL ACAD SCI USA, V87, P7380, DOI 10.1073/pnas.87.19.7380; HACKSTADT T, 1995, P NATL ACAD SCI USA, V92, P4877, DOI 10.1073/pnas.92.11.4877; Hannu T, 2006, BEST PRACT RES CL RH, V20, P419, DOI 10.1016/j.berh.2006.02.003; Haralambieva IH, 2004, J MED MICROBIOL, V53, P1187, DOI 10.1099/jmm.0.45758-0; Heinemann M, 1996, INFECT IMMUN, V64, P4872, DOI 10.1128/IAI.64.11.4872-4875.1996; HOLTMANN H, 1990, INFECT IMMUN, V58, P3168, DOI 10.1128/IAI.58.10.3168-3172.1990; Jia Wei, 2005, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V21, P1; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kohler L, 1997, AKTUEL RHEUMATOL, V22, P170, DOI 10.1055/s-2008-1043652; KOHNO T, 1990, P NATL ACAD SCI USA, V87, P8331, DOI 10.1073/pnas.87.21.8331; LOETSCHER H, 1990, CELL, V61, P351, DOI 10.1016/0092-8674(90)90815-V; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Morrison TE, 2004, J VIROL, V78, P544, DOI 10.1128/JVI.78.1.544-549.2004; Moss ML, 1997, J NEUROIMMUNOL, V72, P127, DOI 10.1016/S0165-5728(96)00180-4; NOPHAR Y, 1990, EMBO J, V9, P3269, DOI 10.1002/j.1460-2075.1990.tb07526.x; NOVICK D, 1989, J EXP MED, V170, P1409, DOI 10.1084/jem.170.4.1409; Paland N, 2006, CELL MICROBIOL, V8, P1643, DOI 10.1111/j.1462-5822.2006.00739.x; Pedron T, 2003, J BIOL CHEM, V278, P20555, DOI 10.1074/jbc.M203551200; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; Quintana A, 2005, J NEUROSCI RES, V82, P701, DOI 10.1002/jnr.20680; Rajalingam K, 2001, INFECT IMMUN, V69, P7880, DOI 10.1128/IAI.69.12.7880-7888.2001; RAQIB R, 1995, INFECT IMMUN, V63, P3079, DOI 10.1128/IAI.63.8.3079-3087.1995; Reddy P, 2000, J BIOL CHEM, V275, P14608, DOI 10.1074/jbc.275.19.14608; Rottenberg ME, 2002, CURR OPIN IMMUNOL, V14, P444, DOI 10.1016/S0952-7915(02)00361-8; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SHEMERAVNI Y, 1988, INFECT IMMUN, V56, P2503, DOI 10.1128/IAI.56.9.2503-2506.1988; Shirey KA, 2006, INFECT IMMUN, V74, P2482, DOI 10.1128/IAI.74.4.2482-2486.2006; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Soond SM, 2005, J CELL SCI, V118, P2371, DOI 10.1242/jcs.02357; Stenner-Liewen F, 2002, J BIOL CHEM, V277, P9633, DOI 10.1074/jbc.C100693200; Stephens RS, 2003, TRENDS MICROBIOL, V11, P44, DOI 10.1016/S0966-842X(02)00011-2; Su H, 2004, J BIOL CHEM, V279, P9409, DOI 10.1074/jbc.M312008200; Tellier E, 2006, EXP CELL RES, V312, P3969, DOI 10.1016/j.yexcr.2006.08.027; Waetzig GH, 2004, FASEB J, V18, P91, DOI 10.1096/fj.04-2073fje; Wang J, 2003, J BIOL CHEM, V278, P21751, DOI 10.1074/jbc.M212662200; Xanthoulea S, 2004, J EXP MED, V200, P367, DOI 10.1084/jem.20040435; Zeidler H, 2004, CURR OPIN RHEUMATOL, V16, P380, DOI 10.1097/01.bor.0000126150.04251.f9; Zhang XD, 2000, J IMMUNOL, V164, P3961, DOI 10.4049/jimmunol.164.8.3961; Zhong GM, 1999, J EXP MED, V189, P1931, DOI 10.1084/jem.189.12.1931; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935; Zhong GM, 2000, J EXP MED, V191, P1525, DOI 10.1084/jem.191.9.1525	59	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6438	6448		10.1074/jbc.M708422200	http://dx.doi.org/10.1074/jbc.M708422200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18167350	hybrid			2022-12-25	WOS:000253779500051
J	Tang, DM; Mar, K; Warren, G; Wang, YZ				Tang, Danming; Mar, Kari; Warren, Graham; Wang, Yanzhuang			Molecular mechanism of mitotic Golgi disassembly and reassembly revealed by a defined reconstitution assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-FREE SYSTEM; PROTEIN PHOSPHATASE 2A; ADP-RIBOSYLATION FACTOR; MEMBRANE-FUSION; COATED VESICLES; STACKING FACTOR; SNARE COMPLEX; CDC2 KINASE; IN-VITRO; APPARATUS	In mammalian cells, flat Golgi cisternae closely arrange together to form stacks. During mitosis, the stacked structure undergoes a continuous fragmentation process. The generated mitotic Golgi fragments are distributed into the daughter cells, where they are reassembled into new Golgi stacks. In this study, an in vitro assay has been developed using purified proteins and Golgi membranes to reconstitute the Golgi disassembly and reassembly processes. This technique provides a useful tool to delineate the mechanisms underlying the morphological change. There are two processes during Golgi disassembly: unstacking and vesiculation. Unstacking is mediated by two mitotic kinases, cdc2 and plk, which phosphorylate the Golgi stacking protein GRASP65 and thus disrupt the oligomer of this protein. Vesiculation is mediated by the COPI budding machinery ARF1 and the coatomer complex. When treated with a combination of purified kinases, ARF1 and coatomer, the Golgi membranes were completely fragmented into vesicles. After mitosis, there are also two processes in Golgi reassembly: formation of single cisternae by membrane fusion, and restacking. Cisternal membrane fusion requires two AAA ATPases, p97 and NSF (N-ethylmaleimide-sensitive fusion protein), each of which functions together with specific adaptor proteins. Restacking of the newly formed Golgi cisternae requires dephosphorylation of Golgi stacking proteins by the protein phosphatase PP2A. This systematic study revealed the minimal machinery that controls the mitotic Golgi disassembly and reassembly processes.	[Tang, Danming; Mar, Kari; Wang, Yanzhuang] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Warren, Graham] Max F Perutz Labs, A-1030 Vienna, Austria	University of Michigan System; University of Michigan; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Tang, DM (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, 830 N Univ Ave, Ann Arbor, MI 48109 USA.	yzwang@umich.edu	Wang, Yanzhuang/AAE-5299-2019	Wang, Yanzhuang/0000-0002-1864-7094	NIGMS NIH HHS [R01 GM087364, R01 GM087364-02, R01 GM087364-01, R01 GM087364-03, R01 GM087364-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087364] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ACHARYA U, 1995, CELL, V82, P895, DOI 10.1016/0092-8674(95)90269-4; Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; COHEN P, 1991, METHOD ENZYMOL, V201, P389; Colanzi A, 2000, J CELL BIOL, V149, P331, DOI 10.1083/jcb.149.2.331; Cosson P, 2005, P NATL ACAD SCI USA, V102, P14647, DOI 10.1073/pnas.0507394102; Farquhar MG, 1998, TRENDS CELL BIOL, V8, P2, DOI 10.1016/S0962-8924(97)01187-2; Glick BS, 1998, CELL, V95, P883, DOI 10.1016/S0092-8674(00)81713-4; Kano F, 2000, J CELL BIOL, V149, P357, DOI 10.1083/jcb.149.2.357; Kondo H, 1997, NATURE, V388, P75, DOI 10.1038/40411; Levine TP, 1996, J BIOL CHEM, V271, P17304, DOI 10.1074/jbc.271.29.17304; Levine TP, 1995, COLD SPRING HARB SYM, V60, P549, DOI 10.1101/SQB.1995.060.01.058; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; LOUVARD D, 1982, J CELL BIOL, V92, P92, DOI 10.1083/jcb.92.1.92; Lowe M, 2000, J CELL BIOL, V149, P341, DOI 10.1083/jcb.149.2.341; Lowe M, 1998, CELL, V94, P783, DOI 10.1016/S0092-8674(00)81737-7; Lucocq J M, 1988, Prog Clin Biol Res, V270, P431; LUCOCQ JM, 1987, J CELL BIOL, V104, P865, DOI 10.1083/jcb.104.4.865; Malsam J, 2005, SCIENCE, V307, P1095, DOI 10.1126/science.1108061; Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737; Mayer-Jaekel Regina E., 1994, Trends in Cell Biology, V4, P287, DOI 10.1016/0962-8924(94)90219-4; McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; MISTELI T, 1995, J CELL SCI, V108, P2715; MISTELI T, 1994, J CELL BIOL, V125, P269, DOI 10.1083/jcb.125.2.269; Molloy SS, 1998, J CELL BIOL, V142, P1399, DOI 10.1083/jcb.142.6.1399; Nickel W, 1998, J CELL SCI, V111, P3081; Otter-Nilsson M, 1999, EMBO J, V18, P2074, DOI 10.1093/emboj/18.8.2074; Pavel J, 1998, P NATL ACAD SCI USA, V95, P2140, DOI 10.1073/pnas.95.5.2140; Pelham HRB, 2000, CELL, V102, P713, DOI 10.1016/S0092-8674(00)00060-X; Pfeffer SR, 2001, J CELL BIOL, V155, P873, DOI 10.1083/jcb.200109095; RABOUILLE C, 1995, CELL, V82, P905, DOI 10.1016/0092-8674(95)90270-8; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; RABOUILLE C, 1995, J CELL BIOL, V129, P605, DOI 10.1083/jcb.129.3.605; RAMBOURG A, 1990, EUR J CELL BIOL, V51, P189; RANDAZZO PA, 1995, METHOD ENZYMOL, V257, P128; ROBBINS E, 1964, J HISTOCHEM CYTOCHEM, V12, P704, DOI 10.1177/12.9.704; Satoh A, 2003, TRAFFIC, V4, P153, DOI 10.1034/j.1600-0854.2003.00103.x; Seemann J, 2002, SCIENCE, V295, P848, DOI 10.1126/science.1068064; SERAFINI T, 1992, METHOD ENZYMOL, V219, P286; SHENOLIKAR S, 1994, ANNU REV CELL BIOL, V10, P55, DOI 10.1146/annurev.cellbio.10.1.55; Shima DT, 1998, J CELL BIOL, V141, P955, DOI 10.1083/jcb.141.4.955; Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949; Shorter J, 2002, ANNU REV CELL DEV BI, V18, P379, DOI 10.1146/annurev.cellbio.18.030602.133733; Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57; Taguchi T, 2003, TRAFFIC, V4, P344, DOI 10.1034/j.1600-0854.2003.00091.x; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.E03-12-0876; Tehrani MA, 1996, J BIOL CHEM, V271, P5164; Trucco A, 2004, NAT CELL BIOL, V6, P1071, DOI 10.1038/ncb1180; Turowski P, 1999, MOL BIOL CELL, V10, P1997, DOI 10.1091/mbc.10.6.1997; Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112; WANG Y, 2006, CELL BIOL LAB HDB; Wang YZ, 2005, J BIOL CHEM, V280, P4921, DOI 10.1074/jbc.M412407200; Wang YZ, 2004, J CELL BIOL, V164, P973, DOI 10.1083/jcb.200401010; Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317; WHITEHEART SW, 1994, J CELL BIOL, V126, P945, DOI 10.1083/jcb.126.4.945; Xiang Y, 2007, J BIOL CHEM, V282, P21829, DOI 10.1074/jbc.M611716200; Xu Y, 2002, MOL BIOL CELL, V13, P3493, DOI 10.1091/mbc.E02-01-0004	58	41	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6085	6094		10.1074/jbc.M707715200	http://dx.doi.org/10.1074/jbc.M707715200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18156178	Green Accepted, hybrid			2022-12-25	WOS:000253779500014
J	Xu, L; Wang, Y; Yamaguchi, N; Pasek, DA; Meissner, G				Xu, Le; Wang, Ying; Yamaguchi, Naohiro; Pasek, Daniel A.; Meissner, Gerhard			Single channel properties of heterotetrameric mutant RyR1 ion channels linked to core myopathies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYANODINE RECEPTOR; RELEASE CHANNEL; TRANSMEMBRANE SEQUENCE; MALIGNANT HYPERTHERMIA; MUTATIONS; DISEASE; COMPLEX; REGION; IDENTIFICATION; PERMEATION	Skeletal muscle excitation-contraction coupling involves activation of homotetrameric ryanodine receptor ion channels (RyR1s), resulting in the rapid release of Ca2+ from the sarcoplasmic reticulum. Previous work has shown that Ca2+ release is impaired by mutations in RyR1 linked to Central Core Disease and Multiple Minicore Disease. We studied the consequences of these mutations on RyR1 function, following their expression in human embryonic kidney 293 cells and incorporation in lipid bilayers. RyR1-G4898E, -G4898R, and -Delta V4926/I4927 mutants in the C-terminal pore region of RyR1 and N-terminal RyR1-R110W/L486V mutant all showed negligible Ca2+ permeation and loss of Ca2+-dependent channel activity but maintained reduced K+ conductances. Co-expression of wild type and mutant RyR1s resulted in Ca2+-dependent channel activities that exhibited intermediate Ca2+ selectivities compared with K+, which suggested the presence of tetrameric RyR1 complexes composed of wild type and mutant subunits. The number of wild-type subunits to maintain a functional heterotetrameric channel differed among the four RyR1 mutants. The results indicate that homozygous RyR1 mutations associated with core myopathies abolish or greatly reduce sarcoplasmic reticulum Ca2+ release during excitation-contraction coupling. They further suggest that in individuals, expressing wild type and mutant alleles, a substantial portion of RyR1 channels is able to release Ca2+ from sarcoplasmic reticulum.	[Xu, Le; Wang, Ying; Yamaguchi, Naohiro; Pasek, Daniel A.; Meissner, Gerhard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Meissner, G (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.	meissner@med.unc.edu	Xu, Le/HDN-9623-2022		NIAMS NIH HHS [AR 018687, R37 AR018687, R01 AR018687-32, R01 AR018687, R01 AR018687-30, R01 AR018687-31] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR018687, R01AR018687] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Avila G, 2003, J GEN PHYSIOL, V121, P277, DOI 10.1085/jgp.200308791; Davis MR, 2003, NEUROMUSCULAR DISORD, V13, P151, DOI 10.1016/S0960-8966(02)00218-3; Dirksen RT, 2002, TRENDS CARDIOVAS MED, V12, P189, DOI 10.1016/S1050-1738(02)00163-9; Du GG, 2004, BIOCHEM J, V382, P557, DOI 10.1042/BJ20040580; Du WL, 2006, J BIOL CHEM, V281, P30143, DOI 10.1074/jbc.M606541200; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Gao L, 2000, BIOPHYS J, V79, P828, DOI 10.1016/S0006-3495(00)76339-9; Gillespie D, 2005, J PHYS CHEM B, V109, P15598, DOI 10.1021/jp052471j; Hirata H, 2007, DEVELOPMENT, V134, P2771, DOI 10.1242/dev.004531; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; LAI FA, 1989, J BIOL CHEM, V264, P16776; LEE HB, 1994, J BIOL CHEM, V269, P13305; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Lyfenko AD, 2007, HUM MUTAT, V28, P61, DOI 10.1002/humu.20409; McCarthy TV, 2000, HUM MUTAT, V15, P410, DOI 10.1002/(SICI)1098-1004(200005)15:5<410::AID-HUMU2>3.0.CO;2-D; Meissner G, 2002, FRONT BIOSCI, V7, pD2072, DOI 10.2741/meissner; Monnier N, 2001, HUM MOL GENET, V10, P2581, DOI 10.1093/hmg/10.22.2581; RIOS E, 1991, PHYSIOL REV, V71, P849, DOI 10.1152/physrev.1991.71.3.849; Robinson R, 2006, HUM MUTAT, V27, P977, DOI 10.1002/humu.20356; Romero NB, 2003, BRAIN, V126, P2341, DOI 10.1093/brain/awg244; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Sutko JL, 1997, PHARMACOL REV, V49, P53; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Tilgen N, 2001, HUM MOL GENET, V10, P2879, DOI 10.1093/hmg/10.25.2879; Wang RW, 2004, J BIOL CHEM, V279, P3635, DOI 10.1074/jbc.M311367200; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Wang Y, 2005, BIOPHYS J, V89, P256, DOI 10.1529/biophysj.104.056002; Wang Y, 2006, J BIOL CHEM, V281, P15572, DOI 10.1074/jbc.M600090200; Xiao BL, 2002, J BIOL CHEM, V277, P41778, DOI 10.1074/jbc.M208210200; Xu L, 2006, BIOPHYS J, V90, P443, DOI 10.1529/biophysj.105.072538; Xu L, 1999, J BIOL CHEM, V274, P32680, DOI 10.1074/jbc.274.46.32680; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhou H, 2007, BRAIN, V130, P2024, DOI 10.1093/brain/awm096; Zhou HY, 2006, AM J HUM GENET, V79, P859, DOI 10.1086/508500; Zhou HY, 2006, HUM MOL GENET, V15, P2791, DOI 10.1093/hmg/ddl221; Zorzato F, 2007, IUBMB LIFE, V59, P14, DOI 10.1080/15216540601187803	37	29	29	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 7	2008	283	10					6321	6329		10.1074/jbc.M707353200	http://dx.doi.org/10.1074/jbc.M707353200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HM	18171678	hybrid, Green Accepted, Green Published			2022-12-25	WOS:000253779500039
J	Brocardo, M; Lei, Y; Tighe, A; Taylor, SS; Mok, MTS; Henderson, BR				Brocardo, Mariana; Lei, Ying; Tighe, Anthony; Taylor, Stephen S.; Mok, Myth T. S.; Henderson, Beric R.			Mitochondrial targeting of adenomatous polyposis coli protein is stimulated by truncating cancer mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APC TUMOR-SUPPRESSOR; BETA-CATENIN; APOPTOSIS; DOMAIN; INSTABILITY; CLEAVAGE; BINDING; SIGNAL; ACTIN; CELLS	The adenomatous polyposis coli (APC) protein tumor suppressor is mutated in the majority of colon cancers. Most APC gene mutations cause deletion of the C terminus and disrupt APC regulation of beta-catenin turnover, microtubule dynamics, and chromosome segregation. Truncated APC mutant peptides may also gain unique properties, not exhibited by wild-type APC, which contribute to tumor cell survival and proliferation. Here we report a differential subcellular localization pattern for wild-type and mutant APC. A pool of APC truncation mutants was detected at mitochondria by cellular fractionation and confocal microscopy. In contrast, wild-type APC located poorly at mitochondria. Similar results were observed for endogenous and stably induced forms of APC, with the shortest N-terminal mutant peptides (N750, N853, N1309, N1337) displaying the strongest mitochondrial staining. The knock down of mutant APC(N1337) in SW480 tumor cells caused an increase in apoptosis and mitochondrial membrane permeability, and this correlated with reduced Bcl-2 protein levels in mitochondrial fractions. Interestingly, the silencing of APC did not alter expression of beta-catenin or the apoptotic regulatory factors Bax, Bcl-xL, or survivin. APC formed a complex with Bcl-2 in mitochondrial fractions, and this may contribute to the APC-dependent regulation of Bcl-2. We propose that a subset of cancer mutations induce APC mitochondrial localization and that APC regulation of Bcl-2 at mitochondria may contribute to tumor cell survival.	[Brocardo, Mariana; Lei, Ying; Mok, Myth T. S.; Henderson, Beric R.] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Westmead Inst Canc Res, Westmead, NSW 2145, Australia; [Tighe, Anthony; Taylor, Stephen S.; Henderson, Beric R.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	University of Sydney; Westmead Institute for Medical Research; University of Manchester	Henderson, BR (corresponding author), Westmead Millennium Inst, Darcy Rd PO Box 412, Westmead, NSW 2145, Australia.	beric_henderson@wmi.usyd.edu.au	Taylor, Stephen/GZL-6499-2022; Mok, Myth/M-2958-2013	Mok, Myth/0000-0003-3156-4944; Brocardo, Mariana/0000-0002-3962-7308; Taylor, Stephen/0000-0003-4621-9326				Bienz M, 2002, NAT REV MOL CELL BIO, V3, P328, DOI 10.1038/nrm806; Boman BM, 2004, AM J PATHOL, V165, P1489, DOI 10.1016/S0002-9440(10)63407-4; Brocardo M, 2005, EMBO REP, V6, P184, DOI 10.1038/sj.embor.7400329; Browne SJ, 1998, CELL DEATH DIFFER, V5, P206, DOI 10.1038/sj.cdd.4400331; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Chartrain I, 2007, CELL BIOL INT, V31, P196, DOI 10.1016/j.cellbi.2006.10.005; Chen TA, 2003, CANCER RES, V63, P4368; Dikovskaya D, 2004, MOL BIOL CELL, V15, P2978, DOI 10.1091/mbc.E03-08-0613; Fearnhead NS, 2001, HUM MOL GENET, V10, P721, DOI 10.1093/hmg/10.7.721; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Galea MA, 2001, J BIOL CHEM, V276, P45833, DOI 10.1074/jbc.M107149200; Green RA, 2003, J CELL BIOL, V163, P949, DOI 10.1083/jcb.200307070; Hanson CA, 2005, GENE, V361, P1, DOI 10.1016/j.gene.2005.07.024; Henderson BR, 2002, EMBO REP, V3, P834, DOI 10.1093/embo-reports/kvf181; Jimbo T, 2002, NAT CELL BIOL, V4, P323, DOI 10.1038/ncb779; Kawasaki Y, 2003, NAT CELL BIOL, V5, P211, DOI 10.1038/ncb937; KRAJEWSKI S, 1993, CANCER RES, V53, P4701; Langford KJ, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-3; Li ZY, 2005, CANCER RES, V65, P5195, DOI 10.1158/0008-5472.CAN-04-4609; Louie RK, 2004, J CELL SCI, V117, P1117, DOI 10.1242/jcs.00939; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; Morin PJ, 1996, P NATL ACAD SCI USA, V93, P7950, DOI 10.1073/pnas.93.15.7950; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Nathke IS, 1996, J CELL BIOL, V134, P165, DOI 10.1083/jcb.134.1.165; Polakis P, 2000, GENE DEV, V14, P1837; Qian J, 2007, ONCOGENE, V26, P4872, DOI 10.1038/sj.onc.1210265; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Schneikert J, 2007, HUM MOL GENET, V16, P199, DOI 10.1093/hmg/ddl464; Senda T, 2007, MED MOL MORPHOL, V40, P68, DOI 10.1007/s00795-006-0352-5; Sharma M, 2006, J BIOL CHEM, V281, P17140, DOI 10.1074/jbc.M513027200; Sinicrope FA, 2005, MOL CANCER THER, V4, P1475, DOI 10.1158/1535-7163.MCT-05-0137; Steigerwald K, 2005, MOL CANCER RES, V3, P78, DOI 10.1158/1541-7786.MCR-03-0189; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Venesio T, 2003, MODERN PATHOL, V16, P57, DOI 10.1097/01.MP.0000042421.83775.0E; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Webb SJ, 1999, FASEB J, V13, P339, DOI 10.1096/fasebj.13.2.339; Wolter KG, 1997, J CELL BIOL, V139, P1281, DOI 10.1083/jcb.139.5.1281; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	38	31	31	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5950	5959		10.1074/jbc.M708775200	http://dx.doi.org/10.1074/jbc.M708775200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18160396	hybrid			2022-12-25	WOS:000253426700073
J	Mora, L; Klepsch, M; Buckingham, RH; Heurgue-Hamard, V; Kervestin, S; de Zamaroczy, M				Mora, Liliana; Klepsch, Mirjam; Buckingham, Richard H.; Heurgue-Hamard, Valerie; Kervestin, Stephanie; de Zamaroczy, Miklos			Dual roles of the central domain of colicin D tRNase in TonB-mediated import and in immunity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE RECEPTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; IN-VIVO; NUCLEOTIDE-SEQUENCE; DEPENDENT COLICINS; PROTEIN; FHUA; TRANSPORT; CLEAVAGE	Colicin D import into Escherichia coli requires an interaction via its TonB box with the energy transducer TonB. Colicin D cytotoxicity is inhibited by specific tonB mutations, but it is restored by suppressor mutations in the TonB box. Here we report that there is a second site of interaction between TonB and colicin D, which is dependent upon a 45-amino acid region, within the uncharacterized central domain of colicin D. In addition, the 8th amino acids of colicin D (a glycine) and colicin B (a valine), adjacent to their TonB boxes, are also required for TonB recognition, suggesting that high affinity complex formation involves multiple interactions between these colicins and TonB. The central domain also contributes to the formation of the immunity complex, as well as being essential for uptake and thus killing. Colicin D is normally secreted in association with the immunity protein, and this complex involves the following two interactions: a major interaction with the C-terminal tRNase domain and a second interaction involving the central domain of colicin D and, most probably, the alpha 4 helix of ImmD, which is on the opposite side of ImmD compared with the major interface. In contrast, formation of the immunity complex with the processed cytotoxic domain, the form expected to be found in the cytoplasm after colicin D uptake, requires only the major interaction. Klebicin D has, like colicin D, a ribonuclease activity toward tRNAArg and a central domain, which can form a complex with ImmD but which does not function in TonB-mediated transport.	[Mora, Liliana; Klepsch, Mirjam; Buckingham, Richard H.; Heurgue-Hamard, Valerie; Kervestin, Stephanie; de Zamaroczy, Miklos] CNRS, IBPC, UPR 9073, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS)	de Zamaroczy, M (corresponding author), CNRS, IBPC, UPR 9073, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	zamaroczy@ibpc.fr		HEURGUE-HAMARD, VALERIE/0000-0003-1576-7231; Buckingham, Richard/0000-0002-8567-4500				BELL PE, 1990, J BACTERIOL, V172, P3826, DOI 10.1128/jb.172.7.3826-3829.1990; BRAUN V, 1994, ARCH MICROBIOL, V161, P199, DOI 10.1007/s002030050042; Braun V, 2003, FRONT BIOSCI-LANDMRK, V8, pS1409, DOI 10.2741/1232; Braun V, 2002, BIOCHIMIE, V84, P365, DOI 10.1016/S0300-9084(02)01427-X; Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Cadieux N, 1999, P NATL ACAD SCI USA, V96, P10673, DOI 10.1073/pnas.96.19.10673; Cadieux N, 2003, P NATL ACAD SCI USA, V100, P10688, DOI 10.1073/pnas.1932538100; Cadieux N, 2000, J BACTERIOL, V182, P5954, DOI 10.1128/JB.182.21.5954-5961.2000; Carter DM, 2006, J MOL BIOL, V357, P236, DOI 10.1016/j.jmb.2005.12.039; Chavan M, 2005, J MOL EVOL, V60, P546, DOI 10.1007/s00239-004-0263-9; de Zamaroczy M, 2002, BIOCHIMIE, V84, P423, DOI 10.1016/S0300-9084(02)01426-8; de Zamaroczy M, 2001, MOL CELL, V8, P159, DOI 10.1016/S1097-2765(01)00276-3; DEGRAAF FK, 1977, EUR J BIOCHEM, V73, P107; Devanathan S, 2007, MOL MICROBIOL, V65, P441, DOI 10.1111/j.1365-2958.2007.05808.x; Duche D, 2007, J BACTERIOL, V189, P4217, DOI 10.1128/JB.00092-07; Endriss F, 2003, J BACTERIOL, V185, P4683, DOI 10.1128/JB.185.16.4683-4692.2003; Faraldo-Gomez JD, 2003, NAT REV MOL CELL BIO, V4, P105, DOI 10.1038/nrm1015; Ferguson AD, 2002, SCIENCE, V295, P1715, DOI 10.1126/science.1067313; Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215; FRENETTE M, 1991, J MOL BIOL, V217, P421, DOI 10.1016/0022-2836(91)90746-S; Ghosh J, 2004, MOL MICROBIOL, V51, P203, DOI 10.1046/j.1365-2958.2003.03816.x; Graille M, 2004, EMBO J, V23, P1474, DOI 10.1038/sj.emboj.7600162; Hilsenbeck JL, 2004, MOL MICROBIOL, V51, P711, DOI 10.1111/j.1365-2958.2003.03884.x; JAKES KS, 1988, J BACTERIOL, V170, P4231, DOI 10.1128/jb.170.9.4231-4238.1988; Kageyama M, 1996, J BACTERIOL, V178, P103, DOI 10.1128/jb.178.1.103-110.1996; Larsen RA, 1997, J BACTERIOL, V179, P3213, DOI 10.1128/jb.179.10.3213-3221.1997; Lazdunski CJ, 1998, J BACTERIOL, V180, P4993, DOI 10.1128/JB.180.19.4993-5002.1998; Locher KP, 1998, CELL, V95, P771, DOI 10.1016/S0092-8674(00)81700-6; MENDE J, 1990, MOL MICROBIOL, V4, P1523, DOI 10.1111/j.1365-2958.1990.tb02063.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Moeck GS, 2001, J BACTERIOL, V183, P2755, DOI 10.1128/JB.183.9.2755-2764.2001; Mora L, 2005, J BACTERIOL, V187, P2693, DOI 10.1128/JB.187.8.2693-2697.2005; Ogierman M, 2003, J BACTERIOL, V185, P1870, DOI 10.1128/JB.185.6.1870-1885.2003; OUDEGA B, 1977, EUR J BIOCHEM, V78, P445, DOI 10.1111/j.1432-1033.1977.tb11757.x; Pawelek PD, 2006, SCIENCE, V312, P1399, DOI 10.1126/science.1128057; Pfennig PL, 2001, MOL GENET GENOMICS, V266, P313, DOI 10.1007/s004380100559; PILSL H, 1993, MOL GEN GENET, V240, P103, DOI 10.1007/BF00276889; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; PUGSLEY AP, 1984, MICROBIOL SCI, V1, P168; PUGSLEY AP, 1977, BIOCHEM BIOPH RES CO, V74, P903, DOI 10.1016/0006-291X(77)91604-7; ROOS U, 1989, MOL MICROBIOL, V3, P891, DOI 10.1111/j.1365-2958.1989.tb00238.x; Sauter A, 2003, J BACTERIOL, V185, P5747, DOI 10.1128/JB.185.19.5747-5754.2003; SCHRAMM E, 1987, J BACTERIOL, V169, P3350, DOI 10.1128/jb.169.7.3350-3357.1987; Shi ZH, 2005, J BIOL CHEM, V280, P24663, DOI 10.1074/jbc.M501216200; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; SKARE JT, 1993, J BIOL CHEM, V268, P16302; Tomita K, 2000, P NATL ACAD SCI USA, V97, P8278, DOI 10.1073/pnas.140213797; Wandersman C, 2004, ANNU REV MICROBIOL, V58, P611, DOI 10.1146/annurev.micro.58.030603.123811	49	10	10	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4993	5003		10.1074/jbc.M706846200	http://dx.doi.org/10.1074/jbc.M706846200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18083710	hybrid			2022-12-25	WOS:000253426500057
J	Chandrasekar, B; Patel, DN; Mummidi, S; Kim, JW; Clark, RA; Valente, AJ				Chandrasekar, Bysani; Patel, Devang N.; Mummidi, Srinivas; Kim, Jae-Woo; Clark, Robert A.; Valente, Anthony J.			Interleukin-18 suppresses adiponectin expression in 3T3-L1 adipocytes via a novel signal transduction pathway involving ERK1/2-dependent NFATc4 phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-CELLS; NF-KAPPA-B; CCAAT/ENHANCER BINDING-PROTEIN; VASCULAR INFLAMMATORY MARKERS; ADIPOSE-SPECIFIC PROTEIN; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; WEIGHT-LOSS; INSULIN-RESISTANCE; GENE-EXPRESSION	An inverse correlation between the pro-inflammatory cytokine interleukin-18 and the anti-atherogenic adipokine adiponectin has been reported in the chronic pathological conditions obesity, insulin resistance, coronary artery disease, and metabolic syndrome. We investigated whether this relationship is coincidental or has a causal basis. Here we show that interleukin-18 (IL-18) suppresses adiponectin transcription, mRNA expression, and secretion by 3T3-L1 adipocytes. IL-18 suppresses adiponectin promoter-reporter activity, an effect reversed by deletion or mutation of the NFATc4 core DNA-binding site. IL-18 induces NFATc4 phosphorylation (Ser(676)), nuclear translocation, and in vivo DNA binding. IL-18 induces ERK1/2 phosphorylation and enzyme activity, and pretreatment with the MEK inhibitor U0126, ERK1/2 inhibitor PD98059, or small interference RNA targeted to ERK1/2 attenuates ERK1/2 activation and NFATc4 phosphorylation. Finally, inhibition of ERK1/2 or NFATc4 knockdown reverses IL-18-mediated adiponectin suppression. In contrast to its inhibitory effects on adiponectin expression, IL-18 potently stimulates PAI-1 secretion. These data demonstrate for the first time that IL-18 selectively suppresses adiponectin expression via ERK1/2-dependent NFATc4 activation and suggest that the inverse relationship observed between IL-18 and adiponectin in various chronic pathological conditions is causally related. Thus, targeting IL-18 expression may enhance adiponectin expression and mitigate disease progression.	[Chandrasekar, Bysani; Patel, Devang N.; Mummidi, Srinivas; Clark, Robert A.; Valente, Anthony J.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Chandrasekar, Bysani; Mummidi, Srinivas; Clark, Robert A.] S Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA; [Kim, Jae-Woo] Yonsei Univ, Coll Med, Med Res Ctr Chron Metab Dis, Dept Biochem & Mol Biol, Seoul 120752, South Korea	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Yonsei University; Yonsei University Health System	Chandrasekar, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	chandraseka@uthscsa.edu	Clark, Robert/Q-6764-2019; Mummidi, Srinivas/H-3335-2017; Mummidi, Srinivas/C-1004-2008	Clark, Robert/0000-0002-4892-3619; Mummidi, Srinivas/0000-0002-4068-6380; Mummidi, Srinivas/0000-0002-4068-6380; Kim, Jae-woo/0000-0001-5456-9495				Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Bruun JM, 2003, AM J PHYSIOL-ENDOC M, V285, pE527, DOI 10.1152/ajpendo.00110.2003; Chandrasekar B, 2005, J BIOL CHEM, V280, P26263, DOI 10.1074/jbc.M502586200; Chandrasekar B, 2004, J BIOL CHEM, V279, P20221, DOI 10.1074/jbc.M313980200; Chandrasekar B, 2003, J BIOL CHEM, V278, P4675, DOI 10.1074/jbc.M207006200; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Elhage R, 2003, CARDIOVASC RES, V59, P234, DOI 10.1016/S0008-6363(03)00343-2; Esposito K, 2003, AM J CLIN NUTR, V78, P1135, DOI 10.1093/ajcn/78.6.1135; Esposito K, 2002, J CLIN ENDOCR METAB, V87, P3864, DOI 10.1210/jc.2002-????; Esposito K, 2003, JAMA-J AM MED ASSOC, V289, P1799, DOI 10.1001/jama.289.14.1799; Fischer CP, 2005, CLIN IMMUNOL, V117, P152, DOI 10.1016/j.clim.2005.07.008; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Gerdes N, 2002, J EXP MED, V195, P245, DOI 10.1084/jem.20011022; Giugliano G, 2004, BRIT J PLAST SURG, V57, P190, DOI 10.1016/j.bjps.2003.12.010; Hara K, 2007, INT HEART J, V48, P149, DOI 10.1536/ihj.48.149; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoo RLC, 2007, ARTERIOSCL THROM VAS, V27, P2777, DOI 10.1161/ATVBAHA.107.152462; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hung J, 2005, ARTERIOSCL THROM VAS, V25, P1268, DOI 10.1161/01.ATV.0000163843.70369.12; Kim HB, 2006, DIABETES, V55, P1342, DOI 10.2337/db05-1507; Kita A, 2005, BIOCHEM BIOPH RES CO, V331, P484, DOI 10.1016/j.bbrc.2005.03.205; Korshunov VA, 2006, ARTERIOSCL THROM VAS, V26, P295, DOI 10.1161/01.ATV.0000196544.73761.82; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lara-Castro C, 2006, DIABETES, V55, P249, DOI 10.2337/diabetes.55.1.249; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Magkos F, 2007, CURR OPIN CLIN NUTR, V10, P571, DOI 10.1097/MCO.0b013e3282bf6ea8; Morel JCM, 2002, J BIOL CHEM, V277, P34679, DOI 10.1074/jbc.M206337200; Morel JCM, 2001, J BIOL CHEM, V276, P37069, DOI 10.1074/jbc.M103574200; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Ouchi N, 2001, CIRCULATION, V103, P1057, DOI 10.1161/01.CIR.103.8.1057; Ouchi N, 1999, CIRCULATION, V100, P2473, DOI 10.1161/01.CIR.100.25.2473; Pajvani UB, 2003, J BIOL CHEM, V278, P9073, DOI 10.1074/jbc.M207198200; Park SK, 2004, DIABETES, V53, P2757, DOI 10.2337/diabetes.53.11.2757; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; Richards AA, 2006, MOL ENDOCRINOL, V20, P1673, DOI 10.1210/me.2005-0390; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Schernthaner GH, 2006, OBES SURG, V16, P709, DOI 10.1381/096089206777346763; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Straczkowski M, 2007, INT J OBESITY, V31, P221, DOI 10.1038/sj.ijo.0803421; Tan KCB, 2004, J CLIN ENDOCR METAB, V89, P765, DOI 10.1210/jc.2003-031012; Thompson SR, 2007, METABOLISM, V56, P662, DOI 10.1016/j.metabol.2006.12.015; Todoric J, 2006, DIABETOLOGIA, V49, P2109, DOI 10.1007/s00125-006-0300-x; Vilarrasa N, 2007, CLIN ENDOCRINOL, V67, P679, DOI 10.1111/j.1365-2265.2007.02945.x; Wagsater D, 2004, BIOCHEM BIOPH RES CO, V325, P1187, DOI 10.1016/j.bbrc.2004.10.160; Whitman SC, 2002, CIRC RES, V90, pE34, DOI 10.1161/hh0202.105292; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Yamagami H, 2005, ARTERIOSCL THROM VAS, V25, P1458, DOI 10.1161/01.ATV.0000168417.52486.56; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Yang JY, 2006, OBESITY, V14, P1691, DOI 10.1038/oby.2006.194; Yang TTC, 2005, MOL CELL BIOL, V25, P907, DOI 10.1128/MCB.25.3.907-920.2005; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	56	27	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4200	4209		10.1074/jbc.M708142200	http://dx.doi.org/10.1074/jbc.M708142200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18086672	hybrid			2022-12-25	WOS:000253083500055
J	Song, CY; Wen, WY; Rayala, SK; Chen, MZ; Ma, JP; Zhang, MJ; Kumar, R				Song, Chunying; Wen, Wenyu; Rayala, Suresh K.; Chen, Mingzhi; Ma, Jianpeng; Zhang, Mingjie; Kumar, Rakesh			Serine 88 phosphorylation of the 8-kDa dynein light chain 1 is a molecular switch for its dimerization status and functions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGHT-CHAIN LC8; NITRIC-OXIDE SYNTHASE; CYTOPLASMIC DYNEIN; MYOSIN-V; PROTEIN; DROSOPHILA; DOMAIN; DIMER; MECHANISM; INTERACTS	Dynein light chain 1 (DLC1, also known as DYNLL1, LC8, and PIN), a ubiquitously expressed and highly conserved protein, participates in a variety of essential intracellular events. Transition of DLC1 between dimer and monomer forms might play a crucial role in its function. However, the molecular mechanism(s) that control the transition remain unknown. DLC1 phosphorylation on Ser(88) by p21-activated kinase 1 (Pak1), a signaling nodule, promotes mammalian cell survival by regulating its interaction with Bim and the stability of Bim. Here we discovered that phosphorylation of Ser(88), which juxtapose each other at the interface of the DLC dimer, disrupts DLC1 dimer formation and consequently impairs its interaction with Bim. Overexpression of a Ser(88) phosphorylation-inactive DLC1 mutant in mammary epithelium cells and in a transgenic animal model caused apoptosis and accelerated mammary gland involution, respectively, with increased Bim levels. Structural and biophysical studies suggested that phosphorylation-mimicking mutation leads to dissociation of the DLC1 dimer to a pure folded monomer. The phosphorylation-induced DLC1 monomer is incapable of binding to its substrate Bim. These findings reveal a previously unrecognized regulatory mechanism of DLC1 in which the Ser(88) phosphorylation acts as a molecular switch for the transition of DLC1 from dimer to monomer, thereby modulating its interaction with substrates and consequently regulating the functions of DLC1.	[Wen, Wenyu; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Kowloon, Hong Kong, Peoples R China; [Song, Chunying; Rayala, Suresh K.; Kumar, Rakesh] Univ Texas Houston, MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Chen, Mingzhi; Ma, Jianpeng; Kumar, Rakesh] Baylor Coll Med, Verna & Marrs Mclean Dept Biochem & Mol Biol, Houston, TX 77030 USA	Hong Kong University of Science & Technology; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Baylor College of Medicine	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk; rkumar@mdanderson.org	Kumar, Rakesh/ABD-1065-2020	Kumar, Rakesh/0000-0001-7664-0803; Zhang, Mingjie/0000-0001-9404-0190; Rayala, Suresh/0000-0003-4394-4450	NCI NIH HHS [CA80066, CA90970] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA080066, R01CA090970] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beckwith SM, 1998, J CELL BIOL, V143, P1239, DOI 10.1083/jcb.143.5.1239; Benashski SE, 1997, J BIOL CHEM, V272, P20929, DOI 10.1074/jbc.272.33.20929; Bokoch GM, 1998, J BIOL CHEM, V273, P8137, DOI 10.1074/jbc.273.14.8137; Chang YWE, 2000, MOL CELL BIOL, V20, P8571, DOI 10.1128/MCB.20.22.8571-8579.2000; Crepieux P, 1997, MOL CELL BIOL, V17, P7375, DOI 10.1128/MCB.17.12.7375; Dick T, 1996, MOL CELL BIOL, V16, P1966; Epstein E, 2000, J CLIN INVEST, V105, P505, DOI 10.1172/JCI8557; Fan JS, 2001, J MOL BIOL, V306, P97, DOI 10.1006/jmbi.2000.4374; Fuhrmann JC, 2002, J NEUROSCI, V22, P5393; Hirokawa N, 1998, CURR OPIN CELL BIOL, V10, P60, DOI 10.1016/S0955-0674(98)80087-2; HOLLANDER P, 2006, CANCER RES, V66, P5941; Jacob Y, 2000, J VIROL, V74, P10217, DOI 10.1128/JVI.74.21.10217-10222.2000; Jaffrey SR, 1996, SCIENCE, V274, P774, DOI 10.1126/science.274.5288.774; King SM, 1996, J BIOL CHEM, V271, P19358, DOI 10.1074/jbc.271.32.19358; KING SM, 1995, J BIOL CHEM, V270, P11445, DOI 10.1074/jbc.270.19.11445; Liang J, 1999, NAT STRUCT BIOL, V6, P735; Lo KWH, 2005, J BIOL CHEM, V280, P8172, DOI 10.1074/jbc.M411408200; Lo KWH, 2001, J BIOL CHEM, V276, P14059, DOI 10.1074/jbc.M010320200; Makokha M, 2004, PROTEIN SCI, V13, P727, DOI 10.1110/ps.03462204; Mohan PMK, 2007, BIOCHEM BIOPH RES CO, V355, P950, DOI 10.1016/j.bbrc.2007.02.072; Naisbitt S, 2000, J NEUROSCI, V20, P4524, DOI 10.1523/JNEUROSCI.20-12-04524.2000; Navarro-Lerida I, 2004, PROTEOMICS, V4, P339, DOI 10.1002/pmic.200300528; Nyarko A, 2005, BIOCHEMISTRY-US, V44, P14248, DOI 10.1021/bi0512694; Nyarko A, 2004, BIOCHEMISTRY-US, V43, P15595, DOI 10.1021/bi048451+; Oiwa K, 2005, CURR OPIN CELL BIOL, V17, P98, DOI 10.1016/j.ceb.2004.12.006; Phillis R, 1996, DEVELOPMENT, V122, P2955; PIPERNO G, 1979, J BIOL CHEM, V254, P3084; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Raux H, 2000, J VIROL, V74, P10212, DOI 10.1128/JVI.74.21.10212-10216.2000; Rayala SK, 2005, EMBO REP, V6, P538, DOI 10.1038/sj.embor.7400417; Rayala SK, 2006, J BIOL CHEM, V281, P19092, DOI 10.1074/jbc.M600021200; Rodriguez-Crespo I, 2001, FEBS LETT, V503, P135, DOI 10.1016/S0014-5793(01)02718-1; Schnorrer F, 2000, NAT CELL BIOL, V2, P185, DOI 10.1038/35008601; Seol MB, 2005, MOL CELLS, V20, P97; Vadlamudi RK, 2004, CANCER CELL, V5, P575, DOI 10.1016/j.ccr.2004.05.022; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vallee RB, 1996, SCIENCE, V271, P1539, DOI 10.1126/science.271.5255.1539; Wang L, 2004, BIOCHEMISTRY-US, V43, P4611, DOI 10.1021/bi036328x; Wang WN, 2003, J BIOL CHEM, V278, P41491, DOI 10.1074/jbc.M307118200; Yang ZB, 2005, J BIOL CHEM, V280, P654, DOI 10.1074/jbc.M408486200	40	42	43	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4004	4013		10.1074/jbc.M704512200	http://dx.doi.org/10.1074/jbc.M704512200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18084006	hybrid			2022-12-25	WOS:000253083500035
J	Umeda, D; Yano, S; Yamada, K; Tachibana, H				Umeda, Daisuke; Yano, Satomi; Yamada, Koji; Tachibana, Hirofumi			Green tea Polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHO-ASSOCIATED KINASE; ELONGATION-FACTOR 1A; GENETIC SUPPRESSOR ELEMENTS; HUMAN T-LYMPHOCYTES; MYOSIN PHOSPHATASE; BINDING PROTEIN; ACTIN-FILAMENTS; NONMUSCLE CELLS; LIGHT-CHAIN; EXPRESSION	(-)-Epigallocatechin-3-gallate (EGCG), the principal polyphenol in green tea, has been shown to be a potent chemopreventive agent. Recently, 67-kDa laminin receptor (67LR) has been identified as a cell surface receptor for EGCG that mediates the anticancer activity of EGCG. Indeed, expression of 67LR confers EGCG responsiveness to tumor cells; however, the molecular basis for the anticancer activity of EGCG in vivo is not entirely understood. Here we show that (i) using a direct genetic screen, eukaryotic translation elongation factor 1A (eEF1A) is identified as a component responsible for the anticancer activity of EGCG; (ii) through both eEF1A and 67LR, EGCG induces the dephosphorylation of myosin phosphatase targeting subunit 1 (MYPT1) at Thr-696 and activates myosin phosphatase; and (iii) silencing of 67LR, eEF1A, or MYPT1 in tumor cells results in abrogation of EGCG-induced tumor growth inhibition in vivo. Additionally, we found that eEF1A is up-regulated by EGCG through 67LR. Overall, these findings implicate both eEF1A and MYPT1 in EGCG signaling for cancer prevention through 67LR.	[Umeda, Daisuke; Yano, Satomi; Yamada, Koji; Tachibana, Hirofumi] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Div Appl Biol Chem,Lab Food Chem, Fukuoka 8128581, Japan; [Tachibana, Hirofumi] Kyushu Univ, Bioarchitecture Ctr, Dept Funct Metab Design, Lab Funct Food Design, Fukuoka 8128581, Japan	Kyushu University; Kyushu University	Tachibana, H (corresponding author), Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tatibana@agr.kyushu-u.ac.jp		Umeda, Daisuke/0000-0001-6301-9938				Aggarwal BB, 2006, ANN NY ACAD SCI, V1091, P151, DOI 10.1196/annals.1378.063; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Ardini E, 1998, MOL BIOL EVOL, V15, P1017, DOI 10.1093/oxfordjournals.molbev.a026000; Belyi Y, 2006, P NATL ACAD SCI USA, V103, P16953, DOI 10.1073/pnas.0601562103; Bettuzzi S, 2006, CANCER RES, V66, P1234, DOI 10.1158/0008-5472.CAN-05-1145; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Canfield SM, 1999, J IMMUNOL, V163, P3430; Chang YWE, 1998, EUR J BIOCHEM, V251, P201, DOI 10.1046/j.1432-1327.1998.2510201.x; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; DEVER TE, 1989, J BIOL CHEM, V264, P20518; DURSO NA, 1994, PLANT CELL, V6, P893, DOI 10.1105/tpc.6.6.893; Edmonds BT, 1996, J CELL SCI, V109, P2705; Eto M, 2000, CELL MOTIL CYTOSKEL, V46, P222, DOI 10.1002/1097-0169(200007)46:3<222::AID-CM6>3.3.CO;2-2; Fratelli M, 2002, P NATL ACAD SCI USA, V99, P3505, DOI 10.1073/pnas.052592699; Fujimura Y, 2006, BIOCHEM BIOPH RES CO, V348, P524, DOI 10.1016/j.bbrc.2006.07.086; Fukata Y, 1998, J CELL BIOL, V141, P409, DOI 10.1083/jcb.141.2.409; Gangwani L, 1998, J CELL BIOL, V143, P1471, DOI 10.1083/jcb.143.6.1471; Givant-Horwitz V, 2004, CANCER RES, V64, P3572, DOI 10.1158/0008-5472.CAN-03-3424; Gloe T, 1999, J BIOL CHEM, V274, P15996, DOI 10.1074/jbc.274.23.15996; GUDKOV AV, 1994, P NATL ACAD SCI USA, V91, P3744, DOI 10.1073/pnas.91.9.3744; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Hong J, 2002, CANCER RES, V62, P7241; Izawa T, 2000, BIOCHEM BIOPH RES CO, V278, P72, DOI 10.1006/bbrc.2000.3772; Khan N, 2006, CANCER RES, V66, P2500, DOI 10.1158/0008-5472.CAN-05-3636; Kim K, 2005, BIOCHEM BIOPH RES CO, V338, P1327, DOI 10.1016/j.bbrc.2005.10.089; Kimura K, 1998, J BIOL CHEM, V273, P5542, DOI 10.1074/jbc.273.10.5542; Lamberti A, 2004, AMINO ACIDS, V26, P443, DOI 10.1007/s00726-004-0088-2; Maciver SK, 1996, BIOESSAYS, V18, P179, DOI 10.1002/bies.950180304; MARTIGNONE S, 1993, J NATL CANCER I, V85, P398, DOI 10.1093/jnci/85.5.398; Menard S, 1997, J CELL BIOCHEM, V67, P155, DOI 10.1002/(SICI)1097-4644(19971101)67:2<155::AID-JCB1>3.3.CO;2-O; Menard S, 1998, BREAST CANCER RES TR, V52, P137, DOI 10.1023/A:1006171403765; Muranyi A, 2005, FEBS LETT, V579, P6611, DOI 10.1016/j.febslet.2005.10.055; Murray JW, 1996, J CELL BIOL, V135, P1309, DOI 10.1083/jcb.135.5.1309; Negrutskii BS, 1998, PROG NUCLEIC ACID RE, V60, P47, DOI 10.1016/S0079-6603(08)60889-2; Newman DJ, 2003, J NAT PROD, V66, P1022, DOI 10.1021/np030096l; Ong LL, 2003, J BIOL CHEM, V278, P32115, DOI 10.1074/jbc.M210917200; Park OJ, 2004, TOXICOL LETT, V150, P43, DOI 10.1016/j.toxlet.2003.06.001; Ren XD, 2004, J CELL SCI, V117, P3511, DOI 10.1242/jcs.01205; RONINSON IB, 1995, CANCER RES, V55, P4023; Satoh K, 1999, BRIT J CANCER, V80, P1115, DOI 10.1038/sj.bjc.6690474; Shammas MA, 2006, BLOOD, V108, P2804, DOI 10.1182/blood-2006-05-022814; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; Surh YJ, 2003, NAT REV CANCER, V3, P768, DOI 10.1038/nrc1189; Tachibana H, 2004, NAT STRUCT MOL BIOL, V11, P380, DOI 10.1038/nsmb743; Ueda K, 2002, ONCOGENE, V21, P5852, DOI 10.1038/sj.onc.1205747; Umeda D, 2005, BIOCHEM BIOPH RES CO, V333, P628, DOI 10.1016/j.bbrc.2005.05.108; VANDEBROEK I, 2001, BRIT J CANCER, V96, P1387; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wool IG, 1996, TRENDS BIOCHEM SCI, V21, P164, DOI 10.1016/S0968-0004(96)20011-8; Yang CS, 1997, NATURE, V389, P134, DOI 10.1038/38154; Yang CS, 2000, J NUTR, V130, p472S, DOI 10.1093/jn/130.2.472S; Yang CS, 2006, MOL NUTR FOOD RES, V50, P170, DOI 10.1002/mnfr.200500105; Yang CS, 2002, ANNU REV PHARMACOL, V42, P25, DOI 10.1146/annurev.pharmtox.42.082101.154309; Zobel-Thropp P, 2000, J BIOL CHEM, V275, P37150, DOI 10.1074/jbc.M001005200	54	169	179	1	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3050	3058		10.1074/jbc.M707892200	http://dx.doi.org/10.1074/jbc.M707892200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18079119	hybrid			2022-12-25	WOS:000253083000008
J	Wonderlich, ER; Williams, M; Collins, KL				Wonderlich, Elizabeth R.; Williams, Maya; Collins, Kathleen L.			The tyrosine binding pocket in the adaptor protein 1 (AP-1) mu 1 subunit is necessary for nef to recruit AP-1 to the major histocompatibility complex class I cytoplasmic tail	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS TYPE-1 NEF; HIV-1 NEF; DOWN-REGULATION; MHC-I; CLATHRIN ADAPTER; SORTING SIGNALS; TRAFFICKING; PROTEIN; CELLS; DISTINCT	To evade the anti-human immunodeficiency virus (HIV) immune response, the HIV Nef protein disrupts major histocompatibility complex class I (MHC-I) trafficking by recruiting the clathrin adaptor protein 1 (AP-1) to the MHC-I cytoplasmic tail. Under normal conditions AP-1 binds dileucine and tyrosine signals (YXX phi motifs) via physically separate binding sites. In the case of the Nef- MHC-I complex, a tyrosine in the human leukocyte antigen (HLA)-A2 cytoplasmic tail ((320)YSQA) and a methionine in Nef (Met(20)) are absolutely required for AP-1 binding. Also present in Nef is a dileucine motif, which does not normally affect MHC-I trafficking and is not needed to recruit AP-1 to the Nef- MHC-I-complex. However, evidence is presented here that this dileucine motif can be activated by fusing Nef to the HLA-A2 tail in cis. Thus, the inability of this motif to function in trans likely results from a structural change that occurs when Nef binds to the MHC-I cytoplasmic tail. The physiologically relevant tyrosine-dependent recruitment of AP-1 to MHC-I, which occurs whether Nef is present in cis or trans, was stabilized by the acidic and polyproline domains within Nef. Additionally, amino acids Ala(324) and Asp(327) in the cytoplasmic tails of HLA-A and (but not HLA-C and HLA-E) molecules also stabilized AP-1 binding. Finally, mutation of the tyrosine binding pocket in the mu subunit of AP-1 created a dominant negative inhibitor of Nef- induced down-modulation of HLA-A2 that disrupted binding of wild type AP-1 to the Nef- MHC-I complex. Thus, these data provide evidence that Nef binding to the MHC-I cytoplasmic tail stabilizes the interaction of a tyrosine in the MHC-I cytoplasmic tail with the natural tyrosine binding pocket in AP-1.	[Collins, Kathleen L.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Wonderlich, Elizabeth R.; Williams, Maya; Collins, Kathleen L.] Univ Michigan, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA; [Collins, Kathleen L.] Univ Michigan, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Collins, KL (corresponding author), Univ Michigan, Dept Internal Med, 3510 MSRB 1 Box 0652,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	klcollin@umich.edu			NIAID NIH HHS [R01AI46998] Funding Source: Medline; NIGMS NIH HHS [T32 GM007315] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007315] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Boll W, 1996, EMBO J, V15, P5789, DOI 10.1002/j.1460-2075.1996.tb00965.x; Chang AH, 1998, FEBS LETT, V441, P307, DOI 10.1016/S0014-5793(98)01569-5; Chaudhuri R, 2007, J VIROL, V81, P3877, DOI 10.1128/JVI.02725-06; Cohen GB, 1999, IMMUNITY, V10, P661, DOI 10.1016/S1074-7613(00)80065-5; Collins KL, 1998, NATURE, V391, P397, DOI 10.1038/34929; Doray B, 2002, SCIENCE, V297, P1700, DOI 10.1126/science.1075327; Greenberg ME, 1998, EMBO J, V17, P2777, DOI 10.1093/emboj/17.10.2777; Hirst J, 2003, MOL BIOL CELL, V14, P625, DOI 10.1091/mbc.E02-09-0552; Honing S, 2005, MOL CELL, V18, P519, DOI 10.1016/j.molcel.2005.04.019; Janvier K, 2003, J BIOL CHEM, V278, P8725, DOI 10.1074/jbc.M210115200; Kasper MR, 2005, J BIOL CHEM, V280, P12840, DOI 10.1074/jbc.M413538200; Kasper MR, 2003, J VIROL, V77, P3041, DOI 10.1128/JVI.77.5.3041-3049.2003; KERKAU T, 1989, AIDS RES HUM RETROV, V5, P613, DOI 10.1089/aid.1989.5.613; Le Gall S, 2000, J VIROL, V74, P9256, DOI 10.1128/JVI.74.19.9256-9266.2000; Le Gall S, 1998, IMMUNITY, V8, P483, DOI 10.1016/S1074-7613(00)80553-1; Liu LX, 2000, J VIROL, V74, P5310, DOI 10.1128/JVI.74.11.5310-5319.2000; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Nesterov A, 1999, EMBO J, V18, P2489, DOI 10.1093/emboj/18.9.2489; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; PARHAM P, 1981, HUM IMMUNOL, V3, P277, DOI 10.1016/0198-8859(81)90065-3; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Robinson MS, 2001, CURR OPIN CELL BIOL, V13, P444, DOI 10.1016/S0955-0674(00)00235-0; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; SCHEPPLER JA, 1989, J IMMUNOL, V143, P2858; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Traub LM, 2003, J CELL BIOL, V163, P203, DOI 10.1083/jcb.200309175; TRAUB LM, 1995, J BIOL CHEM, V270, P4933, DOI 10.1074/jbc.270.9.4933; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Williams M, 2005, J VIROL, V79, P632, DOI 10.1128/JVI.79.1.632-636.2005; Williams M, 2002, J VIROL, V76, P12173, DOI 10.1128/JVI.76.23.12173-12184.2002	36	60	66	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3011	3022		10.1074/jbc.M707760200	http://dx.doi.org/10.1074/jbc.M707760200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18073204	hybrid			2022-12-25	WOS:000253083000004
J	Baras, B; Stittelaar, KJ; Simon, JH; Thoolen, RJMM; Mossman, SP; Pistoor, FHM; van Amerongen, G; Wettendorff, MA; Hanon, E; Osterhaus, ADME				Baras, Benoit; Stittelaar, Koert J.; Simon, James H.; Thoolen, Robert J. M. M.; Mossman, Sally P.; Pistoor, Frank H. M.; van Amerongen, Geert; Wettendorff, Martine A.; Hanon, Emmanuel; Osterhaus, Albert D. M. E.			Cross-Protection against Lethal H5N1 Challenge in Ferrets with an Adjuvanted Pandemic Influenza Vaccine	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; VIRUS-INFECTION; IMMUNOGENICITY; HUMANS; ADULTS	Background. Unprecedented spread between birds and mammals of highly pathogenic avian influenza viruses ( HPAI) of the H5N1 subtype has resulted in hundreds of human infections with a high fatality rate. This has highlighted the urgent need for the development of H5N1 vaccines that can be produced rapidly and in sufficient quantities. Potential pandemic inactivated vaccines will ideally induce substantial intra-subtypic cross-protection in humans to warrant the option of use, either prior to or just after the start of a pandemic outbreak. In the present study, we evaluated a split H5N1 A/H5N1/Vietnam/1194/04, clade 1 candidate vaccine, adjuvanted with a proprietary oil-in-water emulsion based Adjuvant System proven to be well- tolerated and highly immunogenic in the human (Leroux-Roels et al. ( 2007) The Lancet 370: 580-589), for its ability to induce intra-subtypic cross-protection against clade 2 H5N1/A/Indonesia/5/05 challenge in ferrets. Methodology and Principal Findings. All ferrets in control groups receiving non-adjuvanted vaccine or adjuvant alone failed to develop specific or cross-reactive neutralizing antibodies and all died or had to be euthanized within four days of virus challenge. Two doses of adjuvanted split H5N1 vaccine containing >= 1.7 mu g HA induced neutralizing antibodies in the majority of ferrets to both clade 1 (17/23 (74%) responders) and clade 2 viruses (14/23 (61%) responders), and 96% (22/23) of vaccinees survived the lethal challenge. Furthermore lung virus loads and viral shedding in the upper respiratory tract were reduced in vaccinated animals relative to controls suggesting that vaccination might also confer a reduced risk of viral transmission. Conclusion. These protection data in a stringent challenge model in association with an excellent clinical profile highlight the potential of this adjuvanted H5N1 candidate vaccine as an effective tool in pandemic preparedness.	[Stittelaar, Koert J.; Simon, James H.; Pistoor, Frank H. M.; van Amerongen, Geert; Osterhaus, Albert D. M. E.] ViroClin BV, Rotterdam, Netherlands; [Baras, Benoit; Mossman, Sally P.; Wettendorff, Martine A.; Hanon, Emmanuel] GlaxoSmithKline Biologicals, Preclin Virol, Rixensart, Belgium; [Thoolen, Robert J. M. M.] Glob Pathol Sup Toxicol Pathol, The Hague, Netherlands; [Osterhaus, Albert D. M. E.] Erasmus Med Ctr MC, Dept Virol, Rotterdam, Netherlands	GlaxoSmithKline; Erasmus University Rotterdam; Erasmus MC	Osterhaus, ADME (corresponding author), ViroClin BV, Rotterdam, Netherlands.	a.osterhaus@erasmusmc.nl		Osterhaus, Albert/0000-0002-6074-1172	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	This work was supported by GlaxoSmithKline (GSK) Biologicals (Rixensart, Belgium).	Allison AC, 1999, METHODS, V19, P87, DOI 10.1006/meth.1999.0832; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; DEBOER GF, 1990, ARCH VIROL, V115, P47, DOI 10.1007/BF01310622; Doherty PC, 2006, NAT IMMUNOL, V7, P449, DOI 10.1038/ni1343; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Govorkova EA, 2005, J VIROL, V79, P2191, DOI 10.1128/JVI.79.4.2191-2198.2005; Govorkova EA, 2006, J INFECT DIS, V194, P159, DOI 10.1086/505225; Hampson AW, 2006, J INFECT DIS, V194, P143, DOI 10.1086/505229; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Lipatov AS, 2006, J INFECT DIS, V194, P1040, DOI 10.1086/507709; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; McElhaney JE, 2006, J IMMUNOL, V176, P6333, DOI 10.4049/jimmunol.176.10.6333; Ott G, 1995, Pharm Biotechnol, V6, P277; Pashine A, 2005, NAT MED, V11, pS63, DOI 10.1038/nm1210; Pinder M, 2004, CLIN EXP IMMUNOL, V135, P286, DOI 10.1111/j.1365-2249.2004.02371.x; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Rimmelzwaan GF, 1998, J VIROL METHODS, V74, P57, DOI 10.1016/S0166-0934(98)00071-8; Rimmelzwaan GF, 2000, VACCINE, V19, P1180, DOI 10.1016/S0264-410X(00)00310-8; Sambhara S, 2007, LANCET, V370, P544, DOI 10.1016/S0140-6736(07)61269-0; Stephenson I, 2006, LANCET INFECT DIS, V6, P71, DOI 10.1016/S1473-3099(06)70364-4; Subbarao K, 2006, IMMUNITY, V24, P5, DOI 10.1016/j.immuni.2005.12.005; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Tellier R, 2006, EMERG INFECT DIS, V12, P1657, DOI 10.3201/eid1211.060426; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Vandepapeliere P, 2005, VACCINE, V23, P2591, DOI 10.1016/j.vaccine.2004.11.034; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Wood JM, 2002, MED MICROBIOL IMMUN, V191, P197, DOI 10.1007/s00430-002-0146-x; World Health Organization, 2005, WHO GLOB INFL PREP P	30	136	144	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1401	10.1371/journal.pone.0001401	http://dx.doi.org/10.1371/journal.pone.0001401			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167560	Green Published, Green Submitted, gold			2022-12-25	WOS:000260468900029
J	Hao, YH; Wang, Y; Burdette, D; Mukherjee, S; Keitany, G; Goldsmith, E; Orth, K				Hao, Yi-Heng; Wang, Yong; Burdette, Dara; Mukherjee, Sohini; Keitany, Gladys; Goldsmith, Elizabeth; Orth, Kim			Structural Requirements for Yersinia YopJ Inhibition of MAP Kinase Pathways	PLOS ONE			English	Article							NF-KAPPA-B; EFFECTOR YOPJ; ACTIVATION; PROTEINS; PHOSPHORYLATION; RESPONSES	MAPK signaling cascades are evolutionally conserved. The bacterial effector, YopJ, uses the unique activity of Ser/Thr acetylation to inhibit the activation of the MAPK kinase (MKK) and prevent activation by phosphorylation. YopJ is also able to block yeast MAPK signaling pathways using this mechanism. Based on these observations, we performed a genetic screen to isolate mutants in the yeast MKK, Pbs2, that suppress YopJ inhibition. One suppressor contains a mutation in a conserved tyrosine residue and bypasses YopJ inhibition by increasing the basal activity of Pbs2. Mutations on the hydrophobic face of the conserved G alpha-helix in the kinase domain prevent both binding and acetylation by YopJ. Corresponding mutants in human MKKs showed that they are conserved not only structurally, but also functionally. These studies reveal a conserved binding site found on the superfamily of MAPK kinases while providing insight into the molecular interactions required for YopJ inhibition.	[Hao, Yi-Heng; Burdette, Dara; Mukherjee, Sohini; Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Goldsmith, Elizabeth] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX USA; [Wang, Yong] Arizona State Univ, Sch Life Sci, Tempe, AZ USA; [Keitany, Gladys] Univ Washington, Sch Pub Hlth, Seattle, WA USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Arizona State University; Arizona State University-Tempe; University of Washington; University of Washington Seattle	Orth, K (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	kim.orth@utsouthwestern.edu	Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620	NIH AID [AI056404]; NIH/NIDDK [1R21DK072134-01]; Welch Research Foundation [I-1561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI056404] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK072134] Funding Source: NIH RePORTER	NIH AID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Welch Research Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded in part by NIH AID grant AI056404 (to KO), NIH/NIDDK grant 1R21DK072134-01 (to KO) and Welch Research Foundation grant I-1561 (to KO).	Carter RS, 2003, J BIOL CHEM, V278, P48903, DOI 10.1074/jbc.M310686200; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Ghosh P, 2004, MICROBIOL MOL BIOL R, V68, P771, DOI 10.1128/MMBR.68.4.771-795.2004; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; MITTAL R, 2006, P NATL ACAD SCI US; MUKHERJEE S, 2007, TRENDS BIOCH SCI; Mukherjee S, 2006, SCIENCE, V312, P1211, DOI 10.1126/science.1126867; Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014; Ohren JF, 2004, NAT STRUCT MOL BIOL, V11, P1192, DOI 10.1038/nsmb859; Orth K, 2000, SCIENCE, V290, P1594, DOI 10.1126/science.290.5496.1594; Orth K, 1999, SCIENCE, V285, P1920, DOI 10.1126/science.285.5435.1920; Posas F, 1997, SCIENCE, V276, P1702, DOI 10.1126/science.276.5319.1702; Qi MS, 2005, J CELL SCI, V118, P3569, DOI 10.1242/jcs.02470; Rodriguez-Viciana P, 2006, SCIENCE, V311, P1287, DOI 10.1126/science.1124642; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sugimoto T, 1998, EMBO J, V17, P1717, DOI 10.1093/emboj/17.6.1717; Sweet CR, 2007, CELL MICROBIOL, V9, P2700, DOI 10.1111/j.1462-5822.2007.00990.x; Viboud GI, 2005, ANNU REV MICROBIOL, V59, P69, DOI 10.1146/annurev.micro.59.030804.121320; VOJTEK AB, 1995, METHOD ENZYMOL, V255, P331; Yoon S, 2003, J BIOL CHEM, V278, P2131, DOI 10.1074/jbc.M209905200; Zhou HL, 2005, J EXP MED, V202, P1327, DOI 10.1084/jem.20051194	21	23	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1375	10.1371/journal.pone.0001375	http://dx.doi.org/10.1371/journal.pone.0001375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167536	Green Published, Green Submitted, gold			2022-12-25	WOS:000260468900004
J	Pan, A; Ye, XW; Franco, OH; Li, HX; Yu, ZJ; Wang, J; Qi, QB; Gu, WJ; Pang, XH; Liu, H; Lin, X				Pan, An; Ye, Xingwang; Franco, Oscar H.; Li, Huaixing; Yu, Zhijie; Wang, Jing; Qi, Qibin; Gu, Wenjia; Pang, Xinghuo; Liu, Hong; Lin, Xu			The Association of Depressive Symptoms with Inflammatory Factors and Adipokines in Middle-Aged and Older Chinese	PLOS ONE			English	Article							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; ADIPOSE-TISSUE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RISK-FACTORS; OBESITY; MARKERS; HEALTH; MOOD	Background. Studies in Western populations find that depression is associated with inflammation and obesity. The present study aimed to evaluate the relation of depressive symptoms with inflammatory factors and adipose-derived adipokines in middle-aged and older Chinese. Methodology/Principal Findings. Data were from 3289 community residents aged 50-70 from Beijing and Shanghai who participated in the Nutrition and Health of Aging Population in China project. Depressive symptoms were defined as a Center for Epidemiological Studies of Depression Scale (CES-D) score of 16 or higher. Plasma concentrations of C-reactive protein (CRP), interleukin-6 (IL-6), adiponectin, resistin, plasminogen activator inhibitor-1 (PAI-1) and retinol binding protein 4 (RBP4) were measured. Of the 3289 participants, 312 (9.5%) suffered from current depressive symptoms. IL-6 level was higher in participants with depressive symptoms compared to their counterparts in the crude analyses (1.17 vs. 1.05 pg/mL, p = 0.023) and this association lost statistical significance after multiple adjustments (1.13 vs. 1.10 pg/mL, p = 0.520). Depressive symptoms were not associated with increased mean levels of any other inflammatory factors or adipokines in the unadjusted or adjusted analyses. Conclusions/Significance. We found no evidence that depressive symptoms were associated with inflammatory factors and adipokines in the middle-aged and older Chinese populations. Prospective studies and studies in clinically diagnosed patients are needed to confirm our results and clarify the relation of depression with inflammatory factors and adipokines.	[Pan, An; Ye, Xingwang; Li, Huaixing; Yu, Zhijie; Wang, Jing; Qi, Qibin; Gu, Wenjia; Lin, Xu] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Syst Biol, Shanghai, Peoples R China; [Franco, Oscar H.] Unilever Corp Res, Colworth House, Sharnbrook, Beds, England; [Pang, Xinghuo] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Liu, Hong] Shanghai Ctr Dis Control & Prevent, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Unilever; Shanghai Center for Disease Control & Prevention	Lin, X (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, Key Lab Syst Biol, Shanghai, Peoples R China.	xlin@sibs.ac.cn	Ye, Xingwang/D-5193-2011; Qi, Qibin/H-9055-2012; Franco, Óscar H/ABE-2305-2020; Pan, An/C-5572-2011	Franco, Óscar H/0000-0002-4606-4929; Pan, An/0000-0002-1089-7945	Chinese Academy of Sciences; Shanghai-Unilever Research Development Fund; Science and Technology Commission of Shanghai Municipality; Ministry of Science and Technology of China;  [KSCX2-2-25];  [200306];  [04DZ14007];  [2006CB503900]	Chinese Academy of Sciences(Chinese Academy of Sciences); Shanghai-Unilever Research Development Fund(Unilever); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); ; ; ; 	This study was funded by Grants KSCX2-2-25, 200306, 04DZ14007 and 973 Program 2006CB503900 from the Chinese Academy of Sciences, the Shanghai-Unilever Research Development Fund, the Science and Technology Commission of Shanghai Municipality, and the Ministry of Science and Technology of China, respectively. None of the funding sources had any role in the collection of data, interpretation of results, or preparation of this manuscript.	Almeida OP, 2007, PSYCHOL MED, V37, P1775, DOI 10.1017/S0033291707000827; [Anonymous], GUIDELINES DATA PROC; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Beekman ATF, 1997, PSYCHOL MED, V27, P231, DOI 10.1017/S0033291796003510; Bei-Fan Z, 2002, ASIA PAC J CLIN NUTR, V11, pS685, DOI 10.1046/j.1440-6047.11.s8.9.x; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Blake GJ, 2002, J INTERN MED, V252, P283, DOI 10.1046/j.1365-2796.2002.01019.x; Carney RM, 2001, CIRCULATION, V104, P2024, DOI 10.1161/hc4201.097834; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; Dentino AN, 1999, J AM GERIATR SOC, V47, P6, DOI 10.1111/j.1532-5415.1999.tb01894.x; Douglas KM, 2004, PSYCHOSOM MED, V66, P679, DOI 10.1097/01.psy.0000138132.66332.85; Elovainio M, 2006, PSYCHOL MED, V36, P797, DOI 10.1017/S0033291706007574; Eskandari F, 2005, METABOLISM, V54, P918, DOI 10.1016/j.metabol.2005.02.006; Fantuzzi G, 2007, ARTERIOSCL THROM VAS, V27, P996, DOI 10.1161/ATVBAHA.106.131755; Ford DE, 2004, ARCH INTERN MED, V164, P1010, DOI 10.1001/archinte.164.9.1010; Joynt KE, 2003, BIOL PSYCHIAT, V54, P248, DOI 10.1016/S0006-3223(03)00568-7; Kop WJ, 2002, AM J CARDIOL, V89, P419, DOI 10.1016/S0002-9149(01)02264-0; Lahlou-Laforet K, 2006, AM J CARDIOL, V97, P1287, DOI 10.1016/j.amjcard.2005.11.062; Leo R, 2006, NEUROSCI LETT, V407, P211, DOI 10.1016/j.neulet.2006.08.043; Li JJ, 2004, MED HYPOTHESES, V62, P499, DOI 10.1016/j.mehy.2003.12.014; Li ZB, 2004, INT J GERIATR PSYCH, V19, P68, DOI 10.1002/gps.1040; Libby P, 2006, AM J CLIN NUTR, V83, p456S; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; LIN N, 1989, J NERV MENT DIS, V177, P121, DOI 10.1097/00005053-198903000-00001; Liukkonen T, 2006, BIOL PSYCHIAT, V60, P825, DOI 10.1016/j.biopsych.2006.02.016; Mamalakis G, 2006, PHARMACOL BIOCHEM BE, V85, P474, DOI 10.1016/j.pbb.2006.10.008; Matthews KA, 2007, PSYCHOSOM MED, V69, P124, DOI 10.1097/01.psy.0000256574.30389.1b; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; Musselman DL, 2000, ARCH GEN PSYCHIAT, V57, P875, DOI 10.1001/archpsyc.57.9.875; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; Otte C, 2005, AM J PSYCHIAT, V162, P2139, DOI 10.1176/appi.ajp.162.11.2139; Otte C, 2004, BIOL PSYCHIAT, V56, P241, DOI 10.1016/j.biopsych.2004.06.003; Pan A, 2008, J AFFECT DISORDERS, V105, P167, DOI 10.1016/j.jad.2007.05.003; Panagiotakos DB, 2004, EUR HEART J, V25, P492, DOI 10.1016/j.ehj.2004.01.018; Penninx BWJH, 2003, BIOL PSYCHIAT, V54, P566, DOI 10.1016/S0006-3223(02)01811-5; Prins JB, 2002, BEST PRACT RES CL EN, V16, P639, DOI 10.1053/beem.2002.0222; Qi QB, 2007, J CLIN ENDOCR METAB, V92, P4827, DOI 10.1210/jc.2007-1219; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ronti T, 2006, CLIN ENDOCRINOL, V64, P355, DOI 10.1111/j.1365-2265.2006.02474.x; Rosmond R, 2004, MED HYPOTHESES, V62, P976, DOI 10.1016/j.mehy.2003.12.030; Savage DB, 2001, DIABETES, V50, P2199, DOI 10.2337/diabetes.50.10.2199; Steptoe A, 2003, PSYCHOL MED, V33, P667, DOI 10.1017/S0033291702007250; Suarez EC, 2004, PSYCHOSOM MED, V66, P684, DOI 10.1097/01.psy.0000138281.73634.67; Tiemeier H, 2003, EPIDEMIOLOGY, V14, P103, DOI 10.1097/00001648-200301000-00025; Whooley MA, 2007, BIOL PSYCHIAT, V62, P314, DOI 10.1016/j.biopsych.2006.10.016; Wulsin LR, 2003, PSYCHOSOM MED, V65, P201, DOI 10.1097/01.PSY.0000058371.50240.E3; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Ye XW, 2007, J AM COLL CARDIOL, V49, P1798, DOI 10.1016/j.jacc.2007.01.065; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zhang J, 2002, J PERS ASSESS, V79, P492, DOI 10.1207/S15327752JPA7903_06; Ziegelstein RC, 2000, ARCH INTERN MED, V160, P1818, DOI 10.1001/archinte.160.12.1818	51	53	52	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1392	10.1371/journal.pone.0001392	http://dx.doi.org/10.1371/journal.pone.0001392			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	366GP	18167551	Green Published, Green Submitted, gold			2022-12-25	WOS:000260468900020
J	Salemi, M; de Oliveira, T; Ciccozzi, M; Rezza, G; Goodenow, MM				Salemi, Marco; de Oliveira, Tulio; Ciccozzi, Massimo; Rezza, Giovanni; Goodenow, Maureen M.			High-Resolution Molecular Epidemiology and Evolutionary History of HIV-1 Subtypes in Albania	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; POPULATION HISTORY; TYPE-1 EPIDEMIC; ORIGIN; GENE; CIRCULATION; RESISTANCE; DIVERSITY; SELECTION; ANCESTOR	Background. HIV-1 epidemic in Western Europe is largely due to subtype B. Little is known about the HIV-1 in Eastern Europe, but a few studies have shown that non-B subtypes are quite common. In Albania, where a recent study estimated a ten-fold increase of AIDS incidence during the last six years, subtype A and B account for 90% of the know infections. Methodology/Principal Findings. We investigated the demographic history of HIV-1 subtype A and B in Albania by using a statistical framework based on coalescent theory and phylogeography. High-resolution phylogenetic and molecular clock analysis showed a limited introduction to the Balkan country of subtype A during the late 1980s followed by an epidemic outburst in the early 1990s. In contrast, subtype B was apparently introduced multiple times between the mid-1970s and mid-1980s. Both subtypes are growing exponentially, although the HIV-1A epidemic displays a faster growth rate, and a significantly higher basic reproductive number R-0. HIV-1A gene flow occurs primarily from the capital Tirane, in the center of the country, to the periphery, while HIV-1B flow is characterized by a balanced exchange between center and periphery. Finally, we calculated that the actual number of infections in Albania is at least two orders of magnitude higher than previously thought. Conclusions/Significance. Our analysis demonstrates the power of recently developed computational tools to investigate molecular epidemiology of pathogens, and emphasize the complex factors involved in the establishment of HIV-1 epidemics. We suggest that a significant correlation exists between HIV-1 exponential spread and the socio-political changes occurred during the Balkan wars. The fast growth of a relatively new non-B epidemic in the Balkans may have significant consequences for the evolution of HIV-1 epidemiology in neighboring countries in Eastern and Western Europe.	[Salemi, Marco; Goodenow, Maureen M.] Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA; [de Oliveira, Tulio] Med Res Council MRC, Bioinform Unit, Cape Town, South Africa; [Ciccozzi, Massimo; Rezza, Giovanni] Inst Sup Sanita, Rome, Italy	State University System of Florida; University of Florida; Istituto Superiore di Sanita (ISS)	Salemi, M (corresponding author), Univ Florida, Dept Pathol Immunol & Lab Med, Gainesville, FL 32611 USA.	salemi@pathology.ufl.edu	CICCOZZI, MASSIMO/C-6484-2016; Ciccozzi, Massimo/AAC-3271-2022; rezza, giovanni/D-4393-2016	CICCOZZI, MASSIMO/0000-0003-3866-9239; Ciccozzi, Massimo/0000-0003-3866-9239; rezza, giovanni/0000-0003-0268-6790	PHS [HD032259, AI047723, AI065265]; Center for Research in Pediatric Immune Deficiency; Holloway University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047723, R01AI065265] Funding Source: NIH RePORTER	PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Center for Research in Pediatric Immune Deficiency; Holloway University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The research was supported by PHS R01 awards HD032259, AI047723, and AI065265; Center for Research in Pediatric Immune Deficiency; Stephany W. Holloway University Chair for AIDS Research (MMG).	Ciccozzi M, 2005, J INFECT DIS, V192, P475, DOI 10.1086/431599; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Esparza J, 2000, LANCET, V355, P2061, DOI 10.1016/S0140-6736(00)02360-6; Frost SDW, 2000, J VIROL, V74, P6262, DOI 10.1128/JVI.74.14.6262-6268.2000; Gao F, 1999, NATURE, V397, P436, DOI 10.1038/17130; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; GRIFFITHS RC, 1994, PHILOS T ROY SOC B, V344, P403, DOI 10.1098/rstb.1994.0079; HAHN BH, 1984, NATURE, V312, P166, DOI 10.1038/312166a0; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Hue S, 2004, AIDS, V18, P719, DOI [10.1097/00002030-200403260-00002, 10.1097/01.aids.0000111455.61782.c3]; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kingman J, 1982, STOCHASTIC PROCESS A, V13, P235, DOI [10.1016/0304-4149(82)90011-4, DOI 10.1016/0304-4149(82)90011-4]; Korber B, 2000, SCIENCE, V288, P1789, DOI 10.1126/science.288.5472.1789; Lazouskaya NV, 2005, AIDS RES HUM RETROV, V21, P830, DOI 10.1089/aid.2005.21.830; Leal ED, 2004, VIROLOGY, V325, P181, DOI 10.1016/j.virol.2004.04.004; Lemey P, 2003, P NATL ACAD SCI USA, V100, P6588, DOI 10.1073/pnas.0936469100; Lukashov VV, 1999, AIDS RES HUM RETROV, V15, P1577, DOI 10.1089/088922299309874; McCutchan FE, 2000, AIDS, V14, pS31; Peeters M, 2000, AIDS, V14, pS129; Pybus OG, 2000, GENETICS, V155, P1429; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Rambaut A, 2000, BIOINFORMATICS, V16, P395, DOI 10.1093/bioinformatics/16.4.395; Rambaut A, 1998, MOL BIOL EVOL, V15, P442, DOI 10.1093/oxfordjournals.molbev.a025940; RICHMAN DD, 1994, J VIROL, V68, P1660, DOI 10.1128/JVI.68.3.1660-1666.1994; Robbins KE, 2003, J VIROL, V77, P6359, DOI 10.1128/JVI.77.11.6359-6366.2003; Robertson DL, 2000, SCIENCE, V288, P55, DOI 10.1126/science.288.5463.55d; Rouzine IM, 1999, J VIROL, V73, P8167, DOI 10.1128/JVI.73.10.8167-8178.1999; Saad MD, 2006, AIDS RES HUM RETROV, V22, P709, DOI 10.1089/aid.2006.22.709; Salemi M, 2005, J VIROL, V79, P11343, DOI 10.1128/JVI.79.17.11343-11352.2005; Salemi M, 2005, J MOL EVOL, V60, P598, DOI 10.1007/s00239-004-0206-5; Salemi M, 2001, FASEB J, V15, P276, DOI 10.1096/fj.00-0449fje; SALMINEN MO, 1995, AIDS RES HUM RETROV, V11, P1423, DOI 10.1089/aid.1995.11.1423; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; SEILLIERMOISEIWITSCH F, 1994, ANNU REV GENET, V28, P559; SLATKIN M, 1989, GENETICS, V123, P603; Stanojevic M, 2002, AIDS RES HUM RETROV, V18, P519, DOI 10.1089/088922202317406673; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Suchard MA, 2001, MOL BIOL EVOL, V18, P1001, DOI 10.1093/oxfordjournals.molbev.a003872; SWOFFORD D, 2003, PHYLOGENETIC HDB PRA, P160; Thompson JD, 1994, NUCLEIC ACIDS RES, V24, P4876, DOI DOI 10.1093/NAR/25.24.4876	41	56	57	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1390	10.1371/journal.pone.0001390	http://dx.doi.org/10.1371/journal.pone.0001390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167549	Green Published, gold			2022-12-25	WOS:000260468900018
J	Tanaka, SC; Schweighofer, N; Asahi, S; Shishida, K; Okamoto, Y; Yamawaki, S; Doya, K				Tanaka, Saori C.; Schweighofer, Nicolas; Asahi, Shuji; Shishida, Kazuhiro; Okamoto, Yasumasa; Yamawaki, Shigeto; Doya, Kenji			Serotonin Differentially Regulates Short- and Long-Term Prediction of Rewards in the Ventral and Dorsal Striatum	PLOS ONE			English	Article								Background. The ability to select an action by considering both delays and amount of reward outcome is critical for maximizing long-term benefits. Although previous animal experiments on impulsivity have suggested a role of serotonin in behaviors requiring prediction of delayed rewards, the underlying neural mechanism is unclear. Methodology/Principal Findings. To elucidate the role of serotonin in the evaluation of delayed rewards, we performed a functional brain imaging experiment in which subjects chose small-immediate or large-delayed liquid rewards under dietary regulation of tryptophan, a precursor of serotonin. A model-based analysis revealed that the activity of the ventral part of the striatum was correlated with reward prediction at shorter time scales, and this correlated activity was stronger at low serotonin levels. By contrast, the activity of the dorsal part of the striatum was correlated with reward prediction at longer time scales, and this correlated activity was stronger at high serotonin levels. Conclusions/Significance. Our results suggest that serotonin controls the time scale of reward prediction by differentially regulating activities within the striatum.	[Tanaka, Saori C.; Schweighofer, Nicolas; Doya, Kenji] ATR Computat Neurosci Labs, Dept Computat Neurobiol, Kyoto, Japan; [Tanaka, Saori C.; Schweighofer, Nicolas; Asahi, Shuji; Shishida, Kazuhiro; Okamoto, Yasumasa; Yamawaki, Shigeto; Doya, Kenji] Japan Sci & Technol Agcy, CREST, Kyoto, Japan; [Schweighofer, Nicolas] Univ So Calif, Dept Biokinesiol & Phys Therapy, Los Angeles, CA USA; [Asahi, Shuji; Shishida, Kazuhiro; Okamoto, Yasumasa; Yamawaki, Shigeto] Hiroshima Univ, Dept Psychiat & Neurosci, Hiroshima, Japan; [Doya, Kenji] Okinawa Inst Sci & Technol, Neural Computat Unit, Okinawa, Japan	Japan Science & Technology Agency (JST); University of Southern California; Hiroshima University; Okinawa Institute of Science & Technology Graduate University	Tanaka, SC (corresponding author), ATR Computat Neurosci Labs, Dept Computat Neurobiol, Kyoto, Japan.	xsaori@atr.jp; doya@oist.jp	Doya, Kenji/B-5841-2015; Schweighofer, Nicolas/A-3675-2008	Doya, Kenji/0000-0002-2446-6820; Schweighofer, Nicolas/0000-0003-3362-6088; Tanaka, Saori/0000-0002-7001-5051	"Creating the Brain," the Core Research for Evolutional Science and Technology (CREST); Japan Science and Technology Agency; Japan Society for the Promotion of Science for Young Scientists	"Creating the Brain," the Core Research for Evolutional Science and Technology (CREST)(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research is supported by "Creating the Brain,'' the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency. ST is funded by research fellowships from the Japan Society for the Promotion of Science for Young Scientists.	AINSLIE G, 1975, PSYCHOL BULL, V82, P463, DOI 10.1037/h0076860; Bizot JC, 1999, PSYCHOPHARMACOLOGY, V146, P400, DOI 10.1007/PL00005485; Bjork JM, 1999, PSYCHOPHARMACOLOGY, V142, P24, DOI 10.1007/s002130050858; Bjork JM, 2000, NEUROPSYCHOPHARMACOL, V22, P357, DOI 10.1016/S0893-133X(99)00136-0; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cardinal RN, 2006, NEURAL NETWORKS, V19, P1277, DOI 10.1016/j.neunet.2006.03.004; Carpenter LL, 1998, NEUROPSYCHOPHARMACOL, V19, P26; Compan V, 1998, BRAIN RES, V793, P103, DOI 10.1016/S0006-8993(98)00168-1; Crean J, 2002, BEHAV BRAIN RES, V136, P349, DOI 10.1016/S0166-4328(02)00132-8; DELGADO PL, 1990, ARCH GEN PSYCHIAT, V47, P411; Doya K, 2002, NEURAL NETWORKS, V15, P495, DOI 10.1016/S0893-6080(02)00044-8; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Huang YY, 2005, BIOORG MED CHEM LETT, V15, P4786, DOI 10.1016/j.bmcl.2005.07.024; KAGEL JH, 1986, ANIM BEHAV, V34, P271, DOI 10.1016/0003-3472(86)90032-1; Larisch R, 2003, BEHAV BRAIN RES, V139, P21, DOI 10.1016/S0166-4328(01)00412-0; Mazur J.E., 1987, QUANTITATIVE ANAL BE, V5, P55; Mazur JE, 2001, PSYCHOL REV, V108, P96, DOI 10.1037/0033-295X.108.1.96; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mobini S, 2000, PSYCHOPHARMACOLOGY, V152, P390, DOI 10.1007/s002130000542; Mobini S, 2002, PSYCHOPHARMACOLOGY, V160, P290, DOI 10.1007/s00213-001-0983-0; Pothuizen HHJ, 2005, EUR J NEUROSCI, V22, P2605, DOI 10.1111/j.1460-9568.2005.04388.x; Poulos CX, 1996, BEHAV PHARMACOL, V7, P395, DOI 10.1097/00008877-199608000-00011; Samuelson Paul, 1937, REV ECON STUD, V4, P155, DOI [DOI 10.2307/2967612, 10.2307/2967612]; Schweighofer N, 2006, PLOS COMPUT BIOL, V2, P1349, DOI 10.1371/journal.pcbi.0020152; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Varnas K, 2004, HUM BRAIN MAPP, V22, P246, DOI 10.1002/hbm.20035; Williams WA, 1999, J NEUROCHEM, V72, P1641, DOI 10.1046/j.1471-4159.1999.721641.x; Winstanley CA, 2004, NEUROPSYCHOPHARMACOL, V29, P1331, DOI 10.1038/sj.npp.1300434; WOGAR MA, 1993, PSYCHOPHARMACOLOGY, V111, P239, DOI 10.1007/BF02245530; YOUNG SN, 1981, J NEUROL NEUROSUR PS, V44, P323, DOI 10.1136/jnnp.44.4.323; YOUNG SN, 1985, PSYCHOPHARMACOLOGY, V87, P173, DOI 10.1007/BF00431803	34	127	128	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1333	10.1371/journal.pone.0001333	http://dx.doi.org/10.1371/journal.pone.0001333			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091999	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459600017
J	Banci, L; Bertini, I; Ciofi-Baffoni, S; Janicka, A; Martinelli, M; Kozlowski, H; Palumaa, P				Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Janicka, Anna; Martinelli, Manuele; Kozlowski, Henryk; Palumaa, Peep			A structural-dynamical characterization of human Cox17	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C-OXIDASE; MITOCHONDRIAL INTERMEMBRANE SPACE; NMR STRUCTURE DETERMINATION; COPPER CHAPERONE COX17; CHEMICAL-SHIFT; PROTEIN NMR; SACCHAROMYCES-CEREVISIAE; ATX1 METALLOCHAPERONE; CU(I)-LOADED STATES; HUMAN SCO1	Human Cox17 is a key mitochondrial copper chaperone responsible for supplying copper ions, through the assistance of Sco1, Sco2, and Cox11, to cytochrome c oxidase, the terminal enzyme of the mitochondrial energy transducing respiratory chain. A structural and dynamical characterization of human Cox17 in its various functional metallated and redox states is presented here. The NMR solution structure of the partially oxidized Cox17 ( Cox17(2S-S)) consists of a coiled coil-helix-coiled coil-helix domain stabilized by two disulfide bonds involving Cys(25)-Cys(54) and Cys(35)-Cys(44), preceded by a flexible and completely unstructured N-terminal tail. In human Cu(I) Cox172S-S the copper(I) ion is coordinated by the sulfurs of Cys(22) and Cys(23), and this is the first example of a Cys-Cys binding motif in copper proteins. Copper(I) binding as well as the formation of a third disulfide involving Cys(22) and Cys(23) cause structural and dynamical changes only restricted to the metal-binding region. Redox properties of the disulfides of human Cox17, here investigated, strongly support the current hypothesis that the unstructured fully reduced Cox17 protein is present in the cytoplasm and enters the intermembrane space (IMS) where is then oxidized by Mia40 to Cox17(2S-S), thus becoming partially structured and trapped into the IMS. Cox17(2S-S) is the functional species in the IMS, it can bind only one copper(I) ion and is then ready to enter the pathway of copper delivery to cytochrome c oxidase. The copper(I) form of Cox172(S-S) has features specific for copper chaperones.	[Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Janicka, Anna; Martinelli, Manuele] Univ Florence, CERM, I-50019 Sesto Fiorentino, Italy; [Banci, Lucia; Bertini, Ivano; Ciofi-Baffoni, Simone; Janicka, Anna; Martinelli, Manuele] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Janicka, Anna; Kozlowski, Henryk] Univ Wroclaw, Fac Chem, PL-50383 Wroclaw, Poland; [Palumaa, Peep] Tallinn Univ Technol, Dept Gene Technol, EE-12618 Tallinn, Estonia	University of Florence; University of Florence; University of Wroclaw; Tallinn University of Technology	Bertini, I (corresponding author), Univ Florence, CERM, Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	ivanobertini@cerm.unifi.it	Palumaa, Peep/B-4668-2019; Palumaa, Peep/AAF-7617-2020; Ciofi-Baffoni, Simone/AAH-9778-2021	Palumaa, Peep/0000-0002-3505-3466; Palumaa, Peep/0000-0002-3505-3466; BANCI, LUCIA/0000-0003-0562-5774; Janicka-Klos, Anna/0000-0001-9713-4424; Kozlowski, Henryk/0000-0001-5769-8583; Ciofi Baffoni, Simone/0000-0002-2376-3321; martinelli, manuele/0000-0002-9371-076X				Abajian C, 2004, J BIOL CHEM, V279, P53584, DOI 10.1074/jbc.M408099200; Arnesano F, 2005, STRUCTURE, V13, P713, DOI 10.1016/j.str.2005.02.015; Arnesano F, 2002, GENOME RES, V12, P255, DOI 10.1101/gr.196802; Arnesano F, 2001, BIOCHEMISTRY-US, V40, P1528, DOI 10.1021/bi0014711; Banci L, 2004, J BIOL CHEM, V279, P34833, DOI 10.1074/jbc.M403655200; Banci L, 2004, J BIOL CHEM, V279, P27502, DOI 10.1074/jbc.M402005200; Banci L, 2003, BIOCHEMISTRY-US, V42, P2467, DOI 10.1021/bi0205810; Banci L, 2001, J BIOL CHEM, V276, P8415, DOI 10.1074/jbc.M008389200; Banci L, 2007, P NATL ACAD SCI USA, V104, P15, DOI 10.1073/pnas.0606189103; Banci L, 2006, P NATL ACAD SCI USA, V103, P8595, DOI 10.1073/pnas.0601375103; Barrientos A, 2002, GENE, V286, P53, DOI 10.1016/S0378-1119(01)00803-4; Barros MH, 2004, J BIOL CHEM, V279, P31943, DOI 10.1074/jbc.M405014200; Beinert H, 1995, CHEM BIOL, V2, P781, DOI 10.1016/1074-5521(95)90082-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Carr HS, 2003, ACCOUNTS CHEM RES, V36, P309, DOI 10.1021/ar0200807; CASE DA, 2004, AMBER 8 VERSION 8 U; Chacinska A, 2004, EMBO J, V23, P3735, DOI 10.1038/sj.emboj.7600389; Chen ZW, 1997, EUR J BIOCHEM, V249, P518, DOI 10.1111/j.1432-1033.1997.t01-2-00518.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELEAGE G, 1993, COMPUT APPL BIOSCI, V9, P197; Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620; Gabriel K, 2007, J MOL BIOL, V365, P612, DOI 10.1016/j.jmb.2006.10.038; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Heaton D, 2000, J BIOL CHEM, V275, P37582, DOI 10.1074/jbc.M006639200; Herrmann JM, 2007, J CELL BIOL, V176, P559, DOI 10.1083/jcb.200611060; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Horng YC, 2004, J BIOL CHEM, V279, P35334, DOI 10.1074/jbc.M404747200; Huffman DL, 2000, J BIOL CHEM, V275, P18611, DOI 10.1074/jbc.C000172200; Huffman DL, 2001, ANNU REV BIOCHEM, V70, P677, DOI 10.1146/annurev.biochem.70.1.677; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Keller R., 2004, COMPUTER AIDED RESON, V1; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011; Nobrega MP, 2002, J BIOL CHEM, V277, P40206, DOI 10.1074/jbc.M207348200; OTTING G, 1993, BIOCHEMISTRY-US, V32, P3571, DOI 10.1021/bi00065a008; Palumaa P, 2004, BIOCHEM J, V382, P307, DOI 10.1042/BJ20040360; PELTON JG, 1993, PROTEIN SCI, V2, P543; Poger D, 2005, FEBS LETT, V579, P5287, DOI 10.1016/j.febslet.2005.08.052; Portnoy ME, 1999, J BIOL CHEM, V274, P15041, DOI 10.1074/jbc.274.21.15041; Pufahl RA, 1997, SCIENCE, V278, P853, DOI 10.1126/science.278.5339.853; Punter FA, 2003, J BIOL CHEM, V278, P30875, DOI 10.1074/jbc.M302358200; Ralle M, 2003, J BIOL CHEM, V278, P23163, DOI 10.1074/jbc.M303474200; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Sideris DP, 2007, MOL MICROBIOL, V65, P1360, DOI 10.1111/j.1365-2958.2007.05880.x; Srinivasan C, 1998, BIOCHEMISTRY-US, V37, P7572, DOI 10.1021/bi980418y; Takenouchi T, 1999, BBA-GEN SUBJECTS, V1472, P498, DOI 10.1016/S0304-4165(99)00158-0; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Voronova A, 2007, BIOCHEM J, V408, P139, DOI 10.1042/BJ20070804; Voronova A, 2007, PROTEIN EXPRES PURIF, V53, P138, DOI 10.1016/j.pep.2006.11.014; VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V; Wernimont AK, 2000, NAT STRUCT BIOL, V7, P766; WISHART DS, 1994, J BIOMOL NMR, V4, P171	55	80	83	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 21	2008	283	12					7912	7920		10.1074/jbc.M708016200	http://dx.doi.org/10.1074/jbc.M708016200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	274JP	18093982	hybrid			2022-12-25	WOS:000253997900067
J	Sumida, JP; Wu, E; Lehrer, SS				Sumida, John P.; Wu, Eleanor; Lehrer, Sherwin S.			Conserved Asp-137 imparts flexibility to tropomyosin and affects function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; INFECTED INSECT CELLS; SUBFRAGMENT 1 ATPASE; THIN FILAMENT; COILED-COIL; ALPHA-TROPOMYOSIN; INTRINSIC FLUORESCENCE; HYDROGEN-EXCHANGE; STRIATED-MUSCLE	Tropomyosin (Tm) is an alpha-helical coiled-coil that controls muscle contraction by sterically regulating the myosin-actin interaction. Tm moves between three states on F-actin as either a uniform or a non-uniform semi-flexible rod. Tm is stabilized by hydrophobic residues in the "a" and "d" positions of the heptad repeat. The highly conserved Asp-137 is unusual in that it introduces a negative charge on each chain in a position typically occupied by hydrophobic residues. The occurrence of two charged residues in the hydrophobic region is expected to destabilize the region and impart flexibility. To determine whether this region is unstable, we have substituted hydrophobic Leu for Asp-137 and studied changes in Tm susceptibility to limited proteolysis by trypsin and changes in regulation. We found that native and Tm controls that contain Asp-137 were readily cleaved at Arg-133 with t(1/2) of 5 min. In contrast, the Leu-137 mutant was not cleaved under the same conditions. Actin stabilized Tm, causing a 10-fold reduction in the rate of cleavage at Arg-133. The actin- myosin subfragment S1 ATPase activity was greater for the Leu mutant compared with controls in the absence of troponin and in the presence of troponin and Ca2+. We conclude that the highly conserved Asp-137 destabilizes the middle of Tm, resulting in a more flexible region that is important for the cooperative activation of the thin filament by myosin. We thus have shown a link between the dynamic properties of Tm and its function.	[Sumida, John P.; Wu, Eleanor; Lehrer, Sherwin S.] Boston Biomed Res Inst, Cardiovasc Program, Watertown, MA 02472 USA	Boston Biomedical Research Institute	Lehrer, SS (corresponding author), Boston Biomed Res Inst, Cardiovasc Program, Watertown, MA 02472 USA.	Lehrer@bbri.org	Lehrer, Sherwin/ABF-7282-2021		NHLBI NIH HHS [HL22461] Funding Source: Medline; NIAMS NIH HHS [AR41637] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL022461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR041637] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Anfinsen C B, 1975, Adv Protein Chem, V29, P205, DOI 10.1016/S0065-3233(08)60413-1; BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079; BETTERIDGE DR, 1983, J MOL BIOL, V167, P481, DOI 10.1016/S0022-2836(83)80346-5; Bottinelli R, 1998, CIRC RES, V82, P106; Brown JH, 2005, P NATL ACAD SCI USA, V102, P18878, DOI 10.1073/pnas.0509269102; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; Geeves MA, 2000, BIOCHEMISTRY-US, V39, P9345, DOI 10.1021/bi0002232; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Greenfield NJ, 2006, J MOL BIOL, V364, P80, DOI 10.1016/j.jmb.2006.08.033; HARRISON SM, 1989, AM J PHYSIOL, V256, pC1250, DOI 10.1152/ajpcell.1989.256.6.C1250; Jackman DM, 1996, EUR J BIOCHEM, V242, P363, DOI 10.1111/j.1432-1033.1996.0363r.x; Jagatheesan G, 2007, AM J PHYSIOL-HEART C, V293, pH949, DOI 10.1152/ajpheart.01341.2006; JOHNSON P, 1977, BIOCHEMISTRY-US, V16, P2264, DOI 10.1021/bi00629a035; KLUWE L, 1995, J MUSCLE RES CELL M, V16, P103, DOI 10.1007/BF00122528; LEESMILLER JP, 1991, BIOESSAYS, V13, P429, DOI 10.1002/bies.950130902; Lehrer SS, 1997, BIOCHEMISTRY-US, V36, P13449, DOI 10.1021/bi971568w; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; LEHRER SS, 1972, BIOCHEMISTRY-US, V11, P1211, DOI 10.1021/bi00757a015; Lehrer SS, 1998, J MOL BIOL, V277, P1081, DOI 10.1006/jmbi.1998.1654; LEHRER SS, 1978, J MOL BIOL, V118, P209, DOI 10.1016/0022-2836(78)90413-8; LINDERSTROMLANG K, 1949, COLD SPRING HARB SYM, V14, P117, DOI 10.1101/SQB.1950.014.01.016; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MARTELL AE, 1974, CRITICAL STABILITY C, V1, P139; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Michele DE, 2000, J MOL MED, V78, P543, DOI 10.1007/s001090000161; MONTEIRO PB, 1994, J BIOL CHEM, V269, P10461; Nitanai Y, 2007, ADV EXP MED BIOL, V592, P137; ONISHI H, 1995, P NATL ACAD SCI USA, V92, P704, DOI 10.1073/pnas.92.3.704; OTTESEN M, 1967, ANNU REV BIOCHEM, V36, P55, DOI 10.1146/annurev.bi.36.070167.000415; Park C, 2004, J MOL BIOL, V343, P1467, DOI 10.1016/j.jmb.2004.08.085; PATO MD, 1981, J BIOL CHEM, V256, P602; Singh A, 2006, STRUCTURE, V14, P43, DOI 10.1016/j.str.2005.09.016; Singh A, 2003, BIOCHEMISTRY-US, V42, P14114, DOI 10.1021/bi0348462; SMILEY LB, 1966, BIOCH SMOOTH MUSCLE, P63; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; Sumida J.P., 2006, BIOPHYS J S, V90, P193; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; UENO H, 1984, BIOCHEMISTRY-US, V23, P4791, DOI 10.1021/bi00315a040; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884	42	58	61	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 14	2008	283	11					6728	6734		10.1074/jbc.M707485200	http://dx.doi.org/10.1074/jbc.M707485200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	271HN	18165684	hybrid			2022-12-25	WOS:000253779600014
J	Roehrl, J; Yang, D; Oppenheim, JJ; Hehlgans, T				Roehrl, Johann; Yang, De; Oppenheim, Joost J.; Hehlgans, Thomas			Identification and biological characterization of mouse beta-defensin 14, the orthologue of human beta-defensin 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BETA-DEFENSINS; IMMATURE DENDRITIC CELLS; ANTIMICROBIAL PEPTIDES; INDUCTION; IMMUNITY; KERATINOCYTES; EXPRESSION; DISCOVERY; INCREASE; INNATE	beta-Defensins are small antimicrobial polypeptides that are mainly expressed by epithelial cells and play an important role in the antimicrobial innate immune response. In addition to the direct microbicidal effects of these polypeptides, it became evident that certain members of the beta-defensin super family have the capacity to promote local innate inflammatory and systemic adaptive immune responses by interacting with the CC-chemokine receptor CCR6. We have identified mouse beta-defensin 14 (mBD14, Defb14) as an orthologue of human beta-defensin 3 (hBD3 or DEFB103). Based on primary structural analysis, mBD14 demonstrates greater (68%) homology to its human orthologue, containing three conserved cystein linkages, characteristic for the beta-defensin super family. mBD14 is expressed in a wide variety of tissues including spleen, colon, and tissues of the upper and lower respiratory tract. Interestingly, we also detected mBD14 expression in immature CD11c(+) bone marrow-derived dendritic cells. The expression of mBD14 can be induced by Toll-like receptor agonists such as lipopolysaccharide and poly(I:C) and by pro-inflammatory stimuli e. g. tumor necrosis factor and interferon-gamma. Furthermore, expression of mBD14 seems to be regulated by activation of the intracellular pattern recognition receptor NOD2/CARD15 as revealed by reporter gene analysis. We prepared a recombinant mBD14-Ig fusion protein that retained potent antimicrobial activity against several Escherichia coli strains but not against various Gram-positive Staphylococcus aureus strains. hBD3 and also the newly identified mBD14 were chemotactic for cells expressing the mouse CC-chemokine receptor CCR6. In addition, both hBD3 and mBD14 were chemotactic for freshly isolated mouse resident peritoneal cells. Thus, mBD14, based on structural and functional similarities, appears to be an orthologue of hBD3.	[Roehrl, Johann; Hehlgans, Thomas] Univ Regensburg, Inst Immunol, D-93042 Regensburg, Germany; [Yang, De; Oppenheim, Joost J.] NIH, NCI, Div Basic Sci, Mol Immunoregulat Lab, Frederick, MD 21702 USA	University of Regensburg; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hehlgans, T (corresponding author), Univ Regensburg, Inst Immunol, Franz-Josef-Str-Allee 11, D-93042 Regensburg, Germany.	thomas.hehlgans@klinik.regensburg.de			NATIONAL CANCER INSTITUTE [ZIABC009369, Z01BC009369] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Biragyn A, 2001, J IMMUNOL, V167, P6644, DOI 10.4049/jimmunol.167.11.6644; Chen XJ, 2007, EUR J IMMUNOL, V37, P434, DOI 10.1002/eji.200636379; Chertov O, 1996, J BIOL CHEM, V271, P2935, DOI 10.1074/jbc.271.6.2935; FALK W, 1980, J IMMUNOL METHODS, V33, P239, DOI 10.1016/S0022-1759(80)80014-7; Fang XM, 2003, EUR J CLIN INVEST, V33, P82, DOI 10.1046/j.1365-2362.2003.01076.x; Ganz T, 2002, SCIENCE, V298, P977, DOI 10.1126/science.1078708; Harder J, 2004, J INVEST DERMATOL, V123, P522, DOI 10.1111/j.0022-202X.2004.23234.x; Harder J, 2001, J BIOL CHEM, V276, P5707, DOI 10.1074/jbc.M008557200; Harder Juergen, 2005, V86, P22, DOI 10.1159/000086650; Ishimoto H, 2006, EUR RESPIR J, V27, P253, DOI 10.1183/09031936.06.00105904; Jia HP, 2001, GENE, V263, P211; Joly S, 2005, MOL IMMUNOL, V42, P1073, DOI 10.1016/j.molimm.2004.11.001; Lehrer RI, 2002, CURR OPIN IMMUNOL, V14, P96, DOI 10.1016/S0952-7915(01)00303-X; Lutz MB, 2000, EUR J IMMUNOL, V30, P1813, DOI 10.1002/1521-4141(200007)30:7<1813::AID-IMMU1813>3.0.CO;2-8; McCray PB, 1997, AM J RESP CELL MOL, V16, P343, DOI 10.1165/ajrcmb.16.3.9070620; MICHAELSON D, 1992, J LEUKOCYTE BIOL, V51, P634, DOI 10.1002/jlb.51.6.634; Pazgier M, 2006, CELL MOL LIFE SCI, V63, P1294, DOI 10.1007/s00018-005-5540-2; PIERS KL, 1993, GENE, V134, P7, DOI 10.1016/0378-1119(93)90168-3; Schutte BC, 2002, P NATL ACAD SCI USA, V99, P2129, DOI 10.1073/pnas.042692699; Semple CA, 2006, MOL DIVERS, V10, P575, DOI 10.1007/s11030-006-9031-7; Tsutsumi-Ishii Y, 2003, J IMMUNOL, V170, P4226, DOI 10.4049/jimmunol.170.8.4226; Voss E, 2006, J BIOL CHEM, V281, P2005, DOI 10.1074/jbc.M511044200; Wu ZB, 2003, P NATL ACAD SCI USA, V100, P8880, DOI 10.1073/pnas.1533186100; Yang D, 2000, J LEUKOCYTE BIOL, V68, P9; Yang D, 2002, TRENDS IMMUNOL, V23, P291, DOI 10.1016/S1471-4906(02)02246-9; Yang D, 1999, SCIENCE, V286, P525, DOI 10.1126/science.286.5439.525; Yang D, 2000, J EXP MED, V192, P1069, DOI 10.1084/jem.192.7.1069	27	66	68	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5414	5419		10.1074/jbc.M709103200	http://dx.doi.org/10.1074/jbc.M709103200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167348	hybrid			2022-12-25	WOS:000253426700021
J	Zhdanov, AV; Ward, MW; Prehn, JHM; Papkovsky, DB				Zhdanov, Alexander V.; Ward, Manus W.; Prehn, Jochen H. M.; Papkovsky, Dmitri B.			Dynamics of intracellular oxygen in PC12 cells upon stimulation of neurotransmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMATE EXCITOTOXICITY; POTASSIUM CHANNELS; PROTEIN-KINASE; TETANUS TOXIN; MITOCHONDRIAL; CALCIUM; CA2+; RELEASE; ACTIVATION; SECRETION	Neurotransmission, synaptic plasticity, and maintenance of membrane excitability require high mitochondrial activity in neurosecretory cells. Using a fluorescence-based intracellular O-2 sensing technique, we investigated the respiration of differentiated PC12 cells upon depolarization with 100 mM K+. Single cell confocal analysis identified a significant depolarization of the plasma membrane potential and a relatively minor depolarization of the mitochondrial membrane potential following K+ exposure. We observed a two-phase respiratory response: a first intense spike lasting similar to 10 min, during which average intracellular O-2 was reduced from 85 - 90% of air saturation to 55 - 65%, followed by a second wave of smaller amplitude and longer duration. The fast rise in O-2 consumption coincided with a transient increase in cellular ATP by similar to 60%, which was provided largely by oxidative phosphorylation and by glycolysis. The increase of respiration was orchestrated mainly by Ca2+ release from the endoplasmic reticulum, whereas the influx of extracellular Ca2+ contributed similar to 20%. Depletion of Ca2+ stores by ryanodine, thapsigargin, and 4-chloro- m-cresol reduced the amplitude of respiratory spike by 45, 63, and 71%, respectively, whereas chelation of intracellular Ca2+ abolished the response. Uncoupling of the mitochondria with the protonophore carbonyl cyanide p-trifluoromethoxyphenylhydrazone amplified the responses to K+; elevated respiration induced a profound deoxygenation without increasing the cellular ATP levels reduced by carbonyl cyanide p-trifluoromethoxyphenylhydrazone. Cleavage of synaptobrevin 2 by tetanus toxin, known to reduce neurotransmission, did not affect the respiratory response to K+, whereas the general excitability of (d)PC12 cells increased.	[Zhdanov, Alexander V.; Papkovsky, Dmitri B.] Univ Coll Cork, Dept Biochem, Cork, Ireland; [Ward, Manus W.; Prehn, Jochen H. M.] Royal Coll Surgeons Ireland, Dept Physiol & Med, Dublin 2, Ireland; [Papkovsky, Dmitri B.] Univ Coll Cork, Bioinnovat Ctr, Luxcel Biosci, Cork, Ireland	University College Cork; Royal College of Surgeons - Ireland; University College Cork	Papkovsky, DB (corresponding author), Univ Coll Cork, Dept Biochem, Cavanagh Pharm Bldg, Cork, Ireland.	d.papkovsky@ucc.ie	Prehn, Jochen HM/A-3928-2010	Prehn, Jochen HM/0000-0003-3479-7794; Ward, Manus/0000-0002-7085-9668; Zhdanov, Alexander/0000-0001-5787-2035; Papkovsky, Dmitri/0000-0003-1556-1145				Ames A, 2000, BRAIN RES REV, V34, P42, DOI 10.1016/S0165-0173(00)00038-2; Amino S, 2002, J BIOCHEM, V131, P887, DOI 10.1093/oxfordjournals.jbchem.a003179; Anthony AC, 2005, J BIOL CHEM, V280, P37278, DOI 10.1074/jbc.M504137200; Arnaudeau S, 2001, J BIOL CHEM, V276, P29430, DOI 10.1074/jbc.M103274200; Arnold S, 1997, EUR J BIOCHEM, V249, P350, DOI 10.1111/j.1432-1033.1997.t01-1-00350.x; Billups B, 2002, J NEUROSCI, V22, P5840; Billups D, 2006, J NEUROSCI, V26, P9983, DOI 10.1523/JNEUROSCI.2773-06.2006; BITTNER MA, 1992, J BIOL CHEM, V267, P16219; BRITTON P, 1995, BRAIN RES, V673, P331, DOI 10.1016/0006-8993(94)01458-T; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; Buerk DG, 2004, METHOD ENZYMOL, V381, P665; Busija DW, 2004, BRAIN RES REV, V46, P282, DOI 10.1016/j.brainresrev.2004.06.011; Duchen MR, 2000, J PHYSIOL-LONDON, V529, P57, DOI 10.1111/j.1469-7793.2000.00057.x; Dussmann H, 2003, J CELL SCI, V116, P525, DOI 10.1242/jcs.00236; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Hansford RG, 1998, MOL CELL BIOCHEM, V184, P359, DOI 10.1023/A:1006893903113; Hogan MC, 1999, J APPL PHYSIOL, V86, P720, DOI 10.1152/jappl.1999.86.2.720; Ichas F, 1997, CELL, V89, P1145, DOI 10.1016/S0092-8674(00)80301-3; Kadenbach B, 2003, BBA-BIOENERGETICS, V1604, P77, DOI 10.1016/S0005-2728(03)00027-6; Kann O, 2007, AM J PHYSIOL-CELL PH, V292, pC641, DOI 10.1152/ajpcell.00222.2006; Ladewig T, 2003, J PHYSIOL-LONDON, V547, P775, DOI 10.1113/jphysiol.2002.033605; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Liu HY, 1996, J NEUROSCI, V16, P7557; Luo Y, 1997, P NATL ACAD SCI USA, V94, P9705, DOI 10.1073/pnas.94.18.9705; Marchetti P, 1996, J EXP MED, V184, P1155, DOI 10.1084/jem.184.3.1155; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; MARTIN PT, 1991, J BIOL CHEM, V266, P7388; Mattson MP, 2003, BIOCHEM BIOPH RES CO, V304, P539, DOI 10.1016/S0006-291X(03)00627-2; MCCORMACK JG, 1990, PHYSIOL REV, V70, P391, DOI 10.1152/physrev.1990.70.2.391; Merglen A, 2004, ENDOCRINOLOGY, V145, P667, DOI 10.1210/en.2003-1099; Mironov SL, 2006, J CELL SCI, V119, P4926, DOI 10.1242/jcs.03254; Nicholls DG, 2006, J BIOL CHEM, V281, P14864, DOI 10.1074/jbc.M510916200; Nicholls DG, 2000, TRENDS NEUROSCI, V23, P166, DOI 10.1016/S0166-2236(99)01534-9; NISHI R, 1981, DEV BIOL, V87, P301, DOI 10.1016/0012-1606(81)90153-6; O'Riordan TC, 2007, ANAL CHEM, V79, P9414, DOI 10.1021/ac701770b; O'Riordan TC, 2007, AM J PHYSIOL-REG I, V292, pR1613, DOI 10.1152/ajpregu.00707.2006; Onn SP, 2003, J PHARMACOL EXP THER, V306, P870, DOI 10.1124/jpet.103.050062; Poppe M, 2001, J NEUROSCI, V21, P4551, DOI 10.1523/JNEUROSCI.21-13-04551.2001; REYNOLDS EE, 1982, BIOCHEMISTRY-US, V21, P4795, DOI 10.1021/bi00262a042; Rintoul GL, 2003, J NEUROSCI, V23, P7881; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Rosenkranz JA, 2006, J NEUROSCI, V26, P3229, DOI 10.1523/JNEUROSCI.4333-05.2006; Ryglewski S, 2007, PLOS BIOL, V5, P818, DOI 10.1371/journal.pbio.0050066; SANDBERG K, 1989, J BIOL CHEM, V264, P5679; SCHIAVO G, 1992, NATURE, V359, P832, DOI 10.1038/359832a0; SHAFER TJ, 1991, NEUROTOXICOLOGY, V12, P473; Silver I, 1998, ADV EXP MED BIOL, V454, P7; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Territo PR, 2001, J BIOL CHEM, V276, P2586, DOI 10.1074/jbc.M002923200; TOMASELLI KJ, 1987, J CELL BIOL, V105, P2347, DOI 10.1083/jcb.105.5.2347; VALEUR B, 2002, MOL FLUORESCENCE PRI, P351; Ward MW, 2007, J NEUROSCI, V27, P8238, DOI 10.1523/JNEUROSCI.1984-07.2007; Ward MW, 2000, J NEUROSCI, V20, P7208; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimer RM, 2003, J CELL SCI, V116, P3661, DOI 10.1242/jcs.00687; Westerink RHS, 2000, BIOCHEM BIOPH RES CO, V270, P625, DOI 10.1006/bbrc.2000.2470; Yang F, 2003, J CELL BIOL, V163, P511, DOI 10.1083/jcb.200307027; Zhu WH, 1996, AM J PHYSIOL-CELL PH, V271, pC658, DOI 10.1152/ajpcell.1996.271.2.C658; ZORZATO F, 1993, MOL PHARMACOL, V44, P1192	59	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5650	5661		10.1074/jbc.M706439200	http://dx.doi.org/10.1074/jbc.M706439200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18086678	hybrid			2022-12-25	WOS:000253426700045
J	Birts, CN; Barton, CH; Wilton, DC				Birts, Charles N.; Barton, C. Howard; Wilton, David C.			A catalytically independent physiological function for human acute phase protein group IIA phospholipase A(2) - Cellular uptake facilitates cell debris removal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARGININE-RICH PEPTIDES; PENETRATING PEPTIDES; HEPARAN-SULFATE; ANTIBACTERIAL PROPERTIES; INTERFACIAL BINDING; LIPOPROTEIN-LIPASE; HUMAN NEUTROPHILS; ESCHERICHIA-COLI; ARACHIDONIC-ACID; PLASMA-MEMBRANE	Human group IIA phospholipase A(2) (IIA PLA(2)) is an acute phase protein first identified at high concentrations in synovial fluid from patients with rheumatoid arthritis. Its physiological role has since been debated; the enzyme has a very high affinity for anionic phospholipid interfaces but expresses almost zero activity with zwitter-ionic phospholipid substrates, because of a lack of interfacial binding. We have prepared the cysteine-containing mutant (S74C) to allow the covalent attachment of fluorescent reporter groups. We show that fluorescently labeled IIA was taken up by phorbol 12-myristate 13-acetate-activated THP-1 cells in an energy-dependent process involving cell surface heparan sulfate proteoglycans. Uptake concurrently involved significant cell swelling, characteristic of macropinocytosis and the fluorescent enzyme localized to the nucleus. The endocytic process did not necessitate enzyme catalysis, ruling out membrane phospholipid hydrolysis as an essential requirement. The enzyme produced supramolecular aggregates with anionic phospholipid vesicles as a result of bridging between particles, a property that is unique to this globally cationic IIA PLA2. Uptake of such aggregates labeled with fluorescent anionic phospholipid was dramatically enhanced by the IIA protein, and uptake involved binding to heparan sulfate proteoglycans on activated THP-1 cells. A physiological role for this protein is proposed that involves the removal of anionic extracellular cell debris, including anionic microparticles generated as a result of trauma, infection, and the inflammatory response, and under such conditions serum levels of IIA PLA2 can increase similar to 1000-fold. A similar pathway may be significant in the uptake into cells of anionic vector DNA involving cationic lipid transfection protocols.	[Birts, Charles N.; Barton, C. Howard; Wilton, David C.] Univ Southampton, Sch Biol Sci, Southampton SO16 7PX, Hants, England	University of Southampton	Wilton, DC (corresponding author), Univ Southampton, Sch Biol Sci, Basett Crescent E, Southampton SO16 7PX, Hants, England.	dcw@soton.ac.uk	Birts, Charles N/N-9845-2013	Birts, Charles/0000-0002-0368-8766	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abe A, 2004, J LIPID RES, V45, P667, DOI 10.1194/jlr.M300342-JLR200; Aggarwal A, 2006, CANCER RES, V66, P232, DOI 10.1158/0008-5472.CAN-05-2232; Atsumi G, 1997, BBA-LIPID LIPID MET, V1349, P43, DOI 10.1016/S0005-2760(97)00082-9; Baker SF, 1998, BIOCHEMISTRY-US, V37, P13203, DOI 10.1021/bi981223t; Beck S, 2003, J BIOL CHEM, V278, P29799, DOI 10.1074/jbc.M211763200; Beers SA, 2003, BIOCHEMISTRY-US, V42, P7326, DOI 10.1021/bi0343222; Beers SA, 2002, J BIOL CHEM, V277, P1788, DOI 10.1074/jbc.M109777200; Berges C, 2005, BIOCHEM BIOPH RES CO, V333, P896, DOI 10.1016/j.bbrc.2005.05.171; Berthier A, 2005, FEBS J, V272, P3093, DOI 10.1111/j.1742-4658.2005.04723.x; Bezzine S, 2002, J BIOL CHEM, V277, P48523, DOI 10.1074/jbc.M203137200; Bezzine S, 2000, J BIOL CHEM, V275, P3179, DOI 10.1074/jbc.275.5.3179; Buckland AG, 2000, BBA-MOL CELL BIOL L, V1488, P71, DOI 10.1016/S1388-1981(00)00111-6; Canaan S, 2002, J BIOL CHEM, V277, P30984, DOI 10.1074/jbc.M203649200; CROWL RM, 1991, J BIOL CHEM, V266, P2647; Distler JHW, 2005, P NATL ACAD SCI USA, V102, P2892, DOI 10.1073/pnas.0409781102; Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x; EDWARDS IJ, 1995, ARTERIOSCL THROM VAS, V15, P400, DOI 10.1161/01.ATV.15.3.400; Edwards SH, 2002, BIOCHEMISTRY-US, V41, P15468, DOI 10.1021/bi020485z; Elsbach P, 1998, CURR OPIN IMMUNOL, V10, P45, DOI 10.1016/S0952-7915(98)80030-7; Enomoto A, 2000, BIOCHEM BIOPH RES CO, V276, P667, DOI 10.1006/bbrc.2000.3468; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Femling JK, 2005, J IMMUNOL, V175, P4653, DOI 10.4049/jimmunol.175.7.4653; FOURCADE O, 1995, CELL, V80, P919, DOI 10.1016/0092-8674(95)90295-3; Futaki S, 2007, BIOCHEM SOC T, V35, P784, DOI 10.1042/BST0350784; Groeneveld ABJ, 2003, CLIN IMMUNOL, V106, P106, DOI 10.1016/S1521-6616(02)00025-6; Hack CE, 1997, IMMUNOL TODAY, V18, P111, DOI 10.1016/S0167-5699(97)01002-5; JAIN MK, 1987, BIOCHIM BIOPHYS ACTA, V905, P1, DOI 10.1016/0005-2736(87)90002-2; Janowska-Wieczorek A, 2005, INT J CANCER, V113, P752, DOI 10.1002/ijc.20657; Jones AT, 2007, J CELL MOL MED, V11, P670, DOI 10.1111/j.1582-4934.2007.00062.x; Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018; Kawamura KS, 2006, BIOCHEMISTRY-US, V45, P1116, DOI 10.1021/bi051338e; Khalil IA, 2006, J BIOL CHEM, V281, P3544, DOI 10.1074/jbc.M503202200; Kim HK, 2003, EUR J CANCER, V39, P184, DOI 10.1016/S0959-8049(02)00596-8; Koduri RS, 1998, J BIOL CHEM, V273, P32142, DOI 10.1074/jbc.273.48.32142; KRAMER RM, 1989, J BIOL CHEM, V264, P5768; Kudo I, 2002, PROSTAG OTH LIPID M, V68-9, P3, DOI 10.1016/S0090-6980(02)00020-5; Lambeau G, 1999, TRENDS PHARMACOL SCI, V20, P162, DOI 10.1016/S0165-6147(99)01300-0; Leung SY, 2002, P NATL ACAD SCI USA, V99, P16203, DOI 10.1073/pnas.212646299; Lin Y, 1998, SCIENCE, V279, P1925, DOI 10.1126/science.279.5358.1925; LOIKE JD, 1983, J IMMUNOL METHODS, V57, P373, DOI 10.1016/0022-1759(83)90097-2; Makoveichuk E, 2004, BBA-MOL CELL BIOL L, V1686, P37, DOI 10.1016/j.bbalip.2004.08.015; Melikov K, 2005, CELL MOL LIFE SCI, V62, P2739, DOI 10.1007/s00018-005-5293-y; Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349; Murakami M, 2001, ADV IMMUNOL, V77, P163, DOI 10.1016/S0065-2776(01)77017-4; Murakami M, 2001, J BIOL CHEM, V276, P10083, DOI 10.1074/jbc.M007877200; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; Nevalainen TJ, 2005, BBA-MOL CELL BIOL L, V1733, P210, DOI 10.1016/j.bbalip.2004.12.012; Norbury CC, 2006, IMMUNOLOGY, V117, P443, DOI 10.1111/j.1365-2567.2006.02335.x; Othman R, 1996, BBA-LIPID LIPID MET, V1303, P92, DOI 10.1016/0005-2760(96)00083-5; Parish CR, 2006, NAT REV IMMUNOL, V6, P633, DOI 10.1038/nri1918; Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788; PRUZANSKI W, 1985, J RHEUMATOL, V12, P211; Qu XD, 1998, INFECT IMMUN, V66, P2791, DOI 10.1128/IAI.66.6.2791-2797.1998; Rouault M, 2007, BIOCHEMISTRY-US, V46, P1647, DOI 10.1021/bi062119b; Salanova B, 2007, J BIOL CHEM, V282, P27960, DOI 10.1074/jbc.M704039200; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; SCOTT DL, 1994, BIOPHYS J, V67, P493, DOI 10.1016/S0006-3495(94)80546-6; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Snitko Y, 1997, BIOCHEMISTRY-US, V36, P14325, DOI 10.1021/bi971200z; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Triggiani M, 2005, J ALLERGY CLIN IMMUN, V116, P1000, DOI 10.1016/j.jaci.2005.08.011; VanWijk MJ, 2003, CARDIOVASC RES, V59, P277, DOI 10.1016/S0008-6363(03)00367-5; Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010; Wilton DC, 2005, EUR J LIPID SCI TECH, V107, P193, DOI 10.1002/ejlt.200401089; WILTON DC, 1990, BIOCHEM J, V266, P435, DOI 10.1042/bj2660435; WRIGHT GW, 1990, J BIOL CHEM, V265, P6675	66	25	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5034	5045		10.1074/jbc.M708844200	http://dx.doi.org/10.1074/jbc.M708844200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18089561	hybrid			2022-12-25	WOS:000253426500061
J	Hilger, D; Bohm, M; Hackmann, A; Jung, H				Hilger, Daniel; Bohm, Maret; Hackmann, Alexandra; Jung, Heinrich			Role of Ser-340 and Thr-341 in transmembrane domain IX of the Na+/Proline transporter PutP of Escherichia coli in ligand binding and transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUGAR-BINDING; NA+/GLUCOSE COTRANSPORTER; SYMPORTER FAMILY; PROLINE UPTAKE; PROTEIN; PERMEASE; NA+; MEMBRANE; TOPOLOGY; RECONSTITUTION	The Na+/solute symporter family comprises more than 400 members of pro- and eukaryotic origin. Using the Na+/proline transporter PutP of Escherichia coli as a model, the role of two conserved residues, Ser-340 and Thr-341, is investigated to obtain insights into the mechanism of transport catalyzed by members of this family. Substitution of these amino acids alters the transport kinetics of cells and proteoliposomes containing the PutP variants significantly. In particular, the apparent affinities for Na+ and Li+ are reduced by 2 orders of magnitude or more. Also proline binding is affected, albeit to a lesser extent than ion binding. Thereby, the presence of a hydroxyl group at position 341 is essential for high affinity ligand binding. Furthermore, Cys placed at position 340 or 341 reacts with sulfhydryl reagents of different polarity, indicating accessibility from the water phase. In addition, Cys cross-linking suggests proximity of the residues to other amino acids previously shown to be crucial for ligand binding. For these reasons it is suggested that Ser-340 and Thr-341 are located in a ligand translocation pathway. Furthermore, it is proposed that the side chain of Thr-341 directly participates in Na+ binding.	[Hilger, Daniel; Jung, Heinrich] Ludwig Maximilians Univ Munchen, Dept Biol 1, D-80638 Munich, Germany; [Hilger, Daniel] Munich Ctr Integrated Prot Sci CiPSM, D-80638 Munich, Germany; [Bohm, Maret; Hackmann, Alexandra; Jung, Heinrich] Univ Osnabruck, Dept Microbiol, D-49069 Osnabruck, Germany	University of Munich; University of Munich; University Osnabruck	Jung, H (corresponding author), Ludwig Maximilians Univ Munchen, Dept Biol 1, Maria Ward Str 1A, D-80638 Munich, Germany.	hjung@lmu.de	Hilger, Daniel/C-7297-2019; Jung, Heinrich/K-3790-2014	Hilger, Daniel/0000-0001-5179-1357; Jung, Heinrich/0000-0002-5450-3063				Abramson J, 2003, FEBS LETT, V555, P96, DOI 10.1016/S0014-5793(03)01087-1; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CHEN CC, 1985, J MEMBRANE BIOL, V84, P157, DOI 10.1007/BF01872213; De la Vieja A, 2007, J BIOL CHEM, V282, P25290, DOI 10.1074/jbc.M700147200; Diez-Sampedro A, 2001, J BIOL CHEM, V276, P49188, DOI 10.1074/jbc.M108286200; DILA DK, 1986, J BACTERIOL, V168, P590, DOI 10.1128/jb.168.2.590-594.1986; Dohan O, 2006, MOL ENDOCRINOL, V20, P1121, DOI 10.1210/me.2005-0376; Green NS, 2001, PROTEIN SCI, V10, P1293, DOI 10.1110/ps.51201; Jeschke G, 2004, BIOPHYS J, V86, P2551, DOI 10.1016/S0006-3495(04)74310-6; Jung H, 2006, J MEMBRANE BIOL, V213, P119, DOI 10.1007/s00232-006-0880-x; Jung H, 1998, BBA-BIOENERGETICS, V1365, P60, DOI 10.1016/S0005-2728(98)00044-9; Jung H, 1998, J BIOL CHEM, V273, P26400, DOI 10.1074/jbc.273.41.26400; Jung H, 1998, BIOCHEMISTRY-US, V37, P11083, DOI 10.1021/bi980684b; Jung H, 2002, FEBS LETT, V529, P73, DOI 10.1016/S0014-5793(02)03184-8; Kaback H. R., 1971, METHOD ENZYMOL, V22, P99, DOI DOI 10.1016/0076-6879(71)22015-2; Kumar A, 2007, BIOCHEMISTRY-US, V46, P2758, DOI 10.1021/bi061696x; Meinild AK, 2001, BIOCHEMISTRY-US, V40, P11897, DOI 10.1021/bi011026l; MILLER JH, 1992, SHORT COURSE BACTERI, P439; Padan E, 2000, BACTERIAL STRESS RESPONSES, P117; PanayotovaHeiermann M, 1997, J BIOL CHEM, V272, P20324, DOI 10.1074/jbc.272.33.20324; PanayotovaHeiermann M, 1996, J BIOL CHEM, V271, P10029, DOI 10.1074/jbc.271.17.10029; PETERSON GL, 1977, ANAL BIOCHEM, V83, P346, DOI 10.1016/0003-2697(77)90043-4; Pirch T, 2003, J BIOL CHEM, V278, P42942, DOI 10.1074/jbc.M308253200; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; Quick M, 1996, EUR J BIOCHEM, V239, P732, DOI 10.1111/j.1432-1033.1996.0732u.x; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Racher KI, 1999, BIOCHEMISTRY-US, V38, P1676, DOI 10.1021/bi981279n; REIZER J, 1994, BBA-REV BIOMEMBRANES, V1197, P133, DOI 10.1016/0304-4157(94)90003-5; SCHAFFNE.W, 1973, ANAL BIOCHEM, V56, P502, DOI 10.1016/0003-2697(73)90217-0; Schwan WR, 2006, INFECT IMMUN, V74, P399, DOI 10.1128/IAI.74.1.399-409.2006; STALMACH ME, 1983, J BACTERIOL, V156, P481, DOI 10.1128/JB.156.2.481-486.1983; TABOR S, 1985, P NATL ACAD SCI USA, V82, P1074, DOI 10.1073/pnas.82.4.1074; Turk E, 1997, J MEMBRANE BIOL, V159, P1, DOI 10.1007/s002329900264; Wegener C, 2000, BIOCHEMISTRY-US, V39, P4831, DOI 10.1021/bi992442x; Wright EM, 2007, J INTERN MED, V261, P32, DOI 10.1111/j.1365-2796.2006.01746.x; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAMATO I, 1990, J MEMBRANE BIOL, V114, P143, DOI 10.1007/BF01869095; Yamato I., 1993, ALKALI CATION TRANSP, P53; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zhou A, 2004, J MOL BIOL, V343, P931, DOI 10.1016/j.jmb.2004.09.002	42	24	24	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4921	4929		10.1074/jbc.M706741200	http://dx.doi.org/10.1074/jbc.M706741200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18156179	hybrid			2022-12-25	WOS:000253426500050
J	Picard, N; Eladari, D; El Moghrabi, S; Planes, C; Bourgeois, S; Houillier, P; Wang, Q; Burnier, M; Deschenes, G; Knepper, MA; Meneton, P; Chambrey, R				Picard, Nicolas; Eladari, Dominique; El Moghrabi, Soumaya; Planes, Carole; Bourgeois, Soline; Houillier, Pascal; Wang, Qing; Burnier, Michel; Deschenes, Georges; Knepper, Mark A.; Meneton, Pierre; Chambrey, Regine			Defective ENaC processing and function in tissue kallikrein-deficient mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; CORTICAL COLLECTING DUCT; URINARY KALLIKREIN; SERINE PROTEASES; RENIN-ACTIVITY; ACTIVATION; EXCRETION; RAT; PROSTASIN; LACKING	An inverse relationship exists between urinary tissue kallikrein (TK) excretion and blood pressure in humans and rodents. In the kidney TK is synthesized in large amounts in the connecting tubule and is mainly released into the urinary fluid where its function remains unknown. In the present study mice with no functional gene coding for TK (TK-/-) were used to test whether the enzyme regulates apically expressed sodium transporters. Semiquantitative immunoblotting of the renal cortex revealed an absence of the 70-kDa form of gamma-ENaC in TK-/- mice. Urinary Na+ excretion after amiloride injection was blunted in TK-/- mice, consistent with reduced renal ENaC activity. Amiloride-sensitive transepithelial potential difference in the colon, where TK is also expressed, was decreased in TK-/- mice, whereas amiloride-ensitive alveolar fluid clearance in the lung, where TK is not expressed, was unchanged. In mice lacking the B2 receptor for kinins, the abundance of the 70-kDa form of gamma-ENaC was increased, indicating that its absence in TK-/- mice is not kinin-mediated. Incubation of membrane proteins from renal cortex of TK-/- mice with TK resulted in the appearance of the 70-kDa band of the gamma-ENaC, indicating that TK was able to promote gamma-ENaC cleavage in vitro. Finally, in mouse cortical collecting ducts isolated and microperfused in vitro, the addition of TK in the luminal fluid increased significantly intracellular Na+ concentration, consistent with an activation of the luminal entry of the cation. The results demonstrate that TK, like several other proteases, can activate ENaC in the kidney and the colon.	[Picard, Nicolas; Eladari, Dominique; El Moghrabi, Soumaya; Bourgeois, Soline; Houillier, Pascal; Meneton, Pierre; Chambrey, Regine] Univ Paris 05, INSERM, U872,Fac Med Rene Descartes, Ctr Rech Cordeliers, F-75006 Paris, France; [Planes, Carole] Univ Paris 07, INSERM, U773 CRB3, UFR Med, F-75018 Paris, France; [Eladari, Dominique] Hop Necker Enfants Malad, Dept Physiol, F-75015 Paris, France; [Wang, Qing; Burnier, Michel] CHU Vaudois, Dept Nephrol, CH-1011 Lausanne, Switzerland; [Deschenes, Georges] UPMC, CNRS, UMR 7134, F-75006 Paris, France; [Knepper, Mark A.] NHLBI, Natl Inst Hlth, Kidney & Electrolyte Metab Lab, Bethesda, MD 20892 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Eladari, D (corresponding author), Univ Paris 05, INSERM, U872,Fac Med Rene Descartes, Ctr Rech Cordeliers, 15 Rue Ecole Med, F-75006 Paris, France.	eladari@ccr.jussieu.fr	Knepper, Mark/AAF-8412-2020; Picard, Nicolas/B-6677-2012; Meneton, Pierre/T-1216-2019; Houillier, Pascal/AAD-4903-2019	Picard, Nicolas/0000-0002-1695-3389; Houillier, Pascal/0000-0003-4953-6917; deschenes, georges/0000-0002-5158-2915; planes, carole/0000-0003-2286-366X; Eladari, Dominique/0000-0003-1067-0844	Intramural NIH HHS Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL001285, Z01HL001285] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adachi M, 2001, J AM SOC NEPHROL, V12, P1114, DOI 10.1681/ASN.V1261114; Adebamiro A, 2005, J GEN PHYSIOL, V126, P339, DOI 10.1085/jgp.200509285; Alfie ME, 1997, HYPERTENSION, V29, P483, DOI 10.1161/01.HYP.29.1.483; BERRY TD, 1989, HYPERTENSION, V13, P3, DOI 10.1161/01.HYP.13.1.3; BORKOWSKI JA, 1995, J BIOL CHEM, V270, P13706, DOI 10.1074/jbc.270.23.13706; Bridges RJ, 2001, AM J PHYSIOL-LUNG C, V281, pL16, DOI 10.1152/ajplung.2001.281.1.L16; Bruns JB, 2007, J BIOL CHEM, V282, P6153, DOI 10.1074/jbc.M610636200; Caldwell RA, 2005, AM J PHYSIOL-LUNG C, V288, pL813, DOI 10.1152/ajplung.00435.2004; Caldwell RA, 2004, AM J PHYSIOL-CELL PH, V286, pC190, DOI 10.1152/ajpcell.00342.2003; Chraibi A, 1998, J GEN PHYSIOL, V111, P127, DOI 10.1085/jgp.111.1.127; CUSTER M, 1994, AM J PHYSIOL, V266, pF767, DOI 10.1152/ajprenal.1994.266.5.F767; Delpire E, 1996, NEPHROL DIAL TRANSPL, V11, P1967, DOI 10.1093/oxfordjournals.ndt.a027081; Donaldson SH, 2002, J BIOL CHEM, V277, P8338, DOI 10.1074/jbc.M105044200; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Fukuda N, 2000, J APPL PHYSIOL, V89, P672, DOI 10.1152/jappl.2000.89.2.672; Harris M, 2007, J BIOL CHEM, V282, P58, DOI 10.1074/jbc.M605125200; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Kim GH, 1999, J AM SOC NEPHROL, V10, P935; Komlosi P, 2003, HYPERTENSION, V42, P195, DOI 10.1161/01.HYP.0000081221.36703.01; LECHI A, 1978, CLIN SCI MOL MED, V55, P51, DOI 10.1042/cs0550051; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; Loffing J, 2003, AM J PHYSIOL-RENAL, V284, pF628, DOI 10.1152/ajprenal.00217.2002; Lourdel S, 2005, J AM SOC NEPHROL, V16, P3642, DOI 10.1681/ASN.2005040363; MARGOLIUS HS, 1971, LANCET, V2, P1063; MARGOLIUS HS, 1972, CIRC RES, V30, P358, DOI 10.1161/01.RES.30.3.358; Masilamani S, 2002, AM J PHYSIOL-RENAL, V283, pF648, DOI 10.1152/ajprenal.00016.2002; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; MENARD J, 1972, ENDOCRINOLOGY, V90, P422, DOI 10.1210/endo-90-2-422; Meneton P, 2001, P NATL ACAD SCI USA, V98, P2634, DOI 10.1073/pnas.051619598; Morris RG, 2006, AM J PHYSIOL-RENAL, V290, pF1416, DOI 10.1152/ajprenal.00421.2005; Narikiyo T, 2002, J CLIN INVEST, V109, P401, DOI 10.1172/JCI13229; NISHIMURA K, 1980, P NATL ACAD SCI-BIOL, V77, P4975, DOI 10.1073/pnas.77.8.4975; OBIKA LFO, 1986, CLIN SCI, V71, P497, DOI 10.1042/cs0710497; Pisitkun T, 2004, P NATL ACAD SCI USA, V101, P13368, DOI 10.1073/pnas.0403453101; Planes C, 2005, AM J PHYSIOL-LUNG C, V288, pL1099, DOI 10.1152/ajplung.00332.2004; PROUD D, 1983, AM J PHYSIOL, V244, pF510, DOI 10.1152/ajprenal.1983.244.5.F510; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rossier Bernard C, 2004, Proc Am Thorac Soc, V1, P4, DOI 10.1513/pats.2306007; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; SEINO M, 1975, TOHOKU J EXP MED, V116, P359, DOI 10.1620/tjem.116.359; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; TOMITA K, 1985, J CLIN INVEST, V76, P132, DOI 10.1172/JCI111935; Vallet M, 2006, J AM SOC NEPHROL, V17, P2153, DOI 10.1681/ASN.2005101054; Vallet V, 1997, NATURE, V389, P607, DOI 10.1038/39329; Vallet VR, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133588; Vuagniaux G, 2000, J AM SOC NEPHROL, V11, P828, DOI 10.1681/ASN.V115828; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Zhou H, 2006, KIDNEY INT, V69, P1471, DOI 10.1038/sj.ki.5000273	48	87	88	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4602	4611		10.1074/jbc.M705664200	http://dx.doi.org/10.1074/jbc.M705664200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086683	Green Accepted, hybrid			2022-12-25	WOS:000253426500017
J	Benton, CR; Nickerson, JG; Lally, J; Han, XX; Holloway, GP; Glatz, JFC; Luiken, JJFP; Graham, TE; Heikkila, JJ; Bonen, A				Benton, Carley R.; Nickerson, James G.; Lally, James; Han, Xiao-Xia; Holloway, Graham P.; Glatz, Jan F. C.; Luiken, Joost J. F. P.; Graham, Terry E.; Heikkila, John J.; Bonen, Arend			Modest PGC-1 alpha overexpression in muscle in vivo is sufficient to increase insulin sensitivity and palmitate oxidation in subsarcolemmal, not intermyofibrillar, mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; FATTY-ACID TRANSLOCASE; OBESE ZUCKER RATS; CARNITINE PALMITOYLTRANSFERASE-I; RECEPTOR-GAMMA COACTIVATOR-1; ACTIVATED PROTEIN-KINASE; GENE-TRANSFER; CONTRACTILE ACTIVITY; BINDING PROTEIN	PGC-1 alpha overexpression in skeletal muscle, in vivo, has yielded disappointing and unexpected effects, including disrupted cellular integrity and insulin resistance. These unanticipated results may stem from an excessive PGC-1 alpha overexpression in transgenic animals. Therefore, we examined the effects of a modest PGC-1 alpha overexpression in a single rat muscle, in vivo, on fuel-handling proteins and insulin sensitivity. We also examined whether modest PGC-1 alpha overexpression selectively targeted subsarcolemmal (SS) mitochondrial proteins and fatty acid oxidation, because SS mitochondria are metabolically more plastic than intermyofibrillar (IMF) mitochondria. Among metabolically heterogeneous rat hindlimb muscles, PGC-1 alpha was highly correlated with their oxidative fiber content and with substrate transport proteins (GLUT4, FABPpm, and FAT/ CD36) and mitochondrial proteins (COXIV and mTFA) but not with insulin-signaling proteins (phosphatidylinositol 3-kinase, IRS-1, and Akt2), nor with 5'-AMP-activated protein kinase, alpha 2 subunit, and HSL. Transfection of PGC-1 alpha into the red (RTA) and white tibialis anterior (WTA) compartments of the tibialis anterior muscle increased PGC-1 alpha protein by 23-25%. This also induced the up-regulation of transport proteins (FAT/ CD36, 35-195%; GLUT4, 20-32%) and 5'-AMP-activated protein kinase, alpha 2 subunit (37-48%), but not other proteins (FABPpm, IRS-1, phosphatidylinositol 3-kinase, Akt2, and HSL). SS and IMF mitochondrial proteins were also up-regulated, including COXIV (15-75%), FAT/ CD36 (17-30%), and mTFA (15-85%). PGC-1 alpha overexpression also increased palmitate oxidation in SS (RTA, + 116%; WTA, + 40%) but not in IMF mitochondria, and increased insulin-stimulated phosphorylation of AKT2 (28 - 43%) and rates of glucose transport (RTA, + 20%; WTA, + 38%). Thus, in skeletal muscle in vivo, a modest PGC-1 alpha overexpression up-regulated selected plasmalemmal and mitochondrial fuel-handling proteins, increased SS (not IMF) mitochondrial fatty acid oxidation, and improved insulin sensitivity.	[Benton, Carley R.] Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada; [Heikkila, John J.] Univ Waterloo, Dept Biol, Waterloo, ON N2L 3G1, Canada; [Glatz, Jan F. C.; Luiken, Joost J. F. P.] Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Benton, Carley R.; Nickerson, James G.; Lally, James; Han, Xiao-Xia; Holloway, Graham P.; Graham, Terry E.; Bonen, Arend] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada	University of Waterloo; University of Waterloo; Maastricht University; University of Guelph	Benton, CR (corresponding author), Univ Waterloo, Dept Kinesiol, Waterloo, ON N2L 3G1, Canada.							Akimoto T, 2005, J BIOL CHEM, V280, P19587, DOI 10.1074/jbc.M408862200; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Benton CR, 2006, J PHYSIOL-LONDON, V573, P199, DOI 10.1113/jphysiol.2006.106013; Benton CR, 2004, BIOCHEM BIOPH RES CO, V323, P249, DOI 10.1016/j.bbrc.2004.08.084; BERK PD, 1990, P NATL ACAD SCI USA, V87, P3484, DOI 10.1073/pnas.87.9.3484; Bertrand A, 2003, AM J PHYSIOL-CELL PH, V285, pC1071, DOI 10.1152/ajpcell.00104.2003; Bezaire V, 2006, AM J PHYSIOL-ENDOC M, V290, pE509, DOI 10.1152/ajpendo.00312.2005; Bradbury MW, 2000, BIOCHEM J, V345, P423, DOI 10.1042/0264-6021:3450423; BROZINICK JT, 1993, AM J PHYSIOL, V265, pE419, DOI 10.1152/ajpendo.1993.265.3.E419; Campbell SE, 2004, J BIOL CHEM, V279, P36235, DOI 10.1074/jbc.M400566200; CHOI CS, 2007, KEYSTONE S DIABETES, P157; Christ CY, 2002, J APPL PHYSIOL, V92, P736, DOI 10.1152/japplphysiol.00784.2001; Clarke DC, 2004, PHYSIOL GENOMICS, V17, P31, DOI 10.1152/physiolgenomics.00190.2003; COGSWELL AM, 1993, AM J PHYSIOL, V264, pC383, DOI 10.1152/ajpcell.1993.264.2.C383; Coort SLM, 2005, J LIPID RES, V46, P1295, DOI 10.1194/jlr.M400426-JLR200; Dona M, 2003, BIOCHEM BIOPH RES CO, V312, P1132, DOI 10.1016/j.bbrc.2003.11.032; Han XX, 2007, AM J PHYSIOL-ENDOC M, V293, pE566, DOI 10.1152/ajpendo.00106.2007; HAN XX, 1995, AM J PHYSIOL-REG I, V269, pR544, DOI 10.1152/ajpregu.1995.269.3.R544; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037; Holloway GP, 2006, J PHYSIOL-LONDON, V571, P201, DOI 10.1113/jphysiol.2005.102178; Holloway GP, 2007, J PHYSIOL-LONDON, V582, P393, DOI 10.1113/jphysiol.2007.135301; Hood DA, 2001, J APPL PHYSIOL, V90, P1137, DOI 10.1152/jappl.2001.90.3.1137; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003; Kim H, 2003, DIABETES, V52, P1770, DOI 10.2337/diabetes.52.7.1770; Koonen DPY, 2004, AM J PHYSIOL-ENDOC M, V286, pE1042, DOI 10.1152/ajpendo.00531.2003; Koves TR, 2005, AM J PHYSIOL-CELL PH, V288, pC1074, DOI 10.1152/ajpcell.00391.2004; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Langfort J, 1999, BIOCHEM J, V340, P459, DOI 10.1042/0264-6021:3400459; Lee MJ, 2002, EXP MOL MED, V34, P265, DOI 10.1038/emm.2002.37; Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268; Lemieux K, 2000, DIABETES, V49, P183, DOI 10.2337/diabetes.49.2.183; Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889; Luiken JJFP, 2001, J BIOL CHEM, V276, P40567, DOI 10.1074/jbc.M100052200; Matsuno K, 1996, BRIT J HAEMATOL, V92, P960, DOI 10.1046/j.1365-2141.1996.422962.x; MATTHAI AS, 2006, ACSM INTEGRATIVE PHY, P20; MCGARRY JD, 1983, BIOCHEM J, V214, P21, DOI 10.1042/bj2140021; McMahon JM, 2001, GENE THER, V8, P1264, DOI 10.1038/sj.gt.3301522; MEGENEY LA, 1992, AM J PHYSIOL, V262, pE20, DOI 10.1152/ajpendo.1992.262.1.E20; Mensink M, 2007, INT J OBESITY, V31, P1302, DOI 10.1038/sj.ijo.0803567; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Miura S, 2003, J BIOL CHEM, V278, P31385, DOI 10.1074/jbc.M304312200; Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mortensen OH, 2006, AM J PHYSIOL-ENDOC M, V291, pE807, DOI 10.1152/ajpendo.00591.2005; Muoio DM, 1999, BIOCHEM J, V338, P783, DOI 10.1042/0264-6021:3380783; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Ruderman NB, 2003, ACTA PHYSIOL SCAND, V178, P435, DOI 10.1046/j.1365-201X.2003.01164.x; RUDERMAN NB, 1971, BIOCHEM J, V124, P639, DOI 10.1042/bj1240639; Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874; Russell LK, 2004, CIRC RES, V94, P525, DOI 10.1161/01.RES.0000117088.36577.EB; Schertzer JD, 2006, MOL THER, V13, P795, DOI 10.1016/j.ymthe.2005.09.019; Song XM, 1999, AM J PHYSIOL-REG I, V277, pR1690, DOI 10.1152/ajpregu.1999.277.6.R1690; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Srere PA., 1969, METHODS ENZYMOLOGY, P3, DOI DOI 10.1016/0076-6879(69)13005-0; Sriwijitkamol A, 2006, AM J PHYSIOL-ENDOC M, V290, pE925, DOI 10.1152/ajpendo.00429.2005; STUMP DD, 1993, AM J PHYSIOL, V265, P894; Taylor EB, 2005, AM J PHYSIOL-ENDOC M, V289, pE960, DOI 10.1152/ajpendo.00237.2005; Teboul L, 2001, BIOCHEM J, V360, P305, DOI 10.1042/0264-6021:3600305; Terada S, 2004, AM J PHYSIOL-ENDOC M, V286, pE208, DOI 10.1152/ajpendo.00051.2003; VEERKAMP JH, 1983, BIOCHIM BIOPHYS ACTA, V753, P399, DOI 10.1016/0005-2760(83)90064-4; Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200; Wojtaszewski JFP, 2005, J PHYSIOL-LONDON, V564, P563, DOI 10.1113/jphysiol.2005.082669; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yoshida Y, 2007, J PHYSIOL-LONDON, V582, P1317, DOI 10.1113/jphysiol.2007.135095	75	164	175	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4228	4240		10.1074/jbc.M704332200	http://dx.doi.org/10.1074/jbc.M704332200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18079123	hybrid			2022-12-25	WOS:000253083500058
J	Wu, JH; Bohanan, CS; Neumann, JC; Lingrel, JB				Wu, Jinghai; Bohanan, Cynthia S.; Neumann, Jon C.; Lingrel, Jerry B.			KLF2 transcription factor modulates blood vessel maturation through smooth muscle cell migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KRUPPEL-LIKE FACTOR; IN-VIVO; CARDIOVASCULAR DEVELOPMENT; PROINFLAMMATORY ACTIVATION; SPHINGOSINE 1-PHOSPHATE; TUMOR ANGIOGENESIS; KINASE INHIBITOR; TYROSINE KINASE; GENE-EXPRESSION; C-SRC	Vasculogenesis, angiogenesis, and maturation are three major phases of the development of blood vessels. Although many receptors required for blood vessel formation have been defined, the intracellular signal transduction pathways involved in vascular maturation remain unclear. KLF2(-/-) embryos fail to develop beyond 13.5 days because of a lack of blood vessel stabilization. The molecular mechanism of KLF2 function in embryonic vascular vessels is still largely unknown. Here we show a normal development pattern of endothelial cells in KLF2(-/-) embryos but a defect of smooth muscle cells at the dorsal side of the aorta. This phenotype results from arrested vascular maturation characterized by the failure of mural cells to migrate around endothelial cells. This migration defect is also observed when platelet-derived growth factor-B (PDGF) controlled migration is studied in murine embryonic fibroblast (MEF) cells from KLF2(-/-) animals. In addition, KLF2(-/-) MEFs exhibit a significant growth defect, indicating that KLF2 is required to maintain the viability of MEF cells. The PDGF signal is mediated through the Src signaling pathway, and a downstream target of KLF2 is sphingosine 1-phosphate receptor 1. These studies demonstrate that KLF2 is required for smooth muscle cell migration and elucidate a novel mechanism involving communication between PDGF and KLF2 in vascular maturation.	[Wu, Jinghai; Bohanan, Cynthia S.; Neumann, Jon C.; Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Lingrel, JB (corresponding author), Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, 231 Albert Sabin Way, Cincinnati, OH 45267 USA.	jerry.lingrel@uc.edu			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL057281] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL57281] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Alavi A, 2003, SCIENCE, V301, P94, DOI 10.1126/science.1082015; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; ANDERSON KP, 1995, MOL CELL BIOL, V15, P5957; Bieker JJ, 1996, DNA CELL BIOL, V15, P347, DOI 10.1089/dna.1996.15.347; Bieker JJ, 2001, J BIOL CHEM, V276, P34355, DOI 10.1074/jbc.R100043200; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Buckley AF, 2001, NAT IMMUNOL, V2, P698, DOI 10.1038/90633; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Chae SS, 2004, J CLIN INVEST, V114, P1082, DOI 10.1172/JCI200422716; Chiariello M, 2001, NAT CELL BIOL, V3, P580, DOI 10.1038/35078555; Das H, 2006, P NATL ACAD SCI USA, V103, P6653, DOI 10.1073/pnas.0508235103; Dekker RJ, 2002, BLOOD, V100, P1689, DOI 10.1182/blood-2002-01-0046; Dekker RJ, 2006, BLOOD, V107, P4354, DOI 10.1182/blood-2005-08-3465; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; FONG GH, 1995, NATURE, V376, P66, DOI 10.1038/376066a0; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Groenendijk BCW, 2004, DEV DYNAM, V230, P57, DOI 10.1002/dvdy.20029; Hobson JP, 2001, SCIENCE, V291, P1800, DOI 10.1126/science.1057559; Huddleson JP, 2004, BIOL CHEM, V385, P723, DOI 10.1515/BC.2004.088; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Klinghoffer RA, 2001, MOL CELL, V7, P343, DOI 10.1016/S1097-2765(01)00182-4; Kumar A, 2005, MOL CELL BIOL, V25, P5893, DOI 10.1128/MCB.25.14.5893-5903.2005; Kuo CT, 1997, GENE DEV, V11, P2996, DOI 10.1101/gad.11.22.2996; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Lin Q, 1998, DEVELOPMENT, V125, P4565; Lindahl P, 1997, SCIENCE, V277, P242, DOI 10.1126/science.277.5323.242; Liu YJ, 2000, J CLIN INVEST, V106, P951, DOI 10.1172/JCI10905; Maupas-Schwalm F, 2004, FASEB J, V18, P1398, DOI 10.1096/fj.03-1123fje; McVerry BJ, 2005, CELL SIGNAL, V17, P131, DOI 10.1016/j.cellsig.2004.08.006; MUKHOPADHYAY D, 1995, NATURE, V375, P577, DOI 10.1038/375577a0; Parmar KM, 2006, J CLIN INVEST, V116, P49, DOI 10.1172/JCI24787; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Saksena S, 2005, J BIOL CHEM, V280, P11859, DOI 10.1074/jbc.M411553200; SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Schlessinger J, 2000, CELL, V100, P293, DOI 10.1016/S0092-8674(00)80664-9; SenBanerjee S, 2004, J EXP MED, V199, P1305, DOI 10.1084/jem.20031132; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; SORIANO P, 1994, GENE DEV, V8, P1888, DOI 10.1101/gad.8.16.1888; St Croix B, 2000, SCIENCE, V289, P1197; Takahashi Y, 1996, ANAT EMBRYOL, V194, P515; Wang HU, 1998, CELL, V93, P741, DOI 10.1016/S0092-8674(00)81436-1; Wani MA, 1998, TRANSGENIC RES, V7, P229, DOI 10.1023/A:1008809809843; Wani MA, 1999, J BIOL CHEM, V274, P21180, DOI 10.1074/jbc.274.30.21180; Wu JH, 2005, BIOCHEMISTRY-US, V44, P11098, DOI 10.1021/bi050166i; Wu JH, 2004, ONCOGENE, V23, P8088, DOI 10.1038/sj.onc.1207996; Wu JH, 2005, J IMMUNOL, V175, P3060, DOI 10.4049/jimmunol.175.5.3060; Yang JH, 2000, NAT GENET, V24, P309, DOI 10.1038/73550; Yang X, 1999, DEVELOPMENT, V126, P1571; Zhu YJ, 2003, J BIOL CHEM, V278, P36257, DOI 10.1074/jbc.M303171200	56	71	73	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3942	3950		10.1074/jbc.M707882200	http://dx.doi.org/10.1074/jbc.M707882200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18063572	hybrid			2022-12-25	WOS:000253083500028
J	Zdebik, AA; Zifarelli, G; Bergsdorf, EY; Soliani, P; Scheel, O; Jentsch, TJ; Pusch, M				Zdebik, Anselm A.; Zifarelli, Giovanni; Bergsdorf, Eun-Yeong; Soliani, Paolo; Scheel, Olaf; Jentsch, Thomas J.; Pusch, Michael			Determinants of anion-proton coupling in mammalian endosomal CLC proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							/H+ EXCHANGE TRANSPORTER; CHLORIDE CHANNEL; MOLECULAR-BASIS; ION-TRANSPORT; DISEASE; SELECTIVITY; EXPRESSION; CLONING; SIGNAL; PORES	Many proteins of the CLC gene family are Cl- channels, whereas others, like the bacterial ecClC-1 or mammalian ClC-4 and -5, mediate Cl-/H- exchange. Mutating a "gating glutamate" (Glu-224 in ClC-4 and Glu-211 in ClC-5) converted these exchangers into anion conductances, as did the neutralization of another, intracellular "proton glutamate" in ecClC-1. We show here that neutralizing the proton glutamate of ClC-4 (Glu-281) and ClC-5 (Glu-268), but not replacing it with aspartate, histidine, or tyrosine, rather abolished Cl- and H+ transport. Surface expression was unchanged by these mutations. Uncoupled Cl- transport could be restored in the ClC-4(E281A) and ClC-5(E268A) proton glutamate mutations by additionally neutralizing the gating glutamates, suggesting that wild type proteins transport anions only when protons are supplied through a cytoplasmic H (+) donor. Each monomeric unit of the dimeric protein was found to be able to carry out Cl-/H- exchange independently from the transport activity of the neighboring subunit. NO3- or SCN- transport was partially uncoupled from H+ countertransport but still depended on the proton glutamate. Inserting proton glutamates into CLC channels altered their gating but failed to convert them into Cl-/H+ exchangers. Noise analysis indicated that ClC-5 switches between silent and transporting states with an apparent unitary conductance of 0.5 picosiemens. Our results are consistent with the idea that Cl-/H+ exchange of the endosomal ClC-4 and -5 proteins relies on proton delivery from an intracellular titratable residue at position 268 (numbering of ClC-5) and that the strong rectification of currents arises from the voltage-dependent proton transfer from Glu-268 to Glu-211.	[Zdebik, Anselm A.; Bergsdorf, Eun-Yeong; Jentsch, Thomas J.] Leibniz Inst Mol Pharmakol FMP, D-13125 Berlin, Germany; [Zdebik, Anselm A.; Bergsdorf, Eun-Yeong; Jentsch, Thomas J.] Max Delbruck Centrum Mol Med MDC, D-13125 Berlin, Germany; [Zdebik, Anselm A.; Scheel, Olaf; Jentsch, Thomas J.] Univ Hamburg, Zentrum Mol Neurobiol, D-20246 Hamburg, Germany; [Zifarelli, Giovanni; Soliani, Paolo; Pusch, Michael] CNR, Ist Biofis, I-16149 Genoa, Italy	Leibniz Forschungsinstitut furr Molekulare Pharmakologie (FMP); Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Hamburg; University Medical Center Hamburg-Eppendorf; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR)	Jentsch, TJ (corresponding author), Robert Rossle Str 10, D-13125 Berlin, Germany.	jentsch@fmp-berlin.de	Horstmann, Britta/C-2154-2008	Pusch, Michael/0000-0002-8644-8847; Jentsch, Thomas/0000-0002-3509-2553	Telethon [GGP04018] Funding Source: Medline	Telethon(Fondazione Telethon)		Accardi A, 2005, J GEN PHYSIOL, V126, P563, DOI 10.1085/jgp.200509417; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Accardi A, 2006, J MOL BIOL, V362, P691, DOI 10.1016/j.jmb.2006.07.081; BAUER CK, 1991, P NATL ACAD SCI USA, V88, P11052, DOI 10.1073/pnas.88.24.11052; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Friedrich T, 1999, J BIOL CHEM, V274, P896, DOI 10.1074/jbc.274.2.896; Hebeisen S, 2003, BIOPHYS J, V84, P2306, DOI 10.1016/S0006-3495(03)75036-X; Hilgemann DW, 1996, BIOPHYS J, V71, P759, DOI 10.1016/S0006-3495(96)79275-5; Jentsch TJ, 2007, J PHYSIOL-LONDON, V578, P633, DOI 10.1113/jphysiol.2006.124719; Jentsch TJ, 2002, PHYSIOL REV, V82, P503, DOI 10.1152/physrev.00029.2001; JENTSCH TJ, 1990, NATURE, V348, P510, DOI 10.1038/348510a0; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; KOLB HA, 1980, BIOPHYS CHEM, V12, P21, DOI 10.1016/0301-4622(80)80036-6; Lloyd SE, 1996, NATURE, V379, P445, DOI 10.1038/379445a0; Lorenz L, 1996, P NATL ACAD SCI USA, V93, P13362, DOI 10.1073/pnas.93.23.13362; Ludewig U, 1996, NATURE, V383, P340, DOI 10.1038/383340a0; Middleton RE, 1996, NATURE, V383, P337, DOI 10.1038/383337a0; MILLER C, 1984, P NATL ACAD SCI-BIOL, V81, P2772, DOI 10.1073/pnas.81.9.2772; Nguitragool W, 2006, J MOL BIOL, V362, P682, DOI 10.1016/j.jmb.2006.07.006; Niemeyer MI, 2003, J PHYSIOL-LONDON, V553, P873, DOI 10.1113/jphysiol.2003.055988; Picollo A, 2005, NATURE, V436, P420, DOI 10.1038/nature03720; PUSCH M, 1995, NATURE, V373, P527, DOI 10.1038/373527a0; Scheel O, 2005, NATURE, V436, P424, DOI [10.1038/nature03860, 10.1038/nature0386O]; Schwake M, 2001, J BIOL CHEM, V276, P12049, DOI 10.1074/jbc.M010642200; Steinmeyer K, 1995, J BIOL CHEM, V270, P31172, DOI 10.1074/jbc.270.52.31172; Vanoye CG, 2002, J PHYSIOL-LONDON, V539, P373, DOI 10.1113/jphysiol.2001.013115; Waldegger S, 2000, J BIOL CHEM, V275, P24527, DOI 10.1074/jbc.M001987200; Walden M, 2007, J GEN PHYSIOL, V129, P317, DOI 10.1085/jgp.200709756; Weinreich F, 2001, J BIOL CHEM, V276, P2347, DOI 10.1074/jbc.M005733200; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; ZITARELLI G, 2007, REV PHYSL BIOCH PHAR, V158, P23	33	107	111	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					4219	4227		10.1074/jbc.M708368200	http://dx.doi.org/10.1074/jbc.M708368200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18063579	hybrid			2022-12-25	WOS:000253083500057
J	Dong, WJ; Xing, J; Ouyang, YX; An, JL; Cheung, HC				Dong, Wen-Ji; Xing, Jun; Ouyang, Yexin; An, Jianli; Cheung, Herbert C.			Structural kinetics of cardiac troponin C mutants linked to familial hypertrophic and dilated cardiomyopathy in troponin complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-TERMINAL EXTENSION; I PHOSPHORYLATION; REGULATORY DOMAIN; CONFORMATIONAL EXCHANGE; SKELETAL-MUSCLE; CALCIUM; MUTATIONS; BINDING; PROTEIN; CA2+	The key events in regulating cardiac muscle contraction involve Ca2+ binding to and release from cTnC (troponin C) and structural changes in cTnC and other thin filament proteins triggered by Ca2+ movement. Single mutations L29Q and G159D in human cTnC have been reported to associate with familial hypertrophic and dilated cardiomyopathy, respectively. We have examined the effects of these individual mutations on structural transitions in the regulatory N-domain of cTnC triggered by Ca2+ binding and dissociation. This study was carried out with a double mutant or triple mutants of cTnC, reconstituted into troponin with tryptophanless cTnI and cTnT. The double mutant, cTnC(L12W/N51C) labeled with 1,5-IAEDANS at Cys-51, served as a control to monitor Ca2+-induced opening and closing of the N-domain by Forster resonance energy transfer (FRET). The triple mutants contained both L12W and N51C labeled with 1,5-IAEDANS, and either L29Q or G159D. Both mutations had minimal effects on the equilibrium distance between Trp-12 and Cys-51-AEDANS in the absence or presence of bound Ca2+. L29Q had no effect on the closing rate of the N-domain triggered by release of Ca2+, but reduced the Ca2+-induced opening rate. G159D reduced both the closing and opening rates. Previous results showed that the closing rate of cTnC N-domain triggered by Ca2+ dissociation was substantially enhanced by PKA phosphorylation of cTnI. This rate enhancement was abolished by L29Q or G159D. These mutations alter the kinetics of structural transitions in the regulatory N-domain of cTnC that are involved in either activation (L29Q) or deactivation (G159D). Both mutations appear to be antagonistic toward phosphorylation signaling between cTnI and cTnC.	[Dong, Wen-Ji] Washington State Univ, Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Dong, Wen-Ji; Ouyang, Yexin] Washington State Univ, Dept Vet & Comparat Anat Pharmacol & Physiol, Pullman, WA 99164 USA; [Xing, Jun; An, Jianli; Cheung, Herbert C.] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Washington State University; Washington State University; University of Alabama System; University of Alabama Birmingham	Dong, WJ (corresponding author), Washington State Univ, Sch Chem Engn & Bioengn, Pullman, WA 99164 USA.	wdong@vetmed.wsu.edu	Dong, Wenji/A-8579-2011		NHLBI NIH HHS [HL52508, HL80186, R01 HL080186] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080186, R01HL052508] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abbott MB, 2000, J BIOL CHEM, V275, P20610, DOI 10.1074/jbc.M909252199; Abbott MB, 2000, FEBS LETT, V469, P168, DOI 10.1016/S0014-5793(00)01271-0; Abbott MB, 2001, BIOCHEMISTRY-US, V40, P5992, DOI 10.1021/bi0100642; Biesiadecki BJ, 2007, CIRC RES, V100, P1486, DOI 10.1161/01.RES.0000267744.92677.7f; Chandra M, 1997, BIOCHEMISTRY-US, V36, P13305, DOI 10.1021/bi9710129; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; Dong WJ, 2000, PROTEINS, V41, P438, DOI 10.1002/1097-0134(20001201)41:4<438::AID-PROT20>3.0.CO;2-E; Dong WJ, 1997, BIOCHEMISTRY-US, V36, P6754, DOI 10.1021/bi9622276; Dong WJ, 1997, J BIOL CHEM, V272, P19229, DOI 10.1074/jbc.272.31.19229; Dong WJ, 2003, J BIOL CHEM, V278, P42394, DOI 10.1074/jbc.M304858200; Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dong WJ, 2001, J MOL BIOL, V314, P51, DOI 10.1006/jmbi.2001.5118; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; FABIATO A, 1988, METHOD ENZYMOL, V157, P378; Finley N, 1999, FEBS LETT, V453, P107, DOI 10.1016/S0014-5793(99)00693-6; Gaponenko V, 1999, J BIOL CHEM, V274, P16681, DOI 10.1074/jbc.274.24.16681; GARVEY JL, 1988, BIOCHEM J, V249, P709, DOI 10.1042/bj2490709; Gong Z, 1998, BIOPHYS J, V74, pA51; Heller WT, 2003, BIOCHEMISTRY-US, V42, P7790, DOI 10.1021/bi0341509; Hoffmann B, 2001, Hum Mutat, V17, P524, DOI 10.1002/humu.1143; Johns EC, 1997, PFLUG ARCH EUR J PHY, V433, P842, DOI 10.1007/s004240050353; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Layland J, 2005, CARDIOVASC RES, V66, P12, DOI 10.1016/j.cardiores.2004.12.022; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; LIAO RL, 1994, BIOCHEMISTRY-US, V33, P12729, DOI 10.1021/bi00208a026; Lu QW, 2003, J MOL CELL CARDIOL, V35, P1421, DOI 10.1016/j.yjmcc.2003.09.003; Metzger JM, 2004, CIRC RES, V94, P146, DOI 10.1161/01.RES.0000110083.17024.60; Mirza M, 2005, J BIOL CHEM, V280, P28498, DOI 10.1074/jbc.M412281200; Mogensen J, 2004, J AM COLL CARDIOL, V44, P2033, DOI 10.1016/j.jacc.2004.08.027; RAY KP, 1976, FEBS LETT, V70, P11, DOI 10.1016/0014-5793(76)80716-8; ROBERTSON SP, 1982, J BIOL CHEM, V257, P260; ROSENFELD SS, 1985, J BIOL CHEM, V260, P242; Sakthivel S, 2005, J BIOL CHEM, V280, P703, DOI 10.1074/jbc.M409513200; Schmidtmann A, 2005, FEBS J, V272, P6087, DOI 10.1111/j.1742-4658.2005.05001.x; Schmidtmann A, 2002, FEBS LETT, V513, P289, DOI 10.1016/S0014-5793(02)02340-2; She MD, 1998, J MOL BIOL, V281, P445, DOI 10.1006/jmbi.1998.1933; Sia SK, 1997, J BIOL CHEM, V272, P18216, DOI 10.1074/jbc.272.29.18216; Solaro RJ, 2002, J NUCL CARDIOL, V9, P523, DOI 10.1067/mnc.2002.127626; SOLARO RJ, 2002, HDB PHYSL, V1; Spyracopoulos L, 1997, BIOCHEMISTRY-US, V36, P12138, DOI 10.1021/bi971223d; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Venkatraman G, 2003, J BIOL CHEM, V278, P41670, DOI 10.1074/jbc.M302148200; WANG CK, 1986, J MOL BIOL, V191, P509, DOI 10.1016/0022-2836(86)90145-2; Ward DG, 2004, BIOCHEMISTRY-US, V43, P5772, DOI 10.1021/bi036310m; Ward DG, 2004, BIOCHEMISTRY-US, V43, P4020, DOI 10.1021/bi036128l; Ward DG, 2003, BIOCHEMISTRY-US, V42, P10324, DOI 10.1021/bi034495r; Ward DG, 2002, J BIOL CHEM, V277, P41795, DOI 10.1074/jbc.M206744200; WATTANAPERMPOOL J, 1995, J MOL CELL CARDIOL, V27, P1383, DOI 10.1006/jmcc.1995.0131; ZHANG R, 1995, CIRC RES, V76, P1028, DOI 10.1161/01.RES.76.6.1028	51	43	43	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3424	3432		10.1074/jbc.M703822200	http://dx.doi.org/10.1074/jbc.M703822200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18063575	hybrid			2022-12-25	WOS:000253083000048
J	Lee, HG; Kim, YC; Dunning, JS; Han, KA				Lee, Hyun-Gwan; Kim, Young-Cho; Dunning, Jennifer S.; Han, Kyung-An			Recurring Ethanol Exposure Induces Disinhibited Courtship in Drosophila	PLOS ONE			English	Article							MALE SEXUAL-BEHAVIOR; TARGETED GENE-EXPRESSION; WHITE GENE; MALE-RAT; TYROSINE-HYDROXYLASE; HUMAN HOMOLOG; DOPAMINE; ALCOHOL; MELANOGASTER; FRUITLESS	Alcohol has a strong causal relationship with sexual arousal and disinhibited sexual behavior in humans; however, the physiological support for this notion is largely lacking and thus a suitable animal model to address this issue is instrumental. We investigated the effect of ethanol on sexual behavior in Drosophila. Wild-type males typically court females but not males; however, upon daily administration of ethanol, they exhibited active intermale courtship, which represents a novel type of behavioral disinhibition. The ethanol-treated males also developed behavioral sensitization, a form of plasticity associated with addiction, since their intermale courtship activity was progressively increased with additional ethanol experience. We identified three components crucial for the ethanol-induced courtship disinhibition: the transcription factor regulating male sex behavior Fruitless, the ABC guanine/tryptophan transporter White and the neuromodulator dopamine. fruitless mutant males normally display conspicuous intermale courtship; however, their courtship activity was not enhanced under ethanol. Likewise, white males showed negligible ethanol-induced intermale courtship, which was not only reinstated but also augmented by transgenic White expression. Moreover, inhibition of dopamine neurotransmission during ethanol exposure dramatically decreased ethanol-induced intermale courtship. Chronic ethanol exposure also affected a male's sexual behavior toward females: it enhanced sexual arousal but reduced sexual performance. These findings provide novel insights into the physiological effects of ethanol on sexual behavior and behavioral plasticity.	[Lee, Hyun-Gwan; Han, Kyung-An] Penn State Univ, Dept Biol, Grad Program Genet, Huck Inst, University Pk, PA 16802 USA; [Kim, Young-Cho] Penn State Univ, Huck Inst Neurosci Grad Program, Dept Biol, University Pk, PA USA; [Dunning, Jennifer S.] Penn State Univ, Dept Biol, University Pk, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Han, KA (corresponding author), Penn State Univ, Dept Biol, Grad Program Genet, Huck Inst, University Pk, PA 16802 USA.	kxh29@psu.edu	Kim, Youngcho/C-5676-2014	Kim, Youngcho/0000-0003-4810-2738	NIH [HD048766, GM07838]; NSF [IOB-0620056]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD048766] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by NIH HD048766 and NSF IOB-0620056 grants to K-AH and NIH GM07838, in which K-AH is Co-PI.	Anand A, 2001, GENETICS, V158, P1569; Andretic R, 2005, CURR BIOL, V15, P1165, DOI 10.1016/j.cub.2005.05.025; Baker BS, 2001, CELL, V105, P13, DOI 10.1016/S0092-8674(01)00293-8; Berger KH, 2004, ALCOHOL CLIN EXP RES, V28, P1469, DOI 10.1097/01.ALC.0000141817.15993.98; Billeter JC, 2006, CURR BIOL, V16, pR766, DOI 10.1016/j.cub.2006.08.025; Boileau I, 2003, SYNAPSE, V49, P226, DOI 10.1002/syn.10226; BRAND AH, 1993, DEVELOPMENT, V118, P401; Campbell JL, 2001, J NEUROBIOL, V49, P339, DOI 10.1002/neu.10009; Chang HY, 2006, MOL PSYCHIATR, V11, P99, DOI 10.1038/sj.mp.4001742; Cowmeadow RB, 2005, ALCOHOL CLIN EXP RES, V29, P1777, DOI 10.1097/01.alc.0000183232.56788.62; CURCILLO PG, 1987, BEHAV GENET, V17, P81, DOI 10.1007/BF01066012; Demir E, 2005, CELL, V121, P785, DOI 10.1016/j.cell.2005.04.027; Diegelmann S, 2006, LEARN MEMORY, V13, P72, DOI 10.1101/lm.45506; Drapeau MD, 2003, J NEUROBIOL, V55, P53, DOI 10.1002/neu.10196; El-Ghundi M, 2007, REV NEUROSCIENCE, V18, P37; Ferraro FA, 2004, PHARMACOL BIOCHEM BE, V78, P427, DOI 10.1016/j.pbb.2004.03.020; Ferveur JF, 1997, SCIENCE, V276, P1555, DOI 10.1126/science.276.5318.1555; Floresco SB, 2006, PSYCHOPHARMACOLOGY, V188, P567, DOI 10.1007/s00213-006-0404-5; Friggi-Grelin F, 2003, J NEUROBIOL, V54, P618, DOI 10.1002/neu.10185; Gelbart W, 2003, NUCLEIC ACIDS RES, V31, P172, DOI 10.1093/nar/gkg094; George W H, 2000, Annu Rev Sex Res, V11, P92; Godenschwege TA, 2004, EUR J NEUROSCI, V20, P611, DOI 10.1111/j.1460-9568.2004.03527.x; Gonzales RA, 2004, PHARMACOL THERAPEUT, V103, P121, DOI 10.1016/j.pharmthera.2004.06.002; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; Hingson R, 2005, ANNU REV PUBL HEALTH, V26, P259, DOI 10.1146/annurev.publhealth.26.021304.144652; Horn C, 2003, GENETICS, V163, P647; Hull EM, 2004, PHYSIOL BEHAV, V83, P291, DOI 10.1016/j.physbeh.2004.08.018; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kim YC, 2007, J NEUROSCI, V27, P7640, DOI 10.1523/JNEUROSCI.1167-07.2007; Kimura KI, 2005, NATURE, V438, P229, DOI 10.1038/nature04229; Kirov G, 2001, MOL PSYCHIATR, V6, P671, DOI 10.1038/sj.mp.4000899; Kitamoto T, 2001, J NEUROBIOL, V47, P81, DOI 10.1002/neu.1018; Koob GF, 2004, BIOCHEM PHARMACOL, V68, P1515, DOI 10.1016/j.bcp.2004.07.031; Lee G, 2001, J NEUROSCI, V21, P513, DOI 10.1523/JNEUROSCI.21-02-00513.2001; Lee HG, 2003, DEV BIOL, V264, P179, DOI 10.1016/j.ydbio.2003.07.018; Li H, 2000, CURR BIOL, V10, P211, DOI 10.1016/S0960-9822(00)00340-7; Lovinger DM, 2005, NAT NEUROSCI, V8, P1471, DOI 10.1038/nn1581; Mackenzie SM, 1999, BBA-BIOMEMBRANES, V1419, P173, DOI 10.1016/S0005-2736(99)00064-4; Manoli DS, 2005, NATURE, V436, P395, DOI 10.1038/nature03859; Markos AR, 2005, INT J STD AIDS, V16, P123, DOI 10.1258/0956462053057639; McClung C, 1998, CURR BIOL, V8, P109, DOI 10.1016/S0960-9822(98)70041-7; Nakamura M, 1999, MOL PSYCHIATR, V4, P155, DOI 10.1038/sj.mp.4000515; NASSEL DR, 1992, CELL TISSUE RES, V267, P147, DOI 10.1007/BF00318701; Pfaus JG, 1999, CURR OPIN NEUROBIOL, V9, P751, DOI 10.1016/S0959-4388(99)00034-3; PFAUS JG, 1989, PSYCHOBIOLOGY, V17, P195; PINEL JPJ, 1992, PHARMACOL BIOCHEM BE, V41, P133, DOI 10.1016/0091-3057(92)90072-N; Ryner LC, 1996, CELL, V87, P1079, DOI 10.1016/S0092-8674(00)81802-4; Sari Y, 2006, ALCOHOL CLIN EXP RES, V30, P46, DOI 10.1111/j.1530-0277.2006.00010.x; Scholz H, 2000, NEURON, V28, P261, DOI 10.1016/S0896-6273(00)00101-X; SCOTT MP, 1994, PHARMACOL BIOCHEM BE, V48, P929, DOI 10.1016/0091-3057(94)90202-X; Simon AF, 2006, MECH AGEING DEV, V127, P647, DOI 10.1016/j.mad.2006.02.006; Volkow ND, 1996, ALCOHOL CLIN EXP RES, V20, P1594, DOI 10.1111/j.1530-0277.1996.tb05936.x; Weiss F, 2002, J NEUROSCI, V22, P3332; White AM, 2000, HIPPOCAMPUS, V10, P88, DOI 10.1002/(SICI)1098-1063(2000)10:1<88::AID-HIPO10>3.0.CO;2-L; Wolf FW, 2003, J NEUROBIOL, V54, P161, DOI 10.1002/neu.10166; ZHANG SD, 1995, P NATL ACAD SCI USA, V92, P5525, DOI 10.1073/pnas.92.12.5525	56	47	49	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1391	10.1371/journal.pone.0001391	http://dx.doi.org/10.1371/journal.pone.0001391			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167550	gold, Green Published, Green Submitted			2022-12-25	WOS:000260468900019
J	Rodgers, CI; Armstrong, GAB; Shoemaker, KL; LaBrie, JD; Moyes, CD; Robertson, RM				Rodgers, Corinne I.; Armstrong, Gary A. B.; Shoemaker, Kelly L.; LaBrie, John D.; Moyes, Christopher D.; Robertson, R. Meldrum			Stress Preconditioning of Spreading Depression in the Locust CNS	PLOS ONE			English	Article								Cortical spreading depression (CSD) is closely associated with important pathologies including stroke, seizures and migraine. The mechanisms underlying SD in its various forms are still incompletely understood. Here we describe SD-like events in an invertebrate model, the ventilatory central pattern generator (CPG) of locusts. Using K+-sensitive microelectrodes, we measured extracellular K+ concentration ([K+](o)) in the metathoracic neuropile of the CPG while monitoring CPG output electromyographically from muscle 161 in the second abdominal segment to investigate the role K+ in failure of neural circuit operation induced by various stressors. Failure of ventilation in response to different stressors (hyperthermia, anoxia, ATP depletion, Na+/K+ ATPase impairment, K+ injection) was associated with a disturbance of CNS ion homeostasis that shares the characteristics of CSD and SD-like events in vertebrates. Hyperthermic failure was preconditioned by prior heat shock (3 h, 45 degrees C) and induced-thermotolerance was associated with an increase in the rate of clearance of extracellular K+ that was not linked to changes in ATP levels or total Na+/K+ ATPase activity. Our findings suggest that SD-like events in locusts are adaptive to terminate neural network operation and conserve energy during stress and that they can be preconditioned by experience. We propose that they share mechanisms with CSD in mammals suggesting a common evolutionary origin.	[Rodgers, Corinne I.; Armstrong, Gary A. B.; Shoemaker, Kelly L.; LaBrie, John D.; Moyes, Christopher D.; Robertson, R. Meldrum] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada	Queens University - Canada	Rodgers, CI (corresponding author), Queens Univ, Dept Biol, Biosci Complex, Kingston, ON K7L 3N6, Canada.	9cir@queensu.ca	Robertson, Robert M/B-2482-2009	Robertson, Robert M/0000-0002-2666-7861; Armstrong, Gary/0000-0003-4613-8817	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding: Funded by the Natural Sciences and Engineering Research Council of Canada.	Anderson TR, 2005, J NEUROPHYSIOL, V93, P963, DOI 10.1152/jn.00654.2004; Armstrong GAB, 2006, J NEUROSCI, V26, P12118, DOI 10.1523/JNEUROSCI.3347-06.2006; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; BANKS WM, 1975, COMP BIOCHEM PHYS A, V52, P223, DOI 10.1016/S0300-9629(75)80157-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bustami HP, 2000, J INSECT PHYSIOL, V46, P1285, DOI 10.1016/S0022-1910(00)00050-0; DAVENPORT AP, 1984, INSECT BIOCHEM, V14, P135, DOI 10.1016/0020-1790(84)90021-0; Dawson-Scully K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000773; Evans AM, 2006, J PHYSIOL-LONDON, V574, P113, DOI 10.1113/jphysiol.2006.108381; Gidday JM, 2006, NAT REV NEUROSCI, V7, P437, DOI 10.1038/nrn1927; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; Gulinson SL, 1996, J EXP BIOL, V199, P379; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Henderson DR, 1998, RESP PHYSIOL, V114, P297, DOI 10.1016/S0034-5687(98)00096-6; HUSTERT R, 1975, J COMP PHYSIOL, V97, P159, DOI 10.1007/BF00645359; Kager H, 2002, J NEUROPHYSIOL, V88, P2700, DOI 10.1152/jn.00237.2002; Kretzschmar D, 2002, BRAIN RES BULL, V57, P121, DOI 10.1016/S0361-9230(01)00643-8; Largo C, 1997, J NEUROPHYSIOL, V77, P9, DOI 10.1152/jn.1997.77.1.9; Lauritzen M, 2001, CEPHALALGIA, V21, P757, DOI 10.1046/j.1468-2982.2001.00244.x; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LIGHTON JRB, 1990, J EXP BIOL, V154, P509; Loder E, 2002, CEPHALALGIA, V22, P624, DOI 10.1046/j.1468-2982.2002.00437.x; NEDERGAARD M, 1995, J NEUROBIOL, V28, P433, DOI 10.1002/neu.480280404; Newman AEM, 2003, J INSECT PHYSIOL, V49, P1039, DOI 10.1016/j.jinsphys.2003.08.001; Qin WS, 2003, CELL STRESS CHAPERON, V8, P144, DOI 10.1379/1466-1268(2003)008<0144:CACOAM>2.0.CO;2; Ramirez JM, 1999, J NEUROPHYSIOL, V81, P795, DOI 10.1152/jn.1999.81.2.795; Robertson RM, 2004, J THERM BIOL, V29, P351, DOI 10.1016/j.jtherbio.2004.08.073; Robertson RM, 2004, INTEGR COMP BIOL, V44, P21, DOI 10.1093/icb/44.1.21; Smith JM, 2006, BIOL REV, V81, P457, DOI 10.1017/S1464793106007081; SNYDER GK, 1980, J INSECT PHYSIOL, V26, P699, DOI 10.1016/0022-1910(80)90043-8; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Takano T, 2007, NAT NEUROSCI, V10, P754, DOI 10.1038/nn1902; Tupling AR, 2004, J BIOL CHEM, V279, P52382, DOI 10.1074/jbc.M409336200; van den Maagdenberg AMJM, 2007, CURR OPIN NEUROL, V20, P299, DOI 10.1097/WCO.0b013e3281338d1f; VANHARREVELD A, 1978, J NEUROBIOL, V9, P419, DOI 10.1002/neu.480090602; Walther C, 1998, J NEUROPHYSIOL, V80, P785, DOI 10.1152/jn.1998.80.2.785; WHYARD S, 1986, J COMP PHYSIOL B, V156, P813, DOI 10.1007/BF00694255; Wu J, 2000, J NEUROPHYSIOL, V84, P1355, DOI 10.1152/jn.2000.84.3.1355	39	62	62	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1366	10.1371/journal.pone.0001366	http://dx.doi.org/10.1371/journal.pone.0001366			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159249	gold, Green Submitted, Green Published			2022-12-25	WOS:000207459700023
J	Six, C; Finkel, ZV; Irwin, AJ; Campbell, DA				Six, Christophe; Finkel, Zoe V.; Irwin, Andrew J.; Campbell, Douglas A.			Light Variability Illuminates Niche-Partitioning among Marine Picocyanobacteria	PLOS ONE			English	Article								Prochlorococcus and Synechococcus picocyanobacteria are dominant contributors to marine primary production over large areas of the ocean. Phytoplankton cells are entrained in the water column and are thus often exposed to rapid changes in irradiance within the upper mixed layer of the ocean. An upward fluctuation in irradiance can result in photosystem II photoinactivation exceeding counteracting repair rates through protein turnover, thereby leading to net photoinhibition of primary productivity, and potentially cell death. Here we show that the effective cross-section for photosystem II photoinactivation is conserved across the picocyanobacteria, but that their photosystem II repair capacity and protein-specific photosystem II light capture are negatively correlated and vary widely across the strains. The differences in repair rate correspond to the light and nutrient conditions that characterize the site of origin of the Prochlorococcus and Synechococcus isolates, and determine the upward fluctuation in irradiance they can tolerate, indicating that photoinhibition due to transient high-light exposure influences their distribution in the ocean.	[Six, Christophe; Finkel, Zoe V.; Irwin, Andrew J.; Campbell, Douglas A.] Mt Allison Univ, Sackville, NB E0A 3C0, Canada	Mount Allison University	Campbell, DA (corresponding author), Mt Allison Univ, Sackville, NB E0A 3C0, Canada.	dcampbell@mta.ca	Campbell, Douglas A./B-3768-2010; Finkel, Zoe V/B-9626-2008; Irwin, Andrew/B-2245-2008	Campbell, Douglas A./0000-0001-8996-5463; Finkel, Zoe V/0000-0003-4212-3917; Irwin, Andrew/0000-0001-7784-2319	The Natural Sciences and Engineering Research Council of Canada; University Faculty Award; Canada Research Chair; New Brunswick Innovation Foundations	The Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); University Faculty Award; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); New Brunswick Innovation Foundations	The Natural Sciences and Engineering Research Council of Canada provided Discovery grant (DAC, ZVF, AJI), University Faculty Award (ZVF) and Canada Research Chair (DAC) funding, while the Canada and New Brunswick Innovation Foundations (DAC, ZVF) provided equipment funding.	Bailey S, 2005, FEBS LETT, V579, P275, DOI 10.1016/j.febslet.2004.11.091; Barnett A. B, 2007, FIREWORX; Bibby TS, 2003, NATURE, V424, P1051, DOI 10.1038/nature01933; Boucher NP, 1996, MAR ECOL PROG SER, V144, P223, DOI 10.3354/meps144223; Bouman HA, 2006, SCIENCE, V312, P918, DOI 10.1126/science.1122692; Burns RA, 2006, J PHYCOL, V42, P610, DOI 10.1111/j.1529-8817.2006.00220.x; CULLEN JJ, 1992, SCIENCE, V258, P646, DOI 10.1126/science.258.5082.646; Everroad C, 2006, J BACTERIOL, V188, P3345, DOI 10.1128/JB.188.9.3345-3356.2006; FELDMAN GC, 2007, OCEAN COLOR WEB AQUA; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Fuller NJ, 2003, APPL ENVIRON MICROB, V69, P2430, DOI 10.1128/AEM.69.5.2430-2443.2003; Gorbunov MY, 1999, PHOTOSYNTH RES, V62, P141, DOI 10.1023/A:1006360005033; Hakala M, 2005, BBA-BIOENERGETICS, V1706, P68, DOI 10.1016/j.bbabio.2004.09.001; Heraud P, 2005, J PHYCOL, V41, P1212, DOI 10.1111/j.1529-8817.2005.00149.x; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; KANA TM, 1987, DEEP-SEA RES, V34, P479, DOI 10.1016/0198-0149(87)90001-X; Lantoine F, 1997, DEEP-SEA RES PT I, V44, P223, DOI 10.1016/S0967-0637(96)00094-5; MacIntyre HL, 2000, TRENDS PLANT SCI, V5, P12, DOI 10.1016/S1360-1385(99)01504-6; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Moore LR, 1998, NATURE, V393, P464, DOI 10.1038/30965; MOREL A, 1993, J MAR RES, V51, P617, DOI 10.1357/0022240933223963; Neale PJ, 2001, J PHOTOCH PHOTOBIO B, V62, P1, DOI 10.1016/S1011-1344(01)00159-2; Nishiyama Y, 2006, BBA-BIOENERGETICS, V1757, P742, DOI 10.1016/j.bbabio.2006.05.013; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Not F, 2005, LIMNOL OCEANOGR, V50, P1677, DOI 10.4319/lo.2005.50.5.1677; OLSON RJ, 1990, LIMNOL OCEANOGR, V35, P45, DOI 10.4319/lo.1990.35.1.0045; Palenik B, 2001, APPL ENVIRON MICROB, V67, P991, DOI 10.1128/AEM.67.2.991-994.2001; PARK YI, 1995, PLANTA, V196, P401, DOI 10.1007/BF00203636; Partensky F, 1999, MICROBIOL MOL BIOL R, V63, P106, DOI 10.1128/MMBR.63.1.106-127.1999; Partensky F., 2003, PHOTOSYNTHESIS ALGAE, P29; Richardson TL, 2007, SCIENCE, V315, P838, DOI 10.1126/science.1133471; Rippka R, 2000, INT J SYST EVOL MICR, V50, P1833, DOI 10.1099/00207713-50-5-1833; Sarvikas P, 2006, PLANT CELL PHYSIOL, V47, P391, DOI 10.1093/pcp/pcj006; Schubert H, 2001, HELGOLAND MAR RES, V55, P12, DOI 10.1007/s101520000064; Shelly K, 2002, J PHYCOL, V38, P713, DOI 10.1046/j.1529-8817.2002.01147.x; Sherry ND, 2001, DEEP-SEA RES PT II, V48, P1263, DOI 10.1016/S0967-0645(00)00138-7; Sicora C, 2003, PHOTOSYNTH RES, V75, P127, DOI 10.1023/A:1022852631339; Sinclair J, 1996, PHOTOSYNTH RES, V50, P33, DOI 10.1007/BF00018219; Six C, 2004, AQUAT MICROB ECOL, V35, P17, DOI 10.3354/ame035017; Stomp M, 2004, NATURE, V432, P104, DOI 10.1038/nature03044; Ting CS, 2002, TRENDS MICROBIOL, V10, P134, DOI 10.1016/S0966-842X(02)02319-3; Tyystjarvi E, 1996, P NATL ACAD SCI USA, V93, P2213, DOI 10.1073/pnas.93.5.2213; Wilson A, 2006, PLANT CELL, V18, P992, DOI 10.1105/tpc.105.040121; Wood AM, 1998, MAR ECOL PROG SER, V162, P25, DOI 10.3354/meps162025; Wood AM, 1999, DEEP-SEA RES PT II, V46, P1769; Zwirglmaier K, 2007, ENVIRON MICROBIOL, V9, P1278, DOI 10.1111/j.1462-2920.2007.01246.x	46	92	97	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1341	10.1371/journal.pone.0001341	http://dx.doi.org/10.1371/journal.pone.0001341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092006	gold, Green Published, Green Submitted			2022-12-25	WOS:000207459600024
J	Sharma, S; Brosh, RM				Sharma, Sudha; Brosh, Robert M., Jr.			Human RECQ1 Is a DNA Damage Responsive Protein Required for Genotoxic Stress Resistance and Suppression of Sister Chromatid Exchanges	PLOS ONE			English	Article							BLOOMS-SYNDROME HELICASE; TOPOISOMERASE-III-ALPHA; FAMILY HELICASES; BLM HELICASE; HOMOLOGOUS RECOMBINATION; UNWINDING ACTIVITY; MISMATCH REPAIR; REPLICATION; GENE; LOCALIZATION	Background. DNA helicases are ubiquitous enzymes that unwind DNA in an ATP-dependent and directionally specific manner. Unwinding of double-stranded DNA is essential for the processes of DNA repair, recombination, transcription, and DNA replication. Five human DNA helicases sharing sequence similarity with the E. coli RecQ helicase have been identified. Three of the human RecQ helicases are implicated in hereditary diseases (Bloom syndrome, Werner syndrome, and Rothmund-Thomson syndrome) which display clinical symptoms of premature aging and cancer. RECQ1 helicase is the most highly expressed of the human RecQ helicases; however, a genetic disease has yet not been linked to mutations in the RECQ1 gene, and the biological functions of human RECQ1 in cellular DNA metabolism are not known. Methodology/Principal Findings. In this study, we report that RECQ1 becomes phosphorylated upon DNA damage and forms irradiation-induced nuclear foci that associate with chromatin in human cells. Depletion of RECQ1 renders human cells sensitive to DNA damage induced by ionizing radiation or the topoisomerase inhibitor camptothecin, and results in spontaneous gamma-H2AX foci and elevated sister chromatid exchanges, indicating aberrant repair of DNA breaks. Consistent with a role in homologous recombinational repair, endogenous RECQ1 is associated with the strand exchange protein Rad51 and the two proteins directly interact with high affinity. Conclusion/Significance. Collectively, these results provide the first evidence for a role of human RECQ1 in the response to DNA damage and chromosomal stability maintenance and point to the vital importance of RECQ1 in genome homeostasis.	[Sharma, Sudha; Brosh, Robert M., Jr.] NIA, Lab Mol Gerontol, Dept Hlth & Human Serv, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Brosh, RM (corresponding author), NIA, Lab Mol Gerontol, Dept Hlth & Human Serv, NIH, Baltimore, MD 21224 USA.	BroshR@grc.nia.nih.gov	Sharma, Sudha/AAV-6152-2021	Sharma, Sudha/0000-0003-2765-2482	Intramural Research Program of the NIH-NIA; NATIONAL INSTITUTE ON AGING [Z01AG000741, ZIAAG000741] Funding Source: NIH RePORTER	Intramural Research Program of the NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the Intramural Research Program of the NIH-NIA.	Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Bachrati CZ, 2003, BIOCHEM J, V374, P577, DOI 10.1042/BJ20030491; Bateman JR, 2007, BIOESSAYS, V29, P382, DOI 10.1002/bies.20557; Bischof O, 2001, J CELL BIOL, V153, P367, DOI 10.1083/jcb.153.2.367; Brosh RM, 2000, J BIOL CHEM, V275, P23500, DOI 10.1074/jbc.M001557200; Cheng NC, 2000, HUM MOL GENET, V9, P1805, DOI 10.1093/hmg/9.12.1805; Cogoni C, 1999, SCIENCE, V286, P2342, DOI 10.1126/science.286.5448.2342; Cui S, 2003, J BIOL CHEM, V278, P1424, DOI 10.1074/jbc.M209407200; Cui S, 2004, NUCLEIC ACIDS RES, V32, P2158, DOI 10.1093/nar/gkh540; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Davies SL, 2004, MOL CELL BIOL, V24, P1279, DOI 10.1128/MCB.24.3.1279-1291.2004; de Oca RM, 2005, BLOOD, V105, P1003, DOI 10.1182/blood-2003-11-3997; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dimri GP, 2005, CANCER CELL, V7, P505, DOI 10.1016/j.ccr.2005.05.025; Doherty KM, 2005, J BIOL CHEM, V280, P28085, DOI 10.1074/jbc.M500265200; Goldfarb T, 2005, GENETICS, V169, P563, DOI 10.1534/genetics.104.035204; Gray MD, 1998, EXP CELL RES, V242, P487, DOI 10.1006/excr.1998.4124; Hickson ID, 2003, NAT REV CANCER, V3, P169, DOI 10.1038/nrc1012; Hope JC, 2006, P NATL ACAD SCI USA, V103, P5875, DOI 10.1073/pnas.0601571103; Houghtaling S, 2003, GENE DEV, V17, P2021, DOI 10.1101/gad.1103403; Hu YD, 2005, MOL CELL BIOL, V25, P3431, DOI 10.1128/MCB.25.9.3431-3442.2005; Johnson FB, 2000, CANCER RES, V60, P1162; Kato A, 2006, GENETICS, V172, P113, DOI 10.1534/genetics.105.041756; Kato A, 2004, CURR GENET, V45, P37, DOI 10.1007/s00294-003-0459-3; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Krejci L, 2003, NATURE, V423, P305, DOI 10.1038/nature01577; Lau NC, 2006, SCIENCE, V313, P363, DOI 10.1126/science.1130164; Laursen LV, 2003, MOL CELL BIOL, V23, P3692, DOI 10.1128/MCB.23.10.3692-3705.2003; LeRoy G, 2005, NUCLEIC ACIDS RES, V33, P6251, DOI 10.1093/nar/gki929; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li DH, 2006, J CLIN ONCOL, V24, P1720, DOI 10.1200/JCO.2005.04.4206; Li DH, 2006, CANCER RES, V66, P3323, DOI 10.1158/0008-5472.CAN-05-3032; Lowe SW, 2000, CARCINOGENESIS, V21, P485, DOI 10.1093/carcin/21.3.485; Marciniak RA, 1998, P NATL ACAD SCI USA, V95, P6887, DOI 10.1073/pnas.95.12.6887; Mirzoeva OK, 2001, MOL CELL BIOL, V21, P281, DOI 10.1128/MCB.21.1.281-288.2001; Multani AS, 2007, J CELL SCI, V120, P713, DOI 10.1242/jcs.03397; Muzzolini L, 2007, PLOS BIOL, V5, P157, DOI 10.1371/journal.pbio.0050020; Nakayama H, 2002, ONCOGENE, V21, P9008, DOI 10.1038/sj.onc.1205959; PERRY P, 1974, NATURE, V251, P156, DOI 10.1038/251156a0; Petkovic M, 2005, J CELL SCI, V118, P4261, DOI 10.1242/jcs.02556; Pickford A, 2003, CURR GENET, V42, P220, DOI 10.1007/s00294-002-0351-6; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; PURANAM KL, 1995, GENOMICS, V26, P595, DOI 10.1016/0888-7543(95)80181-K; PURANAM KL, 1994, J BIOL CHEM, V269, P29838; Rao VA, 2005, MOL CELL BIOL, V25, P8925, DOI 10.1128/MCB.25.20.8925-8937.2005; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; SEKI M, 1994, NUCLEIC ACIDS RES, V22, P4566, DOI 10.1093/nar/22.22.4566; Sengupta S, 2005, NAT REV MOL CELL BIO, V6, P44, DOI 10.1038/nrm1546; Sengupta S, 2004, J CELL BIOL, V166, P801, DOI 10.1083/jcb.200405128; Sengupta S, 2003, EMBO J, V22, P1210, DOI 10.1093/emboj/cdg114; Sharma S, 2005, J BIOL CHEM, V280, P28072, DOI 10.1074/jbc.M500264200; Sharma S, 2007, MOL CELL BIOL, V27, P1784, DOI 10.1128/MCB.01620-06; Sharma S, 2006, BIOCHEM J, V398, P319, DOI 10.1042/BJ20060450; SUIJKERBUIJK RF, 1993, CANCER GENET CYTOGEN, V70, P85, DOI 10.1016/0165-4608(93)90173-J; Thompson LH, 2002, MUTAT RES-FUND MOL M, V509, P49, DOI 10.1016/S0027-5107(02)00224-5; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Veaute X, 2003, NATURE, V423, P309, DOI 10.1038/nature01585; Wang WS, 2003, MOL CELL BIOL, V23, P3527, DOI 10.1128/MCB.23.10.3527-3535.2003; Wu L, 2001, J BIOL CHEM, V276, P19375, DOI 10.1074/jbc.M009471200; Wu L, 2005, EMBO J, V24, P2679, DOI 10.1038/sj.emboj.7600740; Wu L, 2003, NATURE, V426, P870, DOI 10.1038/nature02253; Yin JH, 2005, EMBO J, V24, P1465, DOI 10.1038/sj.emboj.7600622	62	85	87	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 12	2007	2	12							e1297	10.1371/journal.pone.0001297	http://dx.doi.org/10.1371/journal.pone.0001297			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JE	18074021	Green Submitted, Green Published, gold			2022-12-25	WOS:000207459500016
J	Choi, SH; Langenbach, R; Bosetti, F				Choi, Sang Ho; Langenbach, Robert; Bosetti, Francesca			Genetic deletion or pharmacological inhibition of cyclooxygenase-1 attenuate lipopolysaccharide-induced inflammatory response and brain injury	FASEB JOURNAL			English	Article						microglia; astrocytes; prostaglandin; NADPH oxidase; oxidative stress	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROSTAGLANDIN E-2 SYNTHESIS; NEURONAL OXIDATIVE DAMAGE; CENTRAL-NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; NADPH OXIDASE; HIPPOCAMPAL-NEURONS; ACTIVATED MICROGLIA; CONTROLLED-TRIAL; RAT HIPPOCAMPUS	Cyclooxygenase (COX) -1 and -2 metabolize arachidonic acid to prostanoids and reactive oxygen species, major players in the neuroinflammatory process. While most reports have focused on the inducible isoform, COX-2, the contribution of COX-1 to the inflammatory response is unclear. In the present study, the contribution of COX-1 in the neuroinflammatory response to intracerebroventricular lipopolysaccharide (LPS) was investigated using COX-1 deficient (COX-1 ) mice or wild-type (COX-1(+/+)) mice pretreated with SC-560, a selective COX-1 inhibitor. Twenty-four hours after lipopolysaccharide (LPS) injection, COX-1(-/-) mice showed decreased protein oxidation and LPS-induced neuronal damage in the hippocampus compared with COX-1(+/+) mice. COX-1(-/-) mice showed a significant reduction of microglial activation, proinflammatory mediators, and expression of COX-2, inducible NOS, and NADPH oxidase. The transcriptional down-regulation of cytokines and other inflammatory markers in COX-1(-/-) mice was mediated by a reduced activation of NF-kappa B and signal transducer and activator of transcription 3. Administration of SC-560 prior to LPS injection also attenuated the neuroinflammatory response by decreasing brain levels of prostaglandin (PG)E-2, PGD(2), PGF(2 alpha), and thromboxane B-2, as well as the expression of proinflammatory cytokines and chemokine. These findings suggest that COX-1 plays a previously unrecognized role in neuroinflammatory damage.	[Choi, Sang Ho; Bosetti, Francesca] NIA, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA; [Langenbach, Robert] Natl Inst Environm Hlth Sci, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Bosetti, F (corresponding author), NIA, Brain Physiol & Metab Sect, NIH, Bethesda, MD 20892 USA.	frances@mail.nih.gov			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES021179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000423, ZIAAG000425] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 AG000423-04] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Aid S, 2007, BRAIN RES BULL, V73, P108, DOI 10.1016/j.brainresbull.2007.02.015; Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BARNETT J, 1994, BBA-PROTEIN STRUCT M, V1209, P130, DOI 10.1016/0167-4838(94)90148-1; Bate C, 2003, NEUROREPORT, V14, P2099, DOI 10.1097/00001756-200311140-00018; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosetti F, 2007, J NEUROCHEM, V102, P577, DOI 10.1111/j.1471-4159.2007.04558.x; BREITNER JCS, 1995, NEUROBIOL AGING, V16, P523, DOI 10.1016/0197-4580(95)00049-K; Candelario-Jalil E, 2003, J NEUROCHEM, V86, P545, DOI 10.1046/j.1471-4159.2003.01812.x; Choi SH, 2006, J NEUROCHEM, V98, P801, DOI 10.1111/j.1471-4159.2006.03926.x; Choi SH, 2005, J NEUROSCI, V25, P4082, DOI 10.1523/JNEUROSCI.4306-04.2005; Delgado M, 2003, FASEB J, V17, P1922, DOI 10.1096/fj.02-1029fje; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Herber DL, 2006, GLIA, V53, P382, DOI 10.1002/glia.20272; Hoozemans JJM, 2001, ACTA NEUROPATHOL, V101, P2, DOI 10.1007/s004010000251; Hoozemans JJM, 2003, CURR DRUG TARGETS, V4, P461, DOI 10.2174/1389450033490902; Hoozemans JJM, 2002, BRAIN RES, V951, P218, DOI 10.1016/S0006-8993(02)03164-5; Ikeda-Matsuo Y, 2005, J NEUROCHEM, V94, P1546, DOI 10.1111/j.1471-4159.2005.03302.x; in 't Veld BA, 2001, NEW ENGL J MED, V345, P1515, DOI 10.1056/NEJMoa010178; Jeohn GH, 1998, J NEUROIMMUNOL, V85, P1, DOI 10.1016/S0165-5728(97)00204-X; Kaufmann WE, 1997, PROSTAG OTH LIPID M, V54, P601, DOI 10.1016/S0090-6980(97)00128-7; Kim HY, 2003, J IMMUNOL, V171, P6072, DOI 10.4049/jimmunol.171.11.6072; LANGENBACH R, 1995, CELL, V83, P483, DOI 10.1016/0092-8674(95)90126-4; Langenbach R, 1999, BIOCHEM PHARMACOL, V58, P1237, DOI 10.1016/S0006-2952(99)00158-6; Liberatore GT, 1999, NAT MED, V5, P1403; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; MCGEER PL, 1987, NEUROSCI LETT, V79, P195, DOI 10.1016/0304-3940(87)90696-3; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; Milatovic D, 2003, J NEUROCHEM, V87, P1518, DOI 10.1046/j.1471-4159.2003.02120.x; Milatovic D, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-20; Montine TJ, 2002, J NEUROCHEM, V83, P463, DOI 10.1046/j.1471-4159.2002.01157.x; Moore AH, 2005, INT J RADIAT ONCOL, V62, P267, DOI 10.1016/j.ijrobp.2005.01.035; Nelson PT, 2002, ANN MED, V34, P491, DOI 10.1080/078538902321117698; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Pepicelli O, 2005, J NEUROCHEM, V93, P1561, DOI 10.1111/j.1471-4159.2005.03150.x; Perry VH, 2003, NAT REV NEUROSCI, V4, P103, DOI 10.1038/nrn1032; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; Planas AM, 2006, BIOCHEM SOC T, V34, P1267, DOI 10.1042/BST0341267; POWELL WS, 1985, ANAL BIOCHEM, V148, P59, DOI 10.1016/0003-2697(85)90628-1; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Reines SA, 2004, NEUROLOGY, V62, P66, DOI 10.1212/WNL.62.1.66; RICH JB, 1995, NEUROLOGY, V45, P51, DOI 10.1212/WNL.45.1.51; ROGERS J, 1993, NEUROLOGY, V43, P1609, DOI 10.1212/WNL.43.8.1609; Rummel C, 2006, AM J PHYSIOL-REG I, V291, pR1316, DOI 10.1152/ajpregu.00301.2006; Scharf S, 1999, NEUROLOGY, V53, P197, DOI 10.1212/WNL.53.1.197; Schmued LC, 1997, BRAIN RES, V751, P37, DOI 10.1016/S0006-8993(96)01387-X; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Schwab JM, 2000, J NEUROIMMUNOL, V111, P122, DOI 10.1016/S0165-5728(00)00372-6; SEIBERT K, 1994, P NATL ACAD SCI USA, V91, P12013, DOI 10.1073/pnas.91.25.12013; Suzumura A, 2006, ANN NY ACAD SCI, V1088, P219, DOI 10.1196/annals.1366.012; Thal LJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1204, DOI 10.1038/sj.npp.1300690; Tsuboi K, 2002, PROSTAG OTH LIPID M, V68-9, P535, DOI 10.1016/S0090-6980(02)00054-0; Xia Y, 2006, BRAIN RES, V1095, P85, DOI 10.1016/j.brainres.2006.03.112; Yermakova AV, 1999, J NEUROPATH EXP NEUR, V58, P1135, DOI 10.1097/00005072-199911000-00003	54	133	136	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2008	22	5					1491	1501		10.1096/fj.07-9411com	http://dx.doi.org/10.1096/fj.07-9411com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18162486	Green Accepted			2022-12-25	WOS:000255898700021
J	Nakayama, T; Hieshima, K; Arao, T; Jin, Z; Nagakubo, D; Shirakawa, AK; Yamada, Y; Fujii, M; Oiso, N; Kawada, A; Nishio, K; Yoshie, O				Nakayama, T.; Hieshima, K.; Arao, T.; Jin, Z.; Nagakubo, D.; Shirakawa, A-K; Yamada, Y.; Fujii, M.; Oiso, N.; Kawada, A.; Nishio, K.; Yoshie, O.			Aberrant expression of Fra-2 promotes CCR4 expression and cell proliferation in adult T-cell leukemia	ONCOGENE			English	Article						adult T-cell leukemia; CCR4; Fra-2; JunD; c-Myb; MDM2; BCL-6	VIRUS TYPE-I; TRANSCRIPTIONAL ACTIVITY; CONSTITUTIVE ACTIVATION; CHEMOKINE RECEPTORS; NONCODING REGION; ATL CELLS; C-MYB; LYMPHOMA; GROWTH; GENE	Adult T-cell leukemia (ATL) is a mature CD4(+) T-cell malignancy etiologically associated with human T-cell leukemia virus type 1 (HTLV-1). Primary ATL cells frequently express CCR4 at high levels. Since HTLV-1 Tax does not induce CCR4 expression, transcription factor(s) constitutively active in ATL may be responsible for its strong expression. We identified an activator protein-1 (AP-1) site in the CCR4 promoter as the major positive regulatory element in ATL cells. Among the AP-1 family members, Fra-2, JunB and JunD are highly expressed in fresh primary ATL cells. Consistently, the Fra-2/JunB and Fra-2/JunD heterodimers strongly activated the CCR4 promoter in Jurkat cells. Furthermore, Fra-2 small interfering RNA (siRNA) or JunD siRNA, but not JunB siRNA, effectively reduced CCR4 expression and cell growth in ATL cells. Conversely, Fra-2 or JunD overexpression promoted cell growth in Jurkat cells. We identified 49 genes, including c-Myb, BCL-6 and MDM2, which were downregulated by Fra-2 siRNA in ATL cells. c-Myb, BCL-6 and MDM2 were also downregulated by JunD siRNA. As Fra-2, these proto-oncogenes were highly expressed in primary ATL cells but not in normal CD4(+) T cells. Collectively, aberrantly expressed Fra-2 in association with JunD may play a major role in CCR4 expression and oncogenesis in ATL.	[Nakayama, T.; Hieshima, K.; Jin, Z.; Nagakubo, D.; Shirakawa, A-K; Yoshie, O.] Kinki Univ, Sch Med, Dept Microbiol, Osaka 5898511, Japan; [Arao, T.; Nishio, K.] Kinki Univ, Sch Med, Dept Genome Sci, Osaka 5898511, Japan; [Yamada, Y.] Nagasaki Univ, Grad Sch Biomed Sci, Dept Lab Med, Nagasaki 852, Japan; [Fujii, M.] Niigata Univ, Grad Sch Med & Dent Sci, Div Virol, Niigata, Japan; [Oiso, N.; Kawada, A.] Kinki Univ, Sch Med, Dept Dermatol, Osaka 5898511, Japan	Kindai University (Kinki University); Kindai University (Kinki University); Nagasaki University; Niigata University; Kindai University (Kinki University)	Yoshie, O (corresponding author), Kinki Univ, Sch Med, Dept Microbiol, 377-2 Ohono Higashi, Osaka 5898511, Japan.	o.yoshie@med.kindai.ac.jp	Kawada, Akira/AAQ-3460-2020; Oiso, Naoki/H-6540-2019; Hieshima, Kunio/AAF-7040-2019; Nagakubo, Daisuke/AAW-3621-2021	Oiso, Naoki/0000-0001-5593-6496; Hieshima, Kunio/0000-0002-7786-4646; Nagakubo, Daisuke/0000-0003-1213-1246; Yoshie, Osamu/0000-0003-4353-5809				Basbous J, 2003, J BIOL CHEM, V278, P43620, DOI 10.1074/jbc.M307275200; CESARMAN E, 1992, BLOOD, V80, P3205; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen F, 1999, INT IMMUNOL, V11, P677, DOI 10.1093/intimm/11.5.677; Dang CV, 1999, MOL CELL BIOL, V19, P1; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Ferenczi K, 2002, J INVEST DERMATOL, V119, P1405, DOI 10.1046/j.1523-1747.2002.19610.x; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Grassmann R, 2005, ONCOGENE, V24, P5976, DOI 10.1038/sj.onc.1208978; Hata T, 1999, LEUKEMIA, V13, P215, DOI 10.1038/sj.leu.2401271; Hess JL, 2006, BLOOD, V108, P297, DOI 10.1182/blood-2005-12-5014; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iellem A, 2001, J EXP MED, V194, P847, DOI 10.1084/jem.194.6.847; Igarashi T, 2007, ONCOGENE, V26, P4749, DOI 10.1038/sj.onc.1210289; Imai T, 1999, INT IMMUNOL, V11, P81, DOI 10.1093/intimm/11.1.81; Ishida T, 2003, CLIN CANCER RES, V9, P3625; Iwai K, 2001, VIROLOGY, V279, P38, DOI 10.1006/viro.2000.0669; JEANG KT, 1991, VIROLOGY, V181, P218, DOI 10.1016/0042-6822(91)90487-V; Jones D, 2000, BLOOD, V96, P685; Karreth F, 2004, DEVELOPMENT, V131, P5717, DOI 10.1242/dev.01414; Karube K, 2004, BRIT J HAEMATOL, V126, P81, DOI 10.1111/j.1365-2141.2004.04999.x; Kerl K, 2001, LAB INVEST, V81, P1693, DOI 10.1038/labinvest.3780382; Kim EJ, 2005, J CLIN INVEST, V115, P798, DOI 10.1172/JCI200524826; Matsubara Y, 2005, LEUKEMIA, V19, P482, DOI 10.1038/sj.leu.2403628; Matsuoka M, 2003, ONCOGENE, V22, P5131, DOI 10.1038/sj.onc.1206551; Migliazza A, 1995, P NATL ACAD SCI USA, V92, P12520, DOI 10.1073/pnas.92.26.12520; Mori N, 1999, BLOOD, V93, P2360; Mori N, 2000, BLOOD, V95, P3915; Nagakubo D, 2007, INT J CANCER, V120, P1591, DOI 10.1002/ijc.22483; NAGATA K, 1989, J VIROL, V63, P3220, DOI 10.1128/JVI.63.8.3220-3226.1989; Oh IH, 1999, ONCOGENE, V18, P3017, DOI 10.1038/sj.onc.1202839; Pasqualucci L, 2003, LEUKEMIA LYMPHOMA, V44, pS5, DOI 10.1080/10428190310001621588; Ramsay RG, 2003, EXPERT OPIN THER TAR, V7, P235; Rayburn E, 2005, CURR CANCER DRUG TAR, V5, P27, DOI 10.2174/1568009053332636; Rengarajan J, 2000, IMMUNOL TODAY, V21, P479, DOI 10.1016/S0167-5699(00)01712-6; Satou Y, 2006, P NATL ACAD SCI USA, V103, P720, DOI 10.1073/pnas.0507631103; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shetzline SE, 2004, BLOOD, V104, P1833, DOI 10.1182/blood-2003-10-3577; Shvarts A, 2002, GENE DEV, V16, P681, DOI 10.1101/gad.929302; Thebault S, 2004, FEBS LETT, V562, P165, DOI 10.1016/S0014-5793(04)00225-X; Vargas DA, 2003, ADV CANCER RES, V89, P1, DOI 10.1016/S0065-230X(03)01001-7; Yamada Y, 1996, LEUKEMIA LYMPHOMA, V21, P443, DOI 10.3109/10428199609093442; YAMAMOTO N, 1985, J GEN VIROL, V66, P1641, DOI 10.1099/0022-1317-66-8-1641; YE BH, 1993, SCIENCE, V262, P747, DOI 10.1126/science.8235596; Yoshida M, 2001, ANNU REV IMMUNOL, V19, P475, DOI 10.1146/annurev.immunol.19.1.475; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; Yoshie O, 2001, ADV IMMUNOL, V78, P57, DOI 10.1016/S0065-2776(01)78002-9	47	45	47	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232			ONCOGENE	Oncogene	MAY	2008	27	23					3221	3232		10.1038/sj.onc.1210984	http://dx.doi.org/10.1038/sj.onc.1210984			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	304LQ	18071306				2022-12-25	WOS:000256111400001
J	Sellers, ZM; Mann, E; Smith, A; Ko, KH; Giannella, R; Cohen, MB; Barrett, KE; Dong, H				Sellers, Zachary M.; Mann, Elizabeth; Smith, Anders; Ko, Kwang Hyun; Giannella, Ralph; Cohen, Mitchell B.; Barrett, Kim E.; Dong, Hui			Heat-stable enterotoxin of Escherichia coli (STa) can stimulate duodenal HCO(3)(-) secretion via a novel GC-C- and CFTR-independent pathway	FASEB JOURNAL			English	Article						cystic fibrosis; guanylyl cyclase C knockout mice; STa-binding receptor	GUANYLYL CYCLASE-C; MUCOSAL BICARBONATE SECRETION; RAT INTESTINAL MEMBRANES; CYSTIC-FIBROSIS; AFFINITY RECEPTORS; MICE LACKING; UROGUANYLIN; BINDING; CELLS; PH	The heat-stable enterotoxin of Escherichia coli (STa) is a potent stimulant of intestinal chloride and bicarbonate secretion. Guanylyl cyclase C (GC-C) has been shown to be the primary receptor involved in mediating this response. However, numerous studies have suggested the existence of an alternative STa-binding receptor. The aims of this study were to determine whether a non-GC-C receptor exists for STa and what is the functional relevance of this for intestinal bicarbonate secretion in mice. (125)I-STa-binding experiments were performed with intestinal mucosae from GC-C knockout (KO) and wild type (WT) mice. Subsequently, the functional relevance of an alternative STa-binding receptor was explored by examining STa-, uroguanylin-, and guanylin-stimulated duodenal bicarbonate secretion (DBS) in GC-C KO mice in vitro and in vivo. Significant (125)I-STa-binding occurred in the proximal small intestines of GC-C KO and WT mice. Analysis of binding coefficients and pH dependence showed that (125)I-STa-binding in GC-C KO mice involved a receptor distinct from that of WT mice. Functionally, STa, uroguanylin, and guanylin all stimulated a significant increase in DBS in GC-C KO mice. Uroguanylin-and guanylin-stimulated DBS were significantly inhibited by glibenclamide, but not by 4,4'-diisothiocyanato-stilbene-2,2'-disulfonic acid (DIDS). However, STa-stimulated DBS was unaffected by glibenclamide but inhibited by DIDS. Taken together, our results suggest that alternative, non-GC-C, receptors likely exist for STa, uroguanylin, and guanylin in the intestines of mice. While uroguanylin- and guanylin-stimulated DBS are cystic fibrosis transmembrane conductance regulator (CFTR) dependent, STa-stimulated DBS is CFTR independent. Further understanding of this alternative receptor and its signaling pathway may provide important insights into rectification of intestinal bicarbonate secretion in cystic fibrosis.	[Sellers, Zachary M.; Smith, Anders; Ko, Kwang Hyun; Barrett, Kim E.; Dong, Hui] Univ Calif San Diego, Dept Med, Div Gastroenterol, La Jolla, CA 92093 USA; [Mann, Elizabeth; Giannella, Ralph; Cohen, Mitchell B.] Univ Cincinnati, Div Digest Dis, Cincinnati, OH USA; [Mann, Elizabeth; Cohen, Mitchell B.] Cincinnati Childrens Hosp Med Ctr, Div Gastroenterol Hepatol & Nutr, Cincinnati, OH USA	University of California System; University of California San Diego; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Dong, H (corresponding author), Univ Calif San Diego, Dept Med, Div Gastroenterol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	h2dong@ucsd.edu	Barrett, Kim/AAE-2794-2022; Sellers, Zachary/AAI-1356-2020; Barrett, Kim Elaine/AAE-7762-2019	Sellers, Zachary/0000-0001-5352-7760; Barrett, Kim Elaine/0000-0002-6704-998X; Cohen, Mitchell/0000-0002-4412-350X	NIDDK NIH HHS [R01-DK-33491, R01-DK-47318] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047318, R01DK033491] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barmeyer C, 2007, PFLUG ARCH EUR J PHY, V454, P441, DOI 10.1007/s00424-007-0213-7; Barraclough M, 1996, J PEDIATR GASTR NUTR, V23, P45, DOI 10.1097/00005176-199607000-00009; Carrithers SL, 2004, KIDNEY INT, V65, P40, DOI 10.1111/j.1523-1755.2004.00375.x; Clarke LL, 1996, LAB ANIM SCI, V46, P612; COHEN M, 1998, GASTROENTEROLOGY, V94, P367; COHEN MB, 1986, PEDIATR RES, V20, P555, DOI 10.1203/00006450-198606000-00017; COHEN MB, 2002, INFECT GASTROINTESTI, P579; CRANE MR, 1992, MOL PHARMACOL, V41, P1073; DAHLQVIST A, 1968, ANAL BIOCHEM, V22, P99, DOI 10.1016/0003-2697(68)90263-7; DESAUVAGE FJ, 1992, J BIOL CHEM, V267, P6479; DESHMANE SP, 1995, BIOCHEMISTRY-US, V34, P9095, DOI 10.1021/bi00028a019; Deshmane SP, 1997, BIOCHEMISTRY-US, V36, P12921, DOI 10.1021/bi971077b; EGGERMONT E, 1991, EUR J PEDIATR, V150, P824, DOI 10.1007/BF01954999; Freel RW, 2006, AM J PHYSIOL-GASTR L, V290, pG719, DOI 10.1152/ajpgi.00481.2005; Giblin MF, 2006, BREAST CANCER RES TR, V98, P7, DOI 10.1007/s10549-005-9040-8; Gilljam M, 2003, CHEST, V123, P37, DOI 10.1378/chest.123.1.37; GUARINO A, 1987, DIGEST DIS SCI, V32, P1017, DOI 10.1007/BF01297193; HAKKI S, 1993, BIOCHIM BIOPHYS ACTA, V1152, P1, DOI 10.1016/0005-2736(93)90224-N; Hasegawa M, 2005, J PEPT RES, V65, P261, DOI 10.1111/j.1399-3011.2005.00218.x; Hirokawa M, 2004, AM J PHYSIOL-GASTR L, V286, pG891, DOI 10.1152/ajpgi.00458.2003; Hogan DL, 1997, AM J PHYSIOL-GASTR L, V272, pG872, DOI 10.1152/ajpgi.1997.272.4.G872; HUGUES M, 1991, BIOCHEMISTRY-US, V30, P10738, DOI 10.1021/bi00108a019; IVENS K, 1990, INFECT IMMUN, V58, P1817, DOI 10.1128/IAI.58.6.1817-1820.1990; Kaur S, 2004, AM J PHYSIOL-GASTR L, V287, pG480, DOI 10.1152/ajpgi.00035.2004; London RM, 1999, AM J PHYSIOL-RENAL, V276, pF882, DOI 10.1152/ajprenal.1999.276.6.F882; London RM, 1997, AM J PHYSIOL-GASTR L, V273, pG93, DOI 10.1152/ajpgi.1997.273.1.G93; MANN EA, 1993, AM J PHYSIOL, V264, pG172, DOI 10.1152/ajpgi.1993.264.1.G172; Mann EA, 1997, BIOCHEM BIOPH RES CO, V239, P463, DOI 10.1006/bbrc.1997.7487; MUNSON PJ, 1980, ANAL BIOCHEM, V107, P220, DOI 10.1016/0003-2697(80)90515-1; Nandi A, 1997, J CELL BIOCHEM, V66, P500, DOI 10.1002/(SICI)1097-4644(19970915)66:4<500::AID-JCB9>3.0.CO;2-P; Pratha VS, 2000, GASTROENTEROLOGY, V118, P1051, DOI 10.1016/S0016-5085(00)70358-1; Rao SP, 2004, AM J PHYSIOL-GASTR L, V286, pG95, DOI 10.1152/ajpgi.00087.2003; ROBINSON PJ, 1990, DIGEST DIS SCI, V35, P1299, DOI 10.1007/BF01536423; SCHMITZ J, 1973, BIOCHIM BIOPHYS ACTA, V323, P98, DOI 10.1016/0005-2736(73)90434-3; Seidler U, 1997, J PHYSIOL-LONDON, V505, P411, DOI 10.1111/j.1469-7793.1997.411bb.x; Sellers ZM, 2005, AM J PHYSIOL-GASTR L, V288, pG654, DOI 10.1152/ajpgi.00386.2004; Simpson JE, 2007, AM J PHYSIOL-GASTR L, V292, pG1079, DOI 10.1152/ajpgi.00354.2006; Sindic A, 2005, KIDNEY INT, V68, P1008, DOI 10.1111/j.1523-1755.2005.00518.x; Sindice A, 2002, J BIOL CHEM, V277, P17758, DOI 10.1074/jbc.M110627200; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; STAPLES SJ, 1980, J BIOL CHEM, V255, P4716; THOMPSON MR, 1984, J CLIN MICROBIOL, V20, P59, DOI 10.1128/JCM.20.1.59-64.1984; THOMPSON MR, 1990, J RECEPTOR RES, V10, P97, DOI 10.3109/10799899009064660; Tuo BG, 2003, GASTROENTEROLOGY, V125, P805, DOI 10.1016/S0016-5085(03)01045-X; Vaandrager AB, 2002, MOL CELL BIOCHEM, V230, P73, DOI 10.1023/A:1014231722696; VAANDRAGER AB, 1993, J BIOL CHEM, V268, P2174; YOUNGBERG CA, 1987, DIGEST DIS SCI, V32, P472, DOI 10.1007/BF01296029	47	21	21	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638			FASEB J	Faseb J.	MAY	2008	22	5					1306	1316		10.1096/fj.06-7540com	http://dx.doi.org/10.1096/fj.06-7540com			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	301LW	18096816				2022-12-25	WOS:000255898700004
J	Goldsteins, G; Keksa-Goldsteine, V; Ahtoniemi, T; Jaronen, M; Arens, E; Akerman, K; Chan, PH; Koistinaho, J				Goldsteins, Gundars; Keksa-Goldsteine, Velta; Ahtoniemi, Toni; Jaronen, Merja; Arens, Egils; Akerman, Karl; Chan, Pak H.; Koistinaho, Jari			Deleterious role of superoxide dismutase in the mitochondrial intermembrane space	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CYTOCHROME-C; OXIDATIVE STRESS; CU,ZN-SUPEROXIDE DISMUTASE; PEROXIDASE-ACTIVITY; HYDROGEN-PEROXIDE; COMPLEX-III; MICE; OVEREXPRESSION; SOD1	This work demonstrates how increased activity of copperzinc superoxide dismutase (SOD1) paradoxically boosts production of toxic reactive oxygen species (ROS) in the intermembrane space (IMS) of mitochondria. Even though SOD1 is a cytosolic enzyme, a fraction of it is found in the IMS, where it is thought to provide protection against oxidative damage. We found that SOD1 controls cytochrome c-catalyzed peroxidation in vitro when superoxide is available. The presence of SOD1 significantly increased the rate of ROS production in mitoplasts, which are devoid of outer membrane and IMS. In response to inhibition of respiration with antimycin A, isolated mouse wildtype mitochondria increased ROS production, but the mitochondria from mice lacking SOD1 (SOD1(-/-)) did not. Also, lymphocytes isolated from SOD1(-/)-mice produced significantly less ROS than did wild-type cells and were more resistant to apoptosis induced by inhibition of respiration. Moreover, an increased amount of the toxic mutant G93A SOD1 in the IMS increased ROS production. The mitochondrial dysfunction and cell damage paradoxically induced by SOD1-mediated ROS production may be implicated in chronic degenerative diseases.	[Goldsteins, Gundars; Keksa-Goldsteine, Velta; Ahtoniemi, Toni; Jaronen, Merja; Arens, Egils; Akerman, Karl; Koistinaho, Jari] Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Neurobiol, FIN-70211 Kuopio, Finland; [Koistinaho, Jari] Kuopio Univ Hosp, Dept Oncol, Kuopio 70211, Finland; [Chan, Pak H.] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA	University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Stanford University	Goldsteins, G (corresponding author), Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Neurobiol, FIN-70211 Kuopio, Finland.	gundars.goldsteins@uku.fi; jari.koistinaho@uku.fi	Goldsteins, Gundars/X-1240-2019	Ahtoniemi, Toni/0000-0003-3239-7172				Barkats M, 2002, J NEUROCHEM, V82, P101, DOI 10.1046/j.1471-4159.2002.00952.x; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Barr DP, 1996, J BIOL CHEM, V271, P15498, DOI 10.1074/jbc.271.26.15498; Basova LV, 2007, BIOCHEMISTRY-US, V46, P3423, DOI 10.1021/bi061854k; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Belikova NA, 2006, BIOCHEMISTRY-US, V45, P4998, DOI 10.1021/bi0525573; Beni SM, 2006, J CEREBR BLOOD F MET, V26, P478, DOI 10.1038/sj.jcbfm.9600209; Chan PH, 2005, ANN NY ACAD SCI, V1042, P203, DOI 10.1196/annals.1338.022; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen ZY, 2000, FREE RADICAL BIO MED, V29, P589, DOI 10.1016/S0891-5849(00)00363-4; Diederix REM, 2002, BIOCHEMISTRY-US, V41, P13067, DOI 10.1021/bi0260841; Endo T, 2005, FREE RADICAL BIO MED, V38, P492, DOI 10.1016/j.freeradbiomed.2004.11.008; Everse J, 2005, FREE RADICAL BIO MED, V38, P1296, DOI 10.1016/j.freeradbiomed.2005.01.018; Ferri A, 2006, P NATL ACAD SCI USA, V103, P13860, DOI 10.1073/pnas.0605814103; Forman HJ, 1997, FASEB J, V11, P374, DOI 10.1096/fasebj.11.5.9141504; Fujimura M, 2000, J NEUROSCI, V20, P2817; Fullerton HJ, 1998, ANN NEUROL, V44, P357, DOI 10.1002/ana.410440311; GOLDSTEINS G, 2006, AMYOTROPHIC LATER S1, V7, P22; Han D, 2003, J BIOL CHEM, V278, P5557, DOI 10.1074/jbc.M210269200; Hempel SL, 1999, FREE RADICAL BIO MED, V27, P146, DOI 10.1016/S0891-5849(99)00061-1; Inarrea P, 2005, BIOCHEM J, V387, P203, DOI 10.1042/BJ20041683; Inoue M, 2003, CURR MED CHEM, V10, P2495, DOI 10.2174/0929867033456477; Jang B, 2006, BIOCHIMIE, V88, P53, DOI 10.1016/j.biochi.2005.06.016; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kirkinezos IG, 2005, J NEUROSCI, V25, P164, DOI 10.1523/JNEUROSCI.3829-04.2005; Lawrence A, 2003, J BIOL CHEM, V278, P29410, DOI 10.1074/jbc.M300054200; Lei XG, 2006, BIOCHEM J, V399, P455, DOI 10.1042/BJ20060784; Liu J, 2004, NEURON, V43, P5, DOI 10.1016/j.neuron.2004.06.016; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Muller FL, 2004, J BIOL CHEM, V279, P49064, DOI 10.1074/jbc.M407715200; OBERLEY LW, 1984, METHOD ENZYMOL, V105, P457; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Qian SY, 2002, BIOCHEM J, V363, P281, DOI 10.1042/0264-6021:3630281; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sturtz LA, 2001, J BIOL CHEM, V276, P38084; Svistunenko DA, 2005, BBA-BIOENERGETICS, V1707, P127, DOI 10.1016/j.bbabio.2005.01.004; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; van Beek-Harmsen BJ, 2005, J HISTOCHEM CYTOCHEM, V53, P803, DOI 10.1369/jhc.4C6527.2005; WOLVETANG EJ, 1994, FEBS LETT, V339, P40, DOI 10.1016/0014-5793(94)80380-3; Ying WH, 2000, J CEREBR BLOOD F MET, V20, P359, DOI 10.1097/00004647-200002000-00018; Yoo HY, 1999, J BIOTECHNOL, V68, P29, DOI 10.1016/S0168-1656(98)00188-6; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	44	64	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8446	8452		10.1074/jbc.M706111200	http://dx.doi.org/10.1074/jbc.M706111200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18171673	hybrid			2022-12-25	WOS:000254288000042
J	Jiang, L; Fan, JM; Bai, L; Wang, Y; Chen, Y; Yang, L; Chen, LY; Xu, T				Jiang, Li; Fan, Junmei; Bai, Li; Wang, Yan; Chen, Yu; Yang, Lu; Chen, Liangyi; Xu, Tao			Direct quantification of fusion rate reveals a distal role for AS160 in insulin-stimulated fusion of GLUT4 storage vesicles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUCOSE-TRANSPORTER GLUT4; REGULATED MEMBRANE AMINOPEPTIDASE; EVANESCENT-WAVE MICROSCOPY; SKELETAL-MUSCLE; 3T3-L1 ADIPOCYTES; PLASMA-MEMBRANE; FLUORESCENT PROTEIN; CELL-SURFACE; TRAFFICKING; TRANSLOCATION	Insulin-stimulated GLUT4 translocation to the plasma membrane constitutes a key process for blood glucose control. However, convenient and robust assays to monitor this dynamic process in real time are lacking, which hinders current progress toward elucidation of the underlying molecular events as well as screens for drugs targeting this particular pathway. Here, we have developed a novel dual colored probe to monitor the translocation process of GLUT4 based on dual color fluorescence measurement. We demonstrate that this probe is more than an order of magnitude more sensitive than the current technology for detecting fusion events from single GLUT4 storage vesicles (GSVs). A small fraction of fusion events were found to be of the "kiss-and-run" type. For the first time, we show that insulin stimulation evokes a similar to 40-fold increase in the fusion of GSVs in 3T3-L1 adipocytes, compared with basal conditions. The probe can also be used to monitor the prefusion behavior of GSVs. By quantifying both the docking and fusion rates simultaneously, we demonstrate a proportional inhibition in both docking and fusion of GSVs by a dominant negative mutant of AS160, indicating a role for AS160 in the docking of GSVs but not in the regulation of GSV fusion after docking.	[Fan, Junmei; Bai, Li; Xu, Tao] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Wuhan 430074, Peoples R China; [Jiang, Li; Wang, Yan; Chen, Yu; Yang, Lu; Chen, Liangyi; Xu, Tao] Chinese Acad Sci, Inst Biophys, Joint Lab, Beijing 100101, Peoples R China; [Jiang, Li; Wang, Yan; Chen, Yu; Yang, Lu; Chen, Liangyi; Xu, Tao] Huazhong Univ Sci & Technol, Natl Lab Biomacromol, Chinese Acad Sci, Beijing 100101, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Huazhong University of Science & Technology	Xu, T (corresponding author), Chinese Acad Sci, Inst Biophys, Joint Lab, Beijing 100101, Peoples R China.	xutao@ibp.ac.cn	Xu, Tao/G-5474-2010; Bai, Li/N-8311-2013; fan, junmei/D-6147-2011; Chen, Liangyi/F-1352-2010; Chen, Yu/G-8724-2013	Chen, Liangyi/0000-0003-1270-7321; 				Abel ED, 2004, MOL ENDOCRINOL, V18, P2491, DOI 10.1210/me.2004-0175; Bai L, 2007, CELL METAB, V5, P47, DOI 10.1016/j.cmet.2006.11.013; BIRNBAUM MJ, 1989, CELL, V57, P305, DOI 10.1016/0092-8674(89)90968-9; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; COLE KS, 1968, J GEN PHYSIOL, V51, pS1; CZECH MP, 1993, J CELL BIOL, V123, P127, DOI 10.1083/jcb.123.1.127; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; HENRY RR, 1995, DIABETES, V44, P936, DOI 10.2337/diabetes.44.8.936; JAMES DE, 1988, NATURE, V333, P183, DOI 10.1038/333183a0; KANDROR K, 1994, J BIOL CHEM, V269, P138; KANDROR KV, 1994, P NATL ACAD SCI USA, V91, P8017, DOI 10.1073/pnas.91.17.8017; Karlsson HKR, 2006, DIABETES, V55, P1283, DOI 10.2337/db05-0853; KELLER SR, 1995, J BIOL CHEM, V270, P23612, DOI 10.1074/jbc.270.40.23612; Koumanov F, 2005, CELL METAB, V2, P179, DOI 10.1016/j.cmet.2005.08.007; Lampson MA, 2000, J CELL SCI, V113, P4065; Lang T, 1997, NEURON, V18, P857, DOI 10.1016/S0896-6273(00)80325-6; Li CH, 2004, CELL RES, V14, P480, DOI 10.1038/sj.cr.7290251; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Martin S, 1997, J CELL SCI, V110, P2281; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; ROBINSON LJ, 1992, J CELL BIOL, V117, P1181, DOI 10.1083/jcb.117.6.1181; Ross SA, 1996, J BIOL CHEM, V271, P3328, DOI 10.1074/jbc.271.6.3328; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Subtil A, 2000, J BIOL CHEM, V275, P4787, DOI 10.1074/jbc.275.7.4787; Sudhof TC, 2000, NEURON, V28, P317, DOI 10.1016/S0896-6273(00)00109-4; Sumitani S, 1997, ENDOCRINOLOGY, V138, P1029, DOI 10.1210/en.138.3.1029; Taraska JW, 2003, P NATL ACAD SCI USA, V100, P2070, DOI 10.1073/pnas.0337526100; Tengholm A, 2002, CURR BIOL, V12, P1871, DOI 10.1016/S0960-9822(02)01223-X; Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3; Yang XF, 2005, BIOCHEM BIOPH RES CO, V330, P914, DOI 10.1016/j.bbrc.2005.03.054; Yang XF, 2006, J BIOL CHEM, V281, P15457, DOI 10.1074/jbc.M513246200; Zeigerer A, 2004, MOL BIOL CELL, V15, P4406, DOI 10.1091/mbc.e04-04-0333	34	64	68	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 28	2008	283	13					8508	8516		10.1074/jbc.M708688200	http://dx.doi.org/10.1074/jbc.M708688200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	278LT	18063571	Green Published, hybrid			2022-12-25	WOS:000254288000049
J	Bompadre, SG; Li, M; Hwang, TC				Bompadre, Silvia G.; Li, Min; Hwang, Tzyh-Chang			Mechanism of G551D-CFTR (cystic fibrosis transmembrane conductance regulator) potentiation by a high affinity ATP analog	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-BINDING DOMAINS; CFTR; CHANNEL; MUTATIONS; DELTA-F508; SITE; PHOSPHORYLATION; IDENTIFICATION; DIMERIZATION; ACTIVATORS	Cystic fibrosis transmembrane conductance regulator (CFTR) is a chloride channel gated by ATP binding and hydrolysis at its nucleotide binding domains (NBD). The NBDs dimerize in a head-to-tail configuration, forming two ATP binding pockets (ABP) with the ATP molecules buried at the dimer interface. Previous studies have indicated that ABP2, formed by the Walker A and B motifs of NBD2 and the signature sequence of NBD1, is the site critical for the ATP-dependent opening of CFTR. The G551D mutation in ABP2, the third most common cystic fibrosis-associated mutation, abolishes ATP-dependent gating, resulting in an open probability that is similar to 100-fold lower than that of wild-type channels. Interestingly, we found that the ATP analog N-6-(2-phenylethyl)-ATP (P-ATP) increases G551D currents mainly by increasing the open time of the channel. This effect is reduced when P-ATP is applied together with ATP, suggesting a competition between ATP and P-ATP for a common binding site. Introducing mutations that lower the nucleotide binding affinity at ABP2 did not alter significantly the effects of P-ATP on G551D-CFTR, whereas an equivalent mutation at ABP1 (consisting of the Walker A and B motifs of NBD1 and the signature sequence of NBD2) dramatically decreased the potency of P-ATP, indicating that ABP1 is the site where P-ATP binds to increase the activity of G551D-CFTR. These results substantiate the idea that nucleotide binding at ABP1 stabilizes the open channel conformation. Our observation that P-ATP enhances the G551D activity by binding at ABP1 implicates that ABP1 can potentially be a target for drugs to bind and increase the channel activity.	[Bompadre, Silvia G.; Li, Min; Hwang, Tzyh-Chang] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Hwang, Tzyh-Chang] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Bompadre, SG (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	BompadreS@missouri.edu			NHLBI NIH HHS [R01HL53455] Funding Source: Medline; NIDDK NIH HHS [K01DK075408, R01 DK055835, R01DK55835] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK075408, R01DK055835] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ai T, 2004, MOL PHARMACOL, V65, P1415, DOI 10.1124/mol.65.6.1415; Aleksandrov L, 2002, J BIOL CHEM, V277, P15419, DOI 10.1074/jbc.M111713200; Basso C, 2003, J GEN PHYSIOL, V122, P333, DOI 10.1085/jgp.200308798; Bompadre SG, 2005, J GEN PHYSIOL, V125, P361, DOI 10.1085/jgp.200409227; Bompadre SG, 2005, J GEN PHYSIOL, V125, P377, DOI 10.1085/jgp.200409228; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Cai ZW, 2006, J BIOL CHEM, V281, P1970, DOI 10.1074/jbc.M510576200; Colquhoun D, 1998, BRIT J PHARMACOL, V125, P924; Csanady L, 2000, BIOPHYS J, V78, P785, DOI 10.1016/S0006-3495(00)76636-7; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DRUMM ML, 1991, SCIENCE, V254, P1797, DOI 10.1126/science.1722350; Galietta LJV, 2001, J BIOL CHEM, V276, P19723, DOI 10.1074/jbc.M101892200; GREGORY RJ, 1991, MOL CELL BIOL, V11, P3886, DOI 10.1128/MCB.11.8.3886; Illek B, 1999, AM J PHYSIOL-CELL PH, V277, pC833, DOI 10.1152/ajpcell.1999.277.4.C833; KEREM BS, 1990, P NATL ACAD SCI USA, V87, P8447, DOI 10.1073/pnas.87.21.8447; Lewis HA, 2005, J BIOL CHEM, V280, P1346, DOI 10.1074/jbc.M410968200; Lewis HA, 2004, EMBO J, V23, P282, DOI 10.1038/sj.emboj.7600040; Mense M, 2006, EMBO J, V25, P4728, DOI 10.1038/sj.emboj.7601373; Moran O, 2005, CELL MOL LIFE SCI, V62, P446, DOI 10.1007/s00018-004-4422-3; Pedemonte N, 2005, MOL PHARMACOL, V67, P1797, DOI 10.1124/mol.105.010959; Powe AC, 2002, J PHYSIOL-LONDON, V539, P333, DOI 10.1113/jphysiol.2001.013162; QUINTON PM, 1990, FASEB J, V4, P2709, DOI 10.1096/fasebj.4.10.2197151; RIORDAN JR, 1989, SCIENCE, V245, P1066; Vergani P, 2005, NATURE, V433, P876, DOI 10.1038/nature03313; Wang W, 2007, J BIOL CHEM, V282, P4533, DOI 10.1074/jbc.M609942200; WELSH MJ, 1993, CELL, V73, P1251, DOI 10.1016/0092-8674(93)90353-R; Zegarra-Moran O, 2007, J BIOL CHEM, V282, P9098, DOI 10.1074/jbc.M611411200; Zhou Z, 2005, J PHYSIOL-LONDON, V569, P447, DOI 10.1113/jphysiol.2005.095083; Zhou Z, 2006, J GEN PHYSIOL, V128, P413, DOI 10.1085/jgp.200609622	29	31	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5364	5369		10.1074/jbc.M709417200	http://dx.doi.org/10.1074/jbc.M709417200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18167357	hybrid			2022-12-25	WOS:000253426700016
J	Worrall, JAR; Howe, FS; McKay, AR; Robinson, CV; Luisi, BF				Worrall, Jonathan A. R.; Howe, Francoise S.; McKay, Adam R.; Robinson, Carol V.; Luisi, Ben F.			Allosteric activation of the ATPase activity of the Escherichia coli RhIB RNA helicase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							JUNCTION CORE COMPLEX; DEAD-BOX HELICASES; MESSENGER-RNA; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROTEIN DBP5; Q-MOTIF; DEGRADOSOME; BINDING; EIF4A	Helicase B (Rh1B) is one of the five DEAD box RNA-dependent ATPases found in Escherichia coli. Unique among these enzymes, Rh1B requires an interaction with the partner protein RNase E for appreciable ATPase and RNA unwinding activities. To explore the basis for this activating effect, we have generated a di-cistronic vector that overexpresses a complex comprising Rh1B and its recognition site within RNase E, corresponding to residues 696 -762. Complex formation has been characterized by isothermal titration calorimetry, revealing an avid, enthalpy-favored interaction between the helicase and RNase E-( 696 762) with an equilibrium binding constant (Ka) of at least 1 X 10(8) M-1. We studied ATPase activity of mutants with substitutions within the ATP binding pocket of Rh1B and on the putative interaction surface that mediates recognition of RNase E. For comparisons, corresponding mutations were prepared in two other E. coli DEAD box ATPases, Rh1E and SrmB. Strikingly, substitutions at a phenylalanine near the Q-motif found in DEAD box proteins boosts the ATPase activity of Rh1B in the absence of RNA, but completely inhibits it in its presence. The data support the proposal that the protein-protein and RNA-binding surfaces both communicate allosterically with the ATPase catalytic center. We conjecture that this communication may govern the mechanical power and efficiency of the helicases, and is tuned in individual helicases in accordance with cellular function.	[Worrall, Jonathan A. R.; Howe, Francoise S.; Luisi, Ben F.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [McKay, Adam R.; Robinson, Carol V.] Univ Cambridge, Chem Lab, Cambridge CB2 1EW, England	University of Cambridge; University of Cambridge	Luisi, BF (corresponding author), Univ Cambridge, Dept Biochem, 80 Tennis Court Rd, Cambridge CB2 1GA, England.	bf120@mole.bio.cam.ac.uk	Howe, Franklyn A/C-3307-2008	robinson, carol/0000-0001-7829-5505; Howe, Franklyn/0000-0002-7135-3351	Wellcome Trust [042079] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981; Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990; Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s; Bleichert F, 2007, MOL CELL, V27, P339, DOI 10.1016/j.molcel.2007.07.014; Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006; Braman J, 1996, Methods Mol Biol, V57, P31; Braun F, 1996, MOL MICROBIOL, V19, P997, DOI 10.1046/j.1365-2958.1996.440971.x; Callaghan AJ, 2004, J MOL BIOL, V340, P965, DOI 10.1016/j.jmb.2004.05.046; Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440; Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080; Chandran V, 2007, J MOL BIOL, V367, P113, DOI 10.1016/j.jmb.2006.12.014; Chang TH, 1997, NUCLEIC ACIDS RES, V25, P5033, DOI 10.1093/nar/25.24.5033; Coburn GA, 1999, GENE DEV, V13, P2594, DOI 10.1101/gad.13.19.2594; COHEN SN, 1995, CELL, V80, P829, DOI 10.1016/0092-8674(95)90284-8; Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019; Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272; Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472; IGGO RD, 1989, EMBO J, V8, P1827, DOI 10.1002/j.1460-2075.1989.tb03577.x; Iost I, 2006, NUCLEIC ACIDS RES, V34, P4189, DOI 10.1093/nar/gkl500; Jankowsky E, 2007, CURR OPIN STRUC BIOL, V17, P316, DOI 10.1016/j.sbi.2007.05.007; Khemici V, 2005, P NATL ACAD SCI USA, V102, P6913, DOI 10.1073/pnas.0501129102; Khemici V, 2004, MOL MICROBIOL, V54, P1422, DOI 10.1111/j.1365-2958.2004.04361.x; Liou GG, 2002, J BIOL CHEM, V277, P41157, DOI 10.1074/jbc.M206618200; Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g; Marcaida MJ, 2006, TRENDS BIOCHEM SCI, V31, P359, DOI 10.1016/j.tibs.2006.05.005; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Schneider S, 2004, J BIOL CHEM, V279, P8617, DOI 10.1074/jbc.M312715200; Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054; Shultis DD, 2006, SCIENCE, V312, P1396, DOI 10.1126/science.1127694; Silverman E, 2003, GENE, V312, P1, DOI 10.1016/S0378-1119(03)00626-7; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Tsu CA, 2001, RNA, V7, P702, DOI 10.1017/S1355838201010135; Turner AMW, 2007, J BACTERIOL, V189, P2769, DOI 10.1128/JB.01509-06; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3; Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165; Yu E, 2000, NUCLEIC ACIDS RES, V28, P3926, DOI 10.1093/nar/28.20.3926	45	25	25	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 29	2008	283	9					5567	5576		10.1074/jbc.M708620200	http://dx.doi.org/10.1074/jbc.M708620200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IC	18165229	hybrid, Green Accepted			2022-12-25	WOS:000253426700037
J	Ghosh, JC; Dohi, T; Kang, BH; Altieri, DC				Ghosh, Jagadish C.; Dohi, Takehiko; Kang, Byoung Heon; Altieri, Dario C.			Hsp60 regulation of tumor cell apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEINS; HSP70 FAMILY-MEMBER; MOLECULAR CHAPERONES; CYTOPLASMIC SEQUESTRATION; CANCER-CELLS; SURVIVIN; P53; EXPRESSION; HSP90; HSP10	Molecular chaperones may promote cell survival, but how this process is regulated, especially in cancer, is not well understood. Using high throughput proteomics screening, we identified the cell cycle regulator and apoptosis inhibitor survivin as a novel protein associated with the molecular chaperone Hsp60. Acute ablation of Hsp60 by small interfering RNA destabilizes the mitochondrial pool of survivin, induces mitochondrial dysfunction, and activates caspase-dependent apoptosis. This response involves disruption of an Hsp60-p53 complex, which results in p53 stabilization, increased expression of pro-apoptotic Bax, and Bax-dependent apoptosis. In vivo, Hsp60 is abundantly expressed in primary human tumors, as compared with matched normal tissues, and small interfering RNA ablation of Hsp60 in normal cells is well tolerated and does not cause apoptosis. Therefore, Hsp60 orchestrates a broad cell survival program centered on stabilization of mitochondrial survivin and restraining of p53 function, and this process is selectively exploited in cancer. Hsp60 inhibitors may function as attractive anticancer agents by differentially inducing apoptosis in tumor cells.	[Ghosh, Jagadish C.; Dohi, Takehiko; Kang, Byoung Heon; Altieri, Dario C.] Univ Massachusetts, Sch Med, Ctr Canc, Dept Canc Biol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Altieri, DC (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 364 Plantat St, Worcester, MA 01605 USA.	dario.altieri@umassmed.edu	Kang, Byoung Heon/E-6165-2010	Kang, Byoung Heon/0000-0001-5902-0549	NATIONAL CANCER INSTITUTE [R01CA078810, R01CA090917] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL054131, R01HL054131] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA090917, CA78810, CA90917] Funding Source: Medline; NHLBI NIH HHS [R37 HL054131, HL54131] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Altieri DC, 2006, CURR OPIN CELL BIOL, V18, P609, DOI 10.1016/j.ceb.2006.08.015; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Beltrami E, 2004, J BIOL CHEM, V279, P2077, DOI 10.1074/jbc.M309479200; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; Cappello F, 2005, BMC CANCER, V5, DOI 10.1186/1471-2407-5-139; Cappello F, 2006, CANCER-AM CANCER SOC, V107, P2417, DOI 10.1002/cncr.22265; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; Dohi T, 2004, J CLIN INVEST, V114, P1117, DOI 10.1172/JCI200422222; Dohi T, 2007, MOL CELL, V27, P17, DOI 10.1016/j.molcel.2007.06.004; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Fortugno P, 2003, P NATL ACAD SCI USA, V100, P13791, DOI 10.1073/pnas.2434345100; Ghosh JC, 2006, CANCER RES, V66, P11576, DOI 10.1158/0008-5472.CAN-06-3095; Graudens E, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-3-r19; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; HARTL FU, 1992, ANNU REV BIOPH BIOM, V21, P293, DOI 10.1146/annurev.bb.21.060192.001453; Isaacs JS, 2003, CANCER CELL, V3, P213, DOI 10.1016/S1535-6108(03)00029-1; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Kang BH, 2006, J BIOL CHEM, V281, P24721, DOI 10.1074/jbc.M603175200; Lens SMA, 2006, CURR OPIN CELL BIOL, V18, P616, DOI 10.1016/j.ceb.2006.08.016; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Ma Z, 2006, ONCOGENE, V25, P5377, DOI 10.1038/sj.onc.1209543; Paul C, 2002, MOL CELL BIOL, V22, P816, DOI 10.1128/MCB.22.3.816-834.2002; Plescia J, 2005, CANCER CELL, V7, P457, DOI 10.1016/j.ccr.2005.03.035; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Salvesen GS, 2002, NAT REV MOL CELL BIO, V3, P401, DOI 10.1038/nrm830; Samali A, 1999, EMBO J, V18, P2040, DOI 10.1093/emboj/18.8.2040; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Soltys BJ, 2000, INT REV CYTOL, V194, P133; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Tang D, 2005, CELL STRESS CHAPERON, V10, P46, DOI 10.1379/CSC-44R.1; Thomas X, 2005, LEUKEMIA RES, V29, P1049, DOI 10.1016/j.leukres.2005.02.010; Velculescu VE, 1999, NAT GENET, V23, P387, DOI 10.1038/70487; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2002, EXP CELL RES, V274, P246, DOI 10.1006/excr.2002.5468; Wadhwa R, 2000, CANCER RES, V60, P6818; Walker C, 2006, AM J PATHOL, V168, P1526, DOI 10.2353/ajpath.2006.050603; Whitesell L, 2005, NAT REV CANCER, V5, P761, DOI 10.1038/nrc1716; Xanthoudakis S, 1999, EMBO J, V18, P2049, DOI 10.1093/emboj/18.8.2049; Yaglom JA, 2007, CANCER RES, V67, P2373, DOI 10.1158/0008-5472.CAN-06-3796; Yano M, 2003, J CELL BIOL, V163, P45, DOI 10.1083/jcb.200305051; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3; Zhao Q, 2002, EMBO J, V21, P4411, DOI 10.1093/emboj/cdf445	45	217	227	2	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5188	5194		10.1074/jbc.M705904200	http://dx.doi.org/10.1074/jbc.M705904200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086682	Green Published, hybrid			2022-12-25	WOS:000253426500076
J	Guo, C; Tang, TS; Bienko, M; Dikic, I; Friedberg, EC				Guo, Caixia; Tang, Tie-Shan; Bienko, Marzena; Dikic, Ivan; Friedberg, Errol C.			Requirements for the interaction of mouse pol kappa with ubiquitin and its biological significance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-KAPPA; REV1 PROTEIN INTERACTS; S-PHASE CHECKPOINT; Y-FAMILY; TRANSLESION SYNTHESIS; REPLICATION FOCI; DAMAGE; PCNA; ETA; LOCALIZATION	Pol kappa protein is a eukaryotic member of the DinB/Pol kappa branch of the Y-family DNA polymerases, which are involved in the tolerance of DNA damage by replicative bypass. Despite universal conservation through evolution, the precise role(s) of Pol kappa in this process has remained unknown. Here we report that mouse Pol kappa can physically interact with ubiquitin by yeast two-hybrid screening, glutathione S-transferase pulldown, and immuno-precipitation methods. The association of Pol kappa with ubiquitin requires the ubiquitin-binding motifs located at the C terminus of Pol kappa. In addition, Pol kappa binds with monoubiquitinated proliferating cell nuclear antigen (PCNA) more robustly than with non-ubiquitinated PCNA. The ubiquitin-binding motifs mediate the enhanced association between monoubiquitinated PCNA and Pol kappa. The ubiquitin-binding motifs are also required for Pol kappa to form nuclear foci after UV radiation. However, the ubiquitin-binding motifs do not affect Pol kappa half-life. Finally, we have examined levels of Pol kappa expression following the exposure of mouse cells to benzo[a] pyrene-dihydrodiol epoxide or UVB radiation.	[Guo, Caixia; Friedberg, Errol C.] Univ Texas SW Med Ctr Dallas, Lab Mol Pathol, Dept Pathol, Dallas, TX 75390 USA; [Tang, Tie-Shan] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Bienko, Marzena; Dikic, Ivan] Univ Frankfurt, Sch Med, Inst Biol 2, D-60590 Frankfurt, Germany	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Goethe University Frankfurt	Friedberg, EC (corresponding author), Univ Texas SW Med Ctr Dallas, Lab Mol Pathol, Dept Pathol, Dallas, TX 75390 USA.	friedberg.errol@pathology.swmed.edu	Dikic, Ivan/O-4650-2015; Bienko, Magda/AAM-8867-2020	Dikic, Ivan/0000-0001-8156-9511; Bienko, Magda/0000-0002-6499-9082	NIEHS NIH HHS [ES11344] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011344] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Bavoux C, 2005, BIOCHIMIE, V87, P637, DOI 10.1016/j.biochi.2005.02.007; Bavoux C, 2005, CANCER RES, V65, P325; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Bergoglio V, 2002, J CELL SCI, V115, P4413, DOI 10.1242/jcs.00162; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Bi XH, 2005, J BIOL CHEM, V280, P22343, DOI 10.1074/jbc.M501562200; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; Friedberg EC, 2005, NAT REV MOL CELL BIO, V6, P943, DOI 10.1038/nrm1781; Gerlach VL, 1999, P NATL ACAD SCI USA, V96, P11922, DOI 10.1073/pnas.96.21.11922; Guo C, 2005, DNA REPAIR, V4, P397, DOI 10.1016/j.dnarep.2004.10.006; Guo CX, 2006, MOL CELL BIOL, V26, P8892, DOI 10.1128/MCB.01118-06; Guo CX, 2006, MOL CELL, V23, P265, DOI 10.1016/j.molcel.2006.05.038; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Huang TT, 2006, NAT REV MOL CELL BIO, V7, P323, DOI 10.1038/nrm1908; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Ogi T, 2005, J CELL SCI, V118, P129, DOI 10.1242/jcs.01603; Ogi T, 2002, P NATL ACAD SCI USA, V99, P15548, DOI 10.1073/pnas.222377899; Ogi T, 2001, GENES CELLS, V6, P943, DOI 10.1046/j.1365-2443.2001.00478.x; Ohashi E, 2004, GENES CELLS, V9, P523, DOI 10.1111/j.1356-9597.2004.00747.x; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Okada T, 2002, J BIOL CHEM, V277, P48690, DOI 10.1074/jbc.M207957200; Plosky BS, 2006, EMBO J, V25, P2847, DOI 10.1038/sj.emboj.7601178; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Schenten D, 2002, EUR J IMMUNOL, V32, P3152, DOI 10.1002/1521-4141(200211)32:11<3152::AID-IMMU3152>3.0.CO;2-2; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Takenaka K, 2006, J BIOL CHEM, V281, P2000, DOI 10.1074/jbc.M506153200; Tissier A, 2004, DNA REPAIR, V3, P1503, DOI 10.1016/j.dnarep.2004.06.015; Ulrich HD, 2004, CELL CYCLE, V3, P15; Velasco-Miguel S, 2003, DNA REPAIR, V2, P91, DOI 10.1016/S1568-7864(02)00189-1; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383	34	55	57	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4658	4664		10.1074/jbc.M709275200	http://dx.doi.org/10.1074/jbc.M709275200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18162470	hybrid			2022-12-25	WOS:000253426500023
J	Liang, FP; Lin, CH; Kuo, CD; Chao, HP; Fu, SL				Liang, Fong-Pin; Lin, Chao-Hsiung; Kuo, Cheng-Deng; Chao, Hsueh-Ping; Fu, Shu-Ling			Suppression of v-Src transformation by andrographolide via degradation of the v-Src protein and attenuation of the Erk signaling pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN CANCER-CELLS; C-SRC; PANICULATA EXTRACT; KINASE INHIBITOR; EPITHELIAL-CELLS; TYROSINE KINASE; MAP KINASE; E-CADHERIN; ACTIVATION; EXPRESSION	Elevated expression and aberrant activation of the src oncogene are strongly associated with cancer initiation and progression, thereby making Src a promising molecular target for anti-cancer therapy. Through drug screening using a temperature-inducible v-Src-transformed epithelial cell line, we found that andrographolide could suppress v-Src-induced transformation and down-regulate v-Src protein expression. In addition, actin cable dissolution and E-cadherin down-regulation, features of transformed phenotype, are perturbed by andrographolide. Moreover, andrographolide promoted v-Src degradation via a ubiquitin-dependent manner. Although andrographolide treatment altered the tyrosine phosphorylation pattern in v-Src-expressing cells, it did not directly affect the kinase activity of v-Src. Both the Erk and phosphatidylinositol 3-kinase signaling pathways were strongly inhibited in andrographolide-treated v-Src cells. However, only MKK inhibitors (PD98059 and U0126) were able to cause a non-transformed morphology similar to that of andrographolide-treated v-Src cells. Moreover, overexpression of constitutively active MKK1 in v-Src cells blocked andrographolide-mediated morphological inhibition. Interestingly, andrographolide treatment could also reduce the protein level of the c-Src truncation mutant (Src531), an Src mutant originally identified from human colon cancer cells. In summary, we demonstrated that andrographolide antagonized v-Src action through promotion of v-Src protein degradation. Furthermore, attenuation of the Erk1/2 signaling pathway is essential for andrographolide-mediated inhibition of v-Src transformation. Our results demonstrate that andrographolide can act as a v-Src inhibitor and reveal a novel action mechanism of andrographolide.	[Liang, Fong-Pin; Chao, Hsueh-Ping; Fu, Shu-Ling] Natl Yang Ming Univ, Inst Tradit Med, Taipei 11221, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Fac Life Sci, Taipei 11221, Taiwan; [Lin, Chao-Hsiung] Natl Yang Ming Univ, Inst Genome Sci, Taipei 11221, Taiwan; [Lin, Chao-Hsiung; Fu, Shu-Ling] Taipei City Hosp, Dept Res & Educ, Taipei 10341, Taiwan; [Kuo, Cheng-Deng] Vet Gen Hosp, Dept Res & Educ, Taipei 11217, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital	Fu, SL (corresponding author), Natl Yang Ming Univ, Inst Tradit Med, 155 Sec 2,Li Nong St, Taipei 11221, Taiwan.	slfu@ym.edu.tw	Kuo, Cheng-Deng/AAP-7010-2021	Kuo, Cheng-Deng/0000-0002-3989-1950; Chao, Hsueh-Ping/0000-0001-9404-4300				An WG, 2000, CELL GROWTH DIFFER, V11, P355; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Bijlmakers MJJE, 2000, MOL BIOL CELL, V11, P1585, DOI 10.1091/mbc.11.5.1585; Blagosklonny MV, 2002, LEUKEMIA, V16, P455, DOI 10.1038/sj.leu.2402415; Bowman T, 2001, P NATL ACAD SCI USA, V98, P7319, DOI 10.1073/pnas.131568898; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Brunton VG, 1998, CANCER CHEMOTH PHARM, V41, P417, DOI 10.1007/s002800050760; Carragher NO, 2002, MOL CELL BIOL, V22, P257, DOI 10.1128/MCB.22.1.257-269.2002; Chen JH, 2004, BIOCHEM PHARMACOL, V67, P1337, DOI 10.1016/j.bcp.2003.12.015; Chiou WF, 2000, BRIT J PHARMACOL, V129, P1553, DOI 10.1038/sj.bjp.0703191; Dehm S, 2001, FEBS LETT, V487, P367, DOI 10.1016/S0014-5793(00)02354-1; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Frame MC, 2002, NAT REV MOL CELL BIO, V3, P233, DOI 10.1038/nrm779; Fu SL, 2005, BIOCHEM BIOPH RES CO, V338, P830, DOI 10.1016/j.bbrc.2005.10.045; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Harris KF, 1999, P NATL ACAD SCI USA, V96, P13738, DOI 10.1073/pnas.96.24.13738; Huang WC, 2003, J BIOL CHEM, V278, P9944, DOI 10.1074/jbc.M208521200; Irby RB, 1999, NAT GENET, V21, P187, DOI 10.1038/5971; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Jiang BH, 1997, CANCER RES, V57, P5328; Kumar RA, 2004, J ETHNOPHARMACOL, V92, P291, DOI 10.1016/j.jep.2004.03.004; KWON HJ, 1992, BIOSCI BIOTECH BIOCH, V56, P538; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; Martin GS, 2001, NAT REV MOL CELL BIO, V2, P467, DOI 10.1038/35073094; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Nam JS, 2002, CLIN CANCER RES, V8, P2430; Nguyen KT, 2000, ONCOGENE, V19, P5385, DOI 10.1038/sj.onc.1203911; Oldham SM, 1998, ONCOGENE, V16, P2565, DOI 10.1038/sj.onc.1201784; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Penuel E, 1999, MOL BIOL CELL, V10, P1693, DOI 10.1091/mbc.10.6.1693; Rajagopal Sriram, 2003, J Exp Ther Oncol, V3, P147, DOI 10.1046/j.1359-4117.2003.01090.x; Riley D, 2001, ONCOGENE, V20, P5941, DOI 10.1038/sj.onc.1204826; Sharma SV, 2006, CANCER CELL, V10, P425, DOI 10.1016/j.ccr.2006.09.014; Sharma SV, 2006, CLIN CANCER RES, V12, p4392S, DOI 10.1158/1078-0432.CCR-06-0096; Sharma SV, 2001, ONCOGENE, V20, P2068, DOI 10.1038/sj.onc.1204296; Sheeja K, 2007, IMMUNOPHARM IMMUNOT, V29, P81, DOI 10.1080/08923970701282726; Sheeja K, 2007, INT IMMUNOPHARMACOL, V7, P211, DOI 10.1016/j.intimp.2006.10.002; Sinibaldi D, 2000, ONCOGENE, V19, P5419, DOI 10.1038/sj.onc.1203947; STOKER AW, 1986, J VIROL, V58, P876, DOI 10.1128/JVI.58.3.876-883.1986; Tsai HR, 2004, EUR J PHARMACOL, V498, P45, DOI 10.1016/j.ejphar.2004.07.077; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; WHITESELL L, 1994, P NATL ACAD SCI USA, V91, P8324, DOI 10.1073/pnas.91.18.8324; Xia YF, 2004, J IMMUNOL, V173, P4207, DOI 10.4049/jimmunol.173.6.4207; Xu Y, 1999, P NATL ACAD SCI USA, V96, P109, DOI 10.1073/pnas.96.1.109; XU Y, 1993, P NATL ACAD SCI USA, V90, P7074, DOI 10.1073/pnas.90.15.7074; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Zhou J, 2006, BIOCHEM PHARMACOL, V72, P132, DOI 10.1016/j.bcp.2006.04.019	49	40	41	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					5023	5033		10.1074/jbc.M705877200	http://dx.doi.org/10.1074/jbc.M705877200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086662	hybrid			2022-12-25	WOS:000253426500060
J	Ross, JA; Nagy, ZS; Kirken, RA				Ross, Jeremy A.; Nagy, Zsuzsanna S.; Kirken, Robert A.			The PHB1/2 phosphocomplex is required for mitochondrial homeostasis and survival of human T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESTROGEN-RECEPTOR ACTIVITY; SIGNAL-TRANSDUCTION; PROHIBITIN FAMILY; ANTIGEN RECEPTOR; TYROSINE KINASE; TRANSCRIPTIONAL ACTIVITY; ACTIVITY REA; EXPRESSION; PROTEIN; ACTIVATION	Many immune pathologies are the result of aberrant regulation of T lymphocytes. A functional proteomics approach utilizing two-dimensional gel electrophoresis coupled with mass spectrometry was employed to identify differentially expressed proteins in response to T cell activation. Two members of the prohibitin family of proteins, Phb1 and Phb2, were determined to be up-regulated 4-5- fold upon activation of primary human T cells. Furthermore, their expression was dependent upon CD3 and CD28 signaling pathways that synergistically led to the up-regulation (13-15-fold) of Phb1 and Phb2 mRNA levels as early as 48 h after activation. Additionally, orthophosphate labeling coupled with phosphoamino acid analysis identified Phb1 to be serine and Phb2 serine and tyrosine phosphorylated. Tyrosine phosphorylation of Phb2 was mapped to Tyr(248) using mass spectrometry and confirmed by mutagenesis and phosphospecific antibodies. In contrast to previous reports of Phb1 and Phb2 being nuclear localized, subcellular fractionation, immunofluorescent, and electron microscopy revealed both proteins to localize to the mitochondrial inner membrane of human T cells. Accordingly, small interfering RNA-mediated knockdown of Phbs in Kit225 cells resulted in disruption of mitochondrial membrane potential. Additionally, Phb1 and Phb2 protein levels were up-regulated 2.5-fold during cytokine deprivation-mediated apoptosis of Kit225 cells, suggesting this complex plays a protective role in human T cells. Taken together, Phb1 and Phb2 are novel phosphoproteins up-regulated during T cell activation that function to maintain mitochondrial integrity and thus represent previously unrecognized therapeutic targets for regulating T cell activation, differentiation, viability, and function.	[Ross, Jeremy A.; Nagy, Zsuzsanna S.; Kirken, Robert A.] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79902 USA	University of Texas System; University of Texas El Paso	Kirken, RA (corresponding author), Univ Texas El Paso, Dept Biol Sci, 500 W Univ Ave, El Paso, TX 79902 USA.	rkirken@utep.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI053566] Funding Source: NIH RePORTER; NCRR NIH HHS [5G12RR008124] Funding Source: Medline; NIAID NIH HHS [AI053566] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aringer M, 2003, J IMMUNOL, V170, P6057, DOI 10.4049/jimmunol.170.12.6057; ARTALSANZ M, 2003, J BIOL CHEM, V279, P32091; Back JW, 2002, PROTEIN SCI, V11, P2471, DOI 10.1110/ps.0212602; Beere HM, 2004, J CELL SCI, V117, P2641, DOI 10.1242/jcs.01284; Berger KH, 1998, MOL CELL BIOL, V18, P4043, DOI 10.1128/MCB.18.7.4043; BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163; Coates PJ, 2001, EXP CELL RES, V265, P262, DOI 10.1006/excr.2001.5166; Coates PJ, 1997, CURR BIOL, V7, P607, DOI 10.1016/S0960-9822(06)00261-2; DANG NH, 1991, J IMMUNOL, V147, P2825; Delage-Mourroux R, 2000, J BIOL CHEM, V275, P35848, DOI 10.1074/jbc.M001327200; Dixit VD, 2003, ENDOCRINOLOGY, V144, P1496, DOI 10.1210/en.2002-220955; DURAND DB, 1987, J EXP MED, V165, P395, DOI 10.1084/jem.165.2.395; EGAN SE, 1993, NATURE, V363, P45, DOI 10.1038/363045a0; EVELETH DD, 1986, NUCLEIC ACIDS RES, V14, P6169, DOI 10.1093/nar/14.15.6169; Finco TS, 1998, IMMUNITY, V9, P617, DOI 10.1016/S1074-7613(00)80659-7; Fusaro G, 2003, J BIOL CHEM, V278, P47853, DOI 10.1074/jbc.M305171200; Gamble SC, 2004, ONCOGENE, V23, P2996, DOI 10.1038/sj.onc.1207444; HE B, 2007, MOL ENDOCRINOL, DOI DOI 10.1210/ME.2007.0400; HORI T, 1987, BLOOD, V70, P1069; HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z; IKONEN E, 1995, FEBS LETT, V358, P273, DOI 10.1016/0014-5793(94)01444-6; IWASHIMA M, 1994, SCIENCE, V263, P1136, DOI 10.1126/science.7509083; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Joshi B, 2003, BIOCHEM BIOPH RES CO, V312, P459, DOI 10.1016/j.bbrc.2003.10.148; Kasashima K, 2006, J BIOL CHEM, V281, P36401, DOI 10.1074/jbc.M605260200; Katial RK, 1998, CLIN DIAGN LAB IMMUN, V5, P78, DOI 10.1128/CDLI.5.1.78-81.1998; KAWAMURA M, 1994, P NATL ACAD SCI USA, V91, P6374, DOI 10.1073/pnas.91.14.6374; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Kirken RA, 1999, J LEUKOCYTE BIOL, V65, P891, DOI 10.1002/jlb.65.6.891; KIRKEN RA, 1995, CYTOKINE, V7, P689, DOI 10.1006/cyto.1995.0081; Kirken RA, 1997, J BIOL CHEM, V272, P15459, DOI 10.1074/jbc.272.24.15459; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Kurtev V, 2004, J BIOL CHEM, V279, P24834, DOI 10.1074/jbc.M312300200; Langer T, 2001, BIOCHEM SOC T, V29, P431, DOI 10.1042/BST0290431; LOWENTHAL JW, 1985, NATURE, V315, P669, DOI 10.1038/315669a0; Manjeshwar S, 2003, CANCER RES, V63, P5251; MCCLUNG JK, 1989, BIOCHEM BIOPH RES CO, V164, P1316, DOI 10.1016/0006-291X(89)91813-5; MIYOSHI I, 1981, GANN, V72, P978; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Nijtmans LGJ, 2002, CELL MOL LIFE SCI, V59, P143, DOI 10.1007/s00018-002-8411-0; Nijtmans LGJ, 2000, EMBO J, V19, P2444, DOI 10.1093/emboj/19.11.2444; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; ROSKAMS AJI, 1993, J CELL PHYSIOL, V157, P289, DOI 10.1002/jcp.1041570211; Schamberger CJ, 2004, FEBS LETT, V573, P19, DOI 10.1016/j.febslet.2004.07.053; SCHNEIDER U, 1977, INT J CANCER, V19, P621, DOI 10.1002/ijc.2910190505; Sharma A, 2004, P NATL ACAD SCI USA, V101, P17492, DOI 10.1073/pnas.0407536101; Steglich G, 1999, MOL CELL BIOL, V19, P3435; Stepkowski SM, 2005, J IMMUNOL, V175, P4236, DOI 10.4049/jimmunol.175.7.4236; STRAUS DB, 1992, CELL, V70, P585, DOI 10.1016/0092-8674(92)90428-F; Takata H, 2007, CURR BIOL, V17, P1356, DOI 10.1016/j.cub.2007.07.009; Tatsuta T, 2005, MOL BIOL CELL, V16, P248, DOI 10.1091/mbc.e04-09-0807; TERASHIMA M, 1994, EMBO J, V13, P3782, DOI 10.1002/j.1460-2075.1994.tb06689.x; Theiss AL, 2007, J BIOL CHEM, V282, P12804, DOI 10.1074/jbc.M609031200; Theiss AL, 2007, FASEB J, V21, P197, DOI 10.1096/fj.06-6801com; Thompson WE, 1997, J REPROD FERTIL, V109, P337, DOI 10.1530/jrf.0.1090337; Wang S, 1999, MOL CELL BIOL, V19, P7447; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Wang S, 2004, EMBO J, V23, P2293, DOI 10.1038/sj.emboj.7600231; Wang S, 2002, ONCOGENE, V21, P8388, DOI 10.1038/sj.onc.1205944; WANGE RL, 1993, J BIOL CHEM, V268, P19797; Winter A, 2007, PROTEINS, V68, P353, DOI 10.1002/prot.21355; Woodlock TJ, 2001, BLOOD CELL MOL DIS, V27, P27, DOI 10.1006/bcmd.2000.0348; Zhang J, 1998, J IMMUNOL, V160, P1148; Zhang WG, 2000, J BIOL CHEM, V275, P23355, DOI 10.1074/jbc.M000404200	68	76	77	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 22	2008	283	8					4699	4713		10.1074/jbc.M708232200	http://dx.doi.org/10.1074/jbc.M708232200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	266IA	18086671	hybrid			2022-12-25	WOS:000253426500028
J	Serrano-Gomez, D; Sierra-Filardi, E; Martinez-Nunez, RT; Caparros, E; Delgado, R; Munoz-Fernandez, MA; Abad, MA; Jimenez-Barbero, J; Leal, M; Corbi, AL				Serrano-Gomez, Diego; Sierra-Filardi, Elena; Martinez-Nunez, Rocio T.; Caparros, Esther; Delgado, Rafael; Munoz-Fernandez, Mari Angeles; Abad, Maria Antonia; Jimenez-Barbero, Jesus; Leal, Manuel; Corbi, Angel L.			Structural requirements for multimerization of the pathogen receptor dendritic cell-specific ICAM3-grabbing non-integrin (CD209) on the cell surface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TYPE LECTIN; DC-SIGN CD209; MOLECULE-3 (ICAM-3)-GRABBING NONINTEGRIN; SELECTIVE RECOGNITION; REGION POLYMORPHISMS; TRANS-INFECTION; LIGAND-BINDING; VIRUS; EXPRESSION; ANTIGEN	The myeloid C-type lectin dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN, CD209) recognizes oligosaccharide ligands on clinically relevant pathogens (HIV, Mycobacterium, and Aspergillus). Alternative splicing and genomic polymorphism generate DC-SIGN mRNA variants, which have been detected at sites of pathogen entrance and transmission. We present evidence that DC-SIGN neck variants are expressed on dendritic and myeloid cells at the RNA and protein levels. Structural analysis revealed that multimerization of DC-SIGN within a cellular context depends on the lectin domain and the number and arrangement of the repeats within the neck region, whose glycosylation negatively affects oligomer formation. Naturally occurring DC-SIGN neck variants differ in multimerization competence in the cell membrane, exhibit altered sugar binding ability, and retain pathogen-interacting capacity, implying that pathogen-induced cluster formation predominates over the basal multimerization capability. Analysis of DC-SIGN neck polymorphisms indicated that the number of allelic variants is higher than previously thought and that multimerization of the prototypic molecule is modulated in the presence of allelic variants with a different neck structure. Our results demonstrate that the presence of allelic variants or a high level of expression of neck domain splicing isoforms might influence the presence and stability of DC-SIGN multimers on the cell surface, thus providing a molecular explanation for the correlation between DC-SIGN polymorphisms and altered susceptibility to HIV-1 and other pathogens.	[Serrano-Gomez, Diego; Sierra-Filardi, Elena; Martinez-Nunez, Rocio T.; Caparros, Esther; Jimenez-Barbero, Jesus; Corbi, Angel L.] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain; [Delgado, Rafael] Hosp 12 Octubre, Mol Microbiol Lab, E-28041 Madrid, Spain; [Munoz-Fernandez, Mari Angeles] Hosp Gen Gregorio Maranon, Serv Immunol, E-28007 Madrid, Spain; [Abad, Maria Antonia; Leal, Manuel] Hosp Univ Virgen Rocio, Serv Enfermedades Infec, E-41013 Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Hospital Universitario 12 de Octubre; General University Gregorio Maranon Hospital; Virgen del Rocio University Hospital	Corbi, AL (corresponding author), CSIC, Ctr Invest Biol, Ramiro Maeztu 9, E-28040 Madrid, Spain.	acorbi@cib.csic.es	Corbí, Angel L./ABC-8146-2020; JIMENEZ-BARBERO, JESUS/D-4431-2014; Sierra-Filardi, Elena/H-9775-2015; Caparrós, Esther/AHD-3233-2022; Serrano-Gómez, Diego/W-2857-2018; Leal, Manuel/C-8458-2015; Delgado, Rafael/C-4910-2016; DELGADO, RAFAEL/A-2938-2012	Corbí, Angel L./0000-0003-1980-5733; JIMENEZ-BARBERO, JESUS/0000-0001-5421-8513; Sierra-Filardi, Elena/0000-0003-4439-2037; Caparrós, Esther/0000-0002-9681-0408; Serrano-Gómez, Diego/0000-0003-4965-8869; Delgado, Rafael/0000-0002-6912-4736; Martinez-Nunez, Rocio Teresa/0000-0003-2507-4738; Munoz-Fernandez/0000-0002-0813-4500				Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Barreiro LB, 2005, AM J HUM GENET, V77, P869, DOI 10.1086/497613; Barreiro LB, 2006, HUM IMMUNOL, V67, P102, DOI 10.1016/j.humimm.2006.02.028; Barreiro LB, 2006, J INFECT DIS, V194, P1184, DOI 10.1086/507845; Bernhard OK, 2004, J BIOL CHEM, V279, P51828, DOI 10.1074/jbc.M402741200; Bleijs DA, 2001, TRENDS IMMUNOL, V22, P457, DOI 10.1016/S1471-4906(01)01974-3; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Cambi A, 2003, CURR OPIN CELL BIOL, V15, P539, DOI 10.1016/j.ceb.2003.08.004; Cambi A, 2003, EUR J IMMUNOL, V33, P532, DOI 10.1002/immu.200310029; Caparros E, 2006, BLOOD, V107, P3950, DOI 10.1182/blood-2005-03-1252; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; Colmenares M, 2004, J IMMUNOL, V172, P1186, DOI 10.4049/jimmunol.172.2.1186; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; CURTIS BM, 1992, P NATL ACAD SCI USA, V89, P8356, DOI 10.1073/pnas.89.17.8356; de la Rosa G, 2005, J LEUKOCYTE BIOL, V77, P699, DOI 10.1189/jlb.0904529; Engering A, 2002, J IMMUNOL, V168, P2118, DOI 10.4049/jimmunol.168.5.2118; Falkowska E, 2006, J GEN VIROL, V87, P2571, DOI 10.1099/vir.0.82034-0; Feinberg H, 2005, J BIOL CHEM, V280, P1327, DOI 10.1074/jbc.M409925200; Feinberg H, 2001, SCIENCE, V294, P2163, DOI 10.1126/science.1066371; Frison N, 2003, J BIOL CHEM, V278, P23922, DOI 10.1074/jbc.M302483200; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Geijtenbeek TBH, 2001, PLACENTA, V22, pS19, DOI 10.1053/plac.2001.0674; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Guo Y, 2004, NAT STRUCT MOL BIOL, V11, P591, DOI 10.1038/nsmb784; Guo Y, 2006, J BIOL CHEM, V281, P16794, DOI 10.1074/jbc.M602430200; Kang YS, 2006, CELL, V125, P47, DOI 10.1016/j.cell.2006.01.046; Kwon DS, 2002, IMMUNITY, V16, P135, DOI 10.1016/S1074-7613(02)00259-5; Lee B, 2001, J VIROL, V75, P12028, DOI 10.1128/JVI.75.24.12028-12038.2001; Liu HL, 2005, EUR J HUM GENET, V13, P707, DOI 10.1038/sj.ejhg.5201409; Liu HL, 2004, J INFECT DIS, V190, P1055, DOI 10.1086/423209; Liu HL, 2006, J INFECT DIS, V193, P698, DOI 10.1086/499820; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; Lozach PY, 2003, J BIOL CHEM, V278, P20358, DOI 10.1074/jbc.M301284200; Mari S, 2005, ANGEW CHEM INT EDIT, V44, P296, DOI 10.1002/anie.200461574; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; Mitchell DA, 2001, J BIOL CHEM, V276, P28939, DOI 10.1074/jbc.M104565200; Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200; Nattermann J, 2006, J VIRAL HEPATITIS, V13, P42, DOI 10.1111/j.1365-2893.2005.00652.x; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Puig-Kroger A, 2004, J BIOL CHEM, V279, P25680, DOI 10.1074/jbc.M311516200; Puig-Kroger A, 2000, J IMMUNOL, V165, P4338, DOI 10.4049/jimmunol.165.8.4338; Relloso M, 2002, J IMMUNOL, V168, P2634, DOI 10.4049/jimmunol.168.6.2634; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Serrano-Gomez D, 2004, J IMMUNOL, V173, P5635, DOI 10.4049/jimmunol.173.9.5635; Serrano-Gomez D, 2007, ANTIMICROB AGENTS CH, V51, P2313, DOI 10.1128/AAC.01289-06; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Soilleux EJ, 2001, J PATHOL, V195, P586, DOI 10.1002/path.1026; Su SV, 2004, J BIOL CHEM, V279, P19122, DOI 10.1074/jbc.M400184200; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; van Gisbergen KPJM, 2005, J EXP MED, V201, P1281, DOI 10.1084/jem.20041276; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182	60	34	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3889	3903		10.1074/jbc.M706004200	http://dx.doi.org/10.1074/jbc.M706004200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18073208	hybrid, Green Published			2022-12-25	WOS:000253083500023
J	Tartari, CJ; Gunby, RH; Coluccia, AML; Sottocornola, R; Cimbro, B; Scapozza, L; Donella-Deana, A; Pinna, LA; Gambacorti-Passerini, C				Tartari, Carmen J.; Gunby, Rosalind H.; Coluccia, Addolorata M. L.; Sottocornola, Roberta; Cimbro, Barbara; Scapozza, Leonardo; Donella-Deana, Arianna; Pinna, Lorenzo A.; Gambacorti-Passerini, Carlo			Characterization of some molecular mechanisms governing autoactivation of the catalytic domain of the anaplastic lymphoma kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; SIGNAL TRANSDUCER; MAMMALIAN TARGET; ALK EXPRESSION; FUSION PROTEIN; STAT3; NUCLEOPHOSMIN; ACTIVATION; PHOSPHORYLATION; CONTRIBUTES	NPM/ALK is an oncogenic fusion protein expressed in similar to 50% of anaplastic large cell lymphoma cases. It derives from the t(2; 5)(p23; q35) chromosomal translocation that fuses the catalytic domain of the tyrosine kinase, anaplastic lymphoma kinase (ALK), with the dimerization domain of the ubiquitously expressed nucleophosmin (NPM) protein. Dimerization of the ALK kinase domain leads to its autophosphorylation and constitutive activation. Activated NPM/ALK stimulates downstream survival and proliferation signaling pathways leading to malignant transformation. Herein, we investigated the molecular mechanisms of autoactivation of the catalytic domain of ALK. Because kinases are typically regulated by autophosphorylation of their activation loops, we systematically mutated (Tyr --> Phe) three potential autophosphorylation sites contained in the "YXXXYY" motif of the ALK activation loop, and determined the effect of these mutations on the catalytic activity and biological function of NPM/ALK. We observed that mutation of both the second and third tyrosine residues (YFF mutant) did not affect the kinase activity or transforming ability of NPM/ALK. In contrast, mutation of the first and second (FFY), first and third (FYF), or all three (FFF) tyrosine residues impaired both kinase activity and transforming ability of NPM/ALK. Furthermore, a DFF mutant, in which the aspartic residue introduces a negative charge similar to a phosphorylated tyrosine, possessed catalytic activity similar to the YFF mutant. Together, our findings indicate that phosphorylation of the first tyrosine of the YXXXYY motif is necessary for the autoactivation of the ALK kinase domain and the transforming activity of NPM/ALK.	[Tartari, Carmen J.; Gunby, Rosalind H.; Coluccia, Addolorata M. L.; Sottocornola, Roberta; Cimbro, Barbara; Gambacorti-Passerini, Carlo] Univ Milano Bicocca, Dept Clin & Prevent Med, I-20052 Monza, Italy; [Tartari, Carmen J.] Natl Canc Inst Fdn, Dept Expt Oncol, I-20133 Milan, Italy; [Scapozza, Leonardo] Univ Geneva, Sch Pharmaceut Sci, CH-1211 Geneva, Switzerland; [Scapozza, Leonardo] Univ Lausanne, Sch Pharmaceut Sci, CH-1211 Geneva, Switzerland; [Donella-Deana, Arianna; Pinna, Lorenzo A.] Univ Padua, Venetian Inst Mol Med, Dept Biol Chem, I-35122 Padua, Italy; [Gambacorti-Passerini, Carlo] McGill Univ, Dept Internal Med, Montreal, PQ H3A 2T5, Canada	University of Milano-Bicocca; Fondazione IRCCS Istituto Nazionale Tumori Milan; University of Geneva; University of Lausanne; University of Padua; Veneto Institute Molecular Medicine; McGill University	Tartari, CJ (corresponding author), Univ Milano Bicocca, Dept Clin & Prevent Med, Via Cadore 48, I-20052 Monza, Italy.	carmen.tartari@unimib.it	Tartari, Carmen Julia/AAA-8104-2019	Tartari, Carmen Julia/0000-0002-4576-2928; GAMBACORTI PASSERINI, CARLO/0000-0001-6058-515X; Scapozza, Leonardo/0000-0003-1079-648X; Pinna, Lorenzo A./0000-0002-8856-4956	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Amin HM, 2006, LAB INVEST, V86, P417, DOI 10.1038/labinvest.3700393; Bai RY, 1998, MOL CELL BIOL, V18, P6951, DOI 10.1128/MCB.18.12.6951; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Bischof D, 1997, MOL CELL BIOL, V17, P2312, DOI 10.1128/MCB.17.4.2312; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Cohen P, 2001, EUR J BIOCHEM, V268, P5001, DOI 10.1046/j.0014-2956.2001.02473.x; Coluccia AML, 2005, EXPERT OPIN THER TAR, V9, P515, DOI 10.1517/14728222.9.3.515; Coluccia AML, 2004, BLOOD, V103, P2787, DOI 10.1182/blood-2003-09-3144; Cook JR, 2001, AM J SURG PATHOL, V25, P1364, DOI 10.1097/00000478-200111000-00003; Cordell JL, 1999, BLOOD, V93, P632, DOI 10.1182/blood.V93.2.632; Donella-Deana A, 2005, BIOCHEMISTRY-US, V44, P8533, DOI 10.1021/bi0472954; Fujimoto J, 1996, P NATL ACAD SCI USA, V93, P4181, DOI 10.1073/pnas.93.9.4181; Gunby RH, 2003, HAEMATOLOGICA, V88, P408; Gunby RH, 2007, ANTI-CANCER AGENT ME, V7, P594, DOI 10.2174/187152007784111340; Hubbard SR, 2000, ANNU REV BIOCHEM, V69, P373, DOI 10.1146/annurev.biochem.69.1.373; Hubbard SR, 2002, FRONT BIOSCI, V7, pD330, DOI 10.2741/hubbard; Hubbard SR, 1999, PROG BIOPHYS MOL BIO, V71, P343, DOI 10.1016/S0079-6107(98)00047-9; Hurley SP, 2006, J COMP NEUROL, V495, P202, DOI 10.1002/cne.20887; Kasprzycka M, 2006, P NATL ACAD SCI USA, V103, P9964, DOI 10.1073/pnas.0603507103; Khoury JD, 2003, CLIN CANCER RES, V9, P3692; Lai R, 2005, HUM PATHOL, V36, P939, DOI 10.1016/j.humpath.2005.07.011; Lai R, 2004, AM J PATHOL, V164, P2251, DOI 10.1016/S0002-9440(10)63781-9; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marzec M, 2005, LAB INVEST, V85, P1544, DOI 10.1038/labinvest.3700348; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nieborowska-Skorska M, 2001, CANCER RES, V61, P6517; Pulford K, 2004, CELL MOL LIFE SCI, V61, P2939, DOI 10.1007/s00018-004-4275-9; Pulford K, 2004, J CELL PHYSIOL, V199, P330, DOI 10.1002/jcp.10472; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Rudzki Zbigniew, 2005, Polish Journal of Pathology, V56, P37; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Slupianek A, 2001, CANCER RES, V61, P2194; Vega F, 2006, CANCER RES, V66, P6589, DOI 10.1158/0008-5472.CAN-05-3018; Vernersson E, 2006, GENE EXPR PATTERNS, V6, P448, DOI 10.1016/j.modgep.2005.11.006; Zamo A, 2002, ONCOGENE, V21, P1038, DOI 10.1038/sj.onc.1205152; ZHANG B, 1991, J BIOL CHEM, V266, P990; Zhang Q, 2002, J IMMUNOL, V168, P466, DOI 10.4049/jimmunol.168.1.466	38	46	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 15	2008	283	7					3743	3750		10.1074/jbc.M706067200	http://dx.doi.org/10.1074/jbc.M706067200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MO	18070884	hybrid			2022-12-25	WOS:000253083500007
J	Robertson, PD; Warren, EM; Zhang, H; Friedman, DB; Lary, JW; Cole, JL; Tutter, AV; Walter, JC; Fanning, E; Eichman, BF				Robertson, Patrick D.; Warren, Eric M.; Zhang, Haijiang; Friedman, David B.; Lary, Jeffrey W.; Cole, James L.; Tutter, Antonin V.; Walter, Johannes C.; Fanning, Ellen; Eichman, Brandt F.			Domain architecture and biochemical characterization of vertebrate Mcm10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-ALPHA; REPLICATION PROTEIN-A; SINGLE-STRANDED-DNA; CYCLIN-DEPENDENT KINASES; BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; CHROMOSOMAL DNA; FISSION YEAST; SEDIMENTATION-VELOCITY; CHROMATIN ASSOCIATION	Mcm10 plays a key role in initiation and elongation of eukaryotic chromosomal DNA replication. As a first step to better understand the structure and function of vertebrate Mcm10, we have determined the structural architecture of Xenopus laevis Mcm10 (xMcm10) and characterized each domain biochemically. Limited proteolytic digestion of the full-length protein revealed N-terminal-, internal (ID)-, and C-terminal (CTD)-structured domains. Analytical ultracentrifugation revealed that xMcm10 self-associates and that the N-terminal domain forms homodimeric assemblies. DNA binding activity of xMcm10 was mapped to the ID and CTD, each of which binds to single- and double-stranded DNA with low micromolar affinity. The structural integrity of xMcm10-ID and CTD is dependent on the presence of bound zinc, which was experimentally verified by atomic absorption spectroscopy and proteolysis protection assays. The ID and CTD also bind independently to the N-terminal 323 residues of the p180 subunit of DNA polymerase alpha-primase. We propose that the modularity of the protein architecture, with discrete domains for dimerization and for binding to DNA and DNA polymerase alpha-primase, provides an effective means for coordinating the biochemical activities of Mcm10 within the replisome.	[Robertson, Patrick D.; Warren, Eric M.; Zhang, Haijiang; Fanning, Ellen; Eichman, Brandt F.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37232 USA; [Friedman, David B.; Eichman, Brandt F.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Lary, Jeffrey W.; Cole, James L.] Univ Connecticut, Natl Analyt Ultracentrifugat Facil, Storrs, CT 06269 USA; [Tutter, Antonin V.; Walter, Johannes C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Vanderbilt University; Vanderbilt University; University of Connecticut; Harvard University; Harvard Medical School	Eichman, BF (corresponding author), Vanderbilt Univ, VU Stn B, Box 35-1634, Nashville, TN 37235 USA.	brandt.eichman@vanderbilt.edu	Cole, James/G-2586-2011	Walter, Johannes/0000-0002-4186-7570	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000267] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080570, T32GM008320, R01GM052948] Funding Source: NIH RePORTER; NIEHS NIH HHS [P30 ES000267] Funding Source: Medline; NIGMS NIH HHS [GM52948, GM080570, R01 GM080570, R01 GM080570-01, R01 GM052948, T32 GM008320, R01 GM080570-02, T32 GM08320] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anumanthan G, 2006, CANCER RES, V66, P10824, DOI 10.1158/0008-5472.CAN-06-1599; Arunkumar AI, 2003, J BIOL CHEM, V278, P41077, DOI 10.1074/jbc.M305871200; Blow JJ, 2005, NAT REV MOL CELL BIO, V6, P476, DOI 10.1038/nrm1663; Bochkareva E, 2002, EMBO J, V21, P1855, DOI 10.1093/emboj/21.7.1855; Borden KLB, 2000, J MOL BIOL, V295, P1103, DOI 10.1006/jmbi.1999.3429; Christensen TW, 2003, MOL BIOL CELL, V14, P2206, DOI 10.1091/mbc.E02-11-0706; COLLINS KL, 1993, EMBO J, V12, P4555, DOI 10.1002/j.1460-2075.1993.tb06144.x; Cook CR, 2003, J BIOL CHEM, V278, P36051, DOI 10.1074/jbc.M306049200; Das-Bradoo S, 2006, MOL CELL BIOL, V26, P4806, DOI 10.1128/MCB.02062-05; DELATORRE JG, 1981, Q REV BIOPHYS, V14, P81, DOI 10.1017/S0033583500002080; DORNREITER I, 1993, MOL CELL BIOL, V13, P809, DOI 10.1128/MCB.13.2.809; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fien K, 2004, J BIOL CHEM, V279, P16144, DOI 10.1074/jbc.M400142200; Fien K, 2006, J BIOL CHEM, V281, P22248, DOI 10.1074/jbc.M512997200; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Garg P, 2005, CRIT REV BIOCHEM MOL, V40, P115, DOI 10.1080/10409230590935433; Gregan J, 2003, MOL BIOL CELL, V14, P3876, DOI 10.1091/mbc.E03-02-0090; Homesley L, 2000, GENE DEV, V14, P913; Izumi M, 2000, NUCLEIC ACIDS RES, V28, P4769, DOI 10.1093/nar/28.23.4769; Jiang XH, 2006, EMBO J, V25, P5516, DOI 10.1038/sj.emboj.7601432; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kawasaki Y, 2000, GENES CELLS, V5, P975, DOI 10.1046/j.1365-2443.2000.00387.x; Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741; KLUG A, 1995, FASEB J, V9, P597, DOI 10.1096/fasebj.9.8.7768350; Kwon K, 2003, J BIOL CHEM, V278, P19442, DOI 10.1074/jbc.M300934200; LAUE TM, 1992, SEDNTERP; Lee JK, 2003, P NATL ACAD SCI USA, V100, P2334, DOI 10.1073/pnas.0237384100; Lee JY, 2000, EMBO J, V19, P1119, DOI 10.1093/emboj/19.5.1119; Leon O, 2000, BIOL RES, V33, P21; MAINE GT, 1984, GENETICS, V106, P365; Mer G, 2000, CELL, V103, P449, DOI 10.1016/S0092-8674(00)00136-7; Merchant AM, 1997, MOL CELL BIOL, V17, P3261, DOI 10.1128/MCB.17.6.3261; Metz AH, 2007, EMBO J, V26, P2411, DOI 10.1038/sj.emboj.7601649; Michael WM, 2000, SCIENCE, V289, P2133, DOI 10.1126/science.289.5487.2133; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Mizuno T, 1999, MOL CELL BIOL, V19, P7886; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; NASMYTH K, 1981, MOL GEN GENET, V182, P119, DOI 10.1007/BF00422777; Okorokov AL, 2007, EMBO REP, V8, P925, DOI 10.1038/sj.embor.7401064; Ott RD, 2002, MOL CELL BIOL, V22, P5669, DOI 10.1128/MCB.22.16.5669-5678.2002; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480; Ricke RM, 2004, MOL CELL, V16, P173, DOI 10.1016/j.molcel.2004.09.017; Ricke RM, 2006, J BIOL CHEM, V281, P18414, DOI 10.1074/jbc.M513551200; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; SHAMOO Y, 1995, NATURE, V376, P362, DOI 10.1038/376362a0; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; SOLOMON NA, 1992, YEAST, V8, P273, DOI 10.1002/yea.320080405; STAFFORD WF, 1992, ANAL BIOCHEM, V203, P295, DOI 10.1016/0003-2697(92)90316-Y; Stafford WF, 2004, BIOPHYS CHEM, V108, P231, DOI 10.1016/j.bpc.2003.10.028; Stauffer ME, 2004, J BIOL CHEM, V279, P30915, DOI 10.1074/jbc.R400015200; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Takayama Y, 2003, GENE DEV, V17, P1153, DOI 10.1101/gad.1065903; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tanaka TU, 1998, EMBO J, V17, P5182, DOI 10.1093/emboj/17.17.5182; Voitenleitner C, 1997, ONCOGENE, V14, P1611, DOI 10.1038/sj.onc.1200975; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter J, 1998, MOL CELL, V1, P519, DOI 10.1016/S1097-2765(00)80052-0; Wohlschlegel JA, 2002, MOL CELL, V9, P233, DOI 10.1016/S1097-2765(02)00456-2; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zou L, 2000, MOL CELL BIOL, V20, P3086, DOI 10.1128/MCB.20.9.3086-3096.2000	66	39	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 8	2008	283	6					3338	3348		10.1074/jbc.M706267200	http://dx.doi.org/10.1074/jbc.M706267200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	261MJ	18065420	Green Accepted, Green Submitted, hybrid			2022-12-25	WOS:000253083000038
J	Vannberg, FO; Chapman, SJ; Khor, CC; Tosh, K; Floyd, S; Jackson-Sillah, D; Crampin, A; Sichali, L; Bah, B; Gustafson, P; Aaby, P; McAdam, KPWJ; Bah-Sow, O; Lienhardt, C; Sirugo, G; Fine, P; Hill, AVS				Vannberg, Fredrik O.; Chapman, Stephen J.; Khor, Chiea C.; Tosh, Kerrie; Floyd, Sian; Jackson-Sillah, Dolly; Crampin, Amelia; Sichali, Lifted; Bah, Boubacar; Gustafson, Per; Aaby, Peter; McAdam, Keith P. W. J.; Bah-Sow, Oumou; Lienhardt, Christian; Sirugo, Giorgio; Fine, Paul; Hill, Adrian V. S.			CD209 Genetic Polymorphism and Tuberculosis Disease	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; HUMAN DENDRITIC CELLS; LECTINS DC-SIGN; MYCOBACTERIUM-TUBERCULOSIS; IMMUNE-RESPONSES; TRANS-INFECTION; CUTTING EDGE; RISK-FACTORS; T-CELLS; VIRUS	Background. Tuberculosis causes significant morbidity and mortality worldwide, especially in sub-Saharan Africa. DC-SIGN, encoded by CD209, is a receptor capable of binding and internalizing Mycobacterium tuberculosis. Previous studies have reported that the CD209 promoter single nucleotide polymorphism (SNP)-336A/G exerts an effect on CD209 expression and is associated with human susceptibility to dengue, HIV-1 and tuberculosis in humans. The present study investigates the role of the CD209-336A/G variant in susceptibility to tuberculosis in a large sample of individuals from sub-Saharan Africa. Methods and Findings. A total of 2,176 individuals enrolled in tuberculosis case-control studies from four sub-Saharan Africa countries were genotyped for the CD209-336A/G SNP (rs4804803). Significant overall protection against pulmonary tuberculosis was observed with the -336G allele when the study groups were combined (n = 914 controls vs. 1262 cases, Mantel-Haenszel 2x2 chi(2) = 7.47, P = 0.006, odds ratio = 0.86, 95% CI 0.77-0.96). In addition, the patients with -336GG were associated with a decreased risk of cavitory tuberculosis, a severe form of tuberculosis disease (n = 557, Pearson's 262 chi(2) = 17.34, P = 0.00003, odds ratio = 0.42, 95% CI 0.27-0.65). This direction of association is opposite to a previously observed result in a smaller study of susceptibility to tuberculosis in a South African Coloured population, but entirely in keeping with the previously observed protective effect of the -336G allele. Conclusion. This study finds that the CD209-336G variant allele is associated with significant protection against tuberculosis in individuals from sub-Saharan Africa and, furthermore, cases with -336GG were significantly less likely to develop tuberculosis-induced lung cavitation. Previous in vitro work demonstrated that the promoter variant -336G allele causes down-regulation of CD209 mRNA expression. Our present work suggests that decreased levels of the DC-SIGN receptor may therefore be protective against both clinical tuberculosis in general and cavitory tuberculosis disease in particular. This is consistent with evidence that Mycobacteria can utilize DC-SIGN binding to suppress the protective pro-inflammatory immune response.	[Vannberg, Fredrik O.; Chapman, Stephen J.; Khor, Chiea C.; Tosh, Kerrie; Hill, Adrian V. S.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Floyd, Sian; Crampin, Amelia; Fine, Paul] London Sch Hyg & Trop Med, London, England; [Jackson-Sillah, Dolly; McAdam, Keith P. W. J.; Lienhardt, Christian; Sirugo, Giorgio] MRC Labs, Fajara, Gambia; [Crampin, Amelia; Sichali, Lifted] Karonga Prevent Study, Chilumba, Malawi; [Bah, Boubacar; Bah-Sow, Oumou] Univ Ignace Deen, Conakry, Guinea; [Gustafson, Per; Aaby, Peter] Bandim Hlth Project, Bissau, Guinea Bissau; [Lienhardt, Christian] Inst Rech Dev IRD, UMR 145, Dakar, Senegal	University of Oxford; Wellcome Centre for Human Genetics; University of London; London School of Hygiene & Tropical Medicine; MRC Laboratory Molecular Biology; Malawi Epidemiology and Intervention Research Unit	Vannberg, FO (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England.	fredrik.vannberg@well.ox.ac.uk	Lienhardt, Christian/AAU-4969-2021; Sirugo, Giorgio/N-9056-2019; Sirugo, Giorgio/L-1628-2016	Lienhardt, Christian/0000-0003-0233-893X; Crampin, Amelia/0000-0002-1513-4330; Aaby, Peter/0000-0001-8331-1389; Khor, Chiea Chuen/0000-0002-1128-4729	EU GenoSept; UK Overseas Research Student Scheme; Wellcome Trust [Clinical Research Fellow, Principal Fellow, IC18CT980375]; Agency for Science, Technology and Research (A-STAR), Singapore; EU	EU GenoSept; UK Overseas Research Student Scheme; Wellcome Trust(Wellcome Trust); Agency for Science, Technology and Research (A-STAR), Singapore(Agency for Science Technology & Research (A*STAR)); EU(European Commission)	FOV is supported by the EU GenoSept Grant and the UK Overseas Research Student Scheme. SJC is a Wellcome Trust Clinical Research Fellow; AVSH is a Wellcome Trust Principal Fellow. CCK is a scholar of the Agency for Science, Technology and Research (A-STAR), Singapore and member of the MBBS-PhD programme, Faculty of Medicine, National University of Singapore. The tuberculosis samples were collected as part of an EU-funded project (contract number IC18CT980375). This work was funded by the Wellcome Trust.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Appelmelk BJ, 2003, J IMMUNOL, V170, P1635, DOI 10.4049/jimmunol.170.4.1635; Barreiro LB, 2006, PLOS MED, V3, P230, DOI 10.1371/journal.pmed.0030020; Barreiro LB, 2006, HUM IMMUNOL, V67, P102, DOI 10.1016/j.humimm.2006.02.028; Bellamy R, 1998, NEW ENGL J MED, V338, P640, DOI 10.1056/NEJM199803053381002; Bennett S, 2002, AM J EPIDEMIOL, V155, P1074, DOI 10.1093/aje/155.11.1074; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Colmenares M, 2002, J BIOL CHEM, V277, P36766, DOI 10.1074/jbc.M205270200; COMSTOCK GW, 1978, AM REV RESPIR DIS, V117, P621; Condos R, 1998, AM J RESP CRIT CARE, V157, P729, DOI 10.1164/ajrccm.157.3.9705044; Cooke GS, 2001, NAT REV GENET, V2, P967, DOI 10.1038/35103577; Doffinger R, 2002, MOL IMMUNOL, V38, P903, DOI 10.1016/S0161-5890(02)00017-2; Fitness J, 2004, AM J TROP MED HYG, V71, P341, DOI 10.4269/ajtmh.2004.71.341; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Frieden TR, 2003, LANCET, V362, P887, DOI 10.1016/S0140-6736(03)14333-4; Geijtenbeek TBH, 2003, J EXP MED, V197, P7, DOI 10.1084/jem.20021229; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Geijtenbeek TBH, 2000, CELL, V100, P575, DOI 10.1016/S0092-8674(00)80693-5; Geijtenbeek TBH, 2000, NAT IMMUNOL, V1, P353, DOI 10.1038/79815; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Koppel EA, 2004, IMMUNOBIOLOGY, V209, P117, DOI 10.1016/j.imbio.2004.03.003; Lienhardt C, 2002, AM J EPIDEMIOL, V155, P1066, DOI 10.1093/aje/155.11.1066; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; Martin MP, 2004, J VIROL, V78, P14053, DOI 10.1128/JVI.78.24.14053-14056.2004; Mazzarella G, 2003, CLIN EXP IMMUNOL, V132, P283, DOI 10.1046/j.1365-2249.2003.02121.x; Pohlmann S, 2003, J VIROL, V77, P4070, DOI 10.1128/JVI.77.7.4070-4080.2003; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550; Soilleux EJ, 2006, J PATHOL, V209, P182, DOI 10.1002/path.1972; Soilleux EJ, 2002, J LEUKOCYTE BIOL, V71, P445; Soilleux EJ, 2000, J IMMUNOL, V165, P2937, DOI 10.4049/jimmunol.165.6.2937; STEAD WW, 1990, NEW ENGL J MED, V322, P422, DOI 10.1056/NEJM199002153220702; Storm Niels, 2003, Methods Mol Biol, V212, P241; Tailleux L, 2005, PLOS MED, V2, P1269, DOI 10.1371/journal.pmed.0020381; Tailleux L, 2003, TRENDS MICROBIOL, V11, P259, DOI 10.1016/S0966-842X(03)00102-1; Tailleux L, 2003, J EXP MED, V197, P121, DOI 10.1084/jem.20021468; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Torrelles JB, 2006, J IMMUNOL, V177, P1805, DOI 10.4049/jimmunol.177.3.1805; van Crevel R, 2000, J INFECT DIS, V181, P1194, DOI 10.1086/315325; van Kooyk Y, 2004, CURR OPIN IMMUNOL, V16, P488, DOI 10.1016/j.coi.2004.05.010; van Kooyk Y, 2003, TRENDS MOL MED, V9, P153, DOI 10.1016/S1471-4914(03)00027-3; van Kooyk Y, 2003, NAT REV IMMUNOL, V3, P697, DOI 10.1038/nri1182; 2003, WKLY EPIDEMIOL REC, V78, P122	44	84	90	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 2	2008	3	1							e1388	10.1371/journal.pone.0001388	http://dx.doi.org/10.1371/journal.pone.0001388			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	366GP	18167547	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000260468900016
J	Miller, WG; Parker, CT; Rubenfield, M; Mendz, GL; Wosten, MMSM; Ussery, DW; Stolz, JF; Binnewies, TT; Hallin, PF; Wang, GL; Malek, JA; Rogosin, A; Stanker, LH; Mandrell, RE				Miller, William G.; Parker, Craig T.; Rubenfield, Marc; Mendz, George L.; Woesten, Marc M. S. M.; Ussery, David W.; Stolz, John F.; Binnewies, Tim T.; Hallin, Peter F.; Wang, Guilin; Malek, Joel A.; Rogosin, Andrea; Stanker, Larry H.; Mandrell, Robert E.			The Complete Genome Sequence and Analysis of the Epsilonproteobacterium Arcobacter butzleri	PLOS ONE			English	Article							CAMPYLOBACTER-JEJUNI; ESCHERICHIA-COLI; VIBRIO-CHOLERAE; SP-NOV.; COASTAL ENVIRONMENT; AMINE DEHYDROGENASE; NUCLEOTIDE-SEQUENCE; SULFUR OXIDATION; MISMATCH REPAIR; COMB-NOV	Background. Arcobacter butzleri is a member of the epsilon subdivision of the Proteobacteria and a close taxonomic relative of established pathogens, such as Campylobacter jejuni and Helicobacter pylori. Here we present the complete genome sequence of the human clinical isolate, A. butzleri strain RM4018. Methodology/Principal Findings. Arcobacter butzleri is a member of the Campylobacteraceae, but the majority of its proteome is most similar to those of Sulfuromonas denitrificans and Wolinella succinogenes, both members of the Helicobacteraceae, and those of the deep-sea vent Epsilonproteobacteria Sulfurovum and Nitratiruptor. In addition, many of the genes and pathways described here, e.g. those involved in signal transduction and sulfur metabolism, have been identified previously within the epsilon subdivision only in S. denitrificans, W. succinogenes, Sulfurovum, and/or Nitratiruptor, or are unique to the subdivision. In addition, the analyses indicated also that a substantial proportion of the A. butzleri genome is devoted to growth and survival under diverse environmental conditions, with a large number of respiration-associated proteins, signal transduction and chemotaxis proteins and proteins involved in DNA repair and adaptation. To investigate the genomic diversity of A. butzleri strains, we constructed an A. butzleri DNA microarray comprising 2238 genes from strain RM4018. Comparative genomic indexing analysis of 12 additional A. butzleri strains identified both the core genes of A. butzleri and intraspecies hypervariable regions, where <70% of the genes were present in at least two strains. Conclusion/Significance. The presence of pathways and loci associated often with non-host-associated organisms, as well as genes associated with virulence, suggests that A. butzleri is a free-living, water-borne organism that might be classified rightfully as an emerging pathogen. The genome sequence and analyses presented in this study are an important first step in understanding the physiology and genetics of this organism, which constitutes a bridge between the environment and mammalian hosts.	[Miller, William G.; Parker, Craig T.; Wang, Guilin; Mandrell, Robert E.] ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA; [Rubenfield, Marc; Malek, Joel A.; Rogosin, Andrea] Agencourt Biosci Corp, Beverly, MA USA; [Mendz, George L.] Univ Notre Dame Australia, Broadway, NSW, Australia; [Mendz, George L.] Univ New S Wales, Sch Med, Sydney, NSW, Australia; [Woesten, Marc M. S. M.] Univ Utrecht, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Ussery, David W.; Binnewies, Tim T.; Hallin, Peter F.] Tech Univ Denmark, Ctr Biol Sequence, DK-2800 Lyngby, Denmark; [Stolz, John F.] Duquesne Univ, Dept Biol Sci, Pittsburgh, PA 15219 USA; [Stanker, Larry H.] ARS, Foodborne Contaminants Res Unit, USDA, Albany, CA USA	United States Department of Agriculture (USDA); University of Notre Dame Australia; University of New South Wales Sydney; Utrecht University; Technical University of Denmark; Duquesne University; United States Department of Agriculture (USDA)	Miller, WG (corresponding author), ARS, Produce Safety & Microbiol Res Unit, USDA, Albany, CA USA.	bmiller@pw.usda.gov	Mandrell, Robert E/O-9814-2018; Ussery, David/J-2026-2019	Ussery, David/0000-0003-3632-5512; Wosten, Marc/0000-0002-7464-7232; Parker, Craig/0000-0002-7719-8882	United States Department of Agriculture, Agricultural Research Service, CRIS [5325-42000-230-043, 5325-42000-230-045]	United States Department of Agriculture, Agricultural Research Service, CRIS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding: This work was funded by the United States Department of Agriculture, Agricultural Research Service, CRIS projects 5325-42000-230-043 and 5325-42000-230-045.	Abdelbaqi K, 2007, FEMS IMMUNOL MED MIC, V49, P337, DOI 10.1111/j.1574-695X.2006.00208.x; Adachi O, 2003, BIOSCI BIOTECH BIOCH, V67, P2115, DOI 10.1271/bbb.67.2115; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Anantharaman V, 2000, TRENDS BIOCHEM SCI, V25, P535, DOI 10.1016/S0968-0004(00)01672-8; Appia-Ayme C, 2002, BIOCHEM BIOPH RES CO, V296, P737, DOI 10.1016/S0006-291X(02)00936-1; Appia-Ayme C, 2001, J BACTERIOL, V183, P6107, DOI 10.1128/JB.183.20.6107-6118.2001; Assanta MA, 2002, J FOOD PROTECT, V65, P1240, DOI 10.4315/0362-028X-65.8.1240; Atabay HI, 2003, INT J FOOD MICROBIOL, V81, P21, DOI 10.1016/S0168-1605(02)00163-0; Atabay HI, 2001, LETT APPL MICROBIOL, V33, P430, DOI 10.1046/j.1472-765X.2001.01025.x; Baar C, 2003, P NATL ACAD SCI USA, V100, P11690, DOI 10.1073/pnas.1932838100; Bagchi A, 2006, BIOPHYS CHEM, V119, P7, DOI 10.1016/j.bpc.2005.08.011; Bayles KW, 2000, TRENDS MICROBIOL, V8, P274, DOI 10.1016/S0966-842X(00)01762-5; Berg IA, 2002, FEMS MICROBIOL LETT, V216, P49, DOI 10.1111/j.1574-6968.2002.tb11413.x; Bick JA, 2000, J BACTERIOL, V182, P135, DOI 10.1128/JB.182.1.135-142.2000; Burrows LL, 1996, MOL MICROBIOL, V22, P481, DOI 10.1046/j.1365-2958.1996.1351503.x; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Collins CI, 1996, J FOOD PROTECT, V59, P448, DOI 10.4315/0362-028X-59.5.448; Da Re S, 2006, J BACTERIOL, V188, P3073, DOI 10.1128/JB.188.8.3073-3087.2006; DEANGELIS MM, 1995, NUCLEIC ACIDS RES, V23, P4742, DOI 10.1093/nar/23.22.4742; Dhamabutra Narathorn, 1992, Journal of the Medical Association of Thailand, V75, P350; Donachie SP, 2005, INT J SYST EVOL MICR, V55, P1271, DOI 10.1099/ijs.0.63581-0; Eisen JA, 2002, P NATL ACAD SCI USA, V99, P9509, DOI 10.1073/pnas.132181499; Engberg J, 2000, J CLIN MICROBIOL, V38, P286; Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; Fera MT, 2004, APPL ENVIRON MICROB, V70, P1271, DOI 10.1128/AEM.70.3.1271-1276.2004; Forsythe SJ, 2006, WOODHEAD PUBL FOOD S, P181, DOI 10.1533/9781845691394.2.181; Fouts DE, 2005, PLOS BIOL, V3, P72, DOI 10.1371/journal.pbio.0030015; FOX JG, 1988, INFECT IMMUN, V56, P2994, DOI 10.1128/IAI.56.11.2994-2996.1988; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Friedmann S, 2006, J BACTERIOL, V188, P2646, DOI 10.1128/JB.188.7.2646-2655.2006; Friedrich CG, 2001, APPL ENVIRON MICROB, V67, P2873, DOI 10.1128/AEM.67.7.2873-2882.2001; Friedrich CG, 2000, J BACTERIOL, V182, P4677, DOI 10.1128/JB.182.17.4677-4687.2000; Gilbert M, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P219; GJERMANSEN M, 2006, FEMS MICROBIOL LETT; Glaab WE, 2005, MUTAT RES-FUND MOL M, V578, P238, DOI 10.1016/j.mrfmmm.2005.05.021; GOLDBERG MB, 1990, INFECT IMMUN, V58, P55, DOI 10.1128/IAI.58.1.55-60.1990; GOLDIE J, 1989, J CLIN MICROBIOL, V27, P2080, DOI 10.1128/JCM.27.9.2080-2082.1989; Golla SC, 2002, J FOOD PROTECT, V65, P1849, DOI 10.4315/0362-028X-65.12.1849; Grabowski A, 2005, FEMS MICROBIOL ECOL, V54, P427, DOI 10.1016/j.femsec.2005.05.007; Grimek TL, 2004, J BACTERIOL, V186, P454, DOI 10.1128/JB.186.2.454-462.2004; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; Hacisalihoglu A, 1997, MICROBIOL-UK, V143, P505, DOI 10.1099/00221287-143-2-505; Hallam SJ, 2006, PLOS BIOL, V4, P520, DOI 10.1371/journal.pbio.0040095; Hawkins TL, 1997, SCIENCE, V276, P1887, DOI 10.1126/science.276.5320.1887; Hofreuter D, 2006, INFECT IMMUN, V74, P4694, DOI 10.1128/IAI.00210-06; Houf K, 2005, INT J SYST EVOL MICR, V55, P713, DOI 10.1099/ijs.0.63103-0; Houf K, 2001, INT J FOOD MICROBIOL, V71, P189, DOI 10.1016/S0168-1605(01)00605-5; Houf K, 2000, FEMS MICROBIOL LETT, V193, P89, DOI 10.1111/j.1574-6968.2000.tb09407.x; Houf K, 2007, J MICROBIOL METH, V68, P408, DOI 10.1016/j.mimet.2006.09.020; Hughes KT, 1998, ANNU REV MICROBIOL, V52, P231, DOI 10.1146/annurev.micro.52.1.231; Hume ME, 2001, J FOOD PROTECT, V64, P645, DOI 10.4315/0362-028X-64.5.645; Ivanovsky RN, 1997, FEMS MICROBIOL LETT, V153, P399, DOI 10.1016/S0378-1097(97)00280-2; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; JACOB J, 1993, ZBL HYG UMWELTMED, V193, P557; Jacob J, 1998, ZBL HYG UMWELTMED, V201, P189; Jin SM, 2001, MOL MICROBIOL, V39, P1225, DOI 10.1046/j.1365-2958.2001.02294.x; Johnson JR, 2005, INFECT IMMUN, V73, P965, DOI 10.1128/IAI.73.2.965-971.2005; Johnson LG, 2002, J FOOD PROTECT, V65, P1789, DOI 10.4315/0362-028X-65.11.1789; Kaniuk NA, 2002, MOL MICROBIOL, V46, P1305, DOI 10.1046/j.1365-2958.2002.03243.x; Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x; Kazmierczak MJ, 2005, MICROBIOL MOL BIOL R, V69, P527, DOI 10.1128/MMBR.69.4.527-543.2005; KIEHLBAUCH JA, 1991, J CLIN MICROBIOL, V29, P376, DOI 10.1128/JCM.29.2.376-385.1991; Korolik V, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P349; KREDICH NM, 1996, ESCHERICHIA COLI SAL, V2, P514; Larsen NA, 2006, BIOCHEMISTRY-US, V45, P10184, DOI 10.1021/bi060950i; LASTOVICA AJ, 2000, CAMPYLOBACTER, P89; Lau SKP, 2002, J CLIN PATHOL-MOL PA, V55, P182, DOI 10.1136/mp.55.3.182; LERNER J, 1994, EUR J CLIN MICROBIOL, V13, P660, DOI 10.1007/BF01973994; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Malik HS, 2000, TRENDS BIOCHEM SCI, V25, P414, DOI 10.1016/S0968-0004(00)01623-6; Mandrell RE, 2006, WOODHEAD PUBL FOOD S, P476, DOI 10.1533/9781845691394.2.476; Manke TR, 1998, J FOOD PROTECT, V61, P1623, DOI 10.4315/0362-028X-61.12.1623; Marshall B.J., 2001, HELICOBACTER PYLORI; MARTINUSSEN J, 1994, J BACTERIOL, V176, P6457, DOI 10.1128/JB.176.21.6457-6463.1994; Maugeri TL, 2005, NEW MICROBIOL, V28, P177; Maugeri TL, 2000, MICROBIOLOGICA, V23, P143; MCCLUNG CR, 1983, INT J SYST BACTERIOL, V33, P605, DOI 10.1099/00207713-33-3-605; McGarvey JA, 2005, J APPL MICROBIOL, V99, P867, DOI 10.1111/j.1365-2672.2005.02662.x; Miller WG, 2005, MICROBIOL-SGM, V151, P337, DOI 10.1099/mic.0.27327-0; Morgan GJ, 2002, J MOL BIOL, V317, P337, DOI 10.1006/jmbi.2002.5437; MOUSSARD H, 2006, E PACIFIC RISE; Naganuma Takeshi, 1997, Journal of Oceanography, V53, P193; Nakagawa S, 2007, P NATL ACAD SCI USA, V104, P12146, DOI 10.1073/pnas.0700687104; NEILL SD, 1985, INT J SYST BACTERIOL, V35, P342, DOI 10.1099/00207713-35-3-342; NEUWALD AF, 1992, J BACTERIOL, V174, P415, DOI 10.1128/jb.174.2.415-425.1992; Niehus E, 2004, MOL MICROBIOL, V52, P947, DOI 10.1111/j.1365-2958.2004.04006.x; Oh JD, 2006, P NATL ACAD SCI USA, V103, P9999, DOI 10.1073/pnas.0603784103; Ono K, 2006, J BIOL CHEM, V281, P13672, DOI 10.1074/jbc.M600029200; OSHEA TM, 2006, J BACTERIOL; Parker CT, 2006, J CLIN MICROBIOL, V44, P4125, DOI 10.1128/JCM.01231-06; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; Parkhill J, 2000, NATURE, V403, P665, DOI 10.1038/35001088; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Pearson BM, 2007, J BACTERIOL, V189, P8402, DOI 10.1128/JB.01404-07; PEI ZH, 1993, J BIOL CHEM, V268, P18717; Pickett CL, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P385; Pin C, 2006, APPL MICROBIOL BIOT, V72, P852, DOI 10.1007/s00253-006-0536-x; PRABAGARAN SR, 2006, FEMS MICROBIOL ECOL; Prouzet-Mauleon V, 2006, EMERG INFECT DIS, V12, P307; Rice EW, 1999, LETT APPL MICROBIOL, V28, P31, DOI 10.1046/j.1365-2672.1999.00483.x; Rivas L, 2004, INT J FOOD MICROBIOL, V91, P31, DOI 10.1016/S0168-1605(03)00328-3; Rojas CM, 2002, P NATL ACAD SCI USA, V99, P13142, DOI 10.1073/pnas.202358699; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Ruiz J, 2003, J ANTIMICROB CHEMOTH, V51, P1109, DOI 10.1093/jac/dkg222; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SANDSTEDT K, 1983, CURR MICROBIOL, V8, P209, DOI 10.1007/BF01579548; Skirrow M.B., 2000, CAMPYLOBACTER, V2nd ed., P69; Snaidr J, 1997, APPL ENVIRON MICROB, V63, P2884, DOI 10.1128/AEM.63.7.2884-2896.1997; Sourjik V, 2000, J BACTERIOL, V182, P782, DOI 10.1128/JB.182.3.782-788.2000; Stampi S, 1999, ZBL HYG UMWELTMED, V202, P19, DOI 10.1016/S0934-8859(99)80048-0; Stoeva K, 2006, FEMS MICROBIOL LETT, V256, P290, DOI 10.1111/j.1574-6968.2006.00135.x; Suerbaum S, 2003, P NATL ACAD SCI USA, V100, P7901, DOI 10.1073/pnas.1332093100; Summer EJ, 2004, J MOL BIOL, V340, P49, DOI 10.1016/j.jmb.2004.04.053; Szurmant L, 2004, MICROBIOL MOL BIOL R, V68, P301, DOI 10.1128/MMBR.68.2.301-319.2004; Takagi K, 1999, BIOCHEMISTRY-US, V38, P6935, DOI 10.1021/bi9828268; Takagi K, 2001, EUR J BIOCHEM, V268, P470, DOI 10.1046/j.1432-1033.2001.01912.x; Takai K, 2006, INT J SYST EVOL MICR, V56, P1725, DOI 10.1099/ijs.0.64255-0; Taylor DE, 2005, CAMPYLOBACTER: MOLECULAR AND CELLULAR BIOLOGY, P193; TAYLOR DN, 1991, J INFECT DIS, V163, P1062, DOI 10.1093/infdis/163.5.1062; Thamdrup B, 2000, APPL ENVIRON MICROB, V66, P2888, DOI 10.1128/AEM.66.7.2888-2897.2000; Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; TSANG N, 1973, SCIENCE, V181, P60, DOI 10.1126/science.181.4094.60; Valdes J, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-51; Van Driessche E, 2003, FEMS MICROBIOL LETT, V229, P243, DOI 10.1016/S0378-1097(03)00840-1; VANDAMME P, 1992, J CLIN MICROBIOL, V30, P2335, DOI 10.1128/JCM.30.9.2335-2337.1992; VANDAMME P, 1992, INT J SYST BACTERIOL, V42, P344, DOI 10.1099/00207713-42-3-344; Vandamme P., 2000, CAMPYLOBACTER, P3; Vandenberg O, 2004, EMERG INFECT DIS, V10, P1863, DOI 10.3201/eid1010.040241; Vandenberghe I, 2001, J BIOL CHEM, V276, P42923, DOI 10.1074/jbc.M107164200; Viswanathan M, 1999, J BIOL CHEM, V274, P30094, DOI 10.1074/jbc.274.42.30094; Viswanathan M, 1998, GENETICS, V149, P7; Wesley IV, 2000, APPL ENVIRON MICROB, V66, P1994, DOI 10.1128/AEM.66.5.1994-2000.2000; Williams SJ, 2002, J BIOL CHEM, V277, P32606, DOI 10.1074/jbc.M204613200; Wirsen CO, 2002, APPL ENVIRON MICROB, V68, P316, DOI 10.1128/AEM.68.1.316-325.2002; Wodara C, 1997, J BACTERIOL, V179, P5014, DOI 10.1128/jb.179.16.5014-5023.1997; Wosten MMSM, 2004, J BIOL CHEM, V279, P16214, DOI 10.1074/jbc.M400357200; Yan JJ, 2000, J FORMOS MED ASSOC, V99, P166; YOSHIDA H, 1990, J BACTERIOL, V172, P6942, DOI 10.1128/jb.172.12.6942-6949.1990; ZOOMABLE ARCOBACTER; BASYS BACTERIAL ANNO; ARTEMIS RELEASE 8 0; TRNASCAN SE V 1 23	146	164	395	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 26	2007	2	12							e1358	10.1371/journal.pone.0001358	http://dx.doi.org/10.1371/journal.pone.0001358			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JG	18159241	Green Submitted, gold, Green Published			2022-12-25	WOS:000207459700015
J	Breen, RAM; Hardy, GAD; Perrin, FMR; Lear, S; Kinloch, S; Smith, CJ; Cropley, I; Janossy, G; Lipman, MCI				Breen, Ronan A. M.; Hardy, Gareth A. D.; Perrin, Felicity M. R.; Lear, Sara; Kinloch, Sabine; Smith, Colette J.; Cropley, Ian; Janossy, George; Lipman, Marc C. I.			Rapid Diagnosis of Smear-Negative Tuberculosis Using Immunology and Microbiology with Induced Sputum in HIV-Infected and Uninfected Individuals	PLOS ONE			English	Article								Rationale and Objectives. Blood-based studies have demonstrated the potential of immunological assays to detect tuberculosis. However lung fluid sampling may prove superior as it enables simultaneous microbiological detection of mycobacteria to be performed. Until now this has only been possible using the expensive and invasive technique of broncho-alveolar lavage. We sought to evaluate an immunoassay using non-invasive induced-sputum to diagnose active tuberculosis. Methods and Results. Prospective cohort study of forty-two spontaneous sputum smear-negative or sputum non-producing adults under investigation for tuberculosis. CD4 lymphocytes specific to purified-protein-derivative of Mycobacterium tuberculosis actively synthesising interferon-gamma were measured by flow cytometry and final diagnosis compared to immunoassay using a cut-off of 0.5%. Sixteen subjects (38%) were HIV-infected (median CD4 count [range] = 332 cells/mu l [103748]). Thirty-eight (90%) were BCG-vaccinated. In 27 subjects diagnosed with active tuberculosis, the median [range] percentage of interferon-gamma synthetic CD4+ lymphocytes was 2.77% [0-23.93%] versus 0% [0-2.10%] in 15 negative for active infection (p<0.0001). Sensitivity and specificity of the immunoassay versus final diagnosis of active tuberculosis were 89% (24 of 27) and 80% (12 of 15) respectively. The 3 positive assays in the latter group occurred in subjects diagnosed with quiescent/latent tuberculosis. Assay performance was unaffected by HIV-status, BCG-vaccination or disease site. Combining this approach with traditional microbiological methods increased the diagnostic yield to 93% (25 of 27) alongside acid-fast bacilli smear and 96% (26 of 27) alongside tuberculosis culture. Conclusions. These data demonstrate for the first time that a rapid immunological assay to diagnose active tuberculosis can be performed successfully in combination with microbiological methods on a single induced-sputum sample.	[Breen, Ronan A. M.; Hardy, Gareth A. D.; Lear, Sara; Kinloch, Sabine; Janossy, George] Royal Free & Univ Coll Med Sch, Dept Immunol, London WC1E 6BT, England; [Breen, Ronan A. M.; Perrin, Felicity M. R.; Kinloch, Sabine; Cropley, Ian; Lipman, Marc C. I.] Royal Free Hosp, Dept Thorac, London NW3 2QG, England; [Breen, Ronan A. M.; Perrin, Felicity M. R.; Kinloch, Sabine; Cropley, Ian; Lipman, Marc C. I.] Royal Free Hosp, Dept HIV Med, London NW3 2QG, England; [Smith, Colette J.] Royal Free & Univ Coll Med Sch, Dept Primary Care & Populat Sci, London WC1E 6BT, England; [Perrin, Felicity M. R.] Royal Free & Univ Coll Med Sch, Ctr Med Microbiol, London WC1E 6BT, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of London; University College London	Breen, RAM (corresponding author), Royal Free & Univ Coll Med Sch, Dept Immunol, London WC1E 6BT, England.	ronan.breen@gstt.nhs.uk	Abrams, William R/A-5782-2008	Lipman, Marc/0000-0001-7501-4448; Smith, Colette/0000-0003-2847-3355	Henry Smith Charity	Henry Smith Charity	RAMB and MCIL are in a receipt of a grant from the Henry Smith Charity. The Charity had no role in the execution of this study or production of the manuscript.	Barry SM, 2004, J IMMUNOL METHODS, V285, P15, DOI 10.1016/j.jim.2003.10.016; Barry SM, 2003, J INFECT DIS, V187, P243, DOI 10.1086/346112; BREEN RA, 2007, THORAX; Breen RAM, 2006, AIDS, V20, P1330, DOI 10.1097/01.aids.0000232243.51286.32; Brock L, 2004, AM J RESP CRIT CARE, V170, P65, DOI 10.1164/rccm.200402-232OC; Brown M, 2007, CLIN INFECT DIS, V44, P1415, DOI 10.1086/516782; Conde MB, 2000, AM J RESP CRIT CARE, V162, P2238, DOI 10.1164/ajrccm.162.6.2003125; Dewan PK, 2007, CLIN INFECT DIS, V44, P69, DOI 10.1086/509928; Ewer K, 2003, LANCET, V361, P1168, DOI 10.1016/S0140-6736(03)12950-9; Fireman E, 1999, RESP MED, V93, P827, DOI 10.1016/S0954-6111(99)90269-X; Harboe M, 1996, INFECT IMMUN, V64, P16, DOI 10.1128/IAI.64.1.16-22.1996; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Hoft DF, 2000, CLIN INFECT DIS, V30, pS217, DOI 10.1086/313864; Jafari C, 2006, AM J RESP CRIT CARE, V174, P1048, DOI 10.1164/rccm.200604-465OC; Kang YA, 2007, CHEST, V132, P959, DOI 10.1378/chest.06-2805; Keeler Emmett, 2006, Nature, V444 Suppl 1, P49, DOI 10.1038/nature05446; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Liebeschuetz S, 2004, LANCET, V364, P2196, DOI 10.1016/S0140-6736(04)17592-2; Mazurek GH, 2007, CLIN INFECT DIS, V45, P837, DOI 10.1086/521107; McWilliams T, 2002, THORAX, V57, P1010, DOI 10.1136/thorax.57.12.1010; Menzies D, 2007, ANN INTERN MED, V146, P340, DOI 10.7326/0003-4819-146-5-200703060-00006; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Pai M, 2004, LANCET INFECT DIS, V4, P761, DOI 10.1016/S1473-3099(04)01206-X; Pai M, 2007, CLIN INFECT DIS, V44, P74, DOI 10.1086/509927; Perrin FMR, 2007, LANCET INFECT DIS, V7, P481, DOI 10.1016/S1473-3099(07)70112-3; Rangaka MX, 2007, AM J RESP CRIT CARE, V175, P514, DOI 10.1164/rccm.200610-1439OC; Raviglione M, 2006, INT J TUBERC LUNG D, V10, P1185; Schwander SK, 1998, J INFECT DIS, V178, P1434, DOI 10.1086/314454; Schwander SK, 2000, J IMMUNOL, V165, P1479, DOI 10.4049/jimmunol.165.3.1479; Streitz M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000735; Zaharatos GJ, 2001, CLIN INFECT DIS, V33, pE125, DOI 10.1086/324086	31	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1335	10.1371/journal.pone.0001335	http://dx.doi.org/10.1371/journal.pone.0001335			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18092001	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459600019
J	Claudino, M; Ceolin, DS; Alberti, S; Cestari, TM; Spadella, CT; Rubira-Bullen, IRF; Garlet, GP; de Assis, GF				Claudino, Marcela; Ceolin, Danielle Santi; Alberti, Sandra; Cestari, Tania Mary; Spadella, Cesar Tadeu; Fischer Rubira-Bullen, Izabel Regina; Garlet, Gustavo Pompermaier; de Assis, Gerson Francisco			Alloxan-Induced Diabetes Triggers the Development of Periodontal Disease in Rats	PLOS ONE			English	Article								Background. Periodontal disease in diabetic patients presents higher severity and prevalence; and increased severity of ligature-induced periodontal disease has been verified in diabetic rats. However, in absence of aggressive stimuli such as ligatures, the influence of diabetes on rat periodontal tissues is incompletely explored. The aim of this study was to evaluate the establishment and progression of periodontal diseases in rats only with diabetes induction. Methodology/Principal Findings. Diabetes was induced in Wistar rats (n = 25) by intravenous administration of alloxan (42 mg/kg) and were analyzed at 1, 3, 6, 9 and 12 months after diabetes induction. The hemimandibles were removed and submitted to radiographical and histopathological procedures. A significant reduction was observed in height of bone crest in diabetic animals at 3, 6, 9 and 12 months, which was associated with increased numbers of osteoclasts and inflammatory cells. The histopathological analyses of diabetic rats also showed a reduction in density of collagen fibers, fibroblasts and blood vessels. Severe caries were also detected in the diabetic group. Conclusions/Significance. The results demonstrate that diabetes induction triggers, or even co-induces the onset of alterations which are typical of periodontal diseases even in the absence of aggressive factors such as ligatures. Therefore, diabetes induction renders a previously resistant host into a susceptible phenotype, and hence diabetes can be considered a very important risk factor to the development of periodontal disease.	[Claudino, Marcela; Ceolin, Danielle Santi; Cestari, Tania Mary; Garlet, Gustavo Pompermaier; de Assis, Gerson Francisco] Univ Sao Paulo, Dept Biol Sci, Sch Dent Bauru, Sao Paulo, Brazil; [Fischer Rubira-Bullen, Izabel Regina] Univ Sao Paulo, Dept Stomatol, Sch Dent Bauru, Sao Paulo, Brazil; [Alberti, Sandra; Spadella, Cesar Tadeu] Sao Paulo State Univ, Sch Med Botucatu, Dept Surg & Orthoped, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual Paulista	de Assis, GF (corresponding author), Univ Sao Paulo, Dept Biol Sci, Sch Dent Bauru, Sao Paulo, Brazil.	gfassis@fob.usp.br	Spadella, César/C-3442-2009; Assis, Gerson Francisco/E-5871-2012; Garlet, Gustavo Pompermaier/E-6762-2012; Rubira-Bullen, Izabel R. F./A-8537-2008; Cestari, Tania Mary/E-7060-2012	Assis, Gerson Francisco/0000-0001-8225-3164; Garlet, Gustavo Pompermaier/0000-0002-5071-8382; Rubira-Bullen, Izabel R. F./0000-0002-5069-9433; Cestari, Tania Mary/0000-0003-1287-5974				Alpagot T, 2001, J PERIODONTAL RES, V36, P169, DOI 10.1034/j.1600-0765.2001.360305.x; Anderson JLR, 2006, MOL BIOSYST, V2, P350, DOI 10.1039/b607813c; BARNETT ML, 1984, J PERIODONTOL, V55, P402, DOI 10.1902/jop.1984.55.7.402; BENVENIS.R, 1967, J PERIODONTOL, V38, P271, DOI 10.1902/jop.1967.38.4.271; Chung AWY, 2006, CIRC RES, V99, P140, DOI 10.1161/01.RES.0000232352.90786.fa; Engebretson SP, 2004, J PERIODONTOL, V75, P1203, DOI 10.1902/jop.2004.75.9.1203; Garlet GP, 2006, ORAL MICROBIOL IMMUN, V21, P12, DOI 10.1111/j.1399-302X.2005.00245.x; Garlet GP, 2005, MICROBES INFECT, V7, P738, DOI 10.1016/j.micinf.2005.01.012; Genco R.J., 1998, COMP CONT ED DENT, V19, P40; GOLUB LM, 1978, J DENT RES, V57, P520, DOI 10.1177/00220345780570032101; Golub LM, 2006, J DENT RES, V85, P102, DOI 10.1177/154405910608500201; Graves DT, 2006, J DENT RES, V85, P15, DOI 10.1177/154405910608500103; Graves DT, 2005, J DENT RES, V84, P324, DOI 10.1177/154405910508400406; Holzhausen M, 2004, J PERIODONTAL RES, V39, P188, DOI 10.1111/j.1600-0765.2004.00723.x; JOHNSON RB, 1992, J PERIODONTAL RES, V27, P40, DOI 10.1111/j.1600-0765.1992.tb02084.x; Kusuyama T, 2006, J PHARMACOL SCI, V102, P96, DOI 10.1254/jphs.FP0060256; Lalla E, 1998, Ann Periodontol, V3, P13, DOI 10.1902/annals.1998.3.1.13; Lalla E, 2000, J CLIN INVEST, V105, P1117, DOI 10.1172/JCI8942; Lalla E, 1998, J PERIODONTAL RES, V33, P387; Liu R, 2006, J DENT RES, V85, P510, DOI 10.1177/154405910608500606; Liu RK, 2004, ENDOCRINOLOGY, V145, P2997, DOI 10.1210/en.2003-1601; LOE H, 1993, DIABETES CARE, V16, P329, DOI 10.2337/diacare.16.1.329; Mahay S, 2004, MOL CELL BIOCHEM, V261, P175, DOI 10.1023/B:MCBI.0000028753.33225.68; Mata AD, 2004, MOL CELL BIOCHEM, V261, P137, DOI 10.1023/B:MCBI.0000028748.40917.6f; Miley DD, 2005, QUINTESSENCE INT, V36, P779; Miralles Lucia, 2006, Med Oral Patol Oral Cir Bucal, V11, pE256; Moore PA, 2001, ORAL SURG ORAL MED O, V92, P281, DOI 10.1067/moe.2001.117815; Nagasawa T, 2007, PERIODONTOL 2000, V43, P65, DOI 10.1111/j.1600-0757.2006.00185.x; Naguib G, 2004, J INVEST DERMATOL, V123, P87, DOI 10.1111/j.0022-202X.2004.22711.x; Ogasawara T, 2004, J PERIODONTAL RES, V39, P42, DOI 10.1111/j.1600-0765.2004.00699.x; OLIVER RC, 1994, J PERIODONTOL, V65, P530, DOI 10.1902/jop.1994.65.5s.530; Pucher Jeffery J, 2002, J Calif Dent Assoc, V30, P312; RAMAMURTHY NS, 1983, J PERIODONTAL RES, V18, P23, DOI 10.1111/j.1600-0765.1983.tb00331.x; RAMAMURTHY NS, 1974, J PERIODONTAL RES, V9, P199, DOI 10.1111/j.1600-0765.1974.tb00673.x; REUTERVING CO, 1986, J DENT RES, V65, P689, DOI 10.1177/00220345860650051201; RUSSELL BG, 1966, ACTA PATHOL MIC SC, V68, P161, DOI 10.1111/apm.1966.68.2.161; SAFKANSEPPALA B, 1992, J CLIN PERIODONTOL, V19, P24, DOI 10.1111/j.1600-051X.1992.tb01144.x; Salvi G E, 1998, Ann Periodontol, V3, P40, DOI 10.1902/annals.1998.3.1.40; Salvi GE, 2005, J CLIN PERIODONTOL, V32, P310, DOI 10.1111/j.1600-051X.2005.00682.x; Seppala B, 1997, J PERIODONTOL, V68, P1237, DOI 10.1902/jop.1997.68.12.1237; Shoji T, 2006, DIABETES, V55, P2245, DOI 10.2337/db05-1375; Siudikiene J, 2006, EUR J ORAL SCI, V114, P8, DOI 10.1111/j.1600-0722.2006.00277.x; Soskolne W A, 2001, Ann Periodontol, V6, P91, DOI 10.1902/annals.2001.6.1.91; STALLARD RE, 1970, J PERIODONTOL, V41, P620, DOI 10.1902/jop.1970.41.11.620	44	30	31	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1320	10.1371/journal.pone.0001320	http://dx.doi.org/10.1371/journal.pone.0001320			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091993	Green Published, gold, Green Submitted			2022-12-25	WOS:000207459600008
J	Haas-Stapleton, EJ; Lu, Y; Hong, S; Arita, M; Favoreto, S; Nigam, S; Serhan, CN; Agabian, N				Haas-Stapleton, Eric J.; Lu, Yan; Hong, Song; Arita, Makoto; Favoreto, Silvio; Nigam, Santosh; Serhan, Charles N.; Agabian, Nina			Candida albicans Modulates Host Defense by Biosynthesizing the Pro-Resolving Mediator Resolvin E1	PLOS ONE			English	Article								Candida albicans is an opportunistic fungal pathogen of humans that resides commensally on epithelial surfaces, but can cause inflammation when pathogenic. Resolvins are a class of anti-inflammatory lipids derived from omega-3 polyunsaturated fatty acids (PUFA) that attenuate neutrophil migration during the resolution phase of inflammation. In this report we demonstrate that C. albicans biosynthesizes resolvins that are chemically identical to those produced by human cells. In contrast to the trans-cellular biosynthesis of human Resolvin E1 (RvE1), RvE1 biosynthesis in C. albicans occurs in the absence of other cellular partners. C. albicans biosynthesis of RvE1 is sensitive to lipoxygenase and cytochrome P450 monoxygenase inhibitors. We show that 10nM RvE1 reduces neutrophil chemotaxis in response to IL-8; 1nM RvE1 enhanced phagocytosis of Candida by human neutrophils, as well as intracellular ROS generation and killing, while having no direct affect on neutrophil motility. In a mouse model of systemic candidiasis, RvE1 stimulated clearance of the fungus from circulating blood. These results reveal an inter-species chemical signaling system that modulates host immune functions and may play a role in balancing host carriage of commensal and pathogenic C. albicans.	[Haas-Stapleton, Eric J.; Favoreto, Silvio; Agabian, Nina] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Lu, Yan; Hong, Song; Arita, Makoto; Serhan, Charles N.] Harvard Univ, Sch Dent Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Brigham &, Boston, MA 02115 USA; [Lu, Yan; Hong, Song; Arita, Makoto; Serhan, Charles N.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lu, Yan; Hong, Song; Arita, Makoto; Serhan, Charles N.] Harvard Univ, Sch Dent Med, Dept Oral Med Infect & Immun, Boston, MA 02115 USA; [Nigam, Santosh] Charite, Ctr Benjamin Franklin, Eicosanoid & Lipid Res Div, Ctr Expt Gynecol & Breast Res, D-13353 Berlin, Germany	University of California System; University of California San Francisco; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School; Harvard University; Harvard School of Dental Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Agabian, N (corresponding author), Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA.	agabian@itsa.ucsf.edu		Arita, Makoto/0000-0001-9902-0463	University-wide AIDS Research Projects [F04-SF-211 to EHS]; National Institutes of Health [R21 DE15290, PO1 DE0794, GM38765, DK074448, P50-DE01619]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [P01DE007946, R21DE015290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074448] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM038765, R01GM038765, R29GM038765] Funding Source: NIH RePORTER	University-wide AIDS Research Projects; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The present work in Nina Agabian's laboratory is supported in part by University-wide AIDS Research Projects postdoctoral fellowship F04-SF-211 to EHS and by NIH/NIDCR grants R21 DE15290 and PO1 DE07946 to NA from the National Institutes of Health. The present work in Charles Serhan's laboratory is supported in part by NIH Grants GM38765, DK074448 and P50-DE01619.	Ali A, 2006, ORAL MICROBIOL IMMUN, V21, P223, DOI 10.1111/j.1399-302X.2006.00280.x; Arita M, 2005, BIOCHEM BIOPH RES CO, V338, P149, DOI 10.1016/j.bbrc.2005.07.181; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arita M, 2007, J IMMUNOL, V178, P3912, DOI 10.4049/jimmunol.178.6.3912; Busetto S, 2004, CYTOM PART A, V58A, P201, DOI 10.1002/cyto.a.20014; Chiang N, 2006, METH MOL B, V341, P227; CREELMAN RA, 1997, BIOSYNTHESIS, V48, P355; Decleva E, 2006, J LEUKOCYTE BIOL, V79, P87, DOI 10.1189/jlb.0605338; Erb-Downward JR, 2007, INFECT IMMUN, V75, P3498, DOI 10.1128/IAI.00232-07; Erb-Downward JR, 2007, EUKARYOT CELL, V6, P346, DOI 10.1128/EC.00336-06; Fidel P L Jr, 2006, Adv Dent Res, V19, P80; Fidel PL, 2004, INFECT IMMUN, V72, P2939, DOI 10.1128/IAI.72.5.2939-2946.2004; Fidel PL, 2002, ORAL DIS, V8, P69, DOI 10.1034/j.1601-0825.2002.00015.x; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hillyer P, 2003, CLIN EXP IMMUNOL, V134, P431, DOI 10.1111/j.1365-2249.2003.02323.x; Howe GA, 2002, CURR OPIN PLANT BIOL, V5, P230, DOI 10.1016/S1369-5266(02)00250-9; Hugel B, 2005, PHYSIOLOGY, V20, P22, DOI 10.1152/physiol.00029.2004; Jones SA, 1996, P NATL ACAD SCI USA, V93, P6682, DOI 10.1073/pnas.93.13.6682; Jones T, 2004, P NATL ACAD SCI USA, V101, P7329, DOI 10.1073/pnas.0401648101; La Camera S, 2004, IMMUNOL REV, V198, P267, DOI 10.1111/j.0105-2896.2004.0129.x; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Mavor AL, 2005, CURR DRUG TARGETS, V6, P863, DOI 10.2174/138945005774912735; Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785; Park JY, 2006, CLIN IMMUNOL, V119, P229, DOI 10.1016/j.clim.2006.01.016; Richardson MD, 2005, J ANTIMICROB CHEMOTH, V56, P5, DOI 10.1093/jac/dki218; Rotstein D, 2000, SHOCK, V14, P278, DOI 10.1097/00024382-200014030-00006; Scheel-Toellner D, 2004, BLOOD, V104, P2557, DOI 10.1182/blood-2004-01-0191; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2004, PROSTAG OTH LIPID M, V73, P155, DOI 10.1016/j.prostaglandins.2004.03.005; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shen L, 2006, IMMUNOLOGY, V117, P205, DOI 10.1111/j.1365-2567.2005.02280.x; Sheng WH, 2007, J FORMOS MED ASSOC, V106, P110, DOI 10.1016/S0929-6646(09)60226-6; Simons MP, 2005, INFECT IMMUN, V73, P1971, DOI 10.1128/IAI.73.4.1971-1977.2005; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Urban CF, 2006, CELL MICROBIOL, V8, P668, DOI 10.1111/j.1462-5822.2005.00659.x; Weerasuriya N, 2006, DIS ESOPHAGUS, V19, P189, DOI 10.1111/j.1442-2050.2006.00563.x; Zaoutis TE, 2005, CLIN INFECT DIS, V41, P1232, DOI 10.1086/496922	41	79	82	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 19	2007	2	12							e1316	10.1371/journal.pone.0001316	http://dx.doi.org/10.1371/journal.pone.0001316			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JF	18091990	Green Published, Green Submitted, gold			2022-12-25	WOS:000207459600004
J	Thorpe, JD; Duan, XB; Forrest, R; Lowe, K; Brown, L; Segal, E; Nelson, B; Anderson, GL; McIntosh, M; Urban, N				Thorpe, Jason D.; Duan, Xiaobo; Forrest, Robin; Lowe, Kimberly; Brown, Lauren; Segal, Elliot; Nelson, Brad; Anderson, Garnet L.; McIntosh, Martin; Urban, Nicole			Effects of Blood Collection Conditions on Ovarian Cancer Serum Markers	PLOS ONE			English	Article							MIGRATION INHIBITORY FACTOR; FACTOR MIF; PROLACTIN; ANGIOGENESIS; SURGERY; BINDING; PLASMA; P53	Background. Evaluating diagnostic and early detection biomarkers requires comparing serum protein concentrations among biosamples ascertained from subjects with and without cancer. Efforts are generally made to standardize blood processing and storage conditions for cases and controls, but blood sample collection conditions cannot be completely controlled. For example, blood samples from cases are often obtained from persons aware of their diagnoses, and collected after fasting or in surgery, whereas blood samples from some controls may be obtained in different conditions, such as a clinic visit. By measuring the effects of differences in collection conditions on three different markers, we investigated the potential of these effects to bias validation studies. Methodology and Principle Findings. We analyzed serum concentrations of three previously studied putative ovarian cancer serum biomarkers-CA 125, Prolactin and MIF-in healthy women, women with ovarian cancer undergoing gynecologic surgery, women undergoing surgery for benign ovary pathology, and women undergoing surgery with pathologically normal ovaries. For women undergoing surgery, a blood sample was collected either in the clinic 1 to 39 days prior to surgery, or on the day of surgery after anesthesia was administered but prior to the surgical procedure, or both. We found that one marker, prolactin, was dramatically affected by collection conditions, while CA 125 and MIF were unaffected. Prolactin levels were not different between case and control groups after accounting for the conditions of sample collection, suggesting that sample ascertainment could explain some or all of the previously reported results about its potential as a biomarker for ovarian cancer. Conclusions. Biomarker validation studies should use standardized collection conditions, use multiple control groups, and/or collect samples from cases prior to influence of diagnosis whenever feasible to detect and correct for potential biases associated with sample collection.	[Thorpe, Jason D.; Anderson, Garnet L.] Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, Seattle, WA 98104 USA; [Segal, Elliot] Onco Detectors Int LLC, Bethesda, MD USA; [Duan, Xiaobo; Nelson, Brad] BC Canc Agcy, Trev & Joyce Deeley Res Ctr, Victoria, BC, Canada	Fred Hutchinson Cancer Center; British Columbia Cancer Agency	Thorpe, JD (corresponding author), Fred Hutchinson Canc Res Ctr, Div Publ Hlth Sci, 1124 Columbia St, Seattle, WA 98104 USA.	jthorpe@fhcrc.org		Anderson, Garnet/0000-0001-5087-7837; Nelson, Brad/0000-0002-4445-5539	Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer [P50 CA83636]; Department of Defense/CDMRP [DAMD17-02-1-0691]; Canary Foundation; NATIONAL CANCER INSTITUTE [P50CA083636] Funding Source: NIH RePORTER	Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer; Department of Defense/CDMRP(United States Department of Defense); Canary Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful for generous funding from the Pacific Ovarian Cancer Research Consortium (POCRC)/SPORE in Ovarian Cancer (P50 CA83636, N.U.), the Department of Defense/CDMRP (DAMD17-02-1-0691, N.U.), and the Canary Foundation.	Andersen MR, 2003, CANCER EPIDEM BIOMAR, V12, P314; Bjorge T, 2004, BRIT J CANCER, V91, P1829, DOI 10.1038/sj.bjc.6602199; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; DAOUD E, 1991, CLIN CHEM, V37, P1968; DONNERER J, 1990, ENDOCRINOLOGY, V126, P921, DOI 10.1210/endo-126-2-921; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Gubbels JAA, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-50; HAGEN C, 1980, ACTA ENDOCRINOL-COP, V94, P151, DOI 10.1530/acta.0.0940151; Hira E, 2005, CANCER, V103, P588, DOI 10.1002/cncr.20818; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Indinnimeo M, 2001, ONCOL REP, V8, P1351; Lolis Elias, 2001, Current Opinion in Pharmacology, V1, P662, DOI 10.1016/S1471-4892(01)00112-6; Metz CE, 1998, MED DECIS MAKING, V18, P110, DOI 10.1177/0272989X9801800118; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Mor G, 2005, P NATL ACAD SCI USA, V102, P7677, DOI 10.1073/pnas.0502178102; Mujagic Z, 2004, CROAT MED J, V45, P176; Mujagic Zlata, 2005, Med Arh, V59, P33; Nevalainen MT, 1997, J CLIN INVEST, V99, P618, DOI 10.1172/JCI119204; NILOFF JM, 1986, AM J OBSTET GYNECOL, V155, P56, DOI 10.1016/0002-9378(86)90077-3; Pauler DK, 2001, CANCER EPIDEM BIOMAR, V10, P489; Pepe MS, 2001, J NATL CANCER I, V93, P1054, DOI 10.1093/jnci/93.14.1054; Pepe MS, 2005, STAT MED, V24, P3687, DOI 10.1002/sim.2431; Rosenthal AN, 2006, CLIN OBSTET GYNECOL, V49, P433, DOI 10.1097/00003081-200609000-00004; Rump A, 2004, J BIOL CHEM, V279, P9190, DOI 10.1074/jbc.M312372200; Rustin GJS, 1996, J CLIN ONCOL, V14, P1545, DOI 10.1200/JCO.1996.14.5.1545; Scholler N, 2006, CLIN CANCER RES, V12, P2117, DOI 10.1158/1078-0432.CCR-05-2007; Singh RJ, 2005, GEN RESOUR CHROM ENG, V1, P1; Skates SJ, 2003, J CLIN ONCOL S, V21, P206, DOI DOI 10.1200/JC0.2003.02.955; Team RDC, 2006, R LANG ENV STAT COMP; Tworoger SS, 2004, CANCER RES, V64, P6814, DOI 10.1158/0008-5472.CAN-04-1870; [No title captured]; [No title captured]; [No title captured]	34	44	45	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2007	2	12							e1281	10.1371/journal.pone.0001281	http://dx.doi.org/10.1371/journal.pone.0001281			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V10JD	18060075	gold, Green Submitted, Green Published			2022-12-25	WOS:000207459400028
